Citrus Sinensis ID: 001867

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000--
Protein Sequence
MELLTGMLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDASDQGSVA
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccccccccccccccccccccEEEEEccccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEcccccccccccccHHHHccccccEEEccccccccccccccccccccccccccccccEEccccccccccccccEEcccccccccccHHHHHcccccEEEcccccccccccccccccccccEEcccccccccccHHccccccccEEEcccccccccccccccccccccEEEccccEEEEcccHHHHcccccccccccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHcccccccEEccccccccccHHHHHcccccccccccccccccccHHHHHcccccccccccccccccccccccccccccEEEEccccccccccHHHHHccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccEEccccccccHHHHHcccccccEEccccccEEEEEEEccccEEEEEEEccccccccccccccccccccccccHHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccEEEccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccHHHHHHHHHccccccEEccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHcccHcccHHHHHHHHHHHHccccccccHcccccccccccccccEEEEcccccEEEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccEEEEEccccccccccHHHHHcccccEEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEEccHHHHcccHHHEEcccccccccccHHHcccccccEEEEEcccccccccHHHccccccEEEEEcccccccccccHHcccccEEEEEEEcccccccccHHHcccccEEEEEEccccccccccHHHccccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEEccHHHHccccccEEEcccccccccccHHHccccEEEEEEEcccccccccccHHHHcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEEcEcccccHHHHHHHccHccEEEcccccEEEEEEcccccEEEEEEcccccccccHccccccccccccccccccHHHHHHHHHHcHHHHHHHHHHHccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEccccccHHHHcHHHHHHHccccccccccHEEcccccEcccHEEEEEEcccccEEHHHHEHHHHHccccccccccccccHHHHHHHHHcccccHHHcccHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MELLTGMLVLVAFLlsplpslslnqegLYLERVKlslsdpdsalsswgrnprddspcswrgvecdprshsvasidlsnaniagpfpsllcrlenltFLTLFNnsinstlpddisacqnlqhldlsqnlltgtltpaladlpnlkfldltgnnfsgdipesfgrFQKLEVISLVYNLldgtipafLGNISTLKMLNlsynpflpgrippelgnltnlEILWLTECnlvgeipdSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYnnsltgdlptgwsnltSLRLLDASmndltgpipddltrlplesLNLYENrlegslpatiadspglyELRLFRNrlngtlpgdlgknsplrwvdlsnnqftgeipaslcekgELEELLMIYNSFtgqlpdglghcqsLTRVRLGynrltgkvppllwglphvyLLELTDNFLSGEISKNIAGAANLSLLIISknnlsgslpeeIGFLKSLVVLsgsenkftgslpesltnlaelgsldlhandlsgelpssvssWKKLNelnladnlfygnipedignlsVLNYLdlsnnrlsgripvglqnlklnqlnvsnnrlsgelpsLFAKEMYRnsflgnpglcgdleglcdgrgeeknrgYVWVLRSIFILAGLVFVFGLVWFYLKYRkfkngraidkskwtlmsfhklgfseyeildgldednvigsgssgKVYKVVLSNGEAVAVKKLWRGMskecesgcdvekgqvqdqvQDDGFQAEVETLGKIRHKNIVKLWcccttrdcKLLVYeympngslgdllhsckgglldwptRYKIIVDAAEglsylhhdcvpsivhrdvksnnilldgdfgarvADFGVAKvvdasgkpksmsviagscgyiapeyaytlrvneksdiYSFGVVILELVtgrlpvdpefgekDLVKWVCSTldqkgvdhvldpkldccfkEEICKVLNIgllctsplpinrpAMRRVVKLLQEVgaenrsktgkkdgklspyyhedasdqgsva
Flexible Loop (DISEMBL)
MELLTGMLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDpdsalsswgrnprddspcSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRlegslpatiadspGLYELRLFRNRLNGtlpgdlgknspLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFkngraidkskwTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETlgkirhknivklWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKvvdasgkpksmsviAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCtsplpinrpAMRRVVKLLQevgaenrsktgkkdgklspyyhedasdqgsva
Low Complexity Region (SEG)
MELLTGMLVLVAFllsplpslslNQEGLYLERVKlslsdpdsalssWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLEnltfltlfnnSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRlaklvdldlalnnlvGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAnlslliisknnlsgslPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPglcgdleglcdgrgeeKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGqvqdqvqddGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDASDQGSVA
Disordered region (IsUnstruct)
***LTGMLVLVAFLLSPLPSLSLNQEGLYLERVKL***********************WRGVEC******VASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGS*************************************SWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVE*******VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ********************************
Disordered Region (DISOPRED)
*ELLTGMLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCG*********************RSIFILAGLVFVFGLVWFYL********************FHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGC*************DGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG**KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL**********************************
Disordered Region (DISEMBL)
MELLTGMLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMS**********KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYH**********
Disordered Region (DISPRO)
MELLTGMLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWR***********************DGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG*****************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MELLTGMLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDASDQGSVA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1002	2.2.26 [Sep-21-2011]
Q9SGP2	996	Receptor-like protein kin	yes	no	0.976	0.981	0.728	0.0
P47735	999	Receptor-like protein kin	no	no	0.964	0.966	0.598	0.0
C0LGX3	993	LRR receptor-like serine/	no	no	0.929	0.937	0.456	0.0
O49545	1003	Leucine-rich repeat recep	no	no	0.887	0.886	0.411	0.0
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.919	0.919	0.398	0.0
O65440	992	Leucine-rich repeat recep	no	no	0.946	0.955	0.412	0.0
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.925	0.915	0.397	1e-180
Q9FRS6	1029	Leucine-rich repeat recep	no	no	0.957	0.931	0.385	1e-173
Q9LJM4	991	Receptor-like protein kin	no	no	0.962	0.972	0.377	1e-172
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.914	0.879	0.386	1e-170

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score = 1452 bits (3759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 719/987 (72%), Positives = 828/987 (83%), Gaps = 9/987 (0%)

Query: 21   LSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNAN 80
             SLNQ+G  L++VKLSL DPDS LSSW  N  D SPC W GV C     SV S+DLS+AN
Sbjct: 14   FSLNQDGFILQQVKLSLDDPDSYLSSWNSN--DASPCRWSGVSCAGDFSSVTSVDLSSAN 71

Query: 81   IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL 140
            +AGPFPS++CRL NL  L+L+NNSINSTLP +I+AC++LQ LDLSQNLLTG L   LAD+
Sbjct: 72   LAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADI 131

Query: 141  PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            P L  LDLTGNNFSGDIP SFG+F+ LEV+SLVYNLLDGTIP FLGNISTLKMLNLSYNP
Sbjct: 132  PTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNP 191

Query: 201  FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            F P RIPPE GNLTNLE++WLTEC+LVG+IPDSLG+L+KLVDLDLALN+LVG IP SL  
Sbjct: 192  FSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGG 251

Query: 261  LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
            L +VVQIELYNNSLTG++P    NL SLRLLDASMN LTG IPD+L R+PLESLNLYEN 
Sbjct: 252  LTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENN 311

Query: 321  LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
            LEG LPA+IA SP LYE+R+F NRL G LP DLG NSPLRW+D+S N+F+G++PA LC K
Sbjct: 312  LEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAK 371

Query: 381  GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNF 440
            GELEELL+I+NSF+G +P+ L  C+SLTR+RL YNR +G VP   WGLPHV LLEL +N 
Sbjct: 372  GELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNS 431

Query: 441  LSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
             SGEISK+I GA+NLSLLI+S N  +GSLPEEIG L +L  LS S NKF+GSLP+SL +L
Sbjct: 432  FSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSL 491

Query: 501  AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             ELG+LDLH N  SGEL S + SWKKLNELNLADN F G IP++IG+LSVLNYLDLS N 
Sbjct: 492  GELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNM 551

Query: 561  LSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGE 620
             SG+IPV LQ+LKLNQLN+S NRLSG+LP   AK+MY+NSF+GNPGLCGD++GLC    E
Sbjct: 552  FSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGDIKGLCGSENE 611

Query: 621  EKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYE 680
             K RGYVW+LRSIF+LA +V + G+ WFY KYR FK  RA+++SKWTLMSFHKLGFSE+E
Sbjct: 612  AKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHE 671

Query: 681  ILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD 740
            IL+ LDEDNVIG+G+SGKVYKVVL+NGE VAVK+LW G  KE    CD EKG  +  VQD
Sbjct: 672  ILESLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKET-GDCDPEKG-YKPGVQD 729

Query: 741  DGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
            + F+AEVETLGKIRHKNIVKLWCCC+TRDCKLLVYEYMPNGSLGDLLHS KGG+L W TR
Sbjct: 730  EAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTR 789

Query: 801  YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK-PKS 859
            +KII+DAAEGLSYLHHD VP IVHRD+KSNNIL+DGD+GARVADFGVAK VD +GK PKS
Sbjct: 790  FKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKS 849

Query: 860  MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
            MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE+VT + PVDPE GEKDLVKWVCST
Sbjct: 850  MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEKDLVKWVCST 909

Query: 920  LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSK 979
            LDQKG++HV+DPKLD CFKEEI K+LN+GLLCTSPLPINRP+MRRVVK+LQE+G  +   
Sbjct: 910  LDQKGIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEIGGGDEDS 969

Query: 980  TGK----KDGKLSPYYHEDASDQGSVA 1002
              K    KDGKL+PYY+ED SDQGS+A
Sbjct: 970  LHKIRDDKDGKLTPYYNEDTSDQGSIA 996

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1

 Score = 1100 bits (2846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 593/991 (59%), Positives = 728/991 (73%), Gaps = 25/991 (2%)

Query: 18  LPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLS 77
           LPSLSLNQ+   L + KL LSDP  +LSSW  N  D +PC W GV CD  S+ V S+DLS
Sbjct: 16  LPSLSLNQDATILRQAKLGLSDPAQSLSSWSDN-NDVTPCKWLGVSCDATSN-VVSVDLS 73

Query: 78  NANIAGPFPSLLCRLENLTFLTLFNNSINSTL-PDDISACQNLQHLDLSQNLLTGTLTPA 136
           +  + GPFPS+LC L +L  L+L+NNSIN +L  DD   C NL  LDLS+NLL G++  +
Sbjct: 74  SFMLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKS 133

Query: 137 LA-DLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLN 195
           L  +LPNLKFL+++GNN S  IP SFG F+KLE ++L  N L GTIPA LGN++TLK L 
Sbjct: 134 LPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELK 193

Query: 196 LSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIP 255
           L+YN F P +IP +LGNLT L++LWL  CNLVG IP SL RL  LV+LDL  N L G+IP
Sbjct: 194 LAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIP 253

Query: 256 SSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLN 315
           S +T+L +V QIEL+NNS +G+LP    N+T+L+  DASMN LTG IPD+L  L LESLN
Sbjct: 254 SWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLLNLESLN 313

Query: 316 LYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPA 375
           L+EN LEG LP +I  S  L EL+LF NRL G LP  LG NSPL++VDLS N+F+GEIPA
Sbjct: 314 LFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPA 373

Query: 376 SLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLE 435
           ++C +G+LE L++I NSF+G++ + LG C+SLTRVRL  N+L+G++P   WGLP + LLE
Sbjct: 374 NVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLE 433

Query: 436 LTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE 495
           L+DN  +G I K I GA NLS L ISKN  SGS+P EIG L  ++ +SG+EN F+G +PE
Sbjct: 434 LSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPE 493

Query: 496 SLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLD 555
           SL  L +L  LDL  N LSGE+P  +  WK LNELNLA+N   G IP+++G L VLNYLD
Sbjct: 494 SLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLD 553

Query: 556 LSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLC 615
           LS+N+ SG IP+ LQNLKLN LN+S N LSG++P L+A ++Y + F+GNPGLC DL+GLC
Sbjct: 554 LSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLCVDLDGLC 613

Query: 616 DGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFK--NGRAIDKSKWTLMSFHK 673
                 KN GYVW+L +IF+LAGLVFV G+V F  K RK +      +  SKW   SFHK
Sbjct: 614 RKITRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWR--SFHK 671

Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQ 733
           L FSE+EI D LDE NVIG GSSGKVYKV L  GE VAVKKL + +      G D E   
Sbjct: 672 LHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSV-----KGGDDEYS- 725

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
             D +  D F AEVETLG IRHK+IV+LWCCC++ DCKLLVYEYMPNGSL D+LH  + G
Sbjct: 726 -SDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKG 784

Query: 794 --LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
             +L WP R +I +DAAEGLSYLHHDCVP IVHRDVKS+NILLD D+GA+VADFG+AKV 
Sbjct: 785 GVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVG 844

Query: 852 DASGK--PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
             SG   P++MS IAGSCGYIAPEY YTLRVNEKSDIYSFGVV+LELVTG+ P D E G+
Sbjct: 845 QMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGD 904

Query: 910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL 969
           KD+ KWVC+ LD+ G++ V+DPKLD  FKEEI KV++IGLLCTSPLP+NRP+MR+VV +L
Sbjct: 905 KDMAKWVCTALDKCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIML 964

Query: 970 QEV------GAENRSKTGKKDGKLSPYYHED 994
           QEV       + N SK  K  GKLSPYY ED
Sbjct: 965 QEVSGAVPCSSPNTSKRSKTGGKLSPYYTED 995

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  785 bits (2027), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 451/987 (45%), Positives = 612/987 (62%), Gaps = 56/987 (5%)

Query: 21  LSLNQEGLYLERVKLS-LSDPDSALSSWGRNPRDDSPCSWRGVECDPR---SHSVASIDL 76
           +S N +   L RVK + L DPD  L  W     + SPC+W G+ C  R   S +V +IDL
Sbjct: 22  VSSNGDAEILSRVKKTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDL 81

Query: 77  SNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDD-ISACQNLQHLDLSQNLLTGTLTP 135
           S  NI+G FP   CR+  L  +TL  N++N T+    +S C  LQ+L L+QN  +G L  
Sbjct: 82  SGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPE 141

Query: 136 ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLN 195
              +   L+ L+L  N F+G+IP+S+GR   L+V++L  N L G +PAFLG ++ L  L+
Sbjct: 142 FSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLD 201

Query: 196 LSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIP 255
           L+Y  F P  IP  LGNL+NL  L LT  NLVGEIPDS+  L  L +LDLA+N+L G IP
Sbjct: 202 LAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIP 261

Query: 256 SSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLN 315
            S+  L SV QIELY+N L+G LP    NLT LR  D S N+LTG +P+ +  L L S N
Sbjct: 262 ESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFN 321

Query: 316 LYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPA 375
           L +N   G LP  +A +P L E ++F N   GTLP +LGK S +   D+S N+F+GE+P 
Sbjct: 322 LNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPP 381

Query: 376 SLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLE 435
            LC + +L++++   N  +G++P+  G C SL  +R+  N+L+G+VP   W LP   L  
Sbjct: 382 YLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLEL 441

Query: 436 LTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE 495
             +N L G I  +I+ A +LS L IS NN SG +P ++  L+ L V+  S N F GS+P 
Sbjct: 442 ANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPS 501

Query: 496 SLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLD 555
            +  L  L  +++  N L GE+PSSVSS  +L ELNL++N   G IP ++G+L VLNYLD
Sbjct: 502 CINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLD 561

Query: 556 LSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCG-DLEGL 614
           LSNN+L+G IP  L  LKLNQ NVS+N+L G++PS F ++++R SFLGNP LC  +L+ +
Sbjct: 562 LSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPI 621

Query: 615 CDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKL 674
              R + + R   ++L  I IL  +     LVW ++K +     +    +K T+  F ++
Sbjct: 622 RPCRSKRETR---YIL-PISILCIVALTGALVWLFIKTKPLFKRKPKRTNKITI--FQRV 675

Query: 675 GFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
           GF+E +I   L EDN+IGSG SG VY+V L +G+ +AVKKLW    ++ ES         
Sbjct: 676 GFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTES--------- 726

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-- 792
                +  F++EVETLG++RH NIVKL  CC   + + LVYE+M NGSLGD+LHS K   
Sbjct: 727 -----ESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHR 781

Query: 793 --GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
               LDW TR+ I V AA+GLSYLHHD VP IVHRDVKSNNILLD +   RVADFG+AK 
Sbjct: 782 AVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKP 841

Query: 851 V---DASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           +   D  G    SMS +AGS GYIAPEY YT +VNEKSD+YSFGVV+LEL+TG+ P D  
Sbjct: 842 LKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSS 901

Query: 907 FGE-KDLVKWVCSTL-------------------DQKGVDHVLDPKLDCCFK--EEICKV 944
           FGE KD+VK+                        + + +  ++DPK+    +  EEI KV
Sbjct: 902 FGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKV 961

Query: 945 LNIGLLCTSPLPINRPAMRRVVKLLQE 971
           L++ LLCTS  PINRP MR+VV+LL+E
Sbjct: 962 LDVALLCTSSFPINRPTMRKVVELLKE 988

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  654 bits (1687), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/972 (41%), Positives = 546/972 (56%), Gaps = 83/972 (8%)

Query: 39  DPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNAN------------------ 80
           D +S LSSW  +    S C+W GV CD     V S+DLS  N                  
Sbjct: 42  DKNSPLSSWKVS---TSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNL 98

Query: 81  ------IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISA-CQNLQHLDLSQNLLTGTL 133
                 I+GP P  +  L  L  L L NN  N + PD+IS+   NL+ LD+  N LTG L
Sbjct: 99  SLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDL 158

Query: 134 TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKM 193
             ++ +L  L+ L L GN F+G IP S+G +  +E +++  N L G IP  +GN++TL+ 
Sbjct: 159 PVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRE 218

Query: 194 LNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGA 253
           L + Y       +PPE+GNL+ L       C L GEIP  +G+L KL  L L +N   G 
Sbjct: 219 LYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGP 278

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLES 313
           +   L  L+S+  ++L NN  TG++P  ++ L +L LL                      
Sbjct: 279 LTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLL---------------------- 316

Query: 314 LNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEI 373
            NL+ N+L G +P  I D P L  L+L+ N   G++P  LG+N  L  VDLS+N+ TG +
Sbjct: 317 -NLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTL 375

Query: 374 PASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL 433
           P ++C   +LE L+ + N   G +PD LG C+SLTR+R+G N L G +P  L+GLP +  
Sbjct: 376 PPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQ 435

Query: 434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSL 493
           +EL DN+LSGE+      + NL  + +S N LSG LP  IG    +  L    NKF G +
Sbjct: 436 VELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPI 495

Query: 494 PESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNY 553
           P  +  L +L  +D   N  SG +   +S  K L  ++L+ N   G IP +I  + +LNY
Sbjct: 496 PSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNY 555

Query: 554 LDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPSLFAKEMYR-NSFLGNPGLCGDL 611
           L+LS N L G IP  + +++ L  L+ S N LSG +P       +   SFLGNP LCG  
Sbjct: 556 LNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPY 615

Query: 612 EGLCD-----GRGEEKNRGYVWV---LRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDK 663
            G C      G  +  ++G +     L  +  L      F +V   +K R  K  +A + 
Sbjct: 616 LGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAI-IKARSLK--KASES 672

Query: 664 SKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKEC 723
             W L +F +L F+  ++LD L EDN+IG G +G VYK V+ NG+ VAVK+L   MS+  
Sbjct: 673 RAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRL-AAMSRGS 731

Query: 724 ESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
                           D GF AE++TLG+IRH++IV+L   C+  +  LLVYEYMPNGSL
Sbjct: 732 S--------------HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 777

Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
           G++LH  KGG L W TRYKI ++AA+GL YLHHDC P IVHRDVKSNNILLD +F A VA
Sbjct: 778 GEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVA 837

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
           DFG+AK +  SG  + MS IAGS GYIAPEYAYTL+V+EKSD+YSFGVV+LELVTGR PV
Sbjct: 838 DFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV 897

Query: 904 DPEFGEK-DLVKWVCSTLD--QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
             EFG+  D+V+WV    D  +  V  VLDP+L      E+  V  + +LC     + RP
Sbjct: 898 G-EFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERP 956

Query: 961 AMRRVVKLLQEV 972
            MR VV++L E+
Sbjct: 957 TMREVVQILTEI 968

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  653 bits (1685), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 402/1009 (39%), Positives = 567/1009 (56%), Gaps = 88/1009 (8%)

Query: 32   RVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNAN----------- 80
            +   ++ +    L+SW  +    + CSW GV CD     V S+DLS  N           
Sbjct: 35   KSSFTIDEHSPLLTSWNLS---TTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAH 91

Query: 81   -------------IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISA-CQNLQHLDLSQ 126
                         I+GP P  +  L  L  L L NN  N + PD++S+   NL+ LDL  
Sbjct: 92   LPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYN 151

Query: 127  NLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLG 186
            N LTG L  +L +L  L+ L L GN FSG IP ++G +  LE +++  N L G IP  +G
Sbjct: 152  NNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIG 211

Query: 187  NISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA 246
            N++TL+ L + Y       +PPE+GNL+ L       C L GEIP  +G+L KL  L L 
Sbjct: 212  NLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQ 271

Query: 247  LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDL 306
            +N   G I   L  ++S+  ++L NN  TG++PT +S L +L LL               
Sbjct: 272  VNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLL--------------- 316

Query: 307  TRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN 366
                    NL+ N+L G++P  I + P L  L+L+ N   G++P  LG+N  L  +DLS+
Sbjct: 317  --------NLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSS 368

Query: 367  NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLW 426
            N+ TG +P ++C    L  L+ + N   G +PD LG C+SLTR+R+G N L G +P  L+
Sbjct: 369  NKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELF 428

Query: 427  GLPHVYLLELTDNFLSGEISKNIAG-AANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGS 485
            GLP +  +EL DN+L+GE+  +  G + +L  + +S N LSGSLP  IG L  +  L   
Sbjct: 429  GLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLD 488

Query: 486  ENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDI 545
             NKF+GS+P  +  L +L  LD   N  SG +   +S  K L  ++L+ N   G+IP ++
Sbjct: 489  GNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNEL 548

Query: 546  GNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPSLFAKEMYR-NSFLG 603
              + +LNYL+LS N L G IPV + +++ L  ++ S N LSG +PS      +   SF+G
Sbjct: 549  TGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVG 608

Query: 604  NPGLCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLV------FVFGLVWFYLKYRKFKN 657
            N  LCG   G C   G+  ++ +V  L +   L  ++       VF +V   +K R  +N
Sbjct: 609  NSHLCGPYLGPC---GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAI-IKARSLRN 664

Query: 658  GRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWR 717
              A +   W L +F +L F+  ++LD L EDN+IG G +G VYK  +  G+ VAVK+L  
Sbjct: 665  --ASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL-- 720

Query: 718  GMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEY 777
                       +  G   D     GF AE++TLG+IRH++IV+L   C+  +  LLVYEY
Sbjct: 721  ---------ATMSHGSSHDH----GFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEY 767

Query: 778  MPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD 837
            MPNGSLG++LH  KGG L W TRYKI ++AA+GL YLHHDC P IVHRDVKSNNILLD +
Sbjct: 768  MPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSN 827

Query: 838  FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            F A VADFG+AK +  SG  + MS IAGS GYIAPEYAYTL+V+EKSD+YSFGVV+LEL+
Sbjct: 828  FEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELI 887

Query: 898  TGRLPVDPEFGEK-DLVKWVCSTLD--QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSP 954
            TG+ PV  EFG+  D+V+WV S  D  +  V  V+D +L      E+  V  + LLC   
Sbjct: 888  TGKKPVG-EFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEE 946

Query: 955  LPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLS---PYYHEDASDQGS 1000
              + RP MR VV++L E+     SK    +  ++   P  +E + D GS
Sbjct: 947  QAVERPTMREVVQILTEIPKIPLSKQQAAESDVTEKAPAINESSPDSGS 995

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3

 Score =  637 bits (1644), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/993 (41%), Positives = 570/993 (57%), Gaps = 45/993 (4%)

Query: 9   VLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRS 68
           +L + L+SPL +LSL ++   L  +K S    D +L SW   P  +S CSW GV CD  +
Sbjct: 18  LLCSSLISPL-NLSLIRQANVLISLKQSFDSYDPSLDSWNI-PNFNSLCSWTGVSCDNLN 75

Query: 69  HSVASIDLSNANIAGPFPSLLCRLE-NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQN 127
            S+  +DLSN NI+G     + RL  +L FL + +NS +  LP +I     L+ L++S N
Sbjct: 76  QSITRLDLSNLNISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSN 135

Query: 128 LLTGTL-TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLG 186
           +  G L T   + +  L  LD   N+F+G +P S     +LE + L  N  DG IP   G
Sbjct: 136 VFEGELETRGFSQMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYG 195

Query: 187 NISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECN-LVGEIPDSLGRLAKLVDLDL 245
           +  +LK L+LS N  L GRIP EL N+T L  L+L   N   G IP   GRL  LV LDL
Sbjct: 196 SFLSLKFLSLSGND-LRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDL 254

Query: 246 ALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDD 305
           A  +L G+IP+ L  L ++  + L  N LTG +P    N+TSL+ LD S N L G IP +
Sbjct: 255 ANCSLKGSIPAELGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLE 314

Query: 306 LTRL-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDL 364
           L+ L  L+  NL+ NRL G +P  +++ P L  L+L+ N   G +P  LG N  L  +DL
Sbjct: 315 LSGLQKLQLFNLFFNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDL 374

Query: 365 SNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPL 424
           S N+ TG IP SLC    L+ L++  N   G LP+ LG C+ L R RLG N LT K+P  
Sbjct: 375 STNKLTGLIPESLCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKG 434

Query: 425 LWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLI---ISKNNLSGSLPEEIGFLKSLVV 481
           L  LP++ LLEL +NFL+GEI +  AG A  S L    +S N LSG +P  I  L+SL +
Sbjct: 435 LIYLPNLSLLELQNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQI 494

Query: 482 LSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNI 541
           L    N+ +G +P  + +L  L  +D+  N+ SG+ P        L  L+L+ N   G I
Sbjct: 495 LLLGANRLSGQIPGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQI 554

Query: 542 PEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPSLFAKEMYRN- 599
           P  I  + +LNYL++S N  +  +P  L  +K L   + S+N  SG +P+      + N 
Sbjct: 555 PVQISQIRILNYLNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQFSYFNNT 614

Query: 600 SFLGNPGLCGDLEGLCDG-----------RGEEKNRGYVWVLRSIFILAGLVFVFGLVWF 648
           SFLGNP LCG     C+G           +   ++RG +     +F   GL+  F +   
Sbjct: 615 SFLGNPFLCGFSSNPCNGSQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVV 674

Query: 649 YLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGE 708
               +  +  R  + + W L+ F KLGF    IL+ + E++VIG G  G VYK V+ NGE
Sbjct: 675 LAVVKN-RRMRKNNPNLWKLIGFQKLGFRSEHILECVKENHVIGKGGRGIVYKGVMPNGE 733

Query: 709 AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTR 768
            VAVKKL             + KG   D    +G  AE++TLG+IRH+NIV+L   C+ +
Sbjct: 734 EVAVKKL-----------LTITKGSSHD----NGLAAEIQTLGRIRHRNIVRLLAFCSNK 778

Query: 769 DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK 828
           D  LLVYEYMPNGSLG++LH   G  L W TR +I ++AA+GL YLHHDC P I+HRDVK
Sbjct: 779 DVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVK 838

Query: 829 SNNILLDGDFGARVADFGVAK-VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIY 887
           SNNILL  +F A VADFG+AK ++  +G  + MS IAGS GYIAPEYAYTLR++EKSD+Y
Sbjct: 839 SNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGYIAPEYAYTLRIDEKSDVY 898

Query: 888 SFGVVILELVTGRLPVDPEFGEK--DLVKW--VCSTLDQKGVDHVLDPKLDCCFKEEICK 943
           SFGVV+LEL+TGR PVD  FGE+  D+V+W  + +  +++GV  ++D +L      E  +
Sbjct: 899 SFGVVLLELITGRKPVD-NFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSNIPLAEAME 957

Query: 944 VLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN 976
           +  + +LC     + RP MR VV+++ +    N
Sbjct: 958 LFFVAMLCVQEHSVERPTMREVVQMISQAKQPN 990

Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  631 bits (1628), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 390/980 (39%), Positives = 564/980 (57%), Gaps = 53/980 (5%)

Query: 33  VKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRL 92
           VK +L DP + L  W  +   D  C+W GV C+   + V  +DL+  N+ G     + +L
Sbjct: 37  VKSTLVDPLNFLKDWKLSDTSDH-CNWTGVRCNSNGN-VEKLDLAGMNLTGKISDSISQL 94

Query: 93  ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN 152
            +L    +  N   S LP  I     L+ +D+SQN  +G+L     +   L  L+ +GNN
Sbjct: 95  SSLVSFNISCNGFESLLPKSIPP---LKSIDISQNSFSGSLFLFSNESLGLVHLNASGNN 151

Query: 153 FSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGN 212
            SG++ E  G    LEV+ L  N   G++P+   N+  L+ L LS N  L G +P  LG 
Sbjct: 152 LSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNN-LTGELPSVLGQ 210

Query: 213 LTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNN 272
           L +LE   L      G IP   G +  L  LDLA+  L G IPS L +L S+  + LY N
Sbjct: 211 LPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYEN 270

Query: 273 SLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNL-YENRLEGSLPATIAD 331
           + TG +P    ++T+L++LD S N LTG IP ++T+L    L     N+L GS+P  I+ 
Sbjct: 271 NFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISS 330

Query: 332 SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYN 391
              L  L L+ N L+G LP DLGKNSPL+W+D+S+N F+GEIP++LC KG L +L++  N
Sbjct: 331 LAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNN 390

Query: 392 SFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAG 451
           +FTGQ+P  L  CQSL RVR+  N L G +P     L  +  LEL  N LSG I  +I+ 
Sbjct: 391 TFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISD 450

Query: 452 AANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAN 511
           + +LS +  S+N +  SLP  I  + +L     ++N  +G +P+   +   L +LDL +N
Sbjct: 451 SVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSN 510

Query: 512 DLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGL-Q 570
            L+G +PSS++S +KL  LNL +N   G IP  I  +S L  LDLSNN L+G +P  +  
Sbjct: 511 TLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGT 570

Query: 571 NLKLNQLNVSNNRLSGELP-SLFAKEMYRNSFLGNPGLCGDLEGLCDG-----------R 618
           +  L  LNVS N+L+G +P + F K +  +   GN GLCG +   C              
Sbjct: 571 SPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLH 630

Query: 619 GEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSK------WTLMSFH 672
           G+    G++  + S+  L     +  +V   L  + + NG   D++       W LM+FH
Sbjct: 631 GKRIVAGWLIGIASVLALG----ILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFH 686

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEK 731
           +LGF+  +IL  + E N+IG G++G VYK  +S    V AVKKLWR       S  D+E 
Sbjct: 687 RLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWR-------SAADIED 739

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
           G   D      F  EV  LGK+RH+NIV+L          ++VYE+M NG+LGD +H   
Sbjct: 740 GTTGD------FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKN 793

Query: 792 GG---LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
                L+DW +RY I +  A GL+YLHHDC P ++HRD+KSNNILLD +  AR+ADFG+A
Sbjct: 794 AAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLA 853

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           +++  + K +++S++AGS GYIAPEY YTL+V+EK DIYS+GVV+LEL+TGR P++PEFG
Sbjct: 854 RMM--ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFG 911

Query: 909 EK-DLVKWVCSTL-DQKGVDHVLDPKLDCC--FKEEICKVLNIGLLCTSPLPINRPAMRR 964
           E  D+V+WV   + D   ++  LDP +  C   +EE+  VL I LLCT+ LP +RP+MR 
Sbjct: 912 ESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRD 971

Query: 965 VVKLLQEVGAENRSKTGKKD 984
           V+ +L E     +S + +++
Sbjct: 972 VISMLGEAKPRRKSNSNEEN 991

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1

 Score =  609 bits (1571), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 391/1014 (38%), Positives = 572/1014 (56%), Gaps = 55/1014 (5%)

Query: 7    MLVLVAFLLSPLPSLSL--NQEGLYLERVKLSLSDPDSALSSWGRNPRDDSP------CS 58
            +   + F L P  S     N E   L   K  L DP + L  W R P + +       C 
Sbjct: 9    LFYYIGFALFPFVSSETFQNSEQEILLAFKSDLFDPSNNLQDWKR-PENATTFSELVHCH 67

Query: 59   WRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQN 118
            W GV CD   + VA + LSN N++G     +    +L  L L NN+  S+LP  +S   +
Sbjct: 68   WTGVHCDANGY-VAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTS 126

Query: 119  LQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLD 178
            L+ +D+S N   GT    L     L  ++ + NNFSG +PE  G    LEV+       +
Sbjct: 127  LKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFE 186

Query: 179  GTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLA 238
            G++P+   N+  LK L LS N F  G++P  +G L++LE + L     +GEIP+  G+L 
Sbjct: 187  GSVPSSFKNLKNLKFLGLSGNNF-GGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKLT 245

Query: 239  KLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDL 298
            +L  LDLA+ NL G IPSSL +L  +  + LY N LTG LP     +TSL  LD S N +
Sbjct: 246  RLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQI 305

Query: 299  TGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNS 357
            TG IP ++  L  L+ LNL  N+L G +P+ IA+ P L  L L++N L G+LP  LGKNS
Sbjct: 306  TGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNS 365

Query: 358  PLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRL 417
            PL+W+D+S+N+ +G+IP+ LC    L +L++  NSF+GQ+P+ +  C +L RVR+  N +
Sbjct: 366  PLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHI 425

Query: 418  TGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLK 477
            +G +P     LP +  LEL  N L+G+I  +IA + +LS + IS N+LS      I    
Sbjct: 426  SGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSSLS-SSIFSSP 484

Query: 478  SLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLF 537
            +L     S N F G +P  + +   L  LDL  N  SG +P  ++S++KL  LNL  N  
Sbjct: 485  NLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQL 544

Query: 538  YGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGL-QNLKLNQLNVSNNRLSGELPS--LFAK 594
             G IP+ +  + +L  LDLSNN L+G IP  L  +  L  LNVS N+L G +PS  LFA 
Sbjct: 545  VGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLFAA 604

Query: 595  EMYRNSFLGNPGLCGDLEGLCDG----RGEEKNRGYVWVLRSIF---------ILAGLVF 641
             +     +GN GLCG +   C        + +N G + V  ++F         +  G++F
Sbjct: 605  -IDPKDLVGNNGLCGGVLPPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMGMMF 663

Query: 642  VFGLVWFYLKYRKFKN--------GRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGS 693
            + G  W Y ++  + N         +  ++  W L++F +L F+  +IL  + E N+IG 
Sbjct: 664  LAGR-WIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNIIGM 722

Query: 694  GSSGKVYKVVLSNGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLG 751
            G+ G VYK  +       VAVKKLWR  S + +     ++   +D +       EV  LG
Sbjct: 723  GAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDI-----LREVNLLG 777

Query: 752  KIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL--DWPTRYKIIVDAAE 809
             +RH+NIVK+          ++VYEYMPNG+LG  LHS     L  DW +RY + V   +
Sbjct: 778  GLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQ 837

Query: 810  GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
            GL+YLH+DC P I+HRD+KSNNILLD +  AR+ADFG+AK++    K +++S++AGS GY
Sbjct: 838  GLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMM--LHKNETVSMVAGSYGY 895

Query: 870  IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK-DLVKWVCSTLDQ-KGVDH 927
            IAPEY YTL+++EKSDIYS GVV+LELVTG++P+DP F +  D+V+W+   + + + ++ 
Sbjct: 896  IAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKNESLEE 955

Query: 928  VLDPKL--DC-CFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
            V+D  +  DC    EE+   L I LLCT+ LP +RP++R V+ +L E     +S
Sbjct: 956  VIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPRRKS 1009

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJM4|IKU2_ARATH Receptor-like protein kinase HAIKU2 OS=Arabidopsis thaliana GN=IKU2 PE=1 SV=1

 Score =  605 bits (1561), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 384/1018 (37%), Positives = 570/1018 (55%), Gaps = 54/1018 (5%)

Query: 3   LLTGMLVLVAFLLSPLPSLSLNQ----EGLYLERVKLSLSDPDSALSSWGRNPRDDSPCS 58
           +L  + ++    L PL S   N     E L   +     +  D    +W      +S C 
Sbjct: 1   MLRLLFIVRLLFLMPLASSRSNHSEEVENLLKLKSTFGETKSDDVFKTW---THRNSACE 57

Query: 59  WRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLP-DDISACQ 117
           + G+ C+   + V  I+L +        SL+ R ++  F         + LP D I   +
Sbjct: 58  FAGIVCNSDGN-VVEINLGSR-------SLINRDDDGRF---------TDLPFDSICDLK 100

Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLL 177
            L+ L L  N L G +   L     L++LDL  NNFSG+ P +    Q LE +SL  + +
Sbjct: 101 LLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFP-AIDSLQLLEFLSLNASGI 159

Query: 178 DGTIP-AFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGR 236
            G  P + L ++  L  L++  N F     P E+ NLT L+ ++L+  ++ G+IP+ +  
Sbjct: 160 SGIFPWSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWVYLSNSSITGKIPEGIKN 219

Query: 237 LAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMN 296
           L +L +L+L+ N + G IP  + +L ++ Q+E+Y+N LTG LP G+ NLT+LR  DAS N
Sbjct: 220 LVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLPLGFRNLTNLRNFDASNN 279

Query: 297 DLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKN 356
            L G + +      L SL ++ENRL G +P    D   L  L L+RN+L G LP  LG  
Sbjct: 280 SLEGDLSELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAALSLYRNQLTGKLPRRLGSW 339

Query: 357 SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR 416
           +  +++D+S N   G+IP  +C+KG +  LLM+ N FTGQ P+    C++L R+R+  N 
Sbjct: 340 TAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFPESYAKCKTLIRLRVSNNS 399

Query: 417 LTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFL 476
           L+G +P  +WGLP++  L+L  N+  G ++ +I  A +L  L +S N  SGSLP +I   
Sbjct: 400 LSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSLDLSNNRFSGSLPFQISGA 459

Query: 477 KSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNL 536
            SLV ++   NKF+G +PES   L EL SL L  N+LSG +P S+     L +LN A N 
Sbjct: 460 NSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIPKSLGLCTSLVDLNFAGNS 519

Query: 537 FYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEM 596
               IPE +G+L +LN L+LS N+LSG IPVGL  LKL+ L++SNN+L+G +P    + +
Sbjct: 520 LSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLDLSNNQLTGSVP----ESL 575

Query: 597 YRNSFLGNPGLCGDLE--------GLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWF 648
              SF GN GLC            G    +G+ K+   V +   +  +  L F+F  V F
Sbjct: 576 VSGSFEGNSGLCSSKIRYLRPCPLGKPHSQGKRKHLSKVDMCFIVAAILALFFLFSYVIF 635

Query: 649 YLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGE 708
            ++  K  N     K+ W + SF  L F+E EI+D +  +N+IG G  G VYKV L +GE
Sbjct: 636 KIRRDKL-NKTVQKKNDWQVSSFRLLNFNEMEIIDEIKSENIIGRGGQGNVYKVSLRSGE 694

Query: 709 AVAVKKLW-RGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT 767
            +AVK +W    S E             ++  +  F+AEV TL  I+H N+VKL+C  T 
Sbjct: 695 TLAVKHIWCPESSHESFRSSTAMLSDGNNRSNNGEFEAEVATLSNIKHINVVKLFCSITC 754

Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGL-LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRD 826
            D KLLVYEYMPNGSL + LH  +G   + W  R  + + AA+GL YLHH     ++HRD
Sbjct: 755 EDSKLLVYEYMPNGSLWEQLHERRGEQEIGWRVRQALALGAAKGLEYLHHGLDRPVIHRD 814

Query: 827 VKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS--VIAGSCGYIAPEYAYTLRVNEKS 884
           VKS+NILLD ++  R+ADFG+AK++ A    +  S  ++ G+ GYIAPEYAYT +VNEKS
Sbjct: 815 VKSSNILLDEEWRPRIADFGLAKIIQADSVQRDFSAPLVKGTLGYIAPEYAYTTKVNEKS 874

Query: 885 DIYSFGVVILELVTGRLPVDPEFGE-KDLVKWVCST---LDQKGVDHVLDPKLDCCFKEE 940
           D+YSFGVV++ELVTG+ P++ +FGE  D+V WV S     +++ +  ++D  ++  +KE+
Sbjct: 875 DVYSFGVVLMELVTGKKPLETDFGENNDIVMWVWSVSKETNREMMMKLIDTSIEDEYKED 934

Query: 941 ICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDASDQ 998
             KVL I LLCT   P  RP M+ VV +L+++       +G+        Y E A+D+
Sbjct: 935 ALKVLTIALLCTDKSPQARPFMKSVVSMLEKIEPSYNKNSGEAS------YGESANDE 986

Modulates the seed size by negatively regulating the cellularization of syncytial endosperm.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  598 bits (1541), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 379/981 (38%), Positives = 541/981 (55%), Gaps = 65/981 (6%)

Query: 40   PDSALSSW-----GRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLEN 94
            P SA   W     G+N  D   CSW GV CD  +  V S+DLS+ N++G  P  +  L +
Sbjct: 49   PPSAFQDWKVPVNGQN--DAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLSS 106

Query: 95   LTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFS 154
            L +L L  NS+  + P  I     L  LD+S+N    +  P ++ L  LK  +   NNF 
Sbjct: 107  LLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFE 166

Query: 155  GDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLT 214
            G +P    R + LE ++   +  +G IPA  G +  LK ++L+ N  L G++PP LG LT
Sbjct: 167  GLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGN-VLGGKLPPRLGLLT 225

Query: 215  NLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSL 274
             L+ + +   +  G IP     L+ L   D++  +L G++P  L  L+++  + L+ N  
Sbjct: 226  ELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGF 285

Query: 275  TGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSP 333
            TG++P  +SNL SL+LLD S N L+G IP   + L  L  L+L  N L G +P  I + P
Sbjct: 286  TGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELP 345

Query: 334  GLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSF 393
             L  L L+ N   G LP  LG N  L  +D+SNN FTG IP+SLC   +L +L++  N F
Sbjct: 346  ELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMF 405

Query: 394  TGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAA 453
             G+LP  L  C+SL R R   NRL G +P     L ++  ++L++N  + +I  + A A 
Sbjct: 406  EGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAP 465

Query: 454  NLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL 513
             L  L +S N     LPE I    +L + S S +   G +P +         ++L  N L
Sbjct: 466  VLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIP-NYVGCKSFYRIELQGNSL 524

Query: 514  SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK 573
            +G +P  +   +KL  LNL+ N   G IP +I  L  +  +DLS+N L+G IP    + K
Sbjct: 525  NGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSK 584

Query: 574  -LNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGL-------------CDGRG 619
             +   NVS N+L G +PS     +  + F  N GLCGDL G               DG  
Sbjct: 585  TITTFNVSYNQLIGPIPSGSFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHH 644

Query: 620  EEKNR-----GYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSK--------W 666
            +E+         VW+L +   +   V V     F   Y     G  +D           W
Sbjct: 645  KEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSY-----GNRVDGGGRNGGDIGPW 699

Query: 667  TLMSFHKLGFSEYEILDGLDE-DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECES 725
             L +F +L F+  ++++ L + DN++G GS+G VYK  + NGE +AVKKLW         
Sbjct: 700  KLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLW--------- 750

Query: 726  GCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD 785
            G + E G+++   +  G  AEV+ LG +RH+NIV+L  CCT RDC +L+YEYMPNGSL D
Sbjct: 751  GKNKENGKIRR--RKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDD 808

Query: 786  LLH---SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
            LLH          +W   Y+I +  A+G+ YLHHDC P IVHRD+K +NILLD DF ARV
Sbjct: 809  LLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARV 868

Query: 843  ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            ADFGVAK++      +SMSV+AGS GYIAPEYAYTL+V++KSDIYS+GV++LE++TG+  
Sbjct: 869  ADFGVAKLIQTD---ESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRS 925

Query: 903  VDPEFGEKD-LVKWVCSTLDQK-GVDHVLDPKL--DCCF-KEEICKVLNIGLLCTSPLPI 957
            V+PEFGE + +V WV S L  K  V+ VLD  +   C   +EE+ ++L I LLCTS  P 
Sbjct: 926  VEPEFGEGNSIVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPT 985

Query: 958  NRPAMRRVVKLLQEVGAENRS 978
            +RP MR V+ +LQE   + ++
Sbjct: 986  DRPPMRDVLLILQEAKPKRKT 1006

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1002
224079165	992	predicted protein [Populus trichocarpa]	0.978	0.987	0.791	0.0
255536713	994	protein with unknown function [Ricinus c	0.974	0.981	0.786	0.0
224125428	992	predicted protein [Populus trichocarpa]	0.988	0.997	0.766	0.0
47498987	987	leucine-rich repeat receptor-like protei	0.974	0.988	0.766	0.0
134142356	998	LRR receptor-like protein kinase m4 [Mal	0.970	0.973	0.768	0.0
134142352	998	LRR receptor-like protein kinase m2 [Mal	0.970	0.973	0.768	0.0
47498983	998	leucine-rich repeat receptor-like protei	0.970	0.973	0.760	0.0
47498985	998	leucine-rich repeat receptor-like protei	0.970	0.973	0.760	0.0
134142350	999	LRR receptor-like protein kinase m1' [Ma	0.970	0.972	0.756	0.0
3641252	999	leucine-rich receptor-like protein kinas	0.970	0.972	0.755	0.0

>gi|224079165|ref|XP_002305776.1| predicted protein [Populus trichocarpa] gi|222848740|gb|EEE86287.1| predicted protein [Populus trichocarpa]

 Score = 1582 bits (4096), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 780/986 (79%), Positives = 868/986 (88%), Gaps = 6/986 (0%)

Query: 17   PLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDL 76
            P PSLSLNQEGLYL+++KLSLSDPDSALSSW  + RD +PCSW G++CDP ++SV SIDL
Sbjct: 13   PSPSLSLNQEGLYLQQIKLSLSDPDSALSSW--SGRDTTPCSWFGIQCDPTTNSVTSIDL 70

Query: 77   SNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPA 136
            SN NIAGPFPSLLCRL+NLTFL++FNN IN+TLP DIS C+NLQHLDLSQNLLTGTL   
Sbjct: 71   SNTNIAGPFPSLLCRLQNLTFLSVFNNYINATLPSDISTCRNLQHLDLSQNLLTGTLPHT 130

Query: 137  LADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNL 196
            LADLPNL++LDLTGNNFSGDIP++F RFQKLEVISLVYNL DG IP FLGNISTLK+LNL
Sbjct: 131  LADLPNLRYLDLTGNNFSGDIPDTFARFQKLEVISLVYNLFDGIIPPFLGNISTLKVLNL 190

Query: 197  SYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPS 256
            SYNPF PGRIPPELGNLTNLEILWLT CNL+GEIPDSL RL KL DLDLA N+LVG+IPS
Sbjct: 191  SYNPFTPGRIPPELGNLTNLEILWLTACNLIGEIPDSLSRLKKLTDLDLAFNSLVGSIPS 250

Query: 257  SLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNL 316
            SLTEL S+VQIELYNNSLTG+LP G   LT L+ LDASMN LTG IPD+L RLPLESLNL
Sbjct: 251  SLTELTSIVQIELYNNSLTGELPRGMGKLTDLKRLDASMNQLTGSIPDELCRLPLESLNL 310

Query: 317  YENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPAS 376
            YEN   GSLP +IADSP LYELRLFRN L G LP +LGKNS L W+D+SNN F+G+IPAS
Sbjct: 311  YENGFTGSLPPSIADSPNLYELRLFRNGLTGELPQNLGKNSALIWLDVSNNHFSGQIPAS 370

Query: 377  LCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLEL 436
            LCE GELEE+LMIYNSF+GQ+P+ L  C SLTRVRLGYNRL+G+VP  LWGLPHV L +L
Sbjct: 371  LCENGELEEILMIYNSFSGQIPESLSQCWSLTRVRLGYNRLSGEVPTGLWGLPHVSLFDL 430

Query: 437  TDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPES 496
             +N LSG ISK IAGAANLS+LII +NN  G+LPEEIGFL +L   SGSEN+F+GSLP S
Sbjct: 431  VNNSLSGPISKTIAGAANLSMLIIDRNNFDGNLPEEIGFLANLSEFSGSENRFSGSLPGS 490

Query: 497  LTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDL 556
            + NL ELGSLDLH N LSGELP  V+SWKK+NELNLA+N   G IP+ IG +SVLNYLDL
Sbjct: 491  IVNLKELGSLDLHGNALSGELPDGVNSWKKMNELNLANNALSGKIPDGIGGMSVLNYLDL 550

Query: 557  SNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCD 616
            SNNR SG+IP+GLQNLKLNQLN+SNNRLSGE+P LFAKEMY++SF+GNPGLCGD+EGLCD
Sbjct: 551  SNNRFSGKIPIGLQNLKLNQLNLSNNRLSGEIPPLFAKEMYKSSFIGNPGLCGDIEGLCD 610

Query: 617  GRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGF 676
            GRG  + RGY W++RSIF+LA LV + G+VWFY KYR FK  RA++KSKWTL+SFHKLGF
Sbjct: 611  GRGGGRGRGYAWLMRSIFVLAVLVLIVGVVWFYFKYRNFKKARAVEKSKWTLISFHKLGF 670

Query: 677  SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            SEYEILD LDEDNVIGSG SGKVYKVVLSNGEAVAVKK+W G+ K+ +   DVEKGQ   
Sbjct: 671  SEYEILDCLDEDNVIGSGLSGKVYKVVLSNGEAVAVKKIWGGVKKQSDD-VDVEKGQA-- 727

Query: 737  QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
             +QDDGF AEV TLGKIRHKNIVKLWCCCT +D KLLVYEYMPNGSLGDLLHS KGGLLD
Sbjct: 728  -IQDDGFDAEVATLGKIRHKNIVKLWCCCTNKDYKLLVYEYMPNGSLGDLLHSSKGGLLD 786

Query: 797  WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
            WPTRYKI+VDAAEGLSYLHHDCVP IVHRDVKSNNILLDGDFGARVADFGVAKVVD++GK
Sbjct: 787  WPTRYKIVVDAAEGLSYLHHDCVPPIVHRDVKSNNILLDGDFGARVADFGVAKVVDSTGK 846

Query: 857  PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
            PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG+ PVDPE+GEKDLVKWV
Sbjct: 847  PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGKRPVDPEYGEKDLVKWV 906

Query: 917  CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN 976
            C+TLDQKGVDHV+DPKLD CFKEEICKVLNIG+LCTSPLPINRP+MRRVVK+LQE+GAEN
Sbjct: 907  CTTLDQKGVDHVIDPKLDSCFKEEICKVLNIGILCTSPLPINRPSMRRVVKMLQEIGAEN 966

Query: 977  RSKTGKKDGKLSPYYHEDASDQGSVA 1002
             SK  KKDGKL+PYY+ED SD GSVA
Sbjct: 967  LSKIAKKDGKLTPYYYEDTSDHGSVA 992

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255536713|ref|XP_002509423.1| protein with unknown function [Ricinus communis] gi|223549322|gb|EEF50810.1| protein with unknown function [Ricinus communis]

 Score = 1568 bits (4061), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 773/983 (78%), Positives = 865/983 (87%), Gaps = 7/983 (0%)

Query: 20   SLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNA 79
            +LSLNQEGL+L ++KLS SDPDS+LSSW  + RD SPCSW G+ CDP ++SV SIDLSNA
Sbjct: 19   ALSLNQEGLFLHQIKLSFSDPDSSLSSW--SDRDSSPCSWFGITCDPTANSVTSIDLSNA 76

Query: 80   NIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALAD 139
            NIAGPFPSL+CRL+NLTFL+  NNSI+S LP DISACQNLQHLDL+QN LTG+L   LAD
Sbjct: 77   NIAGPFPSLICRLQNLTFLSFNNNSIDSILPLDISACQNLQHLDLAQNYLTGSLPYTLAD 136

Query: 140  LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYN 199
            LPNLK+LDLTGNNFSGDIP+SFGRFQKLEVISLVYNL DG IP FLGNI+TLKMLNLSYN
Sbjct: 137  LPNLKYLDLTGNNFSGDIPDSFGRFQKLEVISLVYNLFDGIIPPFLGNITTLKMLNLSYN 196

Query: 200  PFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLT 259
            PF P RIPPELGNLTNLEILWLT+CNLVGEIPDSLG+L KL DLDLA+NNLVG IPSSLT
Sbjct: 197  PFSPSRIPPELGNLTNLEILWLTDCNLVGEIPDSLGQLKKLQDLDLAVNNLVGEIPSSLT 256

Query: 260  ELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYEN 319
            EL SVVQIELYNNSLTG LP+G  NL++LRLLDASMN+LTGPIPD+L +L LESLNLYEN
Sbjct: 257  ELTSVVQIELYNNSLTGHLPSGLGNLSALRLLDASMNELTGPIPDELCQLQLESLNLYEN 316

Query: 320  RLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCE 379
              EG LPA+I DS  LYELRLF+NR +G LP +LGKNSPLRW+D+S+N+FTGEIP SLC 
Sbjct: 317  HFEGRLPASIGDSKKLYELRLFQNRFSGELPQNLGKNSPLRWLDVSSNKFTGEIPESLCS 376

Query: 380  KGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDN 439
            KGELEELL+I+NSF+GQ+P+ L  C+SLTRVRLGYNRL+G+VP   WGLPHVYL+EL +N
Sbjct: 377  KGELEELLVIHNSFSGQIPESLSLCKSLTRVRLGYNRLSGEVPSGFWGLPHVYLVELVNN 436

Query: 440  FLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTN 499
              +G+I K IAGAANLS LII  N  +GSLPEEIG+L++L   SGS N+FTGSLP S+ N
Sbjct: 437  SFTGQIGKTIAGAANLSQLIIDNNRFNGSLPEEIGWLENLGSFSGSGNEFTGSLPGSIVN 496

Query: 500  LAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNN 559
            L +LG+LDLH N LSGELPS + SWKK+NELNLA+N F G IP++IG L VLNYLDLS+N
Sbjct: 497  LKQLGNLDLHGNLLSGELPSGIDSWKKINELNLANNEFSGKIPDEIGRLPVLNYLDLSSN 556

Query: 560  RLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRG 619
            R SG+IP  LQNLKLNQLN+SNNRLSG++P  FAKEMY++SFLGNPGLCGD++GLCDGR 
Sbjct: 557  RFSGKIPFSLQNLKLNQLNLSNNRLSGDIPPFFAKEMYKSSFLGNPGLCGDIDGLCDGRS 616

Query: 620  EEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEY 679
            E K  GY W+L+SIFILA LV V G+VWFY KYR +KN RAIDKS+WTLMSFHKLGFSE+
Sbjct: 617  EGKGEGYAWLLKSIFILAALVLVIGVVWFYFKYRNYKNARAIDKSRWTLMSFHKLGFSEF 676

Query: 680  EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            EIL  LDEDNVIGSG+SGKVYKVVLSNGEAVAVKKLW G SK+     DVEKG    QVQ
Sbjct: 677  EILASLDEDNVIGSGASGKVYKVVLSNGEAVAVKKLWGG-SKKGSDESDVEKG----QVQ 731

Query: 740  DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            DDGF AEV+TLGKIRHKNIVKLWCCC+TRDCKLLVYEYMPNGSLGDLLH  KGGLLDWPT
Sbjct: 732  DDGFGAEVDTLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHGSKGGLLDWPT 791

Query: 800  RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
            RYKI++DAAEGLSYLHHDCVP IVHRDVKSNNILLDGD+GARVADFGVAKVVD++GKPKS
Sbjct: 792  RYKILLDAAEGLSYLHHDCVPPIVHRDVKSNNILLDGDYGARVADFGVAKVVDSTGKPKS 851

Query: 860  MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
            MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT RLPVDPEFGEKDLVKWVC+T
Sbjct: 852  MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTRRLPVDPEFGEKDLVKWVCTT 911

Query: 920  LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSK 979
            LDQKGVDHV+D KLD CFK EICKVLNIG+LCTSPLPINRP+MRRVVK+LQE+  EN  K
Sbjct: 912  LDQKGVDHVIDSKLDSCFKAEICKVLNIGILCTSPLPINRPSMRRVVKMLQEIRPENMPK 971

Query: 980  TGKKDGKLSPYYHEDASDQGSVA 1002
              KKDGKL+PYY+EDASDQGSVA
Sbjct: 972  AAKKDGKLTPYYYEDASDQGSVA 994

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125428|ref|XP_002329803.1| predicted protein [Populus trichocarpa] gi|222870865|gb|EEF07996.1| predicted protein [Populus trichocarpa]

 Score = 1546 bits (4004), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 763/996 (76%), Positives = 859/996 (86%), Gaps = 6/996 (0%)

Query: 7    MLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDP 66
            + V ++ L  P  +LSLNQEGLYL+++KLSLSDPDSALSSW  + RD +PCSW G++CDP
Sbjct: 3    LFVFLSILFFPSSTLSLNQEGLYLQQIKLSLSDPDSALSSW--SDRDTTPCSWSGIKCDP 60

Query: 67   RSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQ 126
             + S+ SIDLSN+N+AGPFPSLLCRL+NLT L+   N+INSTLP DIS CQNLQHLDLSQ
Sbjct: 61   TTSSITSIDLSNSNVAGPFPSLLCRLQNLTSLSFSINNINSTLPLDISTCQNLQHLDLSQ 120

Query: 127  NLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLG 186
            NLLTGTL   LADLPNL++LDLTGNNFSGDIP++F RFQKLEVISLVYNL+DG IP FLG
Sbjct: 121  NLLTGTLPHTLADLPNLRYLDLTGNNFSGDIPDTFARFQKLEVISLVYNLMDGIIPPFLG 180

Query: 187  NISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA 246
            NI+TL+MLNLSYNPF PGR+PPE GNLTNLE LWLT+CNL GEIPDSLGRL KL DLDLA
Sbjct: 181  NITTLRMLNLSYNPFTPGRVPPEFGNLTNLETLWLTQCNLNGEIPDSLGRLKKLKDLDLA 240

Query: 247  LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDL 306
            LNNL G+IP SLTEL SVVQIELYNNSLTG LP G   LT L+ LD SMN LTG IPD+L
Sbjct: 241  LNNLGGSIPGSLTELTSVVQIELYNNSLTGGLPRGLGKLTELKRLDVSMNRLTGWIPDEL 300

Query: 307  TRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN 366
             +LPLESLNLYEN   G+LPA+IADSP LYELRLF+NRL G LP +LGKN+PLRW+D+SN
Sbjct: 301  CQLPLESLNLYENGFTGTLPASIADSPSLYELRLFQNRLTGELPQNLGKNAPLRWIDVSN 360

Query: 367  NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLW 426
            N  TG+IPASLCE GELEE+LMIYNSF+GQ+P+ L  C+SLTRVRLGYNRL+G+VP  LW
Sbjct: 361  NDLTGQIPASLCENGELEEILMIYNSFSGQIPESLSQCRSLTRVRLGYNRLSGEVPAGLW 420

Query: 427  GLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSE 486
            GLPHV L +L +N  SG ISK IA AANLS LII  NN  G++PEEIGFL +L   SGSE
Sbjct: 421  GLPHVSLFDLFNNSFSGPISKTIASAANLSKLIIDMNNFDGNIPEEIGFLANLSEFSGSE 480

Query: 487  NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIG 546
            N+F GSLP S+ NL ELGSLDLH N LSG+LP  V+SWKK+NELNLA N F GNIP+ IG
Sbjct: 481  NRFNGSLPGSIVNLKELGSLDLHGNALSGDLPDGVNSWKKMNELNLASNAFSGNIPDGIG 540

Query: 547  NLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPG 606
             +S+LNYLDLSNNRLSG+IP+GLQNLKLN+LN+SNNRLSGE+P LFAKEMY++SF+GNPG
Sbjct: 541  GMSLLNYLDLSNNRLSGKIPIGLQNLKLNKLNLSNNRLSGEIPPLFAKEMYKSSFVGNPG 600

Query: 607  LCGDLEGLCDGRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKW 666
            LCGD+EGLCDGRG  +  GY W +RSIF LA  + +FG+VWFY KYR FK  RA+DKSKW
Sbjct: 601  LCGDIEGLCDGRGGGRGIGYAWSMRSIFALAVFLLIFGVVWFYFKYRNFKKARAVDKSKW 660

Query: 667  TLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESG 726
            TLMSFH LGFSEYEILD LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLW G  K+    
Sbjct: 661  TLMSFHNLGFSEYEILDCLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWGGQKKQ-GGD 719

Query: 727  CDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL 786
             DVEKGQV   +QD+GF AEV TL KIRHKNIVKLWCCCTTRDC LLVYEYM NGSLGDL
Sbjct: 720  VDVEKGQV---IQDNGFDAEVATLSKIRHKNIVKLWCCCTTRDCNLLVYEYMSNGSLGDL 776

Query: 787  LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
            LHS KGGLLDWPTRYKI+ DAAEGLSYLHHDCVP IVHRDVKSNNILLDGD+GARVADFG
Sbjct: 777  LHSSKGGLLDWPTRYKIVADAAEGLSYLHHDCVPPIVHRDVKSNNILLDGDYGARVADFG 836

Query: 847  VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
            VAKV +++GK KSMS+IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG+ PVDP+
Sbjct: 837  VAKVFESTGKLKSMSIIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGKRPVDPD 896

Query: 907  FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
            +GEKDLV WVC+TLD KGVDHV+DP+LD CFKEEICKVLNIG+LCTSPLPINRP+MRRVV
Sbjct: 897  YGEKDLVNWVCTTLDLKGVDHVIDPRLDSCFKEEICKVLNIGILCTSPLPINRPSMRRVV 956

Query: 967  KLLQEVGAENRSKTGKKDGKLSPYYHEDASDQGSVA 1002
            K+LQE+GA+N+SKT KKDGKL+PYY EDASD GSVA
Sbjct: 957  KMLQEIGADNQSKTAKKDGKLTPYYFEDASDHGSVA 992

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|47498987|gb|AAT28309.1| leucine-rich repeat receptor-like protein kinase [Pyrus pyrifolia]

 Score = 1531 bits (3963), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 757/988 (76%), Positives = 857/988 (86%), Gaps = 12/988 (1%)

Query: 20   SLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS---VASIDL 76
            +LSLNQEGLYL+  KLS  DPDSALSSW  N  D +PC+W GVECD  S S   V S+DL
Sbjct: 7    TLSLNQEGLYLQHFKLSHDDPDSALSSW--NDADSTPCNWLGVECDDASSSSPVVRSLDL 64

Query: 77   SNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPA 136
             +AN+AGPFP++LCRL NLT L+L+NNSINSTLP  +S CQNL+HLDLSQNLLTG L   
Sbjct: 65   PSANLAGPFPTVLCRLPNLTHLSLYNNSINSTLPPSLSTCQNLEHLDLSQNLLTGGLPAT 124

Query: 137  LADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNL 196
            L+D+PNLK+LDLTGNNFSG IP+SFGRFQKLEV+SLVYNL++ TIP FLGNISTLKMLNL
Sbjct: 125  LSDVPNLKYLDLTGNNFSGPIPDSFGRFQKLEVLSLVYNLIESTIPPFLGNISTLKMLNL 184

Query: 197  SYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPS 256
            SYNPF PGRIP ELGNLTNLE+LWLTECNLVGEIPDSLGRL  L DLDLA+N L G IP 
Sbjct: 185  SYNPFHPGRIPAELGNLTNLEVLWLTECNLVGEIPDSLGRLKNLKDLDLAINGLTGRIPP 244

Query: 257  SLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNL 316
            SL+EL SVVQIELYNNSLTG+LP G S LT LRLLDASMN L+GPIPD+L RLPLESLNL
Sbjct: 245  SLSELTSVVQIELYNNSLTGELPPGMSKLTRLRLLDASMNQLSGPIPDELCRLPLESLNL 304

Query: 317  YENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPAS 376
            YEN  EGS+PA+IA+SP LYELRLFRNRL G LP +LGKNSPL+W+D+S+NQFTG IPAS
Sbjct: 305  YENNFEGSVPASIANSPHLYELRLFRNRLTGELPQNLGKNSPLKWLDVSSNQFTGTIPAS 364

Query: 377  LCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLEL 436
            LCEK ++EELLMI+N F+G++P  LG CQSLTRVRLG+NRL+G+VP   WGLP VYL+EL
Sbjct: 365  LCEKRQMEELLMIHNEFSGEIPARLGECQSLTRVRLGHNRLSGEVPVGFWGLPRVYLMEL 424

Query: 437  TDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPES 496
             +N LSG I+K IAGA NL+LLI++KN   G +PEEIG++++L+  SG ENKF+G LPES
Sbjct: 425  VENELSGTIAKTIAGATNLTLLIVAKNKFWGQIPEEIGWVENLMEFSGGENKFSGPLPES 484

Query: 497  LTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDL 556
            +  L +LG+LDLH+N++SGELP  + SW KLNELNLA N   G IP+ IGNLSVLNYLDL
Sbjct: 485  IVRLGQLGTLDLHSNEISGELPIGIQSWTKLNELNLASNQLSGKIPDGIGNLSVLNYLDL 544

Query: 557  SNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCD 616
            S NR SG+IP GLQN+KLN  N+SNNRLSGELP LFAKE+YR+SFLGNPGLCGDL+GLCD
Sbjct: 545  SGNRFSGKIPFGLQNMKLNVFNLSNNRLSGELPPLFAKEIYRSSFLGNPGLCGDLDGLCD 604

Query: 617  GRGEEKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNG-RAIDKSKWTLMSFHKLG 675
            GR E K++GY+W+LR IFIL+GLVF+ G+VWFYLKY+ FK   R IDKSKWTLMSFHKLG
Sbjct: 605  GRAEVKSQGYLWLLRCIFILSGLVFIVGVVWFYLKYKNFKKANRTIDKSKWTLMSFHKLG 664

Query: 676  FSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            FSEYEILD LDEDNVIGSG+SGKVYKV+LS+GE VAVKKLWRG  +ECE+G DVEKG   
Sbjct: 665  FSEYEILDCLDEDNVIGSGASGKVYKVILSSGEVVAVKKLWRGKVQECEAG-DVEKG--- 720

Query: 736  DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
              VQDDGF+AEVETLG+IRHKNIVKLWCCCT RDCKLLVYEYM NGSLGDLLHS KGGLL
Sbjct: 721  -WVQDDGFEAEVETLGRIRHKNIVKLWCCCTARDCKLLVYEYMQNGSLGDLLHSSKGGLL 779

Query: 796  DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
            DWPTR+KI +DAAEGLSYLHHDCVP IVHRDVKSNNILLDGDFGARVADFGVAK VD +G
Sbjct: 780  DWPTRFKIALDAAEGLSYLHHDCVPPIVHRDVKSNNILLDGDFGARVADFGVAKEVDVTG 839

Query: 856  KP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
            K  KSMS+IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK
Sbjct: 840  KGLKSMSIIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 899

Query: 915  WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA 974
            WVC+TLDQKGVD+V+DPKL+ C+KEE+CKVLNIGLLCTSPLPINRP+MRRVVKLLQEVG 
Sbjct: 900  WVCTTLDQKGVDNVVDPKLESCYKEEVCKVLNIGLLCTSPLPINRPSMRRVVKLLQEVGT 959

Query: 975  ENRSKTGKKDGKLSPYYHEDASDQGSVA 1002
            E   +  KK+GKL+PYY+ED SD GSVA
Sbjct: 960  EKHPQATKKEGKLTPYYYEDVSDHGSVA 987

Source: Pyrus pyrifolia

Species: Pyrus pyrifolia

Genus: Pyrus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|134142356|gb|ABO61514.1| LRR receptor-like protein kinase m4 [Malus x domestica]

 Score = 1524 bits (3945), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 756/984 (76%), Positives = 851/984 (86%), Gaps = 12/984 (1%)

Query: 24   NQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS---VASIDLSNAN 80
            NQEGLYL+  KLSL DPDSAL SW  N  D +PC+W GV+CD  S S   V S+DL +AN
Sbjct: 22   NQEGLYLQHFKLSLDDPDSALDSW--NDADSTPCNWLGVKCDDASSSSPVVRSLDLPSAN 79

Query: 81   IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL 140
            +AGPFP++LCRL NLT L+L+NNSINSTLP  +S CQNL+HLDLSQNLLTG L   L DL
Sbjct: 80   LAGPFPTVLCRLPNLTHLSLYNNSINSTLPPSLSTCQNLEHLDLSQNLLTGALPATLPDL 139

Query: 141  PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            PNLK+LDLTGNNFSG IP+SFGRFQKLEV+SLVYNL++GTIP FLGNISTLKMLNLSYNP
Sbjct: 140  PNLKYLDLTGNNFSGPIPDSFGRFQKLEVLSLVYNLIEGTIPPFLGNISTLKMLNLSYNP 199

Query: 201  FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            FLPGRIP ELGNLTNLE+LWLTECN+VGEIPDSLGRL  L DLDLA+N L G IP SL+E
Sbjct: 200  FLPGRIPAELGNLTNLEVLWLTECNIVGEIPDSLGRLKNLKDLDLAINGLTGRIPPSLSE 259

Query: 261  LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
            L SVVQIELYNNSLTG LP G S LT LRLLDASMN L+GPIPD+L RLPLESLNLYEN 
Sbjct: 260  LTSVVQIELYNNSLTGKLPPGMSKLTRLRLLDASMNQLSGPIPDELCRLPLESLNLYENN 319

Query: 321  LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
             EGS+PA+IA+SP LYELRLFRN+L+G LP +LGKNSPL+W+D+S+NQFTG IPASLCEK
Sbjct: 320  FEGSVPASIANSPNLYELRLFRNKLSGELPQNLGKNSPLKWLDVSSNQFTGTIPASLCEK 379

Query: 381  GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNF 440
             ++EELLMI+N F+G +P  LG CQSLTRVRLG+NRL+G+VP   WGLP VYL+EL +N 
Sbjct: 380  RQMEELLMIHNEFSGGIPVRLGECQSLTRVRLGHNRLSGEVPAGFWGLPRVYLMELVENE 439

Query: 441  LSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
            LSG ISK IAGA NLSLLI++KN  SG +PEEIG++++L+  SG ENKF G LPES+  L
Sbjct: 440  LSGAISKTIAGATNLSLLIVAKNKFSGQIPEEIGWVENLMEFSGGENKFNGPLPESIVRL 499

Query: 501  AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             +LG+LDLH+N++SGELP  + SW KLNELNLA N   G IP+ IGNLSVLNYLDLS NR
Sbjct: 500  GQLGTLDLHSNEISGELPIGIQSWTKLNELNLASNQLSGKIPDGIGNLSVLNYLDLSGNR 559

Query: 561  LSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGE 620
             SG+IP GLQN+KLN  N+SNNRLSGELP LFAKE+YR+SFLGNPGLCGDL+GLCDG+ E
Sbjct: 560  FSGKIPFGLQNMKLNVFNLSNNRLSGELPPLFAKEIYRSSFLGNPGLCGDLDGLCDGKAE 619

Query: 621  EKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNG-RAIDKSKWTLMSFHKLGFSEY 679
             K++GY+W+LR IFIL+GLVFV G+VWFYLKY+ FK   R IDKSKWTLMSFHKLGFSEY
Sbjct: 620  VKSQGYLWLLRCIFILSGLVFVVGVVWFYLKYKNFKKANRTIDKSKWTLMSFHKLGFSEY 679

Query: 680  EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            EILD LDEDNVIGSG+SGKVYKV LS+GE VAVKKLW G  +ECE+G DVEKG     VQ
Sbjct: 680  EILDCLDEDNVIGSGASGKVYKVXLSSGEVVAVKKLWGGKVQECEAG-DVEKG----WVQ 734

Query: 740  DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            DDGF+AEVETLG+IRHKNIVKLWCCCTTRDCKLLVYEYM NGSLGD+LHS KGGLLDWPT
Sbjct: 735  DDGFEAEVETLGRIRHKNIVKLWCCCTTRDCKLLVYEYMQNGSLGDMLHSIKGGLLDWPT 794

Query: 800  RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK-PK 858
            R+KI +DAAEGLSYLHHDCVP+IVHRDVKSNNILLDGDFGARVADFGVAKVVD +GK P+
Sbjct: 795  RFKIALDAAEGLSYLHHDCVPAIVHRDVKSNNILLDGDFGARVADFGVAKVVDVTGKGPQ 854

Query: 859  SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
            SMS I GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC+
Sbjct: 855  SMSGITGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCT 914

Query: 919  TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
             LDQKGVD V+DPKL+ C+KEE+ KVLNIGLLCTSPLPINRP+MRRVVKLLQEVG E   
Sbjct: 915  ALDQKGVDSVVDPKLESCYKEEVGKVLNIGLLCTSPLPINRPSMRRVVKLLQEVGTEKHP 974

Query: 979  KTGKKDGKLSPYYHEDASDQGSVA 1002
            +  KK+GKLSPYY+EDASD GSVA
Sbjct: 975  QAAKKEGKLSPYYYEDASDHGSVA 998

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|134142352|gb|ABO61512.1| LRR receptor-like protein kinase m2 [Malus x domestica]

 Score = 1523 bits (3942), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 756/984 (76%), Positives = 851/984 (86%), Gaps = 12/984 (1%)

Query: 24   NQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS---VASIDLSNAN 80
            NQEGLYL+  KLSL DPDSAL SW  N  D +PC+W GV+CD  S S   V S+DL +AN
Sbjct: 22   NQEGLYLQHFKLSLDDPDSALDSW--NDADSTPCNWLGVKCDDASSSSPVVRSLDLPSAN 79

Query: 81   IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL 140
            +AGPFP++LCRL NLT L+L+NNSINSTLP  +S CQNL+HLDLSQNLLTG L   L DL
Sbjct: 80   LAGPFPTVLCRLPNLTHLSLYNNSINSTLPPSLSTCQNLEHLDLSQNLLTGALPATLPDL 139

Query: 141  PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            PNLK+LDLTGNNFSG IP+SFGRFQKLEV+SLVYNL++GTIP FLGNISTLKMLNLSYNP
Sbjct: 140  PNLKYLDLTGNNFSGPIPDSFGRFQKLEVLSLVYNLIEGTIPPFLGNISTLKMLNLSYNP 199

Query: 201  FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            FLPGRIP ELGNLTNLE+LWLTECN+VGEIPDSLGRL  L DLDLA+N L G IP SL+E
Sbjct: 200  FLPGRIPAELGNLTNLEVLWLTECNIVGEIPDSLGRLKNLKDLDLAINGLTGRIPPSLSE 259

Query: 261  LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
            L SVVQIELYNNSLTG LP G S LT LRLLDASMN L+GPIPD+L RLPLESLNLYEN 
Sbjct: 260  LTSVVQIELYNNSLTGKLPPGMSKLTRLRLLDASMNQLSGPIPDELCRLPLESLNLYENN 319

Query: 321  LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
             EGS+PA+IA+SP LYELRLFRN+L+G LP +LGKNSPL+W+D+S+NQFTG IPASLCEK
Sbjct: 320  FEGSVPASIANSPNLYELRLFRNKLSGELPQNLGKNSPLKWLDVSSNQFTGTIPASLCEK 379

Query: 381  GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNF 440
             ++EELLMI+N F+G +P  LG CQSLTRVRLG+NRL+G+VP   WGLP VYL+EL +N 
Sbjct: 380  RQMEELLMIHNEFSGGIPARLGECQSLTRVRLGHNRLSGEVPAGFWGLPRVYLMELVENE 439

Query: 441  LSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
            LSG ISK IAGA NLSLLI++KN  SG +PEEIG++++L+  SG ENKF G LPES+  L
Sbjct: 440  LSGAISKTIAGATNLSLLIVAKNKFSGQIPEEIGWVENLMEFSGGENKFNGPLPESIVRL 499

Query: 501  AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             +LG+LDLH+N++SGELP  + SW KLNELNLA N   G IP+ IGNLSVLNYLDLS NR
Sbjct: 500  GQLGTLDLHSNEISGELPIGIQSWTKLNELNLASNQLSGKIPDGIGNLSVLNYLDLSGNR 559

Query: 561  LSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGE 620
             SG+IP GLQN+KLN  N+SNNRLSGELP LFAKE+YR+SFLGNPGLCGDL+GLCDG+ E
Sbjct: 560  FSGKIPFGLQNMKLNVFNLSNNRLSGELPPLFAKEIYRSSFLGNPGLCGDLDGLCDGKAE 619

Query: 621  EKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNG-RAIDKSKWTLMSFHKLGFSEY 679
             K++GY+W+LR IFIL+GLVF  G VWFYLKY+ FK   R IDKSKWTLMSFHKLGFSEY
Sbjct: 620  VKSQGYLWLLRCIFILSGLVFGCGGVWFYLKYKNFKKANRTIDKSKWTLMSFHKLGFSEY 679

Query: 680  EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            EILD LDEDNVIGSG+SGKVYKV+LS+GE VAVKKLW G  +ECE+G DVEKG     VQ
Sbjct: 680  EILDCLDEDNVIGSGASGKVYKVILSSGEVVAVKKLWGGKVQECEAG-DVEKG----WVQ 734

Query: 740  DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            DDGF+AEVETLG+IRHKNIVKLWCCCTTRDCKLLVYEYM NGSLGD+LHS KGGLLDWPT
Sbjct: 735  DDGFEAEVETLGRIRHKNIVKLWCCCTTRDCKLLVYEYMQNGSLGDMLHSIKGGLLDWPT 794

Query: 800  RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK-PK 858
            R+KI +DAAEGLSYLHHDCVP+IVHRDVKSNNILLDGDFGARVADFGVAKVVD +GK P+
Sbjct: 795  RFKIALDAAEGLSYLHHDCVPAIVHRDVKSNNILLDGDFGARVADFGVAKVVDVTGKGPQ 854

Query: 859  SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
            SMS I GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC+
Sbjct: 855  SMSGITGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCT 914

Query: 919  TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
             LDQKGVD V+DPKL+ C+KEE+CKVLNIGLLCTSPLPINRP+MRRVVKLLQEVG E   
Sbjct: 915  ALDQKGVDSVVDPKLESCYKEEVCKVLNIGLLCTSPLPINRPSMRRVVKLLQEVGTEKHP 974

Query: 979  KTGKKDGKLSPYYHEDASDQGSVA 1002
            +  KK+GKLSPYY+EDASD GSVA
Sbjct: 975  QAAKKEGKLSPYYYEDASDHGSVA 998

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|47498983|gb|AAT28307.1| leucine-rich repeat receptor-like protein kinase [Pyrus pyrifolia]

 Score = 1516 bits (3924), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 748/984 (76%), Positives = 852/984 (86%), Gaps = 12/984 (1%)

Query: 24   NQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS---VASIDLSNAN 80
            NQEGLYL+  KLSL DPDSALSSW  N  D +PC+W GV CD  S S   V S+DL +AN
Sbjct: 22   NQEGLYLQHFKLSLDDPDSALSSW--NDADSTPCNWLGVSCDDASSSYPVVLSLDLPSAN 79

Query: 81   IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL 140
            +AGPFP++LCRL NLT L+L+NNSINSTLP  +S CQNL+HLDLSQNLLTG L   L+D+
Sbjct: 80   LAGPFPTVLCRLPNLTHLSLYNNSINSTLPPSLSTCQNLEHLDLSQNLLTGGLPATLSDV 139

Query: 141  PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            PNLK+LDLTGNNFSG IP+SFGRFQKLEV+SLVYNL++ TIP FLGNISTLKMLNLSYNP
Sbjct: 140  PNLKYLDLTGNNFSGPIPDSFGRFQKLEVLSLVYNLIESTIPPFLGNISTLKMLNLSYNP 199

Query: 201  FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            F PGRIP ELGNLTNLE+LWLTECNLVGEIPDSLGRL  L DLDLA+N L G IP SL+E
Sbjct: 200  FHPGRIPAELGNLTNLEVLWLTECNLVGEIPDSLGRLKNLKDLDLAINGLTGRIPPSLSE 259

Query: 261  LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
            L SVVQIELYNNSLTG+LP G S LT LRLLDASMN L+G IPD+L RLPLESLNLYEN 
Sbjct: 260  LTSVVQIELYNNSLTGELPPGMSKLTRLRLLDASMNQLSGQIPDELCRLPLESLNLYENN 319

Query: 321  LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
            LEGS+PA+IA+SP LYE+RLFRN+L+G LP +LGKNSPL+W D+S+NQFTG IPASLCEK
Sbjct: 320  LEGSVPASIANSPNLYEVRLFRNKLSGELPQNLGKNSPLKWFDVSSNQFTGTIPASLCEK 379

Query: 381  GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNF 440
            G++EE+LM++N F+G++P  LG CQSL RVRLG+NRL+G+VP   WGLP VYL+EL +N 
Sbjct: 380  GQMEEILMLHNEFSGEIPARLGECQSLARVRLGHNRLSGEVPVGFWGLPRVYLMELAENE 439

Query: 441  LSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
            LSG I+K+IAGA NLSLLI++KN  SG +PEEIG++K+L+  SG +NKF+G LPE +  L
Sbjct: 440  LSGPIAKSIAGATNLSLLILAKNKFSGPIPEEIGWVKNLMEFSGGDNKFSGPLPEGIARL 499

Query: 501  AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             +LG+LDLH+N++SGELP  + SW KLNELNLA N   G IP+ I NLSVLNYLDLS NR
Sbjct: 500  GQLGTLDLHSNEVSGELPVGIQSWTKLNELNLASNQLSGKIPDGIANLSVLNYLDLSGNR 559

Query: 561  LSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGE 620
             SG+IP GLQN+KLN  N+S N+LSGELP LFAKE+YR+SFLGNPGLCGDL+GLCDGR E
Sbjct: 560  FSGKIPFGLQNMKLNVFNLSYNQLSGELPPLFAKEIYRSSFLGNPGLCGDLDGLCDGRAE 619

Query: 621  EKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNG-RAIDKSKWTLMSFHKLGFSEY 679
             K++GY+W+LR IFIL+GLVF+ G+VWFYLKY+ FK   R IDKSKWTLMSFHKLGFSEY
Sbjct: 620  VKSQGYLWLLRCIFILSGLVFIVGVVWFYLKYKNFKKANRTIDKSKWTLMSFHKLGFSEY 679

Query: 680  EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            EILD LDEDNVIGSG+SGKVYKV+LS+GE VAVKKLWRG  +ECE+G DVEKG     VQ
Sbjct: 680  EILDCLDEDNVIGSGASGKVYKVILSSGEVVAVKKLWRGKVQECEAG-DVEKG----WVQ 734

Query: 740  DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            DDGF+AEVETLG+IRHKNIVKLWCCCT RDCKLLVYEYM NGSLGDLLHS KGGLLDWPT
Sbjct: 735  DDGFEAEVETLGRIRHKNIVKLWCCCTARDCKLLVYEYMQNGSLGDLLHSSKGGLLDWPT 794

Query: 800  RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-K 858
            R+KI +DAAEGLSYLHHDCVP IVHRDVKSNNILLDGDFGARVADFGVAK VD +GK  K
Sbjct: 795  RFKIALDAAEGLSYLHHDCVPPIVHRDVKSNNILLDGDFGARVADFGVAKEVDVTGKGLK 854

Query: 859  SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
            SMS+IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC+
Sbjct: 855  SMSIIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCT 914

Query: 919  TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
            TLDQKGVD+V+DPKL+ C+KEE+CKVLNIGLLCTSPLPINRP+MRRVVKLLQEVG E   
Sbjct: 915  TLDQKGVDNVVDPKLESCYKEEVCKVLNIGLLCTSPLPINRPSMRRVVKLLQEVGTEKHP 974

Query: 979  KTGKKDGKLSPYYHEDASDQGSVA 1002
            +  KK+GKL+PYY+ED SD GSVA
Sbjct: 975  QAAKKEGKLTPYYYEDVSDHGSVA 998

Source: Pyrus pyrifolia

Species: Pyrus pyrifolia

Genus: Pyrus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|47498985|gb|AAT28308.1| leucine-rich repeat receptor-like protein kinase [Pyrus pyrifolia]

 Score = 1515 bits (3922), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 748/984 (76%), Positives = 850/984 (86%), Gaps = 12/984 (1%)

Query: 24   NQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS---VASIDLSNAN 80
            NQEGLYL   KLSL DPDSALSSW  N  D +PC+W GVECD  S S   V S+DL +AN
Sbjct: 22   NQEGLYLRHFKLSLDDPDSALSSW--NDADSTPCNWLGVECDDASSSSPVVRSLDLPSAN 79

Query: 81   IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL 140
            +AGPFP++LCRL NLT L+L+NNSINSTLP  +S CQ L+HLDL+QNLLTG L   L DL
Sbjct: 80   LAGPFPTVLCRLPNLTHLSLYNNSINSTLPPSLSTCQTLEHLDLAQNLLTGALPATLPDL 139

Query: 141  PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            PNLK+LDLTGNNFSG IP+SFGRFQKLEV+SLVYNL++ TIP FLGNISTLKMLNLSYNP
Sbjct: 140  PNLKYLDLTGNNFSGPIPDSFGRFQKLEVLSLVYNLIESTIPPFLGNISTLKMLNLSYNP 199

Query: 201  FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            F PGRIP ELGNLTNLE+LWLTECNLVGEIPDSLGRL  L DLDLA+N L G IP SL+E
Sbjct: 200  FHPGRIPAELGNLTNLEVLWLTECNLVGEIPDSLGRLKNLKDLDLAINGLTGRIPPSLSE 259

Query: 261  LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
            L SVVQIELYNNSLTG+LP G S LT LRLLDASMN L+G IPD+L RLPLESLNLYEN 
Sbjct: 260  LTSVVQIELYNNSLTGELPPGMSKLTRLRLLDASMNQLSGQIPDELCRLPLESLNLYENN 319

Query: 321  LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
            LEGS+PA+IA+SP LYE+RLFRN+L+G LP +LGKNSPL+W D+S+NQFTG IPASLCEK
Sbjct: 320  LEGSVPASIANSPNLYEVRLFRNKLSGELPQNLGKNSPLKWFDVSSNQFTGTIPASLCEK 379

Query: 381  GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNF 440
            G++EE+LM++N F+G++P  LG CQSL RVRLG+NRL+G+VP   WGLP VYL+EL +N 
Sbjct: 380  GQMEEILMLHNEFSGEIPARLGECQSLARVRLGHNRLSGEVPVGFWGLPRVYLMELAENE 439

Query: 441  LSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
            LSG I+K+IAGA NLSLLI++KN  SG +PEEIG++K+L+  SG +NKF+G LPE +  L
Sbjct: 440  LSGPIAKSIAGATNLSLLILAKNKFSGPIPEEIGWVKNLMEFSGGDNKFSGPLPEGIARL 499

Query: 501  AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             +LG+LDLH+N++SGELP  + SW KLNELNLA N   G IP+ I NLSVLNYLDLS NR
Sbjct: 500  GQLGTLDLHSNEVSGELPVGIQSWTKLNELNLASNQLSGKIPDGIANLSVLNYLDLSGNR 559

Query: 561  LSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGE 620
             SG+IP GLQN+KLN  N+S N+LSGELP LFAKE+YR+SFLGNPGLCGDL+GLCDGR E
Sbjct: 560  FSGKIPFGLQNMKLNVFNLSYNQLSGELPPLFAKEIYRSSFLGNPGLCGDLDGLCDGRAE 619

Query: 621  EKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNG-RAIDKSKWTLMSFHKLGFSEY 679
             K++GY+W+LR IFIL+GLVF+ G+VWFYLKY+ FK   R IDKSKWTLMSFHKLGFSEY
Sbjct: 620  VKSQGYLWLLRCIFILSGLVFIVGVVWFYLKYKNFKKANRTIDKSKWTLMSFHKLGFSEY 679

Query: 680  EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            EILD LDEDNVIGSG+SGKVYKV+LS+GE VAVKKLWRG  +ECE+G DVEKG     VQ
Sbjct: 680  EILDCLDEDNVIGSGASGKVYKVILSSGEVVAVKKLWRGKVQECEAG-DVEKG----WVQ 734

Query: 740  DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            DDGF+AEVETLG+IRHKNIVKLWCCCT RDCKLLVYEYM NGSLGDLLHS KGGLLDWPT
Sbjct: 735  DDGFEAEVETLGRIRHKNIVKLWCCCTARDCKLLVYEYMQNGSLGDLLHSSKGGLLDWPT 794

Query: 800  RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-K 858
            R+KI +DAAEGLSYLHHDCVP IVHRDVKSNNILLDGDFGARVADFGVAK VD +GK  K
Sbjct: 795  RFKIALDAAEGLSYLHHDCVPPIVHRDVKSNNILLDGDFGARVADFGVAKEVDVTGKGLK 854

Query: 859  SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
            SMS+IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC+
Sbjct: 855  SMSIIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCT 914

Query: 919  TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
            TLDQKGVD+V+DPKL+ C+KEE+CKVLNIGLLCTSPLPINRP+MRRVVKLLQEVG E   
Sbjct: 915  TLDQKGVDNVVDPKLESCYKEEVCKVLNIGLLCTSPLPINRPSMRRVVKLLQEVGTEKHP 974

Query: 979  KTGKKDGKLSPYYHEDASDQGSVA 1002
            +  KK+GKL+PYY+ED SD GSVA
Sbjct: 975  QAAKKEGKLTPYYYEDVSDHGSVA 998

Source: Pyrus pyrifolia

Species: Pyrus pyrifolia

Genus: Pyrus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|134142350|gb|ABO61511.1| LRR receptor-like protein kinase m1' [Malus x domestica]

 Score = 1500 bits (3884), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 744/984 (75%), Positives = 847/984 (86%), Gaps = 12/984 (1%)

Query: 24   NQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS---VASIDLSNAN 80
            NQEGLYL   KLSL DPDSALSSW  N  D +PC+W GV CD  S S   V S+DL +AN
Sbjct: 23   NQEGLYLRHFKLSLDDPDSALSSW--NYADSTPCNWLGVTCDDASSSSPVVRSLDLPSAN 80

Query: 81   IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL 140
            +AGPFP++LCRL NLT L+L+NNSINSTLP  +S CQ L+ LDL+QNLLTG L   L DL
Sbjct: 81   LAGPFPTVLCRLPNLTHLSLYNNSINSTLPPSLSTCQTLEDLDLAQNLLTGALPATLPDL 140

Query: 141  PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            PNLK+LDL+GNNFSG IP+SFGRFQKLEV+SLVYNL++ TIP FLGNISTLKMLNLSYNP
Sbjct: 141  PNLKYLDLSGNNFSGAIPDSFGRFQKLEVLSLVYNLIENTIPPFLGNISTLKMLNLSYNP 200

Query: 201  FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            F PGRIP ELGNLTNLE+LWLTECNLVGEIPDSLGRL  L DLDLA+N L G IP SL+E
Sbjct: 201  FHPGRIPAELGNLTNLEVLWLTECNLVGEIPDSLGRLKNLKDLDLAINGLTGRIPPSLSE 260

Query: 261  LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
            L SVVQIELYNNSLTG+LP G S LT LRLLDASMN L+G IPD+L RLPLESLNLYEN 
Sbjct: 261  LTSVVQIELYNNSLTGELPPGMSKLTRLRLLDASMNQLSGQIPDELCRLPLESLNLYENN 320

Query: 321  LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
            LEGS+PA+IA+SP LYE+RLFRN+L+G LP +LGKNSPL+W D+S+NQFTG IPASLCEK
Sbjct: 321  LEGSVPASIANSPNLYEVRLFRNKLSGELPQNLGKNSPLKWFDVSSNQFTGTIPASLCEK 380

Query: 381  GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNF 440
            G++E++LM++N F+G++P  LG CQSL RVRLG+NRL+G+VP   WGLP VYL+EL +N 
Sbjct: 381  GQMEQILMLHNEFSGEIPARLGECQSLARVRLGHNRLSGEVPVGFWGLPRVYLMELAENE 440

Query: 441  LSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
            LSG I+K+IA A NLSLLI++KN  SG +PEEIG++++L+  SG +NKF+G LPES+  L
Sbjct: 441  LSGPIAKSIARATNLSLLILAKNKFSGPIPEEIGWVENLMEFSGGDNKFSGPLPESIVRL 500

Query: 501  AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             +LG+LDLH+N++SGELP  + SW KLNELNLA N   G IP+ IGNLSVLNYLDLS NR
Sbjct: 501  GQLGTLDLHSNEVSGELPVGIQSWTKLNELNLASNQLSGKIPDGIGNLSVLNYLDLSGNR 560

Query: 561  LSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGE 620
             SG+IP GLQN+KLN  N+S N+LSGELP LFAKE+YRNSFLGNPGLCGDL+GLCD R E
Sbjct: 561  FSGKIPFGLQNMKLNVFNLSYNQLSGELPPLFAKEIYRNSFLGNPGLCGDLDGLCDSRAE 620

Query: 621  EKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKN-GRAIDKSKWTLMSFHKLGFSEY 679
             K++GY+W+LR +FIL+GLVFV G+VWFYLKY+ FK   R IDKSKWTLMSFHKLGFSEY
Sbjct: 621  VKSQGYIWLLRCMFILSGLVFVVGVVWFYLKYKNFKKVNRTIDKSKWTLMSFHKLGFSEY 680

Query: 680  EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            EILD LDEDNVIGSG+SGKVYKVVL++GE VAVKKLWR   KECE   DVEKG     VQ
Sbjct: 681  EILDCLDEDNVIGSGASGKVYKVVLNSGEVVAVKKLWRRKVKECEVE-DVEKG----WVQ 735

Query: 740  DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            DDGF+AEV+TLGKIRHKNIVKLWCCCT RDCKLLVYEYM NGSLGDLLHS KGGLLDWPT
Sbjct: 736  DDGFEAEVDTLGKIRHKNIVKLWCCCTARDCKLLVYEYMQNGSLGDLLHSSKGGLLDWPT 795

Query: 800  RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-K 858
            R+KI +DAAEGLSYLHHDCVP+IVHRDVKSNNILLDGDFGARVADFGVAK VDA+GK  K
Sbjct: 796  RFKIALDAAEGLSYLHHDCVPAIVHRDVKSNNILLDGDFGARVADFGVAKEVDATGKGLK 855

Query: 859  SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
            SMS+IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC+
Sbjct: 856  SMSIIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCT 915

Query: 919  TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
            TLDQKGVD+V+DPKL+ C+KEE+CKVLNIGLLCTSPLPINRP+MRRVVKLLQEVG E   
Sbjct: 916  TLDQKGVDNVVDPKLESCYKEEVCKVLNIGLLCTSPLPINRPSMRRVVKLLQEVGTEKHP 975

Query: 979  KTGKKDGKLSPYYHEDASDQGSVA 1002
            +  KK+GKL+PYY+ED SD GSVA
Sbjct: 976  QAAKKEGKLTPYYYEDTSDHGSVA 999

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|3641252|gb|AAC36318.1| leucine-rich receptor-like protein kinase [Malus x domestica]

 Score = 1495 bits (3870), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 743/984 (75%), Positives = 845/984 (85%), Gaps = 12/984 (1%)

Query: 24   NQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS---VASIDLSNAN 80
            NQEGLYL   KLSL DPDSALSSW  N  D +PC+W GV CD  S S   V S+DL +AN
Sbjct: 23   NQEGLYLRHFKLSLDDPDSALSSW--NYADSTPCNWLGVTCDDASSSSPVVRSLDLPSAN 80

Query: 81   IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL 140
            +AGPFP++LCRL NLT L+L+NNSINSTLP  +S CQ L+ LDL+QNLLTG L   L DL
Sbjct: 81   LAGPFPTVLCRLPNLTHLSLYNNSINSTLPPSLSTCQTLEDLDLAQNLLTGALPATLPDL 140

Query: 141  PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            PNLK+LDL+GNNFSG IP+SFGRFQKLEV+SLVYNL++ TIP FLGNISTLKMLNLSYNP
Sbjct: 141  PNLKYLDLSGNNFSGAIPDSFGRFQKLEVLSLVYNLIENTIPPFLGNISTLKMLNLSYNP 200

Query: 201  FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            F PGRIP ELGNLTNLE+L LTECNLVGEIPDSLGRL  L DLDLA+N L G IP SL+E
Sbjct: 201  FHPGRIPAELGNLTNLEVLRLTECNLVGEIPDSLGRLKNLKDLDLAINGLTGRIPPSLSE 260

Query: 261  LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
            L SVVQIELYNNSLTG+LP G S LT LRLLDASMN L+G IPD+L RLPLESLNLYEN 
Sbjct: 261  LTSVVQIELYNNSLTGELPPGMSKLTRLRLLDASMNQLSGQIPDELCRLPLESLNLYENN 320

Query: 321  LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
            LEGS+PA+IA+SP LYE+RLFRN+L+G LP +LGKNSPL+W D+S+NQFTG IPASLCEK
Sbjct: 321  LEGSVPASIANSPNLYEVRLFRNKLSGELPQNLGKNSPLKWFDVSSNQFTGTIPASLCEK 380

Query: 381  GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNF 440
            G++EE+LM++N F+G++P  LG CQSL RVRLG+NRL+G+VP   WGLP VYL+EL +N 
Sbjct: 381  GQMEEILMLHNEFSGEIPARLGECQSLARVRLGHNRLSGEVPVGFWGLPRVYLMELAENE 440

Query: 441  LSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
            LSG I+K+IA A NLSLLI++KN  SG +PEEIG++++L+  SG +NKF+G LPES+  L
Sbjct: 441  LSGPIAKSIARATNLSLLILAKNKFSGPIPEEIGWVENLMEFSGGDNKFSGPLPESIVRL 500

Query: 501  AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             +LG+LDLH+N++SGELP  + SW  LNELNLA N   G IP+ IGNLSVLNYLDLS NR
Sbjct: 501  GQLGTLDLHSNEVSGELPVGIQSWTNLNELNLASNQLSGKIPDGIGNLSVLNYLDLSGNR 560

Query: 561  LSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGLCDGRGE 620
             SG+IP GLQN+KLN  N+S N+LSGELP LFAKE+YRNSFLGNPGLCGDL+GLCD R E
Sbjct: 561  FSGKIPFGLQNMKLNVFNLSYNQLSGELPPLFAKEIYRNSFLGNPGLCGDLDGLCDSRAE 620

Query: 621  EKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKN-GRAIDKSKWTLMSFHKLGFSEY 679
             K++GY+W+LR +FIL+GLVFV G+VWFYLKY+ FK   R IDKSKWTLMSFHKLGFSEY
Sbjct: 621  VKSQGYIWLLRCMFILSGLVFVVGVVWFYLKYKNFKKVNRTIDKSKWTLMSFHKLGFSEY 680

Query: 680  EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            EILD LDEDNVIGSG+SGKVYKVVL++GE VAVKKLWR   KECE   DVEKG     VQ
Sbjct: 681  EILDCLDEDNVIGSGASGKVYKVVLNSGEVVAVKKLWRRKVKECEVE-DVEKG----WVQ 735

Query: 740  DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            DDGF+AEV+TLGKIRHKNIVKLWCCCT RDCKLLVYEYM NGSLGDLLHS KGGLLDWPT
Sbjct: 736  DDGFEAEVDTLGKIRHKNIVKLWCCCTARDCKLLVYEYMQNGSLGDLLHSSKGGLLDWPT 795

Query: 800  RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-K 858
            R+KI +DAAEGLSYLHHDCVP+IVHRDVKSNNILLDGDFGARVADFGVAK VDA+GK  K
Sbjct: 796  RFKIALDAAEGLSYLHHDCVPAIVHRDVKSNNILLDGDFGARVADFGVAKEVDATGKGLK 855

Query: 859  SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
            SMS+IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC+
Sbjct: 856  SMSIIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCT 915

Query: 919  TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
            TLDQKGVD+V+DPKL+ C+KEE+CKVLNIGLLCTSPLPINRP+MRRVVKLLQEVG E   
Sbjct: 916  TLDQKGVDNVVDPKLESCYKEEVCKVLNIGLLCTSPLPINRPSMRRVVKLLQEVGTEKHP 975

Query: 979  KTGKKDGKLSPYYHEDASDQGSVA 1002
            +  KK+GKL+PYY+ED SD GSVA
Sbjct: 976  QAAKKEGKLTPYYYEDTSDHGSVA 999

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1002
TAIR|locus:2032553	996	HSL1 "HAESA-like 1" [Arabidops	0.973	0.978	0.675	0.0
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.979	0.981	0.547	2.7e-281
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.840	0.847	0.443	3e-192
TAIR|locus:2180617	1005	AT5G25930 [Arabidopsis thalian	0.900	0.897	0.396	2.5e-168
TAIR|locus:2024432	977	LRR XI-23 [Arabidopsis thalian	0.857	0.879	0.401	4.1e-168
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.923	0.923	0.387	2.7e-162
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.912	0.902	0.386	1.2e-161
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.893	0.892	0.395	1.5e-161
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.905	0.914	0.393	1.8e-158
TAIR|locus:2091206	991	IKU2 "HAIKU2" [Arabidopsis tha	0.881	0.891	0.385	1.4e-156

TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 3445 (1217.8 bits), Expect = 0., P = 0.
 Identities = 665/984 (67%), Positives = 764/984 (77%)

Query:    24 NQEGLYLERVKXXXXXXXXXXXXWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAG 83
             NQ+G  L++VK            W  N  D SPC W GV C     SV S+DLS+AN+AG
Sbjct:    17 NQDGFILQQVKLSLDDPDSYLSSWNSN--DASPCRWSGVSCAGDFSSVTSVDLSSANLAG 74

Query:    84 PFPSLLCRLEXXXXXXXXXXSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNL 143
             PFPS++CRL           SINSTLP +I+AC++LQ LDLSQNLLTG L   LAD+P L
Sbjct:    75 PFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTL 134

Query:   144 KFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLP 203
               LDLTGNNFSGDIP SFG+F+ LEV+SLVYNLLDGTIP FLGNISTLKMLNLSYNPF P
Sbjct:   135 VHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSP 194

Query:   204 GRIPPELGNLTNLEILWLTECNLVGEIPDSLGRXXXXXXXXXXXXXXXGAIPSSLTELAS 263
              RIPPE GNLTNLE++WLTEC+LVG+IPDSLG+               G IP SL  L +
Sbjct:   195 SRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTN 254

Query:   264 VVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEG 323
             VVQIELYNNSLTG++P    NL SLRLLDASMN LTG IPD+L R+PLESLNLYEN LEG
Sbjct:   255 VVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENNLEG 314

Query:   324 SLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGEL 383
              LPA+IA SP LYE+R+F NRL G LP DLG NSPLRW+D+S N+F+G++PA LC KGEL
Sbjct:   315 ELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGEL 374

Query:   384 EELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
             EELL+I+NSF+G +P+ L  C+SLTR+RL YNR +G VP   WGLPHV LLEL +N  SG
Sbjct:   375 EELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSG 434

Query:   444 EISKNIAGAAXXXXXXXXXXXXXXXXPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAEL 503
             EISK+I GA+                PEEIG L +L  LS S NKF+GSLP+SL +L EL
Sbjct:   435 EISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGEL 494

Query:   504 GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG 563
             G+LDLH N  SGEL S + SWKKLNELNLADN F G IP++IG+LSVLNYLDLS N  SG
Sbjct:   495 GTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSG 554

Query:   564 RIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPXXXXXXXXXXXXXXXXKN 623
             +IPV LQ+LKLNQLN+S NRLSG+LP   AK+MY+NSF+GNP                K 
Sbjct:   555 KIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGDIKGLCGSENEAKK 614

Query:   624 RGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILD 683
             RGYVW+LRSIF+LA +V + G+ WFY KYR FK  RA+++SKWTLMSFHKLGFSE+EIL+
Sbjct:   615 RGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILE 674

Query:   684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
              LDEDNVIG+G+SGKVYKVVL+NGE VAVK+LW G  KE    CD EKG          F
Sbjct:   675 SLDEDNVIGAGASGKVYKVVLTNGETVAVKRLWTGSVKET-GDCDPEKGYKPGVQDEA-F 732

Query:   744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             +AEVETLGKIRHKNIVKLWCCC+TRDCKLLVYEYMPNGSLGDLLHS KGG+L W TR+KI
Sbjct:   733 EAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKI 792

Query:   804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK-PKSMSV 862
             I+DAAEGLSYLHHD VP IVHRD+KSNNIL+DGD+GARVADFGVAK VD +GK PKSMSV
Sbjct:   793 ILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSV 852

Query:   863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ 922
             IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE+VT + PVDPE GEKDLVKWVCSTLDQ
Sbjct:   853 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEKDLVKWVCSTLDQ 912

Query:   923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGK 982
             KG++HV+DPKLD CFKEEI K+LN+GLLCTSPLPINRP+MRRVVK+LQE+G  +     K
Sbjct:   913 KGIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEIGGGDEDSLHK 972

Query:   983 ----KDGKLSPYYHEDASDQGSVA 1002
                 KDGKL+PYY+ED SDQGS+A
Sbjct:   973 IRDDKDGKLTPYYNEDTSDQGSIA 996

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 2703 (956.6 bits), Expect = 2.7e-281, P = 2.7e-281
 Identities = 551/1006 (54%), Positives = 681/1006 (67%)

Query:     3 LLTGMLVLVAFXXXXXXXXXXNQEGLYLERVKXXXXXXXXXXXXWGRNPRDDSPCSWRGV 62
             +L  +++L+            NQ+   L + K            W  N  D +PC W GV
Sbjct:     1 MLYCLILLLCLSSTYLPSLSLNQDATILRQAKLGLSDPAQSLSSWSDN-NDVTPCKWLGV 59

Query:    63 ECDPRSHSVASIDLSNANIAGPFPSLLCRLEXXXXXXXXXXSINSTLP-DDISACQNLQH 121
              CD  S+ V S+DLS+  + GPFPS+LC L           SIN +L  DD   C NL  
Sbjct:    60 SCDATSN-VVSVDLSSFMLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLIS 118

Query:   122 LDLSQNLLTGTLTPALA-DLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGT 180
             LDLS+NLL G++  +L  +LPNLKFL+++GNN S  IP SFG F+KLE ++L  N L GT
Sbjct:   119 LDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGT 178

Query:   181 IPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRXXXX 240
             IPA LGN++TLK L L+YN F P +IP +LGNLT L++LWL  CNLVG IP SL R    
Sbjct:   179 IPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSL 238

Query:   241 XXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG 300
                        G+IPS +T+L +V QIEL+NNS +G+LP    N+T+L+  DASMN LTG
Sbjct:   239 VNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTG 298

Query:   301 PIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLR 360
              IPD+L  L LESLNL+EN LEG LP +I  S  L EL+LF NRL G LP  LG NSPL+
Sbjct:   299 KIPDNLNLLNLESLNLFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQ 358

Query:   361 WVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGK 420
             +VDLS N+F+GEIPA++C +G+LE L++I NSF+G++ + LG C+SLTRVRL  N+L+G+
Sbjct:   359 YVDLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQ 418

Query:   421 VPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXXXXXXPEEIGFLKSLV 480
             +P   WGLP + LLEL+DN  +G I K I GA                 P EIG L  ++
Sbjct:   419 IPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGII 478

Query:   481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGN 540
              +SG+EN F+G +PESL  L +L  LDL  N LSGE+P  +  WK LNELNLA+N   G 
Sbjct:   479 EISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGE 538

Query:   541 IPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNS 600
             IP+++G L VLNYLDLS+N+ SG IP+ LQNLKLN LN+S N LSG++P L+A ++Y + 
Sbjct:   539 IPKEVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHD 598

Query:   601 FLGNPXXXXXXXXXXXXXXXXKNRGYVWVLRSIFILAGLVFVFGLVWFYLKYRKFK--NG 658
             F+GNP                KN GYVW+L +IF+LAGLVFV G+V F  K RK +    
Sbjct:   599 FIGNPGLCVDLDGLCRKITRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKS 658

Query:   659 RAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG 718
               +  SKW   SFHKL FSE+EI D LDE NVIG GSSGKVYKV L  GE VAVKKL   
Sbjct:   659 STLAASKWR--SFHKLHFSEHEIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKL--- 713

Query:   719 MSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYM 778
              +K  + G D              F AEVETLG IRHK+IV+LWCCC++ DCKLLVYEYM
Sbjct:   714 -NKSVKGGDDEYSSDSLNRDV---FAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYM 769

Query:   779 PNGSLGDLLHSC-KGGL-LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG 836
             PNGSL D+LH   KGG+ L WP R +I +DAAEGLSYLHHDCVP IVHRDVKS+NILLD 
Sbjct:   770 PNGSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDS 829

Query:   837 DFGARVADFGVAKVVDASGK--PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL 894
             D+GA+VADFG+AKV   SG   P++MS IAGSCGYIAPEY YTLRVNEKSDIYSFGVV+L
Sbjct:   830 DYGAKVADFGIAKVGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLL 889

Query:   895 ELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSP 954
             ELVTG+ P D E G+KD+ KWVC+ LD+ G++ V+DPKLD  FKEEI KV++IGLLCTSP
Sbjct:   890 ELVTGKQPTDSELGDKDMAKWVCTALDKCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSP 949

Query:   955 LPINRPAMRRVVKLLQEV-GA-----ENRSKTGKKDGKLSPYYHED 994
             LP+NRP+MR+VV +LQEV GA      N SK  K  GKLSPYY ED
Sbjct:   950 LPLNRPSMRKVVIMLQEVSGAVPCSSPNTSKRSKTGGKLSPYYTED 995

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1760 (624.6 bits), Expect = 3.0e-192, Sum P(2) = 3.0e-192
 Identities = 388/874 (44%), Positives = 521/874 (59%)

Query:    55 SPCSWRGVECDPRSHS---VASIDLSNANIAGPFPSLLCRLEXXXXXXXXXXSINSTLPD 111
             SPC+W G+ C  R  S   V +IDLS  NI+G FP   CR+           ++N T+  
Sbjct:    57 SPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFCRIRTLINITLSQNNLNGTIDS 116

Query:   112 -DISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVI 170
               +S C  LQ+L L+QN  +G L     +   L+ L+L  N F+G+IP+S+GR   L+V+
Sbjct:   117 APLSLCSKLQNLILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVL 176

Query:   171 SLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEI 230
             +L  N L G +PAFLG ++ L  L+L+Y  F P  IP  LGNL+NL  L LT  NLVGEI
Sbjct:   177 NLNGNPLSGIVPAFLGYLTELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEI 236

Query:   231 PDSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRL 290
             PDS+                 G IP S+  L SV QIELY+N L+G LP    NLT LR 
Sbjct:   237 PDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRN 296

Query:   291 LDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLP 350
              D S N+LTG +P+ +  L L S NL +N   G LP  +A +P L E ++F N   GTLP
Sbjct:   297 FDVSQNNLTGELPEKIAALQLISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLP 356

Query:   351 GDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV 410
              +LGK S +   D+S N+F+GE+P  LC + +L++++   N  +G++P+  G C SL  +
Sbjct:   357 RNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYI 416

Query:   411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXXXXXXP 470
             R+  N+L+G+VP   W LP   L    +N L G I  +I+ A                 P
Sbjct:   417 RMADNKLSGEVPARFWELPLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIP 476

Query:   471 EEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNEL 530
              ++  L+ L V+  S N F GS+P  +  L  L  +++  N L GE+PSSVSS  +L EL
Sbjct:   477 VKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTEL 536

Query:   531 NLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPS 590
             NL++N   G IP ++G+L VLNYLDLSNN+L+G IP  L  LKLNQ NVS+N+L G++PS
Sbjct:   537 NLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPS 596

Query:   591 LFAKEMYRNSFLGNPXXXXXXXXXXXXXXXXKNRGYVWVLRSIFILAGLVFVFGLVWFYL 650
              F ++++R SFLGNP                +   Y+  +  + I+A       LVW ++
Sbjct:   597 GFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRETRYILPISILCIVA---LTGALVWLFI 653

Query:   651 KYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAV 710
             K +     +    +K T+  F ++GF+E +I   L EDN+IGSG SG VY+V L +G+ +
Sbjct:   654 KTKPLFKRKPKRTNKITI--FQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTL 711

Query:   711 AVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC 770
             AVKKLW G     E+G   E            F++EVETLG++RH NIVKL  CC   + 
Sbjct:   712 AVKKLW-G-----ETGQKTESESV--------FRSEVETLGRVRHGNIVKLLMCCNGEEF 757

Query:   771 KLLVYEYMPNGSLGDLLHSCKG----GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRD 826
             + LVYE+M NGSLGD+LHS K       LDW TR+ I V AA+GLSYLHHD VP IVHRD
Sbjct:   758 RFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRD 817

Query:   827 VKSNNILLDGDFGARVADFGVAKVV---DASG-KPKSMSVIAGSCGYIAPEYAYTLRVNE 882
             VKSNNILLD +   RVADFG+AK +   D  G    SMS +AGS GYIAPEY YT +VNE
Sbjct:   818 VKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNE 877

Query:   883 KSDIYSFGVVILELVTGRLPVDPEFGE-KDLVKW 915
             KSD+YSFGVV+LEL+TG+ P D  FGE KD+VK+
Sbjct:   878 KSDVYSFGVVLLELITGKRPNDSSFGENKDIVKF 911

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2180617 AT5G25930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1637 (581.3 bits), Expect = 2.5e-168, P = 2.5e-168
 Identities = 376/949 (39%), Positives = 534/949 (56%)

Query:    55 SPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLEXXXXXXXXXXSINSTLPDDIS 114
             SPC+W  + C   + +V  I+  N N  G  P+ +C L                 P  + 
Sbjct:    51 SPCNWSEITCT--AGNVTGINFKNQNFTGTVPTTICDLSNLNFLDLSFNYFAGEFPTVLY 108

Query:   115 ACQNLQHLDLSQNLLTGTLTPALADL-PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV 173
              C  LQ+LDLSQNLL G+L   +  L P L +LDL  N FSGDIP+S GR  KL+V++L 
Sbjct:   109 NCTKLQYLDLSQNLLNGSLPVDIDRLSPELDYLDLAANGFSGDIPKSLGRISKLKVLNLY 168

Query:   174 YNLLDGTIPAFLGNISTLKMLNLSYNP-FLPGRIPPELGNLTNLEILWLTECNLVGEI-P 231
              +  DGT P+ +G++S L+ L L+ N  F P +IP E G L  L+ +WL E NL+GEI P
Sbjct:   169 QSEYDGTFPSEIGDLSELEELRLALNDKFTPAKIPIEFGKLKKLKYMWLEEMNLIGEISP 228

Query:   232 DSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLL 291
                                 G IP  L  L ++ +  L+ N LTG++P   S  T+L  L
Sbjct:   229 VVFENMTDLEHVDLSVNNLTGRIPDVLFGLKNLTEFYLFANGLTGEIPKSIS-ATNLVFL 287

Query:   292 DASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLP 350
             D S N+LTG IP  +  L  L+ LNL+ N+L G +P  I   PGL E ++F N+L G +P
Sbjct:   288 DLSANNLTGSIPVSIGNLTKLQVLNLFNNKLTGEIPPVIGKLPGLKEFKIFNNKLTGEIP 347

Query:   351 GDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV 410
              ++G +S L   ++S NQ TG++P +LC+ G+L+ +++  N+ TG++P+ LG C +L  V
Sbjct:   348 AEIGVHSKLERFEVSENQLTGKLPENLCKGGKLQGVVVYSNNLTGEIPESLGDCGTLLTV 407

Query:   411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXXXXXXP 470
             +L  N  +GK P  +W    +Y L++++N  +GE+ +N+A                   P
Sbjct:   408 QLQNNDFSGKFPSRIWNASSMYSLQVSNNSFTGELPENVAW--NMSRIEIDNNRFSGEIP 465

Query:   471 EEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNEL 530
             ++IG   SLV      N+F+G  P+ LT+L+ L S+ L  NDL+GELP  + SWK L  L
Sbjct:   466 KKIGTWSSLVEFKAGNNQFSGEFPKELTSLSNLISIFLDENDLTGELPDEIISWKSLITL 525

Query:   531 NLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPS 590
             +L+ N   G IP  +G L  L  LDLS N+ SG IP  + +LKL   NVS+NRL+G +P 
Sbjct:   526 SLSKNKLSGEIPRALGLLPRLLNLDLSENQFSGGIPPEIGSLKLTTFNVSSNRLTGGIPE 585

Query:   591 LFAKEMYRNSFLGNPXXXXXXXXXXXXXXXXKNRGYVW----VLRSIFILAGLVFVFGL- 645
                   Y  SFL N                 + RG       +L  I ++A L+    L 
Sbjct:   586 QLDNLAYERSFLNNSNLCADNPVLSLPDCRKQRRGSRGFPGKILAMILVIAVLLLTITLF 645

Query:   646 VWFYL--KYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKV- 702
             V F++   Y + +  R ++   W L SFH++ F+E +I+  L E  VIGSG SGKVYK+ 
Sbjct:   646 VTFFVVRDYTRKQRRRGLET--WKLTSFHRVDFAESDIVSNLMEHYVIGSGGSGKVYKIF 703

Query:   703 VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLW 762
             V S+G+ VAVK++W   SK+ +   + E            F AEVE LG IRH NIVKL 
Sbjct:   704 VESSGQCVAVKRIWD--SKKLDQKLEKE------------FIAEVEILGTIRHSNIVKLL 749

Query:   763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCK-GGLLD-----WPTRYKIIVDAAEGLSYLHH 816
             CC +  D KLLVYEY+   SL   LH  K GG ++     W  R  I V AA+GL Y+HH
Sbjct:   750 CCISREDSKLLVYEYLEKRSLDQWLHGKKKGGTVEANNLTWSQRLNIAVGAAQGLCYMHH 809

Query:   817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV-VDASGKPKSMSVIAGSCGYIAPEYA 875
             DC P+I+HRDVKS+NILLD +F A++ADFG+AK+ +  + +P +MS +AGS GYIAPEYA
Sbjct:   810 DCTPAIIHRDVKSSNILLDSEFNAKIADFGLAKLLIKQNQEPHTMSAVAGSFGYIAPEYA 869

Query:   876 YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK--DLVKWVCSTLDQ-KGVDHVLDPK 932
             YT +V+EK D+YSFGVV+LELVTGR   +   G++  +L  W        K      D  
Sbjct:   870 YTSKVDEKIDVYSFGVVLLELVTGR---EGNNGDEHTNLADWSWKHYQSGKPTAEAFDED 926

Query:   933 L-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKT 980
             + +    E +  V  +GL+CT+ LP +RP+M+ V+ +L++ G E   KT
Sbjct:   927 IKEASTTEAMTTVFKLGLMCTNTLPSHRPSMKEVLYVLRQQGLEATKKT 975

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)]

 Score = 1635 (580.6 bits), Expect = 4.1e-168, P = 4.1e-168
 Identities = 353/879 (40%), Positives = 514/879 (58%)

Query:   105 INSTLP-DDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGR 163
             ++   P D +   Q+L+ L L  N L+G +   L +  +LK+LDL  N FSG  PE F  
Sbjct:    84 LSGNFPFDSVCEIQSLEKLSLGFNSLSGIIPSDLKNCTSLKYLDLGNNLFSGAFPE-FSS 142

Query:   164 FQKLEVISLVYNLLDGTIP-AFLGNISTLKMLNLSYNPF-LPGRIPPELGNLTNLEILWL 221
               +L+ + L  +   G  P   L N ++L +L+L  NPF      P E+ +L  L  L+L
Sbjct:   143 LNQLQFLYLNNSAFSGVFPWKSLRNATSLVVLSLGDNPFDATADFPVEVVSLKKLSWLYL 202

Query:   222 TECNLVGEIPDSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTG 281
             + C++ G+IP ++G                G IPS +++L ++ Q+ELYNNSLTG LPTG
Sbjct:   203 SNCSIAGKIPPAIGDLTELRNLEISDSGLTGEIPSEISKLTNLWQLELYNNSLTGKLPTG 262

Query:   282 WSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLF 341
             + NL +L  LDAS N L G + +  +   L SL ++EN   G +P    +   L  L L+
Sbjct:   263 FGNLKNLTYLDASTNLLQGDLSELRSLTNLVSLQMFENEFSGEIPLEFGEFKDLVNLSLY 322

Query:   342 RNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGL 401
              N+L G+LP  LG  +   ++D S N  TG IP  +C+ G+++ LL++ N+ TG +P+  
Sbjct:   323 TNKLTGSLPQGLGSLADFDFIDASENLLTGPIPPDMCKNGKMKALLLLQNNLTGSIPESY 382

Query:   402 GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXX 461
              +C +L R R+  N L G VP  LWGLP + ++++  N   G I+ +I            
Sbjct:   383 ANCLTLQRFRVSENNLNGTVPAGLWGLPKLEIIDIEMNNFEGPITADIKNGKMLGALYLG 442

Query:   462 XXXXXXXXPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSV 521
                     PEEIG  +SL  +  + N+FTG +P S+  L  L SL + +N  SGE+P S+
Sbjct:   443 FNKLSDELPEEIGDTESLTKVELNNNRFTGKIPSSIGKLKGLSSLKMQSNGFSGEIPDSI 502

Query:   522 SSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSN 581
              S   L+++N+A N   G IP  +G+L  LN L+LS+N+LSGRIP  L +L+L+ L++SN
Sbjct:   503 GSCSMLSDVNMAQNSISGEIPHTLGSLPTLNALNLSDNKLSGRIPESLSSLRLSLLDLSN 562

Query:   582 NRLSGELPSLFAKEMYRNSFLGNPXXXXXXXXXXXXXXX-XKNRG--YVWVLRSIFILAG 638
             NRLSG +P   +   Y  SF GNP                 ++ G   V+VL  +F L  
Sbjct:   563 NRLSGRIP--LSLSSYNGSFNGNPGLCSTTIKSFNRCINPSRSHGDTRVFVLCIVFGL-- 618

Query:   639 LVFVFGLVWF-YLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSG 697
             L+ +  LV+F YLK  + K GR++    W++ SF K+ F+E +I+D + E+N+IG G  G
Sbjct:   619 LILLASLVFFLYLKKTEKKEGRSLKHESWSIKSFRKMSFTEDDIIDSIKEENLIGRGGCG 678

Query:   698 KVYKVVLSNGEAVAVKKL-WRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHK 756
              VY+VVL +G+ VAVK +      K   S   +             F+ EV+TL  IRH 
Sbjct:   679 DVYRVVLGDGKEVAVKHIRCSSTQKNFSSAMPI---LTEREGRSKEFETEVQTLSSIRHL 735

Query:   757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH 816
             N+VKL+C  T+ D  LLVYEY+PNGSL D+LHSCK   L W TRY I + AA+GL YLHH
Sbjct:   736 NVVKLYCSITSDDSSLLVYEYLPNGSLWDMLHSCKKSNLGWETRYDIALGAAKGLEYLHH 795

Query:   817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS-GKPKSMSVIAGSCGYIAP-EY 874
                  ++HRDVKS+NILLD     R+ADFG+AK++ AS G P+S  V+AG+ GYIAP EY
Sbjct:   796 GYERPVIHRDVKSSNILLDEFLKPRIADFGLAKILQASNGGPESTHVVAGTYGYIAPAEY 855

Query:   875 AYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-KDLVKWVCSTLDQK-GVDHVLDPK 932
              Y  +V EK D+YSFGVV++ELVTG+ P++ EFGE KD+V WV + L  K  V  ++D K
Sbjct:   856 GYASKVTEKCDVYSFGVVLMELVTGKKPIEAEFGESKDIVNWVSNNLKSKESVMEIVDKK 915

Query:   933 LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
             +   ++E+  K+L I ++CT+ LP  RP MR VV+++++
Sbjct:   916 IGEMYREDAVKMLRIAIICTARLPGLRPTMRSVVQMIED 954

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0006979 "response to oxidative stress" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0070825 "micropyle" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1580 (561.2 bits), Expect = 2.7e-162, P = 2.7e-162
 Identities = 371/958 (38%), Positives = 526/958 (54%)

Query:    57 CSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLEXXXXXXXXXXSINSTLPDDISAC 116
             CSW GV CD     V S+DLS  N++G   S +  L            I+  +P  IS  
Sbjct:    57 CSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNL 116

Query:   117 QNLQHLDLSQNLLTGTLTPALAD-LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN 175
               L+HL+LS N+  G+    L+  L NL+ LDL  NN +GD+P S     +L  + L  N
Sbjct:   117 YELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGN 176

Query:   176 LLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGE-IPDSL 234
                G IPA  G    L+ L +S N  L G+IPPE+GNLT L  L++   N     +P  +
Sbjct:   177 YFSGKIPATYGTWPVLEYLAVSGNE-LTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEI 235

Query:   235 GRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDAS 294
             G                G IP  + +L  +  + L  N+ TG +      ++SL+ +D S
Sbjct:   236 GNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLS 295

Query:   295 MNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDL 353
              N  TG IP   ++L  L  LNL+ N+L G++P  I + P L  L+L+ N   G++P  L
Sbjct:   296 NNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKL 355

Query:   354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLG 413
             G+N  L  +DLS+N+ TG +P ++C    L  L+ + N   G +PD LG C+SLTR+R+G
Sbjct:   356 GENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMG 415

Query:   414 YNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXXXXXX-PEE 472
              N L G +P  L+GLP +  +EL DN+L+GE+  +  G +                 P  
Sbjct:   416 ENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAA 475

Query:   473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL 532
             IG L  +  L    NKF+GS+P  +  L +L  LD   N  SG +   +S  K L  ++L
Sbjct:   476 IGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDL 535

Query:   533 ADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPSL 591
             + N   G+IP ++  + +LNYL+LS N L G IPV + +++ L  ++ S N LSG +PS 
Sbjct:   536 SRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPST 595

Query:   592 FAKEMYRN--SFLGNPXXXXXXXXXXXXXXXXKNRGYVWVLRSIFILAGLVFVFGLVWFY 649
               +  Y N  SF+GN                  +   +     + ++ GL+F   +V+  
Sbjct:   596 -GQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFC-SMVFAI 653

Query:   650 LKYRKFKNGRAIDKSK-WTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGE 708
             +   K ++ R   ++K W L +F +L F+  ++LD L EDN+IG G +G VYK  +  G+
Sbjct:   654 VAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGD 713

Query:   709 AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTR 768
              VAVK+L             +  G         GF AE++TLG+IRH++IV+L   C+  
Sbjct:   714 LVAVKRL-----------ATMSHGSSHDH----GFNAEIQTLGRIRHRHIVRLLGFCSNH 758

Query:   769 DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK 828
             +  LLVYEYMPNGSLG++LH  KGG L W TRYKI ++AA+GL YLHHDC P IVHRDVK
Sbjct:   759 ETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVK 818

Query:   829 SNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYS 888
             SNNILLD +F A VADFG+AK +  SG  + MS IAGS GYIAPEYAYTL+V+EKSD+YS
Sbjct:   819 SNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYS 878

Query:   889 FGVVILELVTGRLPVDPEFGEK-DLVKWVCSTLDQKG--VDHVLDPKLDCCFKEEICKVL 945
             FGVV+LEL+TG+ PV  EFG+  D+V+WV S  D     V  V+D +L      E+  V 
Sbjct:   879 FGVVLLELITGKKPVG-EFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVF 937

Query:   946 NIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLS---PYYHEDASDQGS 1000
              + LLC     + RP MR VV++L E+     SK    +  ++   P  +E + D GS
Sbjct:   938 YVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAESDVTEKAPAINESSPDSGS 995

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 1574 (559.1 bits), Expect = 1.2e-161, P = 1.2e-161
 Identities = 373/965 (38%), Positives = 535/965 (55%)

Query:    47 WGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLEXXXXXXXXXXSIN 106
             W  +   D  C+W GV C+   + V  +DL+  N+ G     + +L              
Sbjct:    51 WKLSDTSDH-CNWTGVRCNSNGN-VEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFE 108

Query:   107 STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQK 166
             S LP  I     L+ +D+SQN  +G+L     +   L  L+ +GNN SG++ E  G    
Sbjct:   109 SLLPKSIPP---LKSIDISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVS 165

Query:   167 LEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL 226
             LEV+ L  N   G++P+   N+  L+ L LS N  L G +P  LG L +LE   L     
Sbjct:   166 LEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNN-LTGELPSVLGQLPSLETAILGYNEF 224

Query:   227 VGEIPDSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLT 286
              G IP   G                G IPS L +L S+  + LY N+ TG +P    ++T
Sbjct:   225 KGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSIT 284

Query:   287 SLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRL 345
             +L++LD S N LTG IP ++T+L  L+ LNL  N+L GS+P  I+    L  L L+ N L
Sbjct:   285 TLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTL 344

Query:   346 NGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQ 405
             +G LP DLGKNSPL+W+D+S+N F+GEIP++LC KG L +L++  N+FTGQ+P  L  CQ
Sbjct:   345 SGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQ 404

Query:   406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXX 465
             SL RVR+  N L G +P     L  +  LEL  N LSG I  +I+ +             
Sbjct:   405 SLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQI 464

Query:   466 XXXXPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWK 525
                 P  I  + +L     ++N  +G +P+   +   L +LDL +N L+G +PSS++S +
Sbjct:   465 RSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCE 524

Query:   526 KLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGL-QNLKLNQLNVSNNRL 584
             KL  LNL +N   G IP  I  +S L  LDLSNN L+G +P  +  +  L  LNVS N+L
Sbjct:   525 KLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKL 584

Query:   585 SGELP-SLFAKEMYRNSFLGN---------PXXXXXXXXXXXXXXXXKNRGYVWVLRSIF 634
             +G +P + F K +  +   GN         P                K     W++    
Sbjct:   585 TGPVPINGFLKTINPDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIAS 644

Query:   635 ILA-GLVFVFGLVWFYLKYRKFKNGRAIDK--SK----WTLMSFHKLGFSEYEILDGLDE 687
             +LA G++ +      Y K+  + NG   D+  SK    W LM+FH+LGF+  +IL  + E
Sbjct:   645 VLALGILTIVTRT-LYKKW--YSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKE 701

Query:   688 DNVIGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAE 746
              N+IG G++G VYK  +S    V AVKKLWR       S  D+E G          F  E
Sbjct:   702 SNMIGMGATGIVYKAEMSRSSTVLAVKKLWR-------SAADIEDGTTGD------FVGE 748

Query:   747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH--SCKGGLL-DWPTRYKI 803
             V  LGK+RH+NIV+L          ++VYE+M NG+LGD +H  +  G LL DW +RY I
Sbjct:   749 VNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNI 808

Query:   804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
              +  A GL+YLHHDC P ++HRD+KSNNILLD +  AR+ADFG+A+++  + K +++S++
Sbjct:   809 ALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVSMV 866

Query:   864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK-DLVKWVCSTL-D 921
             AGS GYIAPEY YTL+V+EK DIYS+GVV+LEL+TGR P++PEFGE  D+V+WV   + D
Sbjct:   867 AGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRD 926

Query:   922 QKGVDHVLDPKLDCC--FKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSK 979
                ++  LDP +  C   +EE+  VL I LLCT+ LP +RP+MR V+ +L E     +S 
Sbjct:   927 NISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSN 986

Query:   980 TGKKD 984
             + +++
Sbjct:   987 SNEEN 991

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1573 (558.8 bits), Expect = 1.5e-161, P = 1.5e-161
 Identities = 369/933 (39%), Positives = 515/933 (55%)

Query:    57 CSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLEXXXXXXXXXXSINSTLPDDISAC 116
             C+W GV CD     V S+DLS  N++G     +  L            I+  +P +IS+ 
Sbjct:    57 CTWIGVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSL 116

Query:   117 QNLQHLDLSQNLLTGTLTPALAD-LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN 175
               L+HL+LS N+  G+    ++  L NL+ LD+  NN +GD+P S     +L  + L  N
Sbjct:   117 SGLRHLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGN 176

Query:   176 LLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGE-IPDSL 234
                G IP   G+   ++ L +S N  L G+IPPE+GNLT L  L++   N   + +P  +
Sbjct:   177 YFAGKIPPSYGSWPVIEYLAVSGNE-LVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEI 235

Query:   235 GRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDAS 294
             G                G IP  + +L  +  + L  N  +G L      L+SL+ +D S
Sbjct:   236 GNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLS 295

Query:   295 MNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDL 353
              N  TG IP     L  L  LNL+ N+L G +P  I D P L  L+L+ N   G++P  L
Sbjct:   296 NNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKL 355

Query:   354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLG 413
             G+N  L  VDLS+N+ TG +P ++C   +LE L+ + N   G +PD LG C+SLTR+R+G
Sbjct:   356 GENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMG 415

Query:   414 YNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXXXXXXP--E 471
              N L G +P  L+GLP +  +EL DN+LSGE+   +AG                  P   
Sbjct:   416 ENFLNGSIPKGLFGLPKLTQVELQDNYLSGELP--VAGGVSVNLGQISLSNNQLSGPLPP 473

Query:   472 EIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELN 531
              IG    +  L    NKF G +P  +  L +L  +D   N  SG +   +S  K L  ++
Sbjct:   474 AIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVD 533

Query:   532 LADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPS 590
             L+ N   G IP +I  + +LNYL+LS N L G IP  + +++ L  L+ S N LSG +P 
Sbjct:   534 LSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPG 593

Query:   591 LFAKEMYRN--SFLGNPXXXXXXXX-----XXXXXXXXKNRGYVWVLRSIFILAGLVFVF 643
                +  Y N  SFLGNP                      ++G +     + ++ GL+ V 
Sbjct:   594 T-GQFSYFNYTSFLGNPDLCGPYLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLL-VC 651

Query:   644 GLVWFYLKYRKFKNGRAIDKSK-WTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKV 702
              + +  +   K ++ +   +S+ W L +F +L F+  ++LD L EDN+IG G +G VYK 
Sbjct:   652 SIAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKG 711

Query:   703 VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLW 762
             V+ NG+ VAVK+L   MS+   S  D             GF AE++TLG+IRH++IV+L 
Sbjct:   712 VMPNGDLVAVKRL-AAMSRG--SSHD------------HGFNAEIQTLGRIRHRHIVRLL 756

Query:   763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI 822
               C+  +  LLVYEYMPNGSLG++LH  KGG L W TRYKI ++AA+GL YLHHDC P I
Sbjct:   757 GFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLI 816

Query:   823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNE 882
             VHRDVKSNNILLD +F A VADFG+AK +  SG  + MS IAGS GYIAPEYAYTL+V+E
Sbjct:   817 VHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDE 876

Query:   883 KSDIYSFGVVILELVTGRLPVDPEFGEK-DLVKWVCSTLDQK--GVDHVLDPKLDCCFKE 939
             KSD+YSFGVV+LELVTGR PV  EFG+  D+V+WV    D     V  VLDP+L      
Sbjct:   877 KSDVYSFGVVLLELVTGRKPVG-EFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIH 935

Query:   940 EICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             E+  V  + +LC     + RP MR VV++L E+
Sbjct:   936 EVTHVFYVAMLCVEEQAVERPTMREVVQILTEI 968

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1544 (548.6 bits), Expect = 1.8e-158, P = 1.8e-158
 Identities = 375/952 (39%), Positives = 520/952 (54%)

Query:    51 PRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLE-XXXXXXXXXXSINSTL 109
             P  +S CSW GV CD  + S+  +DLSN NI+G     + RL            S +  L
Sbjct:    58 PNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTISPEISRLSPSLVFLDISSNSFSGEL 117

Query:   110 PDDISACQNLQHLDLSQNLLTGTL-TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLE 168
             P +I     L+ L++S N+  G L T   + +  L  LD   N+F+G +P S     +LE
Sbjct:   118 PKEIYELSGLEVLNISSNVFEGELETRGFSQMTQLVTLDAYDNSFNGSLPLSLTTLTRLE 177

Query:   169 VISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECN-LV 227
              + L  N  DG IP   G+  +LK L+LS N  L GRIP EL N+T L  L+L   N   
Sbjct:   178 HLDLGGNYFDGEIPRSYGSFLSLKFLSLSGND-LRGRIPNELANITTLVQLYLGYYNDYR 236

Query:   228 GEIPDSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTS 287
             G IP   GR               G+IP+ L  L ++  + L  N LTG +P    N+TS
Sbjct:   237 GGIPADFGRLINLVHLDLANCSLKGSIPAELGNLKNLEVLFLQTNELTGSVPRELGNMTS 296

Query:   288 LRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN 346
             L+ LD S N L G IP +L+ L  L+  NL+ NRL G +P  +++ P L  L+L+ N   
Sbjct:   297 LKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLHGEIPEFVSELPDLQILKLWHNNFT 356

Query:   347 GTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFT-GQLPDGLGHCQ 405
             G +P  LG N  L  +DLS N+ TG IP SLC  G   ++L+++N+F  G LP+ LG C+
Sbjct:   357 GKIPSKLGSNGNLIEIDLSTNKLTGLIPESLCF-GRRLKILILFNNFLFGPLPEDLGQCE 415

Query:   406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXX 465
              L R RLG N LT K+P  L  LP++ LLEL +NFL+GEI +  AG A            
Sbjct:   416 PLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQFSSLTQINLSN 475

Query:   466 XXXX---PEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVS 522
                    P  I  L+SL +L    N+ +G +P  + +L  L  +D+  N+ SG+ P    
Sbjct:   476 NRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIGSLKSLLKIDMSRNNFSGKFPPEFG 535

Query:   523 SWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSN 581
                 L  L+L+ N   G IP  I  + +LNYL++S N  +  +P  L  +K L   + S+
Sbjct:   536 DCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPNELGYMKSLTSADFSH 595

Query:   582 NRLSGELPSLFAKEMYRN-SFLGNPX-----------XXXXXXXXXXXXXXXKNRGYVWV 629
             N  SG +P+      + N SFLGNP                           ++RG +  
Sbjct:   596 NNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQLLNQNNARSRGEISA 655

Query:   630 LRSIFILAGLVFVFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDN 689
                +F   GL+  F LV+  L   K +  R  + + W L+ F KLGF    IL+ + E++
Sbjct:   656 KFKLFFGLGLLGFF-LVFVVLAVVKNRRMRKNNPNLWKLIGFQKLGFRSEHILECVKENH 714

Query:   690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
             VIG G  G VYK V+ NGE VAVKKL             + KG         G  AE++T
Sbjct:   715 VIGKGGRGIVYKGVMPNGEEVAVKKL-----------LTITKGSSHDN----GLAAEIQT 759

Query:   750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
             LG+IRH+NIV+L   C+ +D  LLVYEYMPNGSLG++LH   G  L W TR +I ++AA+
Sbjct:   760 LGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAK 819

Query:   810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKPKSMSVIAGSCG 868
             GL YLHHDC P I+HRDVKSNNILL  +F A VADFG+AK ++  +G  + MS IAGS G
Sbjct:   820 GLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYG 879

Query:   869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK--DLVKW--VCSTLDQKG 924
             YIAPEYAYTLR++EKSD+YSFGVV+LEL+TGR PVD  FGE+  D+V+W  + +  +++G
Sbjct:   880 YIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVD-NFGEEGIDIVQWSKIQTNCNRQG 938

Query:   925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN 976
             V  ++D +L      E  ++  + +LC     + RP MR VV+++ +    N
Sbjct:   939 VVKIIDQRLSNIPLAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQPN 990

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2091206 IKU2 "HAIKU2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1526 (542.2 bits), Expect = 1.4e-156, P = 1.4e-156
 Identities = 348/903 (38%), Positives = 505/903 (55%)

Query:   109 LP-DDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKL 167
             LP D I   + L+ L L  N L G +   L     L++LDL  NNFSG+ P +    Q L
Sbjct:    91 LPFDSICDLKLLEKLVLGNNSLRGQIGTNLGKCNRLRYLDLGINNFSGEFP-AIDSLQLL 149

Query:   168 EVISLVYNLLDGTIP-AFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL 226
             E +SL  + + G  P + L ++  L  L++  N F     P E+ NLT L+ ++L+  ++
Sbjct:   150 EFLSLNASGISGIFPWSSLKDLKRLSFLSVGDNRFGSHPFPREILNLTALQWVYLSNSSI 209

Query:   227 VGEIPDSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLT 286
              G+IP+ +                 G IP  + +L ++ Q+E+Y+N LTG LP G+ NLT
Sbjct:   210 TGKIPEGIKNLVRLQNLELSDNQISGEIPKEIVQLKNLRQLEIYSNDLTGKLPLGFRNLT 269

Query:   287 SLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN 346
             +LR  DAS N L G + +      L SL ++ENRL G +P    D   L  L L+RN+L 
Sbjct:   270 NLRNFDASNNSLEGDLSELRFLKNLVSLGMFENRLTGEIPKEFGDFKSLAALSLYRNQLT 329

Query:   347 GTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQS 406
             G LP  LG  +  +++D+S N   G+IP  +C+KG +  LLM+ N FTGQ P+    C++
Sbjct:   330 GKLPRRLGSWTAFKYIDVSENFLEGQIPPYMCKKGVMTHLLMLQNRFTGQFPESYAKCKT 389

Query:   407 LTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXXX 466
             L R+R+  N L+G +P  +WGLP++  L+L  N+  G ++ +I  A              
Sbjct:   390 LIRLRVSNNSLSGMIPSGIWGLPNLQFLDLASNYFEGNLTGDIGNAKSLGSLDLSNNRFS 449

Query:   467 XXXPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK 526
                P +I    SLV ++   NKF+G +PES   L EL SL L  N+LSG +P S+     
Sbjct:   450 GSLPFQISGANSLVSVNLRMNKFSGIVPESFGKLKELSSLILDQNNLSGAIPKSLGLCTS 509

Query:   527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSG 586
             L +LN A N     IPE +G+L +LN L+LS N+LSG IPVGL  LKL+ L++SNN+L+G
Sbjct:   510 LVDLNFAGNSLSEEIPESLGSLKLLNSLNLSGNKLSGMIPVGLSALKLSLLDLSNNQLTG 569

Query:   587 ELP-SLFAKEMYRNSFLGNPXXXXXXXXXXXXXXXXKNRGYVWVLRSIFILAGLVFVFGL 645
              +P SL +     NS L +                   R ++  +   FI+A ++ +F L
Sbjct:   570 SVPESLVSGSFEGNSGLCSSKIRYLRPCPLGKPHSQGKRKHLSKVDMCFIVAAILALFFL 629

Query:   646 VWFYL-KYRKFKNGRAIDKSK-WTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV 703
               + + K R+ K  + + K   W + SF  L F+E EI+D +  +N+IG G  G VYKV 
Sbjct:   630 FSYVIFKIRRDKLNKTVQKKNDWQVSSFRLLNFNEMEIIDEIKSENIIGRGGQGNVYKVS 689

Query:   704 LSNGEAVAVKKLW-RGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLW 762
             L +GE +AVK +W    S E                    F+AEV TL  I+H N+VKL+
Sbjct:   690 LRSGETLAVKHIWCPESSHESFRSSTAMLSDGNNRSNNGEFEAEVATLSNIKHINVVKLF 749

Query:   763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-LDWPTRYKIIVDAAEGLSYLHHDCVPS 821
             C  T  D KLLVYEYMPNGSL + LH  +G   + W  R  + + AA+GL YLHH     
Sbjct:   750 CSITCEDSKLLVYEYMPNGSLWEQLHERRGEQEIGWRVRQALALGAAKGLEYLHHGLDRP 809

Query:   822 IVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS--VIAGSCGYIAPEYAYTLR 879
             ++HRDVKS+NILLD ++  R+ADFG+AK++ A    +  S  ++ G+ GYIAPEYAYT +
Sbjct:   810 VIHRDVKSSNILLDEEWRPRIADFGLAKIIQADSVQRDFSAPLVKGTLGYIAPEYAYTTK 869

Query:   880 VNEKSDIYSFGVVILELVTGRLPVDPEFGEK-DLVKWVCSTLDQKGVD---HVLDPKLDC 935
             VNEKSD+YSFGVV++ELVTG+ P++ +FGE  D+V WV S   +   +    ++D  ++ 
Sbjct:   870 VNEKSDVYSFGVVLMELVTGKKPLETDFGENNDIVMWVWSVSKETNREMMMKLIDTSIED 929

Query:   936 CFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDA 995
              +KE+  KVL I LLCT   P  RP M+ VV +L+++         K  G+ S  Y E A
Sbjct:   930 EYKEDALKVLTIALLCTDKSPQARPFMKSVVSMLEKI----EPSYNKNSGEAS--YGESA 983

Query:   996 SDQ 998
             +D+
Sbjct:   984 NDE 986

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009960 "endosperm development" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SGP2	HSL1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7284	0.9760	0.9819	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pm.C_LG_IV000169 hypothetical protein (992 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1002
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-169
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-43
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-35
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	5e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-07
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.003
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.003
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.003
COG5238	388	COG5238, RNA1, Ran GTPase-activating protein (RanG	0.004
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  520 bits (1340), Expect = e-169
 Identities = 344/992 (34%), Positives = 515/992 (51%), Gaps = 63/992 (6%)

Query: 6   GMLVLVAFLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECD 65
             L+ + F L    S+   +E   L   K S++DP   LS+W  N   D  C W+G+ C+
Sbjct: 10  PYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNW--NSSADV-CLWQGITCN 66

Query: 66  PRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISA-CQNLQHLDL 124
             S  V SIDLS  NI+G   S + RL  +  + L NN ++  +PDDI     +L++L+L
Sbjct: 67  NSSR-VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 125 SQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAF 184
           S N  TG++      +PNL+ LDL+ N  SG+IP   G F  L+V+ L  N+L G IP  
Sbjct: 126 SNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 185 LGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLD 244
           L N+++L+ L L+ N  + G+IP ELG + +L+ ++L   NL GEIP  +G L  L  LD
Sbjct: 184 LTNLTSLEFLTLASNQLV-GQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242

Query: 245 LALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPD 304
           L  NNL G IPSSL  L ++  + LY N L+G +P    +L  L  LD S N L+G IP+
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302

Query: 305 DLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVD 363
            + +L  LE L+L+ N   G +P  +   P L  L+L+ N+ +G +P +LGK++ L  +D
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362

Query: 364 LSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP 423
           LS N  TGEIP  LC  G L +L++  NS  G++P  LG C+SL RVRL  N  +G++P 
Sbjct: 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422

Query: 424 LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLS 483
               LP VY L++++N L G I+       +L +L +++N   G LP+  G  K L  L 
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLD 481

Query: 484 GSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPE 543
            S N+F+G++P  L +L+EL  L L  N LSGE+P  +SS KKL  L+L+ N   G IP 
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541

Query: 544 DIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPSLFA-KEMYRNSF 601
               + VL+ LDLS N+LSG IP  L N++ L Q+N+S+N L G LPS  A   +  ++ 
Sbjct: 542 SFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAV 601

Query: 602 LGNPGLCGD--LEGLCDGRGEEKNRGYVWVLRSIF--ILAGLVFVFGLVWFY----LKYR 653
            GN  LCG     GL   +   K   + + +       L   +  FG V+      L+ +
Sbjct: 602 AGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK 661

Query: 654 KFKNGRAIDKSKWTLMSFHKL---GFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAV 710
           + +N    +   W L  F        +  +IL  L E+NVI  G  G  YK         
Sbjct: 662 RVEN----EDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQ 717

Query: 711 AVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDC 770
            V K                  ++ D   +    +E+  +GK++H NIVKL   C +   
Sbjct: 718 FVVK------------------EINDV--NSIPSSEIADMGKLQHPNIVKLIGLCRSEKG 757

Query: 771 KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN 830
             L++EY+   +L ++L +     L W  R KI +  A+ L +LH  C P++V  ++   
Sbjct: 758 AYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPE 812

Query: 831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFG 890
            I++DG     +        +   G   + +    S  Y+APE   T  + EKSDIY FG
Sbjct: 813 KIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFG 865

Query: 891 VVILELVTGRLPVDPEFG-EKDLVKWVCSTLDQKGVDHVLDPKLD---CCFKEEICKVLN 946
           ++++EL+TG+ P D EFG    +V+W         +D  +DP +       + EI +V+N
Sbjct: 866 LILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMN 925

Query: 947 IGLLCTSPLPINRPAMRRVVKLLQEVGAENRS 978
           + L CT+  P  RP    V+K L+     + S
Sbjct: 926 LALHCTATDPTARPCANDVLKTLESASRSSSS 957

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (399), Expect = 1e-43
 Identities = 72/209 (34%), Positives = 102/209 (48%), Gaps = 25/209 (11%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G VY       G+ VA+K + +  S                    +    E+E 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL----------------EELLREIEI 44

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L K+ H NIVKL+      +   LV EY   GSL DLL   +G  L      +I++   E
Sbjct: 45  LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILE 103

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           GL YLH +    I+HRD+K  NILLD D G  ++ADFG++K++        +  I G+  
Sbjct: 104 GLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPA 158

Query: 869 YIAPE-YAYTLRVNEKSDIYSFGVVILEL 896
           Y+APE        +EKSDI+S GV++ EL
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  158 bits (401), Expect = 2e-43
 Identities = 76/226 (33%), Positives = 109/226 (48%), Gaps = 33/226 (14%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLW-RGMSKECESGCDVEKGQVQD 736
           YEIL+       +G GS GKVY       G+ VA+K +  + + K+ E            
Sbjct: 1   YEILE------KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER----------- 43

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                    E++ L K++H NIV+L+      D   LV EY   G L DLL   +G L +
Sbjct: 44  ------ILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSE 96

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
              R+  +      L YLH      IVHRD+K  NILLD D   ++ADFG+A+ +D   K
Sbjct: 97  DEARF-YLRQILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK 152

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             +     G+  Y+APE        +  DI+S GV++ EL+TG+ P
Sbjct: 153 LTTF---VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (400), Expect = 3e-43
 Identities = 74/218 (33%), Positives = 106/218 (48%), Gaps = 30/218 (13%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +GSGS G VYK      G+ VAVK L +               + +   +D   + E+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKK---------------RSEKSKKDQTARREIR 50

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L ++ H NIV+L      +D   LV EY   G L D L   +GG L      KI +   
Sbjct: 51  ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQIL 108

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
            GL YLH +    I+HRD+K  NILLD +   ++ADFG+AK +  S     ++   G+  
Sbjct: 109 RGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPW 163

Query: 869 YIAPEYAYTLRVNE----KSDIYSFGVVILELVTGRLP 902
           Y+APE    L        K D++S GV++ EL+TG+ P
Sbjct: 164 YMAPE---VLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  149 bits (378), Expect = 3e-40
 Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 31/221 (14%)

Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
            ++G GS G VY  +    GE +AVK +        E   D E+       + +  + E+
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSV--------ELSGDSEE-------ELEALEREI 50

Query: 748 ETLGKIRHKNIVK-LWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLLDWPT--RY-K 802
             L  ++H NIV+            L ++ EY+  GSL  LL   K G L  P   +Y +
Sbjct: 51  RILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTR 108

Query: 803 IIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            I+   EGL+YLH +     IVHRD+K  NIL+D D   ++ADFG AK +      +   
Sbjct: 109 QIL---EGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161

Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + G+  ++APE          +DI+S G  ++E+ TG+ P
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  145 bits (368), Expect = 8e-39
 Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 60/302 (19%)

Query: 689 NVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
             +G G+ G+VYK  L   +     VAVK L     KE  S     + + +D      F 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-----KEDAS-----EEERKD------FL 44

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-------GGLLDW 797
            E   + K+ H N+V+L   CT  +   LV EYM  G L D L   +          L  
Sbjct: 45  KEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSL 104

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                  +  A+G+ YL        VHRD+ + N L+  D   +++DFG+++ V      
Sbjct: 105 KDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY 161

Query: 858 KSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP---VDPEFG 908
           +       + G +     APE         KSD++SFGV++ E+ T G  P   +  E  
Sbjct: 162 RKK-----TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-- 214

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
             ++++++     +KG  + L PK + C  E    +  + L C    P +RP    +V+ 
Sbjct: 215 --EVLEYL-----RKG--YRL-PKPEYCPDE----LYELMLSCWQLDPEDRPTFSELVER 260

Query: 969 LQ 970
           L+
Sbjct: 261 LE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  143 bits (364), Expect = 2e-38
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 49/296 (16%)

Query: 685 LDEDNVIGSGSSGKVYKVVLSNG-----EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
           L     +G G+ G+VYK  L          VAVK L     KE  S         + Q++
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-----KEDAS---------EQQIE 46

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           +  F  E   + K+ H NIVKL   CT  +  ++V EYMP G L D L   +   L    
Sbjct: 47  E--FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD 104

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
                +  A G+ YL        +HRD+ + N L+  +   +++DFG+++ +        
Sbjct: 105 LLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY------D 155

Query: 860 MSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLV 913
                   G +     APE     +   KSD++SFGV++ E+ T G  P  P     +++
Sbjct: 156 DDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY-PGMSNAEVL 214

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL 969
           +++     +KG  + L    +C    E+ K++   L C +  P +RP    +V++L
Sbjct: 215 EYL-----KKG--YRLPKPPNC--PPELYKLM---LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  141 bits (358), Expect = 1e-37
 Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 49/296 (16%)

Query: 685 LDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
           L+    +G G+ G+VYK  L          VAVK L  G S+E              + +
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--------------ERE 46

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           +  F  E   + K+ H NIV+L   CT  +   +V EYMP G L D L    G  L    
Sbjct: 47  E--FLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKD 103

Query: 800 RYKIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
             ++ +  A+G+ YL   +     VHRD+ + N L+  +   +++DFG+++ +       
Sbjct: 104 LLQMALQIAKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIY----ED 155

Query: 859 SMSVIAGSCG----YIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLV 913
                 G       ++APE     +   KSD++SFGV++ E+ T G  P  P    ++++
Sbjct: 156 DYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVL 214

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL 969
           + +          + L    +C   +E+ +++   L C +  P +RP    +V+ L
Sbjct: 215 ELLED-------GYRLPRPENCP--DELYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  140 bits (354), Expect = 4e-37
 Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 31/226 (13%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            +EIL+       IG G  G+VYK      G+ VA+K +             +E  + ++
Sbjct: 1   LFEILE------KIGKGGFGEVYKARHKRTGKEVAIKVI------------KLESKEKKE 42

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
           ++       E++ L K +H NIVK +     +D   +V E+   GSL DLL S    L +
Sbjct: 43  KII-----NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTE 97

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
               Y +  +  +GL YLH +    I+HRD+K+ NILL  D   ++ DFG++  +  +  
Sbjct: 98  SQIAY-VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             +M    G+  ++APE       + K+DI+S G+  +EL  G+ P
Sbjct: 154 RNTM---VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (340), Expect = 3e-35
 Identities = 73/298 (24%), Positives = 124/298 (41%), Gaps = 54/298 (18%)

Query: 685 LDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
           L     +G G+ G+VYK  L          VAVK L     KE  S   +E+        
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-----KEDASEQQIEE-------- 47

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
              F  E   + K+ H N+VKL   CT  +   +V EYM  G L   L   +   L    
Sbjct: 48  ---FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSD 103

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
                +  A G+ YL        +HRD+ + N L+  +   +++DFG+++ +        
Sbjct: 104 LLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY------D 154

Query: 860 MSVIAGSCG-----YIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLV 913
                   G     ++APE     +   KSD++SFGV++ E+ T G  P  P    ++++
Sbjct: 155 DDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVL 213

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAMRRVVKLL 969
           +++     + G  + L            C  ++ ++ L C +  P +RP    +V++L
Sbjct: 214 EYL-----KNG--YRLPQ-------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  120 bits (304), Expect = 3e-30
 Identities = 73/231 (31%), Positives = 113/231 (48%), Gaps = 30/231 (12%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +YE++       VIG G++  VY  + L N E VA+K++            D+EK Q  
Sbjct: 1   DDYELI------EVIGVGATAVVYAAICLPNNEKVAIKRI------------DLEKCQTS 42

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGL 794
                D  + EV+ + +  H N+VK +      D   LV  Y+  GSL D++  S   G 
Sbjct: 43  V----DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG 98

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           LD      ++ +  +GL YLH +     +HRD+K+ NILL  D   ++ADFGV+  +   
Sbjct: 99  LDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155

Query: 855 G--KPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLP 902
           G    K      G+  ++APE    +   + K+DI+SFG+  +EL TG  P
Sbjct: 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 25/216 (11%)

Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           ++IG G+ G VYK + L  G+ VA+K+    +S E      +++  ++          E+
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQ----ISLE-----KIKEEALKS------IMQEI 50

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
           + L  ++H NIVK      T D   ++ EY  NGSL  ++   K G          +   
Sbjct: 51  DLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQV 108

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGS 866
            +GL+YLH      ++HRD+K+ NIL   D   ++ADFGVA K+ D S    S   + G+
Sbjct: 109 LQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGT 162

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             ++APE       +  SDI+S G  ++EL+TG  P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (296), Expect = 2e-29
 Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 39/232 (16%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKL-WRGMSKECESGCDVEKGQVQD 736
           YEI+        IG GS GKVY V   S+G+   +K++    MS++       E+     
Sbjct: 2   YEII------KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-------EREDAL- 47

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGL 794
                    EV+ L K+ H NI+K +     +    +V EY   G L   +   K  G  
Sbjct: 48  --------NEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP 99

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                     V     L YLH      I+HRD+K  NI L  +   ++ DFG++KV+ ++
Sbjct: 100 FPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156

Query: 855 GKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               + +V+ G+  Y++PE      Y    N KSDI+S G V+ EL T + P
Sbjct: 157 -VDLAKTVV-GTPYYLSPELCQNKPY----NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (289), Expect = 2e-28
 Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 47/229 (20%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G GSSG VYKV     G+  A+KK+     +E              Q+       E++
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----------QLL-----RELK 51

Query: 749 TLGKIRHKNIVKLW---CCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRY--K 802
           TL       +VK +        ++ ++ +V EYM  GSL DLL          P      
Sbjct: 52  TLRSCESPYVVKCYGAFY----KEGEISIVLEYMDGGSLADLLKKVGK----IPEPVLAY 103

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           I     +GL YLH      I+HRD+K +N+L++     ++ADFG++KV++ +    +  V
Sbjct: 104 IARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV 161

Query: 863 IAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
             G+  Y++PE      Y+Y       +DI+S G+ +LE   G+ P  P
Sbjct: 162 --GTVTYMSPERIQGESYSY------AADIWSLGLTLLECALGKFPFLP 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (293), Expect = 4e-28
 Identities = 81/293 (27%), Positives = 119/293 (40%), Gaps = 36/293 (12%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
            Y IL        +G GS G+VY     + + VA+K L               K      
Sbjct: 1   SYRIL------RKLGEGSFGEVYLAR--DRKLVALKVL--------------AKKLESKS 38

Query: 738 VQDDGFQAEVETLGKIRH-KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-KGGLL 795
            + + F  E++ L  + H  NIVKL+          LV EY+  GSL DLL    + G L
Sbjct: 39  KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPL 98

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD-FGARVADFGVAKVVDAS 854
                  I+      L YLH      I+HRD+K  NILLD D    ++ DFG+AK++   
Sbjct: 99  SESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155

Query: 855 GKPKS----MSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPVDPEF 907
           G   S     S   G+ GY+APE    L     +  SDI+S G+ + EL+TG  P + E 
Sbjct: 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215

Query: 908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
                 + +   + +     +  P      +       ++     +  P NR 
Sbjct: 216 NSSATSQTLKI-ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267

Length = 384

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  113 bits (284), Expect = 8e-28
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 29/231 (12%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKL-WRGMSKECESGCDVEKGQVQ 735
           ++EIL      N IG GS G V+KVV  ++    A+K++    M++        E+ +  
Sbjct: 1   DFEIL------NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-------EREEAI 47

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
           D         E   L K+    I++ +     +    +V EY  NG L  LL   +G  L
Sbjct: 48  D---------EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL 98

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
                ++  +    GL++LH      I+HRD+KS N+ LD     ++ D GVAK++  + 
Sbjct: 99  PEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
                + I G+  Y++PE       NEKSD+++ GVV+ E  TG+ P D  
Sbjct: 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 7e-26
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 29/216 (13%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +G+G  G+V++ + +N   VAVK L  G                   +    F AE + +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPG------------------TMDPKDFLAEAQIM 55

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            K+RH  +++L+  CT  +   +V E M  GSL + L    G  L  P    +    A G
Sbjct: 56  KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASG 115

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS---GKPKSMSVIAGSC 867
           ++YL      + +HRD+ + N+L+  +   +VADFG+A+V+       +  +   I    
Sbjct: 116 MAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK--- 169

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            + APE A   R + KSD++SFG+++ E+VT GR+P
Sbjct: 170 -WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (271), Expect = 7e-26
 Identities = 69/239 (28%), Positives = 104/239 (43%), Gaps = 51/239 (21%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           +IG GS   V         +  A+K L              +K Q+  + +    + E E
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKIL--------------DKRQLIKEKKVKYVKIEKE 53

Query: 749 TLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP-TRYKI--I 804
            L ++  H  I+KL+      +    V EY PNG L   +   K G LD   TR+    I
Sbjct: 54  VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR--KYGSLDEKCTRFYAAEI 111

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
           + A   L YLH      I+HRD+K  NILLD D   ++ DFG AKV+D +  P+S    A
Sbjct: 112 LLA---LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165

Query: 865 GS---------------CG---YIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLP 902
            +                G   Y++PE    L      + SD+++ G +I +++TG+ P
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 3e-25
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 36/220 (16%)

Query: 691 IGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G GS GKV  V     G+  A+K L              +K ++  + + +    E   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVL--------------KKKKIIKRKEVEHTLTERNI 46

Query: 750 LGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           L +I H  IVKL     T + KL LV EY P G L   L   +G   +   R+    +  
Sbjct: 47  LSRINHPFIVKLHYAFQTEE-KLYLVLEYAPGGELFSHLSK-EGRFSEERARF-YAAEIV 103

Query: 809 EGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKPKSMSVIAGS 866
             L YLH       I++RD+K  NILLD D   ++ DFG+AK +     +  +     G+
Sbjct: 104 LALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF---CGT 156

Query: 867 CGYIAPEY----AYTLRVNEKSDIYSFGVVILELVTGRLP 902
             Y+APE      Y   V    D +S GV++ E++TG+ P
Sbjct: 157 PEYLAPEVLLGKGYGKAV----DWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 3e-25
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G+G  G+V+    +    VAVK L  G MS E                    F  E + 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-------------------AFLQEAQI 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH  +V+L+  C+  +   +V EYM  GSL D L S +G  L  P    +    AE
Sbjct: 55  MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV-DASGKPKSMSVIAGSCG 868
           G++YL      + +HRD+ + NIL+  +   ++ADFG+A+++ D     +  +       
Sbjct: 115 GMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIK 169

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           + APE A   R   KSD++SFG+++ E+VT GR+P
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 73/234 (31%), Positives = 104/234 (44%), Gaps = 43/234 (18%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           IG G  G V       G+ VAVK L                    D      F AE   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKD------------------DSTAAQAFLAEASVM 54

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
             +RH N+V+L       +   +V EYM  GSL D L S    ++    +    +D  EG
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD---ASGK-PKSMSVIAGS 866
           + YL      + VHRD+ + N+L+  D  A+V+DFG+AK       SGK P         
Sbjct: 115 MEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--------- 162

Query: 867 CGYIAPEYAYTLRVNE---KSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV 916
             + APE    LR  +   KSD++SFG+++ E+ + GR+P  P    KD+V  V
Sbjct: 163 VKWTAPE---ALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPHV 212

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  103 bits (258), Expect = 2e-24
 Identities = 76/224 (33%), Positives = 108/224 (48%), Gaps = 42/224 (18%)

Query: 691 IGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +GSGS G VY+ + L +G+  AVK          E     +    Q+ V+    + E+  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVK----------EVSLADDGQTGQEAVKQ--LEQEIAL 55

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLLDWP-----TRYKI 803
           L K++H NIV+        D  L ++ E +P GSL  LL   K G    P     TR +I
Sbjct: 56  LSKLQHPNIVQYLGTEREED-NLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTR-QI 111

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           ++    GL YLH     + VHRD+K  NIL+D +   ++ADFG+AK V      KS    
Sbjct: 112 LL----GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK-- 162

Query: 864 AGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGRLP 902
            GS  ++APE       Y L      DI+S G  +LE+ TG+ P
Sbjct: 163 -GSPYWMAPEVIAQQGGYGLAA----DIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (256), Expect = 4e-24
 Identities = 66/218 (30%), Positives = 115/218 (52%), Gaps = 18/218 (8%)

Query: 690 VIGSGSSGKVY-KVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           +IGSGS G VY  +  S+GE +AVK++   +     S  D ++  +      D    E+ 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQV--ELPSVSASSKDRKRSML------DALAREIA 58

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L +++H+NIV+        D   +  EY+P GS+  LL++   G  +       +    
Sbjct: 59  LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQIL 116

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS----GKPKSMSVIA 864
           +GL+YLH+     I+HRD+K  NIL+D   G +++DFG++K ++A+        +   + 
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           GS  ++APE         K+DI+S G +++E++TG+ P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  102 bits (256), Expect = 6e-24
 Identities = 70/217 (32%), Positives = 115/217 (52%), Gaps = 17/217 (7%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           +IG G+ G+VY  + ++ GE +AVK++         +G    +   +D V     ++E+E
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQV---ELPATIAGRHDSR--QKDMV--KALRSEIE 60

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           TL  + H NIV+     TT +   +  EY+P GS+G  L     G  +            
Sbjct: 61  TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVL 118

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKPKSMSVIAGSC 867
           EGL+YLH      I+HRD+K++N+L+D D   +++DFG++K   D     ++MS + GS 
Sbjct: 119 EGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSV 174

Query: 868 GYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLP 902
            ++APE  ++     + K DI+S G V+LE+  GR P
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  101 bits (254), Expect = 9e-24
 Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 30/228 (13%)

Query: 683 DGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
           D L+    +G+G+SG V KV+    G+ +AVK +   +++            +Q Q+   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA-----------IQKQIL-- 47

Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E++ L K     IV  +          +  EYM  GSL  +L   +G +   P R 
Sbjct: 48  ---RELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI---PERI 101

Query: 802 --KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV-VDASGKPK 858
             KI V   +GL+YLH      I+HRDVK +NIL++     ++ DFGV+   V++  K  
Sbjct: 102 LGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157

Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
                 G+  Y+APE       + KSDI+S G+ ++EL TGR P  PE
Sbjct: 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  101 bits (253), Expect = 1e-23
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 23/213 (10%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +GSG  G+V++ +  N   VA+K L                       Q D FQ EV+ L
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDL----------------LKQQD-FQKEVQAL 56

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            ++RHK+++ L+  C+  +   ++ E M  GSL   L S +G +L   +   +    AEG
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           ++YL      + +HRD+ + NIL+  D   +VADFG+A+++       S   I     + 
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT 171

Query: 871 APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           APE A     + KSD++SFG+++ E+ T G++P
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 4e-23
 Identities = 70/237 (29%), Positives = 103/237 (43%), Gaps = 53/237 (22%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE +        IG G+ G+VYK      GE VA+KK    +  E E             
Sbjct: 1   YEKIAQ------IGEGTYGQVYKARNKKTGELVALKK----IRMENE------------- 37

Query: 738 VQDDGF--QA--EVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDL--LHS 789
              +GF   A  E++ L K+RH NIV+L    T++      +V+EYM +    DL  L  
Sbjct: 38  --KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH----DLTGLLD 91

Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                         +    EGL YLH +    I+HRD+K +NIL++ D   ++ADFG+A+
Sbjct: 92  SPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148

Query: 850 VVDASGKPKSMS-VIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR 900
                      + VI  +  Y  PE       Y   V    D++S G ++ EL  G+
Sbjct: 149 PYTKRNSADYTNRVI--TLWYRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (250), Expect = 5e-23
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 36/222 (16%)

Query: 689 NVIGSGSSGKVYKVVLSN-----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
             +G G  GKV            GE VAVK L                   ++Q + D F
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG---------------EEQHRSD-F 53

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           + E+E L  + H+NIVK    C     +   L+ EY+P+GSL D L   +  + +     
Sbjct: 54  EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI-NLKRLL 112

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS-----GK 856
                  +G+ YL        +HRD+ + NIL++ +   +++DFG+AKV+         K
Sbjct: 113 LFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               S I     + APE   T + +  SD++SFGV + EL T
Sbjct: 170 EPGESPIF----WYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 34/218 (15%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +G GS G VYK +    G+ VA+K +                  V++ +Q+     E+ 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV-----------------PVEEDLQE--IIKEIS 50

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV--- 805
            L +     IVK +          +V EY   GS+ D++      L    T  +I     
Sbjct: 51  ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL----TEEEIAAILY 106

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
              +GL YLH +     +HRD+K+ NILL+ +  A++ADFGV+ ++ D   K  ++    
Sbjct: 107 QTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV---I 160

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  ++APE    +  N K+DI+S G+  +E+  G+ P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.6 bits (249), Expect = 6e-23
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 29/216 (13%)

Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            IG G+SG+VYK    + G+ VA+KK               ++  +           E+ 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKK--------MRLRKQNKELIIN----------EIL 67

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            +   +H NIV  +      D   +V EYM  GSL D++      + +    Y +  +  
Sbjct: 68  IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCREVL 126

Query: 809 EGLSYLH--HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
           +GL YLH  +     ++HRD+KS+NILL  D   ++ADFG A  +    K K  SV+ G+
Sbjct: 127 QGLEYLHSQN-----VIHRDIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVV-GT 179

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             ++APE         K DI+S G++ +E+  G  P
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 7e-23
 Identities = 70/218 (32%), Positives = 109/218 (50%), Gaps = 33/218 (15%)

Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            IG GS G+VYK +     + VA+K +            D+E+ +  D+++D   Q E++
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVI------------DLEEAE--DEIED--IQQEIQ 51

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            L + R   I K +     +  KL ++ EY   GS  DLL   K G LD      I+ + 
Sbjct: 52  FLSQCRSPYITKYYGS-FLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREV 107

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILL--DGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
             GL YLH +     +HRD+K+ NILL  +GD   ++ADFGV+ ++     K  +     
Sbjct: 108 LLGLEYLHEE---GKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNTF---V 159

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  ++APE       +EK+DI+S G+  +EL  G  P
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 30/222 (13%)

Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ--DQVQDDGFQA 745
           N IG G+ GKVY  V L  GE +AVK++             ++    +   ++ D     
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEI------------RIQDNDPKTIKEIAD----- 48

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E++ L  ++H N+VK +     R+   +  EY   G+L +LL    G +LD        +
Sbjct: 49  EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTL 106

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP--KSMSVI 863
              EGL+YLH      IVHRD+K  NI LD +   ++ DFG A  +  +     + +  +
Sbjct: 107 QLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163

Query: 864 AGSCGYIAPE-YAYTLRVNE--KSDIYSFGVVILELVTGRLP 902
           AG+  Y+APE             +DI+S G V+LE+ TG+ P
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 73/240 (30%), Positives = 107/240 (44%), Gaps = 53/240 (22%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +YE++        IGSG+ G VYK   ++ GE VA+K               V K +  
Sbjct: 3   EDYELI------QRIGSGTYGDVYKARDIATGELVAIK---------------VIKLEPG 41

Query: 736 DQVQDDGFQAEVETLGKIRHKNIV----------KLWCCCTTRDCKLLVYEYMPNGSLGD 785
           D  +    Q E+  L + RH NIV          KLW             EY   GSL D
Sbjct: 42  DDFEI--IQQEISMLKECRHPNIVAYFGSYLRRDKLWIV----------MEYCGGGSLQD 89

Query: 786 LLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
           +    +G L +    Y +  +  +GL+YLH       +HRD+K  NILL  D   ++ADF
Sbjct: 90  IYQVTRGPLSELQIAY-VCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADF 145

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYA---YTLRVNEKSDIYSFGVVILELVTGRLP 902
           GV+  + A+   K  S I G+  ++APE A        + K DI++ G+  +EL   + P
Sbjct: 146 GVSAQLTATIA-KRKSFI-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 69/229 (30%), Positives = 104/229 (45%), Gaps = 41/229 (17%)

Query: 691 IGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G+V  V V S     A+K               V+K  + +  Q +   +E E 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKC--------------VKKRHIVETGQQEHIFSEKEI 46

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVY---EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
           L +  H  IVKL+   T +D K  +Y   EY   G L  +L   +G   ++  R+  I  
Sbjct: 47  LEECNHPFIVKLYR--TFKD-KKYIYMLMEYCLGGELWTILRD-RGLFDEYTARF-YIAC 101

Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
                 YLH+     I++RD+K  N+LLD +   ++ DFG AK + +  K  +     G+
Sbjct: 102 VVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGT 155

Query: 867 CGYIAPEY----AYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
             Y+APE      Y   V    D +S G+++ EL+TGR P    FGE D
Sbjct: 156 PEYVAPEIILNKGYDFSV----DYWSLGILLYELLTGRPP----FGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 32/233 (13%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKL-WRGMSKECESGCDVEKGQVQ 735
           +YE+L+       IG GS G V KV   S+G+ +  K++ +  M+       + EK Q+ 
Sbjct: 1   DYEVLE------TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-------EKEKQQLV 47

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLHSCK-- 791
                    +EV  L +++H NIV+ +     R  + L  V EY   G L  L+  CK  
Sbjct: 48  ---------SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE 98

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDFGARVADFGVAK 849
              ++    ++I+      L   H+   P   ++HRD+K  NI LD +   ++ DFG+AK
Sbjct: 99  RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++          V  G+  Y++PE    +  +EKSDI+S G +I EL     P
Sbjct: 159 ILGHDSSFAKTYV--GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.5 bits (240), Expect = 5e-22
 Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 22/219 (10%)

Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            V+G G+ G VY  + + G+ +AVK++    S    +  + EK            Q EV+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEK-----------LQEEVD 54

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            L  ++H NIV+    C   D  + ++ E++P GS+  +L+  + G L  P   K     
Sbjct: 55  LLKSLKHVNIVQYLGTCL-DDNTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQI 111

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK---VVDASGKPKSM-SVI 863
            +G++YLH++CV   VHRD+K NN++L  +   ++ DFG A+    V   G   +M   +
Sbjct: 112 LDGVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE         KSDI+S G  + E+ TG+ P
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 67/227 (29%), Positives = 96/227 (42%), Gaps = 33/227 (14%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKE-CESGCDVEKGQVQD 736
           +E+L       VIG G+ GKV  V      +  A+K     M+K+ C     VEKG V++
Sbjct: 2   FELL------RVIGKGAFGKVCIVQKRDTKKMFAMKY----MNKQKC-----VEKGSVRN 46

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL-LHSCKGGLL 795
            +       E   L ++ H  +V LW      +   LV + +  G  GDL  H  +    
Sbjct: 47  VLN------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLL-LG--GDLRYHLSQKVKF 97

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
                   I +    L YLH      I+HRD+K +NILLD      + DF +A  V    
Sbjct: 98  SEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              S S   G+ GY+APE       +   D +S GV   E + G+ P
Sbjct: 155 LTTSTS---GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 26/216 (12%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IGSG  G V+         VA+K +  G MS+E                    F  E + 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-------------------DFIEEAQV 52

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ H  +V+L+  CT R    LV+E+M +G L D L + + G     T   + +D  E
Sbjct: 53  MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCE 111

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YL    V   +HRD+ + N L+  +   +V+DFG+ + V    +  S +       +
Sbjct: 112 GMAYLESSNV---IHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKW 167

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
            +PE     + + KSD++SFGV++ E+ + G+ P +
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 93.3 bits (232), Expect = 9e-21
 Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 63/307 (20%)

Query: 690 VIGSGSSGKVYKVVLSNGEA------VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
            +G G+ GKV+     + E       VAVK L               K    +  + D F
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTL---------------KETASNDARKD-F 55

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWP--- 798
           + E E L   +H+NIVK +  CT  D  ++V+EYM +G L   L  H      L  P   
Sbjct: 56  EREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115

Query: 799 ----TR---YKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
               T     +I V  A G+ YL   H      VHRD+ + N L+  D   ++ DFG+++
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Query: 850 VVDASGKPKSMSVIAGS----CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
            V  +   +    + G       ++ PE     +   +SD++SFGVV+ E+ T G+    
Sbjct: 171 DVYTTDYYR----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK---Q 223

Query: 905 PEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR 964
           P +G  +  + V   + Q     +L     C    E+  ++   L C    P  R  ++ 
Sbjct: 224 PWYGLSN--EEVIECITQG---RLLQRPRTC--PSEVYDIM---LGCWKRDPQQRINIKD 273

Query: 965 VVKLLQE 971
           + + LQ+
Sbjct: 274 IHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 41/232 (17%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            ++E +        +G+GS G+V  V    +G+  A+K L               K ++ 
Sbjct: 1   DDFEFIK------TLGTGSFGRVMLVRHKGSGKYYALKIL--------------SKAKIV 40

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLHSCKGG 793
              Q +    E   L  IRH  +V L+   + +D   L  V EY+P G L   L      
Sbjct: 41  KLKQVEHVLNEKRILQSIRHPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRF 98

Query: 794 LLDWPTRYKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
                  Y     AA+    L YLH      IV+RD+K  N+LLD D   ++ DFG AK 
Sbjct: 99  PEPVARFY-----AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR 150

Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           V           + G+  Y+APE   +    +  D ++ G++I E++ G  P
Sbjct: 151 VK-----GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 90.2 bits (224), Expect = 6e-20
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 38/218 (17%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDD--GFQAEVE 748
           IG G+ G VYK VL     VAVK         C S              D    F  E E
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKT--------CRS----------TLPPDLKRKFLQEAE 44

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKIIVD 806
            L +  H NIVKL   C  +    +V E +P GSL   L   K  L     +   ++ +D
Sbjct: 45  ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRL---TVKKLLQMSLD 101

Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-----VVDASGKPKSMS 861
           AA G+ YL        +HRD+ + N L+  +   +++DFG+++     +   S   K + 
Sbjct: 102 AAAGMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158

Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           +      + APE     R   +SD++S+G+++ E  + 
Sbjct: 159 I-----KWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 26/219 (11%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           I  G+ G+V+     S G+  A+K + +          D+ +    DQV       E + 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKK---------ADMIRKNQVDQVL-----TERDI 46

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L + +   +VKL+     +    LV EY+P G L  LL +   G LD       I +   
Sbjct: 47  LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVL 104

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV------VDASGKPKSMSVI 863
            L YLH +    I+HRD+K +NIL+D +   ++ DFG++KV      ++ +   K    I
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  YIAPE       ++  D +S G ++ E + G  P
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 25/217 (11%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G+ G+VY    +  G  +AVK++            + +K     +V     + E++ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQV-----PFDPDSPETKK-----EVN--ALECEIQL 57

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR---YKIIVD 806
           L  ++H+ IV+ + C    +   +  EYMP GS+ D L +  G L +  TR    +I+  
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQIL-- 114

Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVIAG 865
             EG+ YLH +    IVHRD+K  NIL D     ++ DFG +K +         M  + G
Sbjct: 115 --EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  +++PE         K+D++S G  ++E++T + P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 32/217 (14%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G+G  G+V+    +    VA+K L +G MS E                    F AE   
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-------------------AFLAEANL 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H  +V+L+    T++   ++ EYM NGSL D L + +G  L       +    AE
Sbjct: 55  MKQLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
           G++++      + +HRD+++ NIL+      ++ADFG+A++++ +      +   G+   
Sbjct: 114 GMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN----EYTAREGAKFP 166

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
             + APE         KSD++SFG+++ E+VT GR+P
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.3 bits (216), Expect = 5e-19
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 27/234 (11%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           F AE   + ++RH N+V+L          L +V EYM  GSL D L S    +L      
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           K  +D  E + YL  +   + VHRD+ + N+L+  D  A+V+DFG+ K   ++     + 
Sbjct: 106 KFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162

Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL 920
           V      + APE     + + KSD++SFG+++ E+ + GR+P  P    KD+V  V    
Sbjct: 163 V-----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRV---- 212

Query: 921 DQKGVDHVLDPKLDCCFKEEICK--VLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
            +KG       K+D     + C   V ++   C       RP+  ++ + L+ +
Sbjct: 213 -EKGY------KMDA---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G+G  G+V+    +N   VAVK L  G MS +                    F  E   
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-------------------AFLEEANL 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +  ++H  +V+L+   T  +   ++ EYM  GSL D L S +GG +  P         AE
Sbjct: 55  MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + +HRD+++ N+L+      ++ADFG+A+V++   +  +         +
Sbjct: 115 GMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKW 170

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE         KSD++SFG+++ E+VT G++P
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 8e-19
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 39/223 (17%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +G G+ GKVYK         A  K+             +E     ++++D  F  E++ L
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKI-----------IQIESE---EELED--FMVEIDIL 56

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
            + +H NIV L+      + KL +  E+   G+L  ++   + GL +   RY +     E
Sbjct: 57  SECKHPNIVGLYEA-YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLE 114

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIAGSCG 868
            L++LH      ++HRD+K+ NILL  D   ++ADFGV AK  + S   K  + I G+  
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFI-GTPY 168

Query: 869 YIAPEY---------AYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE           Y    + K+DI+S G+ ++EL     P
Sbjct: 169 WMAPEVVACETFKDNPY----DYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.5 bits (218), Expect = 8e-19
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 52/226 (23%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA---- 745
           +G G+ G VYK      GE VA+KK+                    D  +++G  +    
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI------------------RLDN-EEEGIPSTALR 47

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR----- 800
           E+  L +++H NIVKL     T     LV+EY     L   L    G L           
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPL---SPNLIKSI 103

Query: 801 -YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
            Y+++     GL+Y H      I+HRD+K  NIL++ D   ++ADFG+A+      +  +
Sbjct: 104 MYQLL----RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156

Query: 860 MSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
             V+  +  Y APE       Y+  V    DI+S G +  E++TG+
Sbjct: 157 HEVV--TLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 31/219 (14%)

Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           +IG G+ G VY+   +  G  VA+K +            D     V D       Q EV 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKII----------NLDTPDDDVSD------IQREVA 51

Query: 749 TLGKIRH---KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
            L ++R     NI K +          ++ EY   GS+  L+   K G +       II 
Sbjct: 52  LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIR 108

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIA 864
           +    L Y+H      ++HRD+K+ NIL+      ++ DFGV A +   S K  +     
Sbjct: 109 EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF---V 162

Query: 865 GSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLP 902
           G+  ++APE     +  + K+DI+S G+ I E+ TG  P
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 45/298 (15%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEA--VAVKKL------WRGMSKECESGCDV 729
           EY +L+ L      GSG+ G VYKV   N     +A+K++      +    +E +     
Sbjct: 1   EYAVLEHL------GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDK---- 50

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
               + D V +     E     ++RH NIV+ +      D   +V + +    LG+  +S
Sbjct: 51  ---SIGDIVSEVTIIKE-----QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102

Query: 790 CK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
            K           + I V     L YLH +    IVHRD+  NNI+L  D    + DFG+
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160

Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF 907
           AK      K  S   + G+  Y  PE        EK+D+++FG ++ ++ T    + P F
Sbjct: 161 AKQKQPESKLTS---VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT----LQPPF 213

Query: 908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV 965
              +++     +L  K V+ V +P  +  + E++  V+     C +P    RP + +V
Sbjct: 214 YSTNML-----SLATKIVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G+G  G+V+    +    VAVK L  G MS E                    F  E + 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-------------------SFLEEAQI 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH  +V+L+   +      +V EYM  GSL D L   +G  L  P    +    A 
Sbjct: 55  MKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + +HRD++S NIL+      ++ADFG+A++++   +  +         +
Sbjct: 114 GMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKW 169

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ ELVT GR+P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 55  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 114 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 169

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 71/239 (29%), Positives = 105/239 (43%), Gaps = 60/239 (25%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD--DGFQAE 746
           VIG G+ GKVYK      G+ VA+K                    + D ++D  +  + E
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--------------------IMDIIEDEEEEIKEE 52

Query: 747 VETLGKI-RHKNIVKLWCC-----CTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
              L K   H NI   +           D +L LV E    GS+ DL+     GL     
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK----GLRKKGK 108

Query: 800 RYK------IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           R K      I+ +   GL+YLH +    ++HRD+K  NILL  +   ++ DFGV+  +D+
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165

Query: 854 S--------GKPKSMS--VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +        G P  M+  VIA  C    P+ +Y  R    SD++S G+  +EL  G+ P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIA--CDE-QPDASYDAR----SDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.4 bits (208), Expect = 8e-18
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 25/219 (11%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G G+ G+VY    +  G  +A K++            D E  +   +V     + E++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQV----------QFDPESPETSKEVS--ALECEIQ 56

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLV--YEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
            L  ++H+ IV+ + C   R  K L    EYMP GS+ D L +  G L +  TR K    
Sbjct: 57  LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGALTESVTR-KYTRQ 114

Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK---VVDASGKPKSMSVI 863
             EG+SYLH +    IVHRD+K  NIL D     ++ DFG +K    +  SG    +  +
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG--TGIRSV 169

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  +++PE         K+D++S G  ++E++T + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 59/291 (20%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +GSG  G V+         VA+K +  G   E                  D F  E + +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE------------------DDFIEEAKVM 53

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            K+ H N+V+L+  CT +    +V EYM NG L + L   K G L       +  D  E 
Sbjct: 54  MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEA 112

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVD----ASGKPKSMSVIAG 865
           + YL  +     +HRD+ + N L+  D   +V+DFG+A+ V+D    +S   K       
Sbjct: 113 MEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF------ 163

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKG 924
              +  PE     R + KSD++SFGV++ E+ + G++P +         ++  S +    
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE---------RFSNSEV---- 210

Query: 925 VDHVLD------PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL 969
           V+ V        PKL     E    V  I   C    P +RPA ++++  L
Sbjct: 211 VESVSAGYRLYRPKL--APTE----VYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 84.6 bits (209), Expect = 9e-18
 Identities = 72/225 (32%), Positives = 108/225 (48%), Gaps = 36/225 (16%)

Query: 685 LDEDNVIGSGSSGKV--YKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
           L +  V+G G  GKV  Y    +N   GE VAVK L R   ++  SG             
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG------------- 52

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDW 797
              ++ E+  L  + H+NIVK   CC+ +  K   L+ EY+P GSL D L   K  L   
Sbjct: 53  ---WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--- 106

Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
               ++++ A    EG++YLH       +HRD+ + N+LLD D   ++ DFG+AK V   
Sbjct: 107 ---AQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160

Query: 855 GKPKSMSVIAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            +   +     S   + A E     + +  SD++SFGV + EL+T
Sbjct: 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 28/230 (12%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           EYE  D   E  V+G G+ G VY    LS    +A+K++                   +D
Sbjct: 4   EYE-YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-----------------PERD 45

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                    E+     ++H+NIV+     +      +  E +P GSL  LL S  G L D
Sbjct: 46  SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD 105

Query: 797 -WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDAS 854
              T         EGL YLH +    IVHRD+K +N+L++   G  +++DFG +K +  +
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--A 160

Query: 855 GKPKSMSVIAGSCGYIAPEYA-YTLR-VNEKSDIYSFGVVILELVTGRLP 902
           G         G+  Y+APE      R     +DI+S G  I+E+ TG+ P
Sbjct: 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 34/237 (14%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            Y+IL        IG G+ G V+K      GE VA+KK+     +            + +
Sbjct: 1   RYKILG------RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----------IPN 44

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
           Q        E++ L   +H  +VKL          +LV EYMP   L ++L   +  L +
Sbjct: 45  QAL-----REIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPE 98

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
              +   +    +G++Y+H +    I+HRD+K  N+L+  D   ++ADFG+A++     +
Sbjct: 99  AQVK-SYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFS-EEE 153

Query: 857 PKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPEF-GEKD 911
           P+  S    +  Y APE  Y  R  +   D+++ G +  EL+ G     P F GE D
Sbjct: 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS----PLFPGEND 206

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 29/214 (13%)

Query: 689 NVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           + +G G  G+VY+ V       VAVK L     KE             D ++ + F  E 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KE-------------DTMEVEEFLKEA 53

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
             + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    
Sbjct: 54  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 113

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS- 866
           +  + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+ 
Sbjct: 114 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAK 166

Query: 867 --CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               + APE     + + KSD+++FGV++ E+ T
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 46/234 (19%)

Query: 688 DNVIGSGSSGKVYKVVLS-NGE---AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + VIG G  G+V +  L   G+    VA+K L               K    D+ + D F
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL---------------KAGSSDKQRLD-F 52

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             E   +G+  H NI++L    T     +++ EYM NGSL   L     G         +
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGM 111

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV-DASGKPKSMSV 862
           +   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++ + D+     +   
Sbjct: 112 LRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG- 167

Query: 863 IAGSCGYI-----APEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
                G I     APE A   R     SD++SFG+V+ E+++        +GE+
Sbjct: 168 -----GKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMS--------YGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 87.6 bits (217), Expect = 1e-17
 Identities = 43/108 (39%), Positives = 61/108 (56%), Gaps = 4/108 (3%)

Query: 506 LDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRI 565
           L L    L G +P+ +S  + L  +NL+ N   GNIP  +G+++ L  LDLS N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 566 PVGLQNL-KLNQLNVSNNRLSGELP-SLFAKEMYRNSF--LGNPGLCG 609
           P  L  L  L  LN++ N LSG +P +L  + ++R SF    N GLCG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530

Length = 623

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.9 bits (210), Expect = 2e-17
 Identities = 71/237 (29%), Positives = 109/237 (45%), Gaps = 59/237 (24%)

Query: 685 LDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           L+  N IGSG+ G VYKV+    G   A+K ++               G  +D V+    
Sbjct: 76  LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY---------------GNHEDTVRRQ-I 119

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD----WPT 799
             E+E L  + H N+VK         C  +   +  NG +  LL    GG L+       
Sbjct: 120 CREIEILRDVNHPNVVK---------CHDM---FDHNGEIQVLLEFMDGGSLEGTHIADE 167

Query: 800 RYKIIVDAA----EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           ++  + D A     G++YLH      IVHRD+K +N+L++     ++ADFGV++++  + 
Sbjct: 168 QF--LADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEK----------SDIYSFGVVILELVTGRLP 902
            P + SV  G+  Y++PE     R+N             DI+S GV ILE   GR P
Sbjct: 223 DPCNSSV--GTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 45/230 (19%)

Query: 690 VIGSGSSGKVYKVV-LSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           V+GSG+ G VYK V +  GE     VA+K L     +E  S       +   ++ D+ + 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-----REETSP------KANKEILDEAY- 61

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPT 799
                +  + H ++V+L   C +     L+ + MP G L D + + K       LL+W  
Sbjct: 62  ----VMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC- 115

Query: 800 RYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                V  A+G+SYL         +VHRD+ + N+L+      ++ DFG+AK++D     
Sbjct: 116 -----VQIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV--DE 163

Query: 858 KSMSVIAGSC--GYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
           K      G     ++A E         KSD++S+GV + EL+T G  P +
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G+V+    +    VA+K L  G M  E                    F  E + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-------------------AFLQEAQI 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH  +V L+    + +   +V E+M  GSL D L    G  L  P    +    A+
Sbjct: 55  MKKLRHDKLVPLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + +HRD+++ NIL+  +   ++ADFG+A++++   +  +         +
Sbjct: 114 GMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKW 169

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ ELVT GR+P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLW--RGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           V+G G+ G V+       + + + K      M+K+                +    Q E 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD----------------ERLAAQNEC 50

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
           + L  + H NI++ +         ++V EY P G+L + +      LLD  T     V  
Sbjct: 51  QVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDG-DFGARVADFGVAKVVDASGKPKSMSVIAGS 866
              L  LHH     I+HRD+K+ NILLD      ++ DFG++K++  S K K+ +V+   
Sbjct: 111 ---LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTP 165

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           C YI+PE       N+KSDI++ G V+ EL +
Sbjct: 166 C-YISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)

Query: 691 IGSGSSGKVYK---VVLSNGE---AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           +G G+ GKVYK      +      +VA+K L     KE              +VQ + F+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTL-----KENAEP----------KVQQE-FR 56

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-----HSCKGG------ 793
            E E +  ++H NIV L   CT      +++EY+ +G L + L     HS  G       
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 794 ---LLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
               LD      I +  A G+ YL  HH      VHRD+ + N L+      +++DFG++
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
           + + ++   +  S       ++ PE     +   +SDI+SFGVV+ E+
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.9 bits (202), Expect = 6e-17
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 43/231 (18%)

Query: 690 VIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           VIG+G  G+V++ +L        AVA+K L              + G  + Q QD  F +
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTL--------------KPGYTEKQRQD--FLS 55

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII- 804
           E   +G+  H NI++L    T     +++ EYM NG+L   L    G      + Y+++ 
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF----SSYQLVG 111

Query: 805 --VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                A G+ YL      + VHRD+ + NIL++ +   +V+DFG+++V++    P+    
Sbjct: 112 MLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD--PEGTYT 166

Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
            +G      + APE     +    SD++SFG+V+ E+++        FGE+
Sbjct: 167 TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS--------FGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 6e-17
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 37/238 (15%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA---- 745
           IG G+ G VYK      GE VA+KK+                       + +G       
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRF-------------------ESEGIPKTALR 47

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG--LLDWPTRYKI 803
           E++ L ++ H NI+KL      +    LV+E+M      DL    K     L        
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSY 103

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +    +GL++ H      I+HRD+K  N+L++ +   ++ADFG+A+   +  +P +  V+
Sbjct: 104 LYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160

Query: 864 AGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
             +  Y APE     +  +   DI+S G +  EL++ R P+ P   E D +  +  TL
Sbjct: 161 --TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTL 215

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 74/241 (30%), Positives = 116/241 (48%), Gaps = 42/241 (17%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE+L       V+G G+ G V K    + GE VA+KK      KE E   DV+K  ++  
Sbjct: 3   YEVL------GVVGEGAYGVVLKCRNKATGEIVAIKKF-----KESEDDEDVKKTALR-- 49

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   EV+ L ++RH+NIV L      +    LV+EY+   +L +LL +  GGL   
Sbjct: 50  --------EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD 100

Query: 798 PTRYKIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
             R   I    + ++Y H H+    I+HRD+K  NIL+      ++ DFG A+ + A   
Sbjct: 101 AVR-SYIWQLLQAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKS-----DIYSFGVVILELVTGRLPVDPEFGEKD 911
                 +A +  Y APE    L V + +     D+++ G ++ EL+ G  P+ P  G+ D
Sbjct: 156 SPLTDYVA-TRWYRAPE----LLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFP--GDSD 207

Query: 912 L 912
           +
Sbjct: 208 I 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 30/228 (13%)

Query: 690 VIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G GS GKV    L    E  AVK L + +  + +   DVE    + +V        + 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD---DVECTMTEKRV--------LA 50

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDA 807
             G  +H  + +L  C  T+D    V EY+ NG  GDL+ H  + G  D P   +    A
Sbjct: 51  LAG--KHPFLTQLHSCFQTKDRLFFVMEYV-NG--GDLMFHIQRSGRFDEP---RARFYA 102

Query: 808 AE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
           AE   GL +LH      I++RD+K +N+LLD +   ++ADFG+ K  +      + S   
Sbjct: 103 AEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFC 157

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           G+  YIAPE           D ++ GV++ E++ G+ P + +  E +L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 43/283 (15%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +IG G  G V +   + G+ VAVK +           CDV             F  E   
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNI----------KCDVTA---------QAFLEETAV 52

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ HKN+V+L       +   +V E M  G+L + L +    L+      +  +D AE
Sbjct: 53  MTKLHHKNLVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G+ YL       +VHRD+ + NIL+  D  A+V+DFG+A+V         +        +
Sbjct: 112 GMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKW 163

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE     + + KSD++S+GV++ E+ + GR P  P+   K++ + V     +KG  + 
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY-PKMSLKEVKECV-----EKG--YR 215

Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           ++P   C        V  +   C    P  RP+  ++ + L++
Sbjct: 216 MEPPEGC-----PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 80.3 bits (199), Expect = 3e-16
 Identities = 75/235 (31%), Positives = 109/235 (46%), Gaps = 31/235 (13%)

Query: 691 IGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G+ G VY       GE VA+KK    M K+  S         ++ +       EV++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK----MKKKFYS--------WEECMN----LREVKS 50

Query: 750 LGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           L K+  H NIVKL       D    V+EYM  G+L  L+   KG          II    
Sbjct: 51  LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           +GL+++H        HRD+K  N+L+ G    ++ADFG+A+ +  S  P +  V   +  
Sbjct: 110 QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYV--STRW 163

Query: 869 YIAPEYAYTLRVNEKS---DIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
           Y APE    LR    S   DI++ G ++ EL T R P+ P   E D +  +CS L
Sbjct: 164 YRAPE--ILLRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVL 215

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 11/150 (7%)

Query: 757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH 816
            + KL+    ++D   LV EY+  G    L+ +  G   DW  +Y  I +   G+  LH 
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ 115

Query: 817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY 876
                I+HRD+K  N+L+D     ++ DFG+++    + K        G+  Y+APE   
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETIL 166

Query: 877 TLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
            +  ++ SD +S G VI E + G  P   E
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 34/232 (14%)

Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
           + + E + +G G+ G V K  L N   +   K         +   D++K  ++       
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILR------- 48

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTT-RDCKL-LVYEYMPNGSLGDLLHSCK--GGLLDWP 798
              E+E     +   IVK +          + +  EY   GSL  +    K  GG +   
Sbjct: 49  ---ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK 105

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
              KI     +GLSYLH      I+HRD+K +NILL      ++ DFGV+  +  S    
Sbjct: 106 VLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-- 160

Query: 859 SMSVIAGSCGYIAPEY----AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
                 G+  Y+APE      Y++     SD++S G+ +LE+   R P  PE
Sbjct: 161 --GTFTGTSFYMAPERIQGKPYSIT----SDVWSLGLTLLEVAQNRFPFPPE 206

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.9 bits (197), Expect = 5e-16
 Identities = 72/227 (31%), Positives = 103/227 (45%), Gaps = 32/227 (14%)

Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQV 738
           ++   L E   IG GS G VY        E VA+KK    MS    SG      Q  ++ 
Sbjct: 15  KLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKK----MSY---SG-----KQSNEKW 59

Query: 739 QDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           QD     EV  L ++RH N ++   C        LV EY   GS  D+L   K  L +  
Sbjct: 60  QD--IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVE 116

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
               I   A +GL+YLH       +HRD+K+ NILL      ++ADFG A +V     P 
Sbjct: 117 IA-AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PA 168

Query: 859 SMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLP 902
           +  V  G+  ++APE    +   + + K D++S G+  +EL   + P
Sbjct: 169 NSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 39/289 (13%)

Query: 685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGQVQDQVQDDGF 743
           L  +  +G+G  G+V+    +    VAVK +  G MS E                    F
Sbjct: 8   LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-------------------AF 48

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            AE   +  ++H  +VKL     T++   ++ E+M  GSL D L S +G     P     
Sbjct: 49  LAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
               AEG++++      + +HRD+++ NIL+      ++ADFG+A+V++   +  +    
Sbjct: 108 SAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGA 163

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQ 922
                + APE         KSD++SFG++++E+VT GR+P  P     ++++ +     +
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRAL-----E 217

Query: 923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           +G      P+ + C +E    + NI + C    P  RP    +  +L +
Sbjct: 218 RGYRM---PRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 1e-15
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G G+ G+VY       G  +AVK++            D E  +   +V  +  + E++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQV----------QFDPESPETSKEV--NALECEIQ 56

Query: 749 TLGKIRHKNIVKLWCCC-TTRDCKLLVY-EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
            L  + H+ IV+ + C     +  L ++ E+MP GS+ D L S  G L +  TR K    
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTR-KYTRQ 114

Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA---SGKPKSMSVI 863
             EG+SYLH +    IVHRD+K  NIL D     ++ DFG +K +     SG    M  +
Sbjct: 115 ILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG--TGMKSV 169

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  +++PE         K+DI+S G  ++E++T + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 34/202 (16%)

Query: 705 SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC 764
           + GE VAVKKL                    + ++D  F+ E+E L  ++H NIVK    
Sbjct: 31  NTGEVVAVKKLQHS---------------TAEHLRD--FEREIEILKSLQHDNIVKYKGV 73

Query: 765 CTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI 822
           C +  R    LV EY+P GSL D L   +  L D            +G+ YL        
Sbjct: 74  CYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYLG---SKRY 129

Query: 823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASG------KPKSMSVIAGSCGYIAPEYAY 876
           VHRD+ + NIL++ +   ++ DFG+ KV+          +P    +      + APE   
Sbjct: 130 VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-----WYAPESLT 184

Query: 877 TLRVNEKSDIYSFGVVILELVT 898
             + +  SD++SFGVV+ EL T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+SG VY  + ++ G+ VA+K++                  +Q Q + +    E+  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQM-----------------NLQQQPKKELIINEILV 69

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + + +H NIV         D   +V EY+  GSL D++       +D      +  +  +
Sbjct: 70  MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQ 126

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG-VAKVVDASGKPKSMSVIAGSCG 868
            L +LH +    ++HRD+KS+NILL  D   ++ DFG  A++     K  +M    G+  
Sbjct: 127 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPY 180

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E+V G  P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)

Query: 685 LDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           LD    IG GS+G V      S G  VAVKK+            D+ K Q ++ + +   
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------------DLRKQQRRELLFN--- 65

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +   +H NIV+++      D   +V E++  G+L D++   +   ++      +
Sbjct: 66  --EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATV 120

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG-VAKVVDASGKPKSMSV 862
            +   + LS+LH      ++HRD+KS++ILL  D   +++DFG  A+V     + KS+  
Sbjct: 121 CLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL-- 175

Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+  ++APE    L    + DI+S G++++E+V G  P
Sbjct: 176 -VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 27/217 (12%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G GS GKV+   L    +  A+K L + +    +   DVE   V+ +V    ++    
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDD---DVECTMVEKRVLSLAWE---- 54

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
                 H  +  L+C   T++    V EY+  G L   + SC    L   T Y     AA
Sbjct: 55  ------HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY-----AA 103

Query: 809 E---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           E   GL +LH      IV+RD+K +NILLD D   ++ADFG+ K  +  G  K+     G
Sbjct: 104 EIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK-ENMLGDAKT-CTFCG 158

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  YIAPE     + N   D +SFGV++ E++ G+ P
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.3 bits (190), Expect = 3e-15
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 34/218 (15%)

Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++GSG  G V+K + +  G+++ +                V    +QD+     FQ   +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIP---------------VAIKTIQDRSGRQTFQEITD 58

Query: 749 ---TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTR 800
               +G + H  IV+L   C     +L V +  P GSL D +   +       LL+W   
Sbjct: 59  HMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW--- 114

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
               V  A+G+ YL       +VHR++ + NILL  D   ++ADFGVA ++    K    
Sbjct: 115 ---CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY 168

Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           S       ++A E     R   +SD++S+GV + E+++
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 75/235 (31%), Positives = 113/235 (48%), Gaps = 34/235 (14%)

Query: 690 VIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G GS GKV    L    E  A+K L + +  E +   DVE   V+ +V    ++    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD---DVECTMVERRVLALAWE---- 54

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH---SCKGGLLDWPTRYKIIV 805
                 H  +  L+C   T++    V EY+ NG  GDL+    S           Y    
Sbjct: 55  ------HPFLTHLFCTFQTKEHLFFVMEYL-NG--GDLMFHIQSSGRFDEARARFY---- 101

Query: 806 DAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            AAE   GL +LH      I++RD+K +N+LLD D   ++ADFG+ K  + +G+ K+ S 
Sbjct: 102 -AAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKA-ST 155

Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
             G+  YIAPE     + NE  D +SFGV++ E++ G+ P   E  E +L   + 
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 22/218 (10%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +G+G+    Y+   +  G  +AVK++         +       + ++ V+    + E+ 
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQV---------TYVRNTSSEQEEVVEA--LRKEIR 55

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            + ++ H +I+++    T  D    ++ E+M  GS+  LL   K G              
Sbjct: 56  LMARLNHPHIIRMLGA-TCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQL 112

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGD-FGARVADFGVAKVVDA--SGKPKSMSVIA 864
             GLSYLH +    I+HRDVK  N+L+D      R+ADFG A  + A  +G  +    + 
Sbjct: 113 LRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  ++APE     +     D++S G VI+E+ T + P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G G+ G+VY       G  +AVK++        +        +V      +  + E++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQV------PFDPDSQETSKEV------NALECEIQ 56

Query: 749 TLGKIRHKNIVKLWCCCTTRDC---KLLVY-EYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            L  +RH  IV+ + C   RD    KL ++ EYMP GS+ D L +  G L +  TR +  
Sbjct: 57  LLKNLRHDRIVQYYGC--LRDPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTR-RYT 112

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA---SGKPKSMS 861
               +G+SYLH +    IVHRD+K  NIL D     ++ DFG +K +     SG    + 
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG--TGIK 167

Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + G+  +++PE         K+D++S    ++E++T + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 34/222 (15%)

Query: 691 IGSGSSGKVYKV--VLSNGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAE 746
           +G GS G V +     S G+   VAVK L                 ++ D + D  F  E
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD--------------KLSDIMDD--FLKE 46

Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
              +  + H+N+++L+    T    + V E  P GSL D L     G     T     V 
Sbjct: 47  AAIMHSLDHENLIRLYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ 105

Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV---- 862
            A G+ YL        +HRD+ + NILL  D   ++ DFG+ + +  +     M      
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 863 -IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
             A    + APE   T   +  SD++ FGV + E+ T G  P
Sbjct: 163 PFA----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IGSG+ G VYK   ++ GE  A+K +             +E G+    VQ      E+  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVI------------KLEPGEDFAVVQQ-----EIIM 59

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +   +H NIV  +     RD   +  E+   GSL D+ H   G L +    Y +  +  +
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAY-VSRETLQ 117

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS-GKPKSMSVIAGSCG 868
           GL YLH       +HRD+K  NILL  +   ++ADFGV+  + A+  K KS     G+  
Sbjct: 118 GLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF---IGTPY 171

Query: 869 YIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLPV 903
           ++APE A   R    N+  DI++ G+  +EL   + P+
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 30/218 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +GSG+ G VYK   L  GE  AVK +      + E G D               Q E+  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKII------KLEPGDDFSL-----------IQQEIFM 59

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + + +H NIV  +    +R+   +  EY   GSL D+ H   G L +    Y +  +  +
Sbjct: 60  VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAY-VCRETLQ 117

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS-GKPKSMSVIAGSCG 868
           GL+YLH       +HRD+K  NILL  +   ++ADFGVA  + A+  K KS     G+  
Sbjct: 118 GLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF---IGTPY 171

Query: 869 YIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLPV 903
           ++APE A   +    N+  DI++ G+  +EL   + P+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.7 bits (187), Expect = 9e-15
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 40/232 (17%)

Query: 691 IGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA--EV 747
           +G G+   VYK      G  VA+KK+  G  KE + G +              F A  E+
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN--------------FTALREI 53

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW-PTRYK-IIV 805
           + L +++H NI+ L      +    LV+E+M      DL    K   +   P   K  ++
Sbjct: 54  KLLQELKHPNIIGLLDVFGHKSNINLVFEFME----TDLEKVIKDKSIVLTPADIKSYML 109

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL YLH +    I+HRD+K NN+L+  D   ++ADFG+A+   +  +  +  V+  
Sbjct: 110 MTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT- 165

Query: 866 SCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
              Y APE       Y + V    D++S G +  EL+  R+P  P  G+ D+
Sbjct: 166 -RWYRAPELLFGARHYGVGV----DMWSVGCIFAELLL-RVPFLP--GDSDI 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 690 VIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            IG GS GK+Y     S+ E   +K++            D+ K  V+++   +  + EV 
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEI------------DLTKMPVKEK---EASKKEVI 51

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L K++H NIV  +          +V EY   G L   ++  +G L          V  +
Sbjct: 52  LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGD-FGARVADFGVAKVVDASGKPKSMSVIAGSC 867
            GL ++H      I+HRD+KS NI L  +   A++ DFG+A+ ++ S   +      G+ 
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTP 166

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            Y++PE       N K+DI+S G V+ EL T + P +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 74.9 bits (184), Expect = 9e-15
 Identities = 48/170 (28%), Positives = 88/170 (51%), Gaps = 14/170 (8%)

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           +D F  E + + K+ H+ +V+L+  CT +    +V EYM NG L + L          P+
Sbjct: 43  EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ--PS 100

Query: 800 R-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
           +  ++  D  EG++YL        +HRD+ + N L+D     +V+DFG+++ V       
Sbjct: 101 QLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157

Query: 859 SMSVIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
           S+    GS     +  PE     + + KSD+++FGV++ E+ + G++P +
Sbjct: 158 SV----GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 1e-14
 Identities = 43/128 (33%), Positives = 69/128 (53%), Gaps = 8/128 (6%)

Query: 59  WRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQN 118
           W G  C P+ H  +  D    +  G +         +  L L N  +   +P+DIS  ++
Sbjct: 392 WNGDPCVPQQHPWSGADCQFDSTKGKWF--------IDGLGLDNQGLRGFIPNDISKLRH 443

Query: 119 LQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLD 178
           LQ ++LS N + G + P+L  + +L+ LDL+ N+F+G IPES G+   L +++L  N L 
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503

Query: 179 GTIPAFLG 186
           G +PA LG
Sbjct: 504 GRVPAALG 511

Length = 623

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 26/219 (11%)

Query: 685 LDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           LD    IG GS+G V    V S+G+ VAVKK+            D+ K Q ++ + +   
Sbjct: 22  LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM------------DLRKQQRRELLFN--- 66

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +   +H+N+V+++      D   +V E++  G+L D++   +   ++      +
Sbjct: 67  --EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAV 121

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +   + LS LH      ++HRD+KS++ILL  D   +++DFG    V     P+  S++
Sbjct: 122 CLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLV 177

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE    L    + DI+S G++++E+V G  P
Sbjct: 178 -GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           IG GS G+V+K + +  + V   K+            D+E  + +D+++D   Q E+  L
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKI-----------IDLE--EAEDEIED--IQQEITVL 56

Query: 751 GKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
            +     + K +     +D KL ++ EY+  GS  DLL     G LD      I+ +  +
Sbjct: 57  SQCDSPYVTKYYGS-YLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILK 112

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGSCG 868
           GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K    +   G+  
Sbjct: 113 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPF 166

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 41/223 (18%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKL-WRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           +G GS G VYKV  LS+ +  A+K++    MS++          + +D V       E+ 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK----------EREDAVN------EIR 51

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIV 805
            L  + H NI+  +        KL +V EY P G L   +   K    L+     ++I +
Sbjct: 52  ILASVNHPNIIS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL  LH      I+HRD+KS NILL  +   ++ D G++KV+    K        G
Sbjct: 111 QLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163

Query: 866 SCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y+APE      Y+Y      KSDI+S G ++ E+ T   P
Sbjct: 164 TPHYMAPEVWKGRPYSY------KSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 66/261 (25%), Positives = 117/261 (44%), Gaps = 46/261 (17%)

Query: 688 DNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + VIG+G  G+V +  L         VA+K L  G +++                Q   F
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK----------------QRRDF 52

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H NI+ L    T     +++ E+M NG+L   L     G         +
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGM 111

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV-DASGKPKSMSV 862
           +   A G+ YL      + VHRD+ + NIL++ +   +V+DFG+++ + D +  P   S 
Sbjct: 112 LRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168

Query: 863 IAGSCG--YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW----- 915
           + G     + APE     +    SD++S+G+V+ E+++        +GE+    W     
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPY--WDMSNQ 218

Query: 916 -VCSTLDQKGVDHVLDPKLDC 935
            V + ++Q   D+ L P +DC
Sbjct: 219 DVINAIEQ---DYRLPPPMDC 236

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 26/221 (11%)

Query: 683 DGLDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
           + LD    IG GS+G V        G+ VAVKK+            D+ K Q ++ + + 
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM------------DLRKQQRRELLFN- 68

Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               EV  +    H+N+V ++      D   +V E++  G+L D++   +   ++     
Sbjct: 69  ----EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIA 121

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + +     LSYLH+     ++HRD+KS++ILL  D   +++DFG    V     PK  S
Sbjct: 122 TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-VPKRKS 177

Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++ G+  ++APE    L    + DI+S G++++E++ G  P
Sbjct: 178 LV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 49/228 (21%)

Query: 691 IGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IGSG+ G+VYK+     G  +AVK++ R  +KE       E  ++   + D      ++ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-------ENKRI---LMD------LDV 66

Query: 750 LGKIRH--KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY--KIIV 805
           + K  H    IVK +    T     +  E M    L  LL   +G +   P     K+ V
Sbjct: 67  VLK-SHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPI---PEDILGKMTV 121

Query: 806 DAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSV 862
              + L YL   H     ++HRDVK +NILLD     ++ DFG++ ++VD+  K +S   
Sbjct: 122 AIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--- 174

Query: 863 IAGSCGYIAPEY--------AYTLRVNEKSDIYSFGVVILELVTGRLP 902
            AG   Y+APE          Y +R    +D++S G+ ++EL TG+ P
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIR----ADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 40/232 (17%)

Query: 691 IGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           +G G+ GKV+     N         VAVK L            +  +   QD      FQ
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-----------EASESARQD------FQ 55

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS-------------CK 791
            E E L  ++H++IV+ +  CT     L+V+EYM +G L   L S               
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
            G L       I    A G+ YL        VHRD+ + N L+      ++ DFG+++ +
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            ++   +          ++ PE     +   +SDI+SFGVV+ E+ T G+ P
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 77/304 (25%), Positives = 126/304 (41%), Gaps = 56/304 (18%)

Query: 689 NVIGSGSSGKVY----KVVLSNGEA---VAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
           N +GSG+ G+VY      +L  G     VAVK L +G + +       EK +        
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-------EKKE-------- 45

Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH--------SCKGG 793
            F  E   +    H NIVKL   C   + + ++ E M     GDLL              
Sbjct: 46  -FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEG---GDLLSYLRDARVERFGPP 101

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-----DGDFGARVADFGVA 848
           LL       I +D A+G  YL        +HRD+ + N L+     D D   ++ DFG+A
Sbjct: 102 LLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF 907
           + +  S   +          ++APE     +   +SD++SFGV++ E++T G+ P  P  
Sbjct: 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-PAL 217

Query: 908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
             +++++ V +          L    +C       K+  +   C +  P  RP   R+ +
Sbjct: 218 NNQEVLQHVTA-------GGRLQKPENC-----PDKIYQLMTNCWAQDPSERPTFDRIQE 265

Query: 968 LLQE 971
           +LQ 
Sbjct: 266 ILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 20/171 (11%)

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           ++ F  E + + K+ H  +V+L+  CT +    +V E+M NG L + L   + G L    
Sbjct: 43  EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDM 101

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKPK 858
              +  D  EG+ YL  +   S +HRD+ + N L+      +V+DFG+ + V+D      
Sbjct: 102 LLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---- 154

Query: 859 SMSVIAGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                  S G      +  PE     + + KSD++SFGV++ E+ T G++P
Sbjct: 155 ----YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS GK   V    +G+   +K++   +SK            +  + +++  + EV  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEI--NISK------------MSPKEREES-RKEVAV 52

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL------LDWPTRYKI 803
           L  ++H NIV+            +V +Y   G L   +++ +G L      LDW      
Sbjct: 53  LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------ 106

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            V     L ++H      I+HRD+KS NI L  D   ++ DFG+A+V++++ +     + 
Sbjct: 107 FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI- 162

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            G+  Y++PE       N KSDI++ G V+ E+ T
Sbjct: 163 -GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 27/214 (12%)

Query: 691 IGSGSSGKVYKVVLSNG-EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS G+VYK + +   E VA+K +            D+E  + +D+++D   Q E+  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKII------------DLE--EAEDEIED--IQQEITV 55

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L +     I + +          ++ EY+  GS  DLL   K G L+      I+ +  +
Sbjct: 56  LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILK 112

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGSCG 868
           GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K  +     G+  
Sbjct: 113 GLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF---VGTPF 166

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 70/228 (30%), Positives = 102/228 (44%), Gaps = 32/228 (14%)

Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQV 738
           EI  GL E   IG GS G VY    S+  E VAVKK+     +  E   D+ K       
Sbjct: 21  EIFVGLHE---IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK------- 70

Query: 739 QDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                  EV+ L +++H N ++   C        LV EY   GS  DLL   K  L +  
Sbjct: 71  -------EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVE 122

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
               I   A +GL+YLH      ++HRD+K+ NILL      ++ADFG A     +    
Sbjct: 123 IA-AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-- 176

Query: 859 SMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPV 903
                 G+  ++APE    +   + + K D++S G+  +EL   + P+
Sbjct: 177 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 37/230 (16%)

Query: 690 VIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G GS G V K      G+ VA+KK       E E    V+K  ++          E+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFL-----ESEDDKMVKKIAMR----------EIR 52

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L ++RH+N+V L      +    LV+E++ +  L DL     G  LD     K +    
Sbjct: 53  MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQIL 110

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
            G+ + H     +I+HRD+K  NIL+      ++ DFG A+ + A G+  +  V   +  
Sbjct: 111 RGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRW 165

Query: 869 YIAPEYAYTLRVNEKS-----DIYSFGVVILELVTGRLPVDPEF-GEKDL 912
           Y APE    L V +       DI++ G ++ E++TG    +P F G+ D+
Sbjct: 166 YRAPE----LLVGDTKYGRAVDIWAVGCLVTEMLTG----EPLFPGDSDI 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 74.4 bits (182), Expect = 3e-14
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+SG VY  + ++ G+ VA+K++                  +Q Q + +    E+  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM-----------------NLQQQPKKELIINEILV 69

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + + ++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 70  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 125

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HRD+KS+NILL  D   ++ DFG    +      +S  V  G+  
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 180

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E+V G  P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 33/248 (13%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           +E+E L      N IG G+ G VY+    ++GE VA+KK              V     +
Sbjct: 7   TEFEKL------NRIGEGTYGIVYRARDTTSGEIVALKK--------------VRMDNER 46

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGG 793
           D +     + E+  L  +RH NIV+L      +  D   LV EY     L  LL +    
Sbjct: 47  DGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP 104

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
             +      +++    GL YLH +    I+HRD+K +N+LL      ++ADFG+A+    
Sbjct: 105 FSE-SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDPEFGEKDL 912
             KP +  V+  +  Y APE          + D+++ G ++ EL+  + P+ P   E + 
Sbjct: 161 PAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK-PLLPGKSEIEQ 217

Query: 913 VKWVCSTL 920
           +  +   L
Sbjct: 218 LDLIIQLL 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 8/129 (6%)

Query: 776 EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD 835
           E+M  GSL  +    KGG +      KI V   EGL+YL++  V  I+HRD+K +NIL++
Sbjct: 83  EFMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVN 138

Query: 836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                ++ DFGV+  +  S          G+  Y++PE     +   KSD++S G+ I+E
Sbjct: 139 SRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194

Query: 896 LVTGRLPVD 904
           L  G+ P  
Sbjct: 195 LALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           IG GS G+V+K + +  + V   K+            D+E  + +D+++D   Q E+  L
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKI-----------IDLE--EAEDEIED--IQQEITVL 56

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            +     + K +          ++ EY+  GS  DLL   + G  D      ++ +  +G
Sbjct: 57  SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKG 113

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGSCGY 869
           L YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K  +     G+  +
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF---VGTPFW 167

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +APE       + K+DI+S G+  +EL  G  P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 34/233 (14%)

Query: 684 GLDEDNVIGSGSSGKVYK-----VVLSNGEA-VAVKKLWRGMSKECESGCDVEKGQVQDQ 737
            L E   +G G  G+V+      +    GE  V VK L              +K + ++ 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--------------QKTKDENL 51

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL--- 794
             +  F+ E++   K+ HKN+V+L   C   +   ++ EY   G L   L + K      
Sbjct: 52  QSE--FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKL 109

Query: 795 ----LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
               L    +  +    A G+ +L +      VHRD+ + N L+      +V+   ++K 
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166

Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           V  S   K  + +     ++APE       + KSD++SFGV++ E+ T G LP
Sbjct: 167 VYNSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 5e-14
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS G VY    + N E VA+KK+     +  E   D+ K              EV  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK--------------EVRF 68

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L K+RH N ++   C        LV EY   GS  DLL   K  L +      +   A +
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQ 126

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL+YLH     +++HRDVK+ NILL      ++ DFG A ++  +          G+  +
Sbjct: 127 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYW 177

Query: 870 IAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPV 903
           +APE    +   + + K D++S G+  +EL   + P+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 53/245 (21%)

Query: 685 LDEDNV-----IGSGSSGKVYKVVLSN---GEA---VAVKKLWRGMSKECESGCDVEKGQ 733
           L  + +     +G GS G VY+ +      GE    VA+K +      E  S        
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV-----NENAS-------- 49

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-- 791
           ++++++   F  E   + +    ++V+L    +T    L+V E M  G L   L S +  
Sbjct: 50  MRERIE---FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPE 106

Query: 792 ---GGLLDWPTRYKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
                 L  PT  K I  AAE   G++YL        VHRD+ + N ++  D   ++ DF
Sbjct: 107 AENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163

Query: 846 GVAKVVDASG--KP--KSMSVIAGSCGYIAPEYAYTLR---VNEKSDIYSFGVVILELVT 898
           G+ + +  +   +   K +  +     ++APE   +L+      KSD++SFGVV+ E+ T
Sbjct: 164 GMTRDIYETDYYRKGGKGLLPVR----WMAPE---SLKDGVFTTKSDVWSFGVVLWEMAT 216

Query: 899 -GRLP 902
               P
Sbjct: 217 LAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 73.8 bits (181), Expect = 5e-14
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 27/217 (12%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G GS GKV    L   GE  AVK L +          DV    + D V+    +  V 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKK----------DVV--LIDDDVECTMVEKRVL 49

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L    +  +  L+C   T++    V E++  G L  + H    G  D    Y+    AA
Sbjct: 50  ALA-WENPFLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDL---YRATFYAA 103

Query: 809 E---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           E   GL +LH      I++RD+K +N++LD D   ++ADFG+ K  +  G  ++ S   G
Sbjct: 104 EIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRA-STFCG 158

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  YIAPE    L+     D +SFGV++ E++ G+ P
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 7/154 (4%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+  L  ++H NI+  +      +  L+  EY   G+L D +   KG L +       + 
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS-VIA 864
                +SY+H      I+HRD+K+ NI L      ++ DFG++K++   G   SM+  + 
Sbjct: 109 QIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVV 162

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           G+  Y++PE    ++ N KSDI++ G V+ EL+T
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.5 bits (178), Expect = 9e-14
 Identities = 43/120 (35%), Positives = 61/120 (50%), Gaps = 35/120 (29%)

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG--------VAKVVDA 853
           KI V   + L YLH     S++HRDVK +N+L++ +   ++ DFG        VAK +DA
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNE---------KSDIYSFGVVILELVTGRLPVD 904
             KP           Y+APE     R+N          KSD++S G+ ++EL TGR P D
Sbjct: 165 GCKP-----------YMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.9 bits (184), Expect = 1e-13
 Identities = 37/90 (41%), Positives = 52/90 (57%), Gaps = 1/90 (1%)

Query: 146 LDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGR 205
           L L      G IP    + + L+ I+L  N + G IP  LG+I++L++L+LSYN    G 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN-SFNGS 481

Query: 206 IPPELGNLTNLEILWLTECNLVGEIPDSLG 235
           IP  LG LT+L IL L   +L G +P +LG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 36/238 (15%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            E E+LD L      G G+ G VYKV+    G  +A+K++   +                
Sbjct: 1   DEIEVLDEL------GKGNYGSVYKVLHRPTGVTMAMKEIRLEL---------------- 38

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGL 794
           D+ + +    E++ L K     IV  +          +  EYM  GSL  L         
Sbjct: 39  DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG 98

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           +      +I     +GL +L  +   +I+HRDVK  N+L++G+   ++ DFGV+  + AS
Sbjct: 99  IPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156

Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNE------KSDIYSFGVVILELVTGRLPVDPE 906
               ++    G   Y+APE   +   N+      +SD++S G+ ILE+  GR P  PE
Sbjct: 157 LAKTNI----GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 37/227 (16%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+ GKVYKV    +G   AVK L                  + D   D+  +AE   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKIL----------------DPISDV--DEEIEAEYNI 71

Query: 750 LGKI-RHKNIVKLWCCCTTRDCKL-----LVYEYMPNGSLGDLLHSC--KGGLLDWPTRY 801
           L  +  H N+VK +      D  +     LV E    GS+ +L+      G  LD     
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            I+  A  GL +LH++    I+HRDVK NNILL  + G ++ DFGV+  + ++   ++ S
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 862 VIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGRLPV 903
           V  G+  ++APE       Y    + + D++S G+  +EL  G  P+
Sbjct: 189 V--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 29/222 (13%)

Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+GSG+ G VYK + +  GE V +    + +++      +VE            F  E  
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE------------FMDEAL 61

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYKI 803
            +  + H ++V+L   C +   +L V + MP+G L D +H  K       LL+W      
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------ 114

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            V  A+G+ YL       +VHRD+ + N+L+      ++ DFG+A++++   K  +    
Sbjct: 115 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                ++A E  +  +   +SD++S+GV I EL+T G  P D
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 69/264 (26%), Positives = 117/264 (44%), Gaps = 54/264 (20%)

Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + VIG+G  G+V     K+       VA+K L              + G  + Q +D  F
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--------------KAGYTEKQRRD--F 52

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H NI+ L    T     ++V EYM NGSL   L    G       ++ +
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-------QFTV 105

Query: 804 IV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
           I         A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P
Sbjct: 106 IQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDP 160

Query: 858 KSMSVIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
           ++     G      + APE     +    SD++S+G+V+ E+++        +GE+    
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPY-- 210

Query: 915 WVCSTLDQ-KGVD--HVLDPKLDC 935
           W  S  D  K ++  + L   +DC
Sbjct: 211 WEMSNQDVIKAIEEGYRLPAPMDC 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 28/214 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+SG V+  + ++ G+ VA+K++                  +Q Q + +    E+  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI-----------------NLQKQPKKELIINEILV 69

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + ++++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVCRECL 125

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HRD+KS+N+LL  D   ++ DFG    +      +S  V  G+  
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 180

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E+V G  P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+SG VY  + ++ G+ VA++++                  +Q Q + +    E+  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-----------------NLQQQPKKELIINEILV 70

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + + ++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 126

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HRD+KS+NILL  D   ++ DFG    +      +S  V  G+  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 181

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E++ G  P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 57/306 (18%)

Query: 691 IGSGSSGKVYKV----VLSNGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           IG G+ G+V++     +L       VAVK L               K +    +Q D FQ
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---------------KEEASADMQAD-FQ 56

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC---------KGGL- 794
            E   + +  H NIVKL   C       L++EYM  G L + L                 
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 795 ----------LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
                     L    +  I    A G++YL        VHRD+ + N L+  +   ++AD
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 173

Query: 845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           FG+++ + ++   K+    A    ++ PE  +  R   +SD++++GVV+ E+ +    + 
Sbjct: 174 FGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQ 231

Query: 905 PEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR 964
           P +G             ++ + +V D  +  C      ++ N+  LC S LP +RP+   
Sbjct: 232 PYYG----------MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281

Query: 965 VVKLLQ 970
           + ++LQ
Sbjct: 282 INRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           ++G G+ G+V+K  L +   VAVK     + +E +                  F +E   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK----------------FLSEARI 45

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L +  H NIVKL   CT R    +V E +P G     L   K   L      K  +DAA 
Sbjct: 46  LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAA 104

Query: 810 GLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           G++YL   +C    +HRD+ + N L+  +   +++DFG+++  D  G   S  +      
Sbjct: 105 GMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIK 159

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILE 895
           + APE     R + +SD++S+G+++ E
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 41/229 (17%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD--DGFQAEV 747
           IG G+ GKV+KV+   NG   AVK L                    D + D  +  +AE 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL--------------------DPIHDIDEEIEAEY 65

Query: 748 ETLGKIR-HKNIVKLWCCCTTRDCK-----LLVYEYMPNGSLGDLLHSC--KGGLLDWPT 799
             L  +  H N+VK +     +D K      LV E    GS+ DL+     +G  ++ P 
Sbjct: 66  NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
              I+ +A  GL +LH +     +HRDVK NNILL  + G ++ DFGV+  + ++   ++
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182

Query: 860 MSVIAGSCGYIAPEYAYTLR-----VNEKSDIYSFGVVILELVTGRLPV 903
            SV  G+  ++APE     +      + + D++S G+  +EL  G  P+
Sbjct: 183 TSV--GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 22/224 (9%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G GS GKV    L  +G   AVK L + +  +             D V+    +  + 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ------------DDDVECTMTEKRIL 49

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           +L +  H  + +L+CC  T D    V E++  G L  + H  K    D         +  
Sbjct: 50  SLAR-NHPFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIT 106

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
             L +LH      I++RD+K +N+LLD +   ++ADFG+ K    +G  K+ S   G+  
Sbjct: 107 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPD 161

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           YIAPE    +      D ++ GV++ E++ G  P + E  E DL
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 40/224 (17%)

Query: 690 VIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           V+G G  GKV    YK     GE  A+K L +G     +   +VE    + ++       
Sbjct: 6   VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARD---EVESLMCEKRI------- 52

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
             ET    RH  +V L+ C  T D    V EY   G L   +H+      D  +  + + 
Sbjct: 53  -FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVF 105

Query: 806 DAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            AA    GL YLH +    IV+RD+K +N+LLD +   ++ADFG+ K  +  G     S 
Sbjct: 106 YAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTST 160

Query: 863 IAGSCGYIAPEY----AYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+  ++APE     +YT  V    D +  GV+I E++ G  P
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAV----DWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 58/230 (25%), Positives = 90/230 (39%), Gaps = 38/230 (16%)

Query: 688 DNVIGSGSSGK----VYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
             +IG          + K        VAVKK+            +++    +D       
Sbjct: 3   LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKI------------NLDSCSKEDLKL---L 46

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS-CKGGLLDWPTRYK 802
           Q E+ T  +++H NI+             +V   M  GS  DLL +    GL +    + 
Sbjct: 47  QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF- 105

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK------ 856
           I+ D    L Y+H       +HR VK+++ILL GD    ++    +  +   GK      
Sbjct: 106 ILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 857 --PKSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLP 902
             PKS      +  +++PE         NEKSDIYS G+   EL  G +P
Sbjct: 163 DFPKS---SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.9 bits (173), Expect = 5e-13
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS G VY    +   E VA+KK+     +  E   D+ K              EV+ 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK--------------EVKF 78

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L +I+H N ++   C        LV EY   GS  DLL   K  L +      I   A +
Sbjct: 79  LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQ 136

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL+YLH     +++HRD+K+ NILL      ++ADFG A +   +          G+  +
Sbjct: 137 GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYW 187

Query: 870 IAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPV 903
           +APE    +   + + K D++S G+  +EL   + P+
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 73/259 (28%), Positives = 119/259 (45%), Gaps = 49/259 (18%)

Query: 682 LDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD 740
           +D  D    IG G+ G+VYK    + GE VA+KK+     KE                  
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE------------------ 47

Query: 741 DGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKL----------LVYEYMPNGSLGDL 786
            GF      E++ L ++ H+NIV L    T +   L          LV+EYM +  +G L
Sbjct: 48  -GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-L 105

Query: 787 LHSCKGGLLDWPTRY--KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
           L S   GL+ +   +    +    EGL+Y H     + +HRD+K +NILL+     ++AD
Sbjct: 106 LES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159

Query: 845 FGVAKVVDA-SGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGR-- 900
           FG+A++ ++   +P +  VI  +  Y  PE      R     D++S G ++ EL T +  
Sbjct: 160 FGLARLYNSEESRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217

Query: 901 LPVDPEFGEKDLVKWVCST 919
              + E  + +L+  +C +
Sbjct: 218 FQANQELAQLELISRLCGS 236

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.0 bits (174), Expect = 6e-13
 Identities = 48/150 (32%), Positives = 76/150 (50%), Gaps = 9/150 (6%)

Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAAEGLSYLHH 816
           + +L  C  T D    V EY+ NG  GDL+ H  + G    P       + A GL +LH 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY 876
                I++RD+K +N++LD +   ++ADFG+ K  +     K+     G+  YIAPE   
Sbjct: 120 K---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIA 174

Query: 877 TLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
                +  D ++FGV++ E++ G+ P D E
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 44/133 (33%), Positives = 70/133 (52%), Gaps = 12/133 (9%)

Query: 776 EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD 835
           E+M  GSL  +L   K G +      KI +    GL+YL       I+HRDVK +NIL++
Sbjct: 79  EHMDGGSLDQVLK--KAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVN 134

Query: 836 GDFGARVADFGVA-KVVDASGKPKSMS-VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVI 893
                ++ DFGV+ +++D      SM+    G+  Y++PE         +SDI+S G+ +
Sbjct: 135 SRGEIKLCDFGVSGQLID------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 894 LELVTGRLPVDPE 906
           +E+  GR P+ P 
Sbjct: 189 VEMAIGRYPIPPP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 2e-12
 Identities = 39/96 (40%), Positives = 50/96 (52%), Gaps = 1/96 (1%)

Query: 345 LNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHC 404
           L G +P D+ K   L+ ++LS N   G IP SL     LE L + YNSF G +P+ LG  
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 405 QSLTRVRLGYNRLTGKVPPLLWGLP-HVYLLELTDN 439
            SL  + L  N L+G+VP  L G   H      TDN
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 2e-12
 Identities = 30/81 (37%), Positives = 51/81 (62%), Gaps = 1/81 (1%)

Query: 298 LTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKN 356
           L G IP+D+++L  L+S+NL  N + G++P ++     L  L L  N  NG++P  LG+ 
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 357 SPLRWVDLSNNQFTGEIPASL 377
           + LR ++L+ N  +G +PA+L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 33/247 (13%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS------------- 789
           FQ E E L  ++H++IVK +  C   D  ++V+EYM +G L   L +             
Sbjct: 54  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113

Query: 790 -CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
               G L       I    A G+ YL        VHRD+ + N L+  +   ++ DFG++
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS 170

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF 907
           + V ++   +          ++ PE     +   +SD++SFGV++ E+ T G+ P   + 
Sbjct: 171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF-QL 229

Query: 908 GEKDLVKWVCSTLDQKGVDHVLD-PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
              ++++  C T  +     VL+ P++  C KE    V +I L C    P  R  ++ + 
Sbjct: 230 SNTEVIE--CITQGR-----VLERPRV--CPKE----VYDIMLGCWQREPQQRLNIKEIY 276

Query: 967 KLLQEVG 973
           K+L  +G
Sbjct: 277 KILHALG 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 27/216 (12%)

Query: 691 IGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G+V    V + G+  A KKL              +K +++ +  +     E + 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL--------------DKKRLKKRKGEQMALNEKKI 46

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L K+  + IV L     T+D   LV   M  G L   +++            + I  AA+
Sbjct: 47  LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA---RAIFYAAQ 103

Query: 810 ---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
              GL +LH      IV+RD+K  N+LLD     R++D G+A  +    K K     AG+
Sbjct: 104 IICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGT 157

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            GY+APE       +   D ++ G  + E++ GR P
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 73/295 (24%), Positives = 116/295 (39%), Gaps = 46/295 (15%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           IG+G  GKV       GEA       R + KE  +          +Q+    F  EV+  
Sbjct: 3   IGNGWFGKVLL-----GEAHRGMSKARVVVKELRA-----SATPDEQLL---FLQEVQPY 49

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG---GLLDWPTRYKIIVDA 807
            ++ H N+++    C      LLV E+ P G L + L S +G    +       ++  + 
Sbjct: 50  RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
           A GL +LH       +H D+   N  L  D   ++ D+G+     A  +      I   C
Sbjct: 110 ASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGL-----ALEQYPEDYYITKDC 161

Query: 868 G-----YIAPEYA-------YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
                 ++APE               +KS+I+S GV + EL T      P+  ++ ++K 
Sbjct: 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221

Query: 916 VCSTLDQKGVDHVLD-PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL 969
           V    D K     L  P+LD  + +   +V+    L     P  RP    V +LL
Sbjct: 222 VVREQDIK-----LPKPQLDLKYSDRWYEVMQFCWLD----PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 37/229 (16%)

Query: 687 EDNVIGSGSSGKVYK-VVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
           +  V+GSG+ G VYK + +  GE     VA+K+L    S            +   ++ D+
Sbjct: 11  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----------KANKEILDE 59

Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS-----CKGGLLD 796
            +      +  + + ++ +L   C T   +L + + MP G L D +           LL+
Sbjct: 60  AY-----VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLN 113

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
           W       V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K
Sbjct: 114 W------CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                       ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 40/229 (17%)

Query: 688 DNVIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           ++VIG G+ G+V + ++         A+K     M KE  S  D              F 
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIK-----MLKEFASENDHRD-----------FA 50

Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK------------ 791
            E+E L K+  H NI+ L   C  R    +  EY P G+L D L   +            
Sbjct: 51  GELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110

Query: 792 --GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                L      +   D A G+ YL        +HRD+ + N+L+  +  +++ADFG+++
Sbjct: 111 GTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR 167

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             +   K K+M  +     ++A E         KSD++SFGV++ E+V+
Sbjct: 168 GEEVYVK-KTMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 69.2 bits (169), Expect = 3e-12
 Identities = 81/257 (31%), Positives = 119/257 (46%), Gaps = 9/257 (3%)

Query: 337 ELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQ 396
            L L  N L   LP  L +   L  +  S           L     L  L +  N     
Sbjct: 51  ALNLSSNTLL-LLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLP-LPSLDLNLNRLRSN 108

Query: 397 LPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLS 456
           + + L    +LT + L  N +T   P +     ++  L+L+DN +   +   +    NL 
Sbjct: 109 ISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLK 166

Query: 457 LLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGE 516
            L +S N+LS  LP+ +  L +L  L  S NK +  LP  +  L+ L  LDL  N +  E
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-E 223

Query: 517 LPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQ 576
           L SS+S+ K L+ L L++N    ++PE IGNLS L  LDLSNN++S  I        L +
Sbjct: 224 LLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRE 281

Query: 577 LNVSNNRLSGELPSLFA 593
           L++S N LS  LP +  
Sbjct: 282 LDLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 22/224 (9%)

Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD 740
           L     +  IG G    VYK + L +G  VA+KK              V+  ++ D    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK--------------VQIFEMMDAKAR 46

Query: 741 DGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGG-LLDWP 798
                E++ L ++ H N++K        +   +V E    G L  ++ H  K   L+   
Sbjct: 47  QDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPER 106

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
           T +K  V     L ++H      I+HRD+K  N+ +      ++ D G+ +    S K  
Sbjct: 107 TIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTT 161

Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +   + G+  Y++PE  +    N KSDI+S G ++ E+   + P
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 68.8 bits (168), Expect = 5e-12
 Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 37/278 (13%)

Query: 70  SVASIDLSNANIAGPFPSLLCRL-ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNL 128
           ++ S+DL N NI    P L+  L  NL  L L +N I  +LP  +    NL++LDLS N 
Sbjct: 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFND 174

Query: 129 LTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNI 188
           L+  L   L++L NL  LDL+GN  S                          +P  +  +
Sbjct: 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-------------------------DLPPEIELL 208

Query: 189 STLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALN 248
           S L+ L+LS N  +   +   L NL NL  L L   N + ++P+S+G L+ L  LDL+ N
Sbjct: 209 SALEELDLSNNSII--ELLSSLSNLKNLSGLEL-SNNKLEDLPESIGNLSNLETLDLSNN 265

Query: 249 NLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR 308
            +  +  SSL  L ++ +++L  NSL+  LP     L  L L       LT    +    
Sbjct: 266 QI--SSISSLGSLTNLRELDLSGNSLSNALPL--IALLLLLLELLLNLLLTLKALELKLN 321

Query: 309 LPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN 346
             L + N+  +  E S P  ++    L  L    N L+
Sbjct: 322 SILLNNNI-LSNGETSSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 57/285 (20%)

Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
            ++G G+ G VYK   L     +AVK +   ++ E           +Q Q+      +E+
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-----------LQKQIM-----SEL 50

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
           E L K     I+  +      +   +  E+M  GSL D+       +L      +I V  
Sbjct: 51  EILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAV 104

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGS 866
            +GL+YL       I+HRDVK +N+L++     ++ DFGV+ ++V++  K        G+
Sbjct: 105 VKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK-----TYVGT 156

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD 926
             Y+APE     +    SD++S G+  +EL  GR P  P+               QK   
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY-PQI--------------QKNQG 201

Query: 927 HVLDPKLDCCFKEEICKVLNIGLL----------CTSPLPINRPA 961
            ++  +L  C  +E   VL +G            C    P  RPA
Sbjct: 202 SLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 58/311 (18%)

Query: 689 NVIGSGSSGKVYKV-VLSNGEAV--AVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           +VIG G+ G+V K  +  +G  +  A+K++     KE  S         +D  +D  F  
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYAS---------KDDHRD--FAG 56

Query: 746 EVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           E+E L K+  H NI+ L   C  R    L  EY P+G+L D L   K  +L+    + I 
Sbjct: 57  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIA 114

Query: 805 ----------------VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
                            D A G+ YL        +HRD+ + NIL+  ++ A++ADFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           +  +   K K+M  +     ++A E          SD++S+GV++ E+V+         G
Sbjct: 172 RGQEVYVK-KTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LG 220

Query: 909 EKDLVKWVCSTLDQK-GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
                   C+ L +K    + L+  L+C   +E+  ++     C    P  RP+  +++ 
Sbjct: 221 GTPYCGMTCAELYEKLPQGYRLEKPLNC--DDEVYDLMR---QCWREKPYERPSFAQILV 275

Query: 968 LLQEVGAENRS 978
            L  +  E ++
Sbjct: 276 SLNRMLEERKT 286

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 66.8 bits (164), Expect = 5e-12
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 28/165 (16%)

Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYL 814
           + N +KL+   TT    +L+ +Y+ +G L DLL   K G L      KII    E L+ L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALNDL 125

Query: 815 H-HDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAKVVDASGKPKSMSVIAGSCGYIA 871
           H H    +I+H D+K  N+L D     R+   D+G+ K++         S   G+  Y +
Sbjct: 126 HKH----NIIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFS 174

Query: 872 PE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
           PE      Y  +       D ++ GV+  EL+TG+ P   +  E+
Sbjct: 175 PEKIKGHNYDVSF------DWWAVGVLTYELLTGKHPFKEDEDEE 213

Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 31/211 (14%)

Query: 691 IGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+ G+V+   L ++   VAVK     +  + +                  F  E   
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK----------------AKFLQEARI 46

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L +  H NIV+L   CT +    +V E +  G     L + +G  L      +++ +AA 
Sbjct: 47  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGPRLKVKELIQMVENAAA 105

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-----VVDASGKPKSMSVIA 864
           G+ YL        +HRD+ + N L+      +++DFG+++     V  ++G  K + V  
Sbjct: 106 GMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV-- 160

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
               + APE     R + +SD++SFG+++ E
Sbjct: 161 ---KWTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 27/240 (11%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +Y +L       V+G GS G+   V   N +     K  R + K   S   VE  +    
Sbjct: 1   QYNVL------RVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPK---SSSAVEDSR---- 46

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E   L K++H NIV             +V EY   G L   +   +G L   
Sbjct: 47  -------KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE 99

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            T  +  V    G+ ++H      ++HRD+KS NI L  +   ++ DFG A+++ + G  
Sbjct: 100 DTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156

Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
               V  G+  Y+ PE    +  N KSDI+S G ++ EL T + P       K+L+  VC
Sbjct: 157 ACTYV--GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-SWKNLILKVC 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 1e-11
 Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 61/258 (23%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEKGQVQ 735
            ++E++       VIG G+ G+V+ V   +   V A+K     + K      D+ K   +
Sbjct: 1   DDFEVIK------VIGRGAFGEVWLVRDKDTGQVYAMKV----LRK-----SDMIK---R 42

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
           +Q+     +AE + L       IVKL+      +   LV EYMP G L +LL   +  + 
Sbjct: 43  NQIAH--VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVF 98

Query: 796 D--WPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
                 R+ I  +V A + +  L        +HRD+K +NIL+D D   ++ADFG+ K +
Sbjct: 99  PEET-ARFYIAELVLALDSVHKLGF------IHRDIKPDNILIDADGHIKLADFGLCKKM 151

Query: 852 DASGKPKSMS---------------------------VIAGSCGYIAPEYAYTLRVNEKS 884
           + +   +                                 G+  YIAPE         + 
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC 211

Query: 885 DIYSFGVVILELVTGRLP 902
           D +S GV++ E++ G  P
Sbjct: 212 DWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 76/272 (27%), Positives = 108/272 (39%), Gaps = 82/272 (30%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +YEIL  L      G G+ G+VYK   +  G  VA+KK+     K              
Sbjct: 8   RDYEILGKL------GEGTFGEVYKARQIKTGRVVALKKILMHNEK-------------- 47

Query: 736 DQVQDDGF----QAEVETLGKIRHKNIVKLW--------CCCTTRDCKLLVYEYMPNGSL 783
                DGF      E++ L K++H N+V L              R    +V  YM +   
Sbjct: 48  -----DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH--- 99

Query: 784 GDLLHSCKGGLLDWPTRYK--------IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD 835
            DL      GLL+ P   K         ++   EG++YLH +    I+HRD+K+ NIL+D
Sbjct: 100 -DL-----SGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILID 149

Query: 836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCG----------YIAPEYA-----YTLRV 880
                ++ADFG+A+  D    P       G             Y  PE       YT  V
Sbjct: 150 NQGILKIADFGLARPYDGP-PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV 208

Query: 881 NEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
               DI+  G V  E+ T R P+    G+ D+
Sbjct: 209 ----DIWGIGCVFAEMFTRR-PILQ--GKSDI 233

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 10/160 (6%)

Query: 754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-KGGLLDWPTRYKIIVDAAEGLS 812
           +H  +  L CC  T+D    V EY+ NG  GDL+    +    D P       +    L 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYV-NG--GDLMFQIQRSRKFDEPRSRFYAAEVTLALM 110

Query: 813 YLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAP 872
           +LH      +++RD+K +NILLD +   ++ADFG+ K    +G   + +   G+  YIAP
Sbjct: 111 FLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAP 165

Query: 873 EYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           E    L      D ++ GV++ E++ G+ P + +  E DL
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-NEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.7 bits (168), Expect = 1e-11
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 14/170 (8%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLL-VYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           F+ E     ++ H NIV L          L  V+EY+P  +L ++L +   G L      
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA--DGALPAGETG 82

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
           ++++   + L+  H+     IVHRD+K  NI++        A+V DFG+  ++       
Sbjct: 83  RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139

Query: 859 SMSVIA-----GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
             ++       G+  Y APE      V   SD+Y++G++ LE +TG+  V
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 36/289 (12%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKK--LWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           IG G   +VY+   L +G  VA+KK  ++  M  +  + C                  E+
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADC----------------IKEI 53

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG--LLDWPTRYKIIV 805
           + L ++ H N++K +      +   +V E    G L  ++   K    L+   T +K  V
Sbjct: 54  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
                L ++H      ++HRD+K  N+ +      ++ D G+ +    S K  +   + G
Sbjct: 114 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV 925
           +  Y++PE  +    N KSDI+S G ++ E+   + P    +G+K  +  +C  ++Q   
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLYSLCKKIEQ--C 223

Query: 926 DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA 974
           D+   P     + EE+ +++N   +C +P P  RP +  V  + + + A
Sbjct: 224 DY--PPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 75/304 (24%), Positives = 113/304 (37%), Gaps = 93/304 (30%)

Query: 683 DGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
           + L +   IG G+ G V K++    G  +AVK++              EK Q +      
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI------RSTVD---EKEQKR------ 48

Query: 742 GFQAEVETLGKIRH-KNIVKL----------WCCCTTRDCKL-----LVYE----YMPNG 781
               +++ + +      IVK           W C    D  L      VYE     +P  
Sbjct: 49  -LLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEE 107

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            LG                 KI V   + L+YL  +    I+HRDVK +NILLD +   +
Sbjct: 108 ILG-----------------KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIK 148

Query: 842 VADFG--------VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNE---KSDIYSFG 890
           + DFG        +AK  DA  +P           Y+APE       +    +SD++S G
Sbjct: 149 LCDFGISGQLVDSIAKTRDAGCRP-----------YMAPERIDPSARDGYDVRSDVWSLG 197

Query: 891 VVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ-----KGVDHVLDPKLDCCFKEEICKVL 945
           + + E+ TG+ P           KW  S  DQ     KG   +L    +  F       +
Sbjct: 198 ITLYEVATGKFPYP---------KWN-SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247

Query: 946 NIGL 949
           N+ L
Sbjct: 248 NLCL 251

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 33/224 (14%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+ G VYK      GE VA+KK+   +  E E    V    ++          E+  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEG---VPSTAIR----------EISL 52

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P     +    +
Sbjct: 53  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL++ H   V   +HRD+K  N+L++ +   ++ADFG+A+      +  +  V+  +  Y
Sbjct: 112 GLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWY 166

Query: 870 IAPEYA-----YTLRVNEKSDIYSFGVVILELVTGR--LPVDPE 906
            APE       Y+  V    DI+S G +  E+VT R   P D E
Sbjct: 167 RAPEILLGCKYYSTAV----DIWSLGCIFAEMVTRRALFPGDSE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +G G+ GKVYK       A+A  K              V + + +++++D  +  E+E L
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAK--------------VIETKSEEELED--YMVEIEIL 63

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
               H  IVKL           ++ E+ P G++  ++     GL + P    I     E 
Sbjct: 64  ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEA 122

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIAGSCGY 869
           L YLH      I+HRD+K+ N+LL  D   ++ADFGV AK V    +  S     G+  +
Sbjct: 123 LQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF---IGTPYW 176

Query: 870 IAPEYAYTLRVNE-----KSDIYSFGVVILEL 896
           +APE      + +     K+DI+S G+ ++E+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 33/220 (15%)

Query: 690 VIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G G  G+V    V + G+  A KKL              EK +++ +  +     E +
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKL--------------EKKRIKKRKGESMALNEKQ 52

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
            L K+  + +V L     T+D   LV   M  G L   + H  + G        + +  A
Sbjct: 53  ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF----EEGRAVFYA 108

Query: 808 AE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
           AE   GL  LH +    IV+RD+K  NILLD     R++D G+A  V     P+  ++  
Sbjct: 109 AEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-----PEGQTIKG 160

Query: 865 --GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+ GY+APE     R     D ++ G ++ E++ G+ P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           +G G  GKV    Y     N GE VAVK L      + ESG         + + D   + 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL------KPESG--------GNHIAD--LKK 55

Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  + H+NIVK    CT       KL++ E++P+GSL + L   K  + +   + K
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLPRNKNKI-NLKQQLK 113

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V   +G+ YL        VHRD+ + N+L++ +   ++ DFG+ K ++   +  ++  
Sbjct: 114 YAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170

Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     +    SD++SFGV + EL+T
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 35/226 (15%)

Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEA-VAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
           D L+    +G+G+ G+V+ V     E   A+K +                 +V    Q+ 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM--------------AIPEVIRLKQEQ 46

Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLHSCKGGLLDWPT 799
               E   L ++ H  I++L+   T  D + L  + EY+P G L   L +  G   +   
Sbjct: 47  HVHNEKRVLKEVSHPFIIRLFW--TEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTG 103

Query: 800 RYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGK 856
            +    IV A E   YLH      IV+RD+K  NILLD +   ++ DFG AK + D +  
Sbjct: 104 LFYASEIVCALE---YLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                 + G+  Y+APE   +   N+  D ++ G++I E++ G  P
Sbjct: 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 46/232 (19%)

Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G+G+ G+VYK   +  G+  A+K +            DV + + ++       + E+ 
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVM------------DVTEDEEEE------IKLEIN 64

Query: 749 TLGKI-RHKNIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLL--DWPT 799
            L K   H+NI   +     +      D   LV E+   GS+ DL+ + KG  L  DW  
Sbjct: 65  MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS----- 854
              I  +   GL++LH      ++HRD+K  N+LL  +   ++ DFGV+  +D +     
Sbjct: 125 Y--ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179

Query: 855 ---GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
              G P  M+    +C    P+  Y  R    SDI+S G+  +E+  G  P+
Sbjct: 180 TFIGTPYWMAPEVIACDE-NPDATYDYR----SDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 49/296 (16%)

Query: 689 NVIGSGSSGKVY--KVVLSNGEAV--AVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
            VIG G  G VY   ++ S+G+ +  AVK L R                + D  + + F 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR----------------ITDLEEVEQFL 44

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRD-CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            E   +    H N++ L   C   +   L+V  YM +G L + + S        PT   +
Sbjct: 45  KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN----PTVKDL 100

Query: 804 I---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDAS-GKPK 858
           I   +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+ + D       
Sbjct: 101 IGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157

Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
           + +       ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++  
Sbjct: 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-- 215

Query: 919 TLDQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
            L  +    +L P        E C   +  + L C  P P  RP    +V  ++++
Sbjct: 216 -LQGR---RLLQP--------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 65.9 bits (160), Expect = 3e-11
 Identities = 68/239 (28%), Positives = 105/239 (43%), Gaps = 39/239 (16%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKL---WRGMSKECESGCDVEKGQV 734
           ++EIL       VIG G+ G+V  V L N + V   K+   W  M K  E+ C       
Sbjct: 2   DFEIL------KVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETAC------- 47

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                   F+ E + L    ++ I  L       +   LV +Y   G L  LL   +  L
Sbjct: 48  --------FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99

Query: 795 LDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            +   R+ +  +V A + +  LH+      VHRD+K +NIL+D +   R+ADFG    + 
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLM 153

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVTGRLPVDPE 906
             G  +S SV  G+  YI+PE    +     +   + D +S GV + E++ G  P   E
Sbjct: 154 EDGTVQS-SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 26/213 (12%)

Query: 691 IGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS+G V       +G  VAVK +            D+ K Q ++ + +     EV  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM------------DLRKQQRRELLFN-----EVVI 71

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +   +H+N+V+++      +   ++ E++  G+L D++   +   L+      +     +
Sbjct: 72  MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQ 128

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
            L YLH      ++HRD+KS++ILL  D   +++DFG    + +   PK  S++ G+  +
Sbjct: 129 ALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLV-GTPYW 183

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +APE         + DI+S G++++E+V G  P
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 52/230 (22%)

Query: 690 VIGSGSSGKVY---KVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           V+G GS GKV+   K+   + G+  A+K L +   K            V+D+V+    + 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------------VRDRVRT---KM 47

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK--- 802
           E + L ++ H  IVKL             Y +   G L  +L   +GG  D  TR     
Sbjct: 48  ERDILAEVNHPFIVKLH------------YAFQTEGKLYLILDFLRGG--DLFTRLSKEV 93

Query: 803 ---------IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVD 852
                     + + A  L +LH      I++RD+K  NILLD +   ++ DFG++K  +D
Sbjct: 94  MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              K  S     G+  Y+APE        + +D +SFGV++ E++TG LP
Sbjct: 151 HEKKAYSF---CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 27/219 (12%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           VIG GS  KV  V L   + +   K+             V+K  V D    D  Q E   
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKV-------------VKKELVHDDEDIDWVQTEKHV 48

Query: 750 LGKIRHKN-IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
             +      +V L  C  T     LV EY+  G L  + H  +   L  P  +     AA
Sbjct: 49  FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKL--PEEHARFY-AA 103

Query: 809 E---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           E    L++LH      I++RD+K +N+LLD D   ++ D+G+ K  +  G   + S   G
Sbjct: 104 EICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCG 158

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +  YIAPE           D ++ GV++ E++ GR P D
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 16/179 (8%)

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGG 793
           D  + D F  E E L  ++H++IVK +  C   D  ++V+EYM +G L   L  H     
Sbjct: 48  DNARKD-FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAV 106

Query: 794 LL---DWPTRYK------IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
           L+   + P          I    A G+ YL        VHRD+ + N L+  +   ++ D
Sbjct: 107 LMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163

Query: 845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           FG+++ V ++   +          ++ PE     +   +SD++S GVV+ E+ T G+ P
Sbjct: 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 4e-11
 Identities = 34/88 (38%), Positives = 53/88 (60%)

Query: 434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSL 493
           L L +  L G I  +I+   +L  + +S N++ G++P  +G + SL VL  S N F GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 494 PESLTNLAELGSLDLHANDLSGELPSSV 521
           PESL  L  L  L+L+ N LSG +P+++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 42/230 (18%)

Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G+G+ G+VYK   +  G+  A+K +            DV  G  +++++      E+ 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVM------------DV-TGDEEEEIKQ-----EIN 54

Query: 749 TLGKI-RHKNIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
            L K   H+NI   +     +      D   LV E+   GS+ DL+ + KG  L      
Sbjct: 55  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS------- 854
            I  +   GLS+LH      ++HRD+K  N+LL  +   ++ DFGV+  +D +       
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171

Query: 855 -GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
            G P  M+    +C    P+  Y      KSD++S G+  +E+  G  P+
Sbjct: 172 IGTPYWMAPEVIACDE-NPDATYDF----KSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 25/200 (12%)

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           + E + L +++H NIV         D  L +V  +   G L   L   KG LL      +
Sbjct: 47  EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A  L YLH      I+HRD+K+ N+ L      +V D G+A+V++   +    S 
Sbjct: 107 WFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMAST 161

Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-------------------GRLPV 903
           + G+  Y++PE       N KSD+++ G  + E+ T                   G+LP 
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP 221

Query: 904 DPEFGEKDLVKWVCSTLDQK 923
            P+    +L + + + L ++
Sbjct: 222 MPKDYSPELGELIATMLSKR 241

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 31/265 (11%)

Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           +++G G  G+V  V   + G+  A+K +              +K  +  Q     F+ E 
Sbjct: 7   SLVGRGHFGEVQVVREKATGDIYAMKVM--------------KKSVLLAQETVSFFEEER 52

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
           + L       I +L      +D   LV EY P G L  LL+  +    +   ++ +    
Sbjct: 53  DILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL---- 108

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
           AE +  +H       VHRD+K  N+L+D     ++ADFG A  + A+    S   + G+ 
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTP 167

Query: 868 GYIAPEYAYTLRVNEKS------DIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD 921
            YIAPE   T+  + K       D +S GV+  E++ GR P    F E    K   + ++
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTSAKTYNNIMN 223

Query: 922 -QKGVDHVLDPKLDCCFKEEICKVL 945
            Q+ +    DPK+   F + I  +L
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLL 248

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 35/218 (16%)

Query: 691 IGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G+   VYK    + GE VA+K          E   D E+G     ++      E+  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALK----------EIHLDAEEGTPSTAIR------EISL 51

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL-----LHSCKGGLLDWPTRYKII 804
           + +++H+NIV+L     T +  +LV+EYM      DL      H  +G L D  T     
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYMDK----DLKKYMDTHGVRGAL-DPNTVKSFT 106

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSVI 863
               +G+++ H +    ++HRD+K  N+L++     ++ADFG+A+   A G P  + S  
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR---AFGIPVNTFSNE 160

Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR 900
             +  Y AP+     R    S DI+S G ++ E++TGR
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 35/229 (15%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           ++G G  G V +  LS  +   +K   + M  +  +  ++E            F +E   
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIE-----------EFLSEAAC 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCK------LLVYEYMPNGSLGD-LLHSCKGGL---LDWPT 799
           +    H N++KL   C            +++  +M +G L   LL+S  GGL   L   T
Sbjct: 55  MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-----S 854
             K +VD A G+ YL +    + +HRD+ + N +L  D    VADFG++K + +      
Sbjct: 115 LLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171

Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           G+   M V      +IA E         KSD+++FGV + E+ T G+ P
Sbjct: 172 GRIAKMPV-----KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 64/249 (25%), Positives = 97/249 (38%), Gaps = 61/249 (24%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G G  G+V+ V L   G+  A+K     + K+      + K     +V       E E
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKV----LDKKE-----MIKRNKVKRVL-----TEQE 53

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL-DWPTRYKIIVDA 807
            L  + H  +  L+    T     LV +Y P G L  LL    G  L +   R+     A
Sbjct: 54  ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY----A 109

Query: 808 AE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
           AE    L YLH   +  IV+RD+K  NILL       ++DF ++K  D    P S ++  
Sbjct: 110 AEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166

Query: 865 GSCG---------------------------YIAPE----YAYTLRVNEKSDIYSFGVVI 893
           GS                             YIAPE      +   V    D ++ G+++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILL 222

Query: 894 LELVTGRLP 902
            E++ G  P
Sbjct: 223 YEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 28/228 (12%)

Query: 688 DNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
              IG G  G VY+ V  + E    AVAVK       K C S    EK           F
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVK-----TCKNCTSPSVREK-----------F 54

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             E   + +  H +IVKL    T  +   +V E  P G L   L   K  L D  +    
Sbjct: 55  LQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSL-DLASLILY 112

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
               +  L+YL        VHRD+ + N+L+      ++ DFG+++ ++     K+ S  
Sbjct: 113 SYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKG 168

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
                ++APE     R    SD++ FGV + E++   L V P  G K+
Sbjct: 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM--LGVKPFQGVKN 214

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 51/241 (21%)

Query: 688 DNVIGSGSSGKVYKVV------LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
              +G G  GKV K         +    VAVK L    S                  +  
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS----------------SSELR 48

Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----GGLLDW 797
              +E   L ++ H +++KL+  C+     LL+ EY   GSL   L   +      L   
Sbjct: 49  DLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108

Query: 798 PTRYKIIVDA------------------AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
             R    +D                   + G+ YL       +VHRD+ + N+L+     
Sbjct: 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRK 165

Query: 840 ARVADFGVAKVV--DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            +++DFG+++ V  + S   +S   I     ++A E  +      +SD++SFGV++ E+V
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Query: 898 T 898
           T
Sbjct: 224 T 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 32/231 (13%)

Query: 690 VIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G G  G+V    V + G+  A KKL              EK +++ +  +     E +
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKL--------------EKKRIKKRKGEAMALNEKQ 52

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L K+  + +V L     T+D   LV   M  G L   +++      D     + +  AA
Sbjct: 53  ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAA 109

Query: 809 E---GLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVDASGKPKSMSVIA 864
           E   GL  LH +    IV+RD+K  NILLD D+G  R++D G+A V    G+     V  
Sbjct: 110 EITCGLEDLHRE---RIVYRDLKPENILLD-DYGHIRISDLGLA-VEIPEGETIRGRV-- 162

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
           G+ GY+APE     R     D +  G +I E++ G+ P       K+ VK 
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR---QRKEKVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.6 bits (157), Expect = 6e-11
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQV---QDDGFQA 745
           V+G GS GKV         E  A+K L + +  + +   DVE   V+ +V   QD     
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD---DVECTMVEKRVLALQD----- 58

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
                   +   + +L  C  T D    V EY+  G L  + H  + G    P       
Sbjct: 59  --------KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAA 108

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           + + GL +LH      I++RD+K +N++LD +   ++ADFG+ K     G   +     G
Sbjct: 109 EISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCG 163

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           +  YIAPE        +  D +++GV++ E++ G+ P D E
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 21/171 (12%)

Query: 743 FQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK---------- 791
           F  E+E L K+  H NI+ L   C  R    L  EY P+G+L D L   +          
Sbjct: 42  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 101

Query: 792 ----GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
                  L          D A G+ YL        +HRD+ + NIL+  ++ A++ADFG+
Sbjct: 102 ANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158

Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           ++  +   K K+M  +     ++A E          SD++S+GV++ E+V+
Sbjct: 159 SRGQEVYVK-KTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)

Query: 690 VIGSGSSGKVYK-VVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           V+GSG+ G VYK + + +GE     VA+K L    S            +   ++ D+ + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-----------KANKEILDEAY- 61

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-----GLLDWPT 799
                +  +    + +L   C T   +L V + MP G L D +   K       LL+W  
Sbjct: 62  ----VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW-- 114

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
                V  A+G+SYL       +VHRD+ + N+L+      ++ DFG+A+++D       
Sbjct: 115 ----CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                    ++A E     R   +SD++S+GV + EL+T G  P D
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 7e-11
 Identities = 59/238 (24%), Positives = 94/238 (39%), Gaps = 64/238 (26%)

Query: 691 IGSGSSGKVYKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA-- 745
           IG G+ G+VYK    N   G+  A+KK                     D+ Q  G     
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKF------------------KGDKEQYTGISQSA 49

Query: 746 --EVETLGKIRHKNIVKLWCCCTTRDCKL--LVYEYMPNGSLGDLLHSCK------GGLL 795
             E+  L +++H+N+V L         K   L+++Y  +    DL    K         +
Sbjct: 50  CREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSI 105

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--DGDFGARV--ADFGVAKVV 851
                  ++     G+ YLH +    ++HRD+K  NIL+  +G     V   D G+A++ 
Sbjct: 106 PPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Query: 852 DASGKPKSMSVIAGSCG------YIAPEYA-----YTLRVNEKSDIYSFGVVILELVT 898
           +A  KP     +A          Y APE       YT  +    DI++ G +  EL+T
Sbjct: 163 NAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 63.5 bits (155), Expect = 7e-11
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 38/223 (17%)

Query: 691 IGSGSSGKVYKVV--LSNGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAE 746
           +G G+ G V K V  + +G+   VAVK L                 Q         F  E
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL----------------KQEHIAAGKKEFLRE 46

Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL----HSCKGGLLDWPTRYK 802
              + ++ H  IV+L   C   +  +LV E  P G L   L          L +   +  
Sbjct: 47  ASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ-- 103

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                A G++YL        VHRD+ + N+LL     A+++DFG+++ + A G     + 
Sbjct: 104 ----VAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGA-GSDYYRAT 155

Query: 863 IAGS--CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            AG     + APE     + + KSD++S+GV + E  + G  P
Sbjct: 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 34/231 (14%)

Query: 690 VIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G G  G+V    V + G+  A K+L              EK +++ +  +     E +
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRL--------------EKKRIKKRKGESMALNEKQ 52

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L K+  + +V L     T+D   LV   M  G L   +++      +     + +  AA
Sbjct: 53  ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE---EERALFYAA 109

Query: 809 E---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA- 864
           E   GL  LH +   + V+RD+K  NILLD     R++D G+A  +     P+  S+   
Sbjct: 110 EILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-----PEGESIRGR 161

Query: 865 -GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
            G+ GY+APE     R     D +  G +I E++ G+ P     G K+ VK
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR---GRKEKVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 39/107 (36%), Positives = 55/107 (51%), Gaps = 9/107 (8%)

Query: 245 LALNN--LVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPI 302
           L L+N  L G IP+ +++L  +  I L  NS+ G++P    ++TSL +LD S N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 303 PDDLTRL-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGT 348
           P+ L +L  L  LNL  N L G +PA +          L R   N T
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL------LHRASFNFT 523

Length = 623

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 43/244 (17%)

Query: 662 DKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMS 720
           D S W L        S++E+         +G+GS G+V        GE  A+K L     
Sbjct: 11  DTSSWKL--------SDFEM------GETLGTGSFGRVRIAKHKGTGEYYAIKCL----- 51

Query: 721 KECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPN 780
                    +K ++    Q      E   L ++ H  IV + C     +    + E++  
Sbjct: 52  ---------KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102

Query: 781 GSLGDLLHSCKGGLL--DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
           G L    H  K G    D    Y   +  A    YLH      I++RD+K  N+LLD   
Sbjct: 103 GEL--FTHLRKAGRFPNDVAKFYHAELVLA--FEYLHSK---DIIYRDLKPENLLLDNKG 155

Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             +V DFG AK V     P     + G+  Y+APE   +    +  D ++ GV++ E + 
Sbjct: 156 HVKVTDFGFAKKV-----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA 210

Query: 899 GRLP 902
           G  P
Sbjct: 211 GYPP 214

Length = 329

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 73/252 (28%), Positives = 107/252 (42%), Gaps = 58/252 (23%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE L        IG G+ G VYK   L+ G  VA+KK                   V+  
Sbjct: 1   YEEL------AEIGEGAYGTVYKARDLNTGRFVALKK-------------------VRVP 35

Query: 738 VQDDGFQA----EVETLGKIR---HKNIVKLWCCC----TTRDCKL-LVYEYMPNGSLGD 785
           + ++G       E+  L ++    H NIV+L   C    T R+ KL LV+E++ +  L  
Sbjct: 36  LSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLAT 94

Query: 786 LLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
            L  C    L   T   ++     G+ +LH      IVHRD+K  NIL+  D   ++ADF
Sbjct: 95  YLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF 151

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTG 899
           G+A++        S+ V   +  Y APE      YA  +      D++S G +  EL   
Sbjct: 152 GLARIYSFEMALTSVVV---TLWYRAPEVLLQSSYATPV------DMWSVGCIFAELFR- 201

Query: 900 RLPVDPEFGEKD 911
           R P+     E D
Sbjct: 202 RRPLFRGTSEAD 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 2e-10
 Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 4/103 (3%)

Query: 194 LNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGA 253
           L L  N  L G IP ++  L +L+ + L+  ++ G IP SLG +  L  LDL+ N+  G+
Sbjct: 423 LGLD-NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMN 296
           IP SL +L S+  + L  NSL+G +P   + L    L  AS N
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP---AALGGRLLHRASFN 521

Length = 623

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 19/185 (10%)

Query: 739 QDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           Q  GF AE  TLG+  H NIV+L    T  +  ++V EYM NG+L   L   +G L+   
Sbjct: 49  QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA-G 107

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
               ++   A G+ YL        VH+ + ++ +L++ D   +++ F          +  
Sbjct: 108 QLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQED 157

Query: 859 SMSVIAGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKD 911
               I  +        + APE       +  SD++SFG+V+ E+++ G  P   +   +D
Sbjct: 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY-WDMSGQD 216

Query: 912 LVKWV 916
           ++K V
Sbjct: 217 VIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 63.6 bits (155), Expect = 2e-10
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 37/215 (17%)

Query: 758 IVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDAAEGLSY 813
           IV+L      +D K L  V EYMP G L +L+ +      D P ++      +    L  
Sbjct: 105 IVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDA 157

Query: 814 LHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE 873
           +H       +HRDVK +N+LLD     ++ADFG    +DA+G  +      G+  YI+PE
Sbjct: 158 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC-DTAVGTPDYISPE 213

Query: 874 YAYTLRVN----EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVL 929
              +   +     + D +S GV + E++ G    D  F    LV     T  +     ++
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLV----GTYSK-----IM 260

Query: 930 DPKLDCCFKEEI-----CKVLNIGLLCTSPLPINR 959
           D K    F ++I      K L    L    + + R
Sbjct: 261 DHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGR 295

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +G GS G VY V   + +AVA ++L   + KE   G       VQ          E + L
Sbjct: 8   LGKGSFGTVYLV--KDKKAVAEERL--KVLKEIPVGELNPNETVQANQ-------EAQLL 56

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAA 808
            K+ H  IVK       RD   ++ EY     L   L   K  G  L      +  +   
Sbjct: 57  SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
            G+ Y+H      I+HRD+K+ NI L  +   ++ DFGV++++   G     +   G+  
Sbjct: 117 LGVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPY 170

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILEL 896
           Y++PE       + KSDI+S G ++ E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 2e-10
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 43/237 (18%)

Query: 688 DNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAE 746
             V+GSG++G V     +S+GE  AVK +            D+E     D+ +    QAE
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVV------------DMEGMSEADKNRA---QAE 81

Query: 747 VETLGKIRHKNIVKLWCCCTTRDCK--------LLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           V  L      +IVK       +D +         LV +Y    + GDL    K       
Sbjct: 82  VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDY---ANAGDLRQEIK------- 131

Query: 799 TRYKI---IVDAAEGLSYL------HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
           +R K      +   GL ++      HH     ++HRD+KS NILL  +   ++ DFG +K
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           +  A+          G+  Y+APE       ++K+D++S GV++ EL+T + P D E
Sbjct: 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248

Length = 496

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 41/131 (31%), Positives = 70/131 (53%), Gaps = 10/131 (7%)

Query: 776 EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD 835
           E+M  GSL  +L   K G +      K+ +   +GL+YL       I+HRDVK +NIL++
Sbjct: 83  EHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVN 138

Query: 836 GDFGARVADFGVA-KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL 894
                ++ DFGV+ +++D+           G+  Y++PE       + +SDI+S G+ ++
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 895 ELVTGRLPVDP 905
           E+  GR P+ P
Sbjct: 194 EMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 13/163 (7%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV  L  ++H NIV L     T  C  LV+EY+ +  L   L +C G L+        + 
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMF 110

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GLSY H      I+HRD+K  N+L++     ++ADFG+A+      K  S  V+  
Sbjct: 111 QLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-- 165

Query: 866 SCGYIAPEYAYTLRVNEKS---DIYSFGVVILELVTGRLPVDP 905
           +  Y  P+    L   E S   D++  G ++ E+ TGR P+ P
Sbjct: 166 TLWYRPPD--VLLGSTEYSTPIDMWGVGCILYEMATGR-PMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.7 bits (152), Expect = 3e-10
 Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 691 IGSGSSGKVYKVVLSNGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           +G+GS G+V      N +   VA+K+               EK ++  Q Q D   +E +
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRF--------------EKSKIIKQKQVDHVFSERK 83

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI-IVDA 807
            L  I H   V L+          LV E++  G     L   K    D    Y   IV  
Sbjct: 84  ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
            E L  L      +IV+RD+K  N+LLD D   ++ DFG AKVVD          + G+ 
Sbjct: 144 FEYLQSL------NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTP 192

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            YIAPE    +   + +D ++ G+ I E++ G  P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 21/216 (9%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           VIG GS  KV  V L   E +   K+             V+K  V D    D  Q E   
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKV-------------VKKELVNDDEDIDWVQTEKHV 48

Query: 750 LGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
             +   H  +V L  C  T      V EY+  G L  + H  +   L          + +
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEIS 106

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
             L+YLH      I++RD+K +N+LLD +   ++ D+G+ K     G   + S   G+  
Sbjct: 107 LALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPN 161

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           YIAPE           D ++ GV++ E++ GR P D
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 61/244 (25%), Positives = 115/244 (47%), Gaps = 32/244 (13%)

Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 69  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 185

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            V+     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 244

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P +RP  +++V+ 
Sbjct: 245 VEELFK-----LLKEG--HRMDKPANC--TNELYMMMRD---CWHAIPSHRPTFKQLVED 292

Query: 969 LQEV 972
           L  +
Sbjct: 293 LDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.0 bits (150), Expect = 5e-10
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 11/159 (6%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   L   RH  +  L     T+D    V EY+  G L    H  +  +           
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA 102

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK--VVDASGKPKSMSVI 863
           +    L YLH      IV+RD+K  N++LD D   ++ DFG+ K  + DA+    +M   
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----TMKTF 155

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.5 bits (149), Expect = 6e-10
 Identities = 62/244 (25%), Positives = 109/244 (44%), Gaps = 32/244 (13%)

Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK------------ 791
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +            
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 792 --GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                L +          A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            V      K  S       ++APE  +      +SD++SFG+++ E+ T G  P  P   
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY-PGIP 241

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 242 VEELFK-----LLREG--HRMDKPSNC--THELYMLMR---ECWHAVPTQRPTFKQLVEA 289

Query: 969 LQEV 972
           L +V
Sbjct: 290 LDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.6 bits (149), Expect = 7e-10
 Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 33/227 (14%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKL---WRGMSKECESGCDVEKGQVQDQVQDDGFQAE 746
           VIG G+ G+V  V + + E +   K+   W  M K  E+ C               F+ E
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWE-MLKRAETAC---------------FREE 51

Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--I 804
              L     + I  L       +   LV +Y   G L  LL   +  L +   R+ I  +
Sbjct: 52  RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEM 111

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
           V A   +  LH+      VHRD+K +N+LLD +   R+ADFG    ++  G  +S SV  
Sbjct: 112 VLAIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS-SVAV 164

Query: 865 GSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVTGRLPVDPE 906
           G+  YI+PE    +     +   + D +S GV + E++ G  P   E
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.4 bits (149), Expect = 7e-10
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAE--- 746
           VIG GS  KV  V L     +   K+             ++K  V D    D  Q E   
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKV-------------IKKELVNDDEDIDWVQTEKHV 48

Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
            ET     H  +V L  C  T      V E++  G L  + H  +   L  P  +     
Sbjct: 49  FETASN--HPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKL--PEEHARFY- 101

Query: 807 AAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +AE    L++LH      I++RD+K +N+LLD +   ++ D+G+ K  +      + S  
Sbjct: 102 SAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTF 156

Query: 864 AGSCGYIAPEYAYTLRVNE---KSDIYSFGVVILELVTGRLPVD 904
            G+  YIAPE    LR  +     D ++ GV++ E++ GR P D
Sbjct: 157 CGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.5 bits (152), Expect = 8e-10
 Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 2/96 (2%)

Query: 226 LVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNL 285
           L G IP+ + +L  L  ++L+ N++ G IP SL  + S+  ++L  NS  G +P     L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 286 TSLRLLDASMNDLTGPIPDDLTRLPLE--SLNLYEN 319
           TSLR+L+ + N L+G +P  L    L   S N  +N
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.7 bits (148), Expect = 8e-10
 Identities = 67/246 (27%), Positives = 111/246 (45%), Gaps = 49/246 (19%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           EYE L+ ++E      G+ G VY+      GE VA+KKL   M KE              
Sbjct: 6   EYEKLNRIEE------GTYGVVYRARDKKTGEIVALKKL--KMEKE-------------- 43

Query: 737 QVQDDGFQA----EVETLGKIRHKNIVKL--WCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
               +GF      E+  L K++H NIV +      +  D   +V EY+ +  L  L+ + 
Sbjct: 44  ---KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETM 99

Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
           K   L       +++    G+++LH +    I+HRD+K++N+LL+     ++ DFG+A+ 
Sbjct: 100 KQPFLQ-SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLARE 155

Query: 851 VDASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
                  K  + +  +  Y APE       Y+       D++S G +  EL+T + P+ P
Sbjct: 156 Y--GSPLKPYTQLVVTLWYRAPELLLGAKEYS----TAIDMWSVGCIFAELLTKK-PLFP 208

Query: 906 EFGEKD 911
              E D
Sbjct: 209 GKSEID 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.2 bits (148), Expect = 8e-10
 Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 9/150 (6%)

Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHH 816
           + +L  C  T D    V EY+ NG  GDL++  +  G    P       + A GL +LH 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYV-NG--GDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY 876
                I++RD+K +N++LD +   ++ADFG+ K     G   +     G+  YIAPE   
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIA 174

Query: 877 TLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
                +  D ++FGV++ E++ G+ P + E
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.2 bits (148), Expect = 9e-10
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 10/131 (7%)

Query: 776 EYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD 835
           E+M  GSL  +L   K   +      K+ +    GL+YL       I+HRDVK +NIL++
Sbjct: 83  EHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVN 138

Query: 836 GDFGARVADFGVA-KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL 894
                ++ DFGV+ +++D+           G+  Y++PE       + +SDI+S G+ ++
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193

Query: 895 ELVTGRLPVDP 905
           EL  GR P+ P
Sbjct: 194 ELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 97/349 (27%), Positives = 144/349 (41%), Gaps = 62/349 (17%)

Query: 254 IPSSLTELASVVQIELYNNSLTGDL-PTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLE 312
            P S  E  +V ++ L  +S T  L P+  S L SL LL  S         + L  LPL 
Sbjct: 37  FPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLP 96

Query: 313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP-LRWVDLSNNQFTG 371
           SL+L  NRL  ++   + +   L  L L  N +   +P  +G     L+ +DLS+N+   
Sbjct: 97  SLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE- 153

Query: 372 EIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV 431
                                    LP  L +  +L  + L +N L+  +P LL  L ++
Sbjct: 154 ------------------------SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188

Query: 432 YLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG 491
             L+L+ N +S ++   I   + L  L +S N++   L   +  LK+L  L  S NK   
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE- 245

Query: 492 SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVL 551
            LPES+ NL+ L +LDL  N +S     S+SS                     +G+L+ L
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS-----SISS---------------------LGSLTNL 279

Query: 552 NYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNS 600
             LDLS N LS  +P       L  L      L   L +L  K      
Sbjct: 280 RELDLSGNSLSNALP---LIALLLLLLELLLNLLLTLKALELKLNSILL 325

Length = 394

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.2 bits (148), Expect = 1e-09
 Identities = 64/244 (26%), Positives = 112/244 (45%), Gaps = 32/244 (13%)

Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP----- 798
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +D+      
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 799 -----TRYKIIVD----AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            V      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIP 241

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C       ++  I   C   +P  RP  +++V+ 
Sbjct: 242 VEELFK-----LLKEG--HRMDKPANCTH-----ELYMIMRECWHAVPSQRPTFKQLVED 289

Query: 969 LQEV 972
           L  V
Sbjct: 290 LDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 13/166 (7%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL----------HSCKG 792
           F  E++ + ++++ NI++L   C + D   ++ EYM NG L   L          H+   
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             +       + V  A G+ YL      + VHRD+ + N L+   +  ++ADFG+++ + 
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +    +          ++A E     +    SD+++FGV + E+ T
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 34/222 (15%)

Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA---- 745
           IG G+ G V+K       E VA+K+                   V+    D+G  +    
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKR-------------------VRLDDDDEGVPSSALR 48

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+  L +++HKNIV+L+    +     LV+EY  +  L     SC  G +D       + 
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSC-NGDIDPEIVKSFMF 106

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSVIA 864
              +GL++ H     +++HRD+K  N+L++ +   ++ADFG+A+   A G P +  S   
Sbjct: 107 QLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEV 160

Query: 865 GSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
            +  Y  P+  +  ++   S D++S G +  EL     P+ P
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 39/235 (16%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKL---WRGMSKECESGCDVEKGQV 734
           ++EIL       VIG G+ G+V  V + N   V   K+   W  M K  E+ C       
Sbjct: 2   DFEIL------KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-MLKRAETAC------- 47

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                   F+ E + L     + I  L       +   LV +Y   G L  LL   +  L
Sbjct: 48  --------FREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99

Query: 795 LDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            +   R+ +  +V A + +  L +      VHRD+K +N+LLD +   R+ADFG    + 
Sbjct: 100 PEDMARFYLAEMVLAIDSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVTGRLP 902
           A G  +S +V  G+  YI+PE    +     R   + D +S GV + E++ G  P
Sbjct: 154 ADGTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 56/232 (24%), Positives = 81/232 (34%), Gaps = 59/232 (25%)

Query: 694 GSSGKVYKVVLSNGEA-----VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           G      K    N  A     VAVK L            D      +D      F  EV+
Sbjct: 28  GLQDFSEKAFAENDNADAPVLVAVKVL----------RPDASDNARED------FLKEVK 71

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK------ 802
            L ++   NI +L   CT      ++ EYM NG L   L              K      
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 803 ---IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
              +    A G+ YL      + VHRD+ + N L+  ++  ++ADFG             
Sbjct: 132 LLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG------------- 175

Query: 860 MSVIAGSCGY-------------IAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           MS    S  Y             +A E     +   KSD+++FGV + E++T
Sbjct: 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.2 bits (148), Expect = 2e-09
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 25/181 (13%)

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
           + D+ Q    ++E+  L    H  IVK +    + D  LL+ EY   GS GDL    K  
Sbjct: 103 LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY---GSGGDLNKQIKQR 159

Query: 794 LLD-WPTR--------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
           L +  P +        Y+I++     L  +H      ++HRD+KS NI L      ++ D
Sbjct: 160 LKEHLPFQEYEVGLLFYQIVL----ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGD 212

Query: 845 FGVAKVVDASGKPKSMSVIAGSCG---YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           FG +K    S    S+ V +  CG   Y+APE     R ++K+D++S GV++ EL+T   
Sbjct: 213 FGFSKQYSDS---VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Query: 902 P 902
           P
Sbjct: 270 P 270

Length = 478

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 17/163 (10%)

Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYL 814
           H+NIV L   CT     L++ EY   G L + L   +   L            A+G+++L
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 815 HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC----GYI 870
                 + +HRD+ + N+LL      ++ DFG+A+ +       S  V+ G+      ++
Sbjct: 158 ASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI----MNDSNYVVKGNARLPVKWM 210

Query: 871 APEYAYTLRVNEKSDIYSFGVVILELVT------GRLPVDPEF 907
           APE  +      +SD++S+G+++ E+ +        +PVD +F
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 61/252 (24%), Positives = 105/252 (41%), Gaps = 54/252 (21%)

Query: 660 AIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRG 718
            ++K+ W +          Y+ L      + +GSG+ G+V     +  G  VA+KKL R 
Sbjct: 5   ELNKTVWEVPD-------RYQNL------SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP 51

Query: 719 MSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT-------RDCK 771
                           Q  +       E+  L  + H+N++ L    T        +D  
Sbjct: 52  F---------------QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD-- 94

Query: 772 LLVYEYMP--NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS 829
             VY         L +++   K  L D   ++ ++     GL Y+H      I+HRD+K 
Sbjct: 95  --VYLVTHLMGADLNNIVKCQK--LSDDHIQF-LVYQILRGLKYIHS---AGIIHRDLKP 146

Query: 830 NNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYS 888
           +NI ++ D   ++ DFG+A+  D       M+    +  Y APE     +  N+  DI+S
Sbjct: 147 SNIAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201

Query: 889 FGVVILELVTGR 900
            G ++ EL+TG+
Sbjct: 202 VGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 37/236 (15%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++  S + +L    +   IGSG+ G V   +  VL  G  VAVKKL R            
Sbjct: 11  QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPF---------- 58

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                Q+Q        E+  L  + HKNI+ L    T +          LV E M + +L
Sbjct: 59  -----QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANL 112

Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++H      LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 113 CQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 165

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +     M+    +  Y APE    +   E  DI+S G ++ ELV G
Sbjct: 166 DFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 55/297 (18%)

Query: 691 IGSGSSGKVYKVVL---SNGE---AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           +G    GKVYK  L   + GE   AVA+K L               K + +  ++++ F+
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL---------------KDKAEGPLREE-FK 56

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-----HSCKGGL----- 794
            E     +++H NIV L    T      +++ Y  +  L + L     HS  G       
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 795 ----LDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
               L+      I+   A G+ +L  HH     +VH+D+ + N+L+      +++D G+ 
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLF 171

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           + V A+   K M        +++PE     + +  SDI+S+GVV+ E+ +  L     + 
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV 965
            +D+++ + +         VL    DC        V  + L C +  P  RP  + +
Sbjct: 232 NQDVIEMIRNR-------QVLPCPDDC-----PAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 42/225 (18%)

Query: 691 IGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA--EV 747
           +G GS   VYK +   NG+ VA+K +    S + E G                F A  E 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVP--------------FTAIREA 54

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
             L  ++H NIV L     T++    V+EYM +  L   +    GGL  +  R   +   
Sbjct: 55  SLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQL 112

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL+Y+H      I+HRD+K  N+L+      ++ADFG+A+      +  S  V+  + 
Sbjct: 113 LRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TL 167

Query: 868 GYIAP-------EYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
            Y  P       +Y+  L      DI+  G + +E++ G+ P  P
Sbjct: 168 WYRPPDVLLGATDYSSAL------DIWGAGCIFIEMLQGQ-PAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 44/234 (18%)

Query: 689 NVIGSGSSGKVYKVVLS--NGEA----VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             +G G+ G+VY+ +    +G+A    VAVK L    S++ ES                 
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD---------------- 55

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY- 801
           F  E   + K  H+NIV+L      R  + ++ E M  G L   L   +    + P+   
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPR-PERPSSLT 114

Query: 802 -----KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                    D A+G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 115 MKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171

Query: 854 SG----KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           +       ++M  I     ++ PE         K+D++SFGV++ E+ + G +P
Sbjct: 172 ASYYRKGGRAMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 40/247 (16%)

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
            D      F      + ++ HK++VKL+  C  RD  ++V EY+  G L   LH  K  +
Sbjct: 40  SDHRDSLAFFETASLMSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNV 98

Query: 795 LDWPTRYKIIV--DAAEGLSYLHHDCVPSIVHRDVKSNNILL--DGDFG-----ARVADF 845
                 +K+ V    A  L YL       +VH +V   NIL+   G         +++D 
Sbjct: 99  ---SLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS--DIYSFGVVILELVTGRLPV 903
           G+   V +  +            +IAPE     + +     D +SFG  +LE+ +     
Sbjct: 153 GIPITVLSREERVERI------PWIAPECIRNGQASLTIAADKWSFGTTLLEICSN---- 202

Query: 904 DPEFGEKDLVKWVCSTLDQKGVD-HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM 962
               GE+ L     S  ++   D H L P  DC    E+  ++N    C +  P  RP+ 
Sbjct: 203 ----GEEPLSTLSSSEKERFYQDQHRL-PMPDC---AELANLIN---QCWTYDPTKRPSF 251

Query: 963 RRVVKLL 969
           R +++ L
Sbjct: 252 RAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 41/243 (16%)

Query: 678 EYEI-LDGLDEDNVIGSGSSGKVYK---VVLSNGE---AVAVKKLWRGMSKECESGCDVE 730
           E+E+  D L     +G G+ G+V K   V L N      VAVK L               
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--------------- 50

Query: 731 KGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
           K    ++   D   +E+E +  I +HKNI+ L   CT      +V EY  +G+L D L +
Sbjct: 51  KDDATEKDLSD-LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRA 109

Query: 790 -------CKGGLLDWPTRYKIIVD-------AAEGLSYLHHDCVPSIVHRDVKSNNILLD 835
                          P       D        A G+ +L        +HRD+ + N+L+ 
Sbjct: 110 RRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166

Query: 836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
            D   ++ADFG+A+ +      +  +       ++APE  +      +SD++SFGV++ E
Sbjct: 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 226

Query: 896 LVT 898
           + T
Sbjct: 227 IFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 49/160 (30%), Positives = 69/160 (43%), Gaps = 13/160 (8%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP-TRY--K 802
           E   L   RH  +  L     T D    V EY   G L    H  +  +      R+   
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            IV A   L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M  
Sbjct: 103 EIVSA---LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154

Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 26/213 (12%)

Query: 691 IGSGSSGKVYKV--VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           IG G+ GKV+K   + + G  VA+K++     +E         G     +++      +E
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---------GMPLSTIREVAVLRHLE 59

Query: 749 TLGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           T     H N+V+L+  CT     R+ KL LV+E++ +  L   L       +   T   +
Sbjct: 60  TF---EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 115

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +     GL +LH      +VHRD+K  NIL+      ++ADFG+A++        +++ +
Sbjct: 116 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSV 169

Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
             +  Y APE           D++S G +  E+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 5e-09
 Identities = 75/280 (26%), Positives = 114/280 (40%), Gaps = 103/280 (36%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YEIL        +G G+ G V+K +     E VA+KK++                     
Sbjct: 9   YEIL------QKLGKGAYGIVWKAIDRRTKEVVALKKIF--------------------- 41

Query: 738 VQDDGFQ---------AEVETLGKIR-HKNIVKLWCCCTTRDCKL------------LVY 775
              D F+          E+  L ++  H NIVKL          L            LV+
Sbjct: 42  ---DAFRNATDAQRTFREIMFLQELGDHPNIVKL----------LNVIKAENDKDIYLVF 88

Query: 776 EYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL 833
           EYM      D LH+      L D   RY I+    + L Y+H     +++HRD+K +NIL
Sbjct: 89  EYMET----D-LHAVIRANILEDVHKRY-IMYQLLKALKYIHSG---NVIHRDLKPSNIL 139

Query: 834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIA------PE-----YAYTLRVNE 882
           L+ D   ++ADFG+A+ +    +     V+     Y+A      PE       YT  V  
Sbjct: 140 LNSDCRVKLADFGLARSLSELEENPENPVLT---DYVATRWYRAPEILLGSTRYTKGV-- 194

Query: 883 KSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ 922
             D++S G ++ E++ G+ P+ P  G         STL+Q
Sbjct: 195 --DMWSVGCILGEMLLGK-PLFP--GT--------STLNQ 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 61/255 (23%), Positives = 102/255 (40%), Gaps = 72/255 (28%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S Y+ ++       IGSG+ G V   +   +G+ VA+KK+                    
Sbjct: 5   SRYKPIE------NIGSGAYGVVCSAIDTRSGKKVAIKKI----------------PHAF 42

Query: 736 DQVQDDGFQA-----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG------ 784
           D        A     E++ L   +H NI+ +      RD         P G+        
Sbjct: 43  DVPT----LAKRTLRELKILRHFKHDNIIAI------RDI------LRPPGADFKDVYVV 86

Query: 785 -DLLHS-------CKGGLLDWPTR---YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL 833
            DL+ S           L +   R   Y+++     GL Y+H   V   +HRD+K +N+L
Sbjct: 87  MDLMESDLHHIIHSDQPLTEEHIRYFLYQLL----RGLKYIHSANV---IHRDLKPSNLL 139

Query: 834 LDGDFGARVADFGVAKVVDASGKPKS--MSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFG 890
           ++ D   R+ DFG+A+ + +S       M+    +  Y APE   +L       D++S G
Sbjct: 140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199

Query: 891 VVILELVTGRLPVDP 905
            +  E++ GR  + P
Sbjct: 200 CIFAEML-GRRQLFP 213

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 34/232 (14%)

Query: 690 VIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G G  G+V    V + G+  A KKL              EK +++ +  +     E  
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKL--------------EKKRIKKRKGEAMALNEKR 52

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L K+  + +V L     T+D   LV   M  G L   +++      D     + I  AA
Sbjct: 53  ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAA 109

Query: 809 E---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA- 864
           E   GL  L  +    IV+RD+K  NILLD     R++D G+A  +     P+  +V   
Sbjct: 110 ELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI-----PEGETVRGR 161

Query: 865 -GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
            G+ GY+APE     +     D +  G +I E++ G+ P       K+ VK 
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK---RKERVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 58.3 bits (142), Expect = 6e-09
 Identities = 68/253 (26%), Positives = 101/253 (39%), Gaps = 81/253 (32%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE+L        IGSG+ G V   V    G  VA+KK+                      
Sbjct: 2   YELL------KPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------------------- 35

Query: 738 VQDDGFQA-----EVETLGKIRHKNIVKLWCCCTTRDCKL-----------LVYEYMPNG 781
           V DD   A     E++ L  +RH+NI+ L       D              +V E M   
Sbjct: 36  VFDDLIDAKRILREIKLLRHLRHENIIGL------LDILRPPSPEDFNDVYIVTELMET- 88

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDFG 839
            L  ++ S    L D   +Y  +     GL YLH     S  ++HRD+K +NIL++ +  
Sbjct: 89  DLHKVIKS-PQPLTDDHIQY-FLYQILRGLKYLH-----SANVIHRDLKPSNILVNSNCD 141

Query: 840 ARVADFGVAKVVDASGKPKS-MSVIAGSCGYI------APE-----YAYTLRVNEKSDIY 887
            ++ DFG+A+ VD     K  ++       Y+      APE       YT  +    DI+
Sbjct: 142 LKICDFGLARGVDPDEDEKGFLT------EYVVTRWYRAPELLLSSSRYTKAI----DIW 191

Query: 888 SFGVVILELVTGR 900
           S G +  EL+T +
Sbjct: 192 SVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +G G+ GKVYK        +A  K              V   + +++++D  +  E++ L
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAK--------------VIDTKSEEELED--YMVEIDIL 56

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
               H NIVKL       +   ++ E+   G++  ++   +  L + P    +     E 
Sbjct: 57  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-PQIRVVCKQTLEA 115

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIAGSCGY 869
           L+YLH +    I+HRD+K+ NIL   D   ++ADFGV AK      +  S     G+  +
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---IGTPYW 169

Query: 870 IAPEYAYTLRVNE-----KSDIYSFGVVILEL 896
           +APE        +     K+D++S G+ ++E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.5 bits (141), Expect = 7e-09
 Identities = 62/240 (25%), Positives = 103/240 (42%), Gaps = 32/240 (13%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           VIG G+ G+V  V   + + V   KL             + K ++  +     F  E + 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKL-------------LSKFEMIKRSDSAFFWEERDI 96

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +       +V+L+C         +V EYMP G L +L+ +      D P ++     A  
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEV 151

Query: 810 GLSYLHHDCVPS--IVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
            L+    D + S  ++HRDVK +N+LLD     ++ADFG    +D +G  +  + + G+ 
Sbjct: 152 VLAL---DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTP 207

Query: 868 GYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK 923
            YI+PE   +         + D +S GV + E++ G  P    F    LV      +D K
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP----FYADSLVGTYSKIMDHK 263

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 44/157 (28%), Positives = 64/157 (40%), Gaps = 7/157 (4%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   L   RH  +  L     T D    V EY   G L    H  +  +           
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 102

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K  +      +M    G
Sbjct: 103 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 157

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 8e-09
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 41/231 (17%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA---- 745
           IG G+ G VYK      GE VA+KK                   ++ + +D+G  +    
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKK-------------------IRLETEDEGVPSTAIR 47

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+  L ++ H NIV+L     + +   LV+E++ +  L   + S     LD P     + 
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
              +G++Y H      ++HRD+K  N+L+D +   ++ADFG+A+      +  +  V+  
Sbjct: 107 QLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-- 161

Query: 866 SCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR--LPVDPEFGE 909
           +  Y APE       Y+  V    DI+S G +  E+V  R   P D E  +
Sbjct: 162 TLWYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRRPLFPGDSEIDQ 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 36/217 (16%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS G V+K      G+ VA+KK       E E    ++K  ++          E+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-----VESEDDPVIKKIALR----------EIRM 53

Query: 750 LGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           L +++H N+V L      R  KL LV+EY  +  L +L  + +G  +      KII    
Sbjct: 54  LKQLKHPNLVNL-IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTL 110

Query: 809 EGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
           + +++ H H+C+    HRDVK  NIL+      ++ DFG A+++  +G     +    + 
Sbjct: 111 QAVNFCHKHNCI----HRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATR 164

Query: 868 GYIAPEYAYTLRVNEKS-----DIYSFGVVILELVTG 899
            Y APE    L V +       D+++ G V  EL+TG
Sbjct: 165 WYRAPE----LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 62/287 (21%), Positives = 125/287 (43%), Gaps = 36/287 (12%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKK--LWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           IG G   +VY+   L + + VA+KK  ++  M  +    C                  E+
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDC----------------VKEI 53

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKIIV 805
           + L ++ H N++K        +   +V E    G L  ++   K      P R  +K  V
Sbjct: 54  DLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
                + ++H      ++HRD+K  N+ +      ++ D G+ +    S K  +   + G
Sbjct: 114 QLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV 925
           +  Y++PE  +    N KSDI+S G ++ E+   + P    +G+K  +  +C  ++Q   
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFSLCQKIEQ--C 223

Query: 926 DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           D+   P     + E++ ++++   +C  P P  RP +  V ++ +++
Sbjct: 224 DYPPLPTEH--YSEKLRELVS---MCIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.3 bits (141), Expect = 1e-08
 Identities = 31/87 (35%), Positives = 43/87 (49%), Gaps = 1/87 (1%)

Query: 269 LYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPA 327
           L N  L G +P   S L  L+ ++ S N + G IP  L  +  LE L+L  N   GS+P 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 328 TIADSPGLYELRLFRNRLNGTLPGDLG 354
           ++     L  L L  N L+G +P  LG
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 23/223 (10%)

Query: 691 IGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G+V    + + G+  A KKL               K +++ +   +G   E   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKL--------------NKKRLKKRKGYEGAMVEKRI 46

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA- 808
           L K+  + IV L     T+    LV   M  G L   +++       +P        A  
Sbjct: 47  LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI 106

Query: 809 -EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL +LH      I++RD+K  N+LLD D   R++D G+A V    G+ K+    AG+ 
Sbjct: 107 ISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGY-AGTP 161

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
           G++APE       +   D ++ GV + E++  R P     GEK
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR-GEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 38/125 (30%), Positives = 62/125 (49%), Gaps = 17/125 (13%)

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
           Y+I+     GL Y+H      +VHRD+K +NIL++ +   ++ DFG+A++ D       M
Sbjct: 115 YQIL----RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QM 162

Query: 861 SVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
           +    +  Y APE   T  + + + DI+S G +  E++ G+    P F  KD V      
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK----PLFPGKDHVNQFSII 218

Query: 920 LDQKG 924
            D  G
Sbjct: 219 TDLLG 223

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 63/244 (25%), Positives = 116/244 (47%), Gaps = 32/244 (13%)

Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++   PT+
Sbjct: 72  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131

Query: 801 -------YKIIVD----AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 189 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 247

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 248 VEELFK-----LLKEG--HRMDKPSNC--TNELYMMMRD---CWHAVPSQRPTFKQLVED 295

Query: 969 LQEV 972
           L  +
Sbjct: 296 LDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.4 bits (141), Expect = 2e-08
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 20/161 (12%)

Query: 691 IGSGSSGKVY-KVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           I  G+ GKVY     +N +  AVK +     K+ +    + K  V  QVQ     AE + 
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVV-----KKADM---INKNMVH-QVQ-----AERDA 57

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L   +   IV L+    + +   LV EY+  G +  LLH    G  D     K I + A 
Sbjct: 58  LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVAL 115

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
            L YLH      I+HRD+K +N+L+  +   ++ DFG++KV
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 49/242 (20%)

Query: 691 IGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           +G  + GK+YK  L      + + VA+K L            D+   Q     Q   FQ 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-----------DINNPQ-----QWGEFQQ 56

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-----HSCKG-------- 792
           E   + ++ H NIV L    T      +++EY+  G L + L     HS  G        
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 793 --GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
               LD      I +  A G+ YL        VH+D+ + NIL+      +++D G+++ 
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 851 VDASG----KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           + ++     +PKS+  I     ++ PE     + +  SDI+SFGVV+ E+ +    + P 
Sbjct: 174 IYSADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPY 227

Query: 907 FG 908
           +G
Sbjct: 228 YG 229

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 43/234 (18%)

Query: 679 YEILDGLDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +E+ D   +   +GSG+ G V   +    G  VA+KKL+R                    
Sbjct: 11  WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF------------------ 52

Query: 738 VQDDGFQA----EVETLGKIRHKNIVKL---WCCCTTRDCKLLVYEYMP--NGSLGDLLH 788
            Q + F      E+  L  ++H+N++ L   +    + D     Y  MP     LG L+ 
Sbjct: 53  -QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK 111

Query: 789 SCKGGLLDWPTRYKIIV-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
             K        R + +V    +GL Y+H      I+HRD+K  N+ ++ D   ++ DFG+
Sbjct: 112 HEKLS----EDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 164

Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
           A+  D+      M+    +  Y APE     +   +  DI+S G ++ E++TG+
Sbjct: 165 ARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 12/110 (10%)

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK--VVDASGKPKSMSVIAGS 866
           EGL YLH      I+HRDVK+ NI ++      + D G A+  VV     P  + + AG+
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA----PAFLGL-AGT 219

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT--GRLPVDPEFGEKDLVK 914
               APE     + N K+DI+S G+V+ E++     +  DP    ++ VK
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269

Length = 357

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 6/157 (3%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   L   RH  +  L     T D    V EY   G L    H  +  +           
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH +   ++V+RD+K  N++LD D   ++ DFG+ K     G   +M    G
Sbjct: 103 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCG 158

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 3e-08
 Identities = 67/255 (26%), Positives = 104/255 (40%), Gaps = 66/255 (25%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG G+ G+V  V     G   A+KKL     ++ E    +EK QV         +AE +
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKL-----RKSEM---LEKEQVAH------VRAERD 53

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI----- 803
            L +  +  +VKL+      +   L+ EY+P G +  LL   K    +  TR+ I     
Sbjct: 54  ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETIL 112

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-------------- 849
            +D+   L Y         +HRD+K +N+LLD     +++DFG+                
Sbjct: 113 AIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 850 -------VVDASGKPKSMSVIA---------------GSCGYIAPEYAYTLRVNEKSDIY 887
                   +D   KP S    A               G+  YIAPE       N++ D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 888 SFGVVILELVTGRLP 902
           S GV++ E++ G  P
Sbjct: 224 SLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 30/225 (13%)

Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G+V  V + N G+  A KKL              +K +++ +  +     E E 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKL--------------DKKRLKKKSGEKMALLEKEI 46

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDAA 808
           L K+    IV L     ++    LV   M  G L   + +  + GL       ++I  +A
Sbjct: 47  LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL----EMERVIHYSA 102

Query: 809 E---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +   G+ +LH      IV+RD+K  N+LLD     R++D G+A V    GK  +    AG
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQR--AG 156

Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
           + GY+APE       +   D ++ G  I E+V GR P   +  EK
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK-DHKEK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 36/218 (16%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +GSG+ G V   +    GE VA+KKL R                 Q ++       E+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---------------QSEIFAKRAYRELTL 67

Query: 750 LGKIRHKNIVKLWCCCTTRDCK------LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           L  ++H+N++ L    T+           LV  YM      DL       L +   +Y +
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQY-L 122

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +     GL Y+H      I+HRD+K  N+ ++ D   ++ DFG+A+  DA      M+  
Sbjct: 123 VYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGY 174

Query: 864 AGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
             +  Y APE     +  N+  DI+S G ++ E++TG+
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 5e-08
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 417 LTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFL 476
           L G +P  +  L H+  + L+ N + G I  ++    +L +L +S N+ +GS+PE +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 477 KSLVVLSGSENKFTGSLPESLTNLAELGSLDLH 509
            SL +L+ + N  +G +P      A LG   LH
Sbjct: 490 TSLRILNLNGNSLSGRVP------AALGGRLLH 516

Length = 623

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 67/264 (25%), Positives = 93/264 (35%), Gaps = 51/264 (19%)

Query: 87  SLLCRLEN---LTFLTLFNNSINSTLPDDISACQ---NLQHLDLSQNLLTGTLTPALAD- 139
           SLL  L     L  L L +N++       + +     +LQ L L+ N L       LA  
Sbjct: 72  SLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG 131

Query: 140 ----LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLN 195
                P L+ L L  N   G   E+                L   + A       LK LN
Sbjct: 132 LKDLPPALEKLVLGRNRLEGASCEA----------------LAKALRA----NRDLKELN 171

Query: 196 LSYNPFLPGRIP---PELGNLTNLEILWLTECNL----VGEIPDSLGRLAKLVDLDLALN 248
           L+ N      I      L    NLE+L L    L       + ++L  L  L  L+L  N
Sbjct: 172 LANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN 231

Query: 249 NLVGAI-----PSSLTELASVVQIELYNNSLT----GDLPTGWSNLTSLRLLDASMNDLT 299
           NL  A       + L+   S++ + L  N +T     DL    +   SL  LD   N   
Sbjct: 232 NLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

Query: 300 GPIPDDLTRLPLESLNLYENRLEG 323
               ++  +L  ESL    N LE 
Sbjct: 292 ----EEGAQLLAESLLEPGNELES 311

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.5 bits (134), Expect = 5e-08
 Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 55/249 (22%)

Query: 675 GFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQ 733
             S+YE L        IG G+ G+V+K       + VA+KK+     KE           
Sbjct: 10  EVSKYEKL------AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE----------- 52

Query: 734 VQDQVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTR-----DCK---LLVYEYMPNG 781
                   GF      E++ L  ++H+N+V L   C T+       K    LV+E+  + 
Sbjct: 53  --------GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH- 103

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            L  LL S K          K++     GL Y+H +    I+HRD+K+ NIL+  D   +
Sbjct: 104 DLAGLL-SNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK 159

Query: 842 VADFGVAKVVDAS--GKPKSMSVIAGSCGYIAPEYAYTLRVNEKS-----DIYSFGVVIL 894
           +ADFG+A+    S   KP   +    +  Y  PE    L + E+      D++  G ++ 
Sbjct: 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE----LLLGERDYGPPIDMWGAGCIMA 215

Query: 895 ELVTGRLPV 903
           E+ T R P+
Sbjct: 216 EMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 38/222 (17%)

Query: 691 IGSGSSGKVYKVVLSNG---EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           IG+G  GKV    +++G     V VK+L    S             VQ+Q++   F  E 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------------VQEQMK---FLEEA 46

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL---DWPTRYKII 804
           +    ++H N+++    CT     LLV E+ P G L   L SC+   L   D  T  ++ 
Sbjct: 47  QPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMA 106

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV---VDASGKPKSMS 861
            + A GL +LH +   + +H D+   N LL  D   ++ D+G++      D    P  + 
Sbjct: 107 CEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW 163

Query: 862 VIAGSCGYIAPEYAYTLRVN-------EKSDIYSFGVVILEL 896
           V      +IAPE    +  N       ++S+++S GV I EL
Sbjct: 164 V---PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 20/172 (11%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS------------- 789
           F  EV+ L +++  NI++L   C   D   ++ EYM NG L   L S             
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 790 ----CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
                    + + +   + +  A G+ YL      + VHRD+ + N L+  +   ++ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
           G+++ + A    +          ++A E     +    SD+++FGV + E++
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.7 bits (131), Expect = 8e-08
 Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 14/171 (8%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCC---TTRD---CKLLVYEYMPNGSLGDLLHSCKGG--- 793
           F +E   + +  H N+++L   C      +     +++  +M +G L   L   + G   
Sbjct: 47  FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP 106

Query: 794 -LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             L      K + D A G+ YL      S +HRD+ + N +L+ +    VADFG++K + 
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                +   +      +IA E         KSD++SFGV + E+ T G+ P
Sbjct: 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 15/148 (10%)

Query: 766 TTRDCKLLV---YEYMPNGSLGDLLHSCKGGLLDWP-------TRYKIIVDAAEGLSYLH 815
           +T DC  +V   Y +     L  +L    GG L +        +  ++   AAE +  L 
Sbjct: 52  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE 111

Query: 816 HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE-Y 874
           H     +V+RD+K  NILLD     R++D G+A   D S K    SV  G+ GY+APE  
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV--GTHGYMAPEVL 167

Query: 875 AYTLRVNEKSDIYSFGVVILELVTGRLP 902
              +  +  +D +S G ++ +L+ G  P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 9/161 (5%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV  L  ++H NIV L     T     LV+EY+ +  L   L  C G  ++       + 
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLF 111

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL+Y H      ++HRD+K  N+L++     ++ADFG+A+      K  S  V+  
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-- 166

Query: 866 SCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           +  Y  P+    +   + + D++  G +  E+ TGR P+ P
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 39/165 (23%), Positives = 77/165 (46%), Gaps = 12/165 (7%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLD---- 796
           F  E++ + +++  NI++L   C T D   ++ EYM NG L   L  H  +         
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 797 ---WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
              + T   +    A G+ YL      + VHRD+ + N L+  ++  ++ADFG+++ + +
Sbjct: 126 TISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               +          +++ E     +    SD+++FGV + E++T
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.2 bits (133), Expect = 9e-08
 Identities = 47/177 (26%), Positives = 72/177 (40%), Gaps = 33/177 (18%)

Query: 746 EVETLGKIRHKNIVKL-----W---CCCTTR--DCKLLVY-EYMPNGSLGDLLHSCKGGL 794
           E++ L  I H+ I+ L     W    C       C L  Y +      L   +   +  L
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLL 195

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDA 853
                         E L+YLH      I+HRDVK+ NI LD    A + DFG A K+   
Sbjct: 196 --------------EALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
              P+     +G+    +PE         K+DI+S G+V+ E+    + +   FG++
Sbjct: 239 PDTPQCYG-WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL---FGKQ 291

Length = 392

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 8/196 (4%)

Query: 702 VVLSNGEAVAVKK-LWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK 760
           V L +G    VKK +++   K+ +    V K + +  V+D+    E E + ++ +  IV+
Sbjct: 1   VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDE-MMREAEIMHQLDNPYIVR 59

Query: 761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVP 820
           +   C      +LV E    G L   L S K   +      +++   + G+ YL      
Sbjct: 60  MIGVCEAEAL-MLVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLEGK--- 114

Query: 821 SIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK-PKSMSVIAGSCGYIAPEYAYTLR 879
           + VHRD+ + N+LL     A+++DFG++K + A     K+ S       + APE     +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 880 VNEKSDIYSFGVVILE 895
            + +SD++S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 39/221 (17%)

Query: 690 VIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAE 746
            IGSG+ G V   Y  V   G+ VA+KKL R                 Q+         E
Sbjct: 23  PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPF---------------QNVTHAKRAYRE 65

Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKL-------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           +  +  + HKNI+ L    T     L       LV E M + +L  ++       LD   
Sbjct: 66  LVLMKLVNHKNIIGLLNVFTP-QKSLEEFQDVYLVMELM-DANLCQVIQM----DLDHER 119

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
              ++     G+ +LH      I+HRD+K +NI++  D   ++ DFG+A+    +G    
Sbjct: 120 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFM 173

Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGR 900
           M+    +  Y APE    +   E  DI+S G ++ E++ G 
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 21/165 (12%)

Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +V ++C   T+    +V EY+  G    LL +     +D    Y    +    L YLH+ 
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY--FAETVLALEYLHN- 119

Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKV-------------VDASGKPKSMSVIA 864
               IVHRD+K +N+L+      ++ DFG++K+             ++   +      + 
Sbjct: 120 --YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
           G+  YIAPE        +  D ++ G+++ E + G +P    FG+
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---FGD 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 31/216 (14%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +GSG+ G V        G  VAVKKL R                 Q  +       E+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---------------QSIIHAKRTYRELRL 69

Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLGDLLHS---CKGGLLDWPTRYKIIV 805
           L  ++H+N++ L    T  R  +     Y+    +G  L++   C+  L D   ++ +I 
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQF-LIY 127

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    
Sbjct: 128 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVA 179

Query: 866 SCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
           +  Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 35/220 (15%)

Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G  G+V+     + GE VA+K+    M K       + K      V       E + 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKR----MKKSL-----LFKLNEVRHVLT-----ERDI 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII----- 804
           L   + + +VKL       +   L  EY+P G    LL +  G L +   R+ +      
Sbjct: 55  LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEA 113

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
           VDA   L Y         +HRD+K  N L+D     ++ DFG++K         + SV+ 
Sbjct: 114 VDALHELGY---------IHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVV- 159

Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           GS  Y+APE       +   D +S G ++ E + G  P  
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA---- 745
           IG G+ G VYK     +G  VA+K                    V+ Q  +DG       
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALK-------------------SVRVQTNEDGLPLSTVR 48

Query: 746 EVETLGKIR---HKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDW 797
           EV  L ++    H NIV+L   C T    R+ K+ LV+E++ +  L   L       L  
Sbjct: 49  EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA 107

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            T   ++     GL +LH +C   IVHRD+K  NIL+      ++ADFG+A++       
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--- 161

Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
            +++ +  +  Y APE           D++S G +  E+
Sbjct: 162 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 48.1 bits (115), Expect = 2e-07
 Identities = 23/44 (52%), Positives = 24/44 (54%), Gaps = 3/44 (6%)

Query: 23 LNQEGLYLERVKLSL-SDPDSALSSWGRNPRDDSPCSWRGVECD 65
          LN +   L   K SL  DP  ALSSW  NP    PCSW GV CD
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSW--NPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 54/244 (22%), Positives = 102/244 (41%), Gaps = 55/244 (22%)

Query: 689 NVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           +++  G+ G+++  +L        E V VK +    S                ++Q    
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----------------EIQVTLL 55

Query: 744 QAEVETLGKIRHKNIVKLWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT--R 800
             E   L  + H+NI+ +   C    +   ++Y YM  G+L   L  C+ G  + P    
Sbjct: 56  LQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115

Query: 801 YKIIVDAA----EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV----- 851
            + +V  A     G+SYLH      ++H+D+ + N ++D +   ++ D  +++ +     
Sbjct: 116 TQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY 172

Query: 852 ----DASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP--- 902
               D   +P K M+           E       +  SD++SFGV++ EL+T G+ P   
Sbjct: 173 HCLGDNENRPVKWMA----------LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Query: 903 VDPE 906
           +DP 
Sbjct: 223 IDPF 226

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 37/238 (15%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R            
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPF---------- 54

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                Q+Q        E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 55  -----QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANL 108

Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 109 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 161

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 162 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 57/254 (22%), Positives = 99/254 (38%), Gaps = 61/254 (24%)

Query: 691 IGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+ G+V  V   +  A+ A+K L               K  V  + Q    +AE + 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTL--------------RKADVLMRNQAAHVKAERDI 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L +  ++ +VKL+     +D    V +Y+P G +  LL   + G+ +       I +   
Sbjct: 55  LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDLARFYIAELTC 112

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA--------------------- 848
            +  +H       +HRD+K +NIL+D D   ++ DFG+                      
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169

Query: 849 ----------------KVVDASGKPKSMSVIA----GSCGYIAPEYAYTLRVNEKSDIYS 888
                           K ++   K +    +A    G+  YIAPE        +  D +S
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229

Query: 889 FGVVILELVTGRLP 902
            GV++ E++ G+ P
Sbjct: 230 VGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 33/228 (14%)

Query: 690 VIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           ++G G  G V +  L     + + VAVK L      +  S  D+E+           F  
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKML----KADIFSSSDIEE-----------FLR 50

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCK------LLVYEYMPNGSLGDLLHSCKGG----LL 795
           E   + +  H N++KL         K      +++  +M +G L   L   + G     L
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL 110

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
              T  + ++D A G+ YL      + +HRD+ + N +L+ +    VADFG++K + +  
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
             +          ++A E          SD+++FGV + E++T G+ P
Sbjct: 168 YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSK-ECESGCDV----EKGQVQDQVQDDGFQA 745
           +G GS G VY       E +A     +G+ K E E+   +    E   ++++++   F  
Sbjct: 14  LGQGSFGMVY-------EGIA-----KGVVKDEPETRVAIKTVNEAASMRERIE---FLN 58

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDWPTR 800
           E   + +    ++V+L    +     L++ E M  G L   L S +       +   P+ 
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 801 YKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +   
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175

Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +          +++PE          SD++SFGVV+ E+ T
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 68/245 (27%)

Query: 691 IGSGSSGKVYKVV--LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA--- 745
           IG G+ G VYK    ++N E +A+KK                   ++ + +D+G  +   
Sbjct: 10  IGEGTYGVVYKARDRVTN-ETIALKK-------------------IRLEQEDEGVPSTAI 49

Query: 746 -EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC----KGGLLDWPTR 800
            E+  L +++H NIV+L     +     LV+EY+ +  L   + S     K   L     
Sbjct: 50  REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYL 108

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKP-- 857
           Y+I+     G++Y H      ++HRD+K  N+L+D    A ++ADFG+A+   A G P  
Sbjct: 109 YQIL----RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVR 158

Query: 858 -----------KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGR--LPVD 904
                      ++  ++ GS  Y  P            DI+S G +  E+V  +   P D
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTP-----------VDIWSVGCIFAEMVNQKPLFPGD 207

Query: 905 PEFGE 909
            E  E
Sbjct: 208 SEIDE 212

Length = 294

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 23/215 (10%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG GS GKV       +G+  AVK L              +K  V ++ +     AE  
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVL--------------QKKIVLNRKEQKHIMAERN 47

Query: 749 TLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            L K ++H  +V L     T +    V +++  G L    H  +      P       + 
Sbjct: 48  VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEI 105

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
           A  L YLH     +IV+RD+K  NILLD      + DFG+ K  +   +  + +   G+ 
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTP 160

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            Y+APE       +   D +  G V+ E++ G  P
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 50/238 (21%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y+ LD L      G GS   VYK      G+ VA+K++      E E G           
Sbjct: 7   YKKLDKL------GEGSYATVYKGRSKLTGQLVALKEI----RLEHEEGAP--------- 47

Query: 738 VQDDGFQA--EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
                F A  E   L  ++H NIV L     T+    LV+EY+ +  L   +  C GGL 
Sbjct: 48  -----FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLS 101

Query: 796 DWPTRYKIIV-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                 ++ +     GL+Y H      ++HRD+K  N+L+      ++ADFG+A+     
Sbjct: 102 --MHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156

Query: 855 GKPKSMSVIAGSCGYIAP-------EYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
            K  S  V+  +  Y  P       EY+ +L      D++  G +  E+ TGR P+ P
Sbjct: 157 SKTYSNEVV--TLWYRPPDVLLGSTEYSTSL------DMWGVGCIFYEMATGR-PLFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 18/161 (11%)

Query: 746 EVETLGKIRHKNIVKL--------WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
           E+  LG++ H+NI+K+             T+     +Y +M + +        K   L  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDRPLLK 267

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            TR  I+      + Y+H      ++HRD+K  NI L+ D    + DFG A   +   + 
Sbjct: 268 QTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323

Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
                + G+    +PE        E +DI+S G+++L++++
Sbjct: 324 FDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 32/233 (13%)

Query: 690 VIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
           V+G G  GKV++V        G+  A+K L +                V++Q      +A
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-------------VRNQKDTAHTKA 49

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           E   L  ++H  IV L     T   KL L+ EY+  G L   +H  + G+    T    +
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQT-GGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYL 106

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            + +  L +LH      I++RD+K  NILLD     ++ DFG+ K     G     +V  
Sbjct: 107 SEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-----TVTH 158

Query: 865 GSCG---YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
             CG   Y+APE        +  D +S G ++ +++TG  P   E  +K + K
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 26/164 (15%)

Query: 754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSY 813
           RH NI+  W   TT     ++  +M  GS   LL +     +       I+  A  GL+Y
Sbjct: 57  RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNY 116

Query: 814 LHHDCVPSIVHRDVKSNNILLDGDFGARVADFG-VAKVVDASGKPK--------SMSVIA 864
           LH +     +HR++K+++IL+ GD    ++    +  +V    K K        S SV+ 
Sbjct: 117 LHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP 173

Query: 865 GSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               +++PE      Y Y    N KSDIYS G+   EL TGR+P
Sbjct: 174 ----WLSPELLRQDLYGY----NVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 39/235 (16%)

Query: 688 DNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKG-QVQDQVQDDGFQ- 744
              +G G+ GKV K      G+ VA+KK+     K  E   DV K  Q+       G   
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKV-----KIIEISNDVTKDRQLVGMC---GIHF 65

Query: 745 ---AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E++ + +I+H+NI+ L       D   LV + M    L  ++       L      
Sbjct: 66  TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR--KIRLTESQVK 122

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAK------VVDAS 854
            I++    GL+ LH       +HRD+   NI ++   G  ++ADFG+A+        D  
Sbjct: 123 CILLQILNGLNVLHKW---YFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTL 178

Query: 855 GKPKSMS--------VIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGR 900
            K ++M         V+  +  Y APE      + +   D++S G +  EL+TG+
Sbjct: 179 SKDETMQRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 7e-07
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 37/238 (15%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R            
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPF---------- 61

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                Q+Q        E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 62  -----QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115

Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G +
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 43/235 (18%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+ GKVYK    + G+ VA+KK    M +E      +                E+  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---------------EISL 53

Query: 750 LGKIRHKN-IVKLWCCCTTRD-----CKLLVYEYMPNGSLGDLLHSCKGGL---LDWPTR 800
           L  +     IV+L       +        LV+EY+ +  L   + S   G    L   T 
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKS 859
              +    +G+++ H      ++HRD+K  N+L+D   G  ++AD G+ +      K  +
Sbjct: 113 KSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169

Query: 860 MSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR--LPVDPEF 907
             ++  +  Y APE       Y+  V    DI+S G +  E+   +   P D E 
Sbjct: 170 HEIV--TLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGDSEL 218

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 57/301 (18%)

Query: 691 IGSGSSGKVYKVVLSN---GEA---VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           +G GS G VY+    +   GEA   VAVK +              E   ++++++   F 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------------NESASLRERIE---FL 57

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-------GGLLDW 797
            E   +      ++V+L    +     L+V E M +G L   L S +       G     
Sbjct: 58  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP-- 115

Query: 798 PTRYKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           PT  ++I  AAE   G++YL+       VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 116 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172

Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 230

Query: 913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V   +D   +D             + C  +V ++  +C    P  RP    +V LL+
Sbjct: 231 LKFV---MDGGYLDQ-----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Query: 971 E 971
           +
Sbjct: 277 D 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.9 bits (124), Expect = 8e-07
 Identities = 58/215 (26%), Positives = 89/215 (41%), Gaps = 23/215 (10%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG GS GKV      S+G   AVK L              +K  +  + + +   AE  
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVL--------------QKKTILKKKEQNHIMAERN 47

Query: 749 TLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            L K ++H  +V L     T +    V +Y+  G L    H  +      P       + 
Sbjct: 48  VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEV 105

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
           A  + YLH     +I++RD+K  NILLD      + DFG+ K  +     ++ S   G+ 
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTP 160

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            Y+APE       +   D +  G V+ E++ G  P
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 8e-07
 Identities = 33/113 (29%), Positives = 60/113 (53%), Gaps = 13/113 (11%)

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS- 859
           Y+I+     GL Y+H     +++HRD+K +N+LL+ +   ++ DFG+A++ D        
Sbjct: 113 YQIL----RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDPEFGEKD 911
           ++    +  Y APE     +   K+ DI+S G ++ E+++ R    P F  KD
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR----PLFPGKD 214

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 9e-07
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 9/161 (5%)

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV  L  ++H NIV L     T     LV+EY+ +  L   +  C G ++        + 
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLY 111

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL+Y H      ++HRD+K  N+L++     ++ADFG+A+      K  S  V+  
Sbjct: 112 QILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-- 166

Query: 866 SCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           +  Y  P+    +   + + D++  G +  E+ +GR P+ P
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 19/142 (13%)

Query: 769 DCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           D KL L+ +Y+  G L    H  +            I +    L +LH      I++RD+
Sbjct: 77  DTKLHLILDYVNGGEL--FTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDI 131

Query: 828 KSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS--- 884
           K  NILLD +    + DFG++K   A  + ++ S   G+  Y+APE      +   S   
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEV-----IRGGSGGH 185

Query: 885 ----DIYSFGVVILELVTGRLP 902
               D +S GV+  EL+TG  P
Sbjct: 186 DKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.4 bits (111), Expect = 1e-06
 Identities = 28/60 (46%), Positives = 33/60 (55%)

Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLL 177
           NL+ LDLS N LT     A   LPNLK LDL+GNN +   PE+F     L  + L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 6/102 (5%)

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           L +LH      IV+RD+K  NILLD +    + DFG++K   +  K ++ S   G+  Y+
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173

Query: 871 APEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDPEFGEKD 911
           APE       + K+ D +S G++I EL+TG  P   E GE++
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GERN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 15/136 (11%)

Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI--VHRDVKSN 830
           +V EYMP G L +L+ +      D P ++     A   L+    D + S+  +HRDVK +
Sbjct: 120 MVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLAL---DAIHSMGFIHRDVKPD 171

Query: 831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL----RVNEKSDI 886
           N+LLD     ++ADFG    ++  G  +  + + G+  YI+PE   +         + D 
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 887 YSFGVVILELVTGRLP 902
           +S GV + E++ G  P
Sbjct: 231 WSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 9/99 (9%)

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +I     GL Y+H      I+HRD+K +N+ ++ D   R+ DFG+A+  D       M+ 
Sbjct: 123 LIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD-----DEMTG 174

Query: 863 IAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
              +  Y APE     +  N+  DI+S G ++ EL+ G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 46/248 (18%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y+I +      VIG GS G V   +    GE VA+KK+                  V + 
Sbjct: 2   YKIQE------VIGKGSYGVVCSAIDTHTGEKVAIKKI----------------NDVFEH 39

Query: 738 VQDDG-FQAEVETLGKIRHKNIVK---LWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCK 791
           V D      E++ L  +RH +IV+   +    + R+ K   +V+E M +      LH   
Sbjct: 40  VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESD-----LHQVI 94

Query: 792 GGLLDW-PTRYKIIV-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
               D  P  ++  +      L Y+H     ++ HRD+K  NIL + D   ++ DFG+A+
Sbjct: 95  KANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151

Query: 850 VVDASGKPKSM-SVIAGSCGYIAPEY--AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           V           +    +  Y APE   ++  +     DI+S G +  E++TG+    P 
Sbjct: 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK----PL 207

Query: 907 FGEKDLVK 914
           F  K++V 
Sbjct: 208 FPGKNVVH 215

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 16/98 (16%)

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL ++H+  V   V+RD+K  NILLD     R++D G+A   D S K    SV  G+ GY
Sbjct: 109 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV--GTHGY 161

Query: 870 IAPEY-----AYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +APE      AY    +  +D +S G ++ +L+ G  P
Sbjct: 162 MAPEVLQKGTAY----DSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 25/216 (11%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG GS GKV      ++G+  AVK L              +K  +  + +     AE  
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVL--------------QKKAILKKKEQKHIMAERN 47

Query: 749 TLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            L K ++H  +V L     T D    V +Y+  G L    H  +      P       + 
Sbjct: 48  VLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEI 105

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV-VDASGKPKSMSVIAGS 866
           A  L YLH     +I++RD+K  NILLD      + DFG+ K  ++ S   K+ S   G+
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KTTSTFCGT 159

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             Y+APE       +   D +  G V+ E++ G  P
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 25/224 (11%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G G+ G V K       E VA+KK      K+ E   +V++  ++          E++
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKF-----KDSEENEEVKETTLR----------ELK 52

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK-IIVDA 807
            L  ++ +NIV+L      R    LV+EY+    L +LL     G+   P + +  I   
Sbjct: 53  MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVP--PEKVRSYIYQL 109

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
            + + + H +    IVHRD+K  N+L+  +   ++ DFG A+ + + G   + +    + 
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATR 165

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
            Y +PE        +  D++S G ++ EL  G+ P+ P   E D
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PLFPGESEID 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 18/136 (13%)

Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLH-HDCVPSIVHRDVKSNN 831
           LV +YM  G L    H  K G          I +    L +LH +D    IV+RD+K  N
Sbjct: 73  LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD----IVYRDLKPEN 126

Query: 832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDI 886
           ILLD      + DFG++K  + +   K+ +   G+  Y+APE       YT  V    D 
Sbjct: 127 ILLDATGHIALCDFGLSK-ANLT-DNKTTNTFCGTTEYLAPEVLLDEKGYTKHV----DF 180

Query: 887 YSFGVVILELVTGRLP 902
           +S GV++ E+  G  P
Sbjct: 181 WSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 43/228 (18%)

Query: 683 DGLDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
           D  ++   +G GS   VYK     NG+ VA+K +                 ++Q++ +  
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-----------------RLQEE-EGT 46

Query: 742 GFQA--EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            F A  E   L  ++H NIV L     T++   LV+EY+ +  L   +    GGL   P 
Sbjct: 47  PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGL--HPE 103

Query: 800 RYKI-IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
             K+ +     GLSY+H      I+HRD+K  N+L+      ++ADFG+A+         
Sbjct: 104 NVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160

Query: 859 SMSVIAGSCGYIAP-------EYAYTLRVNEKSDIYSFGVVILELVTG 899
           S  V+  +  Y  P       EY+  L      D++  G + +E++ G
Sbjct: 161 SNEVV--TLWYRPPDVLLGSTEYSTCL------DMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 51.3 bits (123), Expect = 3e-06
 Identities = 34/130 (26%), Positives = 54/130 (41%), Gaps = 21/130 (16%)

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV-ADFGVAKVVDAS-- 854
                I       + Y+H      ++HRD+K +NILL G FG  V  D+G A        
Sbjct: 113 GAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEE 168

Query: 855 -------GKPKSMSV-------IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGR 900
                   +             I G+  Y+APE    +  +E +DIY+ GV++ +++T  
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Query: 901 LPVDPEFGEK 910
            P   + G K
Sbjct: 229 FPYRRKKGRK 238

Length = 932

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)

Query: 690 VIGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG GS GKV        E   AVK L              +K  +  + ++    +E  
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVL--------------QKKAILKKKEEKHIMSERN 47

Query: 749 TLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            L K ++H  +V L     T D    V +Y+  G L    H  +      P       + 
Sbjct: 48  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEI 105

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV-VDASGKPKSMSVIAGS 866
           A  L YLH     +IV+RD+K  NILLD      + DFG+ K  ++ +G   + S   G+
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCGT 159

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             Y+APE  +    +   D +  G V+ E++ G  P
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 41/171 (23%), Positives = 84/171 (49%), Gaps = 17/171 (9%)

Query: 741 DGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL----LVYEYMPNGSLGDLLHSCKGGLLD 796
           D  + E++ L +I   NI+K++         L    L+ EY   G L ++L   K   L 
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LS 120

Query: 797 WPTRYKIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           + T+  + +D  +GL  L+ +   P   ++++ S + L+  ++  ++   G+ K++ +S 
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKIL-SSP 176

Query: 856 KPKSMSVIAGSCGYIAPEYAYTL--RVNEKSDIYSFGVVILELVTGRLPVD 904
             K+++ +     Y + +    +      K DIYS GVV+ E+ TG++P +
Sbjct: 177 PFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA---- 745
           IG G+ G VYK      G+ VA+KK                   ++ + +++G  +    
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKK-------------------IRLESEEEGVPSTAIR 48

Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-KGGLLDWPTRYKII 804
           E+  L +++H NIV L           L++E++ +  L   L S  KG  +D       +
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
               +G+ + H      ++HRD+K  N+L+D     ++ADFG+A+      +  +  V+ 
Sbjct: 108 YQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV- 163

Query: 865 GSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGR 900
            +  Y APE    + R +   DI+S G +  E+ T +
Sbjct: 164 -TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 25/209 (11%)

Query: 691 IGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           +GSG+ G V K +     + + VAVK L               K    D    D    E 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL---------------KNDNNDPALKDELLREA 47

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
             + ++ +  IV++   C      +LV E    G L   L   K   +      +++   
Sbjct: 48  NVMQQLDNPYIVRMIGICEAESW-MLVMELAELGPLNKFLQKNKH--VTEKNITELVHQV 104

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVIAGS 866
           + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +     
Sbjct: 105 SMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
             + APE     + + KSD++SFGV++ E
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.8 bits (119), Expect = 7e-06
 Identities = 22/80 (27%), Positives = 45/80 (56%)

Query: 395 GQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAAN 454
           G +P+ +   + L  + L  N + G +PP L  +  + +L+L+ N  +G I +++    +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 455 LSLLIISKNNLSGSLPEEIG 474
           L +L ++ N+LSG +P  +G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 25/228 (10%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           V+G+G+ GKV+ V   +G      KL+    K  +    V+K +  +  +      E + 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSG--KLY--AMKVLKKATIVQKAKTTEHTR-----TERQV 57

Query: 750 LGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYK---IIV 805
           L  IR    +         D KL L+ +Y+  G L    H      L    R+K   + +
Sbjct: 58  LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTH------LSQRERFKEQEVQI 109

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
            + E +  L H     I++RD+K  NILLD +    + DFG++K        ++ S   G
Sbjct: 110 YSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCG 168

Query: 866 SCGYIAPEYAYTLRV--NEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
           +  Y+AP+         ++  D +S GV++ EL+TG  P   + GEK+
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD-GEKN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 52/227 (22%), Positives = 88/227 (38%), Gaps = 58/227 (25%)

Query: 691 IGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+  +V K      G+  A+K     M K  +S          +QV +     E++ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKC----MKKHFKS---------LEQVNN---LREIQA 50

Query: 750 LGKIR-HKNIVKLWCC-------CTTRDCKLL---VYEYMPNGSLGDLLHSCKGGLLDWP 798
           L ++  H NI++L                +L+   +YE +            +   L   
Sbjct: 51  LRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG----------RKRPLPEK 100

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                +    + L ++H +    I HRD+K  NIL+  D   ++ADFG  + +    KP 
Sbjct: 101 RVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIY--SKPP 154

Query: 859 SMSVIAGSCGYIAPE-------YAYTLRVNEKSDIYSFGVVILELVT 898
               I+ +  Y APE       Y        K DI++ G V  E+++
Sbjct: 155 YTEYIS-TRWYRAPECLLTDGYYGP------KMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 180 TIPAFLGNISTLKMLNLSYNPF--LPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRL 237
           +IPA L +  T++ + LS N    LP R+P  L +L           N +  +P++L   
Sbjct: 234 SIPATLPD--TIQEMELSINRITELPERLPSALQSL-------DLFHNKISCLPENLPE- 283

Query: 238 AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLT---GDLPTGWSNLTSLRLLDAS 294
            +L  L +  N++   +P+ L   + +  + + +NSLT     LP G      L+ L+A 
Sbjct: 284 -ELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLPPG------LKTLEAG 333

Query: 295 MNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLG 354
            N LT  +P  L    L+ L++ +N++   LP T+   P +  L + RN L   LP +L 
Sbjct: 334 ENALTS-LPASLPP-ELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALT-NLPENL- 386

Query: 355 KNSPLRWVDLSNNQFT---GEIPASLCEKGELEELLMIYNSFT 394
             + L+ +  S N        +P    E  +   +++ YN F+
Sbjct: 387 -PAALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428

Length = 754

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 26/61 (42%), Positives = 35/61 (57%), Gaps = 2/61 (3%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNN 152
           NL  L L NN +            NL+ LDLS N LT +++P A + LP+L+ LDL+GNN
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 153 F 153
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 61/237 (25%)

Query: 691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA---- 745
           IG G+ G V     S   E VA+KK+                    D   D    A    
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI----------------ANAFDNRID----AKRTL 52

Query: 746 -EVETLGKIRHKNIVKLWCCCTTRDCKL-----------LVYEYMPNGSLGDLLHSCKGG 793
            E++ L  + H+N++ +      +D              +VYE M +  L  ++ S +  
Sbjct: 53  REIKLLRHLDHENVIAI------KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQT- 104

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           L D   +Y  +     GL Y+H     +++HRD+K +N+LL+ +   ++ DFG+A+    
Sbjct: 105 LSDDHCQY-FLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART--T 158

Query: 854 SGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           S K   M+    +  Y APE       YT  +    D++S G +  EL+ GR P+ P
Sbjct: 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAELL-GRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.6 bits (113), Expect = 2e-05
 Identities = 42/175 (24%), Positives = 88/175 (50%), Gaps = 36/175 (20%)

Query: 808 AEGLSYL-HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
           A+G+S+L   +C+    HRD+ + NILL      ++ DFG+A+ +    +  S  V+ G+
Sbjct: 224 AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDI----RNDSNYVVKGN 275

Query: 867 C----GYIAPEYAYTLRVNEKSDIYSFGVVILELVT------GRLPVDPEFGEKDLVKWV 916
                 ++APE  +      +SD++S+G+++ E+ +        +PVD +F +       
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK------- 328

Query: 917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + ++G   +L P+   C   E+  ++     C    P+ RP  +++V+L+++
Sbjct: 329 ---MIKEGY-RMLSPE---CAPSEMYDIMKS---CWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.7 bits (111), Expect = 4e-05
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 17/106 (16%)

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
           Y+I+     GL YLH      I+HRD+K  N+L++ +   ++ DFG+A+V +   + K M
Sbjct: 110 YQIL----RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-ESKHM 161

Query: 861 SVIAGSCGYIAPEYA-----YTLRVNEKSDIYSFGVVILELVTGRL 901
           +    +  Y APE       YT  V    DI+S G +  EL+  R+
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRRI 203

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 20/170 (11%)

Query: 752 KIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGL 811
           ++ HK+IV L+  C      ++V E++  G L DL    K  +L  P ++K+    A  L
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASAL 118

Query: 812 SYLHHDCVPSIVHRDVKSNNILL-----DGDFGA--RVADFGVAKVVDASGKPKSMSVIA 864
           SYL       +VH +V + NILL     DG+ G   +++D G+   V +  + + +  I 
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS--RQECVERIP 173

Query: 865 GSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELV-TGRLPV-DPEFGEKD 911
               +IAPE     +  +  +D +SFG  + E+   G +P+ D    EK+
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 5e-05
 Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 64/274 (23%)

Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
           D  +   VIG G+ G+V  V   +   +   K+ R           +EK QV        
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-------LEKEQVAH------ 47

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            +AE + L +     +VK++     +    L+ E++P G +  LL   K  L +  T++ 
Sbjct: 48  IRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFY 106

Query: 803 I-----IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK- 856
           I      +DA   L +         +HRD+K +N+LLD     +++DFG+   +  + + 
Sbjct: 107 IAETVLAIDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157

Query: 857 ----------PKSMSV----------------------IAGSCGYIAPEYAYTLRVNEKS 884
                     P   S                         G+  YIAPE       N+  
Sbjct: 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC 217

Query: 885 DIYSFGVVILELVTGRLPV---DPEFGEKDLVKW 915
           D +S GV++ E++ G  P     P+   + ++ W
Sbjct: 218 DWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (110), Expect = 5e-05
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           IG GS GKV +V   + + +   K  R             K  +  + +     AE   L
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIR-------------KAHIVSRSEVTHTLAERTVL 47

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            ++    IV L     + +   LV  ++  G L    H  + G  D  +R +     AE 
Sbjct: 48  AQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL--FHHLQREGRFD-LSRARFYT--AEL 102

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           L  L +    ++++RD+K  NILLD      + DFG+ K+          +   G+  Y+
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYL 160

Query: 871 APEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           APE        +  D ++ GV++ E++TG  P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 51/231 (22%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA----E 746
           +G G+ G VYK    +G+                     EK     Q++  G       E
Sbjct: 9   VGRGTYGHVYKAKRKDGKD--------------------EKEYALKQIEGTGISMSACRE 48

Query: 747 VETLGKIRHKNIV---KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------GGLL 795
           +  L +++H N++   K++   + R   LL ++Y  +    DL H  K           +
Sbjct: 49  IALLRELKHPNVIALQKVFLSHSDRKVWLL-FDYAEH----DLWHIIKFHRASKANKKPM 103

Query: 796 DWPTRY--KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR----VADFGVAK 849
             P      ++    +G+ YLH + V   +HRD+K  NIL+ G+   R    +AD G A+
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFAR 160

Query: 850 VVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVT 898
           + ++  KP   +  +  +  Y APE     R   K+ DI++ G +  EL+T
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 46.2 bits (109), Expect = 7e-05
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 57/232 (24%)

Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ-AE 746
           N+IG+GS G VY+ + +   E VA+KK+                      +QD  ++  E
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKV----------------------LQDPQYKNRE 109

Query: 747 VETLGKIRHKNIVKL----WCCCTTRDCKLL----VYEYMPNGSLGDLLHSCKGG----- 793
           +  +  + H NI+ L    +  C  ++ K +    V E++P      + H  +       
Sbjct: 110 LLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL 169

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVD 852
            L     Y++       L+Y+H      I HRD+K  N+L+D +    ++ DFG AK  +
Sbjct: 170 FLVKLYSYQL----CRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK--N 220

Query: 853 ASGKPKSMSVIAGSCGYIAPEYA-----YTLRVNEKSDIYSFGVVILELVTG 899
                +S+S I  S  Y APE       YT  +    D++S G +I E++ G
Sbjct: 221 LLAGQRSVSYIC-SRFYRAPELMLGATNYTTHI----DLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 8e-05
 Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 54/262 (20%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           VIG G+ G+V  V   +   V   K+ R             K  + ++ Q    +AE + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILR-------------KADMLEKEQVGHIRAERDI 54

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L +     +VK++     +    L+ E++P G +  LL   K  L +  T++  I +   
Sbjct: 55  LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQF-YIAETVL 112

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK-----------PK 858
            +  +H       +HRD+K +N+LLD     +++DFG+   +  + +           P 
Sbjct: 113 AIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 859 SMSV----------------------IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
             +                         G+  YIAPE       N+  D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 897 VTGRLPV---DPEFGEKDLVKW 915
           + G  P     P+   K ++ W
Sbjct: 230 LIGYPPFCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 9e-05
 Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 11/89 (12%)

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           + Y+H +    I+HRD+K+ N+L++G     + DFG A     S        IAG+    
Sbjct: 273 IDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 871 APEY----AYTLRVNEKSDIYSFGVVILE 895
           APE      YT  V    DI+S G+VI E
Sbjct: 330 APEVLAGDPYTPSV----DIWSAGLVIFE 354

Length = 461

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 9/96 (9%)

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR----VADFGVAKVVDASGKP-KSMSVI 863
           +G+ YLH + V   +HRD+K  NIL+ G+   R    +AD G A++ ++  KP   +  +
Sbjct: 119 DGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVT 898
             +  Y APE     R   K+ DI++ G +  EL+T
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 45/223 (20%), Positives = 85/223 (38%), Gaps = 53/223 (23%)

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           +AE + L +  ++ +V+L+     +D    V +Y+P G +  LL   + G+         
Sbjct: 49  KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDLARFY 106

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV---------AKVVDAS 854
           I +    +  +H       +HRD+K +NIL+D D   ++ DFG+         +K   + 
Sbjct: 107 IAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163

Query: 855 GKPKSMSV------------------------------------IAGSCGYIAPEYAYTL 878
              +  S+                                    + G+  YIAPE     
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223

Query: 879 RVNEKSDIYSFGVVILELVTGRLPV---DPEFGEKDLVKWVCS 918
              +  D +S GV++ E++ G+ P     P   +  ++ W  S
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS 266

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 39/148 (26%), Positives = 62/148 (41%), Gaps = 18/148 (12%)

Query: 757 NIVKLWCCCTTRDCKLLVYEYMPNGSL----GDLLHSCKGGLLDWPTRYKIIVDAAEGLS 812
           N+V L     + D   LV ++   G L       L+  +  +  W     + +DA     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 813 YLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAP 872
            LH +    IV RD+  NNILLD     ++  F     V+ S   +++  +     Y AP
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 873 EYAYTLRVNEKSDIYSFGVVILELVTGR 900
           E        E  D +S G ++ EL+TG+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 54/233 (23%), Positives = 103/233 (44%), Gaps = 52/233 (22%)

Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G GS+G V+  V S+  + VAVKK+     +  +                     E++ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----------------REIKI 55

Query: 750 LGKIRHKNIVKLWCCCTTRDCKL--------------LVYEYMPNGSLGDLLHSCKGGLL 795
           + ++ H NIVK++         L              +V EYM    L ++L   +G L 
Sbjct: 56  IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLE--QGPLS 112

Query: 796 DWPTR---YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG-DFGARVADFGVAKVV 851
           +   R   Y+++     GL Y+H     +++HRD+K  N+ ++  D   ++ DFG+A++V
Sbjct: 113 EEHARLFMYQLL----RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Query: 852 DASGKPK---SMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGR 900
           D     K   S  ++  +  Y +P    +     +  D+++ G +  E++TG+
Sbjct: 166 DPHYSHKGYLSEGLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 6/91 (6%)

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV-VDASGKPKSMSVIAGSCGY 869
           + YLH +    I+HRD+K+ NI ++      + DFG A   VD +         AG+   
Sbjct: 195 IQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA--NKYYGWAGTIAT 249

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGR 900
            APE           DI+S G+V+ E+ T  
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.8 bits (101), Expect = 7e-04
 Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 10/107 (9%)

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK--PKSMSVIAGSC 867
           GL Y+H     +++HRD+K  N+L++ D   ++ DFG+A+    +       M+    + 
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 868 GYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDPEFGEKDLV 913
            Y APE   + +   K+ D++S G ++ EL+  +    P F  KD V
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGKDYV 216

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 8e-04
 Identities = 19/60 (31%), Positives = 29/60 (48%)

Query: 215 NLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSL 274
           NL+ L L+   L      +   L  L  LDL+ NNL    P + + L S+  ++L  N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 35/128 (27%), Positives = 49/128 (38%), Gaps = 21/128 (16%)

Query: 781 GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA 840
            SL D+L   +G  L+    + + +     L  LH         R  KS NILL  D   
Sbjct: 1   VSLADIL-EVRGRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWD--G 48

Query: 841 RVADFG-VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
            +   G VA       +P    +        APE        EK+DIYS G+ + E +  
Sbjct: 49  LLKLDGSVAFKTPEQSRPDPYFM--------APEVIQGQSYTEKADIYSLGITLYEALDY 100

Query: 900 RLPVDPEF 907
            LP + E 
Sbjct: 101 ELPYNEER 108

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 21/61 (34%), Positives = 28/61 (45%), Gaps = 3/61 (4%)

Query: 526 KLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNR 583
            L  L+L++N     IP+     L  L  LDLS N L+   P     L  L  L++S N 
Sbjct: 1   NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 584 L 584
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 59/288 (20%), Positives = 106/288 (36%), Gaps = 33/288 (11%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           IG+G  GKV    +     VA     R + KE        K     + Q++ F  + +  
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVA-----RVVVKEL-------KANASSKEQNE-FLQQGDPY 49

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRYKIIVDAA 808
             ++H NI++    C      LLV+EY   G L   L                ++  + A
Sbjct: 50  RILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIA 109

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
            G++++H     + +H D+   N  L  D   +V D+G+          ++         
Sbjct: 110 AGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166

Query: 869 YIAPEYA-------YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD 921
           ++APE          T    + S++++ GV + EL            +++++  V     
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226

Query: 922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL 969
            K    +  P+L+  + E   +VL     C    P  R     V +LL
Sbjct: 227 VK----LFKPQLELPYSERWYEVLQ---FCWLS-PEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 50/219 (22%)

Query: 729 VEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH 788
           + K  V ++ Q    +AE + L +  ++ +VKL+     +D    V +Y+P G +  LL 
Sbjct: 34  LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92

Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
             +  +         I +    +  +H       +HRD+K +NIL+D D   ++ DFG+ 
Sbjct: 93  -IRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLC 148

Query: 849 -----------------------------------------KVVDASGKPKSMSVIA--- 864
                                                    K ++     +    +A   
Sbjct: 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL 208

Query: 865 -GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  YIAPE        +  D +S GV++ E++ G+ P
Sbjct: 209 VGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 0.001
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 54/256 (21%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKL--WRGMSKECESGCDVEKGQ 733
            +EYE++        IG+G  G+V+ V     +     K   +RG+ +        EK Q
Sbjct: 12  LNEYEVIKK------IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-------EKSQ 58

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVK-LWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCK 791
           +           EV  + +++HKNIV+ +       + KL ++ E+   G L   +  C 
Sbjct: 59  LV---------IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCY 109

Query: 792 G--GLLDWPTRYKIIVDAAEGLSYLHH----DCVPSIVHRDVKSNNIL------------ 833
              G ++      I       L+Y H+         ++HRD+K  NI             
Sbjct: 110 KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169

Query: 834 -----LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY--TLRVNEKSDI 886
                L+G   A++ DFG++K +       S     G+  Y +PE     T   ++KSD+
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHS---CVGTPYYWSPELLLHETKSYDDKSDM 226

Query: 887 YSFGVVILELVTGRLP 902
           ++ G +I EL +G+ P
Sbjct: 227 WALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 0.002
 Identities = 31/111 (27%), Positives = 60/111 (54%), Gaps = 19/111 (17%)

Query: 808 AEGLSYL-HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
           A+G+ +L   +C+    HRDV + N+LL     A++ DFG+A+ +       S  V+ G+
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMND----SNYVVKGN 273

Query: 867 C----GYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP-----VDPEF 907
                 ++APE  +      +SD++S+G+++ E+ + G+ P     V+ +F
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 36.3 bits (85), Expect = 0.002
 Identities = 19/38 (50%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 117 QNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFS 154
            NL+ LDLS N +T    P L++LPNL+ LDL+GN  +
Sbjct: 1   TNLETLDLSNNQITDL--PPLSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 47/195 (24%), Positives = 71/195 (36%), Gaps = 26/195 (13%)

Query: 5   TGMLVLVAFLLSP-LPSLSLNQEGLYLERVKL---SLSDPDSALSSW--GRNPRDDSPC- 57
            G  VL + L S  L  L LN  GL    ++L    L D   AL     GRN  + + C 
Sbjct: 96  DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155

Query: 58  SWRGVECDPRSHSVASIDLSNANIAGPFPSLLCR----LENLTFLTLFNNSINSTLPDDI 113
           +         +  +  ++L+N  I       L        NL  L L NN +       +
Sbjct: 156 ALAKAL--RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASAL 213

Query: 114 SAC----QNLQHLDLSQNLLTGTLTPALAD-----LPNLKFLDLTGNNFSGDIPESFGRF 164
           +      ++L+ L+L  N LT     ALA        +L  L L+ N+ + D  +     
Sbjct: 214 AETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEV 273

Query: 165 QK----LEVISLVYN 175
                 L  + L  N
Sbjct: 274 LAEKESLLELDLRGN 288

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.0 bits (96), Expect = 0.003
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 14/98 (14%)

Query: 823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC----GYIAPEYAYTL 878
           +HRD+ + NILL  +   ++ DFG+A+  D    P    V  G       ++APE  +  
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPD--YVRKGDARLPLKWMAPESIFDK 250

Query: 879 RVNEKSDIYSFGVVILELVT-GRLP-----VDPEFGEK 910
               +SD++SFGV++ E+ + G  P     +D EF  +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 8/80 (10%)

Query: 823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC----GYIAPEYAYTL 878
           +HRD+ + NILL  +   ++ DFG+A+  D    P    V  GS      ++APE  +  
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPD--YVRKGSARLPLKWMAPESIFDK 251

Query: 879 RVNEKSDIYSFGVVILELVT 898
               +SD++SFGV++ E+ +
Sbjct: 252 VYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 26/175 (14%)

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK---GGLLDWPT 799
            Q E+       H NIV         +   +V  +M  GS  DL+  C     G+ +   
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMSELAI 103

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
            Y I+    + L Y+HH      VHR VK+++IL+  D   +V   G+   +      + 
Sbjct: 104 AY-ILQGVLKALDYIHH---MGYVHRSVKASHILISVD--GKVYLSGLRSNLSMINHGQR 157

Query: 860 MSVI-------AGSCGYIAPEYAYTLRVN-----EKSDIYSFGVVILELVTGRLP 902
           + V+            +++PE    L+ N      KSDIYS G+   EL  G +P
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPE---VLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

 Score = 40.7 bits (95), Expect = 0.004
 Identities = 57/219 (26%), Positives = 76/219 (34%), Gaps = 44/219 (20%)

Query: 362 VDLSNNQFTGEIPASLCEKGELEELLMIYN---SFTGQLPD-----------GLGHCQSL 407
           VDLS N    E    LC        L + N   +FTG+  D            L  C  L
Sbjct: 35  VDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRL 94

Query: 408 TRVRLGYNRLTGKVPPLL-------WGLPHVYL----------LELTDNFLSGEISKNIA 450
            +V L  N    + P  L         L H+ L            +         +K  A
Sbjct: 95  QKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAA 154

Query: 451 GAANLSLLIISKNNL-SGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGS---- 505
               L ++I  +N L +GS       L+S   L   + +  G  PE +T LA LG     
Sbjct: 155 DKPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSH 214

Query: 506 ----LDLHANDLSGE----LPSSVSSWKKLNELNLADNL 536
               LDL  N  + E    L  ++  W  L EL L D L
Sbjct: 215 SLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCL 253

Length = 388

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.8 bits (93), Expect = 0.004
 Identities = 46/203 (22%), Positives = 93/203 (45%), Gaps = 28/203 (13%)

Query: 714 KLWRGMSKECESGCDVEKGQVQDQVQD-------DGFQAEVETLGKIRHKNIVKLWCCCT 766
           K+++G+ +E     ++ K +V  +V D       + F      + ++ HK++V  +  C 
Sbjct: 10  KIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV 69

Query: 767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSY-LHHDCVPSIVHR 825
             D  ++V EY+  GSL   L   K  +      +K+ V  A+ L++ LH      + H 
Sbjct: 70  CGDESIMVQEYVKFGSLDTYLKKNKNLI---NISWKLEV--AKQLAWALHFLEDKGLTHG 124

Query: 826 DVKSNNILL--DGDFGA------RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
           +V + N+LL  + D         +++D G++  V     PK +  +     ++ PE    
Sbjct: 125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV----LPKEI--LLERIPWVPPECIEN 178

Query: 878 LR-VNEKSDIYSFGVVILELVTG 899
            + ++  +D +SFG  + E+ +G
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1002
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.73
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.72
smart00090	237	RIO RIO-like kinase.	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
PLN03150	623	hypothetical protein; Provisional	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
PLN03150	623	hypothetical protein; Provisional	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.19
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.15
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.13
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.09
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.05
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.04
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.03
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.01
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.99
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.99
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.96
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.96
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.95
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.95
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.93
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.91
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.87
COG4248	637	Uncharacterized protein with protein kinase and he	98.83
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.77
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.76
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.75
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.74
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.57
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.51
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.5
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.47
PRK09902	216	hypothetical protein; Provisional	98.47
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.43

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.7e-118  Score=1136.61  Aligned_cols=919  Identities=36%  Similarity=0.623  Sum_probs=788.6

Q ss_pred             HHHccCCCCCchHHHHHHHHHHHhccCCccccCCCCCCCCCCCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCC
Q 001867           13 FLLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRL   92 (1002)
Q Consensus        13 ~~~~~~~~~~~~~~~~~l~~~k~~~~d~~~~l~sw~~~~~~~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l   92 (1002)
                      +++....+++...|+.||++||+++.||.+.+++|+.   +.+||.|.||+|+. ..+|+.|||+++++++.++..|..+
T Consensus        17 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~---~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l   92 (968)
T PLN00113         17 FFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNS---SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRL   92 (968)
T ss_pred             HHHHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCCC---CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCC
Confidence            3333455666779999999999999999889999953   45799999999985 4589999999999999999999999


Q ss_pred             CCCCEEeccCCCCCCCCCCCcc-ccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceee
Q 001867           93 ENLTFLTLFNNSINSTLPDDIS-ACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVIS  171 (1002)
Q Consensus        93 ~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  171 (1002)
                      ++|++|+|++|++.+.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|..|+.+++|++|+
T Consensus        93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~  170 (968)
T PLN00113         93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD  170 (968)
T ss_pred             CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence            9999999999999988888765 899999999999999988875  5689999999999999999999999999999999


Q ss_pred             eccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccc
Q 001867          172 LVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV  251 (1002)
Q Consensus       172 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  251 (1002)
                      |++|.+.+.+|..++++++|++|+|++|.+ .+.+|..++++++|++|+|++|++++.+|..++++++|++|++++|+++
T Consensus       171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l-~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  249 (968)
T PLN00113        171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQL-VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT  249 (968)
T ss_pred             CccCcccccCChhhhhCcCCCeeeccCCCC-cCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceec
Confidence            999999999999999999999999999996 5788999999999999999999999999999999999999999999999


Q ss_pred             cccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccC
Q 001867          252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIA  330 (1002)
Q Consensus       252 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~  330 (1002)
                      +.+|..+.++++|+.|++++|++.+.+|..+.++++|+.|++++|.+.+.+|..+..++ |+.|++++|.+.+..|..+.
T Consensus       250 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~  329 (968)
T PLN00113        250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT  329 (968)
T ss_pred             cccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHh
Confidence            99999999999999999999999999999999999999999999999999999888875 99999999999999999999


Q ss_pred             CCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEE
Q 001867          331 DSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV  410 (1002)
Q Consensus       331 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  410 (1002)
                      .+++|+.|++++|++.+.+|..++.+.+|+.|+|++|++++.+|..++.+++|+.|++++|.+.+.+|..++.+++|+.|
T Consensus       330 ~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L  409 (968)
T PLN00113        330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV  409 (968)
T ss_pred             cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccC
Q 001867          411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT  490 (1002)
Q Consensus       411 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  490 (1002)
                      ++++|++++..|..|..++.|+.|++++|.+++.++..+..+++|+.|++++|++.+.+|..++ .++|+.|++++|+++
T Consensus       410 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~  488 (968)
T PLN00113        410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFS  488 (968)
T ss_pred             ECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccC
Confidence            9999999999999999999999999999999999999999999999999999999999998764 589999999999999


Q ss_pred             CCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccc
Q 001867          491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ  570 (1002)
Q Consensus       491 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~  570 (1002)
                      +.+|..+.++++|+.|+|++|++++.+|..++.+++|++|+|++|.++|.+|..++++++|+.|||++|+++|.+|..+.
T Consensus       489 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  568 (968)
T PLN00113        489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG  568 (968)
T ss_pred             CccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cc-ccceEEeccccCcCCCChh-hhhhcccccccCCCCCCCCCC----CCCCCCCCcccCCeeEEeeehhhhhhHHHHH-
Q 001867          571 NL-KLNQLNVSNNRLSGELPSL-FAKEMYRNSFLGNPGLCGDLE----GLCDGRGEEKNRGYVWVLRSIFILAGLVFVF-  643 (1002)
Q Consensus       571 ~l-~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~n~~~cg~~~----~~c~~~~~~~~~~~~~~~~~~~~~~~l~~~~-  643 (1002)
                      .+ .|+.|++++|+++|.+|.. .+..+...+|.|||++||.+.    +.|.....  ...  |.++++++++++++++ 
T Consensus       569 ~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~--~~~~~~~~~~~~~~~~~  644 (968)
T PLN00113        569 NVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPS--WWFYITCTLGAFLVLAL  644 (968)
T ss_pred             cCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--cce--eeeehhHHHHHHHHHHH
Confidence            98 7999999999999999976 556677788999999999653    36754322  112  2222222222222222 


Q ss_pred             -HHhhhheeeeeecCCccc--ccCcccccccccc---CCcHHHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEee
Q 001867          644 -GLVWFYLKYRKFKNGRAI--DKSKWTLMSFHKL---GFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLW  716 (1002)
Q Consensus       644 -~~v~~~~~~r~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~  716 (1002)
                       +++++++++|+.+..++.  ....|....+...   .+...++...+...++||+|+||.||+|+. .++..||||++.
T Consensus       645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~  724 (968)
T PLN00113        645 VAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN  724 (968)
T ss_pred             HHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEcc
Confidence             223333333222111111  1111221111110   112233456788889999999999999996 578999999873


Q ss_pred             ccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCC
Q 001867          717 RGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD  796 (1002)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~  796 (1002)
                      ..                     .....+|++++++++|||||++++++.+++..|+||||+++|+|.++++.     ++
T Consensus       725 ~~---------------------~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~  778 (968)
T PLN00113        725 DV---------------------NSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LS  778 (968)
T ss_pred             CC---------------------ccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CC
Confidence            21                     01123468899999999999999999999999999999999999999962     89


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccc
Q 001867          797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY  876 (1002)
Q Consensus       797 ~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  876 (1002)
                      |.++.+++.|+|+|++|||+.+.++|+||||||+||+++.++.+++. ||.+......      ....||+.|||||++.
T Consensus       779 ~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~  851 (968)
T PLN00113        779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRE  851 (968)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCccccc
Confidence            99999999999999999996555599999999999999998888875 6655432211      1236789999999999


Q ss_pred             cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-chhHHHHHHHHhhccCcccccccccc---CCCHHHHHHHHHHHHHcC
Q 001867          877 TLRVNEKSDIYSFGVVILELVTGRLPVDPEFG-EKDLVKWVCSTLDQKGVDHVLDPKLD---CCFKEEICKVLNIGLLCT  952 (1002)
Q Consensus       877 ~~~~~~~~DvwslGvil~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl  952 (1002)
                      +..++.|+|||||||++|||++|+.||+.... .....+|.............+|+...   ....++..++.+++.+||
T Consensus       852 ~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl  931 (968)
T PLN00113        852 TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT  931 (968)
T ss_pred             CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhC
Confidence            99999999999999999999999999975433 24456666554444444455555542   233456678889999999


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          953 SPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       953 ~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      +.||++||+|+||++.|+++.+..
T Consensus       932 ~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        932 ATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             cCCchhCcCHHHHHHHHHHhhccc
Confidence            999999999999999999986533

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-63  Score=636.34  Aligned_cols=513  Identities=35%  Similarity=0.552  Sum_probs=488.0

Q ss_pred             CCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCcccc-ccCCccccccccccccCCCCcccccccccceee
Q 001867           93 ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALA-DLPNLKFLDLTGNNFSGDIPESFGRFQKLEVIS  171 (1002)
Q Consensus        93 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  171 (1002)
                      .+++.|+|++|.+++.+|..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            4789999999999999999999999999999999999988887754 999999999999999998886  5689999999


Q ss_pred             eccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccc
Q 001867          172 LVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV  251 (1002)
Q Consensus       172 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  251 (1002)
                      |++|.+++.+|..++++++|++|+|++|.+ .+.+|..++++++|++|+|++|++.+.+|..++.+++|++|+|++|+++
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l-~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVL-VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcc-cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence            999999999999999999999999999986 5788999999999999999999999999999999999999999999999


Q ss_pred             cccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccC
Q 001867          252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIA  330 (1002)
Q Consensus       252 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~  330 (1002)
                      +.+|..+.++++|+.|++++|.+.+.+|..+.++++|+.|++++|++++.+|..+..++ |+.|+|++|.+.+.+|..+.
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~  305 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI  305 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence            99999999999999999999999999999999999999999999999999999888775 99999999999999999999


Q ss_pred             CCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEE
Q 001867          331 DSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV  410 (1002)
Q Consensus       331 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  410 (1002)
                      .+++|+.|++++|.+.+..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|
T Consensus       306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L  385 (968)
T PLN00113        306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL  385 (968)
T ss_pred             CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccC
Q 001867          411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT  490 (1002)
Q Consensus       411 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  490 (1002)
                      ++++|++.+.+|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.
T Consensus       386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~  465 (968)
T PLN00113        386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF  465 (968)
T ss_pred             ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccc
Q 001867          491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ  570 (1002)
Q Consensus       491 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~  570 (1002)
                      +.+|..+. .++|+.|||++|++++.+|..+.++++|+.|+|++|.++|.+|+.++++++|++|+|++|+++|.+|..++
T Consensus       466 ~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  544 (968)
T PLN00113        466 GGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS  544 (968)
T ss_pred             eecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence            99998764 58999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cc-ccceEEeccccCcCCCChh--hhhhcccccccCCCCCCC
Q 001867          571 NL-KLNQLNVSNNRLSGELPSL--FAKEMYRNSFLGNPGLCG  609 (1002)
Q Consensus       571 ~l-~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~n~~~cg  609 (1002)
                      .+ +|+.|||++|+++|.+|..  ....+....+.+|+..+.
T Consensus       545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~  586 (968)
T PLN00113        545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS  586 (968)
T ss_pred             CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence            99 8999999999999999976  334566777888876653

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=420.50  Aligned_cols=275  Identities=49%  Similarity=0.802  Sum_probs=238.3

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+++|...+.||+|+||.||+|...+|..||||++....                ... ..+|..|++++.+++|||+|+
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~----------------~~~-~~eF~~Ei~~ls~l~H~Nlv~  135 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNS----------------GQG-EREFLNEVEILSRLRHPNLVK  135 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCC----------------Ccc-hhHHHHHHHHHhcCCCcCccc
Confidence            478999999999999999999999999999999874321                010 345999999999999999999


Q ss_pred             eeeEEecCC-eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          761 LWCCCTTRD-CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       761 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++|||.+.+ ..++|||||++|+|.++++.....+++|.++.+||.++|+||+|||+.+.+.||||||||+|||+|++++
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            999999988 5999999999999999998744338999999999999999999999988789999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccc-cccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--CchhHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVI-AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF--GEKDLVKWV  916 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~--~~~~~~~~~  916 (1002)
                      +||+|||+|+.......  ..... .||.+|+|||+...+..+.|+|||||||++.|+++|+.|.+...  .+..+..|+
T Consensus       216 aKlsDFGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             EEccCccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence            99999999965543111  11122 79999999999999999999999999999999999999887543  345589999


Q ss_pred             HHHhhccCcccccccccc-CCCH--HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLD-CCFK--EEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~-~~~~--~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ........+.+++||++. ..+.  ++..++..++.+|++.+|++||+|.||++.|+.+..
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            888888899999999985 4443  688899999999999999999999999999976643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=380.72  Aligned_cols=252  Identities=30%  Similarity=0.479  Sum_probs=210.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+++..+.||+|..|+||+++++ +++.+|+|.++-.                .+...++++.+|++++++.+||+||++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----------------~~~~~~~Qi~rEl~il~~~~spyIV~~  142 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----------------IDPALQKQILRELEILRSCQSPYIVGF  142 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----------------CCHHHHHHHHHHHHHHhhCCCCCeeeE
Confidence            45566789999999999999964 6888999998432                245667889999999999999999999


Q ss_pred             eeEEecCC-eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRD-CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ||+|..++ ..+++||||++|+|+++++.  .+.+++..+.+++.++++||.|||+ +   +||||||||+|||++..|+
T Consensus       143 ygaF~~~~~~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGe  217 (364)
T KOG0581|consen  143 YGAFYSNGEEISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGE  217 (364)
T ss_pred             eEEEEeCCceEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCC
Confidence            99999999 49999999999999999984  3679999999999999999999996 6   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC-CCchhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE-FGEKDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~-~~~~~~~~~~~~  918 (1002)
                      |||||||.++.+.++    .....+||..|||||.+.+..|+.++||||||++++|+++|+.||.+. .+..+..+.+..
T Consensus       218 VKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~  293 (364)
T KOG0581|consen  218 VKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA  293 (364)
T ss_pred             EEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH
Confidence            999999999988766    234568999999999999999999999999999999999999999765 222333333333


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......      |.++..  ....++.+++..|+++||.+||+++|+++
T Consensus       294 Iv~~pp------P~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDEPP------PRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcCCC------CCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            332211      222221  12234778888999999999999999985

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-45  Score=399.12  Aligned_cols=259  Identities=34%  Similarity=0.510  Sum_probs=212.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      ++...+.||+|+||+||+|.+.....||||++.....               +....+.|.+|+.+|.+++|||||+++|
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~---------------~~~~~~~f~~E~~il~~l~HpNIV~f~G  106 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDF---------------DDESRKAFRREASLLSRLRHPNIVQFYG  106 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhc---------------ChHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            4445567999999999999997545599999854321               1122778999999999999999999999


Q ss_pred             EEecCC-eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCCCcEEECCCC-Ce
Q 001867          764 CCTTRD-CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS-IVHRDVKSNNILLDGDF-GA  840 (1002)
Q Consensus       764 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-iiHrDlk~~NIll~~~~-~~  840 (1002)
                      ++.+.. ..++||||+++|+|.++++..+...+++..+.+++.|||+||.|||++   + ||||||||+|||++.++ ++
T Consensus       107 ~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~  183 (362)
T KOG0192|consen  107 ACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTL  183 (362)
T ss_pred             EEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEE
Confidence            999887 799999999999999999875567899999999999999999999999   7 99999999999999997 99


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY--TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      ||+|||+++......  ..++...||+.|||||++.  ...|+.|+|||||||++|||+||+.||..... ......+..
T Consensus       184 KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~  260 (362)
T KOG0192|consen  184 KIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVV  260 (362)
T ss_pred             EECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHh
Confidence            999999998776542  2344468999999999999  56999999999999999999999999987654 222222211


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                         ......+    ...+    ...+..++.+||+.||+.||++.+++..|+.+..
T Consensus       261 ---~~~Rp~~----p~~~----~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  261 ---GGLRPPI----PKEC----PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             ---cCCCCCC----CccC----CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence               1111111    1112    3348888899999999999999999999998865

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=396.75  Aligned_cols=255  Identities=31%  Similarity=0.531  Sum_probs=218.5

Q ss_pred             CCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +...+.||+|.||.||.|.++....||+|.++..                  ....+.|.+|+++|++++|++||+++++
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~------------------~m~~~~f~~Ea~iMk~L~H~~lV~l~gV  269 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG------------------SMSPEAFLREAQIMKKLRHEKLVKLYGV  269 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc------------------ccChhHHHHHHHHHHhCcccCeEEEEEE
Confidence            3456789999999999999987779999998653                  2235678899999999999999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      |..++.+|||||||+.|+|.+|++...+..+...+.+.|+.|||+|++||+++   ++|||||.++||||+++..|||+|
T Consensus       270 ~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsD  346 (468)
T KOG0197|consen  270 CTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISD  346 (468)
T ss_pred             EecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcc
Confidence            99999999999999999999999986778899999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      ||+|+...++.+. ......-...|.|||.+..+.++.|||||||||++|||+| |+.||. ..+..+..+.+.+..+. 
T Consensus       347 FGLAr~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~-~msn~ev~~~le~GyRl-  423 (468)
T KOG0197|consen  347 FGLARLIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP-GMSNEEVLELLERGYRL-  423 (468)
T ss_pred             cccccccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC-CCCHHHHHHHHhccCcC-
Confidence            9999955544332 2223334568999999999999999999999999999999 777764 44566666666655544 


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                             |+...++.+    ++++|..||+.+|++|||++.+...++++..
T Consensus       424 -------p~P~~CP~~----vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  424 -------PRPEGCPDE----VYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             -------CCCCCCCHH----HHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                   344445554    8899999999999999999999999998854

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-45  Score=381.69  Aligned_cols=259  Identities=27%  Similarity=0.380  Sum_probs=209.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|.+.+.||+|+||.|-+|. .++|+.||||++.+.....+.+          .......+.+|++||++++|||||+
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~----------~~~~~~~v~~EieILkkL~HP~IV~  240 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR----------AIAKTRDVQNEIEILKKLSHPNIVR  240 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc----------cccchhhhHHHHHHHHhcCCCCEEE
Confidence            4567788999999999999998 4679999999997764432221          1122344789999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC---
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD---  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~---  837 (1002)
                      ++++|...+..|+||||++||+|.+++-.  .+.+.+..-..+++|++.|+.|||++   ||+||||||+|||++.+   
T Consensus       241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  241 IKDFFEVPDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             EeeeeecCCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence            99999999999999999999999999884  45688888899999999999999999   99999999999999765   


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCC---CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV---NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      ..+||+|||+|+..+..   ..+...+|||.|.|||++.+..+   ..|+|+||+||++|-+++|..||.++.......+
T Consensus       316 ~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e  392 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE  392 (475)
T ss_pred             eEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH
Confidence            66999999999988744   34667799999999999886653   3588999999999999999999987766554443


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .+.+.    .+..  .   +..+.+...+..++|.+|+..||++|||++|+++
T Consensus       393 QI~~G----~y~f--~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 QILKG----RYAF--G---PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHhcC----cccc--c---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            33221    1111  1   1122334456788999999999999999999984

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=395.59  Aligned_cols=251  Identities=26%  Similarity=0.419  Sum_probs=215.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ..|..++.||+|+|+.||+++. ..|+.||+|++.              +..+......+.+.+||+|.+.|+|||||++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVp--------------k~~l~k~~~reKv~~EIeIHr~L~HpnIV~f   83 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVP--------------KKLLKKPKQREKVLNEIEIHRSLKHPNIVQF   83 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEee--------------hHHhcCcchHHHHHHHHHHHHhcCCCcEEee
Confidence            4588899999999999999997 789999999984              3445567778899999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++|++.+.+|+|.|+|+.++|..+++  +.++++|.+++.+++||+.||.|||++   +|+|||||..|++++++.++|
T Consensus        84 ~~~FEDs~nVYivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VK  158 (592)
T KOG0575|consen   84 YHFFEDSNNVYIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVK  158 (592)
T ss_pred             eeEeecCCceEEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEE
Confidence            999999999999999999999999998  567899999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+|..+....  ......+|||.|.|||++....++..+||||+|||+|.++.|+.||+...-.+.+.+.......
T Consensus       159 IgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~  236 (592)
T KOG0575|consen  159 IGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS  236 (592)
T ss_pred             ecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc
Confidence            99999999887542  2234679999999999999999999999999999999999999999765333333333222211


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                              .|.      .......++|..++++||.+|||+++|+..
T Consensus       237 --------~P~------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  237 --------MPS------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             --------ccc------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    111      112235688889999999999999999953

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=376.27  Aligned_cols=203  Identities=32%  Similarity=0.512  Sum_probs=181.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|...+.||+|+||+||+|+. +++..||||.+.+.              . ......+.+..|+.++++++|||||+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~--------------~-l~~k~~e~L~~Ei~iLkel~H~nIV~   73 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKK--------------K-LNKKLVELLLSEIKILKELKHPNIVR   73 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhh--------------c-cCHHHHHHHHHHHHHHHhcCCcceee
Confidence            46788888899999999999995 56899999998432              1 14556788999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC---
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD---  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~---  837 (1002)
                      +++++..++..|+|||||.||+|.+|++.  .+.+++..++.++.|+|.||++||++   +||||||||.|||++..   
T Consensus        74 l~d~~~~~~~i~lVMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~  148 (429)
T KOG0595|consen   74 LLDCIEDDDFIYLVMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARN  148 (429)
T ss_pred             EEEEEecCCeEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCC
Confidence            99999999999999999999999999995  45799999999999999999999999   99999999999999764   


Q ss_pred             ---CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          838 ---FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       838 ---~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                         -.+||+|||+|+.+.+...   ....+|++.|||||++...+|+.|+|+||+|+++|||++|+.||+...
T Consensus       149 ~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  149 DTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             CCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence               4589999999999875533   345689999999999999999999999999999999999999997553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=373.19  Aligned_cols=245  Identities=29%  Similarity=0.375  Sum_probs=204.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.++||+|+||+||.++.+ +++.||+|++.+.              .+......+....|..|+.+++||+||+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~--------------~iv~~~e~~~~~~Er~IL~~v~hPFiv~   89 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKK--------------KIVEKKEVRHTKAERNILSKIKHPFIVK   89 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhh--------------HhhhhhhHHHHHHHHHHHHhCCCCcEee
Confidence            567889999999999999999965 4889999998543              4445567888999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      ++..|++.+.+|+|+||+.||.|...++  +.+.+++..++-++.+|+.||.|||++   +|||||+||+|||+|.+|++
T Consensus        90 l~ysFQt~~kLylVld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi  164 (357)
T KOG0598|consen   90 LIYSFQTEEKLYLVLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHI  164 (357)
T ss_pred             eEEecccCCeEEEEEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcE
Confidence            9999999999999999999999999998  567799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +|+|||+++..-....  .+...+||+.|||||++.+..|+.++|+||+|+++|||++|..||.....    .++.....
T Consensus       165 ~LtDFgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~  238 (357)
T KOG0598|consen  165 KLTDFGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKIL  238 (357)
T ss_pred             EEeccccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHh
Confidence            9999999985543322  23347999999999999999999999999999999999999999976532    23332222


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP  960 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  960 (1002)
                      ... .     +..+.....   +..+++...+..||++|.
T Consensus       239 ~~k-~-----~~~p~~ls~---~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  239 KGK-L-----PLPPGYLSE---EARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cCc-C-----CCCCccCCH---HHHHHHHHHhccCHHHhc
Confidence            221 0     111121222   356778889999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-45  Score=360.83  Aligned_cols=259  Identities=26%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             cCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+|.+.++||+|.||+||++. ..+|..+|.|.+..+               ..+....+...+|+.+|++++|||||++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~---------------~md~k~rq~~v~Ei~lLkQL~HpNIVqY   83 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG---------------MMDAKARQDCVKEISLLKQLNHPNIVQY   83 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh---------------hccHHHHHHHHHHHHHHHhcCCchHHHH
Confidence            345566799999999999998 578999999998543               2356678889999999999999999999


Q ss_pred             ee-EEecCCe-eeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEC
Q 001867          762 WC-CCTTRDC-KLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLD  835 (1002)
Q Consensus       762 ~~-~~~~~~~-~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~~NIll~  835 (1002)
                      ++ .|.++.. +++||||+.+|+|.++++..+  ++.+++..+|+++.|++.||.++|++- ++  |+||||||.||+++
T Consensus        84 y~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~  162 (375)
T KOG0591|consen   84 YAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLT  162 (375)
T ss_pred             HHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEc
Confidence            99 4554444 899999999999999987643  478999999999999999999999931 15  89999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .+|.+|++|||+++.+....  ......+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.++    .+.. 
T Consensus       163 ~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~-  235 (375)
T KOG0591|consen  163 ANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLS-  235 (375)
T ss_pred             CCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHH-
Confidence            99999999999999987643  3345678999999999999999999999999999999999999999865    2222 


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      +...+....+..+.    ...+.+   ++..++..|+.+||+.||+...++..+..
T Consensus       236 L~~KI~qgd~~~~p----~~~YS~---~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  236 LCKKIEQGDYPPLP----DEHYST---DLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHcCCCCCCc----HHHhhh---HHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            23333333332221    122333   47778889999999999996555544443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-42  Score=393.44  Aligned_cols=262  Identities=25%  Similarity=0.406  Sum_probs=219.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      .+....+.||+|+||+||+|+..      +...||||.++..                .+...+++|++|++.+..++||
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----------------a~~~~~~dF~REaeLla~l~H~  549 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----------------AENQARQDFRREAELLAELQHP  549 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----------------ccHHHHHHHHHHHHHHHhccCC
Confidence            34566789999999999999853      3457999988542                2345788999999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC--------C----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------G----LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      |||+++|.|..++.+|+|+|||..|||.+||..+..        .    +++..+.+.||.|||.|+.||.++   .+||
T Consensus       550 nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVH  626 (774)
T KOG1026|consen  550 NIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVH  626 (774)
T ss_pred             CeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccc
Confidence            999999999999999999999999999999986431        2    388999999999999999999999   9999


Q ss_pred             CCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 001867          825 RDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPV  903 (1002)
Q Consensus       825 rDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~  903 (1002)
                      |||..+|+||.++..|||+|||+++..-..++++......-.++|||||.+..++|+.+||||||||++||+++ |+.||
T Consensus       627 RDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy  706 (774)
T KOG1026|consen  627 RDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPY  706 (774)
T ss_pred             cchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcc
Confidence            99999999999999999999999998887777665433345679999999999999999999999999999999 98898


Q ss_pred             CCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ++- ..++.++.+.+...        -+..+.+    +.+++.+|.+||+.+|++||+++||-..|+.....+
T Consensus       707 ~gl-Sn~EVIe~i~~g~l--------L~~Pe~C----P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  707 YGL-SNQEVIECIRAGQL--------LSCPENC----PTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ccc-chHHHHHHHHcCCc--------ccCCCCC----CHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            654 44555554432221        1222334    445999999999999999999999999999986544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.2e-46  Score=387.33  Aligned_cols=470  Identities=27%  Similarity=0.396  Sum_probs=362.5

Q ss_pred             EEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCcccccccc
Q 001867           71 VASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTG  150 (1002)
Q Consensus        71 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~  150 (1002)
                      ...+++++|.+.. +.+.+.+|..|++|++++|++. ..|.+++.+..++.|+.++|+++ .+|+.++.+.+|+.|+.++
T Consensus        47 l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            6778999999984 4566899999999999999997 47889999999999999999999 8899999999999999999


Q ss_pred             ccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccccccc
Q 001867          151 NNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEI  230 (1002)
Q Consensus       151 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~  230 (1002)
                      |.+. .+|+.++.+..|+.|+..+|+++ ..|..++++.+|..|++.+|++  ...|+..-+++.|++|++..|-+. .+
T Consensus       124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l--~~l~~~~i~m~~L~~ld~~~N~L~-tl  198 (565)
T KOG0472|consen  124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKL--KALPENHIAMKRLKHLDCNSNLLE-TL  198 (565)
T ss_pred             ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccch--hhCCHHHHHHHHHHhcccchhhhh-cC
Confidence            9999 78889999999999999999999 6788889999999999999987  466776666999999999999888 88


Q ss_pred             ccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCc-cccccccceeeccccccCCCCCccCCCC
Q 001867          231 PDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGPIPDDLTRL  309 (1002)
Q Consensus       231 p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  309 (1002)
                      |..++.+.+|..|+|.+|+|. ..| .|.++..|.+|+++.|++. .+|.+ ..+++++.+|||..|+++ ..|+.+..+
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL  274 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL  274 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence            999999999999999999998 455 7888888888888888888 45544 458888888888888887 455554444


Q ss_pred             C-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCc---ccc
Q 001867          310 P-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGE---LEE  385 (1002)
Q Consensus       310 ~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~  385 (1002)
                      . |+.||+|+|.|+                         .+|.+++++ +|+.|.+.+|.+. .+-..+-+.+.   |++
T Consensus       275 rsL~rLDlSNN~is-------------------------~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKy  327 (565)
T KOG0472|consen  275 RSLERLDLSNNDIS-------------------------SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKY  327 (565)
T ss_pred             hhhhhhcccCCccc-------------------------cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHH
Confidence            3 555555555554                         344455555 5555555555554 22222221111   222


Q ss_pred             eee--eccccc---------cC-CC---CcCcCCCCCcEEEccCccccCCCCCcCCCCCc---ceEEEcccCcccCcccc
Q 001867          386 LLM--IYNSFT---------GQ-LP---DGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH---VYLLELTDNFLSGEISK  447 (1002)
Q Consensus       386 L~l--~~N~l~---------~~-~p---~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~i~~~~~~  447 (1002)
                      |.-  ..-.++         .. .+   .....+.+.+.|+++.-+++ .+|...+.-..   ....+++.|++. ++|.
T Consensus       328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk  405 (565)
T KOG0472|consen  328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPK  405 (565)
T ss_pred             HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhh
Confidence            211  000000         01 11   12234567888888888888 56665555444   778899999987 5666


Q ss_pred             ccccCCccc-EEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccc
Q 001867          448 NIAGAANLS-LLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK  526 (1002)
Q Consensus       448 ~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  526 (1002)
                      .+..+..+. .+.+++|.++ .+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|.++..+..
T Consensus       406 ~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~  482 (565)
T KOG0472|consen  406 RLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQT  482 (565)
T ss_pred             hhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHH
Confidence            666655544 4566666665 88888999999999999988887 78999999988999999999998 78988888888


Q ss_pred             cccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCc
Q 001867          527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS  585 (1002)
Q Consensus       527 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~  585 (1002)
                      |+.+-.++|++....|+.+.+|.+|..|||.+|.+. .||+.++++ +|++|++++|++.
T Consensus       483 lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  483 LETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            888888889987545555899999999999999998 688889998 7999999999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=344.42  Aligned_cols=240  Identities=26%  Similarity=0.338  Sum_probs=202.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|+..+.||.|+||+|..++. .+|..+|+|++.+              ..+....+.+...+|..+++.+.||++++
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k--------------~~vVklKQveH~~nEk~vL~~v~~PFlv~  108 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDK--------------QKVVKLKQVEHTHNEKRVLKAVSHPFLVK  108 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCH--------------HHHHHHHHHHHHhhHHHHHhhccCceeEE
Confidence            35677789999999999999995 4688999999843              34556677888999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++.+.+.+.+|+||||++||.|..+++.  .+.+++..++-+|.||+.|++|||+.   +|++||+||+|||+|.+|.+
T Consensus       109 l~~t~~d~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~i  183 (355)
T KOG0616|consen  109 LYGTFKDNSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHI  183 (355)
T ss_pred             EEEeeccCCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcE
Confidence            99999999999999999999999999984  46799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||.|+.....     +-..+|||.|+|||++....+..++|+|||||++|||+.|..||........+-+++....
T Consensus       184 KitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v  258 (355)
T KOG0616|consen  184 KITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV  258 (355)
T ss_pred             EEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc
Confidence            99999999987543     3467999999999999999999999999999999999999999987755444333332221


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCC
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINR  959 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  959 (1002)
                      .-           +....   .++.+++...+++|-.+|
T Consensus       259 ~f-----------P~~fs---~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 KF-----------PSYFS---SDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cC-----------CcccC---HHHHHHHHHHHhhhhHhh
Confidence            11           11111   135566667777777776

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=344.30  Aligned_cols=263  Identities=22%  Similarity=0.289  Sum_probs=207.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|+...++|+|+||.||+++.+ +|+.||||++...               ..+....+-..+|++++++++|||+|.+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es---------------edd~~VkKIAlREIrmLKqLkH~NLVnL   66 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES---------------EDDPVVKKIALREIRMLKQLKHENLVNL   66 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC---------------CccHHHHHHHHHHHHHHHhcccchHHHH
Confidence            45677789999999999999975 5899999999543               2245666778999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++|...+.+++|+||++. ++.+-++... ..++.+.+.++++|++.|+.|+|++   ++|||||||+|||++.+|.+|
T Consensus        67 iEVFrrkrklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvK  141 (396)
T KOG0593|consen   67 IEVFRRKRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVK  141 (396)
T ss_pred             HHHHHhcceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEE
Confidence            9999999999999999975 4444444433 3488899999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |||||+|+.+.....  ..+..+.|.+|+|||.+-+ ..|...+||||+||++.||++|..-|.+..+.+.+..+.....
T Consensus       142 LCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  142 LCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG  219 (396)
T ss_pred             eccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence            999999999874332  2334578999999998876 7899999999999999999999988876655555444333221


Q ss_pred             h----------ccC-ccccccccc------cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 D----------QKG-VDHVLDPKL------DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~----------~~~-~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .          ... ...+.-|.+      ...++....-+.+++..|++.||++|++.+|+++
T Consensus       220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1          000 111111111      2223333445789999999999999999999884

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=8.4e-45  Score=373.80  Aligned_cols=450  Identities=30%  Similarity=0.417  Sum_probs=343.5

Q ss_pred             CcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccc
Q 001867          117 QNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNL  196 (1002)
Q Consensus       117 ~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  196 (1002)
                      .-|+.|++++|.++ .+.+.+.+|..|.+|++++|+++ ..|.+++.+..++.|+.++|+++ .+|..++.+.+|..|+.
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            45666777777766 44556667777777777777777 66677777777777777777777 66777777777777777


Q ss_pred             cCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccC
Q 001867          197 SYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTG  276 (1002)
Q Consensus       197 s~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  276 (1002)
                      ++|.+  ..+|++++.+..|+.|+..+|+++ ..|..++++.+|..|++.+|+++...|..+. ++.|++|+...|-++ 
T Consensus       122 s~n~~--~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-  196 (565)
T KOG0472|consen  122 SSNEL--KELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-  196 (565)
T ss_pred             cccce--eecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-
Confidence            77776  467777777777788888888877 6677777777888888888877755444444 666777766666665 


Q ss_pred             CCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCC-CCC
Q 001867          277 DLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGD-LGK  355 (1002)
Q Consensus       277 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~  355 (1002)
                      .+|..++.+.+|..|+|..|+|.                        ..| .|.++..|+++.++.|+|. ++|.+ ...
T Consensus       197 tlP~~lg~l~~L~~LyL~~Nki~------------------------~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~  250 (565)
T KOG0472|consen  197 TLPPELGGLESLELLYLRRNKIR------------------------FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKH  250 (565)
T ss_pred             cCChhhcchhhhHHHHhhhcccc------------------------cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcc
Confidence            55666666666666666666665                        344 5667777777777777777 44444 447


Q ss_pred             CCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccC----------------
Q 001867          356 NSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTG----------------  419 (1002)
Q Consensus       356 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----------------  419 (1002)
                      ++++..|||..|+++ +.|+.+|.+++|++|++++|.++ .+|.+++++ .|+.|-+.+|.+..                
T Consensus       251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy  327 (565)
T KOG0472|consen  251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY  327 (565)
T ss_pred             cccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence            788888888888888 78888888888888888888888 467778888 88888888887642                


Q ss_pred             ---------------------C-CCCcC---CCCCcceEEEcccCcccCccccccccC--CcccEEEccCCcCCCCCccc
Q 001867          420 ---------------------K-VPPLL---WGLPHVYLLELTDNFLSGEISKNIAGA--ANLSLLIISKNNLSGSLPEE  472 (1002)
Q Consensus       420 ---------------------~-~p~~~---~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~  472 (1002)
                                           . .+..|   ..+.+.+.|++++-+++.+....|..-  .-.+..+++.|++. ++|..
T Consensus       328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~  406 (565)
T KOG0472|consen  328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKR  406 (565)
T ss_pred             HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhh
Confidence                                 1 11111   234567889999999986554444332  23789999999999 89999


Q ss_pred             cccccccccc-cccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccc
Q 001867          473 IGFLKSLVVL-SGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVL  551 (1002)
Q Consensus       473 ~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L  551 (1002)
                      +..++.+++. .+++|++ +-+|..++.+++|..|+|++|.+. .+|..++.+..|+.||+|.|+|. .+|+.+..+..|
T Consensus       407 L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~l  483 (565)
T KOG0472|consen  407 LVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTL  483 (565)
T ss_pred             hHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHH
Confidence            9998887665 4555555 488999999999999999999998 78999999999999999999998 899999999999


Q ss_pred             cEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh-hhhhcccccccCCCCC
Q 001867          552 NYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL-FAKEMYRNSFLGNPGL  607 (1002)
Q Consensus       552 ~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~n~~~  607 (1002)
                      +.+-.++|++....|.+++++ .|..|||.+|.+...+|.. ....+...-+.|||..
T Consensus       484 Etllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  484 ETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            999999999997777779999 8999999999999877765 5667788889999976

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=361.08  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=211.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      ..+|.+++.||+|+|++|++|+. ..++.||||++.+.              .+..+...+-+..|-++|.+| .||.|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~--------------~Iike~KvkYV~~Ek~~l~~L~~hPgiv  137 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKR--------------YIIKEKKVKYVTREKEALTQLSGHPGIV  137 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHH--------------HHHhhcccchhhHHHHHHHHhhCCCCeE
Confidence            46788899999999999999995 56899999998443              333445556678899999999 799999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++|..|+++..+|+|+||+++|+|.++++  +.+.+++.-.+.++.||+.|++|||++   |||||||||+|||+|.|++
T Consensus       138 kLy~TFQD~~sLYFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmh  212 (604)
T KOG0592|consen  138 KLYFTFQDEESLYFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGH  212 (604)
T ss_pred             EEEEEeecccceEEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCc
Confidence            99999999999999999999999999998  457899999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCC---------cc--cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 001867          840 ARVADFGVAKVVDASGKP---------KS--MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG  908 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~  908 (1002)
                      +||+|||.|+.+.+....         ..  ....+||-.|++||++.....+..+|+|+||||+|+|+.|..||.....
T Consensus       213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne  292 (604)
T KOG0592|consen  213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE  292 (604)
T ss_pred             EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence            999999999988754322         11  1347899999999999999999999999999999999999999987654


Q ss_pred             chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+.+++.-.+           .....+++   ...+++.+.+..||.+|++.++|.+
T Consensus       293 yliFqkI~~l~y-----------~fp~~fp~---~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  293 YLIFQKIQALDY-----------EFPEGFPE---DARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHHHHHhcc-----------cCCCCCCH---HHHHHHHHHHccCccccccHHHHhh
Confidence            444433332111           11112222   3667888999999999999988875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=366.41  Aligned_cols=267  Identities=30%  Similarity=0.391  Sum_probs=213.4

Q ss_pred             HHHH-hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       678 ~~~~-~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      +++| .+++.+++.||+|.||+||+|+|.  ..||||++....               ....+.+.|+.||.++++-+|.
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~---------------pt~~qlqaFKnEVa~lkkTRH~  448 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDD---------------PTPEQLQAFKNEVAVLKKTRHE  448 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCC---------------CCHHHHHHHHHHHHHHhhcchh
Confidence            3444 356778899999999999999996  479999995431               1334788899999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      ||+=+.||+..++. .||+.+++|.+|..+++..+ ..++..+.+.||+|||+|+.|||.+   +|||||||..||++.+
T Consensus       449 NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~  523 (678)
T KOG0193|consen  449 NILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHE  523 (678)
T ss_pred             hheeeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEcc
Confidence            99999999998887 99999999999999999744 5689999999999999999999999   9999999999999999


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      +++|||+|||++.....-..........|...|||||++...   .|++.+||||||+++|||++|..||... ..+.+.
T Consensus       524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIi  602 (678)
T KOG0193|consen  524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQII  602 (678)
T ss_pred             CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheE
Confidence            999999999999754432222233344577899999998743   5899999999999999999999999833 323222


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      ..+-+++.        .|.+-.....+..++.+++..||..+|++||.+.+|+..|+.+.+.
T Consensus       603 fmVGrG~l--------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  603 FMVGRGYL--------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             EEeccccc--------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            22211111        1222122223344688999999999999999999999999998764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-41  Score=354.22  Aligned_cols=256  Identities=29%  Similarity=0.447  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ..|..++.||+|+||+||++... +|+..|||.+...                 +....+.+.+|+.+|++++|||||++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~-----------------~~~~~~~l~~Ei~iL~~l~~p~IV~~   79 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE-----------------DSPTSESLEREIRILSRLNHPNIVQY   79 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecc-----------------cchhHHHHHHHHHHHHhCCCCCEEee
Confidence            34677889999999999999965 4899999988332                 11115668999999999999999999


Q ss_pred             eeEEecCC--eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC-CC
Q 001867          762 WCCCTTRD--CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG-DF  838 (1002)
Q Consensus       762 ~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~-~~  838 (1002)
                      +|......  .+++.|||+++|+|.+++....+ .+++..+..+++||++||+|||++   +||||||||+|||++. ++
T Consensus        80 ~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~  155 (313)
T KOG0198|consen   80 YGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNG  155 (313)
T ss_pred             CCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCC
Confidence            99865544  68999999999999999997655 799999999999999999999999   9999999999999999 79


Q ss_pred             CeEEccccCcccccC-CCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDA-SGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+||+|||+++.... ...........||+.|||||++..+ ....++||||+||++.||+||+.||.....   ...++
T Consensus       156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~  232 (313)
T KOG0198|consen  156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEAL  232 (313)
T ss_pred             eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHH
Confidence            999999999987764 1122233456899999999999964 334599999999999999999999975311   11111


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      .........     |.++..   ...+..+++.+|+..||++||||+++++.--
T Consensus       233 ~~ig~~~~~-----P~ip~~---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  233 LLIGREDSL-----PEIPDS---LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             HHHhccCCC-----CCCCcc---cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            111111111     122212   2234678888999999999999999997653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=364.33  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=206.7

Q ss_pred             CCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..++||+|+.|.||.|. ..+++.||||++...                 .+..++-+..|+.+|+..+|+|||+++
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~-----------------~Q~~keLilnEi~Vm~~~~H~NiVnfl  336 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR-----------------KQPKKELLLNEILVMRDLHHPNIVNFL  336 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEec-----------------cCCchhhhHHHHHHHHhccchHHHHHH
Confidence            45666789999999999998 467889999998432                 344567789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +.|...+.+++|||||+||+|.+.+..   ..+++.+++.|++++++||+|||.+   +|||||||.+|||++.+|.+||
T Consensus       337 ~Sylv~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKl  410 (550)
T KOG0578|consen  337 DSYLVGDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKL  410 (550)
T ss_pred             HHhcccceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEE
Confidence            999999999999999999999999974   4599999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||++..+......+  ...+||++|||||+.....|.+|+||||||++++||+.|+.||-.+.....+......    
T Consensus       411 tDFGFcaqi~~~~~KR--~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n----  484 (550)
T KOG0578|consen  411 TDFGFCAQISEEQSKR--STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----  484 (550)
T ss_pred             eeeeeeeccccccCcc--ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc----
Confidence            9999998877654322  3468999999999999999999999999999999999999999765433333222211    


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ....+-.+  .    .....+.+++.+|++.||++||++.|+++
T Consensus       485 -g~P~lk~~--~----klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  485 -GTPKLKNP--E----KLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -CCCCcCCc--c----ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence             11111111  1    11224778889999999999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=375.39  Aligned_cols=256  Identities=27%  Similarity=0.441  Sum_probs=217.8

Q ss_pred             CCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      ..+.++||.|.||.||+|+++    ....||+|.++.+                ..+.++.+|..|+.||.+++||||++
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----------------ytekqrrdFL~EAsIMGQFdHPNIIr  694 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----------------YTEKQRRDFLSEASIMGQFDHPNIIR  694 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccC----------------ccHHHHhhhhhhhhhcccCCCCcEEE
Confidence            456789999999999999974    2457999999654                35677889999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +.|+......++||+|||++|+|+.||+.+. +.+++.++..|.++||.|++||.+.   ++|||||.++||||+.+-.+
T Consensus       695 LEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvC  770 (996)
T KOG0196|consen  695 LEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVC  770 (996)
T ss_pred             EEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEE
Confidence            9999999999999999999999999999855 5699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccc--cccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAG--SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      |++|||+++.+.+.. +...+...|  ..+|.|||.+...+++.++|||||||++||.++ |.+||.+. +.++..+.++
T Consensus       771 KVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-SNQdVIkaIe  848 (996)
T KOG0196|consen  771 KVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAIE  848 (996)
T ss_pred             EeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-chHHHHHHHH
Confidence            999999999876544 222223333  359999999999999999999999999999988 99999765 4455555555


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ...+.        |...++    +..+.++|+.||++|..+||.+++++..|.++.+
T Consensus       849 ~gyRL--------PpPmDC----P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  849 QGYRL--------PPPMDC----PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             hccCC--------CCCCCC----cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            44432        222233    3459999999999999999999999999999975

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=346.02  Aligned_cols=260  Identities=29%  Similarity=0.393  Sum_probs=207.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.++||.|..++||+|+ ...++.||||++.-..                .....+.+.+|+..|+.++||||++
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk----------------c~~~ld~l~kE~~~msl~~HPNIv~   88 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK----------------CNNDLDALRKEVQTMSLIDHPNIVT   88 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh----------------hhhhHHHHHHHHHHhhhcCCCCcce
Confidence            3578888999999999999999 5678999999994321                2233678999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      ++..|..+..+|+||.||.+|++.++++..-...+++..+..|.+++++||.|||.+   |.||||||+.|||++.+|.|
T Consensus        89 ~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~V  165 (516)
T KOG0582|consen   89 YHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTV  165 (516)
T ss_pred             EEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcE
Confidence            999999999999999999999999999876667799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcc--cccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKS--MSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ||+|||.+..+..+.....  ....+||++|||||++.+  ..|+.|+||||||+++.|+++|..||..-...    +.+
T Consensus       166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm----kvL  241 (516)
T KOG0582|consen  166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM----KVL  241 (516)
T ss_pred             EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH----HHH
Confidence            9999999876655441111  145689999999999543  46999999999999999999999999643222    222


Q ss_pred             HHHhhccCccc---cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDH---VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ........+..   ..+.   +..+.....+.+++..|+++||++|||++++++
T Consensus       242 l~tLqn~pp~~~t~~~~~---d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  242 LLTLQNDPPTLLTSGLDK---DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHHhcCCCCCcccccCCh---HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            22222211110   1111   111112225778888999999999999999983

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=358.32  Aligned_cols=264  Identities=23%  Similarity=0.293  Sum_probs=211.1

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCce
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNI  758 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni  758 (1002)
                      +.++|...++||.|.||.||+|+. .+|+.||||++++..               .. .++-.-.+|+..+++++ ||||
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf---------------~s-~ee~~nLREvksL~kln~hpni   71 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF---------------YS-WEECMNLREVKSLRKLNPHPNI   71 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh---------------cc-HHHHHHHHHHHHHHhcCCCCcc
Confidence            456788889999999999999994 568999999986531               11 23444568999999998 9999


Q ss_pred             eeeeeEEecCC-eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          759 VKLWCCCTTRD-CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       759 v~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |++.+.+.+.+ .+|+||||| ..+|.++++.+ ++.+++..+..|++||++||+|+|.+   |+.|||+||+|||+...
T Consensus        72 ikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~  146 (538)
T KOG0661|consen   72 IKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGN  146 (538)
T ss_pred             hhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEeccc
Confidence            99999999888 999999999 57999999985 78999999999999999999999999   99999999999999988


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ..+||+|||+|+-......   .+..+.|.+|+|||++. .+.|+.+.|||++|||++|+.+-+.-|.+....+++.++.
T Consensus       147 ~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc  223 (538)
T KOG0661|consen  147 DVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC  223 (538)
T ss_pred             ceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH
Confidence            8999999999998765533   34568999999999865 6679999999999999999999998887665555554443


Q ss_pred             HHHhhcc--C--------------ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          917 CSTLDQK--G--------------VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .-.....  .              ...+..-.+....+....+..+++.+|++.||++|||++|+++.
T Consensus       224 ~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  224 EVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            3221100  0              00111111111222334568889999999999999999999875

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=349.89  Aligned_cols=264  Identities=27%  Similarity=0.378  Sum_probs=208.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhc--CCCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGK--IRHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv  759 (1002)
                      .......++||+|.||.||+|+.. ++.||||++                    ...+.+.|+.|-+|++.  |+|+||+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKif--------------------p~~~kqs~~~Ek~Iy~lp~m~h~nIl  267 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIF--------------------PEQEKQSFQNEKNIYSLPGMKHENIL  267 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEec--------------------CHHHHHHHHhHHHHHhccCccchhHH
Confidence            345666789999999999999986 599999998                    34556778887777765  5799999


Q ss_pred             eeeeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeeeCCCCC
Q 001867          760 KLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD------CVPSIVHRDVKS  829 (1002)
Q Consensus       760 ~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~iiHrDlk~  829 (1002)
                      +++++-....    .+++|+||++.|+|.+|++.   ..++|....+|+..+++||+|||+.      ..++|+|||||.
T Consensus       268 ~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkS  344 (534)
T KOG3653|consen  268 QFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKS  344 (534)
T ss_pred             HhhchhccCCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccc
Confidence            9999887665    78999999999999999974   6799999999999999999999986      357999999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCC-C-----CccchhhHHHHHHHHHhCCCCC
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-N-----EKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DvwslGvil~ell~g~~p~  903 (1002)
                      +||||..|+++.|+|||+|.++............+||.+|||||++.+... .     .+.||||+|.++|||++....+
T Consensus       345 kNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  345 KNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             cceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            999999999999999999999987766666667899999999999886532 1     4789999999999999975544


Q ss_pred             CC------------CCCchhHHHHHHHHhhccCccccccccccCCCHHH------HHHHHHHHHHcCCCCCCCCCCHHHH
Q 001867          904 DP------------EFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEE------ICKVLNIGLLCTSPLPINRPAMRRV  965 (1002)
Q Consensus       904 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~ev  965 (1002)
                      ++            +.+.....+.++...        +.++.+...++.      +.-+.+.+..||++||+.|.|+.=|
T Consensus       425 ~~~~vp~Yqlpfe~evG~hPt~e~mq~~V--------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  425 DPGPVPEYQLPFEAEVGNHPTLEEMQELV--------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             cCCCCCcccCchhHHhcCCCCHHHHHHHH--------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            31            111111111111111        112222222222      3347788999999999999999999


Q ss_pred             HHHHHHhhhhcc
Q 001867          966 VKLLQEVGAENR  977 (1002)
Q Consensus       966 l~~L~~~~~~~~  977 (1002)
                      -+++.++..-..
T Consensus       497 ~eR~~~l~~~~~  508 (534)
T KOG3653|consen  497 EERMAELMMLWE  508 (534)
T ss_pred             HHHHHHHhccCC
Confidence            999999865443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=370.84  Aligned_cols=364  Identities=25%  Similarity=0.267  Sum_probs=307.0

Q ss_pred             cceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhccc
Q 001867          167 LEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA  246 (1002)
Q Consensus       167 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  246 (1002)
                      -+.|++++|+++.+.+..|.++++|+++++.+|.+  ..+|...+...+|+.|+|.+|.|+.+-.+++..++.|+.||||
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~L--t~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNEL--TRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchh--hhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            44577777777777777777777777777777765  4677766666678888888888887777888888888899999


Q ss_pred             CcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcC
Q 001867          247 LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSL  325 (1002)
Q Consensus       247 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~  325 (1002)
                      .|.|+.+...+|..-.++++|+|++|.|+......|.++.+|..|.|+.|+++..++..|..++ |+.|+|..|+|.-.-
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            9888877777888778888999999999888888888888999999999999877777777675 999999999988665


Q ss_pred             CcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCC
Q 001867          326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQ  405 (1002)
Q Consensus       326 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~  405 (1002)
                      --.|.++++|+.|.|.+|.|.....+.|..+.++++|+|+.|+++..-..++.+++.|+.|++++|.|...-++++..++
T Consensus       238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq  317 (873)
T KOG4194|consen  238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ  317 (873)
T ss_pred             hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence            77899999999999999999999999999999999999999999988889999999999999999999999999999999


Q ss_pred             CCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcc---ccccccccccc
Q 001867          406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPE---EIGFLKSLVVL  482 (1002)
Q Consensus       406 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L  482 (1002)
                      +|++|+|++|+|+...++.|..|..|+.|+|++|+|..+-...|.++++|+.|||++|.+++.+.+   .|..|++|+.|
T Consensus       318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL  397 (873)
T KOG4194|consen  318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL  397 (873)
T ss_pred             cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence            999999999999999999999999999999999999988888899999999999999999877654   35557777777


Q ss_pred             cccccccCCCCcccccccccCCeeecCCCcCCccccccccccccccccccc
Q 001867          483 SGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLA  533 (1002)
Q Consensus       483 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  533 (1002)
                      .+.+|++..+.-.+|..+.+|+.|||.+|.|..+-|++|..+ .|++|-++
T Consensus       398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n  447 (873)
T KOG4194|consen  398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN  447 (873)
T ss_pred             eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence            777777774333577777777777777777777777777776 67766664

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.2e-40  Score=325.11  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=212.8

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|...+++|+|.||.||+|+. ++|+.||+|+++.+..+               ........+|+..++.++|+||+.++
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k---------------dGi~~talREIK~Lqel~h~nIi~Li   67 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK---------------DGINRTALREIKLLQELKHPNIIELI   67 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc---------------cCccHHHHHHHHHHHHccCcchhhhh
Confidence            466678999999999999994 67999999999654211               12234578899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      ++|...+.+.+|+|||+ .+|+..++. +...++..++..++.++.+|++|+|++   .|+||||||.|+|++++|.+||
T Consensus        68 D~F~~~~~l~lVfEfm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKi  142 (318)
T KOG0659|consen   68 DVFPHKSNLSLVFEFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKI  142 (318)
T ss_pred             hhccCCCceEEEEEecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEe
Confidence            99999999999999995 599999986 557899999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+|+.+........  ..+-|.+|+|||.+.+. .|+..+||||.|||+.|++-|..-|.++.+.+++...+.....
T Consensus       143 ADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGT  220 (318)
T KOG0659|consen  143 ADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGT  220 (318)
T ss_pred             ecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCC
Confidence            99999999887654333  33789999999988865 5899999999999999999987666666555655555543321


Q ss_pred             cc--------------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QK--------------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~--------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ..              .+.....+..+..++....+..+++..++..||.+|+++.|++++
T Consensus       221 P~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  221 PTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            10              011112222233445555567899999999999999999999865

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.8e-40  Score=354.39  Aligned_cols=250  Identities=25%  Similarity=0.328  Sum_probs=205.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|+..++||+|+||.||.|+.+ +|+.+|+|++++              .......+.+.+..|-.+|...++|+||+
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkK--------------S~M~~~~Qv~hV~aERdiL~~~ds~~vVK  205 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKK--------------SEMLKKNQVEHVRAERDILAEVDSPWVVK  205 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccH--------------HHHHhhhhHHHHHHHHHHhhhcCCCcEEE
Confidence            578889999999999999999965 589999999854              35556777889999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +|.+|++.+.+|+||||+|||++.++|.  +.+.+++..+..++.+++.|+.-+|+.   |||||||||+|+|||..|++
T Consensus       206 LyYsFQD~~~LYLiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHi  280 (550)
T KOG0605|consen  206 LYYSFQDKEYLYLIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHI  280 (550)
T ss_pred             EEEEecCCCeeEEEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCE
Confidence            9999999999999999999999999998  567899999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCC----------------------CC-----ccc------------------ccccccccccCcccc
Q 001867          841 RVADFGVAKVVDASG----------------------KP-----KSM------------------SVIAGSCGYIAPEYA  875 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~----------------------~~-----~~~------------------~~~~gt~~y~aPE~~  875 (1002)
                      ||+|||++.-+....                      ..     ...                  ...+|||.|||||++
T Consensus       281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl  360 (550)
T KOG0605|consen  281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL  360 (550)
T ss_pred             eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence            999999995432200                      00     000                  123699999999999


Q ss_pred             ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCC
Q 001867          876 YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPL  955 (1002)
Q Consensus       876 ~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  955 (1002)
                      .+..|+..+|+||+|||+|||+.|.+||..+...+...+.+.-........+      ....    .+..++|.+|+. |
T Consensus       361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~------~~~s----~eA~DLI~rll~-d  429 (550)
T KOG0605|consen  361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE------VDLS----DEAKDLITRLLC-D  429 (550)
T ss_pred             hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc------Cccc----HHHHHHHHHHhc-C
Confidence            9999999999999999999999999999887666554444332211111111      1111    346678888888 9


Q ss_pred             CCCCCC
Q 001867          956 PINRPA  961 (1002)
Q Consensus       956 P~~Rps  961 (1002)
                      |+.|.-
T Consensus       430 ~~~RLG  435 (550)
T KOG0605|consen  430 PENRLG  435 (550)
T ss_pred             HHHhcC
Confidence            999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=355.92  Aligned_cols=246  Identities=29%  Similarity=0.453  Sum_probs=202.5

Q ss_pred             CCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +...+-||.|+.|.||+|+++ ++.||||++.                        +.-+.+|+-|++++||||+.+.|+
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~------------------------elkETdIKHLRkLkH~NII~FkGV  180 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVR------------------------ELKETDIKHLRKLKHPNIITFKGV  180 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-CceehhHHHh------------------------hhhhhhHHHHHhccCcceeeEeee
Confidence            344677999999999999997 6899999872                        223467888999999999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      |.....+|||||||+.|-|...++  .+.+++-.....|..+||.|+.|||.+   .|||||||.-||||+.+..|||+|
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence            999999999999999999999998  456789999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ||-++.....   .++...+||..|||||++.....+.|+||||||||+|||+||..||.+-.....+.-     +..+.
T Consensus       256 FGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-----VGsNs  327 (904)
T KOG4721|consen  256 FGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-----VGSNS  327 (904)
T ss_pred             ccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-----ccCCc
Confidence            9999876543   223356899999999999999999999999999999999999999975432221110     00011


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      +..   |    .+.++..-+.-+++.||+..|..||++.+++..|+-+.++
T Consensus       328 L~L---p----vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  328 LHL---P----VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             ccc---c----CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            111   1    1122233366778899999999999999999999876553

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=321.98  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=215.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++++.||+|.||.||.|+ .+++-.||+|++.+              .++.......++.+|++|-..++||||.+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfK--------------sqi~~~~v~~qlrREiEIqs~L~hpnilr   86 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFK--------------SQILKTQVEHQLRREIEIQSHLRHPNILR   86 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeH--------------HHHHHhcchhhhhheeEeecccCCccHHh
Confidence            4789999999999999999999 46678899999854              34555566778999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +|++|.+....|+++||.++|++...++..+...+++...+.+++|+|.|+.|+|..   +||||||||+|+|++.++..
T Consensus        87 lY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   87 LYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             hhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCe
Confidence            999999999999999999999999999987788899999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||.+...... .   ....+||..|.|||+..+..++.++|+|++|++.||++.|..||+.....+.+.+......
T Consensus       164 kiAdfGwsV~~p~~-k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~  239 (281)
T KOG0580|consen  164 KIADFGWSVHAPSN-K---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL  239 (281)
T ss_pred             eccCCCceeecCCC-C---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc
Confidence            99999999765422 1   2356899999999999999999999999999999999999999987764444444332211


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .        +|   .   .......+++.+|+..+|.+|.+..|+++.
T Consensus       240 ~--------~p---~---~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 K--------FP---S---TISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             c--------CC---c---ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1        11   1   111236788999999999999999998864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-40  Score=385.83  Aligned_cols=260  Identities=27%  Similarity=0.386  Sum_probs=213.2

Q ss_pred             CCcCCeeeecCCccEEEEEEcC--Cc----EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSN--GE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+..+.||+|+||.||+|...+  +.    +||||.+.+.                .+.....+|.+|..+|++++||||
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----------------~~~~~~~~Fl~Ea~~m~~f~HpNi  757 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----------------SSEQEVSDFLKEALLMSKFDHPNI  757 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----------------CCHHHHHHHHHHHHHHhcCCCcce
Confidence            4556789999999999999643  33    4899988542                356678899999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      |+++|.+.+.+..+|++|||++|+|.+|++..+     ...++..+++.++.|||+|+.||+++   ++|||||.++|+|
T Consensus       758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCL  834 (1025)
T KOG1095|consen  758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCL  834 (1025)
T ss_pred             eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhhee
Confidence            999999999999999999999999999999752     35689999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhH
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL  912 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~  912 (1002)
                      +++...|||+|||+|+.+....+++......-..+|||||.+..+.++.|+|||||||++||++| |..||......+-+
T Consensus       835 L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~  914 (1025)
T KOG1095|consen  835 LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL  914 (1025)
T ss_pred             ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence            99999999999999997766655544333233469999999999999999999999999999999 88888654333322


Q ss_pred             HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ..+.... +.       + ...    .+..+++++|..||+.+|++||++..+++.+.++....
T Consensus       915 ~~~~~gg-RL-------~-~P~----~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  915 LDVLEGG-RL-------D-PPS----YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             HHHHhCC-cc-------C-CCC----CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            2232221 11       1 112    22335889999999999999999999999988886533

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-39  Score=364.34  Aligned_cols=261  Identities=24%  Similarity=0.367  Sum_probs=204.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEE------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.++||+|+||.||+|..      .+++.||||++....                .......+.+|+.+++++ +|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~h   70 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----------------TASEHKALMSELKILIHIGNH   70 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----------------chHHHHHHHHHHHHHHHhccC
Confidence            5688889999999999999974      235689999884321                123346789999999999 89


Q ss_pred             CceeeeeeEEecC-CeeeEEEeccCCCChhhhhhhcC-------------------------------------------
Q 001867          756 KNIVKLWCCCTTR-DCKLLVYEYMPNGSLGDLLHSCK-------------------------------------------  791 (1002)
Q Consensus       756 ~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------  791 (1002)
                      |||+++++++... +..++||||+++|+|.+++...+                                           
T Consensus        71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (338)
T cd05102          71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQ  150 (338)
T ss_pred             cceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccc
Confidence            9999999988764 46789999999999999987532                                           


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCC
Q 001867          792 -----------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS  854 (1002)
Q Consensus       792 -----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~  854 (1002)
                                       ..++++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~  227 (338)
T cd05102         151 PSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKD  227 (338)
T ss_pred             cccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccC
Confidence                             13488899999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccc
Q 001867          855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKL  933 (1002)
Q Consensus       855 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (1002)
                      ..........+++.|+|||++.+..++.++|||||||++|||++ |..||........+...+.    ......    ..
T Consensus       228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~----~~~~~~----~~  299 (338)
T cd05102         228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK----DGTRMR----AP  299 (338)
T ss_pred             cchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh----cCCCCC----CC
Confidence            22222223346678999999999999999999999999999997 9999975433332222211    111100    01


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          934 DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       934 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ...    ...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       300 ~~~----~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         300 ENA----TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            112    2347889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-40  Score=349.81  Aligned_cols=265  Identities=27%  Similarity=0.350  Sum_probs=206.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|+..++||+|.||.||+|+. .+|+.||+|++....               .+..-.....+||.||++++||||+++
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~---------------~~~~~~~t~~REI~ILr~l~HpNIikL  181 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN---------------EKEGFPITAIREIKILRRLDHPNIIKL  181 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc---------------CCCcchHHHHHHHHHHHhcCCCcccce
Confidence            3455567899999999999994 679999999985431               122334557899999999999999999


Q ss_pred             eeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      .+...+.  +.+|+|+|||+ -+|..++.. .+-.+++.++..+++|++.||+|+|++   +|.|||||.+|||+|.+|.
T Consensus       182 ~eivt~~~~~siYlVFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~  256 (560)
T KOG0600|consen  182 EEIVTSKLSGSIYLVFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGV  256 (560)
T ss_pred             eeEEEecCCceEEEEEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCC
Confidence            9999876  78999999996 488888864 456799999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      +||+|||+|+++..... ...+..+-|.+|+|||.+.+. .|+.++|+||.|||+.||+.|+..|.+....+++-.+++-
T Consensus       257 LKiaDFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl  335 (560)
T KOG0600|consen  257 LKIADFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL  335 (560)
T ss_pred             EEeccccceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence            99999999998876543 335566789999999988764 6999999999999999999999888766544443333321


Q ss_pred             H--hhccCcc-------ccccc------cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          919 T--LDQKGVD-------HVLDP------KLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       919 ~--~~~~~~~-------~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .  ..+....       ..+.+      .+.+.+.......++++..++..||++|.|+.++++.
T Consensus       336 cGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  336 CGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             hCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1  1111111       11111      1111122223357788889999999999999999853

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=357.71  Aligned_cols=253  Identities=28%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      .+.|.+++.||+|+||+|+.|.. .+++.||+|++.+....         .  .. ....+.+.+|+.++++++ ||||+
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~---------~--~~-~~~~~~i~rEi~~~~~~~~HpnI~   83 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVS---------S--KS-QKLDELIKREISILRRLRSHPNII   83 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccc---------c--cc-cccchhhHHHHHHHHHhccCCCEe
Confidence            46788899999999999999985 56899999977443111         0  01 123456779999999999 99999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC-C
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD-F  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~-~  838 (1002)
                      ++++++......|+||||+.||+|.+++..  .+++.+..+.++++|++.|++|+|++   +|+||||||+||+++.+ +
T Consensus        84 ~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   84 RLLEVFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEG  158 (370)
T ss_pred             EEEEEEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCC
Confidence            999999999999999999999999999985  56799999999999999999999999   99999999999999999 9


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCC-CC-CccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VN-EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ++||+|||++....  .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++......+..  
T Consensus       159 ~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--  234 (370)
T KOG0583|consen  159 NLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--  234 (370)
T ss_pred             CEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--
Confidence            99999999999874  1222345668999999999999877 75 899999999999999999999987433222222  


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                         +....+.  +...+.      ..++..++.+|+..||.+|+++.+++
T Consensus       235 ---i~~~~~~--~p~~~~------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  235 ---IRKGEFK--IPSYLL------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ---HhcCCcc--CCCCcC------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence               1111110  111111      23477899999999999999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-40  Score=359.30  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=209.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+-|+.++.||+|+.|.|..|+. .+|+.+|||++-+..              .........+++|+-+|+-+.||||++
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~--------------~~s~s~~~~IerEIviMkLi~HpnVl~   76 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS--------------ELSSSQPAGIEREIVIMKLIEHPNVLR   76 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeecccc--------------ccccccccchhhhhHHHHHhcCCCeee
Confidence            45688899999999999999995 679999999984421              223445677999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +|+.|.++.++|+|.||+++|.|.+|+-  +.+++++.++++++.||+.|+.|+|..   +|+|||+||+|+|+|..+++
T Consensus        77 LydVwe~~~~lylvlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nI  151 (786)
T KOG0588|consen   77 LYDVWENKQHLYLVLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNI  151 (786)
T ss_pred             eeeeeccCceEEEEEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCE
Confidence            9999999999999999999999999998  567899999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+|....++.-   ...-||++.|.|||++.+..|. .++||||+|||+|.+++|+.||+++ ....+...++.+
T Consensus       152 KIADFGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-Nir~LLlKV~~G  227 (786)
T KOG0588|consen  152 KIADFGMASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-NIRVLLLKVQRG  227 (786)
T ss_pred             eeeccceeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-cHHHHHHHHHcC
Confidence            9999999986554432   3355899999999999998875 7999999999999999999999844 223333333222


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .-+.             +.....+..+++.+|+.+||++|.|++||++.
T Consensus       228 ~f~M-------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 VFEM-------------PSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cccC-------------CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            2111             11122347789999999999999999999975

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-40  Score=361.52  Aligned_cols=261  Identities=24%  Similarity=0.343  Sum_probs=209.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC--C---cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN--G---EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++....++||+|+||.||+|..+.  +   ..||||..+..              ......+..+|.+|+++|++++|||
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~--------------~~~~~~~~~e~m~EArvMr~l~H~N  222 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS--------------SELTKEQIKEFMKEARVMRQLNHPN  222 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc--------------ccccHHHHHHHHHHHHHHHhCCCCC
Confidence            455666899999999999999643  2   22899987421              2235677889999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ||++||+...+..+|+|||+++||+|.+|++..++ .++..+...++.++|.||+|||++   ++|||||.++|+|++.+
T Consensus       223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~  298 (474)
T KOG0194|consen  223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK  298 (474)
T ss_pred             EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC
Confidence            99999999999999999999999999999996433 699999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccc-cccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMS-VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~  915 (1002)
                      +.+||+|||+++.....   .... ...-..+|+|||.+..+.|+.++|||||||++||+++ |..||.+... .+...+
T Consensus       299 ~~vKISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-~~v~~k  374 (474)
T KOG0194|consen  299 GVVKISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-YEVKAK  374 (474)
T ss_pred             CeEEeCccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-HHHHHH
Confidence            99999999998865411   1111 2234579999999999999999999999999999999 8888865432 333333


Q ss_pred             H-HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          916 V-CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       916 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                      + ....+..     ..   . ..+   .++..++..||..+|+.||+|.++.+.++.+.....
T Consensus       375 I~~~~~r~~-----~~---~-~~p---~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  375 IVKNGYRMP-----IP---S-KTP---KELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             HHhcCccCC-----CC---C-CCH---HHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            3 2222211     11   1 122   246677779999999999999999999999876544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=338.69  Aligned_cols=270  Identities=25%  Similarity=0.330  Sum_probs=216.6

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhc--CCCC
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGK--IRHK  756 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~  756 (1002)
                      ..+.++....+.||+|.||+||+|+|. |+.||||++..                    .+++.+.+|.+|++.  |+|+
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--------------------rdE~SWfrEtEIYqTvmLRHE  265 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--------------------RDERSWFRETEIYQTVMLRHE  265 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc--------------------cchhhhhhHHHHHHHHHhccc
Confidence            455678888999999999999999997 89999999932                    235567778888876  4899


Q ss_pred             ceeeeeeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeeCCC
Q 001867          757 NIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD-----CVPSIVHRDV  827 (1002)
Q Consensus       757 niv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~iiHrDl  827 (1002)
                      ||..++++-..+.    .+++|++|+|.|+|.|||.+   ..++.+..++++..+|.||+|||..     +.|.|+||||
T Consensus       266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl  342 (513)
T KOG2052|consen  266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL  342 (513)
T ss_pred             hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence            9999998876443    57999999999999999974   6799999999999999999999975     6789999999


Q ss_pred             CCCcEEECCCCCeEEccccCcccccCCCCCc--ccccccccccccCccccccCCC------CCccchhhHHHHHHHHHhC
Q 001867          828 KSNNILLDGDFGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTLRV------NEKSDIYSFGVVILELVTG  899 (1002)
Q Consensus       828 k~~NIll~~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwslGvil~ell~g  899 (1002)
                      |+.||||..++++.|+|+|+|..+.......  .....+||.+|||||++...-.      -..+||||||.++||++..
T Consensus       343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999998887653322  2357789999999999875431      2469999999999999863


Q ss_pred             ----------CCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          900 ----------RLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       900 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                                +.||++-.+.+.-.+.+.+..-...++..++.++.  ..+....+.++|..||..+|..|-|+-.+.+.|
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~--s~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK--SDPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc--cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence                      45776654444444444444334444444444433  345677899999999999999999999999999


Q ss_pred             HHhhh
Q 001867          970 QEVGA  974 (1002)
Q Consensus       970 ~~~~~  974 (1002)
                      .++..
T Consensus       501 ~~l~~  505 (513)
T KOG2052|consen  501 AKLSN  505 (513)
T ss_pred             HHHhc
Confidence            99863

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=347.50  Aligned_cols=248  Identities=27%  Similarity=0.359  Sum_probs=207.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|.+.+.||+|+||.||||+. .+.+.||+|.+.+.               ...+.+...+.+|++|+++++|||||.+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~---------------gr~~k~l~~l~~ev~i~r~lkHpniv~m   66 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS---------------GRNEKELKNLRQEVRILRSLKHPNIVEM   66 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhc---------------CCchHHHHHHHHHHHHHHhcCCcchhhH
Confidence            4677778999999999999995 45789999998542               2234556779999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++|+...++++|+||+.| +|.+++.  .++.++++.+..+++|++.||.|||+.   +|.|||+||+||+++..|.+|
T Consensus        67 ~esfEt~~~~~vVte~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~K  140 (808)
T KOG0597|consen   67 LESFETSAHLWVVTEYAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLK  140 (808)
T ss_pred             HHhhcccceEEEEehhhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCcee
Confidence            9999999999999999965 9999998  456799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +||||+|+.+...  ....+...|||-|||||...++.|+..+|+||+||++||+++|+.||...    .+...++....
T Consensus       141 lcdFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~  214 (808)
T KOG0597|consen  141 LCDFGLARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKSILK  214 (808)
T ss_pred             echhhhhhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhc
Confidence            9999999987653  22345667999999999999999999999999999999999999999632    33333333332


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +..       ++   +.+....+..++...+.+||..|.+..+++.
T Consensus       215 d~v-------~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 DPV-------KP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCC-------CC---cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            211       11   1133345778888999999999999999874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-41  Score=359.51  Aligned_cols=367  Identities=23%  Similarity=0.206  Sum_probs=238.4

Q ss_pred             CCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeec
Q 001867           94 NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV  173 (1002)
Q Consensus        94 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  173 (1002)
                      ..+.||+++|+++.+-+..|.++++|+.++|..|.++ .+|.......+|+.|+|.+|.|+..-.+.+..++.|+.|||+
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4456777777777666666677777777777777776 555544455557777777777666656666666667777777


Q ss_pred             cccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccc
Q 001867          174 YNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGA  253 (1002)
Q Consensus       174 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  253 (1002)
                      .|.|+.+.-..|..-.++++|+|++|+|. ..-...|.++.+|..|.|++|+|+...+..|.++++|+.|+|..|+|.-.
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv  236 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV  236 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence            77666554455555556666666666652 22234455555666666666666644445555566666666666665533


Q ss_pred             cCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCc
Q 001867          254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSP  333 (1002)
Q Consensus       254 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~  333 (1002)
                      --..|.++++|+.|.|..|.+...-..+|..+.+++.|+|+.|+++                       ..-..++.+++
T Consensus       237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~-----------------------~vn~g~lfgLt  293 (873)
T KOG4194|consen  237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ-----------------------AVNEGWLFGLT  293 (873)
T ss_pred             hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh-----------------------hhhcccccccc
Confidence            3445555555555555555555444455555555555555555554                       34445556666


Q ss_pred             ccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEcc
Q 001867          334 GLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLG  413 (1002)
Q Consensus       334 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~  413 (1002)
                      .|+.|+|++|.|..+.++.+....+|++||||+|+|+...+.+|..+..|++|+|++|.++..-..+|..+++|++|||+
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr  373 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR  373 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence            77777777777777777777777778888888888877777777777777777777777776666777777788888888


Q ss_pred             CccccCCCCC---cCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccc
Q 001867          414 YNRLTGKVPP---LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSE  486 (1002)
Q Consensus       414 ~N~l~~~~p~---~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  486 (1002)
                      +|.|+..+-+   .|.++++|+.|+|.+|+|..+...+|.++.+|+.|||.+|.+...-|+.|..+ .|+.|.++.
T Consensus       374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            8877754433   46667777777777777777777777777777777777777766666666666 666665544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=355.06  Aligned_cols=245  Identities=25%  Similarity=0.389  Sum_probs=201.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      .++|.+.++||+|.||+|++|..+ +++.+|||.++++              .+....+.+..+.|..|+.... ||+++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~--------------~Il~~d~Ve~~~~EkrI~~la~~HPFL~  432 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKG--------------DILQRDEVESLMCEKRIFELANRHPFLV  432 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecc--------------ceeccccHHHHHHHHHHHHHhccCCeEe
Confidence            467889999999999999999964 5889999999654              3445556777888888888775 99999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      +++++|++.+++|+||||+.||++..+.   +.+.+++..+.-|+..++.||.|||++   +|||||||.+|||+|.+|.
T Consensus       433 ~L~~~fQT~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  433 NLFSCFQTKEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             ecccccccCCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCc
Confidence            9999999999999999999999944433   457799999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++..-..  ...++..+||+.|||||++.+..|+.++|+|||||++|||+.|+.||.++.. ++....+   
T Consensus       507 ~kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-ee~FdsI---  580 (694)
T KOG0694|consen  507 VKIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-EEVFDSI---  580 (694)
T ss_pred             EEecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHH---
Confidence            999999999854322  2245678999999999999999999999999999999999999999986643 3322221   


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      ..    ++...|.  ..    ..+.+.++.+.+..+|++|.-+
T Consensus       581 ~~----d~~~yP~--~l----s~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VN----DEVRYPR--FL----SKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hc----CCCCCCC--cc----cHHHHHHHHHHhccCcccccCC
Confidence            11    1111111  11    2346788889999999999866

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=336.42  Aligned_cols=272  Identities=25%  Similarity=0.285  Sum_probs=208.2

Q ss_pred             HHHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          678 EYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       678 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      .....++|++.+.||+|.||.|-+|+. .+++.||+|++.+....... ++  ...........+...+||.||++++||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~-~~--~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQY-GF--PRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhc-cc--ccccccccCcHHHHHHHHHHHHhcCCc
Confidence            345578899999999999999999995 56899999999665322100 00  001112233456899999999999999


Q ss_pred             ceeeeeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          757 NIVKLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       757 niv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      |||+++++..+.  +.+|+|+||+..|.+...-.  ....+++.++++|++++..||+|||.+   +||||||||+|+|+
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl  243 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL  243 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence            999999999864  67899999999888765432  222399999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCC---CcccccccccccccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          835 DGDFGARVADFGVAKVVDASGK---PKSMSVIAGSCGYIAPEYAYTLR----VNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      +++|++||+|||.+.....+..   .......+|||.|||||...++.    .+.+.||||+||++|.++.|+.||-+++
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            9999999999999987643321   12234568999999999877632    3578999999999999999999997665


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      ..+.+.+++....        .-|    ..++....+.+++.+++++||+.|.+..+|....
T Consensus       324 ~~~l~~KIvn~pL--------~fP----~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  324 ELELFDKIVNDPL--------EFP----ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHHHHHHhcCcc--------cCC----CcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            4444333322111        111    1123445688999999999999999999887543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=331.58  Aligned_cols=253  Identities=23%  Similarity=0.264  Sum_probs=212.6

Q ss_pred             CCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|.-|+||+|+..+ +..+|+|++.+.              ....+....+.+.|.+||+.++||+++.+|+
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~--------------~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa  144 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKE--------------SLASRKKLKRAQTEREILSLLDHPFLPTLYA  144 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHH--------------HHhhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence            4445789999999999999764 589999998543              3334566778899999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      .|+.++..|+|||||+||+|....+.+.++.+++..++.++.+++.||+|||-.   |||+|||||+||||.++|++.|+
T Consensus       145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLs  221 (459)
T KOG0610|consen  145 SFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLS  221 (459)
T ss_pred             eeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEee
Confidence            999999999999999999999999998999999999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCC---------------------------------CC---------------------cccccccccccc
Q 001867          844 DFGVAKVVDASG---------------------------------KP---------------------KSMSVIAGSCGY  869 (1002)
Q Consensus       844 DfGl~~~~~~~~---------------------------------~~---------------------~~~~~~~gt~~y  869 (1002)
                      ||.++..+....                                 ..                     ......+||-.|
T Consensus       222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY  301 (459)
T KOG0610|consen  222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY  301 (459)
T ss_pred             eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence            999986553200                                 00                     001234699999


Q ss_pred             cCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHH
Q 001867          870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGL  949 (1002)
Q Consensus       870 ~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  949 (1002)
                      .|||++.+...+.++|+|+|||++|||+.|..||.+....+.+...+.+...-           ...+ +....+.++|+
T Consensus       302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F-----------p~~~-~vs~~akDLIr  369 (459)
T KOG0610|consen  302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF-----------PEEP-EVSSAAKDLIR  369 (459)
T ss_pred             ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC-----------CCCC-cchhHHHHHHH
Confidence            99999999999999999999999999999999999988878777766433221           1111 22345789999


Q ss_pred             HcCCCCCCCCCC----HHHHH
Q 001867          950 LCTSPLPINRPA----MRRVV  966 (1002)
Q Consensus       950 ~cl~~dP~~Rps----~~evl  966 (1002)
                      +.+.+||.+|..    ++||-
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHhccChhhhhccccchHHhh
Confidence            999999999988    77765

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=343.66  Aligned_cols=248  Identities=28%  Similarity=0.399  Sum_probs=206.1

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..+.||+|+||.||+|.+ +.++.||+|++.-.                ......+++++|+.++..++++||.++|
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----------------~~~deIediqqei~~Ls~~~~~~it~yy   77 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----------------EAEDEIEDIQQEISVLSQCDSPNITEYY   77 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechh----------------hcchhhHHHHHHHHHHHhcCcchHHhhh
Confidence            455568999999999999995 56889999998432                2334567899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +.+..+..++++|||+.||++.+.++  .+..+++..+.-+++++..|+.|||++   +.+|||||+.||++..+|.+|+
T Consensus        78 gsyl~g~~LwiiMey~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl  152 (467)
T KOG0201|consen   78 GSYLKGTKLWIIMEYCGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKL  152 (467)
T ss_pred             hheeecccHHHHHHHhcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEE
Confidence            99999999999999999999999998  445568999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||.+..+......+  ...+||+.|||||++.+..|+.|+||||||++++||++|..|+.......-          .
T Consensus       153 ~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------l  220 (467)
T KOG0201|consen  153 ADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------L  220 (467)
T ss_pred             Eecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------E
Confidence            9999998877654433  467899999999999999999999999999999999999999864422110          0


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      -.+.....|.+.+.+..   .+.+++..|++.||+.||++.++++
T Consensus       221 flIpk~~PP~L~~~~S~---~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  221 FLIPKSAPPRLDGDFSP---PFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             EeccCCCCCccccccCH---HHHHHHHHHhhcCcccCcCHHHHhh
Confidence            01112223334333322   3778888999999999999999985

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=342.37  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=220.7

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      ...+.++||+|.||.|..+....+..||||+++..                .....+.+|.+|+++|.+++|||||+++|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~----------------a~~~~r~~F~kEIkiLsqLkhPNIveLvG  602 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD----------------ATKNARNDFLKEIKILSRLKHPNIVELLG  602 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcc----------------cchhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence            45677899999999999999887899999998543                23455788999999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      +|..++.+++|+|||++|+|.+|+..+...........+|+.||+.|++||.+-   ++|||||.++|+|++.++++||+
T Consensus       603 VC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKia  679 (807)
T KOG1094|consen  603 VCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIA  679 (807)
T ss_pred             eeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEec
Confidence            999999999999999999999999876555556677888999999999999998   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCchhHHHHHHHHhh
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT--GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~--g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |||+++.+-.+++++.....+-..+|||||.+.-+++++++|||+||+++||+++  ...||... ..++..+-......
T Consensus       680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-t~e~vven~~~~~~  758 (807)
T KOG1094|consen  680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-TDEQVVENAGEFFR  758 (807)
T ss_pred             CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh-hHHHHHHhhhhhcC
Confidence            9999998877777666555566789999999999999999999999999999887  67788644 33444444333333


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .... .++-+....++    .++++++.+||+.+-++||+++++...|++.
T Consensus       759 ~~~~-~~~l~~P~~cp----~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  759 DQGR-QVVLSRPPACP----QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCc-ceeccCCCcCc----HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            3332 23333334444    3588999999999999999999999999874

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.9e-38  Score=355.73  Aligned_cols=259  Identities=24%  Similarity=0.403  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.+.||+|+||.||+|.+      .++..||||++....                .....+.+.+|+.+++.+ +|
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~~Ei~il~~l~~H   98 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----------------HLTEREALMSELKVLSYLGNH   98 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----------------CcHHHHHHHHHHHHHHHhcCC
Confidence            4688899999999999999974      235689999884321                122346788999999999 79


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------------------------------------
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------------------------------------  791 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------  791 (1002)
                      |||+++++++...+..++||||+++|+|.++++..+                                            
T Consensus        99 pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  178 (375)
T cd05104          99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYV  178 (375)
T ss_pred             cceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccc
Confidence            999999999999999999999999999999986432                                            


Q ss_pred             -----------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          792 -----------------------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       792 -----------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                                                   ...+++..+.+++.||+.||+|||++   +|+||||||+||+++.++.+||
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl  255 (375)
T cd05104         179 VPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKI  255 (375)
T ss_pred             cccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEE
Confidence                                         12578899999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..........+.+.....
T Consensus       256 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~  335 (375)
T cd05104         256 CDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR  335 (375)
T ss_pred             ecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc
Confidence            99999987654332222222335668999999999999999999999999999998 88888654433343333322211


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ..      .+  ...    ..++.+++.+||+.||++||+++||++.|++.
T Consensus       336 ~~------~~--~~~----~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 ML------SP--ECA----PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CC------CC--CCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            00      01  111    23578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-37  Score=340.31  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=199.4

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      ...||+|++|.||+|.. +|+.||||++....              .......+.+.+|+.++++++||||+++++++.+
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFH--------------KGHKVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccc--------------cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            36799999999999998 58999999984321              1122335678899999999999999999999976


Q ss_pred             ----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          768 ----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       768 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                          ....++||||+++|+|.+++..  .+.+++....+++.|++.|++|||+..  +++||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEc
Confidence                3467999999999999999984  456899999999999999999999731  78899999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |||+++......     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||..... .+....+..   
T Consensus       166 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~~~~~~i~~---  236 (283)
T PHA02988        166 CHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLIIN---  236 (283)
T ss_pred             ccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHh---
Confidence            999998654322     13458899999999876  6789999999999999999999999975432 222222111   


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .. ....++   ...    ...+.+++.+||+.||++|||++|+++.|++..
T Consensus       237 ~~-~~~~~~---~~~----~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        237 KN-NSLKLP---LDC----PLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             cC-CCCCCC---CcC----cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11 111011   112    234788999999999999999999999999874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.8e-37  Score=343.41  Aligned_cols=263  Identities=23%  Similarity=0.353  Sum_probs=203.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-----------------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHH
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-----------------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA  745 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (1002)
                      ++|.+.++||+|+||.||+|.+++                 +..||+|.+....                ......++.+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~   68 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----------------NKNARNDFLK   68 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----------------CHHHHHHHHH
Confidence            467788999999999999998532                 2369999874321                2334567999


Q ss_pred             HHHHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC-----------------CCCCCHHHHHHHHHHHH
Q 001867          746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----------------GGLLDWPTRYKIIVDAA  808 (1002)
Q Consensus       746 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~  808 (1002)
                      |+.++.+++||||+++++++.+.+..++||||+++|+|.+++....                 ...+++..+.+++.|++
T Consensus        69 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~  148 (304)
T cd05096          69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIA  148 (304)
T ss_pred             HHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999999986422                 13478889999999999


Q ss_pred             HHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhh
Q 001867          809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYS  888 (1002)
Q Consensus       809 ~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  888 (1002)
                      .||+|||+.   +|+||||||+||+++.++.+||+|||+++...............++..|||||++.++.++.++||||
T Consensus       149 ~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  225 (304)
T cd05096         149 SGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA  225 (304)
T ss_pred             HHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHH
Confidence            999999999   99999999999999999999999999998765443322223345678999999998889999999999


Q ss_pred             HHHHHHHHHh--CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          889 FGVVILELVT--GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       889 lGvil~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ||+++|||++  +..||... ...+....+......... .........++    ..+.+++.+||+.||++|||+++|.
T Consensus       226 lG~~l~el~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         226 FGVTLWEILMLCKEQPYGEL-TDEQVIENAGEFFRDQGR-QVYLFRPPPCP----QGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             HHHHHHHHHHccCCCCCCcC-CHHHHHHHHHHHhhhccc-cccccCCCCCC----HHHHHHHHHHccCCchhCcCHHHHH
Confidence            9999999987  55677543 223333332222211111 11111111222    3478999999999999999999999


Q ss_pred             HHHH
Q 001867          967 KLLQ  970 (1002)
Q Consensus       967 ~~L~  970 (1002)
                      +.|+
T Consensus       300 ~~l~  303 (304)
T cd05096         300 AFLT  303 (304)
T ss_pred             HHHh
Confidence            8886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.8e-38  Score=342.16  Aligned_cols=253  Identities=22%  Similarity=0.266  Sum_probs=201.4

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|+||.||+|.. .+++.||+|++.+..              .........+.+|+.++++++|++|+++++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~~~~iv~~~~   67 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--------------IKKRKGEAMALNEKRILEKVNSRFVVSLAY   67 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh--------------hhhhhhHHHHHHHHHHHHhcCCCcEEEEEE
Confidence            56778999999999999995 578999999984321              112233456788999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++.+.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        68 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~  144 (285)
T cd05631          68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS  144 (285)
T ss_pred             EEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999888765556799999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||++........   .....||..|+|||++.+..++.++||||+||++|||++|+.||............ .......
T Consensus       145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-~~~~~~~  220 (285)
T cd05631         145 DLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-DRRVKED  220 (285)
T ss_pred             eCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-HHHhhcc
Confidence            9999987543221   22446899999999999999999999999999999999999999765332211111 1111110


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                      ..     +.....    ...+.+++.+||+.||++||+     ++++++
T Consensus       221 ~~-----~~~~~~----s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QE-----EYSEKF----SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cc-----cCCccC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            00     000111    234778999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=7.5e-38  Score=354.99  Aligned_cols=260  Identities=25%  Similarity=0.367  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.+.||+|+||.||+|...      ++..||+|++....                .....+.+.+|+.+++.+ +|
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~il~~l~~h  101 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----------------HTDEREALMSELKILSHLGQH  101 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----------------CHHHHHHHHHHHHHHHhhccC
Confidence            56888999999999999998842      23579999884321                122356788999999999 79


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------------------------------------
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------------------------------------  791 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------  791 (1002)
                      ||||++++++...+..++||||+++|+|.++++...                                            
T Consensus       102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (374)
T cd05106         102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY  181 (374)
T ss_pred             CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence            999999999999999999999999999999986421                                            


Q ss_pred             ------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          792 ------------------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       792 ------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                                              ...+++.++++++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGl  258 (374)
T cd05106         182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGL  258 (374)
T ss_pred             cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeecee
Confidence                                    12478899999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      ++...............+++.|||||++.+..++.++|||||||++|||++ |+.||.................     .
T Consensus       259 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-----~  333 (374)
T cd05106         259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-----Q  333 (374)
T ss_pred             eeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-----C
Confidence            986544322111222335678999999999999999999999999999997 9999975433332222221111     0


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                          +......   ..++.+++.+||+.||++|||+.++++.|+++.
T Consensus       334 ----~~~~~~~---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 ----MSRPDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ----ccCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                0011111   134788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=328.27  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=208.2

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|.||.|-+|.. +.|+.||||.+.++              .+.++.....+.+|++||+.++||||+.+|
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd--------------kIkdeqDlvhIRREIeIMSsLNHPhII~Iy  119 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD--------------KIKDEQDLVHIRREIEIMSSLNHPHIIQIY  119 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh--------------hcccHHHHHHHHHHHHHHhhcCCCceeehh
Confidence            456667999999999999984 77999999988554              445677788899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      ++|...+...+||||..+|.|.+|+..  .+.+++.+++.+++||..|+.|+|.+   +++|||||.+|||+|.++++||
T Consensus       120 EVFENkdKIvivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKI  194 (668)
T KOG0611|consen  120 EVFENKDKIVIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKI  194 (668)
T ss_pred             hhhcCCceEEEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeee
Confidence            999999999999999999999999985  45699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||++-.+....   ..+..+|++-|.+||++.+..|. +.+|.||+||++|.++.|..||++.    +....+++. .
T Consensus       195 ADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~----Dhk~lvrQI-s  266 (668)
T KOG0611|consen  195 ADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR----DHKRLVRQI-S  266 (668)
T ss_pred             eccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc----hHHHHHHHh-h
Confidence            9999998765543   34567999999999999998874 7899999999999999999999753    233333222 2


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .+.+.+   |.-   +    .....+|++|+.++|++|.|+.+|...
T Consensus       267 ~GaYrE---P~~---P----SdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  267 RGAYRE---PET---P----SDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             cccccC---CCC---C----chHHHHHHHHHhcCcccchhHHHHhhh
Confidence            222222   211   1    124568889999999999999998743

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-38  Score=343.14  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=213.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      ++.|+.++++|+|+||.++.++. .++..|++|++.-..               .....+....+|+.++++++|||||.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~---------------~t~~~r~~A~~E~~lis~~~hP~iv~   67 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK---------------LTEPERRSAIQEMDLLSKLLHPNIVE   67 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccc---------------cCchhhHHHHHHHHHHHhccCCCeee
Confidence            35678889999999999999885 467899999984321               22334557899999999999999999


Q ss_pred             eeeEEecCCe-eeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          761 LWCCCTTRDC-KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       761 l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      +.+.|..++. .+|||+|++||++.+.+...++..++++++.+|+.|++.|+.|||++   +|+|||||+.||+++.++.
T Consensus        68 y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~  144 (426)
T KOG0589|consen   68 YKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKK  144 (426)
T ss_pred             eccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCc
Confidence            9999999888 99999999999999999998888999999999999999999999998   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      |||+|||+|+.......  .....+||+.||.||++.+..|..|+||||+||++|||++-+.+|.......-..+.... 
T Consensus       145 VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-  221 (426)
T KOG0589|consen  145 VKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-  221 (426)
T ss_pred             eeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-
Confidence            99999999999877642  334568999999999999999999999999999999999999999765433333332221 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                              ..+|.... +.   .++..++..|++.+|+.||++.+++..
T Consensus       222 --------~~~Plp~~-ys---~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 --------LYSPLPSM-YS---SELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --------cCCCCCcc-cc---HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                    12222222 22   247788889999999999999999865

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=326.43  Aligned_cols=274  Identities=23%  Similarity=0.294  Sum_probs=210.7

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++...|...+.||+|+||.|+.|.. .+|+.||+|++.+               .+......++..+|+.++++++|+|
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~---------------~F~~~~~akRtlRElklLr~~~HeN   82 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN---------------PFENQIDAKRTLRELKLLRHLRHEN   82 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh---------------hhhchHHHHHHHHHHHHHHHhcCCC
Confidence            44555666678999999999999996 5689999999843               3456677888999999999999999


Q ss_pred             eeeeeeEEec-----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          758 IVKLWCCCTT-----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       758 iv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      |+.+.+.+..     -..+|+|+|+| +.+|.+.++.  ++.++...+..+++|+++||+|+|+.   +|+|||+||+|+
T Consensus        83 Ii~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNl  156 (359)
T KOG0660|consen   83 IIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNL  156 (359)
T ss_pred             cceEEeecccccccccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhhe
Confidence            9999999975     35789999999 6799999984  45599999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      +++.+...||+|||+|+..........++..+.|.+|+|||++. ...|+.+.||||.|||+.||++|+.-|.+.....+
T Consensus       157 l~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q  236 (359)
T KOG0660|consen  157 LLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ  236 (359)
T ss_pred             eeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH
Confidence            99999999999999999887654444567788999999999765 56799999999999999999999988865433222


Q ss_pred             HHHHHHHH--------------hhc---cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHHh
Q 001867          912 LVKWVCST--------------LDQ---KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL--LQEV  972 (1002)
Q Consensus       912 ~~~~~~~~--------------~~~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~  972 (1002)
                      +.....-.              ...   ..............++.......+++.+|+..||.+|+|++|+++.  ++..
T Consensus       237 l~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  237 LQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            11111000              000   0000000000011111222346788889999999999999999863  4444


Q ss_pred             h
Q 001867          973 G  973 (1002)
Q Consensus       973 ~  973 (1002)
                      .
T Consensus       317 h  317 (359)
T KOG0660|consen  317 H  317 (359)
T ss_pred             c
Confidence            3

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=346.73  Aligned_cols=255  Identities=20%  Similarity=0.265  Sum_probs=203.7

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|+.. +++.||+|++.+..              .........+.+|++++..++||||++++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~   67 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL--------------LFKLNEVRHVLTERDILTTTKSEWLVKLL   67 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH--------------HhhhhHHHHHHHHHHHHHhCCCCCCccEE
Confidence            6888899999999999999975 58899999985421              11223456788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL  142 (333)
T cd05600          68 YAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKL  142 (333)
T ss_pred             EEEEcCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999974  45689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||++.....     ......||+.|+|||++.+..++.++||||+||++|||++|..||......+... .+......
T Consensus       143 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~  216 (333)
T cd05600         143 TDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYWKET  216 (333)
T ss_pred             EeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-HHHhcccc
Confidence            99999986543     1234568999999999999999999999999999999999999997543322221 11111100


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                        ..   .+...........++.+++.+|+..+|++||+++++++.
T Consensus       217 --~~---~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         217 --LQ---RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             --cc---CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence              00   011110001112347788999999999999999999964

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-38  Score=343.40  Aligned_cols=248  Identities=23%  Similarity=0.291  Sum_probs=200.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++...              ........+.+.+|+.++++++||||+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~   66 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP--------------EVIRLKQEQHVHNEKRVLKEVSHPFIIRL   66 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHH--------------HHhhhHHHHHHHHHHHHHHhCCCCcHhhh
Confidence            36788899999999999999965 6899999998432              11122345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~k  141 (291)
T cd05612          67 FWTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIK  141 (291)
T ss_pred             HhhhccCCeEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence            9999999999999999999999999974  45689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+++......     ....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.   .
T Consensus       142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i~---~  212 (291)
T cd05612         142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKIL---A  212 (291)
T ss_pred             EEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---h
Confidence            99999998664321     23468999999999999889999999999999999999999997543222 111111   1


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~~  968 (1002)
                       ...      ......   ...+.+++.+|++.||.+||+     ++|+++.
T Consensus       213 -~~~------~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         213 -GKL------EFPRHL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -CCc------CCCccC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             110      011111   124778999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=338.48  Aligned_cols=256  Identities=24%  Similarity=0.387  Sum_probs=217.9

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++....+||.|.||.||.|.|+. .-.||||.++.                  +....++|.+|+.+|+.++|||+|+++
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------------------DtMeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------------------DTMEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhh------------------cchhHHHHHHHHHHHHhhcCccHHHHh
Confidence            34456789999999999999864 66899999854                  566788999999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      |+|..+...|||+|||..|+|.+|++.+....++.-.++.|+.||+.|++||..+   ++|||||.++|.||.++..+|+
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence            9999999999999999999999999999988899999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++.+....+.... ...-.+.|.|||-+....++.|+|||+|||++|||.| |..|| +..+..+....++...+
T Consensus       407 ADFGLsRlMtgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqVY~LLEkgyR  484 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYGLLEKGYR  484 (1157)
T ss_pred             eccchhhhhcCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHhcccc
Confidence            999999988655443222 2234568999999999999999999999999999999 77776 34444455555544444


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ..        ...+|++    +++++|+.||+.+|.+||+++|+-+.++.|..
T Consensus       485 M~--------~PeGCPp----kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  485 MD--------GPEGCPP----KVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cc--------CCCCCCH----HHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            32        2234444    59999999999999999999999999998854

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-37  Score=347.45  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=201.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.+.              ........+.+.+|+.++++++||||++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~   82 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR--------------EILKMKQVQHVAQEKSILMELSHPFIVN   82 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--------------HHhhhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            356788899999999999999975 5889999998542              1112334567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  157 (329)
T PTZ00263         83 MMCSFQDENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHV  157 (329)
T ss_pred             EEEEEEcCCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCE
Confidence            99999999999999999999999999974  45689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+   .
T Consensus       158 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i---~  228 (329)
T PTZ00263        158 KVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKI---L  228 (329)
T ss_pred             EEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHH---h
Confidence            999999998764332     23468999999999999999999999999999999999999996543211 11111   1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                       .....      .+....   .++.+++.+||+.||++||+     ++++++
T Consensus       229 -~~~~~------~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        229 -AGRLK------FPNWFD---GRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -cCCcC------CCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             11110      111111   24678999999999999997     677763

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.5e-37  Score=332.29  Aligned_cols=255  Identities=26%  Similarity=0.458  Sum_probs=208.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.++||+|+||.||+|...++..||+|.+...                  ....+.+.+|+.++++++|+||++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~   67 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG------------------TMSVQAFLEEANLMKTLQHDKLVRLY   67 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC------------------chhHHHHHHHHHHHHhCCCCCeeeEE
Confidence            568888999999999999999888889999987321                  12356789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..+++|||+++++|.++++......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l  144 (261)
T cd05072          68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI  144 (261)
T ss_pred             EEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEE
Confidence            9999999999999999999999999876667789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||++......... ......++..|+|||+.....++.++|||||||++|+|++ |..||..... .+....+.....
T Consensus       145 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~~~~~  222 (261)
T cd05072         145 ADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-SDVMSALQRGYR  222 (261)
T ss_pred             CCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-HHHHHHHHcCCC
Confidence            999999876543221 1122345678999999988889999999999999999998 8999865422 222222211110


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                              .+.....+    .++.+++.+||+.+|++||+++++.+.|+++
T Consensus       223 --------~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 --------MPRMENCP----DELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --------CCCCCCCC----HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                    11112222    2478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-37  Score=335.47  Aligned_cols=251  Identities=33%  Similarity=0.528  Sum_probs=196.7

Q ss_pred             cCCeeeecCCccEEEEEEc-----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          687 EDNVIGSGSSGKVYKVVLS-----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       687 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ..+.||.|+||.||+|.+.     .+..|+||.+...                ......+.+.+|++.+++++||||+++
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~ni~~~   66 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----------------SSEEEEEEFLNEIQILRKLRHPNIVKL   66 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----------------SSHHHHHHHHHHHHHHHTHSBTTBE-E
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----------------cccccceeeeecccccccccccccccc
Confidence            3578999999999999976     2578999998331                123347889999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +|++...+..++||||+++|+|.++++......+++..+..|+.||+.||+|||++   +++||||+++||+++.++.+|
T Consensus        67 ~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~K  143 (259)
T PF07714_consen   67 YGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVK  143 (259)
T ss_dssp             EEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence            99999888899999999999999999986567899999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||++................+...|+|||.+.+..++.++||||||+++|||++ |+.||... ...++...+....
T Consensus       144 l~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~  222 (259)
T PF07714_consen  144 LSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQ  222 (259)
T ss_dssp             EESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccc
Confidence            999999987743333233334456779999999999989999999999999999999 67887544 3333333332211


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      ..        +....++    ..+.+++..||+.+|++||+++++++.|
T Consensus       223 ~~--------~~~~~~~----~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RL--------PIPDNCP----KDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ET--------TSBTTSB----HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cc--------eeccchh----HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11        1111122    2477899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=375.25  Aligned_cols=483  Identities=28%  Similarity=0.367  Sum_probs=378.1

Q ss_pred             EEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccc
Q 001867           74 IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF  153 (1002)
Q Consensus        74 l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l  153 (1002)
                      +|.+..+++ .+|..+-.-..++.|+++.|.+-...-+.+.+.-.|+.|||++|.++ ..|..+..+.+|+.|.++.|.|
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i   80 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI   80 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence            566666666 45554544455888888888775432334444556899999999888 6788888889999999999988


Q ss_pred             cCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccc
Q 001867          154 SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDS  233 (1002)
Q Consensus       154 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~  233 (1002)
                      . ..|.+..++.+|++|.|.+|++. ..|..+..+++|++|++|+|++  +.+|..+..++.++++..++|.....    
T Consensus        81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f--~~~Pl~i~~lt~~~~~~~s~N~~~~~----  152 (1081)
T KOG0618|consen   81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHF--GPIPLVIEVLTAEEELAASNNEKIQR----  152 (1081)
T ss_pred             h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhcc--CCCchhHHhhhHHHHHhhhcchhhhh----
Confidence            8 77888888999999999999888 7888899999999999999987  67888888888999999998832222    


Q ss_pred             cccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcce
Q 001867          234 LGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLES  313 (1002)
Q Consensus       234 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~  313 (1002)
                      ++... ++.++|..|.+.+.++..+..+..  .|+|.+|.+.   -..+.++.+|+.|..+.|++...   ......++.
T Consensus       153 lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l---~~~g~~l~~  223 (1081)
T KOG0618|consen  153 LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL---EISGPSLTA  223 (1081)
T ss_pred             hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE---EecCcchhe
Confidence            23222 788888888888888888777776  7899999887   23467888899999999988732   223445888


Q ss_pred             eecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeecccc
Q 001867          314 LNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSF  393 (1002)
Q Consensus       314 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  393 (1002)
                      |+.++|.+....+..  .-.+|+++++++|++++ +|++++.+.+|+.|+..+|+++ .+|..+....+|+.|...+|.+
T Consensus       224 L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel  299 (1081)
T KOG0618|consen  224 LYADHNPLTTLDVHP--VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL  299 (1081)
T ss_pred             eeeccCcceeecccc--ccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence            899999888433322  23578899999999985 4588999999999999999996 8888888899999999999998


Q ss_pred             ccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCc-ceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccc
Q 001867          394 TGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH-VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE  472 (1002)
Q Consensus       394 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  472 (1002)
                      . -+|.....++.|+.|+|..|+|....+..|..+.. |+.|+.+.|++.......=...+.|+.|++.+|.|+...-+.
T Consensus       300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~  378 (1081)
T KOG0618|consen  300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV  378 (1081)
T ss_pred             h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence            8 56777888999999999999998544444444443 788888888887655444445677888999999998877777


Q ss_pred             cccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCcccccccc
Q 001867          473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLN  552 (1002)
Q Consensus       473 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~  552 (1002)
                      +.+++.|++|+|++|++.......+.++..|+.|+||+|+|+ .+|+.+..++.|++|...+|++. .+| .+.++++|+
T Consensus       379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~  455 (1081)
T KOG0618|consen  379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK  455 (1081)
T ss_pred             hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence            888899999999999998444456788889999999999998 77889999999999999999988 777 888899999


Q ss_pred             EEeCcceeeec-ccCCcccccccceEEecccc
Q 001867          553 YLDLSNNRLSG-RIPVGLQNLKLNQLNVSNNR  583 (1002)
Q Consensus       553 ~L~Ls~N~l~~-~ip~~~~~l~L~~l~ls~N~  583 (1002)
                      .+|||.|+|+- .+|.....-+|++|||++|.
T Consensus       456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             EEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            99999999884 33444333478899999987

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.7e-37  Score=335.82  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=206.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|++.+.||+|+||.||+|....      ...||+|.+...                ........+.+|+.++++++||
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----------------~~~~~~~~~~~ei~~l~~l~h~   68 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----------------AEPKVQQEFRQEAELMSDLQHP   68 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----------------CCHHHHHHHHHHHHHHHhcCCc
Confidence            467888999999999999998643      257999987432                1223456789999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSI  822 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  822 (1002)
                      ||+++++++...+..+++|||+++|+|.+++.....              ..+++..+..++.|++.||+|||++   ++
T Consensus        69 ~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i  145 (283)
T cd05048          69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HF  145 (283)
T ss_pred             ccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            999999999999999999999999999999975321              4588999999999999999999999   99


Q ss_pred             eeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCC
Q 001867          823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRL  901 (1002)
Q Consensus       823 iHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~  901 (1002)
                      +||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..
T Consensus       146 ~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~  225 (283)
T cd05048         146 VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ  225 (283)
T ss_pred             eccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999986654433233334456789999999988899999999999999999998 999


Q ss_pred             CCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       902 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      ||..... .+....+...    ...    +.    +.....++.+++.+||+.||++||+++||++.|++
T Consensus       226 p~~~~~~-~~~~~~i~~~----~~~----~~----~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         226 PYYGFSN-QEVIEMIRSR----QLL----PC----PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCCCH-HHHHHHHHcC----CcC----CC----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            9865432 2333222211    111    11    11223458899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.5e-37  Score=348.88  Aligned_cols=260  Identities=24%  Similarity=0.347  Sum_probs=206.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-C
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-H  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  755 (1002)
                      ++|.+.+.||+|+||.||+|....      +..||||++...                ......+.+.+|+++++++. |
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----------------~~~~~~~~~~~Ei~~l~~l~~H  100 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----------------ARSSEKQALMSELKIMTHLGPH  100 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----------------CChHHHHHHHHHHHHHHhcCCC
Confidence            578889999999999999998521      346999988432                12234567999999999996 9


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------------------------------------
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------------------------------------  791 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------  791 (1002)
                      |||+++++++.+.+..|+||||+++|+|.+++....                                            
T Consensus       101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (400)
T cd05105         101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM  180 (400)
T ss_pred             CCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence            999999999999999999999999999999886532                                            


Q ss_pred             --------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 001867          792 --------------------------------------------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPS  821 (1002)
Q Consensus       792 --------------------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  821 (1002)
                                                                        ...+++..+..++.|++.||+|||+.   +
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~  257 (400)
T cd05105         181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---N  257 (400)
T ss_pred             ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                                                              12478889999999999999999999   9


Q ss_pred             eeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CC
Q 001867          822 IVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GR  900 (1002)
Q Consensus       822 iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~  900 (1002)
                      |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+
T Consensus       258 ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~  337 (400)
T cd05105         258 CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG  337 (400)
T ss_pred             eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence            99999999999999999999999999987654332222223456788999999999899999999999999999997 88


Q ss_pred             CCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          901 LPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       901 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .||............+.....        .+.....    ..++.+++.+||+.+|++||++.+|.+.|+++.
T Consensus       338 ~P~~~~~~~~~~~~~~~~~~~--------~~~~~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         338 TPYPGMIVDSTFYNKIKSGYR--------MAKPDHA----TQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             CCCcccchhHHHHHHHhcCCC--------CCCCccC----CHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            998654333333222221110        0111112    235889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.8e-37  Score=331.69  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=203.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.+...                ......+.+.+|+.++++++||||
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i   68 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----------------CSDKQRRGFLAEALTLGQFDHSNI   68 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----------------CCHHHHHHHHHHHHHHhcCCCCCc
Confidence            35778899999999999999853    3568999987432                122345678999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++...+..++||||+++|+|.+++... ...+++..++.++.|++.|++|||++   +++||||||+||+++.++
T Consensus        69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~  144 (266)
T cd05064          69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDL  144 (266)
T ss_pred             CeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCC
Confidence            99999999999999999999999999999753 35689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+|++|||.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||..... .+..+.+.
T Consensus       145 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~~~~  222 (266)
T cd05064         145 VCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVE  222 (266)
T ss_pred             cEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHH
Confidence            999999998765432211 11112345678999999999999999999999999999876 9999965432 22222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .    ...    .+.....    ...+.+++..||+.+|++||+++++.+.|+++
T Consensus       223 ~----~~~----~~~~~~~----~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 D----GFR----LPAPRNC----PNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             C----CCC----CCCCCCC----CHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            1    100    0111222    23478899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.6e-37  Score=330.48  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=202.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+...                  ....+++.+|+.++++++||||++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~   65 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG------------------AMSEEDFIEEAKVMMKLSHPKLVQLY   65 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC------------------CccHHHHHHHHHHHHHCCCCCceeEE
Confidence            457778899999999999999988889999987421                  12245688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..++||||+++|+|.++++... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        66 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl  141 (256)
T cd05114          66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKV  141 (256)
T ss_pred             EEEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEE
Confidence            99999999999999999999999987533 4689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+....+.... 
T Consensus       142 ~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~-  218 (256)
T cd05114         142 SDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGF-  218 (256)
T ss_pred             CCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCC-
Confidence            999999865433221 1122335668999999988889999999999999999999 8889865432 22222222111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                        .   ...+.  ..    ...+.+++.+||+++|++||+++++++.|
T Consensus       219 --~---~~~~~--~~----~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         219 --R---LYRPK--LA----SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --C---CCCCC--CC----CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              0   00111  11    23578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=307.48  Aligned_cols=263  Identities=22%  Similarity=0.288  Sum_probs=206.0

Q ss_pred             cCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|.+.+.||+|+|..||.++ ..+++.||+|++.-                 ......+...+|++..++++|||++++
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-----------------~~~~~~e~~~rEid~~rkf~s~~vl~l   83 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-----------------HSQEDIEEALREIDNHRKFNSPNVLRL   83 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeec-----------------cchHHHHHHHHHHHHHHhhCCcchHHH
Confidence            468888999999999999999 57789999999832                 234567889999999999999999999


Q ss_pred             eeEEecC-----CeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          762 WCCCTTR-----DCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       762 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++...+     ...|++++|+..|+|.+.++..+  +..+++.+++.|+.++++||++||+. .++++||||||.||++
T Consensus        84 ~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILl  162 (302)
T KOG2345|consen   84 VDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILL  162 (302)
T ss_pred             HHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEe
Confidence            9888544     34899999999999999987654  45799999999999999999999997 3469999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCC-------cccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCC
Q 001867          835 DGDFGARVADFGVAKVVDASGKP-------KSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVD  904 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~  904 (1002)
                      ++++.+++.|||.++...-.-..       +.......|..|+|||.+.   +...+.++|||||||++|+|+.|..||+
T Consensus       163 s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  163 SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            99999999999999755422111       1122345788999999765   4567899999999999999999999997


Q ss_pred             CCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          905 PEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .......-...+...      ..+.-|.- ..+++   .+.+++.+|+++||.+||++.+++..++...
T Consensus       243 ~~~~~GgSlaLAv~n------~q~s~P~~-~~yse---~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  243 RIYQQGGSLALAVQN------AQISIPNS-SRYSE---ALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             HHhhcCCeEEEeeec------cccccCCC-CCccH---HHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            543322211110000      00111111 11333   5778899999999999999999999987653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-37  Score=344.34  Aligned_cols=244  Identities=24%  Similarity=0.301  Sum_probs=196.6

Q ss_pred             CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          689 NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      +.||+|+||.||+|+. .+|+.||+|++.+..              .........+.+|+.++++++||||+++++++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~   66 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV--------------IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT   66 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc
Confidence            4799999999999986 468999999985421              1123345667889999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      .+..|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        67 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~  141 (323)
T cd05571          67 HDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            9999999999999999999874  45789999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccc
Q 001867          848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDH  927 (1002)
Q Consensus       848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1002)
                      ++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.    ....  
T Consensus       142 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~~~----~~~~--  212 (323)
T cd05571         142 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL----MEEI--  212 (323)
T ss_pred             CcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-HHHHHHHH----cCCC--
Confidence            87543221  122345799999999999999999999999999999999999999965422 22111111    1110  


Q ss_pred             cccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                          .....   ...++.+++.+|++.||++||     ++.++++
T Consensus       213 ----~~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 ----RFPRT---LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ----CCCCC---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                11111   122477899999999999999     7998874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.9e-38  Score=323.93  Aligned_cols=261  Identities=27%  Similarity=0.338  Sum_probs=200.5

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|...+++|.|+||.||+|.. .+++.||||+++.+.                     +--.+|+++|++++|||||++.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---------------------r~knrEl~im~~l~HpNIV~L~   83 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---------------------RYKNRELQIMRKLDHPNIVRLL   83 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC---------------------CcCcHHHHHHHhcCCcCeeeEE
Confidence            455678999999999999995 457999999986531                     1235799999999999999999


Q ss_pred             eEEecCC-----eeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          763 CCCTTRD-----CKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       763 ~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      .+|....     ...+||||||. +|.++++..  .+..++...++-+++||++||+|||+.   +|+||||||.|+|+|
T Consensus        84 ~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD  159 (364)
T KOG0658|consen   84 YFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVD  159 (364)
T ss_pred             EEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEc
Confidence            8886432     34689999974 999888742  246688888999999999999999998   999999999999999


Q ss_pred             CC-CCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          836 GD-FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       836 ~~-~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      .+ |.+||||||.|+.+..+....   ....|..|+|||.+.+. .|+.+.||||.||++.||+-|+.-|.++.+.+++.
T Consensus       160 ~~tg~LKicDFGSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~  236 (364)
T KOG0658|consen  160 PDTGVLKICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV  236 (364)
T ss_pred             CCCCeEEeccCCcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence            66 889999999999987765432   33567899999988765 69999999999999999999999998876666555


Q ss_pred             HHHHHHhhcc-------Cc--ccccccccc-----C-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHh
Q 001867          914 KWVCSTLDQK-------GV--DHVLDPKLD-----C-CFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEV  972 (1002)
Q Consensus       914 ~~~~~~~~~~-------~~--~~~~~~~~~-----~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~  972 (1002)
                      .++.......       ..  .+...|.+.     . .......+..+++.++++.+|.+|.++.|++.  .+.++
T Consensus       237 eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  237 EIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             HHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence            5544321100       00  011112111     1 12223346889999999999999999999984  44444

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-37  Score=313.82  Aligned_cols=265  Identities=24%  Similarity=0.219  Sum_probs=203.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +++|+..+.|++|+||.||+|++ ++++.||+|+++....+               ..-.-...+||.++.+.+|||||.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek---------------~GFPItsLREIniLl~~~H~NIV~  139 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK---------------EGFPITSLREINILLKARHPNIVE  139 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc---------------CCCcchhHHHHHHHHhcCCCCeee
Confidence            45677778999999999999996 56899999999543211               111223578999999999999999


Q ss_pred             eeeEEe--cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          761 LWCCCT--TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       761 l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +-.+..  +-+..|+||||++. +|...++..+ +++...++..++.|+++|++|||.+   .|+|||||++|+|++..|
T Consensus       140 vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G  214 (419)
T KOG0663|consen  140 VKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKG  214 (419)
T ss_pred             eEEEEeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCC
Confidence            988886  44679999999964 9999998765 6799999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||+|+.++...  ..++..+-|.+|+|||.+.+. .|++++||||+|||+.|+++++.-|.+....+++-+++.
T Consensus       215 ~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~  292 (419)
T KOG0663|consen  215 ILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK  292 (419)
T ss_pred             cEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence            99999999999887653  345567789999999988765 589999999999999999999988876655454444443


Q ss_pred             HHh--hccCcccc-ccc---------c----ccCCCHH--HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          918 STL--DQKGVDHV-LDP---------K----LDCCFKE--EICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       918 ~~~--~~~~~~~~-~~~---------~----~~~~~~~--~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      -..  .+...... .-|         .    ++..+..  ....-++++...+..||.+|.|++|.++.
T Consensus       293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            221  11100000 000         0    0000110  11234577788999999999999998853

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-37  Score=345.40  Aligned_cols=249  Identities=23%  Similarity=0.271  Sum_probs=200.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC--CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|..++  +..||+|++...              ........+.+.+|+.+++.++||||+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~hp~Iv   94 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--------------KIIKQKQVDHVFSERKILNYINHPFCV   94 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHH--------------HhhhhhhHHHHHHHHHHHHhCCCCCCc
Confidence            3568888999999999999998543  368999988432              111233456788999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+++..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        95 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~  169 (340)
T PTZ00426         95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGF  169 (340)
T ss_pred             ceEEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCC
Confidence            999999999999999999999999999974  45689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++.....     .....||+.|||||++.+..++.++||||+||++|||++|+.||....... ....+.  
T Consensus       170 ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~--  241 (340)
T PTZ00426        170 IKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKIL--  241 (340)
T ss_pred             EEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHh--
Confidence            999999999866432     124569999999999998889999999999999999999999997543221 111111  


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVKL  968 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~  968 (1002)
                        ....  .+.    ...   ...+.+++.+|++.||++|+     +++++++.
T Consensus       242 --~~~~--~~p----~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        242 --EGII--YFP----KFL---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --cCCC--CCC----CCC---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              1110  011    111   12467899999999999995     88888754

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.2e-37  Score=341.83  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.+.||+|+||.||+|...      +++.||+|++....                .......+.+|+.+++++ +|
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~E~~~~~~l~~h   70 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----------------TASEYKALMTELKILIHIGHH   70 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----------------CHHHHHHHHHHHHHHHhhccC
Confidence            45778899999999999999642      24789999874211                122345678899999999 79


Q ss_pred             CceeeeeeEEec-CCeeeEEEeccCCCChhhhhhhcCC------------------------------------------
Q 001867          756 KNIVKLWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKG------------------------------------------  792 (1002)
Q Consensus       756 ~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------  792 (1002)
                      +||+++++++.. +...+++|||+++++|.+++.....                                          
T Consensus        71 ~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (337)
T cd05054          71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIED  150 (337)
T ss_pred             cchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccC
Confidence            999999998865 4568899999999999999864321                                          


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCC
Q 001867          793 -----------------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG  855 (1002)
Q Consensus       793 -----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~  855 (1002)
                                       ..+++..+.+++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~  227 (337)
T cd05054         151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP  227 (337)
T ss_pred             cchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCc
Confidence                             2689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCcccccccccc
Q 001867          856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLD  934 (1002)
Q Consensus       856 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  934 (1002)
                      .........++..|+|||++.+..++.++||||+||++|||++ |..||......+.+.........     ... +  .
T Consensus       228 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~~~-~--~  299 (337)
T cd05054         228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-----MRA-P--E  299 (337)
T ss_pred             chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-----CCC-C--c
Confidence            3223334456778999999999999999999999999999998 99998654333333222211110     000 0  1


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          935 CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       935 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ..    ..++.+++.+||+.+|++||++.|+++.|+++.+
T Consensus       300 ~~----~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         300 YA----TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             cC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11    2357899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-37  Score=337.49  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=213.3

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCce
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNI  758 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni  758 (1002)
                      +.+.|++.+.||.|.||.||+++.+ +|+.+|+|++.+...              ......+.+.+|+.+|+++. ||||
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~--------------~~~~~~~~v~~Ev~il~~l~~hpni   98 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKL--------------RGKEDREDVRREVAILQQLSGHPNI   98 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhc--------------cccccHHHHHHHHHHHHhccCCCCE
Confidence            3457888899999999999999965 499999999965422              22235678999999999998 9999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC-
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD-  837 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~-  837 (1002)
                      |.++++|.+....++|||++.||.|.+.+...   .+++.++..++.|++.+++|||+.   +|+|||+||+|+++... 
T Consensus        99 v~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~  172 (382)
T KOG0032|consen   99 VQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD  172 (382)
T ss_pred             EEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence            99999999999999999999999999998864   399999999999999999999998   99999999999999533 


Q ss_pred             ---CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          838 ---FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       838 ---~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                         +.+|++|||++.....   .......+||+.|+|||++....|+.++||||+||++|.|++|..||..+.....+..
T Consensus       173 ~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~  249 (382)
T KOG0032|consen  173 EGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA  249 (382)
T ss_pred             CCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence               4799999999998766   3345677999999999999999999999999999999999999999988765555553


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......      ..-++.+....    ....+++..|+..||.+|+|+.++++
T Consensus       250 i~~~~~------~f~~~~w~~is----~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  250 ILRGDF------DFTSEPWDDIS----ESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHcCCC------CCCCCCccccC----HHHHHHHHHhcccCcccCCCHHHHhc
Confidence            332211      22223333333    34778899999999999999999998

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=335.37  Aligned_cols=256  Identities=26%  Similarity=0.372  Sum_probs=208.7

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC---Cc--EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN---GE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .....+.||+|-||.||+|...+   |+  .||||.-+.+.                +....+.|..|..+|++++||||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~----------------t~d~tekflqEa~iMrnfdHphI  453 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC----------------TPDDTEKFLQEASIMRNFDHPHI  453 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC----------------ChhhHHHHHHHHHHHHhCCCcch
Confidence            34556789999999999998632   33  48888765432                23347889999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      |+++|.|.+. ..++|||.++-|.|..|++.++ ..++...+..+++||+.||+|||+.   ++|||||..+||||....
T Consensus       454 ikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~  528 (974)
T KOG4257|consen  454 IKLIGVCVEQ-PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQ  528 (974)
T ss_pred             hheeeeeecc-ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcc
Confidence            9999999875 4799999999999999999754 5689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+|++|||+++.+....++... ...-.+.|||||-+.-.+++.++|||.|||++|||++ |..||.+-.+.+-+..   
T Consensus       529 CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~---  604 (974)
T KOG4257|consen  529 CVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH---  604 (974)
T ss_pred             eeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE---
Confidence            9999999999999887665544 3334568999999999999999999999999999999 9999975432221100   


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                        ++.+    -.-|..+.+++    .++.++.+||..+|.+||++.|+...|.++..
T Consensus       605 --iEnG----eRlP~P~nCPp----~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 --IENG----ERLPCPPNCPP----ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --ecCC----CCCCCCCCCCh----HHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence              0000    01123344444    48899999999999999999999999988765

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-37  Score=318.89  Aligned_cols=269  Identities=22%  Similarity=0.252  Sum_probs=207.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc-eee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN-IVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~  760 (1002)
                      ..|+..++||+|+||+||+|+. .+|+.||+|++.-...               ++.......+|+.++++++|+| ||+
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~---------------~EG~P~taiREisllk~L~~~~~iv~   75 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE---------------EEGVPSTAIREISLLKRLSHANHIVR   75 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc---------------ccCCCchhhHHHHHHHHhCCCcceEE
Confidence            3455567899999999999995 5689999999943211               1123445689999999999999 999


Q ss_pred             eeeEEecCC------eeeEEEeccCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          761 LWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCKG--GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       761 l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      +++++....      ..++||||+ ..+|.+|+.....  ..++...+..+++||+.||+|||++   +|+||||||.||
T Consensus        76 L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNl  151 (323)
T KOG0594|consen   76 LHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNL  151 (323)
T ss_pred             EEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceE
Confidence            999998877      789999999 5799999987653  3577789999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      +++++|.+||+|||+|+...-..  +..+..++|.+|+|||++.+. .|+...||||+|||+.||++++.-|.++.+.++
T Consensus       152 Li~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q  229 (323)
T KOG0594|consen  152 LISSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ  229 (323)
T ss_pred             EECCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH
Confidence            99999999999999999765432  235567899999999998876 799999999999999999999988887766666


Q ss_pred             HHHHHHHHhhc--cCccc---cccccc-------cCCCHH----HHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHHh
Q 001867          912 LVKWVCSTLDQ--KGVDH---VLDPKL-------DCCFKE----EICKVLNIGLLCTSPLPINRPAMRRVVKL--LQEV  972 (1002)
Q Consensus       912 ~~~~~~~~~~~--~~~~~---~~~~~~-------~~~~~~----~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~  972 (1002)
                      ....+......  .....   ..+-+.       ......    ......+++.+|++.+|.+|.|++.+++.  +.+.
T Consensus       230 l~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  230 LFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             HHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            55555433211  11111   111110       000001    01257788889999999999999988875  4444

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-37  Score=305.41  Aligned_cols=264  Identities=23%  Similarity=0.348  Sum_probs=210.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      ...|+..+.||.|..+.|.++.. ++|..+|+|++......         +.......-.+.-.+|+.|++++ .||+|+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~---------~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II   86 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATT---------ESGETPYEMREATRQEISILRQVMGHPYII   86 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccc---------cCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence            45677788999999999998774 56889999999543211         11112344556677899999998 599999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++.++|+.+...++|+|.|+.|.|.||+.  ....+++....+|++|+..|++|||.+   .|||||+||+|||++++.+
T Consensus        87 ~l~D~yes~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   87 DLQDVYESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMN  161 (411)
T ss_pred             EeeeeccCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccc
Confidence            99999999999999999999999999998  567899999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT------LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      +||+|||.++.+.++.+.+   ..+|||+|+|||.+.-      ..|+..+|+|++||++|.++.|..||.....    .
T Consensus       162 i~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----m  234 (411)
T KOG0599|consen  162 IKISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----M  234 (411)
T ss_pred             eEEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----H
Confidence            9999999999988776543   4589999999998763      3578899999999999999999999975311    1


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHh
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEV  972 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~  972 (1002)
                      - +...+.++.+ +.-.|.+.+.    .....+++.+|+++||.+|.|++|+++  ++.++
T Consensus       235 l-MLR~ImeGky-qF~speWadi----s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  235 L-MLRMIMEGKY-QFRSPEWADI----SATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             H-HHHHHHhccc-ccCCcchhhc----cccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            1 1112222222 2233333333    334789999999999999999999984  34444

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.1e-37  Score=335.28  Aligned_cols=263  Identities=20%  Similarity=0.245  Sum_probs=200.8

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|+.+ +++.||+|++....               ......+.+.+|+.++++++||||++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~   66 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE---------------ENEEVKETTLRELKMLRTLKQENIVELK   66 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc---------------ccccchhhHHHHHHHHHhCCCccccchh
Confidence            6888899999999999999975 57889999985421               1223356678899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++..++..|+||||++++.+..+..  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl  141 (287)
T cd07848          67 EAFRRRGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKL  141 (287)
T ss_pred             hhEecCCEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEE
Confidence            99999999999999998877765543  235689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH---
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST---  919 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~---  919 (1002)
                      +|||++........ .......|++.|+|||++.+..++.++||||+||++|||++|+.||......+.........   
T Consensus       142 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (287)
T cd07848         142 CDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL  220 (287)
T ss_pred             eeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            99999987643322 12234568999999999998889999999999999999999999997653322222111100   


Q ss_pred             --------hhccCccccccccccC-------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 --------LDQKGVDHVLDPKLDC-------CFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 --------~~~~~~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                              ...........+....       ........+.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    0000000000010000       00011235889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.8e-37  Score=335.19  Aligned_cols=262  Identities=22%  Similarity=0.264  Sum_probs=197.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEc--CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC---CCCce
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS--NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI---RHKNI  758 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~ni  758 (1002)
                      +|++.+.||+|+||.||+|+..  +++.||+|++.....               .......+.+|+.+++++   +||||
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~hpni   66 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------------EEGMPLSTIREVAVLRHLETFEHPNV   66 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC---------------CCCchHHHHHHHHHHHhhcccCCCCc
Confidence            6788899999999999999863  467899998843211               111233456677777665   69999


Q ss_pred             eeeeeEEe-----cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          759 VKLWCCCT-----TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       759 v~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      +++++++.     .....++||||++ ++|.+++.......+++..+..++.|++.||+|||++   +|+||||||+||+
T Consensus        67 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil  142 (290)
T cd07862          67 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNIL  142 (290)
T ss_pred             ceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEE
Confidence            99999985     3456899999995 6999999876666799999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      ++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.+.
T Consensus       143 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~  219 (290)
T cd07862         143 VTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  219 (290)
T ss_pred             EcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence            999999999999999866443   12234568999999999988899999999999999999999999998664444333


Q ss_pred             HHHHHHhhcc--Cc-------ccccccccc----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQK--GV-------DHVLDPKLD----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~--~~-------~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..+.......  ..       ...+.+...    ...++....+.+++.+|++.||++|||+.|+++
T Consensus       220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         220 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            3322110000  00       000111000    000111234678999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=308.31  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=201.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|++.+.||+|+|+.||++.. .+|+.+|+|++.....               .....+.+.+|+.|-+.++|||||++
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~---------------~~~~~e~l~rEarIC~~LqHP~IvrL   75 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---------------SARDFQKLEREARICRKLQHPNIVRL   75 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh---------------ccccHHHHHHHHHHHHhcCCCcEeeh
Confidence            4566677999999999999874 5789999998843211               22256789999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC---CC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DF  838 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~---~~  838 (1002)
                      .+.+...+..|+|+|+|+|++|..-+-.  ...+++..+-.+++||+++|.|+|.+   +|||||+||+|+++-.   ..
T Consensus        76 ~~ti~~~~~~ylvFe~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A  150 (355)
T KOG0033|consen   76 HDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGA  150 (355)
T ss_pred             hhhhcccceeEEEEecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCC
Confidence            9999999999999999999998654432  25688999999999999999999999   9999999999999953   33


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      -+|++|||+|..+..+.   .....+|||+|||||+++..+|+..+|||+.||++|-++.|..||.++....-+-.+...
T Consensus       151 ~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g  227 (355)
T KOG0033|consen  151 AVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG  227 (355)
T ss_pred             ceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence            58999999999887332   223568999999999999999999999999999999999999999876443333332221


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ..     + +..|.+....+    +..+++.+|+..||.+|.|+.|.+
T Consensus       228 ~y-----d-~~~~~w~~is~----~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  228 AY-----D-YPSPEWDTVTP----EAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             cc-----C-CCCcccCcCCH----HHHHHHHHHhccChhhhccHHHHh
Confidence            11     1 11123333333    366888999999999999999887

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-36  Score=339.35  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=196.6

Q ss_pred             CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          689 NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      +.||+|+||.||+|+. .+++.||+|++.+..              .........+.+|+.+++.++||||+++++++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   66 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV--------------IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT   66 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence            4699999999999996 468999999985421              1123345678899999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      .+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        67 ~~~~~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~  141 (328)
T cd05593          67 KDRLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGL  141 (328)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcC
Confidence            9999999999999999988874  45689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccc
Q 001867          848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDH  927 (1002)
Q Consensus       848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1002)
                      ++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+   .. ..   
T Consensus       142 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~~~---~~-~~---  211 (328)
T cd05593         142 CKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI---LM-ED---  211 (328)
T ss_pred             CccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-HHHHHHh---cc-CC---
Confidence            87543221  122345799999999999999999999999999999999999999965422 2111111   11 00   


Q ss_pred             cccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 001867          928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVKL  968 (1002)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~  968 (1002)
                         ...+...   ..++.+++.+|++.||++||     +++|+++.
T Consensus       212 ---~~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         212 ---IKFPRTL---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             ---ccCCCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence               0111111   22477889999999999997     89998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=327.22  Aligned_cols=254  Identities=29%  Similarity=0.455  Sum_probs=205.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|...+++.||+|.+...                  ....+++.+|+.++++++||||++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~   67 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG------------------TMDPKDFLAEAQIMKKLRHPKLIQLY   67 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC------------------cccHHHHHHHHHHHHHCCCCCcccee
Confidence            467888999999999999999877889999987432                  12245688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..+++|||+++++|.+++.......+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l  144 (261)
T cd05068          68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKV  144 (261)
T ss_pred             EEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEE
Confidence            9999999999999999999999999865556789999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++........ .......+..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+..   
T Consensus       145 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~---  219 (261)
T cd05068         145 ADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQ---  219 (261)
T ss_pred             CCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc---
Confidence            999999877533211 1112223457999999998899999999999999999999 9989865432 222221111   


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                       . ...   +.....    ...+.+++.+|++.+|++||+++++++.|++
T Consensus       220 -~-~~~---~~~~~~----~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         220 -G-YRM---PCPPGC----PKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -C-CCC---CCCCcC----CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             1 000   111111    2357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-36  Score=337.50  Aligned_cols=259  Identities=24%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+.+ ++..||+|.+....                .....+.+.+|++++++++||||+++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~   68 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----------------KPAIRNQIIRELQVLHECNSPYIVGF   68 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----------------CHHHHHHHHHHHHHHHHCCCCCCCeE
Confidence            57888899999999999999965 57889999874321                22345679999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..++||||+++|+|.+++..  ...+++..+..++.|++.||+|||+++  +|+||||||+||+++.++.+|
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~k  144 (331)
T cd06649          69 YGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIK  144 (331)
T ss_pred             EEEEEECCEEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEE
Confidence            9999999999999999999999999974  346899999999999999999999851  699999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++.......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .++...+.....
T Consensus       145 l~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~  219 (331)
T cd06649         145 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVV  219 (331)
T ss_pred             EccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhccccc
Confidence            99999997654322    2234689999999999999999999999999999999999999964322 222111111000


Q ss_pred             ccCc----------------------------------cccc---cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 001867          922 QKGV----------------------------------DHVL---DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR  964 (1002)
Q Consensus       922 ~~~~----------------------------------~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  964 (1002)
                      ....                                  ..+.   .+...  ......++.+++.+||+.||++|||++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~e  297 (331)
T cd06649         220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKM  297 (331)
T ss_pred             ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHH
Confidence            0000                                  0000   00000  0011235788999999999999999999


Q ss_pred             HHHH
Q 001867          965 VVKL  968 (1002)
Q Consensus       965 vl~~  968 (1002)
                      +++.
T Consensus       298 ll~h  301 (331)
T cd06649         298 LMNH  301 (331)
T ss_pred             HhcC
Confidence            9865

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=339.66  Aligned_cols=242  Identities=23%  Similarity=0.291  Sum_probs=193.3

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|+||.||+|... +++.||+|++.+.              ..........+.+|+.++++++||||+++++++...+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~--------------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   66 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA--------------HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE   66 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHH--------------HhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC
Confidence            699999999999975 5789999998432              1112334567889999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        67 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~  141 (312)
T cd05585          67 KLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK  141 (312)
T ss_pred             eEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccc
Confidence            99999999999999999974  45689999999999999999999999   99999999999999999999999999997


Q ss_pred             cccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccc
Q 001867          850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVL  929 (1002)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1002)
                      ......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......    ........ ..    
T Consensus       142 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~-~~----  210 (312)
T cd05585         142 LNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQE-PL----  210 (312)
T ss_pred             cCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcC-CC----
Confidence            543322  12234579999999999999999999999999999999999999997543221    11111111 10    


Q ss_pred             cccccCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH
Q 001867          930 DPKLDCCFKEEICKVLNIGLLCTSPLPINRPA---MRRVVK  967 (1002)
Q Consensus       930 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~evl~  967 (1002)
                        ......   ...+.+++.+||+.||++||+   +.|++.
T Consensus       211 --~~~~~~---~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 --RFPDGF---DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             --CCCCcC---CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence              011111   124778899999999999985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-36  Score=325.29  Aligned_cols=257  Identities=27%  Similarity=0.392  Sum_probs=206.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.++.    ...||||.+...                .......++.+|+.++++++||||
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i   67 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----------------SSDKQRLDFLTEASIMGQFDHPNI   67 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----------------CChHHHHHHHHHHHHHHhCCCCCc
Confidence            468888999999999999999742    457999987432                123345678899999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++...+..+++|||+++++|.+++.... ..+++..+.+++.|++.|++|||++   +|+||||||+||+++.++
T Consensus        68 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~  143 (266)
T cd05033          68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNL  143 (266)
T ss_pred             ceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence            999999999999999999999999999997633 4689999999999999999999998   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .++|+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.... .......+.
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~  222 (266)
T cd05033         144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVE  222 (266)
T ss_pred             CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHH
Confidence            999999999987753222222222345678999999998899999999999999999998 999986432 222222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ...   .     .+.....+    ..+.+++.+||+.+|++||+++|+++.|+++
T Consensus       223 ~~~---~-----~~~~~~~~----~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 DGY---R-----LPPPMDCP----SALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             cCC---C-----CCCCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111   0     01111222    3478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.8e-36  Score=326.40  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+|++.+.||+|+||.||+|.++ +++.||+|++...                  ....+.+.+|++++++++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~   67 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------TMEVEEFLKEAAVMKEIKHPNLVQL   67 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------------------chHHHHHHHHHHHHHhCCCCChhhe
Confidence            35777889999999999999964 5889999987321                  2234568899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..+++|||+++++|.+++.......+++..+..++.|++.||+|||++   +++||||||+||+++.++.+|
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~k  144 (263)
T cd05052          68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVK  144 (263)
T ss_pred             EEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEE
Confidence            99999999999999999999999999875666789999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+.........
T Consensus       145 l~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~~~~~~  222 (263)
T cd05052         145 VADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGY  222 (263)
T ss_pred             eCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHCCC
Confidence            99999998765432211 112234568999999998899999999999999999998 888886532 222222221111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                           ..   +.....+    ..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus       223 -----~~---~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 -----RM---ERPEGCP----PKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CC---CCCCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 00   1111222    3478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.5e-36  Score=335.31  Aligned_cols=243  Identities=28%  Similarity=0.394  Sum_probs=190.2

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      ++||+|+||.||+|... +++.||+|++.....              ......+.+..|..++... +||||+++++++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~   66 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--------------LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ   66 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------------hhhhhHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence            47999999999999964 578899999854211              1122344456677777654 7999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      .++..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          67 TKEHLFFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCc
Confidence            99999999999999999999874  34689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+   ....   
T Consensus       142 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i---~~~~---  212 (316)
T cd05592         142 MCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI---LNDR---  212 (316)
T ss_pred             CCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHH---HcCC---
Confidence            997653322  223345799999999999998999999999999999999999999975432 2221111   1110   


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR-RVV  966 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl  966 (1002)
                          +..+...   ..++.+++.+||+.||++||++. ++.
T Consensus       213 ----~~~~~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         213 ----PHFPRWI---SKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ----CCCCCCC---CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                1111111   12467888999999999999875 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.7e-37  Score=339.76  Aligned_cols=244  Identities=24%  Similarity=0.295  Sum_probs=195.6

Q ss_pred             CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          689 NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      +.||+|+||.||+|+. .+|+.||+|++....              .........+.+|+.++++++||||+++++++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~   66 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV--------------IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   66 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            4799999999999996 468999999985421              1123345667889999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      .+..|+||||+++|+|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        67 ~~~~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~  141 (323)
T cd05595          67 HDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHH
Confidence            9999999999999999988874  45689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccc
Q 001867          848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDH  927 (1002)
Q Consensus       848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1002)
                      +.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............    . .... 
T Consensus       142 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~----~-~~~~-  213 (323)
T cd05595         142 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----M-EEIR-  213 (323)
T ss_pred             hccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh----c-CCCC-
Confidence            87543221  12234569999999999999999999999999999999999999996543222111111    0 0000 


Q ss_pred             cccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                       +.   ....    .++.+++.+||+.||++||     ++.++++
T Consensus       214 -~p---~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         214 -FP---RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -CC---CCCC----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence             00   1112    2477889999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.2e-36  Score=335.05  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=204.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCc----EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .+|+..+.||+|+||.||+|++. +++    .||+|++...                ......+++..|+.+++.++|||
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~n   70 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------------TSPKANKEILDEAYVMASVDNPH   70 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence            46788899999999999999864 333    3899987421                12334567889999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++... ..++++||+++|+|.+++... ...+++..+++++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        71 iv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~  145 (316)
T cd05108          71 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTP  145 (316)
T ss_pred             CCeEEEEEcCC-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCC
Confidence            99999999865 567999999999999999853 34688999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+.....
T Consensus       146 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-~~~~~~~~  224 (316)
T cd05108         146 QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSIL  224 (316)
T ss_pred             CcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH
Confidence            9999999999987765433222223334678999999999999999999999999999998 999986532 22222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      ....   ..     +....+.    .++.+++.+||+.+|++||++.+++..+.++..+
T Consensus       225 ~~~~---~~-----~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         225 EKGE---RL-----PQPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             hCCC---CC-----CCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            1110   00     1111222    2477899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-36  Score=327.50  Aligned_cols=254  Identities=28%  Similarity=0.476  Sum_probs=207.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .+|++.++||+|+||.||+|..++++.+|+|.+...                 .......+..|+.+++.++||||++++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~   68 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-----------------DLLKQQDFQKEVQALKRLRHKHLISLF   68 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-----------------chhhHHHHHHHHHHHhcCCCcchhhee
Confidence            457778899999999999999888999999988432                 222355688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..++||||+++++|.++++......+++..+.+++.|++.|++|||++   +|+||||||+||+++.++.+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl  145 (261)
T cd05148          69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKV  145 (261)
T ss_pred             eeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEE
Confidence            9999999999999999999999999876667799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+........  ......++..|+|||...+..++.++||||||+++|+|++ |+.||..... .+..........
T Consensus       146 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~~~~  222 (261)
T cd05148         146 ADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYR  222 (261)
T ss_pred             ccccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHHhCCc
Confidence            99999987643321  1123345678999999988889999999999999999998 8999865432 222222221110


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      .        +.....+    ..+.+++.+||+.||++|||++++++.|+.
T Consensus       223 ~--------~~~~~~~----~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 M--------PCPAKCP----QEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             C--------CCCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            0        1111222    347789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-37  Score=349.37  Aligned_cols=256  Identities=25%  Similarity=0.326  Sum_probs=205.6

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCC-cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNG-EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKL  761 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l  761 (1002)
                      .+++.++|.+|||+.||.|.+..+ ..||+|++...                 ++.....+.+||++|++|+ |+|||.+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----------------de~~L~~v~~EI~~MK~L~gh~nIV~y  100 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----------------DEEALNAVKREIDIMKLLSGHKNIVSY  100 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----------------CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence            356678999999999999997665 99999998532                 6677888999999999997 9999999


Q ss_pred             eeE-Eec------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          762 WCC-CTT------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       762 ~~~-~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      ++. ...      ..++++.||||+||.|-+++..+....+++.++++|++|+++|+++||.. .++|||||||-+|||+
T Consensus       101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLl  179 (738)
T KOG1989|consen  101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLL  179 (738)
T ss_pred             eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEE
Confidence            993 321      24678999999999999999876667799999999999999999999985 5689999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCC-cc------cccccccccccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 001867          835 DGDFGARVADFGVAKVVDASGKP-KS------MSVIAGSCGYIAPEYA---YTLRVNEKSDIYSFGVVILELVTGRLPVD  904 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~-~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~ell~g~~p~~  904 (1002)
                      +.+|..||||||.|.-....... ..      .-....|+.|+|||++   .+..+++|+|||+|||++|-++....||+
T Consensus       180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe  259 (738)
T KOG1989|consen  180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE  259 (738)
T ss_pred             cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence            99999999999999754433211 11      1133578999999976   46779999999999999999999999997


Q ss_pred             CCCCchhHHHHHHHHhhccCcccccccccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          905 PEFGEKDLVKWVCSTLDQKGVDHVLDPKLD-CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ..-..                 .+++.... ..++.-...+.++|..|+++||++||++-+|++.+.++..
T Consensus       260 ~sg~l-----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  260 ESGKL-----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             cCcce-----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            54111                 11111110 0011223458889999999999999999999999988853

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-36  Score=333.84  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=198.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++....                .......+.+|+.++++++||||++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~niv~   67 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE----------------EEGTPFTAIREASLLKGLKHANIVL   67 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc----------------ccccchhHHHHHHHHhhCCCCCcCe
Confidence            467888999999999999999975 68899999984321                1112345778999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..++||||++ ++|.+++.. ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        68 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  142 (303)
T cd07869          68 LHDIIHTKETLTLVFEYVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGEL  142 (303)
T ss_pred             EEEEEecCCeEEEEEECCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence            9999999999999999994 788888765 335689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+++......  .......||+.|+|||++.+ ..++.++||||+||++|||++|..||....+..+....+...
T Consensus       143 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  220 (303)
T cd07869         143 KLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV  220 (303)
T ss_pred             EECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence            999999997543322  12234568899999998765 457889999999999999999999997654333322222111


Q ss_pred             hhccCcc---c-----cccc-cc----cCCCHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVD---H-----VLDP-KL----DCCFKE------EICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~---~-----~~~~-~~----~~~~~~------~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .......   .     ..++ ..    ......      ....+.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            1000000   0     0000 00    000000      0124678999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=331.45  Aligned_cols=254  Identities=23%  Similarity=0.267  Sum_probs=201.9

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..++||+|+||.||++.. .+++.||+|++....              .........+.+|+.++++++||||+++++
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   67 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--------------IKKRKGEAMALNEKQILEKVNSRFVVSLAY   67 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh--------------hhhhhhHHHHHHHHHHHHhcCCCCEeeeee
Confidence            67788999999999999996 468899999984321              112233456788999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++..++..++||||+++|+|.+++.......+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+
T Consensus        68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~  144 (285)
T cd05605          68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             eecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999988765556799999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||++........   .....|+..|+|||++.+..++.++||||+||++|||++|+.||......... +.+.......
T Consensus       145 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~  220 (285)
T cd05605         145 DLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVKED  220 (285)
T ss_pred             eCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhhhc
Confidence            9999987543221   22346899999999999888999999999999999999999999754332221 1111111111


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVKL  968 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~  968 (1002)
                      .         ...+......+.+++.+||+.||++||     +++++++.
T Consensus       221 ~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 Q---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             c---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            0         001111223477899999999999999     78888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-36  Score=353.31  Aligned_cols=251  Identities=23%  Similarity=0.248  Sum_probs=201.6

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-C-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-N-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..                 .+......+..|+.+++.++|||||++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-----------------~~~~~~~~~~~E~~~l~~l~Hpniv~~  130 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-----------------NDERQAAYARSELHCLAACDHFGIVKH  130 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-----------------CCHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence            4778899999999999999853 3 57888887622                 123345567889999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++..++..|+||||+++|+|.++++..  ...++++..+..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       131 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~  207 (478)
T PTZ00267        131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGI  207 (478)
T ss_pred             EEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCc
Confidence            99999999999999999999999988642  345689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++..............+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.....   
T Consensus       208 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~~~~---  283 (478)
T PTZ00267        208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQQV---  283 (478)
T ss_pred             EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH---
Confidence            999999999876544332233455799999999999999999999999999999999999999965422 2211111   


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .. ...    ++......    .++.+++.+||+.||++||+++++++
T Consensus       284 ~~-~~~----~~~~~~~s----~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LY-GKY----DPFPCPVS----SGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             Hh-CCC----CCCCccCC----HHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11 111    11111112    24788999999999999999999874

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-36  Score=332.23  Aligned_cols=263  Identities=22%  Similarity=0.287  Sum_probs=199.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....                .......+.+|+.++++++||||++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~niv~   67 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------------EEGAPCTAIREVSLLKNLKHANIVT   67 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc----------------cCCcchhHHHHHHHHHhCCCCCEee
Confidence            457888899999999999999864 68899999884321                1112345778999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..++||||++ |+|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        68 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~  142 (288)
T cd07871          68 LHDIIHTERCLTLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGEL  142 (288)
T ss_pred             EEEEEcCCCeEEEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCE
Confidence            9999999999999999996 5999988753 34689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+++.......  ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+.........
T Consensus       143 kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  220 (288)
T cd07871         143 KLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL  220 (288)
T ss_pred             EECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999976543221  2234468899999998765 568999999999999999999999997654333222211110


Q ss_pred             hh--c---------cCccccccccccCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LD--Q---------KGVDHVLDPKLDCCF-----KEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~--~---------~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..  .         ........+......     .....+..+++.+|++.||.+|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00  0         000001111110000     001134678999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.1e-36  Score=328.46  Aligned_cols=256  Identities=29%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|.+.+.||+|+||.||+|...+      ++.||+|++...                ......+.+.+|++++++++||
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~~~   68 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----------------ASNDARKDFEREAELLTNFQHE   68 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----------------CCHHHHHHHHHHHHHHHhcCCC
Confidence            456777899999999999998643      478999987432                1122457899999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      ||+++++++......++||||+++++|.++++...            ...+++..+..++.|++.|++|||++   +++|
T Consensus        69 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h  145 (280)
T cd05049          69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVH  145 (280)
T ss_pred             CchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceec
Confidence            99999999999999999999999999999997532            24588999999999999999999999   9999


Q ss_pred             CCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 001867          825 RDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPV  903 (1002)
Q Consensus       825 rDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~  903 (1002)
                      |||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||
T Consensus       146 ~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~  225 (280)
T cd05049         146 RDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW  225 (280)
T ss_pred             cccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999999999986543322222223346788999999999999999999999999999998 99998


Q ss_pred             CCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      ..... .+......    .....    ......    ...+.+++.+||+.||++||+++||++.|+
T Consensus       226 ~~~~~-~~~~~~~~----~~~~~----~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         226 YGLSN-EEVIECIT----QGRLL----QRPRTC----PSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCCCH-HHHHHHHH----cCCcC----CCCCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            65432 22222221    11111    111112    234789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.1e-36  Score=343.70  Aligned_cols=256  Identities=21%  Similarity=0.287  Sum_probs=197.8

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..+.||+|+||+||+|+. .+++.||+|++.+.              ........+.+.+|++++++++||||++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~--------------~~~~~~~~~~~~~E~~il~~l~h~~iv~l~   67 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK--------------DVLNRNQVAHVKAERDILAEADNEWVVKLY   67 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--------------HhhhhHHHHHHHHHHHHHHhcCCCCeeeeE
Confidence            477789999999999999986 45889999998432              112334456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++++||
T Consensus        68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL  142 (381)
T cd05626          68 YSFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKL  142 (381)
T ss_pred             EEEecCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEE
Confidence            999999999999999999999999974  45689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCC---------------------------------------------cccccccccccccCcccccc
Q 001867          843 ADFGVAKVVDASGKP---------------------------------------------KSMSVIAGSCGYIAPEYAYT  877 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~  877 (1002)
                      +|||+++........                                             ......+||+.|+|||++.+
T Consensus       143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  222 (381)
T cd05626         143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR  222 (381)
T ss_pred             eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence            999998643211000                                             00123469999999999998


Q ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHH--cCCCC
Q 001867          878 LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLL--CTSPL  955 (1002)
Q Consensus       878 ~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~d  955 (1002)
                      ..++.++||||+||++|||++|+.||..............    ...  ...-+......+    ++.+++.+  |+..+
T Consensus       223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~----~~~--~~~~~~~~~~s~----~~~dli~~ll~~~~~  292 (381)
T cd05626         223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN----WEN--TLHIPPQVKLSP----EAVDLITKLCCSAEE  292 (381)
T ss_pred             CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc----ccc--ccCCCCCCCCCH----HHHHHHHHHccCccc
Confidence            8899999999999999999999999976543222222110    000  000011111222    35556655  66777


Q ss_pred             CCCCCCHHHHHHH
Q 001867          956 PINRPAMRRVVKL  968 (1002)
Q Consensus       956 P~~Rps~~evl~~  968 (1002)
                      |..||+++|+++.
T Consensus       293 ~~~R~~~~~~l~h  305 (381)
T cd05626         293 RLGRNGADDIKAH  305 (381)
T ss_pred             ccCCCCHHHHhcC
Confidence            7789999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-36  Score=339.35  Aligned_cols=255  Identities=24%  Similarity=0.270  Sum_probs=199.0

Q ss_pred             CCCcCCeeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCce
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNI  758 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni  758 (1002)
                      +|++.+.||+|+||.||+|+.    .+++.||+|++.+...             .......+.+..|+.++++++ ||+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~~i   67 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-------------VQKAKTVEHTRTERNVLEHVRQSPFL   67 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-------------hhhhhHHHHHHHHHHHHHhccCCCCc
Confidence            477889999999999999885    3578999999854211             112234566888999999995 9999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++..++..++||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        68 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~  142 (332)
T cd05614          68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEG  142 (332)
T ss_pred             ccEEEEEecCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCC
Confidence            9999999999999999999999999999874  45689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||+++........ ......||+.|||||++.+. .++.++|||||||++|||++|+.||..............
T Consensus       143 ~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  221 (332)
T cd05614         143 HVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR  221 (332)
T ss_pred             CEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH
Confidence            9999999999865443222 22245799999999998765 478899999999999999999999975433222222211


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .....       ++......   ...+.+++.+|++.||++||     +++++++
T Consensus       222 ~~~~~-------~~~~~~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         222 RILKC-------DPPFPSFI---GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHhcC-------CCCCCCCC---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111       11111111   12467889999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4e-36  Score=330.34  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=206.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|.+.+.||+|+||.||+|+..      ++..+|+|.+...                 .....+.+.+|++++++++||
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~   67 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-----------------TLAARKDFQREAELLTNLQHE   67 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-----------------cHHHHHHHHHHHHHHhcCCCC
Confidence            35677789999999999999742      3456888887321                 223346789999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI  822 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  822 (1002)
                      ||+++++++...+..++||||+++++|.+++....              ...+++..+++++.|++.|++|||++   +|
T Consensus        68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  144 (291)
T cd05094          68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HF  144 (291)
T ss_pred             CcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            99999999999999999999999999999997532              23489999999999999999999999   99


Q ss_pred             eeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCC
Q 001867          823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRL  901 (1002)
Q Consensus       823 iHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~  901 (1002)
                      +||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus       145 ~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  224 (291)
T cd05094         145 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ  224 (291)
T ss_pred             eecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999986654433222334456788999999999999999999999999999999 999


Q ss_pred             CCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       902 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ||..... .+..+..    .......    .....    ...+.+++.+||+.+|++||++++|++.|+++..
T Consensus       225 p~~~~~~-~~~~~~~----~~~~~~~----~~~~~----~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         225 PWFQLSN-TEVIECI----TQGRVLE----RPRVC----PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCCCCH-HHHHHHH----hCCCCCC----CCccC----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            9865422 2222221    1111111    11111    2357899999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.5e-36  Score=341.04  Aligned_cols=206  Identities=25%  Similarity=0.389  Sum_probs=176.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|... +++.||+|++.+.              ..........+..|+.++.+++||||+++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~E~~il~~~~~~~iv~~   66 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA--------------DMLEKEQVGHIRAERDILVEADSLWVVKM   66 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH--------------HHHHhhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36888999999999999999864 5889999998432              11123345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+....|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vk  141 (363)
T cd05628          67 FYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVK  141 (363)
T ss_pred             EEEEecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEE
Confidence            9999999999999999999999999974  45799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCC---------------------------------cccccccccccccCccccccCCCCCccchhh
Q 001867          842 VADFGVAKVVDASGKP---------------------------------KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYS  888 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  888 (1002)
                      |+|||+++........                                 ......+||+.|+|||++.+..++.++||||
T Consensus       142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS  221 (363)
T cd05628         142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (363)
T ss_pred             EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence            9999999765322100                                 0012347999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC
Q 001867          889 FGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       889 lGvil~ell~g~~p~~~~~  907 (1002)
                      |||++|||++|+.||....
T Consensus       222 lGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         222 LGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             hHHHHHHHHhCCCCCCCCC
Confidence            9999999999999997553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.5e-36  Score=329.41  Aligned_cols=259  Identities=25%  Similarity=0.402  Sum_probs=206.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+...                 .......+.+|++++++++||
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~   67 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------------SDNARKDFHREAELLTNLQHE   67 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----------------CHHHHHHHHHHHHHHHhCCCC
Confidence            35777889999999999999852      2456899987321                 233456789999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHR  825 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  825 (1002)
                      ||+++++++...+..++||||+++++|.+++....           ...+++..+..++.|++.||+|||++   +++||
T Consensus        68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~  144 (288)
T cd05093          68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHR  144 (288)
T ss_pred             CcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            99999999999999999999999999999987432           23589999999999999999999999   99999


Q ss_pred             CCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 001867          826 DVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD  904 (1002)
Q Consensus       826 Dlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~  904 (1002)
                      ||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       145 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~  224 (288)
T cd05093         145 DLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  224 (288)
T ss_pred             ccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986644332222233345778999999998899999999999999999999 888886


Q ss_pred             CCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          905 PEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .... .+....+..    ....    +.....+    .++.+++.+||+.||.+|||++++.+.|+++..
T Consensus       225 ~~~~-~~~~~~i~~----~~~~----~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         225 QLSN-NEVIECITQ----GRVL----QRPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             CCCH-HHHHHHHHc----CCcC----CCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            4432 222222211    1111    1111122    248899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.7e-36  Score=323.96  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+...                  ....+.+.+|+.++++++||||++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~   65 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------------SMSEDEFIEEAKVMMKLSHEKLVQLY   65 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC------------------cccHHHHHHHHHHHhcCCCCCeeeEE
Confidence            457778899999999999999877778999987432                  11245689999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl  141 (256)
T cd05113          66 GVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKV  141 (256)
T ss_pred             EEEccCCCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEE
Confidence            99999999999999999999999997533 3689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.++........ ......++..|+|||...+..++.++|||||||++|||++ |..||..... .+....+.....
T Consensus       142 ~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~~~~  219 (256)
T cd05113         142 SDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR  219 (256)
T ss_pred             CCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHhcCCC
Confidence            999999866443221 1112235678999999988889999999999999999999 9999864322 222222211110


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                          .    +.....    ..++.+++.+||+.+|++||++.++++.++
T Consensus       220 ----~----~~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ----L----YRPHLA----SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----C----CCCCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                0    111111    235788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.9e-36  Score=323.37  Aligned_cols=261  Identities=21%  Similarity=0.326  Sum_probs=209.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+. .+++.||+|.+...              ...+......+.+|++++++++||||+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   67 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIF--------------EMMDAKARQDCVKEIDLLKQLNHPNVIKY   67 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecc--------------ccCCHHHHHHHHHHHHHHHhCCCcceeee
Confidence            4688899999999999999996 46899999987431              11234456678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++.+.+..+++|||+++|+|.+++...  +...+++..+..++.|++.||+|||++   +++||||||+||+++.++.
T Consensus        68 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~  144 (267)
T cd08228          68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGV  144 (267)
T ss_pred             eeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCC
Confidence            99999999999999999999999988642  235689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-KDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~-~~~~~~~~~  918 (1002)
                      ++|+|||++........  ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ......+  
T Consensus       145 ~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~--  220 (267)
T cd08228         145 VKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI--  220 (267)
T ss_pred             EEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH--
Confidence            99999999987644321  122346888999999998888999999999999999999999998654321 1222111  


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                        ......    +...   .....++.+++.+||+.+|++||++.+|++.++++.
T Consensus       221 --~~~~~~----~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         221 --EQCDYP----PLPT---EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --hcCCCC----CCCh---hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence              111111    1111   112245888999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-36  Score=340.55  Aligned_cols=268  Identities=21%  Similarity=0.282  Sum_probs=197.6

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|+. .+++.||||++....               .......++.+|+.++++++||||++++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpniv~~~   65 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF---------------EHVSDATRILREIKLLRLLRHPDIVEIK   65 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh---------------ccchhHHHHHHHHHHHHhCCCCCEeeec
Confidence            477789999999999999996 468999999884321               1122345688999999999999999999


Q ss_pred             eEEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          763 CCCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       763 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      +++...     ...|+||||+ +++|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        66 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~  139 (338)
T cd07859          66 HIMLPPSRREFKDIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANAD  139 (338)
T ss_pred             ceEeccCCCCCceEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC
Confidence            988643     3479999999 5799998874  45699999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCC-cccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          838 FGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      +.+||+|||+++........ .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ ..
T Consensus       140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~  218 (338)
T cd07859         140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LD  218 (338)
T ss_pred             CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HH
Confidence            99999999999865332211 11234568999999999875  6789999999999999999999999965432111 11


Q ss_pred             HHHHHhhc-----------c-------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHHhh
Q 001867          915 WVCSTLDQ-----------K-------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL--LQEVG  973 (1002)
Q Consensus       915 ~~~~~~~~-----------~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~  973 (1002)
                      .+......           .       .+............+.....+.+++.+||+.||++||+++|+++.  ++.+.
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             HHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence            11000000           0       000000000000000112347789999999999999999999953  44443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-36  Score=330.19  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+....                .....+.+.+|+.+++++ +|
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~h   98 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----------------HSSEREALMSELKIMSHLGNH   98 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC----------------ChHHHHHHHHHHHHHHhccCC
Confidence            46888999999999999999742      24579999874321                123456789999999999 79


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |||+++++++...+..+++|||+++|+|.++++......+++.++..++.|++.|++|||++   +|+||||||+||+++
T Consensus        99 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~  175 (302)
T cd05055          99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLT  175 (302)
T ss_pred             CCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEc
Confidence            99999999999999999999999999999999865555589999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~  914 (1002)
                      .++.++++|||+++...............++..|+|||.+.+..++.++||||+||++|||++ |..||........+.+
T Consensus       176 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~  255 (302)
T cd05055         176 HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK  255 (302)
T ss_pred             CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence            999999999999986644322111222345678999999999899999999999999999998 9999865543333333


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ........        +.....    ..++.+++.+|++.+|++||++.|+++.|+++
T Consensus       256 ~~~~~~~~--------~~~~~~----~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 LIKEGYRM--------AQPEHA----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHcCCcC--------CCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            32211100        000111    23588899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-36  Score=336.30  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=195.3

Q ss_pred             CeeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          689 NVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +.||+|+||.||+|+.    .+++.||+|++.+...             .........+..|+.+++.++||||++++++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~   68 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-------------VRNQKDTAHTKAERNILEAVKHPFIVDLIYA   68 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-------------HhhhhhHHHHHHHHHHHHhCCCCchhceeeE
Confidence            6899999999999985    3578999999854211             0122334567899999999999999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      +..++..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  143 (323)
T cd05584          69 FQTGGKLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTD  143 (323)
T ss_pred             EecCCeEEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEee
Confidence            9999999999999999999999874  45688999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ||+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||........    ...... ..
T Consensus       144 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~-~~  216 (323)
T cd05584         144 FGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILK-GK  216 (323)
T ss_pred             CcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHc-CC
Confidence            999875433221  12345699999999999988899999999999999999999999975432221    111111 11


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .  .+.   ...    ..++.+++.+|++.||++||     +++++++
T Consensus       217 ~--~~~---~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 L--NLP---PYL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             C--CCC---CCC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            0  011   111    12477899999999999999     7888875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-35  Score=324.71  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCc----EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|.+. +++    .+|+|.+...                .......++..|+.++++++|||
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~~~~~l~~l~h~~   70 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR----------------SGRQTFQEITDHMLAMGSLDHAY   70 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc----------------cchHHHHHHHHHHHHHhcCCCCC
Confidence            46778899999999999999964 454    3666665211                12233456888999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.. ...++++||+++|+|.+++... .+.+++..+..++.|++.||+|||++   +++||||||+||+++.+
T Consensus        71 iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~  145 (279)
T cd05111          71 IVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSD  145 (279)
T ss_pred             cceEEEEECC-CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCC
Confidence            9999998864 4578999999999999999753 35689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++...............++..|+|||+..++.++.++|||||||++||+++ |..||.... .......+
T Consensus       146 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~~  224 (279)
T cd05111         146 SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHEVPDLL  224 (279)
T ss_pred             CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH
Confidence            9999999999987654433333334457789999999998899999999999999999998 999986542 22222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ....      ....+  ..+.    ..+.+++.+||+.+|++|||+.|+.+.|..+..
T Consensus       225 ~~~~------~~~~~--~~~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 EKGE------RLAQP--QICT----IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HCCC------cCCCC--CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1111      00011  1122    246778899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-36  Score=341.78  Aligned_cols=255  Identities=20%  Similarity=0.207  Sum_probs=195.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+|++.+.||+|+||.||+|.. .+++.||+|...                       ...+.+|++++++++||||+++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------------------~~~~~~E~~il~~l~HpnIv~~  148 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------------------RGGTATEAHILRAINHPSIIQL  148 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------------------hhhhHHHHHHHHhCCCCCCCCE
Confidence            4688999999999999999996 468899999641                       2346789999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++......++|||++ +++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       149 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vk  222 (391)
T PHA03212        149 KGTFTYNKFTCLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC  222 (391)
T ss_pred             eEEEEECCeeEEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEE
Confidence            99999999999999999 5789888874  34689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC------chhHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG------EKDLVKW  915 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~------~~~~~~~  915 (1002)
                      |+|||+++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....      .......
T Consensus       223 L~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~  301 (391)
T PHA03212        223 LGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL  301 (391)
T ss_pred             EEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence            999999975432211 122345799999999999999999999999999999999999988743211      1111111


Q ss_pred             HHHHhhccC----------cc---------ccccccccCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKG----------VD---------HVLDPKLDCCF---KEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~----------~~---------~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +........          ..         ....+......   .+...++.+++.+|++.||++|||++|+++
T Consensus       302 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            111000000          00         00000000000   122346788999999999999999999984

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.2e-39  Score=349.03  Aligned_cols=366  Identities=29%  Similarity=0.398  Sum_probs=299.8

Q ss_pred             ccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeee
Q 001867          188 ISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQI  267 (1002)
Q Consensus       188 l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L  267 (1002)
                      |+-.+-.|+++|.+..+.+|.....++++++|.|...++. .+|+.++.+.+|++|.+++|++. .+...++.++.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            3344567788888777778888888888888888888887 77888888888888888888877 455677778888888


Q ss_pred             eccCCccc-CCCCCccccccccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhccccccc
Q 001867          268 ELYNNSLT-GDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRL  345 (1002)
Q Consensus       268 ~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  345 (1002)
                      .+.+|++. .-+|..+..+..|+.||||+|+++ ..|..+.... +-+|+||+|+|+.+....|.+++.|-.|+|++|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            88888775 336777788888999999999988 5677776654 78899999999866666677889999999999999


Q ss_pred             CCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccc-cCCCCcCcCCCCCcEEEccCccccCCCCCc
Q 001867          346 NGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFT-GQLPDGLGHCQSLTRVRLGYNRLTGKVPPL  424 (1002)
Q Consensus       346 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  424 (1002)
                      . .+|+.+..+..|++|+|++|.+...--..+-.+++|+.|.+++.+-+ ..+|.++..+.+|..+|||.|.+. .+|.+
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec  240 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC  240 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence            8 67778888999999999999987554455566788899999887654 568999999999999999999998 89999


Q ss_pred             CCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccC-CCCcccccccccC
Q 001867          425 LWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT-GSLPESLTNLAEL  503 (1002)
Q Consensus       425 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L  503 (1002)
                      +..+++|+.|+||+|+|+ +..-..+...+|+.|+||.|+++ .+|++++.++.|+.|.+.+|+++ .-+|..++.|.+|
T Consensus       241 ly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L  318 (1255)
T KOG0444|consen  241 LYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL  318 (1255)
T ss_pred             HhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence            999999999999999998 44455667788899999999998 88899999999999999988876 2468888888888


Q ss_pred             CeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeee
Q 001867          504 GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       504 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      +.+..++|.+. ..|+.+..+.+|+.|.|+.|++. .+|+.|.-|+.|+.|||..|.=-
T Consensus       319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            88888888887 77888888888888888888887 78888888888888888888543

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.4e-36  Score=323.05  Aligned_cols=253  Identities=28%  Similarity=0.477  Sum_probs=202.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|..+++..||+|.+...                  ....+.+.+|+.++++++|+++++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~------------------~~~~~~~~~E~~~l~~l~~~~i~~~~   67 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG------------------TMSPESFLEEAQIMKKLRHDKLVQLY   67 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCC------------------CCCHHHHHHHHHHHHhcCCCceEEEE
Confidence            467888999999999999999888889999988432                  11235689999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.. ...+++|||+++++|.++++......+++.++..++.|++.||+|||++   +|+||||||+||++++++.++|
T Consensus        68 ~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l  143 (260)
T cd05070          68 AVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKI  143 (260)
T ss_pred             eEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEe
Confidence            98854 5679999999999999999865556689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+.......... .....++..|+|||+..+..++.++||||||+++|||++ |..||..... .+......... 
T Consensus       144 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~~~-  220 (260)
T cd05070         144 ADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGY-  220 (260)
T ss_pred             CCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCC-
Confidence            9999998764432211 112235668999999988889999999999999999999 8888865432 22222221110 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                        ..     + ..   ......+.+++.+|++++|++|||++++.+.|++
T Consensus       221 --~~-----~-~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 --RM-----P-CP---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CC-----C-CC---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              00     0 11   1112358889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=342.25  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+.. +++.||||++...              ..........+.+|+++++.++||||+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~~~E~~il~~l~h~~iv~~   66 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS--------------EMLEKEQVAHVRAERDILAEADNPWVVKL   66 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHH--------------HhhhhhHHHHHHHHHHHHHhCCCCCCcce
Confidence            36888899999999999999964 5899999998532              11123345668899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  141 (364)
T cd05599          67 YYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIK  141 (364)
T ss_pred             EEEEEcCCeEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEE
Confidence            9999999999999999999999999974  45699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCc------------------------------------ccccccccccccCccccccCCCCCccc
Q 001867          842 VADFGVAKVVDASGKPK------------------------------------SMSVIAGSCGYIAPEYAYTLRVNEKSD  885 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  885 (1002)
                      |+|||+++.........                                    .....+||+.|+|||++.+..++.++|
T Consensus       142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  221 (364)
T cd05599         142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD  221 (364)
T ss_pred             EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence            99999987653221100                                    011246999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC---H
Q 001867          886 IYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA---M  962 (1002)
Q Consensus       886 vwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~  962 (1002)
                      |||+||++|||++|+.||.............    ...  .....+......+    .+.+++.+|+. +|.+|++   +
T Consensus       222 iwSlG~il~el~~G~~Pf~~~~~~~~~~~i~----~~~--~~~~~~~~~~~s~----~~~~li~~ll~-~p~~R~~~~~~  290 (364)
T cd05599         222 WWSLGVIMYEMLVGYPPFCSDNPQETYRKII----NWK--ETLQFPDEVPLSP----EAKDLIKRLCC-EAERRLGNNGV  290 (364)
T ss_pred             eecchhHHHHhhcCCCCCCCCCHHHHHHHHH----cCC--CccCCCCCCCCCH----HHHHHHHHHcc-CHhhcCCCCCH
Confidence            9999999999999999997553222211111    100  0000011111122    36677888886 9999998   8


Q ss_pred             HHHHH
Q 001867          963 RRVVK  967 (1002)
Q Consensus       963 ~evl~  967 (1002)
                      +|+++
T Consensus       291 ~~ll~  295 (364)
T cd05599         291 NEIKS  295 (364)
T ss_pred             HHHhc
Confidence            88876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.3e-36  Score=333.17  Aligned_cols=200  Identities=27%  Similarity=0.436  Sum_probs=173.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|... ++..+|+|.+....                .....+.+.+|++++++++||||+++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~   68 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----------------KPAIRNQIIRELQVLHECNSPYIVGF   68 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----------------CHHHHHHHHHHHHHHHHCCCCcccce
Confidence            57888899999999999999975 57889999874321                22345678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..++||||+++|+|.+++..  .+.+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+|
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~k  144 (333)
T cd06650          69 YGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIK  144 (333)
T ss_pred             eEEEEECCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEE
Confidence            9999999999999999999999999974  356899999999999999999999741  799999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      |+|||++.......    .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       145 L~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         145 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             EeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            99999997653321    12346899999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.9e-36  Score=322.57  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=203.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.++||+|+||.||+|.+.++..||+|++...                  ....+.+.+|++++++++||||++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~------------------~~~~~~~~~E~~~l~~l~~~~i~~~~   67 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY   67 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC------------------ccCHHHHHHHHHHHHhCCCCCcceEE
Confidence            468888999999999999999877778999988431                  11235689999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.. +..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        68 ~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L  143 (262)
T cd05071          68 AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  143 (262)
T ss_pred             EEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEe
Confidence            98754 5579999999999999999865556789999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.++......... .....++..|+|||+..+..++.++||||+|+++|||++ |..||....... .....   ..
T Consensus       144 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~~---~~  218 (262)
T cd05071         144 ADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQV---ER  218 (262)
T ss_pred             ccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHH---hc
Confidence            9999998665433211 123346678999999988899999999999999999999 777886543222 11111   11


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ....     +.    ..+....+.+++.+|++.+|++||+++++.+.|++.
T Consensus       219 ~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 GYRM-----PC----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCC-----CC----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            0000     00    112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.8e-36  Score=349.89  Aligned_cols=255  Identities=26%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|.+.+.||+|+||+||+|+. .+++.||||++...               .........+.+|+.++..++|+||+++
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~---------------~~~~~~~~~~~~Ei~~l~~~~h~~iv~~   96 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME---------------GMSEADKNRAQAEVCCLLNCDFFSIVKC   96 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecc---------------cCCHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            5788899999999999999985 56899999998432               1123445678899999999999999999


Q ss_pred             eeEEecCC--------eeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          762 WCCCTTRD--------CKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       762 ~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ++.+...+        ..++||||+++|+|.++++...  ...+++..+..++.|++.||.|||++   +|+||||||+|
T Consensus        97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~N  173 (496)
T PTZ00283         97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSAN  173 (496)
T ss_pred             ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHH
Confidence            88775432        3689999999999999987532  35789999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....   
T Consensus       174 ILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---  250 (496)
T PTZ00283        174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---  250 (496)
T ss_pred             EEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---
Confidence            99999999999999999876543333333456799999999999999999999999999999999999999975422   


Q ss_pred             HHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          912 LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                       ...+..... ..    .++......    .++.+++.+||+.||++||++.++++.
T Consensus       251 -~~~~~~~~~-~~----~~~~~~~~~----~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        251 -EEVMHKTLA-GR----YDPLPPSIS----PEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -HHHHHHHhc-CC----CCCCCCCCC----HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             122221111 11    111112222    347889999999999999999999864

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=322.53  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             CCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      |.+.+.||+|+||.||+|....    +..||+|++...               .........+.+|+++++.++||||++
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~iv~   65 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD---------------IHTYSEIEEFLSEAACMKDFDHPNVMK   65 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC---------------cCCHHHHHHHHHHHHHHHhCCCCCeee
Confidence            5678899999999999998642    367999988432               112334567899999999999999999


Q ss_pred             eeeEEecCCe------eeEEEeccCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          761 LWCCCTTRDC------KLLVYEYMPNGSLGDLLHSCK----GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       761 l~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      +++++.....      .+++|||+++|+|.+++....    ...+++..+..++.|++.||+|||++   +|+||||||+
T Consensus        66 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~  142 (273)
T cd05035          66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAAR  142 (273)
T ss_pred             EEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence            9998876554      799999999999999985432    24689999999999999999999999   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGE  909 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~  909 (1002)
                      ||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus       143 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-~  221 (273)
T cd05035         143 NCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-N  221 (273)
T ss_pred             eEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-H
Confidence            99999999999999999987655443332333345678999999988889999999999999999999 888886432 2


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .+.........    ..    +....    ...++.+++.+||+.||++||++.|+++.|+++
T Consensus       222 ~~~~~~~~~~~----~~----~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         222 HEIYDYLRHGN----RL----KQPED----CLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHHHHcCC----CC----CCCcC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            23222222111    00    01111    223588899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-35  Score=326.52  Aligned_cols=259  Identities=25%  Similarity=0.360  Sum_probs=204.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +|.+.+.||+|+||.||+|....      ...+|+|.+....                .....+++.+|+.+++.++|||
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~   64 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----------------SSSELRDLLSEFNLLKQVNHPH   64 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----------------CHHHHHHHHHHHHHHhhCCCCC
Confidence            36778899999999999998632      3568888774321                1233567899999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----------------------GGLLDWPTRYKIIVDAAEGLSYLH  815 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~LH  815 (1002)
                      |+++++.+...+..+++|||+++|+|.+++....                      ...+++..++.++.|++.|++|||
T Consensus        65 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  144 (290)
T cd05045          65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA  144 (290)
T ss_pred             EeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999986432                      135889999999999999999999


Q ss_pred             hcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHH
Q 001867          816 HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE  895 (1002)
Q Consensus       816 ~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~e  895 (1002)
                      +.   +|+||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++||
T Consensus       145 ~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~e  221 (290)
T cd05045         145 EM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE  221 (290)
T ss_pred             HC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHH
Confidence            98   999999999999999999999999999986644332222223345678999999988889999999999999999


Q ss_pred             HHh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          896 LVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       896 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      |++ |..||.... ..............        +......    .++.+++.+||+.+|++||+++|+++.|+++..
T Consensus       222 l~t~g~~p~~~~~-~~~~~~~~~~~~~~--------~~~~~~~----~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         222 IVTLGGNPYPGIA-PERLFNLLKTGYRM--------ERPENCS----EEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHhcCCCCCCCCC-HHHHHHHHhCCCCC--------CCCCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            998 988885432 23333322211110        1111122    247789999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.7e-36  Score=326.39  Aligned_cols=250  Identities=24%  Similarity=0.281  Sum_probs=196.1

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|+||.||+++.+ +|+.||+|++....              .........+..|++++++++||||+++++++..+.
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~   66 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR--------------LKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT   66 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHH--------------hhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC
Confidence            699999999999864 58999999984321              111223345667999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..|+||||+++++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.
T Consensus        67 ~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~  143 (277)
T cd05607          67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAV  143 (277)
T ss_pred             eEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeee
Confidence            999999999999999988765556789999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccc
Q 001867          850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVL  929 (1002)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1002)
                      ......   ......|+..|+|||++.+..++.++||||+||++|||++|+.||................... .    +
T Consensus       144 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~----~  215 (277)
T cd05607         144 ELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-E----V  215 (277)
T ss_pred             ecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-c----c
Confidence            664432   1223468999999999998889999999999999999999999996543222211221111111 0    1


Q ss_pred             cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          930 DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       930 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      .......    ..++.+++.+||+.||++||+++|+++..
T Consensus       216 ~~~~~~~----~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         216 KFEHQNF----TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ccccccC----CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            1011111    22477899999999999999998876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=341.21  Aligned_cols=256  Identities=26%  Similarity=0.337  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....              .........+..|++++..++||||+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~i~~~   66 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD--------------MIKRNQIAHVRAERDILADADSPWIVKL   66 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH--------------HhhccHHHHHHHHHHHHHhcCCCCccch
Confidence            36888899999999999999965 68999999985421              1122345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+++++|.+++...  +.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~k  141 (350)
T cd05573          67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIK  141 (350)
T ss_pred             hhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence            99999999999999999999999999853  6799999999999999999999998   999999999999999999999


Q ss_pred             EccccCcccccCCC---------------------------CCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          842 VADFGVAKVVDASG---------------------------KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       842 l~DfGl~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      |+|||++.......                           .........||+.|+|||++.+..++.++|||||||++|
T Consensus       142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  221 (350)
T cd05573         142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY  221 (350)
T ss_pred             eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence            99999998765433                           011223456999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Q 001867          895 ELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-MRRVVKL  968 (1002)
Q Consensus       895 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~~  968 (1002)
                      ||++|+.||..........+..    ...  .....+......    .++.+++.+|++ ||++||+ ++++++.
T Consensus       222 ell~g~~Pf~~~~~~~~~~~i~----~~~--~~~~~p~~~~~~----~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         222 EMLYGFPPFYSDTLQETYNKII----NWK--ESLRFPPDPPVS----PEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             hhccCCCCCCCCCHHHHHHHHh----ccC--CcccCCCCCCCC----HHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9999999997654222211111    100  000111111122    247788889997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-35  Score=322.68  Aligned_cols=257  Identities=23%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             CCcCCeeeecCCccEEEEEEcCC-c--EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNG-E--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.++++||+|+||.||+|.+.+. +  .||+|.+...               .......+.+.+|+.++++++||||+++
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   65 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA---------------ICTRSEMEDFLSEAVCMKEFDHPNVMRL   65 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccC---------------cCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            35678999999999999997543 2  6899987432               1234446778999999999999999999


Q ss_pred             eeEEecC------CeeeEEEeccCCCChhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          762 WCCCTTR------DCKLLVYEYMPNGSLGDLLHSC----KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       762 ~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ++++...      ...+++|||+++|+|.+++...    ....+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus        66 ~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~N  142 (272)
T cd05075          66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARN  142 (272)
T ss_pred             EEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccchhh
Confidence            9987532      2468999999999999987432    224589999999999999999999998   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~  910 (1002)
                      |++++++.+||+|||+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||.... ..
T Consensus       143 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~  221 (272)
T cd05075         143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-NS  221 (272)
T ss_pred             eEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-HH
Confidence            9999999999999999987654432222233346678999999999999999999999999999999 788886432 22


Q ss_pred             hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ...+.+..   ....     +.....    ...+.+++.+||+.||++|||++++++.|+++
T Consensus       222 ~~~~~~~~---~~~~-----~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         222 EIYDYLRQ---GNRL-----KQPPDC----LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHHHHc---CCCC-----CCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            22222211   1110     001112    22478899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.3e-36  Score=338.50  Aligned_cols=255  Identities=23%  Similarity=0.282  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....              .......+.+.+|+.+++.++||||+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~i~~~~~~~~i~~~   66 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV--------------LLAQETVSFFEEERDILSISNSPWIPQL   66 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCCcce
Confidence            36888899999999999999964 68899999985421              1123345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~k  142 (330)
T cd05601          67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIK  142 (330)
T ss_pred             eeEEecCCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEE
Confidence            99999999999999999999999999863 35699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY------TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      |+|||++......... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........+...
T Consensus       143 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i  221 (330)
T cd05601         143 LADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI  221 (330)
T ss_pred             eccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH
Confidence            9999999876543322 223446899999999886      456789999999999999999999999765433322221


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .    ........  +......    ..+.+++..|++ +|++||+++++++
T Consensus       222 ~----~~~~~~~~--~~~~~~~----~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         222 M----NFQRFLKF--PEDPKVS----SDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             H----cCCCccCC--CCCCCCC----HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1    11110010  1111112    236778889997 9999999999884

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=342.41  Aligned_cols=256  Identities=21%  Similarity=0.277  Sum_probs=197.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|.. .+++.||||++.+.              ........+.+.+|++++++++||||+++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~E~~il~~l~hp~iv~~   66 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS--------------EMFKKDQLAHVKAERDVLAESDSPWVVSL   66 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHH--------------HHHHhHHHHHHHHHHHHHHhCCCCCcceE
Confidence            3678889999999999999986 46899999998432              11123345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~k  141 (377)
T cd05629          67 YYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIK  141 (377)
T ss_pred             EEEEEcCCeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEE
Confidence            9999999999999999999999999974  45689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCC------------c---------------------------------ccccccccccccCccccc
Q 001867          842 VADFGVAKVVDASGKP------------K---------------------------------SMSVIAGSCGYIAPEYAY  876 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~  876 (1002)
                      |+|||+++........            .                                 .....+||+.|+|||++.
T Consensus       142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  221 (377)
T cd05629         142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL  221 (377)
T ss_pred             EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence            9999999643211000            0                                 001246999999999999


Q ss_pred             cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCC
Q 001867          877 TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLP  956 (1002)
Q Consensus       877 ~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  956 (1002)
                      +..++.++||||+||++|||++|+.||........+..... ..     ....-|......    ..+.+++.+|+. +|
T Consensus       222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~-----~~~~~p~~~~~s----~~~~dli~~lL~-~~  290 (377)
T cd05629         222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN-WR-----ETLYFPDDIHLS----VEAEDLIRRLIT-NA  290 (377)
T ss_pred             cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHc-cC-----CccCCCCCCCCC----HHHHHHHHHHhc-CH
Confidence            99999999999999999999999999976543222222111 00     000001111111    236678888987 66


Q ss_pred             CCC---CCHHHHHHH
Q 001867          957 INR---PAMRRVVKL  968 (1002)
Q Consensus       957 ~~R---ps~~evl~~  968 (1002)
                      .+|   +++.|+++.
T Consensus       291 ~~r~~r~~~~~~l~h  305 (377)
T cd05629         291 ENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhcCCCCCHHHHhcC
Confidence            665   599998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-35  Score=321.49  Aligned_cols=253  Identities=26%  Similarity=0.465  Sum_probs=204.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.++||+|+||.||+|..++++.||+|.+...                  ....+++.+|+.++++++||||++++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~   67 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG------------------SMSPEAFLAEANLMKQLQHPRLVRLY   67 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCC------------------CCcHHHHHHHHHHHHhcCCcCeeeEE
Confidence            568888999999999999999888999999988432                  12245788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++. .+..+++|||+++++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        68 ~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l  143 (260)
T cd05067          68 AVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKI  143 (260)
T ss_pred             EEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEE
Confidence            9874 45689999999999999998765666799999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||++......... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+..+.......
T Consensus       144 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~  221 (260)
T cd05067         144 ADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQNLERGYR  221 (260)
T ss_pred             ccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHcCCC
Confidence            999999876533221 1122345678999999998889999999999999999999 9999965432 222222211110


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                          .    +.....    ..++.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ----~----~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 ----M----PRPDNC----PEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----C----CCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                0    111111    2248889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.2e-36  Score=325.05  Aligned_cols=257  Identities=21%  Similarity=0.362  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      .++|++.+.||+|+||.||+|...      .+..||+|++...                .......++.+|+.+++.++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----------------~~~~~~~~~~~e~~~l~~l~~   68 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----------------ASMRERIEFLNEASVMKEFNC   68 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----------------CCHHHHHHHHHHHHHHHhCCC
Confidence            356888999999999999998753      2467999987321                112335568899999999999


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV  827 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  827 (1002)
                      |||+++++++......++||||+++|+|.+++...+.        ..+++..+..++.|++.|++|||+.   +++||||
T Consensus        69 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dl  145 (277)
T cd05062          69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDL  145 (277)
T ss_pred             CCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCc
Confidence            9999999999999999999999999999999875321        3467889999999999999999998   9999999


Q ss_pred             CCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 001867          828 KSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE  906 (1002)
Q Consensus       828 k~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~  906 (1002)
                      ||+||++++++.++++|||+++...............+++.|||||++.+..++.++|||||||++|||++ |..||...
T Consensus       146 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         146 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             chheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999986644332222223345778999999998889999999999999999999 67888644


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      . .....+.+..    .....    .....    ...+.+++.+||+.+|++||++.|+++.++
T Consensus       226 ~-~~~~~~~~~~----~~~~~----~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         226 S-NEQVLRFVME----GGLLD----KPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             C-HHHHHHHHHc----CCcCC----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            2 2222222211    11100    01112    234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-35  Score=325.07  Aligned_cols=257  Identities=24%  Similarity=0.369  Sum_probs=202.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|..     .++..||+|.+...                ........+.+|++++++++|||
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~n   68 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----------------NNPQQWGEFQQEASLMAELHHPN   68 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----------------CCHHHHHHHHHHHHHHhhCCCCC
Confidence            4577788999999999999984     24578999987421                12233467889999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK---------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI  822 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  822 (1002)
                      |+++++++..++..|+||||+++++|.+++....               ...+++.++..++.|++.||+|||++   +|
T Consensus        69 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  145 (283)
T cd05090          69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FF  145 (283)
T ss_pred             eeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ce
Confidence            9999999999999999999999999999985322               23578999999999999999999999   99


Q ss_pred             eeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCC
Q 001867          823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRL  901 (1002)
Q Consensus       823 iHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~  901 (1002)
                      +||||||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..
T Consensus       146 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~  225 (283)
T cd05090         146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ  225 (283)
T ss_pred             ehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999987644332222233446678999999988889999999999999999999 888


Q ss_pred             CCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       902 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      ||.... .....+.+..    ....    +.....+    .++.+++.+||+.||++||++.++.+.|..
T Consensus       226 p~~~~~-~~~~~~~~~~----~~~~----~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         226 PYYGFS-NQEVIEMVRK----RQLL----PCSEDCP----PRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCCC-HHHHHHHHHc----CCcC----CCCCCCC----HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            886432 2222332221    1111    1111122    347889999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.8e-36  Score=338.07  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=193.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|+..++||+|+||.||+|+.. +++.||||++...                ......+.+.+|++++++++|+||+++
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~iv~~  137 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----------------HEDTVRRQICREIEILRDVNHPNVVKC  137 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC----------------CcHHHHHHHHHHHHHHHhCCCCCccee
Confidence            44566789999999999999964 6899999998432                122345678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..++||||+++|+|.+..      ..++..+..++.||+.||+|||++   +|+||||||+||+++.++.+|
T Consensus       138 ~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k  208 (353)
T PLN00034        138 HDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVK  208 (353)
T ss_pred             eeEeccCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEE
Confidence            99999999999999999999986532      356788899999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+|||+++.......  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..... .+.....
T Consensus       209 L~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~  285 (353)
T PLN00034        209 IADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLM  285 (353)
T ss_pred             Ecccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHH
Confidence            999999987653321  1234578999999998743     2345689999999999999999999974322 2222111


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ........      +...   .....++.+++.+||+.||++||+++|+++.
T Consensus       286 ~~~~~~~~------~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        286 CAICMSQP------PEAP---ATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHhccCC------CCCC---CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111100      0011   1112347889999999999999999999863

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.5e-36  Score=338.46  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=204.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-C
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-H  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  755 (1002)
                      ++|.+.++||+|+||.||+|++.      .++.||+|++....                .....+.+.+|+.++.++. |
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~~E~~~l~~l~~H  100 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----------------RSSEKQALMSELKIMSHLGPH  100 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----------------ChhHHHHHHHHHHHHHhcCCC
Confidence            46778899999999999999863      24689999984321                1223456889999999997 9


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC-------------------------------------------
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-------------------------------------------  792 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------  792 (1002)
                      ||||++++++...+..++||||+++|+|.++++..+.                                           
T Consensus       101 ~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (401)
T cd05107         101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD  180 (401)
T ss_pred             CCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccc
Confidence            9999999999999999999999999999999875321                                           


Q ss_pred             -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          793 -----------------------------------------------------GLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       793 -----------------------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                                                                           ..+++..+.+++.|++.||+|||+.  
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--  258 (401)
T cd05107         181 MSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--  258 (401)
T ss_pred             cCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence                                                                 2467888999999999999999998  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +|+||||||+||+++.++.+||+|||+++...............++..|||||.+.+..++.++|||||||++|||++ 
T Consensus       259 -~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~  337 (401)
T cd05107         259 -NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL  337 (401)
T ss_pred             -CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHc
Confidence             999999999999999999999999999986543322222223356788999999998889999999999999999998 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      |+.||......+.....+.....   ..   .+  ...    ..++.+++.+||+.+|++||+++|+++.|+++.
T Consensus       338 g~~P~~~~~~~~~~~~~~~~~~~---~~---~p--~~~----~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         338 GGTPYPELPMNEQFYNAIKRGYR---MA---KP--AHA----SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCCCCCCchHHHHHHHHcCCC---CC---CC--CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            88898644322222222211110   00   01  111    235888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=334.39  Aligned_cols=254  Identities=25%  Similarity=0.345  Sum_probs=208.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC--C--cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN--G--EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++....++||+|.||.|++|.|..  |  ..||||.+..+.                -.....+|.+|+.+|.+|+|||+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~----------------l~~~mddflrEas~M~~L~H~hl  173 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS----------------LNAIMDDFLREASHMLKLQHPHL  173 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc----------------cchhHHHHHHHHHHHHhccCcce
Confidence            345566789999999999999853  3  469999985431                11256789999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++||...+ ...++|||.++.|+|.+.++......+-...+..|+.|||.|+.||.++   ++||||+.++|+++-...
T Consensus       174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllaspr  249 (1039)
T KOG0199|consen  174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPR  249 (1039)
T ss_pred             eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccc
Confidence            999999988 6788999999999999999986778899999999999999999999999   999999999999999899


Q ss_pred             CeEEccccCcccccCCCCCccccccc-ccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIA-GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      .|||+|||+.+.++.....+.+.... -...|+|||.+....++.++|||+|||++|||++ |..||.+-.. .++.+.+
T Consensus       250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-~qIL~~i  328 (1039)
T KOG0199|consen  250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-IQILKNI  328 (1039)
T ss_pred             eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-HHHHHhc
Confidence            99999999999998777666654333 3458999999999999999999999999999999 8899976533 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      ....+        -+    .++.+.+++++++..||.++|++||++..+++.+
T Consensus       329 D~~er--------Lp----RPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  329 DAGER--------LP----RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccc--------CC----CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            11111        11    2233455699999999999999999999998443

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-36  Score=334.88  Aligned_cols=247  Identities=27%  Similarity=0.363  Sum_probs=193.4

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHH---hcCCCCceee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL---GKIRHKNIVK  760 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~  760 (1002)
                      |++.+.||+|+||.||+|... +++.||||++.+..              .......+.+..|+.++   ++++||||++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~   66 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD--------------IIARDEVESLMCEKRIFETANSERHPFLVN   66 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhccccCCCChhc
Confidence            567789999999999999864 68999999985421              11222345566676655   5667999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..|+||||+++|+|..+++.   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        67 ~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~  140 (324)
T cd05589          67 LFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFV  140 (324)
T ss_pred             eeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcE
Confidence            99999999999999999999999988853   4699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++......  .......|++.|||||++.+..++.++|||||||++|||++|+.||............    .
T Consensus       141 kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i----~  214 (324)
T cd05589         141 KIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI----V  214 (324)
T ss_pred             EeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH----H
Confidence            999999987543221  1223457999999999999999999999999999999999999999754322211111    1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      ... ..  ..   ...    ...+.+++.+|++.||++||     ++.++++
T Consensus       215 ~~~-~~--~p---~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         215 NDE-VR--YP---RFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             hCC-CC--CC---CCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            110 00  00   111    22477899999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.6e-36  Score=339.46  Aligned_cols=256  Identities=23%  Similarity=0.281  Sum_probs=201.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.+.              ........+.+.+|+.+++.++||||++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~il~~~~h~~iv~  107 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--------------EMIKRSDSAFFWEERDIMAHANSEWIVQ  107 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--------------HhhhhhhHHHHHHHHHHHHhCCCCCcce
Confidence            357888899999999999999964 5889999998432              1112234456788999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++..   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~  181 (370)
T cd05596         108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  181 (370)
T ss_pred             EEEEEecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCE
Confidence            99999999999999999999999999864   3588899999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ||+|||++......... ......||+.|+|||++.+.    .++.++||||+||++|||++|+.||........+....
T Consensus       182 kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  260 (370)
T cd05596         182 KLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             EEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence            99999999876543221 22345799999999988653    47889999999999999999999997654322222211


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPIN--RPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~  968 (1002)
                          ....  ....+......    .++.+++.+|++.+|++  ||+++|+++.
T Consensus       261 ----~~~~--~~~~~~~~~~s----~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         261 ----DHKN--SLTFPDDIEIS----KQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----cCCC--cCCCCCcCCCC----HHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                1100  01011111112    24778889999999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.8e-36  Score=325.05  Aligned_cols=248  Identities=23%  Similarity=0.274  Sum_probs=194.2

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|+||+||+|... +++.||+|++.+..              .......+.+..|++++++++||||+++++++..+.
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~   66 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKR--------------LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT   66 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHH--------------HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC
Confidence            699999999999864 68899999984321              112223456788999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          770 CKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      ..|+||||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        67 ~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  143 (280)
T cd05608          67 DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGL  143 (280)
T ss_pred             eEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcc
Confidence            999999999999999887532  335699999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccc
Q 001867          848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDH  927 (1002)
Q Consensus       848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1002)
                      +........  ......||+.|+|||++.+..++.++||||+||++|||++|+.||................. ....  
T Consensus       144 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~--  218 (280)
T cd05608         144 AVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSV--  218 (280)
T ss_pred             ceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCC--
Confidence            976654322  12244689999999999999999999999999999999999999975432222111111111 1000  


Q ss_pred             cccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                          ...   ......+.+++.+|++.||++||     +++++++
T Consensus       219 ----~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 ----TYP---DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ----CCc---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                001   11223477889999999999999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-35  Score=320.02  Aligned_cols=253  Identities=27%  Similarity=0.458  Sum_probs=202.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|...++..+|+|.+...                  ....+.+.+|+.++++++|||+++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~   67 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG------------------TMMPEAFLQEAQIMKKLRHDKLVPLY   67 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC------------------CccHHHHHHHHHHHHhCCCCCeeeEE
Confidence            457788899999999999999877778999987321                  12245688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.. +..+++|||+++++|.++++......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        68 ~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l  143 (260)
T cd05069          68 AVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKI  143 (260)
T ss_pred             EEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEE
Confidence            98854 5679999999999999999865556689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+......... ......++..|+|||...+..++.++||||||+++|||++ |..||...... +...+..... 
T Consensus       144 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~-  220 (260)
T cd05069         144 ADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVERGY-  220 (260)
T ss_pred             CCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCC-
Confidence            999999866443221 1112345678999999998889999999999999999999 88888654322 2222221111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                          ..   +.    +......+.+++.+||+.||++||+++++++.|++
T Consensus       221 ----~~---~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 ----RM---PC----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CC---CC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                00   00    11123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.2e-36  Score=337.51  Aligned_cols=245  Identities=24%  Similarity=0.303  Sum_probs=195.6

Q ss_pred             CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          689 NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      +.||+|+||.||+|.. .+++.||+|++.+..              .........+..|+++++.++||||+++++++..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~   66 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV--------------IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT   66 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc
Confidence            4699999999999985 468999999985421              1123345667889999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      .+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg  141 (325)
T cd05594          67 HDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  141 (325)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCC
Confidence            9999999999999999998874  4568999999999999999999997 6   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.    .... 
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~~~~~~i~----~~~~-  213 (325)
T cd05594         142 LCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL----MEEI-  213 (325)
T ss_pred             CCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-HHHHHHHh----cCCC-
Confidence            9875432211  22345699999999999999999999999999999999999999965432 22221111    0000 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVKL  968 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~  968 (1002)
                           ......   ..++.+++.+|++.||++|+     +++++++.
T Consensus       214 -----~~p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 -----RFPRTL---SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -----CCCCCC---CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                 011111   12477889999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-35  Score=322.51  Aligned_cols=262  Identities=21%  Similarity=0.338  Sum_probs=208.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+...              ...+....+++.+|+.+++.++||||+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~   67 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIF--------------DLMDAKARADCIKEIDLLKQLNHPNVIKY   67 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeeh--------------hhhhHHHHHHHHHHHHHHHHccCCchhhh
Confidence            4577788999999999999995 57899999987432              11233445678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++..++..+++|||+++++|.++++..  ....+++..++.++.|++.|++|||++   +++|+||||+||+++.++.
T Consensus        68 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~  144 (267)
T cd08229          68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGV  144 (267)
T ss_pred             hheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCC
Confidence            99999999999999999999999988742  235689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ++++|||++........  ......|+..|+|||+..+..++.++||||||+++|+|++|..||......  ....... 
T Consensus       145 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-  219 (267)
T cd08229         145 VKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKK-  219 (267)
T ss_pred             EEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhh-
Confidence            99999999876644322  122346889999999998888999999999999999999999998643221  1111111 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ....     ..+...  .......+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       220 ~~~~-----~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 IEQC-----DYPPLP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hhcC-----CCCCCC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1110     011111  0112235788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-36  Score=342.67  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|+. .+++.||||++.+.              ........+.+.+|++++++++||||++++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~--------------~~~~~~~~~~~~~E~~il~~l~h~~iv~~~   67 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--------------DVLMRNQAAHVKAERDILAEADNEWVVKLY   67 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH--------------HHHhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence            578889999999999999996 45889999998432              111223456788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +.+.+++..|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||
T Consensus        68 ~~~~~~~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL  142 (376)
T cd05598          68 YSFQDKDNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL  142 (376)
T ss_pred             EEEEcCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999974  45689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCC-----------------------------------------CcccccccccccccCccccccCCCC
Q 001867          843 ADFGVAKVVDASGK-----------------------------------------PKSMSVIAGSCGYIAPEYAYTLRVN  881 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~  881 (1002)
                      +|||++..+.....                                         ........||+.|||||++.+..++
T Consensus       143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  222 (376)
T cd05598         143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT  222 (376)
T ss_pred             EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence            99999853321000                                         0001134699999999999999999


Q ss_pred             CccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-
Q 001867          882 EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-  960 (1002)
Q Consensus       882 ~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-  960 (1002)
                      .++||||+||++|||++|+.||............    ....  .....+......+    .+.+++.+|+ .+|++|+ 
T Consensus       223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~~~~--~~~~~~~~~~~s~----~~~~li~~l~-~~p~~R~~  291 (376)
T cd05598         223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV----INWE--TTLHIPSQAKLSR----EASDLILRLC-CGAEDRLG  291 (376)
T ss_pred             cceeeeeccceeeehhhCCCCCCCCCHHHHHHHH----hccC--ccccCCCCCCCCH----HHHHHHHHHh-cCHhhcCC
Confidence            9999999999999999999999765432221111    1000  0000111112222    3556666665 5999999 


Q ss_pred             --CHHHHHHH
Q 001867          961 --AMRRVVKL  968 (1002)
Q Consensus       961 --s~~evl~~  968 (1002)
                        ++.|+++.
T Consensus       292 ~~t~~ell~h  301 (376)
T cd05598         292 KNGADEIKAH  301 (376)
T ss_pred             CCCHHHHhCC
Confidence              88998854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-35  Score=328.37  Aligned_cols=275  Identities=25%  Similarity=0.392  Sum_probs=209.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCc--EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.++ ++.  .+|+|.+...                ........+.+|++++.++ +||||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----------------~~~~~~~~~~~Ei~~l~~l~~h~~i   70 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------------ASKDDHRDFAGELEVLCKLGHHPNI   70 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----------------CCHHHHHHHHHHHHHHHHhcCCCCc
Confidence            46777889999999999999964 444  4577765321                1233456788999999999 89999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      +++++++..++..|+||||+++++|.++++...              ...+++.+++.++.|++.|++|||++   +|+|
T Consensus        71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H  147 (303)
T cd05088          71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIH  147 (303)
T ss_pred             ceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            999999999999999999999999999997532              23588999999999999999999999   9999


Q ss_pred             CCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 001867          825 RDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPV  903 (1002)
Q Consensus       825 rDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~  903 (1002)
                      |||||+||+++.++.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       148 ~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  224 (303)
T cd05088         148 RDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  224 (303)
T ss_pred             cccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCc
Confidence            9999999999999999999999986432111   1112234668999999988889999999999999999998 99998


Q ss_pred             CCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCC
Q 001867          904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKK  983 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~  983 (1002)
                      ..... .+..+......   ..     +.....    ...+.+++.+||+.+|++||+++++++.++++...........
T Consensus       225 ~~~~~-~~~~~~~~~~~---~~-----~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~  291 (303)
T cd05088         225 CGMTC-AELYEKLPQGY---RL-----EKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT  291 (303)
T ss_pred             ccCCh-HHHHHHHhcCC---cC-----CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhh
Confidence            64432 22222111100   00     001111    2247889999999999999999999999999876655444444


Q ss_pred             CCCCCcchh
Q 001867          984 DGKLSPYYH  992 (1002)
Q Consensus       984 ~~~~~~~~~  992 (1002)
                      -...++++.
T Consensus       292 ~~~~~~~~~  300 (303)
T cd05088         292 LYEKFTYAG  300 (303)
T ss_pred             hhccCccCC
Confidence            444445443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-35  Score=323.85  Aligned_cols=260  Identities=21%  Similarity=0.346  Sum_probs=207.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|...+     +..||+|++...                ......+.+.+|+.++++++|||
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~n   69 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----------------ASEIQVTLLLQESCLLYGLSHQN   69 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence            467788999999999999999765     688999987321                13445677899999999999999


Q ss_pred             eeeeeeEEec-CCeeeEEEeccCCCChhhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          758 IVKLWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKG------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       758 iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      |+++++++.. +...++++||+++++|.+++.....      ..+++..++.++.|++.||+|||++   +++||||||+
T Consensus        70 i~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~  146 (280)
T cd05043          70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAAR  146 (280)
T ss_pred             CCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHh
Confidence            9999998766 5778999999999999999876432      4689999999999999999999998   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGE  909 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~  909 (1002)
                      ||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.... .
T Consensus       147 nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~  225 (280)
T cd05043         147 NCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-P  225 (280)
T ss_pred             hEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-H
Confidence            99999999999999999986644332222223346678999999988889999999999999999999 999996542 2


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .+...+.....   ..     +.....+    ..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       226 ~~~~~~~~~~~---~~-----~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         226 FEMAAYLKDGY---RL-----AQPINCP----DELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHHHHHcCC---CC-----CCCCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            23322222111   10     0111122    247889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=319.92  Aligned_cols=251  Identities=28%  Similarity=0.415  Sum_probs=200.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .+|++.+.||+|+||.||+|.++++..+|+|++.+.                  ......+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG------------------AMSEDDFIEEAKVMMKLSHPNLVQLY   65 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC------------------CCCHHHHHHHHHHHHhCCCCCEEEEE
Confidence            357778899999999999999887789999987432                  11234688899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..|+||||+++++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl  141 (256)
T cd05059          66 GVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKV  141 (256)
T ss_pred             EEEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEE
Confidence            99999999999999999999999997533 4689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++........ ......++..|+|||...+..++.++||||||+++||+++ |+.||..... .+....+.... 
T Consensus       142 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~-  218 (256)
T cd05059         142 SDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGY-  218 (256)
T ss_pred             CCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHHHHHHcCC-
Confidence            999999865432211 1112224457999999998899999999999999999999 7888864422 22222221111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                          ..   +.....    ..++.+++.+||+.+|++|||+.|+++.|
T Consensus       219 ----~~---~~~~~~----~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 ----RL---YRPKLA----PTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----cC---CCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                00   111112    22588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.2e-36  Score=354.98  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.++||+|+||.||+|... +++.||+|++....              .......+++.+|++++++++||||+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l--------------~~~e~~~~rflrEi~ILs~L~HPNIVkl   67 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL--------------SENPLLKKRFLREAKIAADLIHPGIVPV   67 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc--------------ccCHHHHHHHHHHHHHHHhCCCcCcCeE
Confidence            57888999999999999999964 58999999984321              1123446679999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCK---------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      ++++.+.+..|+||||++||+|.+++....         ....++..+.+++.|++.||+|||++   +|+||||||+||
T Consensus        68 ~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNI  144 (932)
T PRK13184         68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNI  144 (932)
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheE
Confidence            999999999999999999999999986421         13466778899999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCC----------------cccccccccccccCccccccCCCCCccchhhHHHHHHHH
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKP----------------KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el  896 (1002)
                      +++.++.+||+|||+++........                ......+||+.|||||++.+..++.++||||+||++|||
T Consensus       145 LLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyEL  224 (932)
T PRK13184        145 LLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM  224 (932)
T ss_pred             EEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHH
Confidence            9999999999999999876221100                011134699999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHHhhhh
Q 001867          897 VTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-AMRRVVKLLQEVGAE  975 (1002)
Q Consensus       897 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~~~~  975 (1002)
                      ++|+.||..........    ...       ..++.......+....+.+++.+|++.||++|| +++++.+.|+.....
T Consensus       225 LTG~~PF~~~~~~ki~~----~~~-------i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        225 LTLSFPYRRKKGRKISY----RDV-------ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             HHCCCCCCCcchhhhhh----hhh-------ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999997532211110    000       000000000111223477899999999999995 677788888877543

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=362.90  Aligned_cols=481  Identities=28%  Similarity=0.358  Sum_probs=401.5

Q ss_pred             EeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccc
Q 001867           98 LTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLL  177 (1002)
Q Consensus        98 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  177 (1002)
                      +|.+..++. .||..+..-..++.|+++.|.+-...-+.....-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.|
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i   80 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI   80 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence            566677775 56766666666999999999887433334445566999999999998 8999999999999999999999


Q ss_pred             cCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcc
Q 001867          178 DGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSS  257 (1002)
Q Consensus       178 ~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  257 (1002)
                      . ..|....++.+|++|.|.+|.+  ...|.++..+.+|+.|+++.|++. .+|..+..++.++.+..++|.....    
T Consensus        81 ~-~vp~s~~~~~~l~~lnL~~n~l--~~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----  152 (1081)
T KOG0618|consen   81 R-SVPSSCSNMRNLQYLNLKNNRL--QSLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----  152 (1081)
T ss_pred             h-hCchhhhhhhcchhheeccchh--hcCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----
Confidence            9 6678899999999999999986  578999999999999999999998 8899999999999999999932222    


Q ss_pred             cccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCC-CcceeecCCCcccCcCCcccCCCcccc
Q 001867          258 LTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL-PLESLNLYENRLEGSLPATIADSPGLY  336 (1002)
Q Consensus       258 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~  336 (1002)
                      ++... ++.+++..|.+.+.++....+++.  .|||.+|.+.   -..+... .|+.|....|++....    -.-++|+
T Consensus       153 lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~  222 (1081)
T KOG0618|consen  153 LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLT  222 (1081)
T ss_pred             hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchh
Confidence            22222 888999999999999998888888  8999999987   2233333 3899999999987432    2347899


Q ss_pred             hhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCcc
Q 001867          337 ELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR  416 (1002)
Q Consensus       337 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~  416 (1002)
                      .|+.++|.+....+.  .--.+|+++|+++|+++ .+|.+++.+.+|+.+...+|.++ .+|..+...++|+.|.+.+|.
T Consensus       223 ~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~ne  298 (1081)
T KOG0618|consen  223 ALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNE  298 (1081)
T ss_pred             eeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhh
Confidence            999999999843332  23357999999999999 66799999999999999999995 788888999999999999999


Q ss_pred             ccCCCCCcCCCCCcceEEEcccCcccCccccccccCC-cccEEEccCCcCCCCCcc-ccccccccccccccccccCCCCc
Q 001867          417 LTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAA-NLSLLIISKNNLSGSLPE-EIGFLKSLVVLSGSENKFTGSLP  494 (1002)
Q Consensus       417 l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p  494 (1002)
                      +. -+|....++..|+.|+|..|.|....+..+.-.. .|..|+.+.|++. ..|. .=..++.|+.|++.+|.++...-
T Consensus       299 l~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~  376 (1081)
T KOG0618|consen  299 LE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCF  376 (1081)
T ss_pred             hh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccch
Confidence            99 6777888999999999999999865554444443 3888999999998 4552 22347889999999999998887


Q ss_pred             ccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-c
Q 001867          495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-K  573 (1002)
Q Consensus       495 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~  573 (1002)
                      ..+.+..+|+.|+|++|+|.......+.+|..|++|+||+|+++ .+|+++..+..|++|...+|+|. ..| .+..+ +
T Consensus       377 p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~q  453 (1081)
T KOG0618|consen  377 PVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQ  453 (1081)
T ss_pred             hhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCc
Confidence            88999999999999999999666677899999999999999999 89999999999999999999999 577 66666 8


Q ss_pred             cceEEeccccCcCC-CChhhh-hhcccccccCCCCC
Q 001867          574 LNQLNVSNNRLSGE-LPSLFA-KEMYRNSFLGNPGL  607 (1002)
Q Consensus       574 L~~l~ls~N~l~g~-~p~~~~-~~~~~~~~~~n~~~  607 (1002)
                      |+.+|+|.|+|+-. +|.... .++....+.||+|+
T Consensus       454 L~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  454 LKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             ceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99999999999843 444322 67778899999974

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.5e-36  Score=333.51  Aligned_cols=249  Identities=24%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      ++||+|+||.||+|+.+ +++.||+|++.+..              .........+..|..+++++ +||||+++++++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~--------------~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~   66 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL--------------VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ   66 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE
Confidence            47999999999999964 68899999985431              11233455688999999998 6999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +.+..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          67 TESRLFFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCc
Confidence            99999999999999999998864  45699999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC----chhHHHHHHHHhhc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG----EKDLVKWVCSTLDQ  922 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~----~~~~~~~~~~~~~~  922 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....    ......+.......
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  219 (329)
T cd05588         142 MCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             cccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence            987532221  122345799999999999999999999999999999999999999963211    11122222222222


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA------MRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~evl~  967 (1002)
                      ....  +.   ...    ..++.+++.+|++.||.+||+      ++++++
T Consensus       220 ~~~~--~p---~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         220 KQIR--IP---RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCC--CC---CCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            1111  00   111    224778999999999999997      667763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-35  Score=326.59  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=204.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.+.||+|+||.||+|...+      ...+|+|.+...                ........+.+|+++++++ +|
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----------------~~~~~~~~~~~E~~~l~~l~~h   75 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----------------ATEKDLSDLVSEMEMMKMIGKH   75 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----------------CCHHHHHHHHHHHHHHHhhcCC
Confidence            467788899999999999998642      367999987431                1122345688999999999 79


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--------------KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS  821 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  821 (1002)
                      |||+++++++..++..+++|||+++|+|.++++..              ....+++..+++++.|++.||+|||++   +
T Consensus        76 ~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~  152 (293)
T cd05053          76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---K  152 (293)
T ss_pred             CCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            99999999999999999999999999999998642              235789999999999999999999998   9


Q ss_pred             eeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CC
Q 001867          822 IVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GR  900 (1002)
Q Consensus       822 iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~  900 (1002)
                      |+||||||+||+++.++.+||+|||.++...............++..|+|||+..+..++.++|||||||++||+++ |.
T Consensus       153 ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  232 (293)
T cd05053         153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  232 (293)
T ss_pred             ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence            99999999999999999999999999987655433222223345678999999988899999999999999999998 88


Q ss_pred             CCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          901 LPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       901 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .||..... .+..+.......   .     +...    ....++.+++.+||+.||++|||++|+++.|+.+.
T Consensus       233 ~p~~~~~~-~~~~~~~~~~~~---~-----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         233 SPYPGIPV-EELFKLLKEGYR---M-----EKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCCCH-HHHHHHHHcCCc---C-----CCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            88864322 222222211110   0     0011    11235889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.6e-36  Score=333.04  Aligned_cols=244  Identities=26%  Similarity=0.347  Sum_probs=194.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC-Cceeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH-KNIVKL  761 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l  761 (1002)
                      +|++.+.||+|+||.||+|+.+ +++.||||++.+..              .......+.+..|++++..++| ++|+++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~   66 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------------IIQDDDVECTMVEKRVLALPGKPPFLTQL   66 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhcCCCCceeee
Confidence            4778899999999999999965 47889999985421              1122345668889999999976 568899


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k  141 (324)
T cd05587          67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIK  141 (324)
T ss_pred             EEEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEE
Confidence            9999999999999999999999999874  35689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++.......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....+.    
T Consensus       142 L~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~----  214 (324)
T cd05587         142 IADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQSIM----  214 (324)
T ss_pred             EeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHH----
Confidence            99999987533221  1233457999999999999999999999999999999999999999754322 2222111    


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      .....  +   .....    .++.+++.+|++.||++|++.
T Consensus       215 ~~~~~--~---~~~~~----~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         215 EHNVS--Y---PKSLS----KEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             cCCCC--C---CCCCC----HHHHHHHHHHhhcCHHHcCCC
Confidence            11000  0   01112    247789999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.7e-36  Score=340.10  Aligned_cols=254  Identities=21%  Similarity=0.277  Sum_probs=194.7

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..++||+|+||.||+|+. .+++.||+|++.+.              ........+.+.+|+.++++++||||++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~--------------~~~~~~~~~~~~~E~~il~~~~h~~iv~~~   67 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK--------------DVLLRNQVAHVKAERDILAEADNEWVVRLY   67 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH--------------HhhhHHHHHHHHHHHHHHHhCCCCcCCeEE
Confidence            477889999999999999996 45889999998432              112234466789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+++..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        68 ~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL  142 (382)
T cd05625          68 YSFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKL  142 (382)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999874  35689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCC---------------------------------------------CcccccccccccccCcccccc
Q 001867          843 ADFGVAKVVDASGK---------------------------------------------PKSMSVIAGSCGYIAPEYAYT  877 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~  877 (1002)
                      +|||++........                                             .......+||+.|+|||++.+
T Consensus       143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  222 (382)
T cd05625         143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR  222 (382)
T ss_pred             eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence            99999753321000                                             000113468999999999999


Q ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCC
Q 001867          878 LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPI  957 (1002)
Q Consensus       878 ~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  957 (1002)
                      ..++.++||||+||++|||++|+.||..............    ..  .....|......+    +..+++.+++ .+|+
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----~~--~~~~~p~~~~~s~----~~~~li~~l~-~~p~  291 (382)
T cd05625         223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN----WQ--TSLHIPPQAKLSP----EASDLIIKLC-RGPE  291 (382)
T ss_pred             CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHc----cC--CCcCCCCcccCCH----HHHHHHHHHc-cCHh
Confidence            9999999999999999999999999976533222222111    00  0000111111222    2445555554 4899


Q ss_pred             CCCC---HHHHHH
Q 001867          958 NRPA---MRRVVK  967 (1002)
Q Consensus       958 ~Rps---~~evl~  967 (1002)
                      +|++   ++|+++
T Consensus       292 ~R~~~~~~~ei~~  304 (382)
T cd05625         292 DRLGKNGADEIKA  304 (382)
T ss_pred             HcCCCCCHHHHhc
Confidence            9987   888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.1e-36  Score=333.03  Aligned_cols=259  Identities=24%  Similarity=0.247  Sum_probs=203.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-C-----
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-H-----  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----  755 (1002)
                      .+|++.++||+|+||.|-+|.+ ++++.||||++++.                  ..-..+-..|+.+|..++ |     
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~------------------k~f~~Q~~~Ei~iL~~ln~~d~~~~  247 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK------------------KRFLRQAQIEIRILELLNKHDPDDK  247 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC------------------hHHHHHHHHHHHHHHHHhccCCCCC
Confidence            3788899999999999999995 56999999999653                  223455677999999996 4     


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      -|+|+++++|...++.|+|+|.+ ..+|.++++.++...++...++.|+.||+.||.+||+.   +|||+||||+|||+.
T Consensus       248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~  323 (586)
T KOG0667|consen  248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLK  323 (586)
T ss_pred             eeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeec
Confidence            49999999999999999999999 67999999999999999999999999999999999998   999999999999996


Q ss_pred             CCC--CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          836 GDF--GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       836 ~~~--~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      ..+  .+||+|||.|+.......     ...-+..|+|||++.+.+|+.+.||||||||+.||++|..-|.++...+.+.
T Consensus       324 ~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~  398 (586)
T KOG0667|consen  324 DPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA  398 (586)
T ss_pred             cCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence            543  699999999998765433     3456788999999999999999999999999999999976665553333322


Q ss_pred             HHHHHHh-----------------hc-c---------C-----------------ccccccc-cc---cCCCH-HHHHHH
Q 001867          914 KWVCSTL-----------------DQ-K---------G-----------------VDHVLDP-KL---DCCFK-EEICKV  944 (1002)
Q Consensus       914 ~~~~~~~-----------------~~-~---------~-----------------~~~~~~~-~~---~~~~~-~~~~~l  944 (1002)
                      .++....                 .. .         .                 .....-| ..   ..... .+-..+
T Consensus       399 ~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F  478 (586)
T KOG0667|consen  399 RIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF  478 (586)
T ss_pred             HHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence            2221110                 00 0         0                 0000001 00   01111 334467


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          945 LNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       945 ~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .+++.+|+..||.+|+|+.++++.
T Consensus       479 ~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  479 IDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             HHHHHHHhccCchhcCCHHHHhcC
Confidence            899999999999999999999853

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=330.02  Aligned_cols=246  Identities=28%  Similarity=0.393  Sum_probs=203.3

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      -+||+|.||+||.|++. +..++|||.+-..                 +....+-+..|+..-++++|.|||++.|++..
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-----------------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se  643 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-----------------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSE  643 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc-----------------cchhhccHHHHHHHHHHHhhHhHHHHhhccCC
Confidence            37999999999999965 4678999988322                 33345568899999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC-CCCCeEEcc
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLL--DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-GDFGARVAD  844 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~D  844 (1002)
                      ++..-|.||.+|||+|.++++. +.+++  .+.++-.+.+||++||.|||++   .|||||||-.||||+ -.|.+||+|
T Consensus       644 nGf~kIFMEqVPGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISD  719 (1226)
T KOG4279|consen  644 NGFFKIFMEQVPGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISD  719 (1226)
T ss_pred             CCeEEEEeecCCCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecc
Confidence            9999999999999999999986 66778  8888999999999999999999   999999999999995 678999999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL--RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      ||-++.+..-.  ..+....||..|||||++..+  .|..++|||||||++.||.||+.||..-.....  ..++-+   
T Consensus       720 FGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVG---  792 (1226)
T KOG4279|consen  720 FGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVG---  792 (1226)
T ss_pred             cccchhhccCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhc---
Confidence            99999875432  344567899999999999865  588999999999999999999999975433221  111111   


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                            +.+..+..+.+...+...++.+|+.+||..||+++++++.
T Consensus       793 ------myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  793 ------MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             ------ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                  1122244556666778899999999999999999999853

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.9e-35  Score=318.30  Aligned_cols=262  Identities=22%  Similarity=0.348  Sum_probs=209.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..              ...+....+.+.+|++++++++|++++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~~~ei~~l~~~~~~~i~~~   67 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF--------------EMMDAKARQDCLKEIDLLKQLDHPNVIKY   67 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecc--------------cccchhhHHHHHHHHHHHHhCCCCCeeee
Confidence            46888899999999999999975 7899999988432              11223446779999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++...+..++||||+++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~  144 (267)
T cd08224          68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGV  144 (267)
T ss_pred             eeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCc
Confidence            99999999999999999999999998653  235689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ++|+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.....  ...+.... 
T Consensus       145 ~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~-  219 (267)
T cd08224         145 VKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKK-  219 (267)
T ss_pred             EEEeccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhh-
Confidence            99999999876544322  12234688899999999988899999999999999999999999864321  11111111 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .......    +...   +.....+.+++.+||+.+|++||++.+|++.++++.
T Consensus       220 ~~~~~~~----~~~~---~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         220 IEKCDYP----PLPA---DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcCCCC----CCCh---hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1111111    1111   122235778999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.2e-36  Score=332.61  Aligned_cols=244  Identities=25%  Similarity=0.336  Sum_probs=191.1

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      +.||+|+||.||+|+.+ +++.||+|++.+..              .........+..|+.++.++ +||||+++++++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~   66 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL--------------VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   66 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH--------------hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE
Confidence            47999999999999964 57899999985431              11233455678899988877 7999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      ..+..|+||||+++|+|..++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          67 TESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCC
Confidence            99999999999999999988864  45699999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC----chhHHHHHHHHhhc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG----EKDLVKWVCSTLDQ  922 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~----~~~~~~~~~~~~~~  922 (1002)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    ......+.......
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~  219 (329)
T cd05618         142 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  219 (329)
T ss_pred             ccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence            9975432211  22345789999999999999999999999999999999999999953211    11112222222211


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      ....      .+.   ....++.+++.+|++.||++||++
T Consensus       220 ~~~~------~p~---~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         220 KQIR------IPR---SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCC------CCC---CCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1111      111   112347789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3e-35  Score=324.46  Aligned_cols=263  Identities=25%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-----------------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHH
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-----------------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA  745 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (1002)
                      .+|++.+.||+|+||.||+|...+                 +..||+|.+....                .....+.+.+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~   68 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----------------SDNAREDFLK   68 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----------------CHHHHHHHHH
Confidence            467888999999999999988643                 2458888874321                1244677899


Q ss_pred             HHHHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 001867          746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK---------GGLLDWPTRYKIIVDAAEGLSYLHH  816 (1002)
Q Consensus       746 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~  816 (1002)
                      |++++++++||||+++++++..++..+++|||+++++|.+++....         ...+++..++.++.|++.||+|||+
T Consensus        69 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~  148 (296)
T cd05051          69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES  148 (296)
T ss_pred             HHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999999997543         1268999999999999999999999


Q ss_pred             cCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHH
Q 001867          817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       817 ~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el  896 (1002)
                      +   +|+||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||
T Consensus       149 ~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el  225 (296)
T cd05051         149 L---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI  225 (296)
T ss_pred             c---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHH
Confidence            9   9999999999999999999999999999865443322223334567789999999888899999999999999999


Q ss_pred             Hh--CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          897 VT--GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       897 l~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      ++  |..||.... ..+.................. +.....    ..++.+++.+||+.||++|||+.|+++.|+
T Consensus       226 ~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         226 LTLCREQPYEHLT-DQQVIENAGHFFRDDGRQIYL-PRPPNC----PKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HhcCCCCCCCCcC-hHHHHHHHHhccccccccccC-CCccCC----CHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            98  667775432 222222222211111111111 111111    235889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.9e-36  Score=332.40  Aligned_cols=239  Identities=27%  Similarity=0.399  Sum_probs=190.9

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      +.||+|+||.||+|+.+ +++.||+|++.+..              .......+.+..|..+++.+ +||||+++++++.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   66 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV--------------ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ   66 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--------------HhhccHHHHHHHHHHHHHhccCCCchhceeeEEE
Confidence            47999999999999964 58899999985421              11223455677888888876 6999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      ..+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~iv~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG  141 (320)
T cd05590          67 TPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  141 (320)
T ss_pred             cCCEEEEEEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence            99999999999999999998874  35689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..+.+.   . ... 
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~---~-~~~-  213 (320)
T cd05590         142 MCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAIL---N-DEV-  213 (320)
T ss_pred             CCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHh---c-CCC-
Confidence            987543222  122345799999999999999999999999999999999999999975432 22222211   1 100 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                        ..+  ....    .++.+++.+|++.||++||++
T Consensus       214 --~~~--~~~~----~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 --VYP--TWLS----QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CCC--CCCC----HHHHHHHHHHcccCHHHCCCC
Confidence              001  1111    247789999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.4e-35  Score=326.01  Aligned_cols=282  Identities=23%  Similarity=0.373  Sum_probs=216.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCc----EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|+..+.||+|+||.||+|.+. +++    .||+|.+...                ........+.+|+.++++++|||
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~~~~l~h~n   70 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----------------TGPKANVEFMDEALIMASMDHPH   70 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----------------CCHHHHHHHHHHHHHHHhCCCCC
Confidence            46777889999999999999863 444    4688876321                11233446889999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++... ..++++||+++|+|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        71 iv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~  145 (303)
T cd05110          71 LVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSP  145 (303)
T ss_pred             cccEEEEEcCC-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCC
Confidence            99999998764 467999999999999998753 34689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||.... ..+...++
T Consensus       146 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~  224 (303)
T cd05110         146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLL  224 (303)
T ss_pred             CceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH
Confidence            9999999999987654433222333445778999999998889999999999999999998 889986432 22222322


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc--------ccCCCCCCCCC
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR--------SKTGKKDGKLS  988 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~--------~~~~~~~~~~~  988 (1002)
                      ....   ..     +.....    ..++.+++..||..+|++||+++++++.++++..+..        ....-.....+
T Consensus       225 ~~~~---~~-----~~~~~~----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (303)
T cd05110         225 EKGE---RL-----PQPPIC----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDS  292 (303)
T ss_pred             HCCC---CC-----CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeeccCCcCCCCCCchh
Confidence            2111   00     111112    2347789999999999999999999999998865432        22233556778


Q ss_pred             cchhhccccC
Q 001867          989 PYYHEDASDQ  998 (1002)
Q Consensus       989 ~~~~~~~~~~  998 (1002)
                      ||+.++-++|
T Consensus       293 ~~~~~~~~~~  302 (303)
T cd05110         293 KFFQNLLDEE  302 (303)
T ss_pred             hHHhcccccc
Confidence            8888876665

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.3e-36  Score=338.46  Aligned_cols=256  Identities=23%  Similarity=0.293  Sum_probs=198.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.+.              ........+.+.+|+.+++.++||||++
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF--------------EMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--------------HhhhhhhHHHHHHHHHHHHhCCCCCEee
Confidence            357888999999999999999975 5789999998432              1112334556889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++..   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence            99999999999999999999999999964   3588999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ||+|||++........ .......||+.|||||++.+.    .++.++||||+||++|||++|+.||........+....
T Consensus       182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~  260 (370)
T cd05621         182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999987654322 122345799999999998754    37889999999999999999999997653322222221


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPIN--RPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~  968 (1002)
                      .    ...... + |.....    ...+.+++..|+..+|.+  |++++|+++.
T Consensus       261 ~----~~~~~~-~-p~~~~~----s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         261 D----HKNSLN-F-PEDVEI----SKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             h----CCcccC-C-CCcccC----CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1    110000 0 110111    223567778888755543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=319.90  Aligned_cols=255  Identities=29%  Similarity=0.508  Sum_probs=206.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|..+++..||||.+...                  ....+++.+|+.++++++||||+++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~   66 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG------------------TMSPEAFLQEAQIMKKLRHDKLVQL   66 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC------------------ccCHHHHHHHHHHHhhCCCCCEeee
Confidence            3578889999999999999999888889999988432                  1224568999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++......++||||+++++|.+++.......+++..+..++.|++.|++|||++   +++||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~  143 (261)
T cd05034          67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCK  143 (261)
T ss_pred             eeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEE
Confidence            99999989999999999999999999875556799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ++|||.++........ ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... ...........
T Consensus       144 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~  221 (261)
T cd05034         144 IADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERGY  221 (261)
T ss_pred             ECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC
Confidence            9999999876542211 1112234568999999998889999999999999999999 9999865432 22222211111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                           ..   +.....    ..++.+++.+|++.+|++||+++++.+.|+.
T Consensus       222 -----~~---~~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 -----RM---PRPPNC----PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----CC---CCCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                 00   111111    2347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-35  Score=316.58  Aligned_cols=252  Identities=27%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|..+ +++.|++|.+...               .......+.+.+|++++++++||||++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   65 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS---------------KMNRREREEAIDEARVLAKLDSSYIIRYY   65 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehh---------------hCCHHHHHHHHHHHHHHHhcCCCCeehhe
Confidence            4677889999999999999964 6899999987432               11234566789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..|+||||+++++|.++++......+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++|
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l  142 (256)
T cd08529          66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKI  142 (256)
T ss_pred             eeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEE
Confidence            9999999999999999999999999876567899999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||+++........  .....|++.|+|||+..+..++.++||||||+++|||++|+.||.... .........    .
T Consensus       143 ~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~----~  215 (256)
T cd08529         143 GDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKII----R  215 (256)
T ss_pred             cccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH----c
Confidence            999999876543221  234468889999999999889999999999999999999999997543 222221111    1


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ...    .+...    .....+.+++.+||+.+|++||++.++++.
T Consensus       216 ~~~----~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 GVF----PPVSQ----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCC----CCCcc----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            111    11111    122358889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-35  Score=317.19  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=197.0

Q ss_pred             eeeecCCccEEEEEE---cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          690 VIGSGSSGKVYKVVL---SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      .||+|+||.||+|.+   .++..+|+|++...               ..+....+.+..|+.++++++||||+++++++.
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   66 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND---------------NNDPALKDELLREANVMQQLDNPYIVRMIGICE   66 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC---------------CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            689999999999975   35788999987432               112345677899999999999999999999886


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      . +..++||||+++|+|.+++..  ...+++..+.+++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~-~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg  140 (257)
T cd05116          67 A-ESWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFG  140 (257)
T ss_pred             C-CCcEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCc
Confidence            4 467899999999999999974  35689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          847 VAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       847 l~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ++........... .....+++.|+|||.+....++.++|||||||++|||++ |..||.... ..+....+..    ..
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~i~~----~~  215 (257)
T cd05116         141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMIES----GE  215 (257)
T ss_pred             cccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHC----CC
Confidence            9987654432111 122234578999999988889999999999999999998 999996542 2333332221    11


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ...    .....+    .++.+++.+||++||++||++++|++.|++.
T Consensus       216 ~~~----~~~~~~----~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RME----CPQRCP----PEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCC----CCCCCC----HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            111    111222    3477899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-35  Score=334.63  Aligned_cols=265  Identities=25%  Similarity=0.298  Sum_probs=199.5

Q ss_pred             HHHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          678 EYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       678 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      .+.+.++|++.+.||+|+||.||+|.. .+|+.||+|++...               .........+.+|+.+++.++||
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~   80 (359)
T cd07876          16 TFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---------------FQNQTHAKRAYRELVLLKCVNHK   80 (359)
T ss_pred             hhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc---------------ccchhHHHHHHHHHHHHHhCCCC
Confidence            356678999999999999999999986 45899999998432               11233456788999999999999


Q ss_pred             ceeeeeeEEecCC------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          757 NIVKLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       757 niv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      ||+++++++...+      ..|+||||++ +++.+.+.    ..+++..+..++.|++.||+|||++   +|+||||||+
T Consensus        81 niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~  152 (359)
T cd07876          81 NIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS  152 (359)
T ss_pred             CEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHH
Confidence            9999999986543      4799999995 56766664    2478999999999999999999999   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      ||+++.++.+||+|||+++......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......
T Consensus       153 NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~  229 (359)
T cd07876         153 NIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID  229 (359)
T ss_pred             HEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999997543321   2234568999999999999999999999999999999999999997543222


Q ss_pred             hHHHHHHH------------------Hhhcc-Cc-----cccc----cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          911 DLVKWVCS------------------TLDQK-GV-----DHVL----DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       911 ~~~~~~~~------------------~~~~~-~~-----~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      ........                  ..... ..     .+..    .+............+.+++.+|++.||++|||+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  309 (359)
T cd07876         230 QWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV  309 (359)
T ss_pred             HHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH
Confidence            11111100                  00000 00     0000    000000001112347789999999999999999


Q ss_pred             HHHHHH
Q 001867          963 RRVVKL  968 (1002)
Q Consensus       963 ~evl~~  968 (1002)
                      +|+++.
T Consensus       310 ~e~l~h  315 (359)
T cd07876         310 DEALRH  315 (359)
T ss_pred             HHHhcC
Confidence            999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=318.74  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=203.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+......            .......+.+.+|++++++++||||+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~   69 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS------------PETKKEVNALECEIQLLKNLQHERIVQY   69 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc------------hhhHHHHHHHHHHHHHHHhCCCCCeeee
Confidence            4688899999999999999986 46899999988543111            1112334678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..++||||+++++|.+++..  .+.+++..+.+++.|++.|++|||+.   +|+||||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~  144 (263)
T cd06625          70 YGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVK  144 (263)
T ss_pred             EEEEccCCeEEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            9999999999999999999999999874  35689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++.......... .....|+..|+|||++.+..++.++||||+|+++|||++|+.||............    .
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~  220 (263)
T cd06625         145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI----A  220 (263)
T ss_pred             EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH----h
Confidence            999999976543221111 12345788999999999988999999999999999999999999654322222111    1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .....     +...   ......+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~-----~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 TQPTN-----PQLP---SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccCCC-----CCCC---ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11100     1111   1122347889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-35  Score=325.50  Aligned_cols=262  Identities=25%  Similarity=0.373  Sum_probs=206.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc--------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS--------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI  753 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  753 (1002)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.+...                ........+.+|+.+++.+
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----------------~~~~~~~~~~~E~~~l~~l   77 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----------------ATEKDLSDLVSEMEMMKMI   77 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----------------cchHHHHHHHHHHHHHHhh
Confidence            356788899999999999999741        2457999987321                1223456789999999999


Q ss_pred             -CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 001867          754 -RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDC  818 (1002)
Q Consensus       754 -~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~  818 (1002)
                       +||||+++++++...+..|++|||+++|+|.+++...+              ...+++.++..++.|++.||+|||++ 
T Consensus        78 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-  156 (304)
T cd05101          78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-  156 (304)
T ss_pred             ccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-
Confidence             79999999999999999999999999999999997642              23578899999999999999999999 


Q ss_pred             CCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh
Q 001867          819 VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT  898 (1002)
Q Consensus       819 ~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~  898 (1002)
                        +|+||||||+||+++.++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++
T Consensus       157 --givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~  234 (304)
T cd05101         157 --KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT  234 (304)
T ss_pred             --CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence              999999999999999999999999999987755433333333456778999999998889999999999999999998


Q ss_pred             -CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          899 -GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       899 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                       |..||... +..+....+....   . .    ......    ...+.+++.+||+.+|++||++.|+++.|+++...
T Consensus       235 ~g~~p~~~~-~~~~~~~~~~~~~---~-~----~~~~~~----~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         235 LGGSPYPGI-PVEELFKLLKEGH---R-M----DKPANC----TNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CCCCCcccC-CHHHHHHHHHcCC---c-C----CCCCCC----CHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence             77777543 2222222221111   0 0    011112    23477899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9e-36  Score=332.00  Aligned_cols=245  Identities=27%  Similarity=0.402  Sum_probs=194.6

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      ++||+|+||.||+|+.+ +++.||+|++.+..              .......+.+..|.++++.+ +||||+++++++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~   66 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV--------------ILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ   66 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHH--------------hhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence            46999999999999965 47899999985421              11223445677889998876 7999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +++..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          67 TKDRLFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecc
Confidence            99999999999999999998874  45689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      ++........  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....+.   ...   
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~~~~i~---~~~---  212 (321)
T cd05591         142 MCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DLFESIL---HDD---  212 (321)
T ss_pred             cceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HHHHHHH---cCC---
Confidence            9875433221  223456899999999999989999999999999999999999999755322 2222111   111   


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-------AMRRVVKL  968 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-------s~~evl~~  968 (1002)
                       ...|  ....    .++.+++..|++.||++||       +++++++.
T Consensus       213 -~~~p--~~~~----~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 -VLYP--VWLS----KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -CCCC--CCCC----HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             0011  1111    2477889999999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-35  Score=332.04  Aligned_cols=261  Identities=24%  Similarity=0.350  Sum_probs=201.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.+.||+|+||.||+|.+      .+++.||||++....                .......+.+|+.++.++ +|
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~h   70 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGHH   70 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----------------ChHHHHHHHHHHHHHHhccCC
Confidence            5688899999999999999974      346789999984321                122345688999999999 68


Q ss_pred             CceeeeeeEEecC-CeeeEEEeccCCCChhhhhhhcC-------------------------------------------
Q 001867          756 KNIVKLWCCCTTR-DCKLLVYEYMPNGSLGDLLHSCK-------------------------------------------  791 (1002)
Q Consensus       756 ~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------  791 (1002)
                      |||+++++++... ...+++|||+++|+|.+++....                                           
T Consensus        71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (343)
T cd05103          71 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASS  150 (343)
T ss_pred             ccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccc
Confidence            9999999988654 56789999999999999986532                                           


Q ss_pred             ----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          792 ----------------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       792 ----------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                                            ...+++..+.+++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~  227 (343)
T cd05103         151 GFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR  227 (343)
T ss_pred             cccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEeccccc
Confidence                                  12478888999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCcccc
Q 001867          850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV  928 (1002)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (1002)
                      ...............++..|+|||++.+..++.++||||||+++|||++ |..||............+....    ... 
T Consensus       228 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~-  302 (343)
T cd05103         228 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT----RMR-  302 (343)
T ss_pred             ccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC----CCC-
Confidence            6543322122222345678999999988899999999999999999997 8888865433222222211111    000 


Q ss_pred             ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                       .+  ....    .++.+++..||+.+|++||++.|+++.|+.+.+
T Consensus       303 -~~--~~~~----~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         303 -AP--DYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             -CC--CCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             01  1111    247889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.9e-35  Score=316.31  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=196.1

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      +.||+|+||.||+|... +++.||+|.+...                ........+.+|++++++++||||+++++++..
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   64 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----------------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ   64 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc----------------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            46999999999999964 6889999987321                123345678999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      .+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        65 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  140 (252)
T cd05084          65 KQPIYIVMELVQGGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGM  140 (252)
T ss_pred             CCCeEEEEeeccCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECcccc
Confidence            9999999999999999999874 335689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +................++..|+|||.+.++.++.++||||+|+++|||++ |..||..... .........    .. .
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~~~~~~~~~----~~-~  214 (252)
T cd05084         141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIEQ----GV-R  214 (252)
T ss_pred             CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-HHHHHHHHc----CC-C
Confidence            876543221111112223457999999998889999999999999999998 8888854322 221111111    00 0


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      .   +.....    ...+.+++.+|++.+|++||++.++.+.|+
T Consensus       215 ~---~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 L---PCPELC----PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             C---CCcccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            0   111111    235788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-35  Score=323.55  Aligned_cols=267  Identities=28%  Similarity=0.394  Sum_probs=199.6

Q ss_pred             CCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      |.+.+.||+|+||+||++..     .+++.||+|.+....                .....+.+.+|++++++++||||+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~   69 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----------------GQQNTSGWKKEINILKTLYHENIV   69 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----------------ChHHHHHHHHHHHHHHhCCCCCEe
Confidence            37788999999999988653     357789999874321                122456788999999999999999


Q ss_pred             eeeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++...  ...+++|||+++++|.+++..   ..+++..++.++.|++.|++|||++   +|+||||||+||+++.+
T Consensus        70 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~  143 (283)
T cd05080          70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDND  143 (283)
T ss_pred             eEEEEEecCCCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCC
Confidence            999988653  467999999999999999974   3489999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-hhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-KDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~-~~~~~~  915 (1002)
                      +.+||+|||+++.......... .....++..|+|||...+..++.++||||||+++|||++|..|+...... .+....
T Consensus       144 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~  223 (283)
T cd05080         144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP  223 (283)
T ss_pred             CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc
Confidence            9999999999987654322111 11223566799999998888999999999999999999999998643211 011100


Q ss_pred             HHHHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          916 VCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .............++... ...+.....++.+++..||+.+|++|||++++++.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         224 KQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            000000000000011000 0011112235888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-35  Score=321.45  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|.+.+.||+|+||.||+|.+.+      +..||+|.+...                ........+.+|+.++++++|+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~----------------~~~~~~~~~~~e~~~l~~l~~~   69 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES----------------CSEQDESDFLMEALIMSKFNHQ   69 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC----------------CCHHHHHHHHHHHHHHHhCCCC
Confidence            467788999999999999999753      567888876321                1233456789999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-----GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ||+++++++.+.+..++||||+++++|.++++..+.     ..+++..+.+++.||+.|++|||++   +++||||||+|
T Consensus        70 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~n  146 (277)
T cd05036          70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARN  146 (277)
T ss_pred             CEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhe
Confidence            999999999999999999999999999999976432     3589999999999999999999999   99999999999


Q ss_pred             EEECCCC---CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 001867          832 ILLDGDF---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF  907 (1002)
Q Consensus       832 Ill~~~~---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~  907 (1002)
                      |+++.++   .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       147 il~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         147 CLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             EEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9998654   589999999987643322222222234568999999998899999999999999999997 999986543


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      .. .....+..   .....     .....+    ..+.+++.+||+.+|++||++++|++.|+
T Consensus       227 ~~-~~~~~~~~---~~~~~-----~~~~~~----~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         227 NQ-EVMEFVTG---GGRLD-----PPKGCP----GPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HH-HHHHHHHc---CCcCC-----CCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22 22222111   11000     011122    34788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-35  Score=323.34  Aligned_cols=264  Identities=22%  Similarity=0.362  Sum_probs=201.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC---------------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHH
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN---------------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV  747 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  747 (1002)
                      ++|++.+.||+|+||.||+|...+               ...||+|.+....                .....+.+.+|+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~ei   68 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----------------TKTARNDFLKEI   68 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----------------CHHHHHHHHHHH
Confidence            467888999999999999987542               2358999874321                223456799999


Q ss_pred             HHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHhhc
Q 001867          748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----------GGLLDWPTRYKIIVDAAEGLSYLHHD  817 (1002)
Q Consensus       748 ~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~  817 (1002)
                      +++++++|||++++++++...+..++||||+++++|.+++....          ...+++..+..++.|++.|++|||++
T Consensus        69 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  148 (295)
T cd05097          69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL  148 (295)
T ss_pred             HHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999999999999986432          12478899999999999999999999


Q ss_pred             CCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHH
Q 001867          818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV  897 (1002)
Q Consensus       818 ~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  897 (1002)
                         +++||||||+||+++.++.+||+|||++................++..|+|||+..++.++.++|||||||++|||+
T Consensus       149 ---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~  225 (295)
T cd05097         149 ---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF  225 (295)
T ss_pred             ---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHH
Confidence               99999999999999999999999999998654433222222334567899999998888999999999999999999


Q ss_pred             h--CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          898 T--GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       898 ~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      +  |..||..... .+............. ...........+    ..+.+++.+||+.||++||++++|++.|++
T Consensus       226 ~~~~~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         226 TLCKEQPYSLLSD-EQVIENTGEFFRNQG-RQIYLSQTPLCP----SPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HcCCCCCCcccCh-HHHHHHHHHhhhhcc-ccccCCCCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            8  5667754332 222222211111110 000001111112    358899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-36  Score=335.45  Aligned_cols=240  Identities=26%  Similarity=0.338  Sum_probs=192.1

Q ss_pred             CeeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          689 NVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +.||+|+||.||+++.    .+|+.||+|++.+..               ........+..|++++++++||||++++++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   66 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---------------LKVRDRVRTKMERDILAEVNHPFIVKLHYA   66 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH---------------hhhhhHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            5799999999999875    357899999985421               112234567889999999999999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      +.+++..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        67 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~D  141 (318)
T cd05582          67 FQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD  141 (318)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEee
Confidence            9999999999999999999999864  45689999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+   .. ..
T Consensus       142 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~i---~~-~~  214 (318)
T cd05582         142 FGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTMI---LK-AK  214 (318)
T ss_pred             ccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHHH---Hc-CC
Confidence            99998654331  122345789999999999988899999999999999999999999975432 2211111   11 10


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR  964 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  964 (1002)
                      ..  +.   ...    ...+.+++.+||+.||++||++.+
T Consensus       215 ~~--~p---~~~----~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LG--MP---QFL----SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CC--CC---CCC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            00  00   111    124778899999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.7e-35  Score=326.18  Aligned_cols=261  Identities=26%  Similarity=0.391  Sum_probs=204.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc--------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS--------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-  753 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  753 (1002)
                      ++|.+.+.||+|+||.||+|+..        ....||+|.+...                ........+.+|+.+++++ 
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~   75 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----------------ATDKDLADLISEMELMKLIG   75 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----------------CChHHHHHHHHHHHHHHhcc
Confidence            46778899999999999999742        2456899987421                1123356688999999999 


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      +||||+++++++...+..+++|||+++|+|.+++....              ...+++..+.+++.|++.||+|||++  
T Consensus        76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--  153 (314)
T cd05099          76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR--  153 (314)
T ss_pred             CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC--
Confidence            59999999999999999999999999999999997532              24589999999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +|+||||||+||+++.++.+||+|||.++...............++..|||||++.+..++.++|||||||++|||++ 
T Consensus       154 -gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~  232 (314)
T cd05099         154 -RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL  232 (314)
T ss_pred             -CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence             999999999999999999999999999986654322222222234567999999998889999999999999999999 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      |..||... ...+.......    ....    +.....    ..++.+++.+||+.+|++||++.|+++.|+++...
T Consensus       233 g~~p~~~~-~~~~~~~~~~~----~~~~----~~~~~~----~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         233 GGSPYPGI-PVEELFKLLRE----GHRM----DKPSNC----THELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             CCCCCCCC-CHHHHHHHHHc----CCCC----CCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            88888543 22222222211    1100    011112    22477899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=316.46  Aligned_cols=253  Identities=24%  Similarity=0.285  Sum_probs=213.5

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      -.|.+-|+..+.||+|.|..|-.|+ .-+|++||||++.+.               ..+.....++.+|+..|+-++|||
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKT---------------KlD~~st~hlfqEVRCMKLVQHpN   78 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKT---------------KLDTLSTGHLFQEVRCMKLVQHPN   78 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccc---------------ccchhhhhHHHHHHHHHHHhcCcC
Confidence            3456678888999999999999998 457999999999553               224556778999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-CC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-DG  836 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll-~~  836 (1002)
                      ||++|++......+|+|.|.-++|+|.+|+-.+. ..+.+.-..+++.||+.|+.|+|+.   .+|||||||+||++ ..
T Consensus        79 iVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEK  154 (864)
T KOG4717|consen   79 IVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEK  154 (864)
T ss_pred             eeeeeehhcccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeee
Confidence            9999999999999999999999999999987644 4599999999999999999999998   99999999999987 56


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      -|-+|+.|||++-.+.++.+.   ...+|+..|-|||++.+..|+ +++||||+|||+|-+++|+.||....+.+.+..+
T Consensus       155 lGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI  231 (864)
T KOG4717|consen  155 LGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI  231 (864)
T ss_pred             cCceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh
Confidence            789999999999888776543   355899999999999998886 6899999999999999999999876665555443


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +.             .+. ..+.....++.++|..|+..||++|.+.+||+.
T Consensus       232 mD-------------CKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  232 MD-------------CKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hc-------------ccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            32             221 112233446889999999999999999999874

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-35  Score=323.98  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=201.1

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +|.+.+.||+|+||.||+|...+      +..||+|++....                .....+.+.+|+.++++++|||
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~~~~l~h~~   69 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----------------EGPLREEFKHEAMMRSRLQHPN   69 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----------------CHHHHHHHHHHHHHHhcCCCCC
Confidence            35556789999999999998632      4789999884211                1223567899999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--------------KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIV  823 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  823 (1002)
                      |+++++++...+..++++||+++++|.+++...              ....+++..+..++.|++.||+|+|++   +|+
T Consensus        70 iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~  146 (283)
T cd05091          70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVV  146 (283)
T ss_pred             cCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Ccc
Confidence            999999999999999999999999999998531              124588899999999999999999999   999


Q ss_pred             eCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCC
Q 001867          824 HRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP  902 (1002)
Q Consensus       824 HrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p  902 (1002)
                      ||||||+||+++.++.+||+|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..|
T Consensus       147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  226 (283)
T cd05091         147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP  226 (283)
T ss_pred             ccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999886654333222233446789999999988889999999999999999998 7778


Q ss_pred             CCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      |.... ..+..+.+..    ....    +....++    ..+.+++..||+.+|++||++++|+..|+.
T Consensus       227 ~~~~~-~~~~~~~i~~----~~~~----~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         227 YCGYS-NQDVIEMIRN----RQVL----PCPDDCP----AWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCCCC-HHHHHHHHHc----CCcC----CCCCCCC----HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            75432 2222222211    1111    1112222    347889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-35  Score=330.67  Aligned_cols=244  Identities=25%  Similarity=0.336  Sum_probs=193.6

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKL  761 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  761 (1002)
                      +|++.+.||+|+||.||+|+.. +++.||+|++.+..              .......+.+..|..++..+ +|++|+++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~   66 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------------VIQDDDVECTMVEKRVLALSGKPPFLTQL   66 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhccCCCeEeeE
Confidence            4778899999999999999965 57899999985421              11223345567788888877 48999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~k  141 (323)
T cd05616          67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             EEEEecCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEE
Confidence            9999999999999999999999998874  35689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..   
T Consensus       142 L~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~---  215 (323)
T cd05616         142 IADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIME---  215 (323)
T ss_pred             EccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHh---
Confidence            99999997543222  122345799999999999999999999999999999999999999975432 222222111   


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                       ....  +.   ...    ..++.+++.+|++.||++|++.
T Consensus       216 -~~~~--~p---~~~----s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         216 -HNVA--YP---KSM----SKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCC--CC---CcC----CHHHHHHHHHHcccCHHhcCCC
Confidence             1100  00   111    2347789999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.6e-35  Score=322.05  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-----------------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHH
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-----------------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA  745 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  745 (1002)
                      ++|++.+.||+|+||.||+|...                 ++..||+|.+...                .......++.+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----------------~~~~~~~~~~~   68 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----------------ANKNARNDFLK   68 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----------------CCHHHHHHHHH
Confidence            45888899999999999998643                 2346888887321                12334567899


Q ss_pred             HHHHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHhh
Q 001867          746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG---------GLLDWPTRYKIIVDAAEGLSYLHH  816 (1002)
Q Consensus       746 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~  816 (1002)
                      |+.++++++|+||+++++++...+..++||||+++|+|.+++.....         ..+++..+..++.|++.|++|||+
T Consensus        69 E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~  148 (296)
T cd05095          69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS  148 (296)
T ss_pred             HHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999999999875321         347788999999999999999999


Q ss_pred             cCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHH
Q 001867          817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       817 ~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el  896 (1002)
                      +   +|+||||||+||+++.++.++++|||+++...............++..|+|||...++.++.++|||||||++|||
T Consensus       149 ~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el  225 (296)
T cd05095         149 L---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI  225 (296)
T ss_pred             C---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHH
Confidence            9   9999999999999999999999999999866443322222223446789999998888899999999999999999


Q ss_pred             Hh--CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          897 VT--GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       897 l~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      ++  |..||..... .+............. .....+.....+    ..+.+++.+||+.||++||+++||++.|++
T Consensus       226 ~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         226 LTLCKEQPYSQLSD-EQVIENTGEFFRDQG-RQVYLPKPALCP----DSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHhCCCCCccccCh-HHHHHHHHHHHhhcc-ccccCCCCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            98  6778854322 222221111111111 111111112222    357889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=343.68  Aligned_cols=262  Identities=23%  Similarity=0.271  Sum_probs=194.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|... +++.||||++...                     .....+|+.++++++||||+++
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---------------------~~~~~~Ei~il~~l~h~niv~l  124 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---------------------PQYKNRELLIMKNLNHINIIFL  124 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---------------------cchHHHHHHHHHhcCCCCCcce
Confidence            46888999999999999999964 5889999987321                     1224579999999999999999


Q ss_pred             eeEEecC--------CeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          762 WCCCTTR--------DCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       762 ~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ++++...        ...++||||++ +++.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus       125 ~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~N  200 (440)
T PTZ00036        125 KDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQN  200 (440)
T ss_pred             eeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHH
Confidence            9887532        24678999996 5777776532  346799999999999999999999999   99999999999


Q ss_pred             EEECCCC-CeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          832 ILLDGDF-GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       832 Ill~~~~-~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      |+++.++ .+||+|||+++.......   .....||+.|+|||++.+ ..++.++||||+||++|||++|..||......
T Consensus       201 ILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  277 (440)
T PTZ00036        201 LLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV  277 (440)
T ss_pred             EEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            9998665 699999999987654322   223468999999998765 46899999999999999999999999766544


Q ss_pred             hhHHHHHHHHhhc---------cCcccccccc-----ccC-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHHh
Q 001867          910 KDLVKWVCSTLDQ---------KGVDHVLDPK-----LDC-CFKEEICKVLNIGLLCTSPLPINRPAMRRVV--KLLQEV  972 (1002)
Q Consensus       910 ~~~~~~~~~~~~~---------~~~~~~~~~~-----~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl--~~L~~~  972 (1002)
                      +.+.+........         .......-+.     +.. .+.....++.+++.+||+.||.+|||+.|++  .+++++
T Consensus       278 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        278 DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            4433332211000         0000000000     000 0001123578899999999999999999998  445544

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.7e-35  Score=325.78  Aligned_cols=243  Identities=26%  Similarity=0.377  Sum_probs=191.1

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      +.||+|+||.||+|... +++.||||++.....              ......+.+..|..+++.. +||||+++++++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~   66 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--------------LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ   66 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--------------hhcchHHHHHHHHHHHHhccCCCcCcceEEEEE
Confidence            47999999999999965 578999999854311              0112334566778888764 8999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +.+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          67 TKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence            99999999999999999999974  35689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..+.+.    ...  
T Consensus       142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~----~~~--  212 (316)
T cd05619         142 MCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIR----MDN--  212 (316)
T ss_pred             cceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHH----hCC--
Confidence            9875432211  22345689999999999998999999999999999999999999975422 22222211    110  


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR-RVV  966 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl  966 (1002)
                          +..+...   ..++.+++.+||+.||++||++. ++.
T Consensus       213 ----~~~~~~~---~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         213 ----PCYPRWL---TREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ----CCCCccC---CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                1111111   12467889999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.3e-35  Score=315.81  Aligned_cols=249  Identities=29%  Similarity=0.410  Sum_probs=200.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|... ++.||+|.+..                   ....+.+.+|+.++++++|+|+++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~-------------------~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN-------------------DATAQAFLAEASVMTQLRHSNLVQLL   65 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCC-------------------CchHHHHHHHHHHHHhCCCCCeeeEE
Confidence            46788899999999999999875 78899998732                   11245688999999999999999999


Q ss_pred             eEEe-cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCT-TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++. .++..+++|||+++++|.++++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~k  142 (256)
T cd05082          66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAK  142 (256)
T ss_pred             EEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEE
Confidence            9765 456789999999999999999875556689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ++|||++.......     ....++..|+|||+..+..++.++||||||+++|||++ |+.||... ...+....+....
T Consensus       143 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~~  216 (256)
T cd05082         143 VSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGY  216 (256)
T ss_pred             ecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCC
Confidence            99999987554322     12234568999999998889999999999999999998 88888543 2222222222111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .    ..    .....+    ..+.+++.+||+.+|++|||++++++.|+++
T Consensus       217 ~----~~----~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 K----MD----APDGCP----PVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             C----CC----CCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            0    00    011222    3478899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=321.14  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=204.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|++.+.||+|+||.||+|..++      +..||+|.+...                ........+.+|+.+++.++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----------------~~~~~~~~~~~e~~~l~~~~~~   69 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----------------ASMRERIEFLNEASVMKEFNCH   69 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----------------cCHHHHHHHHHHHHHHHhCCCC
Confidence            567888999999999999998642      368999987432                1223356788999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK  828 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk  828 (1002)
                      ||+++++++......++||||+++|+|.+++....        ...+++..+..++.|++.||+|||+.   +|+|||||
T Consensus        70 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~  146 (277)
T cd05032          70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLA  146 (277)
T ss_pred             ceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccC
Confidence            99999999999999999999999999999987532        23478899999999999999999998   99999999


Q ss_pred             CCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 001867          829 SNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF  907 (1002)
Q Consensus       829 ~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~  907 (1002)
                      |+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||... 
T Consensus       147 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-  225 (277)
T cd05032         147 ARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-  225 (277)
T ss_pred             hheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-
Confidence            9999999999999999999986654433222334456789999999988889999999999999999998 88888643 


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      +.....+...    .......    ....    ..++.+++.+||+.+|++|||+.++++.|+
T Consensus       226 ~~~~~~~~~~----~~~~~~~----~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         226 SNEEVLKFVI----DGGHLDL----PENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CHHHHHHHHh----cCCCCCC----CCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            2333333322    1111111    1111    235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.2e-35  Score=326.41  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=191.4

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      ++||+|+||.||+|+.+ +|+.||+|++.+...              ......+.+..|..++... +||+|+++++++.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   66 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--------------LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ   66 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--------------hhcchHHHHHHHHHHHHhccCCCCccCeeEEEE
Confidence            47999999999999975 588999999854211              0112344567788888764 8999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +.+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          67 TKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             eCCEEEEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence            99999999999999999999874  45689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+.    ...  
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~----~~~--  212 (316)
T cd05620         142 MCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIR----VDT--  212 (316)
T ss_pred             CCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHH----hCC--
Confidence            987532221  123345799999999999999999999999999999999999999975432 22222111    110  


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR-RVV  966 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl  966 (1002)
                          +......   ..++.+++.+|++.||++||++. ++.
T Consensus       213 ----~~~~~~~---~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 ----PHYPRWI---TKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCCCCC---CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                1111111   12477899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.7e-35  Score=325.24  Aligned_cols=261  Identities=25%  Similarity=0.351  Sum_probs=204.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc--------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS--------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-  753 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  753 (1002)
                      ++|.+.+.||+|+||.||+|...        ++..||+|.+....                ......++..|+.+++++ 
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~   81 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----------------TEKDLSDLISEMEMMKMIG   81 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----------------ChHHHHHHHHHHHHHHHhc
Confidence            56888899999999999999752        23569999874320                123345688899999999 


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------------GLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      +||||+++++++...+..|+||||+++|+|.+++...+.              ..+++..+.+++.|++.||+|||++  
T Consensus        82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--  159 (307)
T cd05098          82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK--  159 (307)
T ss_pred             CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            799999999999999999999999999999999975421              3589999999999999999999998  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +++||||||+||+++.++.+||+|||.++...............+++.|+|||++.+..++.++||||+||++|||++ 
T Consensus       160 -gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~  238 (307)
T cd05098         160 -KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL  238 (307)
T ss_pred             -CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence             999999999999999999999999999976643322122222234568999999998889999999999999999998 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      |..||... ...+....+..    ....    +....    ...++.+++.+||+.+|++||++.++++.|+++.+.
T Consensus       239 g~~p~~~~-~~~~~~~~~~~----~~~~----~~~~~----~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         239 GGSPYPGV-PVEELFKLLKE----GHRM----DKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             CCCCCCcC-CHHHHHHHHHc----CCCC----CCCCc----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            78887543 22222222211    1100    11111    123577899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-35  Score=314.96  Aligned_cols=249  Identities=29%  Similarity=0.427  Sum_probs=204.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|... |+.||+|.+...                  ....+++.+|+.++++++|+||++++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i~~~~   66 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDD------------------STAAQAFLAEASVMTTLRHPNLVQLL   66 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccc------------------hhHHHHHHHHHHHHHhcCCcceeeeE
Confidence            56788899999999999999875 789999998431                  11456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..++||||+++++|.++++......+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||
T Consensus        67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l  143 (256)
T cd05039          67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKV  143 (256)
T ss_pred             EEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEE
Confidence            9999999999999999999999999865555799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.++.......     ...++..|+|||++.+..++.++||||||+++||+++ |+.||... ...+....+.... 
T Consensus       144 ~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~-  216 (256)
T cd05039         144 SDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGY-  216 (256)
T ss_pred             cccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCC-
Confidence            99999987633211     2234568999999988889999999999999999998 99998644 2232222221111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                         ....    ....    ..++.+++.+|++.+|++||+++|+++.|+.
T Consensus       217 ---~~~~----~~~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 ---RMEA----PEGC----PPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---CCCC----ccCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               0000    0111    2357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.8e-35  Score=320.59  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=200.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|...++||+|+||.||+|...      ++..+|+|.+...                 .....+.+.+|++++++++|+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~   67 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----------------SESARQDFQREAELLTVLQHQ   67 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----------------CHHHHHHHHHHHHHHhcCCCC
Confidence            35667789999999999999742      3567899977321                 234456799999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-------------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIV  823 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  823 (1002)
                      ||+++++++...+..+++|||+++++|.+++.....             ..+++..+..++.|++.|++|||+.   +|+
T Consensus        68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~  144 (280)
T cd05092          68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFV  144 (280)
T ss_pred             CCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence            999999999999999999999999999999875431             3589999999999999999999999   999


Q ss_pred             eCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCC
Q 001867          824 HRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP  902 (1002)
Q Consensus       824 HrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p  902 (1002)
                      ||||||+||++++++.+||+|||++................+++.|+|||...+..++.++|||||||++|||++ |..|
T Consensus       145 H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  224 (280)
T cd05092         145 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP  224 (280)
T ss_pred             cccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999976543322222223345678999999999999999999999999999998 8888


Q ss_pred             CCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      |..... .+......   .....     ......++    .+.+++.+||+.||++||+++||.+.|+
T Consensus       225 ~~~~~~-~~~~~~~~---~~~~~-----~~~~~~~~----~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         225 WYQLSN-TEAIECIT---QGREL-----ERPRTCPP----EVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             CccCCH-HHHHHHHH---cCccC-----CCCCCCCH----HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            854322 22211111   11100     01112222    4778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.1e-35  Score=336.00  Aligned_cols=262  Identities=23%  Similarity=0.275  Sum_probs=198.3

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|.. .+++.||+|++...               ..+.....++.+|+++++.++||||++++
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~niv~~~   65 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV---------------FQNLVSCKRVFRELKMLCFFKHDNVLSAL   65 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc---------------ccchHHHHHHHHHHHHHHhCCCCCcCCHh
Confidence            477889999999999999996 46899999987321               12233456788999999999999999999


Q ss_pred             eEEecCC-----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          763 CCCTTRD-----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       763 ~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      +++...+     ..|+||||+. ++|.+++.  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        66 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~  139 (372)
T cd07853          66 DILQPPHIDPFEEIYVVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSN  139 (372)
T ss_pred             heecCCCccccceEEEEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCC
Confidence            9998776     7899999995 68888876  345699999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||............ 
T Consensus       140 ~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-  217 (372)
T cd07853         140 CVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI-  217 (372)
T ss_pred             CCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH-
Confidence            9999999999986543322 223344688999999998764 4789999999999999999999999765332221111 


Q ss_pred             HHHhhccCc---------------ccccc-ccc---cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          917 CSTLDQKGV---------------DHVLD-PKL---DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~---------------~~~~~-~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .........               ..... +..   .....+...++.+++.+|++.||++|||++|+++.
T Consensus       218 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            110000000               00000 000   00001112357789999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.6e-35  Score=323.51  Aligned_cols=262  Identities=24%  Similarity=0.261  Sum_probs=195.9

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC---CCCcee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI---RHKNIV  759 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv  759 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....               .......+.+|+.+++++   +||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~h~ni~   65 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN---------------EDGLPLSTVREVALLKRLEAFDHPNIV   65 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC---------------CCCCchHHHHHHHHHHHhhhcCCCCee
Confidence            4778899999999999999965 588999998843211               111123455677777665   699999


Q ss_pred             eeeeEEec-----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          760 KLWCCCTT-----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       760 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      ++++++..     ....+++|||++ ++|.+++.......+++..+..++.|++.||+|||++   +|+||||||+||++
T Consensus        66 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili  141 (288)
T cd07863          66 RLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILV  141 (288)
T ss_pred             eeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            99998864     345799999996 5899998765556699999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      +.++.+||+|||+++.......   .....||..|+|||++.+..++.++||||+||++|||++|+.||..........+
T Consensus       142 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~  218 (288)
T cd07863         142 TSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK  218 (288)
T ss_pred             CCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence            9999999999999987643321   2234688999999999988999999999999999999999999976544333333


Q ss_pred             HHHHHhh--ccCc-------cccccccc----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLD--QKGV-------DHVLDPKL----DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~--~~~~-------~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .......  ....       .....+..    ....++...++.+++.+|++.||++|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         219 IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            2221100  0000       00000000    0111112235778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.5e-35  Score=321.60  Aligned_cols=253  Identities=22%  Similarity=0.286  Sum_probs=199.8

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|+||+||+|.. .+++.||+|.+...              ........+.+.+|++++++++|++|+++++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~   67 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK--------------RIKKRKGESMALNEKQILEKVNSQFVVNLAY   67 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehh--------------hhhhhhHHHHHHHHHHHHHHcCCcCceeEEE
Confidence            55678899999999999996 46889999988432              1112233456788999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++..++..+++|||+++++|.+++.......+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        68 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~  144 (285)
T cd05632          68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             EEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999988765556799999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||++........   .....|+..|+|||++.+..++.++|+||+||++|||++|..||...........+ .......
T Consensus       145 Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~-~~~~~~~  220 (285)
T cd05632         145 DLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV-DRRVLET  220 (285)
T ss_pred             cCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHhhhcc
Confidence            9999976543221   12346899999999999889999999999999999999999999754322221111 1111111


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                        ...+.   ...    ...+.+++..|++.||++||+     ++++++
T Consensus       221 --~~~~~---~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 --EEVYS---AKF----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --ccccC---ccC----CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              00011   111    224678899999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=307.49  Aligned_cols=246  Identities=26%  Similarity=0.382  Sum_probs=203.3

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+++++||+|+||.||+|.. ..|+.+|+|.+-                   .....+++.+|+.||++.+.|++|++||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP-------------------V~sDLQEIIKEISIMQQC~S~yVVKYYG   95 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP-------------------VDTDLQEIIKEISIMQQCKSKYVVKYYG   95 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecC-------------------ccchHHHHHHHHHHHHHcCCchhhhhhh
Confidence            55667899999999999985 569999999872                   2334677999999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      .|.....+++|||||-.|+..+.++- +.+++++.++..+++..+.||+|||..   +-||||||+.|||++.+|.+|++
T Consensus        96 SYFK~sDLWIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLA  171 (502)
T KOG0574|consen   96 SYFKHSDLWIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLA  171 (502)
T ss_pred             hhccCCceEeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhh
Confidence            99999999999999999999999886 567899999999999999999999998   88999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||.|..+......+  ..+.||+.|||||++..-.|+.++||||+|++..||..|+.||.+-.....   .+.  +.. 
T Consensus       172 DFGVAGQLTDTMAKR--NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFM--IPT-  243 (502)
T KOG0574|consen  172 DFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFM--IPT-  243 (502)
T ss_pred             hccccchhhhhHHhh--CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEe--ccC-
Confidence            999998765543222  356799999999999999999999999999999999999999864322111   000  000 


Q ss_pred             CccccccccccCCCHHHH-HHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEI-CKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~-~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                            .|...-.-+++| .++-++++.|+-+.|++|-|+-++++
T Consensus       244 ------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  244 ------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             ------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence                  111111223444 45789999999999999999988874

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=333.17  Aligned_cols=263  Identities=23%  Similarity=0.307  Sum_probs=198.7

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++.++|.+.+.||+|+||.||+|.. .+++.||||++...               .......+.+.+|+.++++++|||
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~   75 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP---------------FQSLIHARRTYRELRLLKHMKHEN   75 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch---------------hhhhHHHHHHHHHHHHHHhcCCCc
Confidence            45677899999999999999999986 46789999988432               112234556788999999999999


Q ss_pred             eeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++...      ...|+++|++ +++|.++++.   ..+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus        76 iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~N  148 (343)
T cd07878          76 VIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSN  148 (343)
T ss_pred             hhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhh
Confidence            99999988643      3468999998 8899888753   4599999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      |+++.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.......
T Consensus       149 il~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  223 (343)
T cd07878         149 VAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID  223 (343)
T ss_pred             EEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence            99999999999999999865432     223468999999999876 568899999999999999999999997543322


Q ss_pred             hHHHHHHHHhhc----------c-------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          911 DLVKWVCSTLDQ----------K-------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       911 ~~~~~~~~~~~~----------~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ....+.......          .       ....................+.+++.+|++.||++|||++|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         224 QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            222221110000          0       000000000000000011236789999999999999999999953

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.2e-35  Score=318.85  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=203.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCc----EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.++||+|+||.||+|.+. +++    .||+|.+...                ......+.+.+|+.+++.++|||
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----------------~~~~~~~~~~~e~~~l~~~~~~~   70 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----------------TSPKANKEILDEAYVMAGVGSPY   70 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----------------CCHHHHHHHHHHHHHHHhcCCCC
Confidence            56788899999999999999853 444    4899987432                12334567889999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++... ..+++|||+++|+|.++++.. ...+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        71 i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~  145 (279)
T cd05109          71 VCRLLGICLTS-TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSP  145 (279)
T ss_pred             CceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCC
Confidence            99999999764 468999999999999998753 35689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||.... ......++
T Consensus       146 ~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~  224 (279)
T cd05109         146 NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREIPDLL  224 (279)
T ss_pred             CcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH
Confidence            9999999999987754332222222345678999999998899999999999999999998 888886432 22233332


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      .....   .     +......    .++.+++.+||+.||++||++.++++.++++...
T Consensus       225 ~~~~~---~-----~~~~~~~----~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         225 EKGER---L-----PQPPICT----IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HCCCc---C-----CCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            21110   0     1111122    2477899999999999999999999999888543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-35  Score=333.97  Aligned_cols=265  Identities=24%  Similarity=0.274  Sum_probs=200.7

Q ss_pred             HHHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          678 EYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       678 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      .+...++|++.+.||+|+||.||+|... .++.||||++...               .........+.+|+.+++.++||
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~   76 (355)
T cd07874          12 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------------FQNQTHAKRAYRELVLMKCVNHK   76 (355)
T ss_pred             hhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc---------------ccChHHHHHHHHHHHHHHHhCCC
Confidence            4566789999999999999999999864 5889999988432               12333456788899999999999


Q ss_pred             ceeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          757 NIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       757 niv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      ||+++++++...      ...|+||||++ +++.+++.    ..+++..+..++.|++.||+|||++   +|+||||||+
T Consensus        77 niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~  148 (355)
T cd07874          77 NIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS  148 (355)
T ss_pred             chhceeeeeeccccccccceeEEEhhhhc-ccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChH
Confidence            999999998643      35699999995 57777665    2488999999999999999999999   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      ||+++.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       149 Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  225 (355)
T cd07874         149 NIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID  225 (355)
T ss_pred             HEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999998654332   1234468999999999999899999999999999999999999997543222


Q ss_pred             hHHHHHHHHh------------------hc-cCcccccccc------c---cCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          911 DLVKWVCSTL------------------DQ-KGVDHVLDPK------L---DCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       911 ~~~~~~~~~~------------------~~-~~~~~~~~~~------~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      .....+....                  .. ........+.      .   .........++.+++.+|++.||++|||+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~  305 (355)
T cd07874         226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  305 (355)
T ss_pred             HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence            2211111100                  00 0000000000      0   00011112357889999999999999999


Q ss_pred             HHHHHH
Q 001867          963 RRVVKL  968 (1002)
Q Consensus       963 ~evl~~  968 (1002)
                      +|+++.
T Consensus       306 ~ell~h  311 (355)
T cd07874         306 DEALQH  311 (355)
T ss_pred             HHHhcC
Confidence            999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-35  Score=322.42  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=199.9

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|+||.||+|... +++.||+|.+....              .......+.+..|+.++++++|++++++++
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~   67 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--------------IKKRKGESMALNEKQILEKVNSRFVVSLAY   67 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh--------------ccchHHHHHHHHHHHHHHhCCCCCeeeeeE
Confidence            566789999999999999964 68899999884321              112233456778999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      .+.+.+..++||||+++++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        68 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~  144 (285)
T cd05630          68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS  144 (285)
T ss_pred             EEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999998765556799999999999999999999998   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||++........   .....|+..|+|||++.+..++.++||||+||++|+|++|+.||.......... ........ 
T Consensus       145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~-  219 (285)
T cd05630         145 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-  219 (285)
T ss_pred             eccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh-
Confidence            9999876543221   123468999999999999999999999999999999999999997543221111 11111000 


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                       ...   .......    ..+.+++..||+.||++|||     ++|+++
T Consensus       220 -~~~---~~~~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 -VQE---EYSEKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhh---hcCccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             000   0011112    24778899999999999999     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-35  Score=316.41  Aligned_cols=257  Identities=26%  Similarity=0.448  Sum_probs=202.6

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      +|...+.||+|+||.||+|...+++.+|+|.+......           ........+.+.+|++++++++|+||+++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~-----------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   69 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSN-----------VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG   69 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccc-----------hhhHHHHHHHHHHHHHHHHhcCCCCEeeEee
Confidence            47788999999999999999888999999988532110           1112334567899999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++.+.+..+++|||+++++|.+++.+  ...+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  144 (265)
T cd06631          70 TCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLI  144 (265)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEec
Confidence            99999999999999999999999974  34689999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCC----CCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          844 DFGVAKVVDASG----KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       844 DfGl~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      |||.+.......    .........|+..|+|||+..+..++.++||||+||++|+|++|+.||.............   
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---  221 (265)
T cd06631         145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG---  221 (265)
T ss_pred             cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh---
Confidence            999998653211    1112234468899999999998889999999999999999999999996542222211111   


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ....    ..+......   ...+.+++.+||+.+|++||++.++++
T Consensus       222 -~~~~----~~~~~~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         222 -AHRG----LMPRLPDSF---SAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -hccC----CCCCCCCCC---CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             1100    011111112   224788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-35  Score=315.62  Aligned_cols=253  Identities=26%  Similarity=0.468  Sum_probs=204.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|...++..+|+|.+..                  .....+.+.+|++++++++|+||++++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~------------------~~~~~~~~~~e~~~l~~l~~~~i~~~~   67 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP------------------GSMSVEAFLAEANVMKTLQHDKLVKLH   67 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCC------------------ChhHHHHHHHHHHHHHhcCCCCcceEE
Confidence            57888999999999999999987788899998732                  122356788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.. ...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        68 ~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l  143 (260)
T cd05073          68 AVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI  143 (260)
T ss_pred             EEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEE
Confidence            99987 7789999999999999999865566789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+......... ......++..|+|||++....++.++|||||||++|++++ |..||.... ..+......... 
T Consensus       144 ~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~~~-  220 (260)
T cd05073         144 ADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGY-  220 (260)
T ss_pred             CCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCC-
Confidence            999999766443221 1222345678999999998889999999999999999999 888886542 222222221111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                         .    .+.....    ..++.+++.+||+++|++||++.++.+.|+.
T Consensus       221 ---~----~~~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 ---R----MPRPENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---C----CCCcccC----CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               0    0111122    2347889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-35  Score=330.83  Aligned_cols=240  Identities=26%  Similarity=0.319  Sum_probs=188.3

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHH-HHhcCCCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE-TLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~  766 (1002)
                      +.||+|+||+||+|+.. +|+.||+|++.+..              ........++..|.. +++.++||||+++++++.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~   66 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA--------------ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ   66 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE
Confidence            47999999999999974 68999999985421              111222344555544 567889999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      ..+..|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          67 TADKLYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             eCCEEEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccC
Confidence            99999999999999999999874  45689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.   ...... ....
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~---~~~i~~-~~~~  214 (323)
T cd05575         142 LCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-EM---YDNILN-KPLR  214 (323)
T ss_pred             CCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-HH---HHHHHc-CCCC
Confidence            987543221  2233457999999999999999999999999999999999999999754221 11   111111 1110


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR  963 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  963 (1002)
                        +.+   ..    ...+.+++.+|++.||++||+++
T Consensus       215 --~~~---~~----~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 --LKP---NI----SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCC---CC----CHHHHHHHHHHhhcCHHhCCCCC
Confidence              111   11    23477899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.4e-35  Score=317.57  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=203.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-C---cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-G---EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+|++.+.||+|+||.||+|..+. +   ..||+|.+...                .......++..|+.++++++||||
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~ni   67 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----------------YTEKQRRDFLSEASIMGQFDHPNI   67 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----------------CCHHHHHHHHHHHHHHHhCCCcCc
Confidence            356778999999999999999643 3   36999987432                123345779999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++.+++..++||||+++++|.+++... .+.+++..++.++.|++.|++|||++   +++||||||+||+++.++
T Consensus        68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~  143 (269)
T cd05065          68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNL  143 (269)
T ss_pred             ceEEEEECCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCC
Confidence            99999999999999999999999999999753 35689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCccccc-cc--ccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSV-IA--GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~  914 (1002)
                      .+|++|||++.............. ..  .+..|+|||++.+..++.++||||+||++||+++ |..||.... ..+..+
T Consensus       144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-~~~~~~  222 (269)
T cd05065         144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVIN  222 (269)
T ss_pred             cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-HHHHHH
Confidence            999999999976654332221111 11  2357999999998999999999999999999887 999986542 223333


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ++...   ...     +.....+    ..+.+++.+||+.+|++||++++++..|+++
T Consensus       223 ~i~~~---~~~-----~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         223 AIEQD---YRL-----PPPMDCP----TALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHcC---CcC-----CCcccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            32211   100     1112222    3477899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.9e-35  Score=322.62  Aligned_cols=261  Identities=25%  Similarity=0.411  Sum_probs=202.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-Cc--EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-GE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|..++ +.  .+|+|.++..                ......+.+.+|+.++.++ +||||
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----------------~~~~~~~~~~~E~~~l~~l~~hp~i   65 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----------------ASENDHRDFAGELEVLCKLGHHPNI   65 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----------------CCHHHHHHHHHHHHHHHhhcCCCch
Confidence            467888999999999999998754 33  4688876321                1223356789999999999 69999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      +++++++...+..+++|||+++++|.+++....              ...+++..+..++.|++.|++|||++   +|+|
T Consensus        66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH  142 (297)
T cd05089          66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIH  142 (297)
T ss_pred             hheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            999999999999999999999999999997532              13588999999999999999999998   9999


Q ss_pred             CCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 001867          825 RDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPV  903 (1002)
Q Consensus       825 rDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~  903 (1002)
                      |||||+||+++.++.+||+|||++.......   .......+..|+|||+..+..++.++|||||||++|||++ |+.||
T Consensus       143 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf  219 (297)
T cd05089         143 RDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY  219 (297)
T ss_pred             CcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999986432211   1111223457999999998889999999999999999998 99999


Q ss_pred             CCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccc
Q 001867          904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS  978 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~  978 (1002)
                      ...... +.....   ...  ...   +......    .++.+++.+||+.+|.+||+++++++.|+.+....+.
T Consensus       220 ~~~~~~-~~~~~~---~~~--~~~---~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         220 CGMTCA-ELYEKL---PQG--YRM---EKPRNCD----DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             CCCCHH-HHHHHH---hcC--CCC---CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            654322 222111   111  000   0011122    3478899999999999999999999999998765533

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.3e-35  Score=316.04  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=192.5

Q ss_pred             CeeeecCCccEEEEEEcC---CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          689 NVIGSGSSGKVYKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      +.||+|+||.||+|...+   +..+|+|.+....                .......+.+|+.++++++||||+++++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   64 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----------------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQC   64 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            368999999999998643   4578999873321                122345788999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKG---GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      .+....++||||+++|+|.+++...+.   ...++..+..++.|++.|++|||+.   +++||||||+||+++.++++|+
T Consensus        65 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL  141 (269)
T cd05087          65 TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKI  141 (269)
T ss_pred             cCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEE
Confidence            999999999999999999999975332   3567788889999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-------RVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~  914 (1002)
                      +|||.++...............++..|+|||++.+.       .++.++||||||+++|||++ |+.||........ ..
T Consensus       142 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~  220 (269)
T cd05087         142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LT  220 (269)
T ss_pred             CCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HH
Confidence            999999765433322222344577889999987642       35789999999999999997 9999965432222 11


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      ...    ........++.......+   .+.+++..|| .+|++|||++||+..|+
T Consensus       221 ~~~----~~~~~~~~~~~~~~~~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         221 YTV----REQQLKLPKPRLKLPLSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHh----hcccCCCCCCccCCCCCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111    111112222332222222   3667888999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-35  Score=328.52  Aligned_cols=244  Identities=27%  Similarity=0.386  Sum_probs=193.9

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      +.||+|+||.||+|..+ +++.||+|++.+..              .........+..|..+++.+ +||||+++++++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~   66 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV--------------ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ   66 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE
Confidence            46999999999999965 57899999985431              11223345677889999888 6999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +.+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          67 TKDRLFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccC
Confidence            99999999999999999998874  34699999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+   . .... 
T Consensus       142 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-~~~~~~i---~-~~~~-  213 (318)
T cd05570         142 MCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSI---L-EDEV-  213 (318)
T ss_pred             CCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-HHHHHHH---H-cCCC-
Confidence            987532221  122344689999999999999999999999999999999999999965432 2222111   1 1110 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM-----RRVVK  967 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~  967 (1002)
                       .+ +  ...    ...+.+++.+||+.||++||++     .++++
T Consensus       214 -~~-~--~~~----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 -RY-P--RWL----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CC-C--CcC----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             00 1  111    2247789999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=328.02  Aligned_cols=258  Identities=24%  Similarity=0.296  Sum_probs=196.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.+.              ........+.+.+|+.+++.++|+||+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~   66 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW--------------EMLKRAETACFREERDVLVNGDRRWITNL   66 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH--------------HHhhhhhHHHHHHHHHHHHhCCCCCCCce
Confidence            46888999999999999999964 5889999998432              11123345668899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+++|+|.+++.. ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~k  142 (331)
T cd05597          67 HYAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIR  142 (331)
T ss_pred             EEEEecCCeEEEEEecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEE
Confidence            9999999999999999999999999975 245689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+|||++......... ......||+.|||||++..     ..++.++||||+||++|||++|+.||............ 
T Consensus       143 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i-  220 (331)
T cd05597         143 LADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-  220 (331)
T ss_pred             EEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH-
Confidence            9999999766543221 2223469999999999863     45788999999999999999999999754322222111 


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTS--PLPINRPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~Rps~~evl~~  968 (1002)
                         ....... .+.+.......    .+.+++.+|+.  .++..||+++++++.
T Consensus       221 ---~~~~~~~-~~~~~~~~~~~----~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         221 ---MNHKEHF-QFPPDVTDVSE----EAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ---HcCCCcc-cCCCccCCCCH----HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence               1111100 01111111222    35566666554  444458899998865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.7e-35  Score=319.19  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=202.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      .++|++.+.||+|+||.||+|..++      +..||+|.+...                ........+.+|+.++++++|
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~e~~~l~~l~~   68 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----------------ASLRERIEFLNEASVMKGFTC   68 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----------------CCHHHHHHHHHHHHHHHhCCC
Confidence            3578889999999999999987532      457999987321                112234568889999999999


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV  827 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  827 (1002)
                      |||+++++++...+..|+||||+++|+|.++++...        ....++..+.+++.|++.||+|||++   +|+||||
T Consensus        69 ~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~di  145 (288)
T cd05061          69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDL  145 (288)
T ss_pred             CCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCC
Confidence            999999999999999999999999999999997532        23457788999999999999999999   9999999


Q ss_pred             CCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 001867          828 KSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE  906 (1002)
Q Consensus       828 k~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~  906 (1002)
                      ||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       146 kp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         146 AARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             ChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999986544332222223345678999999998899999999999999999999 77888643


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      . ..+..+...   . .....    .....    ...+.+++.+|++.||++|||+.++++.+++.
T Consensus       226 ~-~~~~~~~~~---~-~~~~~----~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         226 S-NEQVLKFVM---D-GGYLD----QPDNC----PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             C-HHHHHHHHH---c-CCCCC----CCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            2 222222211   1 11100    00111    23588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-35  Score=318.40  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=201.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  762 (1002)
                      .|++.++||+||-+.||++...+.+.||+|++..               ...+......|..|+..|.+++ |.+||++|
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~---------------~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~  426 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVL---------------LEADNQTLDGYRNEIALLNKLKGHDKIIQLY  426 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHH---------------hhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence            4566789999999999999998888999998732               2346677888999999999996 99999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +|-..++.+|+||||= ..+|.++++........| .++.+.+|++.|+.++|++   ||||.||||.|+|+- .|.+||
T Consensus       427 DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKL  500 (677)
T KOG0596|consen  427 DYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKL  500 (677)
T ss_pred             eeeccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEe
Confidence            9999999999999997 579999998755544445 8889999999999999999   999999999999996 579999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCC-----------CCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-----------VNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      +|||+|..+............+||+.|||||.+....           .++++||||+|||+|+|+.|+.||..      
T Consensus       501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~------  574 (677)
T KOG0596|consen  501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ------  574 (677)
T ss_pred             eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH------
Confidence            9999999887766555556778999999999876432           45799999999999999999999952      


Q ss_pred             HHHHHHHHhhc-cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          912 LVKWVCSTLDQ-KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       912 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +.....+.... .+-.++-.|.....+     ++++++..|+..||++||++.|+++
T Consensus       575 ~~n~~aKl~aI~~P~~~Iefp~~~~~~-----~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  575 IINQIAKLHAITDPNHEIEFPDIPEND-----ELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHHHHHHhhcCCCccccccCCCCch-----HHHHHHHHHHhcCcccCCCcHHHhc
Confidence            22111111111 111122222222222     2889999999999999999999984

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.9e-35  Score=315.23  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=202.9

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||++... +++.||+|.+....                .....+.+.+|+.++++++||||++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~   64 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK----------------SSSAVEDSRKEAVLLAKMKHPNIVAFK   64 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc----------------chHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4677899999999999999964 68899999874321                123456788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++..++..|++|||+++|+|.+++.......+++..+..++.|++.|++|||++   +|+|+||||+||+++.++.+++
T Consensus        65 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l  141 (255)
T cd08219          65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKL  141 (255)
T ss_pred             EEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEE
Confidence            9999999999999999999999998765667789999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||.+........  ......|++.|+|||++.+..++.++||||+|+++|+|++|..||....... ...   ... .
T Consensus       142 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~---~~~-~  214 (255)
T cd08219         142 GDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-LIL---KVC-Q  214 (255)
T ss_pred             cccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-HHH---HHh-c
Confidence            99999986654322  1223468889999999998889999999999999999999999996542211 111   111 1


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .....    ....    ...++.+++.+||+.||++||++.+++..
T Consensus       215 ~~~~~----~~~~----~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 GSYKP----LPSH----YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCC----CCcc----cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11111    0111    12347789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-34  Score=314.35  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=203.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+|++.+.||+|+||.||+|...    ++..+|+|.++...                .....+.+.+|+.++++++||||
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i   67 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----------------TEKQRRDFLSEASIMGQFDHPNI   67 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----------------CHHHHHHHHHHHHHHHhCCCCCc
Confidence            45778899999999999999863    23479999874321                12345678999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++..++..|+||||+++++|.+++... ...+++.++..++.|++.|++|||++   +++||||||+||+++.++
T Consensus        68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~  143 (267)
T cd05066          68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNL  143 (267)
T ss_pred             ceEEEEEecCCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCC
Confidence            99999999999999999999999999999753 35689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      .++++|||++.......... ......++..|+|||++.+..++.++||||||+++||+++ |..||..... .+....+
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~~~~  222 (267)
T cd05066         144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAI  222 (267)
T ss_pred             eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHHHHH
Confidence            99999999998765432211 1112223568999999998889999999999999999887 9999865432 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ....   .     .+.....+    ..+.+++.+||+.+|++||++.++++.|+++
T Consensus       223 ~~~~---~-----~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         223 EEGY---R-----LPAPMDCP----AALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             hCCC---c-----CCCCCCCC----HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            2111   0     01111122    3478899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.6e-35  Score=333.75  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=196.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++...              ..........+..|+.++.+++||+|+++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~~~~iv~~   66 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA--------------DMLEKEQVAHIRAERDILVEADGAWVVKM   66 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH--------------HHhhhhhHHHHHHHHHHHHhCCCCCEeeE
Confidence            36788899999999999999964 5889999998432              11123345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++.+.+++..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vk  141 (360)
T cd05627          67 FYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVK  141 (360)
T ss_pred             EEEEEcCCEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEE
Confidence            9999999999999999999999999874  45689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCC---------------------------------cccccccccccccCccccccCCCCCccchhh
Q 001867          842 VADFGVAKVVDASGKP---------------------------------KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYS  888 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  888 (1002)
                      |+|||++.........                                 ......+||+.|+|||++.+..++.++||||
T Consensus       142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS  221 (360)
T cd05627         142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (360)
T ss_pred             EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence            9999998755321100                                 0011346999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHH
Q 001867          889 FGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA---MRRV  965 (1002)
Q Consensus       889 lGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ev  965 (1002)
                      +||++|||++|+.||.............    .. .....+.+. ... .+   ++.+++.+++ .||++|++   ++|+
T Consensus       222 lGvilyel~tG~~Pf~~~~~~~~~~~i~----~~-~~~~~~p~~-~~~-s~---~~~~li~~l~-~~p~~R~~~~~~~ei  290 (360)
T cd05627         222 LGVIMYEMLIGYPPFCSETPQETYRKVM----NW-KETLVFPPE-VPI-SE---KAKDLILRFC-TDSENRIGSNGVEEI  290 (360)
T ss_pred             ccceeeecccCCCCCCCCCHHHHHHHHH----cC-CCceecCCC-CCC-CH---HHHHHHHHhc-cChhhcCCCCCHHHH
Confidence            9999999999999997653322222111    10 000011111 111 12   3556666665 49999985   5555


Q ss_pred             HH
Q 001867          966 VK  967 (1002)
Q Consensus       966 l~  967 (1002)
                      .+
T Consensus       291 ~~  292 (360)
T cd05627         291 KS  292 (360)
T ss_pred             hc
Confidence            53

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4e-35  Score=332.88  Aligned_cols=265  Identities=23%  Similarity=0.274  Sum_probs=200.5

Q ss_pred             HHHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          678 EYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       678 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      .+.+.++|.+.+.||+|+||.||+|... .++.||||++...               .........+.+|+.+++.++||
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~   83 (364)
T cd07875          19 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---------------FQNQTHAKRAYRELVLMKCVNHK   83 (364)
T ss_pred             hhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc---------------ccCchhHHHHHHHHHHHHhcCCC
Confidence            3556789999999999999999999964 5889999998432               12233456688899999999999


Q ss_pred             ceeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          757 NIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       757 niv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      ||+++++++...      ...|+||||++ ++|.+++.    ..+++..+..++.|++.||+|||++   +|+||||||+
T Consensus        84 ~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~  155 (364)
T cd07875          84 NIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS  155 (364)
T ss_pred             CccccceeecccccccccCeEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHH
Confidence            999999988643      35799999995 57777775    2478999999999999999999999   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      ||+++.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       156 NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  232 (364)
T cd07875         156 NIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID  232 (364)
T ss_pred             HEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999998654332   1234468999999999999999999999999999999999999997543322


Q ss_pred             hHHHHHHHHh------------------hcc-Cc-----ccccc----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          911 DLVKWVCSTL------------------DQK-GV-----DHVLD----PKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       911 ~~~~~~~~~~------------------~~~-~~-----~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      .....+....                  ... ..     .....    +...........++.+++.+|++.||++|||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~  312 (364)
T cd07875         233 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV  312 (364)
T ss_pred             HHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence            2222211000                  000 00     00000    00000001112357789999999999999999


Q ss_pred             HHHHHH
Q 001867          963 RRVVKL  968 (1002)
Q Consensus       963 ~evl~~  968 (1002)
                      +|+++.
T Consensus       313 ~e~L~h  318 (364)
T cd07875         313 DEALQH  318 (364)
T ss_pred             HHHhcC
Confidence            999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-34  Score=311.10  Aligned_cols=248  Identities=27%  Similarity=0.364  Sum_probs=197.7

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecC
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTR  768 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  768 (1002)
                      ++||+|+||.||+|...++..||+|.+....                .......+.+|++++++++||||+++++++...
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   64 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----------------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR   64 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC----------------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC
Confidence            4689999999999998888999999874321                123345688999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCc
Q 001867          769 DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA  848 (1002)
Q Consensus       769 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~  848 (1002)
                      +..++||||+++++|.+++... ...+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+|++|||++
T Consensus        65 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~  140 (250)
T cd05085          65 QPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMS  140 (250)
T ss_pred             CccEEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccc
Confidence            9999999999999999998753 35689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCccc
Q 001867          849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDH  927 (1002)
Q Consensus       849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1002)
                      ......... ......+++.|+|||+..+..++.++||||||+++||+++ |..||..... ......+....    ...
T Consensus       141 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-~~~~~~~~~~~----~~~  214 (250)
T cd05085         141 RQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEKGY----RMS  214 (250)
T ss_pred             eeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHHcCC----CCC
Confidence            765433211 1112234668999999998889999999999999999998 8999865422 22222111110    000


Q ss_pred             cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                          .....    ..++.+++.+||+.+|++||++.|+++.|.
T Consensus       215 ----~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 ----CPQKC----PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ----CCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                01111    235888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-34  Score=313.47  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=203.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-C---cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-G---EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+|+..+.||+|+||.||+|..+. +   ..+|+|.+....                .....+.+..|++++++++|||+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i   68 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----------------TEKQRQDFLSEASIMGQFSHHNI   68 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----------------CHHHHHHHHHHHHHHhcCCCCCe
Confidence            356778899999999999999752 3   379999874321                22345678999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++...+..++||||+++++|.+++.. ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~  144 (268)
T cd05063          69 IRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNL  144 (268)
T ss_pred             eEEEEEEccCCCcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCC
Confidence            9999999999999999999999999999975 335689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+|++|||++........... ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+
T Consensus       145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i  223 (268)
T cd05063         145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI  223 (268)
T ss_pred             cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHH
Confidence            999999999986654322111 111223457999999998889999999999999999998 9999865432 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ..   ..     ..+.....+    .++.+++.+||+.+|++||++.+|++.|+++
T Consensus       224 ~~---~~-----~~~~~~~~~----~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 ND---GF-----RLPAPMDCP----SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             hc---CC-----CCCCCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11   11     111112222    3478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.1e-35  Score=332.23  Aligned_cols=256  Identities=21%  Similarity=0.272  Sum_probs=198.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.+.              ........+.+.+|+.+++.++||||++
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~--------------~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--------------EMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH--------------HhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence            368899999999999999999965 5789999998432              1112334556889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++..   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCE
Confidence            99999999999999999999999999864   3488999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ||+|||+++....... .......||+.|||||++.+.    .++.++||||+||++|||++|+.||........+.++.
T Consensus       182 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  260 (371)
T cd05622         182 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (371)
T ss_pred             EEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999987654322 122345799999999998754    37889999999999999999999997543322222211


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPIN--RPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~  968 (1002)
                          ........  +......    ..+.+++..|+..++.+  ||+++|+++.
T Consensus       261 ----~~~~~~~~--~~~~~~s----~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         261 ----NHKNSLTF--PDDNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ----cCCCcccC--CCcCCCC----HHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                11110011  1111122    23667888899744433  7899988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.9e-35  Score=327.48  Aligned_cols=244  Identities=26%  Similarity=0.345  Sum_probs=191.9

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  766 (1002)
                      +.||+|+||.||+|+.. +++.||+|++.+..              ..+....+.+.+|+.++.++ +||+|+++++++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   66 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL--------------VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ   66 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE
Confidence            47999999999999964 57899999985431              11233456688999999888 5999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +.+..|+||||+++|+|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          67 TTSRLFLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccc
Confidence            99999999999999999998874  35699999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc--hhHHHHHHHHhhccC
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE--KDLVKWVCSTLDQKG  924 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~  924 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.........
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  219 (327)
T cd05617         142 MCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP  219 (327)
T ss_pred             cceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC
Confidence            997533221  1223457999999999999999999999999999999999999999642211  111222222222111


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      ..  + |  ....    .++.+++.+|++.||++|+++
T Consensus       220 ~~--~-p--~~~~----~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         220 IR--I-P--RFLS----VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CC--C-C--CCCC----HHHHHHHHHHhccCHHHcCCC
Confidence            11  0 0  1111    246788999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4e-35  Score=326.94  Aligned_cols=240  Identities=25%  Similarity=0.304  Sum_probs=187.8

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHH-HHhcCCCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE-TLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~  766 (1002)
                      ++||+|+||.||+|+.. +++.||+|++.+..              .........+..|.. +++.++||||+++++++.
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~   66 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT--------------ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ   66 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            47999999999999974 58899999985321              112223344555554 678899999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +.+..|+||||+++|+|..++..  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          67 TAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence            99999999999999999988863  45689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+   .. ... 
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i---~~-~~~-  213 (321)
T cd05603         142 LCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDNI---LH-KPL-  213 (321)
T ss_pred             CCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHHH---hc-CCC-
Confidence            987532221  123345789999999999988999999999999999999999999975422 1111111   11 110 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR  963 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  963 (1002)
                      . +.   ..    ....+.+++.+|++.||++||++.
T Consensus       214 ~-~~---~~----~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 Q-LP---GG----KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             C-CC---CC----CCHHHHHHHHHHccCCHhhcCCCC
Confidence            0 00   11    123477899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.5e-35  Score=318.66  Aligned_cols=253  Identities=27%  Similarity=0.341  Sum_probs=198.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++...                 .......+.+|+.++++++||||+++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~ii~~   71 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-----------------PGDDFSLIQQEIFMVKECKHCNIVAY   71 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-----------------ccchHHHHHHHHHHHHhcCCCCeeee
Confidence            5688889999999999999996 56889999988432                 11234468889999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..++||||+++++|.++++.  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++
T Consensus        72 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~  146 (267)
T cd06646          72 FGSYLSREKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVK  146 (267)
T ss_pred             eEEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEE
Confidence            9999999999999999999999999874  35689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |+|||++........  ......|++.|+|||.+.   ...++.++||||+||++|||++|+.||...........+.  
T Consensus       147 l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--  222 (267)
T cd06646         147 LADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--  222 (267)
T ss_pred             ECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--
Confidence            999999987643321  122346888999999874   4457889999999999999999999985432211111110  


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                         ..   ....+.... .......+.+++.+||+.+|++||+++++++.
T Consensus       223 ---~~---~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         223 ---KS---NFQPPKLKD-KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ---cC---CCCCCCCcc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence               00   000111111 01112357789999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.2e-35  Score=321.10  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=202.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|++.+.||+|+||.||+|...      ++..||+|.+....                .......+.+|+.++++++||
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~ei~~l~~l~h~   68 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----------------SADMQADFQREAALMAEFDHP   68 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----------------CHHHHHHHHHHHHHHHhcCCC
Confidence            46788899999999999999863      46789999874321                123356688999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------------GGLLDWPTRYKIIVDAAEGLSYLHH  816 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~  816 (1002)
                      ||+++++++..++..+++|||+++|+|.+++....                    ...+++..++.++.|++.||+|||+
T Consensus        69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~  148 (288)
T cd05050          69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE  148 (288)
T ss_pred             chheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999997432                    1347889999999999999999999


Q ss_pred             cCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHH
Q 001867          817 DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       817 ~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el  896 (1002)
                      +   +++||||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||
T Consensus       149 ~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el  225 (288)
T cd05050         149 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI  225 (288)
T ss_pred             C---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHH
Confidence            9   9999999999999999999999999998765433222222223356789999999988999999999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          897 VT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       897 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      ++ |..||..... .+....+.    .....    +....    ...++.+++.+||+.+|++|||+.|+++.|++
T Consensus       226 ~~~~~~p~~~~~~-~~~~~~~~----~~~~~----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         226 FSYGMQPYYGMAH-EEVIYYVR----DGNVL----SCPDN----CPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HhCCCCCCCCCCH-HHHHHHHh----cCCCC----CCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            98 8788854322 22222111    11111    00111    22358889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.2e-35  Score=349.69  Aligned_cols=262  Identities=21%  Similarity=0.302  Sum_probs=201.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||+||+|... ++..||+|.+...               .........+..|+.++++++|||||+
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~---------------~l~e~~~~~~~~EI~IL~~L~HPNIVr   76 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR---------------GLKEREKSQLVIEVNVMRELKHKNIVR   76 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecc---------------ccCHHHHHHHHHHHHHHHHcCCCCcCe
Confidence            467888999999999999999964 4778999987432               112344567899999999999999999


Q ss_pred             eeeEEec--CCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeeCCCCCCcE
Q 001867          761 LWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCV----PSIVHRDVKSNNI  832 (1002)
Q Consensus       761 l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~iiHrDlk~~NI  832 (1002)
                      ++++|..  .+..|+||||+++|+|.+++....  ...+++..++.|+.||+.||+|||+.+.    .+||||||||+||
T Consensus        77 l~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI  156 (1021)
T PTZ00266         77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI  156 (1021)
T ss_pred             EEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence            9999864  456899999999999999987532  3579999999999999999999998521    2599999999999


Q ss_pred             EECC-----------------CCCeEEccccCcccccCCCCCcccccccccccccCcccccc--CCCCCccchhhHHHHH
Q 001867          833 LLDG-----------------DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVI  893 (1002)
Q Consensus       833 ll~~-----------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil  893 (1002)
                      |++.                 .+.+||+|||++........   .....||+.|+|||++.+  ..++.++|||||||++
T Consensus       157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL  233 (1021)
T PTZ00266        157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII  233 (1021)
T ss_pred             EeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence            9964                 23489999999986643322   223468999999998854  4588999999999999


Q ss_pred             HHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHH
Q 001867          894 LELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV--KLLQE  971 (1002)
Q Consensus       894 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl--~~L~~  971 (1002)
                      |||++|+.||........+...+.    ...     +.......    .++.+++..||+.+|++||++.|++  .++..
T Consensus       234 YELLTGk~PF~~~~~~~qli~~lk----~~p-----~lpi~~~S----~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        234 YELCSGKTPFHKANNFSQLISELK----RGP-----DLPIKGKS----KELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             HHHHHCCCCCCcCCcHHHHHHHHh----cCC-----CCCcCCCC----HHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            999999999975433332222211    110     11111122    3478899999999999999999999  45555


Q ss_pred             hhh
Q 001867          972 VGA  974 (1002)
Q Consensus       972 ~~~  974 (1002)
                      +.+
T Consensus       301 i~~  303 (1021)
T PTZ00266        301 VGP  303 (1021)
T ss_pred             cCC
Confidence            543

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-34  Score=311.82  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=195.1

Q ss_pred             eeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          690 VIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      .||+|+||.||+|.+.   ++..||+|++...                ......+.+.+|+.++++++||||+++++++.
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~   65 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----------------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE   65 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc----------------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc
Confidence            4899999999999763   3557999987432                12234567999999999999999999999886


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      . +..++||||+++++|.+++... ...+++..+++++.|++.|++|||++   +++||||||+||+++.++.+||+|||
T Consensus        66 ~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  140 (257)
T cd05115          66 A-EALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFG  140 (257)
T ss_pred             C-CCeEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCC
Confidence            4 5679999999999999998753 35689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          847 VAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       847 l~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ++.......... ......++..|+|||++.+..++.++|||||||++||+++ |..||..... .+....+.....   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~---  216 (257)
T cd05115         141 LSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVMSFIEQGKR---  216 (257)
T ss_pred             ccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHHHCCCC---
Confidence            998654432211 1122234578999999988889999999999999999996 9999865432 222222221111   


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                       .    +.....    ..++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       217 -~----~~~~~~----~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 -L----DCPAEC----PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -C----CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             0    001112    23577899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-34  Score=313.48  Aligned_cols=253  Identities=27%  Similarity=0.375  Sum_probs=193.4

Q ss_pred             CeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          689 NVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +.||+|+||.||+|.+.+    +..||+|.+...                ......+.+.+|+.+++.++||||++++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   64 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----------------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGI   64 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc----------------CCHHHHHHHHHHHHHHccCCCCCcceEEEE
Confidence            468999999999998632    357999987321                123345678899999999999999999997


Q ss_pred             Ee-cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          765 CT-TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       765 ~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      +. .++..+++|||+++|+|.+++... ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+
T Consensus        65 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~  140 (262)
T cd05058          65 CLPSEGSPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVA  140 (262)
T ss_pred             eecCCCCcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEEC
Confidence            75 456689999999999999999753 34568888899999999999999998   99999999999999999999999


Q ss_pred             cccCcccccCCCCC--cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          844 DFGVAKVVDASGKP--KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       844 DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |||+++........  .......++..|+|||+..+..++.++|||||||++|||++|+.|+.......+....+..   
T Consensus       141 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---  217 (262)
T cd05058         141 DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---  217 (262)
T ss_pred             CccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---
Confidence            99999765432111  1112334567899999998889999999999999999999965554333233332222211   


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ...      +......   ...+.+++..||+.+|++||++.|+++.++++.
T Consensus       218 ~~~------~~~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         218 GRR------LLQPEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCC------CCCCCcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            100      0001111   224778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.3e-38  Score=341.23  Aligned_cols=367  Identities=26%  Similarity=0.337  Sum_probs=264.5

Q ss_pred             cCccccccccccccc-CCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccc
Q 001867          116 CQNLQHLDLSQNLLT-GTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKML  194 (1002)
Q Consensus       116 l~~L~~L~Ls~N~l~-~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  194 (1002)
                      |+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..|+.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            444555666777776 346666777777777777777776 67777777777777777777776 455667777888888


Q ss_pred             cccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcc
Q 001867          195 NLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSL  274 (1002)
Q Consensus       195 ~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  274 (1002)
                      .+..|++-...+|..+..|..|+.|+|++|++. ..|..+..-+++..|+||+|+|..+..+.|.++..|-.|+|++|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            888888767778888888888888888888888 6788888888888888888888755555666777777777777777


Q ss_pred             cCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhccccccc-CCCCCCCC
Q 001867          275 TGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRL-NGTLPGDL  353 (1002)
Q Consensus       275 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~p~~~  353 (1002)
                      . .+|.....+.+|++|+|++|.+...-                       -..+..+++|+.|.+++.+= ..-+|.++
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ-----------------------LrQLPsmtsL~vLhms~TqRTl~N~Ptsl  218 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQ-----------------------LRQLPSMTSLSVLHMSNTQRTLDNIPTSL  218 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhHHH-----------------------HhcCccchhhhhhhcccccchhhcCCCch
Confidence            7 55566777777777777777765211                       11223344455555554332 23456666


Q ss_pred             CCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceE
Q 001867          354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL  433 (1002)
Q Consensus       354 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  433 (1002)
                      ..+.+|..+|||.|.+. ..|..+.++++|+.|+|++|+|+ .+.-..+...+|++|+||+|+++ ..|.+++.++.|+.
T Consensus       219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k  295 (1255)
T KOG0444|consen  219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK  295 (1255)
T ss_pred             hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence            66777777777777776 67777777777777777777776 34445566778888888888888 77888888888888


Q ss_pred             EEcccCcccC-ccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCc
Q 001867          434 LELTDNFLSG-EISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAND  512 (1002)
Q Consensus       434 L~L~~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  512 (1002)
                      |.+.+|+++- -+|+.|+++.+|+.+..++|++. .+|+.++.+..|+.|.|++|++- .+|+++.-|+.|+.|||..|.
T Consensus       296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence            8888888763 36777777777777777777776 77777777777777777777777 677777777777777777776


Q ss_pred             CC
Q 001867          513 LS  514 (1002)
Q Consensus       513 l~  514 (1002)
                      --
T Consensus       374 nL  375 (1255)
T KOG0444|consen  374 NL  375 (1255)
T ss_pred             Cc
Confidence            44

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.1e-35  Score=334.55  Aligned_cols=257  Identities=23%  Similarity=0.246  Sum_probs=198.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      .+|++.+.||+|+||.||+|...   .+..||+|.+..                      .....+|++++++++||||+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~----------------------~~~~~~E~~il~~l~h~~iv  149 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG----------------------GKTPGREIDILKTISHRAII  149 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc----------------------cccHHHHHHHHHhcCCCCcc
Confidence            46888999999999999999753   357899998732                      12356899999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++......|++||++ +++|.+++.  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       150 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~  223 (392)
T PHA03207        150 NLIHAYRWKSTVCMVMPKY-KCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPEN  223 (392)
T ss_pred             ceeeeEeeCCEEEEEehhc-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCC
Confidence            9999999999999999999 478988885  446799999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch---hHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK---DLVKWV  916 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~---~~~~~~  916 (1002)
                      +||+|||+++...............||+.|+|||++.+..++.++||||+||++|||++|+.||.......   .+....
T Consensus       224 ~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~  303 (392)
T PHA03207        224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII  303 (392)
T ss_pred             EEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence            99999999987665443333345579999999999999999999999999999999999999996543221   111111


Q ss_pred             HHHhhccCcc-----------------ccccccc--cCCC--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          917 CSTLDQKGVD-----------------HVLDPKL--DCCF--KEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~-----------------~~~~~~~--~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      . ........                 ....+..  +...  .....++.+++.+|+..||++||++.|++..
T Consensus       304 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        304 R-CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             H-HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1 11000000                 0000000  0000  0011246788999999999999999999864

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-35  Score=330.40  Aligned_cols=243  Identities=25%  Similarity=0.284  Sum_probs=188.7

Q ss_pred             CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHH-HHHhcCCCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV-ETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~  766 (1002)
                      +.||+|+||.||+|+.+ +++.||+|++.+..              .........+..|. .+++.++||||+++++++.
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~   66 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKA--------------ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ   66 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------HHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE
Confidence            47999999999999965 57789999985321              11112233444444 4567789999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      ..+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG  141 (325)
T cd05602          67 TADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  141 (325)
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCC
Confidence            99999999999999999999874  45688999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....+..    ....
T Consensus       142 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~----~~~~  214 (325)
T cd05602         142 LCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILN----KPLQ  214 (325)
T ss_pred             CCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHHh----CCcC
Confidence            997543221  1233456999999999999999999999999999999999999999754322 22222111    1100


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                        +.+   ...    ..+.+++.+|++.||.+||++.+.+
T Consensus       215 --~~~---~~~----~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 --LKP---NIT----NSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             --CCC---CCC----HHHHHHHHHHcccCHHHCCCCCCCH
Confidence              111   111    2477889999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.8e-35  Score=325.97  Aligned_cols=268  Identities=21%  Similarity=0.209  Sum_probs=197.5

Q ss_pred             cCCeeeec--CCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          687 EDNVIGSG--SSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       687 ~~~~LG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      +.++||+|  +||+||++.. .+|+.||+|++....               ......+.+++|+++++.++||||+++++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~hpniv~~~~   66 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA---------------CTNEMVTFLQGELHVSKLFNHPNIVPYRA   66 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhh---------------ccHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            45789999  6789999985 568999999984321               12234556888999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++..++..++||||+++|+|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.++++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~  143 (327)
T cd08227          67 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS  143 (327)
T ss_pred             EEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEc
Confidence            999999999999999999999999765556689999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCc-----ccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          844 DFGVAKVVDASGKPK-----SMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ||+.+..........     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.............
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  223 (327)
T cd08227         144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL  223 (327)
T ss_pred             ccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh
Confidence            998754432211100     1122346778999999876  458899999999999999999999997543222111111


Q ss_pred             HHHhhc--------------cCccccccc------------------cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 001867          917 CSTLDQ--------------KGVDHVLDP------------------KLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR  964 (1002)
Q Consensus       917 ~~~~~~--------------~~~~~~~~~------------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  964 (1002)
                      ......              .......+.                  .......+....+.+++.+||+.||++|||++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e  303 (327)
T cd08227         224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST  303 (327)
T ss_pred             cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH
Confidence            100000              000000000                  000011112235788999999999999999999


Q ss_pred             HHH--HHHHh
Q 001867          965 VVK--LLQEV  972 (1002)
Q Consensus       965 vl~--~L~~~  972 (1002)
                      +++  +++++
T Consensus       304 ll~~p~f~~~  313 (327)
T cd08227         304 LLNHSFFKQI  313 (327)
T ss_pred             HhcChhhhhc
Confidence            986  35443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.9e-35  Score=320.56  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ..|++.+.||+|+||.||+|.. .+++.||+|.+...                 .....+.+.+|+.+++.++||||+++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~v~~~   82 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----------------QQPKKELIINEILVMRENKNPNIVNY   82 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC-----------------CcchHHHHHHHHHHHHhCCCCCEeeE
Confidence            5788889999999999999985 46889999988432                 12234668899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++.+......|+||||+++++|.+++..   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~k  156 (296)
T cd06654          83 LDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK  156 (296)
T ss_pred             EEEEEeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            9999999999999999999999999863   4589999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++........  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+.    .
T Consensus       157 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~----~  230 (296)
T cd06654         157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----T  230 (296)
T ss_pred             ECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh----c
Confidence            999999876543321  1223468899999999998889999999999999999999999997553322211111    1


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .. .....      .+......+.+++.+||+.+|++||+++|+++
T Consensus       231 ~~-~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         231 NG-TPELQ------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CC-CCCCC------CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            10 00000      01122234778999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-35  Score=329.87  Aligned_cols=243  Identities=26%  Similarity=0.307  Sum_probs=189.7

Q ss_pred             CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHH-HHhcCCCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE-TLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~  766 (1002)
                      +.||+|+||+||+|+. .+|+.||+|++.+..              .........+..|.. +++.++||||+++++++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~   66 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI--------------VLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ   66 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            4699999999999996 468999999985421              112233345555655 467789999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      ..+..|+||||+++|+|..++.  +...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          67 TTEKLYFVLDFVNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecC
Confidence            9999999999999999998887  345689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      +++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||........+..    ... ... 
T Consensus       142 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~-~~~-  213 (325)
T cd05604         142 LCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILH-KPL-  213 (325)
T ss_pred             CcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH----HHc-CCc-
Confidence            987543221  122345799999999999999999999999999999999999999975432221111    111 110 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                       .+.+   ..    ...+.+++.+|++.+|.+||++++.+
T Consensus       214 -~~~~---~~----~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         214 -VLRP---GA----SLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -cCCC---CC----CHHHHHHHHHHhccCHHhcCCCCCCH
Confidence             1111   11    22467889999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.8e-35  Score=326.94  Aligned_cols=244  Identities=25%  Similarity=0.351  Sum_probs=193.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKL  761 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l  761 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|++.+..              .......+.+..|..++..+. |++|+++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~i~~~   66 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--------------VIQDDDVECTMVEKRVLALQDKPPFLTQL   66 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHHhccCCCchhhe
Confidence            3677889999999999999964 68899999985421              112233456778899998886 5788899


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ik  141 (323)
T cd05615          67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             eeEEecCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence            9999999999999999999999999874  45699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..   
T Consensus       142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~---  215 (323)
T cd05615         142 IADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIME---  215 (323)
T ss_pred             EeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHh---
Confidence            999999875432221  22344689999999999998999999999999999999999999975432 222221111   


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                       ....  . +  ...    ..++.+++.+|++.+|.+|++.
T Consensus       216 -~~~~--~-p--~~~----~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 -HNVS--Y-P--KSL----SKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCC--C-C--ccC----CHHHHHHHHHHcccCHhhCCCC
Confidence             1100  0 0  111    1246788999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=335.48  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=212.1

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCC----cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNG----EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ....++||+|+||+||+|.| .+|    -+||+|++...                .......++.+|+.+|.+++|||++
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~----------------t~~~~s~e~LdeAl~masldHpnl~  761 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF----------------TSPKASIELLDEALRMASLDHPNLL  761 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc----------------CCchhhHHHHHHHHHHhcCCCchHH
Confidence            44578999999999999986 334    36888887332                2334567899999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.... +.+|++|+|.|+|.+|++.++ ..+-....+.|.+|||+||.|||++   ++|||||.++||||.+...
T Consensus       762 RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~h  836 (1177)
T KOG1025|consen  762 RLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNH  836 (1177)
T ss_pred             HHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCe
Confidence            9999998776 889999999999999999855 4688889999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      +||.|||+++...............-.+.|||=|.+....|+.++|||||||++||++| |..|++.. ..+++.+.++.
T Consensus       837 vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-~~~eI~dlle~  915 (1177)
T KOG1025|consen  837 VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-PAEEIPDLLEK  915 (1177)
T ss_pred             EEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-CHHHhhHHHhc
Confidence            99999999999888776666555555678999999999999999999999999999999 99998654 33343333332


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ..+            -..++.+..+++.++.+||..|++.||+++++.+.+.++.+
T Consensus       916 geR------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  916 GER------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ccc------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            221            11223344568889999999999999999999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.7e-35  Score=313.08  Aligned_cols=251  Identities=27%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|++...                  ......+.+|++++++++||++++++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~------------------~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG------------------AMSEEDFIEEAQVMMKLSHPKLVQLY   65 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC------------------CCCHHHHHHHHHHHHhCCCCCeeeEE
Confidence            357778899999999999999877889999987432                  11235688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++......++||||+++++|.+++... ...++++.+..++.|++.|++|||+.   +++||||||+||+++.++.+||
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l  141 (256)
T cd05112          66 GVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKV  141 (256)
T ss_pred             EEEccCCceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEE
Confidence            9999999999999999999999998753 34689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+........ .......++.+|+|||...+..++.++||||+|+++|||++ |+.||..... ........    
T Consensus       142 ~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~----  215 (256)
T cd05112         142 SDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETIN----  215 (256)
T ss_pred             CCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHh----
Confidence            99999976543321 11112235678999999998889999999999999999998 8999865432 22222111    


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      .. . ....+..  .    ...+.+++.+||+.+|++||+++|+++.|
T Consensus       216 ~~-~-~~~~~~~--~----~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         216 AG-F-RLYKPRL--A----SQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CC-C-CCCCCCC--C----CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            10 0 0011111  1    23588899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-34  Score=310.97  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=204.6

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..+.||+|+||.||.++. .+++.+++|.+....               .......++.+|++++++++|+||++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~---------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~   65 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR---------------LSEKERRDALNEIVILSLLQHPNIIAYY   65 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc---------------cchhHHHHHHHHHHHHHhCCCCCeeEEE
Confidence            367789999999999999985 568899999874321               1233456788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..+++|||+++++|.+++.......+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||
T Consensus        66 ~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl  142 (256)
T cd08221          66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKL  142 (256)
T ss_pred             eEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEE
Confidence            9999999999999999999999999875556789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||.+........  ......|++.|+|||+..+..++.++||||+|+++|||++|+.||.............     .
T Consensus       143 ~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-----~  215 (256)
T cd08221         143 GDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-----Q  215 (256)
T ss_pred             CcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----c
Confidence            99999987644332  2234568999999999988888999999999999999999999996543222222211     1


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ....    +.....    ..++.+++.+||+.+|++||+++++++.
T Consensus       216 ~~~~----~~~~~~----~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         216 GNYT----PVVSVY----SSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCC----CCcccc----CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1111    111111    2347789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=312.47  Aligned_cols=250  Identities=28%  Similarity=0.458  Sum_probs=203.1

Q ss_pred             CeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          689 NVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +.||+|+||.||+|....    +..||+|.+....                .....+.+.+|+++++.++|+||++++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   64 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----------------SEEERKDFLKEARVMKKLGHPNVVRLLGV   64 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeecccc----------------chhHHHHHHHHHHHHhhcCCCChheeeee
Confidence            479999999999999753    7889999985421                11146778999999999999999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCK-------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      +...+..+++|||+++++|.+++....       ...+++..++.++.|++.|++|||++   +|+||||||+||+++.+
T Consensus        65 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~  141 (262)
T cd00192          65 CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGED  141 (262)
T ss_pred             ecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCC
Confidence            999999999999999999999998642       36799999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||.+................++..|+|||.+....++.++||||+|+++|||++ |..||... ...+.....
T Consensus       142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~  220 (262)
T cd00192         142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYL  220 (262)
T ss_pred             CcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence            9999999999987765443233344567889999999988889999999999999999999 68888654 222222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      ..   ....     +.....    ..++.+++.+||+.+|++||+++|+++.|+
T Consensus       221 ~~---~~~~-----~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         221 RK---GYRL-----PKPEYC----PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             Hc---CCCC-----CCCccC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            21   1000     111111    235888999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-35  Score=318.90  Aligned_cols=254  Identities=30%  Similarity=0.454  Sum_probs=199.4

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |++.+.||+|+||+||+|+.. +++.||+|++.....               .........+|+.++++++||||+++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~---------------~~~~~~~~~~e~~~~~~l~~~~i~~~~~   65 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI---------------EEEEREENIREIKILRRLRHPNIVQILD   65 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH---------------HHHHHHHHHHHHHHHHHHTBTTBCHEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc---------------cccccchhhhhhhccccccccccccccc
Confidence            456789999999999999975 467899999854311               1222333455999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++.+....++||||+++++|.+++.  +...+++..+..++.|+++||+|||++   +|+||||||+||+++.++.++|+
T Consensus        66 ~~~~~~~~~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~  140 (260)
T PF00069_consen   66 VFQDDNYLYIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLI  140 (260)
T ss_dssp             EEEESSEEEEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEES
T ss_pred             ccccccccccccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence            9999999999999999999999998  345689999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      |||.+.....  .........++..|+|||+.. +..++.++||||+|+++|+|++|..||..... .+...........
T Consensus       141 Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~~~~~~~~  217 (260)
T PF00069_consen  141 DFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEIIEKILKR  217 (260)
T ss_dssp             SGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHHHHHHHHT
T ss_pred             cccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhhhhhcccc
Confidence            9999986521  222344567899999999998 88899999999999999999999999976521 1222222211111


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ........   .   ......+.+++.+|++.||++||++.++++
T Consensus       218 ~~~~~~~~---~---~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 PLPSSSQQ---S---REKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHTTS---H---TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccccc---c---chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000   0   000146889999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-34  Score=323.15  Aligned_cols=262  Identities=26%  Similarity=0.364  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC--------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN--------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-  753 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  753 (1002)
                      .+|++.+.||+|+||.||+|....        +..||+|.+...                ......+.+.+|+.+++++ 
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~   75 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----------------ATDKDLSDLVSEMEMMKMIG   75 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----------------cCHHHHHHHHHHHHHHHhhc
Confidence            357889999999999999997421        236899977321                1223456789999999999 


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      +||||+++++++...+..+++|||+++|+|.+++....              ...+++.++..++.|++.||+|||++  
T Consensus        76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~--  153 (334)
T cd05100          76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ--  153 (334)
T ss_pred             CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            79999999999999999999999999999999987532              23588899999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ 
T Consensus       154 -givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~  232 (334)
T cd05100         154 -KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL  232 (334)
T ss_pred             -CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence             999999999999999999999999999987654332222223344568999999999999999999999999999999 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      |..||.... ..+....+....    ..    +......    ..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus       233 g~~p~~~~~-~~~~~~~~~~~~----~~----~~~~~~~----~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         233 GGSPYPGIP-VEELFKLLKEGH----RM----DKPANCT----HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             CCCCCCCCC-HHHHHHHHHcCC----CC----CCCCCCC----HHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            888885432 222222221111    00    1111122    34778999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-34  Score=314.73  Aligned_cols=253  Identities=26%  Similarity=0.346  Sum_probs=189.0

Q ss_pred             CeeeecCCccEEEEEEcC---CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          689 NVIGSGSSGKVYKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      +.||+|+||.||+|...+   ...+|+|.+...                ........+.+|+.+++.++||||+++++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~   64 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----------------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQC   64 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc----------------CChHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            368999999999997543   346777765321                1233356688999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKG---GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      ...+..++||||+++|+|.+++...+.   ...++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||
T Consensus        65 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl  141 (269)
T cd05042          65 IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKI  141 (269)
T ss_pred             CCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEE
Confidence            999999999999999999999976432   3457888899999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-------LRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~  914 (1002)
                      +|||++................+++.|+|||+...       ..++.++||||+||++|||++ |..||...........
T Consensus       142 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  221 (269)
T cd05042         142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ  221 (269)
T ss_pred             eccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            99999875433322222233346778999998643       456789999999999999999 7778754422222111


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      .    ... .......+......+   ..+.+++..|| .||++||++++|++.+
T Consensus       222 ~----~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         222 V----VRE-QDIKLPKPQLDLKYS---DRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             H----hhc-cCccCCCCcccccCC---HHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            1    111 111122222222222   23566778898 5999999999999887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-34  Score=312.85  Aligned_cols=250  Identities=27%  Similarity=0.395  Sum_probs=198.7

Q ss_pred             CeeeecCCccEEEEEEcC--C--cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          689 NVIGSGSSGKVYKVVLSN--G--EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      ++||+|+||.||+|.+.+  +  ..||+|.+....               .. ...+.+.+|+.++++++||||++++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~---------------~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~   64 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK---------------LS-DIMDDFLKEAAIMHSLDHENLIRLYGV   64 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcc---------------cH-HHHHHHHHHHHHHhhcCCCCccceeEE
Confidence            468999999999998743  2  368999884321               11 456789999999999999999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      +.. ...++||||+++++|.+++.......+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|
T Consensus        65 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~d  140 (257)
T cd05040          65 VLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGD  140 (257)
T ss_pred             EcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecc
Confidence            988 8899999999999999999864435789999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 001867          845 FGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      ||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... +..+....   .
T Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~---~  216 (257)
T cd05040         141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKIDK---E  216 (257)
T ss_pred             ccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh---c
Confidence            999987755332211 123456788999999998899999999999999999999 99998644222 22222211   1


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      ..  ..  +.....    ...+.+++.+||+.+|++||+++++++.|.
T Consensus       217 ~~--~~--~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         217 GE--RL--ERPEAC----PQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CC--cC--CCCccC----CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00  00  011111    235888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-34  Score=316.39  Aligned_cols=259  Identities=28%  Similarity=0.399  Sum_probs=198.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ..|++.+.||+|+||.||+|..     .+++.||+|++...                 .....+.+.+|++++++++|||
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~   66 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----------------TAEHLRDFEREIEILKSLQHDN   66 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence            3577788999999999999874     35789999987432                 2334567899999999999999


Q ss_pred             eeeeeeEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++..  ....++||||+++|+|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++
T Consensus        67 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~  142 (284)
T cd05081          67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVE  142 (284)
T ss_pred             eeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEEC
Confidence            9999998754  34679999999999999999753 34689999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCccc-ccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSM-SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      .++.+||+|||+++........... ....++..|+|||+..+..++.++|||||||++|||++|..|+.....  ....
T Consensus       143 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~  220 (284)
T cd05081         143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMR  220 (284)
T ss_pred             CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhh
Confidence            9999999999999876543321111 122234569999999888899999999999999999998776542211  1100


Q ss_pred             H-------------HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          915 W-------------VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       915 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .             .........    ..+.....    ..++.+++.+||+.+|++|||++|+++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         221 MMGNDKQGQMIVYHLIELLKNNG----RLPAPPGC----PAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hcccccccccchHHHHHHHhcCC----cCCCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0             000000000    00001112    23588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8e-35  Score=319.16  Aligned_cols=263  Identities=22%  Similarity=0.257  Sum_probs=198.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|++....               .+......+.+|+.++++++||||++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~   65 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---------------EEEGVPSTAIREISLLKELQHPNIVCLQ   65 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc---------------ccCCchHHHHHHHHHHHhcCCCCEeeeE
Confidence            4777889999999999999964 68899999884321               1222345678899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCK-GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++.+++..|+||||++ ++|.+++.... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        66 ~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~  141 (285)
T cd07861          66 DVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIK  141 (285)
T ss_pred             EEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEE
Confidence            99999999999999996 68988886533 36789999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||++........  ......+++.|+|||++.+. .++.++||||+|+++|||++|+.||.................
T Consensus       142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~  219 (285)
T cd07861         142 LADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG  219 (285)
T ss_pred             ECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999976543321  22234578899999987654 578899999999999999999999976543332222211110


Q ss_pred             hc-----------cCcc----ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQ-----------KGVD----HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~-----------~~~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..           ....    ................++.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00           0000    00000000000011234678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-34  Score=315.07  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=196.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.++||+|+||.||+|.. .+++.||+|.+....                .......+.+|++++++++||||+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~   64 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----------------TVELQKQIMSELEILYKCDSPYIIGF   64 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----------------ChHHHHHHHHHHHHHHhCCCCCeeeE
Confidence            3577789999999999999985 568899999874321                12334678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..++||||+++++|..+.      .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++
T Consensus        65 ~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~  135 (279)
T cd06619          65 YGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVK  135 (279)
T ss_pred             EEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEE
Confidence            99999999999999999999986553      378899999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH---HHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL---VKWVCS  918 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~---~~~~~~  918 (1002)
                      |+|||++.......    .....|+..|+|||++.+..++.++||||+|+++|+|++|+.||.........   ......
T Consensus       136 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  211 (279)
T cd06619         136 LCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC  211 (279)
T ss_pred             EeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH
Confidence            99999997654322    23456899999999999989999999999999999999999999653322111   111111


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .. ...     .+....  .....++.+++.+|++.+|++||+++|+++.
T Consensus       212 ~~-~~~-----~~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         212 IV-DED-----PPVLPV--GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             Hh-ccC-----CCCCCC--CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11 000     011100  0111247789999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=310.14  Aligned_cols=249  Identities=25%  Similarity=0.360  Sum_probs=197.1

Q ss_pred             CeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          689 NVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      ++||+|+||.||+|....    +..||+|.+....                .....+++.+|+.++++++||||++++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   64 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH----------------IAAGKKEFLREASVMAQLDHPCIVRLIGV   64 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEeccccc----------------chHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            479999999999998532    2689999874321                11345678999999999999999999998


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      +.. ...++||||+++|+|.+++...  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        65 ~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~d  138 (257)
T cd05060          65 CKG-EPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISD  138 (257)
T ss_pred             EcC-CceEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecc
Confidence            764 4679999999999999999853  3689999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 001867          845 FGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      ||+++.......... .....++..|+|||...+..++.++||||||+++|||++ |..||.... ..+...++......
T Consensus       139 f~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~  217 (257)
T cd05060         139 FGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERL  217 (257)
T ss_pred             ccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHcCCcC
Confidence            999987654432211 112223567999999998899999999999999999998 999986543 23333333221110


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                              +.....    ..++.+++.+||+.+|++||++.++++.|+.+
T Consensus       218 --------~~~~~~----~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 --------PRPEEC----PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --------CCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                    111112    23578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-34  Score=312.25  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=188.5

Q ss_pred             CeeeecCCccEEEEEEcCCc---EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          689 NVIGSGSSGKVYKVVLSNGE---AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      +.||+|+||.||+|...++.   .+++|.+...                ......+.+.+|+.+++.++||||+++++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~   64 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----------------ASSKEQNEFLQQGDPYRILQHPNILQCLGQC   64 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC----------------CChHHHHHHHHHHHHHhccCCcchhheEEEe
Confidence            36999999999999865443   3455554221                1123456799999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      .+....|+||||+++|+|.++++...  ....++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        65 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~  141 (268)
T cd05086          65 VEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVG  141 (268)
T ss_pred             cCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEec
Confidence            99999999999999999999997542  24567778889999999999999998   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-------LRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~  915 (1002)
                      |||++................++..|+|||+..+       ..++.++|||||||++|||++ |..||.... ..+....
T Consensus       142 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~  220 (268)
T cd05086         142 DYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNH  220 (268)
T ss_pred             ccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH
Confidence            9999865332222222234567889999998753       245789999999999999998 456765432 2222221


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      +   ... ......++.....+.+   ++.+++..|| .+|++||++++|++.|.
T Consensus       221 ~---~~~-~~~~~~~~~~~~~~~~---~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         221 V---IKD-QQVKLFKPQLELPYSE---RWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             H---Hhh-cccccCCCccCCCCcH---HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1   111 1122233333333333   3666788899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.5e-35  Score=324.90  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=197.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+.              ..........+.+|+.++..++|++|+++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~l   66 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--------------EMLKRAETACFREERNVLVNGDCQWITTL   66 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--------------HHHhhHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            46888899999999999999964 5788999988432              11123345568889999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~k  142 (331)
T cd05624          67 HYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIR  142 (331)
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEE
Confidence            99999999999999999999999999753 35689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+|||+++....... .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||............ 
T Consensus       143 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i-  220 (331)
T cd05624         143 LADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-  220 (331)
T ss_pred             EEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH-
Confidence            999999986654322 12234569999999998875     46788999999999999999999999754322221111 


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPIN--RPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~  968 (1002)
                         ..... ...+.+......    .++.+++.+|+..++++  |++++++++.
T Consensus       221 ---~~~~~-~~~~p~~~~~~~----~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         221 ---MNHEE-RFQFPSHITDVS----EEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---HcCCC-cccCCCccccCC----HHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               11110 000111111122    34667788888765544  5688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-34  Score=324.44  Aligned_cols=258  Identities=22%  Similarity=0.270  Sum_probs=196.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.++||+|+||.||+++.+ +++.||+|++.+.              ..........+..|+.++..++|++|+++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~   66 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--------------EMLKRAETACFREERDVLVNGDNQWITTL   66 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH--------------HHHHhhHHHHHHHHHHHHhhCCCCCEeeE
Confidence            36888899999999999999965 4778999988432              11123334568889999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~k  142 (332)
T cd05623          67 HYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR  142 (332)
T ss_pred             EEEEecCCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence            99999999999999999999999999752 35689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+|||++........ .......||+.|+|||++.     ...++.++|||||||++|||++|+.||........+..  
T Consensus       143 L~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~--  219 (332)
T cd05623         143 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK--  219 (332)
T ss_pred             EeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH--
Confidence            999999976543322 2223457999999999886     34578999999999999999999999975432222211  


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPL--PINRPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~Rps~~evl~~  968 (1002)
                        ..... ....+........    ..+.+++.+|+..+  +..|++++|+++.
T Consensus       220 --i~~~~-~~~~~p~~~~~~s----~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         220 --IMNHK-ERFQFPAQVTDVS----EDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --HhCCC-ccccCCCccccCC----HHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              11111 0001111111222    23667777777544  4447899999866

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-35  Score=334.92  Aligned_cols=259  Identities=20%  Similarity=0.218  Sum_probs=196.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      ..+|.+.+.||+|+||.||+|... .++.||||...                       ...+.+|++++++++|+|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----------------------~~~~~~E~~iL~~L~HpnIv~  224 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----------------------YASSVHEARLLRRLSHPAVLA  224 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----------------------ccCHHHHHHHHHHCCCCCCCc
Confidence            346888999999999999999964 47889999541                       123568999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..++|||++ .++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       225 l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~v  299 (461)
T PHA03211        225 LLDVRVVGGLTCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDI  299 (461)
T ss_pred             EEEEEEECCEEEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCE
Confidence            999999999999999999 57999888652 34699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-------chhHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG-------EKDLV  913 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~-------~~~~~  913 (1002)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||++|||++|..|+.....       ...+.
T Consensus       300 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~  379 (461)
T PHA03211        300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL  379 (461)
T ss_pred             EEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence            99999999876443222222345699999999999999999999999999999999998766532111       11222


Q ss_pred             HHHHHHhhc-cCccccc----------------cccc-cCCCH---HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          914 KWVCSTLDQ-KGVDHVL----------------DPKL-DCCFK---EEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       914 ~~~~~~~~~-~~~~~~~----------------~~~~-~~~~~---~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      +.+...... .......                .+.. ...+.   .....+.+++.+|++.||.+|||+.|+++.
T Consensus       380 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            222211100 0000000                0000 00000   011257789999999999999999999864

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=298.45  Aligned_cols=245  Identities=24%  Similarity=0.285  Sum_probs=200.7

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      .+++|++.++||+|.||.|..++- ..++.||+|++++.+              +..+...+.-..|-++++..+||++.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev--------------iiakdEVAHTlTE~RVL~~~~HPFLt  231 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV--------------IIAKDEVAHTLTENRVLQNCRHPFLT  231 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh--------------eeehHHhhhhhhHHHHHHhccCcHHH
Confidence            367889999999999999999984 568999999996653              33455566778899999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      .+...|+..+++|+||||+.||.|.-.+.  +...+++...+.+-.+|+.||.|||++   +||+||+|.+|.++|.||+
T Consensus       232 ~LKYsFQt~drlCFVMeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGH  306 (516)
T KOG0690|consen  232 SLKYSFQTQDRLCFVMEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGH  306 (516)
T ss_pred             HhhhhhccCceEEEEEEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCc
Confidence            99999999999999999999999988887  456799999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++---.  ....+...+|||.|+|||++....|..++|+|.+||++|||++|+.||+.... +.+.+.+.. 
T Consensus       307 IKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~-  382 (516)
T KOG0690|consen  307 IKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILM-  382 (516)
T ss_pred             eEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHh-
Confidence            99999999974322  23346678999999999999999999999999999999999999999976532 222222211 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP  960 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  960 (1002)
                            .++.-|  +...+    +...++...+.+||.+|.
T Consensus       383 ------ed~kFP--r~ls~----eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  383 ------EDLKFP--RTLSP----EAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ------hhccCC--ccCCH----HHHHHHHHHhhcChHhhc
Confidence                  111111  11112    244566678899999996

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.7e-35  Score=322.57  Aligned_cols=263  Identities=20%  Similarity=0.260  Sum_probs=198.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|++....                .......+.+|+.++++++||||++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~   68 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH----------------EEGAPCTAIREVSLLKDLKHANIVT   68 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc----------------cCCcchhHHHHHHHHHhCCCCCcce
Confidence            457888899999999999999864 57889999884321                1112345778999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++..++..++||||++ ++|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        69 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~  143 (309)
T cd07872          69 LHDIVHTDKSLTLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGEL  143 (309)
T ss_pred             EEEEEeeCCeEEEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence            9999999999999999996 5888888653 34689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+++.......  ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+.........
T Consensus       144 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  221 (309)
T cd07872         144 KLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL  221 (309)
T ss_pred             EECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            9999999976543321  2223467899999998765 468899999999999999999999997654333222221110


Q ss_pred             hh--ccCcc------c---ccccccc-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LD--QKGVD------H---VLDPKLD-----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~--~~~~~------~---~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..  .....      .   .-.+...     ...+....++.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00  00000      0   0000000     000111234678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-34  Score=314.43  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=204.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-Cc----EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-GE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .+|++.+.||+|+||.||+|.+++ |+    .||+|.+....                .......+.+|+.++++++|||
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~   70 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----------------SPKANKEILDEAYVMASVDHPH   70 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence            467788999999999999998643 33    58888763321                1334567899999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.. ...++||||+++|+|.+++... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.+
T Consensus        71 i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~  145 (279)
T cd05057          71 VVRLLGICLS-SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTP  145 (279)
T ss_pred             cceEEEEEec-CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCC
Confidence            9999999987 7789999999999999999763 34589999999999999999999998   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||.++...............++..|+|||......++.++||||||+++||+++ |+.||.... ..+....+
T Consensus       146 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~  224 (279)
T cd05057         146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIPDLL  224 (279)
T ss_pred             CeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHH
Confidence            9999999999987654332222222234568999999988889999999999999999998 999986542 22333222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ....   ..     +......    .++.+++.+||..+|.+||++.++++.|+++..
T Consensus       225 ~~~~---~~-----~~~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         225 EKGE---RL-----PQPPICT----IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             hCCC---CC-----CCCCCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2110   00     1111112    247788999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-34  Score=310.67  Aligned_cols=252  Identities=24%  Similarity=0.325  Sum_probs=201.1

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|..+ +++.||+|++....               ......+.+.+|++++++++|+|+++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---------------ASRRERKAAEQEAQLLSQLKHPNIVAYR   65 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---------------cCHHHHHHHHHHHHHHHhCCCCCeeeee
Confidence            4788899999999999999964 57889999984321               1233456688999999999999999999


Q ss_pred             eEEec-CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCTT-RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +.+.. +...|++|||+++++|.+++.......+++.++..++.|++.|++|||++   +|+||||||+||+++.++.++
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~  142 (257)
T cd08223          66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIK  142 (257)
T ss_pred             eeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEE
Confidence            98864 44679999999999999999876666799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++........  ......|++.|+|||+..+..++.++||||+|+++|++++|+.||.....    .........
T Consensus       143 l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~  216 (257)
T cd08223         143 VGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----NSLVYRIIE  216 (257)
T ss_pred             EecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHh
Confidence            999999987643322  22244688999999999999999999999999999999999999864321    111111111


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                       ....     ..   .......+.+++.+||+.+|++||++.++++.
T Consensus       217 -~~~~-----~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 -GKLP-----PM---PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -cCCC-----CC---ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             1111     01   11122357889999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-36  Score=319.72  Aligned_cols=244  Identities=29%  Similarity=0.403  Sum_probs=196.9

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |.-.+.||.|+||.||-|++ .+.+.||+|++...              -.+....-.++.+||..+++++|||+|.+.|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS--------------GKQs~EKWqDIlKEVrFL~~l~HPntieYkg   93 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--------------GKQSNEKWQDILKEVRFLRQLRHPNTIEYKG   93 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeecccc--------------ccccHHHHHHHHHHHHHHHhccCCCcccccc
Confidence            44467899999999999995 56789999998332              1123445677999999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      +|-.+...|+||||| -|+-.|++.-.+ +++-+..+..|+.+.+.||+|||+.   +.||||||+.|||+++.|.||++
T Consensus        94 CyLre~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa  168 (948)
T KOG0577|consen   94 CYLREHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA  168 (948)
T ss_pred             eeeccchHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence            999999999999999 567788776633 6799999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |||.|....+..      ..+|||+|||||++.   .+.|+-|+||||+|++..|+...+.|.-..   ...........
T Consensus       169 DFGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM---NAMSALYHIAQ  239 (948)
T KOG0577|consen  169 DFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQ  239 (948)
T ss_pred             cccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc---hHHHHHHHHHh
Confidence            999998776543      468999999999876   567999999999999999999998886432   33333222222


Q ss_pred             hccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          921 DQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       921 ~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      .+.       |.+ ...+.+   .+..++..|+++-|.+|||.++++
T Consensus       240 Nes-------PtLqs~eWS~---~F~~Fvd~CLqKipqeRptse~ll  276 (948)
T KOG0577|consen  240 NES-------PTLQSNEWSD---YFRNFVDSCLQKIPQERPTSEELL  276 (948)
T ss_pred             cCC-------CCCCCchhHH---HHHHHHHHHHhhCcccCCcHHHHh
Confidence            221       111 112222   356778899999999999999887

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-34  Score=315.26  Aligned_cols=250  Identities=25%  Similarity=0.371  Sum_probs=196.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  760 (1002)
                      +.|+..+.||+|+||.||+|... +++.||+|++...                  ......+..|+.+++++ +||||++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~------------------~~~~~~~~~e~~~l~~~~~h~~i~~   67 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------GDEEEEIKQEINMLKKYSHHRNIAT   67 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC------------------CccHHHHHHHHHHHHHhcCCCCeee
Confidence            45677789999999999999864 5788999987431                  12245688999999998 6999999


Q ss_pred             eeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          761 LWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       761 l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++++...      ...|++|||+++++|.+++.......+++..+..++.|++.|++|||++   +|+||||||+||++
T Consensus        68 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili  144 (272)
T cd06637          68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLL  144 (272)
T ss_pred             EeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEE
Confidence            99999753      4579999999999999999875566799999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +.++.++|+|||++.......  .......|+..|+|||++.     +..++.++||||+||++|||++|+.||......
T Consensus       145 ~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~  222 (272)
T cd06637         145 TENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM  222 (272)
T ss_pred             CCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            999999999999998654322  1223456899999999876     345788999999999999999999999643221


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .....     ..........+   ...    ..++.+++.+||+.+|.+|||++|+++
T Consensus       223 ~~~~~-----~~~~~~~~~~~---~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         223 RALFL-----IPRNPAPRLKS---KKW----SKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHH-----HhcCCCCCCCC---CCc----CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11111     01111111111   111    224778999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-34  Score=314.97  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             CCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      |.+.+.||+|+||.||.|+.     .++..||+|.+....                .....+.+.+|++++++++||||+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~   69 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----------------GGNHIADLKKEIEILRNLYHENIV   69 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----------------cHHHHHHHHHHHHHHHhCCCCCee
Confidence            56778999999999999974     347889999874321                223356799999999999999999


Q ss_pred             eeeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++...  ...++||||+++++|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        70 ~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~  145 (284)
T cd05079          70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE  145 (284)
T ss_pred             eeeeEEecCCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCC
Confidence            999999875  5689999999999999998753 34689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------
Q 001867          838 FGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--------  908 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~--------  908 (1002)
                      +.+||+|||+++......... ......++..|+|||+..+..++.++|||||||++|||++++.|......        
T Consensus       146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~  225 (284)
T cd05079         146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP  225 (284)
T ss_pred             CCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc
Confidence            999999999998765433211 11234567789999999888899999999999999999998776532211        


Q ss_pred             ---chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          909 ---EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       909 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                         +........ .......    .+.....    ..++.+++.+||+.+|++||+++++++.++++
T Consensus       226 ~~~~~~~~~~~~-~~~~~~~----~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         226 THGQMTVTRLVR-VLEEGKR----LPRPPNC----PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccccccHHHHHH-HHHcCcc----CCCCCCC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence               111111111 1111100    0111112    23588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-34  Score=311.74  Aligned_cols=250  Identities=26%  Similarity=0.431  Sum_probs=194.2

Q ss_pred             CeeeecCCccEEEEEEcC-Cc--EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeE
Q 001867          689 NVIGSGSSGKVYKVVLSN-GE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCC  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  764 (1002)
                      +.||+|+||.||+|..++ +.  .+|+|.+...                ......+.+.+|+++++++ +||||++++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   64 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----------------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA   64 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----------------CCHHHHHHHHHHHHHHHhhccCCCeeeEEEE
Confidence            368999999999999754 43  4688876321                1233456788999999999 79999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      +...+..++||||+++|+|.+++....              ...+++..+..++.|++.|++|||+.   +++||||||+
T Consensus        65 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~  141 (270)
T cd05047          65 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR  141 (270)
T ss_pred             EecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccc
Confidence            999999999999999999999987532              13578999999999999999999998   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGE  909 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~  909 (1002)
                      ||+++.++.+|++|||++......   ........+..|+|||+.....++.++|||||||++|||++ |+.||..... 
T Consensus       142 nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-  217 (270)
T cd05047         142 NILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-  217 (270)
T ss_pred             eEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-
Confidence            999999999999999998633211   11112234567999999988889999999999999999997 9999864322 


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .+....+..   .....     .....    ...+.+++.+||+.+|.+|||++++++.|+++.
T Consensus       218 ~~~~~~~~~---~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         218 AELYEKLPQ---GYRLE-----KPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHhC---CCCCC-----CCCcC----CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            222221111   10000     00111    234789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-34  Score=311.61  Aligned_cols=258  Identities=27%  Similarity=0.411  Sum_probs=201.9

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|.+.+.||+|+||.||+|.. .+++.||+|.+.......        ..........+.+.+|+.++++++||||++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~--------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSA--------SSKDRKRSMLDALAREIALLKELQHENIVQYL   72 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCccc--------chhHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            367788999999999999986 457899999885432110        00111223346789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..+++|||+++++|.+++..  .+.+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l  147 (267)
T cd06628          73 GSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKI  147 (267)
T ss_pred             EEEEeCCccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEe
Confidence            999999999999999999999999974  35689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCC----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          843 ADFGVAKVVDASGKP----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      +|||.++........    .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||............   
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---  224 (267)
T cd06628         148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI---  224 (267)
T ss_pred             cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH---
Confidence            999999876532111    1112345788999999999888999999999999999999999999754322211111   


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ..      ...+....   .....+.+++.+||+.||++||++.|+++
T Consensus       225 -~~------~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 -GE------NASPEIPS---NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -hc------cCCCcCCc---ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             10      01111111   11235778899999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.6e-34  Score=318.41  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|... ++..+|+|.+....                ......++.+|++++++++||||+++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~   64 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----------------KPAIRNQIIRELKVLHECNSPYIVGF   64 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----------------CHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            36888899999999999999964 57888998874310                12335568899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..++||||+++++|.++++.  .+.+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+|
T Consensus        65 ~~~~~~~~~~~lv~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~  140 (308)
T cd06615          65 YGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIK  140 (308)
T ss_pred             EEEEeeCCEEEEEeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEE
Confidence            9999999999999999999999999974  35689999999999999999999973  1899999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++.......    .....|+..|+|||...+..++.++||||||+++|+|++|+.||..... .....+......
T Consensus       141 l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~  215 (308)
T cd06615         141 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVS  215 (308)
T ss_pred             EccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccc
Confidence            99999987553321    1234688999999999888899999999999999999999999864432 222111111100


Q ss_pred             ccCcc------------------------ccc---cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVD------------------------HVL---DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~------------------------~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .....                        ..+   .+....  .....++.+++.+||+.+|++||+++++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000                        000   000000  0012247899999999999999999998865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-34  Score=310.42  Aligned_cols=249  Identities=26%  Similarity=0.374  Sum_probs=201.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|...+ ++.||+|.+...                   ...+.+.+|++++++++||||+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------------------~~~~~~~~e~~~~~~l~~~~i~~~   63 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------------------EDLQEIIKEISILKQCDSPYIVKY   63 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------------------HHHHHHHHHHHHHHhCCCCcEeee
Confidence            468888999999999999999764 789999987321                   116789999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..|+++||+++++|.+++.. ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|
T Consensus        64 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~  139 (256)
T cd06612          64 YGSYFKNTDLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAK  139 (256)
T ss_pred             eeeeecCCcEEEEEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEE
Confidence            9999999999999999999999999875 345789999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++........  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||............    . 
T Consensus       140 l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~----~-  212 (256)
T cd06612         140 LADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI----P-  212 (256)
T ss_pred             EcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh----c-
Confidence            999999987654322  122345788999999999889999999999999999999999999754222211110    0 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...     .+... ........+.+++.+||+.+|++|||+.|+++
T Consensus       213 ~~~-----~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         213 NKP-----PPTLS-DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCC-----CCCCC-chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            000     00000 01111235788999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-34  Score=314.03  Aligned_cols=252  Identities=26%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|.+...                 .......+.+|+.+++.++||||+++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-----------------~~~~~~~~~~e~~~~~~l~h~~ii~~   71 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-----------------PGEDFAVVQQEIIMMKDCKHSNIVAY   71 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-----------------chhHHHHHHHHHHHHHhCCCCCeeeE
Confidence            3566678899999999999986 46889999987432                 12234567889999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..|+||||+++++|.+++..  .+.+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~  146 (267)
T cd06645          72 FGSYLRRDKLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVK  146 (267)
T ss_pred             EEEEEeCCEEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence            9999999999999999999999999874  45689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |+|||++.......  .......|+..|+|||++.   ...++.++||||+||++|+|++|+.||.............. 
T Consensus       147 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-  223 (267)
T cd06645         147 LADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-  223 (267)
T ss_pred             ECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-
Confidence            99999987664322  1223456899999999874   45588999999999999999999999864432222111111 


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         ........... ...    ...+.+++.+|++.+|++||+++++++
T Consensus       224 ---~~~~~~~~~~~-~~~----~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 ---SNFQPPKLKDK-MKW----SNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ---cCCCCCccccc-CCC----CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence               00000000000 011    124778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.8e-34  Score=314.26  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=195.5

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |++.+.||+|+||.||+|... ++..+|+|.+...                 .....+.+.+|+++++.++||||+++++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~ii~~~~   69 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----------------SEEELEDYMVEIDILASCDHPNIVKLLD   69 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----------------CHHHHHHHHHHHHHHHHCCCCCeeeEEE
Confidence            456678999999999999975 4778888887321                 2234567889999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++..++..++||||+++++|..++.. ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++
T Consensus        70 ~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~  145 (282)
T cd06643          70 AFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLA  145 (282)
T ss_pred             EEeeCCEEEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEc
Confidence            99999999999999999999988764 345799999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |||++.......  .......|++.|+|||++.     +..++.++||||+||++|||++|+.||.............. 
T Consensus       146 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-  222 (282)
T cd06643         146 DFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-  222 (282)
T ss_pred             cccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh-
Confidence            999987654321  1223446889999999874     44577899999999999999999999865432222222111 


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         ... .....+  ...    ..++.+++.+||+.+|++||+++++++
T Consensus       223 ---~~~-~~~~~~--~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         223 ---SEP-PTLAQP--SRW----SSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ---cCC-CCCCCc--ccc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               100 010011  111    234788999999999999999998874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-34  Score=322.00  Aligned_cols=196  Identities=22%  Similarity=0.350  Sum_probs=160.7

Q ss_pred             CCeeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          688 DNVIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +++||+|+||.||+|+.+   +++.||+|.+...                   .....+.+|+.++++++||||++++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~~~~~   66 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-------------------GISMSACREIALLRELKHPNVISLQKV   66 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-------------------CCcHHHHHHHHHHHhcCCCCCcceeee
Confidence            468999999999999864   4678999987321                   112346789999999999999999999


Q ss_pred             Eec--CCeeeEEEeccCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-
Q 001867          765 CTT--RDCKLLVYEYMPNGSLGDLLHSCK-------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-  834 (1002)
Q Consensus       765 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll-  834 (1002)
                      +..  +...|++|||+ +++|.+++....       ...+++..+..++.|++.||+|||++   +|+||||||+||++ 
T Consensus        67 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~  142 (317)
T cd07868          67 FLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVM  142 (317)
T ss_pred             EecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEe
Confidence            864  45689999999 468888875321       23589999999999999999999999   99999999999999 


Q ss_pred             ---CCCCCeEEccccCcccccCCCCC-cccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          835 ---DGDFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       835 ---~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                         +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       143 ~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         143 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence               45678999999999876543221 122345789999999998764 5889999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.2e-34  Score=308.92  Aligned_cols=239  Identities=23%  Similarity=0.369  Sum_probs=185.8

Q ss_pred             CeeeecCCccEEEEEEcC-------------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          689 NVIGSGSSGKVYKVVLSN-------------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      +.||+|+||.||+|...+             ...||+|.+...                 .......+.+|+.+++.++|
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------------~~~~~~~~~~~~~~l~~l~h   63 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----------------HRDISLAFFETASMMRQVSH   63 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----------------hhhHHHHHHHHHHHHHhCCC
Confidence            468999999999998532             225788876321                 22334578889999999999


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |||+++++++..+...++||||+++|+|..++.. +...+++..+++++.||+.|++|||++   +|+||||||+||+++
T Consensus        64 p~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~  139 (262)
T cd05077          64 KHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLA  139 (262)
T ss_pred             CCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEe
Confidence            9999999999999999999999999999998865 335689999999999999999999999   999999999999998


Q ss_pred             CCCC-------eEEccccCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 001867          836 GDFG-------ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVT-GRLPVDPE  906 (1002)
Q Consensus       836 ~~~~-------~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~-g~~p~~~~  906 (1002)
                      .++.       ++++|||++......      ....++..|+|||.+. +..++.++|||||||++|||++ |..|+...
T Consensus       140 ~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         140 REGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             cCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            7664       899999998755322      2345788999999886 4668899999999999999985 77777543


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      .. .+....    .. ... ...    ..    ....+.+++.+||+.||++||++.++++.+
T Consensus       214 ~~-~~~~~~----~~-~~~-~~~----~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         214 TL-AEKERF----YE-GQC-MLV----TP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ch-hHHHHH----Hh-cCc-cCC----CC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            21 111111    00 000 000    11    123578899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.1e-34  Score=314.73  Aligned_cols=263  Identities=24%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++.....               .....+.+.+|+.++++++|||++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~i~~~   65 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED---------------DPVIKKIALREIRMLKQLKHPNLVNL   65 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc---------------CccccHHHHHHHHHHHhCCCCCEeee
Confidence            35788899999999999999975 589999998843211               11223457899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++......++||||++++.|..+...  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|
T Consensus        66 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~  140 (286)
T cd07847          66 IEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIK  140 (286)
T ss_pred             eeEEeeCCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEE
Confidence            9999999999999999999888887653  34689999999999999999999998   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||++........  ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+..........
T Consensus       141 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~  218 (286)
T cd07847         141 LCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG  218 (286)
T ss_pred             ECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999987654332  1223457889999998875 5578999999999999999999999976543332222111110


Q ss_pred             h----------c-cCcccccccccc------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 D----------Q-KGVDHVLDPKLD------CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~----------~-~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .          . ........+...      .........+.+++.+||+.+|++||++.|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0          0 000000001000      000111245789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.7e-34  Score=316.13  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=200.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ..|++.+.||.|+||.||+|.. .+++.||+|.+...                 .....+.+.+|+.+++.++||||+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~   81 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-----------------KQPKKELIINEILVMKELKNPNIVNF   81 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-----------------cCchHHHHHHHHHHHHhcCCCceeee
Confidence            3578889999999999999985 56899999988321                 12234568899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..|+||||+++++|.+++..   ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.+|
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~k  155 (296)
T cd06655          82 LDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVK  155 (296)
T ss_pred             eeeEecCceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence            9999999999999999999999998864   3589999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++........  ......|+..|+|||.+.+..++.++|||||||++|++++|+.||..............    
T Consensus       156 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~----  229 (296)
T cd06655         156 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----  229 (296)
T ss_pred             EccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----
Confidence            999999886544322  12234688899999999988899999999999999999999999976533222221111    


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ........      +......+.+++.+||+.||++||++.++++
T Consensus       230 -~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         230 -NGTPELQN------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -cCCcccCC------cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             00000000      1111224778899999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.1e-34  Score=308.70  Aligned_cols=247  Identities=29%  Similarity=0.445  Sum_probs=197.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||++.. +++.||+|.+...                   ...+.+.+|+.++++++|||+++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-------------------~~~~~~~~e~~~l~~~~~~~i~~~~   65 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-------------------VTAQAFLEETAVMTKLHHKNLVRLL   65 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc-------------------chHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4678889999999999999875 5788999987321                   1245688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++..++ .+++|||+++++|.+++.......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||
T Consensus        66 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl  141 (254)
T cd05083          66 GVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKV  141 (254)
T ss_pred             EEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEE
Confidence            9987654 79999999999999999865555689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+.......     .....+..|+|||++.+..++.++||||+|+++|||++ |+.||..... .+......... 
T Consensus       142 ~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~-  214 (254)
T cd05083         142 SDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECVEKGY-  214 (254)
T ss_pred             CCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHHhCCC-
Confidence            9999987643221     12234568999999998899999999999999999998 8888864322 22222211110 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                          .  .++ ....+    ..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 ----~--~~~-~~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 ----R--MEP-PEGCP----ADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----C--CCC-CCcCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                0  111 11222    347789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.8e-34  Score=310.19  Aligned_cols=257  Identities=23%  Similarity=0.373  Sum_probs=199.6

Q ss_pred             CCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      |.+.+.||+|+||.||+|.+.    +++.||||++...               .......+++.+|+.++++++||||++
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~i~~   65 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---------------IFSSSDIEEFLREAACMKEFDHPNVIK   65 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc---------------cCChHHHHHHHHHHHHHhcCCCCCcce
Confidence            566789999999999999853    3688999988432               223345667899999999999999999


Q ss_pred             eeeEEecCC------eeeEEEeccCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          761 LWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCK----GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       761 l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      +++++...+      ..++++||+++|+|.+++....    ...+++..+.+++.|++.|++|||++   +|+||||||+
T Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~  142 (273)
T cd05074          66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAAR  142 (273)
T ss_pred             EEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchh
Confidence            999886532      2478999999999998875322    13578999999999999999999999   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGE  909 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~  909 (1002)
                      ||+++.++.+|++|||.++...............+++.|++||...+..++.++||||||+++|||++ |+.||.... .
T Consensus       143 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-~  221 (273)
T cd05074         143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-N  221 (273)
T ss_pred             hEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-H
Confidence            99999999999999999987654332222223345678999999998889999999999999999999 788876432 2


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .+...+...   .....     .....    ..++.+++.+||+.+|++||++.++++.|+++
T Consensus       222 ~~~~~~~~~---~~~~~-----~~~~~----~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         222 SEIYNYLIK---GNRLK-----QPPDC----LEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHHHHHc---CCcCC-----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222222211   11100     00112    23588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-34  Score=305.85  Aligned_cols=249  Identities=27%  Similarity=0.381  Sum_probs=197.8

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecC
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTR  768 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  768 (1002)
                      ++||+|+||.||+|...+++.||+|.+....                .....+.+.+|++++++++||||+++++++...
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   64 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTL----------------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK   64 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccC----------------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Confidence            4699999999999998779999999874321                113456789999999999999999999999999


Q ss_pred             CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCc
Q 001867          769 DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA  848 (1002)
Q Consensus       769 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~  848 (1002)
                      ...++||||+++++|.+++... ...+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||.+
T Consensus        65 ~~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~  140 (251)
T cd05041          65 QPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMS  140 (251)
T ss_pred             CCeEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccc
Confidence            9999999999999999998753 34688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCccc
Q 001867          849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDH  927 (1002)
Q Consensus       849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1002)
                      ................++..|+|||++.++.++.++|||||||++|||++ |..||..... ...........     . 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~~~~~~~~-----~-  213 (251)
T cd05041         141 REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIESGY-----R-  213 (251)
T ss_pred             ccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHHHHHhcCC-----C-
Confidence            86543222111122234567999999988899999999999999999999 7888754422 22222211110     0 


Q ss_pred             cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      .  + ..   ......+.+++.+||+.+|++||+++|+++.|+
T Consensus       214 ~--~-~~---~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 M--P-AP---QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             C--C-CC---ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            0  0 01   111235888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.2e-34  Score=313.73  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=197.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|++.++||+|+||.||+|+.. +++.||+|.+...                 +....+.+.+|+.++++++||||+++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i~~~   74 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------------SEEELEDYMVEIEILATCNHPYIVKL   74 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCCcEeee
Confidence            45777889999999999999975 4889999987321                 23446678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..++||||+++++|..++... ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~k  150 (292)
T cd06644          75 LGAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIK  150 (292)
T ss_pred             EEEEEeCCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEE
Confidence            99999999999999999999998887643 35689999999999999999999998   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+|||++.......  .......+++.|+|||++.     ...++.++|||||||++|||++|+.||..........+. 
T Consensus       151 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-  227 (292)
T cd06644         151 LADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-  227 (292)
T ss_pred             EccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH-
Confidence            99999987543321  1122446888999999874     345678999999999999999999998654322211111 


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         .... .....      .......++.+++.+||+.+|++||+++++++
T Consensus       228 ---~~~~-~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         228 ---AKSE-PPTLS------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---hcCC-CccCC------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               1111 00000      01111235788999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-34  Score=308.74  Aligned_cols=253  Identities=28%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+...                 .....+.+.+|++++++++||||+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~i~~~   65 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----------------PGDDFEIIQQEISMLKECRHPNIVAY   65 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC-----------------chhhHHHHHHHHHHHHhCCCCChhce
Confidence            46788899999999999999964 5788999988432                 12245678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..|++|||+++++|.+++... ...+++..+..++.|++.|++|||++   +|+||||+|+||+++.++.+|
T Consensus        66 ~~~~~~~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~  141 (262)
T cd06613          66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVK  141 (262)
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEE
Confidence            99999999999999999999999998753 25689999999999999999999998   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |+|||.+........  ......++..|+|||.+.+.   .++.++||||+|+++|||++|+.||.............. 
T Consensus       142 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-  218 (262)
T cd06613         142 LADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-  218 (262)
T ss_pred             ECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Confidence            999999986654321  12234688899999998776   788999999999999999999999965432222211111 


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                          ....   .+... .......++.+++.+||+.+|.+||++++++.
T Consensus       219 ----~~~~---~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         219 ----SNFP---PPKLK-DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ----ccCC---Ccccc-chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                1000   01110 11122345789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.3e-34  Score=308.90  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=203.0

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||++.. .+++.||+|.+.....               .......+.+|+.++++++||||++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM---------------SPKEREESRKEVAVLSNMKHPNIVQYQ   65 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC---------------ChHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence            477889999999999999985 4688999998843211               123456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..++||||+++++|.+++.......+++..+.+++.|++.|++|||++   +++|+||+|+||+++.++.+++
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l  142 (256)
T cd08218          66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKL  142 (256)
T ss_pred             eeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999999865555689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||++........  ......|++.|+|||+..+..++.++|||||||++|+|++|+.||............    ...
T Consensus       143 ~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~----~~~  216 (256)
T cd08218         143 GDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI----IRG  216 (256)
T ss_pred             eeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH----hcC
Confidence            99999986644321  122345888999999999888999999999999999999999998754322221111    111


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      . ..    +...    ....++.+++.+||+.+|++||++.+|++
T Consensus       217 ~-~~----~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         217 S-YP----PVSS----HYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             C-CC----CCcc----cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1 11    1111    12235888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.1e-34  Score=310.07  Aligned_cols=257  Identities=24%  Similarity=0.326  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|.+.+.||+|+||.||+|...+    ...||+|......                +....+.+.+|+.++++++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----------------~~~~~~~~~~e~~~l~~~~h~~i   69 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----------------SPSVREKFLQEAYIMRQFDHPHI   69 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----------------CHHHHHHHHHHHHHHHhCCCCch
Confidence            357778899999999999998643    2468999874321                13345679999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++.+ +..++||||+++|+|.+++... ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        70 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~  144 (270)
T cd05056          70 VKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPD  144 (270)
T ss_pred             hceeEEEcC-CCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCC
Confidence            999998876 4578999999999999999753 34589999999999999999999998   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+|++|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |..||....... ......
T Consensus       145 ~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~~~  222 (270)
T cd05056         145 CVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VIGRIE  222 (270)
T ss_pred             CeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH
Confidence            99999999998665432211 222234568999999988889999999999999999996 999996553322 222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .   ....     +.....+    ..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus       223 ~---~~~~-----~~~~~~~----~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         223 N---GERL-----PMPPNCP----PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             c---CCcC-----CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1   1100     1111222    347889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.1e-34  Score=317.28  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=201.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+...                 .....+.+.+|+.+++.++||||++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~i~~   80 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-----------------QQPKKELIINEILVMRENKNPNIVN   80 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC-----------------ccchHHHHHHHHHHHHhCCCCCEee
Confidence            36788899999999999999996 56899999988432                 1223466889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..|+||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~  154 (297)
T cd06656          81 YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSV  154 (297)
T ss_pred             EEEEEecCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            99999999999999999999999999863   4589999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +|+|||++........  ......+++.|+|||...+..++.++||||+||++|++++|..||............    .
T Consensus       155 ~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~----~  228 (297)
T cd06656         155 KLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----A  228 (297)
T ss_pred             EECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee----c
Confidence            9999999976544322  122346888999999999888999999999999999999999999654321111100    0


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      . .......      .+......+.+++.+||+.+|++||+++++++
T Consensus       229 ~-~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         229 T-NGTPELQ------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             c-CCCCCCC------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 0000000      01112234678899999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.5e-34  Score=312.41  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=195.8

Q ss_pred             CeeeecCCccEEEEEEcC-------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          689 NVIGSGSSGKVYKVVLSN-------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.||+|+||.||+|+.++       +..+|+|.+....                .......+.+|+.+++.++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~   64 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----------------TDQEKKEFLKEAHLMSNFNHPNIVKL   64 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc----------------chhhHHHHHHHHHHHHhcCCCCeeeE
Confidence            368999999999998643       2578999873321                12335578899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      ++++...+..++||||+++++|.+++....     ...+++.++..++.|++.|++|||+.   +++||||||+||+++.
T Consensus        65 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~  141 (269)
T cd05044          65 LGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSE  141 (269)
T ss_pred             eeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEec
Confidence            999999999999999999999999997532     23478999999999999999999998   9999999999999998


Q ss_pred             CC-----CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 001867          837 DF-----GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEK  910 (1002)
Q Consensus       837 ~~-----~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~  910 (1002)
                      ++     .++++|||++................++..|+|||++.++.++.++|||||||++|||++ |+.||..... .
T Consensus       142 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~  220 (269)
T cd05044         142 KGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-Q  220 (269)
T ss_pred             CCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-H
Confidence            77     899999999976644332222223345678999999999999999999999999999998 9999864422 2


Q ss_pred             hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      +....+..   ....      ....   .....+.+++.+||+.+|++||+++++.+.|+
T Consensus       221 ~~~~~~~~---~~~~------~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         221 EVLQHVTA---GGRL------QKPE---NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHHHhc---CCcc------CCcc---cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            22222111   0000      0011   11235778999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=313.75  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=199.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|... ++..||+|.+...                 .....+.+.+|++++++++||||+++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i~~~   67 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----------------SEEELEDFMVEIDILSECKHPNIVGL   67 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----------------CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence            45677789999999999999964 6889999988432                 23345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..|+||||+++++|.+++... ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~  143 (280)
T cd06611          68 YEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVK  143 (280)
T ss_pred             EEEEecCCeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEE
Confidence            99999999999999999999999998753 35699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+|||.+........  ......|++.|+|||++.     ...++.++||||+|+++|||++|+.||...........+ 
T Consensus       144 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~-  220 (280)
T cd06611         144 LADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI-  220 (280)
T ss_pred             EccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH-
Confidence            999999876543322  223446889999999874     345678999999999999999999999654322222111 


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                         ... .... ++. ....    ...+.+++..||+.+|++||+++++++.
T Consensus       221 ---~~~-~~~~-~~~-~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         221 ---LKS-EPPT-LDQ-PSKW----SSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ---hcC-CCCC-cCC-cccC----CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               111 0000 000 0111    1247788999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-35  Score=326.65  Aligned_cols=243  Identities=25%  Similarity=0.281  Sum_probs=186.5

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC---CCCceeeeeeEEe
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI---RHKNIVKLWCCCT  766 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~  766 (1002)
                      ||+|+||+||+|+.+ +++.||||++.+.              ..........+..|..++.+.   +||+|+++++++.
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~   66 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK--------------EIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ   66 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHH--------------HHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe
Confidence            699999999999964 5899999998432              111222334455677777665   6999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +....|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        67 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          67 TDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             cCCeEEEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCC
Confidence            99999999999999999998874  45689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV  925 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  925 (1002)
                      +++.......  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ..+.+    .....
T Consensus       142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~~~~i----~~~~~  214 (330)
T cd05586         142 LSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNI----AFGKV  214 (330)
T ss_pred             cCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-HHHHH----HcCCC
Confidence            9875433221  22345799999999998754 47899999999999999999999997543222 11111    11111


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHH
Q 001867          926 DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP----AMRRVVK  967 (1002)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~evl~  967 (1002)
                      . .  +  ....   ...+.+++.+|++.||++||    +++++++
T Consensus       215 ~-~--~--~~~~---~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         215 R-F--P--KNVL---SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             C-C--C--CccC---CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0 0  0  0111   12467889999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-35  Score=322.35  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=206.8

Q ss_pred             CcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          686 DEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      .+..+||+|+|-+||+|.+. +|..||=-.++.             ..-.+.....++|..|+.+|+.|+|||||++|.+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~-------------~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S  109 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKI-------------RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDS  109 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhH-------------HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence            34568999999999999974 466665221110             1122345556899999999999999999999999


Q ss_pred             EecCCe--eeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC-CCCeE
Q 001867          765 CTTRDC--KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG-DFGAR  841 (1002)
Q Consensus       765 ~~~~~~--~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~-~~~~k  841 (1002)
                      |.+...  ..+|+|.+..|+|..|+++.  +.++...+..|++||.+||.|||++ .|+|||||||=.||+|+. -|.||
T Consensus       110 W~d~~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VK  186 (632)
T KOG0584|consen  110 WVDTDNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVK  186 (632)
T ss_pred             eecCCCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCcee
Confidence            987654  78899999999999999954  5588899999999999999999996 679999999999999974 58999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|.|+|+....+..    ....|||.|||||+.. ..|+..+||||||+++.||+|+..||..-....++.+.+..+.+
T Consensus       187 IGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK  261 (632)
T KOG0584|consen  187 IGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK  261 (632)
T ss_pred             ecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence            999999998765532    2368999999999766 78999999999999999999999999877777777777777776


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+..+-||           ++.++|.+|+.. .++|||+.|+++
T Consensus       262 P~sl~kV~dP-----------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  262 PAALSKVKDP-----------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHhhccCCH-----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence            6666665554           377899999999 999999999985

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.2e-34  Score=308.88  Aligned_cols=258  Identities=30%  Similarity=0.434  Sum_probs=205.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||.|+||+||+|... ++..+|+|++....                .......+.+|+++++.++|+||+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~   64 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK----------------CQTSVDELRKEVQAMSQCNHPNVVKY   64 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC----------------cchHHHHHHHHHHHHHhcCCCCEEEE
Confidence            46888999999999999999964 57899999874321                11245678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      ++.+...+..+++|||+++++|.++++.... ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.+
T Consensus        65 ~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~  141 (267)
T cd06610          65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSV  141 (267)
T ss_pred             EEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence            9999999999999999999999999976433 5689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCc--ccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +|+|||++..........  ......|+..|+|||++... .++.++|||||||++|||++|+.||........+.+...
T Consensus       142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  221 (267)
T cd06610         142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ  221 (267)
T ss_pred             EEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc
Confidence            999999998766543321  22344688999999998776 789999999999999999999999975543332222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .    .. . ......  ........+.+++.+||+.||++||+++++++
T Consensus       222 ~----~~-~-~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         222 N----DP-P-SLETGA--DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             C----CC-C-CcCCcc--ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1    10 0 011100  01122245788999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-34  Score=315.14  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=202.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|... +++.||+|++....                .....+.+.+|+++++.++||||+++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~~   68 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----------------KSSVRKQILRELQIMHECRSPYIVSF   68 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----------------cchHHHHHHHHHHHHHHcCCCCcceE
Confidence            35666789999999999999964 58899999874321                22345678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++......++||||+++++|.+++..  .+.+++..+..++.|++.|+.|||+.  .+++||||||+||+++.++.++
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~  144 (284)
T cd06620          69 YGAFLNENNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIK  144 (284)
T ss_pred             eeeEecCCEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEE
Confidence            9999999999999999999999999874  45689999999999999999999973  1899999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch-------hHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK-------DLVK  914 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~-------~~~~  914 (1002)
                      |+|||++.......    .....|+..|+|||++.+..++.++|||||||++|++++|+.||.......       ....
T Consensus       145 l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~  220 (284)
T cd06620         145 LCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD  220 (284)
T ss_pred             EccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH
Confidence            99999987543321    123468999999999988889999999999999999999999997543321       1112


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      +.........      +...  ..+...++.+++.+||+.||++||+++|+++..
T Consensus       221 ~~~~~~~~~~------~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         221 LLQQIVQEPP------PRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHHHhhccC------CCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            2222211110      1110  011234588899999999999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.6e-34  Score=306.60  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+....               ........+.+|++++++++||||++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~   65 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ---------------MTKDERLAAQNECQVLKLLSHPNIIEYY   65 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc---------------cccHHHHHHHHHHHHHhhCCCCchhhee
Confidence            467788999999999999986 468899999984321               1223456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-CeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-GAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-~~k  841 (1002)
                      +.+..++..++||||+++++|.+++.......+++..+.+++.|++.|++|||++   +|+||||+|+||+++.++ .+|
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~  142 (256)
T cd08220          66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVK  142 (256)
T ss_pred             eeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999999875566789999999999999999999999   999999999999998554 579


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      ++|||.+........   .....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.............    .
T Consensus       143 l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~----~  215 (256)
T cd08220         143 IGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM----S  215 (256)
T ss_pred             EccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH----h
Confidence            999999987654322   123468889999999998889999999999999999999999996543222211111    1


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ....    +.....    ...+.+++.+||+.+|++|||++|++.
T Consensus       216 -~~~~----~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         216 -GTFA----PISDRY----SPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -cCCC----CCCCCc----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             1011    111112    224788999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-34  Score=326.80  Aligned_cols=190  Identities=24%  Similarity=0.318  Sum_probs=163.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+|++.+.||+|+||.||+|... +++.||+|+...                       .....|+.++++++||||+++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------------------~~~~~E~~~l~~l~h~~iv~~  122 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------------------GTTLIEAMLLQNVNHPSVIRM  122 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------------------cccHHHHHHHHhCCCCCCcCh
Confidence            46889999999999999999975 467899997421                       123468999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..++||||+ .++|.+++.. ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~k  197 (357)
T PHA03209        123 KDTLVSGAITCMVLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVC  197 (357)
T ss_pred             hheEEeCCeeEEEEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence            99999999999999999 5789888865 345799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       198 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        198 IGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             EecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            99999997543221   222456899999999999999999999999999999999965554

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.6e-34  Score=317.52  Aligned_cols=267  Identities=22%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+....                .......+.+|+.++++++||||++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~nI~~   68 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH----------------EEGAPCTAIREVSLLKDLKHANIVT   68 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc----------------ccCchhHHHHHHHHHHhcCCCCcce
Confidence            467888899999999999999864 57899999884321                1112345678999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++..++..++||||++ ++|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        69 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~  143 (301)
T cd07873          69 LHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGEL  143 (301)
T ss_pred             EEEEEecCCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcE
Confidence            9999999999999999996 6999988753 34689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++........  ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||........ ...+...
T Consensus       144 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~  220 (301)
T cd07873         144 KLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRI  220 (301)
T ss_pred             EECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence            9999999976543221  2223457889999998765 4578899999999999999999999975533222 1111111


Q ss_pred             hh---ccCccccc---------ccccc-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHh
Q 001867          920 LD---QKGVDHVL---------DPKLD-----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEV  972 (1002)
Q Consensus       920 ~~---~~~~~~~~---------~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~  972 (1002)
                      ..   ........         .+...     .........+.+++.+|++.||.+|||++|+++  ++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            10   00000000         00000     000011224678999999999999999999986  44443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-34  Score=313.36  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=197.9

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|.+...                ........+.+|+.++++++||||++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~----------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~   65 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE----------------LDESKFNQIIMELDILHKAVSPYIVDFY   65 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc----------------cCHHHHHHHHHHHHHHHhcCCCcHHhhh
Confidence            5778899999999999999975 6899999987431                1223346788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCK-GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++...+..|+||||+++++|.++++... ...+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.+|
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~  143 (286)
T cd06622          66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVK  143 (286)
T ss_pred             hheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999987532 24689999999999999999999963  1899999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR------VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      |+|||++.......    .....++..|+|||.+.+..      ++.++||||+||++|+|++|+.||......... ..
T Consensus       144 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~  218 (286)
T cd06622         144 LCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQ  218 (286)
T ss_pred             EeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HH
Confidence            99999997654322    12345788999999886543      478999999999999999999999654222211 11


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..... ....     +   ..+.+...++.+++.+||+.+|++||+++++++
T Consensus       219 ~~~~~-~~~~-----~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         219 LSAIV-DGDP-----P---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHh-hcCC-----C---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11111 1110     1   111122335778999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.9e-34  Score=309.86  Aligned_cols=238  Identities=21%  Similarity=0.313  Sum_probs=184.4

Q ss_pred             eeeecCCccEEEEEEcC-------------------------CcEEEEEEeeccccccccCCCccccccccchhhHHhHH
Q 001867          690 VIGSGSSGKVYKVVLSN-------------------------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ  744 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (1002)
                      .||+|+||.||+|....                         ...||+|.+...                 .......+.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----------------~~~~~~~~~   64 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----------------HRDIALAFF   64 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----------------HHHHHHHHH
Confidence            58999999999987421                         134777776321                 122345688


Q ss_pred             HHHHHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       745 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      +|+.++++++||||+++++++.++...++||||+++|+|..++.. ..+.+++..+.+++.|++.||+|||++   +|+|
T Consensus        65 ~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH  140 (274)
T cd05076          65 ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK---NLVH  140 (274)
T ss_pred             HHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccC
Confidence            899999999999999999999999999999999999999999875 345689999999999999999999999   9999


Q ss_pred             CCCCCCcEEECCCC-------CeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHH
Q 001867          825 RDVKSNNILLDGDF-------GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       825 rDlk~~NIll~~~~-------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el  896 (1002)
                      |||||+||+++..+       .+|++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++||+
T Consensus       141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el  214 (274)
T cd05076         141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI  214 (274)
T ss_pred             CCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence            99999999997643       3799999988644322      12347788999998865 5688999999999999999


Q ss_pred             H-hCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          897 V-TGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       897 l-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      + +|+.||..... .+.........   ..     +  ...    ..++.+++.+||+.+|++||+++++++.|
T Consensus       215 ~~~g~~p~~~~~~-~~~~~~~~~~~---~~-----~--~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         215 CFDGEVPLKERTP-SEKERFYEKKH---RL-----P--EPS----CKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HhCCCCCccccCh-HHHHHHHHhcc---CC-----C--CCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            5 58888865422 22222111100   00     0  111    12478899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-34  Score=312.16  Aligned_cols=239  Identities=22%  Similarity=0.386  Sum_probs=186.2

Q ss_pred             CeeeecCCccEEEEEEcC-C-------cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          689 NVIGSGSSGKVYKVVLSN-G-------EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +.||+|+||.||+|.... +       .+||+|.+...                 .....+.+..|+.+++.++||||++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~iv~   63 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-----------------HRNYSESFFEAASMMSQLSHKHLVL   63 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-----------------hHHHHHHHHHHHHHHHhCCCCChhh
Confidence            469999999999998642 2       24777765221                 2334567888999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC-
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-  839 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~-  839 (1002)
                      +++++..++..++||||+++|+|.++++..+ ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++. 
T Consensus        64 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~  139 (258)
T cd05078          64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDR  139 (258)
T ss_pred             eeeEEEeCCCcEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEeccccc
Confidence            9999999999999999999999999997533 4689999999999999999999999   9999999999999987765 


Q ss_pred             -------eEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCC-CCCCCCCCch
Q 001867          840 -------ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGR-LPVDPEFGEK  910 (1002)
Q Consensus       840 -------~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~-~p~~~~~~~~  910 (1002)
                             ++++|||.+......      ....++..|+|||++.+. .++.++|||||||++|||++|. .|+... ...
T Consensus       140 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~  212 (258)
T cd05078         140 KTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQ  212 (258)
T ss_pred             ccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHH
Confidence                   699999988654332      234578899999998864 5789999999999999999985 444322 222


Q ss_pred             hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      .......   ..   ..     .+   .....++.+++.+||+.||++|||++++++.|
T Consensus       213 ~~~~~~~---~~---~~-----~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         213 KKLQFYE---DR---HQ-----LP---APKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHH---cc---cc-----CC---CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1111111   00   00     11   11123578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.7e-34  Score=308.53  Aligned_cols=262  Identities=24%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC--CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhc-CCCCceee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGK-IRHKNIVK  760 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~  760 (1002)
                      +|++.+.||+|+||.||+|..+.  ++.+|+|.+.......       .+..........++..|+.++.+ ++||||++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~-------~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~   73 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAF-------GKDKRERDKSIGDIVSEVTIIKEQLRHPNIVR   73 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccc-------ccccccchHHHHHHHHHHHHHhhcCCCCCeee
Confidence            36778899999999999999764  6889999885432110       11111233345567788888875 68999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      +++++..++..+++|||+++++|.+++...  ....+++..+++++.|++.|+.|||+ .   +++||||+|+||+++.+
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~  150 (269)
T cd08528          74 YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED  150 (269)
T ss_pred             EEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence            999999999999999999999999988542  34568999999999999999999996 5   89999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||.+.......   ......|+..|+|||+..+..++.++||||||+++|||++|+.||........ .... 
T Consensus       151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-~~~~-  225 (269)
T cd08528         151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-ATKI-  225 (269)
T ss_pred             CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-HHHH-
Confidence            999999999998755432   23345688999999999988899999999999999999999999864422111 1111 


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                        . .....    +......   ..++.+++.+||+.||++||++.|+.++++
T Consensus       226 --~-~~~~~----~~~~~~~---~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 --V-EAVYE----PLPEGMY---SEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --h-hccCC----cCCcccC---CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              1 11111    1111111   134788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.9e-34  Score=307.79  Aligned_cols=254  Identities=24%  Similarity=0.398  Sum_probs=195.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|... +++.||+|++.....            ........+.+.+|+.++++++||||++++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   70 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE------------SPETSKEVSALECEIQLLKNLQHERIVQYY   70 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcC------------CchhHHHHHHHHHHHHHHHHcCCCCeeeEE
Confidence            5788899999999999999864 588999998743211            011223456789999999999999999999


Q ss_pred             eEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          763 CCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       763 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++.+  ....+++|||+++++|.+++..  ...+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~  145 (266)
T cd06651          71 GCLRDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNV  145 (266)
T ss_pred             EEEEcCCCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence            99875  3577899999999999999974  34589999999999999999999998   99999999999999999999


Q ss_pred             EEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++......... .......++..|+|||++.+..++.++||||+||++|||++|+.||..........    ..
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~  221 (266)
T cd06651         146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KI  221 (266)
T ss_pred             EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH----HH
Confidence            99999999765432211 11123457889999999998889999999999999999999999996542222111    11


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .... .    .+....   .....+.+++ .||..+|++||+++||++
T Consensus       222 ~~~~-~----~~~~~~---~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         222 ATQP-T----NPQLPS---HISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             hcCC-C----CCCCch---hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1110 0    111111   1122345555 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-33  Score=307.32  Aligned_cols=265  Identities=28%  Similarity=0.422  Sum_probs=200.5

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|...+.||+|+||.||+|.. .+++.||+|.+.......       ...........+.+.+|+.++++++|||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   74 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIA-------GRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL   74 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhh-------cccchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence            366778999999999999985 468899999884321100       000011122345788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..++||||+++++|.++++..  ..+++..+..++.|++.||.|||++   +++||||+|+||+++.++.+++
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          75 GFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             EEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEE
Confidence            9999999999999999999999999753  5689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +|||+++...............|+..|+|||......  ++.++||||+|+++||+++|..||..........+.    .
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~  225 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL----G  225 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh----h
Confidence            9999997654332222233446888999999887654  789999999999999999999999643221111111    1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .. .....+++..   ..+....+.+++.+||+++|++||++++|++.
T Consensus       226 ~~-~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         226 NK-RSAPPIPPDV---SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cc-ccCCcCCccc---cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11 1111111111   11122357888999999999999999998853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.5e-34  Score=335.35  Aligned_cols=256  Identities=21%  Similarity=0.231  Sum_probs=188.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC------
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR------  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------  754 (1002)
                      .++|++.++||+|+||+||+|... .++.||||++...                  ......+..|+.++++++      
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~------------------~~~~~~~~~e~~~l~~l~~~~~~~  189 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV------------------PKYTRDAKIEIQFMEKVRQADPAD  189 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc------------------hhhHHHHHHHHHHHHHHhhcCccc
Confidence            357888999999999999999864 5788999998421                  112234556666666664      


Q ss_pred             CCceeeeeeEEecC-CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcE
Q 001867          755 HKNIVKLWCCCTTR-DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       755 h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NI  832 (1002)
                      |++++++++++..+ +..|+|||++ +++|.+++..  .+.+++..+..++.||+.||+|||+ .   +||||||||+||
T Consensus       190 ~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NI  263 (467)
T PTZ00284        190 RFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENI  263 (467)
T ss_pred             CcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence            45689999998764 5789999998 7899998874  3569999999999999999999997 5   999999999999


Q ss_pred             EECCCC----------------CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHH
Q 001867          833 LLDGDF----------------GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       833 ll~~~~----------------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el  896 (1002)
                      |++.++                .+||+|||.+......     ....+||+.|||||++.+..++.++|||||||++|||
T Consensus       264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el  338 (467)
T PTZ00284        264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL  338 (467)
T ss_pred             EEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence            998765                4999999988643221     2345799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCchhHHHHHHHHhhc---------------------cCccccccccc-----cCC-CH--HHHHHHHHH
Q 001867          897 VTGRLPVDPEFGEKDLVKWVCSTLDQ---------------------KGVDHVLDPKL-----DCC-FK--EEICKVLNI  947 (1002)
Q Consensus       897 l~g~~p~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~-----~~~-~~--~~~~~l~~l  947 (1002)
                      ++|+.||......+... .+......                     .......++..     ... ..  .....+.++
T Consensus       339 ltG~~pf~~~~~~~~~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  417 (467)
T PTZ00284        339 YTGKLLYDTHDNLEHLH-LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDL  417 (467)
T ss_pred             HhCCCCCCCCChHHHHH-HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHH
Confidence            99999997654322211 11111000                     00000000000     000 00  011346799


Q ss_pred             HHHcCCCCCCCCCCHHHHHH
Q 001867          948 GLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       948 ~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +.+|++.||++|||++|+++
T Consensus       418 i~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        418 IYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHhCCcChhhCCCHHHHhc
Confidence            99999999999999999996

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.5e-34  Score=314.91  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=200.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||++... +++.||+|.+...              ........+.+.+|+.+++.++||||++++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~   67 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQ--------------NLILRNQIQQVFVERDILTFAENPFVVSMF   67 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehh--------------hhhhHHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence            5788899999999999999964 5789999988432              111233456788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +.+..++..++||||+++++|.+++..  .+.+++..+..++.|++.|++|||++   +++||||||+||+++.++.+|+
T Consensus        68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l  142 (305)
T cd05609          68 CSFETKRHLCMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKL  142 (305)
T ss_pred             EEEecCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEE
Confidence            999999999999999999999999974  35689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCC-------------cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          843 ADFGVAKVVDASGKP-------------KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +|||+++........             .......|+..|+|||.+.+..++.++|+||||+++||+++|..||......
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~  222 (305)
T cd05609         143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE  222 (305)
T ss_pred             eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998742211100             0111235788999999998888999999999999999999999999654222


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                       +.   ........    ...+......   ...+.+++.+||+.+|++||++.++.+.++.
T Consensus       223 -~~---~~~~~~~~----~~~~~~~~~~---~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         223 -EL---FGQVISDD----IEWPEGDEAL---PADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -HH---HHHHHhcc----cCCCCccccC---CHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence             11   11111110    0011111111   2247789999999999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-33  Score=306.31  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=193.8

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .+.....||+|+||.||+|... ++..||+|.+...                 .....+.+.+|+.++++++|+||++++
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~   71 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----------------DSRYVQPLHEEIALHSYLKHRNIVQYL   71 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----------------CHHHHHHHHHHHHHHHhcCCCCeeeee
Confidence            3444568999999999999954 5788999987332                 223456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC-CCC
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL--DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG-DFG  839 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~-~~~  839 (1002)
                      +++..++..++||||+++++|.+++.... ..+  ++..+..++.|++.|++|||++   +|+||||||+||+++. ++.
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~  147 (268)
T cd06624          72 GSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGV  147 (268)
T ss_pred             eeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCe
Confidence            99999999999999999999999997532 334  8888999999999999999999   9999999999999976 678


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      ++|+|||.+........  ......|++.|+|||++.+..  ++.++||||+|+++|+|++|+.||........ ..+..
T Consensus       148 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~  224 (268)
T cd06624         148 VKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKV  224 (268)
T ss_pred             EEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhh
Confidence            99999999976543221  222345889999999986543  78899999999999999999999864322111 11110


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....       ..+...   .....++.+++.+||+.+|++||++.|+++
T Consensus       225 ~~~~-------~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         225 GMFK-------IHPEIP---ESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhc-------cCCCCC---cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0000       011111   112234788899999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.8e-34  Score=310.71  Aligned_cols=262  Identities=27%  Similarity=0.412  Sum_probs=203.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +.|++.+.||+|+||.||+|...     +++.||||.+....                .....+.+.+|++++++++|||
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~----------------~~~~~~~~~~ei~~l~~l~~~~   67 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG----------------EEQHRSDFEREIEILRTLDHEN   67 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc----------------chHHHHHHHHHHHHHHhCCCCC
Confidence            35667789999999999999853     36789999884321                1134678999999999999999


Q ss_pred             eeeeeeEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++..  ....+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++   +++||||||+||+++
T Consensus        68 i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~  143 (284)
T cd05038          68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVE  143 (284)
T ss_pred             hheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEc
Confidence            9999999987  567899999999999999997533 3599999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh---
Q 001867          836 GDFGARVADFGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD---  911 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~---  911 (1002)
                      .++.++|+|||.+........... .....++..|+|||...+..++.++||||||+++|||++|+.|+........   
T Consensus       144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~  223 (284)
T cd05038         144 SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI  223 (284)
T ss_pred             CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc
Confidence            999999999999987763322211 1123455679999999888999999999999999999999999864322110   


Q ss_pred             -------HHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          912 -------LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       912 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                             ............. .   .+....+    ..++.+++.+||+.+|++||++.||+++|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~----~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         224 GIAQGQMIVTRLLELLKEGE-R---LPRPPSC----PDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccccccccHHHHHHHHHcCC-c---CCCCccC----CHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                   0111111111100 0   0111111    24588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.6e-34  Score=305.68  Aligned_cols=252  Identities=29%  Similarity=0.374  Sum_probs=201.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|... +++.||+|.+.....            ........+.+.+|++++++++|+||++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~   68 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADD------------GQTGQEAVKQLEQEIALLSKLQHPNIVQYL   68 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccc------------cccchHHHHHHHHHHHHHHhcCCCCchhee
Confidence            3667789999999999999975 789999998843211            111233456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..+++|||+++++|.+++..  ...+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.+||
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl  143 (258)
T cd06632          69 GTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKL  143 (258)
T ss_pred             eeEecCCeEEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999974  34689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+.......   ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||...........+    ..
T Consensus       144 ~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~  216 (258)
T cd06632         144 ADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI----GR  216 (258)
T ss_pred             ccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH----Hh
Confidence            9999998764432   223456889999999987766 899999999999999999999999754322222111    11


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...... +.   ...    ..++.+++.+||+.+|++||++++++.
T Consensus       217 ~~~~~~-~~---~~~----~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         217 SKELPP-IP---DHL----SDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cccCCC-cC---CCc----CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            111111 11   111    234778899999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.1e-34  Score=311.80  Aligned_cols=253  Identities=28%  Similarity=0.387  Sum_probs=196.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|++...                  ......+..|+.+++++ +||||+
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~------------------~~~~~~~~~e~~~l~~l~~h~~i~   78 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI------------------HDIDEEIEAEYNILKALSDHPNVV   78 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc------------------cchHHHHHHHHHHHHHHhcCCCee
Confidence            568888999999999999999864 5789999987321                  11235678899999999 699999


Q ss_pred             eeeeEEe-----cCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          760 KLWCCCT-----TRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       760 ~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      ++++++.     .++..++||||+++++|.+++...  ....+++..+..++.|++.|+.|||+.   +|+||||||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ni  155 (286)
T cd06638          79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNI  155 (286)
T ss_pred             eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhE
Confidence            9999884     345689999999999999987632  335689999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----LRVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      +++.++.+||+|||+++.......  ......|++.|+|||++..     ..++.++||||+||++|||++|+.||....
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         156 LLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             EECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999999999999999986643321  1223468999999998753     447889999999999999999999997543


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ........    . ........++   ...   ..++.+++.+||+.||++||++.|+++.
T Consensus       234 ~~~~~~~~----~-~~~~~~~~~~---~~~---~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         234 PMRALFKI----P-RNPPPTLHQP---ELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hhHHHhhc----c-ccCCCcccCC---CCc---CHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            22221111    0 0000111111   111   1247789999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.7e-34  Score=318.22  Aligned_cols=196  Identities=23%  Similarity=0.349  Sum_probs=160.0

Q ss_pred             CCeeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          688 DNVIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      +.+||+|+||.||+|+.+   ++..||+|.+...                   .....+.+|+.++++++||||++++++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~~~~~   66 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-------------------GISMSACREIALLRELKHPNVIALQKV   66 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-------------------CCcHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            468999999999999965   3578999987321                   112357789999999999999999999


Q ss_pred             Eec--CCeeeEEEeccCCCChhhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-
Q 001867          765 CTT--RDCKLLVYEYMPNGSLGDLLHSC-------KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-  834 (1002)
Q Consensus       765 ~~~--~~~~~lv~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll-  834 (1002)
                      +..  +...++||||++ ++|.+++...       ....+++..+..++.|++.||+|||++   +|+||||||+||++ 
T Consensus        67 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~  142 (317)
T cd07867          67 FLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVM  142 (317)
T ss_pred             EeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEc
Confidence            853  567899999995 5888776532       123589999999999999999999999   99999999999999 


Q ss_pred             ---CCCCCeEEccccCcccccCCCCC-cccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          835 ---DGDFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       835 ---~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                         +.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       143 ~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         143 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence               55678999999999876543321 12234568999999999876 45789999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=319.05  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=196.1

Q ss_pred             CCcCCeeeecCCccEEEEEEcCC-cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNG-EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |++...||.|+||.||+|..++. -..|.|++                 ........++|.-||+|+...+||+||++++
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-----------------etkseEELEDylVEIeILa~CdHP~ivkLl~   96 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-----------------ETKSEEELEDYLVEIEILAECDHPVIVKLLS   96 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhh-----------------cccchhHHhhhhhhhhhhhcCCChHHHHHHH
Confidence            44455799999999999997653 34566665                 2335667888999999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      .|..++.++|+.|||.||.++..+-. -+.++++.++..+++|++.||.|||++   +|||||||+.|||++-+|.++++
T Consensus        97 ayy~enkLwiliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLA  172 (1187)
T KOG0579|consen   97 AYYFENKLWILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLA  172 (1187)
T ss_pred             HHhccCceEEEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeee
Confidence            99999999999999999998887654 457899999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCcccc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA-----YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |||.+........  ......|||+|||||+.     +...|+.++||||||+++.||..+..|...-....-+.+.   
T Consensus       173 DFGVSAKn~~t~q--kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi---  247 (1187)
T KOG0579|consen  173 DFGVSAKNKSTRQ--KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---  247 (1187)
T ss_pred             cccccccchhHHh--hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH---
Confidence            9999865433221  12356899999999975     4667999999999999999999999886433222222222   


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ..-.+ ....-      +..-...+.+++.+|+..||..||+++++++
T Consensus       248 -aKSeP-PTLlq------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  248 -AKSEP-PTLLQ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -hhcCC-CcccC------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence             11111 11111      1111235778889999999999999999873

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.4e-34  Score=307.07  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=197.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+|++.+.||+|+||.||+|... +++.||+|.+.....            ........+.+.+|+.++++++||||+++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   69 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPE------------SPETSKEVNALECEIQLLKNLLHERIVQY   69 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcC------------CcccHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            46788899999999999999964 589999998743210            01122345678999999999999999999


Q ss_pred             eeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++.+.  ...+++|||+++++|.+++..  ...+++..+.+++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        70 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  144 (265)
T cd06652          70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGN  144 (265)
T ss_pred             EeEeccCCCceEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCC
Confidence            9998763  467899999999999999874  34588999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      ++|+|||++......... .......|+..|+|||...+..++.++|||||||++|||++|+.||..........+    
T Consensus       145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----  220 (265)
T cd06652         145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----  220 (265)
T ss_pred             EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----
Confidence            999999999865432111 122334688999999999888899999999999999999999999964422222111    


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .... ..    .+   ..+......+.+++.+|+. +|++||+++|+++
T Consensus       221 ~~~~-~~----~~---~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IATQ-PT----NP---VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HhcC-CC----CC---CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1111 00    11   1122233457788888984 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-34  Score=316.55  Aligned_cols=255  Identities=24%  Similarity=0.301  Sum_probs=203.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|... +++.||+|.+...              ........+.+..|+++++.++||||++++
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   67 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK--------------EMIKRNKVKRVLTEQEILATLDHPFLPTLY   67 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecc--------------ccchHHHHHHHHHHHHHHHhCCCCCchhhe
Confidence            5778899999999999999975 4899999998542              111223456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +.+...+..|+||||+++++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l  144 (316)
T cd05574          68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIML  144 (316)
T ss_pred             eeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEE
Confidence            9999999999999999999999999865567799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCc---------------------------ccccccccccccCccccccCCCCCccchhhHHHHHHH
Q 001867          843 ADFGVAKVVDASGKPK---------------------------SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE  895 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~e  895 (1002)
                      +|||++..........                           ......|+..|+|||+..+..++.++||||||+++|+
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~  224 (316)
T cd05574         145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE  224 (316)
T ss_pred             eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence            9999987654321110                           1113367889999999999889999999999999999


Q ss_pred             HHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 001867          896 LVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA----MRRVVK  967 (1002)
Q Consensus       896 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~evl~  967 (1002)
                      |++|..||........+.....     ....   .+....    ....+.+++.+||+.||++||+    ++|+++
T Consensus       225 l~~g~~pf~~~~~~~~~~~~~~-----~~~~---~~~~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         225 MLYGTTPFKGSNRDETFSNILK-----KEVT---FPGSPP----VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HhhCCCCCCCCchHHHHHHHhc-----CCcc---CCCccc----cCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            9999999975533332222111     1000   000011    2235889999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-33  Score=303.81  Aligned_cols=252  Identities=29%  Similarity=0.463  Sum_probs=201.0

Q ss_pred             CCcCCeeeecCCccEEEEEEcC-----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSN-----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +++.+.||+|+||.||+|...+     +..||+|++....                .....+.+..|+.++++++|+||+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~   64 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----------------DEQQIEEFLREARIMRKLDHPNIV   64 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----------------ChHHHHHHHHHHHHHHhcCCCchh
Confidence            3567899999999999999754     3789999884321                112467899999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..+++|||+++++|.+++.......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.
T Consensus        65 ~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~  141 (258)
T smart00219       65 KLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV  141 (258)
T ss_pred             eEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCe
Confidence            9999999999999999999999999999864433389999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      ++|+|||++............ ...+++.|+|||.+.+..++.++||||+|+++|+|++ |..||... ...+.......
T Consensus       142 ~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~  219 (258)
T smart00219      142 VKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVLEYLKK  219 (258)
T ss_pred             EEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhc
Confidence            999999999877654322221 2336789999999988889999999999999999999 77777543 22333322221


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      ...    .    +.....    ..++.+++.+|++.+|++|||+.|+++.|
T Consensus       220 ~~~----~----~~~~~~----~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 GYR----L----PKPENC----PPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCC----C----CCCCcC----CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            110    0    111112    23478899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.2e-34  Score=312.52  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=197.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... +|+.||+|++.....               .......+.+|++++++++||||++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~---------------~~~~~~~~~~ei~~l~~l~h~~i~~~~   65 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---------------DEGVPSSALREICLLKELKHKNIVRLY   65 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc---------------cccCccchhHHHHHHHhcCCCCeeeHH
Confidence            3677889999999999999964 688999998843211               122235577899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..++|+||++ ++|.+++... ...+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||
T Consensus        66 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l  140 (284)
T cd07839          66 DVLHSDKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKL  140 (284)
T ss_pred             HHhccCCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEE
Confidence            99999999999999996 6888887653 35689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++.......  ......++..|+|||++.+. .++.++||||+||++|||++|+.|+....+..+..+.......
T Consensus       141 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07839         141 ADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  218 (284)
T ss_pred             CccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999986543321  22334578899999988764 4689999999999999999999997654443332222211110


Q ss_pred             ccC------cccccc----cccc------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKG------VDHVLD----PKLD------CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~------~~~~~~----~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...      .....+    +...      ...+....++.+++.+||+.||.+|||++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000      000000    0000      000111235778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.1e-34  Score=309.44  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|+..+.||+|+||.||+|+.+      +.+.||+|.+...                ......+.+.+|++++++++||
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~   68 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----------------KDENLQSEFRRELDMFRKLSHK   68 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----------------cchHHHHHHHHHHHHHHhcCCc
Confidence            46778889999999999999964      2457898876321                1122456789999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                      ||+++++++.+.+..++||||+++|+|.++++....       ..+++..+..++.|++.||+|||+.   +|+||||||
T Consensus        69 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp  145 (275)
T cd05046          69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAA  145 (275)
T ss_pred             ceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCcc
Confidence            999999999999999999999999999999975442       2689999999999999999999999   999999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG  908 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~  908 (1002)
                      +||+++.++.++++|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       146 ~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~  224 (275)
T cd05046         146 RNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD  224 (275)
T ss_pred             ceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence            999999999999999999875543221 12223356778999999988888999999999999999999 7788854322


Q ss_pred             chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                       ........    ......   +.....+    ..+.+++.+||+.+|++||++.|+++.|.
T Consensus       225 -~~~~~~~~----~~~~~~---~~~~~~~----~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         225 -EEVLNRLQ----AGKLEL---PVPEGCP----SRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -HHHHHHHH----cCCcCC---CCCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence             22222111    111110   0111122    24788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.2e-34  Score=312.50  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=200.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|+.+ +++.||+|++....               ........+.+|++++++++||||++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~   65 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------------ETEGVPSTAIREISLLKELNHPNIVKLL   65 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc---------------cccccchHHHHHHHHHHhcCCCCCcchh
Confidence            3677889999999999999864 68899999874321               1122335688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..++||||++ ++|.+++.......+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||
T Consensus        66 ~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l  141 (284)
T cd07860          66 DVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKL  141 (284)
T ss_pred             hhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence            99999999999999995 6899998776667799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||++........  ......+++.|+|||+..+.. ++.++||||||+++|||++|+.||..........+.......
T Consensus       142 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  219 (284)
T cd07860         142 ADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT  219 (284)
T ss_pred             eeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999876543321  122345788999999877654 588999999999999999999999765433333332221110


Q ss_pred             cc---------------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QK---------------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~---------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..               ..............+....++.+++.+||+.||++||+++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         220 PDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00               00000000000000111234678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.3e-34  Score=311.29  Aligned_cols=263  Identities=24%  Similarity=0.314  Sum_probs=201.6

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++.....               .....+.+.+|+.++++++||||++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---------------~~~~~~~~~~e~~~l~~~~~~~i~~~~   65 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL---------------EGGIPNQALREIKALQACQHPYVVKLL   65 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc---------------cchhhHHHHHHHHHHHhCCCCCCccee
Confidence            477889999999999999996 4689999999843211               123356789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++......++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        66 ~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l  140 (286)
T cd07832          66 DVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKI  140 (286)
T ss_pred             eEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEE
Confidence            9999999999999999 999999987533 6799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+........ .......|+..|+|||++.+. .++.++||||+|+++|||++|..||....+.... ........
T Consensus       141 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~-~~~~~~~~  218 (286)
T cd07832         141 ADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL-AIVFRTLG  218 (286)
T ss_pred             eeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH-HHHHHHcC
Confidence            99999987654322 222345688999999988654 4689999999999999999997777554332222 11111110


Q ss_pred             cc------------Ccccccccc-----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QK------------GVDHVLDPK-----LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~------------~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ..            .......+.     +....++....+.+++.+|++.+|++||+++++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00            000000000     001111223568899999999999999999999853

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=306.66  Aligned_cols=250  Identities=24%  Similarity=0.262  Sum_probs=200.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|..-++||+|+||.||.++. .+|+-||.|++.+.              .+..+........|-.++++++.++||.+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KK--------------RiKkr~ge~maLnEk~iL~kV~s~FiVsl  250 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKK--------------RIKKRKGETMALNEKQILEKVSSPFIVSL  250 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHH--------------HHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence            4566678999999999999985 45889999988543              33345566778889999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      -.+|.+.+.+++|+..|.||+|.=++.......+++..+..++.+|+.||.+||..   +||+||+||+|||+|+.|+++
T Consensus       251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             eeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence            99999999999999999999999888876767899999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|.|+|..+......   ...+||.+|||||++....|+...|+||+||++|||+.|+.||....... -.+-+.+...
T Consensus       328 ISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-k~eEvdrr~~  403 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-KREEVDRRTL  403 (591)
T ss_pred             eeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-hHHHHHHHHh
Confidence            9999999987665432   33489999999999999999999999999999999999999996331111 0111111111


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      ...      .+..+.+.+   +..++....+..||++|.-.
T Consensus       404 ~~~------~ey~~kFS~---eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  404 EDP------EEYSDKFSE---EAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             cch------hhcccccCH---HHHHHHHHHHccCHHHhccC
Confidence            110      111222333   35566667888999988643

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-33  Score=305.27  Aligned_cols=237  Identities=25%  Similarity=0.376  Sum_probs=187.3

Q ss_pred             CeeeecCCccEEEEEEcCCc-----------EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          689 NVIGSGSSGKVYKVVLSNGE-----------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +.||+|+||.||+|...+..           .|++|.+...                  ......+.+|+.++++++|||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~------------------~~~~~~~~~e~~~l~~l~h~~   62 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD------------------HRDSLAFFETASLMSQLSHKH   62 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc------------------hhhHHHHHHHHHHHHcCCCcc
Confidence            46899999999999976433           4677765321                  111577899999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.. +..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        63 i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~  137 (259)
T cd05037          63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARY  137 (259)
T ss_pred             hhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecC
Confidence            9999999988 77899999999999999998533 3689999999999999999999998   99999999999999988


Q ss_pred             C-------CeEEccccCcccccCCCCCcccccccccccccCccccccC--CCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 001867          838 F-------GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL--RVNEKSDIYSFGVVILELVT-GRLPVDPEF  907 (1002)
Q Consensus       838 ~-------~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ell~-g~~p~~~~~  907 (1002)
                      +       .+|++|||++......      ....++..|+|||++.+.  .++.++||||||+++||+++ |..||....
T Consensus       138 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         138 GLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             ccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            7       7999999999865431      123467789999998876  78899999999999999999 566775432


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                       ......+..    ...  ....+  .      ...+.+++.+||..+|++||++.++++.|
T Consensus       212 -~~~~~~~~~----~~~--~~~~~--~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         212 -SSEKERFYQ----DQH--RLPMP--D------CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -chhHHHHHh----cCC--CCCCC--C------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             222121111    000  00000  0      14588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=338.00  Aligned_cols=260  Identities=24%  Similarity=0.382  Sum_probs=210.6

Q ss_pred             CCCcCCeeeecCCccEEEEEEc----C----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS----N----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-  754 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-  754 (1002)
                      +..+.+.||+|+||.|++|..+    .    ...||||.++..                .+..+.+.+..|+++|+.+. 
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~----------------~~~~~~~~~~~El~~m~~~g~  360 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN----------------ASSSEKKDLMSELNVLKELGK  360 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccc----------------cCcHHHHHHHHHHHHHHHhcC
Confidence            3456679999999999999843    1    357999987432                13356788999999999995 


Q ss_pred             CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC------------C--CCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 001867          755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK------------G--GLLDWPTRYKIIVDAAEGLSYLHHDCVP  820 (1002)
Q Consensus       755 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~  820 (1002)
                      ||||+.++|++...+..++|+||++.|+|.+|++.++            .  ..++..+++.++.|||.|++||+++   
T Consensus       361 H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---  437 (609)
T KOG0200|consen  361 HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---  437 (609)
T ss_pred             CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---
Confidence            9999999999999999999999999999999998766            0  1389999999999999999999999   


Q ss_pred             CeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccc-cccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          821 SIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI-AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       821 ~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                      ++||||+.++|||++++..+||+|||+|+.............. .-...|||||.+....|+.|+|||||||++|||+| 
T Consensus       438 ~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  438 PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTL  517 (609)
T ss_pred             CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhC
Confidence            9999999999999999999999999999977665544322111 12347999999999999999999999999999999 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      |..||.+-....++.+++..+.+..        +...+.    .+++++|..||+.+|++||++.++++.++.+..
T Consensus       518 G~~PYp~~~~~~~l~~~l~~G~r~~--------~P~~c~----~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  518 GGTPYPGIPPTEELLEFLKEGNRME--------QPEHCS----DEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCCCCCCCcHHHHHHHHhcCCCCC--------CCCCCC----HHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            8888865332444444444333321        222232    358899999999999999999999999999654

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.1e-34  Score=313.73  Aligned_cols=263  Identities=24%  Similarity=0.365  Sum_probs=199.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++....               ......+.+.+|+++++.++||||+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~   65 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---------------DDKMVKKIAMREIRMLKQLRHENLVNL   65 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc---------------CcchhhHHHHHHHHHHHhcCCcchhhH
Confidence            35778899999999999999975 58899999874321               112234568899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..|+||||+++++|.++...  ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~  140 (286)
T cd07846          66 IEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVK  140 (286)
T ss_pred             HHhcccCCeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEE
Confidence            9999999999999999999888887653  34589999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||++........  ......++..|+|||+..+ ..++.++||||||+++|||++|+.||.................
T Consensus       141 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  218 (286)
T cd07846         141 LCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG  218 (286)
T ss_pred             EEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence            999999987644322  2233457889999998765 4578899999999999999999998865433222111111000


Q ss_pred             h----------ccC-cccccccccc------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 D----------QKG-VDHVLDPKLD------CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~----------~~~-~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .          ... ......+...      ...+.....+.+++.+||+.+|++||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0          000 0000001000      001112345888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=283.44  Aligned_cols=252  Identities=24%  Similarity=0.378  Sum_probs=199.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  760 (1002)
                      ++.+....||.|..|.|++++. ..|..+|||.+.+.                .+..+.+++...++++.+-. .|+||+
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----------------~Nkee~kRILmDldvv~~s~dcpyIV~  155 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----------------GNKEENKRILMDLDVVLKSHDCPYIVQ  155 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----------------CCHHHHHHHHHhhhHHhhccCCCeeee
Confidence            3445566799999999999996 45899999998653                24455667788888877654 799999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      .+|+|..+..+++.||.| ....++++++. .+++++..+-++...++.||.||.+++  +|+|||+||+|||+|+.|.+
T Consensus       156 c~GyFi~n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gni  231 (391)
T KOG0983|consen  156 CFGYFITNTDVFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNI  231 (391)
T ss_pred             eeeEEeeCchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCE
Confidence            999999999999999999 56777777764 467999999999999999999999884  99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT---LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      |+||||++-++-.+..   .+...|.+.|||||.+.-   ..|+.++||||||++++|++||+.||.....+-+....+.
T Consensus       232 KlCDFGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl  308 (391)
T KOG0983|consen  232 KLCDFGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL  308 (391)
T ss_pred             Eeecccccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH
Confidence            9999999987765432   234579999999998763   4688899999999999999999999987655555444333


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...   +  ..+++...  +.   ..+.+++..|+.+|+.+||.+.++++
T Consensus       309 n~e---P--P~L~~~~g--FS---p~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  309 NEE---P--PLLPGHMG--FS---PDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             hcC---C--CCCCcccC--cC---HHHHHHHHHHhhcCcccCcchHHHhc
Confidence            211   1  12222111  22   24667888999999999999998874

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.1e-34  Score=310.21  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=196.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|++..                  .......+..|+.+++++ +||||+
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~------------------~~~~~~~~~~e~~~l~~~~~h~~i~   76 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV------------------TEDEEEEIKLEINMLKKYSHHRNIA   76 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec------------------ChHHHHHHHHHHHHHHHhcCCCcEE
Confidence            35677788999999999999996 4688999998732                  122345688899999998 699999


Q ss_pred             eeeeEEec------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          760 KLWCCCTT------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       760 ~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      ++++++..      ....|++|||+++|+|.+++...+...+++..+..++.|++.|++|||+.   +|+||||||+||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nil  153 (282)
T cd06636          77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVL  153 (282)
T ss_pred             EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence            99999853      45789999999999999999876667789999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFG  908 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~  908 (1002)
                      ++.++.++|+|||++........  ......|+..|+|||.+.     +..++.++|||||||++|||++|..||.....
T Consensus       154 i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~  231 (282)
T cd06636         154 LTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP  231 (282)
T ss_pred             ECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence            99999999999999876543221  122346889999999875     34578899999999999999999999965422


Q ss_pred             chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .......     ....     .+...  .......+.+++.+||+.||++||++.|+++
T Consensus       232 ~~~~~~~-----~~~~-----~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         232 MRALFLI-----PRNP-----PPKLK--SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HhhhhhH-----hhCC-----CCCCc--ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            2211110     0000     01110  0011235888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=310.30  Aligned_cols=263  Identities=23%  Similarity=0.299  Sum_probs=196.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.||+|.+.....                ......+.+|++++++++||||++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i~~   67 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE----------------EGAPFTAIREASLLKDLKHANIVT   67 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc----------------cCCchhHHHHHHHHhhCCCcceee
Confidence            467888999999999999999965 689999999843211                111234678999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        68 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~  142 (291)
T cd07844          68 LHDIIHTKKTLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGEL  142 (291)
T ss_pred             EEEEEecCCeEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCE
Confidence            9999999999999999996 59999887533 4689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+++.......  ......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.......+........
T Consensus       143 kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~  220 (291)
T cd07844         143 KLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV  220 (291)
T ss_pred             EECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHh
Confidence            9999999875432211  1122346789999998865 457899999999999999999999996543222222111111


Q ss_pred             hhccCcc-----------------ccccccccCCCHH--HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVD-----------------HVLDPKLDCCFKE--EICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~-----------------~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .......                 .............  ...++.+++.+|++.+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         221 LGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            1000000                 0000000000000  0145778999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=307.45  Aligned_cols=248  Identities=27%  Similarity=0.380  Sum_probs=200.2

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||.|+||.||+|+.. +++.||+|.+....                .......+.+|++++++++||||++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~   65 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----------------AEDEIEDIQQEIQFLSQCRSPYITKYY   65 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----------------cchHHHHHHHHHHHHHHcCCCCeeeee
Confidence            5777889999999999999964 58899999884321                123345688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.++...|+|+||+++++|.+++...   .+++..+..++.|++.|++|||++   +++||||+|+||+++.++.++|
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l  139 (274)
T cd06609          66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKL  139 (274)
T ss_pred             EEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999999743   789999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||+++.......  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .......   . .
T Consensus       140 ~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-~~~~~~~---~-~  212 (274)
T cd06609         140 ADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-MRVLFLI---P-K  212 (274)
T ss_pred             cccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-HHHHHHh---h-h
Confidence            99999987765421  22234688899999999988899999999999999999999999965421 1111111   1 1


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...     +.....  .....+.+++.+||..+|++||+++++++
T Consensus       213 ~~~-----~~~~~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         213 NNP-----PSLEGN--KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cCC-----CCCccc--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111     111111  01224778899999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-33  Score=306.39  Aligned_cols=252  Identities=29%  Similarity=0.443  Sum_probs=201.8

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|..+ +++.||+|.+....                .....+++.+|++++++++||||++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~~~~~~i~~~~   65 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI----------------NEAIQKQILRELDILHKCNSPYIVGFY   65 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc----------------ChHHHHHHHHHHHHHHHCCCCchhhhh
Confidence            5677889999999999999975 68899999884321                124456788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++..++..++++||+++++|.+++...+ ..+++..+..++.|++.|++|||+ .   +++||||||+||+++.++.++
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~  141 (265)
T cd06605          66 GAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIK  141 (265)
T ss_pred             eeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999998643 678999999999999999999999 8   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-KDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~-~~~~~~~~~~~  920 (1002)
                      |+|||.+........    ....++..|+|||+..+..++.++||||+|+++|+|++|+.||...... ......+....
T Consensus       142 l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  217 (265)
T cd06605         142 LCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV  217 (265)
T ss_pred             EeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh
Confidence            999999876543211    1256888999999999889999999999999999999999999654211 22222222221


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....      +.....  .....+.+++..||..+|++|||+.+++.
T Consensus       218 ~~~~------~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         218 NEPP------PRLPSG--KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             cCCC------CCCChh--hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1110      111100  02234788999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-33  Score=309.66  Aligned_cols=245  Identities=26%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|.+.+.              ........+.+.+|++++++++||||++++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   67 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA--------------KIVKLKQVEHVLNEKRILQSIRHPFLVNLY   67 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH--------------HhhhhhHHHHHHHHHHHHHhCCCCCcccee
Confidence            5778899999999999999964 5899999988432              111233456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..|+||||+++++|.+++..  ...+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.+||
T Consensus        68 ~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl  142 (290)
T cd05580          68 GSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKI  142 (290)
T ss_pred             eEEEcCCeEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999974  35689999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||++......     .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ....+..   . .
T Consensus       143 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~---~-~  212 (290)
T cd05580         143 TDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIYEKI---L-E  212 (290)
T ss_pred             eeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH---h-c
Confidence            999999876543     2234688999999999888889999999999999999999999975432 1111111   1 1


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVV  966 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl  966 (1002)
                      ...      ......   ...+.+++.+||+.||.+|+     +++|++
T Consensus       213 ~~~------~~~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         213 GKV------RFPSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CCc------cCCccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            110      011111   23577899999999999999     777776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.6e-34  Score=336.09  Aligned_cols=253  Identities=24%  Similarity=0.406  Sum_probs=191.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+|++.+.||+||||.||+++.+ ||+.||||++.-.               . .......+.+|+..+.+|+|||||++
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~---------------~-s~~~~skI~rEVk~LArLnHpNVVRY  542 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK---------------A-SDKLYSKILREVKLLARLNHPNVVRY  542 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc---------------h-HHHHHHHHHHHHHHHhhcCCcceeee
Confidence            56788889999999999999964 8999999998321               1 34456678999999999999999999


Q ss_pred             eeEEec--------------------------------------------------------------------------
Q 001867          762 WCCCTT--------------------------------------------------------------------------  767 (1002)
Q Consensus       762 ~~~~~~--------------------------------------------------------------------------  767 (1002)
                      |.+|.+                                                                          
T Consensus       543 ysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d  622 (1351)
T KOG1035|consen  543 YSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDD  622 (1351)
T ss_pred             ehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccc
Confidence            843310                                                                          


Q ss_pred             -------------------------------------C--------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHH
Q 001867          768 -------------------------------------R--------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK  802 (1002)
Q Consensus       768 -------------------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~  802 (1002)
                                                           +        ..+||-||||+...+.++++++.... .....++
T Consensus       623 ~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wr  701 (1351)
T KOG1035|consen  623 SDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWR  701 (1351)
T ss_pred             ccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHH
Confidence                                                 0        12378899999888888887533211 4678899


Q ss_pred             HHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCccccc----------------CCCCCccccccccc
Q 001867          803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD----------------ASGKPKSMSVIAGS  866 (1002)
Q Consensus       803 i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~----------------~~~~~~~~~~~~gt  866 (1002)
                      +++||++||+|+|++   |||||||||.||++++++.|||+|||+|+...                .+......+..+||
T Consensus       702 LFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT  778 (1351)
T KOG1035|consen  702 LFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT  778 (1351)
T ss_pred             HHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence            999999999999999   99999999999999999999999999998732                01112234567899


Q ss_pred             ccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHH
Q 001867          867 CGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICK  943 (1002)
Q Consensus       867 ~~y~aPE~~~~~---~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  943 (1002)
                      --|+|||++.+.   .|+.|+|+||+|||++||+.   ||...+.......-+    +......-     .....+....
T Consensus       779 alYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~L----R~g~iP~~-----~~f~~~~~~~  846 (1351)
T KOG1035|consen  779 ALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNL----RKGSIPEP-----ADFFDPEHPE  846 (1351)
T ss_pred             eeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhc----ccCCCCCC-----cccccccchH
Confidence            999999998765   49999999999999999985   676654433332222    22211111     1122233334


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          944 VLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       944 l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      -..++.+++++||.+|||+.|++.
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhh
Confidence            568899999999999999999984

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=339.27  Aligned_cols=213  Identities=28%  Similarity=0.335  Sum_probs=184.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.++||+|+||.|..++. .+++.||+|++.+.              ........+-|..|-++|..-+.+-|+.+
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~--------------eMlKr~~tA~F~EERDimv~~ns~Wiv~L  140 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW--------------EMLKRAETACFREERDIMVFGNSEWIVQL  140 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH--------------HHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence            5778889999999999999996 45888999998553              22334556779999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +.+|+++.++|+|||||+||+|-.++..  ..++++..++.|+..|+.||.-+|+.   |+|||||||+|||+|..|++|
T Consensus       141 hyAFQD~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  141 HYAFQDERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             HHHhcCccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEe
Confidence            9999999999999999999999999984  34799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc----c-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY----T-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      |+|||.+-.++..+. ......+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||+.+.-...+.++
T Consensus       216 LADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI  293 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI  293 (1317)
T ss_pred             eccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence            999999988876654 3445778999999999876    2 56899999999999999999999999865433444333

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-33  Score=304.32  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=201.6

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|.. .+++.||+|++......           ........+.+.+|+.++++++||||++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   69 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-----------SSEQEEVVEALRKEIRLMARLNHPHIIRML   69 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC-----------chhHHHHHHHHHHHHHHHHHcCCCceehhh
Confidence            367788999999999999985 56899999998532110           011223457789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-CeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-GAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-~~k  841 (1002)
                      +++.+.+..++||||+++++|.+++..  .+.+++..+..++.|++.||+|||++   +++||||+|+||+++.++ .+|
T Consensus        70 ~~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~  144 (268)
T cd06630          70 GATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLR  144 (268)
T ss_pred             ceeccCCeEEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            999999999999999999999999974  35689999999999999999999999   999999999999998776 599


Q ss_pred             EccccCcccccCCCCCc--ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          842 VADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      |+|||.+..........  ......|+..|+|||++.+..++.++||||+|+++|++++|..||...........+ ...
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~  223 (268)
T cd06630         145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKI  223 (268)
T ss_pred             EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-HHH
Confidence            99999997765432111  112346888999999998888999999999999999999999999644322222111 111


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .....     .+.   .+.....++.+++.+|++.+|++||++.|+++
T Consensus       224 ~~~~~-----~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 ASATT-----APS---IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hccCC-----CCC---CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            11000     011   11122235788999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8e-34  Score=311.77  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=196.5

Q ss_pred             CcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          686 DEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      .....||+|+||.||++.. .++..||+|.+...                 .....+.+.+|+.++++++||||+++++.
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~   87 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYHHENVVDMYNS   87 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----------------hHHHHHHHHHHHHHHHhCCCCcHHHHHHh
Confidence            3346799999999999986 45889999987321                 23345668899999999999999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      +...+..|+||||+++++|.+++..   +.+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~d  161 (292)
T cd06658          88 YLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSD  161 (292)
T ss_pred             eecCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcc
Confidence            9999999999999999999998853   4589999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ||++........  ......|+..|+|||+..+..++.++||||+|+++|||++|+.||........... +...     
T Consensus       162 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~-----  233 (292)
T cd06658         162 FGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDN-----  233 (292)
T ss_pred             Ccchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc-----
Confidence            999876543221  22234688999999999888899999999999999999999999975432221111 1110     


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                          +.+...... .....+.+++.+||..||++|||++|+++.
T Consensus       234 ----~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 ----LPPRVKDSH-KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ----CCCcccccc-ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                111111100 111246788899999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=288.12  Aligned_cols=261  Identities=23%  Similarity=0.325  Sum_probs=208.0

Q ss_pred             ccCCcHHHHhcCCCcC-CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHH
Q 001867          673 KLGFSEYEILDGLDED-NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL  750 (1002)
Q Consensus       673 ~~~~~~~~~~~~~~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  750 (1002)
                      .+.+.++.++++|.+. ++||-|-.|.|-.+.. .+++++|+|++..                      .....+|++.-
T Consensus        51 ~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------------------s~KARrEVeLH  108 (400)
T KOG0604|consen   51 DMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------------------SPKARREVELH  108 (400)
T ss_pred             hcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------------------CHHHHhHhhhh
Confidence            3455778888888864 6899999999999885 5689999998732                      23345677765


Q ss_pred             hcC-CCCceeeeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 001867          751 GKI-RHKNIVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHR  825 (1002)
Q Consensus       751 ~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  825 (1002)
                      -.. .|||||.++++|..    ...+.+|||.|+||.|.+.++.+..+.+++.++..|+.||+.|+.|||+.   +|+||
T Consensus       109 w~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHR  185 (400)
T KOG0604|consen  109 WMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHR  185 (400)
T ss_pred             hhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhc
Confidence            554 49999999999864    45678999999999999999988888999999999999999999999999   99999


Q ss_pred             CCCCCcEEECC---CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 001867          826 DVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP  902 (1002)
Q Consensus       826 Dlk~~NIll~~---~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p  902 (1002)
                      ||||+|+|++.   +..+|++|||+|+.-...   ......+-|+.|.|||++...+|+..+|+||+||++|-|++|..|
T Consensus       186 DlKpENLLyt~t~~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPP  262 (400)
T KOG0604|consen  186 DLKPENLLYTTTSPNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP  262 (400)
T ss_pred             cCChhheeeecCCCCcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCc
Confidence            99999999964   446899999999865432   334456789999999999999999999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      |+...+ ..+..-++..+..+.+. ..+|.+    ........++|+..+..+|.+|.|+.++++
T Consensus       263 FYS~hg-~aispgMk~rI~~gqy~-FP~pEW----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  263 FYSNHG-LAISPGMKRRIRTGQYE-FPEPEW----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ccccCC-ccCChhHHhHhhccCcc-CCChhH----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            986654 33333333333333222 222322    233345678899999999999999999985

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=306.58  Aligned_cols=252  Identities=27%  Similarity=0.380  Sum_probs=198.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|++...                  ....+.+.+|+.+++++ +|+||+
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~------------------~~~~~~~~~e~~~l~~~~~h~~i~   66 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------------------EDEEEEIKEEYNILRKYSNHPNIA   66 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC------------------chhHHHHHHHHHHHHHhcCCCChh
Confidence            367888999999999999999974 5789999987431                  12346789999999999 699999


Q ss_pred             eeeeEEecCC------eeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          760 KLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       760 ~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ++++++....      ..++||||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++||||+|+|
T Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~n  143 (275)
T cd06608          67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQN  143 (275)
T ss_pred             eEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHH
Confidence            9999997644      4899999999999999987543  46799999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----LRVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      |+++.++.+||+|||.+........  ......|+..|+|||++..     ..++.++||||+||++|+|++|+.||...
T Consensus       144 i~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         144 ILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             EEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            9999999999999999976543322  1223468889999998753     34678999999999999999999999644


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..........     .....     ... .......++.+++.+||..||++|||++++++
T Consensus       222 ~~~~~~~~~~-----~~~~~-----~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         222 HPMRALFKIP-----RNPPP-----TLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             chHHHHHHhh-----ccCCC-----CCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2222221111     11111     111 01112235788999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3e-33  Score=302.97  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=201.6

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||.|+||.||+|.. .+++.||+|.+...               .......+++..|++++++++||||++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---------------NMTEKEKQQLVSEVNILRELKHPNIVRYY   65 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc---------------cCCHHHHHHHHHHHHHHHhcCCCccceee
Confidence            467788999999999999985 46789999987432               11234456788999999999999999999


Q ss_pred             eEEec--CCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeeCCCCCCcEE
Q 001867          763 CCCTT--RDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLH-----HDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       763 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~iiHrDlk~~NIl  833 (1002)
                      +++..  ....+++|||+++++|.+++....  ...+++..++.++.|++.||+|||     +.   +++||||+|+||+
T Consensus        66 ~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nil  142 (265)
T cd08217          66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIF  142 (265)
T ss_pred             eeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEE
Confidence            98864  456799999999999999987532  467899999999999999999999     66   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      ++.++.+|++|||++........  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .....
T Consensus       143 i~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~  219 (265)
T cd08217         143 LDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLA  219 (265)
T ss_pred             EecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHH
Confidence            99999999999999987754432  1223468899999999998889999999999999999999999997543 22222


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      +.+.    .....     ..   ......++.+++.+|++.+|++||++++|++.
T Consensus       220 ~~~~----~~~~~-----~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         220 SKIK----EGKFR-----RI---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHh----cCCCC-----CC---ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            2221    11111     11   11222457889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=344.19  Aligned_cols=253  Identities=29%  Similarity=0.392  Sum_probs=201.6

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|..+..||.|.||.||-|.. .+|+-.|||.+..-               ..+......+.+|+.++..++|||+|++|
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq---------------~~~~k~~~~i~eEm~vlE~lnHpNlV~Yy 1300 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQ---------------DSDHKTFKLIAEEMKVLEGLNHPNLVRYY 1300 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcC---------------ccccccCcchHHHHHHHHhccCccccccC
Confidence            566778999999999999994 66899999988321               11234455688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      |.=.+.+..+|.||||++|+|.+.++  .++..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|+
T Consensus      1301 GVEvHRekv~IFMEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1301 GVEVHREKVYIFMEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred             ceeecHHHHHHHHHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEe
Confidence            99999999999999999999999998  445578888888999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCC--CcccccccccccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          843 ADFGVAKVVDASGK--PKSMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +|||.|..+.+...  +...+...||+.|||||++.+.   ....++||||+|||..||+||++||..-..+-.+.-.+.
T Consensus      1376 ~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~ 1455 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA 1455 (1509)
T ss_pred             ecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh
Confidence            99999998876532  2233566899999999998754   456799999999999999999999975433322222222


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .+..         |..+.   ....+=.+++..|++.||++|+++.|+++.
T Consensus      1456 ~gh~---------Pq~P~---~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGHK---------PQIPE---RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ccCC---------CCCch---hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2111         11111   112234577889999999999999877754

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.7e-33  Score=307.96  Aligned_cols=253  Identities=29%  Similarity=0.366  Sum_probs=197.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|.. .+++.+|+|.+...                  ....+.+.+|+.+++++ +|||++
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~------------------~~~~~~~~~e~~~l~~l~~h~ni~   82 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI------------------SDVDEEIEAEYNILQSLPNHPNVV   82 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc------------------ccHHHHHHHHHHHHHHhcCCCCeE
Confidence            46788899999999999999996 46889999987321                  12245678899999999 799999


Q ss_pred             eeeeEEecC-----CeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          760 KLWCCCTTR-----DCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       760 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      ++++++...     +..++||||+++++|.++++..  ....+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~ni  159 (291)
T cd06639          83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNI  159 (291)
T ss_pred             EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHE
Confidence            999998753     3589999999999999988642  345689999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      +++.++.+||+|||++.........  .....|+..|+|||++...     .++.++||||+||++|||++|+.||....
T Consensus       160 li~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         160 LLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             EEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            9999999999999999865433221  1234688899999987543     36789999999999999999999997543


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ......++.     ........++      .+....+.+++.+||+.+|++||++.|+++.
T Consensus       238 ~~~~~~~~~-----~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         238 PVKTLFKIP-----RNPPPTLLHP------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHHHHHh-----cCCCCCCCcc------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            322222211     1111111111      1112348889999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-33  Score=330.37  Aligned_cols=281  Identities=18%  Similarity=0.171  Sum_probs=192.6

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEcC--CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++.++|++.+.||+|+||+||+|..+.  ++.++.|.+.............+.+...........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            346789999999999999999987532  333333322111000000000011111122334567899999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK---GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      |+++++++...+..|+|+|++ ++++.+++....   ........+..++.|++.||+|||++   +||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            999999999999999999999 568888765322   12344567788999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch---h
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK---D  911 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~---~  911 (1002)
                      +.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++.......   .
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999876543222 1223569999999999999999999999999999999999886543322211   1


Q ss_pred             HHHHHHHHhhccCccccccc-----------c---ccCCCHHH------HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          912 LVKWVCSTLDQKGVDHVLDP-----------K---LDCCFKEE------ICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~-----------~---~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +.+.+.... . ...+..++           .   ........      ..++.+++.+|++.||++|||+.|+++
T Consensus       380 ~~~~~~~~~-~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLS-V-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcc-c-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            221111000 0 00000000           0   00000000      123567788999999999999999986

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=309.65  Aligned_cols=263  Identities=23%  Similarity=0.277  Sum_probs=200.8

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|..+ +++.||+|++....               ......+.+.+|++++++++|+||++++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   66 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---------------DDEDVKKTALREVKVLRQLRHENIVNLK   66 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc---------------ccccchhHHHHHHHHHHhcCCCCeeehh
Confidence            5788899999999999999965 57899999874321               1233456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++..++..++||||++++.+..+..  +...+++..+..++.|++.|++|||++   +++||||+|+||+++.++.+||
T Consensus        67 ~~~~~~~~~~iv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl  141 (288)
T cd07833          67 EAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKL  141 (288)
T ss_pred             heEEECCEEEEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence            99999999999999998877766554  335589999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+........ .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+...........
T Consensus       142 ~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  220 (288)
T cd07833         142 CDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP  220 (288)
T ss_pred             EeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999987655432 122234678899999999887 8899999999999999999999998754332222211110000


Q ss_pred             -----------ccCcc--cccccccc-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 -----------QKGVD--HVLDPKLD-----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 -----------~~~~~--~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                                 .....  ...+....     ........++.+++.+||+.+|++||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                       00000  00000000     001111356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.8e-33  Score=304.52  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=199.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|+..+.||.|++|.||+|..+ +++.+|+|.+...                .......++.+|++++++++||||+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~   64 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD----------------PNPDLQKQILRELEINKSCKSPYIVKY   64 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC----------------CchHHHHHHHHHHHHHHhCCCCCeeee
Confidence            35777889999999999999974 5789999988432                112345678999999999999999999


Q ss_pred             eeEEecC--CeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          762 WCCCTTR--DCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       762 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++.+.  +..++||||+++++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||+|+||+++.+
T Consensus        65 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~  141 (287)
T cd06621          65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRK  141 (287)
T ss_pred             eeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecC
Confidence            9998653  4689999999999999987642  345689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC----chhHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG----EKDLV  913 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~----~~~~~  913 (1002)
                      +.++|+|||++........    ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....    ..+..
T Consensus       142 ~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  217 (287)
T cd06621         142 GQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL  217 (287)
T ss_pred             CeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH
Confidence            9999999999875543221    133578899999999988999999999999999999999999975522    12222


Q ss_pred             HHHHHHhhccCccccccc-cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDP-KLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .+...    .......+. ......   ...+.+++.+||+.+|++|||+.|+++
T Consensus       218 ~~~~~----~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         218 SYIVN----MPNPELKDEPGNGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHHhc----CCchhhccCCCCCCch---HHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            22211    011111000 001111   235788999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.1e-33  Score=304.07  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=201.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..+.||+|+||.||+|... +++.||+|.+....                .......+.+|+.++++++||||++++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~   68 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----------------AEDEIEDIQQEITVLSQCDSPYVTKYY   68 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----------------cHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4666788999999999999964 58899999874321                123456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.++...++||||+++++|.+++..   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+++
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l  142 (277)
T cd06640          69 GSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKL  142 (277)
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEE
Confidence            999999999999999999999999863   4589999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||++........  ......++..|+|||++.+..++.++|||||||++|||++|..||......... .   . ...
T Consensus       143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~---~-~~~  215 (277)
T cd06640         143 ADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-F---L-IPK  215 (277)
T ss_pred             cccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-h---h-hhc
Confidence            99999976654322  222346788999999999888999999999999999999999998654321111 1   0 000


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ..        ...........+.+++.+||+.+|++||++++++..
T Consensus       216 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         216 NN--------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CC--------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            00        011122334568899999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-33  Score=308.54  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=198.0

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|+||.||+|... +++.||+|.+...                ......+.+.+|+.++++++||||+++++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE----------------EAEDEIEDIQQEITVLSQCDSPYITRYYG   69 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc----------------cchHHHHHHHHHHHHHHcCCCCccHhhhc
Confidence            445678999999999999864 5788999987421                11234567899999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++..+...|+||||+++++|.+++..   ..+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~  143 (277)
T cd06642          70 SYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLA  143 (277)
T ss_pred             ccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEc
Confidence            99999999999999999999999863   4689999999999999999999998   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||++........  ......|+..|+|||++.+..++.++|||||||++|||++|+.|+........ ...    ....
T Consensus       144 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~----~~~~  216 (277)
T cd06642         144 DFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-LFL----IPKN  216 (277)
T ss_pred             cccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-Hhh----hhcC
Confidence            9999976654321  12234578899999999988899999999999999999999999864322111 111    1010


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .     .+....   .....+.+++.+||+.+|++||++.++++.
T Consensus       217 ~-----~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 S-----PPTLEG---QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             C-----CCCCCc---ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            0     111111   122357889999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-33  Score=311.06  Aligned_cols=246  Identities=22%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             cCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          687 EDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       687 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      ....||+|+||.||+|... +++.||+|.+...                 .....+.+.+|+.+++.++||||+++++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~   87 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-----------------KQQRRELLFNEVVIMRDYQHQNVVEMYKSY   87 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-----------------ccchHHHHHHHHHHHHhCCCCchhhhhhhe
Confidence            3457999999999999864 6899999988432                 112345688999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      ..++..|++|||+++++|.+++..   ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        88 ~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~df  161 (297)
T cd06659          88 LVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDF  161 (297)
T ss_pred             eeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeec
Confidence            999999999999999999998753   4589999999999999999999999   9999999999999999999999999


Q ss_pred             cCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCc
Q 001867          846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV  925 (1002)
Q Consensus       846 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  925 (1002)
                      |++........  ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ......    ...
T Consensus       162 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~~  234 (297)
T cd06659         162 GFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRD----SPP  234 (297)
T ss_pred             hhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhc----cCC
Confidence            99875543321  12235688999999999988899999999999999999999999975432221 111111    000


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          926 DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ..  .......    ...+.+++.+||+.+|++||+++++++.
T Consensus       235 ~~--~~~~~~~----~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 PK--LKNAHKI----SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CC--ccccCCC----CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00  0001111    2247788999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-33  Score=309.57  Aligned_cols=266  Identities=23%  Similarity=0.290  Sum_probs=200.8

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|.+......+            ........+..|++++++++|+||++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~~~~~~e~~~l~~~~h~~i~~~~   68 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE------------AKDGINFTALREIKLLQELKHPNIIGLL   68 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc------------ccchhhHHHHHHHHHHhhcCCCCChhhh
Confidence            3677789999999999999964 68999999985432110            0122345677899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..++||||+ +|+|.+++.... ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.++|
T Consensus        69 ~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l  143 (298)
T cd07841          69 DVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKL  143 (298)
T ss_pred             heeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEE
Confidence            9999999999999999 899999997533 4799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++.......  ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||..........+.......
T Consensus       144 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~  221 (298)
T cd07841         144 ADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT  221 (298)
T ss_pred             ccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC
Confidence            99999987654322  1223356788999998764 45788999999999999999997777654433322222111000


Q ss_pred             c--------cCcccc------ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 Q--------KGVDHV------LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~--------~~~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .        ......      ..............++.+++.+||+.+|++||+++|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0        000000      0000011112223468899999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=308.59  Aligned_cols=262  Identities=23%  Similarity=0.291  Sum_probs=199.4

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |++.+.||+|++|.||+|... +|..||+|++....               ......+.+.+|++++++++|||++++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~iv~~~~   65 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET---------------EDEGVPSTAIREISLLKELNHPNIVRLLD   65 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc---------------ccccchhHHHHHHHHHHhcCCCCccCHhh
Confidence            567789999999999999964 68999999884321               11223356788999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++.+.+..|++|||+ +++|.+++.......+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+
T Consensus        66 ~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~  141 (283)
T cd07835          66 VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLA  141 (283)
T ss_pred             eeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEe
Confidence            999999999999999 47999998765545799999999999999999999998   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      |||++........  ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||..........+........
T Consensus       142 df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (283)
T cd07835         142 DFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP  219 (283)
T ss_pred             ecccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999976543221  12233568899999987664 56889999999999999999999997654333333322211000


Q ss_pred             c-----------C----ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 K-----------G----VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~-----------~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .           .    ......+......+.....+.+++.+|++.+|++||+++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0           0    0000000111111111235788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-33  Score=309.28  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=200.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||++.. .+++.||+|.+...                 .....+.+.+|+.++++++||||+++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~hp~i~~~   81 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-----------------QQPKKELIINEILVMRENKHPNIVNY   81 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-----------------cchHHHHHHHHHHHHhhcCCCCeeeh
Confidence            5788889999999999999985 46789999987321                 22335678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..|+|+||+++++|.+++..   ..+++..+..++.|++.|++|||++   +++||||||+||+++.++.+|
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~k  155 (293)
T cd06647          82 LDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK  155 (293)
T ss_pred             hheeeeCCcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEE
Confidence            9999999999999999999999999864   3578999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||++........  ......|++.|+|||...+..++.++||||||+++|++++|+.||.............    .
T Consensus       156 L~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~----~  229 (293)
T cd06647         156 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----T  229 (293)
T ss_pred             EccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh----c
Confidence            999999876554322  1223468889999999988889999999999999999999999997543222111110    0


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .. .     +.. .........+.+++.+||+.+|++||++.+++..
T Consensus       230 ~~-~-----~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 NG-T-----PEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CC-C-----CCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 0     000 0111122357789999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.2e-33  Score=315.84  Aligned_cols=266  Identities=23%  Similarity=0.301  Sum_probs=201.0

Q ss_pred             cHHHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          677 SEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       677 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      ..+.+.++|+..+.||+|+||.||+|.. .+++.||+|++.+.               ..+......+.+|+.++++++|
T Consensus        10 ~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h   74 (353)
T cd07850          10 STFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP---------------FQNVTHAKRAYRELVLMKLVNH   74 (353)
T ss_pred             hhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc---------------ccChhHHHHHHHHHHHHHhcCC
Confidence            3466778999999999999999999996 46899999987432               1123344567789999999999


Q ss_pred             CceeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          756 KNIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       756 ~niv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                      |||+++++++...      ...|+||||++ ++|.+++..    .+++..+..++.|++.||+|||++   +|+||||||
T Consensus        75 ~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp  146 (353)
T cd07850          75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKP  146 (353)
T ss_pred             CCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCH
Confidence            9999999998644      35699999995 688888763    289999999999999999999999   999999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +||+++.++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||+||++|+|++|+.||......
T Consensus       147 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~  223 (353)
T cd07850         147 SNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI  223 (353)
T ss_pred             HHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence            999999999999999999987644322   22345788999999999999999999999999999999999999754322


Q ss_pred             hhHHHHHHHH------------------hhcc------Ccccccccc----c-cCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 001867          910 KDLVKWVCST------------------LDQK------GVDHVLDPK----L-DCCFKEEICKVLNIGLLCTSPLPINRP  960 (1002)
Q Consensus       910 ~~~~~~~~~~------------------~~~~------~~~~~~~~~----~-~~~~~~~~~~l~~l~~~cl~~dP~~Rp  960 (1002)
                      ..........                  ....      .........    . .........++.+++.+|++.||++||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  303 (353)
T cd07850         224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI  303 (353)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence            2111111000                  0000      000000000    0 000112234577899999999999999


Q ss_pred             CHHHHHHH
Q 001867          961 AMRRVVKL  968 (1002)
Q Consensus       961 s~~evl~~  968 (1002)
                      |+.|+++.
T Consensus       304 t~~eiL~~  311 (353)
T cd07850         304 SVDDALQH  311 (353)
T ss_pred             CHHHHhcC
Confidence            99999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.2e-33  Score=307.34  Aligned_cols=269  Identities=19%  Similarity=0.228  Sum_probs=186.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|.+.++||+|+||.||+|...+    +..+|+|+..... .     ...................+...++.+.|+++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~-~-----~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN-E-----TIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC-C-----chhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            578889999999999999999754    3455666431110 0     00000000000111223344555667789999


Q ss_pred             eeeeeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          759 VKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       759 v~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++++++....    ..++++|++ ..++.+.+..  ....++..+..++.|++.||+|||++   +|+||||||+||++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            99998776543    347888887 4567776653  23467888999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          835 DGDFGARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +.++.++|+|||+|+........     .......||+.|+|||+..+..++.++||||+||++|||++|+.||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999876433211     1122346999999999999999999999999999999999999999765333


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      ....................  .....+    ..+.+++..||+.+|++||+++++++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        240 GNLIHAAKCDFIKRLHEGKI--KIKNAN----KFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHhHHHHHHHhhhhhh--ccCCCC----HHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            32222111111000000000  112222    3478899999999999999999999876

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.6e-33  Score=308.48  Aligned_cols=264  Identities=23%  Similarity=0.241  Sum_probs=199.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|.+.....               .......+.+|+.++++++||||++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~ni~~   68 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---------------KEGFPITSLREINILLKLQHPNIVT   68 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc---------------cccchhhHHHHHHHHHhcCCCCEEE
Confidence            356778889999999999999975 588999999853211               1122345678999999999999999


Q ss_pred             eeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          761 LWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       761 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++...  ...|+||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        69 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~  143 (293)
T cd07843          69 VKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRG  143 (293)
T ss_pred             EEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCC
Confidence            99999877  88999999996 59999887533 4689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||++........  ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||..........+...
T Consensus       144 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~  221 (293)
T cd07843         144 ILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK  221 (293)
T ss_pred             cEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999999987654321  22234578899999988754 468899999999999999999999976543332222211


Q ss_pred             HHhh----------c------cCccccccccccCCCHH--HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLD----------Q------KGVDHVLDPKLDCCFKE--EICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~----------~------~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....          .      ..........+....+.  ....+.+++..||+.+|++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            1000          0      00000000001111111  1335778999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-33  Score=308.52  Aligned_cols=264  Identities=22%  Similarity=0.254  Sum_probs=198.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....               ........+.+|++++++++||||+++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~   66 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ---------------EDEGVPSTAIREISLLKEMQHGNIVRL   66 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc---------------ccccchHHHHHHHHHHHhccCCCEeeE
Confidence            56888899999999999999965 68899999874321               112234568889999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC-CCCe
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG-DFGA  840 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~-~~~~  840 (1002)
                      ++++......|+||||++ +++.+++........++..+..++.||+.||+|||++   +++||||+|+||+++. ++.+
T Consensus        67 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~  142 (294)
T PLN00009         67 QDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNAL  142 (294)
T ss_pred             EEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEE
Confidence            999999999999999995 6888888755555578899999999999999999999   9999999999999985 5579


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++.......  .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||......+...+.....
T Consensus       143 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~  220 (294)
T PLN00009        143 KLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL  220 (294)
T ss_pred             EEcccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999997654321  112234578899999988664 57889999999999999999999997654333333222110


Q ss_pred             hh--ccCcc-------------ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LD--QKGVD-------------HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~--~~~~~-------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..  .....             ...........+....++.+++.+|++.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  00000             00000000011111234778999999999999999999986

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.4e-33  Score=302.60  Aligned_cols=250  Identities=22%  Similarity=0.283  Sum_probs=201.1

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||.|+||.||+|... +++.||+|++.+.              ........+.+.+|++++++++||||++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   66 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ--------------KCVEKGSVRNVLNERRILQELNHPFLVNLW   66 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehh--------------hhcchhHHHHHHHHHHHHHhCCCCChHHHH
Confidence            4778899999999999999975 5899999998432              111224467899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++..+...++|+||+++++|.+++...  ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l  141 (258)
T cd05578          67 YSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHI  141 (258)
T ss_pred             HhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEE
Confidence            9999999999999999999999999753  5789999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||.+.......   ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||......  ...........
T Consensus       142 ~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~  216 (258)
T cd05578         142 TDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET  216 (258)
T ss_pred             eecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc
Confidence            9999998765432   223446888999999999888999999999999999999999999765432  11111111111


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM--RRVV  966 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~--~evl  966 (1002)
                        ......       ......+.+++.+||+.||.+||++  +|+.
T Consensus       217 --~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 --ADVLYP-------ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --ccccCc-------ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              000011       1112457889999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7e-33  Score=300.09  Aligned_cols=254  Identities=29%  Similarity=0.421  Sum_probs=200.9

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|...+.||+|+||.||+|.. .+++.||+|.++...               ......+.+..|++++++++|+||++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~~~~l~~~~i~~~~   65 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD---------------NDPKTIKEIADEMKVLELLKHPNLVKYY   65 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc---------------cchHHHHHHHHHHHHHHhCCCCChhhee
Confidence            477789999999999999986 468899999985421               1134567899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++...+..++|+||+++++|.+++..  ...+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.+||
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl  140 (264)
T cd06626          66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKL  140 (264)
T ss_pred             eeEecCCEEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999974  34589999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcc--cccccccccccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKS--MSVIAGSCGYIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +|||.+...........  .....+++.|+|||++.+..   ++.++||||||+++||+++|+.||..............
T Consensus       141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~  220 (264)
T cd06626         141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG  220 (264)
T ss_pred             cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh
Confidence            99999987654432211  12345788999999988766   88999999999999999999999964432221111111


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .    ...     +..+.. ......+.+++.+||+.+|++||+++|++.
T Consensus       221 ~----~~~-----~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         221 A----GHK-----PPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             c----CCC-----CCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1    100     111110 011234678999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.7e-33  Score=300.18  Aligned_cols=251  Identities=30%  Similarity=0.455  Sum_probs=204.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|++....                .......+.+|+.++++++|+|+++++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG----------------DEEFRKQLLRELKTLRSCESPYVVKCY   65 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc----------------chHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            5778899999999999999975 48999999884321                113467799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++...+..++||||+++++|.+++...  ..+++..++.++.|+++|++|||+ .   +++||||+|+||+++.++.++
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~  140 (264)
T cd06623          66 GAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVK  140 (264)
T ss_pred             EEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEE
Confidence            9999999999999999999999999853  668999999999999999999999 8   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC--CchhHHHHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF--GEKDLVKWVCST  919 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~--~~~~~~~~~~~~  919 (1002)
                      |+|||.+..........  ....++..|+|||...+..++.++||||||+++|+|++|+.||....  ...+..+.+.  
T Consensus       141 l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--  216 (264)
T cd06623         141 IADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--  216 (264)
T ss_pred             EccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--
Confidence            99999998765433221  23457889999999998889999999999999999999999997553  2222222221  


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                       .. ..     +.....  .....+.+++.+||+.+|++||++.++++.
T Consensus       217 -~~-~~-----~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         217 -DG-PP-----PSLPAE--EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -cC-CC-----CCCCcc--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             11 10     111111  012358889999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=304.43  Aligned_cols=247  Identities=25%  Similarity=0.370  Sum_probs=196.7

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC---CCceee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR---HKNIVK  760 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~  760 (1002)
                      |+..+.||+|+||.||+|.+ .+++.||+|.+....                .....+++.+|+.++++++   |||+++
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~vi~   66 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----------------PDDDVSDIQREVALLSQLRQSQPPNITK   66 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----------------CchhHHHHHHHHHHHHHhccCCCCCeee
Confidence            56678999999999999996 568999999874321                1223456888999999986   999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++..+...++||||+++++|.++++.   ..+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~  140 (277)
T cd06917          67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNV  140 (277)
T ss_pred             EeeeeeeCCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCE
Confidence            99999999999999999999999999864   3689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +|+|||.+........  ......|+..|+|||...++ .++.++|||||||++|+|++|+.||........    ... 
T Consensus       141 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~-  213 (277)
T cd06917         141 KLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----MML-  213 (277)
T ss_pred             EEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----hhc-
Confidence            9999999987755432  12234688999999987654 468899999999999999999999965422111    110 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....     ..+.+...  ....++.+++.+||+.||++||++.|+++
T Consensus       214 ~~~~-----~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         214 IPKS-----KPPRLEDN--GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cccC-----CCCCCCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0000     11111110  01235788999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.5e-33  Score=300.28  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=201.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|..+ +|..||+|.+....               ......+.+.+|++++++++|+||++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~E~~~l~~~~h~~i~~~~   65 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK---------------MPVKEKEASKKEVILLAKMKHPNIVTFF   65 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh---------------ccchhhHHHHHHHHHHHhCCCCChhhhh
Confidence            3677889999999999999965 57899999884321               0122345688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC-eE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-AR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~-~k  841 (1002)
                      +.+...+..++|+||+++++|.+++.......+++..+..++.|++.|++|||+.   +++||||||+||++++++. +|
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~  142 (257)
T cd08225          66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAK  142 (257)
T ss_pred             heeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEE
Confidence            9999999999999999999999999865555689999999999999999999999   9999999999999998764 69


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      ++|||.+........  ......|++.|+|||+..+..++.++||||||+++|||++|+.||.....    .++......
T Consensus       143 l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~  216 (257)
T cd08225         143 LGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL----HQLVLKICQ  216 (257)
T ss_pred             ecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc
Confidence            999999987654322  12234588899999999888899999999999999999999999864322    222222111


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      . .    +.+......    ..+.+++.+||+.+|++||+++|+++.
T Consensus       217 ~-~----~~~~~~~~~----~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         217 G-Y----FAPISPNFS----RDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             c-c----CCCCCCCCC----HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1 1    111111122    347888999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.6e-33  Score=303.60  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=191.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHH-HhcCCCCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET-LGKIRHKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~  760 (1002)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++....                ......++..|+.+ ++..+||||++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~~~~~~~~~~iv~   64 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV----------------NSQEQKRLLMDLDISMRSVDCPYTVT   64 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC----------------CcHHHHHHHHHHHHHHHHcCCCCeee
Confidence            36788899999999999999965 68999999884321                11123345556665 55668999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++..++..|++|||++ |+|.+++...  ....+++..++.++.|++.|++|||++  .+++||||||+||+++.++
T Consensus        65 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~  141 (283)
T cd06617          65 FYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNG  141 (283)
T ss_pred             eeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCC
Confidence            9999999999999999995 7888887642  235789999999999999999999985  2899999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT----LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      .+||+|||++.......   ......|+..|+|||.+.+    ..++.++|+||+|+++|||++|+.||.......+...
T Consensus       142 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  218 (283)
T cd06617         142 QVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK  218 (283)
T ss_pred             CEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH
Confidence            99999999998654321   1223468889999998764    4468899999999999999999999964322211111


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..   ... ......    ...+   ..++.+++.+||..+|++||+++++++
T Consensus       219 ~~---~~~-~~~~~~----~~~~---~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 QV---VEE-PSPQLP----AEKF---SPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HH---Hhc-CCCCCC----cccc---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11   111 001000    1111   134788999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.8e-33  Score=302.35  Aligned_cols=245  Identities=22%  Similarity=0.213  Sum_probs=185.7

Q ss_pred             eeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHh---cCCCCceeeeeeEE
Q 001867          690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLG---KIRHKNIVKLWCCC  765 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~niv~l~~~~  765 (1002)
                      .||+|+||.||+|... +++.||+|.+.+....              .......+..|..+++   ..+||+|+.+++++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~   66 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--------------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAF   66 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccc--------------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE
Confidence            4899999999999964 5889999988543111              1112233344444333   34699999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      ..++..++||||+++|+|.+++..  .+.+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        67 ~~~~~~~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~df  141 (279)
T cd05633          67 HTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  141 (279)
T ss_pred             ecCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccC
Confidence            999999999999999999999874  45699999999999999999999999   9999999999999999999999999


Q ss_pred             cCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       846 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      |++........    ....|+..|+|||... +..++.++||||+||++|||++|..||........ . ........  
T Consensus       142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~-~~~~~~~~--  213 (279)
T cd05633         142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-H-EIDRMTLT--  213 (279)
T ss_pred             CcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-H-HHHHHhhc--
Confidence            99976543221    2346899999999886 45688999999999999999999999975432211 1 11111100  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVKL  968 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~  968 (1002)
                          ....+..   ....++.+++.+|++.||++||     +++|+++.
T Consensus       214 ----~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 ----VNVELPD---SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----CCcCCcc---ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                1111111   1223577889999999999999     58888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-32  Score=303.36  Aligned_cols=263  Identities=21%  Similarity=0.241  Sum_probs=195.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++....                .......+.+|+.+++.++|+||++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~ni~~   67 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT----------------EEGVPFTAIREASLLKGLKHANIVL   67 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC----------------cCCCcHHHHHHHHHHHhcCCCCEeE
Confidence            35688889999999999999986 468899999984321                1112335678999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++..++..|+||||++ +++.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        68 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~  142 (291)
T cd07870          68 LHDIIHTKETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGEL  142 (291)
T ss_pred             EEEEEecCCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcE
Confidence            9999999999999999995 7887776542 34578889999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+++........  .....+++.|+|||++.+. .++.++||||+||++|||++|+.||....+..+........
T Consensus       143 ~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  220 (291)
T cd07870         143 KLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV  220 (291)
T ss_pred             EEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence            99999999765432211  2234578899999988754 57889999999999999999999997543322211111110


Q ss_pred             hhc-------------cCccccccccccCCCH------HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQ-------------KGVDHVLDPKLDCCFK------EEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~-------------~~~~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...             ................      .....+.+++.+|++.||++|||++|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000             0000000000000000      01235678899999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.7e-33  Score=302.64  Aligned_cols=247  Identities=25%  Similarity=0.334  Sum_probs=196.8

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |...+.||+|+||.||+|.. .+++.+|+|++...                 .....+.+.+|+.+++.++||||+++++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-----------------~~~~~~~~~~e~~~l~~~~h~~vv~~~~   83 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYQHPNIVEMYS   83 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-----------------chhHHHHHHHHHHHHHHcCCCChheEEE
Confidence            33457999999999999985 46889999987321                 2233456889999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++...+..++++||+++++|.+++..   ..+++..+..++.|++.|++|||++   +|+||||+|+||+++.++.++++
T Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~  157 (285)
T cd06648          84 SYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLS  157 (285)
T ss_pred             EEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEc
Confidence            99999999999999999999999875   4589999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||.+........  ......|++.|+|||...+..++.++||||+||++|||++|+.||........    ..... ..
T Consensus       158 d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~----~~~~~-~~  230 (285)
T cd06648         158 DFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA----MKRIR-DN  230 (285)
T ss_pred             ccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH----HHHHH-hc
Confidence            9998876543321  12234688999999999888899999999999999999999999865422111    11111 11


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .......+  .    .....+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~--~----~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         231 LPPKLKNL--H----KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCCCccc--c----cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11111000  1    11235889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-33  Score=302.91  Aligned_cols=261  Identities=25%  Similarity=0.272  Sum_probs=198.8

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC---CCCceee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI---RHKNIVK  760 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~  760 (1002)
                      |++.+.||+|+||.||+|+.+ +++.||+|++.....               .......+.+|+.+++++   +|||+++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~h~~i~~   65 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS---------------EEGIPLSTLREIALLKQLESFEHPNIVR   65 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc---------------cchhhhhHHHHHHHHHHhhccCCCCcce
Confidence            567789999999999999976 489999999843211               112234566787777666   5999999


Q ss_pred             eeeEEecCCe-----eeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          761 LWCCCTTRDC-----KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       761 l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      +++++...+.     .+++|||++ ++|.+++.......+++..++.++.|++.||+|||+.   +++||||+|+||+++
T Consensus        66 ~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~  141 (287)
T cd07838          66 LLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVT  141 (287)
T ss_pred             EEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEc
Confidence            9999988776     899999996 5899998765555699999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .++.+||+|||.+.........   ....++..|+|||++.+..++.++|||||||++|||++|+.||......+...++
T Consensus       142 ~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~  218 (287)
T cd07838         142 SDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI  218 (287)
T ss_pred             cCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence            9999999999999876543221   2234788999999999989999999999999999999999998765444333333


Q ss_pred             HHHHhhccC-------------ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKG-------------VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .........             .............++....+.+++.+||+.||++||+++|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            321111000             0000011111112223356778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.6e-33  Score=303.15  Aligned_cols=250  Identities=28%  Similarity=0.419  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|+..+.||+|+||.||+|... ++..||+|++...                 .. ..+.+.+|++++++++|+|++++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----------------~~-~~~~~~~e~~~l~~l~~~~i~~~   80 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-----------------KQ-NKELIINEILIMKDCKHPNIVDY   80 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecC-----------------ch-hHHHHHHHHHHHHHCCCCCeeEE
Confidence            45677789999999999999975 6889999998431                 11 45678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++...+..|+++||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +|+|+||+|+||+++.++.++
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~  156 (286)
T cd06614          81 YDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVK  156 (286)
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEE
Confidence            999999999999999999999999998643 4799999999999999999999998   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||.+........  ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+..    
T Consensus       157 l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----  230 (286)
T cd06614         157 LADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----  230 (286)
T ss_pred             ECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----
Confidence            999999876543321  12234578899999999888899999999999999999999999975433222221111    


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       .......++  .    .....+.+++.+||+.+|.+||++.++++
T Consensus       231 -~~~~~~~~~--~----~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         231 -KGIPPLKNP--E----KWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -cCCCCCcch--h----hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             111111010  1    11235788999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.1e-33  Score=302.71  Aligned_cols=247  Identities=22%  Similarity=0.239  Sum_probs=193.2

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|+||+||+|... +|+.||+|.+....              .........+..|++++++++||||+++++++...+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   66 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKR--------------LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD   66 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhh--------------hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC
Confidence            699999999999854 68899999884321              112233556778999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..|+||||+++++|.+++.......+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+||+|||.+.
T Consensus        67 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~  143 (277)
T cd05577          67 DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAV  143 (277)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchh
Confidence            999999999999999999865555799999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccc
Q 001867          850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVL  929 (1002)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1002)
                      ......   ......++..|+|||+..+..++.++||||+||++|+|++|+.||.............. .....      
T Consensus       144 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~------  213 (277)
T cd05577         144 ELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-RTLEM------  213 (277)
T ss_pred             hhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-ccccc------
Confidence            654321   12234578899999999888899999999999999999999999965432111111111 11000      


Q ss_pred             cccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          930 DPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       930 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .......   ....+.+++.+||+.+|++||     ++.++++
T Consensus       214 ~~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 AVEYPDK---FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cccCCcc---CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            0001111   123477899999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=314.40  Aligned_cols=269  Identities=21%  Similarity=0.306  Sum_probs=199.1

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|.. .+|+.||+|++...                ........+.+|+.++++++||||+
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~niv   66 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF----------------EHQTFCQRTLREIKILRRFKHENII   66 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc----------------ccchhHHHHHHHHHHHHhCCCCCcC
Confidence            456788999999999999999985 46899999987421                1122345678899999999999999


Q ss_pred             eeeeEEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          760 KLWCCCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       760 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      ++++++...     ...|+++||++ +++.+++..   ..+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus        67 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill  139 (336)
T cd07849          67 GILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLL  139 (336)
T ss_pred             chhheeecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEE
Confidence            999987654     35799999995 588887753   5699999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCc-ccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          835 DGDFGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      +.++.+||+|||++.......... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||........ 
T Consensus       140 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-  218 (336)
T cd07849         140 NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-  218 (336)
T ss_pred             CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            999999999999998664432211 1233468899999998654 5688999999999999999999999965422111 


Q ss_pred             HHHHHHHhhcc---Ccccccc-------------ccc--cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHHh
Q 001867          913 VKWVCSTLDQK---GVDHVLD-------------PKL--DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL--LQEV  972 (1002)
Q Consensus       913 ~~~~~~~~~~~---~~~~~~~-------------~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~  972 (1002)
                      ...+.......   ....+.+             +..  ....+....++.+++.+||+.+|++|||++|+++.  +++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            11111111000   0000000             000  00001112357899999999999999999999986  5554


Q ss_pred             h
Q 001867          973 G  973 (1002)
Q Consensus       973 ~  973 (1002)
                      .
T Consensus       299 ~  299 (336)
T cd07849         299 H  299 (336)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-32  Score=304.92  Aligned_cols=249  Identities=29%  Similarity=0.367  Sum_probs=195.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|+..+.||+|+||.||+|... +++.||+|++....              .......+++.+|++++++++||||+++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~~~~~Ei~~l~~l~h~niv~~   80 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--------------KQSNEKWQDIIKEVRFLQQLRHPNTIEY   80 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--------------cCcHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            45777889999999999999964 68999999884321              1123344678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||++ |++.+++... ...+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++
T Consensus        81 ~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~k  155 (307)
T cd06607          81 KGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVK  155 (307)
T ss_pred             EEEEEeCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEE
Confidence            999999999999999996 6787777643 34689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |+|||++......      ....+++.|+|||++.   ...++.++||||||+++|||++|+.||...........    
T Consensus       156 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----  225 (307)
T cd06607         156 LADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----  225 (307)
T ss_pred             EeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----
Confidence            9999998765432      1345788999999874   45688899999999999999999999864322111111    


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .. ....     +..  ........+.+++.+||+.+|++||++.+++..
T Consensus       226 ~~-~~~~-----~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 IA-QNDS-----PTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             Hh-cCCC-----CCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00 1100     000  011122357889999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-32  Score=298.39  Aligned_cols=245  Identities=25%  Similarity=0.349  Sum_probs=194.8

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|+||.||+|... +++.||+|++.+..              .......+.+.+|+.++++++||||+++++++.++.
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   66 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH--------------IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK   66 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhc--------------chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC
Confidence            699999999999975 48899999985421              122344577999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..+++|||+++++|.+++..  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        67 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~  141 (262)
T cd05572          67 YIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK  141 (262)
T ss_pred             ccEEEEecCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence            99999999999999999974  34589999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccc
Q 001867          850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVL  929 (1002)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1002)
                      ......   ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||......  ..+.......... ....
T Consensus       142 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-~~~~  215 (262)
T cd05572         142 KLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNG-KLEF  215 (262)
T ss_pred             ccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCC-CCCC
Confidence            765442   122346888999999998888999999999999999999999999755321  1122211111000 0000


Q ss_pred             cccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          930 DPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       930 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                      .   ...    ...+.+++.+||+.+|++||+     ++|+++
T Consensus       216 ~---~~~----~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         216 P---NYI----DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             C---ccc----CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            0   111    235889999999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.3e-32  Score=300.16  Aligned_cols=248  Identities=25%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      -|++.+.||+|+||.||+|.. .+++.||+|.+...                ........+.+|+.++++++||||++++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~   68 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----------------EAEDEIEDIQQEITVLSQCDSPYVTKYY   68 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----------------cchHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            366778999999999999986 46889999987321                1123456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++..++..++||||+++++|.+++..   ..+++..+..++.|++.|++|||++   +++|+||+|+||+++.++.++|
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l  142 (277)
T cd06641          69 GSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKL  142 (277)
T ss_pred             EEEEeCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEE
Confidence            999999999999999999999999863   4589999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||++........  ......|+..|+|||...+..++.++||||+||++|+|++|..||..... ......+    ..
T Consensus       143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~----~~  215 (277)
T cd06641         143 ADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKVLFLI----PK  215 (277)
T ss_pred             eecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHHHHHH----hc
Confidence            99999876644321  12234678899999999888899999999999999999999999864321 1111111    11


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ...     +....   .....+.+++.+||+.+|++||+++++++.
T Consensus       216 ~~~-----~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 NNP-----PTLEG---NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCC-----CCCCc---ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111     11111   112347789999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.1e-33  Score=307.85  Aligned_cols=263  Identities=24%  Similarity=0.300  Sum_probs=196.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++.....               .......+.+|+.++++++|+||++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~i~~   70 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE---------------RDGIPISSLREITLLLNLRHPNIVE   70 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC---------------CCCCcchhhHHHHHHHhCCCCCCcc
Confidence            467888999999999999999964 589999998843211               1112234567999999999999999


Q ss_pred             eeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          761 LWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       761 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++...  +..++||||++ ++|.+++.... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  145 (309)
T cd07845          71 LKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKG  145 (309)
T ss_pred             eEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence            99999755  56899999995 58988887533 5689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||++........  ......++..|+|||++.+ ..++.++||||+||++|||++|+.||........+.... 
T Consensus       146 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~-  222 (309)
T cd07845         146 CLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII-  222 (309)
T ss_pred             CEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence            999999999987654321  1223345788999998865 457899999999999999999999997553332222221 


Q ss_pred             HHhhccC--c----------cc-cccccc----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKG--V----------DH-VLDPKL----DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~--~----------~~-~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .......  .          .. ......    .........+..+++.+|++.||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             HhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            1110000  0          00 000000    0000111335678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.8e-33  Score=306.03  Aligned_cols=264  Identities=22%  Similarity=0.237  Sum_probs=195.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  760 (1002)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....               .......+.+|+.+++++. ||||++
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~~~~~i~~   65 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD---------------EEGIPPTALREISLLQMLSESIYIVR   65 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc---------------ccCCchHHHHHHHHHHHccCCCCccc
Confidence            35788899999999999999964 689999998743211               1223356788999999995 699999


Q ss_pred             eeeEEecCCe-----eeEEEeccCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          761 LWCCCTTRDC-----KLLVYEYMPNGSLGDLLHSCK---GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       761 l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      +++++...+.     .|+||||+++ +|.+++....   ...+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus        66 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~ni  141 (295)
T cd07837          66 LLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNL  141 (295)
T ss_pred             eeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHE
Confidence            9999987665     8999999974 8988886533   24689999999999999999999999   999999999999


Q ss_pred             EECC-CCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          833 LLDG-DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       833 ll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      +++. ++.+||+|||++........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus       142 l~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~  219 (295)
T cd07837         142 LVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ  219 (295)
T ss_pred             EEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9998 88999999999986543221  1123356889999998765 457899999999999999999999997654333


Q ss_pred             hHHHHHHHHhhcc--Ccccc------------ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          911 DLVKWVCSTLDQK--GVDHV------------LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       911 ~~~~~~~~~~~~~--~~~~~------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+.........  .....            .........+....++.+++.+|+++||++||+++|++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         220 QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            3322222110000  00000            000000001112345788999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2e-32  Score=295.33  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=204.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|...+.||+|++|.||+|... +++.|++|++....               ......+.+.+|++++++++||||++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG---------------DSEEELEALEREIRILSSLQHPNIVRYY   65 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHHHHHHHHcCCCCEeeEE
Confidence            3667789999999999999975 68899999984321               1134567899999999999999999999


Q ss_pred             eEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          763 CCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       763 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +.+...  +..+++|||+++++|.+++...  ..+++..++.++.|++.|++|||+.   +++||||+|+||+++.++.+
T Consensus        66 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~  140 (260)
T cd06606          66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVV  140 (260)
T ss_pred             EEEecCCCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCE
Confidence            999988  8899999999999999999853  3799999999999999999999998   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +|+|||.+................++..|+|||...+...+.++||||+|+++|+|++|+.||........   ......
T Consensus       141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~  217 (260)
T cd06606         141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIG  217 (260)
T ss_pred             EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhcc
Confidence            99999999877655331122345688899999999888899999999999999999999999976542111   111111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......     ..   +......+.+++.+|++.+|++||++.+++.
T Consensus       218 ~~~~~~-----~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 SSGEPP-----EI---PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccCCCc-----CC---CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            101111     11   1111345888999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2e-32  Score=294.07  Aligned_cols=249  Identities=29%  Similarity=0.418  Sum_probs=201.7

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..+.||+|+||.||+|... +++.+++|++...                 .......+.+|++++++++||++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----------------~~~~~~~~~~e~~~l~~l~~~~i~~~~   63 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE-----------------SKEKKEKIINEIQILKKCKHPNIVKYY   63 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEeccc-----------------chhHHHHHHHHHHHHHhCCCCCEeEEE
Confidence            4677889999999999999975 6889999998432                 113467789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++......++++||+++++|.+++.... ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|
T Consensus        64 ~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l  139 (253)
T cd05122          64 GSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKL  139 (253)
T ss_pred             EEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEE
Confidence            99999999999999999999999987532 5789999999999999999999998   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||.+........   .....++..|+|||++.+..++.++||||||+++|+|++|+.||........... .   .. 
T Consensus       140 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~---~~-  211 (253)
T cd05122         140 IDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-I---AT-  211 (253)
T ss_pred             eecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-H---Hh-
Confidence            99999987655432   2345688899999999888899999999999999999999999865422111111 1   11 


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ........+   ..   ....+.+++.+||+.||++|||+.|+++
T Consensus       212 ~~~~~~~~~---~~---~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         212 NGPPGLRNP---EK---WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCCCCcCcc---cc---cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111111   00   0234788999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.2e-33  Score=304.15  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=193.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKL  761 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l  761 (1002)
                      +|+..+.||+|+||.||++... +++.||+|.+....                .......+.+|+.++.++. ||||+++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~e~~~l~~~~~~~~iv~~   68 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV----------------DEKEQKRLLMDLDVVMRSSDCPYIVKF   68 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc----------------ChHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            4455678999999999999964 58999999884321                1234567889999999996 9999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhh---hhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLL---HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      ++++..++..+++|||++ +++.++.   .......+++..+.+++.|++.||+|||+.  .+|+||||||+||+++.++
T Consensus        69 ~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~  145 (288)
T cd06616          69 YGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNG  145 (288)
T ss_pred             eeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCC
Confidence            999999999999999985 5665543   222346799999999999999999999973  2899999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .+||+|||+++.......   .....|+..|+|||++.+.   .++.++||||+||++|||++|+.||....   .....
T Consensus       146 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~  219 (288)
T cd06616         146 NIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQ  219 (288)
T ss_pred             cEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHH
Confidence            999999999976543321   1233588899999998766   68899999999999999999999996442   11111


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ........ .... ..   ........++.+++.+||+.+|++|||+++|++.
T Consensus       220 ~~~~~~~~-~~~~-~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         220 LTQVVKGD-PPIL-SN---SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HhhhcCCC-CCcC-CC---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111111 0011 00   1101123358899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-33  Score=308.80  Aligned_cols=266  Identities=20%  Similarity=0.255  Sum_probs=196.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +|++.+.||+|+||.||+|..+   +++.||+|.+.....              ......+.+.+|+.++++++||||++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~   66 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--------------QYTGISQSACREIALLRELKHENVVS   66 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--------------cccCccHHHHHHHHHHHhcCCCCccc
Confidence            3677889999999999999974   478999999854210              11223456788999999999999999


Q ss_pred             eeeEEecC--CeeeEEEeccCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          761 LWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCK---GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       761 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      +++++.+.  +..++||||++ +++.+++....   ...+++..++.++.|++.|++|||++   +|+||||||+||+++
T Consensus        67 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~  142 (316)
T cd07842          67 LVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVM  142 (316)
T ss_pred             eEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEc
Confidence            99999988  88999999996 57777665322   23689999999999999999999999   999999999999999


Q ss_pred             C----CCCeEEccccCcccccCCCC-CcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          836 G----DFGARVADFGVAKVVDASGK-PKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       836 ~----~~~~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      .    ++.+||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus       143 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  222 (316)
T cd07842         143 GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK  222 (316)
T ss_pred             CCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence            9    89999999999987654332 1222344678899999987654 5789999999999999999999999754332


Q ss_pred             h---------hHHHHHHHHhh-----------ccCccc----ccccccc-CCCH-------HHHHHHHHHHHHcCCCCCC
Q 001867          910 K---------DLVKWVCSTLD-----------QKGVDH----VLDPKLD-CCFK-------EEICKVLNIGLLCTSPLPI  957 (1002)
Q Consensus       910 ~---------~~~~~~~~~~~-----------~~~~~~----~~~~~~~-~~~~-------~~~~~l~~l~~~cl~~dP~  957 (1002)
                      .         ...+.+.....           ......    ....... ....       ....++.+++.+|++.||+
T Consensus       223 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  302 (316)
T cd07842         223 IKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPT  302 (316)
T ss_pred             ccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcc
Confidence            1         01111100000           000000    0000000 0000       1223588999999999999


Q ss_pred             CCCCHHHHHH
Q 001867          958 NRPAMRRVVK  967 (1002)
Q Consensus       958 ~Rps~~evl~  967 (1002)
                      +|||+.|+++
T Consensus       303 ~Rps~~eil~  312 (316)
T cd07842         303 KRITAEEALE  312 (316)
T ss_pred             cCcCHHHHhc
Confidence            9999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4e-33  Score=312.63  Aligned_cols=265  Identities=23%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|.. .+++.||+|++....               ........+.+|+.++++++||||+
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~iv   67 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------------DVPTLAKRTLRELKILRHFKHDNII   67 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc---------------ccccchHHHHHHHHHHHhcCCCCcc
Confidence            346788889999999999999996 468999999884321               1122345677899999999999999


Q ss_pred             eeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          760 KLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       760 ~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      ++++++..    ....++||||+. ++|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++
T Consensus        68 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~  141 (334)
T cd07855          68 AIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVN  141 (334)
T ss_pred             CHHHhccccCCCCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc
Confidence            99998863    356899999995 689998874  45599999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCc--ccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          836 GDFGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      .++.+||+|||++..........  ......|+..|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus       142 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~  221 (334)
T cd07855         142 EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL  221 (334)
T ss_pred             CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH
Confidence            99999999999997654432211  1224468889999998765 46889999999999999999999999654322211


Q ss_pred             HHHHHHHhhcc-----------Ccccc---cccc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQK-----------GVDHV---LDPK----LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~-----------~~~~~---~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ..+.......           .....   ....    .....+....++.+++.+|++.+|++||++++++.
T Consensus       222 -~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         222 -KLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             -HHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             1111110000           00000   0000    00011122346889999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-33  Score=313.16  Aligned_cols=271  Identities=20%  Similarity=0.255  Sum_probs=202.2

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++.++|.+.+.||+|+||+||+|.. .+++.||||.+....               ........+.+|+.+++.++||||
T Consensus         2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~ni   66 (337)
T cd07858           2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF---------------DNRIDAKRTLREIKLLRHLDHENV   66 (337)
T ss_pred             ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc---------------cccchhHHHHHHHHHHHhcCCCCc
Confidence            4456788899999999999999996 468999999884321               122234567789999999999999


Q ss_pred             eeeeeEEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          759 VKLWCCCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       759 v~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      +++++++...     ...|+||||+. ++|.+++..  .+.+++..+..++.|++.||+|||++   +++||||||+||+
T Consensus        67 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil  140 (337)
T cd07858          67 IAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLL  140 (337)
T ss_pred             cchHHheecccccccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEE
Confidence            9999988654     34799999994 789988874  45699999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      ++.++.+||+|||+++......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........
T Consensus       141 ~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  218 (337)
T cd07858         141 LNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL  218 (337)
T ss_pred             EcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence            9999999999999998764432  12234467889999998765 46889999999999999999999999654322111


Q ss_pred             HHHHHHHh--hccC---------------ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHHhh
Q 001867          913 VKWVCSTL--DQKG---------------VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL--LQEVG  973 (1002)
Q Consensus       913 ~~~~~~~~--~~~~---------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~~  973 (1002)
                      ........  ....               .....++......+....++.+++.+||+.+|++|||++|+++.  ++.+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         219 KLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            11110000  0000               00000011111111223457899999999999999999999976  66653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.9e-33  Score=311.29  Aligned_cols=272  Identities=23%  Similarity=0.329  Sum_probs=202.1

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCc
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKN  757 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n  757 (1002)
                      .+.++|++.+.||+|+||.||+|... +++.||+|++....               ........+.+|+.+++++ +|||
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~h~n   68 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF---------------RNATDAQRTFREIMFLQELGDHPN   68 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc---------------CcchhhhhhhHHHHHHHHhcCCCC
Confidence            34567888899999999999999965 58899999884321               1222345677899999999 9999


Q ss_pred             eeeeeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++...  ...|+||||++ ++|..++..   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        69 i~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~  141 (337)
T cd07852          69 IVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLN  141 (337)
T ss_pred             ccceeeeeccCCCceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc
Confidence            99999998653  36799999996 699988864   2689999999999999999999998   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCC---cccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          836 GDFGARVADFGVAKVVDASGKP---KSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      .++.+||+|||++.........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus       142 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~  221 (337)
T cd07852         142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ  221 (337)
T ss_pred             CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            9999999999999866543321   22234568899999998754 5578899999999999999999999965433322


Q ss_pred             HHHHHHHHh--------------hccCcccccc---ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHHh
Q 001867          912 LVKWVCSTL--------------DQKGVDHVLD---PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL--LQEV  972 (1002)
Q Consensus       912 ~~~~~~~~~--------------~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~  972 (1002)
                      ..+......              ..........   .......+....++.+++.+||+.||++|||+.++++.  ++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         222 LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            221111100              0000000000   00000011123358899999999999999999999965  5555


Q ss_pred             h
Q 001867          973 G  973 (1002)
Q Consensus       973 ~  973 (1002)
                      .
T Consensus       302 ~  302 (337)
T cd07852         302 H  302 (337)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-32  Score=306.56  Aligned_cols=262  Identities=23%  Similarity=0.228  Sum_probs=193.5

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      ++.+|.|+++.||++.. +++.||||++...               .......+.+.+|++++++++||||+++++++..
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~---------------~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~   70 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLD---------------SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV   70 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEecc---------------ccchhHHHHHHHHHHHHHhcCCcchhhhhheeec
Confidence            34455555555555444 5899999998432               1123456779999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      .+..+++|||+++|+|.+++.......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|++|||.
T Consensus        71 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~  147 (314)
T cd08216          71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRY  147 (314)
T ss_pred             CCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCcc
Confidence            99999999999999999999875556789999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCC-----cccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          848 AKVVDASGKP-----KSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       848 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +.........     .......++..|+|||++.+  ..++.++||||+||++|||++|..||.................
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~  227 (314)
T cd08216         148 SVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV  227 (314)
T ss_pred             ceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence            8765432221     11223457788999999875  3578999999999999999999999975433222222111100


Q ss_pred             hc-----------cCccc----cccccc-----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQ-----------KGVDH----VLDPKL-----DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~-----------~~~~~----~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ..           .....    ..++..     .........++.+++.+||+.||++|||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            00           00000    000000     11112223467889999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-32  Score=305.36  Aligned_cols=266  Identities=21%  Similarity=0.266  Sum_probs=196.1

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .+..++|++.+.||+|+||.||+|... +++.||||++.....               .......+.+|+.++++++|||
T Consensus         8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~   72 (310)
T cd07865           8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---------------KEGFPITALREIKILQLLKHEN   72 (310)
T ss_pred             cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC---------------cCCchhHHHHHHHHHHhCCCCC
Confidence            445678999999999999999999964 688999998843211               1112334678999999999999


Q ss_pred             eeeeeeEEecCC--------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          758 IVKLWCCCTTRD--------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       758 iv~l~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                      |+++++++...+        ..++||||++ ++|.+++.. ....+++.+++.++.|++.||+|||++   +++||||||
T Consensus        73 iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p  147 (310)
T cd07865          73 VVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKA  147 (310)
T ss_pred             ccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence            999999987654        3499999995 588888764 334689999999999999999999999   999999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCC--cccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKP--KSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      +||+++.++.+||+|||++.........  .......++..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus       148 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             HHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999866443221  1223345788999999876643 688999999999999999999998754


Q ss_pred             CCchhHHHHHHHHhh---ccCccc------------------cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 001867          907 FGEKDLVKWVCSTLD---QKGVDH------------------VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV  965 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~---~~~~~~------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev  965 (1002)
                      .... ....+.....   ......                  .+...+...  -....+.+++.+||+.||++|||++|+
T Consensus       228 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~dli~~~l~~~P~~R~t~~e~  304 (310)
T cd07865         228 TEQH-QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY--VKDPHALDLIDKLLVLDPAKRIDADTA  304 (310)
T ss_pred             CHHH-HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc--cCCHHHHHHHHHHhcCChhhccCHHHH
Confidence            3221 1111111110   000000                  000000000  011246789999999999999999998


Q ss_pred             HH
Q 001867          966 VK  967 (1002)
Q Consensus       966 l~  967 (1002)
                      ++
T Consensus       305 l~  306 (310)
T cd07865         305 LN  306 (310)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=297.00  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=197.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+.....            ..........+.+|++++++++||||+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~------------~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   69 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD------------SQETSKEVNALECEIQLLKNLRHDRIVQY   69 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcc------------cchhhHHHHHHHHHHHHHHHcCCCCcceE
Confidence            4678899999999999999996 4589999998732210            01123345678999999999999999999


Q ss_pred             eeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++.+.  +..+++|||+++++|.+++..  .+.+++..+.+++.|++.|++|||+.   +++||||||+||+++.++.
T Consensus        70 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~  144 (264)
T cd06653          70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGN  144 (264)
T ss_pred             EEEEEcCCCCEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence            9998764  467899999999999999874  34588999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCC-CcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGK-PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      ++|+|||+++....... ........|+..|+|||++.+..++.++|||||||++|++++|+.||...........    
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----  220 (264)
T cd06653         145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK----  220 (264)
T ss_pred             EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH----
Confidence            99999999986543211 1112234688999999999988899999999999999999999999965422222211    


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .... ...    +..+   ......+.+++.+||+ +|..||++.+++.
T Consensus       221 ~~~~-~~~----~~~p---~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQ-PTK----PMLP---DGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcC-CCC----CCCC---cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111 111    1111   1122347788899998 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-32  Score=304.52  Aligned_cols=252  Identities=27%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..+.||+|+||.||+|+. .++..||+|++....              .........+.+|++++++++|||+++++
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   91 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--------------KQSNEKWQDIIKEVKFLQRIKHPNSIEYK   91 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC--------------CCchHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            366678999999999999996 468899999874321              11223345788999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+++..++||||++ |++.+++... ...+++..+..++.|++.|+.|||++   +|+||||+|+||+++.++.+||
T Consensus        92 ~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl  166 (317)
T cd06635          92 GCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKL  166 (317)
T ss_pred             EEEeeCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEE
Confidence            99999999999999996 5888877643 45689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +|||++......      ....|++.|+|||++.   ++.++.++|||||||++|||++|+.||...........+... 
T Consensus       167 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-  239 (317)
T cd06635         167 ADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-  239 (317)
T ss_pred             ecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-
Confidence            999998754332      2346888999999874   456889999999999999999999998654322222222111 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                         .. ..    ....   .....+.+++.+||+.+|++||++.++++..-..
T Consensus       240 ---~~-~~----~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         240 ---ES-PT----LQSN---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ---cC-CC----CCCc---cccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence               00 00    0011   1123477899999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-32  Score=302.26  Aligned_cols=262  Identities=23%  Similarity=0.296  Sum_probs=198.6

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|++|.||+|+.. +|+.||+|++....                .....+.+.+|++++++++||||++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~~~   64 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA----------------EEGTPSTAIREISLMKELKHENIVRLH   64 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc----------------cccchHHHHHHHHHHHhhcCCCEeeee
Confidence            4778899999999999999975 58899999884321                112235567899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCK-GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++...+..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++
T Consensus        65 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~  140 (284)
T cd07836          65 DVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELK  140 (284)
T ss_pred             eeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEE
Confidence            99999999999999997 58888886533 35689999999999999999999998   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ++|||++........  ......++..|+|||++.+. .++.++||||+||++|+|++|+.||......+..........
T Consensus       141 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07836         141 LADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG  218 (284)
T ss_pred             EeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            999999976543221  22234578899999987654 568899999999999999999999976544333222221100


Q ss_pred             ----------h-ccCccc----cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 ----------D-QKGVDH----VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ----------~-~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                                . ......    ..+.......+.....+.+++.+|++.||.+||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      0 000000    0000000111122345778999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-32  Score=301.32  Aligned_cols=257  Identities=20%  Similarity=0.218  Sum_probs=191.9

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLW  762 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  762 (1002)
                      |++.+.||+|+||.||+|.. .+++.||+|++.....               . .......+|+.++.++. |||+++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~---------------~-~~~~~~~~e~~~l~~l~~h~~i~~~~   64 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK---------------S-LEQVNNLREIQALRRLSPHPNILRLI   64 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC---------------C-chhhhHHHHHHHHhhcCCCCCccceE
Confidence            56678999999999999996 4688999998743211               1 11223457888999885 99999999


Q ss_pred             eEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          763 CCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       763 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++.+.  +..++||||++ |++.+++... ...+++..+..++.|++.||+|||+.   +++||||+|+||+++. +.+
T Consensus        65 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~  138 (282)
T cd07831          65 EVLFDRKTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DIL  138 (282)
T ss_pred             EEEecCCCCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCe
Confidence            999987  88999999996 6888887653 35789999999999999999999999   9999999999999999 999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+++.......   .....++..|+|||+.. +..++.++||||+||++|||++|..||......+. .......
T Consensus       139 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-~~~~~~~  214 (282)
T cd07831         139 KLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-IAKIHDV  214 (282)
T ss_pred             EEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-HHHHHHH
Confidence            9999999987644322   12345788999999764 45578899999999999999999999965432221 1221111


Q ss_pred             hhc-----------cCcccccccc-----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQ-----------KGVDHVLDPK-----LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~-----------~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...           ........+.     .....+.....+.+++.+||+++|++||+++++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            100           0000000000     00011122356889999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=302.70  Aligned_cols=261  Identities=26%  Similarity=0.318  Sum_probs=198.7

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |++.+.||+|+||.||+|... +++.+|+|++....               ........+.+|++++++++|||++++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   65 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---------------EKEGFPITAIREIKLLQKLRHPNIVRLKE   65 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---------------ccccchHHHHHHHHHHHhccCCCeeehee
Confidence            567789999999999999975 48899999985432               12233456889999999999999999999


Q ss_pred             EEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          764 CCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       764 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++...  +..++||||++ ++|.+++... ...+++..++.++.|++.|++|||+.   +++|+||+|+||++++++.+|
T Consensus        66 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~  140 (287)
T cd07840          66 IVTSKGKGSIYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLK  140 (287)
T ss_pred             eEecCCCCcEEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEE
Confidence            99988  88999999996 5898888753 25789999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............. ...
T Consensus       141 l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~-~~~  218 (287)
T cd07840         141 LADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF-ELC  218 (287)
T ss_pred             EccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHh
Confidence            999999987755432 12233456788999997664 457899999999999999999999997654332222211 111


Q ss_pred             hccCcc------c-----------cccccccCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVD------H-----------VLDPKLDCCFKE-EICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~------~-----------~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......      .           ............ ...++.+++.+||+.+|++||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000000      0           000000000111 1346889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-32  Score=306.40  Aligned_cols=267  Identities=24%  Similarity=0.299  Sum_probs=196.4

Q ss_pred             Ceeeec--CCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          689 NVIGSG--SSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       689 ~~LG~G--~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      ..||+|  +||+||+|.. .+|+.||+|++....               ......+.+.+|+.+++.++||||+++++++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~   68 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN---------------CTEEHLKALQNEVVLSHFFRHPNIMTSWTVF   68 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc---------------CCHHHHHHHHHHHHHHHhCCCCCcceEeeeE
Confidence            346666  9999999996 478999999874321               1223457789999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      ..++..++||||++++++.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||
T Consensus        69 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~  145 (328)
T cd08226          69 TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGL  145 (328)
T ss_pred             ecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEech
Confidence            9999999999999999999999875556689999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccccCCCCCcc-----cccccccccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          846 GVAKVVDASGKPKS-----MSVIAGSCGYIAPEYAYTL--RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       846 Gl~~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      +.+...........     .....++..|+|||++.+.  .++.++||||+||++|||++|+.||...............
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~  225 (328)
T cd08226         146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG  225 (328)
T ss_pred             HHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcC
Confidence            86543322111110     1112345679999998763  4789999999999999999999999765333222221110


Q ss_pred             Hhhc--------------------------------cCcccccccccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 001867          919 TLDQ--------------------------------KGVDHVLDPKLD-CCFKEEICKVLNIGLLCTSPLPINRPAMRRV  965 (1002)
Q Consensus       919 ~~~~--------------------------------~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev  965 (1002)
                      ....                                .....+.+.... .........+.+++.+||+.||++|||++|+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~  305 (328)
T cd08226         226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL  305 (328)
T ss_pred             CCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH
Confidence            0000                                000000011111 1112334568899999999999999999999


Q ss_pred             HH--HHHHhh
Q 001867          966 VK--LLQEVG  973 (1002)
Q Consensus       966 l~--~L~~~~  973 (1002)
                      ++  +++.+.
T Consensus       306 l~~~~~~~~~  315 (328)
T cd08226         306 LSHAFFKQVK  315 (328)
T ss_pred             hhCHHHHHHH
Confidence            73  444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.8e-32  Score=295.47  Aligned_cols=241  Identities=23%  Similarity=0.291  Sum_probs=185.4

Q ss_pred             cCCCcCCee--eecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCce
Q 001867          683 DGLDEDNVI--GSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~L--G~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  758 (1002)
                      ++|++.+.+  |+|+||.||++.. .+++.+|+|.+.....                    ..  .|+.+...+ +||||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--------------------~~--~e~~~~~~~~~h~~i   71 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--------------------NA--IEPMVHQLMKDNPNF   71 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--------------------ch--hhHHHHHHhhcCCCE
Confidence            455665555  9999999999995 4688899998743210                    00  122222222 69999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++...+..|+||||+++++|.+++...  ..+++..+..++.|+++|++|||+.   +++||||||+||+++.++
T Consensus        72 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             EEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence            99999999999999999999999999999753  3799999999999999999999999   999999999999999888


Q ss_pred             -CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh-HHHHH
Q 001867          839 -GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD-LVKWV  916 (1002)
Q Consensus       839 -~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~-~~~~~  916 (1002)
                       .++|+|||++.......      ...|+..|+|||++.+..++.++||||+|+++|||++|+.||........ ...+.
T Consensus       147 ~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~  220 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL  220 (267)
T ss_pred             CeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence             99999999987654321      23588999999999998999999999999999999999999974433221 11111


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-MRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~  967 (1002)
                      .. . ....     +...    .....+.+++.+|++.+|++||+ ++++++
T Consensus       221 ~~-~-~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        221 KR-Q-QKKL-----PFIK----NVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             Hh-h-cccC-----Cccc----ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11 1 1000     1111    12234788899999999999996 587763

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.2e-32  Score=297.00  Aligned_cols=244  Identities=21%  Similarity=0.219  Sum_probs=185.5

Q ss_pred             eeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHH---HHHhcCCCCceeeeeeEE
Q 001867          690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV---ETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~  765 (1002)
                      .||+|+||.||+|.. .+++.||+|.+.+...              ........+..|.   ..++...||+|+++++++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~   66 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--------------KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF   66 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeecccc--------------ccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee
Confidence            489999999999986 4588999998854211              1111122233333   344455799999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      ...+..++||||+++|+|.+++..  .+.+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+||
T Consensus        67 ~~~~~~~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~df  141 (278)
T cd05606          67 HTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  141 (278)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccC
Confidence            999999999999999999998873  45799999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       846 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      |++........    ....|+..|+|||++.++ .++.++||||+||++|||++|+.||.......... .. .....  
T Consensus       142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~-~~~~~--  213 (278)
T cd05606         142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID-RMTLT--  213 (278)
T ss_pred             cCccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HH-HHhhc--
Confidence            99876543221    234689999999998754 68899999999999999999999997543222111 11 00000  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                          ..+......   ..++.+++.+|++.+|++||     +++++++
T Consensus       214 ----~~~~~~~~~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 ----MAVELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----cCCCCCCcC---CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                011111111   23577889999999999999     8999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-33  Score=285.04  Aligned_cols=260  Identities=18%  Similarity=0.305  Sum_probs=215.5

Q ss_pred             CCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++....+-+|.||.||+|.|.      +.+.|.||.++.                ...+.+...+..|--.+..+.|||
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----------------~AS~iQv~~~L~es~lly~~sH~n  348 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----------------HASQIQVNLLLQESMLLYGASHPN  348 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----------------cccHHHHHHHHHHHHHHhcCcCCC
Confidence            4666778899999999999764      345567776533                234566778889999999999999


Q ss_pred             eeeeeeEEec-CCeeeEEEeccCCCChhhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          758 IVKLWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKG------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       758 iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      +..+.+.+.+ ....++++.++.-|+|+.|+..+++      +.++..+...++.|++.|++|||.+   +|||.||.++
T Consensus       349 ll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaR  425 (563)
T KOG1024|consen  349 LLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAAR  425 (563)
T ss_pred             ccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhh
Confidence            9999998865 4667899999988999999996654      5678889999999999999999999   9999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGE  909 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~  909 (1002)
                      |.++++.-++||+|=.+++.+.+.++..-.........|||||.+....|+.++|||||||++|||+| |+.|+.. .+.
T Consensus       426 NCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDP  504 (563)
T KOG1024|consen  426 NCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDP  504 (563)
T ss_pred             cceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCH
Confidence            99999999999999999999998888776666667889999999999999999999999999999999 8899853 344


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      .+...+++.+.+....        ..++.    +++.+|..||...|++||++++++..|.++...
T Consensus       505 fEm~~ylkdGyRlaQP--------~NCPD----eLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  505 FEMEHYLKDGYRLAQP--------FNCPD----ELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             HHHHHHHhccceecCC--------CCCcH----HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            5555555544433221        23333    489999999999999999999999999998653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=283.09  Aligned_cols=254  Identities=25%  Similarity=0.332  Sum_probs=197.3

Q ss_pred             CcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeee
Q 001867          686 DEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWC  763 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  763 (1002)
                      +....||.|+||+|+|-.. +.|+..|||++...                .....+.++..|.+...+- +.||||++||
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~----------------n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN----------------NIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec----------------cchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            3356799999999999885 56999999999432                1345677888888877665 5899999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhh---hcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLH---SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +...++..|+.||.| +.+++.+.+   .-+...+++.-+-+|....+.||.||.+.  ..|||||+||+|||++..|.+
T Consensus       131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCE
Confidence            999999999999999 678777543   33457799999999999999999999987  399999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |+||||++-.+..+-   ..+...|...|||||.+..  ..|+-++||||+|+++||+.||..|+....+.   .+.+++
T Consensus       208 KLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---feql~~  281 (361)
T KOG1006|consen  208 KLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---FEQLCQ  281 (361)
T ss_pred             eeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---HHHHHH
Confidence            999999998765432   2345679999999998763  45899999999999999999999999765432   222332


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ...........+..-.    +....+.+++..|+.+|...||.+.++.++
T Consensus       282 Vv~gdpp~l~~~~~~~----~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  282 VVIGDPPILLFDKECV----HYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHcCCCCeecCccccc----ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2222221111111111    122357888999999999999999998753

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.4e-32  Score=292.54  Aligned_cols=252  Identities=27%  Similarity=0.367  Sum_probs=204.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... ++..||+|++...               ..+......+.+|++++++++|||+++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---------------~~~~~~~~~~~~e~~~l~~l~~~~~~~~~   65 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS---------------NMSEKEREDALNEVKILKKLNHPNIIKYY   65 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecc---------------cCChHHHHHHHHHHHHHHhcCCCChhheE
Confidence            4677889999999999999964 6889999998432               11234566789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +.+...+..++|+||+++++|.+++....  ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+
T Consensus        66 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~  142 (258)
T cd08215          66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLV  142 (258)
T ss_pred             EEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcE
Confidence            99999999999999999999999998643  47799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +|+|||.+.......  .......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... ..   ......
T Consensus       143 ~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~---~~~~~~  216 (258)
T cd08215         143 KLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-LE---LALKIL  216 (258)
T ss_pred             EECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-HH---HHHHHh
Confidence            999999998765543  122334688899999999888899999999999999999999999865421 11   111111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      . ...    .+.....    ...+.+++.+||+.+|++||++.|+++.
T Consensus       217 ~-~~~----~~~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         217 K-GQY----PPIPSQY----SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             c-CCC----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1 111    1111112    2347889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-32  Score=300.75  Aligned_cols=244  Identities=26%  Similarity=0.344  Sum_probs=195.2

Q ss_pred             CCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          688 DNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      ..+||+|+||.||+|.. .+++.||+|++...                 .....+.+.+|+.++++++|+||+++++++.
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   87 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYQHENVVEMYNSYL   87 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----------------chhHHHHHHHHHHHHHhcCCcchhheeeEEE
Confidence            35799999999999986 46899999987321                 2234567899999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      ..+..++||||+++++|.+++..   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg  161 (292)
T cd06657          88 VGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  161 (292)
T ss_pred             eCCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccc
Confidence            99999999999999999998753   3589999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      ++.......  .......|+..|+|||...+..++.++||||+|+++|+|++|..||...... ...........     
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~~~~~~-----  233 (292)
T cd06657         162 FCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNLP-----  233 (292)
T ss_pred             cceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhhCC-----
Confidence            987654322  1223456889999999998888999999999999999999999998654222 11121111110     


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       927 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..+ +.....+    ..+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~-~~~~~~~----~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         234 PKL-KNLHKVS----PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccc-CCcccCC----HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            000 0111122    24778899999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-32  Score=301.53  Aligned_cols=259  Identities=24%  Similarity=0.273  Sum_probs=200.5

Q ss_pred             CCCcCCeeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCce
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNI  758 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  758 (1002)
                      +|++.+.||+|+||.||+|..    .+++.||||.+.+..             ........+.+..|+.+++++ +||+|
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~-------------~~~~~~~~~~~~~E~~~l~~~~~~~~i   67 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKAT-------------IVQKAKTAEHTRTERQVLEAVRRCPFL   67 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHH-------------HHhhhhHHHHHHHHHHHHHhccCCcch
Confidence            366778999999999999885    356889999885321             011223456788999999999 59999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++.+..++..++||||+++|+|.+++..  ...+++..+..++.|+++||+|||+.   +++||||+|+||+++.++
T Consensus        68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~  142 (288)
T cd05583          68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEG  142 (288)
T ss_pred             hhhheeeecCCEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence            9999999999999999999999999999874  35689999999999999999999998   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      .++++|||+++........ ......|+..|+|||...+..  .+.++||||+|+++|||++|..||.............
T Consensus       143 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~  221 (288)
T cd05583         143 HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS  221 (288)
T ss_pred             CEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH
Confidence            9999999998876543222 122345889999999987655  7889999999999999999999996432222222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      .......       +.....   ....+.+++.+||+.||++|||+.++.+.++.
T Consensus       222 ~~~~~~~-------~~~~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         222 RRILKSK-------PPFPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHccC-------CCCCcc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            1111110       111111   11247788999999999999999988877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=310.15  Aligned_cols=267  Identities=28%  Similarity=0.374  Sum_probs=202.5

Q ss_pred             CCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |...+.||+|+||.||+++ .+.|+.||||.+.+..                .....+...+|++++++++|||||++.+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----------------~~r~~e~~~~EieilkKLnh~NIVk~f~   78 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----------------SLRPRERWCREIEILKKLNHPNIVKLFD   78 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc----------------ccchHHHHHHHHHHHHHcCchhhhhhcc
Confidence            4556789999999999999 5679999999985431                3445778899999999999999999988


Q ss_pred             EEecC------CeeeEEEeccCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC-
Q 001867          764 CCTTR------DCKLLVYEYMPNGSLGDLLHSCK-GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-  835 (1002)
Q Consensus       764 ~~~~~------~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~-  835 (1002)
                      .=.+.      +...+|||||.||+|...+.+-. ...+++.+.+.+..+++.||.|||++   +||||||||.||++- 
T Consensus        79 iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~  155 (732)
T KOG4250|consen   79 IEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQI  155 (732)
T ss_pred             cCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEee
Confidence            77654      35689999999999999998632 36799999999999999999999999   999999999999983 


Q ss_pred             -CCCC--eEEccccCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          836 -GDFG--ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       836 -~~~~--~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                       ++|+  -||+|||.|+-++...   .+...+||..|.+||+.. ++.|+..+|.|||||++||++||..||.+......
T Consensus       156 Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~  232 (732)
T KOG4250|consen  156 GEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN  232 (732)
T ss_pred             cCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence             4444  6999999999887664   455678999999999988 58899999999999999999999999987655433


Q ss_pred             HHHHHHHHhhcc--Cccccc-------------cccccCCCHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHHhh
Q 001867          912 LVKWVCSTLDQK--GVDHVL-------------DPKLDCCFKEEICKVLNIGLLCTSPLPINRP--AMRRVVKLLQEVG  973 (1002)
Q Consensus       912 ~~~~~~~~~~~~--~~~~~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp--s~~evl~~L~~~~  973 (1002)
                      ..+.+......+  .+....             -|......+.....+......++..+|++|.  .+.+....+.++.
T Consensus       233 ~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  233 NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             cchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            222222211111  110000             1111122233334455666667778888888  6666666665554

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.4e-33  Score=280.46  Aligned_cols=207  Identities=26%  Similarity=0.372  Sum_probs=171.8

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEcC-----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLSN-----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR  754 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  754 (1002)
                      +...+|+..+.||+|.||.||+|.-++     ...+|+|+++...+               ........-+|+..++.++
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd---------------~tGiS~SAcREiaL~REl~   85 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD---------------GTGISMSACREIALLRELK   85 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC---------------CCCcCHHHHHHHHHHHHhc
Confidence            445678889999999999999996432     23689998854311               1122345678999999999


Q ss_pred             CCceeeeeeEEec-CCeeeEEEeccCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          755 HKNIVKLWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCK---GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       755 h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      ||||+.+..+|-. +..+++++||.+. +|.+.++.++   .+.++...+..++.||+.|+.|||++   -|+||||||.
T Consensus        86 h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPa  161 (438)
T KOG0666|consen   86 HPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPA  161 (438)
T ss_pred             CCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcc
Confidence            9999999999977 7889999999975 8888877543   36789999999999999999999999   9999999999


Q ss_pred             cEEECCC----CCeEEccccCcccccCCCCCc-ccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 001867          831 NILLDGD----FGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVD  904 (1002)
Q Consensus       831 NIll~~~----~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~  904 (1002)
                      ||++..+    |+|||+|+|+++.+.+.-.+- ....++-|.+|+|||.+.+. .|+.+.|||+.|||+.||++-..-|.
T Consensus       162 NIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  162 NILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             eEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            9999877    899999999999887654433 44566789999999998876 48999999999999999999877665


Q ss_pred             C
Q 001867          905 P  905 (1002)
Q Consensus       905 ~  905 (1002)
                      .
T Consensus       242 g  242 (438)
T KOG0666|consen  242 G  242 (438)
T ss_pred             c
Confidence            4

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-33  Score=305.25  Aligned_cols=250  Identities=28%  Similarity=0.354  Sum_probs=204.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +..|.+.+.||+|.|+.|..|+. .++..||+|.+++.               ..+....+.+.+|+++|+.++|||||+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt---------------~ln~~~~~k~~rev~imk~l~HPnIvk  119 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKT---------------QLNPSKRQKLGREVDIMKSLNHPNIVK  119 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhc---------------ccChHHHHHHHHHHHHHHhcCCcceee
Confidence            45677889999999999999995 46899999998653               223444555899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      ++.+...+..+|+||||+.+|.+.+|+..  .+...+..+..++.|+.+|++|+|++   .|||||||++||+++.+..+
T Consensus       120 l~~v~~t~~~lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni  194 (596)
T KOG0586|consen  120 LFSVIETEATLYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI  194 (596)
T ss_pred             eeeeeeecceeEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence            99999999999999999999999999984  45577788999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++..+......   ...+|++.|.|||+..+..| .+.+|+||+|+++|.+++|..||++..-. ..    .. 
T Consensus       195 kIaDfgfS~~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-~L----r~-  265 (596)
T KOG0586|consen  195 KIADFGFSTFFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-EL----RP-  265 (596)
T ss_pred             eeeccccceeecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-cc----cc-
Confidence            99999999988765443   34589999999999998776 58999999999999999999999754211 00    00 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                             .++-.+.+ .+--...++.+++.+++-.+|.+|++++++.+.
T Consensus       266 -------rvl~gk~r-Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  266 -------RVLRGKYR-IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -------hheeeeec-ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                   00111110 000112346788889999999999999998753

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-32  Score=309.48  Aligned_cols=268  Identities=24%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++.++|...+.||+|+||.||+|.. .+++.||+|++.+..               ........+.+|+.++++++|||
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~n   75 (342)
T cd07879          11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF---------------QSEIFAKRAYRELTLLKHMQHEN   75 (342)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc---------------ccccchhHHHHHHHHHHhcCCCC
Confidence            34456788889999999999999996 468999999884321               11223456789999999999999


Q ss_pred             eeeeeeEEecCC------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++....      ..++|+||+. .++.++..    ..+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus        76 iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~N  147 (342)
T cd07879          76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGN  147 (342)
T ss_pred             ccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence            999999987543      4589999995 47766552    3589999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      |+++.++.+||+|||+++.....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus       148 Ill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~  222 (342)
T cd07879         148 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD  222 (342)
T ss_pred             EEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999998764322     123457889999998876 468899999999999999999999997543222


Q ss_pred             hHHHHHHHH----------hhccC-------ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHH
Q 001867          911 DLVKWVCST----------LDQKG-------VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV--KLLQE  971 (1002)
Q Consensus       911 ~~~~~~~~~----------~~~~~-------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl--~~L~~  971 (1002)
                      .+.......          .....       ......+......+....++.+++.+||+.||++||++++++  ..+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence            222111100          00000       000000000000111223578999999999999999999999  44777


Q ss_pred             hhh
Q 001867          972 VGA  974 (1002)
Q Consensus       972 ~~~  974 (1002)
                      ...
T Consensus       303 ~~~  305 (342)
T cd07879         303 FRD  305 (342)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3e-32  Score=299.44  Aligned_cols=255  Identities=24%  Similarity=0.280  Sum_probs=196.8

Q ss_pred             CCCcCCeeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCce
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNI  758 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  758 (1002)
                      .|++.+.||+|+||.||+|..    .+|+.||+|++.....             .......+.+.+|+.+++++ +|++|
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~~i   67 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-------------VQKAKTTEHTRTERQVLEHIRQSPFL   67 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-------------hhcchHHHHHHHHHHHHHhcccCCCh
Confidence            367788999999999999986    3688999999843210             11223456788999999999 59999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++..+...|+||||+++++|.+++..  ...+++..+..++.|++.||+|||+.   +++||||+|+||+++.++
T Consensus        68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~  142 (290)
T cd05613          68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNG  142 (290)
T ss_pred             hceeeEeecCCeEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCC
Confidence            9999999999999999999999999999974  35688999999999999999999998   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL--RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+||+|||++........ .......|+..|+|||...+.  .++.++||||||+++|+|++|+.||...........+.
T Consensus       143 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~  221 (290)
T cd05613         143 HVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS  221 (290)
T ss_pred             CEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH
Confidence            999999999986543322 122234688999999998753  46789999999999999999999996433222222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .......       +...   ......+.+++.+||+.||++||     +++++++
T Consensus       222 ~~~~~~~-------~~~~---~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         222 RRILKSE-------PPYP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHhhccC-------CCCC---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            2111110       0011   11123477899999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-34  Score=300.28  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=200.0

Q ss_pred             CCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          688 DNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      .++||+|.||+||-|+. ++|+.||||++.+-..               ...+...+..|+.|++++.||.||.+...|+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF---------------p~kqesqlR~EVaILq~l~HPGiV~le~M~E  633 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF---------------PTKQESQLRNEVAILQNLHHPGIVNLECMFE  633 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccC---------------CCchHHHHHHHHHHHHhcCCCCeeEEEEeec
Confidence            57999999999999994 6799999999965422               2334578999999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC---CCeEEc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD---FGARVA  843 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~---~~~kl~  843 (1002)
                      ..+..++|||.+ .|++.+++-....+.+++.....++.||+.||+|||.+   +|+|+||||+|||+...   .++|||
T Consensus       634 T~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlC  709 (888)
T KOG4236|consen  634 TPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLC  709 (888)
T ss_pred             CCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeec
Confidence            999999999999 67888887777788999999999999999999999999   99999999999999643   469999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||+|++.+.....   ...+||+.|+|||++....|+..-||||.|||+|.-++|..||..+.+..+..+-.       
T Consensus       710 DFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-------  779 (888)
T KOG4236|consen  710 DFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-------  779 (888)
T ss_pred             cccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-------
Confidence            99999999876443   24589999999999999999999999999999999999999997664443332211       


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                        ..+..+   ..+++.....+++|...+++.-.+|-+.++.+
T Consensus       780 --aFMyPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  780 --AFMYPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             --ccccCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence              111111   11233333466777788888888888777654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=279.88  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             CeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  766 (1002)
                      +.||+|+|+.|--++ ..+|..||||++.+                 +....+.++.+|++++...+ |+||+.++++|.
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidK-----------------q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDK-----------------QPGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhc-----------------CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            589999999999988 68899999999843                 24566888999999999985 999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC---eEEc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG---ARVA  843 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~---~kl~  843 (1002)
                      ++...|+|||.|.||.|...++  +.+.+++.++.++.++|+.||.|||.+   ||+|||+||+|||-.....   +|||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ccceEEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence            9999999999999999999888  456799999999999999999999999   9999999999999976654   7999


Q ss_pred             cccCcccccCCC-----CCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch---
Q 001867          844 DFGVAKVVDASG-----KPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK---  910 (1002)
Q Consensus       844 DfGl~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~---  910 (1002)
                      ||.+..-.....     .+......+|+-.|||||+..     ...|+.++|.||+|||+|-|++|..||.+..+.+   
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            998764332111     122233557888999999753     3458899999999999999999999998765432   


Q ss_pred             ---hHHHHHH----HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          911 ---DLVKWVC----STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       911 ---~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         +.-+...    ..+.++. -+..|+.+    .....+..+++...+..|+..|.++.+++.
T Consensus       302 drGe~Cr~CQ~~LFesIQEGk-YeFPdkdW----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGK-YEFPDKDW----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccC-CcCChhhh----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence               1111111    1111221 22222222    222234557777788899999999998886

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-32  Score=294.17  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=187.4

Q ss_pred             CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHh-cCCCCceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLG-KIRHKNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~  766 (1002)
                      +.||+|+||.||+|.. .+++.||+|++.+..              .........+..|..++. ..+|||++++++++.
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   67 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSD--------------MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ   67 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchh--------------hhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE
Confidence            5799999999999986 458899999884321              111122233455555444 457999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      ..+..|+||||+++++|.+++..  .+.+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||
T Consensus        68 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  142 (260)
T cd05611          68 SKDYLYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG  142 (260)
T ss_pred             cCCeEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecc
Confidence            99999999999999999999974  35689999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVD  926 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  926 (1002)
                      ++.....      .....|+..|+|||...+..++.++||||+|+++|||++|..||..............     ....
T Consensus       143 ~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~  211 (260)
T cd05611         143 LSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-----RRIN  211 (260)
T ss_pred             cceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----cccC
Confidence            9875433      1234578899999999888889999999999999999999999975433221111111     0000


Q ss_pred             ccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          927 HVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       927 ~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                        ..+.. ...+    ..+.+++.+||+.+|++||++.++.+.
T Consensus       212 --~~~~~~~~~~----~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         212 --WPEEVKEFCS----PEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             --CCCcccccCC----HHHHHHHHHHccCCHHHccCCCcHHHH
Confidence              00111 1122    347889999999999999987666544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.4e-32  Score=302.17  Aligned_cols=265  Identities=26%  Similarity=0.307  Sum_probs=197.8

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|++.....               .......+.+|++++++++||||+
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------------~~~~~~~~~~e~~~~~~l~h~~i~   69 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE---------------KEGFPITAIREIKILRQLNHRNIV   69 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc---------------ccCchHHHHHHHHHHHhCCCCCee
Confidence            3567888999999999999999975 588999998853211               112234677899999999999999


Q ss_pred             eeeeEEecCC----------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          760 KLWCCCTTRD----------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       760 ~l~~~~~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                      ++++++.+..          ..++||||+++ ++.+++... ...+++..+..++.|++.||+|||+.   +|+||||||
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p  144 (302)
T cd07864          70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKC  144 (302)
T ss_pred             eeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            9999987654          78999999965 777777643 34689999999999999999999999   999999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFG  908 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~  908 (1002)
                      +||++++++.+||+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....
T Consensus       145 ~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~  223 (302)
T cd07864         145 SNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE  223 (302)
T ss_pred             HHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            999999999999999999987654332 11223346778999998764 4578899999999999999999999975433


Q ss_pred             chhHHHHHHHHhhccCc---ccc--------ccc------cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          909 EKDLVKWVCSTLDQKGV---DHV--------LDP------KLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~---~~~--------~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...... +.........   ..+        .++      ............+.+++..||+.+|++||+++++++
T Consensus       224 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         224 LAQLEL-ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHH-HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222222 2221111000   000        000      000001111245889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=298.87  Aligned_cols=261  Identities=23%  Similarity=0.263  Sum_probs=200.7

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |++.+.||.|++|.||+|... +++.+|+|++.....               .......+.+|++++++++||||+++++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~   65 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE---------------SEGIPKTALREIKLLKELNHPNIIKLLD   65 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc---------------cchhHHHHHHHHHHHHHhcCCCcchHHH
Confidence            566789999999999999964 688999998844211               2234567888999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++..++..++||||++ +++.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+
T Consensus        66 ~~~~~~~~~~v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~  140 (283)
T cd05118          66 VFRHKGDLYLVFEFMD-TDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLA  140 (283)
T ss_pred             hhccCCCEEEEEeccC-CCHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEe
Confidence            9999999999999996 5888888753 35799999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      |||.+.......  .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+............
T Consensus       141 df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd05118         141 DFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP  218 (283)
T ss_pred             eeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999998775543  122234578899999998776 78899999999999999999999996554333222221111000


Q ss_pred             --cCccccc--------------cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 --KGVDHVL--------------DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 --~~~~~~~--------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                        .......              +.......++...++.+++.+||++||.+||++++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              0000000              00001111223456889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-32  Score=307.99  Aligned_cols=267  Identities=22%  Similarity=0.317  Sum_probs=200.6

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++.++|++.+.||+|+||.||+|.. .+++.||||++.+..               ......+.+.+|+.++++++|||
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~   75 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---------------QSELFAKRAYRELRLLKHMKHEN   75 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---------------cchHHHHHHHHHHHHHHhcCCCC
Confidence            34567899999999999999999985 568999999884321               12333456889999999999999


Q ss_pred             eeeeeeEEecCC------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++....      ..++||||+ +++|.+++..   ..+++..+..++.|++.|++|||+.   +|+||||||+|
T Consensus        76 iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~N  148 (343)
T cd07880          76 VIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGN  148 (343)
T ss_pred             ccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            999999997653      358999999 7899888863   4689999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      |+++.++.+|++|||++.......     ....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||.......
T Consensus       149 ill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  223 (343)
T cd07880         149 LAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD  223 (343)
T ss_pred             EEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999998654321     23457889999998876 458899999999999999999999997553322


Q ss_pred             hHHHHHHHHhh----------cc-------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHH
Q 001867          911 DLVKWVCSTLD----------QK-------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV--KLLQE  971 (1002)
Q Consensus       911 ~~~~~~~~~~~----------~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl--~~L~~  971 (1002)
                      ...........          ..       .......+......+.....+.+++.+|++.||++|||+.+++  .+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence            22221110000          00       0000000000000011123477999999999999999999999  55555


Q ss_pred             h
Q 001867          972 V  972 (1002)
Q Consensus       972 ~  972 (1002)
                      .
T Consensus       304 ~  304 (343)
T cd07880         304 F  304 (343)
T ss_pred             h
Confidence            5

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-32  Score=298.35  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=197.0

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|+||.||+|... +++.||+|.+...              ........+.+.+|++++++++||||+++++.+..++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   66 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKA--------------DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK   66 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecch--------------hhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc
Confidence            689999999999976 4899999988432              1122345677899999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..|++|||+++++|.+++++.  +.+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        67 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~  141 (265)
T cd05579          67 NLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSK  141 (265)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccch
Confidence            999999999999999999853  3689999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCC------CcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          850 VVDASGK------PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       850 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      .......      ........++..|+|||...+...+.++||||||+++|++++|..||...... .......   . .
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~---~-~  216 (265)
T cd05579         142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQNIL---N-G  216 (265)
T ss_pred             hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh---c-C
Confidence            6543321      11223446788999999998888999999999999999999999999654322 2111111   1 1


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                      ....   +....    ....+.+++.+||+.+|++|||+.++.+.++
T Consensus       217 ~~~~---~~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         217 KIEW---PEDVE----VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CcCC---Ccccc----CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            1100   00000    1234788999999999999999977766553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.1e-32  Score=293.55  Aligned_cols=249  Identities=27%  Similarity=0.323  Sum_probs=201.6

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+++. .+++.+|+|.+....               ........+.+|++++++++|+||++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS---------------MSQKEREDAVNEIRILASVNHPNIISYK   65 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh---------------ccHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence            367788999999999999985 467899999984321               1223456778899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++......++||||+++++|.+++....  ...+++..++.++.|++.|++|||+.   +++||||+|+||+++.++.+
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~  142 (256)
T cd08530          66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLV  142 (256)
T ss_pred             hhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcE
Confidence            99999999999999999999999987532  35689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |++|||++.......    .....++..|+|||...+..++.++|+||+|+++|||++|+.||..... ..+....    
T Consensus       143 kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~----  213 (256)
T cd08530         143 KIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKV----  213 (256)
T ss_pred             EEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH----
Confidence            999999998765541    2234578899999999998899999999999999999999999965422 2221111    


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......        ........++.+++.+|++.+|++||++.++++
T Consensus       214 ~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         214 QRGKYP--------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             hcCCCC--------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111111        111122345889999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-32  Score=289.73  Aligned_cols=249  Identities=28%  Similarity=0.416  Sum_probs=201.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|... +++.||+|.+....               ......+.+.+|++++++++|||+++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---------------IKEEALKSIMQEIDLLKNLKHPNIVKYI   65 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---------------cCHHHHHHHHHHHHHHHhCCCCCccEEE
Confidence            4677899999999999999864 57899999985421               1123456799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..+++|||+++++|.+++...  ..+++..+..++.|++.|++|||++   +|+||||+|+||+++.++.++|
T Consensus        66 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l  140 (254)
T cd06627          66 GSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKL  140 (254)
T ss_pred             EEEEeCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999999753  5799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||.+.........  .....++..|+|||...+..++.++||||+|+++|+|++|+.||............    . .
T Consensus       141 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~----~-~  213 (254)
T cd06627         141 ADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI----V-Q  213 (254)
T ss_pred             eccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----h-c
Confidence            999999877654321  22346888999999988888899999999999999999999998654321111111    1 0


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...     +......   ...+.+++.+|++.+|++||++.+++.
T Consensus       214 ~~~-----~~~~~~~---~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 DDH-----PPLPEGI---SPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             cCC-----CCCCCCC---CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            111     1111111   224778999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-32  Score=298.81  Aligned_cols=260  Identities=25%  Similarity=0.310  Sum_probs=197.3

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLW  762 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  762 (1002)
                      |++.+.||+|+||+||+|... +++.||+|++....                .........+|+..+++++ |||+++++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~----------------~~~~~~~~~~e~~~l~~~~~h~~i~~~~   64 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----------------YSWEECMNLREVKSLRKLNEHPNIVKLK   64 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhc----------------cchhHHHHHHHHHHHHhccCCCCchhHH
Confidence            567789999999999999975 47889999874321                1122334567999999999 99999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++..++..++||||+ +|+|.+++.......+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|
T Consensus        65 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l  140 (283)
T cd07830          65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKI  140 (283)
T ss_pred             HHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEE
Confidence            9999999999999999 88999998865546789999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH----
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC----  917 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~----  917 (1002)
                      +|||.+........   .....++..|+|||++. ...++.++||||||+++|||++|+.||......+.+.+...    
T Consensus       141 ~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  217 (283)
T cd07830         141 ADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT  217 (283)
T ss_pred             eecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCC
Confidence            99999986644322   12345788999999875 45578999999999999999999999865533222221111    


Q ss_pred             --------HHhhccCcccccccc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 --------STLDQKGVDHVLDPK----LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 --------~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                              ...........+...    +....+....++.+++.+||+.+|++||+++|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                    000000011111000    11111111346889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.6e-32  Score=297.57  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=193.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|.+++ ++.||||.+....                .......+..|+.++.+.. ||||+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----------------~~~~~~~~~~e~~~~~~~~~~~~i~   77 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----------------NKEENKRILMDLDVVLKSHDCPYIV   77 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC----------------ChHHHHHHHHHHHHHHhccCCCchH
Confidence            3567888999999999999999764 8899999984321                1123445667777777765 99999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      ++++++.+....|++|||+ ++++.++.... ...+++..+..++.|++.|++|||+ .   +|+||||+|+||+++.++
T Consensus        78 ~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~  152 (296)
T cd06618          78 KCYGYFITDSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASG  152 (296)
T ss_pred             hhheeeecCCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCC
Confidence            9999999999999999998 45787777653 3478999999999999999999997 5   899999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR----VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      .+||+|||++........   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.......+...
T Consensus       153 ~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  229 (296)
T cd06618         153 NVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT  229 (296)
T ss_pred             CEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH
Confidence            999999999976543322   12335788999999987553    78899999999999999999999965322222211


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .   ..... .......  ...    ..++.+++.+||+.||++||+++++++.
T Consensus       230 ~---~~~~~-~~~~~~~--~~~----~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 K---ILQEE-PPSLPPN--EGF----SPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             H---HhcCC-CCCCCCC--CCC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1   11111 0110000  011    2347889999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-32  Score=309.30  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=198.2

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++.++|++.+.||+|+||.||+|+.. +++.||+|++...               .........+.+|+.++++++|||+
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~i   76 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---------------FQSAIHAKRTYRELRLLKHMDHENV   76 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc---------------cchhhHHHHHHHHHHHHHhccCCCH
Confidence            44678888999999999999999974 5789999987432               1122344567889999999999999


Q ss_pred             eeeeeEEecCCe------eeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          759 VKLWCCCTTRDC------KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       759 v~l~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      +++++++...+.      .++|+||+ +++|.+++..   ..+++..+..++.|++.|++|||+.   +|+||||||+||
T Consensus        77 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Ni  149 (343)
T cd07851          77 IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNI  149 (343)
T ss_pred             HHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            999998876654      89999999 7799998864   4699999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      +++.++.+||+|||++......     .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||........
T Consensus       150 ll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~  224 (343)
T cd07851         150 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ  224 (343)
T ss_pred             EECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            9999999999999999865432     223457889999998765 4678999999999999999999999975533322


Q ss_pred             HHHHHHHHhhccC------------------ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          912 LVKWVCSTLDQKG------------------VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       912 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +...... .....                  ......+.....+.....++.+++.+|++.+|++|||+.|+++
T Consensus       225 ~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         225 LKRIMNL-VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHh-cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            2221111 00000                  0000000000001111346889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-32  Score=305.83  Aligned_cols=263  Identities=23%  Similarity=0.298  Sum_probs=196.2

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .++.++|++.+.||+|+||.||+|.. .+++.||+|++...               .......+.+.+|+.++++++|||
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~Ei~~l~~l~h~~   77 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------------FQSIIHAKRTYRELRLLKHMKHEN   77 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc---------------chhhHHHHHHHHHHHHHHHcCCCc
Confidence            34567899999999999999999985 56899999988432               112334566888999999999999


Q ss_pred             eeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++...      ...|++++++ +++|.++++.   ..+++..+..++.|+++|++|||++   +|+||||||+|
T Consensus        78 iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~N  150 (345)
T cd07877          78 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSN  150 (345)
T ss_pred             ccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHH
Confidence            99999988643      3467888887 8899888763   3589999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      |+++.++.+||+|||+++.....     .....|+..|+|||...+ ..++.++||||+||++|||++|+.||.......
T Consensus       151 Ill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  225 (345)
T cd07877         151 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID  225 (345)
T ss_pred             EEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999998764332     223467889999998766 567889999999999999999999996543222


Q ss_pred             hHHHHHHHHhh----------cc-------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          911 DLVKWVCSTLD----------QK-------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       911 ~~~~~~~~~~~----------~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ...........          ..       ...................++.+++.+|++.||.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            22211111000          00       000000000000000112347799999999999999999998854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-32  Score=303.84  Aligned_cols=266  Identities=25%  Similarity=0.280  Sum_probs=195.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++......               ......+.+|++++++++||||++
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------~~~~~~~~~e~~~l~~l~h~~i~~   71 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---------------DGFPITALREIKILKKLKHPNVVP   71 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC---------------CCcchhHHHHHHHHHhcCCCCccc
Confidence            478889999999999999999964 5889999988432111               111235678999999999999999


Q ss_pred             eeeEEecCC--------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          761 LWCCCTTRD--------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       761 l~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      +++++....        ..++||||++ +++...+.. ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~ni  146 (311)
T cd07866          72 LIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANI  146 (311)
T ss_pred             hhhheecccccccccCceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            999875433        4699999995 577777654 345699999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCc---------ccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCC
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPK---------SMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLP  902 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p  902 (1002)
                      ++++++.+||+|||++..........         ......|++.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus       147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~  226 (311)
T cd07866         147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI  226 (311)
T ss_pred             EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence            99999999999999998664332211         11234578889999987654 578999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHHhh--cc------Cccc----c----ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          903 VDPEFGEKDLVKWVCSTLD--QK------GVDH----V----LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~--~~------~~~~----~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      |..................  ..      ....    .    ..+.+..........+.+++.+|++.||++|||+.|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell  306 (311)
T cd07866         227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL  306 (311)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence            9755433222221111000  00      0000    0    00111111111224578999999999999999999987


Q ss_pred             H
Q 001867          967 K  967 (1002)
Q Consensus       967 ~  967 (1002)
                      .
T Consensus       307 ~  307 (311)
T cd07866         307 E  307 (311)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-32  Score=304.32  Aligned_cols=271  Identities=24%  Similarity=0.292  Sum_probs=205.8

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....               .+....+.+.+|+.+++.++||||++++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF---------------DDLIDAKRILREIKLLRHLRHENIIGLL   65 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc---------------ccchhhhhHHHHHHHHHhcCCcchhhhh
Confidence            4778899999999999999975 48999999884321               1233456789999999999999999999


Q ss_pred             eEEecCC-----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          763 CCCTTRD-----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       763 ~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      +++...+     ..|++|||++ ++|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        66 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~  139 (330)
T cd07834          66 DILRPPSPEDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSN  139 (330)
T ss_pred             hhhcccCcccccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            9998775     7899999996 589888874  34799999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCC-cccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      +.++|+|||++......... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||............
T Consensus       140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i  219 (330)
T cd07834         140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI  219 (330)
T ss_pred             CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            99999999999876554311 122344678899999999887 7899999999999999999999999755432222111


Q ss_pred             HHHHhhccCc-----------cccc---cc----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHhhhh
Q 001867          916 VCSTLDQKGV-----------DHVL---DP----KLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEVGAE  975 (1002)
Q Consensus       916 ~~~~~~~~~~-----------~~~~---~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~~~~  975 (1002)
                      . ........           ...+   ..    ......+.....+.+++.+||+.+|++||++++++.  ++++....
T Consensus       220 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         220 V-EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             H-HhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            1 11000000           0000   00    000011112345788999999999999999999997  47666544


Q ss_pred             c
Q 001867          976 N  976 (1002)
Q Consensus       976 ~  976 (1002)
                      .
T Consensus       299 ~  299 (330)
T cd07834         299 E  299 (330)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.7e-32  Score=305.21  Aligned_cols=276  Identities=21%  Similarity=0.218  Sum_probs=198.3

Q ss_pred             hcCCC-cCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          682 LDGLD-EDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       682 ~~~~~-~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      .++|. +.+.||+|+||.||+|..+ +++.||+|++.........  +. .............+.+|++++++++||||+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDV--TK-DRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeecccccccc--cc-chhhhcccccchhHHHHHHHHHhCCCccee
Confidence            34554 3567999999999999964 6899999998543111000  00 000000011123578899999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++..++..++||||++ |+|.+++..  ...+++.....++.|++.||+|||+.   +|+||||+|+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence            99999999999999999996 699999874  45689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCC------------CcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          840 ARVADFGVAKVVDASGK------------PKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      +||+|||.+........            ........++..|+|||++.+. .++.++||||+||++|||++|..||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999987652111            1112233567889999988764 4689999999999999999999999765


Q ss_pred             CCchhHHHHHHHHhhccCc---------------cccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGV---------------DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+....... .......               .....+...........++.+++.+|++.+|++||+++|++.
T Consensus       238 ~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        238 NEIDQLGRIFE-LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CHHHHHHHHHH-HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            44333222211 1100000               000001111111112345778999999999999999999985

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=288.04  Aligned_cols=244  Identities=25%  Similarity=0.292  Sum_probs=191.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      ..+|.+..+||+|+||.|..|..+ +.+.||||+++++..-              .....+--+.|-+++.-- +-|.++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVii--------------QdDDvectm~EKrvLAL~~kppFL~  413 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVII--------------QDDDVECTMVEKRVLALPGKPPFLV  413 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceee--------------ecCcccceehhhhheecCCCCchHH
Confidence            457889999999999999999854 4678999999765321              111222233455555544 478999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      .++.+|+.-+.+|+||||+.||+|--.++  +-+.+-++.+..+|.+||-||-|||++   +||+||||..||+++.+|+
T Consensus       414 qlHScFQTmDRLyFVMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGH  488 (683)
T KOG0696|consen  414 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGH  488 (683)
T ss_pred             HHHHHhhhhhheeeEEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCc
Confidence            99999999999999999999999977676  446688899999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++.--..  ..++...+||+.|+|||++....|...+|+|||||++|||+.|+.||+++...+-+..+..  
T Consensus       489 iKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e--  564 (683)
T KOG0696|consen  489 IKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME--  564 (683)
T ss_pred             eEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--
Confidence            999999999743332  2345577999999999999999999999999999999999999999987643333222211  


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP  960 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  960 (1002)
                        .          --.+++....+.+.+....+-+.|.+|.
T Consensus       565 --h----------nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 --H----------NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --c----------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence              1          0112233334466677777888888885

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.2e-31  Score=297.54  Aligned_cols=247  Identities=27%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |...+.||+|+||.||+|+. .+++.||+|++....              .......+.+.+|++++++++|||++++++
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   88 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG--------------KQTNEKWQDIIKEVKFLQQLKHPNTIEYKG   88 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc--------------cCchHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            45567899999999999996 458899999884321              112234457889999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++.+....|+||||+. |++.+++.. ....+++..+..++.|++.|++|||++   +|+||||+|+||+++.++.+||+
T Consensus        89 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~  163 (313)
T cd06633          89 CYLKEHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA  163 (313)
T ss_pred             EEEeCCEEEEEEecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEe
Confidence            9999999999999995 688887765 345689999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |||++.....      .....|+..|+|||++.   ...++.++|||||||++|||++|..||............    .
T Consensus       164 dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~----~  233 (313)
T cd06633         164 DFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----A  233 (313)
T ss_pred             ecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----H
Confidence            9999864322      22346888999999874   456888999999999999999999998654322222111    1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ... .....    ...+   ...+.+++.+||+.+|.+||++.+++..
T Consensus       234 ~~~-~~~~~----~~~~---~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         234 QND-SPTLQ----SNEW---TDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             hcC-CCCCC----cccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111 11110    1111   1247789999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.5e-32  Score=297.39  Aligned_cols=252  Identities=26%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  760 (1002)
                      ++|.+.+.||+|+||.||+|... ++..||+|++.+.              ........+.+.+|++++++++ ||||++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~~~e~~~~~~l~~~~~i~~   66 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--------------QLIKEKKVKYVKIEKEVLTRLNGHPGIIK   66 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechH--------------hccchHHHHHHHHHHHHHHhcccCCCchh
Confidence            36788899999999999999964 6899999988432              1122334567889999999998 999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..++||||+++++|.+++..  ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~  141 (280)
T cd05581          67 LYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI  141 (280)
T ss_pred             HHHHhcCCceEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCE
Confidence            99999999999999999999999999974  34699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCC------------------cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 001867          841 RVADFGVAKVVDASGKP------------------KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP  902 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p  902 (1002)
                      +++|||++.........                  .......|+..|+|||+..+..++.++||||+|+++|++++|+.|
T Consensus       142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p  221 (280)
T cd05581         142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP  221 (280)
T ss_pred             EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            99999999876543321                  112234578899999999888899999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Q 001867          903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM----RRVVK  967 (1002)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~evl~  967 (1002)
                      |........+..    ....   ..    ......   ...+.+++.+||+.+|++||++    +++++
T Consensus       222 ~~~~~~~~~~~~----~~~~---~~----~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         222 FRGSNEYLTFQK----ILKL---EY----SFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCccHHHHHHH----HHhc---CC----CCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            975432111111    1100   00    011111   2347889999999999999999    66553

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=6.8e-32  Score=302.43  Aligned_cols=263  Identities=21%  Similarity=0.263  Sum_probs=192.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-C--CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-N--GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      +|++.+.||+|+||.||+|... +  +..||+|++....               ......+.+.+|+++++++ +||||+
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~h~~iv   65 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---------------SKKILAKRALRELKLLRHFRGHKNIT   65 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc---------------ccchhHHHHHHHHHHHHHhcCCCChh
Confidence            3677889999999999999964 3  6789999874321               1222355678899999999 599999


Q ss_pred             eeeeEEecC----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          760 KLWCCCTTR----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       760 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      ++++++...    ...|+++||+. ++|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++
T Consensus        66 ~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~  139 (332)
T cd07857          66 CLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVN  139 (332)
T ss_pred             eeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEc
Confidence            999875432    45788999984 799998863  45689999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCc--ccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          836 GDFGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      .++.+||+|||+++.........  ......|+..|+|||+..+ ..++.++||||+||++|++++|..||.........
T Consensus       140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~  219 (332)
T cd07857         140 ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL  219 (332)
T ss_pred             CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHH
Confidence            99999999999998665432211  1223468999999998765 46889999999999999999999998754322111


Q ss_pred             HHHHHHHh-----------hcc------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTL-----------DQK------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~-----------~~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+....           ...      ..............+.....+.+++.+|++.||++|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         220 NQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111000           000      00000000000011111235789999999999999999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=9.4e-32  Score=297.88  Aligned_cols=248  Identities=28%  Similarity=0.347  Sum_probs=193.3

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+....              ........++.+|+++++.++|+|++++++
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   82 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRG   82 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc--------------ccChHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            555678999999999999964 57889999874210              112233456888999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++......++||||+. |++.+++... ...+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+
T Consensus        83 ~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~  157 (308)
T cd06634          83 CYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG  157 (308)
T ss_pred             EEEcCCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEEC
Confidence            9999999999999996 6888877543 35689999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |||++......      ....|++.|+|||.+.   ...++.++|||||||++|+|++|+.||...........+..   
T Consensus       158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---  228 (308)
T cd06634         158 DFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---  228 (308)
T ss_pred             CcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---
Confidence            99998765432      2345788999999874   35678899999999999999999999865422221111111   


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                        .....    ....   .....+.+++.+||+.+|++||+++++++.-
T Consensus       229 --~~~~~----~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         229 --NESPA----LQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --cCCCC----cCcc---cccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              10000    0011   1123477899999999999999999998663

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=5.9e-32  Score=295.89  Aligned_cols=261  Identities=25%  Similarity=0.296  Sum_probs=199.1

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|+||.||+|+.. +++.||+|++....               ......+.+..|+.++++++|+|++++++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   65 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---------------EEEGIPSTALREISLLKELKHPNIVKLLD   65 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc---------------ccccccHHHHHHHHHHHhcCCCCHHHHHh
Confidence            456688999999999999965 58999999985421               12233456788999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++...+..++||||++ ++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||+|+||+++.++.+||+
T Consensus        66 ~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~  140 (282)
T cd07829          66 VIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLA  140 (282)
T ss_pred             hhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEe
Confidence            9999999999999996 69999998632 4699999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh--
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL--  920 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~--  920 (1002)
                      |||.+........  ......++..|+|||.+.+. .++.++||||+||++|||++|+.||..........+......  
T Consensus       141 d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07829         141 DFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP  218 (282)
T ss_pred             cCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCC
Confidence            9999987654322  22234467789999998766 789999999999999999999999976543222222111000  


Q ss_pred             --------hccC-ccccccc----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 --------DQKG-VDHVLDP----KLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 --------~~~~-~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                              .... .......    ......+.....+.+++..||+.+|++||++++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                    0000 0000000    000111112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=6.7e-33  Score=299.93  Aligned_cols=207  Identities=25%  Similarity=0.372  Sum_probs=178.2

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      -|...+.||-|+||+|.+++..| ...||+|.+.+              +.+..+.+...++.|-+||..-+.+-||++|
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK--------------aDVl~rnQvaHVKAERDILAEADn~WVVrLy  695 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK--------------ADVLMRNQVAHVKAERDILAEADNEWVVRLY  695 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHH--------------HHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence            36667889999999999998654 56689998843              3455667788899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      ..|++++.+|+||||++||++-.+|-  +-+.+.++-++.++.++..|+++.|..   |+|||||||.|||||.+|++||
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceee
Confidence            99999999999999999999999887  457799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCC---C------Cc-------------------------------ccccccccccccCccccccCCCCC
Q 001867          843 ADFGVAKVVDASG---K------PK-------------------------------SMSVIAGSCGYIAPEYAYTLRVNE  882 (1002)
Q Consensus       843 ~DfGl~~~~~~~~---~------~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~  882 (1002)
                      .|||+++-+....   +      .+                               .....+||+.|+|||++....|+.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            9999996443211   0      00                               012346999999999999999999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          883 KSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       883 ~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      .+|+||.|||+|||+.|+.||-.+...
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCCC
Confidence            999999999999999999999765443

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=8.6e-32  Score=300.46  Aligned_cols=263  Identities=23%  Similarity=0.309  Sum_probs=197.1

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +.+.++|++.+.||+|+||.||+|... +++.||+|++.+..               ......+.+.+|++++++++|||
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hpn   70 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF---------------STPVLAKRTYRELKLLKHLRHEN   70 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc---------------cccchhHHHHHHHHHHHhcCCCC
Confidence            456678999999999999999999854 78999999874321               12233466888999999999999


Q ss_pred             eeeeeeEEec-CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          758 IVKLWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       758 iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      |+++++++.. ....|++|||+ +++|.++++.   ..+++..+..++.|++.||+|||+.   +|+||||+|+||+++.
T Consensus        71 iv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~  143 (328)
T cd07856          71 IISLSDIFISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINE  143 (328)
T ss_pred             eeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECC
Confidence            9999999875 56789999999 6789888853   4578889999999999999999999   9999999999999999


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      ++.++|+|||.+......     .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||...........+
T Consensus       144 ~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~  218 (328)
T cd07856         144 NCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII  218 (328)
T ss_pred             CCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999998754322     123357889999998765 56889999999999999999999999654322111111


Q ss_pred             HHH-----------HhhccCcccccc-----c-cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          916 VCS-----------TLDQKGVDHVLD-----P-KLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       916 ~~~-----------~~~~~~~~~~~~-----~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ...           ............     + ......+....++.+++.+|++.+|++||++++++..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            100           000000000000     0 0000000112458889999999999999999999755

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=2.7e-32  Score=306.73  Aligned_cols=267  Identities=21%  Similarity=0.285  Sum_probs=195.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      ..+|.+.+.||+|+||.||+|.. .+++.||+|++...                 .....+.+.+|++++++++||||++
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~-----------------~~~~~~~~~~Ei~~l~~l~h~~i~~   66 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT-----------------DPQSVKHALREIKIIRRLDHDNIVK   66 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC-----------------CCchHHHHHHHHHHHHhcCCCcchh
Confidence            46788899999999999999996 45889999988432                 1123466888999999999999999


Q ss_pred             eeeEEecC--------------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 001867          761 LWCCCTTR--------------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRD  826 (1002)
Q Consensus       761 l~~~~~~~--------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  826 (1002)
                      +++++...              ...|+||||++ ++|.+++..   ..+++..+..++.|++.||.|||+.   +|+|||
T Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~d  139 (342)
T cd07854          67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRD  139 (342)
T ss_pred             hHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            99877643              35789999996 689888853   4589999999999999999999999   999999


Q ss_pred             CCCCcEEECC-CCCeEEccccCcccccCCCCCc-ccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          827 VKSNNILLDG-DFGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       827 lk~~NIll~~-~~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                      |||+||+++. ++.+|++|||.++......... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus       140 ikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf  219 (342)
T cd07854         140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF  219 (342)
T ss_pred             CCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999974 5578999999998654322111 1123357889999997654 56788999999999999999999999


Q ss_pred             CCCCCchhHHHHHHHHhhcc---------Cccc-c------ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Q 001867          904 DPEFGEKDLVKWVCSTLDQK---------GVDH-V------LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV-  966 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~---------~~~~-~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl-  966 (1002)
                      ....................         .... .      .........+....++.+++.+|++.||++||+++|++ 
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         220 AGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            75543322222211100000         0000 0      00000000011223577899999999999999999998 


Q ss_pred             -HHHHHh
Q 001867          967 -KLLQEV  972 (1002)
Q Consensus       967 -~~L~~~  972 (1002)
                       .+++..
T Consensus       300 h~~~~~~  306 (342)
T cd07854         300 HPYMSCY  306 (342)
T ss_pred             CCccccc
Confidence             455543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=297.50  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=208.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCc-EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGE-AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .+++....||-|+||.|=.++.+... .+|+|+++              |..+.+..+.+++..|-.||...+.|+||++
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilk--------------K~hIVdtkQqeHv~sEr~Im~~~~s~fIvrL  485 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILK--------------KKHIVDTKQQEHVFSERNIMMECRSDFIVRL  485 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHh--------------HhhccchhHHHHHHhHHHHHHhcCchHHHHH
Confidence            45566778999999999998865433 48999874              4566778889999999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      |..|.+...+|+.||-|-||.+.+.++  +.+.+++.....++..+.+|++|||++   +||+|||||+|.+++.+|-+|
T Consensus       486 YrTfrd~kyvYmLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~K  560 (732)
T KOG0614|consen  486 YRTFRDSKYVYMLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLK  560 (732)
T ss_pred             HHHhccchhhhhhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceE
Confidence            999999999999999999999999998  456799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |.|||+|+.++.+.++.+   .+||+.|.|||++.....+.++|.||+|+++||+++|..||........+..++ +.+.
T Consensus       561 LVDFGFAKki~~g~KTwT---FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-kGid  636 (732)
T KOG0614|consen  561 LVDFGFAKKIGSGRKTWT---FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-KGID  636 (732)
T ss_pred             EeehhhHHHhccCCceee---ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-hhhh
Confidence            999999999988776544   489999999999999999999999999999999999999998654433333222 2222


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                      ....     |      +.......+++.+.+..+|.+|.-     +.||.+
T Consensus       637 ~i~~-----P------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  637 KIEF-----P------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             hhhc-----c------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            2111     1      111223557788888999999975     555543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1e-32  Score=285.05  Aligned_cols=257  Identities=23%  Similarity=0.231  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CC---
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HK---  756 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~---  756 (1002)
                      ..+|.+...+|+|.||.|-++.+. .+..||||+++.                  -....+...-|+++++++. +.   
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~------------------V~kYreAa~iEi~vLqki~~~DP~g  149 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN------------------VDKYREAALIEIEVLQKINESDPNG  149 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH------------------HHHHhhHHHHHHHHHHHHHhcCCCC
Confidence            467888899999999999998864 478999999843                  2234566778999999994 32   


Q ss_pred             --ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          757 --NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       757 --niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                        -+|.+.+||.-.++.|+|+|.+ |-++.+++..++..+++...+..|++|++++++|||+.   +++|-||||+||++
T Consensus       150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILf  225 (415)
T KOG0671|consen  150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILF  225 (415)
T ss_pred             ceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEE
Confidence              4688889999999999999999 77999999998889999999999999999999999999   99999999999998


Q ss_pred             CC--------------------CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          835 DG--------------------DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       835 ~~--------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      ..                    ...+|++|||.|++.....     +..+.|..|+|||++.+-.++.++||||+|||++
T Consensus       226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV  300 (415)
T ss_pred             eccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence            32                    2348999999998765543     3567899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCchhHHHHHHHHhhccCccc--------------ccc----------------ccc----cCCCHHH
Q 001867          895 ELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDH--------------VLD----------------PKL----DCCFKEE  940 (1002)
Q Consensus       895 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~----------------~~~----~~~~~~~  940 (1002)
                      |+.+|..-|....+.+.+ ..++.... .....              .+|                ++.    ......+
T Consensus       301 ElytG~~LFqtHen~EHL-aMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e  378 (415)
T KOG0671|consen  301 ELYTGETLFQTHENLEHL-AMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLE  378 (415)
T ss_pred             EeeccceecccCCcHHHH-HHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHH
Confidence            999999998765433322 11111111 00000              011                000    1222455


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          941 ICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       941 ~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+.+++.+|+..||.+|+|+.|++.
T Consensus       379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  379 HVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HhHHHHHHHHHHccCccccccHHHHhc
Confidence            678999999999999999999999874

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=1.5e-31  Score=323.40  Aligned_cols=149  Identities=30%  Similarity=0.434  Sum_probs=132.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +++|.+.+.||+|+||.||+|... +++.||+|++...              ..........+..|+.++..++||||++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~--------------~~~~~~~~~~~~~E~~~l~~l~hp~Iv~   68 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--------------DMINKNMVHQVQAERDALALSKSPFIVH   68 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehh--------------hccCHHHHHHHHHHHHHHHhcCCCCcCe
Confidence            367888899999999999999975 6899999998432              1223444577899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..|+||||+++++|.+++..  .+.+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+
T Consensus        69 ~~~~~~~~~~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~v  143 (669)
T cd05610          69 LYYSLQSANNVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHI  143 (669)
T ss_pred             EEEEEEECCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCE
Confidence            99999999999999999999999999974  34689999999999999999999998   99999999999999999999


Q ss_pred             EEccccCcc
Q 001867          841 RVADFGVAK  849 (1002)
Q Consensus       841 kl~DfGl~~  849 (1002)
                      ||+|||+++
T Consensus       144 kL~DFGls~  152 (669)
T cd05610         144 KLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCc
Confidence            999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-32  Score=249.05  Aligned_cols=212  Identities=25%  Similarity=0.369  Sum_probs=176.2

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..++||+|.||+||+|+. .+++.||+|++.-+..               ++.......+|+-+++.++|.|||+++
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd---------------degvpssalreicllkelkhknivrl~   67 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD---------------DEGVPSSALREICLLKELKHKNIVRLH   67 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC---------------CCCCcHHHHHHHHHHHHhhhcceeehh
Confidence            345567899999999999995 5688999999854322               222344578899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +....+..+-+|+||+ +.+|.+|..... +.++.+.++.++.|+.+||.|.|++   ++.|||+||.|.+++.+|+.|+
T Consensus        68 dvlhsdkkltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkl  142 (292)
T KOG0662|consen   68 DVLHSDKKLTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKL  142 (292)
T ss_pred             hhhccCceeEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEe
Confidence            9999999999999999 679999998754 5689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCC-CCCCCCchhHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLP-VDPEFGEKDLVKWVC  917 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p-~~~~~~~~~~~~~~~  917 (1002)
                      +|||+++.++-.  .+..+..+-|.+|++|.++.+.. |+...|+||-||++.|+.....| |.+....+++.++++
T Consensus       143 adfglarafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~  217 (292)
T KOG0662|consen  143 ADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_pred             cccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence            999999987654  33455667899999999998765 78899999999999999984445 544433444444444

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.7e-31  Score=288.52  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=194.7

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|.+.+.||+|+||.||+|.... +..+++|.++.....            ........++..|+.++++++||||++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   68 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVG------------ELNPNETVQANQEAQLLSKLDHPAIVKFH   68 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccc------------ccCcchHHHHHHHHHHHHhCCCCcHHHHH
Confidence            47778999999999999998643 455666665432111            01122344577899999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++.+....++||||+++++|.+++...  ....+++..++.++.|++.|++|||+.   +++||||+|+||+++. +.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~  144 (260)
T cd08222          69 ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLL  144 (260)
T ss_pred             HHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCE
Confidence            9999999999999999999999988642  346799999999999999999999999   9999999999999975 579


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +++|||.+........  ......|++.|+|||...+..++.++||||+|+++|+|++|..||.....    ........
T Consensus       145 ~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~~~  218 (260)
T cd08222         145 KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----LSVVLRIV  218 (260)
T ss_pred             eecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHH
Confidence            9999999976644322  12234578899999998888889999999999999999999999864321    11111111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      . ..     .+...   .....++.+++.+||+.+|++||++.|+++
T Consensus       219 ~-~~-----~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         219 E-GP-----TPSLP---ETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             c-CC-----CCCCc---chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1 11     11111   122235778999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-31  Score=284.43  Aligned_cols=239  Identities=28%  Similarity=0.352  Sum_probs=193.4

Q ss_pred             eeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|+||.||++... +++.||+|.+.+..              .......+.+..|++++++++||||+++++.+..++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   66 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK--------------IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE   66 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhh--------------hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC
Confidence            699999999999965 58999999985431              122345667899999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        67 ~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~  141 (250)
T cd05123          67 KLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK  141 (250)
T ss_pred             eeEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcce
Confidence            999999999999999999743  4689999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccc
Q 001867          850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVL  929 (1002)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1002)
                      ......  .......++..|+|||...+...+.++|+||||+++|++++|+.||..... ......+..    ..     
T Consensus       142 ~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~----~~-----  209 (250)
T cd05123         142 ELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILK----DP-----  209 (250)
T ss_pred             ecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhc----CC-----
Confidence            765432  122345688899999999888889999999999999999999999965432 222221111    10     


Q ss_pred             cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 001867          930 DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR  964 (1002)
Q Consensus       930 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  964 (1002)
                       .......   ..++.+++.+||..||++||++++
T Consensus       210 -~~~~~~~---~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 -LRFPEFL---SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -CCCCCCC---CHHHHHHHHHHhcCCHhhCCCccc
Confidence             0111111   234788999999999999999965

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=282.15  Aligned_cols=264  Identities=24%  Similarity=0.300  Sum_probs=202.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      -++|-....||+|+|+.||+|.+ ...+.||||+-.....+.          ......-.+...+|..|-+.++||.||+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr----------dEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR----------DEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh----------hHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            34566778999999999999984 567889999864432221          0111223455778999999999999999


Q ss_pred             eeeEEe-cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC---C
Q 001867          761 LWCCCT-TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---G  836 (1002)
Q Consensus       761 l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~---~  836 (1002)
                      +|++|. +.+..|-|+||++|-+|+-|++.  .+.+++.+++.|+.||+.||.||.+. .++|||-||||.|||+.   .
T Consensus       532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             eeeeeeeccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence            999997 55778999999999999999984  45699999999999999999999996 56999999999999994   3


Q ss_pred             CCCeEEccccCcccccCCCCCc-----ccccccccccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          837 DFGARVADFGVAKVVDASGKPK-----SMSVIAGSCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      -|.+||.|||++++++...+..     -++...||.+|++||.+--+    ..+.|+||||.|||+|+++.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            4679999999999987665432     23456799999999976533    46789999999999999999999999887


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ...++...-. .+....+..  .++ +...+    +...+|++|++.--++|.+..++.
T Consensus       689 sQQdILqeNT-IlkAtEVqF--P~K-PvVss----eAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  689 SQQDILQENT-ILKATEVQF--PPK-PVVSS----EAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hHHHHHhhhc-hhcceeccC--CCC-CccCH----HHHHHHHHHHHhhhhhhhhHHHHc
Confidence            7766654321 111111111  111 11112    256788899999999998777664

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-31  Score=296.05  Aligned_cols=249  Identities=26%  Similarity=0.369  Sum_probs=203.7

Q ss_pred             cCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  760 (1002)
                      +.|++.++||+|.+|.||+++ .++++.+|+|+...                  +....++++.|..+++... |||++.
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~------------------~~d~deEiE~eynil~~~~~hpnv~~   80 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP------------------TEDEEEEIELEYNMLKKYSHHPNVAT   80 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecC------------------CccccHHHHHHHHHHHhccCCCCcce
Confidence            567888999999999999999 56788999998743                  3344677889999999884 999999


Q ss_pred             eeeEEe-----cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          761 LWCCCT-----TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       761 l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      +||+|.     .++.+|+|||||.+|+..|+++.-.+..+.|+.+..|++.++.|+.+||.+   .++|||||-.|||++
T Consensus        81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT  157 (953)
T KOG0587|consen   81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLT  157 (953)
T ss_pred             EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEe
Confidence            999996     357899999999999999999988888999999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      .++.||++|||.+..++.....  .....||+.|||||++..     ..|+.++|+||+|++..||..|..|+-+.....
T Consensus       158 ~e~~VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr  235 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR  235 (953)
T ss_pred             ccCcEEEeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence            9999999999999887765332  234579999999999863     347789999999999999999999985443222


Q ss_pred             hHHHHHHHHhhccCccccccccccCC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          911 DLVKWVCSTLDQKGVDHVLDPKLDCC-FKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      .+..            ....|.+.-. ++.-..++.++|..|+.+|.+.||++.+++
T Consensus       236 aLF~------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll  280 (953)
T KOG0587|consen  236 ALFL------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL  280 (953)
T ss_pred             hhcc------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence            1111            0111222111 223335688999999999999999998876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=252.34  Aligned_cols=210  Identities=26%  Similarity=0.365  Sum_probs=174.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  760 (1002)
                      ++......||+|+||.|-+.+. .+|...|||.+...               . .....++..+|+.+..+- ..|++|+
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t---------------v-n~q~q~r~L~dldi~~r~~~CPf~V~  109 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT---------------V-NSQEQKRLLMDLDIIMRTVDCPFTVH  109 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh---------------c-ChHHHHHHHHhhhhhccCCCCCeEEE
Confidence            3455567899999999988774 67999999998432               1 234566677888887665 5899999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +||.+.+++..++.||.| ..+|+.+-+.  .+++.+++..+-+|+..+.+||.|||++  ..|||||+||+|||++.+|
T Consensus       110 FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~G  186 (282)
T KOG0984|consen  110 FYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDG  186 (282)
T ss_pred             eehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCC
Confidence            999999999999999999 5788887553  2568899999999999999999999998  4899999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccc----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      ++|+||||++-.+.++-.   .+...|...|||||.+.    ...|+-|+||||+|+++.||.+++.||+.....-+..+
T Consensus       187 qVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk  263 (282)
T KOG0984|consen  187 QVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK  263 (282)
T ss_pred             cEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence            999999999988765422   23456889999999865    34789999999999999999999999987766554443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=266.06  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=194.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      ..+|+..++||+|+|++|..++. ++.+.||+|++++.+..              +.....-.+.|-.+.... +||++|
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~n--------------ddedidwvqtek~vfe~asn~pflv  314 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVN--------------DDEDIDWVQTEKHVFEQASNNPFLV  314 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcC--------------CcccchhHHhhHHHHHhccCCCeEE
Confidence            46788899999999999999995 56788999999776543              233344566777777766 599999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      .++.+|+.+..+++|.||++||+|--.++  +...++++.++.+..+|+.||.|||++   |||+||+|..||++|.+|+
T Consensus       315 glhscfqtesrlffvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaegh  389 (593)
T KOG0695|consen  315 GLHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGH  389 (593)
T ss_pred             ehhhhhcccceEEEEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCc
Confidence            99999999999999999999999976666  445699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC---CCchhHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE---FGEKDLVKWV  916 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~---~~~~~~~~~~  916 (1002)
                      +|+.|+|+++.--...  ..++..+|||.|.|||++.+..|...+|+|++||+++||+.|+.||+--   ..+.....++
T Consensus       390 ikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl  467 (593)
T KOG0695|consen  390 IKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL  467 (593)
T ss_pred             eeecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence            9999999997533322  2456789999999999999999999999999999999999999999731   1122222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP  960 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  960 (1002)
                      -+.+.+..++         .+.....+...++..-+++||.+|.
T Consensus       468 fqvilekqir---------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  468 FQVILEKQIR---------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHhhhccc---------ccceeehhhHHHHHHhhcCCcHHhc
Confidence            2222221111         0111112344566678899999885

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-31  Score=291.46  Aligned_cols=239  Identities=23%  Similarity=0.252  Sum_probs=188.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++...+|.|+|+.|..+.. .++...+||++.+.                     ..+-.+|+.++... +||||+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---------------------~~~~~~e~~~~~~~~~h~niv  379 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---------------------ADDNQDEIPISLLVRDHPNIV  379 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc---------------------ccccccccchhhhhcCCCcce
Confidence            35667777899999999999884 56788999998432                     12234566666655 599999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-CCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-DGDF  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll-~~~~  838 (1002)
                      ++++.+.+..+.|+|||.+.|+-+.+.+...  + .....+..|+.||+.|+.|||++   ||||||+||+|||+ +..+
T Consensus       380 ~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~--~-~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g  453 (612)
T KOG0603|consen  380 KSHDVYEDGKEIYLVMELLDGGELLRRIRSK--P-EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAG  453 (612)
T ss_pred             eecceecCCceeeeeehhccccHHHHHHHhc--c-hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCC
Confidence            9999999999999999999998877766532  2 23367778999999999999999   99999999999999 5889


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      +++|+|||.++.....     ....+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+.++..    
T Consensus       454 ~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~----  524 (612)
T KOG0603|consen  454 HLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT----  524 (612)
T ss_pred             cEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH----
Confidence            9999999999877654     2233567889999999999999999999999999999999999986544422221    


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .+......        ....+   ...+++.+|++.||.+||+++++..
T Consensus       525 ~i~~~~~s--------~~vS~---~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  525 RIQMPKFS--------ECVSD---EAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             hhcCCccc--------cccCH---HHHHHHHHhccCChhhCcChhhhcc
Confidence            12111111        11122   3567888999999999999999874

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.1e-30  Score=275.45  Aligned_cols=222  Identities=22%  Similarity=0.167  Sum_probs=174.2

Q ss_pred             cCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCCeee
Q 001867          694 GSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL  772 (1002)
Q Consensus       694 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  772 (1002)
                      |.||.||+|+. .+++.||+|.+...                      ..+..|...+....||||+++++++.+.+..+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~----------------------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~   61 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKS----------------------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVF   61 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecch----------------------hhhhhHHHHHHhcCCCceeehhhheecCCeEE
Confidence            89999999996 46889999998432                      11233444444557999999999999999999


Q ss_pred             EEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCccccc
Q 001867          773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD  852 (1002)
Q Consensus       773 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~  852 (1002)
                      +||||+++|+|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++|||.+....
T Consensus        62 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          62 LVLQHAEGGKLWSHISK--FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             EEEecCCCCCHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence            99999999999999874  34589999999999999999999998   99999999999999999999999999886654


Q ss_pred             CCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcccccccc
Q 001867          853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPK  932 (1002)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (1002)
                      ...     ....++..|+|||...+..++.++||||+|+++|||++|..|+.......          .. . .   ...
T Consensus       137 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~-~-~---~~~  196 (237)
T cd05576         137 DSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NT-H-T---TLN  196 (237)
T ss_pred             ccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------cc-c-c---ccC
Confidence            321     12345678999999988889999999999999999999998875321100          00 0 0   000


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 001867          933 LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV  965 (1002)
Q Consensus       933 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev  965 (1002)
                      .+..   ....+.+++.+|++.||++||++.+.
T Consensus       197 ~~~~---~~~~~~~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         197 IPEW---VSEEARSLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             Cccc---CCHHHHHHHHHHccCCHHHhcCCCcc
Confidence            1111   12347788999999999999997444

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=9.8e-32  Score=261.13  Aligned_cols=265  Identities=22%  Similarity=0.340  Sum_probs=191.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ..|+...+||+|.||.||+|+. +.|++||+|++.-.-.               ...-.....+|+.+++.++|+|++.+
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene---------------KeGfpitalreikiL~~lkHenv~nl   81 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE---------------KEGFPITALREIKILQLLKHENVVNL   81 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc---------------ccCCcHHHHHHHHHHHHhcchhHHHH
Confidence            3455567899999999999995 5578889987632100               11123446789999999999999999


Q ss_pred             eeEEec--------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          762 WCCCTT--------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       762 ~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      ++.|..        ....|+||++++. +|..++.. ....++..++.+++.++..||.|+|..   .|+|||+||.|+|
T Consensus        82 iEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvL  156 (376)
T KOG0669|consen   82 IEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVL  156 (376)
T ss_pred             HHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEE
Confidence            988753        3457999999964 88888865 345689999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCC--CcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          834 LDGDFGARVADFGVAKVVDASGK--PKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      ++.+|.+||+|||+++.+.....  ....+..+-|.+|++||.+.+ ..|+++.|||.-||++.||++|..-+.......
T Consensus       157 It~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq  236 (376)
T KOG0669|consen  157 ITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ  236 (376)
T ss_pred             EcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence            99999999999999976653321  122345567999999998775 468999999999999999999987776554333


Q ss_pred             hH--HHHHHHHhhcc--------Cccccc--cccccCC---CHHHHH------HHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          911 DL--VKWVCSTLDQK--------GVDHVL--DPKLDCC---FKEEIC------KVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       911 ~~--~~~~~~~~~~~--------~~~~~~--~~~~~~~---~~~~~~------~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .+  ....+......        .+...+  .|.....   .++...      ...+++..++..||.+|+++++++.
T Consensus       237 ql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  237 QLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            21  11111111111        000111  1111110   111111      3557777889999999999988774

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-31  Score=259.70  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=200.8

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      .+..+.||-|+||.||.+.+ .+|+.||.|++-.               .++.-..-+++.+|+.+++.++|+|+....+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn---------------vfq~L~s~krvFre~kmLcfFkHdNVLSaLD  119 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN---------------VFQNLASCKRVFREIKMLSSFRHDNVLSLLD  119 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcch---------------HHHHHHHHHHHHHHHHHHHhhccccHHHHHH
Confidence            44567899999999999986 5799999998832               3445666788999999999999999999888


Q ss_pred             EEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          764 CCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       764 ~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      ..+..     ++.|+++|.| ..+|.+.+-  .-+.++.+.+.-+.+||.+||+|||+.   +|.||||||.|.+++.+.
T Consensus       120 ILQPph~dfFqEiYV~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNC  193 (449)
T KOG0664|consen  120 ILQPANPSFFQELYVLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNC  193 (449)
T ss_pred             hcCCCCchHHHHHHHHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCc
Confidence            77654     3568899999 578998887  456799999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchh------
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD------  911 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~------  911 (1002)
                      ..||||||+++..+.. ....++..+-|.+|+|||++.+. .|+.+.||||.||++.|++..+.-|......+.      
T Consensus       194 vLKICDFGLARvee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd  272 (449)
T KOG0664|consen  194 ILKICDFGLARTWDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID  272 (449)
T ss_pred             eEEecccccccccchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence            9999999999977654 34556677889999999998876 589999999999999999998888865433221      


Q ss_pred             --------HHHHHHHHhhccCccccc-ccccc-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 001867          912 --------LVKWVCSTLDQKGVDHVL-DPKLD-----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       912 --------~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~  970 (1002)
                              ..+..+...+...++.-. .|...     ....+...+-+.+...++..||++|.+.++.+....
T Consensus       273 LLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  273 LLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence                    112222111111111100 01110     111122234567778899999999999998886653

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.3e-29  Score=296.42  Aligned_cols=260  Identities=19%  Similarity=0.159  Sum_probs=166.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-C----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-N----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      .++|++.+.||+|+||.||+|... +    +..||+|++...                   ...+....|  .+++..+.
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~-------------------~~~e~~~~e--~l~~~~~~  189 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY-------------------GAVEIWMNE--RVRRACPN  189 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEeccc-------------------chhHHHHHH--HHHhhchh
Confidence            467889999999999999999974 4    689999987321                   001111111  11111222


Q ss_pred             ceeeeeeE------EecCCeeeEEEeccCCCChhhhhhhcCCC------------------CCCHHHHHHHHHHHHHHHH
Q 001867          757 NIVKLWCC------CTTRDCKLLVYEYMPNGSLGDLLHSCKGG------------------LLDWPTRYKIIVDAAEGLS  812 (1002)
Q Consensus       757 niv~l~~~------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~L~  812 (1002)
                      +++.++..      ...+...++||||+++++|.+++......                  ...+..+..++.|++.||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~  269 (566)
T PLN03225        190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALD  269 (566)
T ss_pred             hHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHH
Confidence            22222221      24566789999999999999998753210                  1123346689999999999


Q ss_pred             HHhhcCCCCeeeCCCCCCcEEECC-CCCeEEccccCcccccCCCCCcccccccccccccCccccccC-------------
Q 001867          813 YLHHDCVPSIVHRDVKSNNILLDG-DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-------------  878 (1002)
Q Consensus       813 ~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------  878 (1002)
                      |||++   +|+||||||+|||++. ++.+||+|||+++........ ......+++.|||||.+...             
T Consensus       270 yLH~~---gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~  345 (566)
T PLN03225        270 GLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT  345 (566)
T ss_pred             HHHHC---CEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccc
Confidence            99999   9999999999999985 578999999999866443221 22345789999999964322             


Q ss_pred             ---------CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-ccCccccccccccCC-------CHHHH
Q 001867          879 ---------RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD-QKGVDHVLDPKLDCC-------FKEEI  941 (1002)
Q Consensus       879 ---------~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~  941 (1002)
                               .++.++||||+||++|||+++..|++..  ...+.+.+..... .......+.+.....       .....
T Consensus       346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  423 (566)
T PLN03225        346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDG  423 (566)
T ss_pred             cccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccc
Confidence                     2345679999999999999977665322  1111111110000 000000011110000       00011


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          942 CKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       942 ~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ....+++.+|++.||++|||++|+++.
T Consensus       424 ~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        424 GAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             hHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            234579999999999999999999863

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=6.8e-29  Score=264.76  Aligned_cols=239  Identities=29%  Similarity=0.397  Sum_probs=192.3

Q ss_pred             CCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCCeeeE
Q 001867          695 SSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL  773 (1002)
Q Consensus       695 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  773 (1002)
                      +||.||+|... +++.+|+|++.....                ....+.+.+|++.+++++|+|++++++++......++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~----------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   64 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKI----------------KKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYL   64 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccc----------------ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEE
Confidence            58999999976 489999999843211                1115789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccC
Q 001867          774 VYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA  853 (1002)
Q Consensus       774 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~  853 (1002)
                      +|||+++++|.+++....  .+++..++.++.+++.+++|||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        65 ~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  139 (244)
T smart00220       65 VMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDP  139 (244)
T ss_pred             EEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence            999999999999987533  389999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccc
Q 001867          854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKL  933 (1002)
Q Consensus       854 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  933 (1002)
                      ..   ......++..|+|||...+..++.++||||+|+++|++++|..||..........+.......    ...  +. 
T Consensus       140 ~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~--~~-  209 (244)
T smart00220      140 GG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP----PFP--PP-  209 (244)
T ss_pred             cc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC----CCc--cc-
Confidence            42   223456888999999998888899999999999999999999999753333333332221111    000  00 


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          934 DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       934 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..   ....++.+++.+|+..+|++||++.++++
T Consensus       210 ~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 EW---KISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cc---cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00   01235888999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=290.86  Aligned_cols=242  Identities=29%  Similarity=0.443  Sum_probs=186.7

Q ss_pred             cCCeeeecCCcc-EEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeeeeE
Q 001867          687 EDNVIGSGSSGK-VYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCC  764 (1002)
Q Consensus       687 ~~~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  764 (1002)
                      ..+++|.|+-|+ ||+|... |+.||||++-.                    .......+||..++.-+ |||||++|+.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~--------------------e~~~~A~rEi~lL~eSD~H~NviRyyc~  571 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLE--------------------EFFDFAQREIQLLQESDEHPNVIRYYCS  571 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC-CceehHHHHhh--------------------HhHHHHHHHHHHHHhccCCCceEEEEee
Confidence            346789999986 5899985 78999999832                    33455789999999885 9999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhc-CC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC---C--
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSC-KG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---D--  837 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~---~--  837 (1002)
                      -.+++..||+.|.| ..+|.++++.. .. ........+....|++.||++||+-   +||||||||.||||+.   +  
T Consensus       572 E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~  647 (903)
T KOG1027|consen  572 EQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGT  647 (903)
T ss_pred             ccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcc
Confidence            99999999999999 57999999863 11 1111145678899999999999998   9999999999999975   3  


Q ss_pred             CCeEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~  915 (1002)
                      .+++|+|||+++.+..+... .......||-+|+|||++....-+.++||||+||++|+.++ |..||++....+  ..+
T Consensus       648 ~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NI  725 (903)
T KOG1027|consen  648 LRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANI  725 (903)
T ss_pred             eeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhh
Confidence            36899999999988765432 22456679999999999999988999999999999999999 489997653221  111


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      +.....   +.. +.+    . .++  ...++|.+|++++|..||++.+|+
T Consensus       726 l~~~~~---L~~-L~~----~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  726 LTGNYT---LVH-LEP----L-PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             hcCccc---eee-ecc----C-chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            111110   000 111    0 111  466889999999999999999997

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=261.67  Aligned_cols=259  Identities=22%  Similarity=0.262  Sum_probs=197.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-----C-
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-----H-  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h-  755 (1002)
                      .+|.+.++||=|.|++||+|.+ .+.+.||+|+.+.                  .+.-.+....||.+|++++     | 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------------------AqhYtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------------------AQHYTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------------------hhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            5678899999999999999985 5678999999843                  3455677889999999984     2 


Q ss_pred             --CceeeeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          756 --KNIVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       756 --~niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                        ..||+++++|..    +.++|+|+|++ |-+|..++..+..+.++...+.+|++|++.||.|||.++  +|||.||||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP  216 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP  216 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence              479999999974    56899999999 889999999888889999999999999999999999997  999999999


Q ss_pred             CcEEECCC------------------------------------------------------------------------
Q 001867          830 NNILLDGD------------------------------------------------------------------------  837 (1002)
Q Consensus       830 ~NIll~~~------------------------------------------------------------------------  837 (1002)
                      +|||+...                                                                        
T Consensus       217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~  296 (590)
T KOG1290|consen  217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE  296 (590)
T ss_pred             ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            99998220                                                                        


Q ss_pred             --------------------------------------------------------------------------------
Q 001867          838 --------------------------------------------------------------------------------  837 (1002)
Q Consensus       838 --------------------------------------------------------------------------------  837 (1002)
                                                                                                      
T Consensus       297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~  376 (590)
T KOG1290|consen  297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS  376 (590)
T ss_pred             cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence                                                                                            


Q ss_pred             --------------CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          838 --------------FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       838 --------------~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                                    -+|||+|||-|+.....     ++....|..|+|||++.+..|+..+||||++|++||++||...|
T Consensus       377 n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLF  451 (590)
T KOG1290|consen  377 NPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLF  451 (590)
T ss_pred             ccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceee
Confidence                          01445555555443221     22334677899999999999999999999999999999999998


Q ss_pred             CCCCCc------hhHHHHHH---HHh---------------hccCcc---ccccccc-------cCCCHHHHHHHHHHHH
Q 001867          904 DPEFGE------KDLVKWVC---STL---------------DQKGVD---HVLDPKL-------DCCFKEEICKVLNIGL  949 (1002)
Q Consensus       904 ~~~~~~------~~~~~~~~---~~~---------------~~~~~~---~~~~~~~-------~~~~~~~~~~l~~l~~  949 (1002)
                      ++..+.      +.+..+++   ...               +.+.+.   ......+       -.-..++..++.+++.
T Consensus       452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~  531 (590)
T KOG1290|consen  452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLS  531 (590)
T ss_pred             cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHH
Confidence            764332      22222211   110               000010   0000000       2344677889999999


Q ss_pred             HcCCCCCCCCCCHHHHHH
Q 001867          950 LCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       950 ~cl~~dP~~Rps~~evl~  967 (1002)
                      -|++.+|++||||+++++
T Consensus       532 PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  532 PMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHhcCccccccHHHHhc
Confidence            999999999999999984

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.5e-28  Score=281.37  Aligned_cols=270  Identities=20%  Similarity=0.226  Sum_probs=177.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-----------------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHH
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-----------------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ  744 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  744 (1002)
                      .++|++.++||+|+||.||+|..                 .+++.||||++.......   .....+.........+...
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~---~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGV---RQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhh---HHHHHhhhhhhhcccchhH
Confidence            46789999999999999999964                 235679999984321000   0000000000011123355


Q ss_pred             HHHHHHhcCCCCce-----eeeeeEEec--------CCeeeEEEeccCCCChhhhhhhcCC-------------------
Q 001867          745 AEVETLGKIRHKNI-----VKLWCCCTT--------RDCKLLVYEYMPNGSLGDLLHSCKG-------------------  792 (1002)
Q Consensus       745 ~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------  792 (1002)
                      .|+.++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            67778888876554     677777753        3568999999999999999874211                   


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccc
Q 001867          793 ---GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY  869 (1002)
Q Consensus       793 ---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y  869 (1002)
                         ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||++........ .......+|+.|
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y  376 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRY  376 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcce
Confidence               2346778899999999999999999   999999999999999999999999999976543321 111223457899


Q ss_pred             cCccccccCC----------------------CCCccchhhHHHHHHHHHhCCC-CCCCCCCc--------hhHHHHHHH
Q 001867          870 IAPEYAYTLR----------------------VNEKSDIYSFGVVILELVTGRL-PVDPEFGE--------KDLVKWVCS  918 (1002)
Q Consensus       870 ~aPE~~~~~~----------------------~~~~~DvwslGvil~ell~g~~-p~~~~~~~--------~~~~~~~~~  918 (1002)
                      +|||.+....                      ...+.||||+||++|||++|.. |+......        .+...|.. 
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-  455 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-  455 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-
Confidence            9999875322                      1235799999999999999875 65422110        11111111 


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCC---CCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLP---INRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rps~~evl~  967 (1002)
                       .....++.   +.+...    .....+++.+++..+|   .+|+|++|+++
T Consensus       456 -~~~~~~~~---~~~d~~----s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 -YKGQKYDF---SLLDRN----KEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -hcccCCCc---cccccc----ChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             11111111   011111    2246677888888765   68999999874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=6.3e-29  Score=238.43  Aligned_cols=203  Identities=24%  Similarity=0.369  Sum_probs=169.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      .++|++.+++|+|.|+.||.|. ..++++++||+++                    ....+.+.+|+.|++.+. ||||+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK--------------------PVkkkKIkREikIL~nL~gg~NIi   96 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK--------------------PVKKKKIKREIKILQNLRGGPNII   96 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec--------------------hHHHHHHHHHHHHHHhccCCCCee
Confidence            3567778899999999999998 4678999999984                    345677999999999997 99999


Q ss_pred             eeeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++...+.  ....+|+||+.+.+.....     +.++..++..++.|++.||.|+|++   ||+|||+||.|+++|..
T Consensus        97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~  168 (338)
T KOG0668|consen   97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHE  168 (338)
T ss_pred             ehhhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechh
Confidence            999999875  4568999999988776655     3488889999999999999999999   99999999999999965


Q ss_pred             -CCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-hhHHH
Q 001867          838 -FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-KDLVK  914 (1002)
Q Consensus       838 -~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~-~~~~~  914 (1002)
                       -..+|+|+|+|.+..+...   ....+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-.+.+. +++++
T Consensus       169 ~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk  245 (338)
T KOG0668|consen  169 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK  245 (338)
T ss_pred             hceeeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence             4689999999998876533   345567788999998765 45788999999999999999999998655443 33333


Q ss_pred             H
Q 001867          915 W  915 (1002)
Q Consensus       915 ~  915 (1002)
                      .
T Consensus       246 I  246 (338)
T KOG0668|consen  246 I  246 (338)
T ss_pred             H
Confidence            3

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-29  Score=268.23  Aligned_cols=207  Identities=24%  Similarity=0.349  Sum_probs=173.1

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC---C
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR---H  755 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h  755 (1002)
                      ....+|...+.+|+|+||.|+.|..+ +...|++|.+++...--   -+++      .....-.+..|++||..++   |
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~---DtWv------rDrkLGtVp~EIqIla~l~~~sH  628 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILV---DTWV------RDRKLGTVPSEIQILATLNKHSH  628 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhh---hhhh------cccccCccchhHHHHHHhhhcCc
Confidence            33456888999999999999999965 45679999887652110   0001      1112234677999999997   9


Q ss_pred             CceeeeeeEEecCCeeeEEEecc-CCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYM-PNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +||++++++|++++.+|++||-. ++.+|.+++.  ....+++..+..|++|++.|+++||+.   +|||||||-+||.+
T Consensus       629 ~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv  703 (772)
T KOG1152|consen  629 ENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV  703 (772)
T ss_pred             cchhhhhheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence            99999999999999999999986 4558999998  456799999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVD  904 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~  904 (1002)
                      +.+|-+||+|||.|.....+    .....+||..|.|||++.+..| ...-|||++|+++|.++....||+
T Consensus       704 d~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999999999876544    3457789999999999998877 467899999999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-28  Score=238.08  Aligned_cols=271  Identities=23%  Similarity=0.348  Sum_probs=198.5

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCc
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKN  757 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n  757 (1002)
                      ...+.|++.+.+|+|.||.+-.+..+ ....+++|.+.+                  .....++|.+|..---.+. |.|
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------------------p~tt~~dF~rEfhY~~~Ls~H~h   82 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------------------PQTTQADFVREFHYSFFLSPHQH   82 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------------------chhhHHHHHHHhccceeeccchh
Confidence            34577888999999999999999964 567899998743                  3455778999987766665 899


Q ss_pred             eeeeee-EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE-C
Q 001867          758 IVKLWC-CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-D  835 (1002)
Q Consensus       758 iv~l~~-~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll-~  835 (1002)
                      |+.-|+ .|+..+..++++||+|.|+|.+-+..   ..+.+....+++.|++.|+.|||++   ++||||||.+|||| +
T Consensus        83 Ii~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~  156 (378)
T KOG1345|consen   83 IIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFD  156 (378)
T ss_pred             hhHHHHHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEec
Confidence            998775 45677888999999999999998864   4588899999999999999999999   99999999999999 3


Q ss_pred             C-CCCeEEccccCcccccCCCCCcccccccccccccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCC-CC
Q 001867          836 G-DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVTGRLPVDPE-FG  908 (1002)
Q Consensus       836 ~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~ell~g~~p~~~~-~~  908 (1002)
                      . ..++|+||||.++..+..-.     ...-+..|.|||.....     ...+.+|||.||+++|.+++|..||... ..
T Consensus       157 ~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~  231 (378)
T KOG1345|consen  157 ADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM  231 (378)
T ss_pred             CCccEEEeeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence            3 34799999999987654322     22245579999975432     2467899999999999999999999733 23


Q ss_pred             chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCCCCC
Q 001867          909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGK  986 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~  986 (1002)
                      ...+.+|..-..+..       ++++..+.....+..++..+-+.++|++|=-..++-++..+..........+.+-.
T Consensus       232 d~~Y~~~~~w~~rk~-------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee  302 (378)
T KOG1345|consen  232 DKPYWEWEQWLKRKN-------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEE  302 (378)
T ss_pred             CchHHHHHHHhcccC-------ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhh
Confidence            344555543222211       22222233333456677778999999999555666655555554444444333333

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-28  Score=244.92  Aligned_cols=262  Identities=24%  Similarity=0.271  Sum_probs=196.7

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +.+..+|.-.+.+|.|+- .|..|.+ -.+++||+|+.-..               +++.....+..+|..++..++|+|
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p---------------f~n~~~akra~rel~l~~~v~~~n   76 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP---------------FQNQTHAKRAYRELKLMKCVNHKN   76 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc---------------cccCccchhhhhhhhhhhhhcccc
Confidence            344556777788899988 5555553 35889999987332               344556677899999999999999


Q ss_pred             eeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |++++.+|...      ...|+||||| .++|...+.    -.++-..+..+.+|++.|++|||+.   +|+||||||+|
T Consensus        77 ii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsn  148 (369)
T KOG0665|consen   77 IISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSN  148 (369)
T ss_pred             eeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCccc
Confidence            99999999754      3579999999 679988876    2377889999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |++..+..+||.|||+|+..+..   -.++..+.|..|+|||++.+..+.+.+||||.||++.||++|..-|.+..-.+.
T Consensus       149 ivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ  225 (369)
T KOG0665|consen  149 IVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ  225 (369)
T ss_pred             ceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence            99999999999999999865443   345677889999999999998899999999999999999999988864432222


Q ss_pred             HHHHHHHHh----------------------hc--cCccc-cccccc---cCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 001867          912 LVKWVCSTL----------------------DQ--KGVDH-VLDPKL---DCCFKEEICKVLNIGLLCTSPLPINRPAMR  963 (1002)
Q Consensus       912 ~~~~~~~~~----------------------~~--~~~~~-~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  963 (1002)
                      ..+.+....                      +.  -...+ ..|...   ....+-......+++.+|+-.||++|.+++
T Consensus       226 ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~  305 (369)
T KOG0665|consen  226 WNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD  305 (369)
T ss_pred             HHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence            111111110                      00  00001 111111   111122233456788899999999999999


Q ss_pred             HHHH
Q 001867          964 RVVK  967 (1002)
Q Consensus       964 evl~  967 (1002)
                      +++.
T Consensus       306 daL~  309 (369)
T KOG0665|consen  306 DALR  309 (369)
T ss_pred             HHhc
Confidence            9885

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=3.5e-26  Score=237.94  Aligned_cols=211  Identities=35%  Similarity=0.538  Sum_probs=182.2

Q ss_pred             eeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      ||+|.+|.||++...+ ++.+++|++.....                ....+.+.+|++.++.++|++++++++++....
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   64 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS----------------SSLLEELLREIEILKKLNHPNIVKLYGVFEDEN   64 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccc----------------hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC
Confidence            6899999999999754 89999999844211                003567999999999999999999999999999


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC-CCCeEEccccCc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG-DFGARVADFGVA  848 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGl~  848 (1002)
                      ..+++|||+++++|.+++.... ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+
T Consensus        65 ~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~  140 (215)
T cd00180          65 HLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLS  140 (215)
T ss_pred             eEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCce
Confidence            9999999999899999997532 4689999999999999999999999   9999999999999998 899999999999


Q ss_pred             ccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccc
Q 001867          849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDH  927 (1002)
Q Consensus       849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1002)
                      ........  ......+...|++||..... .++.++|+|++|+++|+|                               
T Consensus       141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------  187 (215)
T cd00180         141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------  187 (215)
T ss_pred             EEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence            87655432  12234577889999998877 788999999999999999                               


Q ss_pred             cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       928 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                                    ..+.+++..|++.+|++||+++++++.
T Consensus       188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                          237788899999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=261.44  Aligned_cols=250  Identities=29%  Similarity=0.382  Sum_probs=195.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|+..+++|.|.||.||||++ ..++..|+|+++-.                 .......+++|+-+++..+|||||.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-----------------p~dd~~~iqqei~~~~dc~h~niva   76 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-----------------PGDDFSGIQQEIGMLRDCRHPNIVA   76 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeecc-----------------CCccccccccceeeeecCCCcChHH
Confidence            46788889999999999999995 46889999998543                 2223455788999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++.+-..+..+++|||+.+|+|.+.-+  -.+++++.++...++...+|++|||++   +-+|||||-.||++++.|.+
T Consensus        77 y~gsylr~dklwicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDv  151 (829)
T KOG0576|consen   77 YFGSYLRRDKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDV  151 (829)
T ss_pred             HHhhhhhhcCcEEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCce
Confidence            9999999999999999999999999876  568899999999999999999999999   88999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA---YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      |++|||.+-.+...-.  ......||++|||||+.   ..+.|..++|||+.|+...|+-.-+.|--+-   ......+.
T Consensus       152 klaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl---hpmr~l~L  226 (829)
T KOG0576|consen  152 KLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL---HPMRALFL  226 (829)
T ss_pred             eecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc---chHHHHHH
Confidence            9999999876654321  11245799999999975   3667999999999999999998777663221   22111111


Q ss_pred             HHhhccCcccccccccc--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          918 STLDQKGVDHVLDPKLD--CCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      .  ....++   .|.+.  ..+.+   .+-++++.|+-.+|++||+++.++
T Consensus       227 m--TkS~~q---pp~lkDk~kws~---~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  227 M--TKSGFQ---PPTLKDKTKWSE---FFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             h--hccCCC---CCcccCCccchH---HHHHHHHHHhcCCCccCCChhhhe
Confidence            1  111111   12221  11122   345778889999999999998765

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-28  Score=253.70  Aligned_cols=287  Identities=23%  Similarity=0.235  Sum_probs=145.1

Q ss_pred             EEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCccccccccc-ccccCCCCccccccCCccccccc
Q 001867           71 VASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQ-NLLTGTLTPALADLPNLKFLDLT  149 (1002)
Q Consensus        71 v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~L~~L~~L~Ls  149 (1002)
                      .+.++|..|+|+.+.|.+|+.+++|++|||++|+|+.+-|++|.++.+|.+|-+-+ |+|+......|++|..|+.|.+.
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN  148 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN  148 (498)
T ss_pred             ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence            44445555555544444555555555555555555544555555554444433332 44544434444555555555555


Q ss_pred             cccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccc
Q 001867          150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGE  229 (1002)
Q Consensus       150 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  229 (1002)
                      -|++.-...+.|..+++|..|.|.+|.+..+--..|..+..++.+.+..|.+..      ..+++-+..       +...
T Consensus       149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic------dCnL~wla~-------~~a~  215 (498)
T KOG4237|consen  149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC------DCNLPWLAD-------DLAM  215 (498)
T ss_pred             hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc------ccccchhhh-------HHhh
Confidence            555444444444445555555555554442222344444444444444444210      111111111       1112


Q ss_pred             cccccccccccchhcccCcccccccCccccc-ccceeeeeccCCcccCCCCC-ccccccccceeeccccccCCCCCccCC
Q 001867          230 IPDSLGRLAKLVDLDLALNNLVGAIPSSLTE-LASVVQIELYNNSLTGDLPT-GWSNLTSLRLLDASMNDLTGPIPDDLT  307 (1002)
Q Consensus       230 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~  307 (1002)
                      .|..++...-..-..+.++++....+..|.. +.++..-..+.+...++-|. .|..+++|+.|+|++|+|++.-+.+|.
T Consensus       216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe  295 (498)
T KOG4237|consen  216 NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFE  295 (498)
T ss_pred             chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhc
Confidence            3344444444444455555555444433322 22222222233333334443 477777777777777777766666666


Q ss_pred             CCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCcccc
Q 001867          308 RLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT  370 (1002)
Q Consensus       308 ~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  370 (1002)
                      ... ++.|+|..|+|+..-...|.++.+|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+.
T Consensus       296 ~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  296 GAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             chhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            653 666666666666555566666666666666666666666666666666666666666654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=2.5e-25  Score=234.41  Aligned_cols=200  Identities=35%  Similarity=0.469  Sum_probs=171.4

Q ss_pred             CCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |++.+.||+|++|.||+|...+ ++.+|+|.+.....                ....+.+.+|++.+++++|+|++++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------------~~~~~~~~~e~~~~~~~~~~~i~~~~~   64 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKT----------------EKQREEFLREIRILKKLKHPNIVKLYG   64 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccc----------------hHHHHHHHHHHHHHHhCCCCChhhhee
Confidence            4567899999999999999764 88999999843210                024678899999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++......++++||+++++|.+++..... .+++..+..++.+++.++.|||+.   +++|+|++|+||+++.++.++|+
T Consensus        65 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~  140 (225)
T smart00221       65 VFEDPEPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLA  140 (225)
T ss_pred             eeecCCceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence            99999999999999999999999985332 289999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA-YTLRVNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      |||.+........ .......++..|++||.. ....++.++|||+||+++|||++|+.||..
T Consensus       141 d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      141 DFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            9999987755421 122344677889999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.7e-26  Score=245.83  Aligned_cols=199  Identities=22%  Similarity=0.270  Sum_probs=167.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC------C
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR------H  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h  755 (1002)
                      ..|.+....|+|-|++|.+|.+. .|..||||+|...                  +.-.+.=.+|++||++|.      .
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN------------------E~M~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN------------------EVMHKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc------------------hHHhhhhhHHHHHHHHhhccCchhh
Confidence            46788888999999999999964 4789999999553                  223344567999999995      4


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      -|.++++..|...+++|+|||-+ ..+|.+.++.. +...+...++..+++|++.||..|..-   +|+|.||||.||||
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILV  569 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEe
Confidence            58999999999999999999998 67999999863 335688899999999999999999997   99999999999999


Q ss_pred             CCC-CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          835 DGD-FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       835 ~~~-~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      .+. ..+||||||.|.......-    +...-+..|+|||++.+..|+...|+||.||++||+.||+.-|.+..
T Consensus       570 NE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            865 4579999999987655432    22234567999999999999999999999999999999999886553

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=5.1e-26  Score=239.29  Aligned_cols=200  Identities=30%  Similarity=0.419  Sum_probs=166.5

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-C
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-H  755 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  755 (1002)
                      +.+.|...++||+|.|++||+|.+.    .++.||+|.+...                   ....++..|++++..+. +
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-------------------s~p~ri~~El~~L~~~gG~   94 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-------------------SSPSRILNELEMLYRLGGS   94 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-------------------cCchHHHHHHHHHHHhccc
Confidence            4567888999999999999999853    3678999998653                   23456899999999995 9


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      .||+++.+++..++.+.+|+||++.-...++...     ++...+..+++.+..||+++|.+   |||||||||+|++++
T Consensus        95 ~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n  166 (418)
T KOG1167|consen   95 DNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYN  166 (418)
T ss_pred             hhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccc
Confidence            9999999999999999999999999888888763     67889999999999999999999   999999999999998


Q ss_pred             C-CCCeEEccccCcccccCCC----------------------------------CCc--------ccccccccccccCc
Q 001867          836 G-DFGARVADFGVAKVVDASG----------------------------------KPK--------SMSVIAGSCGYIAP  872 (1002)
Q Consensus       836 ~-~~~~kl~DfGl~~~~~~~~----------------------------------~~~--------~~~~~~gt~~y~aP  872 (1002)
                      . .+.-.|+|||+|...+...                                  +..        ......||++|+||
T Consensus       167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP  246 (418)
T KOG1167|consen  167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP  246 (418)
T ss_pred             cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence            4 4678999999998322110                                  000        01133699999999


Q ss_pred             ccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          873 EYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       873 E~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      |++.. ...++++||||.|||+.-+++++.||-...
T Consensus       247 EvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  247 EVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             HHHhhccCcCCccceeeccceeehhhccccccccCc
Confidence            98775 457889999999999999999999986443

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-27  Score=245.24  Aligned_cols=254  Identities=23%  Similarity=0.251  Sum_probs=198.8

Q ss_pred             CeEEEEEcCCCCcCCCCCccccCCCCCCEEeccC-CCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccc
Q 001867           69 HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFN-NSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLD  147 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~  147 (1002)
                      ++++.|||++|+|+.+-|.+|.+|.+|.+|-+.+ |+|+.+..+.|.+|..|+.|.+.-|++.-.....|..|++|..|.
T Consensus        91 ~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLs  170 (498)
T KOG4237|consen   91 HRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLS  170 (498)
T ss_pred             hhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhc
Confidence            5699999999999999999999999999988776 999988888999999999999999999988888999999999999


Q ss_pred             cccccccCCCCcccccccccceeeeccccc------------cCccccccccccccccccccCCCCCCCCCCcccCCCCc
Q 001867          148 LTGNNFSGDIPESFGRFQKLEVISLVYNLL------------DGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTN  215 (1002)
Q Consensus       148 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l------------~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~  215 (1002)
                      |..|.+..+--.+|..+..++.+.+..|.+            ....|..++......-..+.++++....--.....+..
T Consensus       171 lyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~es  250 (498)
T KOG4237|consen  171 LYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLES  250 (498)
T ss_pred             ccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHh
Confidence            999999944444999999999999999982            23445556666656666666665421111111222333


Q ss_pred             cchhhccCccccccccc-ccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeecc
Q 001867          216 LEILWLTECNLVGEIPD-SLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDAS  294 (1002)
Q Consensus       216 L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  294 (1002)
                      +..-..+.+...++.|. .|..+++|+.|+|++|+|+.+-+.+|.++..+++|+|..|++..+-...|.++..|+.|+|.
T Consensus       251 l~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~  330 (498)
T KOG4237|consen  251 LPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLY  330 (498)
T ss_pred             HHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeec
Confidence            33333344444445453 58888888888888888888888888888888888888888887777788888888888888


Q ss_pred             ccccCCCCCccCCCCC-cceeecCCCccc
Q 001867          295 MNDLTGPIPDDLTRLP-LESLNLYENRLE  322 (1002)
Q Consensus       295 ~N~l~~~~p~~~~~~~-L~~L~L~~N~l~  322 (1002)
                      +|+|+...|..|.... |..|+|-.|.+.
T Consensus       331 ~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  331 DNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             CCeeEEEecccccccceeeeeehccCccc
Confidence            8888887788887764 888888777654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=4e-24  Score=216.01  Aligned_cols=169  Identities=23%  Similarity=0.283  Sum_probs=130.4

Q ss_pred             CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCccc
Q 001867          781 GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM  860 (1002)
Q Consensus       781 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~  860 (1002)
                      |+|.++++. ++..+++.+++.++.|++.||+|||++   +      ||+||+++.++.+|+  ||.+.......     
T Consensus         1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence            689999975 345699999999999999999999998   5      999999999999999  99998765432     


Q ss_pred             ccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHH
Q 001867          861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEE  940 (1002)
Q Consensus       861 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  940 (1002)
                        ..||+.|||||++.+..++.++|||||||++|||++|+.||.....................      +.........
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~  135 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------PRDRSNLESV  135 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------ccccccHHHH
Confidence              25889999999999999999999999999999999999999755433332222222111110      0000111111


Q ss_pred             H--HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          941 I--CKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       941 ~--~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .  .++.+++.+||+.+|++||++.|+++.+..+..
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            1  258899999999999999999999999877653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=5.6e-25  Score=273.44  Aligned_cols=196  Identities=19%  Similarity=0.249  Sum_probs=140.6

Q ss_pred             cCCC-CceeeeeeEE-------ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 001867          752 KIRH-KNIVKLWCCC-------TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIV  823 (1002)
Q Consensus       752 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  823 (1002)
                      .++| +||++++++|       ...+..+.+|||+ +++|.+++.. ....+++.+++.+++||++||+|||++   +|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            3456 6888888887       2334677889988 6799999974 245699999999999999999999999   999


Q ss_pred             eCCCCCCcEEECC-------------------CCCeEEccccCcccccCCCC--------------Cccccccccccccc
Q 001867          824 HRDVKSNNILLDG-------------------DFGARVADFGVAKVVDASGK--------------PKSMSVIAGSCGYI  870 (1002)
Q Consensus       824 HrDlk~~NIll~~-------------------~~~~kl~DfGl~~~~~~~~~--------------~~~~~~~~gt~~y~  870 (1002)
                      ||||||+|||++.                   ++.+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   44566777777654321000              00011245889999


Q ss_pred             CccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHH
Q 001867          871 APEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLL  950 (1002)
Q Consensus       871 aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  950 (1002)
                      |||++.+..++.++|||||||++|||++|..|+....   ........    .    .+.+...    ....+...++.+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~----~----~~~~~~~----~~~~~~~~~~~~  247 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRH----R----VLPPQIL----LNWPKEASFCLW  247 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHH----h----hcChhhh----hcCHHHHHHHHH
Confidence            9999999999999999999999999999887764221   11111110    0    0111111    112235577889


Q ss_pred             cCCCCCCCCCCHHHHHH
Q 001867          951 CTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       951 cl~~dP~~Rps~~evl~  967 (1002)
                      ||+++|.+||++.|+++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999975

>PLN03210 Resistant to P

Probab=99.91  E-value=1.1e-23  Score=269.33  Aligned_cols=344  Identities=20%  Similarity=0.223  Sum_probs=167.3

Q ss_pred             ccccccccceeeecccc------ccCcccccccccc-ccccccccCCCCCCCCCCcccCCCCccchhhccCccccccccc
Q 001867          160 SFGRFQKLEVISLVYNL------LDGTIPAFLGNIS-TLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPD  232 (1002)
Q Consensus       160 ~~~~l~~L~~L~L~~N~------l~~~~p~~l~~l~-~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~  232 (1002)
                      +|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+  ..+|..| ...+|++|+|.+|++. .++.
T Consensus       553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l--~~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPL--RCMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCC--CCCCCcC-CccCCcEEECcCcccc-cccc
Confidence            44555555555554332      1223344444442 355555555554  3445444 3455556666666555 4455


Q ss_pred             ccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcc
Q 001867          233 SLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLE  312 (1002)
Q Consensus       233 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~  312 (1002)
                      .+..+++|+.|+|++|.....+|. +..+++|+.|+|++|.....+|..+.++++|+.|++++|...+.+|..+...+|+
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~  707 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLY  707 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCC
Confidence            555566666666655543334442 5555566666666655444555556666666666666544333444443222355


Q ss_pred             eeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccc
Q 001867          313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNS  392 (1002)
Q Consensus       313 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  392 (1002)
                      .|++++|...+.+|..   .++|++|++++|.+. .+|..+ .+++|+.|++.++.... +...                
T Consensus       708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~-l~~~----------------  765 (1153)
T PLN03210        708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK-LWER----------------  765 (1153)
T ss_pred             EEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh-cccc----------------
Confidence            5555555433333322   234455555555544 233322 34445555554432110 0000                


Q ss_pred             cccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccc
Q 001867          393 FTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE  472 (1002)
Q Consensus       393 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  472 (1002)
                      +....+......++|+.|+|++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|..
T Consensus       766 ~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~  844 (1153)
T PLN03210        766 VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI  844 (1153)
T ss_pred             ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc
Confidence            000011111122344444444444444444444444455555554443333333333 3455555555554433334432


Q ss_pred             cccccccccccccccccCCCCcccccccccCCeeecCCC-cCCcccccccccccccccccccCcc
Q 001867          473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAN-DLSGELPSSVSSWKKLNELNLADNL  536 (1002)
Q Consensus       473 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~  536 (1002)
                         ..+|+.|+|++|.++ .+|.++..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus       845 ---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        845 ---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             ---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence               245666666666666 45666666666666666663 333 455566666666666666553

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=1.3e-23  Score=268.73  Aligned_cols=336  Identities=20%  Similarity=0.239  Sum_probs=199.2

Q ss_pred             cccccccccchhcccCcc------cccccCccccccc-ceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCc
Q 001867          232 DSLGRLAKLVDLDLALNN------LVGAIPSSLTELA-SVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPD  304 (1002)
Q Consensus       232 ~~~~~l~~L~~L~L~~N~------l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  304 (1002)
                      .+|.++.+|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|+.|++++|++. .++.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            445556666666554432      2223444444443 3666666666554 444444 3456666666666665 3444


Q ss_pred             cCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcc
Q 001867          305 DLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGEL  383 (1002)
Q Consensus       305 ~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  383 (1002)
                      .+..++ |+.|+|++|.....+|. +..+++|++|+|++|.....+|..+..+++|+.|++++|..-+.+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            444433 66666665543334442 5556666666666665555566666666666666666654333555444 56666


Q ss_pred             cceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCccc-------CccccccccCCccc
Q 001867          384 EELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLS-------GEISKNIAGAANLS  456 (1002)
Q Consensus       384 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~-------~~~~~~~~~l~~L~  456 (1002)
                      +.|++++|...+.+|..   ..+|++|+|++|.++ .+|..+ .+++|+.|++.++...       ...+..+...++|+
T Consensus       707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~  781 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT  781 (1153)
T ss_pred             CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence            66666666555455532   345666677776665 344433 4566666666553321       11122223345677


Q ss_pred             EEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcc
Q 001867          457 LLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNL  536 (1002)
Q Consensus       457 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  536 (1002)
                      .|+|++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|..   ..+|+.|+|++|.
T Consensus       782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~  857 (1153)
T PLN03210        782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTG  857 (1153)
T ss_pred             heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCC
Confidence            77777777666777777777777777777765444666655 5777777777776554455543   2467777777777


Q ss_pred             cccCCCCCccccccccEEeCcc-eeeecccCCccccc-ccceEEecccc
Q 001867          537 FYGNIPEDIGNLSVLNYLDLSN-NRLSGRIPVGLQNL-KLNQLNVSNNR  583 (1002)
Q Consensus       537 l~~~ip~~~~~l~~L~~L~Ls~-N~l~~~ip~~~~~l-~L~~l~ls~N~  583 (1002)
                      ++ .+|.++..+++|++|+|++ |+|. .+|..+..+ .|+.++++++.
T Consensus       858 i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        858 IE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             Cc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            76 6777777777777777777 4555 466666666 67777777663

syringae 6; Provisional

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-22  Score=224.57  Aligned_cols=277  Identities=22%  Similarity=0.283  Sum_probs=204.3

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCC--cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC----Cc
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNG--EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH----KN  757 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~n  757 (1002)
                      .|.+.+.||+|+||.||.|.....  ..+|+|......                 ......+..|+.++..+..    ++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~-----------------~~~~~~l~~E~~vl~~l~~~~~~~~   81 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL-----------------GSKPSVLKIEIQVLKKLEKKNGPSH   81 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc-----------------cCCCccchhHHHHHHHHhhhcCCCC
Confidence            688899999999999999997543  478888763321                 1111257888899888862    68


Q ss_pred             eeeeeeEE-ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          758 IVKLWCCC-TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       758 iv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      +..+++.. ..++..|+||+.+ |.+|.++......+.++..+..+++.|++.+|+++|+.   |++||||||.|+.+..
T Consensus        82 ~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~  157 (322)
T KOG1164|consen   82 FPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQ  157 (322)
T ss_pred             CCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecC
Confidence            99999999 5788899999999 89999988765667899999999999999999999999   9999999999999975


Q ss_pred             C-----CCeEEccccCccccc--CCC-----CCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          837 D-----FGARVADFGVAKVVD--ASG-----KPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       837 ~-----~~~kl~DfGl~~~~~--~~~-----~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                      .     ..+.+.|||+++...  ...     ..+. .....||.+|.++....+...+++.|+||++.++.|+..|..||
T Consensus       158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW  237 (322)
T KOG1164|consen  158 SSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW  237 (322)
T ss_pred             CCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence            4     358999999998332  111     1111 23456999999999999999999999999999999999999999


Q ss_pred             CCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCC
Q 001867          904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKK  983 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~  983 (1002)
                      ..........+... .......    .. .....+.+..++..   .+-..+..++|....+.+.+++.....      .
T Consensus       238 ~~~~~~~~~~~~~~-~~~~~~~----~~-~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~------~  302 (322)
T KOG1164|consen  238 EALEMTDLKSKFEK-DPRKLLT----DR-FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSE------G  302 (322)
T ss_pred             ccccccchHHHHHH-Hhhhhcc----cc-ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhc------C
Confidence            65433222222111 1111111    11 22233344444444   444588999999999999998876544      2


Q ss_pred             CCCCCcchhhccc
Q 001867          984 DGKLSPYYHEDAS  996 (1002)
Q Consensus       984 ~~~~~~~~~~~~~  996 (1002)
                      ....+|+.|+...
T Consensus       303 ~~~~~~~dw~~~~  315 (322)
T KOG1164|consen  303 SKEDSPFDWEVKL  315 (322)
T ss_pred             CCCCCCCcccccc
Confidence            2333777777543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=8.4e-24  Score=208.04  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=189.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .+..+..+|.+...|+.|+|+|+ |..+++|++....               .......+|..|.-.++.+.||||.+++
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~---------------~t~risrdfneefp~lrifshpnilpvl  253 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVRE---------------VTARISRDFNEEFPALRIFSHPNILPVL  253 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc-Ccchhhhhhhhhh---------------cchhhcchhhhhCcceeeecCCchhhhh
Confidence            34555678899999999999997 4556667773321               1233456799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee-eCCCCCCcEEECCCCCeE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIV-HRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii-HrDlk~~NIll~~~~~~k  841 (1002)
                      +.|.......++..||+.|+|...++....-.++..++.+++.++|+|++|||+. + +++ ---+..+.|++|++.+++
T Consensus       254 gacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-e-p~ipr~~lns~hvmidedltar  331 (448)
T KOG0195|consen  254 GACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-E-PMIPRFYLNSKHVMIDEDLTAR  331 (448)
T ss_pred             hhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-c-hhhhhhhcccceEEecchhhhh
Confidence            9999999999999999999999999987777889999999999999999999996 3 444 346889999999998887


Q ss_pred             Ec--cccCcccccCCCCCcccccccccccccCccccccCCC---CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VA--DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV---NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~--DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+  |--++...         ....-.+.||+||.+.....   ..++|+|||++++||+.|...||.+-...+--.+..
T Consensus       332 ismad~kfsfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia  402 (448)
T KOG0195|consen  332 ISMADTKFSFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA  402 (448)
T ss_pred             eecccceeeeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh
Confidence            74  32222111         12234578999999887653   368999999999999999999997543322111111


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                           .+.++.-+.|    ...   ..+.+++.-|++.||.+||.++.|+-.|+++.
T Consensus       403 -----leglrv~ipp----gis---~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 -----LEGLRVHIPP----GIS---RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----hccccccCCC----Ccc---HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                 1122222222    222   23666777899999999999999999999874

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=6.3e-23  Score=242.70  Aligned_cols=261  Identities=30%  Similarity=0.361  Sum_probs=137.6

Q ss_pred             eeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhccccc
Q 001867          264 VVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRN  343 (1002)
Q Consensus       264 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  343 (1002)
                      -..|+|++|.++ .+|..+.  ++|+.|++++|+++. +|...  ..|++|+|++|+|+. +|..   .++|+.|++++|
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~lp--~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N  272 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALP--PELRTLEVSGNQLTS-LPVL---PPGLLELSIFSN  272 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCCC--CCCcEEEecCCccCc-ccCc---ccccceeeccCC
Confidence            345677777776 4555443  356667777777663 33321  135555666555553 2321   234445555555


Q ss_pred             ccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCC
Q 001867          344 RLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP  423 (1002)
Q Consensus       344 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~  423 (1002)
                      .++. +|..   ..+|+.|++++|+++                        . +|.   ..++|+.|+|++|++++ +|.
T Consensus       273 ~L~~-Lp~l---p~~L~~L~Ls~N~Lt------------------------~-LP~---~p~~L~~LdLS~N~L~~-Lp~  319 (788)
T PRK15387        273 PLTH-LPAL---PSGLCKLWIFGNQLT------------------------S-LPV---LPPGLQELSVSDNQLAS-LPA  319 (788)
T ss_pred             chhh-hhhc---hhhcCEEECcCCccc------------------------c-ccc---cccccceeECCCCcccc-CCC
Confidence            5442 2221   133444445555444                        2 222   12445555555555553 232


Q ss_pred             cCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccC
Q 001867          424 LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAEL  503 (1002)
Q Consensus       424 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  503 (1002)
                      ..   .+|+.|++++|.|+++ |.   -..+|+.|+|++|+|+ .+|..   ..+|+.|++++|+|+ .+|...   .+|
T Consensus       320 lp---~~L~~L~Ls~N~L~~L-P~---lp~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L  384 (788)
T PRK15387        320 LP---SELCKLWAYNNQLTSL-PT---LPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPALP---SGL  384 (788)
T ss_pred             Cc---ccccccccccCccccc-cc---cccccceEecCCCccC-CCCCC---Ccccceehhhccccc-cCcccc---ccc
Confidence            11   2344555555555532 21   1135666666666666 34432   235556666666666 355432   456


Q ss_pred             CeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccc
Q 001867          504 GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNN  582 (1002)
Q Consensus       504 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N  582 (1002)
                      +.|+|++|+|++ +|...   ++|+.|++++|.|+ .+|...   .+|+.|+|++|+|+ .+|..+..+ .|+.|+|++|
T Consensus       385 ~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N  455 (788)
T PRK15387        385 KELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN  455 (788)
T ss_pred             ceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence            666777776663 44322   45666677777766 355432   34566777777776 566666666 5677777777


Q ss_pred             cCcCCCChh
Q 001867          583 RLSGELPSL  591 (1002)
Q Consensus       583 ~l~g~~p~~  591 (1002)
                      +|+|.+|+.
T Consensus       456 ~Ls~~~~~~  464 (788)
T PRK15387        456 PLSERTLQA  464 (788)
T ss_pred             CCCchHHHH
Confidence            777666653

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=4.6e-23  Score=243.85  Aligned_cols=267  Identities=32%  Similarity=0.409  Sum_probs=193.0

Q ss_pred             ccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCC
Q 001867          239 KLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYE  318 (1002)
Q Consensus       239 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~  318 (1002)
                      .-..|+|+.|.++ .+|..+.  .+|+.|++.+|+++. +|.   .+++|++|++++|+|+. +|...  ..|+.|+|++
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~lp--~sL~~L~Ls~  271 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVLP--PGLLELSIFS  271 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCcc--cccceeeccC
Confidence            4567899999998 5677765  489999999999995 554   35899999999999994 55432  2589999999


Q ss_pred             CcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCC
Q 001867          319 NRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLP  398 (1002)
Q Consensus       319 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  398 (1002)
                      |.++. +|..+   ++|+.|++++|+++. +|..   .++|+.|+|++|+|++ +|...   .+|+.|++++|.+++ +|
T Consensus       272 N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP  338 (788)
T PRK15387        272 NPLTH-LPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LP  338 (788)
T ss_pred             Cchhh-hhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cc
Confidence            99984 44433   568899999999985 4442   4679999999999985 44322   345666666666653 33


Q ss_pred             CcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccc
Q 001867          399 DGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKS  478 (1002)
Q Consensus       399 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  478 (1002)
                      ..   ..+|+.|+|++|+|++ +|..                           ..+|+.|++++|+|+ .+|..   ..+
T Consensus       339 ~l---p~~Lq~LdLS~N~Ls~-LP~l---------------------------p~~L~~L~Ls~N~L~-~LP~l---~~~  383 (788)
T PRK15387        339 TL---PSGLQELSVSDNQLAS-LPTL---------------------------PSELYKLWAYNNRLT-SLPAL---PSG  383 (788)
T ss_pred             cc---ccccceEecCCCccCC-CCCC---------------------------Ccccceehhhccccc-cCccc---ccc
Confidence            21   1355666666666653 2321                           134555666666666 34543   246


Q ss_pred             cccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcc
Q 001867          479 LVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSN  558 (1002)
Q Consensus       479 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~  558 (1002)
                      |+.|++++|+|+ .+|...   ++|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .+|..++++++|+.|+|++
T Consensus       384 L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~  454 (788)
T PRK15387        384 LKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  454 (788)
T ss_pred             cceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence            777788888877 355433   578889999999985 56543   46788999999998 7999999999999999999


Q ss_pred             eeeecccCCccccc
Q 001867          559 NRLSGRIPVGLQNL  572 (1002)
Q Consensus       559 N~l~~~ip~~~~~l  572 (1002)
                      |+|+|.+|..+..+
T Consensus       455 N~Ls~~~~~~L~~l  468 (788)
T PRK15387        455 NPLSERTLQALREI  468 (788)
T ss_pred             CCCCchHHHHHHHH
Confidence            99999888776554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=221.84  Aligned_cols=170  Identities=21%  Similarity=0.192  Sum_probs=130.7

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc--CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS--NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ..++|++.+.||+|+||+||+|..+  +++.||||++.....            ........+.+.+|++++++++|+|+
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~------------~~~~~~~~~~~~~E~~iL~~L~h~~i   83 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVP------------WWSKPLARHLAAREIRALKTVRGIGV   83 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccc------------ccccHHHHHHHHHHHHHHHhccCCCC
Confidence            4578999999999999999999864  477789998732110            00122345679999999999999999


Q ss_pred             ee-eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCcEEECC
Q 001867          759 VK-LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV-KSNNILLDG  836 (1002)
Q Consensus       759 v~-l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl-k~~NIll~~  836 (1002)
                      ++ ++++    +..|+||||++|++|... .  ...      ...++.|+++||+|||++   +|+|||| ||+||+++.
T Consensus        84 v~~l~~~----~~~~LVmE~~~G~~L~~~-~--~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~  147 (365)
T PRK09188         84 VPQLLAT----GKDGLVRGWTEGVPLHLA-R--PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGP  147 (365)
T ss_pred             CcEEEEc----CCcEEEEEccCCCCHHHh-C--ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcC
Confidence            85 4432    457999999999999632 1  111      146789999999999999   9999999 999999999


Q ss_pred             CCCeEEccccCcccccCCCCC------cccccccccccccCccccccC
Q 001867          837 DFGARVADFGVAKVVDASGKP------KSMSVIAGSCGYIAPEYAYTL  878 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~  878 (1002)
                      ++.+||+|||+|+.+......      .......+++.|+|||++...
T Consensus       148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999999999977654321      112356788899999987643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.8e-22  Score=236.72  Aligned_cols=259  Identities=22%  Similarity=0.228  Sum_probs=190.9

Q ss_pred             cCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          687 EDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       687 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      ...++|.|++|.|+.+.. ...+.++.|.+... .          ............+..|+-+-..++|||++.....+
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~----------~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~  390 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-V----------KPTESERKYNYNITSEFCIGSSLSHPNIIETLDIV  390 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcc-c----------CCcccHHHHhhhhhhheeecccccCCchhhhHHHH
Confidence            457899999998887764 33444555543210 0          01111222223377788888899999998888777


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      .+....+-+|||+++ +|..++..  ...++..++..++.|+..|++|+|+.   ||.|||+|++|++++.+|.+||+||
T Consensus       391 ~~~~~~~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Df  464 (601)
T KOG0590|consen  391 QEIDGILQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDF  464 (601)
T ss_pred             hhcccchhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeec
Confidence            776666666999998 99999974  34688899999999999999999999   9999999999999999999999999


Q ss_pred             cCcccccCCCCC--cccccccccccccCccccccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          846 GVAKVVDASGKP--KSMSVIAGSCGYIAPEYAYTLRVNE-KSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       846 Gl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      |.+..+.-....  ......+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......++.....     .
T Consensus       465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-----~  539 (601)
T KOG0590|consen  465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-----N  539 (601)
T ss_pred             CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----c
Confidence            999877655443  3445678999999999999999875 6899999999999999999998654433321000     0


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......+.................++.+++++||.+|.|+++|++
T Consensus       540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000111111112222344456778999999999999999999985

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.2e-21  Score=188.38  Aligned_cols=265  Identities=20%  Similarity=0.258  Sum_probs=196.7

Q ss_pred             HHHHhcCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC-
Q 001867          678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH-  755 (1002)
Q Consensus       678 ~~~~~~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-  755 (1002)
                      ++.+...|.++++||+|+||.+|.|. ..+|++||+|.-...                   ...-++..|..+++.+++ 
T Consensus        10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-------------------a~hpqL~yEskvY~iL~~g   70 (341)
T KOG1163|consen   10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-------------------AKHPQLLYESKVYRILQGG   70 (341)
T ss_pred             hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-------------------CCCcchhHHHHHHHHhccC
Confidence            34446789999999999999999999 578999999975321                   122346778899999974 


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      ..|..+..+..+...-.+|||.+ |.+|++.+.-+. ..++..+++..+-|++.-++|+|.+   ++|||||||+|+|..
T Consensus        71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMG  145 (341)
T KOG1163|consen   71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMG  145 (341)
T ss_pred             CCCchhhhhccccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeec
Confidence            78888888889999999999999 899999988765 4589999999999999999999999   999999999999995


Q ss_pred             C---CCCeEEccccCcccccCCCC-----CcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          836 G---DFGARVADFGVAKVVDASGK-----PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       836 ~---~~~~kl~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      -   -..+.++|||+|+...+...     .+......||-+|.+--...+...+.+.|+=|+|.++.+.--|..||.+-.
T Consensus       146 lgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  146 LGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             cccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            3   34689999999987754322     223345579999998888788888899999999999999999999997653


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .....-++  ..+.+......+.....+.+.|    +...+..|-..-=++-|+..-+.+.+.-+
T Consensus       226 a~tk~QKy--EkI~EkK~s~~ie~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  226 AATKKQKY--EKISEKKMSTPIEVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             hhhHHHHH--HHHHHhhcCCCHHHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            32211111  1111111222122222333333    44455567666667778777777666544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=8.5e-21  Score=192.75  Aligned_cols=263  Identities=20%  Similarity=0.255  Sum_probs=201.4

Q ss_pred             cCCCcCCeeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  760 (1002)
                      -.|.++++||+|.||.++.|+ .-+++.||+|.--.                   +...-++..|...++.|. .++|..
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-------------------kS~APQLrdEYr~YKlL~g~~GIP~   88 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-------------------KSEAPQLRDEYRTYKLLGGTEGIPQ   88 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccc-------------------cCCcchHHHHHHHHHHHcCCCCCCc
Confidence            368889999999999999999 56799999995311                   122345778888888886 699999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC--
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF--  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~--  838 (1002)
                      .|.+..++.+-.+|+|.+ |-+|+|+++-|. ..++..+++.+|.|++.-++|+|++   ..|+|||||+|+||...+  
T Consensus        89 vYYFGqeG~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k  163 (449)
T KOG1165|consen   89 VYYFGQEGKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTK  163 (449)
T ss_pred             eeeeccccchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCC
Confidence            999999998899999999 899999998865 4699999999999999999999999   999999999999997544  


Q ss_pred             ---CeEEccccCcccccCCCC-----CcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          839 ---GARVADFGVAKVVDASGK-----PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       839 ---~~kl~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                         .+.++|||+|+...+...     .+......||-+||+=-...+.+.+.+.|+=|+|=++++.+-|..||.+-....
T Consensus       164 ~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  164 DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence               389999999997765432     222345579999999999999999999999999999999999999997653322


Q ss_pred             hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      . .+..++.. +......++. +-..+++++...++.++   +.+=++-|+.+-+...+.+....
T Consensus       244 n-K~kYeKIG-e~Kr~T~i~~-Lc~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  244 N-KEKYEKIG-ETKRSTPIEV-LCEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             h-HHHHHHhc-cccccCCHHH-HHhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHh
Confidence            2 21111111 1111111111 12235666666666665   44566779999988888877543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=6e-20  Score=206.06  Aligned_cols=261  Identities=30%  Similarity=0.393  Sum_probs=199.6

Q ss_pred             CCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC-ceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK-NIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~  763 (1002)
                      |...+.||.|+||.||++...  ..+|+|.+......              .......+.+|+.+++.+.|+ +++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~--------------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~   65 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLES--------------KSKEVERFLREIQILASLNHPPNIVKLYD   65 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhcc--------------chhHHHHHHHHHHHHHHccCCcceeeEEE
Confidence            566788999999999999976  78899988543211              113577899999999999988 7999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-CeE
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-GAR  841 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-~~k  841 (1002)
                      .+......+++++|+.++++.+++..... ..++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++
T Consensus        66 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~  142 (384)
T COG0515          66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVK  142 (384)
T ss_pred             EEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEE
Confidence            99888878999999999999977764221 2689999999999999999999999   999999999999999888 699


Q ss_pred             EccccCcccccCCCCCc----ccccccccccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC---chh
Q 001867          842 VADFGVAKVVDASGKPK----SMSVIAGSCGYIAPEYAYT---LRVNEKSDIYSFGVVILELVTGRLPVDPEFG---EKD  911 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~ell~g~~p~~~~~~---~~~  911 (1002)
                      ++|||.+..........    ......|+..|+|||.+.+   ..+....|+||+|++++++++|..||.....   ...
T Consensus       143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~  222 (384)
T COG0515         143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ  222 (384)
T ss_pred             EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH
Confidence            99999998655443221    2356689999999999887   5788999999999999999999999765543   222


Q ss_pred             HHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          912 LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ....+...... .......+   .........+.+++..|+..+|..|.+..+....
T Consensus       223 ~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         223 TLKIILELPTP-SLASPLSP---SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHhcCCc-ccccccCc---cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            22222221111 00000000   0001222457788889999999999999988765

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=8.5e-21  Score=226.59  Aligned_cols=247  Identities=27%  Similarity=0.426  Sum_probs=148.0

Q ss_pred             CCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeee
Q 001867           93 ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISL  172 (1002)
Q Consensus        93 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  172 (1002)
                      .+.+.|+++++.++. +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+ .+|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            456677777777764 555443  46777777777777 3454443  47777777777777 4565543  36777777


Q ss_pred             ccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCccccc
Q 001867          173 VYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG  252 (1002)
Q Consensus       173 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  252 (1002)
                      ++|++. .+|..+.  ++|+.|+|++|++.  .+|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|+++.
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~--~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~  318 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKIS--CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA  318 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccC--ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc
Confidence            777777 4555443  46777777777762  4565553  36777777777777 3454443  367777777777764


Q ss_pred             ccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCC
Q 001867          253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADS  332 (1002)
Q Consensus       253 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l  332 (1002)
                       +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .+|..+. ..|+.|+|++|+++. +|..+.  
T Consensus       319 -LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp-~~L~~LdLs~N~Lt~-LP~~l~--  387 (754)
T PRK15370        319 -LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP-PTITTLDVSRNALTN-LPENLP--  387 (754)
T ss_pred             -CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-CCcCEEECCCCcCCC-CCHhHH--
Confidence             343332  466777777777764 444432  56777777777766 3444332 246666666666663 333332  


Q ss_pred             cccchhcccccccCCCCCCCC----CCCCCCceEEccCcccc
Q 001867          333 PGLYELRLFRNRLNGTLPGDL----GKNSPLRWVDLSNNQFT  370 (1002)
Q Consensus       333 ~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~  370 (1002)
                      ..|+.|++++|++. .+|..+    ..++++..|+|.+|.++
T Consensus       388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            24566666666665 233322    22344555555555554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=5.5e-21  Score=228.19  Aligned_cols=276  Identities=27%  Similarity=0.464  Sum_probs=147.5

Q ss_pred             cchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccc
Q 001867          216 LEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASM  295 (1002)
Q Consensus       216 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  295 (1002)
                      ...|++++++++ .+|..+.  +.|+.|+|++|+++. +|..+.  .+|+.|                        ++++
T Consensus       180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L------------------------~Ls~  229 (754)
T PRK15370        180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTL------------------------YANS  229 (754)
T ss_pred             ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEE------------------------ECCC
Confidence            445666666666 3454442  345556666665552 232222  244444                        4444


Q ss_pred             cccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCCh
Q 001867          296 NDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPA  375 (1002)
Q Consensus       296 N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  375 (1002)
                      |+++ .+|..+.. .|+.|+|++|++. .+|..+.  ++|+.|++++|+++ .+|..+.  .+|+.|+|++|+|++ +|.
T Consensus       230 N~Lt-sLP~~l~~-~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~  300 (754)
T PRK15370        230 NQLT-SIPATLPD-TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPA  300 (754)
T ss_pred             Cccc-cCChhhhc-cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccc
Confidence            4444 23332211 2455555555554 3333332  34566666666665 3444443  367777777777773 444


Q ss_pred             hhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcc
Q 001867          376 SLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANL  455 (1002)
Q Consensus       376 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  455 (1002)
                      .+.  .+|+.|++++|.++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+. +|..+  .++|
T Consensus       301 ~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l--p~~L  369 (754)
T PRK15370        301 HLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL--PPTI  369 (754)
T ss_pred             cch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh--cCCc
Confidence            332  357777777777764 444332  567777777777774 454442  567777777777663 34333  2467


Q ss_pred             cEEEccCCcCCCCCccccccccccccccccccccCCCCccccc----ccccCCeeecCCCcCCccccccccccccccccc
Q 001867          456 SLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLT----NLAELGSLDLHANDLSGELPSSVSSWKKLNELN  531 (1002)
Q Consensus       456 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  531 (1002)
                      +.|++++|+|+ .+|..+.  .+|+.|++++|+|+ .+|..+.    .++++..|+|.+|+++      ...+.+|+.| 
T Consensus       370 ~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls------~~tl~~L~~L-  438 (754)
T PRK15370        370 TTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS------ERTIQNMQRL-  438 (754)
T ss_pred             CEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc------HHHHHHHHHh-
Confidence            77777777776 4555443  35777777777776 4554332    3355666677776665      1344444455 


Q ss_pred             ccCccccc-CCCCCcccccccc
Q 001867          532 LADNLFYG-NIPEDIGNLSVLN  552 (1002)
Q Consensus       532 Ls~N~l~~-~ip~~~~~l~~L~  552 (1002)
                      ++.+.+.| .++..++.+++++
T Consensus       439 l~s~~~~gp~i~~~~~~~~~l~  460 (754)
T PRK15370        439 MSSVGYQGPRVLFAMGDFSIVR  460 (754)
T ss_pred             hhcccccCCccccccccccccc
Confidence            33344433 2333344444433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=5.6e-20  Score=186.15  Aligned_cols=158  Identities=16%  Similarity=0.154  Sum_probs=113.3

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccC------CCcc---ccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECES------GCDV---EKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ...||+|+||.||+|...+|+.||||+++.........      ..+.   ................|+++++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            36799999999999998789999999997642211000      0000   00000011123345679999999988776


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCCCCCCcEEECCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYL-HHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      .........  ..++||||++++++.....  ....+++..+..++.|++.+|+|+ |+.   +|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence            444333222  2389999998877665432  235689999999999999999999 687   999999999999998 5


Q ss_pred             CCeEEccccCcccccC
Q 001867          838 FGARVADFGVAKVVDA  853 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~  853 (1002)
                      +.++|+|||+|...+.
T Consensus       154 ~~v~LiDFG~a~~~~~  169 (190)
T cd05147         154 GKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CcEEEEEccccccCCC
Confidence            7899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=5.2e-20  Score=187.54  Aligned_cols=179  Identities=13%  Similarity=0.171  Sum_probs=133.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      -++|...+++|.|+||.||.+.. ++..+|+|.+.+....+        ............+.+|+..+.++.||+|..+
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--------~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--------ERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--------HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            46899999999999999999766 57789999985432210        0000000112236899999999999999999


Q ss_pred             eeEEecC--------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          762 WCCCTTR--------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       762 ~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      .+++...        +..+++|||++|.+|.++..      +++    ....+++.+++.+|+.   +++|||+||+||+
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nil  167 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFI  167 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEE
Confidence            9886643        35789999999999988742      233    2456999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHH
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV  897 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  897 (1002)
                      ++.+| ++++|||.......... ..             .+.....+..++|+|+|||++....
T Consensus       168 i~~~g-i~liDfg~~~~~~e~~a-~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        168 VSKNG-LRIIDLSGKRCTAQRKA-KD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EeCCC-EEEEECCCcccccchhh-HH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            99888 99999998875532211 00             1344445667999999999877544

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.2e-19  Score=177.29  Aligned_cols=191  Identities=17%  Similarity=0.100  Sum_probs=142.1

Q ss_pred             CcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeeeeE
Q 001867          686 DEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCC  764 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  764 (1002)
                      .+...|++|+||+||.+.. .+++++.+.+......             ........+.+|+++++++. |+++++++++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~-------------~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWW-------------LRGVAWWLARREALALRQLDGLPRTPRLLHW   70 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhh-------------hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE
Confidence            4567899999999997766 5677776665322110             11222346899999999996 5889999886


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC-CCCcEEECCCCCeEEc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV-KSNNILLDGDFGARVA  843 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl-k~~NIll~~~~~~kl~  843 (1002)
                          +..+++|||++|.+|.+....         ....++.|++.+++++|++   ||+|||| ||+||+++.++.++|+
T Consensus        71 ----~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LI  134 (218)
T PRK12274         71 ----DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVI  134 (218)
T ss_pred             ----cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEE
Confidence                346899999999888654321         1235788999999999999   9999999 7999999999999999


Q ss_pred             cccCcccccCCCCC------cc-----cccccccccccCccccccC-CCC-CccchhhHHHHHHHHHhCCCCCCCC
Q 001867          844 DFGVAKVVDASGKP------KS-----MSVIAGSCGYIAPEYAYTL-RVN-EKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       844 DfGl~~~~~~~~~~------~~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      |||++.........      .+     ......++.|++|+...-. ..+ .+.++++-|..+|.++|++.+...+
T Consensus       135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            99999866554321      10     1123467888888854322 222 5789999999999999999987544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.1e-20  Score=209.50  Aligned_cols=227  Identities=27%  Similarity=0.277  Sum_probs=178.5

Q ss_pred             eeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeeeeE
Q 001867          690 VIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCC  764 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  764 (1002)
                      ++|+|+||.|+.+..    ..|.-+|+|..++....              ... ......|..++...+ ||.+|++...
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~--------------~~~-~~~t~~er~il~~~~~~~f~v~lhya   65 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLK--------------VRD-RTHTKQERIILAFVHNTPFLVKLHYA   65 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccc--------------ccc-ccccccHHHHHhhccCCCceeeeeee
Confidence            379999999998653    23677999988654221              111 115566788888887 9999999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      ++.+...+++++|..+|+|...+.  +...+++.....+...++-+++++|+.   +|+|||+|++||+++.+|.+++.|
T Consensus        66 fqt~~kl~l~ld~~rgg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~td  140 (612)
T KOG0603|consen   66 FQTDGKLYLILDFLRGGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTD  140 (612)
T ss_pred             eccccchhHhhhhcccchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCC
Confidence            999999999999999999988876  456688889999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ||+++..-....      .+||..|||||++.  ....++|.||||++++||++|-.||..     +..+.+.   +.  
T Consensus       141 fglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il---~~--  202 (612)
T KOG0603|consen  141 FGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRIL---KA--  202 (612)
T ss_pred             chhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHh---hh--
Confidence            999986654332      28999999999988  677899999999999999999999975     2222111   10  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                              -...+.+......+++..+...+|..|.-.
T Consensus       203 --------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 --------ELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             --------ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                    012233444456667777888888888644

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=3e-19  Score=181.88  Aligned_cols=157  Identities=18%  Similarity=0.176  Sum_probs=115.1

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCcc-----ccc----cccchhhHHhHHHHHHHHhcCCCCce
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDV-----EKG----QVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~-----~~~----~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+.||+|+||.||+|...+|+.||||++.............+     ...    ..........+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999977899999999976522100000000     000    00011123345789999999999987


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDL-LHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~  836 (1002)
                      .....+....  .++||||++|+++... +.   ...++.....+++.|++.++.++|+ .   +|+||||||+||+++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            5544444333  4899999988755433 32   3457888999999999999999999 8   999999999999999 


Q ss_pred             CCCeEEccccCcccccC
Q 001867          837 DFGARVADFGVAKVVDA  853 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~  853 (1002)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=1.6e-21  Score=179.58  Aligned_cols=181  Identities=31%  Similarity=0.492  Sum_probs=139.0

Q ss_pred             CCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccc
Q 001867          403 HCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVL  482 (1002)
Q Consensus       403 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  482 (1002)
                      ++++.+.|.||+|+++ .+|..+..+.+|+.|++++|+|. ..|..++.+++|+.|+++.|++. ..|..||.++.|++|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            4556666667777776 45555666667777777777765 56667777777888888888887 788888888888888


Q ss_pred             cccccccCC-CCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceee
Q 001867          483 SGSENKFTG-SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       483 ~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      ||..|++.. .+|..|-.++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+. .+|.+++.+.+|++|.+.+|+|
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            888888874 67888888888999999999998 78888999999999999999988 7899999999999999999999


Q ss_pred             ecccCCcccccc----cceEEeccccCcCCCC
Q 001867          562 SGRIPVGLQNLK----LNQLNVSNNRLSGELP  589 (1002)
Q Consensus       562 ~~~ip~~~~~l~----L~~l~ls~N~l~g~~p  589 (1002)
                      + .+|..++++.    =+++.+.+|++..+|.
T Consensus       186 ~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa  216 (264)
T KOG0617|consen  186 T-VLPPELANLDLVGNKQVMRMEENPWVNPIA  216 (264)
T ss_pred             e-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence            8 6777777652    2344555555554443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=9.6e-19  Score=195.12  Aligned_cols=219  Identities=25%  Similarity=0.410  Sum_probs=165.6

Q ss_pred             HhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-eeCCCC
Q 001867          750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI-VHRDVK  828 (1002)
Q Consensus       750 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i-iHrDlk  828 (1002)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.....++++|+.||+|+|+.   .| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence            3567899999999999999999999999999999999986 456799999999999999999999987   44 899999


Q ss_pred             CCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCC-------CCCccchhhHHHHHHHHHhCCC
Q 001867          829 SNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-------VNEKSDIYSFGVVILELVTGRL  901 (1002)
Q Consensus       829 ~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~ell~g~~  901 (1002)
                      ++|.+++....+|++|||+.................-..-|.|||.+....       .+.++||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999998774311111111222335699999887631       4678999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       902 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      ||.......+..+.+.....  .-...+-|.+.... +....+..++..||..+|++||++++|...++.+...
T Consensus       157 ~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccccCChHHHHHHHHh--cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99864333322222222111  11111222221111 2233588899999999999999999999999887653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=1.9e-18  Score=181.39  Aligned_cols=233  Identities=21%  Similarity=0.236  Sum_probs=148.7

Q ss_pred             CcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC---------
Q 001867          686 DEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH---------  755 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---------  755 (1002)
                      ..++.||.|+|+.||.+.+. +++.+|||++....              .......+++++|.-....+.+         
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--------------~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~   80 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--------------DASANEYEQLKEEQLAITLFPGVKNPKEAYR   80 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--------------TTHTTHHHHHHHHHHGGGGSTT--SHHHHHH
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEeccc--------------ccchHHHHHHHHHHHHhhhhccCCCHHHHHH
Confidence            34678999999999999985 48999999985432              1233446667777766555322         


Q ss_pred             -CceeeeeeEEe---------cC---C-----eeeEEEeccCCCChhhhhhh---cCCC--CCCHHHHHHHHHHHHHHHH
Q 001867          756 -KNIVKLWCCCT---------TR---D-----CKLLVYEYMPNGSLGDLLHS---CKGG--LLDWPTRYKIIVDAAEGLS  812 (1002)
Q Consensus       756 -~niv~l~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~--~l~~~~~~~i~~qi~~~L~  812 (1002)
                       -.++..++...         ..   .     ..+++|+-+ .++|.+++..   ....  ......+..+..|+++.++
T Consensus        81 ~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA  159 (288)
T PF14531_consen   81 HLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVA  159 (288)
T ss_dssp             HH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHH
Confidence             12222222221         11   1     236788888 5788887542   2211  2333455667789999999


Q ss_pred             HHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc--------CCCCCcc
Q 001867          813 YLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT--------LRVNEKS  884 (1002)
Q Consensus       813 ~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~  884 (1002)
                      +||+.   |++|+||+|+|++++.+|.++|+||+.....+....     ....+..|.+||....        ..++.+.
T Consensus       160 ~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~  231 (288)
T PF14531_consen  160 NLHSY---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFAT  231 (288)
T ss_dssp             HHHHT---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred             HHhhc---ceEecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeecc
Confidence            99999   999999999999999999999999988776544211     1234578999997644        2478899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCC
Q 001867          885 DIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINR  959 (1002)
Q Consensus       885 DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  959 (1002)
                      |.|++|+++|.|++|+.||+.......                 .++....|. +....+..+|..+++.+|++|
T Consensus       232 DaW~LG~~ly~lWC~~lPf~~~~~~~~-----------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  232 DAWQLGITLYSLWCGRLPFGLSSPEAD-----------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHHHSS-STCCCGGGST-----------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CHHHHHHHHHHHHHccCCCCCCCcccc-----------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999999975422111                 001233344 555678899999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=3.7e-19  Score=184.65  Aligned_cols=196  Identities=24%  Similarity=0.270  Sum_probs=139.2

Q ss_pred             CCCceeeeeeEEec---------------------------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHH
Q 001867          754 RHKNIVKLWCCCTT---------------------------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD  806 (1002)
Q Consensus       754 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~q  806 (1002)
                      +|||||++.++|.+                           ...+|+||..++ .+|.+|+..   ...+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence            59999999988854                           234689999884 699999974   34667778889999


Q ss_pred             HHHHHHHHhhcCCCCeeeCCCCCCcEEEC--CCCC--eEEccccCcccccCCCC----CcccccccccccccCccccccC
Q 001867          807 AAEGLSYLHHDCVPSIVHRDVKSNNILLD--GDFG--ARVADFGVAKVVDASGK----PKSMSVIAGSCGYIAPEYAYTL  878 (1002)
Q Consensus       807 i~~~L~~LH~~~~~~iiHrDlk~~NIll~--~~~~--~kl~DfGl~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~  878 (1002)
                      +.+|+.|||.+   +|+|||+|.+|||+.  .|+.  ..++|||++-..+...-    ....-...|.-.-||||+....
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999   999999999999994  3433  68999999865544221    1111223466789999987643


Q ss_pred             C------CCCccchhhHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHHHhhccCccccccccc-cCCCHHHHHHHHHHHHH
Q 001867          879 R------VNEKSDIYSFGVVILELVTGRLPVDPEFGE-KDLVKWVCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLL  950 (1002)
Q Consensus       879 ~------~~~~~DvwslGvil~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~  950 (1002)
                      .      .-.|+|.|+.|.+.||++....||+..-.. -+...          +.+.--|.+ ..+++    .+.+++..
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------Yqe~qLPalp~~vpp----~~rqlV~~  492 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------YQESQLPALPSRVPP----VARQLVFD  492 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------hhhhhCCCCcccCCh----HHHHHHHH
Confidence            2      125899999999999999999999752111 11111          111111222 22222    36788888


Q ss_pred             cCCCCCCCCCCHHHHHHHHH
Q 001867          951 CTSPLPINRPAMRRVVKLLQ  970 (1002)
Q Consensus       951 cl~~dP~~Rps~~evl~~L~  970 (1002)
                      .++.||.+|++..-.-..+.
T Consensus       493 lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HhcCCccccCCccHHHhHHH
Confidence            99999999998776665554

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=3e-20  Score=171.19  Aligned_cols=157  Identities=36%  Similarity=0.649  Sum_probs=106.9

Q ss_pred             ccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccc
Q 001867           89 LCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLE  168 (1002)
Q Consensus        89 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  168 (1002)
                      +.++++.+.|.|++|+++ .+|..+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            445667777777777776 35556777777777777777776 56667777777777777777776 6677777777777


Q ss_pred             eeeecccccc-CccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccC
Q 001867          169 VISLVYNLLD-GTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL  247 (1002)
Q Consensus       169 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  247 (1002)
                      +|||++|++. ..+|..|..+..|+.|+|+.|.+  ..+|+.++++++|+.|.+..|.+- .+|..++.++.|++|++.+
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndf--e~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg  182 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF--EILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG  182 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCc--ccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence            7777777664 24566666666666667766665  456666666666666666666666 5666666666666666666


Q ss_pred             cccc
Q 001867          248 NNLV  251 (1002)
Q Consensus       248 N~l~  251 (1002)
                      |+++
T Consensus       183 nrl~  186 (264)
T KOG0617|consen  183 NRLT  186 (264)
T ss_pred             ceee
Confidence            6666

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=3.2e-18  Score=203.77  Aligned_cols=247  Identities=20%  Similarity=0.245  Sum_probs=185.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC---CCcee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR---HKNIV  759 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv  759 (1002)
                      +.|.+.+.||+|+||+||+|...+|+.||+|+=++...+                    +|.-=.+++.+|+   -+.|+
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--------------------EfYI~~q~~~RLk~~~~~~~~  757 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--------------------EFYICLQVMERLKPQMLPSIM  757 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--------------------eeeehHHHHHhhchhhhcchH
Confidence            467788899999999999999878999999987544322                    2333334445554   34566


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC---
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---  836 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~---  836 (1002)
                      ++..++.-.+..++|+||.+.|+|.+++.  ..+.++|.-+..++.|+++.+++||..   +|||+||||+|.++..   
T Consensus       758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~  832 (974)
T KOG1166|consen  758 HISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREIC  832 (974)
T ss_pred             HHHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccC
Confidence            67777777778899999999999999998  556799999999999999999999999   9999999999999942   


Q ss_pred             ----CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          837 ----DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       837 ----~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                          ...++|+|||.+..+.--.........++|-.+--+|+..+..++..+|.|.++.+++-|+.|+.-          
T Consensus       833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------  902 (974)
T KOG1166|consen  833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------  902 (974)
T ss_pred             CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------
Confidence                234899999999766543333455677889999999999999999999999999999999998632          


Q ss_pred             HHHHHHHhhccCccccccccccCCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          913 VKWVCSTLDQKGVDHVLDPKLDCCF-KEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                          .   ..++....++..++.++ .+.|.++++   .+++.|-..=|...++...++++..
T Consensus       903 ----q---~~~g~~~~~~~~~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  903 ----E---VKNGSSWMVKTNFPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             ----H---hcCCcceeccccchhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHHHH
Confidence                1   11111222333333333 344555555   4555555555888888888887754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=9.4e-19  Score=202.91  Aligned_cols=251  Identities=22%  Similarity=0.208  Sum_probs=175.9

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      ++...+.||.+.|=+|.+|+..+|. |+||++-+..             ....-....+..+|++ ...++|||.+++.-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~-------------p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk   88 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQD-------------PTISLRPFKQRLEEIK-FALMKAPNCLPFQK   88 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccC-------------CCCCchHHHHHHHHHH-HHhhcCCcccchHH
Confidence            6777899999999999999988776 8999984431             1112222333334444 45568999999998


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      +-..++..|+|-+|+. -+|.|.+.  -+..+...+.+=|+.|++.|+..+|..   +|+|||||.+|||++.=.=+.|+
T Consensus        89 ~~~t~kAAylvRqyvk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~Lt  162 (1431)
T KOG1240|consen   89 VLVTDKAAYLVRQYVK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLT  162 (1431)
T ss_pred             HHHhhHHHHHHHHHHh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhh
Confidence            8888888899999995 48888886  345577777788999999999999999   99999999999999987789999


Q ss_pred             cccCccccc-CCCCCccc----ccccccccccCccccccC----------C-CCCccchhhHHHHHHHHHh-CCCCCCCC
Q 001867          844 DFGVAKVVD-ASGKPKSM----SVIAGSCGYIAPEYAYTL----------R-VNEKSDIYSFGVVILELVT-GRLPVDPE  906 (1002)
Q Consensus       844 DfGl~~~~~-~~~~~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslGvil~ell~-g~~p~~~~  906 (1002)
                      ||..-+-.. +++.+...    .....-..|.|||.+-..          . .+++-||||.||++.|+++ |+.||.- 
T Consensus       163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-  241 (1431)
T KOG1240|consen  163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-  241 (1431)
T ss_pred             cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-
Confidence            997654221 11111221    222233479999965431          1 4678899999999999999 7777732 


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                         .++..+....  ....+..+ .++++.      .+..++..|++.||++|.++++.++.
T Consensus       242 ---SQL~aYr~~~--~~~~e~~L-e~Ied~------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  242 ---SQLLAYRSGN--ADDPEQLL-EKIEDV------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ---HHHHhHhccC--ccCHHHHH-HhCcCc------cHHHHHHHHHccCchhccCHHHHHHh
Confidence               2222221110  00111111 111111      36788899999999999999999976

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=1.7e-17  Score=169.25  Aligned_cols=136  Identities=17%  Similarity=0.245  Sum_probs=104.1

Q ss_pred             CcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-----CCCceee
Q 001867          686 DEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-----RHKNIVK  760 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~  760 (1002)
                      ...+.||+|+||.||. ...++. .+||++...                 .....+.+.+|+.+++.+     .||||++
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~-----------------~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr   65 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHR-----------------GDGGDKEIRRELKYYAHLSRRLIDWSGIPR   65 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcC-eEEEEEecc-----------------ccchHHHHHHHHHHHHHhhccCCCCcccce
Confidence            4467899999999996 323334 478887432                 112346789999999999     5799999


Q ss_pred             eeeEEecCC---eee-EEEec--cCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeeCCCCCCcEE
Q 001867          761 LWCCCTTRD---CKL-LVYEY--MPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGL-SYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       761 l~~~~~~~~---~~~-lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      ++|++.++.   ..+ +|+||  +++|+|.+++++   ..+++.  ..++.|++.++ +|||++   +|+||||||+||+
T Consensus        66 ~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NIL  137 (210)
T PRK10345         66 YYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNIL  137 (210)
T ss_pred             eeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEE
Confidence            999998863   434 78999  557999999964   235655  35678888777 999999   9999999999999


Q ss_pred             ECC----CCCeEEccccCc
Q 001867          834 LDG----DFGARVADFGVA  848 (1002)
Q Consensus       834 l~~----~~~~kl~DfGl~  848 (1002)
                      ++.    +++++|+||+-+
T Consensus       138 l~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        138 CQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EeccCCCCCcEEEEECCCC
Confidence            974    337999995444

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.73  E-value=3e-20  Score=207.15  Aligned_cols=204  Identities=25%  Similarity=0.273  Sum_probs=99.9

Q ss_pred             cCcccceeeeccccccCCCCcCcCCCC---CcEEEccCccccC----CCCCcCCCC-CcceEEEcccCcccCc----ccc
Q 001867          380 KGELEELLMIYNSFTGQLPDGLGHCQS---LTRVRLGYNRLTG----KVPPLLWGL-PHVYLLELTDNFLSGE----ISK  447 (1002)
Q Consensus       380 l~~L~~L~l~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~i~~~----~~~  447 (1002)
                      +++|+.|++++|.+.+..+..+..+.+   |+.|++++|++++    .+...+..+ ++|+.|++++|.+++.    ...
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            334444444444443333333333322   5555555555542    111122333 4555555555555421    222


Q ss_pred             ccccCCcccEEEccCCcCCCC----CccccccccccccccccccccCCC----CcccccccccCCeeecCCCcCCccccc
Q 001867          448 NIAGAANLSLLIISKNNLSGS----LPEEIGFLKSLVVLSGSENKFTGS----LPESLTNLAELGSLDLHANDLSGELPS  519 (1002)
Q Consensus       448 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~  519 (1002)
                      .+..+.+|+.|++++|.+++.    ++..+..+++|+.|++++|.+++.    ++..+..+++|+.|++++|.+++..+.
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~  239 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA  239 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence            344455566666666666532    222233344666666666666532    223344556677777777766653333


Q ss_pred             cccc-----ccccccccccCcccc----cCCCCCccccccccEEeCcceeeecc----cCCccccc--ccceEEecccc
Q 001867          520 SVSS-----WKKLNELNLADNLFY----GNIPEDIGNLSVLNYLDLSNNRLSGR----IPVGLQNL--KLNQLNVSNNR  583 (1002)
Q Consensus       520 ~~~~-----l~~L~~L~Ls~N~l~----~~ip~~~~~l~~L~~L~Ls~N~l~~~----ip~~~~~l--~L~~l~ls~N~  583 (1002)
                      .+..     .++|+.|++++|.++    ..++..+..+++|+++|+++|+++..    +...+...  .++.||+.+|+
T Consensus       240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence            3221     256677777777665    12334455556677777777777644    22222222  35566666554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.72  E-value=5.7e-20  Score=204.91  Aligned_cols=278  Identities=26%  Similarity=0.314  Sum_probs=172.8

Q ss_pred             eeeccCCccc-CCCCCccccccccceeeccccccCCC----CCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhc
Q 001867          266 QIELYNNSLT-GDLPTGWSNLTSLRLLDASMNDLTGP----IPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELR  339 (1002)
Q Consensus       266 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  339 (1002)
                      .|+|..+.+. +.....+..+++|+.|+++++.++..    ++..+...+ ++.|+++++.+.+ .+..+          
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~----------   70 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL----------   70 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence            4677777776 34445567777888888888887532    222222222 5566666555542 00000          


Q ss_pred             ccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCc---ccceeeecccccc----CCCCcCcCC-CCCcEEE
Q 001867          340 LFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGE---LEELLMIYNSFTG----QLPDGLGHC-QSLTRVR  411 (1002)
Q Consensus       340 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~----~~p~~l~~l-~~L~~L~  411 (1002)
                             ..++..+..+++|+.|++++|.+.+..+..+..+..   |++|++++|.+++    .+...+..+ ++|+.|+
T Consensus        71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~  143 (319)
T cd00116          71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV  143 (319)
T ss_pred             -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence                   112223444556666666666665545555544444   6666666666652    222334455 6777777


Q ss_pred             ccCccccCC----CCCcCCCCCcceEEEcccCcccCc----cccccccCCcccEEEccCCcCCCCC----cccccccccc
Q 001867          412 LGYNRLTGK----VPPLLWGLPHVYLLELTDNFLSGE----ISKNIAGAANLSLLIISKNNLSGSL----PEEIGFLKSL  479 (1002)
Q Consensus       412 L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L  479 (1002)
                      +++|.+++.    ++..+..+++|+.|++++|.+++.    ++..+..+++|+.|++++|.+++..    +..+..+++|
T Consensus       144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L  223 (319)
T cd00116         144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL  223 (319)
T ss_pred             cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence            777777632    233455666788888888877742    2333455668888888888876442    3445667889


Q ss_pred             ccccccccccCCCCcccccc-----cccCCeeecCCCcCCc----ccccccccccccccccccCcccccC----CCCCcc
Q 001867          480 VVLSGSENKFTGSLPESLTN-----LAELGSLDLHANDLSG----ELPSSVSSWKKLNELNLADNLFYGN----IPEDIG  546 (1002)
Q Consensus       480 ~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----ip~~~~  546 (1002)
                      +.|++++|.+++..+..+..     .+.|+.|++++|.+++    .++..+..+++|+++++++|.++..    +...+-
T Consensus       224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~  303 (319)
T cd00116         224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL  303 (319)
T ss_pred             CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence            99999998887533333322     3789999999998872    3345566678899999999999854    444444


Q ss_pred             cc-ccccEEeCcceee
Q 001867          547 NL-SVLNYLDLSNNRL  561 (1002)
Q Consensus       547 ~l-~~L~~L~Ls~N~l  561 (1002)
                      .. +.|++||+.+|.+
T Consensus       304 ~~~~~~~~~~~~~~~~  319 (319)
T cd00116         304 EPGNELESLWVKDDSF  319 (319)
T ss_pred             hcCCchhhcccCCCCC
Confidence            44 6889999988864

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=7.1e-17  Score=169.20  Aligned_cols=159  Identities=18%  Similarity=0.159  Sum_probs=114.5

Q ss_pred             CCCcCCeeeecCCccEEEEE--EcCCcEEEEEEeeccccccccCCCccc--ccc------ccchhhHHhHHHHHHHHhcC
Q 001867          684 GLDEDNVIGSGSSGKVYKVV--LSNGEAVAVKKLWRGMSKECESGCDVE--KGQ------VQDQVQDDGFQAEVETLGKI  753 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~E~~~l~~l  753 (1002)
                      .|.+.+.||+|+||.||+|.  ..+|+.||+|++......... .....  ...      .........+..|+.+++++
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKR-RDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecc-hhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            36778999999999999998  567999999998654211000 00000  000      00011234577899999999


Q ss_pred             CCC--ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eeeCCCCCC
Q 001867          754 RHK--NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS-IVHRDVKSN  830 (1002)
Q Consensus       754 ~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-iiHrDlk~~  830 (1002)
                      .+.  .+.+++++    ...++||||++++++..+..  ........+...++.|++.++++||++   + |+||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            753  33444443    23589999999888876543  223466667789999999999999999   8 999999999


Q ss_pred             cEEECCCCCeEEccccCcccccC
Q 001867          831 NILLDGDFGARVADFGVAKVVDA  853 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~  853 (1002)
                      ||+++ ++.++++|||.+...+.
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccCC
Confidence            99999 88999999999876544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=4.6e-17  Score=189.21  Aligned_cols=211  Identities=22%  Similarity=0.276  Sum_probs=144.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      ..+|+..+.|..|+||.||.++++. .+++|+|+=++.                       -+.+-  ++.....|.+| 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-----------------------lilRn--ilt~a~npfvv-  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----------------------LILRN--ILTFAGNPFVV-  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-----------------------hhhhc--cccccCCccee-
Confidence            3578888999999999999998754 567888532111                       01100  33333344444 


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                                          |+-.+.++..  +.++..        ++.+++|+|+.   +|+|||+||+|.+|+.-|++
T Consensus       136 --------------------gDc~tllk~~--g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhi  182 (1205)
T KOG0606|consen  136 --------------------GDCATLLKNI--GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHI  182 (1205)
T ss_pred             --------------------chhhhhcccC--CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccc
Confidence                                4444444422  223322        27889999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCC-------------cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          841 RVADFGVAKVVDASGKP-------------KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      |+.|||++++.......             -.....+||+.|+|||++....|...+|+|++|+|+||.+-|+.||.++.
T Consensus       183 KlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt  262 (1205)
T KOG0606|consen  183 KLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  262 (1205)
T ss_pred             cccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC
Confidence            99999999765322110             01234589999999999999999999999999999999999999998875


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      .++-+-..+...+..  .+.  |+   ..++    +..+++...++++|.+|--.
T Consensus       263 peelfg~visd~i~w--pE~--de---a~p~----Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  263 PEELFGQVISDDIEW--PEE--DE---ALPP----EAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             HHHHHhhhhhhhccc--ccc--Cc---CCCH----HHHHHHHHHHHhChHhhccc
Confidence            554444433322111  011  11   1222    36677778899999999533

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=1.7e-16  Score=165.25  Aligned_cols=142  Identities=18%  Similarity=0.302  Sum_probs=116.2

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecC
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTR  768 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  768 (1002)
                      +.||+|++|.||+|.. +|..+++|+.......         ............+.+|+.++..+.|++++....++...
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~---------~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   71 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYR---------HPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP   71 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCc---------ChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC
Confidence            5799999999999987 5788999986422110         11122233456788999999999999988777777777


Q ss_pred             CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCc
Q 001867          769 DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA  848 (1002)
Q Consensus       769 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~  848 (1002)
                      +..+++|||++|++|.+++...     .. .+..++.+++.+++++|+.   +++|||++|.||+++ ++.++++|||.+
T Consensus        72 ~~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a  141 (211)
T PRK14879         72 ENFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLA  141 (211)
T ss_pred             CCCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcc
Confidence            7889999999999999998642     12 7889999999999999999   999999999999999 789999999988


Q ss_pred             cc
Q 001867          849 KV  850 (1002)
Q Consensus       849 ~~  850 (1002)
                      ..
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            64

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=3.4e-16  Score=185.56  Aligned_cols=144  Identities=21%  Similarity=0.294  Sum_probs=114.5

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      .|...+.||+|+||.||+|.+.+ +.+++|+......         ...........+++.+|++++++++|++++..+.
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~---------~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGY---------RHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC-ccceeEEEecccc---------cchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            34567899999999999998754 4455554321100         0111122334567899999999999999998888


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++......++||||+++++|.+++.          ....++.|++++++|||+.   +|+||||||+||++ .++.++|+
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEE
Confidence            8877778899999999999999885          3567899999999999999   99999999999999 57899999


Q ss_pred             cccCcccc
Q 001867          844 DFGVAKVV  851 (1002)
Q Consensus       844 DfGl~~~~  851 (1002)
                      |||+++..
T Consensus       470 DFGla~~~  477 (535)
T PRK09605        470 DFGLGKYS  477 (535)
T ss_pred             eCcccccC
Confidence            99999753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=2.8e-16  Score=161.47  Aligned_cols=154  Identities=20%  Similarity=0.184  Sum_probs=112.0

Q ss_pred             CCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCC---c-cccc--cccchhhHHhHHHHHHHHhcCCCCc-
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGC---D-VEKG--QVQDQVQDDGFQAEVETLGKIRHKN-  757 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---~-~~~~--~~~~~~~~~~~~~E~~~l~~l~h~n-  757 (1002)
                      |.+.+.||+|+||.||+|...+|+.||||++..+... .....   . +...  ..........+..|..++.++.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTS-FRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccch-hhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            5667899999999999999888999999997543210 00000   0 0000  0001122334778999999987773 


Q ss_pred             -eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          758 -IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       758 -iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                       +++.++    ....++||||++|++|.+....        .....++.+++.++.++|+.   +|+||||||+||++++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~  160 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence             444443    2345899999999998765431        34567889999999999998   9999999999999999


Q ss_pred             CCCeEEccccCcccccCC
Q 001867          837 DFGARVADFGVAKVVDAS  854 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~  854 (1002)
                      ++.++|+|||++......
T Consensus       161 ~~~~~liDfg~~~~~~~~  178 (198)
T cd05144         161 DEKIYIIDWPQMVSTDHP  178 (198)
T ss_pred             CCcEEEEECCccccCCCc
Confidence            999999999999766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PLN03150 hypothetical protein; Provisional

Probab=99.66  E-value=2.2e-16  Score=188.68  Aligned_cols=156  Identities=28%  Similarity=0.471  Sum_probs=123.7

Q ss_pred             CCCchHHHHHHHHHHHhccCCccccCCCCCCCCCCCCCccceeEEeC--CC--CeEEEEEcCCCCcCCCCCccccCCCCC
Q 001867           20 SLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDP--RS--HSVASIDLSNANIAGPFPSLLCRLENL   95 (1002)
Q Consensus        20 ~~~~~~~~~~l~~~k~~~~d~~~~l~sw~~~~~~~~~C~w~gv~C~~--~~--~~v~~l~L~~~~l~~~~~~~~~~l~~L   95 (1002)
                      ......|..||+.+|+++.+|..  .+|.+++....+|.|.||.|+.  ..  ..|+.|+|++++++|.+|..++.+++|
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L  444 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL  444 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence            33466799999999999987643  4896432211224799999953  22  358999999999999999999999999


Q ss_pred             CEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccc-cccceeeecc
Q 001867           96 TFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRF-QKLEVISLVY  174 (1002)
Q Consensus        96 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~  174 (1002)
                      +.|+|++|.+.+.+|..++.+++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..++.+ .++..+++.+
T Consensus       445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~  524 (623)
T PLN03150        445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD  524 (623)
T ss_pred             CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence            999999999998889888889999999999999988888888888888888888888888888877653 3556666666


Q ss_pred             ccc
Q 001867          175 NLL  177 (1002)
Q Consensus       175 N~l  177 (1002)
                      |..
T Consensus       525 N~~  527 (623)
T PLN03150        525 NAG  527 (623)
T ss_pred             Ccc
Confidence            643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=3.4e-16  Score=161.38  Aligned_cols=138  Identities=20%  Similarity=0.336  Sum_probs=108.9

Q ss_pred             eeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCC
Q 001867          690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD  769 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  769 (1002)
                      .||+|+||.||+|.+ ++..|++|+.......         ...........++.+|+++++.+.|+++.....++....
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~---------~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~   70 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYR---------HPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD   70 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCc---------CchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC
Confidence            389999999999985 5788999986432100         001112334567889999999999887665555556666


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..++||||++|++|.+++....      .   .++.|++.+++++|+.   +++|||++|+||+++ ++.++++|||++.
T Consensus        71 ~~~lv~e~~~g~~l~~~~~~~~------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~  137 (199)
T TIGR03724        71 NKTIVMEYIEGKPLKDVIEEGN------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGK  137 (199)
T ss_pred             CCEEEEEEECCccHHHHHhhcH------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence            7799999999999999875311      0   7899999999999999   999999999999999 8899999999987


Q ss_pred             c
Q 001867          850 V  850 (1002)
Q Consensus       850 ~  850 (1002)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            5

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=3.1e-17  Score=178.87  Aligned_cols=175  Identities=23%  Similarity=0.348  Sum_probs=132.4

Q ss_pred             CeeeEEEeccCCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          769 DCKLLVYEYMPNGSLGDLLHSC-KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       769 ~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      ...||.|++++-.+|.+++.+. .....++.....++.|++.|++|   +   +.+|||+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            3578999999999999999743 34567888999999999999999   6   899999999999999999999999999


Q ss_pred             cccccCCC----CCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 001867          848 AKVVDASG----KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       848 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      ........    .....+...||..||+||.+.+..|+.|+||||+|++++|++. -..+++..    ..    ....+ 
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t----~~d~r-  473 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----AT----LTDIR-  473 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hh----hhhhh-
Confidence            98776554    1223456789999999999999999999999999999999997 33333211    00    01111 


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV  965 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev  965 (1002)
                         +..++|.....+++    =+.++.+++.+.|.+||++.++
T Consensus       474 ---~g~ip~~~~~d~p~----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  474 ---DGIIPPEFLQDYPE----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ---cCCCChHHhhcCcH----HHHHHHHhcCCCcccCchHHHH
Confidence               12223222222232    3467778999999999954443

>PLN03150 hypothetical protein; Provisional

Probab=99.58  E-value=2.6e-15  Score=179.61  Aligned_cols=115  Identities=36%  Similarity=0.622  Sum_probs=76.8

Q ss_pred             CCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEecc
Q 001867          503 LGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSN  581 (1002)
Q Consensus       503 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~  581 (1002)
                      ++.|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++++++|+.|||++|+|+|.+|..++.+ +|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            5566666666666666666666666666666666666666666666666666666666666666666666 566666666


Q ss_pred             ccCcCCCChhhhh---hcccccccCCCCCCCCCC-CCCCC
Q 001867          582 NRLSGELPSLFAK---EMYRNSFLGNPGLCGDLE-GLCDG  617 (1002)
Q Consensus       582 N~l~g~~p~~~~~---~~~~~~~~~n~~~cg~~~-~~c~~  617 (1002)
                      |+++|.+|.....   ......+.+|+++||.|. ..|..
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~  539 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP  539 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCCCCCCcc
Confidence            6666666654221   223457889999999764 68863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=3.4e-16  Score=184.07  Aligned_cols=256  Identities=23%  Similarity=0.289  Sum_probs=191.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC--CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      ..|.+.+.||+|+|+.|-.+....  ...+|+|.+....               ......++...|..+-+.+. |+|++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---------------~~~~~~~~i~~e~~~~~~~s~h~n~~   84 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---------------KSEDSSEHIDTETDIQKKLSKHSNTV   84 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---------------CccchhhhcCcccccccccccccccc
Confidence            456677889999999998877533  3456666553211               12334455666777877776 99999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhh-hhcCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++.....+..++++||.+++++.+.+ +. .....+......++.|+..++.|+| +.   +++|||+||+|.+++..
T Consensus        85 ~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s  160 (601)
T KOG0590|consen   85 HMIEPSSSPRSYLLSLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDES  160 (601)
T ss_pred             ccCCccCCCcccccccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccC
Confidence            9999999999999999999999998888 42 2225667778889999999999999 77   99999999999999999


Q ss_pred             C-CeEEccccCcccccC-CCCCcccccccc-cccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCch-hH
Q 001867          838 F-GARVADFGVAKVVDA-SGKPKSMSVIAG-SCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEK-DL  912 (1002)
Q Consensus       838 ~-~~kl~DfGl~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~-~~  912 (1002)
                      + ..+++|||+|..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+....... .+
T Consensus       161 ~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~  240 (601)
T KOG0590|consen  161 GSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY  240 (601)
T ss_pred             CCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence            9 999999999998877 555555566778 9999999998874 45678999999999999999999997543322 22


Q ss_pred             HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..|......   ..       ...+........++..+++..+|..|.+.+++..
T Consensus       241 ~~~~~~~~~---~~-------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  241 SSWKSNKGR---FT-------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             eeecccccc---cc-------cCccccCChhhhhcccccccCCchhccccccccc
Confidence            333322100   00       0011111223556677788899999999888764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=1.7e-14  Score=147.16  Aligned_cols=154  Identities=22%  Similarity=0.221  Sum_probs=101.4

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCcc-------ccccccchhhHHhHHHHHHHHhcCCCCc--e
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDV-------EKGQVQDQVQDDGFQAEVETLGKIRHKN--I  758 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~E~~~l~~l~h~n--i  758 (1002)
                      .+.||+|+||+||+|...+++.||||++.............+       ................|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            468999999999999988899999999865321100000000       0000000111112245666666665432  4


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGD-LLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~  836 (1002)
                      .+.+++    ...++||||++++.+.. .+....   .. ....+++.+++.++.++|. .   +|+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            444443    23589999999854322 122111   11 6678899999999999999 7   999999999999999 


Q ss_pred             CCCeEEccccCcccccC
Q 001867          837 DFGARVADFGVAKVVDA  853 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~  853 (1002)
                      ++.++++|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            89999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=6.6e-14  Score=147.18  Aligned_cols=148  Identities=19%  Similarity=0.224  Sum_probs=109.6

Q ss_pred             CCeee-ecCCccEEEEEEcCCcEEEEEEeeccccccccCCCcccccc-ccchhhHHhHHHHHHHHhcCCCCce--eeeee
Q 001867          688 DNVIG-SGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQ-VQDQVQDDGFQAEVETLGKIRHKNI--VKLWC  763 (1002)
Q Consensus       688 ~~~LG-~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~  763 (1002)
                      ...|| .|+.|+||.+... ++.++||++.++-.     ..++.... ..+.....++.+|++++.++.|+++  ++.++
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~-----i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~  109 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGL-----IGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA  109 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcch-----HHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence            45788 9999999999875 78899999854210     00000101 1122345678999999999998775  66776


Q ss_pred             EEecC-C---eeeEEEeccCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          764 CCTTR-D---CKLLVYEYMPN-GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       764 ~~~~~-~---~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +.... .   ..++||||++| .+|.+++..   ..+++.    .+.|++.++++||+.   ||+||||||.|||++.++
T Consensus       110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        110 ARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence            65432 2   23599999997 689988863   345544    357899999999999   999999999999999888


Q ss_pred             CeEEccccCcccc
Q 001867          839 GARVADFGVAKVV  851 (1002)
Q Consensus       839 ~~kl~DfGl~~~~  851 (1002)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999998753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=6e-14  Score=137.57  Aligned_cols=136  Identities=19%  Similarity=0.208  Sum_probs=113.6

Q ss_pred             cCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC--CceeeeeeE
Q 001867          687 EDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH--KNIVKLWCC  764 (1002)
Q Consensus       687 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~  764 (1002)
                      +.+.||+|.++.||++...+ ..+++|.....                 . . ...+.+|+.+++.++|  ..+++++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~-----------------~-~-~~~~~~e~~~~~~l~~~~~~~p~~~~~   61 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSR-----------------E-K-GADREREVAILQLLARKGLPVPKVLAS   61 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCC-----------------C-c-hhHHHHHHHHHHHHHHcCCCCCeEEEE
Confidence            35789999999999999854 78999987321                 0 0 4568899999999976  589999999


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      ....+..+++|||++++.+..+         +......++.+++++++++|.....+++|||++|+||+++..+.+++.|
T Consensus        62 ~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~D  132 (155)
T cd05120          62 GESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIID  132 (155)
T ss_pred             cCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEe
Confidence            9888889999999988777544         5567778899999999999986434799999999999999889999999


Q ss_pred             ccCcccc
Q 001867          845 FGVAKVV  851 (1002)
Q Consensus       845 fGl~~~~  851 (1002)
                      ||.+...
T Consensus       133 f~~~~~~  139 (155)
T cd05120         133 WEYAGYG  139 (155)
T ss_pred             cccccCC
Confidence            9998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.52  E-value=8.2e-16  Score=167.30  Aligned_cols=182  Identities=32%  Similarity=0.508  Sum_probs=115.6

Q ss_pred             CCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEE
Q 001867          355 KNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLL  434 (1002)
Q Consensus       355 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  434 (1002)
                      .++.-...||+.|++. ++|..++.+..|+.+.+..|.+. .+|..++++..|++|||+.|+++ ..|..++.+| |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            3445567899999998 89999999999999999999998 68888999999999999999998 6666666654 5555


Q ss_pred             EcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCC
Q 001867          435 ELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       435 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      -+++|+++ .+|..++....|..||.+.|.+. .+|..++.+.+|+.|++..|++. .+|+++..| .|..||+|.|+++
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis  224 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS  224 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence            55555554 34444444455555555555554 44555555555555555555554 344444433 2445555555554


Q ss_pred             cccccccccccccccccccCcccccCCCCCcc
Q 001867          515 GELPSSVSSWKKLNELNLADNLFYGNIPEDIG  546 (1002)
Q Consensus       515 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~  546 (1002)
                       .+|-.|..|+.|++|-|.+|-+. ..|..|+
T Consensus       225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             -ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence             44444555555555555544444 3444433

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=1.9e-15  Score=164.40  Aligned_cols=173  Identities=32%  Similarity=0.472  Sum_probs=86.2

Q ss_pred             CcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEc
Q 001867          381 GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLII  460 (1002)
Q Consensus       381 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  460 (1002)
                      ..-...+++.|++. .+|..++.+..|+.+.|..|.+. .+|..++++..|++|||+.|+++ ..|..++.++ |+.|.+
T Consensus        75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~  150 (722)
T KOG0532|consen   75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV  150 (722)
T ss_pred             cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence            33344555555555 45555555555555555555555 45555555555555555555554 2333333332 455555


Q ss_pred             cCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccC
Q 001867          461 SKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGN  540 (1002)
Q Consensus       461 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  540 (1002)
                      ++|+++ .+|+.++.+..|..||.+.|++. .+|..++.+.+|+.|.+..|++. .+|+.+..| .|..||+|.|+++ .
T Consensus       151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~  225 (722)
T KOG0532|consen  151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y  225 (722)
T ss_pred             ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence            555554 45555554455555555555554 44445555555555555555554 233333322 2444555555554 4


Q ss_pred             CCCCccccccccEEeCcceeee
Q 001867          541 IPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       541 ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      ||-+|.+|+.|++|-|.+|.|+
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCC
Confidence            5555555555555555555554

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=1.2e-13  Score=141.01  Aligned_cols=203  Identities=24%  Similarity=0.316  Sum_probs=142.7

Q ss_pred             HHhcCCCCceeeeeeEEecCC-----eeeEEEeccCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 001867          749 TLGKIRHKNIVKLWCCCTTRD-----CKLLVYEYMPNGSLGDLLHSCKG--GLLDWPTRYKIIVDAAEGLSYLHHDCVPS  821 (1002)
Q Consensus       749 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  821 (1002)
                      -+-.+.|.|||+++.|+.+.+     +..++.|||+.|++..+|++.+.  ..+......+|+.||..||.|||+ +.|.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            333456999999999997643     46899999999999999987543  567788889999999999999999 6789


Q ss_pred             eeeCCCCCCcEEECCCCCeEEccccCccccc--CCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhC
Q 001867          822 IVHRDVKSNNILLDGDFGARVADFGVAKVVD--ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG  899 (1002)
Q Consensus       822 iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g  899 (1002)
                      |+|+++.-+-|++..+|-+|++--.-.....  ............+-++|.|||.-.....+.++|||+||+...||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999888885321111111  11112223455678899999988888888899999999999999988


Q ss_pred             CCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          900 RLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       900 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ..--....+....-+......      ....   ++.       -.+.+..|++..|..||+|.+++..
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i------~~le---n~l-------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVI------IGLE---NGL-------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eeccCCCcceeehhhhhhhhe------eecc---Ccc-------ccCcCcccccCCCCCCcchhhhhcC
Confidence            754322211111000000000      0000   000       1244567999999999999998743

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=8e-13  Score=151.15  Aligned_cols=165  Identities=18%  Similarity=0.269  Sum_probs=109.3

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCcc------------cc----------ccccc-h
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDV------------EK----------GQVQD-Q  737 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------~~----------~~~~~-~  737 (1002)
                      +...|+ .+.||+|++|.||+|+.++|+.||||+.+++..+.......+            ..          .++.. -
T Consensus       116 ~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       116 LFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             HHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            344455 368999999999999999999999999976632211110000            00          00000 0


Q ss_pred             hhHHhHHHHHHHHhcCC-----CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHH-HH
Q 001867          738 VQDDGFQAEVETLGKIR-----HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE-GL  811 (1002)
Q Consensus       738 ~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~-~L  811 (1002)
                      ..+-+|.+|+..+.+++     ++++.-..-+.......++||||++|++|.++......+ .   ...+++.+++. .+
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l  270 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFL  270 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHH
Confidence            11225667777777663     344332222222234578999999999998876532211 2   23456666666 47


Q ss_pred             HHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccC
Q 001867          812 SYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA  853 (1002)
Q Consensus       812 ~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~  853 (1002)
                      ..+|..   |++|||+||.||+++.+++++++|||++..+..
T Consensus       271 ~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       271 NQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            888988   999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.39  E-value=4.4e-13  Score=153.84  Aligned_cols=199  Identities=34%  Similarity=0.474  Sum_probs=110.9

Q ss_pred             eEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCC-CCcEEEccCccccCCCCCcCCCCCcceEEEcccC
Q 001867          361 WVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQ-SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDN  439 (1002)
Q Consensus       361 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  439 (1002)
                      .++++.|++. .....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            4666666664 22223333455556666666655 3444444453 6666666666666 34445555666666666666


Q ss_pred             cccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccc
Q 001867          440 FLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPS  519 (1002)
Q Consensus       440 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  519 (1002)
                      ++.. ++......++|+.|++++|+++ .+|..++....|+.|.+++|.+. ..+..+.++.++..|.+++|++. .+|.
T Consensus       174 ~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~  249 (394)
T COG4886         174 DLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE  249 (394)
T ss_pred             hhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence            6653 2222335556666666666666 55555555555666666666433 34555566666666666666665 2355


Q ss_pred             ccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCc
Q 001867          520 SVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG  568 (1002)
Q Consensus       520 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~  568 (1002)
                      .++.+..|++|++++|.++ .++. ++.+.+|+.|++++|.++..+|..
T Consensus       250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             hhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence            5556666666666666665 3443 556666666666666666544443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=5.9e-12  Score=145.17  Aligned_cols=166  Identities=19%  Similarity=0.203  Sum_probs=102.6

Q ss_pred             cHHHHhcCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeecccccccc------------------CCCcccccccc--
Q 001867          677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECE------------------SGCDVEKGQVQ--  735 (1002)
Q Consensus       677 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~------------------~~~~~~~~~~~--  735 (1002)
                      +..++..+|+. +.||+|++|.||+|+.++ |+.||||+.+++..+..+                  .+.........  
T Consensus       114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e  192 (537)
T PRK04750        114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE  192 (537)
T ss_pred             CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence            33455667777 899999999999999887 999999999766322100                  00000000000  


Q ss_pred             ---chhhHHhHHHHHHHHhcCC----CCceeeeeeEEec-CCeeeEEEeccCCCChhhhhhhcCCC----CCCHHHHHHH
Q 001867          736 ---DQVQDDGFQAEVETLGKIR----HKNIVKLWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKGG----LLDWPTRYKI  803 (1002)
Q Consensus       736 ---~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~l~~~~~~~i  803 (1002)
                         .-..+-++.+|+..+.+++    +...+.+-..+.+ ....++||||++|+.+.++-.-...+    .+.+..+..+
T Consensus       193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~  272 (537)
T PRK04750        193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF  272 (537)
T ss_pred             HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence               0111223555555555542    3333333333322 34568999999999998753211111    2333334444


Q ss_pred             HHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC----CeEEccccCcccccC
Q 001867          804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF----GARVADFGVAKVVDA  853 (1002)
Q Consensus       804 ~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGl~~~~~~  853 (1002)
                      +.|++       ..   |++|+|+||.||+++.++    +++++|||++..+..
T Consensus       273 ~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            44443       45   999999999999999888    999999999987654

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.35  E-value=8.8e-13  Score=151.37  Aligned_cols=197  Identities=34%  Similarity=0.505  Sum_probs=94.5

Q ss_pred             EeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccC-CccccccccccccCCCCcccccccccceeeecccc
Q 001867           98 LTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLP-NLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNL  176 (1002)
Q Consensus        98 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  176 (1002)
                      +++..|.+.. .+..+..++.++.|++.+|.++ .+++....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus        98 l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          98 LDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence            4444444421 1222333345555555555555 3444444442 5555555555555 444445555555555555555


Q ss_pred             ccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCc
Q 001867          177 LDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPS  256 (1002)
Q Consensus       177 l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  256 (1002)
                      ++ .+|...+.+++|+.|++++|++  ..+|..+..+..|++|.+++|++. ..+..+..+.++..|.+.+|++.. .+.
T Consensus       175 l~-~l~~~~~~~~~L~~L~ls~N~i--~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         175 LS-DLPKLLSNLSNLNNLDLSGNKI--SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             hh-hhhhhhhhhhhhhheeccCCcc--ccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence            55 3333333455555555555554  244444444444555555555433 334445555555555555555542 234


Q ss_pred             ccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCc
Q 001867          257 SLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPD  304 (1002)
Q Consensus       257 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  304 (1002)
                      .+..+++++.|++++|+++...+  +..+.+++.|++++|.+...+|.
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence            44444555555555555543222  45555555555555555544333

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.27  E-value=5.1e-11  Score=119.21  Aligned_cols=153  Identities=13%  Similarity=0.116  Sum_probs=104.7

Q ss_pred             CeeeecCCccEEEEEEcC-------CcEEEEEEeeccccccccCCCcccccc--c----cchhhHHhH----HHHHHHHh
Q 001867          689 NVIGSGSSGKVYKVVLSN-------GEAVAVKKLWRGMSKECESGCDVEKGQ--V----QDQVQDDGF----QAEVETLG  751 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~----~~E~~~l~  751 (1002)
                      ..||.|.-+.||.|...+       +..+|||+++..... +..-....+..  +    ........+    ++|+..|+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~-Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNE-FKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEecccee-EcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            578999999999998543       479999998654221 11111111111  0    011223333    48999999


Q ss_pred             cCC--CCceeeeeeEEecCCeeeEEEeccCCCChhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeCCC
Q 001867          752 KIR--HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD-LLHSCKGGLLDWPTRYKIIVDAAEGLSYL-HHDCVPSIVHRDV  827 (1002)
Q Consensus       752 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiHrDl  827 (1002)
                      ++.  .-++.+++++    ...++||||+.+..+.. .++   ...++..+...+..|++.++..+ |..   +|||||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            985  3456666654    45689999996543321 232   22355566778889999999999 777   9999999


Q ss_pred             CCCcEEECCCCCeEEccccCcccccC
Q 001867          828 KSNNILLDGDFGARVADFGVAKVVDA  853 (1002)
Q Consensus       828 k~~NIll~~~~~~kl~DfGl~~~~~~  853 (1002)
                      ++.||+++ ++.+.++|||.+.....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 56899999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=1e-11  Score=139.16  Aligned_cols=250  Identities=23%  Similarity=0.229  Sum_probs=180.6

Q ss_pred             CCCcCCeeee--cCCccEEEEEE---cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCc
Q 001867          684 GLDEDNVIGS--GSSGKVYKVVL---SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKN  757 (1002)
Q Consensus       684 ~~~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n  757 (1002)
                      .|.+.+.+|.  |.+|.||.+..   .++..+|+|+-+...               .......+=.+|+....+++ |++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~---------------s~p~~~~~k~~~~~s~~~i~~~~~  179 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF---------------SPPLDSKRKLREFLSHHKIDSHEN  179 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCC---------------CCccccccccchhhcccccCcccc
Confidence            4566788999  99999999886   457889999753321               12222333456677777775 999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE----GLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      .++.+..+...+..|+-+|++ +.++.++.+. ....++...++.+..+..+    |+.++|+.   .++|-|+||.||+
T Consensus       180 ~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~  254 (524)
T KOG0601|consen  180 PVRDSPAWEGSGILFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIF  254 (524)
T ss_pred             ccccCcccccCCcceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhhee
Confidence            999999999999999999999 6788888764 3345777788888888888    99999999   9999999999999


Q ss_pred             ECCC-CCeEEccccCcccccCCCCCcccc---cccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          834 LDGD-FGARVADFGVAKVVDASGKPKSMS---VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       834 l~~~-~~~kl~DfGl~~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      ...+ ..++++|||+...+..........   ...|...|++||... +.++.+.|+|++|.++.+...+..++......
T Consensus       255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            9999 889999999999887665332221   114667899999755 45688999999999999999987766543111


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                          .|..  .+.   ..+.+.......    .++...+..+++.+|-.|++.+.+..
T Consensus       334 ----~W~~--~r~---~~ip~e~~~~~s----~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 ----SWSQ--LRQ---GYIPLEFCEGGS----SSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ----Cccc--ccc---ccCchhhhcCcc----hhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                1110  000   001111111111    12344677899999999999888764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=3.3e-11  Score=120.63  Aligned_cols=131  Identities=21%  Similarity=0.159  Sum_probs=95.8

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee-eeeeEEe
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV-KLWCCCT  766 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~  766 (1002)
                      .+.++.|.++.||++... ++.|++|......                  .....+.+|+.+++.+.+.+++ +++++..
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~------------------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~   63 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT------------------ELLINRENEAENSKLAAEAGIGPKLYYFDP   63 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCc------------------ccccCHHHHHHHHHHHHHhCCCCceEEEeC
Confidence            357899999999999875 7889999863210                  0123467899999988654444 4554433


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC--VPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                        ...++||||++|.++.+.-          ......+.+++++++.||+..  ..+++|||++|.||+++ ++.++++|
T Consensus        64 --~~~~lv~e~i~G~~l~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liD  130 (170)
T cd05151          64 --ETGVLITEFIEGSELLTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLID  130 (170)
T ss_pred             --CCCeEEEEecCCCcccccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEe
Confidence              3357999999998875430          112345689999999999982  12369999999999999 67899999


Q ss_pred             ccCccc
Q 001867          845 FGVAKV  850 (1002)
Q Consensus       845 fGl~~~  850 (1002)
                      ||.+..
T Consensus       131 f~~a~~  136 (170)
T cd05151         131 WEYAGM  136 (170)
T ss_pred             cccccC
Confidence            998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=2.8e-10  Score=128.49  Aligned_cols=168  Identities=20%  Similarity=0.245  Sum_probs=127.2

Q ss_pred             EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCCh
Q 001867          704 LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL  783 (1002)
Q Consensus       704 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  783 (1002)
                      ..++.+|.|..++..                 .....+...+-++-++.++||+|+++++.+..++..|+|+|.+.  .|
T Consensus        34 k~~~~~vsVF~~~~~-----------------~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl   94 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRS-----------------NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PL   94 (690)
T ss_pred             eccCCceEEEEEeCC-----------------CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cH
Confidence            456888888877432                 11223446667788889999999999999999999999999984  78


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccc
Q 001867          784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI  863 (1002)
Q Consensus       784 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~  863 (1002)
                      ..+++.     ++...+.--+.||+.||.|||+.+  +++|++|....|+|++.|..||++|-++........  .....
T Consensus        95 ~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~  165 (690)
T KOG1243|consen   95 ETVLKE-----LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL  165 (690)
T ss_pred             HHHHHH-----hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc
Confidence            888875     346677778999999999999764  999999999999999999999999988865433222  11111


Q ss_pred             cccccccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 001867          864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL  901 (1002)
Q Consensus       864 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~  901 (1002)
                      .--..|..|+.+....  -..|.|.||+++||++.|..
T Consensus       166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence            1223466777544332  34699999999999999943

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=2.2e-10  Score=108.84  Aligned_cols=151  Identities=21%  Similarity=0.262  Sum_probs=114.7

Q ss_pred             cCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          687 EDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       687 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      ....+-+|+-+.|+++.+. |+.+.||.-...         ...-.....+....+..+|+..+.++.--.|....-++.
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K---------~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~   80 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSK---------RYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI   80 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccc---------cccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE
Confidence            4578999999999999986 788888864221         222334455667788899999999987555554444566


Q ss_pred             cCCeeeEEEeccCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC---CeEE
Q 001867          767 TRDCKLLVYEYMPN-GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF---GARV  842 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl  842 (1002)
                      +...-.++|||++| .++.+++...-...........++.+|-+.+.-||..   +|||+||..+||++..++   .+.+
T Consensus        81 D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~l  157 (229)
T KOG3087|consen   81 DTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPIL  157 (229)
T ss_pred             ecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEE
Confidence            66666799999976 3788888764444444445588999999999999999   999999999999997554   3589


Q ss_pred             ccccCccc
Q 001867          843 ADFGVAKV  850 (1002)
Q Consensus       843 ~DfGl~~~  850 (1002)
                      +|||++..
T Consensus       158 Idfgls~~  165 (229)
T KOG3087|consen  158 IDFGLSSV  165 (229)
T ss_pred             Eeecchhc
Confidence            99999864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.15  E-value=6.4e-12  Score=126.62  Aligned_cols=137  Identities=29%  Similarity=0.278  Sum_probs=77.7

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +..++-|+++|||+|.|+ .+.....-+|.++.|++|+|.|..+.  ++..+++|+.||||+|.++ .+..+-..+.+++
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK  355 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK  355 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence            334456677777777776 44555555566666666666665332  2555556666666666655 3444444455555


Q ss_pred             cccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCccee
Q 001867          481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                      .|.|++|.+.. + ..++.|.+|..||+++|+|...                       .--..||+|+-|+.|.|-+|.
T Consensus       356 tL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~l-----------------------deV~~IG~LPCLE~l~L~~NP  410 (490)
T KOG1259|consen  356 TLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEEL-----------------------DEVNHIGNLPCLETLRLTGNP  410 (490)
T ss_pred             eeehhhhhHhh-h-hhhHhhhhheeccccccchhhH-----------------------HHhcccccccHHHHHhhcCCC
Confidence            55555555541 1 2344444444455555444311                       112467888888888888888


Q ss_pred             eecccCC
Q 001867          561 LSGRIPV  567 (1002)
Q Consensus       561 l~~~ip~  567 (1002)
                      |++ +|.
T Consensus       411 l~~-~vd  416 (490)
T KOG1259|consen  411 LAG-SVD  416 (490)
T ss_pred             ccc-cch
Confidence            885 443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.13  E-value=1.4e-11  Score=124.31  Aligned_cols=107  Identities=22%  Similarity=0.199  Sum_probs=65.5

Q ss_pred             CCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceE
Q 001867          354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL  433 (1002)
Q Consensus       354 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  433 (1002)
                      .....|+.||||+|.|+ .+..+..-.+.++.|++++|.++..  +.+..+++|+.||||+|.++ .+-++-..+-+.+.
T Consensus       281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            33455777777777777 5555565566677777777776632  23677778888888888777 44555555666666


Q ss_pred             EEcccCcccCccccccccCCcccEEEccCCcCC
Q 001867          434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLS  466 (1002)
Q Consensus       434 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~  466 (1002)
                      |.|+.|.|...  +.+..+-+|..||+++|++.
T Consensus       357 L~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  357 LKLAQNKIETL--SGLRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             eehhhhhHhhh--hhhHhhhhheeccccccchh
Confidence            66666666421  33444445555555555554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=6.7e-10  Score=106.45  Aligned_cols=139  Identities=23%  Similarity=0.362  Sum_probs=107.5

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEecC
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTR  768 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  768 (1002)
                      ..+++|+-+.+|.+.+. |.++.+|.--+.         ...-++...+...++-.+|+.++.+++--.|...+=+..+.
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K---------~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~   71 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPK---------RYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP   71 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCc---------ccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC
Confidence            35789999999999875 445666654211         11123444556677788999999998766666666677777


Q ss_pred             CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCc
Q 001867          769 DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA  848 (1002)
Q Consensus       769 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~  848 (1002)
                      +...++|||++|-.|.+++...         ...++..+-.-+.-||..   +|||+|+.++||.+..++ +.++|||++
T Consensus        72 ~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg  138 (204)
T COG3642          72 DNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG  138 (204)
T ss_pred             CCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence            7788999999988898888743         256778888889999999   999999999999998654 999999999


Q ss_pred             cc
Q 001867          849 KV  850 (1002)
Q Consensus       849 ~~  850 (1002)
                      .+
T Consensus       139 ~~  140 (204)
T COG3642         139 EF  140 (204)
T ss_pred             cc
Confidence            74

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=1.3e-10  Score=130.28  Aligned_cols=246  Identities=21%  Similarity=0.180  Sum_probs=172.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE--cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCce
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL--SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNI  758 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni  758 (1002)
                      ..+|..+..||.|.|+.|+.+..  .++..|++|...+...               ....+..-..|+.+...+. |.++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~---------------~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA---------------TFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc---------------chHhhhcchhhhhHhhHhhccccc
Confidence            35678889999999999999874  3578899998755421               2222333445666666664 8999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC-
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD-  837 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~-  837 (1002)
                      ++++..|...+..|+--||++++++.....  -...+++..++++..|++.++.++|+.   .++|+|+||+||++..+ 
T Consensus       329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG  403 (524)
T ss_pred             CCCCCCccccccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch
Confidence            999888888888889999999998776653  224578888999999999999999998   99999999999999886 


Q ss_pred             CCeEEccccCcccccCCCCCccccccccccccc--CccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYI--APEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      +-.+++|||+++.+....    . ...+.-+++  +|+......+..++|++|||..+.+.++|..--. ...     .|
T Consensus       404 ~~~~~~~~~~~t~~~~~~----~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~-----~~  472 (524)
T KOG0601|consen  404 FFSKLGDFGCWTRLAFSS----G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGV-----QS  472 (524)
T ss_pred             hhhhccccccccccceec----c-cccccccccccchhhccccccccccccccccccccccccCcccCc-ccc-----cc
Confidence            778999999987533221    1 112233344  5666667788999999999999999998753221 110     11


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                      ..       +..-.-+......    .....+...+..+++..||.+.+.....
T Consensus       473 ~~-------i~~~~~p~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  473 LT-------IRSGDTPNLPGLK----LQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ee-------eecccccCCCchH----HhhhhhhhhhcCCccccchhhhhhcccc
Confidence            00       0000001111111    2355566678889999999988876553

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.05  E-value=5.3e-11  Score=136.72  Aligned_cols=129  Identities=30%  Similarity=0.386  Sum_probs=60.8

Q ss_pred             ccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccc
Q 001867          115 ACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKML  194 (1002)
Q Consensus       115 ~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  194 (1002)
                      .+..++.+++..|.+.. +-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+.+.+  +..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence            34444455555555542 2233445555555555555555 222224445555555555555553322  3344445555


Q ss_pred             cccCCCCCCCCCCcccCCCCccchhhccCcccccccc-cccccccccchhcccCcccc
Q 001867          195 NLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP-DSLGRLAKLVDLDLALNNLV  251 (1002)
Q Consensus       195 ~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~  251 (1002)
                      ++++|.+   .-...+..+++|+.+++++|++....+ . ...+.+++.+++..|.+.
T Consensus       146 ~l~~N~i---~~~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  146 NLSGNLI---SDISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             eeccCcc---hhccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence            5555554   112233345555555555555553322 1 344455555555555554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.04  E-value=5.5e-11  Score=116.53  Aligned_cols=123  Identities=24%  Similarity=0.296  Sum_probs=28.5

Q ss_pred             cccccccccccccCCCCcccc-ccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccc
Q 001867          118 NLQHLDLSQNLLTGTLTPALA-DLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNL  196 (1002)
Q Consensus       118 ~L~~L~Ls~N~l~~~~~~~~~-~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  196 (1002)
                      .+++|+|++|.|+. + +.++ .+.+|+.|+|++|.|+. ++ .+..+++|++|++++|+|+...+.....+++|++|+|
T Consensus        20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L   95 (175)
T PF14580_consen   20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL   95 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred             cccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence            34444444444442 1 1222 34444555555554442 21 2444455555555555554322211123455555555


Q ss_pred             cCCCCCCCCCCcccCCCCccchhhccCccccccc---ccccccccccchhc
Q 001867          197 SYNPFLPGRIPPELGNLTNLEILWLTECNLVGEI---PDSLGRLAKLVDLD  244 (1002)
Q Consensus       197 s~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~---p~~~~~l~~L~~L~  244 (1002)
                      ++|++..-..-..+..+++|+.|+|.+|.++...   ...+..+++|+.||
T Consensus        96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             cCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            5555421111123344445555555555544211   11234455555554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.03  E-value=4.4e-11  Score=137.38  Aligned_cols=150  Identities=27%  Similarity=0.273  Sum_probs=67.1

Q ss_pred             CcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEE
Q 001867          332 SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVR  411 (1002)
Q Consensus       332 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  411 (1002)
                      +..++.+.+..|.+.. +-..+..+.+|..|++.+|+|.. +...+..+.+|+.|++++|.|+...  .+..+..|+.|+
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence            3444455555555542 22334555666666666666652 2222444445555555555554322  233444455555


Q ss_pred             ccCccccCCCCCcCCCCCcceEEEcccCcccCccc-cccccCCcccEEEccCCcCCCCCccccccccccccccccccccC
Q 001867          412 LGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS-KNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT  490 (1002)
Q Consensus       412 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  490 (1002)
                      +++|.|+.  ...+..++.|+.+++++|++..+.+ . ...+.+++.+++.+|.+.  ....+..+..+..+++..|.++
T Consensus       147 l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  147 LSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             eccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccce
Confidence            55555542  1223334445555555555443322 1 233444444444444443  1222333333333444444444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.01  E-value=4e-11  Score=127.58  Aligned_cols=209  Identities=22%  Similarity=0.242  Sum_probs=129.0

Q ss_pred             cCCCCCCEEeccCCCCCCCCC-CCccccCcccccccccccccCC--CCccccccCCccccccccccccCCCCccc-cccc
Q 001867           90 CRLENLTFLTLFNNSINSTLP-DDISACQNLQHLDLSQNLLTGT--LTPALADLPNLKFLDLTGNNFSGDIPESF-GRFQ  165 (1002)
Q Consensus        90 ~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~  165 (1002)
                      .++++|+...|.+..+....- .....|++++.||||.|-+...  +-.....|++|+.|+|+.|++.-...... ..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            455677777777766652211 3456677777777777766632  12234567777777777777763322222 2466


Q ss_pred             ccceeeeccccccCc-cccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccc--cccccccccch
Q 001867          166 KLEVISLVYNLLDGT-IPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP--DSLGRLAKLVD  242 (1002)
Q Consensus       166 ~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~  242 (1002)
                      +|+.|.|+.|.++.. +...+..+++|+.|+|.+|... .........+..|+.|+|++|++. ..+  ...+.++.|..
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~  275 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ  275 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence            777777777777622 2333455677777787777421 122223344566777888777766 333  44667777777


Q ss_pred             hcccCccccccc-Ccc-----cccccceeeeeccCCcccCCC-CCccccccccceeeccccccCC
Q 001867          243 LDLALNNLVGAI-PSS-----LTELASVVQIELYNNSLTGDL-PTGWSNLTSLRLLDASMNDLTG  300 (1002)
Q Consensus       243 L~L~~N~l~~~~-~~~-----l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~  300 (1002)
                      |+++.+.+...- |+.     ....++|++|++..|++..-. -..+..+.+|+.|....|.++.
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            777777776432 222     245678888888888885221 1235667788888888888873

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.99  E-value=4.6e-11  Score=127.18  Aligned_cols=207  Identities=25%  Similarity=0.212  Sum_probs=99.6

Q ss_pred             cCCccccccccccccCCCC--cccccccccceeeeccccccCccc--cccccccccccccccCCCCCCCCCCcccCCCCc
Q 001867          140 LPNLKFLDLTGNNFSGDIP--ESFGRFQKLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSYNPFLPGRIPPELGNLTN  215 (1002)
Q Consensus       140 L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~  215 (1002)
                      +.+|+...|.+..+. ..+  .....+++++.|||+.|-+....|  .....|++|+.|+|+.|++....-...-..++.
T Consensus       120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            444444444444443 111  133344445555555544432211  233445555555555555421111111123445


Q ss_pred             cchhhccCcccccccc-cccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCC-Cccccccccceeec
Q 001867          216 LEILWLTECNLVGEIP-DSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLP-TGWSNLTSLRLLDA  293 (1002)
Q Consensus       216 L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L  293 (1002)
                      |+.|.|+.|.++...- ..+..+++|+.|+|..|............+..|+.|+|++|++..... ...+.++.|+.|++
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl  278 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL  278 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence            5555555555552211 123345556666666664333333334445556666666665542211 23556666666666


Q ss_pred             cccccCCC-CCcc--C---CC-CCcceeecCCCcccCc-CCcccCCCcccchhcccccccCC
Q 001867          294 SMNDLTGP-IPDD--L---TR-LPLESLNLYENRLEGS-LPATIADSPGLYELRLFRNRLNG  347 (1002)
Q Consensus       294 s~N~l~~~-~p~~--~---~~-~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~  347 (1002)
                      +.+.++.. .|+.  .   .. .+|++|+++.|++... .-..+..+++|+.|+...|.++.
T Consensus       279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            66666532 1221  0   11 1377777777777421 12344556788888888888874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.99  E-value=2.5e-09  Score=112.33  Aligned_cols=143  Identities=20%  Similarity=0.238  Sum_probs=110.0

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC--CceeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH--KNIVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~  766 (1002)
                      +.||.|.++.||++...+|+.+++|......                ......++..|+++++.+.+  ..+.+++.+..
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~----------------~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~   67 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGA----------------LLPSAHDVAREYRVLRALAGTGVPVPKVLALCE   67 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcc----------------cCcccccHHHHHHHHHHhhCCCCCCCCEEEECC
Confidence            5789999999999998767899999863211                00124568899999999975  34567777766


Q ss_pred             cC---CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------
Q 001867          767 TR---DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC-------------------------  818 (1002)
Q Consensus       767 ~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------  818 (1002)
                      ..   +..++||||++|.++.+.+..   ..++..+...++.++++++++||+..                         
T Consensus        68 ~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (223)
T cd05154          68 DPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRR  144 (223)
T ss_pred             CCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHH
Confidence            54   356899999999888776531   34777888888999999999998531                         


Q ss_pred             ----------------------------CCCeeeCCCCCCcEEECC--CCCeEEccccCccc
Q 001867          819 ----------------------------VPSIVHRDVKSNNILLDG--DFGARVADFGVAKV  850 (1002)
Q Consensus       819 ----------------------------~~~iiHrDlk~~NIll~~--~~~~kl~DfGl~~~  850 (1002)
                                                  ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         145 QYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                        246799999999999998  56689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.96  E-value=4e-10  Score=137.70  Aligned_cols=289  Identities=24%  Similarity=0.267  Sum_probs=164.9

Q ss_pred             eEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCC--CCCCCCCCccccCcccccccccccccCCCCccccccCCccccc
Q 001867           70 SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNS--INSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLD  147 (1002)
Q Consensus        70 ~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~  147 (1002)
                      .+..+.+.++++... +.. ...++|++|-+..|.  +..+.++.|..++.|++||||+|.=-+.+|..++.|-+||+|+
T Consensus       524 ~~rr~s~~~~~~~~~-~~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~  601 (889)
T KOG4658|consen  524 SVRRMSLMNNKIEHI-AGS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD  601 (889)
T ss_pred             heeEEEEeccchhhc-cCC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence            355555555555422 222 223478888888886  5444445577788899999988765567888888888999999


Q ss_pred             cccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCC-CCCCCCcccCCCCccchhhccCccc
Q 001867          148 LTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPF-LPGRIPPELGNLTNLEILWLTECNL  226 (1002)
Q Consensus       148 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~-~~~~~p~~~~~l~~L~~L~L~~n~l  226 (1002)
                      |+++.++ .+|..+++|.+|.+|++..+.-...+|.....|.+|++|.+..-.. .+...-..+.+|..|+.+.......
T Consensus       602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~  680 (889)
T KOG4658|consen  602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV  680 (889)
T ss_pred             ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence            9998888 7888888888899998888776656677777788888888865541 1122223345555555555533332


Q ss_pred             ccccccccccccccc----hhcccCcccccccCcccccccceeeeeccCCcccCCCCCcccccc------ccceeecccc
Q 001867          227 VGEIPDSLGRLAKLV----DLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLT------SLRLLDASMN  296 (1002)
Q Consensus       227 ~~~~p~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~------~L~~L~Ls~N  296 (1002)
                        .+-..+..++.|.    .+.+..+... ..+..+..+.+|+.|.+.++.+............      ++..+...+.
T Consensus       681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~  757 (889)
T KOG4658|consen  681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC  757 (889)
T ss_pred             --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence              1111223333333    3333232222 3455677788888888888877643332221111      2222211111


Q ss_pred             ccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCC-CCCCCCCCCCCceEEc
Q 001867          297 DLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGT-LPGDLGKNSPLRWVDL  364 (1002)
Q Consensus       297 ~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L  364 (1002)
                      .....+.......+|+.|++..+.....+.+....+..+.++.+..+.+.+. .-...+.++++..+.+
T Consensus       758 ~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l  826 (889)
T KOG4658|consen  758 HMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL  826 (889)
T ss_pred             ccccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence            1110111111223477777777776666655555555555555555555543 2333344444444333

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.96  E-value=2.4e-10  Score=134.27  Aligned_cols=252  Identities=21%  Similarity=0.259  Sum_probs=168.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+++.+.+-+-+|.++.++-+.-. .|...+.|.....              ........+....+-.+.-...||.+++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~a--------------p~i~~~~~~s~r~~s~~~i~p~~P~v~~  868 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLA--------------PKIRTNDYESIRSKSNILITPRSPAVVR  868 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccc--------------hhhccccccccCCccCccccCCCCceec
Confidence            567788888999999999987643 2433344432110              0000111111222222222234677777


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      ....+......+++++|+.+++|...++.  -++.+.+....+...+.++++|||+.   .+.|||++|.|.+...++..
T Consensus       869 ~~~s~~~rsP~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~  943 (1205)
T KOG0606|consen  869 SFPSFPCRSPLPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHR  943 (1205)
T ss_pred             ccCCCCCCCCcchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCc
Confidence            76666667788999999999999998874  44677778888888999999999997   79999999999999999999


Q ss_pred             EEccccCcccccCC---------------------C--------CCcccccccccccccCccccccCCCCCccchhhHHH
Q 001867          841 RVADFGVAKVVDAS---------------------G--------KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGV  891 (1002)
Q Consensus       841 kl~DfGl~~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  891 (1002)
                      ++.|||.....+-.                     .        ..+......||+.|.|||...+.....++|+|+.|+
T Consensus       944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen  944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred             ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence            99999844322110                     0        001123456899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 001867          892 VILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR  963 (1002)
Q Consensus       892 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  963 (1002)
                      +++|.++|..||..+..+..+....    ..       +..+...+.+......+++...+..+|.+|-.+.
T Consensus      1024 ~l~e~l~g~pp~na~tpq~~f~ni~----~~-------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETPQQIFENIL----NR-------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhcCCCCCCCcchhhhhhccc----cC-------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999999999998765544332211    11       1111222222222344555556666777775544

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.95  E-value=1.6e-11  Score=127.23  Aligned_cols=233  Identities=23%  Similarity=0.303  Sum_probs=134.9

Q ss_pred             CeEEEEEcCCCCcCCC----CCccccCCCCCCEEeccCC---CCCCCCCCC-------ccccCcccccccccccccCCCC
Q 001867           69 HSVASIDLSNANIAGP----FPSLLCRLENLTFLTLFNN---SINSTLPDD-------ISACQNLQHLDLSQNLLTGTLT  134 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~----~~~~~~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~Ls~N~l~~~~~  134 (1002)
                      ..++.++|++|.+...    +.+.+...++|+..++++-   ++...+|.+       +.+++.|++||||+|-|.-..+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            4588999999987532    3345777888888888863   333344433       4556788888888888875444


Q ss_pred             cc----ccccCCccccccccccccCCCCcc-------------cccccccceeeeccccccCc----ccccccccccccc
Q 001867          135 PA----LADLPNLKFLDLTGNNFSGDIPES-------------FGRFQKLEVISLVYNLLDGT----IPAFLGNISTLKM  193 (1002)
Q Consensus       135 ~~----~~~L~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~  193 (1002)
                      ..    +.++..|++|+|.+|.+...--..             .+.-++|+++...+|++..-    +...|...+.|+.
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee  189 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE  189 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence            43    345678888888888776221112             22234555566555555422    1223444455555


Q ss_pred             ccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccc----cCcccccccceeeeec
Q 001867          194 LNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGA----IPSSLTELASVVQIEL  269 (1002)
Q Consensus       194 L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L  269 (1002)
                      +.++.|.|.+..+                    + .+-..|..+++|+.|||..|.++..    +...++.+++|+.|++
T Consensus       190 vr~~qN~I~~eG~--------------------~-al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l  248 (382)
T KOG1909|consen  190 VRLSQNGIRPEGV--------------------T-ALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNL  248 (382)
T ss_pred             EEEecccccCchh--------------------H-HHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecc
Confidence            5555554421111                    0 1223455666666666666665522    2334555666777777


Q ss_pred             cCCcccCCCCCcc-----ccccccceeeccccccCCC----CCccCCCC-CcceeecCCCccc
Q 001867          270 YNNSLTGDLPTGW-----SNLTSLRLLDASMNDLTGP----IPDDLTRL-PLESLNLYENRLE  322 (1002)
Q Consensus       270 ~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~~-~L~~L~L~~N~l~  322 (1002)
                      ++|.+...-..+|     ...++|+.|.|.+|.|+..    +...+... .|..|+|++|++.
T Consensus       249 ~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  249 GDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             cccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            7776664433322     2356788888888877631    11112222 3788888888873

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.95  E-value=5.3e-10  Score=109.67  Aligned_cols=105  Identities=28%  Similarity=0.342  Sum_probs=23.1

Q ss_pred             CCCcEEEccCccccCCCCCcCC-CCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccc-ccccccccc
Q 001867          405 QSLTRVRLGYNRLTGKVPPLLW-GLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVL  482 (1002)
Q Consensus       405 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L  482 (1002)
                      .++++|+|++|+|+. +. .+. .+.+|+.|+|++|.|+.+  ..+..++.|+.|++++|+++ .+++.+ ..+++|+.|
T Consensus        19 ~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   19 VKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             ccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            345555555555552 21 222 344455555555555433  13444555555555555555 232222 234555555


Q ss_pred             cccccccCCCC-cccccccccCCeeecCCCcCC
Q 001867          483 SGSENKFTGSL-PESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       483 ~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      ++++|+|...- -..+..+++|+.|+|.+|+++
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            55555554210 123344445555555555444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.93  E-value=4e-11  Score=124.40  Aligned_cols=197  Identities=24%  Similarity=0.249  Sum_probs=88.6

Q ss_pred             CCCCCCceEEccCccccCCCChhhh----ccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCC
Q 001867          354 GKNSPLRWVDLSNNQFTGEIPASLC----EKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLP  429 (1002)
Q Consensus       354 ~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  429 (1002)
                      ...++|++||||.|.|....+..|.    ...+|+.|+|.||.+...--..++.  -|..|.  .|+.       ...-+
T Consensus        89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~  157 (382)
T KOG1909|consen   89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKP  157 (382)
T ss_pred             hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCc
Confidence            3445788888888888755555443    3466777777777665211111110  011111  1111       11123


Q ss_pred             cceEEEcccCcccCc----cccccccCCcccEEEccCCcCCCC----CccccccccccccccccccccCCC----Ccccc
Q 001867          430 HVYLLELTDNFLSGE----ISKNIAGAANLSLLIISKNNLSGS----LPEEIGFLKSLVVLSGSENKFTGS----LPESL  497 (1002)
Q Consensus       430 ~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~  497 (1002)
                      .|+++....|++...    ....|...+.|+.+.++.|.+...    +-..+.+++.|++|||..|-|+..    +...+
T Consensus       158 ~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL  237 (382)
T KOG1909|consen  158 KLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL  237 (382)
T ss_pred             ceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHh
Confidence            344444444444322    122233445556666666655411    112234455555555555555521    22334


Q ss_pred             cccccCCeeecCCCcCCcccccccc-----cccccccccccCccccc----CCCCCccccccccEEeCcceee
Q 001867          498 TNLAELGSLDLHANDLSGELPSSVS-----SWKKLNELNLADNLFYG----NIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       498 ~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      ..+++|+.|+++++.++..-..+|.     ..++|+.|.|.+|.++.    .+-..+...+.|+.|+|++|+|
T Consensus       238 ~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  238 SSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             cccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            4445555555555555433332221     23445555555555442    1222333444444444444444

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=7.5e-09  Score=103.40  Aligned_cols=143  Identities=23%  Similarity=0.259  Sum_probs=88.9

Q ss_pred             cEEEEEEcCCcEEEEEEeecccccccc-----CC-Cc---cccccccchhhHHhHHHHHHHHhcCCCC--ceeeeeeEEe
Q 001867          698 KVYKVVLSNGEAVAVKKLWRGMSKECE-----SG-CD---VEKGQVQDQVQDDGFQAEVETLGKIRHK--NIVKLWCCCT  766 (1002)
Q Consensus       698 ~Vy~~~~~~~~~vavK~~~~~~~~~~~-----~~-~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  766 (1002)
                      .||.|...+|..+|||+.+.+...-..     .. .+   ...............++|.+.|+++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389999988999999998654211000     00 00   0011223445567788999999999755  456666443 


Q ss_pred             cCCeeeEEEeccC--CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          767 TRDCKLLVYEYMP--NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSY-LHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       767 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                         ..++||||++  |..+..+....    ++......++.+++..+.. +|..   ||+|+|+.+.||+++++ .+.++
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence               3469999998  54555443321    1134456777888886666 4677   99999999999999877 99999


Q ss_pred             cccCccccc
Q 001867          844 DFGVAKVVD  852 (1002)
Q Consensus       844 DfGl~~~~~  852 (1002)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.87  E-value=1.2e-09  Score=133.64  Aligned_cols=299  Identities=23%  Similarity=0.265  Sum_probs=179.5

Q ss_pred             cCCCCCCEEeccCCCCCCCCCCCccccCccccccccccc--ccCCCCccccccCCccccccccccccCCCCccccccccc
Q 001867           90 CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNL--LTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKL  167 (1002)
Q Consensus        90 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L  167 (1002)
                      .+....++..+.+|.+.. ++... .++.|++|-+..|.  +.....+.|..++.|++|||++|.=-+.+|..++.|-+|
T Consensus       520 ~~~~~~rr~s~~~~~~~~-~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIEH-IAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             cchhheeEEEEeccchhh-ccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            444678888888888863 33333 23479999999996  554445558889999999999987667999999999999


Q ss_pred             ceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccc--ccccccccccccccchhcc
Q 001867          168 EVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL--VGEIPDSLGRLAKLVDLDL  245 (1002)
Q Consensus       168 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l--~~~~p~~~~~l~~L~~L~L  245 (1002)
                      ++|+|++..++ .+|..+++|++|.+|++..+... ..+|.....|++|++|.+.....  ....-..+..+.+|+.+..
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l-~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRL-ESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheecccccccc-ccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            99999999998 88999999999999999988743 33456666799999988876542  2222333445555555554


Q ss_pred             cCcccccccCccccccccee----eeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcc
Q 001867          246 ALNNLVGAIPSSLTELASVV----QIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRL  321 (1002)
Q Consensus       246 ~~N~l~~~~~~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l  321 (1002)
                      .....  .+-..+..+..|.    .+.+.++... ..+..+..+.+|+.|.+.++.+............  .++      
T Consensus       676 ~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~--~~~------  744 (889)
T KOG4658|consen  676 TISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLI--VLL------  744 (889)
T ss_pred             ecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccc--hhh------
Confidence            33222  0111122222222    2222222222 3334455666666666666665432221111110  000      


Q ss_pred             cCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccC-CCCc
Q 001867          322 EGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQ-LPDG  400 (1002)
Q Consensus       322 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~  400 (1002)
                               .++++..+...++..- ..+.+....++|+.|.+..+.....+......+..+..+.+..+.+.+. .-..
T Consensus       745 ---------~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~  814 (889)
T KOG4658|consen  745 ---------CFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCS  814 (889)
T ss_pred             ---------hHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeec
Confidence                     1223333333332221 2233334557788888888777766666666666666666666666654 3344


Q ss_pred             CcCCCCCcEEEcc
Q 001867          401 LGHCQSLTRVRLG  413 (1002)
Q Consensus       401 l~~l~~L~~L~L~  413 (1002)
                      .+.++++..+.++
T Consensus       815 l~~l~~i~~~~l~  827 (889)
T KOG4658|consen  815 LGGLPQLYWLPLS  827 (889)
T ss_pred             CCCCceeEecccC
Confidence            4445554444443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.83  E-value=1.2e-07  Score=101.09  Aligned_cols=267  Identities=13%  Similarity=0.120  Sum_probs=160.4

Q ss_pred             CCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  763 (1002)
                      ...++.||+|+-+.+|..--- +.. +.|+++.....                 ..   .+.+..|-.. .||-+-.=+.
T Consensus        13 i~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa-----------------~~---aqk~a~la~~p~~p~~~~rva   70 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPA-----------------AQ---AQKVAELAATPDAPLLNYRVA   70 (637)
T ss_pred             cCCCccccCCccceeeecchh-hch-hheeecCCCch-----------------HH---HHHHHHhccCCCCcchhhhhc
Confidence            345678999999999975321 123 34777543211                 11   1122333333 4654433121


Q ss_pred             EE------ec-CCeeeEEEeccCCCC-hhhhhh----hcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          764 CC------TT-RDCKLLVYEYMPNGS-LGDLLH----SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       764 ~~------~~-~~~~~lv~e~~~~g~-L~~~l~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |=      -+ ....-+.|+.+++.. ...+..    +......+|...++.++.++.+.+.||+.   |.+-+|+.++|
T Consensus        71 WPqa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~  147 (637)
T COG4248          71 WPQATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNS  147 (637)
T ss_pred             ccHHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccc
Confidence            11      11 223568888887642 222221    12336789999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCC
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTG-RLPVDP  905 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g-~~p~~~  905 (1002)
                      +|+++++.+.+.|-..-....++   ......+|...|.+||...     +..-+...|-|.+||++++++.| +.||.+
T Consensus       148 ~lVsd~~~V~LVdsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         148 FLVSDDSKVVLVDSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             eeeecCceEEEEcccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            99999999999986544443332   2233557889999999644     34456789999999999999996 899864


Q ss_pred             CCCc----hhHH-HHHHHHh---hccCccccccccccCCCHHHHHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhh
Q 001867          906 EFGE----KDLV-KWVCSTL---DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSP--LPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       906 ~~~~----~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      -.-.    .... .+.....   .+........|. ..-..-....+..+..+|+..  .|.-||+++-++..|..+.+.
T Consensus       225 I~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~-~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         225 IPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPR-SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             ccccCCCCCcchhhhhcceeeechhccCCCCCCCC-CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            3211    0111 1110000   011111111111 001111112345555567653  367899999999999888766


Q ss_pred             ccccC
Q 001867          976 NRSKT  980 (1002)
Q Consensus       976 ~~~~~  980 (1002)
                      .....
T Consensus       304 L~~C~  308 (637)
T COG4248         304 LKKCT  308 (637)
T ss_pred             hhhhh
Confidence            55443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.79  E-value=2.6e-09  Score=86.08  Aligned_cols=61  Identities=43%  Similarity=0.581  Sum_probs=40.9

Q ss_pred             ccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceee
Q 001867          501 AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       501 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      ++|++|++++|+|+...+.+|..+++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566677777777665556667777777777777777655556667777777777777754

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.77  E-value=7.1e-08  Score=102.50  Aligned_cols=152  Identities=17%  Similarity=0.123  Sum_probs=103.3

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc--eeeeeeEEe
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN--IVKLWCCCT  766 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~  766 (1002)
                      +.+-+.....|+++.+ +|+.|.||.........      ..+.-.........+.+|...+.++...+  .++.+++..
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~------~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e  100 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGE------IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGE  100 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHH------HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEE
Confidence            4454444456777766 47889999773321100      00000000112234788988888884322  344455554


Q ss_pred             c-----CCeeeEEEeccCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC----
Q 001867          767 T-----RDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG----  836 (1002)
Q Consensus       767 ~-----~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~----  836 (1002)
                      .     ....++|||++++. +|.+++........+......++.+++..++-||+.   ||+|+|++++||+++.    
T Consensus       101 ~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~  177 (268)
T PRK15123        101 RGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPG  177 (268)
T ss_pred             ecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccC
Confidence            3     23578999999875 799998643334566777889999999999999999   9999999999999975    


Q ss_pred             ---CCCeEEccccCccc
Q 001867          837 ---DFGARVADFGVAKV  850 (1002)
Q Consensus       837 ---~~~~kl~DfGl~~~  850 (1002)
                         ++.+.++||+.+..
T Consensus       178 ~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        178 REEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCceEEEEECCcccc
Confidence               46799999998864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.76  E-value=2.1e-07  Score=102.16  Aligned_cols=167  Identities=22%  Similarity=0.326  Sum_probs=126.3

Q ss_pred             ccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec----CCee
Q 001867          697 GKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT----RDCK  771 (1002)
Q Consensus       697 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  771 (1002)
                      .+.|++. ..||..|++|+++.....              .   ......-+++++++.|+|+|++.++|..    +-.+
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--------------~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl  352 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQ--------------S---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL  352 (655)
T ss_pred             ceeEeeeeccCCceeeeeeecccccc--------------C---cccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence            4678988 468999999998432111              0   1112445788999999999999998873    4567


Q ss_pred             eEEEeccCC-CChhhhhhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          772 LLVYEYMPN-GSLGDLLHSC-------------KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       772 ~lv~e~~~~-g~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++||+|+|+ ++|.++....             .+...++..+|.++.|+..||.++|+.   |.+.+-+.+++|+++.+
T Consensus       353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~  429 (655)
T KOG3741|consen  353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGK  429 (655)
T ss_pred             EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCc
Confidence            999999987 4676653321             124578899999999999999999999   99999999999999998


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP  902 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p  902 (1002)
                      .+++|+..|...........                -+.+   -.+-|.=.+|.++..+.+|..-
T Consensus       430 ~RIriS~C~i~Dvl~~d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  430 MRIRISGCGIMDVLQEDPTE----------------PLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ceEEEecccceeeecCCCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            89999988887766554311                1111   2356999999999999999543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.76  E-value=5.4e-08  Score=99.18  Aligned_cols=152  Identities=24%  Similarity=0.201  Sum_probs=105.5

Q ss_pred             CcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccc----c--ccchhhHHhHHHHHHHHhcCCCC--c
Q 001867          686 DEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKG----Q--VQDQVQDDGFQAEVETLGKIRHK--N  757 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~----~--~~~~~~~~~~~~E~~~l~~l~h~--n  757 (1002)
                      .++..||.|.-+.||.|...+|.++|||.=..+. .++.........    .  ..-...+...++|.++|+++...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~Gr-tsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGR-TSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCc-hhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4568999999999999999999999999643331 111111111000    1  01134556688999999999643  5


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |.+.+++    +...+||||++|-.|...-       ++.+....++..|.+-++.+-..   ||||+|+.+-||++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            6666544    3457999999886664432       23344555666666666666666   99999999999999999


Q ss_pred             CCeEEccccCccccc
Q 001867          838 FGARVADFGVAKVVD  852 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~  852 (1002)
                      |.+.++||--+....
T Consensus       239 g~~~vIDwPQ~v~~~  253 (304)
T COG0478         239 GDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCEEEEeCcccccCC
Confidence            999999998776443

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.75  E-value=8.8e-09  Score=75.77  Aligned_cols=41  Identities=51%  Similarity=0.951  Sum_probs=30.7

Q ss_pred             hHHHHHHHHHHHhcc-CCccccCCCCCCCCCCCCCccceeEEe
Q 001867           24 NQEGLYLERVKLSLS-DPDSALSSWGRNPRDDSPCSWRGVECD   65 (1002)
Q Consensus        24 ~~~~~~l~~~k~~~~-d~~~~l~sw~~~~~~~~~C~w~gv~C~   65 (1002)
                      .+|++||++||+++. ||.+.+++|+... +.+||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-DSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT---S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcC-CCCCeeeccEEeC
Confidence            579999999999998 5789999997542 3689999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.74  E-value=4.5e-09  Score=84.70  Aligned_cols=40  Identities=35%  Similarity=0.652  Sum_probs=14.7

Q ss_pred             cccccCCccccccccccccCCCCcccccccccceeeeccc
Q 001867          136 ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN  175 (1002)
Q Consensus       136 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  175 (1002)
                      .|.++++|++|++++|+++...|+.|.++++|++|++++|
T Consensus        20 ~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen   20 SFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             TTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred             HHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence            3333333333333333333333333333333333333333

...

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.63  E-value=1.8e-09  Score=121.46  Aligned_cols=179  Identities=31%  Similarity=0.268  Sum_probs=112.0

Q ss_pred             CCcCcCCCCCcEEEccCccccCCCCCcCCCC-CcceEEEcccCccc---Ccccccccc------CCcccEEEccCCcCCC
Q 001867          398 PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGL-PHVYLLELTDNFLS---GEISKNIAG------AANLSLLIISKNNLSG  467 (1002)
Q Consensus       398 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~i~---~~~~~~~~~------l~~L~~L~Ls~N~l~~  467 (1002)
                      |-.+-.+.+|+.|.|.++.|.. .-+ +..+ ..|+.| +.+|.+.   .++....+.      ...|...+.+.|.+. 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~-~~G-L~~lr~qLe~L-IC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST-AKG-LQELRHQLEKL-ICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh-hhh-hHHHHHhhhhh-hhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            4455667788888888887763 111 1111 233333 2233322   111111111      235667788888887 


Q ss_pred             CCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccc
Q 001867          468 SLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGN  547 (1002)
Q Consensus       468 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~  547 (1002)
                      .+.+.+.-++.|+.|+|++|+++..  ..+..|++|++|||++|+|....--....++ |+.|+|+||.++. + -.+.+
T Consensus       178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~t-L-~gie~  252 (1096)
T KOG1859|consen  178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTT-L-RGIEN  252 (1096)
T ss_pred             hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHh-h-hhHHh
Confidence            6677777788888888888888743  3777888888888888888843333444444 8888888888873 2 35667


Q ss_pred             cccccEEeCcceeeecccCCc-cccc-ccceEEeccccCc
Q 001867          548 LSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLS  585 (1002)
Q Consensus       548 l~~L~~L~Ls~N~l~~~ip~~-~~~l-~L~~l~ls~N~l~  585 (1002)
                      |.+|+.|||++|-|++.---. +..+ .|..|+|.+|++.
T Consensus       253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            888888888888877532211 2233 6777777777775

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=1e-06  Score=101.34  Aligned_cols=159  Identities=23%  Similarity=0.297  Sum_probs=101.0

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCc------------------cccccc-----cchhhHHhHHH
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCD------------------VEKGQV-----QDQVQDDGFQA  745 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------------------~~~~~~-----~~~~~~~~~~~  745 (1002)
                      +.|+.++-|.||+|++++|+.||||+.+++..+....--.                  ......     ..-..+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999999999999998774331110000                  000000     01122234556


Q ss_pred             HHHHHhcCC-----CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 001867          746 EVETLGKIR-----HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVP  820 (1002)
Q Consensus       746 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~  820 (1002)
                      |..-+.+++     .|.+.-..=++.-.....++|||++|..+.+...-.. ...+...+..-..++.  +..+-..   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d---  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD---  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc---
Confidence            666666652     4554333334444456689999999988888743322 3455333333222221  2333334   


Q ss_pred             CeeeCCCCCCcEEECCCCCeEEccccCcccccC
Q 001867          821 SIVHRDVKSNNILLDGDFGARVADFGVAKVVDA  853 (1002)
Q Consensus       821 ~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~  853 (1002)
                      |+.|+|.+|.||+++.+|++.+.|||+...+..
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999876654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.51  E-value=2.1e-09  Score=120.82  Aligned_cols=179  Identities=27%  Similarity=0.269  Sum_probs=116.7

Q ss_pred             CCCCCCCCCCceEEccCccccCCCChhhhcc-Ccccceeeeccccc----------cCCCCcCcCCCCCcEEEccCcccc
Q 001867          350 PGDLGKNSPLRWVDLSNNQFTGEIPASLCEK-GELEELLMIYNSFT----------GQLPDGLGHCQSLTRVRLGYNRLT  418 (1002)
Q Consensus       350 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~----------~~~p~~l~~l~~L~~L~L~~N~l~  418 (1002)
                      |-.+..+.+|++|.|.++.|..  ...+..+ ..|+.|.-. |.++          |.+..++ ....|...+.++|+++
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH
Confidence            4455667777788877777763  1222222 234443222 1111          1111111 1245788888999998


Q ss_pred             CCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCccccc
Q 001867          419 GKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLT  498 (1002)
Q Consensus       419 ~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  498 (1002)
                       .+...+.-++.|+.|+|++|+++.+.  ++..+..|+.|||+.|.+. .+|..-..-..|+.|.+++|.++. + ..+.
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~t-L-~gie  251 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTT-L-RGIE  251 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHh-h-hhHH
Confidence             66677777888899999999888664  7788888888888888887 555432222238888888888873 2 3567


Q ss_pred             ccccCCeeecCCCcCCcccc-cccccccccccccccCcccc
Q 001867          499 NLAELGSLDLHANDLSGELP-SSVSSWKKLNELNLADNLFY  538 (1002)
Q Consensus       499 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~  538 (1002)
                      +|.+|+.||||+|-|++.-- ..++.|..|+.|+|.+|.+.
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            78888888888888775422 23566777888888888775

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.50  E-value=7.9e-09  Score=93.00  Aligned_cols=114  Identities=25%  Similarity=0.333  Sum_probs=53.2

Q ss_pred             CcccEEEccCCcCCCCCcccc-ccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccccccccccccccc
Q 001867          453 ANLSLLIISKNNLSGSLPEEI-GFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELN  531 (1002)
Q Consensus       453 ~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  531 (1002)
                      ..|+..+|++|.+. ..|+.| ...+.++.|+|++|+|+ .+|+++..++.|+.|+++.|.|. ..|..+..|.+|..|+
T Consensus        53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            34444555555555 233333 23345555555555555 45555555555555555555555 3444444455555555


Q ss_pred             ccCcccccCCCCCccccccccEEeCcceeeecccCCccc
Q 001867          532 LADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ  570 (1002)
Q Consensus       532 Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~  570 (1002)
                      ..+|.+. .||-++.--+..-..++.++.+.+.-|..++
T Consensus       130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ  167 (177)
T ss_pred             CCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence            5555544 4443322222222223344444444444433

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=6e-08  Score=110.45  Aligned_cols=152  Identities=16%  Similarity=0.246  Sum_probs=102.4

Q ss_pred             HHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCc------cc-ccccccccccCccccc
Q 001867          804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK------SM-SVIAGSCGYIAPEYAY  876 (1002)
Q Consensus       804 ~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~------~~-~~~~gt~~y~aPE~~~  876 (1002)
                      +.+++.|+.|+|..  +++||+.|.|++|.++..+..||+.|+.+..........      .. ........|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34555899999987  599999999999999999999999999887554421111      11 1122345799999999


Q ss_pred             cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCC
Q 001867          877 TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLP  956 (1002)
Q Consensus       877 ~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  956 (1002)
                      +...+.++|+||+|+.+|.+..|+.+.....+...........   .      +-....+..+...++.+-+.+.+..++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~---~------~~~~~~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL---L------NAGAFGYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc---c------ccccccccccCcHHHHHHHHHHhcCCc
Confidence            9888999999999999999997665543332222211111000   0      001111112223346777778999999


Q ss_pred             CCCCCHHHHH
Q 001867          957 INRPAMRRVV  966 (1002)
Q Consensus       957 ~~Rps~~evl  966 (1002)
                      ..||++.++.
T Consensus       254 ~~rp~~~~l~  263 (700)
T KOG2137|consen  254 AVRPTLDLLL  263 (700)
T ss_pred             ccCcchhhhh
Confidence            9999777665

>PRK09902 hypothetical protein; Provisional

Probab=98.47  E-value=1.4e-06  Score=87.45  Aligned_cols=145  Identities=16%  Similarity=0.083  Sum_probs=105.5

Q ss_pred             eeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC--CceeeeeeEEec-
Q 001867          691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH--KNIVKLWCCCTT-  767 (1002)
Q Consensus       691 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-  767 (1002)
                      -|+|+.+-|++.... |..+-+|.-......           ..........|.+|+..++++..  -.+.+.+.+... 
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~-----------s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k   93 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFH-----------SVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVK   93 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccc-----------cccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeec
Confidence            367888999998765 457888876322111           11112356779999999999852  224455422211 


Q ss_pred             ---CCeeeEEEeccCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC--eE
Q 001867          768 ---RDCKLLVYEYMPN-GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG--AR  841 (1002)
Q Consensus       768 ---~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~--~k  841 (1002)
                         ....++|+|-++| -+|.+++....-.+.+......++.+++.+++-||+.   ++.|+|+.+.||+++.++.  ++
T Consensus        94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902         94 IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEE
Confidence               2245899998854 4899988654445678888899999999999999999   9999999999999986667  99


Q ss_pred             EccccCccc
Q 001867          842 VADFGVAKV  850 (1002)
Q Consensus       842 l~DfGl~~~  850 (1002)
                      ++||--++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.43  E-value=2.4e-06  Score=87.94  Aligned_cols=109  Identities=24%  Similarity=0.284  Sum_probs=85.6

Q ss_pred             hHHhHHHHHHHHhcCCC--CceeeeeeEEecC----CeeeEEEeccCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHH
Q 001867          739 QDDGFQAEVETLGKIRH--KNIVKLWCCCTTR----DCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDAAEGL  811 (1002)
Q Consensus       739 ~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L  811 (1002)
                      ...+..+|...+.++..  =.+++.+++....    ...++|+|++++. +|.+++.....  .+......++.+++..+
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLI  131 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHH
Confidence            44567888888888753  3345566666542    2458999999874 79999875222  66677889999999999


Q ss_pred             HHHhhcCCCCeeeCCCCCCcEEECCCC---CeEEccccCccccc
Q 001867          812 SYLHHDCVPSIVHRDVKSNNILLDGDF---GARVADFGVAKVVD  852 (1002)
Q Consensus       812 ~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGl~~~~~  852 (1002)
                      +-||+.   ||+|+|+++.|||++.++   .+.++||+-++...
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999999   999999999999999877   79999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1002
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-50
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-49
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-49
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-33
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-33
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-31
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-07
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		7e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		2e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-04
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		5e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-04
3soa_A	444	Full-Length Human Camkii Length = 444		5e-04
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		6e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		7e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		7e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-04
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  197 bits (501), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 117/309 (37%), Positives = 175/309 (56%), Gaps = 24/309 (7%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXG 742
           D     N++G G  GKVYK  L++G  VAVK+L     +E   G +++            
Sbjct: 38  DNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL----KEERXQGGELQ------------ 81
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL--LDWPTR 800
           FQ EVE +    H+N+++L   C T   +LLVY YM NGS+   L         LDWP R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
            +I + +A GL+YLH  C P I+HRDVK+ NILLD +F A V DFG+AK++D        
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 201
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD----LVKWV 916
           +V  G+ G+IAPEY  T + +EK+D++ +GV++LEL+TG+   D      D    L+ WV
Sbjct: 202 AV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 917 CSTLDQKGVDHVLDPKLDCCFK-EEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE 975
              L +K ++ ++D  L   +K EE+ +++ + LLCT   P+ RP M  VV++L+  G  
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320
Query: 976 NRSKTGKKD 984
            R +  +K+
Sbjct: 321 ERWEEWQKE 329

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  195 bits (496), Expect = 9e-50,   Method: Composition-based stats.
 Identities = 117/309 (37%), Positives = 174/309 (56%), Gaps = 24/309 (7%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXG 742
           D     N++G G  GKVYK  L++G  VAVK+L     +E   G +++            
Sbjct: 30  DNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL----KEERTQGGELQ------------ 73
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL--LDWPTR 800
           FQ EVE +    H+N+++L   C T   +LLVY YM NGS+   L         LDWP R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
            +I + +A GL+YLH  C P I+HRDVK+ NILLD +F A V DFG+AK++D        
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD----LVKWV 916
           +V  G  G+IAPEY  T + +EK+D++ +GV++LEL+TG+   D      D    L+ WV
Sbjct: 194 AV-RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 917 CSTLDQKGVDHVLDPKLDCCFK-EEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE 975
              L +K ++ ++D  L   +K EE+ +++ + LLCT   P+ RP M  VV++L+  G  
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
Query: 976 NRSKTGKKD 984
            R +  +K+
Sbjct: 313 ERWEEWQKE 321

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  193 bits (490), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 170/524 (32%), Positives = 246/524 (46%), Gaps = 41/524 (7%)
Query: 116 CQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN 175
           C  LQHLD+S N L+G  + A++    LK L+++ N F G IP      + L+ +SL  N
Sbjct: 219 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 276
Query: 176 LLDGTIPAFL-GNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP-DS 233
              G IP FL G   TL  L+LS N F  G +PP  G+ + LE L L+  N  GE+P D+
Sbjct: 277 KFTGEIPDFLSGACDTLTGLDLSGNHFY-GAVPPFFGSCSLLESLALSSNNFSGELPMDT 335
Query: 234 LGRXXXXXXXXXXXXXXXGAIPSSLTELASVV---------------------------Q 266
           L +               G +P SLT L++ +                           +
Sbjct: 336 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 395
Query: 267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSL 325
           + L NN  TG +P   SN + L  L  S N L+G IP  L  L  L  L L+ N LEG +
Sbjct: 396 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 455
Query: 326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEE 385
           P  +     L  L L  N L G +P  L   + L W+ LSNN+ TGEIP  +     L  
Sbjct: 456 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 515
Query: 386 LLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEI 445
           L +  NSF+G +P  LG C+SL  + L  N   G +P  ++        ++  NF++G+ 
Sbjct: 516 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKR 571
Query: 446 SKNIA--GAAXXXXXXXXXXXXXXXXPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAEL 503
              I   G                   E++  L +    + +   + G    +  N   +
Sbjct: 572 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 631
Query: 504 GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG 563
             LD+  N LSG +P  + S   L  LNL  N   G+IP+++G+L  LN LDLS+N+L G
Sbjct: 632 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 691
Query: 564 RIPVGLQNLK-LNQLNVSNNRLSGELPSLFAKEMYRNS-FLGNP 605
           RIP  +  L  L ++++SNN LSG +P +   E +  + FL NP
Sbjct: 692 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 735

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  192 bits (489), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 170/524 (32%), Positives = 246/524 (46%), Gaps = 41/524 (7%)
Query: 116 CQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN 175
           C  LQHLD+S N L+G  + A++    LK L+++ N F G IP      + L+ +SL  N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279
Query: 176 LLDGTIPAFL-GNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP-DS 233
              G IP FL G   TL  L+LS N F  G +PP  G+ + LE L L+  N  GE+P D+
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFY-GAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
Query: 234 LGRXXXXXXXXXXXXXXXGAIPSSLTELASVV---------------------------Q 266
           L +               G +P SLT L++ +                           +
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398
Query: 267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSL 325
           + L NN  TG +P   SN + L  L  S N L+G IP  L  L  L  L L+ N LEG +
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEE 385
           P  +     L  L L  N L G +P  L   + L W+ LSNN+ TGEIP  +     L  
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 386 LLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEI 445
           L +  NSF+G +P  LG C+SL  + L  N   G +P  ++        ++  NF++G+ 
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKR 574
Query: 446 SKNIA--GAAXXXXXXXXXXXXXXXXPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAEL 503
              I   G                   E++  L +    + +   + G    +  N   +
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634
Query: 504 GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG 563
             LD+  N LSG +P  + S   L  LNL  N   G+IP+++G+L  LN LDLS+N+L G
Sbjct: 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 694
Query: 564 RIPVGLQNLK-LNQLNVSNNRLSGELPSLFAKEMYRNS-FLGNP 605
           RIP  +  L  L ++++SNN LSG +P +   E +  + FL NP
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (360), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 109/315 (34%), Positives = 160/315 (50%), Gaps = 31/315 (9%)
Query: 671 FHKLGFSEYE-ILDGLDED------NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKEC 723
           FH   F E + + +  DE       N +G G  G VYK  ++N   VAVKKL   +    
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITT 70
Query: 724 ESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
           E                  F  E++ + K +H+N+V+L    +  D   LVY YMPNGSL
Sbjct: 71  EE-------------LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 784 GDLLHSCKGGL--LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            D L SC  G   L W  R KI   AA G+++LH +     +HRD+KS NILLD  F A+
Sbjct: 118 LDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 173
Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           ++DFG+A+  +   +    S I G+  Y+APE A    +  KSDIYSFGVV+LE++TG L
Sbjct: 174 ISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG-L 231
Query: 902 PVDPEFGEKDLV--KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINR 959
           P   E  E  L+         ++K ++  +D K++      +  + ++   C       R
Sbjct: 232 PAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 960 PAMRRVVKLLQEVGA 974
           P +++V +LLQE+ A
Sbjct: 292 PDIKKVQQLLQEMTA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  141 bits (356), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 108/315 (34%), Positives = 159/315 (50%), Gaps = 31/315 (9%)
Query: 671 FHKLGFSEYE-ILDGLDED------NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKEC 723
           FH   F E + + +  DE       N +G G  G VYK  ++N   VAVKKL   +    
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITT 70
Query: 724 ESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
           E                  F  E++ + K +H+N+V+L    +  D   LVY YMPNGSL
Sbjct: 71  EE-------------LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 784 GDLLHSCKGGL--LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            D L SC  G   L W  R KI   AA G+++LH +     +HRD+KS NILLD  F A+
Sbjct: 118 LDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 173
Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           ++DFG+A+  +   +      I G+  Y+APE A    +  KSDIYSFGVV+LE++TG L
Sbjct: 174 ISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG-L 231
Query: 902 PVDPEFGEKDLV--KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINR 959
           P   E  E  L+         ++K ++  +D K++      +  + ++   C       R
Sbjct: 232 PAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 960 PAMRRVVKLLQEVGA 974
           P +++V +LLQE+ A
Sbjct: 292 PDIKKVQQLLQEMTA 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  141 bits (355), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 97/288 (33%), Positives = 148/288 (51%), Gaps = 25/288 (8%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXX 739
           E  +  D   +IG G  GKVYK VL +G  VA+K+     + E   G +           
Sbjct: 36  EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR----RTPESSQGIEEF--------- 82
Query: 740 XXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDW 797
               + E+ETL   RH ++V L   C  R+  +L+Y+YM NG+L   L+        + W
Sbjct: 83  ----ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
             R +I + AA GL YLH     +I+HRDVKS NILLD +F  ++ DFG++K     G+ 
Sbjct: 139 EQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQT 195
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK--DLVKW 915
               V+ G+ GYI PEY    R+ EKSD+YSFGVV+ E++  R  +      +  +L +W
Sbjct: 196 HLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 916 VCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAM 962
              + +   ++ ++DP L D    E + K  +  + C +    +RP+M
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  140 bits (354), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 108/315 (34%), Positives = 159/315 (50%), Gaps = 31/315 (9%)
Query: 671 FHKLGFSEYE-ILDGLDED------NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKEC 723
           FH   F E + + +  DE       N +G G  G VYK  ++N   VAVKKL   +    
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 724 ESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
           E                  F  E++ + K +H+N+V+L    +  D   LVY YMPNGSL
Sbjct: 65  EE-------------LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
Query: 784 GDLLHSCKGGL--LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            D L SC  G   L W  R KI   AA G+++LH +     +HRD+KS NILLD  F A+
Sbjct: 112 LDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 167
Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           ++DFG+A+  +   +      I G+  Y+APE A    +  KSDIYSFGVV+LE++TG L
Sbjct: 168 ISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG-L 225
Query: 902 PVDPEFGEKDLV--KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINR 959
           P   E  E  L+         ++K ++  +D K++      +  + ++   C       R
Sbjct: 226 PAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 285
Query: 960 PAMRRVVKLLQEVGA 974
           P +++V +LLQE+ A
Sbjct: 286 PDIKKVQQLLQEMTA 300

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  138 bits (347), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/288 (33%), Positives = 147/288 (51%), Gaps = 25/288 (8%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXX 739
           E  +  D   +IG G  GKVYK VL +G  VA+K+     + E   G +           
Sbjct: 36  EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR----RTPESSQGIEEF--------- 82
Query: 740 XXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDW 797
               + E+ETL   RH ++V L   C  R+  +L+Y+YM NG+L   L+        + W
Sbjct: 83  ----ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
             R +I + AA GL YLH     +I+HRDVKS NILLD +F  ++ DFG++K      + 
Sbjct: 139 EQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK--DLVKW 915
               V+ G+ GYI PEY    R+ EKSD+YSFGVV+ E++  R  +      +  +L +W
Sbjct: 196 HLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 916 VCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAM 962
              + +   ++ ++DP L D    E + K  +  + C +    +RP+M
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 108/315 (34%), Positives = 153/315 (48%), Gaps = 31/315 (9%)
Query: 671 FHKLGFSEYE-ILDGLDED------NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKEC 723
           FH   F E + + +  DE       N  G G  G VYK  ++N   VAVKKL   +    
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 724 ESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
           E                  F  E++   K +H+N+V+L    +  D   LVY Y PNGSL
Sbjct: 62  EE-------------LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
Query: 784 GDLLHSCKGGL--LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            D L SC  G   L W  R KI   AA G+++LH +     +HRD+KS NILLD  F A+
Sbjct: 109 LDRL-SCLDGTPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAK 164
Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           ++DFG+A+  +   +    S I G+  Y APE A    +  KSDIYSFGVV+LE++TG L
Sbjct: 165 ISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG-L 222
Query: 902 PVDPEFGEKDLV--KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINR 959
           P   E  E  L+         ++K ++  +D K +      +    ++   C       R
Sbjct: 223 PAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKR 282
Query: 960 PAMRRVVKLLQEVGA 974
           P +++V +LLQE  A
Sbjct: 283 PDIKKVQQLLQEXTA 297

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG+GS G V++    +G  VAVK L        E     E+           F  EV  +
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKIL-------MEQDFHAER--------VNEFLREVAIM 88
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH-SCKGGLLDWPTRYKIIVDAAE 809
            ++RH NIV      T      +V EY+  GSL  LLH S     LD   R  +  D A+
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YLH+   P IVHR++KS N+L+D  +  +V DFG++++  AS    S S  AG+  +
Sbjct: 149 GMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSA-AGTPEW 205
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +APE       NEKSD+YSFGV++ EL T + P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 110/213 (51%), Gaps = 20/213 (9%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG+GS G V++    +G  VAVK L        E     E+           F  EV  +
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKIL-------MEQDFHAER--------VNEFLREVAIM 88
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH-SCKGGLLDWPTRYKIIVDAAE 809
            ++RH NIV      T      +V EY+  GSL  LLH S     LD   R  +  D A+
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YLH+   P IVHRD+KS N+L+D  +  +V DFG+++ + AS    S    AG+  +
Sbjct: 149 GMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXA-AGTPEW 205
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +APE       NEKSD+YSFGV++ EL T + P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 90/341 (26%), Positives = 141/341 (41%), Gaps = 70/341 (20%)
Query: 670 SFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           S H + + E E+      + V+G G+ G            V  K  WR          DV
Sbjct: 2   SLHMIDYKEIEV------EEVVGRGAFG------------VVCKAKWRAK--------DV 35
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
                        F  E+  L ++ H NIVKL+  C    C  LV EY   GSL ++LH 
Sbjct: 36  AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG 93
Query: 790 CKGGLLDWPTRYKIIVDA-------AEGLSYLHHDCVPSIVHRDVKSNNILL-DGDFGAR 841
            +      P  Y     A       ++G++YLH     +++HRD+K  N+LL  G    +
Sbjct: 94  AE------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 147
Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           + DFG A  +        M+   GS  ++APE       +EK D++S+G+++ E++T R 
Sbjct: 148 ICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202
Query: 902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA 961
           P D   G    + W         V +   P L    K     + ++   C S  P  RP+
Sbjct: 203 PFDEIGGPAFRIMW--------AVHNGTRPPL---IKNLPKPIESLMTRCWSKDPSQRPS 251
Query: 962 MRRVVKLLQEV-----GAE-------NRSKTGKKDGKLSPY 990
           M  +VK++  +     GA+         S    +DG++ PY
Sbjct: 252 MEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 292

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 90/341 (26%), Positives = 141/341 (41%), Gaps = 70/341 (20%)
Query: 670 SFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           S H + + E E+      + V+G G+ G            V  K  WR          DV
Sbjct: 1   SLHMIDYKEIEV------EEVVGRGAFG------------VVCKAKWRAK--------DV 34
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
                        F  E+  L ++ H NIVKL+  C    C  LV EY   GSL ++LH 
Sbjct: 35  AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG 92
Query: 790 CKGGLLDWPTRYKIIVDA-------AEGLSYLHHDCVPSIVHRDVKSNNILL-DGDFGAR 841
            +      P  Y     A       ++G++YLH     +++HRD+K  N+LL  G    +
Sbjct: 93  AE------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146
Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           + DFG A  +        M+   GS  ++APE       +EK D++S+G+++ E++T R 
Sbjct: 147 ICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA 961
           P D   G    + W         V +   P L    K     + ++   C S  P  RP+
Sbjct: 202 PFDEIGGPAFRIMW--------AVHNGTRPPL---IKNLPKPIESLMTRCWSKDPSQRPS 250
Query: 962 MRRVVKLLQEV-----GAE-------NRSKTGKKDGKLSPY 990
           M  +VK++  +     GA+         S    +DG++ PY
Sbjct: 251 MEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPY 291

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 50
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 51  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 98
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V
Sbjct: 99  --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 118/238 (49%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 4   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 52
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 53  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 100
Query: 797 WPTRYKII--VD----AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I  +D     A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V
Sbjct: 101 --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 155
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 156 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 55
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 56  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 103
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V
Sbjct: 104 --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 158
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 159 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 55
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 56  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 103
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V
Sbjct: 104 --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 158
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 159 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 29  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 77
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 78  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 125
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V
Sbjct: 126 --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 180
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 181 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 78
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 79  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 126
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V
Sbjct: 127 --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 181
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 182 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 30/231 (12%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXX 741
           D  +   VIGSG++  V     +   E VA+K++     ++C++  D             
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI---NLEKCQTSMD------------- 58
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC------KGGLL 795
               E++ + +  H NIV  +     +D   LV + +  GS+ D++         K G+L
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           D  T   I+ +  EGL YLH +     +HRDVK+ NILL  D   ++ADFGV+  +   G
Sbjct: 119 DESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175
Query: 856 ---KPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLP 902
              + K      G+  ++APE    +R  + K+DI+SFG+  +EL TG  P
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 110/228 (48%), Gaps = 34/228 (14%)
Query: 367 NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLW 426
           N   G IP ++ +  +L  L + + + +G +PD L   ++L  +   YN L+G +PP + 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 427 GLPHVYLLELTDNFLSGEISKNIAGAAXXXXXXXXXXXXXXXXPEEIG-FLKSLVVLSGS 485
            LP++  +    N +SG I                        P+  G F K    ++ S
Sbjct: 147 SLPNLVGITFDGNRISGAI------------------------PDSYGSFSKLFTSMTIS 182
Query: 486 ENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDI 545
            N+ TG +P +  NL  L  +DL  N L G+      S K   +++LA N    ++  D+
Sbjct: 183 RNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN----SLAFDL 237
Query: 546 GNLSV---LNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELP 589
           G + +   LN LDL NNR+ G +P GL  LK L+ LNVS N L GE+P
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 65/127 (51%), Gaps = 1/127 (0%)
Query: 470 PEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNE 529
           P  I  L  L  L  +    +G++P+ L+ +  L +LD   N LSG LP S+SS   L  
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 530 LNLADNLFYGNIPEDIGNLSVL-NYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGEL 588
           +    N   G IP+  G+ S L   + +S NRL+G+IP    NL L  +++S N L G+ 
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213
Query: 589 PSLFAKE 595
             LF  +
Sbjct: 214 SVLFGSD 220

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 30/231 (12%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXX 741
           D  +   VIGSG++  V     +   E VA+K++     ++C++  D             
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI---NLEKCQTSMD------------- 53
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC------KGGLL 795
               E++ + +  H NIV  +     +D   LV + +  GS+ D++         K G+L
Sbjct: 54  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 113
Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           D  T   I+ +  EGL YLH +     +HRDVK+ NILL  D   ++ADFGV+  +   G
Sbjct: 114 DESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 170
Query: 856 ---KPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLP 902
              + K      G+  ++APE    +R  + K+DI+SFG+  +EL TG  P
Sbjct: 171 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 115/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 50
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T     +V ++    SL   LH  +     
Sbjct: 51  ------FKNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE----- 98
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V
Sbjct: 99  --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 6   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 54
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH+ +    +
Sbjct: 55  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKF-E 106
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                 I    A G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V      
Sbjct: 107 MKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSG 163
Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNE---KSDIYSFGVVILELVTGRLP 902
                 ++GS  ++APE       N    +SD+Y+FG+V+ EL+TG+LP
Sbjct: 164 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 50
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 51  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 98
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A  
Sbjct: 99  --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATE 153
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 154 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 22  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 70
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 71  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 118
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A  
Sbjct: 119 --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATE 173
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 174 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 44/238 (18%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 30  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 78
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH  +     
Sbjct: 79  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIE----- 126
Query: 797 WPTRYKIIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             T++++I         A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A  
Sbjct: 127 --TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATE 181
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLP 902
                       ++GS  ++APE    +R+ +K      SD+Y+FG+V+ EL+TG+LP
Sbjct: 182 KSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 144/299 (48%), Gaps = 43/299 (14%)
Query: 685 LDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           ++ +  IG G  G V+K  ++ +   VA+K L  G S+          G          F
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE----------GETEMIEKFQEF 70
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRY 801
           Q EV  +  + H NIVKL+      +   +V E++P    GDL H    K   + W  + 
Sbjct: 71  QREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVP---CGDLYHRLLDKAHPIKWSVKL 125
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-----DGDFGARVADFGVAKVVDASGK 856
           ++++D A G+ Y+ +   P IVHRD++S NI L     +    A+VADFG+++       
Sbjct: 126 RLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QS 179
Query: 857 PKSMSVIAGSCGYIAPEY--AYTLRVNEKSDIYSFGVVILELVTGRLPVDP-EFGEKDLV 913
             S+S + G+  ++APE   A      EK+D YSF +++  ++TG  P D   +G+   +
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---I 236
Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           K++ + + ++G+   +    DC       ++ N+  LC S  P  RP    +VK L E+
Sbjct: 237 KFI-NMIREEGLRPTIPE--DCP-----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 39/285 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IGSG  G V+     N + VA+K +  G MS+E                    F  E E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-------------------DFIEEAEV 55
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ H  +V+L+  C  +    LV+E+M +G L D L + + GL    T   + +D  E
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCE 114
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YL   CV   +HRD+ + N L+  +   +V+DFG+ + V    +  S +       +
Sbjct: 115 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKW 170
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            +PE     R + KSD++SFGV++ E+ + G++P +      ++V+ + +         +
Sbjct: 171 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGF------RL 223
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG 973
             P+L       + +++N    C    P +RPA  R+++ L E+ 
Sbjct: 224 YKPRLA---STHVYQIMN---HCWKERPEDRPAFSRLLRQLAEIA 262

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 143/299 (47%), Gaps = 43/299 (14%)
Query: 685 LDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           ++ +  IG G  G V+K  ++ +   VA+K L  G S+          G          F
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE----------GETEMIEKFQEF 70
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRY 801
           Q EV  +  + H NIVKL+      +   +V E++P    GDL H    K   + W  + 
Sbjct: 71  QREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVP---CGDLYHRLLDKAHPIKWSVKL 125
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-----DGDFGARVADFGVAKVVDASGK 856
           ++++D A G+ Y+ +   P IVHRD++S NI L     +    A+VADFG ++       
Sbjct: 126 RLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QS 179
Query: 857 PKSMSVIAGSCGYIAPEY--AYTLRVNEKSDIYSFGVVILELVTGRLPVDP-EFGEKDLV 913
             S+S + G+  ++APE   A      EK+D YSF +++  ++TG  P D   +G+   +
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---I 236
Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           K++ + + ++G+   +    DC       ++ N+  LC S  P  RP    +VK L E+
Sbjct: 237 KFI-NMIREEGLRPTIPE--DCP-----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 39/285 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IGSG  G V+     N + VA+K +  G MS+E                    F  E E 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-------------------DFIEEAEV 53
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ H  +V+L+  C  +    LV+E+M +G L D L + + GL    T   + +D  E
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCE 112
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YL   CV   +HRD+ + N L+  +   +V+DFG+ + V    +  S +       +
Sbjct: 113 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKW 168
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            +PE     R + KSD++SFGV++ E+ + G++P +      ++V+ + +         +
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGF------RL 221
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG 973
             P+L       + +++N    C    P +RPA  R+++ L E+ 
Sbjct: 222 YKPRLA---STHVYQIMN---HCWKERPEDRPAFSRLLRQLAEIA 260

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 39/285 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IGSG  G V+     N + VA+K +  G MS+E                    F  E E 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-------------------DFIEEAEV 58
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ H  +V+L+  C  +    LV+E+M +G L D L + + GL    T   + +D  E
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCE 117
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YL   CV   +HRD+ + N L+  +   +V+DFG+ + V    +  S +       +
Sbjct: 118 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKW 173
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            +PE     R + KSD++SFGV++ E+ + G++P +      ++V+ + +         +
Sbjct: 174 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGF------RL 226
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG 973
             P+L       + +++N    C    P +RPA  R+++ L E+ 
Sbjct: 227 YKPRLA---STHVYQIMN---HCWRERPEDRPAFSRLLRQLAEIA 265

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 108/229 (47%), Gaps = 26/229 (11%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 66
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T+    +V ++    SL   LH+ +    +
Sbjct: 67  ------FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKF-E 118
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                 I    A G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A        
Sbjct: 119 MKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNE---KSDIYSFGVVILELVTGRLP 902
                 ++GS  ++APE       N    +SD+Y+FG+V+ EL+TG+LP
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IGSG  G V+     N + VA+K +  G   E                    F  E E +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE------------------DDFIEEAEVM 76
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            K+ H  +V+L+  C  +    LV+E+M +G L D L + + GL    T   + +D  EG
Sbjct: 77  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEG 135
Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           ++YL   CV   +HRD+ + N L+  +   +V+DFG+ + V    +  S +       + 
Sbjct: 136 MAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA 191
Query: 871 APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVL 929
           +PE     R + KSD++SFGV++ E+ + G++P +      ++V+ + +         + 
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGF------RLY 244
Query: 930 DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG 973
            P+L       + +++N    C    P +RPA  R+++ L E+ 
Sbjct: 245 KPRLA---STHVYQIMN---HCWKERPEDRPAFSRLLRQLAEIA 282

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IGSGS G VYK       AV + K+     ++ ++                 F+ EV  L
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQA-----------------FRNEVAVL 86
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            K RH NI+ L+    T+D   +V ++    SL   LH  +     +     I    A+G
Sbjct: 87  RKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQG 144
Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           + YLH     +I+HRD+KSNNI L      ++ DFG+A V       + +    GS  ++
Sbjct: 145 MDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWM 201
Query: 871 APEYAYTLRVNE------KSDIYSFGVVILELVTGRLP 902
           APE    +R+ +      +SD+YS+G+V+ EL+TG LP
Sbjct: 202 APE---VIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 143/299 (47%), Gaps = 43/299 (14%)
Query: 685 LDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           ++ +  IG G  G V+K  ++ +   VA+K L  G S+          G          F
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE----------GETEMIEKFQEF 70
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRY 801
           Q EV  +  + H NIVKL+      +   +V E++P    GDL H    K   + W  + 
Sbjct: 71  QREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVP---CGDLYHRLLDKAHPIKWSVKL 125
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-----DGDFGARVADFGVAKVVDASGK 856
           ++++D A G+ Y+ +   P IVHRD++S NI L     +    A+VADF +++       
Sbjct: 126 RLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QS 179
Query: 857 PKSMSVIAGSCGYIAPEY--AYTLRVNEKSDIYSFGVVILELVTGRLPVDP-EFGEKDLV 913
             S+S + G+  ++APE   A      EK+D YSF +++  ++TG  P D   +G+   +
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---I 236
Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           K++ + + ++G+   +    DC       ++ N+  LC S  P  RP    +VK L E+
Sbjct: 237 KFI-NMIREEGLRPTIPE--DCP-----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-------------------SFLEEAQI 57
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K++H  +V+L+   +      +V EYM  GSL D L   +G  L  P    +    A 
Sbjct: 58  MKKLKHDKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 116
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + +HRD++S NIL+      ++ADFG+A++++   +  +         +
Sbjct: 117 GMAYIERM---NYIHRDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKW 172
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ ELVT GR+P
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 39/285 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IGSG  G V+     N + VA+K +  G MS+E                    F  E E 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-------------------DFIEEAEV 56
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ H  +V+L+  C  +    LV E+M +G L D L + + GL    T   + +D  E
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCE 115
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YL   CV   +HRD+ + N L+  +   +V+DFG+ + V    +  S +       +
Sbjct: 116 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKW 171
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            +PE     R + KSD++SFGV++ E+ + G++P +      ++V+ + +         +
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGF------RL 224
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG 973
             P+L       + +++N    C    P +RPA  R+++ L E+ 
Sbjct: 225 YKPRLA---STHVYQIMN---HCWRERPEDRPAFSRLLRQLAEIA 263

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 135/286 (47%), Gaps = 39/286 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IGSG  G V+     N + VA+K +  G MS+E                    F  E E 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-------------------DFIEEAEV 55
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ H  +V+L+  C  +    LV+E+M +G L D L + + GL    T   + +D  E
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCE 114
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++YL      S++HRD+ + N L+  +   +V+DFG+ + V    +  S +       +
Sbjct: 115 GMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKW 170
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            +PE     R + KSD++SFGV++ E+ + G++P +      ++V+ + +         +
Sbjct: 171 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGF------RL 223
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA 974
             P+L       + +++N    C    P +RPA  R+++ L  + A
Sbjct: 224 YKPRLA---STHVYQIMN---HCWKERPEDRPAFSRLLRQLAAIAA 263

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           ++EI DG +     IGSGS G VYK       AV +  +     ++ ++           
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA----------- 66
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 F+ EV  L K RH NI+ L+   +T     +V ++    SL   LH+ +    +
Sbjct: 67  ------FKNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKF-E 118
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                 I    A G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A        
Sbjct: 119 MKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNE---KSDIYSFGVVILELVTGRLP 902
                 ++GS  ++APE       N    +SD+Y+FG+V+ EL+TG+LP
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 135/299 (45%), Gaps = 39/299 (13%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXX 741
           + L  +  +G+G  G+V+    +    VAVK +  G MS E                   
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA------------------ 229
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
            F AE   +  ++H  +VKL     T++   ++ E+M  GSL D L S +G     P   
Sbjct: 230 -FLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
                 AEG++++      + +HRD+++ NIL+      ++ADFG+A+V++   +  +  
Sbjct: 288 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTARE 343
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL 920
                  + APE         KSD++SFG++++E+VT GR+P  P     ++++ +    
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRAL---- 398
Query: 921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSK 979
            ++G      P+ + C +E    + NI + C    P  RP    +  +L +      S+
Sbjct: 399 -ERGYRM---PRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 232
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+   +      +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 233 MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 292 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 347
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 232
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+   +      +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 233 MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 292 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 347
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + KIRH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 67  MKKIRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-------------------FLQEAQV 315
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+   +      +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 316 MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 375 GMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 430
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 232
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+   +      +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 233 MKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 292 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 347
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 56
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+   +     + V EYM  GSL D L    G  L  P    +    A 
Sbjct: 57  MKKLRHEKLVQLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 115
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 116 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKW 171
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 27/232 (11%)
Query: 689 NVIGSGSSGKVY--KVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAE 746
           + +G G+ GKV   K  L+ G  VAVK L R   +  +    + +              E
Sbjct: 22  DTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRR--------------E 66
Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
           ++ L   RH +I+KL+   +T     +V EY+  G L D +  CK G LD     ++   
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQ 124
Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
              G+ Y H   V   VHRD+K  N+LLD    A++ADFG++ ++      + +    GS
Sbjct: 125 ILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRXSCGS 178
Query: 867 CGYIAPEY-AYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
             Y APE  +  L    + DI+S GV++  L+ G LP D +     L K +C
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKIC 229

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 59
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 60  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 118
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 119 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 174
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + +IG G  GKVY+     G+ VAVK       ++     +               + E 
Sbjct: 12  EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIE-------------NVRQEA 57
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK---GGLLDWPTRYKII 804
           +    ++H NI+ L   C       LV E+   G L  +L   +     L++W       
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA------ 111
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILL-----DGDFG---ARVADFGVAKVVDASGK 856
           V  A G++YLH + +  I+HRD+KS+NIL+     +GD      ++ DFG+A+    + K
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              MS  AG+  ++APE       ++ SD++S+GV++ EL+TG +P
Sbjct: 172 ---MSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +N   VAVK L  G MS +                    F  E   
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-------------------AFLEEANL 61
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +  ++H  +V+L+   T  +   ++ EYM  GSL D L S +GG +  P         AE
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 121
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + +HRD+++ N+L+      ++ADFG+A+V++   +  +         +
Sbjct: 122 GMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKW 177
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE         KSD++SFG+++ E+VT G++P
Sbjct: 178 TAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 55
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 56  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 114
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 115 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 170
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 57
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 58  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 116
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 117 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 172
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 6/164 (3%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F+ EV    ++ H+NIV +       DC  LV EY+   +L + + S   G L   T   
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAIN 115
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ + H      IVHRD+K  NIL+D +   ++ DFG+AK +  +   ++  V
Sbjct: 116 FTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV 172
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           + G+  Y +PE A     +E +DIYS G+V+ E++ G  P + E
Sbjct: 173 L-GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 73/291 (25%), Positives = 133/291 (45%), Gaps = 39/291 (13%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXX 741
           + L  +  +G+G  G+V+    +    VAVK +  G MS E                   
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE------------------- 55
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
            F AE   +  ++H  +VKL     T++   ++ E+M  GSL D L S +G     P   
Sbjct: 56  AFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 114
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
                 AEG++++      + +HRD+++ NIL+      ++ADFG+A+V++   +  +  
Sbjct: 115 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTARE 170
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL 920
                  + APE         KSD++SFG++++E+VT GR+P  P     ++++ +    
Sbjct: 171 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRAL---- 225
Query: 921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
            ++G      P+ + C +E    + NI + C    P  RP    +  +L +
Sbjct: 226 -ERGYRM---PRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDD 268

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE-------------------AFLQEAQV 233
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+   +      +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 234 MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 292
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+ ++++   +  +         +
Sbjct: 293 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIE-DNEYTARQGAKFPIKW 348
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 49/303 (16%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXX 741
           + L  +  +G+G  G+V+    +    VAVK +  G MS E                   
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA------------------ 223
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
            F AE   +  ++H  +VKL     T++   ++ E+M  GSL D L S +G     P   
Sbjct: 224 -FLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 281
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
                 AEG++++      + +HRD+++ NIL+      ++ADFG+A+V   +  P    
Sbjct: 282 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV--GAKFP---- 332
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL 920
                  + APE         KSD++SFG++++E+VT GR+P  P     ++++ +    
Sbjct: 333 -----IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRAL---- 382
Query: 921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKT 980
            ++G      P+ + C +E    + NI + C    P  RP    +  +L +      S+ 
Sbjct: 383 -ERGYRM---PRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQX 434
Query: 981 GKK 983
            ++
Sbjct: 435 QQQ 437

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 63
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 64  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 123 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 178
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 74/284 (26%), Positives = 139/284 (48%), Gaps = 41/284 (14%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G +G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 61
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 62  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV-DASGKPKSMSVIAGSCG 868
           G++++      + +HRD+++ NIL+      ++ADFG+A+++ DA    +  +       
Sbjct: 121 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF--PIK 175
Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDH 927
           + APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRM 229
Query: 928 VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           V   + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 230 V---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 266

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+ + NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 61
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+   T ++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 62  MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 121 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 176
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 230
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 231 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 266

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 63
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  GSL D L    G  L  P    +    A 
Sbjct: 64  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 123 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKW 178
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  G L D L    G  L  P    +    A 
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 56
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+   T ++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 57  MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 115
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 116 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 171
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 225
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 226 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+V+    +    VA+K L  G MS E                    F  E + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------------------AFLQEAQV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+RH+ +V+L+    + +   +V EYM  G L D L    G  L  P    +    A 
Sbjct: 67  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++   +  +         +
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE A   R   KSD++SFG+++ EL T GR+P
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 12/166 (7%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           F+ E +    + H  IV ++              +V EY+   +L D++H+ +G +   P
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMT--P 115
Query: 799 TR-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            R  ++I DA + L++ H +    I+HRDVK  NI++      +V DFG+A+ +  SG  
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 858 KSMSV-IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + +  + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 37/232 (15%)
Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           V+G G  G+  KV     GE + +K+L R   +E +                  F  EV+
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRT----------------FLKEVK 59
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            +  + H N++K +     +D +L  + EY+  G+L  ++ S       W  R     D 
Sbjct: 60  VMRCLEHPNVLK-FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY-PWSQRVSFAKDI 117
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKP--------- 857
           A G++YLH     +I+HRD+ S+N L+  +    VADFG+A+ +VD   +P         
Sbjct: 118 ASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 858 --KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF 907
             K    + G+  ++APE       +EK D++SFG+V+ E++ GR+  DP++
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDY 225

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 57
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+   T ++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 58  MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HR++++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 117 GMAFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 172
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 226
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 227 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 68  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 127 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 182
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 236
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 237 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 272

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 12/166 (7%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           F+ E +    + H  IV ++              +V EY+   +L D++H+ +G +   P
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMT--P 115
Query: 799 TR-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            R  ++I DA + L++ H +    I+HRDVK  NIL+      +V DFG+A+ +  SG  
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 858 -KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               + + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +N   VAVK L  G MS +                    F  E   
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-------------------AFLEEANL 60
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +  ++H  +V+L+   T  +   ++ E+M  GSL D L S +GG +  P         AE
Sbjct: 61  MKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++Y+      + +HRD+++ N+L+      ++ADFG+A+V++   +  +         +
Sbjct: 121 GMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKW 176
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            APE         KS+++SFG+++ E+VT G++P
Sbjct: 177 TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 63  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 121
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 122 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 177
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 231
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 232 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 267

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 69
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 70  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 128
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 129 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 184
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 238
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 239 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 274

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 70
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 71  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 129
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 130 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 185
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 239
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 240 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 275

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 63
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 64  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 123 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 178
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 232
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 233 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 268

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 61
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 62  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 121 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKW 176
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 230
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 231 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 68  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 127 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 182
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 236
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 237 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 71
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 72  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 130
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 131 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 186
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 240
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 241 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 276

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 67  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 125
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 126 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 181
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 235
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 236 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 271

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 12/166 (7%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           F+ E +    + H  IV ++              +V EY+   +L D++H+ +G +   P
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMT--P 115
Query: 799 TR-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            R  ++I DA + L++ H +    I+HRDVK  NI++      +V DFG+A+ +  SG  
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 858 KSMSV-IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + +  + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 12/166 (7%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           F+ E +    + H  IV ++              +V EY+   +L D++H+ +G +   P
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMT--P 132
Query: 799 TR-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            R  ++I DA + L++ H +    I+HRDVK  NI++      +V DFG+A+ +  SG  
Sbjct: 133 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 858 KSMSV-IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + +  + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 137/283 (48%), Gaps = 39/283 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRG-MSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G  G+V+    +    VAVK L +G MS +                    F AE   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------------------AFLAEANL 61
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +++H+ +V+L+    T++   ++ EYM NGSL D L +  G  L       +    AE
Sbjct: 62  MKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G++++      + +HRD+++ NIL+      ++ADFG+A++++   +  +         +
Sbjct: 121 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 176
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE         KSD++SFG+++ E+VT GR+P  P     ++++ +     ++G   V
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNL-----ERGYRMV 230
Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
              + D C  EE+ +++    LC    P +RP    +  +L++
Sbjct: 231 ---RPDNC-PEELYQLMR---LCWKERPEDRPTFDYLRSVLED 266

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 12/166 (7%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           F+ E +    + H  IV ++              +V EY+   +L D++H+ +G +   P
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMT--P 115
Query: 799 TR-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            R  ++I DA + L++ H +    I+HRDVK  NI++      +V DFG+A+ +  SG  
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 858 KSMSV-IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + +  + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 12/166 (7%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
           F+ E +    + H  IV ++              +V EY+   +L D++H+ +G +   P
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMT--P 115
Query: 799 TR-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            R  ++I DA + L++ H +    I+HRDVK  NI++      +V DFG+A+ +  SG  
Sbjct: 116 KRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 858 KSMSV-IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + +  + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKI 803
           EV  +  + H NIVKL+    T     L+ EY   G + D L    G + +   R  ++ 
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQ 119
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +      GK   +   
Sbjct: 120 IVSAVQ---YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTF 170
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            GS  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 171 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 89/174 (51%), Gaps = 11/174 (6%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
            F AE   + ++RH N+V+L          L +V EYM  GSL D L S    +L     
Sbjct: 45  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 104
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
            K  +D  E + YL  +   + VHRD+ + N+L+  D  A+V+DFG+ K   ++     +
Sbjct: 105 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLV 913
            V      + APE     + + KSD++SFG+++ E+ + GR+P  P    KD+V
Sbjct: 162 PV-----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 209

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 89/174 (51%), Gaps = 11/174 (6%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
            F AE   + ++RH N+V+L          L +V EYM  GSL D L S    +L     
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
            K  +D  E + YL  +   + VHRD+ + N+L+  D  A+V+DFG+ K   ++     +
Sbjct: 120 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLV 913
            V      + APE     + + KSD++SFG+++ E+ + GR+P  P    KD+V
Sbjct: 177 PV-----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 689 NVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAE 746
           + +G G+ GKV K+      G  VAVK L R   +  +    +++              E
Sbjct: 17  DTLGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR--------------E 61
Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
           ++ L   RH +I+KL+   +T     +V EY+  G L D +  CK G ++     ++   
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQ 119
Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
               + Y H   V   VHRD+K  N+LLD    A++ADFG++ ++      + +    GS
Sbjct: 120 ILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGS 173
Query: 867 CGYIAPEY-AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
             Y APE  +  L    + DI+S GV++  L+ G LP D E
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G GS GKV         + VA+K + R + K+ +    VE+              E+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER--------------EISY 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY-KIIVDAA 808
           L  +RH +I+KL+   TT    ++V EY   G L D +   K    D   R+ + I+ A 
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           E   Y H      IVHRD+K  N+LLD +   ++ADFG++ ++      K+     GS  
Sbjct: 122 E---YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPN 172
Query: 869 YIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEF 907
           Y APE     L    + D++S G+V+  ++ GRLP D EF
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 89/174 (51%), Gaps = 11/174 (6%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
            F AE   + ++RH N+V+L          L +V EYM  GSL D L S    +L     
Sbjct: 232 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 291
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
            K  +D  E + YL  +   + VHRD+ + N+L+  D  A+V+DFG+ K   ++     +
Sbjct: 292 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLV 913
            V      + APE     + + KSD++SFG+++ E+ + GR+P  P    KD+V
Sbjct: 349 PV-----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 396

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 88/174 (50%), Gaps = 11/174 (6%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
            F AE   + ++RH N+V+L          L +V EYM  GSL D L S    +L     
Sbjct: 51  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 110
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
            K  +D  E + YL  +   + VHRD+ + N+L+  D  A+V+DFG+ K   ++     +
Sbjct: 111 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 167
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLV 913
            V      + APE       + KSD++SFG+++ E+ + GR+P  P    KD+V
Sbjct: 168 PV-----KWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKI 803
           EV  +  + H NIVKL+    T     LV EY   G + D L    G + +   R  ++ 
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQ 122
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLDGD   ++ADFG +       K   +   
Sbjct: 123 IVSAVQ---YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK---LDTF 173
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            GS  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 174 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG G+ G VYK   + GE  A+KK+      E      +                E+  L
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------------EISIL 54
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            +++H NIVKL+    T+   +LV+E++ +  L  LL  C+GGL +  T    ++    G
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGL-ESVTAKSFLLQLLNG 112
Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           ++Y H      ++HRD+K  N+L++ +   ++ADFG+A+      +  +  V+  +  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYR 167
Query: 871 APEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
           AP+    + + +   DI+S G +  E+V G  P+ P   E D
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEAD 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 135/319 (42%), Gaps = 59/319 (18%)
Query: 691 IGSGSSGKVYK------VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           IG G+ G+V++      +       VAVK L     KE E+  D++            FQ
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KE-EASADMQAD----------FQ 98
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS------CKGGLLDWP 798
            E   + +  + NIVKL   C       L++EYM  G L + L S      C     D  
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 799 TRYK----------------IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
           TR +                I    A G++YL        VHRD+ + N L+  +   ++
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215
Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ADFG+++ + ++   K+    A    ++ PE  +  R   +SD++++GVV+ E+ +  L 
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL- 274
Query: 903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM 962
             P +G             ++ + +V D  +  C +    ++ N+  LC S LP +RP+ 
Sbjct: 275 -QPYYG----------MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSF 323
Query: 963 RRVVKLLQEVGAENRSKTG 981
             + ++LQ +        G
Sbjct: 324 CSIHRILQRMCERAEGTVG 342

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG G+ G VYK   + GE  A+KK+      E      +                E+  L
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------------EISIL 54
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            +++H NIVKL+    T+   +LV+E++ +  L  LL  C+GGL +  T    ++    G
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGL-ESVTAKSFLLQLLNG 112
Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           ++Y H      ++HRD+K  N+L++ +   ++ADFG+A+      +  +  V+  +  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYR 167
Query: 871 APEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
           AP+    + + +   DI+S G +  E+V G  P+ P   E D
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGA-PLFPGVSEAD 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 72/216 (33%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 691 IGSGSSGKV--YKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G  GKV  Y    +N   GE VAVK L  G   +  SG                +Q 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG----------------WQR 59
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E+E L  + H++IVK   CC  +  K   LV EY+P GSL D L     GL       + 
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ 119
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I    EG++YLH       +HR + + N+LLD D   ++ DFG+AK V    +   +   
Sbjct: 120 I---CEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 173
Query: 864 AGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             S   + APE     +    SD++SFGV + EL+T
Sbjct: 174 GDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 72/216 (33%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 691 IGSGSSGKV--YKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G  GKV  Y    +N   GE VAVK L  G   +  SG                +Q 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG----------------WQR 60
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E+E L  + H++IVK   CC  +  K   LV EY+P GSL D L     GL       + 
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ 120
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I    EG++YLH       +HR + + N+LLD D   ++ DFG+AK V    +   +   
Sbjct: 121 I---CEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 174
Query: 864 AGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             S   + APE     +    SD++SFGV + EL+T
Sbjct: 175 GDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 689 NVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAE 746
           + +G G+ GKV K+      G  VAVK L R   +  +    +++              E
Sbjct: 17  DTLGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR--------------E 61
Query: 747 VETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
           ++ L   RH +I+KL+   +T     +V EY+  G L D +  CK G ++     ++   
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEMEARRLFQQ 119
Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS 866
               + Y H   V   VHRD+K  N+LLD    A++ADFG++ ++           +  S
Sbjct: 120 ILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRDS 170
Query: 867 CG---YIAPEY-AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           CG   Y APE  +  L    + DI+S GV++  L+ G LP D E
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 685 LDEDNVIGSGSSGKVYKVVL--SNGEA---VAVKKLWRGMSKECESGCDVEKGXXXXXXX 739
           +    VIG+G  G+VYK +L  S+G+    VA+K L  G +++                 
Sbjct: 46  VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK----------------Q 89
Query: 740 XXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
              F  E   +G+  H NI++L    +     +++ EYM NG+L   L   K G      
Sbjct: 90  RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQ 148
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
              ++   A G+ YL +    + VHRD+ + NIL++ +   +V+DFG+++V++    P++
Sbjct: 149 LVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEA 203
Query: 860 MSVIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               +G      + APE     +    SD++SFG+V+ E++T
Sbjct: 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG G+ G VYK   + GE  A+KK+      E      +                E+  L
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------------EISIL 54
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            +++H NIVKL+    T+   +LV+E++ +  L  LL  C+GGL +  T    ++    G
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGL-ESVTAKSFLLQLLNG 112
Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           ++Y H      ++HRD+K  N+L++ +   ++ADFG+A+      +  +  ++  +  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYR 167
Query: 871 APEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
           AP+    + + +   DI+S G +  E+V G  P+ P   E D
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEAD 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKI 803
           EV  +  + H NIVKL+    T     L+ EY   G + D L    G + +   R  ++ 
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQ 122
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +      GK   +   
Sbjct: 123 IVSAVQ---YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAF 173
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            G+  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+A+V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 64
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 123 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 179
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 180 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 91
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 149
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 150 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 206
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 78
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 136
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 137 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 194 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 59
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 117
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 118 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 174
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 175 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 78
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 136
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 137 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 194 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 65
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 123
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 124 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 180
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 181 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 63
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 121
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 60
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 118
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 66
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 125 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 181
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 182 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 60
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 118
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 58
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 116
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 117 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 173
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 174 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 67
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 125
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 126 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 182
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 183 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI-- 803
           EV  +  + H NIVKL+    T     LV EY   G + D L    G + +   R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQ 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +       K   +   
Sbjct: 122 IVSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTF 172
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            GS  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKI 803
           EV  +  + H NIVKL+    T     LV EY   G + D L    G + +   R  ++ 
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQ 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +       K   +   
Sbjct: 122 IVSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTF 172
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            GS  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/162 (34%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI-- 803
           EV  +  + H NIVKL+    T     LV EY   G + D L    G + +   R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQ 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +       K   +   
Sbjct: 122 IVSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTF 172
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            GS  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 78/152 (51%), Gaps = 13/152 (8%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE---GL 811
           H  +  ++C   T++    V EY+  G L   + SC    L   T Y     AAE   GL
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY-----AAEIILGL 131
Query: 812 SYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIA 871
            +LH      IV+RD+K +NILLD D   ++ADFG+ K  +  G  K+ +   G+  YIA
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKT-NXFCGTPDYIA 186
Query: 872 PEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
           PE     + N   D +SFGV++ E++ G+ P 
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 63
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L +     +D     +
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQA-HAERIDHIKLLQ 121
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 78/152 (51%), Gaps = 13/152 (8%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE---GL 811
           H  +  ++C   T++    V EY+  G L   + SC    L   T Y     AAE   GL
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY-----AAEIILGL 132
Query: 812 SYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIA 871
            +LH      IV+RD+K +NILLD D   ++ADFG+ K  +  G  K+ +   G+  YIA
Sbjct: 133 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKT-NEFCGTPDYIA 187
Query: 872 PEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
           PE     + N   D +SFGV++ E++ G+ P 
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 91
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 151
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 152 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 203
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 204 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 253
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 254 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKI 803
           EV  +  + H NIVKL+    T     LV EY   G + D L    G + +   R  ++ 
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGWMKEKEARAKFRQ 114
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +       K   +   
Sbjct: 115 IVSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTF 165
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            GS  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 166 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 37/234 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMS---KECESGCD 728
           K    +++IL        +G+GS G+V+ +    NG   A+K L + +    K+ E   D
Sbjct: 2   KYSLQDFQIL------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 55
Query: 729 VEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH 788
                            E   L  + H  I+++W          ++ +Y+  G L  LL 
Sbjct: 56  -----------------ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 98
Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
             K      P       +    L YLH      I++RD+K  NILLD +   ++ DFG A
Sbjct: 99  --KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA 153
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           K V     P     + G+  YIAPE   T   N+  D +SFG++I E++ G  P
Sbjct: 154 KYV-----PDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+ +V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 64
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 125 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 176
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 226
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 227 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKI 803
           EV  +  + H NIVKL+    T     LV EY   G + D L    G + +   R  ++ 
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQ 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +       K   +   
Sbjct: 122 IVSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEF 172
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            GS  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI-- 803
           EV  +  + H NIVKL+    T     LV EY   G + D L    G + +   R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQ 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           IV A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +       K   +   
Sbjct: 122 IVSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAF 172
Query: 864 AGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            G+  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 173 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 60
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 118
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 119 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 81
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V EYM NGSL   L  H  +  ++      
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 141
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 142 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 193
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 194 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 243
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 244 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 48/164 (29%), Positives = 87/164 (53%), Gaps = 8/164 (4%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-Y 801
           F  E +T+ K+ H  +VK +  C+      +V EY+ NG L + L S   GL   P++  
Sbjct: 50  FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL--EPSQLL 107
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           ++  D  EG+++L        +HRD+ + N L+D D   +V+DFG+ + V       S+ 
Sbjct: 108 EMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                  + APE  +  + + KSD+++FG+++ E+ + G++P D
Sbjct: 165 T-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 685 LDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           L    V+GSG+ G VYK + +  GE V +    + +++      +VE            F
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE------------F 87
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWP 798
             E   +  + H ++V+L   C +   +L V + MP+G L + +H  K       LL+W 
Sbjct: 88  MDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW- 145
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                 V  A+G+ YL       +VHRD+ + N+L+      ++ DFG+A++++   K  
Sbjct: 146 -----CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 197
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
           +         ++A E  +  +   +SD++S+GV I EL+T G  P D
Sbjct: 198 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 26/232 (11%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G+ G VYK   S G  VA+K++      E      +                E+  L
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---------------EISLL 73
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI-IVDAAE 809
            ++ H NIV L     +  C  LV+E+M    L  +L   K GL D  ++ KI +     
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQD--SQIKIYLYQLLR 130
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G+++ H      I+HRD+K  N+L++ D   ++ADFG+A+      +  +  V+  +  Y
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWY 185
Query: 870 IAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
            AP+    + + +   DI+S G +  E++TG+ P+ P   + D +  + S L
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSIL 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + +++      +VE            F  E 
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE------------FMDEA 68
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + H ++V+L   C +   +L V + MP+G L + +H  K       LL+W     
Sbjct: 69  LIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW----- 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G+ YL       +VHRD+ + N+L+      ++ DFG+A++++   K  +   
Sbjct: 123 -CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 178
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E  +  +   +SD++S+GV I EL+T G  P D
Sbjct: 179 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 26/232 (11%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G+ G VYK   S G  VA+K++      E      +                E+  L
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---------------EISLL 73
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI-IVDAAE 809
            ++ H NIV L     +  C  LV+E+M    L  +L   K GL D  ++ KI +     
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQD--SQIKIYLYQLLR 130
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           G+++ H      I+HRD+K  N+L++ D   ++ADFG+A+      +  +  V+  +  Y
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWY 185
Query: 870 IAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
            AP+    + + +   DI+S G +  E++TG+ P+ P   + D +  + S L
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSIL 236

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 691 IGSGSSGKV--YKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G  GKV  Y    +N   GE VAVK L        ++ C  +           G++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KADCGPQH--------RSGWKQ 65
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E++ L  + H++I+K   CC  +  K   LV EY+P GSL D L     GL       + 
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ 125
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I    EG++YLH       +HR++ + N+LLD D   ++ DFG+AK V    +   +   
Sbjct: 126 I---CEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 864 AGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             S   + APE     +    SD++SFGV + EL+T
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG GS G VY    + N E VA+KK+     +  E   D+ K              EV  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK--------------EVRF 107
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L K+RH N ++   C        LV EY   GS  DLL   K  L +      +   A +
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQ 165
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL+YLH     +++HRDVK+ NILL      ++ DFG A ++  +      +   G+  +
Sbjct: 166 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYW 216
Query: 870 IAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPV 903
           +APE    +   + + K D++S G+  +EL   + P+
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 691 IGSGSSGKV--YKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G  GKV  Y    +N   GE VAVK L        ++ C  +           G++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KADCGPQH--------RSGWKQ 65
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E++ L  + H++I+K   CC  +  K   LV EY+P GSL D L     GL       + 
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ 125
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I    EG++YLH       +HR++ + N+LLD D   ++ DFG+AK V    +   +   
Sbjct: 126 I---CEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 864 AGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             S   + APE     +    SD++SFGV + EL+T
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 61
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ EY+P GSL D L   K  + D     +
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERI-DHIKLLQ 119
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HR++ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 120 YTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 176
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 177 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+ C    +       Y  NG L  L +  K G  D         
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 144
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 145 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N GE VAVKKL     +                     F+ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----------------FER 63
Query: 746 EVETLGKIRHKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           E+E L  ++H NIVK    C +   R+ KL++ E++P GSL + L   K  + D     +
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EFLPYGSLREYLQKHKERI-DHIKLLQ 121
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
                 +G+ YL        +HRD+ + NIL++ +   ++ DFG+ KV+    +   +  
Sbjct: 122 YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 863 IAGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              S   + APE     + +  SD++SFGVV+ EL T
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG GS G VY    + N E VA+KK+     +  E   D+ K              EV  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK--------------EVRF 68
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L K+RH N ++   C        LV EY   GS  DLL   K  L +      +   A +
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQ 126
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL+YLH     +++HRDVK+ NILL      ++ DFG A ++  +      +   G+  +
Sbjct: 127 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYW 177
Query: 870 IAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPV 903
           +APE    +   + + K D++S G+  +EL   + P+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 691 IGSGSSGKV--YKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G  GKV  Y    +N   GE VAVK L      +  SG                ++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG----------------WKQ 82
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E++ L  + H++I+K   CC         LV EY+P GSL D L     GL       + 
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ 142
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I    EG++YLH       +HRD+ + N+LLD D   ++ DFG+AK V    +   +   
Sbjct: 143 I---CEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRED 196
Query: 864 AGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             S   + APE     +    SD++SFGV + EL+T
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V E M NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V E M NGSL   L  H  +  ++      
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 154 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 205
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 255
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD-LLHSCKGGLLDWPTRYKII 804
           EV     + H NIVKL+    T     LV EY   G + D L+   +    +   +++ I
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
           V A +   Y H      IVHRD+K+ N+LLD D   ++ADFG +       K   +    
Sbjct: 123 VSAVQ---YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFC 173
Query: 865 GSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
           G+  Y APE     + +  + D++S GV++  LV+G LP D
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 31/244 (12%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGXXX 735
            +YE+L        IG+GS G+  K+   S+G+ +  K+L  G   E E    V      
Sbjct: 6   EDYEVL------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV------ 53
Query: 736 XXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLH--SCK 791
                    +EV  L +++H NIV+ +     R    L  V EY   G L  ++   + +
Sbjct: 54  ---------SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHH--DCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              LD     +++      L   H   D   +++HRD+K  N+ LDG    ++ DFG+A+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
           +++            G+  Y++PE    +  NEKSDI+S G ++ EL    +P    F +
Sbjct: 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQ 221
Query: 910 KDLV 913
           K+L 
Sbjct: 222 KELA 225

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 28/248 (11%)
Query: 670 SFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCD 728
           S ++LG   +E +       V+G GS GKV    V   G+  AVK L + +  + +   D
Sbjct: 16  SSNRLGIDNFEFI------RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD---D 66
Query: 729 VEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH 788
           VE             +  + +L +  H  + +L+CC  T D    V E++  G L  + H
Sbjct: 67  VECTMT---------EKRILSLAR-NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFH 114
Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
             K    D         +    L +LH      I++RD+K +N+LLD +   ++ADFG+ 
Sbjct: 115 IQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC 171
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           K    +G   + +   G+  YIAPE    +      D ++ GV++ E++ G  P + E  
Sbjct: 172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-N 228
Query: 909 EKDLVKWV 916
           E DL + +
Sbjct: 229 EDDLFEAI 236

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G GS GKV      + G+ VA+K + + +  + +    +E+              E+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER--------------EISY 61
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L  +RH +I+KL+    ++D  ++V EY  N     ++   K    +    ++ I+ A E
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
              Y H      IVHRD+K  N+LLD     ++ADFG++ ++      K+     GS  Y
Sbjct: 122 ---YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 172
Query: 870 IAPEY-AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
            APE  +  L    + D++S GV++  ++  RLP D E
Sbjct: 173 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G GS GKV      + G+ VA+K + + +  + +    +E+              E+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER--------------EISY 57
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L  +RH +I+KL+    ++D  ++V EY  N     ++   K    +    ++ I+ A E
Sbjct: 58  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
              Y H      IVHRD+K  N+LLD     ++ADFG++ ++      K+     GS  Y
Sbjct: 118 ---YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 168
Query: 870 IAPEY-AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
            APE  +  L    + D++S GV++  ++  RLP D E
Sbjct: 169 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G GS GKV      + G+ VA+K + + +  + +    +E+              E+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER--------------EISY 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L  +RH +I+KL+    ++D  ++V EY  N     ++   K    +    ++ I+ A E
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
              Y H      IVHRD+K  N+LLD     ++ADFG++ ++      K+     GS  Y
Sbjct: 128 ---YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 178
Query: 870 IAPEY-AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
            APE  +  L    + D++S GV++  ++  RLP D E
Sbjct: 179 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 31/244 (12%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGXXX 735
            +YE+L        IG+GS G+  K+   S+G+ +  K+L  G   E E    V      
Sbjct: 6   EDYEVL------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV------ 53
Query: 736 XXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLH--SCK 791
                    +EV  L +++H NIV+ +     R    L  V EY   G L  ++   + +
Sbjct: 54  ---------SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHH--DCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              LD     +++      L   H   D   +++HRD+K  N+ LDG    ++ DFG+A+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
           +++            G+  Y++PE    +  NEKSDI+S G ++ EL    +P    F +
Sbjct: 165 ILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQ 221
Query: 910 KDLV 913
           K+L 
Sbjct: 222 KELA 225

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 51/297 (17%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           D V+G+G  G+V     K+      +VA+K L  G +++                    F
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 64
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLLDWPTRY 801
             E   +G+  H NI++L    T     ++V E M NGSL   L  H  +  ++      
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           + I   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++  
Sbjct: 125 RGI---ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAY 176
Query: 862 VIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
              G      + +PE     +    SD++S+G+V+ E+++        +GE+    W  S
Sbjct: 177 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGERPY--WEMS 226
Query: 919 TLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             D  K VD  + L P +DC        +  + L C      NRP   ++V +L ++
Sbjct: 227 NQDVIKAVDEGYRLPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G GS GKV      + G+ VA+K + + +  + +    +E+              E+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER--------------EISY 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L  +RH +I+KL+    ++D  ++V EY  N     ++   K    +    ++ I+ A E
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
              Y H      IVHRD+K  N+LLD     ++ADFG++ ++      K+     GS  Y
Sbjct: 127 ---YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 177
Query: 870 IAPEY-AYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
            APE  +  L    + D++S GV++  ++  RLP D E
Sbjct: 178 AAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG  G V+K V +  GE++ +    + +  E +SG                FQA  
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSG-------------RQSFQAVT 81
Query: 748 E---TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDWPT 799
           +    +G + H +IV+L   C     +L V +Y+P GSL D +   +G L     L+W  
Sbjct: 82  DHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWG- 139
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
                V  A+G+ YL       +VHR++ + N+LL      +VADFGVA ++    K   
Sbjct: 140 -----VQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            S       ++A E  +  +   +SD++S+GV + EL+T
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG  G V+K V +  GE++ +    + +  E +SG                FQA  
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSG-------------RQSFQAVT 63
Query: 748 E---TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDWPT 799
           +    +G + H +IV+L   C     +L V +Y+P GSL D +   +G L     L+W  
Sbjct: 64  DHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWG- 121
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
                V  A+G+ YL       +VHR++ + N+LL      +VADFGVA ++    K   
Sbjct: 122 -----VQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            S       ++A E  +  +   +SD++S+GV + EL+T
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 688 DNVIGSGSSGKV-YKVVLSNGE---AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           + +IGSG SG+V Y  +   G+    VA+K L  G ++                     F
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER----------------QRRDF 97
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H NI++L    T     ++V EYM NGSL   L +   G         +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGM 156
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +     G+ YL        VHRD+ + N+L+D +   +V+DFG+++V++    P +    
Sbjct: 157 LRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD--PDAAXTT 211
Query: 864 AGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILE-LVTGRLP 902
            G      + APE       +  SD++SFGVV+ E L  G  P
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 685 LDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           LD    IG GS+G V    V S+G+ VAVKK+            D+ K            
Sbjct: 76  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM------------DLRKQQRRELLFN--- 120
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +   +H+N+V+++      D   +V E++  G+L D++   +   ++      +
Sbjct: 121 --EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAV 175
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +   + LS LH      ++HRD+KS++ILL  D   +++DFG    V  S +      +
Sbjct: 176 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXL 230
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE    L    + DI+S G++++E+V G  P
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 685 LDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           LD    IG GS+G V    V S+G+ VAVKK+            D+ K            
Sbjct: 33  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM------------DLRKQQRRELLFN--- 77
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +   +H+N+V+++      D   +V E++  G+L D++   +   ++      +
Sbjct: 78  --EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAV 132
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +   + LS LH      ++HRD+KS++ILL  D   +++DFG    V  S +      +
Sbjct: 133 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXL 187
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE    L    + DI+S G++++E+V G  P
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 685 LDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           LD    IG GS+G V    V S+G+ VAVKK+            D+ K            
Sbjct: 31  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM------------DLRKQQRRELLFN--- 75
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +   +H+N+V+++      D   +V E++  G+L D++   +   ++      +
Sbjct: 76  --EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAV 130
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +   + LS LH      ++HRD+KS++ILL  D   +++DFG    V  S +      +
Sbjct: 131 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXL 185
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE    L    + DI+S G++++E+V G  P
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 31/244 (12%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGXXX 735
            +YE+L        IG+GS G+  K+   S+G+ +  K+L  G   E E    V      
Sbjct: 6   EDYEVL------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV------ 53
Query: 736 XXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLH--SCK 791
                    +EV  L +++H NIV+ +     R    L  V EY   G L  ++   + +
Sbjct: 54  ---------SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHH--DCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              LD     +++      L   H   D   +++HRD+K  N+ LDG    ++ DFG+A+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
           +++            G+  Y++PE    +  NEKSDI+S G ++ EL    +P    F +
Sbjct: 165 ILNHD--EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQ 221
Query: 910 KDLV 913
           K+L 
Sbjct: 222 KELA 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCL--LKYIRKIGSFDETCTRFYTA 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE       ++ SD+++ G +I +LV G  P
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 685 LDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           LD    IG GS+G V    V S+G+ VAVKK+            D+ K            
Sbjct: 26  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM------------DLRKQQRRELLFN--- 70
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +   +H+N+V+++      D   +V E++  G+L D++   +   ++      +
Sbjct: 71  --EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAV 125
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +   + LS LH      ++HRD+KS++ILL  D   +++DFG    V  S +      +
Sbjct: 126 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXL 180
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE    L    + DI+S G++++E+V G  P
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 685 LDEDNVIGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           LD    IG GS+G V    V S+G+ VAVKK+            D+ K            
Sbjct: 22  LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM------------DLRKQQRRELLFN--- 66
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +   +H+N+V+++      D   +V E++  G+L D++   +   ++      +
Sbjct: 67  --EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAV 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +   + LS LH      ++HRD+KS++ILL  D   +++DFG    V  S +      +
Sbjct: 122 CLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXL 176
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE    L    + DI+S G++++E+V G  P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 691 IGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG GS+G V    V S+G+ VAVKK+            D+ K              EV  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM------------DLRKQQRRELLFN-----EVVI 201
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +   +H+N+V+++      D   +V E++  G+L D++   +   ++      + +   +
Sbjct: 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQ 258
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
            LS LH   V   +HRD+KS++ILL  D   +++DFG    V  S +      + G+  +
Sbjct: 259 ALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYW 313
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +APE    L    + DI+S G++++E+V G  P
Sbjct: 314 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 688 DNVIGSGSSGKV-YKVVLSNGE---AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           + +IGSG SG+V Y  +   G+    VA+K L  G ++                     F
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER----------------QRRDF 97
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H NI++L    T     ++V EYM NGSL   L +   G         +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGM 156
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +     G+ YL        VHRD+ + N+L+D +   +V+DFG+++V++    P +    
Sbjct: 157 LRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD--PDAAYTT 211
Query: 864 AGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILE-LVTGRLP 902
            G      + APE       +  SD++SFGVV+ E L  G  P
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 117/259 (45%), Gaps = 42/259 (16%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           + VIG+G  G+V     K+       VA+K L  G +++                    F
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK----------------QRRDF 81
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H N++ L    T     +++ E+M NGSL   L     G         +
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGM 140
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV-DASGKPKSMSV 862
           +   A G+ YL      + VHRD+ + NIL++ +   +V+DFG+++ + D +  P   S 
Sbjct: 141 LRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 863 IAGS--CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK---DLVKW-V 916
           + G     + APE     +    SD++S+G+V+ E+++        +GE+   D+    V
Sbjct: 198 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--------YGERPYWDMTNQDV 249
Query: 917 CSTLDQKGVDHVLDPKLDC 935
            + ++Q   D+ L P +DC
Sbjct: 250 INAIEQ---DYRLPPPMDC 265

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 136/327 (41%), Gaps = 59/327 (18%)
Query: 659 RAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWR 717
           RA+ K KW L              + L     IG G+ G+V+   L ++   VAVK    
Sbjct: 102 RAVPKDKWVLNH------------EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE 149
Query: 718 GMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEY 777
            +  + ++                 F  E   L +  H NIV+L   CT +    +V E 
Sbjct: 150 TLPPDLKAK----------------FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193
Query: 778 MPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD 837
           +  G     L + +G  L   T  +++ DAA G+ YL   C    +HRD+ + N L+   
Sbjct: 194 VQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEK 249
Query: 838 FGARVADFGVAK-----VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
              +++DFG+++     V  ASG  + + V      + APE     R + +SD++SFG++
Sbjct: 250 NVLKISDFGMSREEADGVYAASGGLRQVPV-----KWTAPEALNYGRYSSESDVWSFGIL 304
Query: 893 ILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEIC--KVLNIGLL 950
           + E  +      P    +   ++V     +KG       +L C    E+C   V  +   
Sbjct: 305 LWETFSLGASPYPNLSNQQTREFV-----EKG------GRLPC---PELCPDAVFRLMEQ 350
Query: 951 CTSPLPINRPAMRRVVKLLQEVGAENR 977
           C +  P  RP+   + + LQ +   +R
Sbjct: 351 CWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 136/327 (41%), Gaps = 59/327 (18%)
Query: 659 RAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWR 717
           RA+ K KW L              + L     IG G+ G+V+   L ++   VAVK    
Sbjct: 102 RAVPKDKWVLNH------------EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE 149
Query: 718 GMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEY 777
            +  + ++                 F  E   L +  H NIV+L   CT +    +V E 
Sbjct: 150 TLPPDLKAK----------------FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193
Query: 778 MPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD 837
           +  G     L + +G  L   T  +++ DAA G+ YL   C    +HRD+ + N L+   
Sbjct: 194 VQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEK 249
Query: 838 FGARVADFGVAK-----VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
              +++DFG+++     V  ASG  + + V      + APE     R + +SD++SFG++
Sbjct: 250 NVLKISDFGMSREEADGVXAASGGLRQVPV-----KWTAPEALNYGRYSSESDVWSFGIL 304
Query: 893 ILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEIC--KVLNIGLL 950
           + E  +      P    +   ++V     +KG       +L C    E+C   V  +   
Sbjct: 305 LWETFSLGASPYPNLSNQQTREFV-----EKG------GRLPC---PELCPDAVFRLMEQ 350
Query: 951 CTSPLPINRPAMRRVVKLLQEVGAENR 977
           C +  P  RP+   + + LQ +   +R
Sbjct: 351 CWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 688 DNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           + VIG+G  G+V +  L         VA+K L  G ++                     F
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER----------------QRREF 64
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H NI++L    T     +++ E+M NG+L   L     G         +
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGM 123
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSV 862
           +   A G+ YL      S VHRD+ + NIL++ +   +V+DFG+++ ++  S  P   S 
Sbjct: 124 LRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS 180
Query: 863 IAGS--CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
           + G     + APE     +    SD +S+G+V+ E+++        FGE+    W  S  
Sbjct: 181 LGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS--------FGERPY--WDMSNQ 230
Query: 921 DQKGV---DHVLDPKLDC 935
           D       D+ L P  DC
Sbjct: 231 DVINAIEQDYRLPPPPDC 248

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 83/176 (47%), Gaps = 24/176 (13%)
Query: 743 FQAEVETLGK--IRHKNIVKLWCCCTTRDCKL-----LVYEYMPNGSLGDLLHSCKGGLL 795
           +Q+E E      ++H+N+++       R   L     L+  +   GSL D L   KG ++
Sbjct: 54  WQSEREIFSTPGMKHENLLQF-IAAEKRGSNLEVELWLITAFHDKGSLTDYL---KGNII 109
Query: 796 DWPTRYKIIVDAAEGLSYLHHDC--------VPSIVHRDVKSNNILLDGDFGARVADFGV 847
            W     +    + GLSYLH D          PSI HRD KS N+LL  D  A +ADFG+
Sbjct: 110 TWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGL 169
Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEY---AYTLRVNE--KSDIYSFGVVILELVT 898
           A   +    P       G+  Y+APE    A   + +   + D+Y+ G+V+ ELV+
Sbjct: 170 AVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 142
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 143 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 140
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 141 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L   +    G   +  TR+    
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRF-YTA 137
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L   +    G   +  TR+    
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRF-YTA 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 137
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 138 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 140 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L  L +  K G  D         
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA 140
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 141 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 26/259 (10%)
Query: 687 EDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECE---SGCDVEKGXXXXXXXXXGF 743
           E   +G  + G+  K  +  G   + K +++G+  E     + C+++            F
Sbjct: 15  ETKAVGXSNDGRFLKFDIEIGRG-SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-F 72
Query: 744 QAEVETLGKIRHKNIVKLW----CCCTTRDCKLLVYEYMPNGSLGDLLHSCK----GGLL 795
           + E E L  ++H NIV+ +         + C +LV E   +G+L   L   K      L 
Sbjct: 73  KEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLR 132
Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDAS 854
            W  +        +GL +LH    P I+HRD+K +NI + G  G+ ++ D G+A +  AS
Sbjct: 133 SWCRQI------LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
                   + G+  + APE  Y  + +E  D+Y+FG   LE  T   P         + +
Sbjct: 186 ----FAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYR 240
Query: 915 WVCSTLDQKGVDHVLDPKL 933
            V S +     D V  P++
Sbjct: 241 RVTSGVKPASFDKVAIPEV 259

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 5/157 (3%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + + ++ H   VKL+      +       Y  NG L   +    G   +  TR+    
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRF-YTA 136
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +   G
Sbjct: 137 EIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           V+G G+ G VY    LSN   +A+K++    S+  +                     E+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-----------------LHEEIA 57
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
               ++HKNIV+     +      +  E +P GSL  LL S  G L D            
Sbjct: 58  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 117
Query: 809 -EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKSMSVIAGS 866
            EGL YLH +    IVHRD+K +N+L++   G  +++DFG +K +  +G         G+
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGT 172
Query: 867 CGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
             Y+APE          + +DI+S G  I+E+ TG+ P   E GE
Sbjct: 173 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGE 216

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           V+G G+ G VY    LSN   +A+K++    S+  +                     E+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-----------------LHEEIA 71
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
               ++HKNIV+     +      +  E +P GSL  LL S  G L D            
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 809 -EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKSMSVIAGS 866
            EGL YLH +    IVHRD+K +N+L++   G  +++DFG +K +  +G         G+
Sbjct: 132 LEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGT 186
Query: 867 CGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
             Y+APE          + +DI+S G  I+E+ TG+ P   E GE
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGE 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 80  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 135
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 688 DNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           + VIG+G  G+V +  L         VA+K L  G ++                     F
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER----------------QRREF 62
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H NI++L    T     +++ E+M NG+L   L     G         +
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGM 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSV 862
           +   A G+ YL      S VHRD+ + NIL++ +   +V+DFG+++ ++  S  P   S 
Sbjct: 122 LRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178
Query: 863 IAGS--CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
           + G     + APE     +    SD +S+G+V+ E+++        FGE+    W  S  
Sbjct: 179 LGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS--------FGERPY--WDMSNQ 228
Query: 921 DQKGV---DHVLDPKLDC 935
           D       D+ L P  DC
Sbjct: 229 DVINAIEQDYRLPPPPDC 246

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/299 (23%), Positives = 130/299 (43%), Gaps = 32/299 (10%)
Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXX 737
           Y  L     +  IG G   +VY+   L +G  VA+KK+      + ++  D  K      
Sbjct: 28  YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK------ 81
Query: 738 XXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E++ L ++ H N++K +      +   +V E    G L  ++   K      
Sbjct: 82  --------EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 798 PTR--YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           P R  +K  V     L ++H      ++HRD+K  N+ +      ++ D G+ +    S 
Sbjct: 134 PERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SS 188
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
           K  +   + G+  Y++PE  +    N KSDI+S G ++ E+   + P    +G+K  +  
Sbjct: 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLYS 245
Query: 916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA 974
           +C  ++Q   D+   P     + EE+ +++N   +C +P P  RP +  V  + + + A
Sbjct: 246 LCKKIEQ--CDYPPLPSDH--YSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHA 297

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G++G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 83/169 (49%), Gaps = 19/169 (11%)
Query: 746 EVETLGKIRHKNIVKLWCC---CTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           EV +L  ++H+NI++        T+ D  L L+  +   GSL D L   K  ++ W    
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELC 124
Query: 802 KIIVDAAEGLSYLHHDC-------VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
            I    A GL+YLH D         P+I HRD+KS N+LL  +  A +ADFG+A   +A 
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 855 GKPKSMSVIAGSCGYIAPEY---AYTLRVNE--KSDIYSFGVVILELVT 898
                     G+  Y+APE    A   + +   + D+Y+ G+V+ EL +
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  CINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+SG VY  + ++ G+ VA++++      + E   +                 E+  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----------------EILV 71
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + + ++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 127
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HRD+KS+NILL  D   ++ DFG    +      +S  V  G+  
Sbjct: 128 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTPY 182
Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E++ G  P
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 64  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 119
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 120 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 79  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 134
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 135 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G +   L   K    D       
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ--KLSKFDEQRTATY 118
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 171
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 57  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 112
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 113 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 59  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 114
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 115 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 60  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 115
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 116 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 58  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 114 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E + + ++ H   VKL+   T +D + L +   Y  NG L  L +  K G  D       
Sbjct: 80  ERDVMSRLDHPFFVKLYF--TFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 135
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+    K    +  
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 9/162 (5%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            + EVE    +RH NI++L+          L+ EY P G++   L   K    D      
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTAT 138
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + 
Sbjct: 139 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TT 191
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           + G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 25/234 (10%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXX 738
           E ++   +   IG G+ G VYK      GE VA+KK+      E      +         
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-------- 58
Query: 739 XXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                  E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P
Sbjct: 59  -------EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP 110
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  
Sbjct: 111 LIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
           +  V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 168 THEVV--TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 219

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+SG VY  + ++ G+ VA++++      + E   +                 E+  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----------------EILV 70
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + + ++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 126
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HRD+KS+NILL  D   ++ DFG    +      +S  V  G+  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTPY 181
Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E++ G  P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+SG VY  + ++ G+ VA++++      + E   +                 E+  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----------------EILV 70
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + + ++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 126
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HRD+KS+NILL  D   ++ DFG    +      +S  V  G+  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 181
Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E++ G  P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 109/253 (43%), Gaps = 42/253 (16%)
Query: 664 SKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKL---WRGMS 720
           SK   M  H+    ++EIL       VIG G+ G+V  V L N + V   K+   W  M 
Sbjct: 64  SKVKQMRLHR---EDFEIL------KVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-ML 113
Query: 721 KECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPN 780
           K  E+ C               F+ E + L     K I  L       +   LV +Y   
Sbjct: 114 KRAETAC---------------FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158
Query: 781 GSLGDLLHSCKGGLLDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
           G L  LL   +  L +   R+ +  +V A + +  LH+      VHRD+K +NIL+D + 
Sbjct: 159 GDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNG 212
Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVI 893
             R+ADFG    +   G  +S SV  G+  YI+PE    +     R   + D +S GV +
Sbjct: 213 HIRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCM 271
Query: 894 LELVTGRLPVDPE 906
            E++ G  P   E
Sbjct: 272 YEMLYGETPFYAE 284

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 691 IGSGSSGKVYKV-VLSNGEAVAVKKL--WRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           IG GS GK   V    +G    +K++   R  SKE E                   + EV
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-----------------RREV 74
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL------LDWPTRY 801
             L  ++H NIV+            +V +Y   G L   +++ KG L      LDW    
Sbjct: 75  AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---- 130
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
              V     L ++H      I+HRD+KS NI L  D   ++ DFG+A+V++++ +     
Sbjct: 131 --FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +  G+  Y++PE       N KSDI++ G V+ EL T
Sbjct: 186 I--GTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           L+  +    +G G  G VY     N + + A+K L++   ++  +G + +          
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEK--AGVEHQ---------- 54
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
              + EVE    +RH NI++L+          L+ EY P G++   L   K    D    
Sbjct: 55  --LRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQ--KLSKFDEQRT 110
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    
Sbjct: 111 ATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---- 163
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           + + G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 164 AALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 691 IGSGSSGKV-YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG GS+G V        G+ VAVKK+            D+ K              EV  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM------------DLRKQQRRELLFN-----EVVI 95
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +    H N+V ++      D   +V E++  G+L D++   +       T   + +    
Sbjct: 96  MRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLR 152
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
            LSYLH+     ++HRD+KS++ILL  D   +++DFG    V +   PK   ++ G+  +
Sbjct: 153 ALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKXLV-GTPYW 207
Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +APE    L    + DI+S G++++E++ G  P
Sbjct: 208 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY-KIIVDAAEGL 811
           +  +N VK       +    +  EY  NG+L DL+HS    L      Y ++     E L
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEAL 129
Query: 812 SYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS------------GKPKS 859
           SY+H      I+HRD+K  NI +D     ++ DFG+AK V  S            G   +
Sbjct: 130 SYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 860 MSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELV 897
           ++   G+  Y+A E    T   NEK D+YS G++  E++
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 25/234 (10%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXX 738
           E ++   +   IG G+ G VYK      GE VA+KK+      E      +         
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-------- 58
Query: 739 XXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                  E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P
Sbjct: 59  -------EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLP 110
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  
Sbjct: 111 LIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 167
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
           +  V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 168 THEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 219

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 9/162 (5%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            + EVE    +RH NI++L+          L+ EY P G++   L   K    D      
Sbjct: 72  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTAT 129
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + 
Sbjct: 130 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TT 182
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           + G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 183 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+SG VY  + ++ G+ VA++++      + E   +                 E+  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----------------EILV 70
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + + ++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 126
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HRD+KS+NILL  D   ++ DFG    +      +S  V  G+  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV--GTPY 181
Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E++ G  P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD-LLHSCKGGLLDWPTRYKII 804
           EV  L  + H NI+KL+     +    LV E    G L D ++H  K   +D      II
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---II 142
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMS 861
                G++YLH     +IVHRD+K  N+LL+    D   ++ DFG++ V +     K M 
Sbjct: 143 KQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKMK 196
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  YIAPE     + +EK D++S GV++  L+ G  P
Sbjct: 197 ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 114
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTL 167
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 168 SGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 54
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 55  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 112
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 113 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 55
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 113
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 114 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G G+ G+V   V     EAVAVK +    + +C                    + E+
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----------------IKKEI 56
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                + H+N+VK +      + + L  EY   G L D +    G  +  P   +     
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQL 114
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + + + ++ + G+ 
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 868 GYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVD 904
            Y+APE       + E  D++S G+V+  ++ G LP D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 166
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G +   L   K    D       
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ--KLSKFDEQRTATY 118
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +      +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXL 171
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 172 XGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 116
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 169
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 55  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 112
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 113 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 165
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 166 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 118
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 171
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 118
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 171
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 172 CGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/174 (33%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV+ L ++ H NI+KL+     +    LV E    G L D + S K          +II 
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIR 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y+H +    IVHRD+K  N+LL+    D   R+ DFG++   +AS   K M  
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKD 193
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+  YIAPE  +    +EK D++S GV++  L++G  P +    E D++K V
Sbjct: 194 KIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKV 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 39/242 (16%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F +E   +G+  H NI+ L    T     +++ EYM NGSL   L    G       R+ 
Sbjct: 77  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-------RFT 129
Query: 803 IIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
           +I           G+ YL      S VHRD+ + NIL++ +   +V+DFG+++V++    
Sbjct: 130 VIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-- 184
Query: 857 PKSMSVIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
           P++     G      + APE     +    SD++S+G+V+ E+++        +GE+   
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPY- 235
Query: 914 KWVCSTLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
            W  S  D  K ++  + L P +DC        +  + L C      +RP   ++V +L 
Sbjct: 236 -WDMSNQDVIKAIEEGYRLPPPMDCPI-----ALHQLMLDCWQKERSDRPKFGQIVNMLD 289
Query: 971 EV 972
           ++
Sbjct: 290 KL 291

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 116
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AAL 169
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G  GKV    Y     N GE VAVK L      + ESG +               + 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL------KPESGGN----------HIADLKK 72
Query: 746 EVETLGKIRHKNIVKLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E+E L  + H+NIVK    CT    +   L+ E++P+GSL + L   K  + +   + K 
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI-NLKQQLKY 131
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            V   +G+ YL        VHRD+ + N+L++ +   ++ DFG+ K ++   +  ++   
Sbjct: 132 AVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDD 188
Query: 864 AGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             S   + APE     +    SD++SFGV + EL+T
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 691 IGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G  GKV          + GE VAVK L      + ESG +               + 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL------KPESGGN----------HIADLKK 60
Query: 746 EVETLGKIRHKNIVKLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E+E L  + H+NIVK    CT    +   L+ E++P+GSL + L   K  + +   + K 
Sbjct: 61  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI-NLKQQLKY 119
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            V   +G+ YL        VHRD+ + N+L++ +   ++ DFG+ K ++   +  ++   
Sbjct: 120 AVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDD 176
Query: 864 AGS-CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             S   + APE     +    SD++SFGV + EL+T
Sbjct: 177 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 60  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 117
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 170
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AAL 166
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV+ L ++ H NI+KL+     +    LV E    G L D + S K          +II 
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIR 157
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y+H +    IVHRD+K  N+LL+    D   R+ DFG++   +AS   K M  
Sbjct: 158 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKD 211
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+  YIAPE  +    +EK D++S GV++  L++G  P +    E D++K V
Sbjct: 212 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKV 263

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 116
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 169
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV+ L ++ H NI+KL+     +    LV E    G L D + S K          +II 
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIR 156
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y+H +    IVHRD+K  N+LL+    D   R+ DFG++   +AS   K M  
Sbjct: 157 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKD 210
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+  YIAPE  +    +EK D++S GV++  L++G  P +    E D++K V
Sbjct: 211 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKV 262

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F +E   +G+  H N++ L    T     +++ E+M NGSL   L     G         
Sbjct: 55  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVG 113
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV-DASGKPKSMS 861
           ++   A G+ YL      + VHR + + NIL++ +   +V+DFG+++ + D +  P   S
Sbjct: 114 MLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 170
Query: 862 VIAGS--CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK---DLVKW- 915
            + G     + APE     +    SD++S+G+V+ E+++        +GE+   D+    
Sbjct: 171 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--------YGERPYWDMTNQD 222
Query: 916 VCSTLDQKGVDHVLDPKLDC 935
           V + ++Q   D+ L P +DC
Sbjct: 223 VINAIEQ---DYRLPPPMDC 239

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 39/242 (16%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F +E   +G+  H NI+ L    T     +++ EYM NGSL   L    G       R+ 
Sbjct: 62  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-------RFT 114
Query: 803 IIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
           +I           G+ YL      S VHRD+ + NIL++ +   +V+DFG+++V++    
Sbjct: 115 VIQLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-- 169
Query: 857 PKSMSVIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
           P++     G      + APE     +    SD++S+G+V+ E+++        +GE+   
Sbjct: 170 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPY- 220
Query: 914 KWVCSTLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
            W  S  D  K ++  + L P +DC        +  + L C      +RP   ++V +L 
Sbjct: 221 -WDMSNQDVIKAIEEGYRLPPPMDCPI-----ALHQLMLDCWQKERSDRPKFGQIVNMLD 274
Query: 971 EV 972
           ++
Sbjct: 275 KL 276

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 31/225 (13%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXX 738
           E+ D L++   +G GS G VYK +    G+ VA+K++        ES  D+++       
Sbjct: 29  EVFDVLEK---LGEGSYGSVYKAIHKETGQIVAIKQV------PVES--DLQE------- 70
Query: 739 XXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                  E+  + +    ++VK +          +V EY   GS+ D++   +   L   
Sbjct: 71  ----IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR-LRNKTLTED 125
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKP 857
               I+    +GL YLH       +HRD+K+ NILL+ +  A++ADFGVA ++ D   K 
Sbjct: 126 EIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK- 181
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              + + G+  ++APE    +  N  +DI+S G+  +E+  G+ P
Sbjct: 182 --RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEKG 732
           LG      L+  D    +G G  G VY       + + A+K L++           +EK 
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFK---------TQLEKA 53
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                      + EVE    +RH NI++L+          L+ EY P G++   L   K 
Sbjct: 54  GVEHQ-----LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KL 106
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
              D       I + A  LSY H      ++HRD+K  N+LL  +   ++ADFG +    
Sbjct: 107 SRFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP 163
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +S +    + + G+  Y+ PE       +EK D++S GV+  E + G  P +
Sbjct: 164 SSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 53  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 110
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 111 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTL 163
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 164 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV+ L ++ H NI+KL+     +    LV E    G L D + S K          +II 
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIR 133
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y+H +    IVHRD+K  N+LL+    D   R+ DFG++   +AS K K    
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK-- 188
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+  YIAPE  +    +EK D++S GV++  L++G  P +    E D++K V
Sbjct: 189 -IGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKV 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 39/242 (16%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F +E   +G+  H NI+ L    T     +++ EYM NGSL   L    G       R+ 
Sbjct: 56  FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-------RFT 108
Query: 803 IIV------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
           +I           G+ YL      S VHRD+ + NIL++ +   +V+DFG+++V++    
Sbjct: 109 VIQLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD-- 163
Query: 857 PKSMSVIAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
           P++     G      + APE     +    SD++S+G+V+ E+++        +GE+   
Sbjct: 164 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS--------YGERPY- 214
Query: 914 KWVCSTLDQ-KGVD--HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
            W  S  D  K ++  + L P +DC        +  + L C      +RP   ++V +L 
Sbjct: 215 -WDMSNQDVIKAIEEGYRLPPPMDCPI-----ALHQLMLDCWQKERSDRPKFGQIVNMLD 268
Query: 971 EV 972
           ++
Sbjct: 269 KL 270

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXL 166
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           Q E+  L +     + K +     +D KL ++ EY+  GS  DLL     G LD      
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIAT 128
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMS 861
           I+ +  +GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K    +
Sbjct: 129 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RN 182
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 183 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+SG VY  + ++ G+ VA++++      + E   +                 E+  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----------------EILV 71
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTRYKIIVDAA 808
           + + ++ NIV         D   +V EY+  GSL D++  +C    +D      +  +  
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECL 127
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           + L +LH +    ++HR++KS+NILL  D   ++ DFG    +      +S  V  G+  
Sbjct: 128 QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPY 182
Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E++ G  P
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 54
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L D + +     +  P  
Sbjct: 55  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLI 108
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 109 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 166 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 25/223 (11%)
Query: 691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+ G VYK      GE VA+KK+      E      +                E+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------------EISL 55
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L ++ H NIVKL     T +   LV+E++ +  L D + +     +  P     +    +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +     V+  +  Y
Sbjct: 115 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 870 IAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TEL 166
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 18/175 (10%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS------------- 789
           FQ E E L  ++H++IVK +  C   D  ++V+EYM +G L   L +             
Sbjct: 64  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 790 -CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
               G L       I    A G+ YL        VHRD+ + N L+  +   ++ DFG++
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           + V ++   +          ++ PE     +   +SD++SFGV++ E+ T G+ P
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 53
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L D + +     +  P  
Sbjct: 54  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLI 107
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 108 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 165 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 114
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +      +
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTL 167
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY  V       VAVK L        E   +VE+           F  E   
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 81
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      +V EYMP G+L D L  C    +       +    + 
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISS 141
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 142 AMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD----TYTAHAGAKFP 194
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE       + KSD+++FGV++ E+ T
Sbjct: 195 IKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 9/162 (5%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            + EVE    +RH NI++L+          L+ EY P G++   L   K    D      
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTAT 138
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +      
Sbjct: 139 YITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DD 191
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           + G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GLS+ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 106 KSYLFQLLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSNGE-AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTMEVEE-----------FLKEAAV 63
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 124 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHAGAKFP 176
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           Q E+  L +     + K +     +D KL ++ EY+  GS  DLL     G LD      
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIAT 108
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMS 861
           I+ +  +GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K    +
Sbjct: 109 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RN 162
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 163 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           Q E+  L +     + K +     +D KL ++ EY+  GS  DLL     G LD      
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIAT 123
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMS 861
           I+ +  +GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K    +
Sbjct: 124 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RN 177
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 178 XFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +      +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXL 166
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 58  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 115
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +      +
Sbjct: 116 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXL 168
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAV-AVKKLWRGMSKECESGCDVEKG 732
           LG      L+  D    +G G  G VY       + + A+K L++           +EK 
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFK---------TQLEKA 53
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                      + EVE    +RH NI++L+          L+ EY P G++   L   K 
Sbjct: 54  GVEHQ-----LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KL 106
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
              D       I + A  LSY H      ++HRD+K  N+LL  +   ++ADFG +    
Sbjct: 107 SRFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP 163
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +S +      + G+  Y+ PE       +EK D++S GV+  E + G  P +
Sbjct: 164 SSRR----DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDL 166
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E   +G+  H NI+ L    T     ++V EYM NGSL   L     G         
Sbjct: 70  FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKK-NDGQFTVIQLVG 128
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           ++   + G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P++   
Sbjct: 129 MLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--PEAAYT 183
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV 916
             G      + APE     +    SD++S+G+V+ E+V+ G  P   E   +D++K V
Sbjct: 184 TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY-WEMTNQDVIKAV 240

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 61  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 118
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 119 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDL 171
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 60
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 121 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TFTAHAGAKFP 173
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP---VDP----EFGEKD 911
             + APE     + + KSD+++FGV++ E+ T G  P   +DP    E  EKD
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKD 226

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           Q E+  L +     + K +     +D KL ++ EY+  GS  DLL     G LD      
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIAT 108
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMS 861
           I+ +  +GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K    +
Sbjct: 109 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RN 162
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 163 XFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 113
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 114 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDL 166
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 167 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 116
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +      +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXL 169
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 114
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +    + +
Sbjct: 115 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDL 167
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 60
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 121 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHAGAKFP 173
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP---VDP----EFGEKD 911
             + APE     + + KSD+++FGV++ E+ T G  P   +DP    E  EKD
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKD 226

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 58  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 115
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++A+FG +    +S +    + +
Sbjct: 116 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTL 168
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 169 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 116
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++A+FG +    +S +    + +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTL 169
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 55
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 56  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 109
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 110 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 166
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 167 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 216

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 42/248 (16%)
Query: 669 MSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKL---WRGMSKECES 725
           M  H+    ++EI+       VIG G+ G+V  V + N E +   K+   W  M K  E+
Sbjct: 85  MQLHR---EDFEII------KVIGRGAFGEVAVVKMKNTERIYAMKILNKWE-MLKRAET 134
Query: 726 GCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD 785
            C               F+ E + L     + I  L       +   LV +Y   G L  
Sbjct: 135 AC---------------FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLT 179
Query: 786 LLHSCKGGLLDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
           LL   +  L +   R+ I  +V A + +  LH+      VHRD+K +N+LLD +   R+A
Sbjct: 180 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLA 233
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVT 898
           DFG    ++  G  +S SV  G+  YI+PE    +     +   + D +S GV + E++ 
Sbjct: 234 DFGSCLKMNDDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 292
Query: 899 GRLPVDPE 906
           G  P   E
Sbjct: 293 GETPFYAE 300

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EVE L K+ H NI+KL+          +V E    G L D +   K          +II 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK 128
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y+H     +IVHRD+K  NILL+    D   ++ DFG++     + K K    
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-- 183
Query: 863 IAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDLVKWV 916
             G+  YIAPE    LR   +EK D++S GV++  L++G  P    +G  E D++K V
Sbjct: 184 -IGTAYYIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPPF---YGKNEYDILKRV 234

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 42/248 (16%)
Query: 669 MSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKL---WRGMSKECES 725
           M  H+    ++EI+       VIG G+ G+V  V + N E +   K+   W  M K  E+
Sbjct: 69  MQLHR---EDFEII------KVIGRGAFGEVAVVKMKNTERIYAMKILNKWE-MLKRAET 118
Query: 726 GCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD 785
            C               F+ E + L     + I  L       +   LV +Y   G L  
Sbjct: 119 AC---------------FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLT 163
Query: 786 LLHSCKGGLLDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
           LL   +  L +   R+ I  +V A + +  LH+      VHRD+K +N+LLD +   R+A
Sbjct: 164 LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLA 217
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVT 898
           DFG    ++  G  +S SV  G+  YI+PE    +     +   + D +S GV + E++ 
Sbjct: 218 DFGSCLKMNDDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 276
Query: 899 GRLPVDPE 906
           G  P   E
Sbjct: 277 GETPFYAE 284

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + EVE    +RH NI++L+          L+ EY P G++   L   K    D       
Sbjct: 59  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATY 116
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I + A  LSY H      ++HRD+K  N+LL      ++ADFG +    +S +      +
Sbjct: 117 ITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----L 169
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            G+  Y+ PE       +EK D++S GV+  E + G+ P +
Sbjct: 170 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 52
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 53  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 106
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 107 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 163
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 164 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 213

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 60
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 121 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHAGAKFP 173
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP---VDP----EFGEKD 911
             + APE     + + KSD+++FGV++ E+ T G  P   +DP    E  EKD
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKD 226

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 50
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 51  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 104
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 105 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 162 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 25/223 (11%)
Query: 691 IGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+ G VYK      GE VA+KK+      E      +                E+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------------EISL 54
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P     +    +
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
           GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  +  V+  +  Y
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWY 168
Query: 870 IAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 25/228 (10%)
Query: 685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
            +E  V+G G+ G+V K   + +    A+KK+     K      +V             +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY-K 802
            A       +  +N VK       +    +  EY  N +L DL+HS    L      Y +
Sbjct: 68  YA-----AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS--ENLNQQRDEYWR 120
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS-------- 854
           +     E LSY+H      I+HRD+K  NI +D     ++ DFG+AK V  S        
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 855 ----GKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELV 897
               G   +++   G+  Y+A E    T   NEK D+YS G++  E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 87/174 (50%), Gaps = 13/174 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV+ L ++ H NI KL+     +    LV E    G L D + S K          +II 
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIR 133
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y H +    IVHRD+K  N+LL+    D   R+ DFG++   +AS K K    
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK-- 188
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+  YIAPE  +    +EK D++S GV++  L++G  P +    E D++K V
Sbjct: 189 -IGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKV 239

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSNGE-AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTMEVEE-----------FLKEAAV 308
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HR++ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 369 AMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 421
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 55
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 56  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 109
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 110 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 166
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 167 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 216

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 54
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 55  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 108
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 109 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 166 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 215

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 54
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 55  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 108
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 109 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 166 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 215

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 53
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 54  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 107
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 108 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 165 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 214

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 52
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 53  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 106
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 107 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 164 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 213

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 53
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 54  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 107
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 108 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 165 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 214

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 54
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 55  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLI 108
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 109 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 166 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 215

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TXTAHAGAKFP 180
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 32/248 (12%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXX 735
             YE LD       +G G    VYK    N  + VA+KK+  G   E + G +       
Sbjct: 10  KRYEKLD------FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA---- 59
Query: 736 XXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-GGL 794
                     E++ L ++ H NI+ L      +    LV+++M      DL    K   L
Sbjct: 60  --------LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSL 107
Query: 795 LDWPTRYK-IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           +  P+  K  ++   +GL YLH      I+HRD+K NN+LLD +   ++ADFG+AK   +
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
             +     V+  +  Y APE  +  R+     D+++ G ++ EL+  R+P  P   + D 
Sbjct: 165 PNRAYXHQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQ 221
Query: 913 VKWVCSTL 920
           +  +  TL
Sbjct: 222 LTRIFETL 229

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 180
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 50
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 51  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 104
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 105 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 161
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 162 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 64
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 125 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAPAGAKFP 177
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 23/234 (9%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRY 801
           F  EV  +  + H+N+++L+    T   K+ V E  P GSL D L   +G  LL   +RY
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +     M 
Sbjct: 127 AVQV--AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQ 181
Query: 862 VIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
                   + APE   T   +  SD + FGV + E+ T        +G++    W+   L
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------YGQE---PWI--GL 228
Query: 921 DQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           +   + H +D + +   + E C   + N+ + C +  P +RP    +   L E 
Sbjct: 229 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 50
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 51  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 104
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 105 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 161
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 162 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 63
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 124 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAPAGAKFP 176
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 180
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 75
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 136 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 188
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 189 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 175
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 66
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 127 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 179
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 175
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 64
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 125 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 177
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 64
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 125 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 177
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 104/240 (43%), Gaps = 21/240 (8%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXX 738
           E ++     N++G GS   VY+   +  G  VA+K               ++K       
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKM--------------IDKKAMYKAG 53
Query: 739 XXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                Q EV+   +++H +I++L+      +   LV E   NG +   L +      +  
Sbjct: 54  MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE 113
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
            R+  +     G+ YLH      I+HRD+  +N+LL  +   ++ADFG+A  +    +  
Sbjct: 114 ARH-FMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
               + G+  YI+PE A       +SD++S G +   L+ GR P D +  +  L K V +
Sbjct: 170 Y--TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    ++      +    + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 180
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 132/321 (41%), Gaps = 56/321 (17%)
Query: 679 YEILD--GLDEDNVIGSGSSGKVYKVVLSNG---EAVAVKKLWRGMSKECESGCDVEKGX 733
           Y +LD   +   +VIG G+ G+V K  +         A+K++    SK+           
Sbjct: 9   YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----------- 57
Query: 734 XXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK- 791
                    F  E+E L K+  H NI+ L   C  R    L  EY P+G+L D L   + 
Sbjct: 58  -----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 112
Query: 792 -------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
                           L          D A G+ YL        +HRD+ + NIL+  ++
Sbjct: 113 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 169
Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            A++ADFG+++  +   K K+M  +     ++A E          SD++S+GV++ E+V+
Sbjct: 170 VAKIADFGLSRGQEVYVK-KTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
Query: 899 GRLPVDPEFGEKDLVKWVCSTLDQK-GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPI 957
                    G        C+ L +K    + L+  L+C   +E+  ++     C    P 
Sbjct: 227 --------LGGTPYCGMTCAELYEKLPQGYRLEKPLNC--DDEVYDLMR---QCWREKPY 273
Query: 958 NRPAMRRVVKLLQEVGAENRS 978
            RP+  +++  L  +  E ++
Sbjct: 274 ERPSFAQILVSLNRMLEERKT 294

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 52
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 53  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 106
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 107 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 164 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 132/321 (41%), Gaps = 56/321 (17%)
Query: 679 YEILD--GLDEDNVIGSGSSGKVYKVVLSNG---EAVAVKKLWRGMSKECESGCDVEKGX 733
           Y +LD   +   +VIG G+ G+V K  +         A+K++    SK+           
Sbjct: 19  YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----------- 67
Query: 734 XXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK- 791
                    F  E+E L K+  H NI+ L   C  R    L  EY P+G+L D L   + 
Sbjct: 68  -----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122
Query: 792 -------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
                           L          D A G+ YL        +HRD+ + NIL+  ++
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 179
Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            A++ADFG+++  +   K K+M  +     ++A E          SD++S+GV++ E+V+
Sbjct: 180 VAKIADFGLSRGQEVYVK-KTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
Query: 899 GRLPVDPEFGEKDLVKWVCSTLDQK-GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPI 957
                    G        C+ L +K    + L+  L+C   +E+  ++     C    P 
Sbjct: 237 --------LGGTPYCGMTCAELYEKLPQGYRLEKPLNC--DDEVYDLMR---QCWREKPY 283
Query: 958 NRPAMRRVVKLLQEVGAENRS 978
            RP+  +++  L  +  E ++
Sbjct: 284 ERPSFAQILVSLNRMLEERKT 304

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 53
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 54  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 107
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 108 KSYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 164
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 165 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 214

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSNGE-AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTMEVEE-----------FLKEAAV 269
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HR++ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 330 AMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 382
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 52
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 53  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 106
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 107 KSYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 164 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           Q E+  L +     + K +          ++ EY+  GS  DLL   + G  D      +
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL---RAGPFDEFQIATM 125
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSV 862
           + +  +GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K    + 
Sbjct: 126 LKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNT 179
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+  ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 180 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 50
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 51  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLI 104
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 105 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 162 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 7/185 (3%)
Query: 720 SKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMP 779
           +KE  +G  V K              E+     + H+++V         D   +V E   
Sbjct: 65  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
             SL +L H  +  L +   RY  +     G  YLH +    ++HRD+K  N+ L+ D  
Sbjct: 125 RRSLLEL-HKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 179
Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
            ++ DFG+A  V+  G+ K   V+ G+  YIAPE       + + D++S G ++  L+ G
Sbjct: 180 VKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
Query: 900 RLPVD 904
           + P +
Sbjct: 238 KPPFE 242

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 30/225 (13%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXX 738
           E+   LD    IG GS G+VYK + ++  E VA+K +                       
Sbjct: 19  ELFTKLDR---IGKGSFGEVYKGIDNHTKEVVAIKII----------------DLEEAED 59
Query: 739 XXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                Q E+  L +     I + +          ++ EY+  GS  DLL   K G L+  
Sbjct: 60  EIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEET 116
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKP 857
               I+ +  +GL YLH +     +HRD+K+ N+LL      ++ADFGVA ++ D   K 
Sbjct: 117 YIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 172
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              +   G+  ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 173 --RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 7/185 (3%)
Query: 720 SKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMP 779
           +KE  +G  V K              E+     + H+++V         D   +V E   
Sbjct: 63  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 122
Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
             SL +L H  +  L +   RY  +     G  YLH +    ++HRD+K  N+ L+ D  
Sbjct: 123 RRSLLEL-HKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 177
Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
            ++ DFG+A  V+  G+ K   V+ G+  YIAPE       + + D++S G ++  L+ G
Sbjct: 178 VKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 235
Query: 900 RLPVD 904
           + P +
Sbjct: 236 KPPFE 240

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 23/234 (9%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRY 801
           F  EV  +  + H+N+++L+    T   K+ V E  P GSL D L   +G  LL   +RY
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +     M 
Sbjct: 127 AVQV--AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 862 VIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
                   + APE   T   +  SD + FGV + E+ T        +G++    W+   L
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------YGQE---PWI--GL 228
Query: 921 DQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           +   + H +D + +   + E C   + N+ + C +  P +RP    +   L E 
Sbjct: 229 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRY 801
           F  EV  +  + H+N+++L+    T   K+ V E  P GSL D L   +G  LL   +RY
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +     M 
Sbjct: 117 AVQV--AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQ 171
Query: 862 VIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
                   + APE   T   +  SD + FGV + E+ T        +G++    W+   L
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------YGQE---PWI--GL 218
Query: 921 DQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAM 962
           +   + H +D + +   + E C   + N+ + C +  P +RP  
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 688 DNVIGSGSSGKV----YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGF 743
           + VIG+G  G+V     K+      AVA+K L  G +++                    F
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK----------------QRRDF 91
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             E   +G+  H N+V L    T     ++V E+M NG+L   L     G         +
Sbjct: 92  LCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGM 150
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++V++    P+++   
Sbjct: 151 LRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD--PEAVYTT 205
Query: 864 AGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            G      + APE     +    SD++S+G+V+ E+++
Sbjct: 206 TGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 175
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 175
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 54
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 55  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLI 108
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 109 KSYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 166 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 215

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRY 801
           F  EV  +  + H+N+++L+    T   K+ V E  P GSL D L   +G  LL   +RY
Sbjct: 62  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 120
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +     M 
Sbjct: 121 AVQV--AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 175
Query: 862 VIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
                   + APE   T   +  SD + FGV + E+ T        +G++    W+   L
Sbjct: 176 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------YGQE---PWI--GL 222
Query: 921 DQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAM 962
           +   + H +D + +   + E C   + N+ + C +  P +RP  
Sbjct: 223 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 67
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 180
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 41/252 (16%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMS-KECESGCDVEKGXXXXXXXXXGFQAEVE 748
           +G+G  G V + +  + GE VA+K+  + +S K  E  C                  E++
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC-----------------LEIQ 64
Query: 749 TLGKIRHKNIVKLWCC------CTTRDCKLLVYEYMPNGSLGDLLHSCKG--GLLDWPTR 800
            + K+ H N+V               D  LL  EY   G L   L+  +   GL + P R
Sbjct: 65  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---GDFGARVADFGVAKVVDASGKP 857
             ++ D +  L YLH +    I+HRD+K  NI+L         ++ D G AK +D     
Sbjct: 125 -TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--- 177
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
           +  +   G+  Y+APE     +     D +SFG +  E +TG  P  P +     V+W  
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQW-H 233
Query: 918 STLDQKGVDHVL 929
             + +K  +H++
Sbjct: 234 GKVREKSNEHIV 245

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 175
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G  G+VY+ V       VAVK L        E   +VE+           F  E   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-------EDTMEVEE-----------FLKEAAV 62
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGS--- 866
            + YL      + +HRD+ + N L+  +   +VADFG+++++       + +  AG+   
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 175
Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             + APE     + + KSD+++FGV++ E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 52
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 53  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLI 106
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 107 KSYLFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH 163
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 164 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 213

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 41/252 (16%)
Query: 691 IGSGSSGKVYKVVLSN-GEAVAVKKLWRGMS-KECESGCDVEKGXXXXXXXXXGFQAEVE 748
           +G+G  G V + +  + GE VA+K+  + +S K  E  C                  E++
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC-----------------LEIQ 65
Query: 749 TLGKIRHKNIVKLWCC------CTTRDCKLLVYEYMPNGSLGDLLHSCKG--GLLDWPTR 800
            + K+ H N+V               D  LL  EY   G L   L+  +   GL + P R
Sbjct: 66  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 125
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---GDFGARVADFGVAKVVDASGKP 857
             ++ D +  L YLH +    I+HRD+K  NI+L         ++ D G AK +D     
Sbjct: 126 -TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--- 178
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
           +  +   G+  Y+APE     +     D +SFG +  E +TG  P  P +     V+W  
Sbjct: 179 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQW-H 234
Query: 918 STLDQKGVDHVL 929
             + +K  +H++
Sbjct: 235 GKVREKSNEHIV 246

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+KK+      E      +           
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------- 54
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 55  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLI 108
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +    
Sbjct: 109 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH 165
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 166 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 215

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRY 801
           F  EV  +  + H+N+++L+    T   K+ V E  P GSL D L   +G  LL   +RY
Sbjct: 62  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 120
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +     M 
Sbjct: 121 AVQV--AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 175
Query: 862 VIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
                   + APE   T   +  SD + FGV + E+ T        +G++    W+   L
Sbjct: 176 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------YGQE---PWI--GL 222
Query: 921 DQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAM 962
           +   + H +D + +   + E C   + N+ + C +  P +RP  
Sbjct: 223 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 7/185 (3%)
Query: 720 SKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMP 779
           +KE  +G  V K              E+     + H+++V         D   +V E   
Sbjct: 39  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98
Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
             SL +L H  +  L +   RY  +     G  YLH +    ++HRD+K  N+ L+ D  
Sbjct: 99  RRSLLEL-HKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 153
Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
            ++ DFG+A  V+  G+ K   V+ G+  YIAPE       + + D++S G ++  L+ G
Sbjct: 154 VKIGDFGLATKVEYDGERK--KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
Query: 900 RLPVD 904
           + P +
Sbjct: 212 KPPFE 216

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRY 801
           F  EV  +  + H+N+++L+    T   K+ V E  P GSL D L   +G  LL   +RY
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +     M 
Sbjct: 117 AVQV--AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
Query: 862 VIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
                   + APE   T   +  SD + FGV + E+ T        +G++    W+   L
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------YGQE---PWI--GL 218
Query: 921 DQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAM 962
           +   + H +D + +   + E C   + N+ + C +  P +RP  
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRY 801
           F  EV  +  + H+N+++L+    T   K+ V E  P GSL D L   +G  LL   +RY
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            + V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +     M 
Sbjct: 117 AVQV--AEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
Query: 862 VIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
                   + APE   T   +  SD + FGV + E+ T        +G++    W+   L
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------YGQE---PWI--GL 218
Query: 921 DQKGVDHVLDPKLDCCFKEEIC--KVLNIGLLCTSPLPINRPAM 962
           +   + H +D + +   + E C   + N+ + C +  P +RP  
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 104/236 (44%), Gaps = 27/236 (11%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 81
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 137
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+ +    +  S+   
Sbjct: 138 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEXXSVHNK 193
Query: 864 AGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
            G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 194 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 249

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+ K+      E      +           
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---------- 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 52  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 105
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 106 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 163 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 212

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           ++   +   IG G+ G VYK      GE VA+ K+      E      +           
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---------- 50
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E+  L ++ H NIVKL     T +   LV+E++ +  L   + +     +  P  
Sbjct: 51  -----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLI 104
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
              +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      +  + 
Sbjct: 105 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGR--LPVDPEFGE 909
            V+  +  Y APE     +    + DI+S G +  E+VT R   P D E  +
Sbjct: 162 EVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 29/237 (12%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 101
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 102 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 157
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 158 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 212
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 213 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 269

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXX 738
           E     D  +VIG G S  V + V  + G   AVK +   ++ E  S   +E+       
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM--EVTAERLSPEQLEE------- 141
Query: 739 XXXGFQAEVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                + E   L ++  H +I+ L     +     LV++ M  G L D L + K  L + 
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEK 200
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
            TR  I+    E +S+LH +   +IVHRD+K  NILLD +   R++DFG +  ++   K 
Sbjct: 201 ETR-SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK- 255
Query: 858 KSMSVIAGSCGYIAPEYAYTLR------VNEKSDIYSFGVVILELVTGRLP 902
             +  + G+ GY+APE              ++ D+++ GV++  L+ G  P
Sbjct: 256 --LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 45/314 (14%)
Query: 690 VIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           ++G+G+ G+VYK   +  G+  A+K +     +E E                   + E+ 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE------------------IKQEIN 72
Query: 749 TLGKI-RHKNIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
            L K   H+NI   +     +      D   LV E+   GS+ DL+ + KG  L      
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS------- 854
            I  +   GLS+LH      ++HRD+K  N+LL  +   ++ DFGV+  +D +       
Sbjct: 133 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 189
Query: 855 -GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP---VDPEFGEK 910
            G P  M+    +C    P+  Y      KSD++S G+  +E+  G  P   + P     
Sbjct: 190 IGTPYWMAPEVIACDE-NPDATYDF----KSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244
Query: 911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
            + +     L  K         ++ C  +   +      L   P   ++P  R+V   L+
Sbjct: 245 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304
Query: 971 EVGAENRSKTGKKD 984
           +     + K G+KD
Sbjct: 305 DHIDRTKKKRGEKD 318

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 11/163 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRY 801
            + E+E    + H NI++L+     R    L+ EY P G L  +L  SC     D     
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTA 126
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
            I+ + A+ L Y H      ++HRD+K  N+LL      ++ADFG + V   S + K+M 
Sbjct: 127 TIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTM- 181
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
              G+  Y+ PE       NEK D++  GV+  EL+ G  P +
Sbjct: 182 --CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 29/237 (12%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 100
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 101 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 156
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 157 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 211
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 212 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 268

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 25/230 (10%)
Query: 683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXG 742
           D  ++ + +G+G+ G V+KV       V  +KL     K       +             
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR------------ 53
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
              E++ L +     IV  +    +     +  E+M  GSL  +L   K G +      K
Sbjct: 54  ---ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGK 108
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMS 861
           + +   +GL+YL       I+HRDVK +NIL++     ++ DFGV+ +++D+       +
Sbjct: 109 VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----N 161
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
              G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P   ++D
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKED 211

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/176 (32%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EVE L K+ H NI+KL+          +V E    G L D +   K          +II 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK 128
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y+H     +IVHRD+K  NILL+    D   ++ DFG++     + K K    
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-- 183
Query: 863 IAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+  YIAPE    LR   +EK D++S GV++  L++G  P   +  E D++K V
Sbjct: 184 -IGTAYYIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRV 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 58/176 (32%), Positives = 86/176 (48%), Gaps = 17/176 (9%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EVE L K+ H NI+KL+          +V E    G L D +   K          +II 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK 128
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSV 862
               G++Y+H     +IVHRD+K  NILL+    D   ++ DFG++     + K K    
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-- 183
Query: 863 IAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+  YIAPE    LR   +EK D++S GV++  L++G  P   +  E D++K V
Sbjct: 184 -IGTAYYIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRV 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 29/237 (12%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 81
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 137
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 138 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 192
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 193 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 249

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           ++G GS G V K      G  VA+KK       E +    V+K              E++
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFL-----ESDDDKMVKKIA----------MREIK 76
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L ++RH+N+V L   C  +    LV+E++ +  L DL     G  LD+    K +    
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQII 134
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
            G+ + H     +I+HRD+K  NIL+      ++ DFG A+ + A G+     V   +  
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRW 189
Query: 869 YIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           Y APE     ++  +  D+++ G ++ E+  G  P+ P  G+ D+
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PLFP--GDSDI 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 29/237 (12%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 82
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 138
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 139 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 193
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 194 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/321 (23%), Positives = 132/321 (41%), Gaps = 56/321 (17%)
Query: 679 YEILD--GLDEDNVIGSGSSGKVYKVVLSNG---EAVAVKKLWRGMSKECESGCDVEKGX 733
           Y +LD   +   +VIG G+ G+V K  +         A+K++    SK+           
Sbjct: 16  YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----------- 64
Query: 734 XXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK- 791
                    F  E+E L K+  H NI+ L   C  R    L  EY P+G+L D L   + 
Sbjct: 65  -----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 119
Query: 792 -------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
                           L          D A G+ YL        +HR++ + NIL+  ++
Sbjct: 120 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENY 176
Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            A++ADFG+++  +   K K+M  +     ++A E          SD++S+GV++ E+V+
Sbjct: 177 VAKIADFGLSRGQEVYVK-KTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
Query: 899 GRLPVDPEFGEKDLVKWVCSTLDQK-GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPI 957
                    G        C+ L +K    + L+  L+C   +E+  ++     C    P 
Sbjct: 234 --------LGGTPYCGMTCAELYEKLPQGYRLEKPLNC--DDEVYDLMR---QCWREKPY 280
Query: 958 NRPAMRRVVKLLQEVGAENRS 978
            RP+  +++  L  +  E ++
Sbjct: 281 ERPSFAQILVSLNRMLEERKT 301

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 29/237 (12%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 82
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 138
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 139 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 193
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 194 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKGGLL---DW 797
           F  E E L  ++H++IVK +  C   D  ++V+EYM +G L   L  H     L+   + 
Sbjct: 62  FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP 121
Query: 798 PTRYK------IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
           PT         I    A G+ YL        VHRD+ + N L+  +   ++ DFG+++ V
Sbjct: 122 PTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV 178
Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            ++   +          ++ PE     +   +SD++S GVV+ E+ T G+ P
Sbjct: 179 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 74
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 75  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 130
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 131 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 185
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++   
Sbjct: 186 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 245
Query: 920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
                 ++  DP  +   K            C  P    RP+   +V  +  +
Sbjct: 246 RRLLQPEYCPDPLYEVMLK------------CWHPKAEMRPSFSELVSRISAI 286

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E++ L +     IV  +    +     +  E+M  GSL  +L   K G +      K+ +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSI 173
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
              +GL+YL       I+HRDVK +NIL++     ++ DFGV+ +++D+       +   
Sbjct: 174 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFV 226
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 691 IGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V   V    G  VA+KKL+R    E  +                    E+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR---------------ELRL 77
Query: 750 LGKIRHKNIVKLWCCCT---TRDCKLLVYEYMP--NGSLGDLLHSCKGGLLDWPTRYKII 804
           L  +RH+N++ L    T   T D     Y  MP     LG L+   K G      R + +
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG----EDRIQFL 133
Query: 805 V-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           V    +GL Y+H      I+HRD+K  N+ ++ D   ++ DFG+A+  D+      M   
Sbjct: 134 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMXGX 185
Query: 864 AGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
             +  Y APE     +R  +  DI+S G ++ E++TG+
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 77
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 133
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 134 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 188
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++   
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
                 ++  DP  +   K            C  P    RP+   +V  +  +
Sbjct: 249 RRLLQPEYCPDPLYEVMLK------------CWHPKAEMRPSFSELVSRISAI 289

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 29/237 (12%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 79
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 135
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 136 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 190
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 41/293 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 80
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 136
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
            +  A+G+ YL        VHRD+ + N +LD  F  +VADFG+A+  D   K   S+  
Sbjct: 137 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHN 191
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
             G+     ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++   
Sbjct: 192 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 251
Query: 920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
                 ++  DP  +   K            C  P    RP+   +V  +  +
Sbjct: 252 RRLLQPEYCPDPLYEVMLK------------CWHPKAEMRPSFSELVSRISAI 292

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 72/134 (53%), Gaps = 10/134 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E+M  GSL  +L   K G +      K+ +   +GL+YL       I+HRDVK +NI
Sbjct: 108 ICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNI 163
Query: 833 LLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGV 891
           L++     ++ DFGV+ +++D+       +   G+  Y++PE       + +SDI+S G+
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 218
Query: 892 VILELVTGRLPVDP 905
            ++E+  GR P+ P
Sbjct: 219 SLVEMAVGRYPIPP 232

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 7/185 (3%)
Query: 720 SKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMP 779
           +KE  +G  V K              E+     + H+++V         D   +V E   
Sbjct: 41  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 100
Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
             SL +L H  +  L +   RY  +     G  YLH +    ++HRD+K  N+ L+ D  
Sbjct: 101 RRSLLEL-HKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 155
Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
            ++ DFG+A  V+  G+ K    + G+  YIAPE       + + D++S G ++  L+ G
Sbjct: 156 VKIGDFGLATKVEYDGERK--KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213
Query: 900 RLPVD 904
           + P +
Sbjct: 214 KPPFE 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 7/185 (3%)
Query: 720 SKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMP 779
           +KE  +G  V K              E+     + H+++V         D   +V E   
Sbjct: 45  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 104
Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
             SL +L H  +  L +   RY  +     G  YLH +    ++HRD+K  N+ L+ D  
Sbjct: 105 RRSLLEL-HKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 159
Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
            ++ DFG+A  V+  G+ K    + G+  YIAPE       + + D++S G ++  L+ G
Sbjct: 160 VKIGDFGLATKVEYDGERK--KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 217
Query: 900 RLPVD 904
           + P +
Sbjct: 218 KPPFE 222

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 298
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 299 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 346
Query: 969 LQEVGA 974
           L  + A
Sbjct: 347 LDRIVA 352

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 7/185 (3%)
Query: 720 SKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMP 779
           +KE  +G  V K              E+     + H+++V         D   +V E   
Sbjct: 41  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 100
Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
             SL +L H  +  L +   RY  +     G  YLH +    ++HRD+K  N+ L+ D  
Sbjct: 101 RRSLLEL-HKRRKALTEPEARY-YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 155
Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
            ++ DFG+A  V+  G+ K    + G+  YIAPE       + + D++S G ++  L+ G
Sbjct: 156 VKIGDFGLATKVEYDGERK--KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213
Query: 900 RLPVD 904
           + P +
Sbjct: 214 KPPFE 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 65
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 66  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 119
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  AEG++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 120 -CVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 175
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 17/174 (9%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS------------- 789
           FQ E E L  ++H++IV+ +  CT     L+V+EYM +G L   L S             
Sbjct: 67  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 126
Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              G L       +    A G+ YL        VHRD+ + N L+      ++ DFG+++
Sbjct: 127 VAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            + ++   +          ++ PE     +   +SD++SFGVV+ E+ T G+ P
Sbjct: 184 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 17/174 (9%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS------------- 789
           FQ E E L  ++H++IV+ +  CT     L+V+EYM +G L   L S             
Sbjct: 61  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 120
Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              G L       +    A G+ YL        VHRD+ + N L+      ++ DFG+++
Sbjct: 121 VAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            + ++   +          ++ PE     +   +SD++SFGVV+ E+ T G+ P
Sbjct: 178 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 17/174 (9%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS------------- 789
           FQ E E L  ++H++IV+ +  CT     L+V+EYM +G L   L S             
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              G L       +    A G+ YL        VHRD+ + N L+      ++ DFG+++
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            + ++   +          ++ PE     +   +SD++SFGVV+ E+ T G+ P
Sbjct: 207 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 12/158 (7%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLS 812
           +RH NIV+      T     +V EY   G L + +  C  G                G+S
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVS 129
Query: 813 YLHHDCVPSIVHRDVKSNNILLDGDFGAR--VADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           Y H      + HRD+K  N LLDG    R  +ADFG +K      +PKS     G+  YI
Sbjct: 130 YAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA---VGTPAYI 183
Query: 871 APEYAYTLRVNEK-SDIYSFGVVILELVTGRLPV-DPE 906
           APE       + K +D++S GV +  ++ G  P  DPE
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           + +L  C  T D    V EY+  G L  + H  + G    P       + + GL +LH  
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               I++RD+K +N++LD +   ++ADFG+ K     G   +     G+  YIAPE    
Sbjct: 140 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG--VTTREFCGTPDYIAPEIIAY 194
Query: 878 LRVNEKSDIYSFGVVILELVTGRLPVDPE 906
               +  D +++GV++ E++ G+ P D E
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGE 223

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 35/240 (14%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 83
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 139
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKPKSMSV 862
            +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+ ++D     K    
Sbjct: 140 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLD-----KEFDS 191
Query: 863 IAGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
           +    G      ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 192 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 80
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 136
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+        K    +
Sbjct: 137 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 189
Query: 864 AGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
               G      ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 190 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 248

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 87
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 88  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 143
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+        K    +
Sbjct: 144 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 196
Query: 864 AGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
               G      ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 197 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 255

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 69
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW----- 123
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 124 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E++ L +     IV  +    +     +  E+M  GSL  +L   K G +      K+ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSI 111
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
              +GL+YL       I+HRDVK +NIL++     ++ DFGV+ +++D+       +   
Sbjct: 112 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFV 164
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 691 IGSGSSG--KVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IGSG+ G  ++ +  L+  E VAVK + RG + +                     Q E+ 
Sbjct: 28  IGSGNFGVARLMRDKLTK-ELVAVKYIERGAAID------------------ENVQREII 68
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
               +RH NIV+      T     ++ EY   G L + +  C  G               
Sbjct: 69  NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLL 126
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR--VADFGVAKVVDASGKPKSMSVIAGS 866
            G+SY H      I HRD+K  N LLDG    R  + DFG +K      +PKS     G+
Sbjct: 127 SGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 180
Query: 867 CGYIAPEYAYTLRVNEK-SDIYSFGVVILELVTGRLPV-DPE 906
             YIAPE       + K +D++S GV +  ++ G  P  DPE
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSH 141
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 199 DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 258 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 305
Query: 969 LQEVGA 974
           L  + A
Sbjct: 306 LDRIVA 311

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E++ L +     IV  +    +     +  E+M  GSL  +L   K G +      K+ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSI 111
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
              +GL+YL       I+HRDVK +NIL++     ++ DFGV+ +++D+       +   
Sbjct: 112 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFV 164
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 83
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 139
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+        K    +
Sbjct: 140 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 192
Query: 864 AGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
               G      ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 251

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 82
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 138
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+        K    +
Sbjct: 139 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 191
Query: 864 AGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
               G      ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E++ L +     IV  +    +     +  E+M  GSL  +L   K G +      K+ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSI 111
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
              +GL+YL       I+HRDVK +NIL++     ++ DFGV+ +++D+       +   
Sbjct: 112 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFV 164
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E++ L +     IV  +    +     +  E+M  GSL  +L   K G +      K+ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSI 111
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
              +GL+YL       I+HRDVK +NIL++     ++ DFGV+ +++D+       +   
Sbjct: 112 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFV 164
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 33/239 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 82
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 138
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+        K    +
Sbjct: 139 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 191
Query: 864 AGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
               G      ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 250

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 68
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW----- 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 68
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 746 EVETLGKIRHKNIVKLWCC--CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E E L K+ HKNIVKL+     TT   K+L+ E+ P GSL  +L           + + I
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 804 IV-DAAEGLSYLHHDCVPSIVHRDVKSNNILL----DGDFGARVADFGVAKVVDASGKPK 858
           ++ D   G+++L  +    IVHR++K  NI+     DG    ++ DFG A+ ++     +
Sbjct: 117 VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---E 170
Query: 859 SMSVIAGSCGYIAP---EYAYTLRVNEKS-----DIYSFGVVILELVTGRLPVDP 905
               + G+  Y+ P   E A   + ++K      D++S GV      TG LP  P
Sbjct: 171 QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 45/295 (15%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + VIG G  G VY   L + +   +    + +++  + G                F  E 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG------------EVSQFLTEG 141
Query: 748 ETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII-- 804
             +    H N++ L   C  +    L+V  YM +G L + + +        PT   +I  
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 197
Query: 805 -VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+        K    +
Sbjct: 198 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSV 250
Query: 864 AGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
               G      ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++ 
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
                   ++  DP  +   K            C  P    RP+   +V  +  +
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLK------------CWHPKAEMRPSFSELVSRISAI 353

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 746 EVETLGKIRHKNIVKLWCC--CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E E L K+ HKNIVKL+     TT   K+L+ E+ P GSL  +L           + + I
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 804 IV-DAAEGLSYLHHDCVPSIVHRDVKSNNILL----DGDFGARVADFGVAKVVDASGKPK 858
           ++ D   G+++L  +    IVHR++K  NI+     DG    ++ DFG A+ ++   +  
Sbjct: 117 VLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 859 SMSVIAGSCGYIAP---EYAYTLRVNEKS-----DIYSFGVVILELVTGRLPVDP 905
           S+    G+  Y+ P   E A   + ++K      D++S GV      TG LP  P
Sbjct: 174 SL---YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 72
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 126
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 127 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 182
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 69
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 123
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 124 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 71
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 125
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 126 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 691 IGSGSSG--KVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IGSG+ G  ++ +   SN E VAVK + RG           EK            + E+ 
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERG-----------EK-------IAANVKREII 67
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
               +RH NIV+      T     +V EY   G L + +  C  G               
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 125
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR--VADFGVAKVVDASGKPKSMSVIAGS 866
            G+SY H      + HRD+K  N LLDG    R  + DFG +K      +PKS     G+
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 179
Query: 867 CGYIAPEYAYTLRVNEK-SDIYSFGVVILELVTGRLPV-DPE 906
             YIAPE       + K +D++S GV +  ++ G  P  DPE
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   R+ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + + +GE V +    + + +      + E               E 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE------------ILDEA 70
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-----GLLDWPTRYK 802
             +  +    + +L   C T   +L V + MP G L D +   +G      LL+W     
Sbjct: 71  YVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNW----- 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             +  A+G+SYL       +VHRD+ + N+L+      ++ DFG+A+++D          
Sbjct: 125 -CMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 180
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E     R   +SD++S+GV + EL+T G  P D
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 746 EVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           EV+ L K+  H NI++L     T     LV++ M  G L D L + K  L +  TR KI+
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR-KIM 130
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
               E +  LH     +IVHRD+K  NILLD D   ++ DFG +  +D   K +S   + 
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS---VC 184
Query: 865 GSCGYIAPEYAY-TLRVN-----EKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE    ++  N     ++ D++S GV++  L+ G  P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 70
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 93
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 94  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 147
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 148 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 203
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 204 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 10/134 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E+M  GSL  +L   K   +      K+ +    GL+YL       I+HRDVK +NI
Sbjct: 91  ICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNI 146
Query: 833 LLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGV 891
           L++     ++ DFGV+ +++D+       +   G+  Y+APE       + +SDI+S G+
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMAPERLQGTHYSVQSDIWSMGL 201
Query: 892 VILELVTGRLPVDP 905
            ++EL  GR P+ P
Sbjct: 202 SLVELAVGRYPIPP 215

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 71  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 130
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 188 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 246
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 247 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 294
Query: 969 LQEVGA 974
           L  + A
Sbjct: 295 LDRIVA 300

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 141
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 199 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 258 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 305
Query: 969 LQEVGA 974
           L  + A
Sbjct: 306 LDRIVA 311

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 71
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 125
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 126 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 74  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 133
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 191 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 249
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 250 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 297
Query: 969 LQEVGA 974
           L  + A
Sbjct: 298 LDRIVA 303

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           + +L  C  T D    V EY+  G L  + H  + G    P       + A GL +L   
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               I++RD+K +N++LD +   ++ADFG+ K     G   +     G+  YIAPE    
Sbjct: 141 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPDYIAPEIIAY 195
Query: 878 LRVNEKSDIYSFGVVILELVTGRLPVDPE 906
               +  D ++FGV++ E++ G+ P + E
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 68
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 78
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 79  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 132
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 133 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 188
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 189 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 75  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 134
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 192 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 250
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 251 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 298
Query: 969 LQEVGA 974
           L  + A
Sbjct: 299 LDRIVA 304

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 31/258 (12%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           S++E+L       V+G GS GKV+ V   +G     ++L+            V K     
Sbjct: 25  SQFELL------KVLGQGSFGKVFLVKKISGSDA--RQLY---------AMKVLKKATLK 67
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                  + E + L ++ H  IVKL     T     L+ +++  G L   L   K  +  
Sbjct: 68  VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFT 125
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASG 855
                  + + A  L +LH      I++RD+K  NILLD +   ++ DFG++K  +D   
Sbjct: 126 EEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 182
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
           K  S     G+  Y+APE        + +D +SFGV++ E++TG LP    F  KD  + 
Sbjct: 183 KAYSF---CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP----FQGKDRKET 235
Query: 916 VCSTLDQK-GVDHVLDPK 932
           +   L  K G+   L P+
Sbjct: 236 MTMILKAKLGMPQFLSPE 253

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 31/258 (12%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           S++E+L       V+G GS GKV+ V   +G     ++L+            V K     
Sbjct: 24  SQFELL------KVLGQGSFGKVFLVKKISGSDA--RQLY---------AMKVLKKATLK 66
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                  + E + L ++ H  IVKL     T     L+ +++  G L   L   K  +  
Sbjct: 67  VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFT 124
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASG 855
                  + + A  L +LH      I++RD+K  NILLD +   ++ DFG++K  +D   
Sbjct: 125 EEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
           K  S     G+  Y+APE        + +D +SFGV++ E++TG LP    F  KD  + 
Sbjct: 182 KAYSF---CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP----FQGKDRKET 234
Query: 916 VCSTLDQK-GVDHVLDPK 932
           +   L  K G+   L P+
Sbjct: 235 MTMILKAKLGMPQFLSPE 252

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 31/258 (12%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           S++E+L       V+G GS GKV+ V   +G     ++L+            V K     
Sbjct: 24  SQFELL------KVLGQGSFGKVFLVKKISGSDA--RQLY---------AMKVLKKATLK 66
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                  + E + L ++ H  IVKL     T     L+ +++  G L   L   K  +  
Sbjct: 67  VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFT 124
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASG 855
                  + + A  L +LH      I++RD+K  NILLD +   ++ DFG++K  +D   
Sbjct: 125 EEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
           K  S     G+  Y+APE        + +D +SFGV++ E++TG LP    F  KD  + 
Sbjct: 182 KAYSF---CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP----FQGKDRKET 234
Query: 916 VCSTLDQK-GVDHVLDPK 932
           +   L  K G+   L P+
Sbjct: 235 MTMILKAKLGMPQFLSPE 252

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 71
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 125
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 126 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 71
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 125
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 126 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 24/226 (10%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           S +E+L       V+G GS GKV+           V+K+ R  S    +   V K     
Sbjct: 28  SHFELL------KVLGQGSFGKVF----------LVRKVTRPDSGHLYA-MKVLKKATLK 70
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                  + E + L  + H  +VKL     T     L+ +++  G L   L   K  +  
Sbjct: 71  VRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFT 128
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                  + + A GL +LH      I++RD+K  NILLD +   ++ DFG++K  +A   
Sbjct: 129 EEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDH 183
Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            K      G+  Y+APE       +  +D +S+GV++ E++TG LP
Sbjct: 184 EKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 15/175 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD-LLHSCKGGLLDWPTRYKII 804
           E+  L  + H NI+KL+     +    LV E+   G L + +++  K    D     K I
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD---FGARVADFGVAKVVDASGKPKSMS 861
           +    G+ YLH     +IVHRD+K  NILL+        ++ DFG++       K +   
Sbjct: 156 LS---GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR- 208
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
              G+  YIAPE     + NEK D++S GV++  L+ G  P   +  ++D++K V
Sbjct: 209 --LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQ-NDQDIIKKV 259

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 74
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 75  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 128
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 129 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 184
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 185 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 80/163 (49%), Gaps = 6/163 (3%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L   +          +
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLE 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +  D  E + YL        +HRD+ + N L++     +V+DFG+++ V    +  S+  
Sbjct: 125 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGS 181
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 +  PE     + + KSDI++FGV++ E+ + G++P +
Sbjct: 182 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 75
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 129
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 130 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 70
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 141
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 199 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 258 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 305
Query: 969 LQEVGA 974
           L  + A
Sbjct: 306 LDRIVA 311

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 35/282 (12%)
Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
            ++G G  G V +  L   +  ++K   + M  +  S  ++E+           F +E  
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-----------FLSEAA 88
Query: 749 TLGKIRHKNIVKLWCCCTTRDCK-----LLVYEYMPNGSLGD-LLHS-CKGGLLDWP--T 799
            +    H N+++L   C     +     +++  +M  G L   LL+S  + G    P  T
Sbjct: 89  CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
             K +VD A G+ YL +    + +HRD+ + N +L  D    VADFG++K + +    + 
Sbjct: 149 LLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
             +      +IA E         KSD+++FGV + E+ T  +   P     ++  ++   
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
Query: 920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA 961
                  H L    DC     + ++  I   C    P++RP 
Sbjct: 266 -------HRLKQPEDC-----LDELYEIMYSCWRTDPLDRPT 295

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+E    +RH NI++++     R    L+ E+ P G L   L   K G  D       + 
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFME 121
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           + A+ L Y H      ++HRD+K  N+L+      ++ADFG + V   S + + M    G
Sbjct: 122 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXM---CG 174
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +  Y+ PE       +EK D++  GV+  E + G  P D
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+E    +RH NI++++     R    L+ E+ P G L   L   K G  D       + 
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFME 122
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           + A+ L Y H      ++HRD+K  N+L+      ++ADFG + V   S + + M    G
Sbjct: 123 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXM---CG 175
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +  Y+ PE       +EK D++  GV+  E + G  P D
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 691 IGSGSSG--KVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IGSG+ G  ++ +   SN E VAVK + RG           EK            + E+ 
Sbjct: 26  IGSGNFGVARLMRDKQSN-ELVAVKYIERG-----------EK-------IDENVKREII 66
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
               +RH NIV+      T     +V EY   G L + +  C  G               
Sbjct: 67  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 124
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR--VADFGVAKVVDASGKPKSMSVIAGS 866
            G+SY H      + HRD+K  N LLDG    R  + DFG +K      +PKS     G+
Sbjct: 125 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 178
Query: 867 CGYIAPEYAYTLRVNEK-SDIYSFGVVILELVTGRLPV-DPE 906
             YIAPE       + K +D++S GV +  ++ G  P  DPE
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 220

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 27/232 (11%)
Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGX 733
           LG  ++++L       VIG GS  KV  V L   + +   K+             V+K  
Sbjct: 6   LGLQDFDLL------RVIGRGSYAKVLLVRLKKTDRIYAMKV-------------VKKEL 46
Query: 734 XXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     Q E     +   H  +V L  C  T      V EY+  G L  + H  + 
Sbjct: 47  VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQ 104
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             L          + +  L+YLH      I++RD+K +N+LLD +   ++ D+G+ K   
Sbjct: 105 RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
             G   + S   G+  YIAPE           D ++ GV++ E++ GR P D
Sbjct: 162 RPG--DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 62
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 116
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 117 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 126
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 242
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 243 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 290
Query: 969 LQEVGA 974
           L  + A
Sbjct: 291 LDRIVA 296

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 116/240 (48%), Gaps = 37/240 (15%)
Query: 691 IGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G+G+   VYK +  + G  VA+K          E   D E+G             E+  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALK----------EVKLDSEEGTPSTAI------REISL 56
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNG--------SLGDLLHSCKGGLLDWPTRY 801
           + +++H+NIV+L+    T +   LV+E+M N         ++G+     +  L+ +  ++
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-FQW 115
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           +++    +GL++ H +    I+HRD+K  N+L++     ++ DFG+A+         S  
Sbjct: 116 QLL----QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 862 VIAGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
           V+  +  Y AP+     R    S DI+S G ++ E++TG+ P+ P   +++ +K +   +
Sbjct: 169 VV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIM 225

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           + +L  C  T D    V EY+  G L  + H  + G    P       + A GL +L   
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               I++RD+K +N++LD +   ++ADFG+ K     G   +     G+  YIAPE    
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTPDYIAPEIIAY 516
Query: 878 LRVNEKSDIYSFGVVILELVTGRLPVDPE 906
               +  D ++FGV++ E++ G+ P + E
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +      + +      + E               E 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKE------------ILDEA 102
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 103 YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 156
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 157 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 212
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 213 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW---PTR 800
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++   P+ 
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH 141
Query: 801 -----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                             A G+ YL        +HRD+ + N+L+  D   ++ADFG+A+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            +      K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 199 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 258 VEELFK-----LLKEG--HRMDKPSNCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 305
Query: 969 LQEVGA 974
           L  + A
Sbjct: 306 LDRIVA 311

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 27/232 (11%)
Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGX 733
           LG  ++++L       VIG GS  KV  V L   + +   K+             V+K  
Sbjct: 2   LGLQDFDLL------RVIGRGSYAKVLLVRLKKTDRIYAMKV-------------VKKEL 42
Query: 734 XXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     Q E     +   H  +V L  C  T      V EY+  G L  + H  + 
Sbjct: 43  VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQ 100
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             L          + +  L+YLH      I++RD+K +N+LLD +   ++ D+G+ K   
Sbjct: 101 RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 157
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
             G   + S   G+  YIAPE           D ++ GV++ E++ GR P D
Sbjct: 158 RPG--DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 38/233 (16%)
Query: 678 EYE-ILDGLDEDNV------IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVE 730
           EYE +   LD + V      +G G+ GKVYK       A+A  K+    S+E     ++E
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-----ELE 61
Query: 731 KGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHS 789
                       +  E+E L    H  IVKL       D KL ++ E+ P G++  ++  
Sbjct: 62  D-----------YIVEIEILATCDHPYIVKL-LGAYYHDGKLWIMIEFCPGGAVDAIMLE 109
Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-A 848
              GL + P    +     E L++LH      I+HRD+K+ N+L+  +   R+ADFGV A
Sbjct: 110 LDRGLTE-PQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA 165
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNE-----KSDIYSFGVVILEL 896
           K +    K  S     G+  ++APE      + +     K+DI+S G+ ++E+
Sbjct: 166 KNLKTLQKRDSF---IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 68
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD-LLHSCKGGLLDWPTRYKII 804
           EV  L ++ H NI+KL+     +    LV E    G L D ++   K   +D      I+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IM 127
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMS 861
                G +YLH     +IVHRD+K  N+LL+    D   ++ DFG++   +  GK K   
Sbjct: 128 KQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER- 183
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  YIAPE     + +EK D++S GV++  L+ G  P
Sbjct: 184 --LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 72
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 126
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG AK++ A  K      
Sbjct: 127 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 182
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 132/306 (43%), Gaps = 49/306 (16%)
Query: 689 NVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G+G+ GKV +      G+  AV K+   M K      + E              +E+
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-----------ALMSEL 92
Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD----WPTRYK 802
           + +  + +H+NIV L   CT     L++ EY   G L + L       LD     P   +
Sbjct: 93  KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR 152
Query: 803 IIV----DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
            ++      A+G+++L      + +HRDV + N+LL     A++ DFG+A+ +       
Sbjct: 153 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MND 205
Query: 859 SMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
           S  ++ G+      ++APE  +      +SD++S+G+++ E+ +  L ++P  G   LV 
Sbjct: 206 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--LGLNPYPG--ILVN 261
Query: 915 WVCSTLDQKGVDH---VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
                L + G         PK           + +I   C +  P +RP  +++   LQE
Sbjct: 262 SKFYKLVKDGYQMAQPAFAPK----------NIYSIMQACWALEPTHRPTFQQICSFLQE 311
Query: 972 VGAENR 977
              E+R
Sbjct: 312 QAQEDR 317

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 38/236 (16%)
Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGX 733
           + F  +EIL        IG GS GKV  +V  N      KK++  M    +  C VE+  
Sbjct: 12  VNFDHFEIL------RAIGKGSFGKVC-IVQKND----TKKMY-AMKYMNKQKC-VERNE 58
Query: 734 XXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
                       E++ +  + H  +V LW      +   +V + +  G L    H  +  
Sbjct: 59  VRNVF------KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNV 110
Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
                T    I +    L YL +     I+HRD+K +NILLD      + DF +A ++  
Sbjct: 111 HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-- 165
Query: 854 SGKPKSMSVIAGSCGYIAPEY-------AYTLRVNEKSDIYSFGVVILELVTGRLP 902
             +   ++ +AG+  Y+APE         Y+  V    D +S GV   EL+ GR P
Sbjct: 166 -PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 70
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG AK++ A  K      
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 115/244 (47%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K+ +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 27/232 (11%)
Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGX 733
           LG  ++++L       VIG GS  KV  V L   + +   K+             V+K  
Sbjct: 17  LGLQDFDLL------RVIGRGSYAKVLLVRLKKTDRIYAMKV-------------VKKEL 57
Query: 734 XXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     Q E     +   H  +V L  C  T      V EY+  G L  + H  + 
Sbjct: 58  VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQ 115
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             L          + +  L+YLH      I++RD+K +N+LLD +   ++ D+G+ K   
Sbjct: 116 RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 172
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
             G   + S   G+  YIAPE           D ++ GV++ E++ GR P D
Sbjct: 173 RPG--DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 70/132 (53%), Gaps = 10/132 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E+M  GSL  +L   K G +      K+ +   +GL+YL       I+HRDVK +NI
Sbjct: 100 ICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNI 155
Query: 833 LLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGV 891
           L++     ++ DFGV+ +++D+           G+  Y++PE       + +SDI+S G+
Sbjct: 156 LVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYSVQSDIWSMGL 210
Query: 892 VILELVTGRLPV 903
            ++E+  GR P+
Sbjct: 211 SLVEMAVGRYPI 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 746 EVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           EV+ L K+  H NI++L     T     LV++ M  G L D L + K  L +  TR KI+
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR-KIM 117
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
               E +  LH     +IVHRD+K  NILLD D   ++ DFG +  +D   K +    + 
Sbjct: 118 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VC 171
Query: 865 GSCGYIAPEYAY-TLRVN-----EKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE    ++  N     ++ D++S GV++  L+ G  P
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G+ GKVYK       A+A  K+    S+E     ++E            +  E+E L
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEE-----ELED-----------YIVEIEIL 62
Query: 751 GKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
               H  IVKL       D KL ++ E+ P G++  ++     GL + P    +     E
Sbjct: 63  ATCDHPYIVKL-LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVVCRQMLE 120
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIAGSCG 868
            L++LH      I+HRD+K+ N+L+  +   R+ADFGV AK +    K  S     G+  
Sbjct: 121 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF---IGTPY 174
Query: 869 YIAPEYAYTLRVNE-----KSDIYSFGVVILEL 896
           ++APE      + +     K+DI+S G+ ++E+
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 49/308 (15%)
Query: 689 NVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G+G+ GKV +      G+  AV K+   M K      + E              +E+
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-----------ALMSEL 100
Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD----WPTRYK 802
           + +  + +H+NIV L   CT     L++ EY   G L + L       LD     P   +
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELR 160
Query: 803 IIV----DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
            ++      A+G+++L      + +HRDV + N+LL     A++ DFG+A+ +       
Sbjct: 161 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MND 213
Query: 859 SMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
           S  ++ G+      ++APE  +      +SD++S+G+++ E+ +  L ++P  G   LV 
Sbjct: 214 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--LGLNPYPG--ILVN 269
Query: 915 WVCSTLDQKGVDH---VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
                L + G         PK           + +I   C +  P +RP  +++   LQE
Sbjct: 270 SKFYKLVKDGYQMAQPAFAPK----------NIYSIMQACWALEPTHRPTFQQICSFLQE 319
Query: 972 VGAENRSK 979
              E+R +
Sbjct: 320 QAQEDRRE 327

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 70
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG AK++ A  K      
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGD-LLHSCKGGLLDWPTRYKII 804
           EV  L ++ H NI+KL+     +    LV E    G L D ++   K   +D      I+
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IM 110
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSMS 861
                G +YLH     +IVHRD+K  N+LL+    D   ++ DFG++   +  GK K   
Sbjct: 111 KQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER- 166
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  YIAPE     + +EK D++S GV++  L+ G  P
Sbjct: 167 --LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+  L KI+H+NIV L     + +   LV + +  G L D +   + G         +I 
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIR 127
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSV 862
              + + YLH      IVHRD+K  N+L    D +    ++DFG++K+    GK   MS 
Sbjct: 128 QVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMST 181
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
             G+ GY+APE       ++  D +S GV+   L+ G  P   E
Sbjct: 182 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + E+  L KI+H NIV L     +     L+ + +  G L D +   + G        ++
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRL 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNIL---LDGDFGARVADFGVAKVVDASGKPKS- 859
           I    + + YLH      IVHRD+K  N+L   LD D    ++DFG++K+ D    P S 
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED----PGSV 174
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +S   G+ GY+APE       ++  D +S GV+   L+ G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + E+  L KI+H NIV L     +     L+ + +  G L D +   + G        ++
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRL 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNIL---LDGDFGARVADFGVAKVVDASGKPKS- 859
           I    + + YLH      IVHRD+K  N+L   LD D    ++DFG++K+ D    P S 
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED----PGSV 174
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +S   G+ GY+APE       ++  D +S GV+   L+ G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + E+  L KI+H NIV L     +     L+ + +  G L D +   + G        ++
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRL 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNIL---LDGDFGARVADFGVAKVVDASGKPKS- 859
           I    + + YLH      IVHRD+K  N+L   LD D    ++DFG++K+ D    P S 
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED----PGSV 174
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +S   G+ GY+APE       ++  D +S GV+   L+ G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + E+  L KI+H NIV L     +     L+ + +  G L D +   + G        ++
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRL 121
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNIL---LDGDFGARVADFGVAKVVDASGKPKS- 859
           I    + + YLH      IVHRD+K  N+L   LD D    ++DFG++K+ D    P S 
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED----PGSV 174
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +S   G+ GY+APE       ++  D +S GV+   L+ G  P
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L   +          +
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLE 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +  D  E + YL        +HRD+ + N L++     +V+DFG+++ V       S+  
Sbjct: 125 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 +  PE     + + KSDI++FGV++ E+ + G++P +
Sbjct: 182 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 70
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 124
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG AK++ A  K      
Sbjct: 125 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + L K+  + +V L     T+D   LV   M  G L    H    G   +P   + + 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFP-EARAVF 290
Query: 806 DAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            AAE   GL  LH +    IV+RD+K  NILLD     R++D G+A  V      +++  
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKG 344
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+ GY+APE     R     D ++ G ++ E++ G+ P
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 68
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG AK++ A  K      
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 178
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L   +          +
Sbjct: 50  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLE 108
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +  D  E + YL        +HRD+ + N L++     +V+DFG+++ V       S+  
Sbjct: 109 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 165
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 +  PE     + + KSDI++FGV++ E+ + G++P +
Sbjct: 166 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L   +          +
Sbjct: 51  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLE 109
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +  D  E + YL        +HRD+ + N L++     +V+DFG+++ V       S+  
Sbjct: 110 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 166
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 +  PE     + + KSDI++FGV++ E+ + G++P +
Sbjct: 167 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 14/164 (8%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY-K 802
           + EV  L +IRH NI+ L      +   +L+ E +  G L D L   +    D  T++ K
Sbjct: 77  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 136
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAKVVDASGKPK 858
            I+D   G+ YLH      I H D+K  NI LLD +      ++ DFG+A  ++A  + K
Sbjct: 137 QILD---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 190
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 191 N---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 746 EVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           EV+ L K+  H NI++L     T     LV++ M  G L D L + K  L +  TR KI+
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR-KIM 130
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
               E +  LH     +IVHRD+K  NILLD D   ++ DFG +  +D   K +    + 
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VC 184
Query: 865 GSCGYIAPEYAY-TLRVN-----EKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE    ++  N     ++ D++S GV++  L+ G  P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 7/158 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M    
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFC 166
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 27/232 (11%)
Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGX 733
           LG  ++++L       VIG GS  KV  V L   + +   ++             V+K  
Sbjct: 49  LGLQDFDLL------RVIGRGSYAKVLLVRLKKTDRIYAMRV-------------VKKEL 89
Query: 734 XXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     Q E     +   H  +V L  C  T      V EY+  G L  + H  + 
Sbjct: 90  VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQ 147
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             L          + +  L+YLH      I++RD+K +N+LLD +   ++ D+G+ K   
Sbjct: 148 RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
             G   + S   G+  YIAPE           D ++ GV++ E++ GR P D
Sbjct: 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 7/158 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 116
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M    
Sbjct: 117 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFC 171
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+GSG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 75
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 129
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG AK++ A  K      
Sbjct: 130 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 185
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 78  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 194
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 195 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 253
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 254 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 301
Query: 969 LQEV 972
           L  +
Sbjct: 302 LDRI 305

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 7/158 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 114
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M    
Sbjct: 115 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFC 169
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 170 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 81  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 140
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 141 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 197
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 198 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 256
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 257 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 304
Query: 969 LQEV 972
           L  +
Sbjct: 305 LDRI 308

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L   +          +
Sbjct: 57  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLE 115
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +  D  E + YL        +HRD+ + N L++     +V+DFG+++ V       S+  
Sbjct: 116 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 172
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 +  PE     + + KSDI++FGV++ E+ + G++P +
Sbjct: 173 -KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 7/158 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M    
Sbjct: 112 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFC 166
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 6/118 (5%)
Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           LH  +  + +   RY  +    +G+ YLH++    ++HRD+K  N+ L+ D   ++ DFG
Sbjct: 132 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +A  ++  G+ K    + G+  YIAPE       + + DI+S G ++  L+ G+ P +
Sbjct: 188 LATKIEFDGERK--KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 113/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----------GG 793
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +            
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 794 LLDWPTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
           + +    +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 76  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR 192
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 193 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 251
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 252 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 299
Query: 969 LQEV 972
           L  +
Sbjct: 300 LDRI 303

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 7/158 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M    
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFC 166
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 65/158 (41%), Gaps = 7/158 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYG 111
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M    
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKXFC 166
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 25/231 (10%)
Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEK 731
           H++  +E+E L       ++G G+ GKV   +L   +A       + + KE     D   
Sbjct: 146 HRVTMNEFEYL------KLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKD--- 193
Query: 732 GXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
                         E   L   RH  +  L     T D    V EY   G L    H  +
Sbjct: 194 -------EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSR 244
Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
             +           +    L YLH +   ++V+RD+K  N++LD D   ++ DFG+ K  
Sbjct: 245 ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 302
Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G   +M    G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 303 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E + L K+  + +V L     T+D   LV   M  G L    H    G   +P   + + 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPE-ARAVF 290
Query: 806 DAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
            AAE   GL  LH +    IV+RD+K  NILLD     R++D G+A  V      +++  
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKG 344
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+ GY+APE     R     D ++ G ++ E++ G+ P
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L   +          +
Sbjct: 51  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT-QQLLE 109
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +  D  E + YL        +HRD+ + N L++     +V+DFG+++ V    +  S   
Sbjct: 110 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRG 165
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 +  PE     + + KSDI++FGV++ E+ + G++P +
Sbjct: 166 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 94/239 (39%), Gaps = 25/239 (10%)
Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEK 731
           H++  +E+E L       ++G G+ GKV   +L   +A       + + KE     D   
Sbjct: 143 HRVTMNEFEYL------KLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKD--- 190
Query: 732 GXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
                         E   L   RH  +  L     T D    V EY   G L    H  +
Sbjct: 191 -------EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSR 241
Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
             +           +    L YLH +   ++V+RD+K  N++LD D   ++ DFG+ K  
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299
Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
              G   +M    G+  Y+APE           D +  GVV+ E++ GRLP   +  EK
Sbjct: 300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 100/242 (41%), Gaps = 36/242 (14%)
Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRG--MSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           VIG G+ G+V  V     + V   KL     M K  +S                 F  E 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF---------------FWEER 126
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
           + +       +V+L+C         +V EYMP G L +L+ +      D P ++     A
Sbjct: 127 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTA 181
Query: 808 AEGLSYLHHDCVPSI--VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
              L+    D + S+  +HRDVK +N+LLD     ++ADFG    +D +G     + + G
Sbjct: 182 EVVLAL---DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-G 237
Query: 866 SCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD 921
           +  YI+PE   +         + D +S GV + E++ G  P    F    LV      +D
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP----FYADSLVGTYSKIMD 293
Query: 922 QK 923
            K
Sbjct: 294 HK 295

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 6/118 (5%)
Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           LH  +  + +   RY  +    +G+ YLH++    ++HRD+K  N+ L+ D   ++ DFG
Sbjct: 132 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +A  ++  G+ K    + G+  YIAPE       + + DI+S G ++  L+ G+ P +
Sbjct: 188 LATKIEFDGERKKX--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 131/316 (41%), Gaps = 49/316 (15%)
Query: 683 DGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXX 741
           + L     +G+G+ GKV +      G+  AV K+   M K      + E           
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE----------- 94
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
              +E++ +  + +H+NIV L   CT     L++ EY   G L + L   K  +L+    
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR-KSRVLETDPA 153
Query: 801 YKIIVDAAEGLSYLHHD----------CVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
           + I    A     LH               + +HRDV + N+LL     A++ DFG+A+ 
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 851 VDASGKPKSMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           +       S  ++ G+      ++APE  +      +SD++S+G+++ E+ +  L ++P 
Sbjct: 214 I----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--LGLNPY 267
Query: 907 FGEKDLVKWVCSTLDQKGVDH---VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR 963
            G   LV      L + G         PK           + +I   C +  P +RP  +
Sbjct: 268 PG--ILVNSKFYKLVKDGYQMAQPAFAPK----------NIYSIMQACWALEPTHRPTFQ 315
Query: 964 RVVKLLQEVGAENRSK 979
           ++   LQE   E+R +
Sbjct: 316 QICSFLQEQAQEDRRE 331

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP--T 799
           G   E + L K+  + IV L     T+    LV   M NG  GD+ +       D P   
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQ 287
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
             + I   A+ +S L H    +I++RD+K  N+LLD D   R++D G+A  + A G+ K+
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-GQTKT 346
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV--------DPEFGEKD 911
               AG+ G++APE       +   D ++ GV + E++  R P         + E  ++ 
Sbjct: 347 KGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405
Query: 912 LVKWV-------------CSTLDQKGVDHVLDPKLDCC--------FKEEICKVLNIGLL 950
           L + V             C  L QK  +  L  +   C        F++   + L  G+L
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 951 CTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDAS 996
               +P +R       K +Q+VGA +  K    +   + ++ E AS
Sbjct: 466 TPPFVPDSRTV---YAKCIQDVGAFSTVKGVAFEKADTEFFQEFAS 508

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP--T 799
           G   E + L K+  + IV L     T+    LV   M NG  GD+ +       D P   
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQ 287
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
             + I   A+ +S L H    +I++RD+K  N+LLD D   R++D G+A  + A G+ K+
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-GQTKT 346
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV--------DPEFGEKD 911
               AG+ G++APE       +   D ++ GV + E++  R P         + E  ++ 
Sbjct: 347 KGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405
Query: 912 LVKWV-------------CSTLDQKGVDHVLDPKLDCC--------FKEEICKVLNIGLL 950
           L + V             C  L QK  +  L  +   C        F++   + L  G+L
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 951 CTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDAS 996
               +P +R       K +Q+VGA +  K    +   + ++ E AS
Sbjct: 466 TPPFVPDSRTV---YAKNIQDVGAFSTVKGVAFEKADTEFFQEFAS 508

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 310
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 311 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 358
Query: 969 LQEV 972
           L  +
Sbjct: 359 LDRI 362

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP--T 799
           G   E + L K+  + IV L     T+    LV   M NG  GD+ +       D P   
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQ 287
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
             + I   A+ +S L H    +I++RD+K  N+LLD D   R++D G+A  + A G+ K+
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-GQTKT 346
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV--------DPEFGEKD 911
               AG+ G++APE       +   D ++ GV + E++  R P         + E  ++ 
Sbjct: 347 KGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405
Query: 912 LVKWV-------------CSTLDQKGVDHVLDPKLDCC--------FKEEICKVLNIGLL 950
           L + V             C  L QK  +  L  +   C        F++   + L  G+L
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 951 CTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDAS 996
               +P +R       K +Q+VGA +  K    +   + ++ E AS
Sbjct: 466 TPPFVPDSRTV---YAKNIQDVGAFSTVKGVAFEKADTEFFQEFAS 508

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/319 (23%), Positives = 135/319 (42%), Gaps = 55/319 (17%)
Query: 683 DGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXX 741
           + L     +G+G+ GKV +      G+  AV K+   M K      + E           
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE----------- 94
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
              +E++ +  + +H+NIV L   CT     L++ EY   G L + L   K  +L+    
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR-KSRVLETDPA 153
Query: 801 YKII-------------VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
           + I                 A+G+++L      + +HRDV + N+LL     A++ DFG+
Sbjct: 154 FAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
Query: 848 AKVVDASGKPKSMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
           A+ +       S  ++ G+      ++APE  +      +SD++S+G+++ E+ +  L +
Sbjct: 211 ARDI----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--LGL 264
Query: 904 DPEFGEKDLVKWVCSTLDQKGVDH---VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
           +P  G   LV      L + G         PK           + +I   C +  P +RP
Sbjct: 265 NPYPG--ILVNSKFYKLVKDGYQMAQPAFAPK----------NIYSIMQACWALEPTHRP 312
Query: 961 AMRRVVKLLQEVGAENRSK 979
             +++   LQE   E+R +
Sbjct: 313 TFQQICSFLQEQAQEDRRE 331

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+ SG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 75
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L++ + MP G L D +   K       LL+W     
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 129
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 130 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP--T 799
           G   E + L K+  + IV L     T+    LV   M NG  GD+ +       D P   
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQ 287
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
             + I   A+ +S L H    +I++RD+K  N+LLD D   R++D G+A  + A G+ K+
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-GQTKT 346
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV--------DPEFGEKD 911
               AG+ G++APE       +   D ++ GV + E++  R P         + E  ++ 
Sbjct: 347 KGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405
Query: 912 LVKWV-------------CSTLDQKGVDHVLDPKLDCC--------FKEEICKVLNIGLL 950
           L + V             C  L QK  +  L  +   C        F++   + L  G+L
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML 465
Query: 951 CTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDAS 996
               +P +R       K +Q+VGA +  K    +   + ++ E AS
Sbjct: 466 TPPFVPDSRTV---YAKNIQDVGAFSTVKGVAFEKADTEFFQEFAS 508

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+ SG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 68
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 123 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E++ L +     IV  +    +     +  E+M  GSL  +L   K G +      K+ +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSI 114
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIA 864
              +GL+YL       I+HRDVK +NIL++     ++ DFGV+ +++D            
Sbjct: 115 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE-----FV 167
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           G+  Y++PE       + +SDI+S G+ ++E+  GR P  P
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           + E+  L ++ H NI+KL     T     LV E +  G L D +   + G          
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADA 153
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVDASGKPKSM 860
           +    E ++YLH +    IVHRD+K  N+L      D   ++ADFG++K+V+       M
Sbjct: 154 VKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLM 207
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             + G+ GY APE         + D++S G++   L+ G  P   E G++ + + +
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMAGFVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMAGFVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 689 NVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            V+ SG+ G VYK + +  GE V +    + + +      + E               E 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------ILDEA 75
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDWPTRYK 802
             +  + + ++ +L   C T   +L+  + MP G L D +   K       LL+W     
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW----- 129
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 130 -CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
                 ++A E         +SD++S+GV + EL+T G  P D
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V   +   +GE VA+KKL R    E  +                    E+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR---------------ELLL 94
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYE-YMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           L  ++H+N++ L    T        Y+ Y+    +   L    G          ++    
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQML 154
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           +GL Y+H      +VHRD+K  N+ ++ D   ++ DFG+A+  DA      M+    +  
Sbjct: 155 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRW 206
Query: 869 YIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV 925
           Y APE   + +  N+  DI+S G ++ E++TG+      F  KD +  +   L   GV
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL----FKGKDYLDQLTQILKVTGV 260

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 6/118 (5%)
Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           LH  +  + +   RY  +    +G+ YLH++    ++HRD+K  N+ L+ D   ++ DFG
Sbjct: 116 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFG 171
Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +A  ++  G+ K    + G+  YIAPE       + + DI+S G ++  L+ G+ P +
Sbjct: 172 LATKIEFDGERK--KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 29/265 (10%)
Query: 714 KLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCK-- 771
           +LW+G  +  +    V K           F  E   L    H N++ +   C +      
Sbjct: 25  ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 772 LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN 831
            L+  + P GSL ++LH     ++D     K  +D A G ++L H   P I    + S +
Sbjct: 85  TLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL-HTLEPLIPRHALNSRS 143
Query: 832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS-DIYSFG 890
           + +D D  AR++   V     + G+  + + +A       PE       N +S D +SF 
Sbjct: 144 VXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPE-----DTNRRSADXWSFA 198
Query: 891 VVILELVTGRLPV----DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLN 946
           V++ ELVT  +P     + E G K  ++              L P +       + K+  
Sbjct: 199 VLLWELVTREVPFADLSNXEIGXKVALE-------------GLRPTIPPGISPHVSKLXK 245
Query: 947 IGLLCTSPLPINRPAMRRVVKLLQE 971
           I   C +  P  RP    +V +L++
Sbjct: 246 I---CXNEDPAKRPKFDXIVPILEK 267

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 70
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMAGFVATR 182
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 25/176 (14%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGG---------- 793
           +E   L ++ H +++KL+  C+     LL+ EY   GSL G L  S K G          
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 794 ---LLDWPTRYKIIV--------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
               LD P    + +          ++G+ YL      S+VHRD+ + NIL+      ++
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKI 191
Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +DFG+++ V         S       ++A E  +      +SD++SFGV++ E+VT
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY-KIIVDAAEGL 811
           +  +N VK       +    +  EY  N +L DL+HS    L      Y ++     E L
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS--ENLNQQRDEYWRLFRQILEAL 129
Query: 812 SYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS------------GKPKS 859
           SY+H      I+HR++K  NI +D     ++ DFG+AK V  S            G   +
Sbjct: 130 SYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 860 MSVIAGSCGYIAPEYA-YTLRVNEKSDIYSFGVVILELV 897
           ++   G+  Y+A E    T   NEK D YS G++  E +
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 70
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQI 130
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 182
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 24/230 (10%)
Query: 689 NVIGSGSSGKVYKVV----LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
            V+G G  GKV++V      + G+  A+K L + M                        +
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM-------------IVRNAKDTAHTK 69
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   L +++H  IV L     T     L+ EY+  G L   +   + G+    T    +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYL 127
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            + +  L +LH      I++RD+K  NI+L+     ++ DFG+ K     G         
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFC 182
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
           G+  Y+APE       N   D +S G ++ +++TG  P   E  +K + K
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 6/118 (5%)
Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           LH  +  + +   RY  +    +G+ YLH++    ++HRD+K  N+ L+ D   ++ DFG
Sbjct: 132 LHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFG 187
Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           +A  ++  G+ K    + G+  YIAPE       + + DI+S G ++  L+ G+ P +
Sbjct: 188 LATKIEFDGERK--KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IGSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 79
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 140 LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----DEMTGYVATR 191
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V   +   +GE VA+KKL R    E  +                    E+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR---------------ELLL 76
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYE-YMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           L  ++H+N++ L    T        Y+ Y+    +   L    G          ++    
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML 136
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           +GL Y+H      +VHRD+K  N+ ++ D   ++ DFG+A+  DA      M+    +  
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRW 188
Query: 869 YIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV 925
           Y APE   + +  N+  DI+S G ++ E++TG+      F  KD +  +   L   GV
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL----FKGKDYLDQLTQILKVTGV 242

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 26/146 (17%)
Query: 772 LLVYEYMPNGSLGDLL--HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC------VPSIV 823
           LLV EY PNGSL   L  H+      DW +  ++      GL+YLH +        P+I 
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142
Query: 824 HRDVKSNNILLDGDFGARVADFGVA------KVVDASGKPKSMSVIAGSCGYIAPEY--- 874
           HRD+ S N+L+  D    ++DFG++      ++V    +  +     G+  Y+APE    
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 875 AYTLRVNEKS----DIYSFGVVILEL 896
           A  LR  E +    D+Y+ G++  E+
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 49/226 (21%)
Query: 691 IGSGSSGKV----YKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +G G+ G V    Y  +  N G  VAVK+L         SG D ++           FQ 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-------HSGPDQQRD----------FQR 73
Query: 746 EVETLGKIRHKNIVKLWCCC--TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E++ L  +    IVK         R    LV EY+P+G L D L            R++ 
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----------RHRA 122
Query: 804 IVDAAEGLSYLHHDC-------VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
            +DA+  L Y    C           VHRD+ + NIL++ +   ++ADFG+AK++     
Sbjct: 123 RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-- 180
Query: 857 PKSMSVI----AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            K   V+         + APE       + +SD++SFGVV+ EL T
Sbjct: 181 -KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 70
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 182
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 84
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 144
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 145 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 196
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 197 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 12/166 (7%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
           F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L   +          +
Sbjct: 46  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLE 104
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +  D  E + YL        +HRD+ + N L++     +V+DFG+++ V       S+  
Sbjct: 105 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-- 159
Query: 863 IAGS---CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD 904
             GS     +  PE     + + KSDI++FGV++ E+ + G++P +
Sbjct: 160 --GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 92/222 (41%), Gaps = 33/222 (14%)
Query: 691 IGSGSSG--KVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IGSG+ G  ++ +   SN E VAVK + RG           EK            + E+ 
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERG-----------EK-------IDENVKREII 67
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
               +RH NIV+      T     +V EY   G L + +  C  G               
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 125
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR--VADFGVAKVVDASGKPKSMSVIAGS 866
            G+SY H      + HRD+K  N LLDG    R  +  FG +K      +PKS     G+
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST---VGT 179
Query: 867 CGYIAPEYAYTLRVNEK-SDIYSFGVVILELVTGRLPV-DPE 906
             YIAPE       + K +D++S GV +  ++ G  P  DPE
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 80
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 141 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 192
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 691 IGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G    GKVYK  L         +AVA+K L     K+   G   E+           F+
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-----KDKAEGPLREE-----------FR 77
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-----HSCKGGL----- 794
            E     +++H N+V L    T      +++ Y  +G L + L     HS  G       
Sbjct: 78  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 795 ----LDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
               L+ P    ++   A G+ YL  HH     +VH+D+ + N+L+      +++D G+ 
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLF 192
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           + V A+   K +        ++APE     + +  SDI+S+GVV+ E+ +        +G
Sbjct: 193 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--------YG 244
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
               ++  C   +Q  V+ + + ++  C  +    V  + + C +  P  RP  + +   
Sbjct: 245 ----LQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300
Query: 969 LQEVG 973
           L+  G
Sbjct: 301 LRAWG 305

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 24/230 (10%)
Query: 689 NVIGSGSSGKVYKVV----LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
            V+G G  GKV++V      + G+  A+K L + M                        +
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM-------------IVRNAKDTAHTK 69
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   L +++H  IV L     T     L+ EY+  G L   +   + G+    T    +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYL 127
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            + +  L +LH      I++RD+K  NI+L+     ++ DFG+ K     G         
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHXFC 182
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
           G+  Y+APE       N   D +S G ++ +++TG  P   E  +K + K
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 60/106 (56%), Gaps = 11/106 (10%)
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSM 860
           KI +   + L++L  +    I+HRD+K +NILLD     ++ DFG++ ++VD+  K +  
Sbjct: 129 KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD- 185
Query: 861 SVIAGSCGYIAPEY----AYTLRVNEKSDIYSFGVVILELVTGRLP 902
              AG   Y+APE     A     + +SD++S G+ + EL TGR P
Sbjct: 186 ---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 94
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 155 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 206
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 27/169 (15%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCC--TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
           FQ E++ L  +    IVK         R    LV EY+P+G L D L            R
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----------R 107
Query: 801 YKIIVDAAEGLSYLHHDC-------VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           ++  +DA+  L Y    C           VHRD+ + NIL++ +   ++ADFG+AK++  
Sbjct: 108 HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 167
Query: 854 SGKPKSMSVI----AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               K   V+         + APE       + +SD++SFGVV+ EL T
Sbjct: 168 D---KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 27/169 (15%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCC--TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
           FQ E++ L  +    IVK         R    LV EY+P+G L D L            R
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-----------R 106
Query: 801 YKIIVDAAEGLSYLHHDC-------VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           ++  +DA+  L Y    C           VHRD+ + NIL++ +   ++ADFG+AK++  
Sbjct: 107 HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 166
Query: 854 SGKPKSMSVI----AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               K   V+         + APE       + +SD++SFGVV+ EL T
Sbjct: 167 D---KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 93
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 154 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 205
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP----- 798
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 799 -----TRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP----- 798
           +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 799 -----TRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/320 (22%), Positives = 135/320 (42%), Gaps = 55/320 (17%)
Query: 683 DGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXX 741
           + L     +G+G+ GKV +      G+  AV K+   M K      + E           
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE----------- 94
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW--- 797
              +E++ +  + +H+NIV L   CT     L++ EY   G L + L   +   L++   
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYN 154
Query: 798 PTR-----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           P+                   A+G+++L      + +HRDV + N+LL     A++ DFG
Sbjct: 155 PSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFG 211
Query: 847 VAKVVDASGKPKSMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +A+ +       S  ++ G+      ++APE  +      +SD++S+G+++ E+ +  L 
Sbjct: 212 LARDI----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--LG 265
Query: 903 VDPEFGEKDLVKWVCSTLDQKGVDH---VLDPKLDCCFKEEICKVLNIGLLCTSPLPINR 959
           ++P  G   LV      L + G         PK           + +I   C +  P +R
Sbjct: 266 LNPYPG--ILVNSKFYKLVKDGYQMAQPAFAPK----------NIYSIMQACWALEPTHR 313
Query: 960 PAMRRVVKLLQEVGAENRSK 979
           P  +++   LQE   E+R +
Sbjct: 314 PTFQQICSFLQEQAQEDRRE 333

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 113/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++  Y   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 69/166 (41%), Gaps = 6/166 (3%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 114
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH +   ++V+RD+K  N++LD D   ++ DFG+ K     G   +M    
Sbjct: 115 AEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKXFC 170
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
           G+  Y+APE           D +  GVV+ E++ GRLP   +  EK
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    SK  +S    ++              E+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL----SKPFQSIIHAKRTYR-----------ELRL 86
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 147 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 198
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 691 IGSGSSGKVYKV--VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IG G+ GKV+K   + + G  VA+K++        ++G   E+G              +E
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV------RVQTG---EEGMPLSTIREVAVLRHLE 69
Query: 749 TLGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           T     H N+V+L+  CT     R+ KL LV+E++ +  L   L       +   T   +
Sbjct: 70  TF---EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 125
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +     GL +LH      +VHRD+K  NIL+      ++ADFG+A++        +++ +
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
             +  Y APE           D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 79
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 140 LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----DEMTGYVATR 191
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/157 (28%), Positives = 65/157 (41%), Gaps = 7/157 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   L   RH  +  L     T D    V EY   G L    H  +  +           
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA 112
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           +    L YLH      +V+RD+K  N++LD D   ++ DFG+ K   + G   +M    G
Sbjct: 113 EIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCG 167
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 82/323 (25%), Positives = 136/323 (42%), Gaps = 77/323 (23%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G  G+V++  L +GE+VAVK      S++ +S                  + E+   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF---SSRDEQSWFR---------------ETEIYNT 56
Query: 751 GKIRHKNIVKLWCC-CTTRDCKL---LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
             +RH NI+       T+R+      L+  Y  +GSL D L   +   L+     ++ V 
Sbjct: 57  VLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFL---QRQTLEPHLALRLAVS 113
Query: 807 AAEGLSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKV-------VDAS 854
           AA GL++LH +       P+I HRD KS N+L+  +    +AD G+A +       +D  
Sbjct: 114 AACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIG 173
Query: 855 GKPKSMSVIAGSCGYIAPEYA-YTLRVN-----EKSDIYSFGVVILELVTGRL------- 901
             P+      G+  Y+APE     +R +     + +DI++FG+V+ E+    +       
Sbjct: 174 NNPR-----VGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVED 228
Query: 902 ---------PVDPEFGEKDLVKWVCSTLDQKGVDHVL--DPKLDCCFKEEICKVLNIGLL 950
                    P DP F  +D+ K VC       + + L  DP L          +  +   
Sbjct: 229 YRPPFYDVVPNDPSF--EDMKKVVCVDQQTPTIPNRLAADPVLS--------GLAQMMRE 278
Query: 951 CTSPLPINRPAMRRVVKLLQEVG 973
           C  P P  R    R+ K LQ++ 
Sbjct: 279 CWYPNPSARLTALRIKKTLQKIS 301

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 62/262 (23%), Positives = 109/262 (41%), Gaps = 21/262 (8%)
Query: 714 KLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCK-- 771
           +LW+G  +  +    V K           F  E   L    H N++ +   C +      
Sbjct: 25  ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 772 LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN 831
            L+  +MP GSL ++LH     ++D     K  +D A G+++L H   P I    + S +
Sbjct: 85  TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL-HTLEPLIPRHALNSRS 143
Query: 832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS-DIYSFG 890
           +++D D  AR++   V     + G+  + + +A       PE       N +S D++SF 
Sbjct: 144 VMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPE-----DTNRRSADMWSFA 198
Query: 891 VVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLL 950
           V++ ELVT  +P        DL       +  K     L P +       + K++ I   
Sbjct: 199 VLLWELVTREVPF------ADLSNM---EIGMKVALEGLRPTIPPGISPHVSKLMKI--- 246
Query: 951 CTSPLPINRPAMRRVVKLLQEV 972
           C +  P  RP    +V +L+++
Sbjct: 247 CMNEDPAKRPKFDMIVPILEKM 268

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 14/174 (8%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY-K 802
           + EV  L +IRH NI+ L      +   +L+ E +  G L D L   +    D  T++ K
Sbjct: 56  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 115
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFG---ARVADFGVAKVVDASGKPK 858
            I+D   G+ YLH      I H D+K  NI LLD +      ++ DFG+A  ++A  + K
Sbjct: 116 QILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           +   I G+  ++APE      +  ++D++S GV+   L++G  P   E  ++ L
Sbjct: 170 N---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 220

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 691 IGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G    GKVYK  L         +AVA+K L     K+   G   E+           F+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-----KDKAEGPLREE-----------FR 60
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-----HSCKGGL----- 794
            E     +++H N+V L    T      +++ Y  +G L + L     HS  G       
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 795 ----LDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
               L+ P    ++   A G+ YL  HH     +VH+D+ + N+L+      +++D G+ 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           + V A+   K +        ++APE     + +  SDI+S+GVV+ E+ +        +G
Sbjct: 176 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--------YG 227
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
               ++  C   +Q  V+ + + ++  C  +    V  + + C +  P  RP  + +   
Sbjct: 228 ----LQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 969 LQEVG 973
           L+  G
Sbjct: 284 LRAWG 288

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 66/158 (41%), Gaps = 6/158 (3%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 116
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH +   ++V+RD+K  N++LD D   ++ DFG+ K     G   +M    
Sbjct: 117 AEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKXFC 172
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 14/174 (8%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY-K 802
           + EV  L +IRH NI+ L      +   +L+ E +  G L D L   +    D  T++ K
Sbjct: 63  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 122
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFG---ARVADFGVAKVVDASGKPK 858
            I+D   G+ YLH      I H D+K  NI LLD +      ++ DFG+A  ++A  + K
Sbjct: 123 QILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 176
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           +   I G+  ++APE      +  ++D++S GV+   L++G  P   E  ++ L
Sbjct: 177 N---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 61/113 (53%), Gaps = 21/113 (18%)
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSM 860
           KI V   + L +LH     S++HRDVK +N+L++     ++ DFG++  +VD+  K    
Sbjct: 157 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK---- 210
Query: 861 SVIAGSCGYIAPEYAYTLRVNE---------KSDIYSFGVVILELVTGRLPVD 904
           ++ AG   Y+APE     R+N          KSDI+S G+ ++EL   R P D
Sbjct: 211 TIDAGCKPYMAPE-----RINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 41/157 (26%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV  +   +H N+V+++      +   ++ E++  G+L D++   +       T  + ++
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL 151
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
            A   L+YLH      ++HRD+KS++ILL  D   +++DFG    + +   PK   ++ G
Sbjct: 152 QA---LAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKXLV-G 203
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  ++APE         + DI+S G++++E+V G  P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 69/166 (41%), Gaps = 6/166 (3%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   L   RH  +  L     T D    V EY   G L    H  +  +          
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG 115
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
            +    L YLH +   ++V+RD+K  N++LD D   ++ DFG+ K     G   +M    
Sbjct: 116 AEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKXFC 171
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
           G+  Y+APE           D +  GVV+ E++ GRLP   +  EK
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 85
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 146 LRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----DEMTGYVATR 197
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 94
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M     + 
Sbjct: 155 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMXGXVATR 206
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 25/212 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+ G VYK     +G  VA+K +             V  G            A +  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV------------RVPNGEEGLPISTVREVALLRR 59
Query: 750 LGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           L    H N+V+L   C T    R+ K+ LV+E++ +  L   L       L   T   ++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
                GL +LH +C   IVHRD+K  NIL+      ++ADFG+A++        +++ + 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVV 172
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
            +  Y APE           D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 691 IGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G+V+K+     G  +AVK++ R  +KE                       +++ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE----------------ENKRILMDLDV 76
Query: 750 LGKIRH-KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
           + K      IV+ +    T     +  E M  G+  + L     G +      K+ V   
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA-KVVDASGKPKSMSVIAGSC 867
           + L YL       ++HRDVK +NILLD     ++ DFG++ ++VD   K +S    AG  
Sbjct: 135 KALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCA 188
Query: 868 GYIAPEYA---------YTLRVNEKSDIYSFGVVILELVTGRLP 902
            Y+APE           Y +R    +D++S G+ ++EL TG+ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIR----ADVWSLGISLVELATGQFP 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 76
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 137 LRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-----DEMTGYVATR 188
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 113/244 (46%), Gaps = 32/244 (13%)
Query: 745 AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW------ 797
           +E+E +  I +HKNI+ L   CT      ++  Y   G+L + L + +   +++      
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 798 ----PTRYKIIVDA----AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                  +K +V      A G+ YL        +HRD+ + N+L+  +   ++ADFG+A+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
            ++     K  +       ++APE  +      +SD++SFGV++ E+ T G  P  P   
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
            ++L K     L ++G  H +D   +C    E+  ++     C   +P  RP  +++V+ 
Sbjct: 265 VEELFK-----LLKEG--HRMDKPANCT--NELYMMMRD---CWHAVPSQRPTFKQLVED 312
Query: 969 LQEV 972
           L  +
Sbjct: 313 LDRI 316

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 80
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 141 LRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-----DEMTGYVATR 192
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGG---------- 793
           +E   L ++ H +++KL+  C+     LL+ EY   GSL G L  S K G          
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 794 ---LLDWPTRYKIIV--------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
               LD P    + +          ++G+ YL       +VHRD+ + NIL+      ++
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +DFG+++ V         S       ++A E  +      +SD++SFGV++ E+VT
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 76
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 137 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 188
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGXVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 79
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 140 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 191
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 73
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 133
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 134 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 185
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 186 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 86
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 147 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 198
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 76
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 137 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 188
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 86
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 147 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 198
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 79
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 140 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 191
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 97
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 158 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 209
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 81
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 193
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 94
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 155 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 206
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 93
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 154 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 205
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G+ GKVYK        +A  K+    S+E                    +  E++ L
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE----------------ELEDYMVEIDIL 88
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA-E 809
               H NIVKL       +   ++ E+   G++  ++   +  L +  ++ +++     +
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE--SQIQVVCKQTLD 146
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
            L+YLH +    I+HRD+K+ NIL   D   ++ADFGV+     +   +      G+  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYW 201
Query: 870 IAPEYAYTLRVNE-----KSDIYSFGVVILELVTGRLP 902
           +APE        +     K+D++S G+ ++E+     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 76
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 137 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 188
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 71
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 132 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 183
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 80
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 141 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 192
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 70
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 182
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 85
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 146 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 197
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 72
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 132
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 133 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 184
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 71
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 132 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 183
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 41/120 (34%), Positives = 58/120 (48%), Gaps = 35/120 (29%)
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG--------VAKVVDA 853
           KI V   + L +LH     S++HRDVK +N+L++     ++ DFG        VAK +DA
Sbjct: 113 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNE---------KSDIYSFGVVILELVTGRLPVD 904
             KP           Y+APE     R+N          KSDI+S G+ ++EL   R P D
Sbjct: 171 GCKP-----------YMAPE-----RINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 47/241 (19%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLL-----HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
             ++     H     LL     Y+++V    G+ +LH      I+HRD+K +NI++  D 
Sbjct: 116 SQVIQMELDHERMSYLL-----YQMLV----GIKHLHS---AGIIHRDLKPSNIVVKSDA 163
Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             ++ DFG+A+    +G    M+    +  Y APE    +   E  DI+S GV++ E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIK 220
Query: 899 G 899
           G
Sbjct: 221 G 221

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+ G VYK     +G  VA+K +             V  G            A +  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV------------RVPNGEEGLPISTVREVALLRR 59
Query: 750 LGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           L    H N+V+L   C T    R+ K+ LV+E++ +  L   L       L   T   ++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
                GL +LH +C   IVHRD+K  NIL+      ++ADFG+A++        ++  + 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVV 172
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
            +  Y APE           D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 80
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+    + 
Sbjct: 141 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATR 192
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 115/267 (43%), Gaps = 61/267 (22%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G  G+V++     GE VAVK       K      ++            GF A   T 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT- 102
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
              RH +  +LW          L+  Y   GSL D L       LD  +  +I++  A G
Sbjct: 103 --SRHSS-TQLW----------LITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASG 146
Query: 811 LSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKV-------VDASGKPK 858
           L++LH +       P+I HRD+KS NIL+  +    +AD G+A +       +D    P+
Sbjct: 147 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 206
Query: 859 SMSVIAGSCGYIAPEYA-YTLRVN-----EKSDIYSFGVVILELVTGR------------ 900
                 G+  Y+APE    T++V+     ++ DI++FG+V+ E+                
Sbjct: 207 -----VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 261
Query: 901 ----LPVDPEFGEKDLVKWVCSTLDQK 923
               +P DP F  +D+ K VC  +DQ+
Sbjct: 262 FYDVVPNDPSF--EDMRKVVC--VDQQ 284

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 90/222 (40%), Gaps = 33/222 (14%)
Query: 691 IGSGSSG--KVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IGSG+ G  ++ +   SN E VAVK + RG   +                     + E+ 
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERGEKID------------------ENVKREII 67
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
               +RH NIV+      T     +V EY   G L + +  C  G               
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 125
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR--VADFGVAKVVDASGKPKSMSVIAGS 866
            G+SY H      + HRD+K  N LLDG    R  +  FG +K      +PK      G+
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VGT 179
Query: 867 CGYIAPEYAYTLRVNEK-SDIYSFGVVILELVTGRLPV-DPE 906
             YIAPE       + K +D++S GV +  ++ G  P  DPE
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 27/169 (15%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCC--TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
           FQ E++ L  +    IVK         R    LV EY+P+G L D L            R
Sbjct: 55  FQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQ-----------R 103
Query: 801 YKIIVDAAEGLSYLHHDC-------VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           ++  +DA+  L Y    C           VHRD+ + NIL++ +   ++ADFG+AK++  
Sbjct: 104 HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 163
Query: 854 SGKPKSMSVI----AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               K   V+         + APE       + +SD++SFGVV+ EL T
Sbjct: 164 D---KDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 47/241 (19%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLL-----HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
             ++     H     LL     Y+++V    G+ +LH      I+HRD+K +NI++  D 
Sbjct: 116 SQVIQMELDHERMSYLL-----YQMLV----GIKHLHS---AGIIHRDLKPSNIVVKSDA 163
Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             ++ DFG+A+    +G    M+    +  Y APE    +   E  DI+S GV++ E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIK 220
Query: 899 G 899
           G
Sbjct: 221 G 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 25/176 (14%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGG---------- 793
           +E   L ++ H +++KL+  C+     LL+ EY   GSL G L  S K G          
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 794 ---LLDWPTRYKIIV--------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
               LD P    + +          ++G+ YL       +VHRD+ + NIL+      ++
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +DFG+++ V         S       ++A E  +      +SD++SFGV++ E+VT
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 124 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 180
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 181 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 238
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 239 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLK 284
Query: 971 E 971
           +
Sbjct: 285 D 285

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G+ GKVYK        +A  K+    S+E                    +  E++ L
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE----------------ELEDYMVEIDIL 88
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA-E 809
               H NIVKL       +   ++ E+   G++  ++   +  L +  ++ +++     +
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE--SQIQVVCKQTLD 146
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
            L+YLH +    I+HRD+K+ NIL   D   ++ADFGV+     +   +      G+  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYW 201
Query: 870 IAPEYAYTLRVNE-----KSDIYSFGVVILELVTGRLP 902
           +APE        +     K+D++S G+ ++E+     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    IG+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EYMP G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +VADFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G+ GKVYK        +A  K+    S+E                    +  E++ L
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE----------------ELEDYMVEIDIL 88
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA-E 809
               H NIVKL       +   ++ E+   G++  ++   +  L +  ++ +++     +
Sbjct: 89  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE--SQIQVVCKQTLD 146
Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGY 869
            L+YLH +    I+HRD+K+ NIL   D   ++ADFGV+     +   +      G+  +
Sbjct: 147 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYW 201
Query: 870 IAPEYAYTLRVNE-----KSDIYSFGVVILELVTGRLP 902
           +APE        +     K+D++S G+ ++E+     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 97
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M     + 
Sbjct: 158 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMXGYVATR 209
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    IG+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EYMP G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +VADFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+ +  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 241
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 242 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLK 287
Query: 971 E 971
           +
Sbjct: 288 D 288

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 115/267 (43%), Gaps = 61/267 (22%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G  G+V++     GE VAVK       K      ++            GF A   T 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT- 73
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
              RH +  +LW          L+  Y   GSL D L       LD  +  +I++  A G
Sbjct: 74  --SRHSS-TQLW----------LITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASG 117
Query: 811 LSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKV-------VDASGKPK 858
           L++LH +       P+I HRD+KS NIL+  +    +AD G+A +       +D    P+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 859 SMSVIAGSCGYIAPEYA-YTLRVN-----EKSDIYSFGVVILELVTGR------------ 900
                 G+  Y+APE    T++V+     ++ DI++FG+V+ E+                
Sbjct: 178 -----VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 901 ----LPVDPEFGEKDLVKWVCSTLDQK 923
               +P DP F  +D+ K VC  +DQ+
Sbjct: 233 FYDVVPNDPSF--EDMRKVVC--VDQQ 255

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 116/267 (43%), Gaps = 61/267 (22%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           +G G  G+V++     GE VAVK       K      ++            GF A   T 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT- 73
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
              RH +  +LW          L+  Y   GSL D L   +   LD  +  +I++  A G
Sbjct: 74  --SRHSS-TQLW----------LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 811 LSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKV-------VDASGKPK 858
           L++LH +       P+I HRD+KS NIL+  +    +AD G+A +       +D    P+
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 859 SMSVIAGSCGYIAPEYA-YTLRVN-----EKSDIYSFGVVILELVTGR------------ 900
                 G+  Y+APE    T++V+     ++ DI++FG+V+ E+                
Sbjct: 178 -----VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 901 ----LPVDPEFGEKDLVKWVCSTLDQK 923
               +P DP F  +D+ K VC  +DQ+
Sbjct: 233 FYDVVPNDPSF--EDMRKVVC--VDQQ 255

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 72  R---------------ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 XQVIQME----LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG G+ G VYK     +G  VA+K +             V  G            A +  
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV------------RVPNGEEGLPISTVREVALLRR 59
Query: 750 LGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           L    H N+V+L   C T    R+ K+ LV+E++ +  L   L       L   T   ++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
                GL +LH +C   IVHRD+K  NIL+      ++ADFG+A++        ++  + 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVV 172
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
            +  Y APE           D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRY 801
           +AE+E L  + H NI+K++          +V E    G L + + S   +G  L      
Sbjct: 68  EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG---ARVADFGVAKVVDASGKPK 858
           +++      L+Y H      +VH+D+K  NIL          ++ DFG+A++  +    +
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---E 181
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             +  AG+  Y+APE  +   V  K DI+S GVV+  L+TG LP
Sbjct: 182 HSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXET 183
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 184 DXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 241
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 242 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPNMRPTFLEIVNLLK 287
Query: 971 E 971
           +
Sbjct: 288 D 288

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 50/248 (20%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII---------- 804
           H NIV L   CT     L++ EY   G L + L   +   +   T   I+          
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 805 ------VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                    A+G+++L      + +HRD+ + NILL      ++ DFG+A+ +    K  
Sbjct: 169 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHI----KND 221
Query: 859 SMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVT------GRLPVDPEFG 908
           S  V+ G+      ++APE  +      +SD++S+G+ + EL +        +PVD +F 
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 281
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
           +          + ++G   +L P      +    ++ +I   C    P+ RP  +++V+L
Sbjct: 282 K----------MIKEGF-RMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 324
Query: 969 LQEVGAEN 976
           +++  +E+
Sbjct: 325 IEKQISES 332

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 58
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 59  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 111
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 112 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 166 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 50/248 (20%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII---------- 804
           H NIV L   CT     L++ EY   G L + L   +   +   T   I+          
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 805 ------VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                    A+G+++L      + +HRD+ + NILL      ++ DFG+A+ +    K  
Sbjct: 164 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI----KND 216
Query: 859 SMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVT------GRLPVDPEFG 908
           S  V+ G+      ++APE  +      +SD++S+G+ + EL +        +PVD +F 
Sbjct: 217 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 276
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
           +          + ++G   +L P      +    ++ +I   C    P+ RP  +++V+L
Sbjct: 277 K----------MIKEGF-RMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 319
Query: 969 LQEVGAEN 976
           +++  +E+
Sbjct: 320 IEKQISES 327

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 50/248 (20%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII---------- 804
           H NIV L   CT     L++ EY   G L + L   +   +   T   I+          
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 805 ------VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                    A+G+++L      + +HRD+ + NILL      ++ DFG+A+ +    K  
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI----KND 198
Query: 859 SMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVT------GRLPVDPEFG 908
           S  V+ G+      ++APE  +      +SD++S+G+ + EL +        +PVD +F 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
           +          + ++G   +L P      +    ++ +I   C    P+ RP  +++V+L
Sbjct: 259 K----------MIKEGF-RMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 969 LQEVGAEN 976
           +++  +E+
Sbjct: 302 IEKQISES 309

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 50/248 (20%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII---------- 804
           H NIV L   CT     L++ EY   G L + L   +   +   T   I+          
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 805 ------VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                    A+G+++L      + +HRD+ + NILL      ++ DFG+A+ +    K  
Sbjct: 162 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI----KND 214
Query: 859 SMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVT------GRLPVDPEFG 908
           S  V+ G+      ++APE  +      +SD++S+G+ + EL +        +PVD +F 
Sbjct: 215 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 274
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
           +          + ++G   +L P      +    ++ +I   C    P+ RP  +++V+L
Sbjct: 275 K----------MIKEGF-RMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 317
Query: 969 LQEVGAEN 976
           +++  +E+
Sbjct: 318 IEKQISES 325

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 58
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 59  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 111
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 112 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 166 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ D+G+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 50/248 (20%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII---------- 804
           H NIV L   CT     L++ EY   G L + L   +   +   T   I+          
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 805 ------VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
                    A+G+++L      + +HRD+ + NILL      ++ DFG+A+ +    K  
Sbjct: 169 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI----KND 221
Query: 859 SMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVT------GRLPVDPEFG 908
           S  V+ G+      ++APE  +      +SD++S+G+ + EL +        +PVD +F 
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 281
Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
           +          + ++G   +L P      +    ++ +I   C    P+ RP  +++V+L
Sbjct: 282 K----------MIKEGF-RMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 324
Query: 969 LQEVGAEN 976
           +++  +E+
Sbjct: 325 IEKQISES 332

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 132/319 (41%), Gaps = 62/319 (19%)
Query: 689 NVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
             +G+G+ GKV +      G+  AV K+   M K      + E              +E+
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-----------ALMSEL 85
Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD---------- 796
           + +  + +H+NIV L   CT     L++ EY   G L + L      +L           
Sbjct: 86  KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPE 145
Query: 797 -------WPTRYKIIV----DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
                   P   + ++      A+G+++L      + +HRDV + N+LL     A++ DF
Sbjct: 146 GLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 846 GVAKVVDASGKPKSMSVIAGSC----GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           G+A+ +       S  ++ G+      ++APE  +      +SD++S+G+++ E+ +  L
Sbjct: 203 GLARDI----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--L 256
Query: 902 PVDPEFGEKDLVKWVCSTLDQKGVDH---VLDPKLDCCFKEEICKVLNIGLLCTSPLPIN 958
            ++P  G   LV      L + G         PK           + +I   C +  P +
Sbjct: 257 GLNPYPG--ILVNSKFYKLVKDGYQMAQPAFAPK----------NIYSIMQACWALEPTH 304
Query: 959 RPAMRRVVKLLQEVGAENR 977
           RP  +++   LQE   E+R
Sbjct: 305 RPTFQQICSFLQEQAQEDR 323

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 46/233 (19%)
Query: 684 GLD--EDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           G+D  E  +IGSG  G+V+K     +G+   +K++     K                   
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA------------------ 51
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRD----------------CKLLVYEYMPNGSLG 784
              + EV+ L K+ H NIV    C    D                C  +  E+   G+L 
Sbjct: 52  ---EREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 785 DLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
             +   +G  LD     ++     +G+ Y+H      +++RD+K +NI L      ++ D
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGD 165
Query: 845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
           FG+   +   GK        G+  Y++PE   +    ++ D+Y+ G+++ EL+
Sbjct: 166 FGLVTSLKNDGKRXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+  L KI+H+NIV L     +     LV + +  G L D +   + G+        +I 
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQ 113
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSV 862
                + YLH +    IVHRD+K  N+L    + +    + DFG++K+ + +G    MS 
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNG---IMST 166
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
             G+ GY+APE       ++  D +S GV+   L+ G  P   E
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           A +  L    H N+V+L   C T    R+ K+ LV+E++ +  L   L       L   T
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAET 121
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
              ++     GL +LH +C   IVHRD+K  NIL+      ++ADFG+A++        +
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MA 175
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
           ++ +  +  Y APE           D++S G +  E+
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           + ++G G  G+VY+ V +N  GE + V        K C+  C ++            F +
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVA------VKTCKKDCTLDNKEK--------FMS 74
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   +  + H +IVKL       +   ++ E  P G LG  L   K  L    T     +
Sbjct: 75  EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSL-KVLTLVLYSL 132
Query: 806 DAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
              + ++YL   +CV    HRD+   NIL+      ++ DFG+++ ++     K+ SV  
Sbjct: 133 QICKAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA-SVTR 187
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG 924
               +++PE     R    SD++ F V + E+++        FG++    W    L+ K 
Sbjct: 188 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFF-W----LENKD 234
Query: 925 VDHVLDPKLDCCFKEEICKVLNIGLL--CTSPLPINRPAMRRVVKLLQEV 972
           V  VL+ K D   K ++C  +   L+  C    P +RP    +V  L +V
Sbjct: 235 VIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DF +A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 183
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 184 AYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 241
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 242 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLK 287
Query: 971 E 971
           +
Sbjct: 288 D 288

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 19/136 (13%)
Query: 786 LLHSCKGGLLDW---PTRYKIIVD-------AAEGLSYLHHDCVPSIVHRDVKSNNILLD 835
           L + C G LL +   P R   + D        A G+ YL        VHRD+ + N +LD
Sbjct: 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLD 158
Query: 836 GDFGARVADFGVAK-VVDASGKPKSMSVIAG-SCGYIAPEYAYTLRVNEKSDIYSFGVVI 893
             F  +VADFG+A+ ++D           A     + A E   T R   KSD++SFGV++
Sbjct: 159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218
Query: 894 LELVTGRLP----VDP 905
            EL+T   P    +DP
Sbjct: 219 WELLTRGAPPYRHIDP 234

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +G + +                       
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---------------------NR 62
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 121
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 122 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 177
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 178 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 224

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +  +     L  
Sbjct: 60  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 119
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 120 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 176
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 8/165 (4%)
Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           + E++ L ++RHKN+++L       + +   +V EY   G + ++L S           +
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAH 112
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
                  +GL YLH      IVH+D+K  N+LL      +++  GVA+ +       +  
Sbjct: 113 GYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 862 VIAGSCGYIAPEYAYTLRVNE--KSDIYSFGVVILELVTGRLPVD 904
              GS  +  PE A  L      K DI+S GV +  + TG  P +
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +G + +                       
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---------------------NR 62
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 121
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 122 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 177
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 178 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 224

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 81
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+          M+    + 
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATR 193
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 81
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+          M+    + 
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATR 193
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           EV  L  ++H NIV L     T     LV+EY+ +  L   L  C G +++       + 
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNIINMHNVKLFLF 107
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL+Y H      ++HRD+K  N+L++     ++ADFG+A+      K     V+  
Sbjct: 108 QLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-- 162
Query: 866 SCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           +  Y  P+    +   + + D++  G +  E+ TGR P+ P
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFP 202

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           + ++G G  G+VY+ V +N  GE + V        K C+  C ++            F +
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVA------VKTCKKDCTLDNKEK--------FMS 62
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   +  + H +IVKL       +   ++ E  P G LG  L   K  L    T     +
Sbjct: 63  EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSL-KVLTLVLYSL 120
Query: 806 DAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
              + ++YL   +CV    HRD+   NIL+      ++ DFG+++ ++     K+ SV  
Sbjct: 121 QICKAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA-SVTR 175
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG 924
               +++PE     R    SD++ F V + E+++        FG++    W    L+ K 
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFF-W----LENKD 222
Query: 925 VDHVLDPKLDCCFKEEICKVLNIGLL--CTSPLPINRPAMRRVVKLLQEV 972
           V  VL+ K D   K ++C  +   L+  C    P +RP    +V  L +V
Sbjct: 223 VIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 40/290 (13%)
Query: 688 DNVIGSGSSGKVYKVVLSN--GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           + ++G G  G+VY+ V +N  GE + V        K C+  C ++            F +
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVA------VKTCKKDCTLDNKE--------KFMS 58
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   +  + H +IVKL       +   ++ E  P G LG  L   K  L    T     +
Sbjct: 59  EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSL-KVLTLVLYSL 116
Query: 806 DAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
              + ++YL   +CV    HRD+   NIL+      ++ DFG+++ ++     K+ SV  
Sbjct: 117 QICKAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA-SVTR 171
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG 924
               +++PE     R    SD++ F V + E+++        FG++    W    L+ K 
Sbjct: 172 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS--------FGKQPFF-W----LENKD 218
Query: 925 VDHVLDPKLDCCFKEEICKVLNIGLL--CTSPLPINRPAMRRVVKLLQEV 972
           V  VL+ K D   K ++C  +   L+  C    P +RP    +V  L +V
Sbjct: 219 VIGVLE-KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 108/242 (44%), Gaps = 46/242 (19%)
Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
            VIG+GS G V++  L   + VA+KK+ +    +                       E++
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK---------------------NRELQ 84
Query: 749 TLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCK-----GGLLDW 797
            +  ++H N+V L     +   K       LV EY+P        H  K       LL  
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK 144
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
              Y+++      L+Y+H      I HRD+K  N+LLD   G  ++ DFG AK++ A G+
Sbjct: 145 LYMYQLL----RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-GE 196
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP-EFGEKDLVK 914
           P ++S I  S  Y APE  +         DI+S G V+ EL+ G+ P+ P E G   LV+
Sbjct: 197 P-NVSXIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVE 253
Query: 915 WV 916
            +
Sbjct: 254 II 255

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 81
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+          M+    + 
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATR 193
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG G+ G V+K    N E   +  L R    + + G                   E+  L
Sbjct: 10  IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGV------------PSSALREICLL 55
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            +++HKNIV+L     +     LV+E+  +  L     SC G L D       +    +G
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDL-DPEIVKSFLFQLLKG 113
Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           L + H     +++HRD+K  N+L++ +   ++ADFG+A+      +  S  V+  +  Y 
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYR 168
Query: 871 APEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
            P+  +  ++   S D++S G +  EL     P+ P
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 64
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 65  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 108
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 109 XQVIQME----LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 161
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 162 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 691 IGSGSSGKVYKV--VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IG G+ GKV+K   + + G  VA+K++        ++G   E+G              +E
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV------RVQTG---EEGMPLSTIREVAVLRHLE 69
Query: 749 TLGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           T     H N+V+L+  CT     R+ KL LV+E++ +  L   L       +   T   +
Sbjct: 70  TF---EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 125
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +     GL +LH      +VHRD+K  NIL+      ++ADFG+A++        +++ +
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
             +  Y APE           D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 691 IGSGSSGKVYKV--VLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           IG G+ GKV+K   + + G  VA+K++        ++G   E+G              +E
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV------RVQTG---EEGMPLSTIREVAVLRHLE 69
Query: 749 TLGKIRHKNIVKLWCCCTT----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           T     H N+V+L+  CT     R+ KL LV+E++ +  L   L       +   T   +
Sbjct: 70  TF---EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 125
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +     GL +LH      +VHRD+K  NIL+      ++ADFG+A++        +++ +
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
             +  Y APE           D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 183
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 241
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 242 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLK 287
Query: 971 E 971
           +
Sbjct: 288 D 288

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---- 59
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 60  -------DIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAK 849
            +  T + K I++   G+ YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 113 EEEATEFLKQILN---GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 KIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +G + +                       
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---------------------NR 62
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQ-TLPV 121
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 122 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 177
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 178 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 224

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 XQVIQME----LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 13/162 (8%)
Query: 746 EVETLGKIRHKNIVKLWCCCT--TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
           E+  L K+ H N+VKL         D   +V+E +  G + ++  + K    D    Y  
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQARFY-- 142
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
             D  +G+ YLH+     I+HRD+K +N+L+  D   ++ADFGV+   +  G    +S  
Sbjct: 143 FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN--EFKGSDALLSNT 197
Query: 864 AGSCGYIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLP 902
            G+  ++APE     R     +  D+++ GV +   V G+ P
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 66  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 125
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 126 PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 182
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 183 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 240
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 241 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLK 286
Query: 971 E 971
           +
Sbjct: 287 D 287

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    IG+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +VADFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 41/120 (34%), Positives = 55/120 (45%), Gaps = 35/120 (29%)
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG--------VAKVVDA 853
           KI V   + L +LH     S++HRDVK +N+L++     +  DFG        VAK +DA
Sbjct: 140 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNE---------KSDIYSFGVVILELVTGRLPVD 904
             KP           Y APE     R+N          KSDI+S G+  +EL   R P D
Sbjct: 198 GCKP-----------YXAPE-----RINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 72  R---------------ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 XQVIQME----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 87/217 (40%), Gaps = 27/217 (12%)
Query: 690 VIGSGSSGKVYKVVLSNGEAV--AVKKLWRG--MSKECESGCDVEKGXXXXXXXXXGFQA 745
           VIG GS GKV  +     E V  AVK L +   + K+ E     E+              
Sbjct: 45  VIGKGSFGKVL-LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL----------- 92
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
               L  ++H  +V L     T D    V +Y+  G L    H  +      P       
Sbjct: 93  ----LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAA 146
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
           + A  L YLH     +IV+RD+K  NILLD      + DFG+ K  +      + S   G
Sbjct: 147 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCG 201
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y+APE  +    +   D +  G V+ E++ G  P
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++  FG+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 47/241 (19%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLL-----HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
             ++     H     LL     Y+++V    G+ +LH      I+HRD+K +NI++  D 
Sbjct: 116 SQVIQMELDHERMSYLL-----YQMLV----GIKHLHS---AGIIHRDLKPSNIVVKSDA 163
Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
             ++ DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ 
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 899 G 899
           G
Sbjct: 221 G 221

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F + ++ D  D    +GSG    V K    S G   A K + +  S+    G   E+   
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE--- 61
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L ++ H NI+ L      R   +L+ E +  G L D L   +   
Sbjct: 62  --------IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAKV 850
            +  T +  I    +G++YLH      I H D+K  NI LLD +      ++ DFG+A  
Sbjct: 114 EEEATSF--IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 169 IEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E +  GSLG L+     G L        +  A EGL YLH      I+H DVK++N+
Sbjct: 141 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 195
Query: 833 LLDGDFGARVA--DFGVAKVVDASGKPKSM---SVIAGSCGYIAPEYAYTLRVNEKSDIY 887
           LL  D G+R A  DFG A  +   G  KS+     I G+  ++APE       + K DI+
Sbjct: 196 LLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 254
Query: 888 SFGVVILELVTGRLPVDPEF 907
           S   ++L ++ G  P    F
Sbjct: 255 SSCCMMLHMLNGCHPWTQYF 274

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 100/226 (44%), Gaps = 27/226 (11%)
Query: 680 EILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXX 738
            +LD  D    +G+G+ G V++V   + G   A K +      + E+             
Sbjct: 48  HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET------------- 94
Query: 739 XXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                + E++T+  +RH  +V L       +  +++YE+M  G L + + + +   +   
Sbjct: 95  ----VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSED 149
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA--RVADFGVAKVVDASGK 856
              + +    +GL ++H +   + VH D+K  NI+         ++ DFG+   +D    
Sbjct: 150 EAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 204
Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +S+ V  G+  + APE A    V   +D++S GV+   L++G  P
Sbjct: 205 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ D G+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 38/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG--MSKECESGCDVE 730
           ++   +YE++       VIG G+ G+V  V   +   V   KL     M K  +S     
Sbjct: 70  RMKAEDYEVV------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--- 120
Query: 731 KGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
                       F  E + +       +V+L+          +V EYMP G L +L+ + 
Sbjct: 121 ------------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN- 167
Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI--VHRDVKSNNILLDGDFGARVADFGVA 848
                D P ++     A   L+    D + S+  +HRDVK +N+LLD     ++ADFG  
Sbjct: 168 ----YDVPEKWARFYTAEVVLAL---DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 220
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLP 902
             ++  G  +  + + G+  YI+PE   +         + D +S GV + E++ G  P
Sbjct: 221 MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++  S + +L    +   IGSG+ G V   +  VL  G  VAVKKL R    +  +    
Sbjct: 12  QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY 69
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  L  + HKNI+ L    T +          LV E M + +L
Sbjct: 70  R---------------ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 113
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++H      LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 114 CQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 166
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +     M+    +  Y APE    +   E  DI+S G ++ ELV G
Sbjct: 167 DFGLARTASTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 11/140 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E +  GSLG L+   + G L        +  A EGL YLH      I+H DVK++N+
Sbjct: 127 IFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 181
Query: 833 LLDGDFGARVA--DFGVAKVVDASGKPKSM---SVIAGSCGYIAPEYAYTLRVNEKSDIY 887
           LL  D G+R A  DFG A  +   G  KS+     I G+  ++APE       + K DI+
Sbjct: 182 LLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240
Query: 888 SFGVVILELVTGRLPVDPEF 907
           S   ++L ++ G  P    F
Sbjct: 241 SSCCMMLHMLNGCHPWTQYF 260

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 691 IGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           +GSG+ G V   Y   L   + VAVKKL    S+  +S     +              E+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKL----SRPFQSLIHARRTYR-----------EL 78
Query: 748 ETLGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIV 805
             L  ++H+N++ L    T     +     Y+    +G DL +  K   L       ++ 
Sbjct: 79  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVY 138
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL Y+H      I+HRD+K +N+ ++ D   R+ DFG+A+  D     + M+    
Sbjct: 139 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQAD-----EEMTGYVA 190
Query: 866 SCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
           +  Y APE     +  N+  DI+S G ++ EL+ G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 26/175 (14%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-KGGLLDW------- 797
           EV+ L K+ H  IV+ +     ++    +    P   L   +  C K  L DW       
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 798 PTRYK-----IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             R +     I +  AE + +LH      ++HRD+K +NI    D   +V DFG+   +D
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 853 ASGKPKS----MSVIAGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELV 897
              + ++    M   A   G      Y++PE  +    + K DI+S G+++ EL+
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 99/225 (44%), Gaps = 27/225 (12%)
Query: 681 ILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXX 739
           +LD  D    +G+G+ G V++V   + G   A K +      + E+              
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-------------- 200
Query: 740 XXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
               + E++T+  +RH  +V L       +  +++YE+M  G L + +      + +   
Sbjct: 201 ---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-DE 256
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA--RVADFGVAKVVDASGKP 857
             + +    +GL ++H +   + VH D+K  NI+         ++ DFG+   +D     
Sbjct: 257 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 310
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +S+ V  G+  + APE A    V   +D++S GV+   L++G  P
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ D G+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 38/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG--MSKECESGCDVE 730
           ++   +YE++       VIG G+ G+V  V   +   V   KL     M K  +S     
Sbjct: 65  RMKAEDYEVV------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--- 115
Query: 731 KGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
                       F  E + +       +V+L+          +V EYMP G L +L+ + 
Sbjct: 116 ------------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN- 162
Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI--VHRDVKSNNILLDGDFGARVADFGVA 848
                D P ++     A   L+    D + S+  +HRDVK +N+LLD     ++ADFG  
Sbjct: 163 ----YDVPEKWARFYTAEVVLAL---DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLP 902
             ++  G  +  + + G+  YI+PE   +         + D +S GV + E++ G  P
Sbjct: 216 MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 691 IGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           +GSG+ G V   Y V   +G  +AVKKL    S+  +S    ++              E+
Sbjct: 59  VGSGAYGSVCSSYDV--KSGLKIAVKKL----SRPFQSIIHAKRTYR-----------EL 101
Query: 748 ETLGKIRHKNIVKLWCCCTTRDC-----KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
             L  ++H+N++ L    T          + +  ++    L +++   K  L D   ++ 
Sbjct: 102 RLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQF- 158
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           +I     GL Y+H      I+HRD+K +N+ ++ D   ++ DFG+A+  D       M+ 
Sbjct: 159 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTG 210
Query: 863 IAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
              +  Y APE     +  N   DI+S G ++ EL+TGR
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E +  GSLG L+     G L        +  A EGL YLH      I+H DVK++N+
Sbjct: 143 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 197
Query: 833 LLDGDFGARVA--DFGVAKVVDASGKPKSM---SVIAGSCGYIAPEYAYTLRVNEKSDIY 887
           LL  D G+R A  DFG A  +   G  KS+     I G+  ++APE       + K DI+
Sbjct: 198 LLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 256
Query: 888 SFGVVILELVTGRLPVDPEF 907
           S   ++L ++ G  P    F
Sbjct: 257 SSCCMMLHMLNGCHPWTQYF 276

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 72  R---------------ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-----CKNCTSDSVREK- 57
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 58  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKF 106
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 107 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 163 DSTXXKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 689 NVIGSGSSGKVYKVVLSNG--EAVAVK-----KLWRGMSKECESGCDVEKGXXXXXXXXX 741
             +GSG+ G+V K+       + VA+K     K   G ++E +   +VE           
Sbjct: 16  KTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE----------- 63
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E+E L K+ H  I+K+       D   +V E M  G L D +   K   L   T  
Sbjct: 64  ---TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCK 117
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
                    + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+  
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 171
Query: 859 SMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLP 902
            M  + G+  Y+APE      T   N   D +S GV++   ++G  P
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +  +     L  
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 178
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 38/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG--MSKECESGCDVE 730
           ++   +YE++       VIG G+ G+V  V   +   V   KL     M K  +S     
Sbjct: 70  RMKAEDYEVV------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--- 120
Query: 731 KGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
                       F  E + +       +V+L+          +V EYMP G L +L+ + 
Sbjct: 121 ------------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN- 167
Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI--VHRDVKSNNILLDGDFGARVADFGVA 848
                D P ++     A   L+    D + S+  +HRDVK +N+LLD     ++ADFG  
Sbjct: 168 ----YDVPEKWARFYTAEVVLAL---DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 220
Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTL----RVNEKSDIYSFGVVILELVTGRLP 902
             ++  G  +  + + G+  YI+PE   +         + D +S GV + E++ G  P
Sbjct: 221 MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 62
Query: 746 EVETLGKIRHKNIVKL-WCCCTTRDCKLLVY-----EYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L +   ++ + K +VY     +Y+P        H  +      P 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 121
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 122 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 177
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 178 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 224

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 689 NVIGSGSSGKVYKVVLSNG--EAVAVK-----KLWRGMSKECESGCDVEKGXXXXXXXXX 741
             +GSG+ G+V K+       + VA+K     K   G ++E +   +VE           
Sbjct: 22  KTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE----------- 69
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E+E L K+ H  I+K+       D   +V E M  G L D +   K   L   T  
Sbjct: 70  ---TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCK 123
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
                    + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+  
Sbjct: 124 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 177
Query: 859 SMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLP 902
            M  + G+  Y+APE      T   N   D +S GV++   ++G  P
Sbjct: 178 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 56/276 (20%)
Query: 671 FHKLGFSEYEI-------LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKEC 723
           +  + F EYE         + L+   V+GSG+ GKV      N  A  + K   G+S + 
Sbjct: 26  YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV-----MNATAYGISK--TGVSIQV 78
Query: 724 ESGCDVEKGXXXXXXXXXGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGS 782
                 EK             +E++ + ++  H+NIV L   CT      L++EY   G 
Sbjct: 79  AVKMLKEKADSSERE---ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 783 LGDLLHSCKGGLLDWPTRYK---------------------IIVDAAEGLSYLHHDCVPS 821
           L + L S +    +    Y+                          A+G+ +L      S
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 192
Query: 822 IVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC----GYIAPEYAYT 877
            VHRD+ + N+L+      ++ DFG+A+ + +     S  V+ G+      ++APE  + 
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD----SNYVVRGNARLPVKWMAPESLFE 248
Query: 878 LRVNEKSDIYSFGVVILELVT------GRLPVDPEF 907
                KSD++S+G+++ E+ +        +PVD  F
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 689 NVIGSGSSGKVYKVVLSNG--EAVAVK-----KLWRGMSKECESGCDVEKGXXXXXXXXX 741
             +GSG+ G+V K+       + VA+K     K   G ++E +   +VE           
Sbjct: 16  KTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE----------- 63
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E+E L K+ H  I+K+       D   +V E M  G L D +   K   L   T  
Sbjct: 64  ---TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCK 117
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
                    + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+  
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 171
Query: 859 SMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLP 902
            M  + G+  Y+APE      T   N   D +S GV++   ++G  P
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 55/232 (23%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG G  G+V++     GE VAVK      S+E  S                  +AE+   
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFR---------------EAEIYQT 90
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL----HSCKGGLLDWPTRYKIIVD 806
             +RH+NI+             +  +   NG+   L     +   G L D+  RY + V+
Sbjct: 91  VMLRHENILGF-----------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 139
Query: 807 --------AAEGLSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
                    A GL++LH + V     P+I HRD+KS NIL+  +    +AD G+A   D+
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 854 SGKPKSMS--VIAGSCGYIAPEY------AYTLRVNEKSDIYSFGVVILELV 897
           +     ++     G+  Y+APE              +++DIY+ G+V  E+ 
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +GSG+ G V        G  VAVKKL    S+  +S    ++              E+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYR-----------ELRL 74
Query: 750 LGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIVDA 807
           L  ++H+N++ L    T  R  +     Y+    +G DL +  K   L       +I   
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
             GL Y+H      I+HRD+K +N+ ++ D   ++ D G+A+  D       M+    + 
Sbjct: 135 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTD-----DEMTGYVATR 186
Query: 868 GYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
            Y APE     +  N+  DI+S G ++ EL+TGR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 55/232 (23%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG G  G+V++     GE VAVK      S+E  S                  +AE+   
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFR---------------EAEIYQT 77
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL----HSCKGGLLDWPTRYKIIVD 806
             +RH+NI+             +  +   NG+   L     +   G L D+  RY + V+
Sbjct: 78  VMLRHENILGF-----------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE 126
Query: 807 --------AAEGLSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
                    A GL++LH + V     P+I HRD+KS NIL+  +    +AD G+A   D+
Sbjct: 127 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 186
Query: 854 SGKPKSMS--VIAGSCGYIAPEY------AYTLRVNEKSDIYSFGVVILELV 897
           +     ++     G+  Y+APE              +++DIY+ G+V  E+ 
Sbjct: 187 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 689 NVIGSGSSGKVYKVVLSNG--EAVAVK-----KLWRGMSKECESGCDVEKGXXXXXXXXX 741
             +GSG+ G+V K+       + VA+K     K   G ++E +   +VE           
Sbjct: 15  KTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE----------- 62
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E+E L K+ H  I+K+       D   +V E M  G L D +   K   L   T  
Sbjct: 63  ---TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCK 116
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
                    + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+  
Sbjct: 117 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 170
Query: 859 SMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLP 902
            M  + G+  Y+APE      T   N   D +S GV++   ++G  P
Sbjct: 171 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCV-----PSIVHRDV 827
           L+ +Y  NGSL D L   K   LD  +  K+   +  GL +LH +       P+I HRD+
Sbjct: 112 LITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 828 KSNNILLDGDFGARVADFGVA-KVVDASGK---PKSMSVIAGSCGYIAPEYA-YTLRVNE 882
           KS NIL+  +    +AD G+A K +  + +   P +  V  G+  Y+ PE    +L  N 
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV--GTKRYMPPEVLDESLNRNH 226
Query: 883 -----KSDIYSFGVVILEL----VTGRLPVDPEFGEKDLV 913
                 +D+YSFG+++ E+    V+G +  + +    DLV
Sbjct: 227 FQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 689 NVIGSGSSGKVYKVVLSNG--EAVAVK-----KLWRGMSKECESGCDVEKGXXXXXXXXX 741
             +GSG+ G+V K+       + VA+K     K   G ++E +   +VE           
Sbjct: 16  KTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE----------- 63
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E+E L K+ H  I+K+       D   +V E M  G L D +   K   L   T  
Sbjct: 64  ---TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCK 117
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
                    + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+  
Sbjct: 118 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 171
Query: 859 SMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLP 902
            M  + G+  Y+APE      T   N   D +S GV++   ++G  P
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 SQVIQME----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +  +     L  
Sbjct: 97  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 156
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 157 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 213
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 22/216 (10%)
Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETL 750
           IG G+ G V+K    N E   +  L R    + + G                   E+  L
Sbjct: 10  IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGV------------PSSALREICLL 55
Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            +++HKNIV+L     +     LV+E+  +  L     SC G L D       +    +G
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDL-DPEIVKSFLFQLLKG 113
Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI 870
           L + H     +++HRD+K  N+L++ +   ++A+FG+A+      +  S  V+  +  Y 
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYR 168
Query: 871 APEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
            P+  +  ++   S D++S G +  EL     P+ P
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 68  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHR++ + N ++  DF  ++ DFG+ + +  +
Sbjct: 128 PTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 184
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 185 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 242
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 243 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPNMRPTFLEIVNLLK 288
Query: 971 E 971
           +
Sbjct: 289 D 289

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 103/241 (42%), Gaps = 31/241 (12%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR-- 800
           F  E   +      ++V+L    +     L+V E M +G L   L S +    + P R  
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 801 ------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
                  ++  + A+G++YL+       VHR++ + N ++  DF  ++ DFG+ + +  +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYET 183
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG--EKDL 912
              +          ++APE          SD++SFGVV+ E+ +  L   P  G   + +
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQGLSNEQV 241
Query: 913 VKWVCS--TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           +K+V     LDQ           D C +    +V ++  +C    P  RP    +V LL+
Sbjct: 242 LKFVMDGGYLDQP----------DNCPE----RVTDLMRMCWQFNPNMRPTFLEIVNLLK 287
Query: 971 E 971
           +
Sbjct: 288 D 288

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 689 NVIGSGSSGKVYKVVLSNG--EAVAVK-----KLWRGMSKECESGCDVEKGXXXXXXXXX 741
             +GSG+ G+V K+       + VA++     K   G ++E +   +VE           
Sbjct: 155 KTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE----------- 202
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E+E L K+ H  I+K+       D   +V E M  G L D +   K   L   T  
Sbjct: 203 ---TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCK 256
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
                    + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+  
Sbjct: 257 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 310
Query: 859 SMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLP 902
            M  + G+  Y+APE      T   N   D +S GV++   ++G  P
Sbjct: 311 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 689 NVIGSGSSGKVYKVVLSNG--EAVAVK-----KLWRGMSKECESGCDVEKGXXXXXXXXX 741
             +GSG+ G+V K+       + VA++     K   G ++E +   +VE           
Sbjct: 141 KTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE----------- 188
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
               E+E L K+ H  I+K+       D   +V E M  G L D +   K   L   T  
Sbjct: 189 ---TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCK 242
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPK 858
                    + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+  
Sbjct: 243 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 296
Query: 859 SMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLP 902
            M  + G+  Y+APE      T   N   D +S GV++   ++G  P
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 64
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 65  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 108
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 109 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 162 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 8   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 65
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 66  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 109
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 110 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 163 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 217

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 691 IGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           +GSG+ G V   Y   L   + VAVKKL    S+  +S     +              E+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKL----SRPFQSLIHARRTYR-----------EL 78
Query: 748 ETLGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIV 805
             L  ++H+N++ L    T     +     Y+    +G DL +  K   L       ++ 
Sbjct: 79  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVY 138
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL Y+H      I+HRD+K +N+ ++ D   R+ DFG+A+  D     + M+    
Sbjct: 139 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQAD-----EEMTGYVA 190
Query: 866 SCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
           +  Y APE     +  N+  DI+S G ++ EL+ G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 8   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 65
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 66  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 109
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 110 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 163 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 217

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +       +L  
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 71
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 72  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHA 129
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 130 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 181
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 182 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F + ++ D  D    +GSG    V K    S G   A K + +  S+    G   E+   
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE--- 61
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L ++ H N++ L      R   +L+ E +  G L D L   +   
Sbjct: 62  --------IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I+D   G++YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 114 EEEATSFIKQILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            ++   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 168 EIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F + ++ D  D    +GSG    V K    S G   A K + +  S+    G   E+   
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE--- 61
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L ++ H N++ L      R   +L+ E +  G L D L   +   
Sbjct: 62  --------IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I+D   G++YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 114 EEEATSFIKQILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            ++   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 168 EIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F + ++ D  D    +GSG    V K    S G   A K + +  S+    G   E+   
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE--- 61
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L ++ H N++ L      R   +L+ E +  G L D L   +   
Sbjct: 62  --------IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I+D   G++YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 114 EEEATSFIKQILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            ++   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 168 EIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F + ++ D  D    +GSG    V K    S G   A K + +  S+    G   E+   
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE--- 61
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L ++ H N++ L      R   +L+ E +  G L D L   +   
Sbjct: 62  --------IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I+D   G++YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 114 EEEATSFIKQILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            ++   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 168 EIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F + ++ D  D    +GSG    V K    S G   A K + +  S+    G   E+   
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE--- 61
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L ++ H N++ L      R   +L+ E +  G L D L   +   
Sbjct: 62  --------IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 795 LDWPTRY-KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDF---GARVADFGVAK 849
            +  T + K I+D   G++YLH      I H D+K  NI LLD +      ++ DFG+A 
Sbjct: 114 EEEATSFIKQILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            ++   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 168 EIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 SQVIQME----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 14  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 15  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 72
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 73  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 116
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 117 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 170 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 224

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-----CKNCTSDSVREK- 57
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 58  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY 106
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 107 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 163 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 13  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 70
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 71  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 114
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 115 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 167
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 168 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 222

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGXX 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED--- 60
Query: 735 XXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D L   +   
Sbjct: 61  --------IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT 112
Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI-LLDGDFGA---RVADFGVAKV 850
            +  T +  +     G+ YLH      I H D+K  NI LLD +      ++ DFG+A  
Sbjct: 113 EEEATEF--LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +D   + K+   I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 168 IDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 15  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 72
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 73  R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 116
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 117 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 170 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 224

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-----CKNCTSDSVREK- 85
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 86  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY 134
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 135 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 190
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 191 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY P G +    H  + G    P              YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 160
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +VADFG AK V           + G+  Y+APE   +
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 213
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 25  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 63
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 122
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 123 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 178
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 179 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 62
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 121
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 122 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 177
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 178 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 224

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-----CKNCTSDSVREK- 57
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 58  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY 106
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 107 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 163 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 86
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHA 144
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 196
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 197 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 54/246 (21%), Positives = 99/246 (40%), Gaps = 59/246 (23%)
Query: 684 GLD--EDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           G+D  E  +IGSG  G+V+K     +G+   ++++     K                   
Sbjct: 11  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA------------------ 52
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRD-----------------------------CK 771
              + EV+ L K+ H NIV    C    D                             C 
Sbjct: 53  ---EREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCL 109
Query: 772 LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN 831
            +  E+   G+L   +   +G  LD     ++     +G+ Y+H      ++HRD+K +N
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSN 166
Query: 832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGV 891
           I L      ++ DFG+   +   GK ++ S   G+  Y++PE   +    ++ D+Y+ G+
Sbjct: 167 IFLVDTKQVKIGDFGLVTSLKNDGK-RTRS--KGTLRYMSPEQISSQDYGKEVDLYALGL 223
Query: 892 VILELV 897
           ++ EL+
Sbjct: 224 ILAELL 229

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 691 IGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           +GSG+ G V   Y   L   + VAVKKL    S+  +S     +              E+
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKL----SRPFQSLIHARRTYR-----------EL 70
Query: 748 ETLGKIRHKNIVKLWCCCT-TRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKIIV 805
             L  ++H+N++ L    T     +     Y+    +G DL +  K   L       ++ 
Sbjct: 71  RLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVY 130
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
               GL Y+H      I+HRD+K +N+ ++ D   R+ DFG+A+  D     + M+    
Sbjct: 131 QLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD-----EEMTGYVA 182
Query: 866 SCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGR 900
           +  Y APE     +  N+  DI+S G ++ EL+ G+
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 117 QNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPES-FGRFQKLEVISLVYN 175
           ++LQ+L+LS N   G    A  + P L+ LD+   +     P S F     L V++L + 
Sbjct: 375 RHLQYLNLSYNEPLGLEDQAFKECPQLELLDVAFTHLHVKAPHSPFQNLHLLRVLNLSHC 434
Query: 176 LLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE--LGNLTNLEILWLTECNLVGEIPDS 233
           LLD +    L  +  L+ LNL  N F  G I     L  + +LEIL L+ CNL+      
Sbjct: 435 LLDTSNQHLLAGLQDLRHLNLQGNSFQDGSISKTNLLQMVGSLEILILSSCNLL------ 488
Query: 234 LGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDA 293
                                  +   L +V  ++L +NSLTGD     S+L  L L  A
Sbjct: 489 ------------------SIDQQAFHGLRNVNHLDLSHNSLTGDSMDALSHLKGLYLNMA 530
Query: 294 SMNDLTGPIPDDLTRLPLES-LNLYENRLE 322
           S N    P P  L  L  +S +NL  N L+
Sbjct: 531 SNNIRIIP-PHLLPALSQQSIINLSHNPLD 559

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 62
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 121
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 122 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 177
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 178 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 62
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 121
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 122 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 177
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 178 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E +  GSLG L+   + G L        +  A EGL YLH      I+H DVK++N+
Sbjct: 162 IFMELLEGGSLGQLVK--EQGCLPEDRALYYLGQALEGLEYLHSR---RILHGDVKADNV 216
Query: 833 LLDGDFG-ARVADFGVAKVVDASGKPKSM---SVIAGSCGYIAPEYAYTLRVNEKSDIYS 888
           LL  D   A + DFG A  +   G  KS+     I G+  ++APE       + K D++S
Sbjct: 217 LLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWS 276
Query: 889 FGVVILELVTGRLP 902
              ++L ++ G  P
Sbjct: 277 SCCMMLHMLNGCHP 290

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 31/225 (13%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMS---KECESGCDVEKGXXXXX 737
           LD  +    +G+GS G+V  V  +  G   A+K L +      KE E   +         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN--------- 90
Query: 738 XXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E   L  +    +VKL           +V EY P G +    H  + G    
Sbjct: 91  --------EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSE 140
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
           P              YLH      +++RD+K  N+++D     +V DFG+AK V      
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG---- 193
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 36  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 74
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 133
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 134 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 189
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 190 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 236

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 37  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 75
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 134
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 135 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 190
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 191 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 237

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 SQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 28  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 66
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 125
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 126 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 181
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 182 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-----TCKNCTSDSVREK- 54
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 55  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY 103
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 104 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 160 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-----CKNCTSDSVREK- 57
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 58  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKF 106
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+      ++ DFG+++ ++
Sbjct: 107 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME 162
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 163 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +  +     L  
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N  +  DF  ++ DFG+ + +  +
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYET 178
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 86
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHA 144
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 196
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-----TCKNCTSDSVREK- 59
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 60  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY 108
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 109 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 164
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 165 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 56/188 (29%)
Query: 744 QAEVETLGKIRHKNIV--------------KLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
           +AE+     +RH+NI+              +LW          LV +Y  +GSL D L+ 
Sbjct: 46  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLW----------LVSDYHEHGSLFDYLN- 94
Query: 790 CKGGLLDWPTRYKIIVDA--------AEGLSYLHHDCV-----PSIVHRDVKSNNILLDG 836
                     RY + V+         A GL++LH + V     P+I HRD+KS NIL+  
Sbjct: 95  ----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 144
Query: 837 DFGARVADFGVAKVVDASGKPKSMSV--IAGSCGYIAPEY---AYTLRVNE---KSDIYS 888
           +    +AD G+A   D++     ++     G+  Y+APE    +  ++  E   ++DIY+
Sbjct: 145 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 204
Query: 889 FGVVILEL 896
            G+V  E+
Sbjct: 205 MGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 56/188 (29%)
Query: 744 QAEVETLGKIRHKNIV--------------KLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
           +AE+     +RH+NI+              +LW          LV +Y  +GSL D L+ 
Sbjct: 45  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLW----------LVSDYHEHGSLFDYLN- 93
Query: 790 CKGGLLDWPTRYKIIVDA--------AEGLSYLHHDCV-----PSIVHRDVKSNNILLDG 836
                     RY + V+         A GL++LH + V     P+I HRD+KS NIL+  
Sbjct: 94  ----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143
Query: 837 DFGARVADFGVAKVVDASGKPKSMSV--IAGSCGYIAPEY---AYTLRVNE---KSDIYS 888
           +    +AD G+A   D++     ++     G+  Y+APE    +  ++  E   ++DIY+
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203
Query: 889 FGVVILEL 896
            G+V  E+
Sbjct: 204 MGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 56/188 (29%)
Query: 744 QAEVETLGKIRHKNIV--------------KLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
           +AE+     +RH+NI+              +LW          LV +Y  +GSL D L+ 
Sbjct: 51  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLW----------LVSDYHEHGSLFDYLN- 99
Query: 790 CKGGLLDWPTRYKIIVDA--------AEGLSYLHHDCV-----PSIVHRDVKSNNILLDG 836
                     RY + V+         A GL++LH + V     P+I HRD+KS NIL+  
Sbjct: 100 ----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 149
Query: 837 DFGARVADFGVAKVVDASGKPKSMSV--IAGSCGYIAPEY---AYTLRVNE---KSDIYS 888
           +    +AD G+A   D++     ++     G+  Y+APE    +  ++  E   ++DIY+
Sbjct: 150 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 209
Query: 889 FGVVILEL 896
            G+V  E+
Sbjct: 210 MGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 56/188 (29%)
Query: 744 QAEVETLGKIRHKNIV--------------KLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
           +AE+     +RH+NI+              +LW          LV +Y  +GSL D L+ 
Sbjct: 48  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLW----------LVSDYHEHGSLFDYLN- 96
Query: 790 CKGGLLDWPTRYKIIVDA--------AEGLSYLHHDCV-----PSIVHRDVKSNNILLDG 836
                     RY + V+         A GL++LH + V     P+I HRD+KS NIL+  
Sbjct: 97  ----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 146
Query: 837 DFGARVADFGVAKVVDASGKPKSMSV--IAGSCGYIAPEY---AYTLRVNE---KSDIYS 888
           +    +AD G+A   D++     ++     G+  Y+APE    +  ++  E   ++DIY+
Sbjct: 147 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 206
Query: 889 FGVVILEL 896
            G+V  E+
Sbjct: 207 MGLVFWEI 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 7   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-----TCKNCTSDSVREK- 60
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 61  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY 109
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 110 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 165
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 166 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-----CKNCTSDSVREK- 62
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 63  ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKY 111
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 112 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 168 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 52  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY 109
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 110 R---------------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 153
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 154 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 207 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 43  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 81
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 140
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 141 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 196
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 197 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 29  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 67
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 126
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 127 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 182
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 183 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 229

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 31/225 (13%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMS---KECESGCDVEKGXXXXX 737
           LD  +    +G+GS G+V  V  +  G   A+K L +      KE E   +         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN--------- 90
Query: 738 XXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E   L  +    +VKL           +V EY P G +    H  + G    
Sbjct: 91  --------EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSE 140
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
           P              YLH      +++RD+K  N+++D     +V DFG+AK V      
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG---- 193
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 32  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 70
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 129
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 130 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 185
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 186 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 232

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  VL     VA+KKL R    +  +    
Sbjct: 52  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAK--- 106
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          LV E M + +L
Sbjct: 107 ------------RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL 153
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 154 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 207 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +  +     L  
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 181
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 36  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 74
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPV 133
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 134 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 189
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 190 P-NVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 236

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 100/246 (40%), Gaps = 47/246 (19%)
Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPES-FGRFQKLEVISLVYNL 176
           +LQ L+LS N   G  + A  + P L+ LDL       + P+S F     L+V++L Y  
Sbjct: 374 HLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQSPFQNLHFLQVLNLTYCF 433
Query: 177 LDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE--LGNLTNLEILWLTECNLVGEIPDSL 234
           LD +    L  +  L+ LNL  N F  G I     L  + +LE+L L+ C L+       
Sbjct: 434 LDTSNQHLLAGLPVLRHLNLKGNHFQDGTITKTNLLQTVGSLEVLILSSCGLL------- 486
Query: 235 GRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRL-LDA 293
                                 +   L  +  ++L +NSLT D     S+L  + L L A
Sbjct: 487 -----------------SIDQQAFHSLGKMSHVDLSHNSLTCDSIDSLSHLKGIYLNLAA 529
Query: 294 SMNDLTGPI----------------PDDLTRLPLESLNLYE---NRLEGSLPATIADSPG 334
           +  ++  P                 P D T   +  L  Y+   ++LEGS   T A+ P 
Sbjct: 530 NSINIISPRLLPILSQQSTINLSHNPLDCTCSNIHFLTWYKENLHKLEGSEETTCANPPS 589
Query: 335 LYELRL 340
           L  ++L
Sbjct: 590 LRGVKL 595

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 86
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHA 144
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 196
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKL-WRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           ++G G  G+V+K    + G  +A K +  RGM  + E                   + E+
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE------------------VKNEI 137
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
             + ++ H N+++L+    +++  +LV EY+  G L D +      L +  T    +   
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-FMKQI 196
Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNIL-LDGDFGA-RVADFGVAKVVDASGKPK-SMSVIA 864
            EG+ ++H      I+H D+K  NIL ++ D    ++ DFG+A+      KP+  + V  
Sbjct: 197 CEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY----KPREKLKVNF 249
Query: 865 GSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+  ++APE      V+  +D++S GV+   L++G  P
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 96
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPV 155
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 156 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 211
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P    +   S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 212 PNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 258

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +  +     L  
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 96
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPV 155
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 156 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 211
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 212 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 122
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 183 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +G  +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 295
Query: 913 VKWVCS 918
           +++V S
Sbjct: 296 LEFVTS 301

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG-DLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +G DL    K   L        +
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 150
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 151 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 249

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 52  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 90
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPV 149
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 150 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 205
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 206 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 252

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY+P G +    H  + G    P              YLH  
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 159
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 212
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY+P G +    H  + G    P              YLH  
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 159
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 212
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 25/225 (11%)
Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
            ++G G  G V +  L   +   VK   + +  +  +  D+E+           F  E  
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-----------FLREAA 77
Query: 749 TLGKIRHKNIVKLWCCCTTRDCK------LLVYEYMPNGSLGDLLHSCKGGL----LDWP 798
            + +  H ++ KL         K      +++  +M +G L   L + + G     L   
Sbjct: 78  CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
           T  + +VD A G+ YL      + +HRD+ + N +L  D    VADFG+++ + +    +
Sbjct: 138 TLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                     ++A E          SD+++FGV + E++T G+ P
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY+P G +    H  + G    P              YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 160
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 213
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY+P G +    H  + G    P              YLH  
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 159
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 212
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-----TCKNCTSDSVREK- 437
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 438 ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKF 486
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 487 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 543 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 60  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 98
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPV 157
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 158 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 213
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 214 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 260

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY+P G +    H  + G    P              YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 160
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 213
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY+P G +    H  + G    P              YLH  
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 180
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 181 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 233
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY+P G +    H  + G    P              YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 160
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+L+D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 161 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 213
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 169 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 15  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 72
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 73  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 116
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 117 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 170 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 62  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 100
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPV 159
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 160 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 215
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 216 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 262

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 687 EDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +  VIG+GS G VY+  L + GE VA+KK+ +    +                       
Sbjct: 103 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---------------------NR 141
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPT 799
           E++ + K+ H NIV+L     +   K       LV +Y+P        H  +      P 
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPV 200
Query: 800 RYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
            Y    +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +   G+
Sbjct: 201 IYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGE 256
Query: 857 PKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           P ++S I  S  Y APE  +         D++S G V+ EL+ G+ P+ P
Sbjct: 257 P-NVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFP 303

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 10/157 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   L  +    +VKL           +V EY+P G +    H  + G    P       
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFSEPHARFYAA 141
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
                  YLH      +++RD+K  N+L+D     +V DFG AK V           + G
Sbjct: 142 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 193
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 10/157 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E   L  +    +VKL           +V EY+P G +    H  + G    P       
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAA 141
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
                  YLH      +++RD+K  N+L+D     +V DFG AK V           + G
Sbjct: 142 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 193
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 690 VIGSGSSGKVYKVVL--SNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           +I + + GK  K++L   + +  A+KK  + + ++                    F+ E+
Sbjct: 35  IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG---------DLLHSCKGGLLDWP 798
           + +  I+++  +      T  D   ++YEYM N S+          D  ++C    +   
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC---FIPIQ 151
Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKP 857
               II       SY+H++   +I HRDVK +NIL+D +   +++DFG ++ +VD     
Sbjct: 152 VIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----- 204
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNE------KSDIYSFGVVILELVTGRLP 902
           K +    G+  ++ PE+      NE      K DI+S G+ +  +    +P
Sbjct: 205 KKIKGSRGTYEFMPPEFF----SNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 99
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 100 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 159
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 160 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 213
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +G  +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 214 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 272
Query: 913 VKWVCS 918
           +++V S
Sbjct: 273 LEFVTS 278

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +       +L  
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +       +L  
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 182
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 183 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +       +L  
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 185
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 71
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 72  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M+    +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 169 DFGLAR---TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 27/225 (12%)
Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K       K C S    EK 
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK-----TCKNCTSDSVREK- 437
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     F  E  T+ +  H +IVKL     T +   ++ E    G L   L   K 
Sbjct: 438 ----------FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKF 486
Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+      ++ DFG+++ ++
Sbjct: 487 SL-DLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME 542
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            S   K+ S       ++APE     R    SD++ FGV + E++
Sbjct: 543 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+++D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 25/242 (10%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKG 732
           K+G   +E+L       V+G+G+ GKV+ V   +G      KL+    K  +    V+K 
Sbjct: 50  KVGIENFELL------KVLGTGAYGKVFLVRKISGHDTG--KLY--AMKVLKKATIVQKA 99
Query: 733 XXXXXXXXXGFQAEVETLGKIRHKN-IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
                      + E + L  IR    +V L     T     L+ +Y+  G L   L    
Sbjct: 100 KTTEHT-----RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR- 153
Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
               +  T +++ +   E +  L H     I++RD+K  NILLD +    + DFG++K  
Sbjct: 154 ----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 852 DASGKPKSMSVIAGSCGYIAPEYAY--TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
            A    ++     G+  Y+AP+         ++  D +S GV++ EL+TG  P   + GE
Sbjct: 210 VADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-GE 267
Query: 910 KD 911
           K+
Sbjct: 268 KN 269

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 31/225 (13%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMS---KECESGCDVEKGXXXXX 737
           LD  D    +G+GS G+V  V    +G   A+K L +      K+ E   +         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------- 90
Query: 738 XXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E   L  +    +VKL           +V EY+  G +    H  + G    
Sbjct: 91  --------EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSE 140
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
           P              YLH      +++RD+K  N+L+D     +V DFG AK V      
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                +AG+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 194 -RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +       +L  
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 37/236 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 16  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 73
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 74  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 117
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 118 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 170
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG+A+    +G    M     +  Y APE    +   E  DI+S G ++ E++ G
Sbjct: 171 DFGLAR---TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----GGLLDW 797
           F  E   + +    ++V+L    +     L++ E M  G L   L S +       +L  
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 134
Query: 798 PTRYKIIVDA---AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           P+  K+I  A   A+G++YL+ +     VHRD+ + N ++  DF  ++ DFG+ + +  +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
              +          +++PE          SD++SFGVV+ E+ T
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+++D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY P G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+++D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 766 TTRDCKLLV---YEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE----------GLS 812
           +T DC  +V   Y +     L  +L    GG L +      +   A+          GL 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 813 YLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAP 872
           ++H+  V   V+RD+K  NILLD     R++D G+A   D S K    SV  G+ GY+AP
Sbjct: 307 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV--GTHGYMAP 359
Query: 873 EYAYT-LRVNEKSDIYSFGVVILELVTGRLP 902
           E     +  +  +D +S G ++ +L+ G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 766 TTRDCKLLV---YEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE----------GLS 812
           +T DC  +V   Y +     L  +L    GG L +      +   A+          GL 
Sbjct: 246 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 305
Query: 813 YLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAP 872
           ++H+  V   V+RD+K  NILLD     R++D G+A   D S K    SV  G+ GY+AP
Sbjct: 306 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV--GTHGYMAP 358
Query: 873 EYAYT-LRVNEKSDIYSFGVVILELVTGRLP 902
           E     +  +  +D +S G ++ +L+ G  P
Sbjct: 359 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 60/145 (41%), Gaps = 10/145 (6%)
Query: 758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD 817
           +VKL           +V EY P G +    H  + G    P              YLH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS- 160
Query: 818 CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT 877
               +++RD+K  N+++D     +V DFG AK V           + G+  Y+APE   +
Sbjct: 161 --LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILS 213
Query: 878 LRVNEKSDIYSFGVVILELVTGRLP 902
              N+  D ++ GV+I E+  G  P
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 54/251 (21%), Positives = 102/251 (40%), Gaps = 35/251 (13%)
Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
            F+ EV    + RH+N+V     C +     ++       +L  ++   K  +LD     
Sbjct: 75  AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTR 133
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG------DFGARVADFGVAKVVDASG 855
           +I  +  +G+ YLH      I+H+D+KS N+  D       DFG     F ++ V+ A  
Sbjct: 134 QIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKVVITDFGL----FSISGVLQAGR 186
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLR---------VNEKSDIYSFGVVILELVTGRLPVDPE 906
           +   + +  G   ++APE    L           ++ SD+++ G +  EL     P   +
Sbjct: 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
             E   + W   T  +  +  +          +EI  +L   L C +     RP   +++
Sbjct: 247 PAEA--IIWQMGTGMKPNLSQI-------GMGKEISDIL---LFCWAFEQEERPTFTKLM 294
Query: 967 KLLQEVGAENR 977
            +L+++   NR
Sbjct: 295 DMLEKLPKRNR 305

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +  E +  GSLG L+   + G L        +  A EGL YLH      I+H DVK++N+
Sbjct: 143 IFMELLEGGSLGQLVK--EQGCLPEDRALYYLGQALEGLEYLHSR---RILHGDVKADNV 197
Query: 833 LLDGDFG-ARVADFGVAKVVDASGKPKSM---SVIAGSCGYIAPEYAYTLRVNEKSDIYS 888
           LL  D   A + DFG A  +   G  K +     I G+  ++APE       + K D++S
Sbjct: 198 LLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWS 257
Query: 889 FGVVILELVTGRLP 902
              ++L ++ G  P
Sbjct: 258 SCCMMLHMLNGCHP 271

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 766 TTRDCKLLV---YEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE----------GLS 812
           +T DC  +V   Y +     L  +L    GG L +      +   A+          GL 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 813 YLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAP 872
           ++H+  V   V+RD+K  NILLD     R++D G+A   D S K    SV  G+ GY+AP
Sbjct: 307 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV--GTHGYMAP 359
Query: 873 EYAYT-LRVNEKSDIYSFGVVILELVTGRLP 902
           E     +  +  +D +S G ++ +L+ G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 766 TTRDCKLLV---YEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE----------GLS 812
           +T DC  +V   Y +     L  +L    GG L +      +   A+          GL 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 813 YLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAP 872
           ++H+  V   V+RD+K  NILLD     R++D G+A   D S K    SV  G+ GY+AP
Sbjct: 307 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV--GTHGYMAP 359
Query: 873 EYAYT-LRVNEKSDIYSFGVVILELVTGRLP 902
           E     +  +  +D +S G ++ +L+ G  P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 475
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 476 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                + APE     + + KSD++SFGV++ E  + G+ P
Sbjct: 533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 28/164 (17%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           +G G+ G V+K +    GE VAVKK++       ++  D ++              E+  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF----QNSTDAQRTF-----------REIMI 61
Query: 750 LGKIR-HKNIVKLWCCCTT---RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           L ++  H+NIV L         RD   LV++YM      DL    +  +L+   +  ++ 
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDV-YLVFDYMET----DLHAVIRANILEPVHKQYVVY 116
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              + + YLH      ++HRD+K +NILL+ +   +VADFG+++
Sbjct: 117 QLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 23/220 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            VIG G+   V + +    G+  AVK +            DV K            + E 
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIV------------DVAKFTSSPGLSTEDLKREA 77
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG-DLLHSCKGGLL-DWPTRYKIIV 805
                ++H +IV+L    ++     +V+E+M    L  +++     G +         + 
Sbjct: 78  SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSV 862
              E L Y H +   +I+HRDVK  N+LL   +     ++ DFGVA  +  SG      V
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV 194
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+  ++APE        +  D++  GV++  L++G LP
Sbjct: 195 --GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 476
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 477 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 533
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                + APE     + + KSD++SFGV++ E  + G+ P
Sbjct: 534 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 10/130 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +V EY P G +    H  + G    P              YLH      +++RD+K  N+
Sbjct: 119 MVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENL 173
Query: 833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
           ++D     +V DFG AK V           + G+  Y+APE   +   N+  D ++ GV+
Sbjct: 174 MIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVL 228
Query: 893 ILELVTGRLP 902
           I E+  G  P
Sbjct: 229 IYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 10/130 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +V EY P G +    H  + G    P              YLH      +++RD+K  N+
Sbjct: 119 MVMEYAPGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENL 173
Query: 833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
           ++D     +V DFG AK V           + G+  Y+APE   +   N+  D ++ GV+
Sbjct: 174 MIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVL 228
Query: 893 ILELVTGRLP 902
           I E+  G  P
Sbjct: 229 IYEMAAGYPP 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 84/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 106
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 164
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V       + 
Sbjct: 165 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----AT 216
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 217 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 10/130 (7%)
Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           +V EY P G +    H  + G    P              YLH      +++RD+K  N+
Sbjct: 119 MVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENL 173
Query: 833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
           ++D     +V DFG AK V           + G+  Y+APE   +   N+  D ++ GV+
Sbjct: 174 MIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVL 228
Query: 893 ILELVTGRLP 902
           I E+  G  P
Sbjct: 229 IYEMAAGYPP 238

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 105/273 (38%), Gaps = 63/273 (23%)
Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
            IG GS G V   + +   A+   K+         +  DVE+            + EV  
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-----------IKTEVRL 81
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH--------------------- 788
           + K+ H NI +L+          LV E    G L D L+                     
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 789 -------SCKGGL------LDWPTRYKIIVDAAE----GLSYLHHDCVPSIVHRDVKSNN 831
                  +  G +      LD+  R K+I +        L YLH+     I HRD+K  N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPEN 198
Query: 832 ILL--DGDFGARVADFGVAKVVDA--SGKPKSMSVIAGSCGYIAPEYAYTLRVNE----K 883
            L   +  F  ++ DFG++K      +G+   M+  AG+  ++APE   T   NE    K
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT--TNESYGPK 256
Query: 884 SDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
            D +S GV++  L+ G +P  P   + D +  V
Sbjct: 257 CDAWSAGVLLHLLLMGAVPF-PGVNDADTISQV 288

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG--LLDWPTRYKI 803
           E++ L   +H+NI+ ++        +     Y+    +   LH       L D   +Y  
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-F 117
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS--------G 855
           I      +  LH     +++HRD+K +N+L++ +   +V DFG+A+++D S        G
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 856 KPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDP 905
           +   M+    +  Y APE   T  + +   D++S G ++ EL   R P+ P
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFP 224

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG--LLDWPTRYKI 803
           E++ L   +H+NI+ ++        +     Y+    +   LH       L D   +Y  
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-F 117
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS--------G 855
           I      +  LH     +++HRD+K +N+L++ +   +V DFG+A+++D S        G
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 856 KPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDP 905
           +   M+    +  Y APE   T  + +   D++S G ++ EL   R P+ P
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFP 224

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGX 733
           S + +L    +   IGSG+ G V   +  VL  G  VAVKKL R    +  +        
Sbjct: 18  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAK------- 68
Query: 734 XXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSLGDLL 787
                       E+  L  + HKNI+ L    T +          LV E M + +L  ++
Sbjct: 69  --------RAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI 119
Query: 788 HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
           H      LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ DFG+
Sbjct: 120 HM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG 899
           A+    +     M+    +  Y APE    +      DI+S G ++ ELV G
Sbjct: 173 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 21/187 (11%)
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLLDWPT 799
              +E++ L  I  H N+V L   CT     L+V  E+   G+L   L S +   + +  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 800 RYKIIV----------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
            YK  +            A+G+ +L        +HRD+ + NILL      ++ DFG+A+
Sbjct: 136 LYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP-----V 903
            +                 ++APE  +      +SD++SFGV++ E+ + G  P     +
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 252
Query: 904 DPEFGEK 910
           D EF  +
Sbjct: 253 DEEFXRR 259

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 82
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K+ H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 83  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 142
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 143 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 196
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 255
Query: 913 VKWVCS 918
           +++V S
Sbjct: 256 LEFVTS 261

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 134/310 (43%), Gaps = 64/310 (20%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + ++G GSSG V       G  VAVK++           CD+                E+
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDIA-------------LMEI 59
Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRY--- 801
           + L +   H N+++ +C  TT D  L +   + N +L DL+ S       L     Y   
Sbjct: 60  KLLTESDDHPNVIRYYCSETT-DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--------DGDFGAR-----VADFGVA 848
            ++   A G+++LH      I+HRD+K  NIL+        D   GA      ++DFG+ 
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 849 KVVDA--SGKPKSMSVIAGSCGYIAPE-------YAYTLRVNEKSDIYSFGVVILELVT- 898
           K +D+  S    +++  +G+ G+ APE            R+    DI+S G V   +++ 
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 899 GRLPVDPEFG-EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPI 957
           G+ P   ++  E ++++ + S LD+    H  D  L     + I ++++         P+
Sbjct: 236 GKHPFGDKYSRESNIIRGIFS-LDEMKCLH--DRSLIAEATDLISQMIDHD-------PL 285
Query: 958 NRPAMRRVVK 967
            RP   +V++
Sbjct: 286 KRPTAMKVLR 295

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + ++G GSSG V       G  VAVK++           CD+                E+
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDIA-------------LMEI 77
Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRY--- 801
           + L +   H N+++ +C  TT D  L +   + N +L DL+ S       L     Y   
Sbjct: 78  KLLTESDDHPNVIRYYCSETT-DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 136
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--------DGDFGAR-----VADFGVA 848
            ++   A G+++LH      I+HRD+K  NIL+        D   GA      ++DFG+ 
Sbjct: 137 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 193
Query: 849 KVVDASGKP--KSMSVIAGSCGYIAPEY---AYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           K +D+       +++  +G+ G+ APE    +   R+    DI+S G V   +++ G+ P
Sbjct: 194 KKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
Query: 903 VDPEFG-EKDLVKWVCSTLDQK 923
              ++  E ++++ + S  + K
Sbjct: 254 FGDKYSRESNIIRGIFSLDEMK 275

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 19  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY 76
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 77  R---------------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 120
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 121 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 173
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  D++S G ++ E+V  ++
Sbjct: 174 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 228

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 96
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K+ H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 97  MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 156
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 157 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 269
Query: 913 VKWVCS 918
           +++V S
Sbjct: 270 LEFVTS 275

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 746 EVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           EVE L + + H+N+++L       D   LV+E M  GS+  L H  K    +      ++
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEASVVV 117
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD---FGARVADFGVAKVVDASGKPKSMS 861
            D A  L +LH+     I HRD+K  NIL +        ++ DFG+   +  +G    +S
Sbjct: 118 QDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS 174
Query: 862 -----VIAGSCGYIAPEYAYTLR-----VNEKSDIYSFGVVILELVTGRLP 902
                   GS  Y+APE            +++ D++S GV++  L++G  P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 8   EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAK--- 62
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 63  ------------RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 109
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 110 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 162
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M+    +  Y APE    +   E  D++S G ++ E+V  ++
Sbjct: 163 DFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 217

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 233

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 50/262 (19%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + ++G GSSG V       G  VAVK++           CD+                E+
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDIA-------------LMEI 77
Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRY--- 801
           + L +   H N+++ +C  TT D  L +   + N +L DL+ S       L     Y   
Sbjct: 78  KLLTESDDHPNVIRYYCSETT-DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 136
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--------DGDFGAR-----VADFGVA 848
            ++   A G+++LH      I+HRD+K  NIL+        D   GA      ++DFG+ 
Sbjct: 137 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 193
Query: 849 KVVDASGKP--KSMSVIAGSCGYIAPEY---AYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           K +D+       +++  +G+ G+ APE    +   R+    DI+S G V   +++ G+ P
Sbjct: 194 KKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
Query: 903 VDPEFG-EKDLVKWVCSTLDQK 923
              ++  E ++++ + S  + K
Sbjct: 254 FGDKYSRESNIIRGIFSLDEMK 275

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKIIVDAAEGL 811
           ++H NIV+L    +      LV++ +  G L  D++        D       I    E +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIHQILESV 143
Query: 812 SYLH-HDCVPSIVHRDVKSNNILLDGD---FGARVADFGVAKVVDASGKPKSMSVIAGSC 867
           +++H HD    IVHRD+K  N+LL         ++ADFG+A  ++  G+ ++    AG+ 
Sbjct: 144 NHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTP 197
Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           GY++PE        +  DI++ GV++  L+ G  P
Sbjct: 198 GYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 27/233 (11%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVET 749
           IG GS G V+K      G+ VA+KK       E E    ++K              E+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFL-----ESEDDPVIKKIAL----------REIRM 55
Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           L +++H N+V L      +    LV+EY  +  L +L    +G  +       I     +
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQ 113
Query: 810 GLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
            +++ H H+C+    HRDVK  NIL+      ++ DFG A+++  +G          +  
Sbjct: 114 AVNFCHKHNCI----HRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRW 167
Query: 869 YIAPEYAY-TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
           Y +PE      +     D+++ G V  EL++G +P+ P   + D +  +  TL
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTL 219

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 100/242 (41%), Gaps = 41/242 (16%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKL--WRGMSKECESGCDV 729
           +L   ++EIL       VIG G+  +V  V +   G+  A+K +  W  M K  E  C  
Sbjct: 57  RLQRDDFEIL------KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-DMLKRGEVSC-- 107
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
                        F+ E + L     + I +L       +   LV EY   G L  LL  
Sbjct: 108 -------------FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK 154
Query: 790 CKGGLLDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
               +     R+ +  IV A + +  L +      VHRD+K +NILLD     R+ADFG 
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLGY------VHRDIKPDNILLDRCGHIRLADFGS 208
Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNE-------KSDIYSFGVVILELVTGR 900
              + A G  +S+ V  G+  Y++PE    +           + D ++ GV   E+  G+
Sbjct: 209 CLKLRADGTVRSL-VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 901 LP 902
            P
Sbjct: 268 TP 269

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 82
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 142
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 143 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 196
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 255
Query: 913 VKWVCS 918
           +++V S
Sbjct: 256 LEFVTS 261

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDE----------------LDFL 96
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 156
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 157 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 269
Query: 913 VKWVCS 918
           +++V S
Sbjct: 270 LEFVTS 275

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 16/171 (9%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG--LLDWPTRYKI 803
           E++ L   +H+NI+ ++        +     Y+    +   LH       L D   +Y  
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-F 117
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS--------G 855
           I      +  LH     +++HRD+K +N+L++ +   +V DFG+A+++D S        G
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 856 KPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDP 905
           +   M     +  Y APE   T  + +   D++S G ++ EL   R P+ P
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFP 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEY 187
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 233

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAK--- 68
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 69  ------------RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M     +  Y APE    +   E  DI+S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI 223

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 31/225 (13%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMS---KECESGCDVEKGXXXXX 737
           LD  D    +G+GS G+V  V    +G   A+K L +      K+ E   +         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN--------- 90
Query: 738 XXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E   L  +    +VKL           +V EY+  G +    H  + G    
Sbjct: 91  --------EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSE 140
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
           P              YLH      +++RD+K  N+L+D     +V DFG AK V      
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 194 -RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 44/249 (17%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ----A 745
           IG G+ G+V+K      G+ VA+KK+     KE                   GF      
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-------------------GFPITALR 66
Query: 746 EVETLGKIRHKNIVKLWCCCTTR-----DCK---LLVYEYMPNGSLGDLLHSCKGGLLDW 797
           E++ L  ++H+N+V L   C T+      CK    LV+++  +   G L +      L  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD--ASG 855
             R  ++     GL Y+H +    I+HRD+K+ N+L+  D   ++ADFG+A+      + 
Sbjct: 127 IKR--VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPV---DPEFGEKD 911
           +P        +  Y  PE     R      D++  G ++ E+ T R P+   + E  +  
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLA 240
Query: 912 LVKWVCSTL 920
           L+  +C ++
Sbjct: 241 LISQLCGSI 249

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 229

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 772 LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN 831
           +L+ EY   G +  L       ++      ++I    EG+ YLH +   +IVH D+K  N
Sbjct: 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQN 161
Query: 832 ILLDGDF---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYS 888
           ILL   +     ++ DFG+++ +   G    +  I G+  Y+APE      +   +D+++
Sbjct: 162 ILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 889 FGVVILELVTGRLP 902
            G++   L+T   P
Sbjct: 219 IGIIAYMLLTHTSP 232

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 72
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 73  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 130
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 131 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RT 182
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 183 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            + E     K++H NIV+L           LV++ +  G L + + + +           
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASH 132
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF---GARVADFGVAKVVDASGKPKS 859
            I    E ++Y H +    IVHR++K  N+LL         ++ADFG+A  V+ S   ++
Sbjct: 133 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 186
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               AG+ GY++PE       ++  DI++ GV++  L+ G  P
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 96
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 97  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 156
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 157 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 210
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 269
Query: 913 VKWVCS 918
           +++V S
Sbjct: 270 LEFVTS 275

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 88
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 89  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 148
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 149 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 202
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 203 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 261
Query: 913 VKWVCS 918
           +++V S
Sbjct: 262 LEFVTS 267

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 50/252 (19%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ----A 745
           IG G+ G+V+K      G+ VA+KK+     KE                   GF      
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-------------------GFPITALR 66
Query: 746 EVETLGKIRHKNIVKLWCCCTTR-----DCKLLVY------EYMPNGSLGDLLHSCKGGL 794
           E++ L  ++H+N+V L   C T+      CK  +Y      E+   G L ++L   K  L
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL--VKFTL 124
Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD-- 852
            +     +++++   GL Y+H +    I+HRD+K+ N+L+  D   ++ADFG+A+     
Sbjct: 125 SEIKRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 178
Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPV---DPEFG 908
            + +P        +  Y  PE     R      D++  G ++ E+ T R P+   + E  
Sbjct: 179 KNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQH 237
Query: 909 EKDLVKWVCSTL 920
           +  L+  +C ++
Sbjct: 238 QLALISQLCGSI 249

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 98
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 99  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 158
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 159 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 212
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 271
Query: 913 VKWVCS 918
           +++V S
Sbjct: 272 LEFVTS 277

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 73
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 74  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 133
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 134 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 187
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 188 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 246
Query: 913 VKWVCS 918
           +++V S
Sbjct: 247 LEFVTS 252

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 82
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 83  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 142
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 143 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYR 196
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 255
Query: 913 VKWVCS 918
           +++V S
Sbjct: 256 LEFVTS 261

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 108
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 109 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 168
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 169 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 222
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 223 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 281
Query: 913 VKWVCS 918
           +++V S
Sbjct: 282 LEFVTS 287

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 30/105 (28%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS--- 859
           I +  AE + +LH      ++HRD+K +NI    D   +V DFG+   +D   + ++   
Sbjct: 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 860 -MSVIAGSCG------YIAPEYAYTLRVNEKSDIYSFGVVILELV 897
            M   A   G      Y++PE  +    + K DI+S G+++ EL+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 86
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 144
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 145 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 196
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 81
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 142 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 254
Query: 913 VKWVCS 918
           +++V S
Sbjct: 255 LEFVTS 260

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 9/129 (6%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-KGGLLDWPTRYKII 804
           E+  L ++ H NI+K+      +    LV E   +GS  DL     +   LD P    I 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
                 + YL    +  I+HRD+K  NI++  DF  ++ DFG A  ++   + K      
Sbjct: 137 RQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYTFC 190
Query: 865 GSCGYIAPE 873
           G+  Y APE
Sbjct: 191 GTIEYCAPE 199

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAV--AVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +N IG GS G+V K+ +  G  +  A KK+ +   +      DV++           F+ 
Sbjct: 14  ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVE------DVDR-----------FKQ 55
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+E +  + H NI++L+          LV E    G L + +      +       +I+ 
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMK 113
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKP-KSMS 861
           D    ++Y H     ++ HRD+K  N L      D   ++ DFG+A    A  KP K M 
Sbjct: 114 DVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA----ARFKPGKMMR 166
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  Y++P+    L    + D +S GV++  L+ G  P
Sbjct: 167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAV--AVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQA 745
           +N IG GS G+V K+ +  G  +  A KK+ +   +      DV++           F+ 
Sbjct: 31  ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVE------DVDR-----------FKQ 72
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+E +  + H NI++L+          LV E    G L + +      +       +I+ 
Sbjct: 73  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMK 130
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKP-KSMS 861
           D    ++Y H     ++ HRD+K  N L      D   ++ DFG+A    A  KP K M 
Sbjct: 131 DVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA----ARFKPGKMMR 183
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G+  Y++P+    L    + D +S GV++  L+ G  P
Sbjct: 184 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 223

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  +    +G+GS G+V  V  +  G   A+K L              +K         
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 691 IGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           +G G+ G+VY+  +S          VAVK L    S++ E                  F 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----------------LDFL 81
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------GLLD 796
            E   + K  H+NIV+          + ++ E M  G L   L   +          +LD
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA---DFGVAKVVDA 853
                 +  D A G  YL  +     +HRD+ + N LL      RVA   DFG+A+ +  
Sbjct: 142 L---LHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL 912
           +   +          ++ PE         K+D +SFGV++ E+ + G +P  P    +++
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV 254
Query: 913 VKWVCS 918
           +++V S
Sbjct: 255 LEFVTS 260

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 227

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 80
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 81  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHA 138
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 139 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 190
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 191 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 15/169 (8%)
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLLDWPT 799
              +E++ L  I  H N+V L   CT     L+V  E+   G+L   L S +   + +  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 800 RYKIIV----------DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
            YK  +            A+G+ +L        +HRD+ + NILL      ++ DFG+A+
Sbjct: 136 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192
Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            +                 ++APE  +      +SD++SFGV++ E+ +
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 138
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 139 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 195
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 196 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 233

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 192
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 136
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 137 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 193
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 194 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 127
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 128 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 184
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 185 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 106
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHA 164
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 165 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 216
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 44/249 (17%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ----A 745
           IG G+ G+V+K      G+ VA+KK+     KE                   GF      
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-------------------GFPITALR 65
Query: 746 EVETLGKIRHKNIVKLWCCCTTR-----DCK---LLVYEYMPNGSLGDLLHSCKGGLLDW 797
           E++ L  ++H+N+V L   C T+      CK    LV+++  +   G L +      L  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV--VDASG 855
             R  ++     GL Y+H +    I+HRD+K+ N+L+  D   ++ADFG+A+   +  + 
Sbjct: 126 IKR--VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPV---DPEFGEKD 911
           +P        +  Y  PE     R      D++  G ++ E+ T R P+   + E  +  
Sbjct: 181 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLA 239
Query: 912 LVKWVCSTL 920
           L+  +C ++
Sbjct: 240 LISQLCGSI 248

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFAEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYL 814
           H NIVKL      +    LV E +  G L + +   K    +    Y I+      +S++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASY-IMRKLVSAVSHM 122
Query: 815 HHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIA 871
           H      +VHRD+K  N+L    + +   ++ DFG A++     +P  +     +  Y A
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAA 177
Query: 872 PEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           PE       +E  D++S GV++  +++G++P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+N++ +         + +   Y+    +  DL    K   L        +
Sbjct: 91  EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFL 150
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+L++     ++ DFG+A++ D        ++  
Sbjct: 151 YQILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 249

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 231

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 150
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++  
Sbjct: 151 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 249

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 44/249 (17%)
Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ----A 745
           IG G+ G+V+K      G+ VA+KK+     KE                   GF      
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-------------------GFPITALR 66
Query: 746 EVETLGKIRHKNIVKLWCCCTTR-----DCK---LLVYEYMPNGSLGDLLHSCKGGLLDW 797
           E++ L  ++H+N+V L   C T+      CK    LV+++  +   G L +      L  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV--VDASG 855
             R  ++     GL Y+H +    I+HRD+K+ N+L+  D   ++ADFG+A+   +  + 
Sbjct: 127 IKR--VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 856 KPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPV---DPEFGEKD 911
           +P        +  Y  PE     R      D++  G ++ E+ T R P+   + E  +  
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLA 240
Query: 912 LVKWVCSTL 920
           L+  +C ++
Sbjct: 241 LISQLCGSI 249

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            ++G G+  KV   V L NG+  AVK +      E ++G    +              EV
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKII------EKQAGHSRSRVFR-----------EV 61
Query: 748 ETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVD 806
           ETL + + +KNI++L           LV+E +  GS+  L H  K    +     +++ D
Sbjct: 62  ETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI--LAHIQKQKHFNEREASRVVRD 119
Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG---ARVADF--GVAKVVDASGKPKSMS 861
            A  L +LH      I HRD+K  NIL +        ++ DF  G    ++ S  P +  
Sbjct: 120 VAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP 176
Query: 862 VIAGSCG---YIAPEYAYTLR-----VNEKSDIYSFGVVILELVTGRLP 902
            +   CG   Y+APE            +++ D++S GVV+  +++G  P
Sbjct: 177 ELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 11/163 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            + E     K++H NIV+L           LV++ +  G L + +               
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASH 109
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF---GARVADFGVAKVVDASGKPKS 859
            I    E ++Y H +    IVHR++K  N+LL         ++ADFG+A  V+ S   ++
Sbjct: 110 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 163
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               AG+ GY++PE       ++  DI++ GV++  L+ G  P
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVIAGSC 867
            GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++    + 
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 868 GYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
            Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 233

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 28/79 (35%), Positives = 38/79 (48%), Gaps = 1/79 (1%)
Query: 824 HRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK 883
           HRDVK  NIL+  D  A + DFG+A       K   +    G+  Y APE         +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 884 SDIYSFGVVILELVTGRLP 902
           +DIY+   V+ E +TG  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 133/310 (42%), Gaps = 64/310 (20%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
           + ++G GSSG V       G  VAVK++           CD+                E+
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDIA-------------LMEI 59
Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRY--- 801
           + L +   H N+++ +C  TT D  L +   + N +L DL+ S       L     Y   
Sbjct: 60  KLLTESDDHPNVIRYYCSETT-DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--------DGDFGAR-----VADFGVA 848
            ++   A G+++LH      I+HRD+K  NIL+        D   GA      ++DFG+ 
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 849 KVVDASGKP--KSMSVIAGSCGYIAPE-------YAYTLRVNEKSDIYSFGVVILELVT- 898
           K +D+       +++  +G+ G+ APE            R+    DI+S G V   +++ 
Sbjct: 176 KKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 899 GRLPVDPEFG-EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPI 957
           G+ P   ++  E ++++ + S LD+    H  D  L     + I ++++         P+
Sbjct: 236 GKHPFGDKYSRESNIIRGIFS-LDEMKCLH--DRSLIAEATDLISQMIDHD-------PL 285
Query: 958 NRPAMRRVVK 967
            RP   +V++
Sbjct: 286 KRPTAMKVLR 295

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVIAGSC 867
            GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++    + 
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 868 GYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
            Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+++D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 37/238 (15%)
Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKV---YKVVLSNGEAVAVKKLWRGMSKECESGCDV 729
           ++G S + +L        IGSG+ G V   Y  +L     VA+KKL R    +  +    
Sbjct: 14  EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAK--- 68
Query: 730 EKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC------KLLVYEYMPNGSL 783
                           E+  +  + HKNI+ L    T +          +V E M + +L
Sbjct: 69  ------------RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL 115
Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             ++       LD      ++     G+ +LH      I+HRD+K +NI++  D   ++ 
Sbjct: 116 CQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           DFG+A+    +G    M     +  Y APE    +   E  D++S G ++ E+V  ++
Sbjct: 169 DFGLAR---TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 223

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 11/163 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            + E     K++H NIV+L           LV++ +  G L + +               
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASH 109
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF---GARVADFGVAKVVDASGKPKS 859
            I    E ++Y H +    IVHR++K  N+LL         ++ADFG+A  V+ S   ++
Sbjct: 110 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 163
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               AG+ GY++PE       ++  DI++ GV++  L+ G  P
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVIAGSC 867
            GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        ++    + 
Sbjct: 137 RGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 868 GYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
            Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 231

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+APE   +   N+  D ++ GV+I ++  G  P
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        +   
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 191
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 233

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA---- 808
           ++H NIV+L    +      LV++ +  G L + + +           Y    DA+    
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA---------REYYSEADASHCIQ 110
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGD---FGARVADFGVAKVVDASGKPKSMSVIAG 865
           + L  ++H  +  IVHRD+K  N+LL         ++ADFG+A  ++  G  ++    AG
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           + GY++PE        +  D+++ GV++  L+ G  P
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 7/163 (4%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKII 804
           E++ L + RH+NI+ +         + +   Y+    +  DL    K   L        +
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSVI 863
                GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D        +   
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 192
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTGRLPVDP 905
             +  Y APE     +   KS DI+S G ++ E+++ R P+ P
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 234

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 11/163 (6%)
Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            + E     K++H NIV+L           LV++ +  G L + +               
Sbjct: 51  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASH 108
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF---GARVADFGVAKVVDASGKPKS 859
            I    E ++Y H +    IVHR++K  N+LL         ++ADFG+A  V+ S   ++
Sbjct: 109 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 162
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               AG+ GY++PE       ++  DI++ GV++  L+ G  P
Sbjct: 163 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA---- 808
           ++H NIV+L    +      LV++ +  G L + + +           Y    DA+    
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA---------REYYSEADASHCIQ 110
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGD---FGARVADFGVAKVVDASGKPKSMSVIAG 865
           + L  ++H  +  IVHRD+K  N+LL         ++ADFG+A  ++  G  ++    AG
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           + GY++PE        +  D+++ GV++  L+ G  P
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 18/172 (10%)
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLLDWPT 799
              +E++ L  I  H N+V L   CT     L+V  E+   G+L   L S +   + + T
Sbjct: 77  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 136
Query: 800 RYKIIVD-------------AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
              +  D              A+G+ +L        +HRD+ + NILL      ++ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +A+ +                 ++APE  +      +SD++SFGV++ E+ +
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA---- 808
           ++H NIV+L    +      LV++ +  G L + + +           Y    DA+    
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA---------REYYSEADASHCIQ 110
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGD---FGARVADFGVAKVVDASGKPKSMSVIAG 865
           + L  + H     +VHRD+K  N+LL         ++ADFG+A  ++  G  ++    AG
Sbjct: 111 QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAG 168
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           + GY++PE        +  DI++ GV++  L+ G  P
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 117
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 19/171 (11%)
Query: 746 EVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           EVE L + + H+N+++L       D   LV+E M  GS+  L H  K    +      ++
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEASVVV 117
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD---FGARVADFGVAKVVDASGKPKSMS 861
            D A  L +LH+     I HRD+K  NIL +        ++ DF +   +  +G    +S
Sbjct: 118 QDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 862 -----VIAGSCGYIAPEYAYTLR-----VNEKSDIYSFGVVILELVTGRLP 902
                   GS  Y+APE            +++ D++S GV++  L++G  P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 113
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 123
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 133
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 133
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 117
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 174
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 111
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 112 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 168
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 169 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 79/169 (46%), Gaps = 12/169 (7%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
           E+  + ++ H  ++ L      +   +L+ E++  G L D + + +   +        + 
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMR 156
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA--RVADFGVAKVVDASGKPKSMSVI 863
            A EGL ++H     SIVH D+K  NI+ +    +  ++ DFG+A  ++     + + V 
Sbjct: 157 QACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVT 210
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
             +  + APE      V   +D+++ GV+   L++G   + P  GE DL
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG---LSPFAGEDDL 256

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 65/235 (27%)
Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVE 748
           +V+G G+ G +    + +   VAVK++      EC S  D                 EV+
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRIL----PECFSFAD----------------REVQ 69
Query: 749 TLGKI-RHKNIVKLWCCCTTRD--------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
            L +   H N+++ +C    R         C   + EY+       L      GL     
Sbjct: 70  LLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHL------GL----E 119
Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-----DGDFGARVADFGVAKVVDAS 854
              ++     GL++LH     +IVHRD+K +NIL+      G   A ++DFG+ K + A 
Sbjct: 120 PITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL-AV 175
Query: 855 GKP--KSMSVIAGSCGYIAPEY---------AYTLRVNEKSDIYSFGVVILELVT 898
           G+      S + G+ G+IAPE           YT+      DI+S G V   +++
Sbjct: 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV------DIFSAGCVFYYVIS 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      +++
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELV 131
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA-SGKPKSMSVI 863
              + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ +  
Sbjct: 132 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 188
Query: 864 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 895
                + APE     + + KSD++SFGV++ E
Sbjct: 189 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 187
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 244
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 245 DMWSLGVIMYILLCGYPP 262

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 755 HKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLL---------DWPTRYKII 804
           H N+V L   CT     L+V  E+   G+L   L S +   +         D+ T   +I
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 805 ---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
                 A+G+ +L        +HRD+ + NILL      ++ DFG+A+ +          
Sbjct: 152 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
                  ++APE  +      +SD++SFGV++ E+ +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 82/222 (36%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+  Y+AP    +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 141
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 198
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 199 DMWSLGVIMYILLCGYPP 216

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 86  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 142
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 199
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 200 DMWSLGVIMYILLCGYPP 217

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 101 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 157
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 214
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 215 DMWSLGVIMYILLCGYPP 232

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 137 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 193
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 250
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 251 DMWSLGVIMYILLCGYPP 268

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 143
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 200
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 201 DMWSLGVIMYILLCGYPP 218

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 746 EVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           E+E L +  +H NI+ L           +V E M  G L D +   +           ++
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVL 122
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG----ARVADFGVAKVVDASGKPKSM 860
               + + YLH      +VHRD+K +NIL   + G     R+ DFG AK + A      +
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LL 177
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                +  ++APE       +   DI+S GV++  ++TG  P
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           + C L++ E M  G L   +              +I+ D    + +LH     +I HRDV
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 154
Query: 828 KSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L    + D   ++ DFG AK    +    ++     +  Y+APE     + ++  
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSC 210
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 211 DMWSLGVIMYILLCGFPP 228

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 85  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDV 141
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTEPCYTPYYVAPEVLGPEKYDKSC 198
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 199 DMWSLGVIMYILLCGYPP 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 82/222 (36%), Gaps = 25/222 (11%)
Query: 682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXX 740
           LD  D    +G+GS G+V  V    +G   A+K L              +K         
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--------------DKQKVVKLKQI 85
Query: 741 XGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E   L  +    +VKL           +V EY+  G +    H  + G    P  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHA 143
Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                       YLH      +++RD+K  N+L+D     +V DFG AK V         
Sbjct: 144 RFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RT 195
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             + G+   +APE   +   N+  D ++ GV+I E+  G  P
Sbjct: 196 WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 92  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 148
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSC 205
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 206 DMWSLGVIMYILLCGYPP 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA---- 808
           ++H NIV+L    +      L+++ +  G L + + +           Y    DA+    
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA---------REYYSEADASHCIQ 128
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDF---GARVADFGVAKVVDASGKPKSMSVIAG 865
           + L  + H     +VHRD+K  N+LL         ++ADFG+A  ++  G+ ++    AG
Sbjct: 129 QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAG 186
Query: 866 SCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           + GY++PE        +  D+++ GV++  L+ G  P
Sbjct: 187 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 91  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 147
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSC 204
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 205 DMWSLGVIMYILLCGYPP 222

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 87  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 143
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSC 200
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 201 DMWSLGVIMYILLCGYPP 218

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I+    E + YLH     +I HRDV
Sbjct: 93  RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDV 149
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSC 206
Query: 885 DIYSFGVVILELVTGRLP 902
           D++S GV++  L+ G  P
Sbjct: 207 DMWSLGVIMYILLCGYPP 224

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 24/177 (13%)
Query: 755 HKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLL-----------DWPTRYK 802
           H N+V L   CT     L+V  E+   G+L   L S +   +           D+ T   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 803 II---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
           +I      A+G+ +L        +HRD+ + NILL      ++ DFG+A+ +        
Sbjct: 141 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP-----VDPEFGEK 910
                    ++APE  +      +SD++SFGV++ E+ + G  P     +D EF  +
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 19/173 (10%)
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLL---- 795
              +E++ L  I  H N+V L   CT     L+V  E+   G+L   L S +   +    
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 796 -------DWPTRYKII---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
                  D+ T   +I      A+G+ +L        +HRD+ + NILL      ++ DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           G+A+ +                 ++APE  +      +SD++SFGV++ E+ +
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 19/165 (11%)
Query: 746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YKI 803
           E + + ++ +  IV+L   C   +  +LV E    G L   L    G   + P     ++
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAEL 115
Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           +   + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     +    
Sbjct: 116 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT---- 168
Query: 864 AGSCG-----YIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           A S G     + APE     + + +SD++S+GV + E ++ G+ P
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 746 EVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           E+E L +  +H NI+ L           LV E M  G L D +   +           ++
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVL 127
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG----ARVADFGVAKVVDASGKPKSM 860
               + + YLH      +VHRD+K +NIL   + G     R+ DFG AK + A      +
Sbjct: 128 HTIGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG--LL 182
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                +  ++APE       +E  DI+S G+++  ++ G  P
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 104 SINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGR 163
           SI     D     ++L+ L LS+NL+      A   LP+L  L+L  N  +    ++F  
Sbjct: 46  SIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEY 105
Query: 164 FQKLEVISLVYNLLDGTIPAFLGN-ISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLT 222
             KL  + L  N ++ +IP++  N + +L+ L+L     L          L NL  L L 
Sbjct: 106 LSKLRELWLRNNPIE-SIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLNLG 164
Query: 223 ECNLVGEIPDSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGW 282
            CNL  +IP+                         LT L  + ++EL  N L    P  +
Sbjct: 165 MCNL-KDIPN-------------------------LTALVRLEELELSGNRLDLIRPGSF 198
Query: 283 SNLTSLR---LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLP 326
             LTSLR   L+ A +  +     DDL    LE LNL  N L  SLP
Sbjct: 199 QGLTSLRKLWLMHAQVATIERNAFDDLK--SLEELNLSHNNL-MSLP 242

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 24/177 (13%)
Query: 755 HKNIVKLWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLL-----------DWPTRYK 802
           H N+V L   CT     L+V  E+   G+L   L S +   +           D+ T   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 803 II---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
           +I      A+G+ +L        +HRD+ + NILL      ++ DFG+A+ +        
Sbjct: 141 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP-----VDPEFGEK 910
                    ++APE  +      +SD++SFGV++ E+ + G  P     +D EF  +
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 746 EVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           E+E L +  +H NI+ L           LV E M  G L D +   +           ++
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVL 127
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG----ARVADFGVAKVVDASGKPKSM 860
               + + YLH      +VHRD+K +NIL   + G     R+ DFG AK + A      +
Sbjct: 128 HTIGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG--LL 182
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                +  ++APE       +E  DI+S G+++  ++ G  P
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 688 DNVIGSGSSGKVYKVVLSNGEA---VAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQ 744
           D  +G G+ G V + V    +    VA+K L +G  K      D E+             
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEE-----------MM 384
Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR--YK 802
            E + + ++ +  IV+L   C   +  +LV E    G L   L    G   + P     +
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAE 440
Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
           ++   + G+ YL      + VHR++ + N+LL     A+++DFG++K + A         
Sbjct: 441 LLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS----YY 493
Query: 863 IAGSCG-----YIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
            A S G     + APE     + + +SD++S+GV + E ++
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR----VADFGVAKVVDASGKP-KSMSVI 863
           +G+ YLH + V   +HRD+K  NIL+ G+   R    +AD G A++ ++  KP   +  +
Sbjct: 139 DGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 864 AGSCGYIAPEYAYTLRVNEKS-DIYSFGVVILELVTG 899
             +  Y APE     R   K+ DI++ G +  EL+T 
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           EYEI++       IG+G+ G V        G+ VA+KK+         +  DV       
Sbjct: 56  EYEIIE------TIGNGAYGVVSSARRRLTGQQVAIKKI--------PNAFDVVTNAKRT 101
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSC 790
                    E++ L   +H NI+ +                 +V + M    L  ++HS 
Sbjct: 102 LR-------ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSS 153
Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
           +   L+   RY  +     GL Y+H      ++HRD+K +N+L++ +   ++ DFG+A+ 
Sbjct: 154 QPLTLEH-VRY-FLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 208
Query: 851 VDASGKPKS--MSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGR 900
           +  S       M+    +  Y APE   +L    +  D++S G +  E++  R
Sbjct: 209 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 13/193 (6%)
Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLL---DASMNDLTGPIPDDLTRL 309
           AIPS++   A   +++L +N L+      +  LT LRLL   D  +  L   I  +L  L
Sbjct: 30  AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 310 PLESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQ 368
             E+L + +N+L+ +LP  + D    L ELRL RN+L    P      + L ++ L  N+
Sbjct: 88  --ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144
Query: 369 FTGEIPASLCEKGELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPPLLW- 426
               +P  + +K    + L +YN+   ++P+G       L  ++L  N+L  +VP   + 
Sbjct: 145 LQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFD 202
Query: 427 GLPHVYLLELTDN 439
            L  + +L+L +N
Sbjct: 203 SLEKLKMLQLQEN 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 23/220 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            VIG G    V + +    G+  AVK +            DV K            + E 
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIV------------DVAKFTSSPGLSTEDLKREA 79
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG-DLLHSCKGGLL-DWPTRYKIIV 805
                ++H +IV+L    ++     +V+E+M    L  +++     G +         + 
Sbjct: 80  SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 139
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSV 862
              E L Y H +   +I+HRDVK + +LL   +     ++  FGVA  +  SG      V
Sbjct: 140 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 196
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+  ++APE        +  D++  GV++  L++G LP
Sbjct: 197 --GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 19/173 (10%)
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLL---- 795
              +E++ L  I  H N+V L   CT     L+V  E+   G+L   L S +   +    
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 796 -------DWPTRYKII---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
                  D+ T   +I      A+G+ +L        +HRD+ + NILL      ++ DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           G+A+ +                 ++APE  +      +SD++SFGV++ E+ +
Sbjct: 193 GLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 23/220 (10%)
Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGXXXXXXXXXGFQAEV 747
            VIG G    V + +    G+  AVK +            DV K            + E 
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIV------------DVAKFTSSPGLSTEDLKREA 77
Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG-DLLHSCKGGLL-DWPTRYKIIV 805
                ++H +IV+L    ++     +V+E+M    L  +++     G +         + 
Sbjct: 78  SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSV 862
              E L Y H +   +I+HRDVK + +LL   +     ++  FGVA  +  SG      V
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             G+  ++APE        +  D++  GV++  L++G LP
Sbjct: 195 --GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXXX 736
           EYEI++       IG+G+ G V        G+ VA+KK+         +  DV       
Sbjct: 55  EYEIIE------TIGNGAYGVVSSARRRLTGQQVAIKKI--------PNAFDVVTNAKRT 100
Query: 737 XXXXXGFQAEVETLGKIRHKNIVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSC 790
                    E++ L   +H NI+ +                 +V + M    L  ++HS 
Sbjct: 101 LR-------ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSS 152
Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
           +   L+   RY  +     GL Y+H      ++HRD+K +N+L++ +   ++ DFG+A+ 
Sbjct: 153 QPLTLEH-VRY-FLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207
Query: 851 VDASGKPKS--MSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGR 900
           +  S       M+    +  Y APE   +L    +  D++S G +  E++  R
Sbjct: 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 36/145 (24%), Positives = 63/145 (43%), Gaps = 10/145 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           + C L++ E M  G L   +              +I+ D    + +LH     +I HRDV
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 135
Query: 828 KSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L    + D   ++ DFG AK    +    ++     +  Y+APE     + ++  
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSC 191
Query: 885 DIYSFGVVILELVTGRLPVDPEFGE 909
           D++S GV++  L+ G  P     G+
Sbjct: 192 DMWSLGVIMYILLCGFPPFYSNTGQ 216

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 755 HKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLL-----------DWPTRYK 802
           H N+V L   CT     L+V  E+   G+L   L S +   +           D+ T   
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 803 II---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
           +I      A+G+ +L        +HRD+ + NILL      ++ DFG+A+ +        
Sbjct: 187 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
                    ++APE  +      +SD++SFGV++ E+ +
Sbjct: 244 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 715 LWRGMSKECESGCDVEKGXXXXXXXXXGFQAEVETLGKIRHKNIVKLW------------ 762
           ++  +  +C+    ++K              E++ + ++ H NIVK++            
Sbjct: 27  VFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86
Query: 763 --CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVP 820
                T  +   +V EYM    L ++L   +G LL+   R   +     GL Y+H     
Sbjct: 87  DVGSLTELNSVYIVQEYM-ETDLANVLE--QGPLLEEHARL-FMYQLLRGLKYIHS---A 139
Query: 821 SIVHRDVKSNNILLDG-DFGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTL 878
           +++HRD+K  N+ ++  D   ++ DFG+A+++D     K  +S    +  Y +P    + 
Sbjct: 140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP 199
Query: 879 RVNEKS-DIYSFGVVILELVTGR 900
               K+ D+++ G +  E++TG+
Sbjct: 200 NNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 58/138 (42%), Gaps = 9/138 (6%)
Query: 768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           R C L+V E +  G L   +              +I     E + YLH     +I HRDV
Sbjct: 131 RKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI---NIAHRDV 187
Query: 828 KSNNILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKS 884
           K  N+L      +   ++ DFG AK   +     S++    +  Y+APE     + ++  
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 244
Query: 885 DIYSFGVVILELVTGRLP 902
           D +S GV+   L+ G  P
Sbjct: 245 DXWSLGVIXYILLCGYPP 262

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 18/160 (11%)
Query: 754 RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLL-----------DWPTRY 801
            H N+V L   CT     L+V  E+   G+L   L S +   +           D+ T  
Sbjct: 91  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLE 150
Query: 802 KII---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
            +I      A+G+ +L        +HRD+ + NILL      ++ DFG+A+ +       
Sbjct: 151 HLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
                     ++APE  +      +SD++SFGV++ E+ +
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 24/177 (13%)
Query: 755 HKNIVKLWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLL-----------DWPTRYK 802
           H N+V L   CT     L+V  E+   G+L   L S +   +           D+ T   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 803 II---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
           +I      A+G+ +L        +HRD+ + NILL      ++ DFG+A+ +        
Sbjct: 141 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP-----VDPEFGEK 910
                    ++APE  +      +SD++SFGV++ E+ + G  P     +D EF  +
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 19/173 (10%)
Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLLHSCKGGLL---- 795
              +E++ L  I  H N+V L   CT     L+V  E+   G+L   L S +   +    
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 796 -------DWPTRYKII---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
                  D+ T   +I      A+G+ +L        +HRD+ + NILL      ++ DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           G+A+ +                 ++APE  +      +SD++SFGV++ E+ +
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 755 HKNIVKLWCCCTTRDCKLLVYEY-MPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSY 813
           H  +++L     T++  +LV E  +P   L D +   KG L + P+R        + ++ 
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFF----GQVVAA 151
Query: 814 LHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAP 872
           + H     +VHRD+K  NIL+D   G A++ DFG   ++      +  +   G+  Y  P
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----EPYTDFDGTRVYSPP 207
Query: 873 EYAYTLRVNE-KSDIYSFGVVILELVTGRLPV--DPEFGEKDLVKWVCSTLDQKGVDHVL 929
           E+    + +   + ++S G+++ ++V G +P   D E  E +L              HV 
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL----------HFPAHV- 256
Query: 930 DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
               DCC          +   C +P P +RP++  ++
Sbjct: 257 --SPDCC---------ALIRRCLAPKPSSRPSLEEIL 282

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 24/177 (13%)
Query: 755 HKNIVKLWCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLL-----------DWPTRYK 802
           H N+V L   CT     L+V  E+   G+L   L S +   +           D+ T   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 803 II---VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
           +I      A+G+ +L        +HRD+ + NILL      ++ DFG+A+ +        
Sbjct: 141 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP-----VDPEFGEK 910
                    ++APE  +      +SD++SFGV++ E+ + G  P     +D EF  +
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 254

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 104 SINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGR 163
           SI     D     ++L+ L LS+NL+      A   LP+L  L+L  N  +    ++F  
Sbjct: 46  SIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEY 105
Query: 164 FQKLEVISLVYNLLDGTIPAFLGN-ISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLT 222
             KL  + L  N ++ +IP++  N + +L+ L+L     L          L NL  L L 
Sbjct: 106 LSKLRELWLRNNPIE-SIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLNLG 164
Query: 223 ECNLVGEIPDSLGRXXXXXXXXXXXXXXXGAIPSSLTELASVVQIELYNNSLTGDLPTGW 282
            CNL  +IP+                         LT L  + ++EL  N L    P  +
Sbjct: 165 MCNL-KDIPN-------------------------LTALVRLEELELSGNRLDLIRPGSF 198
Query: 283 SNLTSLR---LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLP 326
             LTSLR   L+ A +  +     DDL    LE LNL  N L  SLP
Sbjct: 199 QGLTSLRKLWLMHAQVATIERNAFDDLK--SLEELNLSHNNL-MSLP 242

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 22/190 (11%)
Query: 757 NIVKLWCCCTTRDCKL--LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYL 814
           NIVKL      +  K   L++EY+ N     L  +    L D+  RY  I +  + L Y 
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT----LTDYDIRY-YIYELLKALDYC 162
Query: 815 HHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE 873
           H      I+HRDVK +N+++D +    R+ D+G+A+        K  +V   S  +  PE
Sbjct: 163 HSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 216
Query: 874 YAYTLRVNEKS-DIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHV---- 928
               L+  + S D++S G +   ++  + P        D +  +   L   G++      
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKY 276
Query: 929 ---LDPKLDC 935
              LDP+L+ 
Sbjct: 277 RIELDPQLEA 286

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL-GDLLHSCKGGLLDWPTRYKIIVDAAEGL 811
           ++H NIV+L    +      L+++ +  G L  D++        D     + I++A    
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 812 SYLHHDCVPSIVHRDVKSNNILLDGDF---GARVADFGVAKVVDASGKPKSMSVIAGSCG 868
             +       +VHR++K  N+LL         ++ADFG+A  ++  G+ ++    AG+ G
Sbjct: 127 HQM------GVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPG 178
Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           Y++PE        +  D+++ GV++  L+ G  P
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 52/112 (46%), Gaps = 3/112 (2%)
Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFS-GDIPESFGRFQKLEVISLVYNL 176
           +LQ L+LS N      T A  + P L+ LDL        D    F     L+V++L ++L
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 177 LDGTIPAFLGNISTLKMLNLSYNPFLPGRIPP--ELGNLTNLEILWLTECNL 226
           LD +       +  L+ LNL  N F  G I     L  L  LEIL L+ C+L
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 28/170 (16%)
Query: 747 VETLGKIRHKNIVKLWCCCTT------RDCKL-LVYEYMPNGSLGDLLHSC-----KGGL 794
           ++ L  + H NIV+L     T      RD  L +V EY+P     D LH C     +  +
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQV 124
Query: 795 LDWPTRYKI-IVDAAEGLSYLHHDCVPSIVHRDVKSNNILL-DGDFGARVADFGVAKVVD 852
              P   K+ +      +  LH   V ++ HRD+K +N+L+ + D   ++ DFG AK + 
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 853 ASGKPKSMSVIAGSCG--YIAPEYAY-TLRVNEKSDIYSFGVVILELVTG 899
            S +P     +A  C   Y APE  +         DI+S G +  E++ G
Sbjct: 184 PS-EPN----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 37/187 (19%)
Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGXXX 735
           S+++I D  +  ++IG+GS G V +         VA+KK+ R      E   D ++    
Sbjct: 47  SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF----EDLIDCKR---- 98
Query: 736 XXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
                     E+  L ++ H ++VK+      +D +     Y+    + ++  S    L 
Sbjct: 99  -------ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV----VLEIADSDFKKLF 147
Query: 796 DWPTR----------YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
             P            Y ++V    G+ Y+H      I+HRD+K  N L++ D   +V DF
Sbjct: 148 RTPVYLTELHIKTLLYNLLV----GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDF 200
Query: 846 GVAKVVD 852
           G+A+ VD
Sbjct: 201 GLARTVD 207

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 757 NIVKLWCCCTTRDCKL--LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYL 814
           NIVKL      +  K   L++EY+ N     L  +    L D+  RY  I +  + L Y 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT----LTDYDIRY-YIYELLKALDYC 143
Query: 815 HHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE 873
           H      I+HRDVK +N+++D +    R+ D+G+A+        K  +V   S  +  PE
Sbjct: 144 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 197
Query: 874 YAYTLRVNEKS-DIYSFGVVILELVTGRLP 902
               L+  + S D++S G +   ++  + P
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 227

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 101/267 (37%), Gaps = 56/267 (20%)
Query: 675 GFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEA-VAVKKLWRGMSKECESGCDVEKGX 733
           G     + D     ++IG GS G VY     N E  VA+KK+ R      E   D ++  
Sbjct: 18  GIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF----EDLIDCKR-- 71
Query: 734 XXXXXXXXGFQAEVETLGKIRHKNIVKLWCCCTTRDC----KLLVYEYMPNGSLGDLLHS 789
                       E+  L +++   I++L+      D     +L +   + +  L  L  +
Sbjct: 72  ---------ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT 122
Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
                L       I+ +   G +++H      I+HRD+K  N LL+ D   +V DFG+A+
Sbjct: 123 --PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 850 VVDASGK--------------------PKSMSVIAGSCGYIAPEYAYTLRVNEKS-DIYS 888
            +++                        K ++    +  Y APE         KS DI+S
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 889 FGVVILELV----------TGRLPVDP 905
            G +  EL+          T R P+ P
Sbjct: 238 TGCIFAELLNMLQSHINDPTNRFPLFP 264

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 757 NIVKLWCCCTTRDCKL--LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYL 814
           NIVKL      +  K   L++EY+ N     L  +    L D+  RY  I +  + L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT----LTDYDIRY-YIYELLKALDYC 141
Query: 815 HHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE 873
           H      I+HRDVK +N+++D +    R+ D+G+A+        K  +V   S  +  PE
Sbjct: 142 H---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 195
Query: 874 YAYTLRVNEKS-DIYSFGVVILELVTGRLP 902
               L+  + S D++S G +   ++  + P
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 12/162 (7%)
Query: 746 EVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           E+E L +  +H NI+ L           +V E    G L D +   +           ++
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKI--LRQKFFSEREASAVL 122
Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG----ARVADFGVAKVVDASGKPKSM 860
               + + YLH      +VHRD+K +NIL   + G     R+ DFG AK + A      +
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LL 177
Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                +  ++APE       +   DI+S GV++   +TG  P
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 82/207 (39%), Gaps = 27/207 (13%)
Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN--------FSG-------------- 155
           NL  LD+S+N +   L     DL NLK L++  N+        FSG              
Sbjct: 105 NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164
Query: 156 -DIP-ESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNL 213
             IP E+      L V+ L +  ++         +  LK+L +S+ P+L    P  L  L
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 214 TNLEILWLTECNLVGEIPDSLGRXXXXXXXXXXXXXXXGAIPSS-LTELASVVQIELYNN 272
            NL  L +T CNL   +P    R                 I  S L EL  + +I+L   
Sbjct: 225 -NLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 273 SLTGDLPTGWSNLTSLRLLDASMNDLT 299
            L    P  +  L  LR+L+ S N LT
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLT 309

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1002
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-150
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-147
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-108
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-98
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-96
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-94
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-91
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-89
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-89
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-81
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-89
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-77
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-69
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-39
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-80
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-66
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-79
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-15
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-73
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-20
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-73
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-71
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-67
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-25
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-59
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-56
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-54
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-52
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-31
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-48
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-45
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-39
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-21
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-39
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-36
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-36
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-20
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-31
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-14
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-06
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-22
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-05
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-28
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-11
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-26
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-05
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-09
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-07
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-08
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-04
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	4e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  463 bits (1193), Expect = e-150
 Identities = 172/620 (27%), Positives = 272/620 (43%), Gaps = 55/620 (8%)

Query: 15  LSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRS------ 68
               PS SL +E   L   K  L D  + L  W  N    +PC++ GV C          
Sbjct: 2   FQASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSN---KNPCTFDGVTCRDDKVTSIDL 57

Query: 69  -------------------HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTL 109
                                + S+ LSN++I G          +LT L L  NS++  +
Sbjct: 58  SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPV 116

Query: 110 PDD--ISACQNLQHLDLSQNLLTGTL-TPALADLPNLKFLDLTGNNFSGDIPESF---GR 163
                + +C  L+ L++S N L           L +L+ LDL+ N+ SG     +     
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176

Query: 164 FQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTE 223
             +L+ +++  N + G +   +     L+ L++S N      IP  LG+ + L+ L ++ 
Sbjct: 177 CGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSN-NFSTGIP-FLGDCSALQHLDISG 232

Query: 224 CNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-W 282
             L G+   ++    +L  L+++ N  VG IP     L S+  + L  N  TG++P    
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLS 290

Query: 283 SNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPA-TIADSPGLYELRL 340
               +L  LD S N   G +P        LESL L  N   G LP  T+    GL  L L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350

Query: 341 FRNRLNGTLPGDLGKNSP-LRWVDLSNNQFTGEIPASLCE--KGELEELLMIYNSFTGQL 397
             N  +G LP  L   S  L  +DLS+N F+G I  +LC+  K  L+EL +  N FTG++
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410

Query: 398 PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSL 457
           P  L +C  L  + L +N L+G +P  L  L  +  L+L  N L GEI + +     L  
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470

Query: 458 LIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGEL 517
           LI+  N+L+G +P  +    +L  +S S N+ TG +P+ +  L  L  L L  N  SG +
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530

Query: 518 PSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQ- 576
           P+ +   + L  L+L  NLF G IP  +   S      ++ N ++G+  V ++N  + + 
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKE 586

Query: 577 --LNVSNNRLSGELPSLFAK 594
                +     G       +
Sbjct: 587 CHGAGNLLEFQGIRSEQLNR 606

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  455 bits (1174), Expect = e-147
 Identities = 171/569 (30%), Positives = 253/569 (44%), Gaps = 54/569 (9%)

Query: 69  HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNL 128
            ++  +D+S+ N +   P L      L  L +  N ++      IS C  L+ L++S N 
Sbjct: 200 VNLEFLDVSSNNFSTGIPFL-GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258

Query: 129 LTGTLTPALADLPNLKFLDLTGNNFSGDIPES-FGRFQKLEVISLVYNLLDGTIPAFLGN 187
             G + P    L +L++L L  N F+G+IP+   G    L  + L  N   G +P F G+
Sbjct: 259 FVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316

Query: 188 ISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRL-AKLVDLDL 245
            S L+ L LS N    G +P + L  +  L++L L+     GE+P+SL  L A L+ LDL
Sbjct: 317 CSLLESLALSSN-NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375

Query: 246 ALNNLVGAIPSSL--TELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIP 303
           + NN  G I  +L      ++ ++ L NN  TG +P   SN + L  L  S N L+G IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435

Query: 304 DDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWV 362
             L  L  L  L L+ N LEG +P  +     L  L L  N L G +P  L   + L W+
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495

Query: 363 DLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVP 422
            LSNN+ TGEIP  +     L  L +  NSF+G +P  LG C+SL  + L  N   G +P
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555

Query: 423 PLLWGLP----------------------HVYLLELTDNFLSGEISKNIAGAANLSLLII 460
             ++                                      G  S+ +   +  +   I
Sbjct: 556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615

Query: 461 SKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSS 520
           +     G          S++ L  S N  +G +P+ + ++  L  L+L  ND+SG +P  
Sbjct: 616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675

Query: 521 VSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVS 580
           V   + LN L+L+ N   G IP+ +  L++L  +DLSNN LSG IP   Q         +
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ---FETFPPA 732

Query: 581 NNRLSGELPSLFAKEMYRNSFLGNPGLCG 609
                               FL NPGLCG
Sbjct: 733 -------------------KFLNNPGLCG 742

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  338 bits (868), Expect = e-108
 Identities = 119/318 (37%), Positives = 178/318 (55%), Gaps = 27/318 (8%)

Query: 676 FSEYEIL---DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKG 732
           FS  E+    D     N++G G  GKVYK  L++G  VAVK+L     +E   G +++  
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL----KEERTQGGELQ-- 73

Query: 733 QVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                     FQ EVE +    H+N+++L   C T   +LLVY YM NGS+   L     
Sbjct: 74  ----------FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123

Query: 793 G--LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
               LDWP R +I + +A GL+YLH  C P I+HRDVK+ NILLD +F A V DFG+AK+
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183

Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
           +D      + +V  G+ G+IAPEY  T + +EK+D++ +GV++LEL+TG+   D      
Sbjct: 184 MDYKDTHVTTAV-RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 911 D----LVKWVCSTLDQKGVDHVLDPKLDCCF-KEEICKVLNIGLLCTSPLPINRPAMRRV 965
           D    L+ WV   L +K ++ ++D  L   +  EE+ +++ + LLCT   P+ RP M  V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 966 VKLLQEVGAENRSKTGKK 983
           V++L+  G   R +  +K
Sbjct: 303 VRMLEGDGLAERWEEWQK 320

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  311 bits (799), Expect = 3e-98
 Identities = 104/330 (31%), Positives = 159/330 (48%), Gaps = 28/330 (8%)

Query: 651 KYRKFKNGRAIDKSKWTLMSFHKLGFSEYEIL---DGLDEDNVIGSGSSGKVYKVVLSNG 707
           KY K  N      S   L+ F        ++    +  D   +IG G  GKVYK VL +G
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 708 EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT 767
             VA+K+               E  Q  ++     F+ E+ETL   RH ++V L   C  
Sbjct: 64  AKVALKRR------------TPESSQGIEE-----FETEIETLSFCRHPHLVSLIGFCDE 106

Query: 768 RDCKLLVYEYMPNGSLGDLLH--SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHR 825
           R+  +L+Y+YM NG+L   L+        + W  R +I + AA GL YLH      I+HR
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHR 163

Query: 826 DVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSD 885
           DVKS NILLD +F  ++ DFG++K      +    +V+ G+ GYI PEY    R+ EKSD
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSD 223

Query: 886 IYSFGVVILELVTGRLPVDP--EFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCF-KEEIC 942
           +YSFGVV+ E++  R  +         +L +W   + +   ++ ++DP L      E + 
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLR 283

Query: 943 KVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           K  +  + C +    +RP+M  V+  L+  
Sbjct: 284 KFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  305 bits (783), Expect = 4e-96
 Identities = 102/300 (34%), Positives = 154/300 (51%), Gaps = 23/300 (7%)

Query: 675 GFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
            F E  I  G    N +G G  G VYK  + N   VAVKKL         +  D+   ++
Sbjct: 26  NFDERPISVG---GNKMGEGGFGVVYKGYV-NNTTVAVKKL--------AAMVDITTEEL 73

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
           + Q     F  E++ + K +H+N+V+L    +  D   LVY YMPNGSL D L    G  
Sbjct: 74  KQQ-----FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 795 -LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
            L W  R KI   AA G+++LH +     +HRD+KS NILLD  F A+++DFG+A+  + 
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
             +    S I G+  Y+APE      +  KSDIYSFGVV+LE++TG   VD     + L+
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

Query: 914 KWVCSTL-DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
                   ++K ++  +D K++      +  + ++   C       RP +++V +LLQE+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  311 bits (799), Expect = 3e-94
 Identities = 101/598 (16%), Positives = 185/598 (30%), Gaps = 80/598 (13%)

Query: 38  SDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTF 97
                  ++W  N   D   +  GV  +     V  + L     +G  P  + +L  L  
Sbjct: 51  GFGTQPGANWNFNKELDMWGAQPGVSLNSNGR-VTGLSLEGFGASGRVPDAIGQLTELEV 109

Query: 98  LTLFNNSI----NSTLPDDISACQNLQHLDLSQNLLTGTLTPALA--DLPNLKFLDLTGN 151
           L L ++          P  ISA  + +     +     T        D  +L    +  +
Sbjct: 110 LALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169

Query: 152 NFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELG 211
                I +S     K   I  + N +   +   +  ++ L+   +  +P        E  
Sbjct: 170 PQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSP-FVAENICEAW 227

Query: 212 NLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYN 271
              N E                   L  L D+++     +  +P+ L  L  +  I +  
Sbjct: 228 ENENSEYA-----QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282

Query: 272 NSLT--------GDLPTGWSNLTSLRLLDASMNDL-TGPIPDDLTRLP-LESLNLYENRL 321
           N                       ++++    N+L T P+   L ++  L  L    N+L
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL 342

Query: 322 EGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK- 380
           EG LPA                          G    L  ++L+ NQ T  IPA+ C   
Sbjct: 343 EGKLPA-------------------------FGSEIKLASLNLAYNQITE-IPANFCGFT 376

Query: 381 GELEELLMIYNSFTGQLPD--GLGHCQSLTRVRLGYNRLTG-------KVPPLLWGLPHV 431
            ++E L   +N     +P+         ++ +   YN +          + P  +   +V
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

Query: 432 YLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSG-------SLPEEIGFLKSLVVLSG 484
             + L++N +S    +  +  + LS + +  N L+           E       L  +  
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495

Query: 485 SENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNL------F 537
             NK T    +   T L  L  +DL  N  S   P+   +   L    + +         
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554

Query: 538 YGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG-LQNLKLNQLNVSNNRLSGELPSLFAK 594
               PE I     L  L + +N +   +      N+    L++ +N       S    
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNIS--VLDIKDNPNISIDLSYVCP 609

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  192 bits (490), Expect = 7e-52
 Identities = 59/334 (17%), Positives = 114/334 (34%), Gaps = 32/334 (9%)

Query: 83  GPFPSLLCRLENLTFLTLFNNSINS-TLPDDISACQNLQHLDLSQNLLTGTLTPALADLP 141
               +     E +  + +  N++ +  +   +   + L  L+   N L G L PA     
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL-PAFGSEI 353

Query: 142 NLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPA--FLGNISTLKMLNLSYN 199
            L  L+L  N  +       G  +++E +S  +N L   IP      ++S +  ++ SYN
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYN 412

Query: 200 PF------LPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG- 252
                       + P      N+  + L+   +     +     + L  ++L  N L   
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472

Query: 253 ------AIPSSLTELASVVQIELYNNSLTGDLPT--GWSNLTSLRLLDASMNDLTGPIPD 304
                     +      +  I+L  N LT  L      + L  L  +D S N  +   P 
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPT 530

Query: 305 DLTRLP-LESLNLYE------NRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNS 357
                  L+   +        NR     P  I   P L +L++  N +   +   +  N 
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPN- 588

Query: 358 PLRWVDLSNNQFTGEIPASLCEKGELEELLMIYN 391
            +  +D+ +N       + +C   E    ++ Y+
Sbjct: 589 -ISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 1e-11
 Identities = 22/108 (20%), Positives = 39/108 (36%), Gaps = 10/108 (9%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFN------NSINSTLPDDISACQNLQHLDLSQN 127
           IDLS  + +  FP+       L    + N      N      P+ I+ C +L  L +  N
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576

Query: 128 LLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN 175
            +   +   +   PN+  LD+  N            + +  +  L Y+
Sbjct: 577 DIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 13/78 (16%), Positives = 24/78 (30%), Gaps = 3/78 (3%)

Query: 75  DLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLT 134
           D         +P  +    +LT L + +N I   + + I    N+  LD+  N       
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDL 604

Query: 135 PALADLPNLKFLDLTGNN 152
             +          L  + 
Sbjct: 605 SYVCPYIEAGMYMLFYDK 622

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  305 bits (783), Expect = 2e-91
 Identities = 113/560 (20%), Positives = 201/560 (35%), Gaps = 38/560 (6%)

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
           ++  ++L++  +     +   R   LT L +  N+I+   P+       L+ L+L  N L
Sbjct: 26  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85

Query: 130 TGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNIS 189
           +       A   NL  L L  N+        F + + L  + L +N L  T       + 
Sbjct: 86  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145

Query: 190 TLKMLNLSYNPFLPGRIPPE---LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA 246
            L+ L LS N      +  E   +   ++L+ L L+   +    P     + +L  L L 
Sbjct: 146 NLQELLLSNNKIQ--ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203

Query: 247 LNNLVGAIPSSLTELASVVQIE---LYNNSLTGDLPTGWSNL--TSLRLLDASMNDLTGP 301
              L  ++   L    +   I    L N+ L+    T +  L  T+L +LD S N+L   
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 302 IPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTL---------PG 351
             D    LP LE   L  N ++     ++     +  L L R+    ++           
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323

Query: 352 DLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYN-----SFTGQLPDGLGHCQS 406
                  L  +++ +N   G           L+ L +  +     + T +    L H   
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SP 382

Query: 407 LTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKN-IAGAANLSLLIISKNNL 465
           L  + L  N+++         L H+ +L+L  N +  E++     G  N+  + +S N  
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442

Query: 466 SGSLPEEIGFLKSLVVLSGSENKFTG--SLPESLTNLAELGSLDLHANDLSGELPSSVSS 523
                     + SL  L           S P     L  L  LDL  N+++      +  
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502

Query: 524 WKKLNELNLADN--------LFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-L 574
            +KL  L+L  N           G     +  LS L+ L+L +N          ++L  L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562

Query: 575 NQLNVSNNRLSGELPSLFAK 594
             +++  N L+    S+F  
Sbjct: 563 KIIDLGLNNLNTLPASVFNN 582

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  299 bits (768), Expect = 2e-89
 Identities = 117/574 (20%), Positives = 192/574 (33%), Gaps = 36/574 (6%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            ++L +  ++           NLT L L +NSI     +     +NL  LDLS N L+ T
Sbjct: 77  VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQ--KLEVISLVYNLLDGTIPAFLGNIST 190
                  L NL+ L L+ N       E    F    L+ + L  N +    P     I  
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196

Query: 191 LKMLNLSYNPFLPGRIPPELG---NLTNLEILWLTECNLVGEIPDSLG--RLAKLVDLDL 245
           L  L L+    L   +  +L      T++  L L+   L      +    +   L  LDL
Sbjct: 197 LFGLFLNNV-QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

Query: 246 ALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLD---------ASMN 296
           + NNL      S   L  +    L  N++          L ++R L+          S+ 
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315

Query: 297 DLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN-GTLPGDLG 354
            L          L  LE LN+ +N + G           L  L L  +  +  TL  +  
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375

Query: 355 KN---SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDG-LGHCQSLTRV 410
            +   SPL  ++L+ N+ +     +    G LE L +  N    +L        +++  +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435

Query: 411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG--EISKNIAGAANLSLLIISKNNLSGS 468
            L YN+           +P +  L L    L              NL++L +S NN++  
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495

Query: 469 LPEEIGFLKSLVVLSGSENKFT--------GSLPESLTNLAELGSLDLHANDLSGELPSS 520
             + +  L+ L +L    N           G     L  L+ L  L+L +N         
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555

Query: 521 VSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL--KLNQLN 578
                +L  ++L  N           N   L  L+L  N ++             L +L+
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615

Query: 579 VSNNRLSGELPSLFA-KEMYRNSFLGNPGLCGDL 611
           +  N       S+         +    P L    
Sbjct: 616 MRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  299 bits (768), Expect = 2e-89
 Identities = 120/553 (21%), Positives = 191/553 (34%), Gaps = 37/553 (6%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
             D S+  +    P  L    N+T L L +N +      + +    L  LD+  N ++  
Sbjct: 8   VADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKL 64

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
                  LP LK L+L  N  S    ++F     L  + L+ N +             L 
Sbjct: 65  EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI 124

Query: 193 MLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLA--KLVDLDLALNNL 250
            L+LS+N  L          L NL+ L L+   +     + L   A   L  L+L+ N +
Sbjct: 125 TLDLSHN-GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 251 VGAIPSSLTELASVVQIELYNNSLTGDLPTG---WSNLTSLRLLDASMNDLTGPIPDDLT 307
               P     +  +  + L N  L   L          TS+R L  S + L+        
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 308 RLP---LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDL 364
            L    L  L+L  N L      + A  P L    L  N +       L     +R+++L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 365 SNN---------QFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN 415
             +                 S      LE L M  N   G   +      +L  + L  +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363

Query: 416 RLTGKVPP--LLWGLPHVYL--LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP- 470
             + +         L H  L  L LT N +S   S   +   +L +L +  N +   L  
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423

Query: 471 EEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSG--ELPSSVSSWKKLN 528
           +E   L+++  +  S NK+      S   +  L  L L    L      PS     + L 
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483

Query: 529 ELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS--------GRIPVGLQNL-KLNQLNV 579
            L+L++N       + +  L  L  LDL +N L+        G     L+ L  L+ LN+
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543

Query: 580 SNNRLSGELPSLF 592
            +N        +F
Sbjct: 544 ESNGFDEIPVEVF 556

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  278 bits (713), Expect = 1e-81
 Identities = 106/500 (21%), Positives = 179/500 (35%), Gaps = 29/500 (5%)

Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLL 177
           + +  D S   LT  +   L    N+  L+LT N        +F R+ +L  + + +N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 178 DGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRL 237
               P     +  LK+LNL +N  L           TNL  L L   ++     +   + 
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNE-LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 238 AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTG--DLPTGWSNLTSLRLLDASM 295
             L+ LDL+ N L      +  +L ++ ++ L NN +             +SL+ L+ S 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 296 NDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLY---ELRLFRNRLNGTLPG 351
           N +    P     +  L  L L   +L  SL   +           L L  ++L+ T   
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 352 DLG--KNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLT- 408
                K + L  +DLS N        S     +LE   + YN+        L    ++  
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 409 --------RVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLII 460
                   +  +    L          L  +  L + DN + G  S    G  NL  L +
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360

Query: 461 SKNNLSGSLPEEIGF----LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGE 516
           S +  S        F       L +L+ ++NK +    ++ + L  L  LDL  N++  E
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420

Query: 517 LPSSV-SSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG--RIPVGLQNL- 572
           L        + + E+ L+ N +          +  L  L L    L      P   Q L 
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

Query: 573 KLNQLNVSNNRLSGELPSLF 592
            L  L++SNN ++     + 
Sbjct: 481 NLTILDLSNNNIANINDDML 500

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  179 bits (456), Expect = 4e-47
 Identities = 67/325 (20%), Positives = 113/325 (34%), Gaps = 18/325 (5%)

Query: 68  SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQN 127
             S     +S A++          L+ L  L + +N I     +  +   NL++L LS +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363

Query: 128 LLTGTLTPALA----DLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPA 183
             +                L  L+LT N  S    ++F     LEV+ L  N +   +  
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423

Query: 184 -FLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL--VGEIPDSLGRLAKL 240
                +  +  + LSYN +L          + +L+ L L    L  V   P     L  L
Sbjct: 424 QEWRGLENIFEIYLSYNKYL-QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482

Query: 241 VDLDLALNNLVGAIPSSLTELASVVQIELYNNSLT--------GDLPTGWSNLTSLRLLD 292
             LDL+ NN+       L  L  +  ++L +N+L         G        L+ L +L+
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542

Query: 293 ASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPG 351
              N       +    L  L+ ++L  N L     +   +   L  L L +N +      
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602

Query: 352 DLGKN-SPLRWVDLSNNQFTGEIPA 375
             G     L  +D+  N F     +
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  116 bits (292), Expect = 7e-27
 Identities = 46/192 (23%), Positives = 74/192 (38%), Gaps = 6/192 (3%)

Query: 406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNL 465
           S       + +LT +VP  L    ++ +L LT N L    + N    + L+ L +  N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 466 SGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWK 525
           S   PE    L  L VL+   N+ +    ++      L  L L +N +     +     K
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 526 KLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK---LNQLNVSNN 582
            L  L+L+ N            L  L  L LSNN++       L       L +L +S+N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 583 RLSGELPSLFAK 594
           ++    P  F  
Sbjct: 182 QIKEFSPGCFHA 193

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  298 bits (764), Expect = 1e-89
 Identities = 110/538 (20%), Positives = 184/538 (34%), Gaps = 32/538 (5%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF 153
           +   L L  N +         +   LQ LDLS+  +      A   L +L  L LTGN  
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 154 SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNL 213
                 +F     L+ +  V   L       +G++ TLK LN+++N     ++P    NL
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 214 TNLEILWLTECNLVGEIPDSLGRLAKL----VDLDLALNNLVGAIPSSLTELASVVQIEL 269
           TNLE L L+   +       L  L ++    + LDL+LN +    P +  E+  + ++ L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL 207

Query: 270 YNNSLTGDLPTGW-SNLTSLRLLDASMNDLTG----PIPDDLTRLPLESLNLYENRLE-- 322
            NN  + ++       L  L +    + +          D      L +L + E RL   
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

Query: 323 ----GSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLC 378
                 +         +    L    +          N   + ++L N +F       L 
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKL- 324

Query: 379 EKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLT--GKVPPLLWGLPHVYLLEL 436
               L+ L    N              SL  + L  N L+  G      +G   +  L+L
Sbjct: 325 --KSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 437 TDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVLSGSENKFTGSLPE 495
           + N +   +S N  G   L  L    +NL       +   L++L+ L  S      +   
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 496 SLTNLAELGSLDLHANDLSGELPSSV-SSWKKLNELNLADNLFYGNIPEDIGNLSVLNYL 554
               L+ L  L +  N         + +  + L  L+L+        P    +LS L  L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 555 DLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPSLFAKEMYRNSFL---GNPGLC 608
           ++S+N          + L  L  L+ S N +               +FL    N   C
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  265 bits (679), Expect = 1e-77
 Identities = 106/544 (19%), Positives = 185/544 (34%), Gaps = 32/544 (5%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            +DLS   I          L +L+ L L  N I S      S   +LQ L   +  L   
Sbjct: 56  VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115

Query: 133 LTPALADLPNLKFLDLTGNNF-SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTL 191
               +  L  LK L++  N   S  +PE F     LE + L  N +       L  +  +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 192 KM----LNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP-DSLGRLAKLVDLDLA 246
            +    L+LS NP     I P       L  L L        +    +  LA L    L 
Sbjct: 176 PLLNLSLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233

Query: 247 LN------NLVGAIPSSLTELASVVQIEL---YNNSLTGDLPTGWSNLTSLRLLDASMND 297
           L       NL     S+L  L ++   E    Y +    D+   ++ LT++         
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293

Query: 298 LTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNS 357
           +             + L L   +        +     L  L    N+             
Sbjct: 294 IERVKDFSYNFG-WQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAFS--EVDLP 347

Query: 358 PLRWVDLSNNQ--FTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN 415
            L ++DLS N   F G    S      L+ L + +N     +       + L  +   ++
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406

Query: 416 RLTGKVPP-LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSL-PEEI 473
            L       +   L ++  L+++        +    G ++L +L ++ N+   +  P+  
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466

Query: 474 GFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLA 533
             L++L  L  S+ +     P +  +L+ L  L++  N+              L  L+ +
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 526

Query: 534 DNLFYGNIPEDIGNL-SVLNYLDLSNNRLSGRIPVG--LQNLK-LNQLNVSNNRLSGELP 589
            N    +  +++ +  S L +L+L+ N  +        LQ +K   QL V   R+    P
Sbjct: 527 LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586

Query: 590 SLFA 593
           S   
Sbjct: 587 SDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  243 bits (621), Expect = 1e-69
 Identities = 102/530 (19%), Positives = 174/530 (32%), Gaps = 54/530 (10%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
           ++ L+   I          L +L  L     ++ S     I   + L+ L+++ NL+   
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 133 -LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEV----ISLVYNLLDGTIPAFLGN 187
            L    ++L NL+ LDL+ N              ++ +    + L  N ++   P     
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 188 ISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLT------ECNLVGEIPDSLGRLAKLV 241
           I  L  L L  N      +   +  L  LE+  L       E NL      +L  L  L 
Sbjct: 200 IR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

Query: 242 DLDLALNNL---VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDL 298
             +  L  L   +  I      L +V    L + ++       +S     + L+      
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316

Query: 299 TGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN--GTLPGDLGKN 356
                  L  L      L     +G    +  D P L  L L RN L+  G         
Sbjct: 317 GQFPTLKLKSL----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 357 SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYN 415
           + L+++DLS N     + ++     +LE L   +++             ++L  + + + 
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 416 RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIG 474
                   +  GL  + +L++  N        +I     NL+ L +S+  L    P    
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 475 FLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW-KKLNELNLA 533
            L SL VL+ S N F          L  L  LD   N +       +  +   L  LNL 
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 534 DNLFYGNI--------------------------PEDIGNLSVLNYLDLS 557
            N F                              P D   + VL+ L+++
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS-LNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  153 bits (388), Expect = 6e-39
 Identities = 54/255 (21%), Positives = 94/255 (36%), Gaps = 9/255 (3%)

Query: 69  HSVASIDLSNANIA--GPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQ 126
            S+  +DLS   ++  G          +L +L L  N +  T+  +    + L+HLD   
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQH 405

Query: 127 NLLTGTLTP-ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTI-PAF 184
           + L           L NL +LD++  +        F     LEV+ +  N       P  
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

Query: 185 LGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLD 244
              +  L  L+LS    L    P    +L++L++L ++  N           L  L  LD
Sbjct: 466 FTELRNLTFLDLSQC-QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524

Query: 245 LALNNLVGAIPSSLTELA-SVVQIELYNNSLTGDLPTGW--SNLTSLRLLDASMNDLTGP 301
            +LN+++ +    L     S+  + L  N              +   R L   +  +   
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584

Query: 302 IPDDLTRLPLESLNL 316
            P D   +P+ SLN+
Sbjct: 585 TPSDKQGMPVLSLNI 599

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  278 bits (713), Expect = 5e-80
 Identities = 91/595 (15%), Positives = 193/595 (32%), Gaps = 58/595 (9%)

Query: 32  RVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCR 91
           R      +      +W  N   D      GV+ D     V  + L+     G  P  + +
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGR-VTGLSLAGFGAKGRVPDAIGQ 345

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTG 150
           L  L  L+   +S   +              +  ++ +        L     L   DL  
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405

Query: 151 NNFSGD---IPESFGRFQKLEV--ISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGR 205
           +  + +    P        L+   I  + N +   I   +  ++ L+++  + +PF    
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPF--TY 462

Query: 206 IPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVV 265
               +                      S   L  L D++L     +  +P  L +L  + 
Sbjct: 463 DNIAVDWEDAN----SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518

Query: 266 QIELYNNSLTG---------DLPTGWSNLTSLRLLDASMNDLTG-PIPDDLTRLP-LESL 314
            + +  N              L         +++     N+L   P    L ++  L  L
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL 578

Query: 315 NLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP-LRWVDLSNNQFTGEI 373
           +   N++   L A    +  L +L+L  N++   +P D    +  +  +  S+N+    I
Sbjct: 579 DCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI 634

Query: 374 P--ASLCEKGELEELLMIYNSFTGQLPD-----GLGHCQSLTRVRLGYNRLTGKVPPLLW 426
           P   +      +  +   YN    +  +           + + V L YN +      L  
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694

Query: 427 GLPHVYLLELTDNFLS-------GEISKNIAGAANLSLLIISKNNLSGSLPEEIGF--LK 477
               +  + L++N ++            N      L+ + +  N L+ SL ++     L 
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753

Query: 478 SLVVLSGSENKFTGSLPESLTNLAELGSLDL------HANDLSGELPSSVSSWKKLNELN 531
            L  +  S N F+ S P    N ++L +  +        N +  + P+ +++   L +L 
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812

Query: 532 LADNLFYGNIPEDIGNLSVLNYLDLSNNRL-SGRIPVGLQNLKLNQLNVSNNRLS 585
           +  N     + E +     L  LD+++N   S  +      ++     +  ++  
Sbjct: 813 IGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  240 bits (613), Expect = 1e-66
 Identities = 104/614 (16%), Positives = 202/614 (32%), Gaps = 76/614 (12%)

Query: 65  DPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDL 124
           D +    A++ +     A               L   N    S   ++     N    + 
Sbjct: 248 DNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNK 306

Query: 125 SQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPA- 183
             ++        L +   +  L L G    G +P++ G+  +L+V+S   +    +    
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 184 ------------------------FLGNISTLKMLNLSYNPF--LPGRIPPELGNLTNLE 217
                                   FL     L + +L  +     P   P +  +  +L+
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426

Query: 218 ILWLTEC-NLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTG 276
              +    N +  I  ++ RL KL  +  A +       +   E A+             
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN-----SDYAKQYE 481

Query: 277 DLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEG---------SLP 326
           +    WSNL  L  ++         +PD L  LP L+SLN+  NR             L 
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 327 ATIADSPGLYELRLFRNRLNG-TLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEE 385
                 P +    +  N L        L K   L  +D  +N+    +  +     +L +
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTD 599

Query: 386 LLMIYNSFTGQLPDGLG-HCQSLTRVRLGYNRLTGKVPPL--LWGLPHVYLLELTDNFLS 442
           L + YN    ++P+        +  +   +N+L   +P +     +  +  ++ + N + 
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 443 GE-----ISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT------- 490
            E      S +     N S + +S N +     E       +  +  S N  T       
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSS--VSSWKKLNELNLADNLFYGNIPEDIGNL 548
                +  N   L ++DL  N L+  L      ++   L+ ++++ N F  + P    N 
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNS 775

Query: 549 SVLNYLDL------SNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSLFAKEMYRNSF 601
           S L    +        NR+  + P G+     L QL + +N +  ++      ++Y    
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDI 834

Query: 602 LGNPGLCGDLEGLC 615
             NP +  D+  +C
Sbjct: 835 ADNPNISIDVTSVC 848

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  228 bits (584), Expect = 7e-63
 Identities = 88/543 (16%), Positives = 166/543 (30%), Gaps = 61/543 (11%)

Query: 20  SLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNA 79
           S   + E +           PD +     R             +    S  +      N 
Sbjct: 353 SFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP 412

Query: 80  NIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALAD 139
            +          L++     L N    + +   I     LQ +  + +  T         
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRI--TFISKAIQRLTKLQIIYFANSPFTY-----DNI 465

Query: 140 LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYN 199
             + +  +        +   S+   + L  + L        +P FL ++  L+ LN++ N
Sbjct: 466 AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525

Query: 200 PF--------LPGRIPPELGNLTNLEILWLTECNLVGEIPDS--LGRLAKLVDLDLALNN 249
                        R+  +      ++I ++   NL  E P S  L ++ KL  LD   N 
Sbjct: 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNK 584

Query: 250 LVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTG-PIPDDLT 307
           +      +      +  ++L  N +   +P    +    +  L  S N L   P   +  
Sbjct: 585 V--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK 641

Query: 308 RLP-LESLNLYENRLEGSLPATIADSPG------LYELRLFRNRLNGTLPGDLGKNSPLR 360
            +  + S++   N++  S    I+ S           + L  N +           SP+ 
Sbjct: 642 SVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS 700

Query: 361 WVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGK 420
            + LSNN  T  IP +                          +   LT + L +N+LT  
Sbjct: 701 TIILSNNLMT-SIPENSL----------------KPKDGNYKNTYLLTTIDLRFNKLTS- 742

Query: 421 VPP--LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLL------IISKNNLSGSLPEE 472
           +        LP++  ++++ N  S         ++ L             N +    P  
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801

Query: 473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL 532
           I    SL+ L    N     + E L    +L  LD+  N       +SV  + +     L
Sbjct: 802 ITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVL 858

Query: 533 ADN 535
             +
Sbjct: 859 LYD 861

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  270 bits (692), Expect = 2e-79
 Identities = 119/555 (21%), Positives = 197/555 (35%), Gaps = 36/555 (6%)

Query: 68  SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQN 127
            +S   ++ S   +     +   RL NLTFL L    I     D   +   L  L L+ N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 128 LLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGN 187
            L      AL+    LK L       S          + LE + L  N +          
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 188 ISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWL-TECNLVGEIPDSLGRLAKLVDLDLA 246
              LK+L+   N  +      ++ +L     L L    N +  I       A    L+  
Sbjct: 152 TEKLKVLDFQNN-AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFG 210

Query: 247 LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDL 306
               +  I   L            N+++         +L      D    D++  + + L
Sbjct: 211 GTQNLLVIFKGLK-----------NSTI--------QSLWLGTFEDMDDEDISPAVFEGL 251

Query: 307 TRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN 366
             + +ES+NL ++        T     GL EL L    L+  LP  L   S L+ + LS 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 367 NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLT--GKVPP 423
           N+F      S      L  L +  N+   +L  G L + ++L  + L ++ +        
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 424 LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVL 482
            L  L H+  L L+ N      ++       L LL ++   L     +     L  L VL
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 483 SGSENKFTGSLPESLTNLAELGSLDLHANDLSG---ELPSSVSSWKKLNELNLADNLFYG 539
           + S +    S  +    L  L  L+L  N       +  +S+ +  +L  L L+      
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 540 NIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAK----- 594
                  +L ++N++DLS+NRL+      L +LK   LN+++N +S  LPSL        
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQR 550

Query: 595 --EMYRNSFLGNPGL 607
              + +N        
Sbjct: 551 TINLRQNPLDCTCSN 565

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  121 bits (305), Expect = 2e-28
 Identities = 56/256 (21%), Positives = 91/256 (35%), Gaps = 20/256 (7%)

Query: 74  IDLSNANIA--GPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTG 131
           +DLS+ +I         L  L +L  L L  N   S   +    C  L+ LDL+   L  
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414

Query: 132 TLTP-ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTI---PAFLGN 187
                   +L  LK L+L+ +       + F     L+ ++L  N            L  
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

Query: 188 ISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA 246
           +  L++L LS+       I      +L  +  + L+   L     ++L  L  +  L+LA
Sbjct: 475 LGRLEILVLSFCDL--SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLA 531

Query: 247 LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPI---- 302
            N++   +PS L  L+    I L  N L       +     L     +M  L        
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY----FLEWYKENMQKLEDTEDTLC 587

Query: 303 --PDDLTRLPLESLNL 316
             P  L  + L  + L
Sbjct: 588 ENPPLLRGVRLSDVTL 603

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.1 bits (198), Expect = 2e-15
 Identities = 26/134 (19%), Positives = 42/134 (31%), Gaps = 4/134 (2%)

Query: 461 SKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSS 520
               L+  +P  +    S   L  S N        + + L  L  LDL    +      +
Sbjct: 20  ENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 521 VSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNV 579
             S  +L+ L L  N         +     L +L      +S    + L N K L  L +
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136

Query: 580 SNNRLSGELPSLFA 593
            +N +S        
Sbjct: 137 GSNHISSIKLPKGF 150

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  245 bits (627), Expect = 1e-73
 Identities = 85/313 (27%), Positives = 131/313 (41%), Gaps = 32/313 (10%)

Query: 21  LSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNAN 80
           L   Q+   L ++K  L +P + LSSW     D    +W GV CD  + +          
Sbjct: 2   LCNPQDKQALLQIKKDLGNP-TTLSSWLPTT-DCCNRTWLGVLCDTDTQTY--------- 50

Query: 81  IAGPFPSLLCRLENLTFLTLFNNSINST--LPDDISACQNLQHLDLS-QNLLTGTLTPAL 137
                         +  L L   ++     +P  ++    L  L +   N L G + PA+
Sbjct: 51  -------------RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97

Query: 138 ADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLS 197
           A L  L +L +T  N SG IP+   + + L  +   YN L GT+P  + ++  L  +   
Sbjct: 98  AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157

Query: 198 YNPFLPGRIPPELGNLTNL-EILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPS 256
            N  + G IP   G+ + L   + ++   L G+IP +   L  L  +DL+ N L G    
Sbjct: 158 GN-RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215

Query: 257 SLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLN 315
                 +  +I L  NSL  DL        +L  LD   N + G +P  LT+L  L SLN
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 316 LYENRLEGSLPAT 328
           +  N L G +P  
Sbjct: 275 VSFNNLCGEIPQG 287

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  238 bits (610), Expect = 2e-71
 Identities = 81/282 (28%), Positives = 129/282 (45%), Gaps = 6/282 (2%)

Query: 146 LDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGT--IPAFLGNISTLKMLNLSYNPFLP 203
            D     + G + ++  +  ++  + L    L     IP+ L N+  L  L +     L 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 204 GRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELAS 263
           G IPP +  LT L  L++T  N+ G IPD L ++  LV LD + N L G +P S++ L +
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 264 VVQIELYNNSLTGDLPTGWSNLTSL-RLLDASMNDLTGPIPDDLTRLPLESLNLYENRLE 322
           +V I    N ++G +P  + + + L   +  S N LTG IP     L L  ++L  N LE
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210

Query: 323 GSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGE 382
           G             ++ L +N L   L   +G +  L  +DL NN+  G +P  L +   
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

Query: 383 LEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR-LTGKVPP 423
           L  L + +N+  G++P G G+ Q         N+ L G   P
Sbjct: 270 LHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  232 bits (593), Expect = 5e-69
 Identities = 79/274 (28%), Positives = 127/274 (46%), Gaps = 8/274 (2%)

Query: 342 RNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE--IPASLCEKGELEEL-LMIYNSFTGQLP 398
                G L     +   +  +DLS         IP+SL     L  L +   N+  G +P
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 399 DGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLL 458
             +     L  + + +  ++G +P  L  +  +  L+ + N LSG +  +I+   NL  +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 459 IISKNNLSGSLPEEIGFLKSLV-VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGEL 517
               N +SG++P+  G    L   ++ S N+ TG +P +  NL  L  +DL  N L G+ 
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213

Query: 518 PSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQ 576
                S K   +++LA N    ++ + +G    LN LDL NNR+ G +P GL  LK L+ 
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272

Query: 577 LNVSNNRLSGELPSLFA-KEMYRNSFLGNPGLCG 609
           LNVS N L GE+P     +    +++  N  LCG
Sbjct: 273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  145 bits (368), Expect = 2e-38
 Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 12/191 (6%)

Query: 436 LTDNFLSGEISKNIAGAANLSLLIISKNNLSGS--LPEEIGFLKSLVVLS-GSENKFTGS 492
             +    G +         ++ L +S  NL     +P  +  L  L  L  G  N   G 
Sbjct: 33  CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92

Query: 493 LPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLN 552
           +P ++  L +L  L +   ++SG +P  +S  K L  L+ + N   G +P  I +L  L 
Sbjct: 93  IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152

Query: 553 YLDLSNNRLSGRIPVGLQNLK--LNQLNVSNNRLSGELPSLFAK------EMYRNSFLGN 604
            +    NR+SG IP    +       + +S NRL+G++P  FA       ++ RN   G+
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212

Query: 605 -PGLCGDLEGL 614
              L G  +  
Sbjct: 213 ASVLFGSDKNT 223

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 91.8 bits (229), Expect = 3e-20
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 2/106 (1%)

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
           ++A +DLS   + G    L    +N   + L  NS+   L   +   +NL  LDL  N +
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256

Query: 130 TGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN 175
            GTL   L  L  L  L+++ NN  G+IP+  G  Q+ +V +   N
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  243 bits (622), Expect = 5e-73
 Identities = 78/325 (24%), Positives = 118/325 (36%), Gaps = 48/325 (14%)

Query: 674 LGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKG 732
           LG          L    V   G  G V+K  L   E VAVK        + +     E  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEY- 67

Query: 733 QVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDC----KLLVYEYMPNGSLGDLLH 788
                        EV +L  ++H+NI++                L+  +   GSL D L 
Sbjct: 68  -------------EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114

Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCV-------PSIVHRDVKSNNILLDGDFGAR 841
                ++ W     I    A GL+YLH D         P+I HRD+KS N+LL  +  A 
Sbjct: 115 ---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171

Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA-----YTLRVNEKSDIYSFGVVILEL 896
           +ADFG+A   +A           G+  Y+APE       +      + D+Y+ G+V+ EL
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

Query: 897 VTGRLPVDPEFGEKDL----VKWVCSTLD--QKGVDH-VLDPKL-DCCFKEE-ICKVLNI 947
            +     D    E  L          +L+  Q+ V H    P L D   K   +  +   
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291

Query: 948 GLLCTSPLPINRPAMRRVVKLLQEV 972
              C       R +   V + + ++
Sbjct: 292 IEECWDHDAEARLSAGCVGERITQM 316

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  246 bits (631), Expect = 6e-71
 Identities = 105/540 (19%), Positives = 180/540 (33%), Gaps = 31/540 (5%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
           +    +  ++   P  +    +   + L  N +        S    LQ LDLS+  +   
Sbjct: 15  TYQCMDQKLSK-VPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
              A   L +L  L LTGN      P SF     LE +  V   L       +G + TLK
Sbjct: 72  EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131

Query: 193 MLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKL----VDLDLALN 248
            LN+++N     ++P    NLTNL  + L+   +     + L  L +     + LD++LN
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

Query: 249 NLVGAIPSSLTELASVVQIELYNNSLTGDLP-TGWSNLTSLRLLDASMNDLTG------- 300
            +   I     +   + ++ L  N  + ++  T   NL  L +    + +          
Sbjct: 192 PI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250

Query: 301 --PIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP 358
              I + L  + ++   L                  +  + L    +      D+ K+  
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFK 308

Query: 359 LRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLT 418
            + + +   Q        L     L+ L +  N  +  +        SL+ + L  N L+
Sbjct: 309 WQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS 363

Query: 419 GKVPPLLWGLPHVYL--LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE-IGF 475
                    L    L  L+L+ N     +S N  G   L  L    + L           
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

Query: 476 LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW-KKLNELNLAD 534
           L+ L+ L  S              L  L +L +  N       S+V +    L  L+L+ 
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482

Query: 535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPSLFA 593
                        L  L  L++S+N L          L  L+ L+ S NR+      L  
Sbjct: 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  235 bits (601), Expect = 7e-67
 Identities = 98/537 (18%), Positives = 175/537 (32%), Gaps = 32/537 (5%)

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
           S  +IDLS   +             L +L L    I +          +L +L L+ N +
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 130 TGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDG-TIPAFLGNI 188
                 + + L +L+ L       +       G+   L+ +++ +N +    +PA+  N+
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152

Query: 189 STLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLT---ECNLVGEIPDSLGRLAKLVDLD 244
           + L  ++LSYN      I    L  L     + L+     N +  I D   +  KL +L 
Sbjct: 153 TNLVHVDLSYNYI--QTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELT 210

Query: 245 LALNNLVGAIP-------SSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRL--LDASM 295
           L  N     I        + L     ++       +L    P+    L  + +     + 
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270

Query: 296 NDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLG 354
            +           L  + +++L    +       +        L + R +L      DL 
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLP 328

Query: 355 KNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGH---CQSLTRVR 411
               L+ + L+ N+ +            L  L +  N+ +              SL  + 
Sbjct: 329 F---LKSLTLTMNKGSISFKKVALPS--LSYLDLSRNALSF-SGCCSYSDLGTNSLRHLD 382

Query: 412 LGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKN-IAGAANLSLLIISKNNLSGSLP 470
           L +N     +     GL  +  L+   + L      +       L  L IS  N      
Sbjct: 383 LSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 471 EEIGFLKSLVVLSGSENKFTGSLPES-LTNLAELGSLDLHANDLSGELPSSVSSWKKLNE 529
                L SL  L  + N F  +   +   N   L  LDL    L         +  +L  
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501

Query: 530 LNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLS 585
           LN++ N            L  L+ LD S NR+     +     K L   N++NN ++
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  138 bits (349), Expect = 5e-34
 Identities = 63/376 (16%), Positives = 124/376 (32%), Gaps = 41/376 (10%)

Query: 252 GAIPSSLTELASVVQIELYNNSLT---GDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR 308
           G++   +  + ++   +  +  L+    D+P+      S + +D S N L        + 
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSKVPDDIPS------STKNIDLSFNPLKILKSYSFSN 54

Query: 309 LP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNN 367
              L+ L+L    +E            L  L L  N +    PG     + L  +     
Sbjct: 55  FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114

Query: 368 QFTGEIPASLCEKGELEELLMIYNSFTG-QLPDGLGHCQSLTRVRLGYNRLTGKVPPLLW 426
           +        + +   L++L + +N     +LP    +  +L  V L YN +       L 
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174

Query: 427 GLPHVYL----LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF-LKSLVV 481
            L         L+++ N +   I         L  L +  N  S ++ +     L  L V
Sbjct: 175 FLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233

Query: 482 LSGSENKFTG---------SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL 532
                 +F           S+ E L ++       L   +   +          ++ ++L
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTID-EFRLTYTNDFSDDIVKFHCLANVSAMSL 292

Query: 533 ADNLFYGNIPEDIG--NLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLS----- 585
           A       + +         L+   +   +L     + L  LK   L ++ N+ S     
Sbjct: 293 AGVSI-KYLEDVPKHFKWQSLS---IIRCQLKQFPTLDLPFLK--SLTLTMNKGSISFKK 346

Query: 586 GELPSLFAKEMYRNSF 601
             LPSL   ++ RN+ 
Sbjct: 347 VALPSLSYLDLSRNAL 362

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  115 bits (291), Expect = 8e-27
 Identities = 51/260 (19%), Positives = 89/260 (34%), Gaps = 16/260 (6%)

Query: 69  HSVASIDLSNANI----AGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDL 124
            S++ +DLS   +       +  L     +L  L L  N     +  +    + LQHLD 
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDL--GTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDF 406

Query: 125 SQNLLTGTLTP-ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN-LLDGTIP 182
             + L       A   L  L +LD++  N   D    F     L  + +  N   D T+ 
Sbjct: 407 QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466

Query: 183 AFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLV 241
               N + L  L+LS       +I       L  L++L ++  NL+        +L  L 
Sbjct: 467 NVFANTTNLTFLDLSKCQL--EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524

Query: 242 DLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGP 301
            LD + N +  +         S+    L NNS+          L  ++     + ++   
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQK-FLQWVKEQKQFLVNVEQM 583

Query: 302 I---PDDLTRLPLESLNLYE 318
               P ++    +   N   
Sbjct: 584 TCATPVEMNTSLVLDFNNST 603

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  110 bits (278), Expect = 3e-25
 Identities = 45/239 (18%), Positives = 82/239 (34%), Gaps = 9/239 (3%)

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
           G +   +           +    + ++PD +    S   + L +N L             
Sbjct: 2   GSLNPCIE-VVPNITYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L+L+   +     K   G  +LS LI++ N +    P     L SL  L   E K  
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 491 GSLPESLTNLAELGSLDLHANDLSG-ELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLS 549
                 +  L  L  L++  N +   +LP+  S+   L  ++L+ N        D+  L 
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 550 VLN----YLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGN 604
                   LD+S N +        Q +KL++L +  N  S  +     + +        
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  211 bits (538), Expect = 1e-61
 Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 41/298 (13%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S + I    ++ + V+G G+ G V K      + VA+K++                   +
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI-------------------E 40

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL- 794
            + +   F  E+  L ++ H NIVKL+  C    C  LV EY   GSL ++LH  +    
Sbjct: 41  SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPY 98

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVDA 853
                     +  ++G++YLH     +++HRD+K  N+LL       ++ DFG A  +  
Sbjct: 99  YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
                 M+   GS  ++APE       +EK D++S+G+++ E++T R P    F E    
Sbjct: 159 -----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGP 209

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
            +        G      P L     + I  ++     C S  P  RP+M  +VK++  
Sbjct: 210 AFRIMWAVHNG----TRPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTH 260

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (527), Expect = 3e-60
 Identities = 82/306 (26%), Positives = 138/306 (45%), Gaps = 42/306 (13%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
               +  + ++ +  IG G  G V+K   + +   VA+K L          G    + ++
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL--------ILGDSEGETEM 63

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
            ++ Q+  FQ EV  +  + H NIVKL+          +V E++P G L   L   K   
Sbjct: 64  IEKFQE--FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHP 118

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-----GDFGARVADFGVAK 849
           + W  + ++++D A G+ Y+ +   P IVHRD++S NI L          A+VADFG+++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

Query: 850 VVDASGKPKSMSVIAGSCGYIAPE--YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF 907
                    S+S + G+  ++APE   A      EK+D YSF +++  ++TG  P    F
Sbjct: 178 Q-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----F 228

Query: 908 GEKDL--VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV 965
            E     +K++    ++      L P +       +  V+    LC S  P  RP    +
Sbjct: 229 DEYSYGKIKFINMIREEG-----LRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYI 280

Query: 966 VKLLQE 971
           VK L E
Sbjct: 281 VKELSE 286

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (519), Expect = 6e-59
 Identities = 85/311 (27%), Positives = 141/311 (45%), Gaps = 33/311 (10%)

Query: 676 FSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
             + +I    L+    IG+GS G V++    +G  VAVK L                 Q 
Sbjct: 29  GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKIL---------------MEQD 72

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
               + + F  EV  + ++RH NIV      T      +V EY+  GSL  LLH      
Sbjct: 73  FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132

Query: 795 -LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
            LD   R  +  D A+G++YLH+   P IVHR++KS N+L+D  +  +V DFG++++  +
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
           +    S    AG+  ++APE       NEKSD+YSFGV++ EL T + P    +G  +  
Sbjct: 192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP----WGNLNPA 245

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG 973
           + V +   +         ++      ++  ++     C +  P  RP+   ++ LL+ + 
Sbjct: 246 QVVAAVGFKC-----KRLEIPRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLI 297

Query: 974 AENRSKTGKKD 984
                   + D
Sbjct: 298 KSAVPPPNRSD 308

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  203 bits (519), Expect = 4e-56
 Identities = 111/521 (21%), Positives = 186/521 (35%), Gaps = 33/521 (6%)

Query: 93  ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN 152
            +   L L  N +         +   LQ LDLS+  +      A   L +L  L LTGN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 153 FSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGN 212
                  +F     L+ +  V   L       +G++ TLK LN+++N     ++P    N
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 213 LTNLEILWLTECNLVGEIPDSLGRLAKL----VDLDLALNNLVGAIPSSLTELASVVQIE 268
           LTNLE L L+   +       L  L ++    + LDL+LN +    P +  E+  + ++ 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206

Query: 269 LYNNSLTGDLPTG-WSNLTSLRLLD------ASMNDLTGPIPDDLTRLP-LESLNLYENR 320
           L NN  + ++       L  L +         +  +L       L  L  L         
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 321 LEGSLPATIADSPGLYELR---LFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL 377
           L+  L   I     L  +    L    +          N   + ++L N +F       L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKL 324

Query: 378 CEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLT--GKVPPLLWGLPHVYLLE 435
                L+ L    N              SL  + L  N L+  G      +G   +  L+
Sbjct: 325 ---KSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 436 LTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSL 493
           L+ N +   +S N  G   L  L    +NL   + E   F  L++L+ L  S      + 
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 494 PESLTNLAELGSLDLHANDLSGELPSSV-SSWKKLNELNLADNLFYGNIPEDIGNLSVLN 552
                 L+ L  L +  N         + +  + L  L+L+        P    +LS L 
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 553 YLDLSNNRLSGRIPVG-LQNLK-LNQLNVSNNRLSGELPSL 591
            L++++N+L   +P G    L  L ++ +  N      P +
Sbjct: 498 VLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  172 bits (437), Expect = 2e-45
 Identities = 108/508 (21%), Positives = 165/508 (32%), Gaps = 52/508 (10%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL 133
           +DLS   I          L +L+ L L  N I S      S   +LQ L   +  L    
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 134 TPALADLPNLKFLDLTGNNF-SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
              +  L  LK L++  N   S  +PE F     LE + L  N +       L  +  + 
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176

Query: 193 M----LNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPD-SLGRLAKLVDLDLAL 247
           +    L+LS NP     I P       L  L L        +    +  LA L    L L
Sbjct: 177 LLNLSLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 248 ------NNLVGAIPSSLTELASVVQIELYNNSLTG---DLPTGWSNLTSLRLLDASMNDL 298
                  NL     S+L  L ++   E     L     D+   ++ LT++         +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 299 TGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP 358
              + D       + L L   +     P     S  L  L    N+              
Sbjct: 295 ER-VKDFSYNFGWQHLELVNCKFG-QFPTLKLKS--LKRLTFTSNKGGNAFSEV--DLPS 348

Query: 359 LRWVDLSNNQFT--GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR 416
           L ++DLS N  +  G    S      L+ L + +N     +       + L  +   ++ 
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN 407

Query: 417 LTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFL 476
           L          +    +                    NL  L IS  +   +       L
Sbjct: 408 LKQ--------MSEFSVF---------------LSLRNLIYLDISHTHTRVAFNGIFNGL 444

Query: 477 KSLVVLSGSENKFTGSL-PESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADN 535
            SL VL  + N F  +  P+  T L  L  LDL    L    P++ +S   L  LN+A N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504

Query: 536 LFYGNIPEDI-GNLSVLNYLDLSNNRLS 562
               ++P+ I   L+ L  + L  N   
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  119 bits (300), Expect = 4e-28
 Identities = 58/264 (21%), Positives = 107/264 (40%), Gaps = 16/264 (6%)

Query: 69  HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNL 128
            +V+S  L +  I                L L N       P      ++L+ L  + N 
Sbjct: 282 TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ-FPTL--KLKSLKRLTFTSNK 336

Query: 129 LTGTLTPALADLPNLKFLDLTGN--NFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLG 186
                  +  DLP+L+FLDL+ N  +F G   +S      L+ + L +N +  T+ +   
Sbjct: 337 GGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 393

Query: 187 NISTLKMLNLSYNPFLPGRIPPE--LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLD 244
            +  L+ L+  ++     ++       +L NL  L ++  +           L+ L  L 
Sbjct: 394 GLEQLEHLDFQHSNL--KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451

Query: 245 LALNNLVGAIPS-SLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIP 303
           +A N+          TEL ++  ++L    L    PT +++L+SL++L+ + N L     
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511

Query: 304 DDLTRLP-LESLNLYENRLEGSLP 326
               RL  L+ + L+ N  + S P
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 99.8 bits (249), Expect = 8e-22
 Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 11/241 (4%)

Query: 69  HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSIN--STLPDDISACQNLQHLDLSQ 126
            S+  +  ++      F  +   L +L FL L  N ++             +L++LDLS 
Sbjct: 325 KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382

Query: 127 NLLTGTLTPALADLPNLKFLDLTGNNFSGDIPES-FGRFQKLEVISLVYNLLDGTIPAFL 185
           N +  T++     L  L+ LD   +N       S F   + L  + + +           
Sbjct: 383 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441

Query: 186 GNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDL 245
             +S+L++L ++ N F    +P     L NL  L L++C L    P +   L+ L  L++
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501

Query: 246 ALNNLVGAIPSSLTELASVVQIELYNNSLTGDLP-----TGWSNLTSLRLLDASMNDLTG 300
           A N L          L S+ +I L+ N      P     + W N  S +   ++    +G
Sbjct: 502 ASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSG 561

Query: 301 P 301
            
Sbjct: 562 K 562

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 94.4 bits (235), Expect = 4e-20
 Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 8/218 (3%)

Query: 390 YNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI 449
             +F  ++PD L    S   + L +N L        +  P + +L+L+   +        
Sbjct: 16  ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 450 AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLH 509
              ++LS LI++ N +          L SL  L   E          + +L  L  L++ 
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 510 ANDL-SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNY----LDLSNNRLSGR 564
            N + S +LP   S+   L  L+L+ N        D+  L  +      LDLS N ++  
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 565 IPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFL 602
            P   + ++L++L + NN  S  +     + +      
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  194 bits (495), Expect = 4e-56
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 42/302 (13%)

Query: 680 EI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQV 738
           EI    L  + +IG G  GKVY+     G+ VAVK              D +  Q  +  
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAA--------RHDPDEDISQTIEN- 52

Query: 739 QDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                + E +    ++H NI+ L   C       LV E+   G L  +L   +   +   
Sbjct: 53  ----VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPD 105

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR--------VADFGVAKV 850
                 V  A G++YLH + +  I+HRD+KS+NIL+               + DFG+A+ 
Sbjct: 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165

Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
              +    +    AG+  ++APE       ++ SD++S+GV++ EL+TG +P    F   
Sbjct: 166 WHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRGI 217

Query: 911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
           D +         K     L   +     E   K++     C +P P +RP+   ++  L 
Sbjct: 218 DGLAVAYGVAMNK-----LALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

Query: 971 EV 972
            +
Sbjct: 270 TI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (494), Expect = 5e-56
 Identities = 62/301 (20%), Positives = 115/301 (38%), Gaps = 42/301 (13%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
               I    L+    +    SG+++K     G  + VK L              +     
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVL--------------KVRDWS 47

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLHSCKGG 793
            +   D F  E   L    H N++ +   C +        +  +MP GSL ++LH     
Sbjct: 48  TRKSRD-FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           ++D     K  +D A G+++LH    P I    + S ++++D D  AR++   V     +
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165

Query: 854 SGKPKSMSVIAGSCGYIAPE---YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
            G+         +  ++APE             +D++SF V++ ELVT  +P    F + 
Sbjct: 166 PGR-------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADL 214

Query: 911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
             ++       +      L P +       + K++ I   C +  P  RP    +V +L+
Sbjct: 215 SNMEIGMKVALEG-----LRPTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILE 266

Query: 971 E 971
           +
Sbjct: 267 K 267

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  199 bits (507), Expect = 2e-55
 Identities = 99/519 (19%), Positives = 177/519 (34%), Gaps = 63/519 (12%)

Query: 72  ASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTG 131
           ++    +  I   F      L       L   ++  T+    +    +  L   +  +  
Sbjct: 5   SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS 60

Query: 132 TLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTL 191
                +  L NL  ++ + N  +   P       KL  I +  N +    P  L N++ L
Sbjct: 61  --IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL 114

Query: 192 KMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV 251
             L L  N          L NLTNL  L L+   +      +L  L  L  L    N + 
Sbjct: 115 TGLTLFNNQI---TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVT 168

Query: 252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP- 310
              P  L  L ++ ++++ +N ++    +  + LT+L  L A+ N ++   P  L  L  
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTN 222

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
           L+ L+L  N+L+     T+A    L +L L  N+++   P  L   + L  + L  NQ +
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
              P                          L    +LT + L  N+L       +  L +
Sbjct: 279 NISP--------------------------LAGLTALTNLELNENQLED--ISPISNLKN 310

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L L  N +S      ++    L  L    N +S      +  L ++  LS   N+ +
Sbjct: 311 LTYLTLYFNNISDIS--PVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQIS 366

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSV 550
                 L NL  +  L L+    +    +  ++    N +           P  I +   
Sbjct: 367 D--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGS 422

Query: 551 LNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELP 589
               D++ N  S    V     +   +       SG + 
Sbjct: 423 YTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  160 bits (406), Expect = 4e-42
 Identities = 105/426 (24%), Positives = 164/426 (38%), Gaps = 56/426 (13%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            I ++N  IA   P  L  L NLT LTLFNN I     D +    NL  L+LS N ++  
Sbjct: 94  DILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD- 148

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
              AL+ L +L+ L   GN  +   P                          L N++TL+
Sbjct: 149 -ISALSGLTSLQQLSF-GNQVTDLKP--------------------------LANLTTLE 180

Query: 193 MLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG 252
            L++S N          L  LTNLE L  T   +    P  LG L  L +L L  N L  
Sbjct: 181 RLDISSNKV---SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-L 311
               +L  L ++  ++L NN ++       S LT L  L    N ++   P  L  L  L
Sbjct: 236 --IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTAL 289

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
            +L L EN+LE   P  I++   L  L L+ N ++   P  +   + L+ +   NN+ + 
Sbjct: 290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345

Query: 372 EIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV 431
              +SL     +  L   +N  +      L +   +T++ L     T         +   
Sbjct: 346 --VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIP 401

Query: 432 YLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG 491
             ++     L       I+   + +   I+ N  S    E        V +      F+G
Sbjct: 402 NTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSG 458

Query: 492 SLPESL 497
           ++ + L
Sbjct: 459 TVTQPL 464

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (496), Expect = 2e-55
 Identities = 69/335 (20%), Positives = 111/335 (33%), Gaps = 63/335 (18%)

Query: 676 FSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
            SE  + LD L    +IG G  G VYK  L +   VAVK                     
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF------------------- 44

Query: 735 QDQVQDDGFQAEVE--TLGKIRHKNIVKLWCCCTTRDC-----KLLVYEYMPNGSLGDLL 787
                   F  E     +  + H NI +                LLV EY PNGSL   L
Sbjct: 45  -SFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103

Query: 788 HSCKGGLLDWPTRYKIIVDAAEGLSYLHHD------CVPSIVHRDVKSNNILLDGDFGAR 841
                   DW +  ++      GL+YLH +        P+I HRD+ S N+L+  D    
Sbjct: 104 SLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160

Query: 842 VADFGVAKVVDASGKPK------SMSVIAGSCGYIAPEYA-------YTLRVNEKSDIYS 888
           ++DFG++  +  +   +      +     G+  Y+APE               ++ D+Y+
Sbjct: 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220

Query: 889 FGVVILELVTGRLPVDPEFGEK-------DLVKWVCSTLDQKG--VDHVLDPKL-DCCFK 938
            G++  E+      + P              V    +  D +         PK  +   +
Sbjct: 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280

Query: 939 EEICKVLNIGLL--CTSPLPINRPAMRRVVKLLQE 971
             +        +  C       R   +   + + E
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  192 bits (490), Expect = 3e-55
 Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 34/302 (11%)

Query: 678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           ++EI    +     IGSGS G VYK    +G+ VAVK L                     
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVYKGKW-HGD-VAVKML---------------NVTAPT 60

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
             Q   F+ EV  L K RH NI+      T      +V ++    SL   LH+      +
Sbjct: 61  PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHA-SETKFE 118

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                 I    A G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A        
Sbjct: 119 MKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175

Query: 857 PKSMSVIAGSCGYIAPE---YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
                 ++GS  ++APE      +   + +SD+Y+FG+V+ EL+TG+LP    +   +  
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNR 231

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG 973
             +   + +  +   L      C K     +  +   C       RP+  R++  ++E+ 
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEIEELA 287

Query: 974 AE 975
            E
Sbjct: 288 RE 289

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  192 bits (489), Expect = 1e-54
 Identities = 66/318 (20%), Positives = 129/318 (40%), Gaps = 51/318 (16%)

Query: 676 FSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
             E++I  + L+   +IG G  G+VY     +GE VA++ +                 + 
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLI---------------DIER 67

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
            ++ Q   F+ EV    + RH+N+V     C +     ++       +L  ++      +
Sbjct: 68  DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIV 126

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV---V 851
           LD     +I  +  +G+ YLH      I+H+D+KS N+  D +    + DFG+  +   +
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182

Query: 852 DASGKPKSMSVIAGSCGYIAPE---------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            A  +   + +  G   ++APE             L  ++ SD+++ G +  EL     P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

Query: 903 VDPEFGEKDL--VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
               F  +    + W        G+   L  ++     +EI  +L   L C +     RP
Sbjct: 243 ----FKTQPAEAIIWQM----GTGMKPNL-SQIGM--GKEISDIL---LFCWAFEQEERP 288

Query: 961 AMRRVVKLLQEVGAENRS 978
              +++ +L+++   NR 
Sbjct: 289 TFTKLMDMLEKLPKRNRR 306

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  193 bits (491), Expect = 1e-52
 Identities = 102/506 (20%), Positives = 191/506 (37%), Gaps = 42/506 (8%)

Query: 107 STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQK 166
           +++P  ++A   ++ LDLS N +T      L    NL+ L L  +  +    ++F     
Sbjct: 18  TSIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75

Query: 167 LEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL 226
           LE + L  N L     ++ G +S+LK LNL  NP+    +     NLTNL+ L +     
Sbjct: 76  LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 227 VGEIP-DSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNL 285
             EI       L  L +L++   +L      SL  +  +  + L+ +     L      L
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195

Query: 286 TSLRLLDASMNDLT----GPIPDDLTRLPLESLNLYENRLE----GSLPATIADSPGLYE 337
           +S+R L+    +L      P+P D    P++ L    + L       L   +     L E
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255

Query: 338 LRLFRNRLNGTLPGDLGKNSP-----------LRWVDLSNNQFTGEIPASLCEKGELEEL 386
           +      LNG    +  ++             +R + +       ++        +++ +
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315

Query: 387 LMIYNSFTGQLPDGLG-HCQSLTRVRLGYNRLTGKVPP---LLWGLPHVYLLELTDNFLS 442
            +  +     +P     H +SL  + L  N +  +           P +  L L+ N L 
Sbjct: 316 TVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374

Query: 443 --GEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNL 500
              +  + +    NL+ L IS+N     +P+   + + +  L+ S       +   +   
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--P 430

Query: 501 AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
             L  LD+  N+L       +     L EL ++ N     +P+      VL  + +S N+
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQ 484

Query: 561 LSGRIPVG-LQNLK-LNQLNVSNNRL 584
           L   +P G    L  L ++ +  N  
Sbjct: 485 LK-SVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  183 bits (465), Expect = 3e-49
 Identities = 91/502 (18%), Positives = 172/502 (34%), Gaps = 29/502 (5%)

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
           ++ S+DLS   I       L    NL  L L ++ IN+   D   +  +L+HLDLS N L
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 130 TGTLTPALADLPNLKFLDLTGNNFSG-DIPESFGRFQKLEVISLVYNLLDGTIPA-FLGN 187
           +   +     L +LK+L+L GN +    +   F     L+ + +        I       
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146

Query: 188 ISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA 246
           +++L  L +            + L ++ ++  L L        +      L+ +  L+L 
Sbjct: 147 LTSLNELEIKALSL--RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204

Query: 247 LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDL 306
             NL     S L        ++      +      ++ L  L      ++++        
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------F 258

Query: 307 TRLPLESL-NLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLS 365
               L  L +   +  +        ++  +  L + +  L   L         ++ + + 
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318

Query: 366 NNQFTGEIPASLCEK-GELEELLMIYNSFT---GQLPDGLGHCQSLTRVRLGYNRLT--G 419
           N++    +P S  +    LE L +  N       +     G   SL  + L  N L    
Sbjct: 319 NSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377

Query: 420 KVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSL 479
           K   +L  L ++  L+++ N     +  +      +  L +S   +   +   I   ++L
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTL 433

Query: 480 VVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYG 539
            VL  S N    S    L  L E   L +  N L   LP +      L  + ++ N    
Sbjct: 434 EVLDVSNNNLD-SFSLFLPRLQE---LYISRNKLK-TLPDASLF-PVLLVMKISRNQLKS 487

Query: 540 NIPEDIGNLSVLNYLDLSNNRL 561
                   L+ L  + L  N  
Sbjct: 488 VPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  174 bits (443), Expect = 2e-46
 Identities = 99/512 (19%), Positives = 168/512 (32%), Gaps = 56/512 (10%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
             D  + +     PS L     +  L L  N I      D+ AC NLQ L L  + +   
Sbjct: 9   VCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDG-TIPAFLGNISTL 191
              A   L +L+ LDL+ N+ S      FG    L+ ++L+ N      + +   N++ L
Sbjct: 66  EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125

Query: 192 KMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL 250
           + L +         I       LT+L  L +   +L      SL  +  +  L L L+  
Sbjct: 126 QTLRIGNVETF-SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184

Query: 251 VGAIPSSLTELASVVQIELYNNSLTG-----------DLPTGWSNLTSLRLLDASMNDLT 299
              +      L+SV  +EL + +L               P          L D S N+L 
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244

Query: 300 GPIPDDLTRLPLESLNLYENRLEGSLPATIADSPG--------LYELRLFRNRLNGTLPG 351
             +   L    +E  +   N L    P+               +  L + +  L   L  
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304

Query: 352 DLGKNSPLRWVDLSNNQFTGEIPASLCEK-GELEELLMIYNSFT---GQLPDGLGHCQSL 407
                  ++ + + N++    +P S  +    LE L +  N       +     G   SL
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 408 TRVRLGYNRLT--GKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNL 465
             + L  N L    K   +L  L ++  L+++ N     +  +      +  L +S   +
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422

Query: 466 SGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELG-------------------SL 506
              +   I   ++L VL  S N    S    L  L EL                     +
Sbjct: 423 R-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVM 478

Query: 507 DLHANDLSGELPSSVSSWKKLNELNLADNLFY 538
            +  N L             L ++ L  N + 
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  130 bits (328), Expect = 1e-31
 Identities = 72/468 (15%), Positives = 140/468 (29%), Gaps = 66/468 (14%)

Query: 73  SIDLSNAN-IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTG 131
           ++ + N    +         L +L  L +   S+ +     + + +++ HL L  +    
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186

Query: 132 TLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTL 191
            L      L ++++L+L   N +          +    +  +              +  L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 192 KMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV 251
               L  +         E  + T   +                     +  L +    L 
Sbjct: 247 LRYILELSEV-------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299

Query: 252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPL 311
             + +  + L  V +I + N+ +     +   +L SL  LD S N +             
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV------------ 347

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN--GTLPGDLGKNSPLRWVDLSNNQF 369
               L  +  +G+ P+       L  L L +N L         L     L  +D+S N F
Sbjct: 348 -EEYLKNSACKGAWPS-------LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399

Query: 370 TGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLP 429
                                      +PD     + +  + L    +   V   +    
Sbjct: 400 H-------------------------PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQ 431

Query: 430 HVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKF 489
            + +L++++N L    S  +     L  L IS+N L  +LP+       L+V+  S N+ 
Sbjct: 432 TLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQL 485

Query: 490 TGSLPESLTNLAELGSLDLHANDLSG--ELPSSVSSWKKLNELNLADN 535
                     L  L  + LH N           +S W   N      +
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGS 533

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 87.5 bits (217), Expect = 7e-18
 Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 9/230 (3%)

Query: 362 VDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKV 421
            D  +  FT  IP+ L     ++ L + +N  T      L  C +L  + L  +R+    
Sbjct: 10  CDGRSRSFT-SIPSGLTAA--MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 422 PPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSG-SLPEEIGFLKSLV 480
               + L  +  L+L+DN LS   S      ++L  L +  N      +      L +L 
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126

Query: 481 VLS-GSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYG 539
            L  G+   F+         L  L  L++ A  L      S+ S + ++ L L  +    
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186

Query: 540 NIPEDIGNLSVLNYLDLSNNRLS----GRIPVGLQNLKLNQLNVSNNRLS 585
            +      LS + YL+L +  L+      +PV   +  + +L    + L+
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 84.8 bits (210), Expect = 4e-17
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 16/214 (7%)

Query: 69  HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDD---ISACQNLQHLDLS 125
             V  I + N+ +     S    L++L FL L  N +      +     A  +LQ L LS
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369

Query: 126 QNLLT--GTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPA 183
           QN L         L  L NL  LD++ N F   +P+S    +K+  ++L    +   +  
Sbjct: 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT 427

Query: 184 FLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDL 243
                 TL++L++S N             L  L+ L+++   L   +PD+      L+ +
Sbjct: 428 --CIPQTLEVLDVSNNNL--DSFSL---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVM 478

Query: 244 DLALNNLVGAIPSSLTELASVVQIELYNNSLTGD 277
            ++ N L          L S+ +I L+ N     
Sbjct: 479 KISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  193 bits (492), Expect = 4e-51
 Identities = 101/564 (17%), Positives = 186/564 (32%), Gaps = 50/564 (8%)

Query: 69  HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQN 127
           ++   + LS   I     S    LE L  L L +     T+  +      NL+ LDL  +
Sbjct: 24  NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83

Query: 128 LLTGTLTPALADLPNLKFLDLTGNNFSGDI--PESFGRFQKLEVISLVYNLLDG-TIPAF 184
            +      A   L +L  L L     S  +     F   + L  + L  N +    +   
Sbjct: 84  KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143

Query: 185 LGNISTLKMLNLSYNPFLPGRIPPE-LGNLT--NLEILWLTECNLVGEIPDSLGRLAK-- 239
            G +++LK ++ S N      +    L  L    L    L   +L   +    G+     
Sbjct: 144 FGKLNSLKSIDFSSNQI--FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201

Query: 240 ----LVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASM 295
               L  LD++ N     I  +             +N+++            +       
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNF------------SNAISKSQAFSLILAHHIMGAGFGF 249

Query: 296 NDLTGPIPDDLTRLP---LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGD 352
           +++  P  +    L    +  L+L    +             L  L L  N++N      
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA 309

Query: 353 LGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRL 412
                 L+ ++LS N       ++     ++  + +  N             + L  + L
Sbjct: 310 FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369

Query: 413 GYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE 472
             N LT      +  +P +  + L+ N L      N+      +L+ +S+N L  +L   
Sbjct: 370 RDNALTT-----IHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLE-NLDIL 419

Query: 473 IGF--LKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLHANDLSGELPSSVSSW----- 524
                +  L +L  ++N+F+    +   +    L  L L  N L     + +        
Sbjct: 420 YFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479

Query: 525 KKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRL 584
             L  L L  N      P    +L+ L  L L++NRL+  +        L  L++S N+L
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQL 538

Query: 585 SGELPSLFAKEMYRNSFLGNPGLC 608
               P +F      +    N  +C
Sbjct: 539 LAPNPDVFVSLSVLD-ITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  185 bits (471), Expect = 2e-48
 Identities = 97/521 (18%), Positives = 175/521 (33%), Gaps = 50/521 (9%)

Query: 102 NNSIN--STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDI-P 158
                  + +P  ++     + L LS N +      +   L  L+ L+L        I  
Sbjct: 10  FYRFCNLTQVPQVLN---TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66

Query: 159 ESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLE 217
           E+F     L ++ L  + +    P     +  L  L L +       +      NL  L 
Sbjct: 67  EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126

Query: 218 ILWLTECNLVG-EIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELA--SVVQIELYNNSL 274
            L L++  +    +  S G+L  L  +D + N +       L  L   ++    L  NSL
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186

Query: 275 TGDLPTGWSNL------TSLRLLDASMNDLTGPIPDDLTRLP-------------LESLN 315
              +   W           L +LD S N  T  I  + +                +    
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246

Query: 316 LYENRLEGSLPATIA--DSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEI 373
              + ++     T A      +  L L    +             L+ ++L+ N+     
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306

Query: 374 PASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL 433
             +      L+ L + YN               +  + L  N +          L  +  
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366

Query: 434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG-S 492
           L+L DN L+      I    ++  + +S N L  +LP+       + +   SEN+     
Sbjct: 367 LDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHL---SENRLENLD 417

Query: 493 LPESLTNLAELGSLDLHANDLSGELPSSVSSW-KKLNELNLADNLFYGNIPEDI-----G 546
           +   L  +  L  L L+ N  S        S    L +L L +N+       ++      
Sbjct: 418 ILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477

Query: 547 NLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLS 585
            LS L  L L++N L+  +P G   +L  L  L++++NRL+
Sbjct: 478 GLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  127 bits (320), Expect = 6e-30
 Identities = 69/336 (20%), Positives = 114/336 (33%), Gaps = 25/336 (7%)

Query: 68  SHSVASIDLSNANIAGPFPSLLCRLE--NLTFLTLFNNSINSTLPDDISACQNLQHLDLS 125
           +H +        NI  P  +    L   ++  L L +  + S         ++L+ L+L+
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298

Query: 126 QNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFL 185
            N +      A   L NL+ L+L+ N        +F    K+  I L  N +        
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTF 358

Query: 186 GNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDL 245
             +  L+ L+L  N          +  + ++  ++L+   LV     +L        + L
Sbjct: 359 KFLEKLQTLDLRDNAL------TTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHL 408

Query: 246 ALNNLVG-AIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGPI- 302
           + N L    I   L  +  +  + L  N  +        S   SL  L    N L     
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468

Query: 303 ----PDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNS 357
                D    L  L+ L L  N L    P   +    L  L L  NRL   L  +    +
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPAN 527

Query: 358 PLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSF 393
            L  +D+S NQ        +     L  L + +N F
Sbjct: 528 -LEILDISRNQLL-APNPDVFVS--LSVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 48.6 bits (116), Expect = 1e-05
 Identities = 28/144 (19%), Positives = 56/144 (38%), Gaps = 7/144 (4%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL 133
           + L++  +    P +   L  L  L+L +N + + L  +     NL+ LD+S+N L    
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL-TVLSHN-DLPANLEILDISRNQLL--- 539

Query: 134 TPALADLPNLKFLDLTGNNFSGDIP-ESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
            P      +L  LD+T N F  +    +F  +     +++     D     +  + S + 
Sbjct: 540 APNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPAD-IYCVYPDSFSGVS 598

Query: 193 MLNLSYNPFLPGRIPPELGNLTNL 216
           + +LS        +   L     +
Sbjct: 599 LFSLSTEGCDEEEVLKSLKFSLFI 622

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  180 bits (460), Expect = 7e-51
 Identities = 72/311 (23%), Positives = 120/311 (38%), Gaps = 50/311 (16%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
                    L    V+G G  G+  KV     GE + +K+L R                 
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----------------- 45

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
            D+     F  EV+ +  + H N++K             + EY+  G+L  ++ S     
Sbjct: 46  FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQ 104

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
             W  R     D A G++YLH     +I+HRD+ S+N L+  +    VADFG+A+++   
Sbjct: 105 YPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161

Query: 855 G------------KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                          K    + G+  ++APE       +EK D++SFG+V+ E++     
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

Query: 903 VDPEFGEKDLVKWVCSTLD-QKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRP 960
            DP+        ++  T+D    V   LD      C          I + C    P  RP
Sbjct: 222 -DPD--------YLPRTMDFGLNVRGFLDRYCPPNCPPS----FFPITVRCCDLDPEKRP 268

Query: 961 AMRRVVKLLQE 971
           +  ++   L+ 
Sbjct: 269 SFVKLEHWLET 279

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (457), Expect = 1e-50
 Identities = 72/314 (22%), Positives = 117/314 (37%), Gaps = 51/314 (16%)

Query: 685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           +     +G G  G+V++     GE VAVK                         +    +
Sbjct: 10  ITLLECVGKGRYGEVWRGSW-QGENVAVKIF------------------SSRDEKSWFRE 50

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCK----LLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
            E+     +RH+NI+       T         L+  Y   GSL D L       LD  + 
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSC 107

Query: 801 YKIIVDAAEGLSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
            +I++  A GL++LH +       P+I HRD+KS NIL+  +    +AD G+A +   S 
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167

Query: 856 KPK--SMSVIAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF 907
                  +   G+  Y+APE              ++ DI++FG+V+ E+    +      
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

Query: 908 GEK----DLVKWVCSTLDQKGVDHVLD----PKLDCCFKEEICKVLNIGLL--CTSPLPI 957
             K    D+V    S  D + V  V      P +   +  +        L+  C    P 
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKV--VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285

Query: 958 NRPAMRRVVKLLQE 971
            R    R+ K L +
Sbjct: 286 ARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  181 bits (460), Expect = 1e-50
 Identities = 74/316 (23%), Positives = 114/316 (36%), Gaps = 47/316 (14%)

Query: 681 ILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD 740
           I   +     IG G  G+V+      GE VAVK          E                
Sbjct: 35  IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEE--------------AS 75

Query: 741 DGFQAEVETLGKIRHKNIVKLWCCCTTRDCK----LLVYEYMPNGSLGDLLHSCKGGLLD 796
              + E+     +RH+NI+                 L+ +Y  NGSL D L S     LD
Sbjct: 76  WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LD 132

Query: 797 WPTRYKIIVDAAEGLSYLH-----HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
             +  K+   +  GL +LH         P+I HRD+KS NIL+  +    +AD G+A   
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 852 DASGKPK--SMSVIAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
            +         +   G+  Y+ PE           +    +D+YSFG+++ E+    +  
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 904 DPEFGEK----DLVKWVCSTLDQKG--VDHVLDPKLDCCFKEEICKVLNIGLL--CTSPL 955
                 +    DLV    S  D +       L P     +  + C      L+  C +  
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312

Query: 956 PINRPAMRRVVKLLQE 971
           P +R    RV K L +
Sbjct: 313 PASRLTALRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (455), Expect = 6e-50
 Identities = 75/333 (22%), Positives = 128/333 (38%), Gaps = 63/333 (18%)

Query: 680 EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
            I   +     IG G  G+V++     GE VAVK                       + +
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIF------------------SSREER 79

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCK----LLVYEYMPNGSLGDLLHSCKGGLL 795
               +AE+     +RH+NI+         +       LV +Y  +GSL D L+      +
Sbjct: 80  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---V 136

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
                 K+ +  A GL++LH + V     P+I HRD+KS NIL+  +    +AD G+A  
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196

Query: 851 VDASGKPKSMSVI--AGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGR-- 900
            D++     ++     G+  Y+APE              +++DIY+ G+V  E+      
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

Query: 901 --------------LPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLN 946
                         +P DP     ++ K VC   +QK   ++ +    C     + K++ 
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVE--EMRKVVC---EQKLRPNIPNRWQSCEALRVMAKIMR 311

Query: 947 IGLLCTSPLPINRPAMRRVVKLLQEVGAENRSK 979
               C       R    R+ K L ++  +   K
Sbjct: 312 ---ECWYANGAARLTALRIKKTLSQLSQQEGIK 341

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  172 bits (439), Expect = 1e-47
 Identities = 70/371 (18%), Positives = 143/371 (38%), Gaps = 29/371 (7%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
           ++    A I   FP     L       L   S+   +       +++  L ++   +   
Sbjct: 4   TLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI 59

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
               +  L NL++L+L GN  +           KL  + +  N +  T  + L N++ L+
Sbjct: 60  --QGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLR 113

Query: 193 MLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG 252
            L L+ +          L NLT +  L L   + +      L  +  L  L +  + +  
Sbjct: 114 ELYLNEDNI---SDISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD 169

Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-L 311
             P  +  L  +  + L  N +     +  ++LTSL    A +N +T   P  +  +  L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRL 223

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
            SL +  N++    P  +A+   L  L +  N+++  +   +   + L+ +++ +NQ + 
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD 279

Query: 372 EIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV 431
              + L    +L  L +  N    +  + +G   +LT + L  N +T   P  L  L  +
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335

Query: 432 YLLELTDNFLS 442
              +  +  + 
Sbjct: 336 DSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  165 bits (420), Expect = 5e-45
 Identities = 78/373 (20%), Positives = 143/373 (38%), Gaps = 29/373 (7%)

Query: 95  LTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFS 154
              L      IN   PD  +         L +  +T        +L ++  L + G   +
Sbjct: 2   AATLATLPAPINQIFPD--ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 155 GDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLT 214
             I         LE ++L  N +    P  L N+  L  L +  N          L NLT
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI---TDISALQNLT 110

Query: 215 NLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSL 274
           NL  L+L E N+       L  L K+  L+L  N+ +    S L+ +  +  + +  + +
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167

Query: 275 TGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSP 333
                T  +NLT L  L  + N +    P  L  L  L     Y N++    P  +A+  
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221

Query: 334 GLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSF 393
            L  L++  N++    P  L   S L W+++  NQ +     ++ +  +L+ L +  N  
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277

Query: 394 TGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAA 453
           +      L +   L  + L  N+L  +   ++ GL ++  L L+ N ++    + +A  +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLS 333

Query: 454 NLSLLIISKNNLS 466
            +     +   + 
Sbjct: 334 KMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  158 bits (401), Expect = 2e-42
 Identities = 77/397 (19%), Positives = 145/397 (36%), Gaps = 54/397 (13%)

Query: 191 LKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL 250
              L     P    +I P   +L       L + ++   +      L  +  L +A   +
Sbjct: 2   AATLATLPAPI--NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56

Query: 251 VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP 310
                  +  L ++  + L  N +T    +  SNL  L  L    N +T      L  L 
Sbjct: 57  AS--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDISA--LQNLT 110

Query: 311 -LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQF 369
            L  L L E+ +    P  +A+   +Y L L  N    +    L   + L ++ ++ ++ 
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKV 167

Query: 370 TGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLP 429
               P                          + +   L  + L YN++   + PL   L 
Sbjct: 168 KDVTP--------------------------IANLTDLYSLSLNYNQIED-ISPL-ASLT 199

Query: 430 HVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKF 489
            ++      N ++      +A    L+ L I  N ++      +  L  L  L    N+ 
Sbjct: 200 SLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQI 255

Query: 490 TGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLS 549
           +     ++ +L +L  L++ +N +S    S +++  +LN L L +N       E IG L+
Sbjct: 256 SD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311

Query: 550 VLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS 585
            L  L LS N ++   P  L +L K++  + +N  + 
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  119 bits (302), Expect = 2e-29
 Identities = 67/313 (21%), Positives = 129/313 (41%), Gaps = 31/313 (9%)

Query: 285 LTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNR 344
             +L  L A +N +  P  D L         L +  +   +     +   + +L +   +
Sbjct: 2   AATLATLPAPINQIF-PDAD-LAEG--IRAVLQKASVTDVVT--QEELESITKLVVAGEK 55

Query: 345 LNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHC 404
           +  ++ G +   + L +++L+ NQ T   P S   K  L  L +  N  T      L + 
Sbjct: 56  VA-SIQG-IEYLTNLEYLNLNGNQITDISPLSNLVK--LTNLYIGTNKITD--ISALQNL 109

Query: 405 QSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNN 464
            +L  + L  + ++      L  L  +Y L L  N    ++S  ++    L+ L ++++ 
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK 166

Query: 465 LSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW 524
           +       I  L  L  LS + N+        L +L  L     + N ++    + V++ 
Sbjct: 167 VKDV--TPIANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITD--ITPVANM 220

Query: 525 KKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNR 583
            +LN L + +N         + NLS L +L++  N++S  I   +++L KL  LNV +N+
Sbjct: 221 TRLNSLKIGNNKI--TDLSPLANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQ 276

Query: 584 LS-----GELPSL 591
           +S       L  L
Sbjct: 277 ISDISVLNNLSQL 289

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  175 bits (446), Expect = 2e-47
 Identities = 94/502 (18%), Positives = 166/502 (33%), Gaps = 76/502 (15%)

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN 151
              L      ++++ + +P +    ++      + +       P   +   +    L   
Sbjct: 10  NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 152 NFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELG 211
                        ++   + L    L  ++P    +   L+ L  S N      +P    
Sbjct: 69  -----------LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSL--TELPELPQ 111

Query: 212 NLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYN 271
           +L +L +        + ++P        L  L ++ N L   +P  L   + +  I++ N
Sbjct: 112 SLKSLLVDNN-NLKALSDLPPL------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDN 162

Query: 272 NSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIA 330
           NSL   LP       SL  + A  N L      +L  LP L ++    N L+  LP    
Sbjct: 163 NSLK-KLP---DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPL 215

Query: 331 DSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIY 390
               L  +    N L      +L     L  +   NN     +P        LE L +  
Sbjct: 216 ---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRD 266

Query: 391 NSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIA 450
           N  T  LP+       L      ++ L+          P++Y L  + N +   +     
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFSGLSEL-------PPNLYYLNASSNEIR-SLCDLP- 316

Query: 451 GAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHA 510
              +L  L +S N L   LP     L+ L+    S N     +PE   NL +   L +  
Sbjct: 317 --PSLEELNVSNNKLI-ELPALPPRLERLIA---SFNHLA-EVPELPQNLKQ---LHVEY 366

Query: 511 NDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ 570
           N L  E P    S + L   +         +PE   NL     L +  N L    P   +
Sbjct: 367 NPLR-EFPDIPESVEDLRMNSH-----LAEVPELPQNLKQ---LHVETNPLR-EFPDIPE 416

Query: 571 NLKLNQLNVSNNRLSGELPSLF 592
           +++   L +++ R+        
Sbjct: 417 SVE--DLRMNSERVVDPYEFAH 436

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  158 bits (402), Expect = 1e-41
 Identities = 101/420 (24%), Positives = 154/420 (36%), Gaps = 66/420 (15%)

Query: 189 STLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALN 248
           + L+      +      +P E  N+ +    +          P   G        ++A++
Sbjct: 11  TFLQEPLRHSSNL--TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQ-----REMAVS 63

Query: 249 NLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR 308
            L   +     EL      EL N  L+  LP    +L SL     S N LT  +P+    
Sbjct: 64  RLRDCLDRQAHEL------ELNNLGLS-SLPELPPHLESLVA---SCNSLT-ELPELPQS 112

Query: 309 LP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNN 367
           L  L   N     L   LP      P L  L +  N+L   LP +L  +S L+ +D+ NN
Sbjct: 113 LKSLLVDNNNLKALS-DLP------PLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNN 163

Query: 368 QFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWG 427
               ++P        LE +    N    +LP+ L +   LT +    N L  K+P L   
Sbjct: 164 SLK-KLPDLP---PSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLS 216

Query: 428 LPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN 487
           L     +   +N L       +     L+ +    N L  +LP+    L++L V    +N
Sbjct: 217 LES---IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNV---RDN 267

Query: 488 KFTGSLPESLTNLAELGSLDLHANDLSGELPS-------------SVSSWKKLNELNLAD 534
             T  LPE   +L  L   +   + LS   P+                    L ELN+++
Sbjct: 268 YLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 326

Query: 535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAK 594
           N     +P     L     L  S N L+  +P   QNLK  QL+V  N L  E P +   
Sbjct: 327 NKLI-ELPALPPRLER---LIASFNHLA-EVPELPQNLK--QLHVEYNPLR-EFPDIPES 378

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  152 bits (385), Expect = 1e-39
 Identities = 85/409 (20%), Positives = 142/409 (34%), Gaps = 65/409 (15%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLP---------------DDISACQ 117
           S+  S  ++    P L   L++L        +++   P                ++    
Sbjct: 95  SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSS 153

Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLL 177
            L+ +D+  N L     P L   P+L+F+    N    ++PE       L  I    N L
Sbjct: 154 FLKIIDVDNNSLKK--LPDL--PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL 207

Query: 178 DGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRL 237
              +P    +   L+ +    N        PEL NL  L  ++  + NL+  +PD    L
Sbjct: 208 K-KLPDLPLS---LESIVAGNNIL---EELPELQNLPFLTTIYA-DNNLLKTLPDLPPSL 259

Query: 238 AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMND 297
             L   D  L +L   +P SLT L      ++  N  +G L     NL  L       N+
Sbjct: 260 EALNVRDNYLTDLP-ELPQSLTFL------DVSENIFSG-LSELPPNLYYLNASS---NE 308

Query: 298 LTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNS 357
           +   + D      LE LN+  N+L   LPA     P L  L    N L   +P       
Sbjct: 309 IRS-LCDLPPS--LEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQN-- 358

Query: 358 PLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRL 417
            L+ + +  N    E P        +E+L M  NS   ++P+   + + L    +  N L
Sbjct: 359 -LKQLHVEYNPLR-EFPDIP---ESVEDLRM--NSHLAEVPELPQNLKQLH---VETNPL 408

Query: 418 TGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLS 466
             + P +   +     L +    +             L   +   ++  
Sbjct: 409 R-EFPDIPESVED---LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 74.6 bits (184), Expect = 5e-14
 Identities = 36/160 (22%), Positives = 57/160 (35%), Gaps = 26/160 (16%)

Query: 445 ISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELG 504
           I+        L   +   +NL+  +P E   +KS      + +++  + P       E+ 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 505 -------------SLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVL 551
                         L+L+   LS  LP        L  L  + N     +PE   +L  L
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSL-TELPELPQSLKSL 116

Query: 552 NYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSL 591
              + +   LS   P       L  L VSNN+L  +LP L
Sbjct: 117 LVDNNNLKALSDLPP------LLEYLGVSNNQLE-KLPEL 149

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  171 bits (434), Expect = 1e-45
 Identities = 73/498 (14%), Positives = 149/498 (29%), Gaps = 44/498 (8%)

Query: 109 LPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLE 168
           + +        +   ++ + L   L        N+K LDL+GN  S         F KLE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 169 VISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVG 228
           +++L  N+L         ++STL+ L+L+ N         EL    ++E L     N + 
Sbjct: 62  LLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV------QELLVGPSIETLHAAN-NNIS 112

Query: 229 EIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTG-DLPTGWSNLTS 287
            +  S G+     ++ LA N +           + V  ++L  N +   +     ++  +
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 288 LRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNG 347
           L  L+   N +   +   +    L++L+L  N+L   +      + G+  + L  N+L  
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227

Query: 348 TLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSL 407
            +   L  +  L   DL  N F          K       +   +           C   
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN-QRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 408 TRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSG 467
           T    G         P    L  +   E                            + + 
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ--------------------GSETE 326

Query: 468 SLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKL 527
            L  E         +   + ++   + +         +L+     L  ++ +   +  +L
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386

Query: 528 NELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGE 587
           +   L   +    +       S L  L     R         +     Q   +N     +
Sbjct: 387 D-GTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE-------EMYVEQQSVQNNAIRDWD 438

Query: 588 LPSLFAKEMYRNSFLGNP 605
           +      ++   +     
Sbjct: 439 MYQHKETQLAEENARLKK 456

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  152 bits (386), Expect = 2e-39
 Identities = 80/481 (16%), Positives = 141/481 (29%), Gaps = 53/481 (11%)

Query: 75  DLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLT 134
            ++++++     SL     N+  L L  N ++     D++    L+ L+LS N+L    T
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--T 73

Query: 135 PALADLPNLKFLDLTGNNFSGDIPE-----------------SFGRFQKLEVISLVYNLL 177
             L  L  L+ LDL  N    ++                   S  R Q  + I L  N +
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKI 132

Query: 178 DGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRL 237
                   G  S ++ L+L  N            +   LE L L    +  ++   +   
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-F 190

Query: 238 AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMND 297
           AKL  LDL+ N L   +       A V  I L NN L   +        +L   D   N 
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248

Query: 298 LTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNS 357
                  D          + +  ++        +                    DL    
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-----DLPAPF 303

Query: 358 PLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRL 417
             R + L   +                 LL    S T +L     +      +     + 
Sbjct: 304 ADRLIALKRKE---------------HALLSGQGSETERLECERENQARQREIDALKEQY 348

Query: 418 TGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLS---LLIISKNNLSGSLPEEIG 474
              +  +         LE     L  ++S      A L       + +  L  +  E   
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE--- 405

Query: 475 FLKSLVVLSGSENKFT-GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLA 533
               L +L     ++    + +       +   D++ +  + +L    +  KKLN     
Sbjct: 406 -QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLNGEADL 463

Query: 534 D 534
            
Sbjct: 464 A 464

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  139 bits (352), Expect = 5e-35
 Identities = 71/435 (16%), Positives = 121/435 (27%), Gaps = 43/435 (9%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            +DLS   ++    + L     L  L L +N +     D + +   L+ LDL+ N +   
Sbjct: 38  ELDLSGNPLSQISAADLAPFTKLELLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ-- 93

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
               L   P+++ L    NN S  +     R Q  + I L  N +        G  S ++
Sbjct: 94  ---ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ 147

Query: 193 MLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG 252
            L+L  N            +   LE L L    +  ++   +   AKL  LDL+ N L  
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA- 204

Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLE 312
            +       A V  I L NN L   +        +L   D   N        D       
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLN-------------------------- 346
              + +  ++        +                                         
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323

Query: 347 --GTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHC 404
               L  +    +  R +D    Q+   I      K     L     +   Q+ +G    
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383

Query: 405 QSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNN 464
             L                     P   L  +   +    + +       +    + ++ 
Sbjct: 384 AELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443

Query: 465 LSGSLPEEIGFLKSL 479
            +  L EE   LK L
Sbjct: 444 ET-QLAEENARLKKL 457

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  123 bits (310), Expect = 9e-30
 Identities = 61/354 (17%), Positives = 109/354 (30%), Gaps = 20/354 (5%)

Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-L 311
           AI             ++ ++SL   L +   +  +++ LD S N L+     DL     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
           E LNL  N L       +     L  L L  N +      +L     +  +  +NN  + 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 372 EIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTG-KVPPLLWGLPH 430
            +  S  +    + + +  N  T       G    +  + L  N +       L      
Sbjct: 113 RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L L  NF+  ++   +   A L  L +S N L+  +  E      +  +S   NK  
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 491 GSLPESLTNLAELGSLDLHANDLS-GELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLS 549
             + ++L     L   DL  N    G L    S  +++    +A         ++    +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECT 284

Query: 550 VLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSLFAKEMYRNSFL 602
           V                     L  L +   +     G        E    +  
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  158 bits (402), Expect = 2e-43
 Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 33/263 (12%)

Query: 688 DNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAE 746
           D  IG GS   VYK +       VA  +L              ++   + + Q   F+ E
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCEL-------------QDRKLTKSERQR--FKEE 75

Query: 747 VETLGKIRHKNIVKL---WCCCTTRDCKLLVY-EYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            E L  ++H NIV+    W         +++  E M +G+L   L   +  ++       
Sbjct: 76  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRS 133

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVDASGKPKSMS 861
                 +GL +LH    P I+HRD+K +NI + G  G  ++ D G+A +  AS   K++ 
Sbjct: 134 WCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAV- 190

Query: 862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD 921
              G+  ++APE  Y  + +E  D+Y+FG+ +LE+ T   P         + + V S + 
Sbjct: 191 --IGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 922 QKGVDHVLDPK----LDCCFKEE 940
               D V  P+    ++ C ++ 
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQN 270

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  150 bits (382), Expect = 3e-40
 Identities = 64/389 (16%), Positives = 111/389 (28%), Gaps = 77/389 (19%)

Query: 207 PPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQ 266
                + +  E L+      +    D L +  +  + D    +                 
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----------- 53

Query: 267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG--PIPDDLTRLPLESLNLYENRLEGS 324
                            N  + ++   +   L     + +D T+    +L L    L   
Sbjct: 54  -----------------NSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95

Query: 325 LPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELE 384
            P                          L     L+ + +       E+P ++ +   LE
Sbjct: 96  FPDQA---------------------FRLSH---LQHMTIDAAGLM-ELPDTMQQFAGLE 130

Query: 385 ELLMIYNSFTGQLPDGLGHCQSLTRVRL-GYNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
            L +  N     LP  +     L  + +     LT                EL +   S 
Sbjct: 131 TLTLARNPLR-ALPASIASLNRLRELSIRACPELT----------------ELPEPLAST 173

Query: 444 EISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAEL 503
           + S    G  NL  L +    +  SLP  I  L++L  L    +  + +L  ++ +L +L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231

Query: 504 GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG 563
             LDL         P        L  L L D      +P DI  L+ L  LDL       
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 564 RIPVGLQNLK-LNQLNVSNNRLSGELPSL 591
           R+P  +  L     + V  +  +      
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  149 bits (379), Expect = 7e-40
 Identities = 52/249 (20%), Positives = 99/249 (39%), Gaps = 15/249 (6%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
           +++L +  +   FP    RL +L  +T+    +   LPD +     L+ L L++N L   
Sbjct: 85  ALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-A 141

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRF---------QKLEVISLVYNLLDGTIPA 183
           L  ++A L  L+ L +       ++PE                L+ + L +  +  ++PA
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200

Query: 184 FLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDL 243
            + N+  LK L +  +P     + P + +L  LE L L  C  +   P   G  A L  L
Sbjct: 201 SIANLQNLKSLKIRNSPLS--ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258

Query: 244 DLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIP 303
            L   + +  +P  +  L  + +++L        LP+  + L +  ++    +       
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

Query: 304 DDLTRLPLE 312
                 P E
Sbjct: 319 HRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  145 bits (367), Expect = 3e-38
 Identities = 56/310 (18%), Positives = 106/310 (34%), Gaps = 27/310 (8%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
           ++    +    P+  +L + +                 +      N Q    +   L   
Sbjct: 16  NLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGRALK-A 70

Query: 133 LTPALADL--PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNIST 190
               L D   P    L+L         P+   R   L+ +++    L   +P  +   + 
Sbjct: 71  TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128

Query: 191 LKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGR---------LAKLV 241
           L+ L L+ NP     +P  + +L  L  L +  C  + E+P+ L           L  L 
Sbjct: 129 LETLTLARNPL--RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186

Query: 242 DLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDAS-MNDLTG 300
            L L    +  ++P+S+  L ++  +++ N+ L+  L     +L  L  LD      L  
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244

Query: 301 PIPDDLTRLP-LESLNLYE-NRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP 358
             P        L+ L L + + L  +LP  I     L +L L        LP  + +   
Sbjct: 245 -YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302

Query: 359 LRWVDLSNNQ 368
              + +  + 
Sbjct: 303 NCIILVPPHL 312

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  139 bits (353), Expect = 2e-36
 Identities = 58/336 (17%), Positives = 114/336 (33%), Gaps = 25/336 (7%)

Query: 107 STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQK 166
            +           ++L    +         L+        D    + +     S      
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NN 57

Query: 167 LEVISLVYNLLDGTIPAFLGNIS--TLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTEC 224
            ++ +     L       L + +      L L   P    + P +   L++L+ + +   
Sbjct: 58  PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPL--PQFPDQAFRLSHLQHMTIDAA 114

Query: 225 NLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIEL-YNNSLT-------- 275
            L+ E+PD++ + A L  L LA N L  A+P+S+  L  + ++ +     LT        
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 276 GDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPG 334
            D       L +L+ L      +   +P  +  L  L+SL +  + L  +L   I   P 
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPK 230

Query: 335 LYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN-NQFTGEIPASLCEKGELEELLMIYNSF 393
           L EL L         P   G  +PL+ + L + +     +P  +    +LE+L +     
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVN 289

Query: 394 TGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLP 429
             +LP  +    +   + +  +             P
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 94.2 bits (235), Expect = 5e-21
 Identities = 40/227 (17%), Positives = 70/227 (30%), Gaps = 36/227 (15%)

Query: 395 GQLPDGLGHCQSLTRVRL-GYNRLT----------------GKVPPLLWGLPHVYLLELT 437
           G       H      +   G   L                        W   +    ++ 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 438 DNFLSG--EISKNIAGAANLSL--LIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSL 493
                     +  +  A       L +    L    P++   L  L  ++         L
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 494 PESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSV--- 550
           P+++   A L +L L  N L   LP+S++S  +L EL++        +PE + +      
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 551 ------LNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLSGELPS 590
                 L  L L    +   +P  + NL+ L  L + N+ LS  L  
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  153 bits (388), Expect = 5e-39
 Identities = 90/398 (22%), Positives = 135/398 (33%), Gaps = 70/398 (17%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
           C       L +  + + +TLPD +    ++  L +  N LT +L       P L+ L+++
Sbjct: 37  CLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPAL---PPELRTLEVS 89

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE 209
           GN  +  +P       +L + S         +PA       L  L +  N      +P  
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSG---LCKLWIFGNQL--TSLPVL 139

Query: 210 LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIEL 269
              L  L +      N +  +P     L KL                             
Sbjct: 140 PPGLQELSVS----DNQLASLPALPSELCKL---------------------------WA 168

Query: 270 YNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATI 329
           YNN LT  LP   S L  L + D   N L   +P   +   L  L  Y NRL  SLPA  
Sbjct: 169 YNNQLT-SLPMLPSGLQELSVSD---NQLAS-LPTLPSE--LYKLWAYNNRLT-SLPALP 220

Query: 330 ADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMI 389
               GL EL +  NRL  +LP    +   L+ + +S N+ T  +P        L  L + 
Sbjct: 221 ---SGLKELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPMLP---SGLLSLSVY 269

Query: 390 YNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI 449
            N  T +LP+ L H  S T V L  N L+ +    L  +                 +   
Sbjct: 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAP 328

Query: 450 AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN 487
                L L     + L  +   E        +    +N
Sbjct: 329 RETRALHLAA--ADWLVPAREGEPAPADRWHMFGQEDN 364

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  141 bits (356), Expect = 6e-35
 Identities = 97/402 (24%), Positives = 142/402 (35%), Gaps = 91/402 (22%)

Query: 213 LTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNN 272
                +L + E  L   +PD L   A +  L +  NNL  ++P+   EL     +E+  N
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGN 91

Query: 273 SLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADS 332
            LT  LP     L  L +    +  L   +P  L       L ++ N+L  SLP      
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLC-----KLWIFGNQLT-SLPVLP--- 140

Query: 333 PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNS 392
           PGL EL +  N+L  +LP    +   L  +   NNQ T  +P        L+EL +  N 
Sbjct: 141 PGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLP---SGLQELSVSDNQ 192

Query: 393 FTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGA 452
               LP        L ++    NRLT  +P L                            
Sbjct: 193 LA-SLPTLPS---ELYKLWAYNNRLT-SLPALP--------------------------- 220

Query: 453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAND 512
           + L  LI+S N L+ SLP     LK L+V   S N+ T SLP   + L    SL ++ N 
Sbjct: 221 SGLKELIVSGNRLT-SLPVLPSELKELMV---SGNRLT-SLPMLPSGLL---SLSVYRNQ 272

Query: 513 LSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL 572
           L+                          +PE + +LS    ++L  N LS R    L+ +
Sbjct: 273 LT-------------------------RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307

Query: 573 KLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDLEGL 614
                            +   +E           L    EG 
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  133 bits (335), Expect = 3e-32
 Identities = 71/345 (20%), Positives = 115/345 (33%), Gaps = 65/345 (18%)

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
            + ++ + + N+     SL      L  L +  N + ++LP        L         L
Sbjct: 62  HITTLVIPDNNLT----SLPALPPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHL 116

Query: 130 TGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNIS 189
                   A    L  L + GN  +                         ++P       
Sbjct: 117 P-------ALPSGLCKLWIFGNQLT-------------------------SLPVLPPG-- 142

Query: 190 TLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNN 249
            L+ L++S N      +P     L  L        N +  +P        L +L ++ N 
Sbjct: 143 -LQELSVSDNQL--ASLPALPSELCKLWAY----NNQLTSLPMLPS---GLQELSVSDNQ 192

Query: 250 LVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL 309
           L  ++P+  +EL     +  YNN LT  LP   +  + L+ L  S N LT  +P   +  
Sbjct: 193 LA-SLPTLPSELYK---LWAYNNRLT-SLP---ALPSGLKELIVSGNRLTS-LPVLPSE- 242

Query: 310 PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQF 369
            L+ L +  NRL  SLP       GL  L ++RN+L   LP  L   S    V+L  N  
Sbjct: 243 -LKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296

Query: 370 TGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGY 414
           +     +L E             F           ++L      +
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  148 bits (376), Expect = 7e-39
 Identities = 77/369 (20%), Positives = 136/369 (36%), Gaps = 26/369 (7%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            ID+   ++   F  +   L N   +T  N+++       + + + ++ L+L+   +   
Sbjct: 27  HIDMQTQDVYFGFEDI--TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 84

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
            T A A    ++ L +  N      P  F     L V+ L  N L         N   L 
Sbjct: 85  DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144

Query: 193 MLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV 251
            L++S N     RI  +     T+L+ L L+   L   +  SL  +  L   +++ N L 
Sbjct: 145 TLSMSNNNL--ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLL- 198

Query: 252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-PIPDDLTRLP 310
               S+L    +V +++  +NS+   +         L +L    N+LT      +     
Sbjct: 199 ----STLAIPIAVEELDASHNSIN-VVRGP--VNVELTILKLQHNNLTDTAWLLNYPG-- 249

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
           L  ++L  N LE  +         L  L +  NRL   L         L+ +DLS+N   
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
             +  +  +   LE L + +NS    L   L    +L  + L +N        L     +
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC--NSLRALFRN 362

Query: 431 VYLLELTDN 439
           V    + D 
Sbjct: 363 VARPAVDDA 371

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (347), Expect = 4e-35
 Identities = 75/368 (20%), Positives = 131/368 (35%), Gaps = 30/368 (8%)

Query: 103 NSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFG 162
             I+S L  D     ++     +Q++  G        L N K +    +           
Sbjct: 11  KCIDSNLQYDCV-FYDVHIDMQTQDVYFG---FEDITLNNQKIVTFKNSTMRKLPAALLD 66

Query: 163 RFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWL 221
            F+++E+++L    ++           T++ L + +N      +PP    N+  L +L L
Sbjct: 67  SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI--RYLPPHVFQNVPLLTVLVL 124

Query: 222 TECNLVGEIP-DSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPT 280
              N +  +P        KL  L ++ NNL      +     S+  ++L +N LT  +  
Sbjct: 125 ER-NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL 182

Query: 281 GWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELR 339
               + SL   + S N L+      L     +E L+   N +   +   +  +  L  L+
Sbjct: 183 S--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 340 LFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK-GELEELLMIYNSFTGQLP 398
           L  N L  T    L     L  VDLS N+   +I      K   LE L +  N     L 
Sbjct: 233 LQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 399 DGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLL 458
                  +L  + L +N L   V         +  L L  N +    +  ++    L  L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNL 344

Query: 459 IISKNNLS 466
            +S N+  
Sbjct: 345 TLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  135 bits (343), Expect = 1e-34
 Identities = 71/394 (18%), Positives = 129/394 (32%), Gaps = 28/394 (7%)

Query: 230 IPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSL 288
           I  +L       D+ + +             L +   +   N+++   LP     +   +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 289 RLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNG 347
            LL+ +   +             ++ L +  N +    P    + P L  L L RN L+ 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 348 TLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK-GELEELLMIYNSFTGQLPDGLGHCQS 406
              G       L  + +SNN     I     +    L+ L +  N  T  +   L    S
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPS 187

Query: 407 LTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLS 466
           L    + YN L+      L     V  L+ + N ++  +   +     L++L +  NNL+
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT 239

Query: 467 GSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK 526
                 +     LV +  S N+    +      +  L  L +  N L   L         
Sbjct: 240 -DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296

Query: 527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG-LQNLKLNQLNVSNNRLS 585
           L  L+L+ N    ++  +      L  L L +N +   + +     LK   L +S+N   
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK--NLTLSHNDWD 352

Query: 586 GELPSLFAKEMYRNSFLGNPGLCG----DLEGLC 615
                   + + R +       C        GLC
Sbjct: 353 CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 386

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 25/144 (17%), Positives = 46/144 (31%), Gaps = 16/144 (11%)

Query: 468 SLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSV-SSWKK 526
            +   + +      +                 L     +    + +  +LP+++  S+++
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 527 LNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNR 583
           +  LNL D      I          +  L +  N +   +P    QN+  L  L +  N 
Sbjct: 71  VELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128

Query: 584 LSGELPSLFAKEMYRNSFLGNPGL 607
           LS  LP        R  F   P L
Sbjct: 129 LS-SLP--------RGIFHNTPKL 143

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  151 bits (382), Expect = 2e-38
 Identities = 98/534 (18%), Positives = 180/534 (33%), Gaps = 38/534 (7%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            ID+   ++   F  +   L N   +T  N+++       + + + ++ L+L+   +   
Sbjct: 33  HIDMQTQDVYFGFEDI--TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 90

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
            T A A    ++ L +  N      P  F     L V+ L  N L         N   L 
Sbjct: 91  DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150

Query: 193 MLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV 251
            L++S N     RI  +     T+L+ L L+   L   +  SL  +  L   +++ N L 
Sbjct: 151 TLSMSNNNL--ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLL- 204

Query: 252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP- 310
               S+L    +V +++  +NS+   +         L +L    N+LT      L   P 
Sbjct: 205 ----STLAIPIAVEELDASHNSIN-VVRGP--VNVELTILKLQHNNLTD--TAWLLNYPG 255

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
           L  ++L  N LE  +         L  L +  NRL   L         L+ +DLS+N   
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
             +  +  +   LE L + +NS    L   L    +L  + L +N        L     +
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC--NSLRALFRN 368

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           V    + D        ++      L   +  K +    L   + ++    V+   +    
Sbjct: 369 VARPAVDDA------DQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQG 422

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSV 550
                   N  +  S  +        L  +     ++NEL            +    L  
Sbjct: 423 RCSATDTINSVQSLSHYITQQGGVP-LQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQG 481

Query: 551 LNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGN 604
           L+    +N R        L    L + + + N++   L    A ++        
Sbjct: 482 LHAEIDTNLRRY-----RLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRT 530

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  142 bits (359), Expect = 2e-35
 Identities = 89/533 (16%), Positives = 170/533 (31%), Gaps = 67/533 (12%)

Query: 78  NANIAGPFPSLLCRLENLTFLTLF-NNSINSTLPDDISA-----CQNLQHLDLSQNLLTG 131
             N+    P   C   NL +  +F +  I+    D           N + +    + +  
Sbjct: 6   RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65

Query: 132 TLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTL 191
                L     ++ L+L           +F     ++ + + +N +    P    N+  L
Sbjct: 66  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 125

Query: 192 KMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV 251
            +L L  N            +L++L                      KL  L ++ NNL 
Sbjct: 126 TVLVLERN------------DLSSLP-------------RGIFHNTPKLTTLSMSNNNLE 160

Query: 252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPL 311
                +     S+  ++L +N LT  +      + SL   + S N L+  +   +    +
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNLLST-LAIPIA---V 213

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
           E L+   N +   +   +  +  L  L+L  N L  T    L     L  VDLS N+   
Sbjct: 214 EELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE- 267

Query: 372 EIPASLCEK-GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
           +I      K   LE L +  N     L        +L  + L +N L   V         
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L L  N +    +  ++    L  L +S N+   +        +++   +  +    
Sbjct: 326 LENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQH 380

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNL-FYGNIPEDIGNLS 549
             +   L +       D    D            + L  + L   +              
Sbjct: 381 CKIDYQLEHGLCCKESDKPYLD------------RLLQYIALTSVVEKVQRAQGRCSATD 428

Query: 550 VLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFL 602
            +N +   ++ ++ +  V LQ  +  QL    N L  E+  L  +++ +   L
Sbjct: 429 TINSVQSLSHYITQQGGVPLQGNE--QLEAEVNELRAEVQQLTNEQIQQEQLL 479

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  142 bits (361), Expect = 1e-37
 Identities = 59/335 (17%), Positives = 119/335 (35%), Gaps = 21/335 (6%)

Query: 109 LPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLE 168
           + +        +   ++ + L   L        N+K LDL+GN  S         F KLE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 169 VISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVG 228
           +++L  N+L         ++STL+ L+L+ N         EL    ++E L     N + 
Sbjct: 62  LLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV------QELLVGPSIETLHAAN-NNIS 112

Query: 229 EIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTG-DLPTGWSNLTS 287
            +  S G+     ++ LA N +           + V  ++L  N +   +     ++  +
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 288 LRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNG 347
           L  L+   N +   +   +    L++L+L  N+L   +      + G+  + L  N+L  
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227

Query: 348 TLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSL 407
            +   L  +  L   DL  N F            + + +  +      +L        ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 408 TRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLS 442
             +   Y     +  P  +      L+ L  +   
Sbjct: 286 PTL-GHYGAYCCEDLPAPFADR---LIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  141 bits (357), Expect = 5e-37
 Identities = 53/298 (17%), Positives = 100/298 (33%), Gaps = 18/298 (6%)

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN 151
                   + ++S+   L     +  N++ LDLS N L+      LA    L+ L+L+ N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 152 NFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELG 211
               +  +       L  + L  N +       L    +++ L+ + N     R+     
Sbjct: 69  VLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI--SRVSCS-- 117

Query: 212 NLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG-AIPSSLTELASVVQIELY 270
                + ++L    +        G  +++  LDL LN +             ++  + L 
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATI 329
            N +  D+         L+ LD S N L   +  +      +  ++L  N+L   +   +
Sbjct: 178 YNFIY-DVKGQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKAL 233

Query: 330 ADSPGLYELRLFRNRLN-GTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEEL 386
             S  L    L  N  + GTL     KN  ++ V     +         C    L   
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  131 bits (331), Expect = 1e-33
 Identities = 64/315 (20%), Positives = 101/315 (32%), Gaps = 35/315 (11%)

Query: 75  DLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLT 134
            ++++++     SL     N+  L L  N ++     D++    L+ L+LS N+L    T
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--T 73

Query: 135 PALADLPNLKFLDLTGNNFSGDIPE-----------------SFGRFQKLEVISLVYNLL 177
             L  L  L+ LDL  N    ++                   S  R Q  + I L  N +
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKI 132

Query: 178 DGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRL 237
                   G  S ++ L+L  N            +   LE L L    +  ++   +   
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-F 190

Query: 238 AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMND 297
           AKL  LDL+ N L   +       A V  I L NN L   +        +L   D   N 
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN- 247

Query: 298 LTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRL---NGTLPGDLG 354
                        L        R++     T+    G  E       L         DL 
Sbjct: 248 -------GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300

Query: 355 KNSPLRWVDLSNNQF 369
                R + L ++  
Sbjct: 301 APFADRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  129 bits (327), Expect = 4e-33
 Identities = 57/327 (17%), Positives = 99/327 (30%), Gaps = 41/327 (12%)

Query: 284 NLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFR 342
           N    ++   + + L   +         ++ L+L  N L     A +A    L  L L  
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 343 NRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLG 402
           N L      DL   S LR +DL+NN         L     +E L    N+ + ++    G
Sbjct: 68  NVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG 119

Query: 403 HCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG-EISKNIAGAANLSLLIIS 461
             Q    + L  N++T            V  L+L  N +     ++  A +  L  L + 
Sbjct: 120 --QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 462 KNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSV 521
            N +   +  ++     L  L  S NK    +     + A +  + L  N L        
Sbjct: 178 YNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV------- 227

Query: 522 SSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSN 581
                              I + +     L + DL  N           +       V+ 
Sbjct: 228 ------------------LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269

Query: 582 NRLSGELPSLFAKEMYRNSFLGNPGLC 608
             +  +L     +E    +       C
Sbjct: 270 QTVK-KLTGQNEEECTVPTLGHYGAYC 295

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  123 bits (310), Expect = 6e-31
 Identities = 57/346 (16%), Positives = 107/346 (30%), Gaps = 41/346 (11%)

Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-L 311
           AI             ++ ++SL   L +   +  +++ LD S N L+     DL     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
           E LNL  N L       +     L  L L  N +      +L     +  +  +NN  + 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 372 EIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV 431
                                   ++    G  Q    + L  N++T            V
Sbjct: 113 ------------------------RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 432 YLLELTDNFLSG-EISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
             L+L  N +     ++  A +  L  L +  N +   +  ++     L  L  S NK  
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSV 550
             +     + A +  + L  N L   +  ++   + L   +L  N F+            
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKN 261

Query: 551 LNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEM 596
                ++   +        +   +  L         +LP+ FA  +
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  141 bits (358), Expect = 5e-37
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 34/220 (15%)

Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
             +G GS G+V+++     G   AVKK+             +E  +V+          E+
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKV------------RLEVFRVE----------EL 101

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
                +    IV L+          +  E +  GSLG L+   + G L        +  A
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQA 159

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAKVVDASGKPKSMSV--- 862
            EGL YLH      I+H DVK++N+LL  D G+R    DFG A  +   G  KS+     
Sbjct: 160 LEGLEYLHTRR---ILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           I G+  ++APE       + K DI+S   ++L ++ G  P
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (356), Expect = 1e-36
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 29/227 (12%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKL-WRGMSKECESGCDVEKGQVQ 735
           +Y  L        IG GS GK   V    +G    +K++    MS +             
Sbjct: 25  KYVRLQ------KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-------- 70

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
                   + EV  L  ++H NIV+            +V +Y   G L   +++ KG L 
Sbjct: 71  --------RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
                    V     L ++H      I+HRD+KS NI L  D   ++ DFG+A+V++ S 
Sbjct: 123 QEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-ST 178

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              + + I G+  Y++PE       N KSDI++ G V+ EL T +  
Sbjct: 179 VELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (351), Expect = 2e-36
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 35/222 (15%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G G+ G VY    LSN   +A+K++                   +D         E+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI-----------------PERDSRYSQPLHEEIA 71

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV-DA 807
               ++HKNIV+     +      +  E +P GSL  LL S  G L D            
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKSMSVIAGS 866
            EGL YLH +    IVHRD+K +N+L++   G  +++DFG +K + A   P + +   G+
Sbjct: 132 LEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFT-GT 186

Query: 867 CGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             Y+APE        Y       +DI+S G  I+E+ TG+ P
Sbjct: 187 LQYMAPEIIDKGPRGYGK----AADIWSLGCTIIEMATGKPP 224

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  141 bits (358), Expect = 5e-36
 Identities = 77/474 (16%), Positives = 151/474 (31%), Gaps = 46/474 (9%)

Query: 93  ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN 152
           +N          + +T          L  LD   + +T      +  L  L  L  T NN
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75

Query: 153 FSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGN 212
            +  +     +   L  ++   N L   +   +  ++ L  LN   N         ++  
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKL----TKLDVSQ 125

Query: 213 LTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNN 272
              L  L      L  EI   +    +L +LD  LN  +  +   +T    +  ++   N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180

Query: 273 SLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIAD 331
            +T +L    S    L  L+   N++T     DL +   L  L+   N+L   +   +  
Sbjct: 181 KIT-ELDV--SQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTP 231

Query: 332 SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYN 391
              L       N L   L   +   S L  +         EI  +   +  L        
Sbjct: 232 LTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNTQ--LIYFQAEGC 285

Query: 392 SFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAG 451
               +L   + H   L  +      +T ++   L   P +  L L +  L+     +++ 
Sbjct: 286 RKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT---ELDVSH 337

Query: 452 AANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAN 511
              L  L     ++       +G + +L     +E +      E+LTN +   ++     
Sbjct: 338 NTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLL 395

Query: 512 DLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRI 565
           D  G   +       + +    + + + N+  D   ++        N  + G +
Sbjct: 396 DQFGNPMNIEPGDGGVYDQA-TNTITWENLSTDNPAVTYT--FTSENGAIVGTV 446

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 93.6 bits (233), Expect = 4e-20
 Identities = 60/297 (20%), Positives = 102/297 (34%), Gaps = 33/297 (11%)

Query: 290 LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTL 349
           L            PDD       S       ++ +   +      L  L    + +   +
Sbjct: 3   LKAGQTQSFNDWFPDDN----FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DM 57

Query: 350 PGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTR 409
            G + K + L  +  ++N  T  +  S      L  L    N  T  L   +     LT 
Sbjct: 58  TG-IEKLTGLTKLICTSNNIT-TLDLSQNTN--LTYLACDSNKLT-NLD--VTPLTKLTY 110

Query: 410 VRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSL 469
           +    N+LT K+       P +  L    N L+     +++    L+ L    N     L
Sbjct: 111 LNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKL 164

Query: 470 PEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNE 529
              +     L  L  S NK T  L   ++    L  L+   N+++ +L   ++   +L  
Sbjct: 165 D--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216

Query: 530 LNLADNLFYGNIPE-DIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLS 585
           L+ + N     + E D+  L+ L Y D S N L+  + V     KL  L+     L 
Sbjct: 217 LDCSSN----KLTEIDVTPLTQLTYFDCSVNPLT-ELDVS-TLSKLTTLHCIQTDLL 267

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  139 bits (353), Expect = 3e-35
 Identities = 72/322 (22%), Positives = 115/322 (35%), Gaps = 16/322 (4%)

Query: 57  CSWRGVECDPR--SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDI- 113
           C  +     P         +DL    I            +L  L L  N + S +     
Sbjct: 18  CHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAF 76

Query: 114 SACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV 173
           +   NL+ L L  N L          L NL  LD++ N     +   F     L+ + + 
Sbjct: 77  NNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136

Query: 174 YNLLDGTIP--AFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEI 230
            N L   I   AF G  S L+ L L         IP E L +L  L +L L   N+    
Sbjct: 137 DNDL-VYISHRAFSGLNS-LEQLTLEKCNL--TSIPTEALSHLHGLIVLRLRHLNINAIR 192

Query: 231 PDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSLR 289
             S  RL +L  L+++    +  +  +     ++  + + + +LT  +P     +L  LR
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLR 251

Query: 290 LLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGT 348
            L+ S N ++      L  L  L+ + L   +L    P        L  L +  N+L  T
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-T 310

Query: 349 LPGDL-GKNSPLRWVDLSNNQF 369
           L   +      L  + L +N  
Sbjct: 311 LEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  127 bits (321), Expect = 4e-31
 Identities = 72/357 (20%), Positives = 127/357 (35%), Gaps = 36/357 (10%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
           C  ++   +          +P+ I      + LDL +N +        A  P+L+ L+L 
Sbjct: 9   CSAQDRA-VLCHRKRF-VAVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELN 64

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE 209
            N  S  +    G F  L                       L+ L L  N      IP  
Sbjct: 65  ENIVS-AVEP--GAFNNL---------------------FNLRTLGLRSNRL--KLIPLG 98

Query: 210 -LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIE 268
               L+NL  L ++E  +V  +      L  L  L++  N+LV     + + L S+ Q+ 
Sbjct: 99  VFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT 158

Query: 269 LYNNSLTGDLPTGW-SNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLP 326
           L   +LT  +PT   S+L  L +L     ++         RL  L+ L +       ++ 
Sbjct: 159 LEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217

Query: 327 ATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK-GELEE 385
                   L  L +    L       +     LR+++LS N  +  I  S+  +   L+E
Sbjct: 218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQE 276

Query: 386 LLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLS 442
           + ++        P        L  + +  N+LT     +   + ++  L L  N L+
Sbjct: 277 IQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  123 bits (311), Expect = 8e-30
 Identities = 63/307 (20%), Positives = 120/307 (39%), Gaps = 12/307 (3%)

Query: 189 STLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL 247
           +  ++L+L  N      +  +   +  +LE L L E  +    P +   L  L  L L  
Sbjct: 32  TETRLLDLGKNRI--KTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89

Query: 248 NNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGW-SNLTSLRLLDASMNDLTGPIPDDL 306
           N L        T L+++ ++++  N +   L      +L +L+ L+   NDL        
Sbjct: 90  NRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAF 148

Query: 307 TRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLS 365
           + L  LE L L +  L       ++   GL  LRL    +N        +   L+ +++S
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208

Query: 366 NNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPPL 424
           +  +   +  +      L  L + + + T  +P   + H   L  + L YN ++     +
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSM 267

Query: 425 LWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVL 482
           L  L  +  ++L    L+  +      G   L +L +S N L+ +L E +   + +L  L
Sbjct: 268 LHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETL 325

Query: 483 SGSENKF 489
               N  
Sbjct: 326 ILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  122 bits (309), Expect = 1e-29
 Identities = 68/317 (21%), Positives = 125/317 (39%), Gaps = 15/317 (4%)

Query: 205 RIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASV 264
            +P  +   T   +L L +  +     D       L +L+L  N +    P +   L ++
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 265 VQIELYNNSLTGDLPTGW-SNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLE 322
             + L +N L   +P G  + L++L  LD S N +   +      L  L+SL + +N L 
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141

Query: 323 GSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGE 382
                  +    L +L L +  L       L     L  + L +         S      
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR 201

Query: 383 LEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-LLWGLPHVYLLELTDNFL 441
           L+ L + +  +   +     +  +LT + + +  LT  VP   +  L ++  L L+ N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260

Query: 442 SGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPESL- 497
           S  I  ++      L  + +    L+  +     F  L  L VL+ S N+ T +L ES+ 
Sbjct: 261 S-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYA-FRGLNYLRVLNVSGNQLT-TLEESVF 316

Query: 498 TNLAELGSLDLHANDLS 514
            ++  L +L L +N L+
Sbjct: 317 HSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  118 bits (298), Expect = 3e-28
 Identities = 70/325 (21%), Positives = 119/325 (36%), Gaps = 13/325 (4%)

Query: 267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSL 325
           +  +       +P G    T  RLLD   N +     D+    P LE L L EN +    
Sbjct: 16  VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEE 385
           P    +   L  L L  NRL     G     S L  +D+S N+    +     +   L+ 
Sbjct: 73  PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132

Query: 386 LLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGE 444
           L +  N     +         SL ++ L    LT      L  L  + +L L    ++  
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191

Query: 445 ISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE-SLTNLAEL 503
              +      L +L IS      ++     +  +L  LS +    T ++P  ++ +L  L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250

Query: 504 GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLS 562
             L+L  N +S    S +    +L E+ L        +       L+ L  L++S N+L+
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT 309

Query: 563 GRIPVGL--QNLKLNQLNVSNNRLS 585
             +   +      L  L + +N L+
Sbjct: 310 -TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  107 bits (270), Expect = 1e-24
 Identities = 59/302 (19%), Positives = 111/302 (36%), Gaps = 25/302 (8%)

Query: 313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE 372
           ++  +  R   ++P  I        L L +NR+      +      L  ++L+ N  +  
Sbjct: 15  AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-A 70

Query: 373 IPASLCEK-GELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPP-LLWGLP 429
           +          L  L +  N     +P G      +LT++ +  N++   +   +   L 
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLY 128

Query: 430 HVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENK 488
           ++  LE+ DN L   IS    +G  +L  L + K NL+    E +  L  L+VL      
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187

Query: 489 FTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPED-IGN 547
                  S   L  L  L++        +  +      L  L++        +P   + +
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRH 246

Query: 548 LSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNP 605
           L  L +L+LS N +S  I    L  L +L ++ +   +L+  +           +F G  
Sbjct: 247 LVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVE--------PYAFRGLN 296

Query: 606 GL 607
            L
Sbjct: 297 YL 298

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 74.8 bits (184), Expect = 4e-14
 Identities = 43/187 (22%), Positives = 65/187 (34%), Gaps = 9/187 (4%)

Query: 403 HCQSLTR-VRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIIS 461
            C +  R V     R    VP  +       LL+L  N +        A   +L  L ++
Sbjct: 8   ECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELN 64

Query: 462 KNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSV 521
           +N +S   P     L +L  L    N+         T L+ L  LD+  N +   L    
Sbjct: 65  ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMF 124

Query: 522 SSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLN 578
                L  L + DN     I       L+ L  L L    L+  IP   L +L  L  L 
Sbjct: 125 QDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLR 182

Query: 579 VSNNRLS 585
           + +  ++
Sbjct: 183 LRHLNIN 189

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  135 bits (341), Expect = 5e-35
 Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 41/238 (17%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
            Y IL        IGSG S KV++V+    +  A+K               V   +  +Q
Sbjct: 29  IYSILK------QIGSGGSSKVFQVLNEKKQIYAIKY--------------VNLEEADNQ 68

Query: 738 VQDDGFQAEVETLGKIRHKN--IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
              D ++ E+  L K++  +  I++L+    T     +V E   N  L   L   K   +
Sbjct: 69  TL-DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSI 124

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           D   R     +  E +  +H      IVH D+K  N L+  D   ++ DFG+A  +    
Sbjct: 125 DPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180

Query: 856 KPKSMSVIAGSCGYIAPE-----------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                    G+  Y+ PE                +++ KSD++S G ++  +  G+ P
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  139 bits (351), Expect = 8e-35
 Identities = 101/490 (20%), Positives = 174/490 (35%), Gaps = 36/490 (7%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF 153
           +   +    N +   +P D+S       L++SQN ++   T  +  L  L+ L ++ N  
Sbjct: 1   SEFLVDRSKNGLIH-VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57

Query: 154 SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNL 213
                  F   Q+LE + L +N L   I         LK L+LS+N F    I  E GN+
Sbjct: 58  QYLDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNM 114

Query: 214 TNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAI-PSSLTELA--SVVQIELY 270
           + L+ L L+  +L       +  L     L +          P  L +    S+  +   
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLE-------- 322
           N      L      + +L L +             L+ L     N   + L         
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234

Query: 323 ---GSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP-----LRWVDLSNNQFTGEIP 374
                +   +  +  ++   +   +L G L       S      L    + ++ F     
Sbjct: 235 NSFIRILQLVWHTT-VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQ 292

Query: 375 ASLCEKGELEELLMIYNSFTGQLPDGL-GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL 433
           + + E      +     S T  +             +    N LT  V      L  +  
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352

Query: 434 LELTDNFLS--GEISKNIAGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVLSGSENKFT 490
           L L  N L    +I++      +L  L IS+N++S    +    + KSL+ L+ S N  T
Sbjct: 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDI-GNLS 549
            ++   L     +  LDLH+N +   +P  V   + L ELN+A N    ++P+ I   L+
Sbjct: 413 DTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLT 468

Query: 550 VLNYLDLSNN 559
            L  + L  N
Sbjct: 469 SLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 93.0 bits (231), Expect = 1e-19
 Identities = 42/223 (18%), Positives = 77/223 (34%), Gaps = 27/223 (12%)

Query: 75  DLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLT 134
            + +     P   +     N+       +          S      HLD S NLLT T+ 
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341

Query: 135 PALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKML 194
                L  L+ L L  N    ++ +      ++                      +L+ L
Sbjct: 342 ENCGHLTELETLILQMNQLK-ELSKIAEMTTQM---------------------KSLQQL 379

Query: 195 NLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAI 254
           ++S N         +     +L  L ++   L   I   L    ++  LDL  N +  +I
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SI 436

Query: 255 PSSLTELASVVQIELYNNSLTGDLPTGW-SNLTSLRLLDASMN 296
           P  + +L ++ ++ + +N L   +P G    LTSL+ +    N
Sbjct: 437 PKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  136 bits (344), Expect = 9e-35
 Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 44/241 (18%)

Query: 677 SEYEILDGLDEDNVIGSGSS--GKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQ 733
             YE+L       VIG G      V        GE V V+++            ++E   
Sbjct: 25  GCYELLT------VIGKGFEDLMTVNLARYKPTGEYVTVRRI------------NLEACS 66

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
             + V     Q E+       H NIV         +   +V  +M  GS  DL+ +    
Sbjct: 67  -NEMVTF--LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD 123

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
            ++      I+    + L Y+HH      VHR VK+++IL+  D    ++       + +
Sbjct: 124 GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180

Query: 854 SGKPKSMSVIAGSCGYI------APE------YAYTLRVNEKSDIYSFGVVILELVTGRL 901
            G+ +   V       +      +PE        Y    + KSDIYS G+   EL  G +
Sbjct: 181 HGQ-RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHV 235

Query: 902 P 902
           P
Sbjct: 236 P 236

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (338), Expect = 1e-34
 Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 34/232 (14%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKK--LWRGMSKECESGCDVEKGQ 733
           + + I         IG G   +VY+   L +G  VA+KK  ++  M  +        +  
Sbjct: 32  ANFRIEK------KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK-------ARAD 78

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-- 791
                       E++ L ++ H N++K +      +   +V E    G L  ++   K  
Sbjct: 79  CI---------KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
             L+   T +K  V     L ++H      ++HRD+K  N+ +      ++ D G+ +  
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186

Query: 852 DAS-GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +      S+    G+  Y++PE  +    N KSDI+S G ++ E+   + P
Sbjct: 187 SSKTTAAHSL---VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (339), Expect = 2e-34
 Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 41/238 (17%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
            Y IL        IGSG S KV++V+    +  A+K               V   +  +Q
Sbjct: 10  IYSILK------QIGSGGSSKVFQVLNEKKQIYAIKY--------------VNLEEADNQ 49

Query: 738 VQDDGFQAEVETLGKIRHKN--IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
              D ++ E+  L K++  +  I++L+    T     +V E   N  L   L   K   +
Sbjct: 50  TL-DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSI 105

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           D   R     +  E +  +H      IVH D+K  N L+  D   ++ DFG+A  +    
Sbjct: 106 DPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161

Query: 856 KPKSMSVIAGSCGYIAPE-----------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                    G+  Y+ PE                +++ KSD++S G ++  +  G+ P
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (335), Expect = 2e-34
 Identities = 49/246 (19%), Positives = 96/246 (39%), Gaps = 56/246 (22%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +++ +       +IGSG  G+V+K     +G+   +K+    +    E           
Sbjct: 11  MDFKEI------ELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEK---------- 50

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCC---------------CTTRDCKL-LVYEYMP 779
                   + EV+ L K+ H NIV    C                 ++   L +  E+  
Sbjct: 51  -------AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD 103

Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
            G+L   +   +G  LD     ++     +G+ Y+H      +++RD+K +NI L     
Sbjct: 104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160

Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCG---YIAPEYAYTLRVNEKSDIYSFGVVILEL 896
            ++ DFG+   +   GK           G   Y++PE   +    ++ D+Y+ G+++ EL
Sbjct: 161 VKIGDFGLVTSLKNDGKRTRS------KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

Query: 897 VTGRLP 902
           +     
Sbjct: 215 LHVCDT 220

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  135 bits (342), Expect = 2e-34
 Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 41/238 (17%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
            Y IL        IGSG S KV++V+    +  A+K               V   +  +Q
Sbjct: 57  IYSILK------QIGSGGSSKVFQVLNEKKQIYAIKY--------------VNLEEADNQ 96

Query: 738 VQDDGFQAEVETLGKIRHKN--IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
              D ++ E+  L K++  +  I++L+    T     +V E   N  L   L   K   +
Sbjct: 97  TL-DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK--KKKSI 152

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           D   R     +  E +  +H      IVH D+K  N L+  D   ++ DFG+A  +    
Sbjct: 153 DPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208

Query: 856 KPKSMSVIAGSCGYIAPE-----------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                    G+  Y+ PE                +++ KSD++S G ++  +  G+ P
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (333), Expect = 3e-34
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 32/233 (13%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKL-WRGMSKECESGCDVEKGQVQ 735
           +YE+L        IG+GS G+  K+   S+G+ +  K+L +  M++        EK  + 
Sbjct: 7   DYEVLY------TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-------EKQMLV 53

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLW-CCCTTRDCKL-LVYEYMPNGSLGDLLHSCK-- 791
                    +EV  L +++H NIV+ +       +  L +V EY   G L  ++      
Sbjct: 54  ---------SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLH--HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              LD     +++      L   H   D   +++HRD+K  N+ LDG    ++ DFG+A+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +++      + + + G+  Y++PE    +  NEKSDI+S G ++ EL     P
Sbjct: 165 ILN-HDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  133 bits (336), Expect = 5e-34
 Identities = 49/241 (20%), Positives = 97/241 (40%), Gaps = 31/241 (12%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
            +  G   K+      + +  A+KK  + + ++          ++  + + D F+ E++ 
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY------KI 803
           +  I+++  +      T  D   ++YEYM N S+            ++           I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
           I       SY+H++   +I HRDVK +NIL+D +   +++DFG ++ +           I
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-------KKI 207

Query: 864 AGSCG---YIAPE-------YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
            GS G   ++ PE       Y        K DI+S G+ +  +    +P   +    +L 
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262

Query: 914 K 914
            
Sbjct: 263 N 263

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (338), Expect = 6e-34
 Identities = 65/295 (22%), Positives = 116/295 (39%), Gaps = 45/295 (15%)

Query: 690 VIGSGSSGKVYKVVLSNGE-AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            IG G+ G+V+   L      VAVK     +  +                    F  E  
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--------------LKAK--FLQEAR 164

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L +  H NIV+L   CT +    +V E +  G     L + +G  L   T  +++ DAA
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAA 223

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
            G+ YL        +HRD+ + N L+      +++DFG+++          +   +G   
Sbjct: 224 AGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-----DGVYAASGGLR 275

Query: 869 YI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQ 922
            +     APE     R + +SD++SFG+++ E  + G  P  P    +   ++V      
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-PNLSNQQTREFVEK---- 330

Query: 923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR 977
                 L     C   + + +++     C +  P  RP+   + + LQ +   +R
Sbjct: 331 ---GGRLPCPELC--PDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  132 bits (333), Expect = 6e-34
 Identities = 54/260 (20%), Positives = 94/260 (36%), Gaps = 45/260 (17%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEK 731
            +    Y  +        +G G    V  V  L +G   A+K++                
Sbjct: 25  IIDNKHYLFIQ------KLGEGGFSYVDLVEGLHDGHFYALKRI---------------- 62

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCK----LLVYEYMPNGSLGDLL 787
               +Q   +  Q E +      H NI++L   C           L+  +   G+L + +
Sbjct: 63  -LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121

Query: 788 --HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
                KG  L       +++    GL  +H        HRD+K  NILL  +    + D 
Sbjct: 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDL 178

Query: 846 GVAKV----VDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVIL 894
           G        V+ S +  ++   A       Y APE     ++   ++E++D++S G V+ 
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLY 237

Query: 895 ELVTGRLPVDPEFGEKDLVK 914
            ++ G  P D  F + D V 
Sbjct: 238 AMMFGEGPYDMVFQKGDSVA 257

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (329), Expect = 1e-33
 Identities = 66/244 (27%), Positives = 101/244 (41%), Gaps = 44/244 (18%)

Query: 663 KSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSK 721
           K +W L         ++EI         +G G  G VY      +   +A+K L     K
Sbjct: 3   KRQWAL--------EDFEIG------RPLGKGKFGNVYLAREKQSKFILALKVL----FK 44

Query: 722 ECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNG 781
                  +EK  V+ Q++      EVE    +RH NI++L+          L+ EY P G
Sbjct: 45  A-----QLEKAGVEHQLRR-----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
           ++   L   K    D       I + A  LSY H      ++HRD+K  N+LL      +
Sbjct: 95  TVYRELQ--KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 149

Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCG---YIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +ADFG +     S +   +      CG   Y+ PE       +EK D++S GV+  E + 
Sbjct: 150 IADFGWSVHAP-SSRRTDL------CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202

Query: 899 GRLP 902
           G+ P
Sbjct: 203 GKPP 206

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  130 bits (329), Expect = 1e-33
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 35/229 (15%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             +  L+       IG GS G+V+K +     + VA+K +            D+E  + +
Sbjct: 22  ELFTKLE------KIGKGSFGEVFKGIDNRTQKVVAIKII------------DLE--EAE 61

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGL 794
           D+++D   Q E+  L +     + K +     +D KL ++ EY+  GS  DLL   + G 
Sbjct: 62  DEIED--IQQEITVLSQCDSPYVTKYYGS-YLKDTKLWIIMEYLGGGSALDLL---EPGP 115

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDA 853
           LD      I+ +  +GL YLH +     +HRD+K+ N+LL      ++ADFGV  ++ D 
Sbjct: 116 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             K  +     G+  ++APE       + K+DI+S G+  +EL  G  P
Sbjct: 173 QIKRNTF---VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  130 bits (329), Expect = 1e-33
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 31/227 (13%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYK---VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           Y+I+D       +G G    VY     +L     VA+K ++                  +
Sbjct: 13  YKIVD------KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPR--------------E 50

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
            +     F+ EV    ++ H+NIV +       DC  LV EY+   +L + +     G L
Sbjct: 51  KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPL 108

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
              T         +G+ + H      IVHRD+K  NIL+D +   ++ DFG+AK +  + 
Sbjct: 109 SVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             ++  V+ G+  Y +PE A     +E +DIYS G+V+ E++ G  P
Sbjct: 166 LTQTNHVL-GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (328), Expect = 2e-33
 Identities = 46/246 (18%), Positives = 95/246 (38%), Gaps = 49/246 (19%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           +++E +        +G G  G V++     +    A+K++     +              
Sbjct: 5   TDFEPIQ------CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV-------- 50

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDC---------KLLVY---EYMPNGSL 783
                     EV+ L K+ H  IV+ +     ++          K+ +Y   +     +L
Sbjct: 51  --------MREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL 102

Query: 784 GDLLHSCKGG-LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
            D ++        +      I +  AE + +LH      ++HRD+K +NI    D   +V
Sbjct: 103 KDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV 159

Query: 843 ADFGVAKVVDASGKPKSMSVIAGS-------CG---YIAPEYAYTLRVNEKSDIYSFGVV 892
            DFG+   +D   + +++     +        G   Y++PE  +    + K DI+S G++
Sbjct: 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLI 219

Query: 893 ILELVT 898
           + EL+ 
Sbjct: 220 LFELLY 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  128 bits (324), Expect = 6e-33
 Identities = 66/242 (27%), Positives = 106/242 (43%), Gaps = 46/242 (19%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +YE+ +      VIGSG++  V         E VA+K++            ++EK Q  
Sbjct: 15  DDYELQE------VIGSGATAVVQAAYCAPKKEKVAIKRI------------NLEKCQ-- 54

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGL 794
             + +     E++ + +  H NIV  +        +L LV + +  GS+ D++       
Sbjct: 55  TSMDE--LLKEIQAMSQCHHPNIVSYYTS-FVVKDELWLVMKLLSGGSVLDIIKHIVAKG 111

Query: 795 LDWPTRYK------IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
                         I+ +  EGL YLH +     +HRDVK+ NILL  D   ++ADFGV+
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168

Query: 849 KVVDASGKPKSMSV---IAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
             +   G      V     G+  ++APE       Y    + K+DI+SFG+  +EL TG 
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGA 224

Query: 901 LP 902
            P
Sbjct: 225 AP 226

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (321), Expect = 2e-32
 Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 55/250 (22%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S++E +       V+G G+ G+V K     +    A+KK    +                
Sbjct: 6   SDFEEIA------VLGQGAFGQVVKARNALDSRYYAIKK----IRH-------------- 41

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCC------------CTTRDCKL-LVYEYMPNGS 782
            + +     +EV  L  + H+ +V+ +                 +   L +  EY  NG+
Sbjct: 42  TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT 101

Query: 783 LGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
           L DL+HS +         +++     E LSY+H      I+HRD+K  NI +D     ++
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157

Query: 843 ADFGVAKVVDASGKPKSMSVIAGS---------CG---YIAPE-YAYTLRVNEKSDIYSF 889
            DFG+AK V  S     +                G   Y+A E    T   NEK D+YS 
Sbjct: 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217

Query: 890 GVVILELVTG 899
           G++  E++  
Sbjct: 218 GIIFFEMIYP 227

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  126 bits (318), Expect = 3e-32
 Identities = 48/252 (19%), Positives = 91/252 (36%), Gaps = 62/252 (24%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           +E+  L+       IGSG  G V+K V   +G   A+K+  + ++   +          Q
Sbjct: 11  TEFHELE------KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---------EQ 55

Query: 736 DQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL--HSCKG 792
           + ++      EV     + +H ++V+ +      D  L+  EY   GSL D +  +    
Sbjct: 56  NALR------EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM 109

Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD--------------- 837
                     +++    GL Y+H     S+VH D+K +NI +                  
Sbjct: 110 SYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166

Query: 838 ----FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYS 888
                  ++ D G    +       S  V  G   ++A E     Y +      K+DI++
Sbjct: 167 ASNKVMFKIGDLGHVTRIS------SPQVEEGDSRFLANEVLQENYTH----LPKADIFA 216

Query: 889 FGVVILELVTGR 900
             + ++      
Sbjct: 217 LALTVVCAAGAE 228

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (318), Expect = 6e-32
 Identities = 61/264 (23%), Positives = 102/264 (38%), Gaps = 46/264 (17%)

Query: 669 MSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGC 727
           M         + + D      ++G G++  V++      G+  A+K              
Sbjct: 1   MGSQSTSNHLWLLSD------ILGQGATANVFRGRHKKTGDLFAIKVF------------ 42

Query: 728 DVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC--CTTRDCKLLVYEYMPNGSLGD 785
                     V  D    E E L K+ HKNIVKL+     TT   K+L+ E+ P GSL  
Sbjct: 43  --NNISFLRPV--DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98

Query: 786 LLHSCKGGLLDWPTRY--KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL----DGDFG 839
           +L          P      ++ D   G+++L  +    IVHR++K  NI+     DG   
Sbjct: 99  VLEE-PSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154

Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE--------YAYTLRVNEKSDIYSFGV 891
            ++ DFG A+ ++   +      + G+  Y+ P+          +  +     D++S GV
Sbjct: 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

Query: 892 VILELVTGRLPVDPEFGEKDLVKW 915
                 TG LP  P  G +   + 
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEV 235

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  126 bits (318), Expect = 6e-32
 Identities = 52/233 (22%), Positives = 84/233 (36%), Gaps = 42/233 (18%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             ++ L        +G GS G+V+KV    +G   AVK+         +           
Sbjct: 57  QSFQRLS------RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD---------RA 101

Query: 736 DQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
            ++       EV +  K+ +H   V+L           L  E     SL     +  G  
Sbjct: 102 RKLA------EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA-WGAS 153

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
           L     +  + D    L++LH      +VH DVK  NI L      ++ DFG+   +  +
Sbjct: 154 LPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210

Query: 855 GKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G  +      G   Y+APE     Y         +D++S G+ ILE+      
Sbjct: 211 GAGEVQ---EGDPRYMAPELLQGSY------GTAADVFSLGLTILEVACNMEL 254

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (319), Expect = 2e-31
 Identities = 64/264 (24%), Positives = 106/264 (40%), Gaps = 46/264 (17%)

Query: 669 MSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGC 727
           M         + + D      ++G G++  V++      G+  A+K              
Sbjct: 1   MGSQSTSNHLWLLSD------ILGQGATANVFRGRHKKTGDLFAIKVF------------ 42

Query: 728 DVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC--CTTRDCKLLVYEYMPNGSLGD 785
                     V  D    E E L K+ HKNIVKL+     TT   K+L+ E+ P GSL  
Sbjct: 43  --NNISFLRPV--DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98

Query: 786 LL--HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL----DGDFG 839
           +L   S   GL +      ++ D   G+++L  +    IVHR++K  NI+     DG   
Sbjct: 99  VLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV 154

Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE--------YAYTLRVNEKSDIYSFGV 891
            ++ DFG A+ ++   +  S+    G+  Y+ P+          +  +     D++S GV
Sbjct: 155 YKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

Query: 892 VILELVTGRLPVDPEFGEKDLVKW 915
                 TG LP  P  G +   + 
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEV 235

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  127 bits (321), Expect = 2e-31
 Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 40/237 (16%)

Query: 686 DEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA 745
              +V+G G+ G +    + +   VAVK+    +  EC S    ++              
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNRDVAVKR----ILPECFS--FADR-------------- 66

Query: 746 EVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
           EV+ L +   H N+++ +C    R  + +  E     +L + +   K           ++
Sbjct: 67  EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLL 124

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILL-----DGDFGARVADFGVAKVVDA-SGKPK 858
                GL++LH     +IVHRD+K +NIL+      G   A ++DFG+ K +        
Sbjct: 125 QQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181

Query: 859 SMSVIAGSCGYIAPEY---AYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKD 911
             S + G+ G+IAPE              DI+S G V   +++ G  P    FG+  
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP----FGKSL 234

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (311), Expect = 3e-31
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 44/244 (18%)

Query: 663 KSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSK 721
           K K+T+         +++I         +G G  G VY      N   +A+K L     K
Sbjct: 8   KRKFTI--------DDFDIG------RPLGKGKFGNVYLAREKQNKFIMALKVL----FK 49

Query: 722 ECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNG 781
                  +EK  V+ Q++      E+E    +RH NI++++     R    L+ E+ P G
Sbjct: 50  S-----QLEKEGVEHQLRR-----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG 99

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            L   L   K G  D       + + A+ L Y H      ++HRD+K  N+L+      +
Sbjct: 100 ELYKELQ--KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154

Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCG---YIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           +ADFG +     S + ++M      CG   Y+ PE       +EK D++  GV+  E + 
Sbjct: 155 IADFGWSVHAP-SLRRRTM------CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207

Query: 899 GRLP 902
           G  P
Sbjct: 208 GMPP 211

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  123 bits (312), Expect = 3e-31
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 39/232 (16%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +EI+        +G G+ GKVYK      G   A K              + +    +++
Sbjct: 21  WEIVG------ELGDGAFGKVYKAKNKETGALAAAKV------------IETKS---EEE 59

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKGGLLD 796
           ++D  +  E+E L    H  IVKL       D KL ++ E+ P G++  ++     GL +
Sbjct: 60  LED--YIVEIEILATCDHPYIVKLLGAYY-HDGKLWIMIEFCPGGAVDAIMLELDRGLTE 116

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASG 855
              +  +     E L++LH      I+HRD+K+ N+L+  +   R+ADFGV AK +    
Sbjct: 117 PQIQV-VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRV-----NEKSDIYSFGVVILELVTGRLP 902
           K  S     G+  ++APE      +     + K+DI+S G+ ++E+     P
Sbjct: 173 KRDSF---IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (311), Expect = 4e-31
 Identities = 54/237 (22%), Positives = 86/237 (36%), Gaps = 51/237 (21%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYK---VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           Y +        ++G G  G VY+    V      VA+K +   +S               
Sbjct: 36  YRLRR------LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLS--------------S 73

Query: 736 DQVQDDGFQAEVETLGKIRHKNIV----------KLWCCCTTRDCKLLVYEYMPNGSLGD 785
           D V     Q E  T G+++  ++V          +L+          +    +    L  
Sbjct: 74  DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY----------VDMRLINGVDLAA 123

Query: 786 LLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
           +L   + G L  P    I+      L   H        HRDVK  NIL+  D  A + DF
Sbjct: 124 MLR--RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDF 178

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+A         +  + + G+  Y+APE         ++DIY+   V+ E +TG  P
Sbjct: 179 GIASATTDEKLTQLGNTV-GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (308), Expect = 5e-31
 Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 43/245 (17%)

Query: 667 TLMSFHKLGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECES 725
           ++ +  +   S + + +  L     IG G  G V       G  VAVK +    + +   
Sbjct: 4   SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--- 59

Query: 726 GCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLG 784
                            F AE   + ++RH N+V+L          L +V EYM  GSL 
Sbjct: 60  ----------------AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103

Query: 785 DLLHSCKGGLLDWPTRYKIIVDAAEGLSYL-HHDCVPSIVHRDVKSNNILLDGDFGARVA 843
           D L S    +L      K  +D  E + YL  ++     VHRD+ + N+L+  D  A+V+
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVS 159

Query: 844 DFGVAKVV---DASGK-P-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
           DFG+ K       +GK P K            APE     + + KSD++SFG+++ E+ +
Sbjct: 160 DFGLTKEASSTQDTGKLPVKWT----------APEALREKKFSTKSDVWSFGILLWEIYS 209

Query: 899 -GRLP 902
            GR+P
Sbjct: 210 FGRVP 214

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (310), Expect = 6e-31
 Identities = 61/232 (26%), Positives = 106/232 (45%), Gaps = 35/232 (15%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYK---VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           YE+ +      ++G G   +V+    +       VAVK L   ++              +
Sbjct: 14  YELGE------ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLA--------------R 51

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKL--WCCCTTRDCKL--LVYEYMPNGSLGDLLHSCK 791
           D      F+ E +    + H  IV +       T    L  +V EY+   +L D++H   
Sbjct: 52  DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--T 109

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
            G +      ++I DA + L++ H +    I+HRDVK  NI++      +V DFG+A+ +
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166

Query: 852 DASGKPKSM-SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             SG   +  + + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  122 bits (308), Expect = 7e-31
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 689 NVIGSGSSGKVYKVVLSNGE-AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           + +G G  G+VY+ V       VAVK L     KE             D ++ + F  E 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KE-------------DTMEVEEFLKEA 60

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
             + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
           +  + YL      + +HRD+ + N L+  +   +VADFG+++++         +  A + 
Sbjct: 121 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAG 171

Query: 868 GYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                   APE     + + KSD+++FGV++ E+ T G  P
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  122 bits (309), Expect = 7e-31
 Identities = 70/308 (22%), Positives = 116/308 (37%), Gaps = 58/308 (18%)

Query: 689 NVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
             +G G  GKV          + GE VAVK L               K +       D  
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---------------KPESGGNHIAD-L 70

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           + E+E L  + H+NIVK    CT        L+ E++P+GSL + L   K   ++   + 
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQL 129

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD-------AS 854
           K  V   +G+ YL        VHRD+ + N+L++ +   ++ DFG+ K ++         
Sbjct: 130 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186

Query: 855 GKPKS----MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGE 909
               S               APE     +    SD++SFGV + EL+T       P    
Sbjct: 187 DDRDSPVFWY----------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236

Query: 910 KDLVKWVCSTLDQKGVDHVLD-----PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR 964
             ++      +    + + L      P    C  E    V  +   C    P NR + + 
Sbjct: 237 LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQN 292

Query: 965 VVKLLQEV 972
           +++  + +
Sbjct: 293 LIEGFEAL 300

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  125 bits (316), Expect = 1e-30
 Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 43/240 (17%)

Query: 672 HKLGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVE 730
            +   S + + +  L     IG G  G V       G  VAVK +    + +        
Sbjct: 181 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-------- 231

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHS 789
                       F AE   + ++RH N+V+L          L +V EYM  GSL D L S
Sbjct: 232 -----------AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYL-HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
               +L      K  +D  E + YL  ++     VHRD+ + N+L+  D  A+V+DFG+ 
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLT 336

Query: 849 KVV---DASGK-P-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           K       +GK P K            APE     + + KSD++SFG+++ E+ + GR+P
Sbjct: 337 KEASSTQDTGKLPVKWT----------APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (307), Expect = 1e-30
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 28/216 (12%)

Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
             +G GS G VYK +    G+ VA+K++                  V+  +Q+     E+
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV-----------------PVESDLQE--IIKEI 75

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
             + +    ++VK +          +V EY   GS+ D++      L +      I+   
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-ILQST 134

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIAGS 866
            +GL YLH       +HRD+K+ NILL+ +  A++ADFGV  ++ D   K  ++    G+
Sbjct: 135 LKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV---IGT 188

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             ++APE    +  N  +DI+S G+  +E+  G+ P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  122 bits (308), Expect = 1e-30
 Identities = 76/320 (23%), Positives = 117/320 (36%), Gaps = 68/320 (21%)

Query: 689 NVIGSGSSGKVYKVVLSN-----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
             +G G  GKV            GE VAVK L               K     Q +   +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---------------KADAGPQHRSG-W 80

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           + E++ L  + H++I+K   CC         LV EY+P GSL D L       +      
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLL 137

Query: 802 KIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD-------A 853
                  EG++YLH        +HRD+ + N+LLD D   ++ DFG+AK V         
Sbjct: 138 LFAQQICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193

Query: 854 SGKPKS----MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFG 908
                S               APE     +    SD++SFGV + EL+T       P   
Sbjct: 194 REDGDSPVFWY----------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT- 242

Query: 909 EKDLVKWVCSTLDQKGVDHVLD--------PKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
               ++ +     Q  V  + +        P+ D C  E    V ++   C       RP
Sbjct: 243 --KFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRP 296

Query: 961 AMRRVVKLLQEVGAENRSKT 980
               ++ +L+ V  + + + 
Sbjct: 297 TFENLIPILKTVHEKYQGQA 316

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (315), Expect = 2e-30
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)

Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
             +G+G  G+V+    +    VAVK +  G                        F AE  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA------------------FLAEAN 235

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            +  ++H  +VKL    T ++   ++ E+M  GSL D L S +G     P         A
Sbjct: 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           EG++++      + +HRD+++ NIL+      ++ADFG+A+V++ +      +   G+  
Sbjct: 295 EGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN----EYTAREGAKF 347

Query: 869 YI---APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            I   APE         KSD++SFG++++E+VT GR+P
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  126 bits (319), Expect = 2e-30
 Identities = 107/517 (20%), Positives = 192/517 (37%), Gaps = 61/517 (11%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDL 148
              E  + +   N ++   +P D+      + L LSQN ++  L    ++ L  L+ L L
Sbjct: 28  FSNELESMVDYSNRNLTH-VPKDLPP--RTKALSLSQNSIS-ELRMPDISFLSELRVLRL 83

Query: 149 TGNNFSGDIPES-FGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIP 207
           + N     +    F   Q LE + + +N L   I      +++L+ L+LS+N F    + 
Sbjct: 84  SHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFDVLPVC 139

Query: 208 PELGNLTNLEILWLTECNLVGEIPDSLGRLA-KLVDLDLALNNLVGAIPSSLTELASVV- 265
            E GNLT L  L L+           +  L    + LDL   ++ G    SL    + V 
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199

Query: 266 QIELYNNSL------TGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYEN 319
            +  + NSL            G   L++++L D +   L   + +      L ++ L   
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259

Query: 320 RLEGSLPATI---ADSPGLYELRLFRNRLNGTLPGDLGKNS-----PLRWVDLSNNQFTG 371
                    +        +  L ++   +   +  +    S      L    + N  F  
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319

Query: 372 EIPASLCEKGELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
              A      E+  + M+  S T  +         S T +    N  T  V      L  
Sbjct: 320 SKEALYSVFAEMN-IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 431 VYLLELTDNFLS--GEISKNIAGAANLSLLIISKNNL-SGSLPEEIGFLKSLVVLSGSEN 487
           +  L L  N L    +++      ++L  L +S N+L S +      + +S++VL+ S N
Sbjct: 379 LQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438

Query: 488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGN 547
             TGS+   L    ++  LDLH N +                          +IP+D+ +
Sbjct: 439 MLTGSVFRCLP--PKVKVLDLHNNRIM-------------------------SIPKDVTH 471

Query: 548 LSVLNYLDLSNNRLSGRIPVG-LQNLK-LNQLNVSNN 582
           L  L  L++++N+L   +P G    L  L  + + +N
Sbjct: 472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 86.5 bits (214), Expect = 1e-17
 Identities = 66/375 (17%), Positives = 132/375 (35%), Gaps = 43/375 (11%)

Query: 10  LVAFLLSPLPSLSLNQEGLYLERVKL-SLSDPDSALSSWGRNPRDDSPCSWRGVECDPRS 68
           L+      L  + L+    +++  +  SL  P++ +     +P                 
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222

Query: 69  HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQN-----LQHLD 123
             +++I L++ N       L       T L +    I +T    +   Q      +++L+
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282

Query: 124 LSQNLLTGTLTPALAD-----LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLD 178
           +    +T  +           L +L    +    F       +  F ++ +  L  +   
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342

Query: 179 GTIPAFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNL--VGEIPDSLG 235
                   + S+   LN + N F       +    L  L+ L L    L    ++     
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFT--DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400

Query: 236 RLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASM 295
            ++ L  LD++LN+L                     NS   D    W    S+ +L+ S 
Sbjct: 401 NMSSLETLDVSLNSL---------------------NSHAYDRTCAW--AESILVLNLSS 437

Query: 296 NDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGK 355
           N LTG +   L    ++ L+L+ NR+  S+P  +     L EL +  N+L  ++P  +  
Sbjct: 438 NMLTGSVFRCLPPK-VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFD 494

Query: 356 NSP-LRWVDLSNNQF 369
               L+++ L +N +
Sbjct: 495 RLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 34/138 (24%), Positives = 58/138 (42%), Gaps = 8/138 (5%)

Query: 453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLHAN 511
                L +S+N++S     +I FL  L VL  S N+   SL   +     +L  LD+  N
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110

Query: 512 DLSGELPSSVSSWKKLNELNLADNLFYGNIPE--DIGNLSVLNYLDLSNNRLSGRIPVGL 569
            L   +         L  L+L+ N F   +P   + GNL+ L +L LS  +      + +
Sbjct: 111 RLQ-NISCCP--MASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166

Query: 570 QNLKLNQLNVSNNRLSGE 587
            +L L+ + +       +
Sbjct: 167 AHLHLSCILLDLVSYHIK 184

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  126 bits (317), Expect = 2e-30
 Identities = 61/286 (21%), Positives = 123/286 (43%), Gaps = 39/286 (13%)

Query: 689 NVIGSGSSGKVYKVVLSNGE-AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           + +G G  G+VY+ V       VAVK       KE             D ++ + F  E 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVK-----TLKE-------------DTMEVEEFLKEA 267

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
             + +I+H N+V+L   CT      ++ E+M  G+L D L  C    +       +    
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV-DASGKPKSMSVIAGS 866
           +  + YL      + +HR++ + N L+  +   +VADFG+++++   +    + +     
Sbjct: 328 SSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384

Query: 867 CGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGV 925
             + APE     + + KSD+++FGV++ E+ T G  P  P      + + +     +K  
Sbjct: 385 --WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELL-----EKD- 435

Query: 926 DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
            + ++    C   E++ +++     C    P +RP+   + +  + 
Sbjct: 436 -YRMERPEGC--PEKVYELM---RACWQWNPSDRPSFAEIHQAFET 475

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (308), Expect = 2e-30
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 44/238 (18%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +E+++      ++G+G+ G+VYK   +  G+  A+K +            DV   + ++ 
Sbjct: 26  FELVE------LVGNGTYGQVYKGRHVKTGQLAAIKVM------------DVTGDEEEE- 66

Query: 738 VQDDGFQAEVETLGKI-RHKNIVK-----LWCCCTTRDCKL-LVYEYMPNGSLGDLLHSC 790
                 + E+  L K   H+NI       +       D +L LV E+   GS+ DL+ + 
Sbjct: 67  -----IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AK 849
           KG  L       I  +   GLS+LH   V   +HRD+K  N+LL  +   ++ DFGV A+
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-----NEKSDIYSFGVVILELVTGRLP 902
           +    G+  +     G+  ++APE            + KSD++S G+  +E+  G  P
Sbjct: 179 LDRTVGRRNTF---IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (321), Expect = 2e-30
 Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 52/305 (17%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            +E+ +       +G+G  G V + +    GE VA+K+  + +S +              
Sbjct: 15  PWEMKE------RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR------------ 56

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCC------CTTRDCKLLVYEYMPNGSLGDLL--H 788
               + +  E++ + K+ H N+V               D  LL  EY   G L   L   
Sbjct: 57  ----ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF 112

Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR---VADF 845
               GL + P R  ++ D +  L YLH +    I+HRD+K  NI+L          + D 
Sbjct: 113 ENCCGLKEGPIR-TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP 905
           G AK +D        +   G+  Y+APE     +     D +SFG +  E +TG  P  P
Sbjct: 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

Query: 906 EFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV 965
            +            + +K  +H+          +++   +    +  +P  ++     ++
Sbjct: 226 NWQPVQWHG----KVREKSNEHI-------VVYDDLTGAVKFSSVLPTPNHLSGILAGKL 274

Query: 966 VKLLQ 970
            + LQ
Sbjct: 275 ERWLQ 279

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  122 bits (307), Expect = 2e-30
 Identities = 75/302 (24%), Positives = 117/302 (38%), Gaps = 49/302 (16%)

Query: 689 NVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + +G G+ G V          + G  VAVK+L               +    DQ +D  F
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---------------QHSGPDQQRD--F 71

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           Q E++ L  +    IVK          +   LV EY+P+G L D L   +   LD     
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLL 130

Query: 802 KIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
                  +G+ YL    C    VHRD+ + NIL++ +   ++ADFG+AK++         
Sbjct: 131 LYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD----KD 182

Query: 861 SVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVK 914
             +    G       APE       + +SD++SFGVV+ EL T       P      ++ 
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242

Query: 915 WVCSTLDQKGVDHVLD-----PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL 969
                     +  +L+     P    C  E    V  +  LC +P P +RP+   +   L
Sbjct: 243 CERDVPALSRLLELLEEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQL 298

Query: 970 QE 971
             
Sbjct: 299 DM 300

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  120 bits (304), Expect = 2e-30
 Identities = 64/236 (27%), Positives = 112/236 (47%), Gaps = 43/236 (18%)

Query: 678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           E+E+  + L     +G+G  G+V+    +    VAVK L     K+              
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQ-------------G 48

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
            +  D F AE   + +++H+ +V+L+   T ++   ++ EYM NGSL D L +  G  L 
Sbjct: 49  SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLT 107

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD---- 852
                 +    AEG++++      + +HRD+++ NIL+      ++ADFG+A++++    
Sbjct: 108 INKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164

Query: 853 ---ASGK-P-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                 K P K            APE         KSD++SFG+++ E+VT GR+P
Sbjct: 165 TAREGAKFPIKWT----------APEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (303), Expect = 2e-30
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 31/218 (14%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G GS   VY+   +  G  VA+K     + K+      + K  +  +VQ      EV+ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKM----IDKK-----AMYKAGMVQRVQ-----NEVKI 64

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDA 807
             +++H +I++L+      +   LV E   NG +   L +      +   R+ +  I+  
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
              + YLH   +   +HRD+  +N+LL  +   ++ADFG+A  +    +          C
Sbjct: 125 ---MLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-----TLC 173

Query: 868 G---YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G   YI+PE A       +SD++S G +   L+ GR P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  120 bits (304), Expect = 3e-30
 Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 32/220 (14%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G   K +++      E  A K               V K  +    Q +    E+  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKI--------------VPKSLLLKPHQREKMSMEISI 68

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDA 807
              + H+++V         D   +V E     SL +L    +  L +   RY +  IV  
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLG 127

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
                YLH + V   +HRD+K  N+ L+ D   ++ DFG+A  V+  G+ K +      C
Sbjct: 128 ---CQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LC 176

Query: 868 G---YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           G   YIAPE       + + D++S G ++  L+ G+ P +
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (306), Expect = 4e-30
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G   K +++      E  A K               V K  +    Q +    E+  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKI--------------VPKSLLLKPHQREKMSMEISI 94

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDA 807
              + H+++V         D   +V E     SL +L    +  L +   RY +  IV  
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLG 153

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
                YLH + V   +HRD+K  N+ L+ D   ++ DFG+A  V+  G+ K +      C
Sbjct: 154 ---CQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LC 202

Query: 868 G---YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G   YIAPE       + + D++S G ++  L+ G+ P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  120 bits (302), Expect = 6e-30
 Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 51/298 (17%)

Query: 688 DNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + VIG G  G VY   L + +      AVK L            +V +           F
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRITDIGEVSQ-----------F 73

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLL-VYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
             E   +    H N++ L   C   +   L V  YM +G L + + + +           
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIG 132

Query: 803 IIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
             +  A+G+ YL          VHRD+ + N +LD  F  +VADFG+A+ +         
Sbjct: 133 FGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YY 184

Query: 861 SVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVK 914
           SV   +   +     A E   T +   KSD++SFGV++ EL+T G  P  P+    D+  
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-PDVNTFDITV 243

Query: 915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           ++      +G    L     C   + + +V+   L C  P    RP+   +V  +  +
Sbjct: 244 YL-----LQG--RRLLQPEYC--PDPLYEVM---LKCWHPKAEMRPSFSELVSRISAI 289

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  123 bits (310), Expect = 7e-30
 Identities = 82/343 (23%), Positives = 148/343 (43%), Gaps = 42/343 (12%)

Query: 634 FILAGLVF--VFGLVWFYLKYRKFKNGRAIDKSKWTLMSFHKLGFSEYEI-LDGLDEDNV 690
           +I +   F  +  LV +Y K+      R       +      L    +EI  + L  +  
Sbjct: 132 YITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVK 191

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           +G G  G+V+    +    VA+K L  G                      + F  E + +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------------------EAFLQEAQVM 233

Query: 751 GKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEG 810
            K+RH+ +V+L+   +  +   +V EYM  GSL D L    G  L  P    +    A G
Sbjct: 234 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG-KPKSMSVIAGSCGY 869
           ++Y+      + VHRD+++ NIL+  +   +VADFG+A++++ +    +  +       +
Sbjct: 293 MAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKW 347

Query: 870 IAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV 928
            APE A   R   KSD++SFG+++ EL T GR+P  P    ++++  V     ++G  + 
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQV-----ERG--YR 399

Query: 929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           +    +C   E +  ++     C    P  RP    +   L++
Sbjct: 400 MPCPPEC--PESLHDLM---CQCWRKEPEERPTFEYLQAFLED 437

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  119 bits (300), Expect = 9e-30
 Identities = 72/312 (23%), Positives = 113/312 (36%), Gaps = 54/312 (17%)

Query: 677 SEYEILD---GLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDV 729
            +  I         D VIG G  G VY     +        A+K L             V
Sbjct: 12  KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-----SRITEMQQV 66

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD-CKLLVYEYMPNGSLGDLLH 788
           E            F  E   +  + H N++ L       +    ++  YM +G L   + 
Sbjct: 67  EA-----------FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR 115

Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           S +             +  A G+ YL          VHRD+ + N +LD  F  +VADFG
Sbjct: 116 SPQRNP-TVKDLISFGLQVARGMEYLAEQK-----FVHRDLAARNCMLDESFTVKVADFG 169

Query: 847 VAKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GR 900
           +A+ +      +  SV       +     A E   T R   KSD++SFGV++ EL+T G 
Sbjct: 170 LARDILDR---EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226

Query: 901 LPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
            P        DL  ++      +G    L     C   + + +V+     C    P  RP
Sbjct: 227 PPY-RHIDPFDLTHFL-----AQG--RRLPQPEYC--PDSLYQVM---QQCWEADPAVRP 273

Query: 961 AMRRVVKLLQEV 972
             R +V  ++++
Sbjct: 274 TFRVLVGEVEQI 285

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  119 bits (300), Expect = 9e-30
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 689 NVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
             +G G+ G V          + GE VAVKKL               +   ++ ++D  F
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRD--F 58

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           + E+E L  ++H NIVK    C +   +   L+ EY+P GSL D L   K   +D     
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLL 117

Query: 802 KIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD-------A 853
           +      +G+ YL         +HRD+ + NIL++ +   ++ DFG+ KV+         
Sbjct: 118 QYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173

Query: 854 SGKPKS----MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT 898
               +S               APE     + +  SD++SFGVV+ EL T
Sbjct: 174 KEPGESPIFWY----------APESLTESKFSVASDVWSFGVVLYELFT 212

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (300), Expect = 1e-29
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+SG VY  + ++ G+ VA+++             ++++   Q + +      E+  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQ------------MNLQQ---QPKKEL--IINEILV 70

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + + ++ NIV         D   +V EY+  GSL D++       +D      +  +  +
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQ 127

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIAGSCG 868
            L +LH +    ++HRD+KS+NILL  D   ++ DFG  A++     K  +M    G+  
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPY 181

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         K DI+S G++ +E++ G  P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  120 bits (302), Expect = 1e-29
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 688 DNVIGSGSSGKVYKVVL---SNGE-AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + +IGSG SG+V    L      +  VA+K L  G ++                 Q   F
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER----------------QRRDF 97

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            +E   +G+  H NI++L    T     ++V EYM NGSL   L +   G         +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGM 156

Query: 804 IVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           +     G+ YL          VHRD+ + N+L+D +   +V+DFG+++V++        +
Sbjct: 157 LRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD----PDA 207

Query: 862 VIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
               + G I     APE       +  SD++SFGVV+ E++  G  P
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (301), Expect = 1e-29
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 39/223 (17%)

Query: 689 NVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
             +G G+ G V          + GE VAVKKL               +   ++ ++D  F
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRD--F 89

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           + E+E L  ++H NIVK    C +   +   L+ EY+P GSL D L   K   +D     
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLL 148

Query: 802 KIIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
           +      +G+ YL         +HRD+ + NIL++ +   ++ DFG+ KV+         
Sbjct: 149 QYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQD----KE 200

Query: 861 SVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT 898
                  G       APE     + +  SD++SFGVV+ EL T
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  123 bits (311), Expect = 2e-29
 Identities = 73/417 (17%), Positives = 135/417 (32%), Gaps = 35/417 (8%)

Query: 172 LVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP 231
             YN + GT   +       +   L            +   +     L L   NL   +P
Sbjct: 17  SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLP 75

Query: 232 DSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLL 291
           D+L    ++  L++  N L+ ++P     L     ++  +N L+  LP       SL+ L
Sbjct: 76  DNLPP--QITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLP---ELPASLKHL 125

Query: 292 DASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPG 351
           D   N LT  +P+    L  E +N   N+L   LP        L  L +  N+L   LP 
Sbjct: 126 DVDNNQLTM-LPELPALL--EYINADNNQLT-MLPELP---TSLEVLSVRNNQLT-FLPE 177

Query: 352 DLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMI----YNSFTGQLPDGLGHCQSL 407
                  L  +D+S N     +PA        EE  +      N  T  +P+ +      
Sbjct: 178 LPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPT 232

Query: 408 TRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSG 467
             + L  N L+ ++   L              + S    +      +  L          
Sbjct: 233 CTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPE 290

Query: 468 SLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKL 527
           +   ++  +          N F+  L + L++     +       ++      +S+  +L
Sbjct: 291 NKQSDVSQIWHAFEHEEHANTFSAFL-DRLSDTVSARNTSGFREQVA-AWLEKLSASAEL 348

Query: 528 NELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRL 584
            + + A      +  E   +   L + +L    L  +   GL +     L      +
Sbjct: 349 RQQSFAVA---ADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGREM 402

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (276), Expect = 4e-25
 Identities = 58/338 (17%), Positives = 112/338 (33%), Gaps = 36/338 (10%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
           C +   + L L   ++ S+LPD++     +  L+++QN L  +L P L    +L++LD  
Sbjct: 56  CLINQFSELQLNRLNL-SSLPDNL--PPQITVLEITQNALI-SL-PEL--PASLEYLDAC 108

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE 209
            N  S  +PE     + L    +  N L   +P        L+ +N   N      +P  
Sbjct: 109 DNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPAL---LEYINADNNQL--TMLPEL 158

Query: 210 LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELAS----VV 265
               T+LE+L +    L   +P+    L  L D+     NL+ ++P+            +
Sbjct: 159 ---PTSLEVLSVRNNQL-TFLPELPESLEAL-DVS---TNLLESLPAVPVRNHHSEETEI 210

Query: 266 QIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSL 325
                 N +T  +P    +L     +    N L+  I + L++   +             
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS 269

Query: 326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEE 385
                        R   + +    P +   +    W    + +      A L    +   
Sbjct: 270 DGQQNTLH-----RPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVS 324

Query: 386 LLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP 423
                + F  Q+   L    +   +R     +      
Sbjct: 325 ARN-TSGFREQVAAWLEKLSASAELRQQSFAVAADATE 361

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  108 bits (272), Expect = 1e-24
 Identities = 60/274 (21%), Positives = 100/274 (36%), Gaps = 36/274 (13%)

Query: 340 LFRNRLNGT---LPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQ 396
            F N ++GT         K         + N+    +   L  +    EL +   + +  
Sbjct: 17  SFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ--FSELQLNRLNLS-S 73

Query: 397 LPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLS 456
           LPD L     +T + +  N L   +P L   L +   L+  DN LS  + +  A   +L 
Sbjct: 74  LPDNLP--PQITVLEITQNALI-SLPELPASLEY---LDACDNRLS-TLPELPA---SLK 123

Query: 457 LLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGE 516
            L +  N L+  LPE    L+ +       N+ T  LPE  T+L  L    +  N L+  
Sbjct: 124 HLDVDNNQLT-MLPELPALLEYINA---DNNQLT-MLPELPTSLEVL---SVRNNQLT-F 174

Query: 517 LPSSVSSWKKLNELNLADNLFYGNIPEDIGNL----SVLNYLDLSNNRLSGRIPVGLQNL 572
           LP    S   L  L+++ NL   ++P              +     NR++  IP  + +L
Sbjct: 175 LPELPES---LEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSL 229

Query: 573 -KLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNP 605
                + + +N LS         +         P
Sbjct: 230 DPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGP 262

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (259), Expect = 4e-23
 Identities = 66/347 (19%), Positives = 132/347 (38%), Gaps = 40/347 (11%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            ++++   +     SL     +L +L   +N +++ LP+  +   +L+HLD+  N LT  
Sbjct: 84  VLEITQNALI----SLPELPASLEYLDACDNRLST-LPELPA---SLKHLDVDNNQLT-- 133

Query: 133 LTPALADLP-NLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTL 191
               L +LP  L++++   N  +  +PE       LEV+S+  N L   +P    +   L
Sbjct: 134 ---MLPELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQL-TFLPELPES---L 182

Query: 192 KMLNLSYNPFLPGRIPPELGNLTNLEILWLT---ECNLVGEIPDSLGRLAKLVDLDLALN 248
           + L++S N      +P       + E   +      N +  IP+++  L     + L  N
Sbjct: 183 EALDVSTNLL--ESLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDN 240

Query: 249 NLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR 308
            L   I  SL++  +    + +   +   +  G  N     L DA           D+++
Sbjct: 241 PLSSRIRESLSQQTAQP--DYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQ 298

Query: 309 LPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQ 368
           +     +        +    ++D+        FR ++       L  ++ LR     +  
Sbjct: 299 IWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQV-AAWLEKLSASAELR---QQSFA 354

Query: 369 FTGEIPASLCEKG------ELEELLMIYNSFTGQLPDGLGHCQSLTR 409
              +   S CE         L + L+++ +  G   +  G   SL R
Sbjct: 355 VAADATES-CEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGR 400

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 89.6 bits (222), Expect = 2e-18
 Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 50/234 (21%)

Query: 363 DLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQ--SLTRVRLGYNRLTGK 420
           +   N  +    A      +  E   +      +    L  C     + ++L    L+  
Sbjct: 16  NSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-- 72

Query: 421 VPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV 480
                          L DN               +++L I++N L  SLPE    L+ L 
Sbjct: 73  --------------SLPDNLPP-----------QITVLEITQNALI-SLPELPASLEYLD 106

Query: 481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGN 540
                +N+ + +LPE   +L  L   D+  N L+  LP   +    L  +N  +N     
Sbjct: 107 A---CDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPAL---LEYINADNNQL-TM 154

Query: 541 IPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAK 594
           +PE   +L VL    + NN+L+  +P   ++L+   L+VS N L   LP++  +
Sbjct: 155 LPELPTSLEVL---SVRNNQLT-FLPELPESLE--ALDVSTNLLE-SLPAVPVR 201

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 74.6 bits (183), Expect = 7e-14
 Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 21/169 (12%)

Query: 454 NLSLLIISKNNLSGSLPEEIGF----LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLH 509
           N SL   S  N       +        +   +   + N+    L E L  + +   L L+
Sbjct: 10  NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLN 67

Query: 510 ANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGL 569
             +LS  LP ++    ++  L +  N    ++PE   +L    YLD  +NRLS  +P   
Sbjct: 68  RLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLE---YLDACDNRLS-TLPELP 119

Query: 570 QNLKLNQLNVSNNRLSGELPSLFAK----EMYRNSFLGNPGLCGDLEGL 614
            +LK   L+V NN+L+  LP L A         N     P L   LE L
Sbjct: 120 ASLK--HLDVDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLEVL 165

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (298), Expect = 3e-29
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS+G V       +G  VAVK              D+ K   Q + +      EV  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKM------------MDLRK---QQRREL--LFNEVVI 95

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           +   +H N+V+++      +   ++ E++  G+L D++   +   L+      +     +
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQ 152

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV-AKVVDASGKPKSMSVIAGSCG 868
            L+YLH      ++HRD+KS++ILL  D   +++DFG  A++     K KS+    G+  
Sbjct: 153 ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPY 206

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           ++APE         + DI+S G++++E+V G  P
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (304), Expect = 3e-29
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 57/253 (22%)

Query: 688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           + ++G GSSG V       G  VAVK+    M  +                  D    E+
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKR----MLIDFC----------------DIALMEI 59

Query: 748 ETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY----- 801
           + L +   H N+++ +C  TT     +  E   N +L DL+ S      +   +      
Sbjct: 60  KLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI 118

Query: 802 KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-------------GDFGARVADFGVA 848
            ++   A G+++LH      I+HRD+K  NIL+               +    ++DFG+ 
Sbjct: 119 SLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 849 KVVDA--SGKPKSMSVIAGSCGYIAPE-------YAYTLRVNEKSDIYSFGVVILELVT- 898
           K +D+  S    +++  +G+ G+ APE            R+    DI+S G V   +++ 
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 899 GRLPVDPEFGEKD 911
           G+ P    FG+K 
Sbjct: 236 GKHP----FGDKY 244

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  117 bits (295), Expect = 4e-29
 Identities = 57/242 (23%), Positives = 98/242 (40%), Gaps = 47/242 (19%)

Query: 674 LGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKG 732
           LG+  +EI    L     +G+G  G V          VA+K +  G   E          
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---------- 63

Query: 733 QVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                   D F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L     
Sbjct: 64  --------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MR 114

Query: 793 GLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
                    ++  D  E + YL          +HRD+ + N L++     +V+DFG+++ 
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169

Query: 851 VD-------ASGK-P-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GR 900
           V           K P +             PE     + + KSDI++FGV++ E+ + G+
Sbjct: 170 VLDDEYTSSVGSKFPVRWS----------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219

Query: 901 LP 902
           +P
Sbjct: 220 MP 221

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (302), Expect = 4e-29
 Identities = 33/241 (13%), Positives = 67/241 (27%), Gaps = 27/241 (11%)

Query: 685 LDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEK--------GQVQ 735
           L    V+G        +      GE+  V   +        +   +++          ++
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYM----PNGSLGDLL---- 787
           +Q Q       +     ++     K+           ++  +        +L        
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 788 -HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
            HS     L    R ++ +     L+ LHH     +VH  ++  +I+LD   G  +  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRL 901
                 AS                A             +    D ++ G+ I  +    L
Sbjct: 257 HLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 902 P 902
           P
Sbjct: 316 P 316

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (298), Expect = 6e-29
 Identities = 58/239 (24%), Positives = 109/239 (45%), Gaps = 25/239 (10%)

Query: 682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD 740
            D  ++ + +G+G+ G V+KV    +G  +A K +   +              +++Q+  
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----------IRNQII- 79

Query: 741 DGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
                E++ L +     IV  +    +     +  E+M  GSL  +L   K G +     
Sbjct: 80  ----RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQIL 133

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM 860
            K+ +   +GL+YL       I+HRDVK +NIL++     ++ DFGV+  +  S    S 
Sbjct: 134 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS- 189

Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST 919
               G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P   ++  + + C  
Sbjct: 190 --FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  116 bits (292), Expect = 6e-29
 Identities = 63/238 (26%), Positives = 106/238 (44%), Gaps = 47/238 (19%)

Query: 678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           ++ I    L     IGSG  G V+     N + VA+K +     +E              
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-----REGAM----------- 45

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
              ++ F  E E + K+ H  +V+L+  C  +    LV E+M +G L D L + + GL  
Sbjct: 46  --SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFA 102

Query: 797 WPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD-- 852
             T   + +D  EG++YL         ++HRD+ + N L+  +   +V+DFG+ + V   
Sbjct: 103 AETLLGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157

Query: 853 -----ASGK-P-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                   K P K            +PE     R + KSD++SFGV++ E+ + G++P
Sbjct: 158 QYTSSTGTKFPVKWA----------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  117 bits (296), Expect = 6e-29
 Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 61/238 (25%)

Query: 688 DNVIGSGSSGKVYKVVLSNGE-----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             V+GSG+ G VYK +           VA+K+L               +     +   + 
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---------------REATSPKANKE- 63

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDW 797
              E   +  + + ++ +L   C T     L+ + MP G L D +   K       LL+W
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122

Query: 798 PTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS- 854
                  V  A+G++YL         +VHRD+ + N+L+      ++ DFG+AK++ A  
Sbjct: 123 ------CVQIAKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171

Query: 855 -------GK-P-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                  GK P K M          A E         +SD++S+GV + EL+T G  P
Sbjct: 172 KEYHAEGGKVPIKWM----------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  121 bits (305), Expect = 7e-29
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 39/285 (13%)

Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
             +G G  G+V+    +    VA+K L  G                      + F  E +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------------------EAFLQEAQ 314

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            + K+RH+ +V+L+   +  +   +V EYM  GSL D L    G  L  P    +    A
Sbjct: 315 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG-KPKSMSVIAGSC 867
            G++Y+      + VHRD+++ NIL+  +   +VADFG+A++++ +    +  +      
Sbjct: 374 SGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--I 428

Query: 868 GYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVD 926
            + APE A   R   KSD++SFG+++ EL T GR+P  P    ++++  V     ++G  
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQV-----ERG-- 480

Query: 927 HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           + +    +C   E +  ++     C    P  RP    +   L++
Sbjct: 481 YRMPCPPEC--PESLHDLM---CQCWRKEPEERPTFEYLQAFLED 520

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (297), Expect = 8e-29
 Identities = 43/331 (12%), Positives = 104/331 (31%), Gaps = 63/331 (19%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV------LSNGEAVAVKKLWRGMSKECESG 726
           +LG     +       +++G G+  +VY+          N +   +K             
Sbjct: 61  QLGSKLVYVH------HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ----------- 103

Query: 727 CDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL 786
              +     +          +E L        +K +     ++  +LV E    G+L + 
Sbjct: 104 ---KPANPWEFYI---GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157

Query: 787 LHSCK---GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--------- 834
           ++  K     ++         +     +  +H      I+H D+K +N +L         
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214

Query: 835 --DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
             D   G  + D G +  +    K    +    + G+   E       N + D +     
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274

Query: 893 ILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCT 952
           +  ++ G         + +  +     L ++     +       + E    +LNI     
Sbjct: 275 VYCMLFGTYM----KVKNEGGECKPEGLFRRLPHLDM-------WNEFFHVMLNI----- 318

Query: 953 SPLPINRPAMRRVVKLLQEVGAENRSKTGKK 983
            P   + P++  + + L++V  ++ +   + 
Sbjct: 319 -PDCHHLPSLDLLRQKLKKVFQQHYTNKIRA 348

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  117 bits (295), Expect = 9e-29
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 35/224 (15%)

Query: 690 VIGSGSSGKVYKVVLSNGEA-----VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           VIG+G  G+VYK +L          VA+K L  G +++                Q   F 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK----------------QRVDFL 94

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E   +G+  H NI++L    +     +++ EYM NG+L   L   K G         ++
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGML 153

Query: 805 VDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA 864
              A G+ YL +    + VHRD+ + NIL++ +   +V+DFG+++V++        +   
Sbjct: 154 RGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYT 206

Query: 865 GSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            S G I     APE     +    SD++SFG+V+ E++T G  P
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  118 bits (297), Expect = 1e-28
 Identities = 71/296 (23%), Positives = 117/296 (39%), Gaps = 47/296 (15%)

Query: 688 DNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + VIG G  G VY   L + +      AVK L            +V +           F
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRITDIGEVSQ-----------F 137

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLL-VYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
             E   +    H N++ L   C   +   L V  YM +G L + + + +           
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIG 196

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             +  A+G+ +L        VHRD+ + N +LD  F  +VADFG+A+ +         SV
Sbjct: 197 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---FDSV 250

Query: 863 IAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV 916
              +   +     A E   T +   KSD++SFGV++ EL+T G  P  P+    D+  ++
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-PDVNTFDITVYL 309

Query: 917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
                 +G    L     C   + + +V+   L C  P    RP+   +V  +  +
Sbjct: 310 -----LQG--RRLLQPEYCP--DPLYEVM---LKCWHPKAEMRPSFSELVSRISAI 353

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  115 bits (290), Expect = 1e-28
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 42/223 (18%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
            +GSG  G V          VAVK +     KE       ++           F  E +T
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI-----KEGSM--SEDE-----------FFQEAQT 56

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAE 809
           + K+ H  +VK +  C+      +V EY+ NG L + L S  G  L+     ++  D  E
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCE 115

Query: 810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD-------ASGK-P-KSM 860
           G+++L        +HRD+ + N L+D D   +V+DFG+ + V           K P K  
Sbjct: 116 GMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172

Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                     APE  +  + + KSD+++FG+++ E+ + G++P
Sbjct: 173 ----------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  118 bits (297), Expect = 1e-28
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 38/227 (16%)

Query: 688 DNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           D V+G+G  G+V    L        +VA+K L  G +++                Q   F
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------QRRDF 93

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             E   +G+  H NI++L    T     ++V EYM NGSL   L               +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGM 152

Query: 804 IVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           +   A G+ YL          VHRD+ + NIL++ +   +V+DFG+ +V++        +
Sbjct: 153 LRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED----DPEA 203

Query: 862 VIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                 G I     +PE     +    SD++S+G+V+ E+++ G  P
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (295), Expect = 1e-28
 Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 35/228 (15%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +  L        IG GS G VY    + N E VA+KK+                 Q  ++
Sbjct: 56  FSDLR------EIGHGSFGAVYFARDVRNSEVVAIKKM------------SYSGKQSNEK 97

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
            QD     EV  L K+RH N ++   C        LV EY   GS  DLL   K  L + 
Sbjct: 98  WQD--IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV 154

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                +   A +GL+YLH     +++HRDVK+ NILL      ++ DFG A ++      
Sbjct: 155 EIAA-VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----- 205

Query: 858 KSMSVIAGSCGYIAPEYAYTLRV---NEKSDIYSFGVVILELVTGRLP 902
            + S + G+  ++APE    +     + K D++S G+  +EL   + P
Sbjct: 206 PANSFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  115 bits (291), Expect = 2e-28
 Identities = 66/305 (21%), Positives = 119/305 (39%), Gaps = 59/305 (19%)

Query: 689 NVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
            ++G G  G V +  L   +     VAVK +      +  S  ++E+           F 
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTM----KLDNSSQREIEE-----------FL 84

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRD-----CKLLVYEYMPNGSLGDLLHSCK----GGLL 795
           +E   +    H N+++L   C           +++  +M  G L   L   +       +
Sbjct: 85  SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144

Query: 796 DWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
              T  K +VD A G+ YL   +      +HRD+ + N +L  D    VADFG++K + +
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199

Query: 854 SGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF 907
               +      G    +     A E         KSD+++FGV + E+ T G  P  P  
Sbjct: 200 GDYYR-----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-PGV 253

Query: 908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
              ++  ++       G  H L    DC   +E+ +++     C    P++RP    +  
Sbjct: 254 QNHEMYDYL-----LHG--HRLKQPEDC--LDELYEIM---YSCWRTDPLDRPTFSVLRL 301

Query: 968 LLQEV 972
            L+++
Sbjct: 302 QLEKL 306

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (290), Expect = 4e-28
 Identities = 55/240 (22%), Positives = 102/240 (42%), Gaps = 40/240 (16%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
             ++   + L +   IG G+ G V K+V   +G+ +AVK++                  V
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI------------RST---V 59

Query: 735 QDQVQDDGFQAEVETLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL---HSC 790
            ++ Q      +++ + +      IV+ +          +  E M + S        +S 
Sbjct: 60  DEKEQKQ-LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSV 117

Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
              ++      KI +   + L++L  +    I+HRD+K +NILLD     ++ DFG++  
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 851 VDASGKPKSMSVIAGSCGYIAPE--------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +  S    + +  AG   Y+APE          Y    + +SD++S G+ + EL TGR P
Sbjct: 176 LVDS---IAKTRDAGCRPYMAPERIDPSASRQGY----DVRSDVWSLGITLYELATGRFP 228

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  114 bits (287), Expect = 4e-28
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 38/227 (16%)

Query: 687 EDNVIGSGSSGKVYKVVLSNGEA---VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           ED  +GSG+ G V K      +    VAVK L               K +  D    D  
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL---------------KNEANDPALKDEL 65

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      ++
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIEL 122

Query: 804 IVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           +   + G+ YL   +      VHRD+ + N+LL     A+++DFG++K + A        
Sbjct: 123 VHQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD----ENY 173

Query: 862 VIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
             A + G       APE     + + KSD++SFGV++ E  + G+ P
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  117 bits (296), Expect = 5e-28
 Identities = 87/475 (18%), Positives = 153/475 (32%), Gaps = 110/475 (23%)

Query: 118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLL 177
           ++ ++DLS N +      + + L +L+FL +        I      F+ L          
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGL---------- 78

Query: 178 DGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEI--PDSL 234
                      S+L +L L YN FL  ++       L NLE+L LT+CNL G +   +  
Sbjct: 79  -----------SSLIILKLDYNQFL--QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF 125

Query: 235 GRLAKLVDLDLALNNLVGAIPSSL-TELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDA 293
             L  L  L L  NN+    P+S    +     ++L  N +         N         
Sbjct: 126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL- 184

Query: 294 SMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDL 353
                               L L    L                  +    L     G+ 
Sbjct: 185 --------------------LRLSSITL----------------QDMNEYWLGWEKCGNP 208

Query: 354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLG 413
            KN+ +  +DLS N F   +     +     ++  +  S +  +    GH          
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268

Query: 414 YNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEI 473
           +  L                                  A+ +    +SK+ +  +L + +
Sbjct: 269 FKGLE---------------------------------ASGVKTCDLSKSKIF-ALLKSV 294

Query: 474 -GFLKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSV-SSWKKLNEL 530
                 L  L+ ++N+    + + +   L  L  L+L  N L   + S +  +  KL  L
Sbjct: 295 FSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVL 352

Query: 531 NLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG-LQNLK-LNQLNVSNN 582
           +L+ N     + +     L  L  L L  N+L   +P G    L  L ++ +  N
Sbjct: 353 DLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  117 bits (294), Expect = 9e-28
 Identities = 85/428 (19%), Positives = 150/428 (35%), Gaps = 63/428 (14%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNN 152
           ++ ++ L  NSI        S  Q+LQ L + Q      +       L +L  L L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 153 FSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPEL-G 211
           F   +    G F  L                     + L++L L+        +      
Sbjct: 91  FL-QLET--GAFNGL---------------------ANLEVLTLTQCNLDGAVLSGNFFK 126

Query: 212 NLTNLEILWLTECNLVGEIPDSL-GRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELY 270
            LT+LE+L L + N+    P S    + +   LDL  N +       L          L 
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL- 185

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATI 329
                         L+S+ L D +   L      +  +   + +L+L  N  + S+    
Sbjct: 186 -------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232

Query: 330 ADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMI 389
            D+    +++      +  +    G  +   + D  N  F G   +       ++   + 
Sbjct: 233 FDAIAGTKIQSLILSNSYNMGSSFGHTN---FKDPDNFTFKGLEASG------VKTCDLS 283

Query: 390 YNSFTGQLPDGL-GHCQSLTRVRLGYNRLTGKVPP-LLWGLPHVYLLELTDNFLSGEISK 447
            +     L   +  H   L ++ L  N +  K+     WGL H+  L L+ NFL   I  
Sbjct: 284 KSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDS 340

Query: 448 NI-AGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPES-LTNLAEL 503
            +      L +L +S N++  +L ++  F  L +L  L+   N+   S+P+     L  L
Sbjct: 341 RMFENLDKLEVLDLSYNHIR-ALGDQS-FLGLPNLKELALDTNQLK-SVPDGIFDRLTSL 397

Query: 504 GSLDLHAN 511
             + LH N
Sbjct: 398 QKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  100 bits (250), Expect = 3e-22
 Identities = 69/375 (18%), Positives = 133/375 (35%), Gaps = 37/375 (9%)

Query: 74  IDLSNANIAGPFPSLLCR-LENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTG 131
           + +          +   R L +L  L L  N     L     +   NL+ L L+Q  L G
Sbjct: 59  LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDG 117

Query: 132 TLTP--ALADLPNLKFLDLTGNNFSGDIPES-FGRFQKLEVISLVYNLLDGTIPAFLGNI 188
            +        L +L+ L L  NN     P S F   ++  V+ L +N +  +I     ++
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICE--EDL 174

Query: 189 STLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALN 248
              +  + +               L+++ +  + E  L  E   +  +   +  LDL+ N
Sbjct: 175 LNFQGKHFTLL------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGN 222

Query: 249 NLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR 308
               ++     +  +  +I+         L    S          +  D        L  
Sbjct: 223 GFKESMAKRFFDAIAGTKIQ--------SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA 274

Query: 309 LPLESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNN 367
             +++ +L ++++  +L  ++      L +L L +N +N          + L  ++LS N
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN 333

Query: 368 QFTGEIPASLCEK-GELEELLMIYNSFTGQLPDGL-GHCQSLTRVRLGYNRLTGKVPP-L 424
                I + + E   +LE L + YN     L D       +L  + L  N+L   VP  +
Sbjct: 334 FLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390

Query: 425 LWGLPHVYLLELTDN 439
              L  +  + L  N
Sbjct: 391 FDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 97.5 bits (243), Expect = 2e-21
 Identities = 65/316 (20%), Positives = 108/316 (34%), Gaps = 36/316 (11%)

Query: 86  PSLLCRLENLTFLTLFNNSINST-LPDDI-SACQNLQHLDLSQNLLTGTLTPALAD--LP 141
                 L NL  LTL   +++   L  +      +L+ L L  N +   + PA     + 
Sbjct: 96  TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMR 154

Query: 142 NLKFLDLTGNNFSGDIPESFGRFQK--LEVISLVYNLL---------DGTIPAFLGNIST 190
               LDLT N       E    FQ     ++ L    L                  N S 
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS- 213

Query: 191 LKMLNLSYNPF--LPGRIPPELGNLTNLEILWLTE---------CNLVGEIPD-SLGRL- 237
           +  L+LS N F     +   +    T ++ L L+               +  + +   L 
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273

Query: 238 -AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASM 295
            + +   DL+ + +   + S  +    + Q+ L  N +   +    +  LT L  L+ S 
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332

Query: 296 NDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDL 353
           N L          L  LE L+L  N +  +L        P L EL L  N+L     G  
Sbjct: 333 NFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIF 391

Query: 354 GKNSPLRWVDLSNNQF 369
            + + L+ + L  N +
Sbjct: 392 DRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 41/291 (14%), Positives = 92/291 (31%), Gaps = 35/291 (12%)

Query: 306 LTRLP-----LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP-L 359
           L ++P     +  ++L  N +      + +    L  L++ +      +  +  +    L
Sbjct: 22  LHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 360 RWVDLSNNQFTGEIPASLCEK-GELEELLMIYNSFTG-QLPDGL-GHCQSLTRVRLGYNR 416
             + L  NQF  ++          LE L +   +  G  L         SL  + L  N 
Sbjct: 82  IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Query: 417 LTGKVPP--LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIG 474
           +  K+ P      +   ++L+LT N +     +++         ++              
Sbjct: 141 IK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR------------- 186

Query: 475 FLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLAD 534
            L S+ +   +E         +      + +LDL  N     +           ++    
Sbjct: 187 -LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI---Q 242

Query: 535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLS 585
           +L   N      +    N+ D  N    G     L+   +   ++S +++ 
Sbjct: 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKG-----LEASGVKTCDLSKSKIF 288

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.8 bits (153), Expect = 3e-10
 Identities = 25/148 (16%), Positives = 54/148 (36%), Gaps = 7/148 (4%)

Query: 453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHAN 511
           A+++ + +S N+++         L+ L  L   +      +   +   L+ L  L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 512 DLSGELPSSV-SSWKKLNELNLADN-LFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG 568
               +L +   +    L  L L    L    +  +    L+ L  L L +N +    P  
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 569 L-QNL-KLNQLNVSNNRLSGELPSLFAK 594
              N+ + + L+++ N++          
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLN 176

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.1 bits (107), Expect = 9e-05
 Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 2/82 (2%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTG 131
            ++LS   +      +   L+ L  L L  N I + L D       NL+ L L  N L  
Sbjct: 327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKS 385

Query: 132 TLTPALADLPNLKFLDLTGNNF 153
                   L +L+ + L  N +
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (291), Expect = 6e-28
 Identities = 39/242 (16%), Positives = 75/242 (30%), Gaps = 38/242 (15%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVK----------KLWRGMSKECESGCDVEKGQVQDQV 738
           V+G        +      GE+  V              + M +E      +   + Q Q 
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 739 QD-DGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYM-PNGSLGDLL-----HSCK 791
           +    F    + +   + K ++++             + Y     +L         HS  
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
              L    R ++ +     L+ LHH     +VH  ++  +I+LD   G  +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 852 DASGKPKSMSVIAGSCGYIAPEY-----------AYTLRVNEKSDIYSFGVVILELVTGR 900
               +  +  V + S G+  PE                 +    D ++ G+VI  +    
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 901 LP 902
           LP
Sbjct: 311 LP 312

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  114 bits (288), Expect = 6e-28
 Identities = 61/306 (19%), Positives = 115/306 (37%), Gaps = 60/306 (19%)

Query: 689 NVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
            ++G G  G V +  L   +     VAVK L   +                  +++  F 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-------------SDIEE--FL 73

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCK----GGL 794
            E   + +  H ++ KL                +++  +M +G L   L + +       
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133

Query: 795 LDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
           L   T  + +VD A G+ YL   +      +HRD+ + N +L  D    VADFG+++ + 
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

Query: 853 ASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE 906
           +    +      G    +     A E          SD+++FGV + E++T G+ P    
Sbjct: 189 SGDYYR-----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-AG 242

Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
               ++  ++       G  + L    +C   EE+  ++     C S  P  RP+   + 
Sbjct: 243 IENAEIYNYL-----IGG--NRLKQPPEC--MEEVYDLM---YQCWSADPKQRPSFTCLR 290

Query: 967 KLLQEV 972
             L+ +
Sbjct: 291 MELENI 296

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (283), Expect = 1e-27
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 42/242 (17%)

Query: 674 LGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEA----VAVKKLWRGMSKECESGCD 728
           +G  +Y I  + +  + ++G G  G+VY+ V +N +     VAVK       K+  +  +
Sbjct: 2   MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDN 56

Query: 729 VEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH 788
            EK           F +E   +  + H +IVKL       +   ++ E  P G LG  L 
Sbjct: 57  KEK-----------FMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLE 104

Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
                 L   T     +   + ++YL   +      VHRD+   NIL+      ++ DFG
Sbjct: 105 R-NKNSLKVLTLVLYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFG 158

Query: 847 VAKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GR 900
           +++ ++             S   +     +PE     R    SD++ F V + E+++ G+
Sbjct: 159 LSRYIEDE------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 212

Query: 901 LP 902
            P
Sbjct: 213 QP 214

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  112 bits (283), Expect = 1e-27
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 38/227 (16%)

Query: 687 EDNVIGSGSSGKVYKVVLSNGE---AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
            D  +G G+ G V + V    +    VA+K L               K   +    ++  
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---------------KQGTEKADTEE-M 57

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             E + + ++ +  IV+L   C   +  +LV E    G L   L   K   +      ++
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAEL 115

Query: 804 IVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMS 861
           +   + G+ YL   +      VHRD+ + N+LL     A+++DFG++K + A        
Sbjct: 116 LHQVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD----DSY 166

Query: 862 VIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
             A S G       APE     + + +SD++S+GV + E ++ G+ P
Sbjct: 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  118 bits (298), Expect = 1e-27
 Identities = 51/232 (21%), Positives = 83/232 (35%), Gaps = 46/232 (19%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYK---VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           YE+         I  G  G +Y      + NG  V +K L                    
Sbjct: 82  YEVKG------CIAHGGLGWIYLALDRNV-NGRPVVLKGL----------------VHSG 118

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-----LVYEYMPNGSLGDLLHSC 790
           D        AE + L ++ H +IV+++      D        +V EY+   SL       
Sbjct: 119 DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--- 175

Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
            G  L        +++    LSYLH      +V+ D+K  NI+L  +   ++ D G    
Sbjct: 176 -GQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230

Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +++ G       + G+ G+ APE   T      +DIY+ G  +  L      
Sbjct: 231 INSFG------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 2e-27
 Identities = 28/233 (12%), Positives = 58/233 (24%), Gaps = 29/233 (12%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKL----------WRGMSKECESGCDVEKGQVQDQV 738
            +  G    V+ V  +   E  A+K               + +   +   +     ++  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 739 QDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCK--LLVYEYMPNGSLGDLLHSCK----- 791
                    + +         +L            LL+     +  L  L  +       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
            G       + +        + L       +VH     +N+ +  D    + D      V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 852 DASGKPKSMSVIAGSCGYIAPEY--AYTLRVNEKSDIYSFGVVILELVTGRLP 902
              G        +    Y   E+  A T       + +  G+ I  +    LP
Sbjct: 245 GTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  113 bits (285), Expect = 2e-27
 Identities = 67/330 (20%), Positives = 108/330 (32%), Gaps = 50/330 (15%)

Query: 57  CSWRGVECDPR---------SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINS 107
           C  R V+C                A +DL N  I          L+NL  L L NN I+ 
Sbjct: 31  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90

Query: 108 TLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKL 167
             P   +    L+ L LS+N L   L   +     L+ L +  N  +  + +    F  L
Sbjct: 91  ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRK--SVFNGL 144

Query: 168 EVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNL 226
                                + + ++ L  NP     I       +  L  + + + N+
Sbjct: 145 ---------------------NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183

Query: 227 VGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLT 286
              IP  L     L +L L  N +     +SL  L ++ ++ L  NS++       +N  
Sbjct: 184 T-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240

Query: 287 SLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEG------SLPATIADSPGLYELR 339
            LR L  + N L   +P  L     ++ + L+ N +          P           + 
Sbjct: 241 HLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 299

Query: 340 LFRNRLNGTL--PGDLGKNSPLRWVDLSNN 367
           LF N +      P           V L N 
Sbjct: 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (272), Expect = 8e-26
 Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 23/306 (7%)

Query: 267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSL 325
           ++  +  L   +P          LLD   N +T     D   L  L +L L  N++    
Sbjct: 36  VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92

Query: 326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEE 385
           P   A    L  L L +N+L   LP  + K   L+ + +  N+ T    +      ++  
Sbjct: 93  PGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENEITKVRKSVFNGLNQMIV 149

Query: 386 LLMIYNSFT-GQLPDG-LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
           + +  N      + +G     + L+ +R+    +T  +P  L   P +  L L  N ++ 
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT- 205

Query: 444 EISKNI-AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAE 502
           ++      G  NL+ L +S N++S      +     L  L  + NK    +P  L +   
Sbjct: 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264

Query: 503 LGSLDLHANDLSG------ELPSSVSSWKKLNELNLADN-LFYGNIPEDI-GNLSVLNYL 554
           +  + LH N++S         P   +     + ++L  N + Y  I       + V   +
Sbjct: 265 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324

Query: 555 DLSNNR 560
            L N +
Sbjct: 325 QLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  103 bits (258), Expect = 6e-24
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 21/285 (7%)

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
           L  +   +  LE  +P  +   P    L L  N++     GD      L  + L NN+ +
Sbjct: 33  LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-LLWGLP 429
              P +     +LE L +  N    +LP+ +   ++L  +R+  N +T KV   +  GL 
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLN 145

Query: 430 HVYLLELTDNFL-SGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN 487
            + ++EL  N L S  I      G   LS + I+  N++ ++P+  G   SL  L    N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202

Query: 488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGN 547
           K T     SL  L  L  L L  N +S     S+++   L EL+L +N     +P  + +
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261

Query: 548 LSVLNYLDLSNNRLSG------RIPVGLQNL-KLNQLNVSNNRLS 585
              +  + L NN +S         P         + +++ +N + 
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  113 bits (285), Expect = 2e-27
 Identities = 53/254 (20%), Positives = 91/254 (35%), Gaps = 49/254 (19%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEK 731
           +LG     +        V+  G    VY+   + +G   A+K+L                
Sbjct: 24  ELGELRLRVRR------VLAEGGFAFVYEAQDVGSGREYALKRL---------------- 61

Query: 732 GQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCCCTTRDCK--------LLVYEYMPNGS 782
               ++ ++     EV  + K+  H NIV+     +    +        LL+ E      
Sbjct: 62  -LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120

Query: 783 LGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
           +  L      G L   T  KI       + ++H    P I+HRD+K  N+LL      ++
Sbjct: 121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKL 179

Query: 843 ADFGVAKV----VDASGKPKSMSVI---AGSCG---YIAPE----YAYTLRVNEKSDIYS 888
            DFG A       D S   +  +++           Y  PE    Y+    + EK DI++
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN-FPIGEKQDIWA 238

Query: 889 FGVVILELVTGRLP 902
            G ++  L   + P
Sbjct: 239 LGCILYLLCFRQHP 252

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (284), Expect = 2e-27
 Identities = 62/305 (20%), Positives = 122/305 (40%), Gaps = 61/305 (20%)

Query: 689 NVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             +G GS G VY+ V            VA+K +      E  S  +  +           
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRERIE----------- 74

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY- 801
           F  E   + +    ++V+L    +     L++ E M  G L   L S +  + + P    
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 802 -------KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
                  ++  + A+G++YL  +       VHRD+ + N ++  DF  ++ DFG+ + + 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189

Query: 853 ASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE 906
            +   +      G  G +     +PE          SD++SFGVV+ E+ T    P    
Sbjct: 190 ETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QG 243

Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
              + ++++V      +G   +LD   +C   + + +++    +C    P  RP+   ++
Sbjct: 244 LSNEQVLRFV-----MEG--GLLDKPDNC--PDMLFELM---RMCWQYNPKMRPSFLEII 291

Query: 967 KLLQE 971
             ++E
Sbjct: 292 SSIKE 296

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  111 bits (281), Expect = 3e-27
 Identities = 66/311 (21%), Positives = 120/311 (38%), Gaps = 67/311 (21%)

Query: 689 NVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             +G    GKVYK  L          AVA+K L     K+               ++++ 
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-----KDKAE----------GPLREE- 58

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC------------ 790
           F+ E     +++H N+V L    T      +++ Y  +G L + L               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 791 --KGGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
                 L+ P    ++   A G+ YL  HH     +VH+D+ + N+L+      +++D G
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLG 173

Query: 847 VAKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GR 900
           + + V A+   K           +     APE     + +  SDI+S+GVV+ E+ + G 
Sbjct: 174 LFREVYAADYYK-----LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228

Query: 901 LPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
            P    +  +D+V+ +     +     VL    DC     +     + + C +  P  RP
Sbjct: 229 QPY-CGYSNQDVVEMI-----RNR--QVLPCPDDC--PAWVY---ALMIECWNEFPSRRP 275

Query: 961 AMRRVVKLLQE 971
             + +   L+ 
Sbjct: 276 RFKDIHSRLRA 286

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  112 bits (282), Expect = 3e-27
 Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 29/277 (10%)

Query: 55  SPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDIS 114
           S CS     C         I  ++  +    P+ +    + T L L +N + S       
Sbjct: 3   SRCS-----CSGTE-----IRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFD 49

Query: 115 ACQNLQHLDLSQNLLTGTLTPALA--DLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISL 172
               L  L LS N L+     + +     +LK+LDL+ N     +  +F   ++LE +  
Sbjct: 50  KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108

Query: 173 VYNLLDGTIPA--FLGNISTLKMLNLSYN--PFLPGRIPPELGNLTNLEILWLTECNLVG 228
            ++ L   +       ++  L  L++S+         I      L++LE+L +   +   
Sbjct: 109 QHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI---FNGLSSLEVLKMAGNSFQE 164

Query: 229 EI-PDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGW-SNLT 286
              PD    L  L  LDL+   L    P++   L+S+  + + +N+    L T     L 
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLN 223

Query: 287 SLRLLDASMNDLTGPIPDDLTRLP--LESLNLYENRL 321
           SL++LD S+N +      +L   P  L  LNL +N  
Sbjct: 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 55/282 (19%), Positives = 98/282 (34%), Gaps = 38/282 (13%)

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
             +      L  S+P  I        L L  N+L     G   K + L  + LS+N  + 
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 372 EIPASLCEKG--ELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-LLWGL 428
           +   S  + G   L+ L + +N     +       + L  +   ++ L       +   L
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125

Query: 429 PHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN 487
            ++  L+++           I  G ++L +L ++ N+   +                   
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL----------------- 167

Query: 488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSV-SSWKKLNELNLADNLFYGNIPEDIG 546
                 P+  T L  L  LDL    L  +L  +  +S   L  LN++ N F+        
Sbjct: 168 ------PDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220

Query: 547 NLSVLNYLDLSNNRLSGRIPVG-LQNL--KLNQLNVSNNRLS 585
            L+ L  LD S N +        LQ+    L  LN++ N  +
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 47/243 (19%), Positives = 80/243 (32%), Gaps = 13/243 (5%)

Query: 205 RIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL--VGAIPSSLTELA 262
            +P  +   ++   L L    L         +L +L  L L+ N L   G    S     
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 263 SVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-PIPDDLTRLP-LESLNLYENR 320
           S+  ++L  N +   + + +  L  L  LD   ++L           L  L  L++    
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 321 LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP-LRWVDLSNNQFTGEIPASLCE 379
              +          L  L++  N        D+      L ++DLS  Q   ++  +   
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 196

Query: 380 K-GELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPPLLWGLP-HVYLLEL 436
               L+ L M +N+F   L         SL  +    N +       L   P  +  L L
Sbjct: 197 SLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255

Query: 437 TDN 439
           T N
Sbjct: 256 TQN 258

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (283), Expect = 3e-27
 Identities = 47/312 (15%), Positives = 99/312 (31%), Gaps = 82/312 (26%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKL-------------------- 715
           +++E +        +G G  G V++     +    A+K++                    
Sbjct: 6   TDFEPIQ------CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 59

Query: 716 ---------------------WRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR 754
                                W+    E     +     +      D    ++  +    
Sbjct: 60  KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119

Query: 755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-LDWPTRYKIIVDAAEGLSY 813
            KN V      + +    +  +     +L D ++        +      I +  AE + +
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179

Query: 814 LHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIA-------GS 866
           LH      ++HRD+K +NI    D   +V DFG+   +D   + +++           G 
Sbjct: 180 LHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 867 CG---YIAPEYAYTLRVNEKSDIYSFGVVILELVT-----------------GRLPVDPE 906
            G   Y++PE  +    + K DI+S G+++ EL+                   + P+   
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFT 296

Query: 907 F---GEKDLVKW 915
                E  +V+ 
Sbjct: 297 QKYPQEHMMVQD 308

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  113 bits (284), Expect = 3e-27
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 19/267 (7%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNN 152
            +  L L NN I      D+  C NLQ L L+ N +  T+   + + L +L+ LDL+ N 
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 153 FSGDIPESFGRFQKLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSYNPFLPGRIPPE- 209
            S      F     L  ++L+ N    T+   +   +++ L++L +        +I  + 
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF-TKIQRKD 169

Query: 210 LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIEL 269
              LT LE L +   +L    P SL  +  +  L L +   +  +   +   +SV  +EL
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 270 YNNSLTG----DLPTGWSN----LTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENR 320
            +  L      +L TG +N      + R +  +   L   +   L ++  L  L    N+
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288

Query: 321 LEGSLPATIADS-PGLYELRLFRNRLN 346
           L+ S+P  I D    L ++ L  N  +
Sbjct: 289 LK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 92.1 bits (229), Expect = 4e-20
 Identities = 60/264 (22%), Positives = 93/264 (35%), Gaps = 17/264 (6%)

Query: 189 STLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL 247
             +K L+LS N      I    L    NL+ L LT   +     DS   L  L  LDL+ 
Sbjct: 52  EAVKSLDLSNNRI--TYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109

Query: 248 NNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGW-SNLTSLRLLDASMNDLTGPIPDD- 305
           N L     S    L+S+  + L  N       T   S+LT L++L     D    I    
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 306 LTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDL 364
              L  LE L +  + L+   P ++     +  L L   +    L   +   S +  ++L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 365 SNNQFTG----EIPA----SLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR 416
            +         E+      SL +K     + +   S   Q+   L     L  +    N+
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288

Query: 417 LTGKVPP-LLWGLPHVYLLELTDN 439
           L   VP  +   L  +  + L  N
Sbjct: 289 LKS-VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.7 bits (228), Expect = 5e-20
 Identities = 48/278 (17%), Positives = 95/278 (34%), Gaps = 19/278 (6%)

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATI 329
           + SL   +P+G +   +++ LD S N +T     DL R   L++L L  N +  ++    
Sbjct: 40  SGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95

Query: 330 ADS-PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL-CEKGELEELL 387
             S   L  L L  N L+          S L +++L  N +      SL     +L+ L 
Sbjct: 96  FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155

Query: 388 MIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS 446
           +       ++          L  + +  + L    P  L  + +V  L L        + 
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL 214

Query: 447 KNI-AGAANLSLLIISKNNLSGSLPEEI--------GFLKSLVVLSGSENKFTGSLPESL 497
           +      +++  L +   +L      E+            +   +  ++      + + L
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLL 273

Query: 498 TNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADN 535
             ++ L  L+   N L             L ++ L  N
Sbjct: 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 18/224 (8%)

Query: 86  PSLLCRLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTGTLTP--ALADLPN 142
                 L +L  L L  N + S L         +L  L+L  N    TL      + L  
Sbjct: 93  EDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTK 150

Query: 143 LKFLDLTGNNFSGDIPE-SFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPF 201
           L+ L +   +    I    F     LE + +  + L    P  L +I  +  L L     
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210

Query: 202 --LPGRIPPELGNLTNLEI--LWLTECNLVGEIP----DSLGRLAKLVDLDLALNNLVGA 253
             L         ++  LE+    L   +   E+     +SL +     ++ +   +L   
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFS-ELSTGETNSLIKKFTFRNVKITDESLF-Q 268

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGW-SNLTSLRLLDASMN 296
           +   L +++ ++++E   N L   +P G    LTSL+ +    N
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 36/194 (18%), Positives = 69/194 (35%), Gaps = 10/194 (5%)

Query: 91  RLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDL 148
            L +LTFL L  N   +     + S    LQ L +        +     A L  L+ L++
Sbjct: 122 PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI 181

Query: 149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPF------- 201
             ++     P+S    Q +  + L        +  F+   S+++ L L            
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241

Query: 202 LPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTEL 261
           L       L        + +T    + ++   L +++ L++L+ + N L          L
Sbjct: 242 LSTGETNSLIKKFTFRNVKIT-DESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRL 300

Query: 262 ASVVQIELYNNSLT 275
            S+ +I L+ N   
Sbjct: 301 TSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.0 bits (195), Expect = 9e-16
 Identities = 53/287 (18%), Positives = 101/287 (35%), Gaps = 29/287 (10%)

Query: 313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE 372
                   L  S+P+ +  +  +  L L  NR+      DL +   L+ + L++N     
Sbjct: 35  ICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-T 90

Query: 373 IPASLCEK-GELEELLMIYNSFTGQLPDGL-GHCQSLTRVRLGYNRLTGKVPP--LLWGL 428
           I        G LE L + YN  +  L         SLT + L  N     +    L   L
Sbjct: 91  IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHL 148

Query: 429 PHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN 487
             + +L + +     +I +   AG   L  L I  ++L    P+ +  ++++  L     
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208

Query: 488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGN 547
           +    L   +   + +  L+L   DL     S +S+          ++L           
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-------GETNSL---------IK 252

Query: 548 LSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSLFA 593
                 + +++  L  ++   L  +  L +L  S N+L      +F 
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFD 298

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 28/173 (16%), Positives = 52/173 (30%), Gaps = 11/173 (6%)

Query: 87  SLLCRLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTGTLTPALADLPNLKF 145
           SL   L  L  L + N    + +     +    L+ L++  + L      +L  + N+  
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202

Query: 146 LDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGT--------IPAFLGNISTLKMLNLS 197
           L L        +         +E + L    LD              L    T + + ++
Sbjct: 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262

Query: 198 YNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL 250
                  ++   L  ++ L  L  +   L         RL  L  + L  N  
Sbjct: 263 DESLF--QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 20/138 (14%), Positives = 52/138 (37%), Gaps = 11/138 (7%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            +++  +++    P  L  ++N++ L L        L   +    +++ L+L    L   
Sbjct: 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF 237

Query: 133 --------LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPA- 183
                    T +L      + + +T  +    + +   +   L  +    N L  ++P  
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDG 295

Query: 184 FLGNISTLKMLNLSYNPF 201
               +++L+ + L  NP+
Sbjct: 296 IFDRLTSLQKIWLHTNPW 313

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (282), Expect = 4e-27
 Identities = 63/233 (27%), Positives = 98/233 (42%), Gaps = 51/233 (21%)

Query: 688 DNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             V+GSG  G V+K V      S    V +K +               + +   Q     
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---------------EDKSGRQSFQA- 61

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-----LLDW 797
               +  +G + H +IV+L   C       LV +Y+P GSL D +   +G      LL+W
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 798 PTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
                  V  A+G+ YL  H      +VHR++ + N+LL      +VADFGVA ++    
Sbjct: 121 ------GVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

Query: 856 KPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           K      +  S         A E  +  +   +SD++S+GV + EL+T G  P
Sbjct: 170 K-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (281), Expect = 4e-27
 Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 31/244 (12%)

Query: 670 SFHKLGFSEYEI-LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGC 727
            +  +G   Y+  ++ L+    +GSG+ G+V+K+     G  +AVK++            
Sbjct: 11  GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM------------ 58

Query: 728 DVEKGQVQDQVQDDGFQAEVETLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL 786
                    +        +++ + K      IV+ +    T     +  E M      + 
Sbjct: 59  RRS---GNKEENKR-ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCA-EK 112

Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           L     G +      K+ V   + L YL       ++HRDVK +NILLD     ++ DFG
Sbjct: 113 LKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFG 170

Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNE-----KSDIYSFGVVILELVTGRL 901
           ++  +      K+    AG   Y+APE        +     ++D++S G+ ++EL TG+ 
Sbjct: 171 ISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

Query: 902 PVDP 905
           P   
Sbjct: 228 PYKN 231

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  111 bits (279), Expect = 4e-27
 Identities = 57/225 (25%), Positives = 87/225 (38%), Gaps = 33/225 (14%)

Query: 688 DNVIGSGSSGKVYKVVLSNGEA----VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
              +G GS G V +            VAVK L     K            +      D F
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-----KP---------DVLSQPEAMDDF 68

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             EV  +  + H+N+++L+    T     +V E  P GSL D L     G     T  + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRY 126

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVI 863
            V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ + +  +        +
Sbjct: 127 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYV 179

Query: 864 AGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                 +     APE   T   +  SD + FGV + E+ T G+ P
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  111 bits (279), Expect = 5e-27
 Identities = 58/248 (23%), Positives = 100/248 (40%), Gaps = 38/248 (15%)

Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD 740
            D L+    +G G+ G V K+  + +G+ +AVK++                  V  Q Q 
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI------------RAT---VNSQEQK 50

Query: 741 DGFQAEVETLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDW 797
                +++   + +     V  +          +  E M + SL         KG  +  
Sbjct: 51  R-LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE 108

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
               KI V   + L +LH     S++HRDVK +N+L++     ++ DFG++  +      
Sbjct: 109 DILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--- 163

Query: 858 KSMSVIAGSCGYIAPE--------YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
            +  + AG   Y+APE          Y++    KSDI+S G+ ++EL   R P D     
Sbjct: 164 VAKDIDAGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTP 219

Query: 910 KDLVKWVC 917
              +K V 
Sbjct: 220 FQQLKQVV 227

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  110 bits (278), Expect = 7e-27
 Identities = 74/311 (23%), Positives = 126/311 (40%), Gaps = 68/311 (21%)

Query: 689 NVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             +G G+ GKV+     N         VAVK L     K+                + D 
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-----KDPT-----------LAARKD- 63

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC------------ 790
           FQ E E L  ++H++IVK +  C   D  ++V+EYM +G L   L +             
Sbjct: 64  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123

Query: 791 --KGGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
               G L       I    A G+ YL   H      VHRD+ + N L+  +   ++ DFG
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFG 178

Query: 847 VAKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GR 900
           +++ V ++   +      G    +      PE     +   +SD++SFGV++ E+ T G+
Sbjct: 179 MSRDVYSTDYYR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 233

Query: 901 LPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP 960
            P   +    ++++ +      +G   VL+    C   +E+  V+   L C    P  R 
Sbjct: 234 QPW-FQLSNTEVIECI-----TQG--RVLERPRVC--PKEVYDVM---LGCWQREPQQRL 280

Query: 961 AMRRVVKLLQE 971
            ++ + K+L  
Sbjct: 281 NIKEIYKILHA 291

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (277), Expect = 7e-27
 Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 40/237 (16%)

Query: 678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  + E    AVA+K      S            
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------------ 56

Query: 733 QVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
              D V++  F  E  T+ +  H +IVKL    T  +   ++ E    G L   L   + 
Sbjct: 57  ---DSVREK-FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV-RK 110

Query: 793 GLLDWPTRYKIIVDAAEGLSYL-HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
             LD  +        +  L+YL     V    HRD+ + N+L+  +   ++ DFG+++ +
Sbjct: 111 YSLDLASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYM 166

Query: 852 DASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
           + S      +    S G +     APE     R    SD++ FGV + E++  G  P
Sbjct: 167 EDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  111 bits (280), Expect = 8e-27
 Identities = 78/343 (22%), Positives = 135/343 (39%), Gaps = 76/343 (22%)

Query: 688  DNVIGSGSSGKVYKVVLSNGEA---VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
             +VIG G+ G+V K  +         A+K++     KE  S  D              F 
Sbjct: 30   QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRD-----------FA 73

Query: 745  AEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK------------ 791
             E+E L K+  H NI+ L   C  R    L  EY P+G+L D L   +            
Sbjct: 74   GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 792  --GGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
                 L          D A G+ YL          +HRD+ + NIL+  ++ A++ADFG+
Sbjct: 134  STASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGL 188

Query: 848  AKVVDASGKPKSMSVIAGSCGYI-----APE----YAYTLRVNEKSDIYSFGVVILELVT 898
            ++  +          +  + G +     A E      YT      SD++S+GV++ E+V+
Sbjct: 189  SRGQEV--------YVKKTMGRLPVRWMAIESLNYSVYT----TNSDVWSYGVLLWEIVS 236

Query: 899  -GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPI 957
             G  P        +L + +      +G  + L+  L+C   +E+    ++   C    P 
Sbjct: 237  LGGTPY-CGMTCAELYEKL-----PQG--YRLEKPLNC--DDEVY---DLMRQCWREKPY 283

Query: 958  NRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDASDQGS 1000
             RP+  +++  L  +  E ++       +   Y   D S + +
Sbjct: 284  ERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEA 326

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  111 bits (279), Expect = 1e-26
 Identities = 71/310 (22%), Positives = 119/310 (38%), Gaps = 67/310 (21%)

Query: 689 NVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             +G G+ GKV+     N         VAVK L     KE             +  + D 
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----KEAS-----------ESARQD- 89

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY- 801
           FQ E E L  ++H++IV+ +  CT     L+V+EYM +G L   L S             
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149

Query: 802 ------------KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
                        +    A G+ YL   H      VHRD+ + N L+      ++ DFG+
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGM 204

Query: 848 AKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRL 901
           ++ + ++   +      G    +      PE     +   +SD++SFGVV+ E+ T G+ 
Sbjct: 205 SRDIYSTDYYR-----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

Query: 902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA 961
           P   +    + +  +      +G    L+    C    E+  ++     C    P  R +
Sbjct: 260 PW-YQLSNTEAIDCI-----TQG--RELERPRAC--PPEVYAIM---RGCWQREPQQRHS 306

Query: 962 MRRVVKLLQE 971
           ++ V   LQ 
Sbjct: 307 IKDVHARLQA 316

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (275), Expect = 1e-26
 Identities = 58/259 (22%), Positives = 108/259 (41%), Gaps = 48/259 (18%)

Query: 669 MSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGC 727
           M+   +    +++         +G G+ G+V   V     EAVAVK +            
Sbjct: 1   MAVPFVED--WDL------VQTLGEGAYGEVQLAVNRVTEEAVAVKIV------------ 40

Query: 728 DVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL 787
             +  +  D    +  + E+     + H+N+VK +      + + L  EY   G L D +
Sbjct: 41  --DMKRAVDCP--ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 96

Query: 788 HSCKGGLLDWPTRYK---IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
                G+ +   +     ++     G+ YLH      I HRD+K  N+LLD     +++D
Sbjct: 97  EP-DIGMPEPDAQRFFHQLM----AGVVYLHGI---GITHRDIKPENLLLDERDNLKISD 148

Query: 845 FGVAKVVDASGKPKSMSVIAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVT 898
           FG+A V   + + + ++ + G+  Y+APE      +       E  D++S G+V+  ++ 
Sbjct: 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLA 203

Query: 899 GRLPV-DPEFGEKDLVKWV 916
           G LP   P    ++   W 
Sbjct: 204 GELPWDQPSDSCQEYSDWK 222

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  110 bits (277), Expect = 2e-26
 Identities = 68/328 (20%), Positives = 123/328 (37%), Gaps = 61/328 (18%)

Query: 689 NVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             +G G+ G+VY+  +S          VAVK L                    +Q + D 
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---------------PEVCSEQDELD- 79

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-----KGGLLDW 797
           F  E   + K  H+NIV+          + ++ E M  G L   L        +   L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139

Query: 798 PTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVD 852
                +  D A G  YL  +H      +HRD+ + N LL        A++ DFG+A+ + 
Sbjct: 140 LDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194

Query: 853 ASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE 906
            +   +      G C  +      PE         K+D +SFGV++ E+ + G +P  P 
Sbjct: 195 RASYYRK-----GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PS 248

Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
              ++++++V       G    +DP  +C     + +++     C    P +RP    ++
Sbjct: 249 KSNQEVLEFV-----TSG--GRMDPPKNC--PGPVYRIM---TQCWQHQPEDRPNFAIIL 296

Query: 967 KLLQEVGAENRSKTGKKDGKLSPYYHED 994
           + ++    +          +  P   E+
Sbjct: 297 ERIEYCTQDPDVINTALPIEYGPLVEEE 324

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  109 bits (274), Expect = 2e-26
 Identities = 43/237 (18%), Positives = 85/237 (35%), Gaps = 57/237 (24%)

Query: 690 VIGSGSSGKVYKVVLSNGEA--------VAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
            +G G+  K++K V              V +K L      +             +  +  
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-----DKAHR----------NYSES- 58

Query: 742 GFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
            F      + K+ HK++V  +  C   D  +LV E++  GSL   L       ++   + 
Sbjct: 59  -FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKL 116

Query: 802 KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGAR--------VADFGVAKVV 851
           ++    A  + +L  +      ++H +V + NILL  +   +        ++D G++  V
Sbjct: 117 EVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

Query: 852 DASG---KP-KSMSVIAGSCGYIAPE-YAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                  +    +           PE       +N  +D +SFG  + E+ + G  P
Sbjct: 172 LPKDILQERIPWV----------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  110 bits (276), Expect = 2e-26
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 37/226 (16%)

Query: 688 DNVIGSGSSGKVYKVVLSNGE-----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             V+GSG+ G VYK +           VA+K+L               +     +   + 
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---------------REATSPKANKE- 63

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
              E   +  + + ++ +L   C T     L+ + MP G L D +   K  +        
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLN 121

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
             V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++ A  K      
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----E 173

Query: 863 IAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
                G +     A E         +SD++S+GV + EL+T G  P
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  109 bits (274), Expect = 2e-26
 Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 35/235 (14%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVK-----KLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           IG GS G V      ++    A+K     KL R             +      +Q  G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 745 A----EVETLGKIRHKNIVKLWC--CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                E+  L K+ H N+VKL         D   +V+E +  G + ++       L +  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQ 138

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
            R     D  +G+ YLH+     I+HRD+K +N+L+  D   ++ADFGV+     S    
Sbjct: 139 AR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--- 191

Query: 859 SMSVIAGSCG---YIAPEYAYTLRVNEK------SDIYSFGVVILELVTGRLPVD 904
             ++++ + G   ++APE   +L    K       D+++ GV +   V G+ P  
Sbjct: 192 --ALLSNTVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (283), Expect = 3e-26
 Identities = 65/271 (23%), Positives = 103/271 (38%), Gaps = 54/271 (19%)

Query: 651 KYRKFKNGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEA 709
           +   +  G AI+   +      K+    Y           +GSG+ G+V      +    
Sbjct: 11  RENLYFQGIAINPGMYVRKKEGKI-GESYFK------VRKLGSGAYGEVLLCKEKNGHSE 63

Query: 710 VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRD 769
            A+K +     K               +   +    E+  L  + H NI+KL+     + 
Sbjct: 64  KAIKVI----KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119

Query: 770 CKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRYKII-------VDAA-------EGLSYL 814
              LV E+             +GG L +     +II        DAA        G+ YL
Sbjct: 120 YFYLVTEF------------YEGGELFE-----QIINRHKFDECDAANIMKQILSGICYL 162

Query: 815 HHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIA 871
           H     +IVHRD+K  NILL   +     ++ DFG++       K   +    G+  YIA
Sbjct: 163 HKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLGTAYYIA 216

Query: 872 PEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           PE     + NEK D++S GV++  L+ G  P
Sbjct: 217 PE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (274), Expect = 4e-26
 Identities = 59/259 (22%), Positives = 109/259 (42%), Gaps = 48/259 (18%)

Query: 669 MSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGC 727
           M+   +    +++         +G G+ G+V   V     EAVAVK +            
Sbjct: 1   MAVPFVED--WDL------VQTLGEGAYGEVQLAVNRVTEEAVAVKIV------------ 40

Query: 728 DVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL 787
             +  +  D    +  + E+     + H+N+VK +      + + L  EY   G L D +
Sbjct: 41  --DMKRAVDCP--ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 96

Query: 788 HSCKGGLLDWPTRYK---IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
                G+ +   +     ++     G+ YLH      I HRD+K  N+LLD     +++D
Sbjct: 97  EP-DIGMPEPDAQRFFHQLM----AGVVYLHGI---GITHRDIKPENLLLDERDNLKISD 148

Query: 845 FGVAKVVDASGKPKSMSVIAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVT 898
           FG+A V   + + + ++ + G+  Y+APE      +       E  D++S G+V+  ++ 
Sbjct: 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLA 203

Query: 899 GRLPVD-PEFGEKDLVKWV 916
           G LP D P    ++   W 
Sbjct: 204 GELPWDQPSDSCQEYSDWK 222

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  113 bits (285), Expect = 5e-26
 Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 39/226 (17%)

Query: 688 DNVIGSGSSGKVYKVVLSNGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
              IG G  G V++ +  + E    AVA+K       K C S          D V++  F
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-----KNCTS----------DSVREK-F 438

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             E  T+ +  H +IVKL    T  +   ++ E    G L   L   K  L D  +    
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSL-DLASLILY 496

Query: 804 IVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
               +  L+YL     V    HRD+ + N+L+  +   ++ DFG+++ ++ S      + 
Sbjct: 497 AYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TY 546

Query: 863 IAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
              S G +     APE     R    SD++ FGV + E++  G  P
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  109 bits (274), Expect = 5e-26
 Identities = 67/332 (20%), Positives = 111/332 (33%), Gaps = 53/332 (15%)

Query: 57  CSWRGVECDPR---------SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINS 107
           C  R V+C            S     +DL N +I+         L++L  L L NN I+ 
Sbjct: 33  CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92

Query: 108 TLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKL 167
                 S  + LQ L +S+N L   + P L    +L  L +  N     +P+  G F  L
Sbjct: 93  IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPK--GVFSGL 146

Query: 168 EVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLV 227
                                  +  + +  NP       P   +   L  L ++E  L 
Sbjct: 147 ---------------------RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185

Query: 228 GEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLT 286
             IP  L     L +L L  N +       L   + + ++ L +N +   +  G  S L 
Sbjct: 186 -GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLP 241

Query: 287 SLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATI-------ADSPGLYEL 338
           +LR L    N L+  +P  L  L  L+ + L+ N +   +                   +
Sbjct: 242 TLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGI 299

Query: 339 RLFRNRL-NGTLPGDLGKNSP-LRWVDLSNNQ 368
            LF N +    +     +       +   N +
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (265), Expect = 8e-25
 Identities = 58/308 (18%), Positives = 113/308 (36%), Gaps = 28/308 (9%)

Query: 267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSL 325
           ++  +  L   +P   S      LLD   ND++    DD   L  L +L L  N++    
Sbjct: 38  VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIH 94

Query: 326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK-GELE 384
               +    L +L + +N L   +P +L  +  L  + + +N+   ++P  +      + 
Sbjct: 95  EKAFSPLRKLQKLYISKNHLV-EIPPNLPSS--LVELRIHDNRIR-KVPKGVFSGLRNMN 150

Query: 385 ELLMIYNSFT-GQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
            + M  N         G      L  +R+   +LT  +P  L     +  L L  N +  
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ- 206

Query: 444 EISKNI-AGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVLSGSENKFTGSLPESLTNLA 501
            I        + L  L +  N +   +      FL +L  L    NK +  +P  L +L 
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264

Query: 502 ELGSLDLHANDLSGELPSSV-------SSWKKLNELNLADN-LFYGNIPEDI-GNLSVLN 552
            L  + LH N+++ ++  +              N ++L +N + Y  +       ++   
Sbjct: 265 LLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323

Query: 553 YLDLSNNR 560
            +   N +
Sbjct: 324 AIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 65/309 (21%), Positives = 117/309 (37%), Gaps = 45/309 (14%)

Query: 287 SLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN 346
            LR++  S   L   +P +++      L+L  N +             LY L L  N+++
Sbjct: 34  HLRVVQCSDLGLKA-VPKEISPD-TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 347 GTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQS 406
                       L+ + +S N    EIP +L                            S
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL---------------P-----------SS 124

Query: 407 LTRVRLGYNRLTGKVPP-LLWGLPHVYLLELTDNFL-SGEISKNIAGAANLSLLIISKNN 464
           L  +R+  NR+  KVP  +  GL ++  +E+  N L +            L+ L IS+  
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183

Query: 465 LSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW 524
           L+  +P+     ++L  L    NK      E L   ++L  L L  N +      S+S  
Sbjct: 184 LT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240

Query: 525 KKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG--------LQNLKLNQ 576
             L EL+L +N     +P  + +L +L  + L  N ++ ++ V         ++    N 
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298

Query: 577 LNVSNNRLS 585
           +++ NN + 
Sbjct: 299 ISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 63.9 bits (156), Expect = 8e-11
 Identities = 36/145 (24%), Positives = 65/145 (44%), Gaps = 7/145 (4%)

Query: 453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAND 512
            + +LL +  N++S    ++   L+ L  L    NK +    ++ + L +L  L +  N 
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113

Query: 513 LSGELPSSVSSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRL-SGRIPVG-L 569
           L  E+P ++     L EL + DN     +P+ +   L  +N +++  N L +     G  
Sbjct: 114 LV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169

Query: 570 QNLKLNQLNVSNNRLSGELPSLFAK 594
             LKLN L +S  +L+G    L   
Sbjct: 170 DGLKLNYLRISEAKLTGIPKDLPET 194

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  112 bits (282), Expect = 9e-26
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 38/226 (16%)

Query: 688 DNVIGSGSSGKVYKVVLSNGEA---VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
           D  +G G+ G V + V    +    VA+K L               K   +    ++   
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---------------KQGTEKADTEE-MM 384

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKII 804
            E + + ++ +  IV+L   C   +  +LV E    G L   L   K   +      +++
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELL 442

Query: 805 VDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSV 862
              + G+ YL   +      VHR++ + N+LL     A+++DFG++K + A         
Sbjct: 443 HQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD----DSYY 493

Query: 863 IAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
            A S G       APE     + + +SD++S+GV + E ++ G+ P
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (274), Expect = 2e-25
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 25/230 (10%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +GSG+ G+V         + VA++ +    SK          G  ++       + E+E
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRII----SKR-----KFAIGSAREADPALNVETEIE 192

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
            L K+ H  I+K+       D   +V E M  G L D +       L   T         
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQML 249

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASGKPKSMSVIAG 865
             + YLH +    I+HRD+K  N+LL   + D   ++ DFG +K++   G+   M  + G
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCG 303

Query: 866 SCGYIAPE---YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           +  Y+APE      T   N   D +S GV++   ++G  P      +  L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (267), Expect = 3e-25
 Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 32/235 (13%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
            K    +++         ++G GS   V      +     A+K L              E
Sbjct: 25  RKKRPEDFKFGK------ILGEGSFSTVVLARELATSREYAIKIL--------------E 64

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
           K  +  + +      E + + ++ H   VKL+      +       Y  NG L  L +  
Sbjct: 65  KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIR 122

Query: 791 KGGLLDWP-TRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
           K G  D   TR+    IV A   L YLH      I+HRD+K  NILL+ D   ++ DFG 
Sbjct: 123 KIGSFDETCTRFYTAEIVSA---LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT 176

Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           AKV+    K    +   G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (267), Expect = 3e-25
 Identities = 61/252 (24%), Positives = 102/252 (40%), Gaps = 32/252 (12%)

Query: 669 MSFHKLGFSE-YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESG 726
           MS +     + Y +         +GSG+ G+V         + VA+K + +   ++   G
Sbjct: 1   MSVYPKALRDEYIM------SKTLGSGACGEVKLAFERKTCKKVAIKIISK---RKFAIG 51

Query: 727 CDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL 786
              E     +       + E+E L K+ H  I+K+       D   +V E M  G L D 
Sbjct: 52  SAREADPALN------VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDK 104

Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVA 843
           +       L   T           + YLH +    I+HRD+K  N+LL   + D   ++ 
Sbjct: 105 V--VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPE---YAYTLRVNEKSDIYSFGVVILELVTGR 900
           DFG +K++   G+   M  + G+  Y+APE      T   N   D +S GV++   ++G 
Sbjct: 160 DFGHSKIL---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216

Query: 901 LPVDPEFGEKDL 912
            P      +  L
Sbjct: 217 PPFSEHRTQVSL 228

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  107 bits (269), Expect = 4e-25
 Identities = 69/328 (21%), Positives = 124/328 (37%), Gaps = 61/328 (18%)

Query: 689 NVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             +G G+ G+VY+  +S          VAVK L                    +Q + D 
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---------------PEVCSEQDELD- 120

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC-----KGGLLDW 797
           F  E   + K  H+NIV+          + ++ E M  G L   L        +   L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180

Query: 798 PTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDG---DFGARVADFGVAKVVD 852
                +  D A G  YL  +H      +HRD+ + N LL        A++ DFG+A+ + 
Sbjct: 181 LDLLHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235

Query: 853 ASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE 906
            +G  +      G C  +      PE         K+D +SFGV++ E+ + G +P  P 
Sbjct: 236 RAGYYRK-----GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PS 289

Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
              ++++++V       G    +DP  +C     + +++     C    P +RP    ++
Sbjct: 290 KSNQEVLEFV-----TSG--GRMDPPKNC--PGPVYRIM---TQCWQHQPEDRPNFAIIL 337

Query: 967 KLLQEVGAENRSKTGKKDGKLSPYYHED 994
           + ++    +          +  P   E+
Sbjct: 338 ERIEYCTQDPDVINTALPIEYGPLVEEE 365

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (267), Expect = 4e-25
 Identities = 54/271 (19%), Positives = 87/271 (32%), Gaps = 66/271 (24%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +Y +         IG GS G V   +        A+K +            +  K +  
Sbjct: 26  KKYHLKG------AIGQGSYGVVRVAIENQTRAIRAIKIM------------NKNKIRQI 67

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
           +    +  + EV  + K+ H NI +L+          LV E    G L D L+       
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127

Query: 796 DWPTRYKIIV-------------------------------DAA-------EGLSYLHHD 817
                  +                                   +         L YLH+ 
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187

Query: 818 CVPSIVHRDVKSNNILLDGDFGARV--ADFGVAKVVDAS--GKPKSMSVIAGSCGYIAPE 873
               I HRD+K  N L   +    +   DFG++K       G+   M+  AG+  ++APE
Sbjct: 188 ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 874 --YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                      K D +S GV++  L+ G +P
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  108 bits (272), Expect = 6e-25
 Identities = 71/245 (28%), Positives = 104/245 (42%), Gaps = 63/245 (25%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y+         V+G GS G+V        G+  AVK               + K QV+
Sbjct: 26  DRYKG------QRVLGKGSFGEVILCKDKITGQECAVKV--------------ISKRQVK 65

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
            +   +    EV+ L ++ H NI+KL+     +    LV E               GG L
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV------------YTGGEL 113

Query: 795 LDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGD 837
            D     +II       VDAA        G++Y+H +    IVHRD+K  N+LL     D
Sbjct: 114 FD-----EIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD 165

Query: 838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
              R+ DFG++   +AS   K M    G+  YIAPE       +EK D++S GV++  L+
Sbjct: 166 ANIRIIDFGLSTHFEAS---KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILL 221

Query: 898 TGRLP 902
           +G  P
Sbjct: 222 SGCPP 226

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  106 bits (267), Expect = 8e-25
 Identities = 71/319 (22%), Positives = 127/319 (39%), Gaps = 78/319 (24%)

Query: 688 DNVIGSGSSGKVYK---VVLSNGEA-----VAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
              +G G  G+V     V +   +      VAVK L     K+  +  D+          
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSD-------- 132

Query: 740 DDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK------- 791
                +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +       
Sbjct: 133 ---LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189

Query: 792 -------GGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARV 842
                     + +          A G+ YL          +HRD+ + N+L+  +   ++
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKI 244

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYI-----APE----YAYTLRVNEKSDIYSFGVVI 893
           ADFG+A+ ++             + G +     APE      YT     +SD++SFGV++
Sbjct: 245 ADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLM 295

Query: 894 LELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCT 952
            E+ T G  P  P    ++L K +     ++G  H +D   +C    E+  ++     C 
Sbjct: 296 WEIFTLGGSPY-PGIPVEELFKLL-----KEG--HRMDKPANC--TNELYMMM---RDCW 342

Query: 953 SPLPINRPAMRRVVKLLQE 971
             +P  RP  +++V+ L  
Sbjct: 343 HAVPSQRPTFKQLVEDLDR 361

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  107 bits (268), Expect = 2e-24
 Identities = 68/245 (27%), Positives = 98/245 (40%), Gaps = 64/245 (26%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y+          +GSG+ G+V            A+K +     K   S     K    
Sbjct: 37  EMYQR------VKKLGSGAYGEVLLCRDKVTHVERAIKII----RKTSVSTSSNSK---- 82

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
                     EV  L  + H NI+KL+     +    LV E              KGG L
Sbjct: 83  -------LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC------------YKGGEL 123

Query: 795 LDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGD 837
            D     +II       VDAA        G++YLH     +IVHRD+K  N+LL   + D
Sbjct: 124 FD-----EIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKD 175

Query: 838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
              ++ DFG++ V +     K M    G+  YIAPE     + +EK D++S GV++  L+
Sbjct: 176 ALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231

Query: 898 TGRLP 902
            G  P
Sbjct: 232 AGYPP 236

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  104 bits (262), Expect = 2e-24
 Identities = 74/320 (23%), Positives = 127/320 (39%), Gaps = 77/320 (24%)

Query: 689 NVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG 742
             IG G+ G+V++              VAVK L     KE  S            +Q D 
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEAS----------ADMQAD- 96

Query: 743 FQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY- 801
           FQ E   + +  + NIVKL   C       L++EYM  G L + L S     +   +   
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 802 ---------------------KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDF 838
                                 I    A G++YL          VHRD+ + N L+  + 
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENM 211

Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRV-NEKSDIYSFGVV 892
             ++ADFG+++ + ++   K     A     I      PE +        +SD++++GVV
Sbjct: 212 VVKIADFGLSRNIYSADYYK-----ADGNDAIPIRWMPPE-SIFYNRYTTESDVWAYGVV 265

Query: 893 ILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLC 951
           + E+ + G  P       ++++ +V     + G  ++L    +C    E+  ++    LC
Sbjct: 266 LWEIFSYGLQPY-YGMAHEEVIYYV-----RDG--NILACPENC--PLELYNLM---RLC 312

Query: 952 TSPLPINRPAMRRVVKLLQE 971
            S LP +RP+   + ++LQ 
Sbjct: 313 WSKLPADRPSFCSIHRILQR 332

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (258), Expect = 3e-24
 Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 54/230 (23%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G GS G+V K       +  AVK +    +K      D                 EVE
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI----NKASAKNKDTST-----------ILREVE 73

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDW---PTRY--- 801
            L K+ H NI+KL+          +V E               GG L D      R+   
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGEL------------YTGGELFDEIIKRKRFSEH 121

Query: 802 ---KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASG 855
              +II     G++Y+H     +IVHRD+K  NILL   + D   ++ DFG++     + 
Sbjct: 122 DAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177

Query: 856 KPKSMSVIAGSCGYIAPE---YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               M    G+  YIAPE     Y    +EK D++S GV++  L++G  P
Sbjct: 178 --TKMKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  102 bits (257), Expect = 4e-24
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 59/234 (25%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +GSG+ G V+ V   S+G    +K +               K + Q  ++    +AE+E
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTI--------------NKDRSQVPMEQ--IEAEIE 72

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLD-------WPTR 800
            L  + H NI+K++          +V E             C+GG LL+           
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMET------------CEGGELLERIVSAQARGKA 120

Query: 801 Y------KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVV 851
                  +++      L+Y H      +VH+D+K  NIL          ++ DFG+A++ 
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177

Query: 852 DASGKPKSMSVIAGSCGYIAPE---YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            +    +  +  AG+  Y+APE            K DI+S GVV+  L+TG LP
Sbjct: 178 KSD---EHSTNAAGTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  103 bits (258), Expect = 4e-24
 Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 32/233 (13%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y + D      ++G GS GKV +V+        AVK L +   +             +  
Sbjct: 7   YLMGD------LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--------IPNGEAN 52

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLW--CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
           V+      E++ L ++RHKN+++L        +    +V EY   G    L    +    
Sbjct: 53  VK-----KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP 107

Query: 796 DWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
                     ++D   GL YLH      IVH+D+K  N+LL      +++  GVA+ +  
Sbjct: 108 VCQAHGYFCQLID---GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNE--KSDIYSFGVVILELVTGRLPVD 904
                +     GS  +  PE A  L      K DI+S GV +  + TG  P +
Sbjct: 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  103 bits (259), Expect = 4e-24
 Identities = 66/296 (22%), Positives = 121/296 (40%), Gaps = 67/296 (22%)

Query: 644 GLVWFYLKYRKF----KNGRAIDKSKWTLMSFHKLGF-SEYEI-LDGLDEDNVIGSGSSG 697
           G+ + Y +  K+    K   + + + +T +   +L +  ++E   + L     +G+G+ G
Sbjct: 1   GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFG 60

Query: 698 KVYK---VVLSNGEA---VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLG 751
           KV +     L   +A   VAVK L     K      + E              +E++ + 
Sbjct: 61  KVVEATAFGLGKEDAVLKVAVKML-----KSTAHADEKEA-----------LMSELKIMS 104

Query: 752 KI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRY--------- 801
            + +H+NIV L   CT     L++ EY   G L + L      L   P            
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 802 ---KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                    A+G+++L   +      +HRDV + N+LL     A++ DFG+A+ +     
Sbjct: 165 DLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIM---- 215

Query: 857 PKSMSVIAGSCGYI-----APE----YAYTLRVNEKSDIYSFGVVILELVT-GRLP 902
               + I      +     APE      YT+    +SD++S+G+++ E+ + G  P
Sbjct: 216 -NDSNYIVKGNARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFSLGLNP 266

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  103 bits (260), Expect = 5e-24
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 52/229 (22%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IGSG+ G    +      E VAVK + RG                     D+  Q E+  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERG------------------AAIDENVQREIIN 69

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK---IIVD 806
              +RH NIV+      T     ++ EY   G L + + +  G   +   R+    ++  
Sbjct: 70  HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLL-- 126

Query: 807 AAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR--VADFGVAKVVDASGKPKSMSVIA 864
              G+SY H      I HRD+K  N LLDG    R  + DFG +K      +PKS     
Sbjct: 127 --SGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----- 176

Query: 865 GSCG---YIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
            + G   YIAPE      Y       + +D++S GV +  ++ G  P +
Sbjct: 177 -TVGTPAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFE 219

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (264), Expect = 6e-24
 Identities = 69/247 (27%), Positives = 99/247 (40%), Gaps = 68/247 (27%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y I        ++G GS G+V K       +  AVK +    +K      D       
Sbjct: 22  ERYNI------VCMLGKGSFGEVLKCKDRITQQEYAVKVI----NKASAKNKDTST---- 67

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
                     EVE L K+ H NI+KL+          +V E               GG L
Sbjct: 68  -------ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL------------YTGGEL 108

Query: 795 LDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGD 837
            D     +II        DAA        G++Y+H     +IVHRD+K  NILL   + D
Sbjct: 109 FD-----EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160

Query: 838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILE 895
              ++ DFG++     +     M    G+  YIAPE    LR   +EK D++S GV++  
Sbjct: 161 CDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPE---VLRGTYDEKCDVWSAGVILYI 214

Query: 896 LVTGRLP 902
           L++G  P
Sbjct: 215 LLSGTPP 221

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  102 bits (257), Expect = 6e-24
 Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 61/248 (24%)

Query: 688 DNVIGSGSSGKVYK---VVLSNGEA---VAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
              +G+G+ GKV +     L   +A   VAVK L     K      + E           
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-----KPSAHLTEREA---------- 72

Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
              +E++ L  +  H NIV L   CT     L++ EY   G L + L   +   +   T 
Sbjct: 73  -LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 801 YKIIVDA----------------AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD 844
             I+ D                 A+G+++L      + +HRD+ + NILL      ++ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICD 188

Query: 845 FGVAKVVDASGKPKSMSVIAGSCGYI-----APE----YAYTLRVNEKSDIYSFGVVILE 895
           FG+A+ +         + +      +     APE      YT     +SD++S+G+ + E
Sbjct: 189 FGLARDIK-----NDSNYVVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYGIFLWE 239

Query: 896 LVT-GRLP 902
           L + G  P
Sbjct: 240 LFSLGSSP 247

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  101 bits (254), Expect = 8e-24
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 44/226 (19%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G+ GKV        G  VAVK L               + +++        + E++ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKIL--------------NRQKIRSLDVVGKIKREIQN 64

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDA 807
           L   RH +I+KL+   +T     +V EY+  G L D +    G + +   R     I+ A
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSA 123

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
              + Y H      +VHRD+K  N+LLD    A++ADFG++ ++      ++      SC
Sbjct: 124 ---VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SC 171

Query: 868 G---YIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           G   Y APE      YA       + DI+S GV++  L+ G LP D
Sbjct: 172 GSPNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFD 212

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  102 bits (256), Expect = 1e-23
 Identities = 72/325 (22%), Positives = 128/325 (39%), Gaps = 88/325 (27%)

Query: 688 DNVIGSGSSGKVYKVVLSNGEA-------------VAVKKLWRGMSKECESGCDVEKGQV 734
              +G G+ G+V        EA             VAVK L     K+  +  D+     
Sbjct: 40  GKPLGEGAFGQVVM-----AEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSD--- 86

Query: 735 QDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-- 791
                     +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +  
Sbjct: 87  --------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138

Query: 792 ------------GGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGD 837
                          + +          A G+ YL          +HRD+ + N+L+  +
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTEN 193

Query: 838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYI-----APE----YAYTLRVNEKSDIYS 888
              ++ADFG+A+ ++             + G +     APE      YT     +SD++S
Sbjct: 194 NVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYT----HQSDVWS 244

Query: 889 FGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNI 947
           FGV++ E+ T G  P  P    ++L K +     ++G  H +D   +C    E+  ++  
Sbjct: 245 FGVLMWEIFTLGGSPY-PGIPVEELFKLL-----KEG--HRMDKPANC--TNELYMMM-- 292

Query: 948 GLLCTSPLPINRPAMRRVVKLLQEV 972
              C   +P  RP  +++V+ L  +
Sbjct: 293 -RDCWHAVPSQRPTFKQLVEDLDRI 316

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  101 bits (255), Expect = 1e-23
 Identities = 67/226 (29%), Positives = 96/226 (42%), Gaps = 45/226 (19%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+  KV     +  G  VA+K +     K   +   ++K              EV  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII----DKTQLNPTSLQK-----------LFREVRI 67

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDA 807
           +  + H NIVKL+    T     L+ EY   G + D L +  G + +   R K   IV A
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSA 126

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
              + Y H      IVHRD+K+ N+LLD D   ++ADFG       S +      +   C
Sbjct: 127 ---VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDAFC 174

Query: 868 G---YIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           G   Y APE      Y        + D++S GV++  LV+G LP D
Sbjct: 175 GAPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFD 215

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  103 bits (258), Expect = 2e-23
 Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 6/207 (2%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            + LS  +I          L NL  L LF+N + +           L+ L L  N +   
Sbjct: 92  ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESI 151

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPE-SFGRFQKLEVISLVYNLLDGTIPAFLGNISTL 191
            + A   +P+L+ LDL        I E +F     L  ++L    L   IP     +  L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLT-PLIKL 209

Query: 192 KMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL 250
             L+LS N      I P     L +L+ LW+ +  +     ++   L  LV+++LA NNL
Sbjct: 210 DELDLSGNHL--SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267

Query: 251 VGAIPSSLTELASVVQIELYNNSLTGD 277
                   T L  + +I L++N    +
Sbjct: 268 TLLPHDLFTPLHHLERIHLHHNPWNCN 294

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  101 bits (254), Expect = 7e-23
 Identities = 67/249 (26%), Positives = 98/249 (39%), Gaps = 29/249 (11%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            ++L    I     +    L +L  L L  N I +      +   NL  L+L  N LT  
Sbjct: 68  LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTI 127

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
              A   L  LK L L  N     IP     F ++                      +L+
Sbjct: 128 PNGAFVYLSKLKELWLRNNPIE-SIPS--YAFNRI---------------------PSLR 163

Query: 193 MLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV 251
            L+L     L   I       L+NL  L L  CNL  EIP+ L  L KL +LDL+ N+L 
Sbjct: 164 RLDLGELKRL-SYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS 220

Query: 252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP- 310
              P S   L  + ++ +  + +       + NL SL  ++ + N+LT    D  T L  
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280

Query: 311 LESLNLYEN 319
           LE ++L+ N
Sbjct: 281 LERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.4 bits (240), Expect = 4e-21
 Identities = 65/298 (21%), Positives = 104/298 (34%), Gaps = 69/298 (23%)

Query: 83  GPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPN 142
             F  ++C  +NL             +PD IS   N + L+L +N +      +   L +
Sbjct: 43  NQFSKVICVRKNLR-----------EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRH 89

Query: 143 LKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFL 202
           L+ L L+ N+       +F     L  + L  N L          +S LK L L  NP  
Sbjct: 90  LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI- 148

Query: 203 PGRIPPEL-GNLTNLEILWLTECNLVGEIP-DSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
              IP      + +L  L L E   +  I   +   L+ L  L+LA+ NL   IP+    
Sbjct: 149 -ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN---- 202

Query: 261 LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYEN 319
                                 + L  L  LD S N L+   P     L  L+ L + ++
Sbjct: 203 ---------------------LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 320 RLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL 377
           +++  +               F N     L         L  ++L++N  T  +P  L
Sbjct: 242 QIQ-VIER-----------NAFDN-----LQS-------LVEINLAHNNLT-LLPHDL 274

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 89.4 bits (222), Expect = 9e-19
 Identities = 57/261 (21%), Positives = 99/261 (37%), Gaps = 17/261 (6%)

Query: 356 NSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN 415
           ++    V         E+P  +        L +  N       +   H + L  ++L  N
Sbjct: 42  SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98

Query: 416 RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEI- 473
            +         GL ++  LEL DN L+  I        + L  L +  N +  S+P    
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156

Query: 474 GFLKSLVVLS-GSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL 532
             + SL  L  G   + +     +   L+ L  L+L   +L  E+P+ ++   KL+EL+L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL 214

Query: 533 ADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLSGELP 589
           + N     I       L  L  L +  +++   I      NL  L ++N+++N L+    
Sbjct: 215 SGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPH 272

Query: 590 SLFA--KEMYRNSFLGNPGLC 608
            LF     + R     NP  C
Sbjct: 273 DLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.7 bits (215), Expect = 6e-18
 Identities = 58/258 (22%), Positives = 98/258 (37%), Gaps = 17/258 (6%)

Query: 332 SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYN 391
           S    ++   R  L   +P  +  ++  R ++L  NQ       S      LE L +  N
Sbjct: 42  SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98

Query: 392 SFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-LLWGLPHVYLLELTDNFLSGEISKNI- 449
                         +L  + L  NRLT  +P      L  +  L L +N +   I     
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156

Query: 450 AGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPESLTNLAELGSLD 507
               +L  L + +      + E   F  L +L  L+ +       +P +LT L +L  LD
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGA-FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELD 213

Query: 508 LHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPED-IGNLSVLNYLDLSNNRLSGRIP 566
           L  N LS   P S      L +L +  +     I  +   NL  L  ++L++N L+  +P
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLT-LLP 271

Query: 567 VGL--QNLKLNQLNVSNN 582
             L      L ++++ +N
Sbjct: 272 HDLFTPLHHLERIHLHHN 289

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (256), Expect = 2e-23
 Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 54/246 (21%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKE-CESGCDV 729
             + F  +EIL        IG GS GKV  V      +  A+K     M+K+ C     V
Sbjct: 10  EDVNFDHFEIL------RAIGKGSFGKVCIVQKNDTKKMYAMKY----MNKQKC-----V 54

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL-LH 788
           E+ +V           E++ +  + H  +V LW      +   +V + +  G  GDL  H
Sbjct: 55  ERNEV------RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL-LG--GDLRYH 105

Query: 789 SCKGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             +         + +       E    L YL +     I+HRD+K +NILLD      + 
Sbjct: 106 LQQNVHFKEETVKLF-----ICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHIT 157

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPE-------YAYTLRVNEKSDIYSFGVVILEL 896
           DF +A ++    +  +M+   G+  Y+APE         Y+  V    D +S GV   EL
Sbjct: 158 DFNIAAMLPRETQITTMA---GTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYEL 210

Query: 897 VTGRLP 902
           + GR P
Sbjct: 211 LRGRRP 216

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  100 bits (252), Expect = 2e-23
 Identities = 79/342 (23%), Positives = 131/342 (38%), Gaps = 84/342 (24%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDV 729
            ++E     L     +G G  GKV K    + +       VAVK L     KE  S  ++
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-----KENASPSEL 70

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
                          +E   L ++ H +++KL+  C+     LL+ EY   GSL   L  
Sbjct: 71  RD-----------LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119

Query: 790 CK----------------------GGLLDWPTRYKIIVDAAEGLSYL--HHDCVPSIVHR 825
            +                         L            ++G+ YL         +VHR
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHR 174

Query: 826 DVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI-----APE----YAY 876
           D+ + NIL+      +++DFG+++ V      +  S +  S G I     A E    + Y
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVY-----EEDSYVKRSQGRIPVKWMAIESLFDHIY 229

Query: 877 TLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDC 935
           T     +SD++SFGV++ E+VT G  P  P    + L   +     + G  H ++   +C
Sbjct: 230 TT----QSDVWSFGVLLWEIVTLGGNPY-PGIPPERLFNLL-----KTG--HRMERPDNC 277

Query: 936 CFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR 977
              EE+     + L C    P  RP    + K L+++  + R
Sbjct: 278 --SEEMY---RLMLQCWKQEPDKRPVFADISKDLEKMMVKRR 314

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (251), Expect = 4e-23
 Identities = 57/257 (22%), Positives = 97/257 (37%), Gaps = 57/257 (22%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGE------AVAVKKLWRGMSKECESGCDV 729
           S++E   D L     +G G+ G+V +      +       VAVK L     KE  +  + 
Sbjct: 20  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEH 74

Query: 730 EKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLL 787
                          +E++ L  I  H N+V L   CT     L+V  E+   G+L   L
Sbjct: 75  RA-----------LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123

Query: 788 HSCKGGLLDWPTRY--------------KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNN 831
            S +   + +                        A+G+ +L          +HRD+ + N
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARN 178

Query: 832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDI 886
           ILL      ++ DFG+A+ +           +      +     APE  +      +SD+
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233

Query: 887 YSFGVVILELVT-GRLP 902
           +SFGV++ E+ + G  P
Sbjct: 234 WSFGVLLWEIFSLGASP 250

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  101 bits (253), Expect = 4e-23
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 45/231 (19%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG G S  V + V  + G   AVK     M    E     +  +V++  +      E  
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKI----MEVTAERLSPEQLEEVREATRR-----ETH 151

Query: 749 TLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDW---PTRY-- 801
            L ++  H +I+ L     +     LV++              + G L D+         
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDL------------MRKGELFDYLTEKVALSE 199

Query: 802 ----KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                I+    E +S+LH +   +IVHRD+K  NILLD +   R++DFG +  ++   K 
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK- 255

Query: 858 KSMSVIAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             +  + G+ GY+APE              ++ D+++ GV++  L+ G  P
Sbjct: 256 --LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 24/221 (10%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G G S  V + +     +  AVK +         S  +V++ +       +    EV+
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGS-FSAEEVQELR-------EATLKEVD 75

Query: 749 TLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
            L K+  H NI++L     T     LV++ M  G L D L   K  L +  TR KI+   
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETR-KIMRAL 133

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
            E +  LH     +IVHRD+K  NILLD D   ++ DFG +  +D     + +  + G+ 
Sbjct: 134 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTP 187

Query: 868 GYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            Y+APE              ++ D++S GV++  L+ G  P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (254), Expect = 8e-23
 Identities = 51/237 (21%), Positives = 92/237 (38%), Gaps = 66/237 (27%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +G G+   V + V +  G+  A   +    + +  S  D +K            + E  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMII----NTKKLSARDHQK-----------LEREAR 62

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRYKIIV-- 805
               ++H NIV+L    +      L+++               GG L +       IV  
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDL------------VTGGELFED------IVAR 104

Query: 806 ------DAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAK 849
                 DA+       E + + H      +VHR++K  N+LL         ++ADFG+A 
Sbjct: 105 EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161

Query: 850 VVDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            V+     ++    AG+ GY++PE      Y     +  D+++ GV++  L+ G  P
Sbjct: 162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPY----GKPVDLWACGVILYILLVGYPP 212

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  101 bits (254), Expect = 8e-23
 Identities = 61/255 (23%), Positives = 100/255 (39%), Gaps = 31/255 (12%)

Query: 68  SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQ 126
             +   ++L   NI          L +L  L L  NSI   +     +   +L  L+L  
Sbjct: 74  PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFD 132

Query: 127 NLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLG 186
           N LT   + A   L  L+ L L  N     IP     F ++                   
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPS--YAFNRV------------------- 170

Query: 187 NISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDL 245
              +L  L+L     L   I       L NL+ L L  CN+  ++P+ L  L  L +L++
Sbjct: 171 --PSLMRLDLGELKKL-EYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225

Query: 246 ALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDD 305
           + N+     P S   L+S+ ++ + N+ ++      +  L SL  L+ + N+L+    D 
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285

Query: 306 LTRLP-LESLNLYEN 319
            T L  L  L+L+ N
Sbjct: 286 FTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 99.4 bits (248), Expect = 5e-22
 Identities = 61/317 (19%), Positives = 101/317 (31%), Gaps = 74/317 (23%)

Query: 83  GPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPN 142
             F  ++C    L+            +P  I +  N ++L+L +N +          L +
Sbjct: 54  NQFSKVVCTRRGLS-----------EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHH 100

Query: 143 LKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSYNP 200
           L+ L L  N+       +F     L  + L  N L   IP  AF      L+ L L  NP
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSK-LRELWLRNNP 158

Query: 201 FLPGRIPPE-LGNLTNLEILWLTECNLVGEIP-DSLGRLAKLVDLDLALNNLVGAIPSSL 258
                IP      + +L  L L E   +  I   +   L  L  L+L + N+   +P+  
Sbjct: 159 I--ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-- 213

Query: 259 TELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLY 317
                                   + L  L  L+ S N      P     L  L+ L + 
Sbjct: 214 -----------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 318 ENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL 377
            +++             L EL                        +L++N  +  +P  L
Sbjct: 251 NSQVSLIERNAFDGLASLVEL------------------------NLAHNNLS-SLPHDL 285

Query: 378 CEK-GELEELLMIYNSF 393
                 L EL + +N +
Sbjct: 286 FTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 89.8 bits (223), Expect = 6e-19
 Identities = 61/262 (23%), Positives = 102/262 (38%), Gaps = 19/262 (7%)

Query: 356 NSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN 415
           ++    V  +    + E+P  +        L ++ N+      D   H   L  ++LG N
Sbjct: 53  SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 416 RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEI- 473
            +         GL  +  LEL DN+L+  I        + L  L +  N +  S+P    
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 474 GFLKSLVVLS-GSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL 532
             + SL+ L  G   K       +   L  L  L+L   ++  ++P+ ++    L EL +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225

Query: 533 ADNLFYGNIPED-IGNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLSGELP 589
           + N F   I       LS L  L + N+++S  I       L  L +LN+++N LS  LP
Sbjct: 226 SGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLP 282

Query: 590 SLFAKEMYRNSFL---GNPGLC 608
                 +     L    NP  C
Sbjct: 283 HDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 89.8 bits (223), Expect = 6e-19
 Identities = 54/278 (19%), Positives = 90/278 (32%), Gaps = 39/278 (14%)

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
              +      L   +P  I        L L  N +             L  + L  N   
Sbjct: 56  FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-LLWGLP 429
            +I                  +F G          SL  + L  N LT  +P      L 
Sbjct: 113 -QIEV---------------GAFNG--------LASLNTLELFDNWLT-VIPSGAFEYLS 147

Query: 430 HVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVLSGSEN 487
            +  L L +N +   I         +L  L + +      + E     L +L  L+    
Sbjct: 148 KLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206

Query: 488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPED-IG 546
                +P +LT L  L  L++  N      P S      L +L + ++     I  +   
Sbjct: 207 NIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFD 263

Query: 547 NLSVLNYLDLSNNRLSGRIPVG-LQNLK-LNQLNVSNN 582
            L+ L  L+L++N LS  +P      L+ L +L++ +N
Sbjct: 264 GLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 87.1 bits (216), Expect = 5e-18
 Identities = 60/272 (22%), Positives = 91/272 (33%), Gaps = 33/272 (12%)

Query: 267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSL 325
           +      L+ ++P G    ++ R L+   N++     D    L  LE L L  N +    
Sbjct: 59  VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115

Query: 326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEE 385
                    L  L LF N L     G     S LR + L NN     IP           
Sbjct: 116 VGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP----------- 163

Query: 386 LLMIYNSFTGQLPDGLGHCQSLTRVRLG-YNRLTGKVPPLLWGLPHVYLLELTDNFLSGE 444
                               SL R+ LG   +L         GL ++  L L    +  +
Sbjct: 164 ------------SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-D 210

Query: 445 ISKNIAGAANLSLLIISKNNLSGSLPEE-IGFLKSLVVLSGSENKFTGSLPESLTNLAEL 503
           +  N+     L  L +S N+    +       L SL  L    ++ +     +   LA L
Sbjct: 211 MP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 504 GSLDLHANDLSGELPSSVSSWKKLNELNLADN 535
             L+L  N+LS       +  + L EL+L  N
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  101 bits (254), Expect = 9e-23
 Identities = 74/300 (24%), Positives = 113/300 (37%), Gaps = 60/300 (20%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
            +L   ++EIL       VIG G+ G+V  V L +  +  A+K L               
Sbjct: 69  MRLHREDFEIL------KVIGRGAFGEVAVVKLKNADKVFAMKIL--------------N 108

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
           K ++  + +   F+ E + L     K I  L       +   LV +Y   G L  LL   
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168

Query: 791 KGGLLDWPTR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           +  L +   R Y      AE    +  +H       VHRD+K +NIL+D +   R+ADFG
Sbjct: 169 EDRLPEEMARFY-----LAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220

Query: 847 VAKVVDASGKPKSMSVIAGSCG---YIAPE---------YAYTLRVNEKSDIYSFGVVIL 894
               +   G  +S        G   YI+PE           Y        D +S GV + 
Sbjct: 221 SCLKLMEDGTVQSSVA----VGTPDYISPEILQAMEGGKGRYGPEC----DWWSLGVCMY 272

Query: 895 ELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSP 954
           E++ G  P    F  + LV+     ++ K  +    P       E   K L   L+C+  
Sbjct: 273 EMLYGETP----FYAESLVETYGKIMNHK--ERFQFPTQVTDVSEN-AKDLIRRLICSRE 325

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 52/235 (22%), Positives = 86/235 (36%), Gaps = 12/235 (5%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
           C  E     +     + + +P  I A    Q + L  N ++     +     NL  L L 
Sbjct: 8   CYNEPKVTTSCPQQGLQA-VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLH 64

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSYNPFLPGRIP 207
            N  +     +F     LE + L  N    ++    F G    L  L+L         + 
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGR-LHTLHLDRCGL--QELG 121

Query: 208 PE-LGNLTNLEILWLTECNLVGEIPD-SLGRLAKLVDLDLALNNLVGAIPSSLTELASVV 265
           P     L  L+ L+L +  L   +PD +   L  L  L L  N +      +   L S+ 
Sbjct: 122 PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180

Query: 266 QIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYEN 319
           ++ L+ N +    P  + +L  L  L    N+L+    + L  L  L+ L L +N
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 47/209 (22%), Positives = 76/209 (36%), Gaps = 8/209 (3%)

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
           +   I L    I+    +      NLT L L +N +        +    L+ LDLS N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 130 TGTLTP-ALADLPNLKFLDLTGNNFSGDIPE-SFGRFQKLEVISLVYNLLDGTIPA-FLG 186
             ++ P     L  L  L L       ++    F     L+ + L  N L   +P     
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150

Query: 187 NISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDL 245
           ++  L  L L  N      +P      L +L+ L L +  +    P +   L +L+ L L
Sbjct: 151 DLGNLTHLFLHGNRI--SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 246 ALNNLVGAIPSSLTELASVVQIELYNNSL 274
             NNL      +L  L ++  + L +N  
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 53/235 (22%), Positives = 85/235 (36%), Gaps = 17/235 (7%)

Query: 356 NSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN 415
           N P              +P  +      + + +  N  +         C++LT + L  N
Sbjct: 10  NEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66

Query: 416 RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIG 474
            L         GL  +  L+L+DN     +      G   L  L + +  L   L   + 
Sbjct: 67  VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL- 124

Query: 475 F--LKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSV-SSWKKLNEL 530
           F  L +L  L   +N    +LP+ +  +L  L  L LH N +S  +P         L+ L
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRL 182

Query: 531 NLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNN 582
            L  N    ++      +L  L  L L  N LS  +P   L  L  L  L +++N
Sbjct: 183 LLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 45/187 (24%), Positives = 67/187 (35%), Gaps = 9/187 (4%)

Query: 189 STLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL 247
           +  + + L  N      +P        NL ILWL    L      +   LA L  LDL+ 
Sbjct: 32  AASQRIFLHGNRI--SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89

Query: 248 NNLVGAIPSS-LTELASVVQIELYNNSLTGDLPTGW-SNLTSLRLLDASMNDLTGPIPDD 305
           N  + ++  +    L  +  + L    L  +L  G    L +L+ L    N L   +PDD
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDD 147

Query: 306 -LTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVD 363
               L  L  L L+ NR+             L  L L +NR+    P        L  + 
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 364 LSNNQFT 370
           L  N  +
Sbjct: 208 LFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 13/218 (5%)

Query: 324 SLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGEL 383
           ++P  I        + L  NR++            L  + L +N       A+      L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 384 EELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGKVPP-LLWGLPHVYLLELTDNFL 441
           E+L +  N+    +          L  + L    L  ++ P L  GL  +  L L DN L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 442 SGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPESLT 498
              +  +      NL+ L +  N +S S+PE   F  L SL  L   +N+     P +  
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERA-FRGLHSLDRLLLHQNRVAHVHPHAFR 198

Query: 499 NLAELGSLDLHANDLSGELPSSV-SSWKKLNELNLADN 535
           +L  L +L L AN+LS  LP+   +  + L  L L DN
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 27/128 (21%), Positives = 49/128 (38%), Gaps = 7/128 (5%)

Query: 461 SKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSS 520
            +  L  ++P   G   +   +    N+ +     S      L  L LH+N L+    ++
Sbjct: 19  PQQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 521 VSSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQL 577
            +    L +L+L+DN    ++       L  L+ L L    L   +  G  + L  L  L
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134

Query: 578 NVSNNRLS 585
            + +N L 
Sbjct: 135 YLQDNALQ 142

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 65/236 (27%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +G G+   V + V  + G   A K     ++ +  S  D +K            + E  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKI----INTKKLSARDFQK-----------LEREAR 57

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRYKII--- 804
              K++H NIV+L           LV++               GG L +      I+   
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDL------------VTGGELFE-----DIVARE 100

Query: 805 ----VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKV 850
                DA+       E ++Y H +    IVHR++K  N+LL         ++ADFG+A  
Sbjct: 101 FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157

Query: 851 VDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           V+ S         AG+ GY++PE      Y    ++  DI++ GV++  L+ G  P
Sbjct: 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 206

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  100 bits (250), Expect = 1e-22
 Identities = 72/320 (22%), Positives = 124/320 (38%), Gaps = 78/320 (24%)

Query: 688 DNVIGSGSSGKVYKVVL--------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
              +G G+ G+V             +    VAVK L     K   +  D+          
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEKDLSD-------- 120

Query: 740 DDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                +E+E +  I +HKNI+ L   CT      ++ EY   G+L + L + +   L++ 
Sbjct: 121 ---LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177

Query: 799 TRY--------------KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGDFGARV 842
                                  A G+ YL          +HRD+ + N+L+  D   ++
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKI 232

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYI-----APE----YAYTLRVNEKSDIYSFGVVI 893
           ADFG+A+ +              + G +     APE      YT     +SD++SFGV++
Sbjct: 233 ADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYT----HQSDVWSFGVLL 283

Query: 894 LELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCT 952
            E+ T G  P  P    ++L K +     ++G  H +  K   C  E    +  +   C 
Sbjct: 284 WEIFTLGGSPY-PGVPVEELFKLL-----KEG--HRM-DKPSNCTNE----LYMMMRDCW 330

Query: 953 SPLPINRPAMRRVVKLLQEV 972
             +P  RP  +++V+ L  +
Sbjct: 331 HAVPSQRPTFKQLVEDLDRI 350

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.4 bits (246), Expect = 1e-22
 Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 52/221 (23%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+GSG+  +V+ V     G+  A+K               ++K        D   + E+ 
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKC--------------IKKSPAFR---DSSLENEIA 58

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDW---PTRY--- 801
            L KI+H+NIV L     +     LV +               GG L D       Y   
Sbjct: 59  VLKKIKHENIVTLEDIYESTTHYYLVMQL------------VSGGELFDRILERGVYTEK 106

Query: 802 ---KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVVDASG 855
               +I      + YLH +    IVHRD+K  N+L    + +    + DFG++K+     
Sbjct: 107 DASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---- 159

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV--IL 894
           +   MS   G+ GY+APE       ++  D +S GV+  IL
Sbjct: 160 QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYIL 200

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 57/255 (22%), Positives = 95/255 (37%), Gaps = 70/255 (27%)

Query: 688 DNVIGSGSSGKVYKVVLSNGEA------VAVKKLWRGMSKECESGCDVEKGQVQDQVQDD 741
             V+GSG+ GKV                VAVK L     KE     + E           
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-----KEKADSSEREA---------- 94

Query: 742 GFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR 800
              +E++ + ++  H+NIV L   CT      L++EY   G L + L S +    +    
Sbjct: 95  -LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153

Query: 801 Y---------------------KIIVDAAEGLSYL--HHDCVPSIVHRDVKSNNILLDGD 837
           Y                           A+G+ +L          VHRD+ + N+L+   
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHG 208

Query: 838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYI-----APE----YAYTLRVNEKSDIYS 888
              ++ DFG+A+ +         + +      +     APE      YT     KSD++S
Sbjct: 209 KVVKICDFGLARDIM-----SDSNYVVRGNARLPVKWMAPESLFEGIYT----IKSDVWS 259

Query: 889 FGVVILELVT-GRLP 902
           +G+++ E+ + G  P
Sbjct: 260 YGILLWEIFSLGVNP 274

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 60/252 (23%), Positives = 95/252 (37%), Gaps = 70/252 (27%)

Query: 675 GFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQ 733
           G ++ +I      +N IG GS G+V   V        A KK              + K  
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK--------------IPKYF 46

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
           V+D    D F+ E+E +  + H NI++L+          LV E             C GG
Sbjct: 47  VEDV---DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL------------CTGG 91

Query: 794 -LLDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---D 835
            L +     +++        DAA         ++Y H     ++ HRD+K  N L     
Sbjct: 92  ELFE-----RVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDS 143

Query: 836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFG 890
            D   ++ DFG+A         K M    G+  Y++P+     Y        + D +S G
Sbjct: 144 PDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVLEGLY------GPECDEWSAG 194

Query: 891 VVILELVTGRLP 902
           V++  L+ G  P
Sbjct: 195 VMMYVLLCGYPP 206

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 62/271 (22%), Positives = 113/271 (41%), Gaps = 20/271 (7%)

Query: 62  VECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQH 121
           +  DP   +   I    +N+          L+ +T L+ F   + +   + +    NL  
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIG 67

Query: 122 LDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTI 181
           L+L  N +T  L P L +L  +  L+L+GN    ++  +    Q ++ + L    +    
Sbjct: 68  LELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVT 123

Query: 182 PAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLV 241
           P  L  +S L++L L  N      I P L  LTNL+ L +    +    P  L  L+KL 
Sbjct: 124 P--LAGLSNLQVLYLDLNQI--TNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176

Query: 242 DLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGP 301
            L    N +     S L  L +++++ L NN ++ D+    +N ++L ++  +   +T  
Sbjct: 177 TLKADDNKISDI--SPLASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVTLTNQTITNQ 232

Query: 302 IPDDLTRLPLESLNLYENRLEGSLPATIADS 332
                  L +    +         PATI+D+
Sbjct: 233 PVFYNNNLVVP-NVVKGPSGAPIAPATISDN 262

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 54/272 (19%), Positives = 109/272 (40%), Gaps = 42/272 (15%)

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
              +   ++ +      T AD  G+  L  F   +  T+ G +   + L  ++L +NQ T
Sbjct: 21  AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
            ++                           L +   +T + L  N L   V  +  GL  
Sbjct: 77  -DLA-------------------------PLKNLTKITELELSGNPLK-NVSAIA-GLQS 108

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L+LT   ++ +++  +AG +NL +L +  N ++      +  L +L  LS    + +
Sbjct: 109 IKTLDLTSTQIT-DVT-PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS 164

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSV 550
                 L NL++L +L    N +S    S ++S   L E++L +N    ++   + N S 
Sbjct: 165 DL--TPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQI-SDVSP-LANTSN 218

Query: 551 LNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNN 582
           L  + L+N  ++ +      NL +  +    +
Sbjct: 219 LFIVTLTNQTITNQPVFYNNNLVVPNVVKGPS 250

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 75.5 bits (186), Expect = 9e-15
 Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 20/214 (9%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            ++LS   +       +  L+++  L L +  I       ++   NLQ L L  N +T  
Sbjct: 89  ELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI 144

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
               LA L NL++L +     S D+        KL  +    N +   I   L ++  L 
Sbjct: 145 --SPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLI 198

Query: 193 MLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG 252
            ++L  N      + P L N +NL I+ LT   +  +       L     +       + 
Sbjct: 199 EVHLKNNQIS--DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI- 254

Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLT 286
             P+++++          + +LT +L +  +N++
Sbjct: 255 -APATISDN-----GTYASPNLTWNLTSFINNVS 282

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 18/92 (19%), Positives = 39/92 (42%), Gaps = 7/92 (7%)

Query: 495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYL 554
                LA    +    ++++     + +    +  L+         I E +  L+ L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTI-EGVQYLNNLIGL 68

Query: 555 DLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS 585
           +L +N+++  +   L+NL K+ +L +S N L 
Sbjct: 69  ELKDNQIT-DLA-PLKNLTKITELELSGNPLK 98

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 99.4 bits (248), Expect = 3e-22
 Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 54/247 (21%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
            ++   +YE++       VIG G+ G+V  V   S  +  A+K L               
Sbjct: 64  LRMKAEDYEVV------KVIGRGAFGEVQLVRHKSTRKVYAMKLL--------------S 103

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
           K ++  +     F  E + +       +V+L+          +V EYMP G L +L+   
Sbjct: 104 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-- 161

Query: 791 KGGLLDWPTR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
              + +   R Y      AE    L  +H       +HRDVK +N+LLD     ++ADFG
Sbjct: 162 NYDVPEKWARFY-----TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213

Query: 847 VAKVVDASGKPKSMSVIAGSCG---YIAPE--------YAYTLRVNEKSDIYSFGVVILE 895
               ++  G  +  +    + G   YI+PE          Y        D +S GV + E
Sbjct: 214 TCMKMNKEGMVRCDT----AVGTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYE 265

Query: 896 LVTGRLP 902
           ++ G  P
Sbjct: 266 MLVGDTP 272

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.1 bits (245), Expect = 3e-22
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 45/226 (19%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G GS GKV         + VA+K +               +  ++        + E+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFI--------------SRQLLKKSDMHMRVEREISY 62

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDA 807
           L  +RH +I+KL+   TT    ++V EY   G L D +   K  + +   R     I+ A
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICA 120

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
              + Y H      IVHRD+K  N+LLD +   ++ADFG++ ++      K+      SC
Sbjct: 121 ---IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT------SC 168

Query: 868 G---YIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           G   Y APE      YA       + D++S G+V+  ++ GRLP D
Sbjct: 169 GSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFD 209

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  100 bits (250), Expect = 3e-22
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 44/226 (19%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           +G G+ GKV        G  VAVK L               + +++        + E++ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKIL--------------NRQKIRSLDVVGKIRREIQN 69

Query: 750 LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI--IVDA 807
           L   RH +I+KL+   +T     +V EY+  G L D +    G L +  +R     I+  
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSG 128

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
            +   Y H   V   VHRD+K  N+LLD    A++ADFG++ ++      ++      SC
Sbjct: 129 VD---YCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SC 176

Query: 868 G---YIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
           G   Y APE      YA       + DI+S GV++  L+ G LP D
Sbjct: 177 GSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLPFD 217

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.9 bits (244), Expect = 4e-22
 Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 42/237 (17%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y  +        +GSG+ G V+  V     + V VK + +    E     D + G+V   
Sbjct: 26  YSTMS------PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT-- 77

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH--SCKGGLL 795
                   E+  L ++ H NI+K+      +    LV E   +G   DL         L 
Sbjct: 78  -------LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLD 128

Query: 796 DWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
           +    Y    +V A     YL       I+HRD+K  NI++  DF  ++ DFG A  ++ 
Sbjct: 129 EPLASYIFRQLVSAVG---YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182

Query: 854 SGKPKSMSVIAGSCGYIAPE------YAYTLRVNEKSDIYSFGVVILELVTGRLPVD 904
                      G+  Y APE      Y        + +++S GV +  LV    P  
Sbjct: 183 GKL---FYTFCGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFC 231

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.1 bits (245), Expect = 5e-22
 Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 55/235 (23%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG G    V + +    G+  AVK +            DV K      +  +  + E  
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIV------------DVAKFTSSPGLSTEDLKREAS 78

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLD-------WPTR 800
               ++H +IV+L    ++     +V+E+              G  L             
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEF------------MDGADLCFEIVKRADAGFV 126

Query: 801 Y------KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKVV 851
           Y        +    E L Y H +   +I+HRDVK + +LL   +     ++  FGVA  +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

Query: 852 DASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             SG         G+  ++APE      Y     +  D++  GV++  L++G LP
Sbjct: 184 GESG--LVAGGRVGTPHFMAPEVVKREPY----GKPVDVWGCGVILFILLSGCLP 232

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 98.6 bits (246), Expect = 6e-22
 Identities = 70/295 (23%), Positives = 109/295 (36%), Gaps = 54/295 (18%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
            +L   ++EIL       VIG G+  +V  V +   G+  A+K +               
Sbjct: 56  VRLQRDDFEIL------KVIGRGAFSEVAVVKMKQTGQVYAMKIM--------------N 95

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
           K  +  + +   F+ E + L     + I +L       +   LV EY   G L  LL   
Sbjct: 96  KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF 155

Query: 791 KGGLLDWPTR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
              +     R Y      AE    +  +H       VHRD+K +NILLD     R+ADFG
Sbjct: 156 GERIPAEMARFY-----LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207

Query: 847 VAKVVDASGKPKSMSVIAGSCG---YIAPEYAYTLRVNEKSDIY-------SFGVVILEL 896
               + A G  +S+       G   Y++PE    +     +  Y       + GV   E+
Sbjct: 208 SCLKLRADGTVRSLVA----VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

Query: 897 VTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLC 951
             G+ P    F      +     +  K  +H+  P +D    EE  +     LLC
Sbjct: 264 FYGQTP----FYADSTAETYGKIVHYK--EHLSLPLVDEGVPEE-ARDFIQRLLC 311

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.4 bits (243), Expect = 8e-22
 Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 65/236 (27%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +G G+   V + V  + G   A K +    + +  S  D +K            + E  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQK-----------LEREAR 80

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRYKII--- 804
              K++H NIV+L           LV++               GG L +      I+   
Sbjct: 81  ICRKLQHPNIVRLHDSIQEESFHYLVFDL------------VTGGELFE-----DIVARE 123

Query: 805 ----VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAKV 850
                DA+       E ++Y H +    IVHR++K  N+LL         ++ADFG+A  
Sbjct: 124 FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 851 VDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           V+ S   ++    AG+ GY++PE      Y    ++  DI++ GV++  L+ G  P
Sbjct: 181 VNDS---EAWHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 229

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 55/238 (23%), Positives = 89/238 (37%), Gaps = 62/238 (26%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE+ +       +GSG    V K      G+  A K + +        G   E+      
Sbjct: 7   YEMGE------ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE------ 54

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLD 796
                 + EV  L +IRH NI+ L      +   +L+ E               GG L D
Sbjct: 55  -----IEREVNILREIRHPNIITLHDIFENKTDVVLILEL------------VSGGELFD 97

Query: 797 WPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL----DGDF 838
                 +         +A        +G+ YLH      I H D+K  NI+L      + 
Sbjct: 98  -----FLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP 149

Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV--IL 894
             ++ DFG+A  ++A         I G+  ++APE      +  ++D++S GV+  IL
Sbjct: 150 RIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 204

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 61/247 (24%), Positives = 98/247 (39%), Gaps = 47/247 (19%)

Query: 665 KWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKEC 723
           KW   S +     +++ +        +G+GS G+V  V    +G   A+K L        
Sbjct: 29  KWETPSQNTAQLDQFDRIK------TLGTGSFGRVMLVKHKESGNHYAMKIL-------- 74

Query: 724 ESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
                 +K +V    Q +    E   L  +    +VKL           +V EY+  G +
Sbjct: 75  ------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128

Query: 784 GDLLHSCKGGLLDWPTR--YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
               H  + G    P    Y     AA+      YLH      +++RD+K  N+L+D   
Sbjct: 129 --FSHLRRIGRFSEPHARFY-----AAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQG 178

Query: 839 GARVADFGVAKVVDASGKPKSMSVIAGSCG---YIAPEYAYTLRVNEKSDIYSFGVVILE 895
             +V DFG AK V   G+  ++      CG    +APE   +   N+  D ++ GV+I E
Sbjct: 179 YIQVTDFGFAKRVK--GRTWTL------CGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 896 LVTGRLP 902
           +  G  P
Sbjct: 231 MAAGYPP 237

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 57/251 (22%), Positives = 99/251 (39%), Gaps = 73/251 (29%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
           +  Y++     +D  +G GS     K V   + +A AVK +    SK  E+  + +K   
Sbjct: 7   YQHYDLDL---KDKPLGEGSFSICRKCVHKKSNQAFAVKII----SKRMEA--NTQK--- 54

Query: 735 QDQVQDDGFQAEVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
                      E+  L     H NIVKL      +    LV E               GG
Sbjct: 55  -----------EITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL------------LNGG 91

Query: 794 -LLDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---D 835
            L +     +I         +A+         +S++H      +VHRD+K  N+L    +
Sbjct: 92  ELFE-----RIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDEN 143

Query: 836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGV 891
            +   ++ DFG A++     +P  +     +  Y APE      Y    +E  D++S GV
Sbjct: 144 DNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGY----DESCDLWSLGV 197

Query: 892 VILELVTGRLP 902
           ++  +++G++P
Sbjct: 198 ILYTMLSGQVP 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.5 bits (238), Expect = 3e-21
 Identities = 56/246 (22%), Positives = 94/246 (38%), Gaps = 60/246 (24%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y+I +       +GSG    V K    S G   A K + +  S+    G   E+    
Sbjct: 12  DFYDIGE------ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE---- 61

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
                   + EV  L ++ H NI+ L      R   +L+ E               GG L
Sbjct: 62  -------IEREVSILRQVLHPNIITLHDVYENRTDVVLILEL------------VSGGEL 102

Query: 795 LDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGD 837
            D      +         +A        +G++YLH      I H D+K  NI+L   +  
Sbjct: 103 FD-----FLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP 154

Query: 838 FGA-RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
               ++ DFG+A  ++   +      I G+  ++APE      +  ++D++S GV+   L
Sbjct: 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211

Query: 897 VTGRLP 902
           ++G  P
Sbjct: 212 LSGASP 217

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 94.6 bits (236), Expect = 4e-21
 Identities = 55/246 (22%), Positives = 94/246 (38%), Gaps = 60/246 (24%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y+I +       +GSG    V K    S G   A K + +  S+    G   E+    
Sbjct: 12  DFYDIGE------ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE---- 61

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
                   + EV  L ++ H N++ L      R   +L+ E               GG L
Sbjct: 62  -------IEREVSILRQVLHHNVITLHDVYENRTDVVLILEL------------VSGGEL 102

Query: 795 LDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGD 837
            D      +         +A        +G++YLH      I H D+K  NI+L   +  
Sbjct: 103 FD-----FLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP 154

Query: 838 FGA-RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
               ++ DFG+A  ++   +      I G+  ++APE      +  ++D++S GV+   L
Sbjct: 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211

Query: 897 VTGRLP 902
           ++G  P
Sbjct: 212 LSGASP 217

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 6e-21
 Identities = 65/249 (26%), Positives = 103/249 (41%), Gaps = 47/249 (18%)

Query: 665 KWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKEC 723
           +W  +    +  + +          V+G G  G+V    V + G+  A KKL        
Sbjct: 172 QWKWLERQPVTKNTFRQY------RVLGKGGFGEVCACQVRATGKMYACKKL-------- 217

Query: 724 ESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
                 EK +++ +  +     E + L K+  + +V L     T+D   LV   M NG  
Sbjct: 218 ------EKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM-NG-- 268

Query: 784 GDL---LHSCKGGLLDWPTRYKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGD 837
           GDL   ++             + +  AAE   GL  LH +    IV+RD+K  NILLD  
Sbjct: 269 GDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322

Query: 838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGVVI 893
              R++D G+A  V      K      G+ GY+APE      YT       D ++ G ++
Sbjct: 323 GHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSP----DWWALGCLL 375

Query: 894 LELVTGRLP 902
            E++ G+ P
Sbjct: 376 YEMIAGQSP 384

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 94.2 bits (235), Expect = 6e-21
 Identities = 55/246 (22%), Positives = 89/246 (36%), Gaps = 60/246 (24%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y+  +       +GSG    V K    S G   A K + +  +K    G   E     
Sbjct: 11  DYYDTGE------ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED---- 60

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
                   + EV  L +I+H N++ L      +   +L+ E               GG L
Sbjct: 61  -------IEREVSILKEIQHPNVITLHEVYENKTDVILILEL------------VAGGEL 101

Query: 795 LDWPTRYKII-------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL----DG 836
            D      +         +A         G+ YLH      I H D+K  NI+L      
Sbjct: 102 FD-----FLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVP 153

Query: 837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
               ++ DFG+A  +D          I G+  ++APE      +  ++D++S GV+   L
Sbjct: 154 KPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210

Query: 897 VTGRLP 902
           ++G  P
Sbjct: 211 LSGASP 216

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.4 bits (240), Expect = 1e-20
 Identities = 64/254 (25%), Positives = 104/254 (40%), Gaps = 54/254 (21%)

Query: 665 KWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKEC 723
           +W  +    +G   +          V+G G  G+V+   + + G+  A KKL        
Sbjct: 173 QWKWLEAQPMGEDWFLDF------RVLGRGGFGEVFACQMKATGKLYACKKL-------- 218

Query: 724 ESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
                  K +++ +    G   E + L K+  + IV L     T+    LV   M NG  
Sbjct: 219 ------NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM-NG-- 269

Query: 784 GDL------LHSCKGGLLDWPTR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNIL 833
           GD+      +     G  +     Y      A+   GL +LH     +I++RD+K  N+L
Sbjct: 270 GDIRYHIYNVDEDNPGFQEPRAIFY-----TAQIVSGLEHLHQR---NIIYRDLKPENVL 321

Query: 834 LDGDFGARVADFGVAK-VVDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYS 888
           LD D   R++D G+A  +     K K     AG+ G++APE      Y   V    D ++
Sbjct: 322 LDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMAPELLLGEEYDFSV----DYFA 374

Query: 889 FGVVILELVTGRLP 902
            GV + E++  R P
Sbjct: 375 LGVTLYEMIAARGP 388

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 93.9 bits (234), Expect = 1e-20
 Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 63/243 (25%)

Query: 690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            +G G++  VY+       +  A+K L              +K   +  V+      E+ 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL--------------KKTVDKKIVRT-----EIG 100

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-LLDWPTRYKIIV-- 805
            L ++ H NI+KL     T     LV E               GG L D       IV  
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLEL------------VTGGELFDR------IVEK 142

Query: 806 ------DAA-------EGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFGVAK 849
                 DAA       E ++YLH +    IVHRD+K  N+L      D   ++ADFG++K
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199

Query: 850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE 909
           +V+       M  + G+ GY APE         + D++S G++   L+ G  P   E G+
Sbjct: 200 IVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256

Query: 910 KDL 912
           + +
Sbjct: 257 QFM 259

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 54/248 (21%), Positives = 105/248 (42%), Gaps = 69/248 (27%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S Y +     +  ++G G  G+V+K    + G  +A K               ++   ++
Sbjct: 87  SFYTV----SKTEILGGGRFGQVHKCEETATGLKLAAKI--------------IKTRGMK 128

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
           D+   +  + E+  + ++ H N+++L+    +++  +LV EY              GG L
Sbjct: 129 DK---EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY------------VDGGEL 173

Query: 795 LDWPTRYKII--------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
            D     +II        +D         EG+ ++H      I+H D+K  NIL      
Sbjct: 174 FD-----RIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDA 225

Query: 840 ARV--ADFGVAKVVDASGKPKSMSVIAGSCGYIAPE---YAYTLRVNEKSDIYSFGVVIL 894
            ++   DFG+A+        + + V  G+  ++APE   Y +   V+  +D++S GV+  
Sbjct: 226 KQIKIIDFGLARRYKPR---EKLKVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAY 279

Query: 895 ELVTGRLP 902
            L++G  P
Sbjct: 280 MLLSGLSP 287

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 65/243 (26%), Positives = 99/243 (40%), Gaps = 55/243 (22%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEK 731
           K    +++IL        +G+GS G+V+ +    NG   A+K L              +K
Sbjct: 2   KYSLQDFQILR------TLGTGSFGRVHLIRSRHNGRYYAMKVL--------------KK 41

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
             V    Q +    E   L  + H  I+++W          ++ +Y+  G L       K
Sbjct: 42  EIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRK 99

Query: 792 GGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
                 P  + Y     AAE    L YLH      I++RD+K  NILLD +   ++ DFG
Sbjct: 100 SQRFPNPVAKFY-----AAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 151

Query: 847 VAKVVDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVILELVTG 899
            AK V       ++      CG   YIAPE      Y   +    D +SFG++I E++ G
Sbjct: 152 FAKYVP--DVTYTL------CGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAG 199

Query: 900 RLP 902
             P
Sbjct: 200 YTP 202

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.1 bits (239), Expect = 2e-20
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 48/228 (21%)

Query: 690 VIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           +IG G  G+VY       G+  A+K L              +K +++ +  +     E  
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL--------------DKKRIKMKQGETLALNERI 241

Query: 749 TLGKIRHKN---IVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSCKGGLLDWPTR--YK 802
            L  +   +   IV +     T D    + + M NG  GDL  H  + G+        Y 
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM-NG--GDLHYHLSQHGVFSEADMRFY- 297

Query: 803 IIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS 859
               AAE   GL ++H+     +V+RD+K  NILLD     R++D G+A       KP +
Sbjct: 298 ----AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHA 349

Query: 860 MSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                G+ GY+APE      AY        D +S G ++ +L+ G  P
Sbjct: 350 S---VGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 44/245 (17%), Positives = 90/245 (36%), Gaps = 66/245 (26%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +Y I +       +G G  G V++ V  S+ +    K     +  +      V+K    
Sbjct: 5   EKYMIAE------DLGRGEFGIVHRCVETSSKKTYMAKF----VKVKGTDQVLVKK---- 50

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
                     E+  L   RH+NI+ L     + +  ++++E+              G  +
Sbjct: 51  ----------EISILNIARHRNILHLHESFESMEELVMIFEF------------ISGLDI 88

Query: 795 LDWPTRYKII--------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
            +     +I          +         E L +LH     +I H D++  NI+      
Sbjct: 89  FE-----RINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRS 140

Query: 840 ARV--ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
           + +   +FG A+ +       +  ++  +  Y APE      V+  +D++S G ++  L+
Sbjct: 141 STIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197

Query: 898 TGRLP 902
           +G  P
Sbjct: 198 SGINP 202

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 56/243 (23%), Positives = 104/243 (42%), Gaps = 48/243 (19%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
            S+Y++        ++GSG  G VY  + +S+   VA+K               VEK ++
Sbjct: 42  ESQYQVGP------LLGSGGFGSVYSGIRVSDNLPVAIKH--------------VEKDRI 81

Query: 735 QDQVQDDGFQA---EVETLGKIRHK--NIVKLWCCCTTRDCKLLVYEY-MPNGSLGDLLH 788
            D  +         EV  L K+      +++L       D  +L+ E   P   L D + 
Sbjct: 82  SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT 141

Query: 789 SCKGGLLDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADF 845
             +G L +   R     +++A     + H+     ++HRD+K  NIL+D + G  ++ DF
Sbjct: 142 E-RGALQEELARSFFWQVLEAVR---HCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEY----AYTLRVNEKSDIYSFGVVILELVTGRL 901
           G   ++    K    +   G+  Y  PE+     Y  R    + ++S G+++ ++V G +
Sbjct: 195 GSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDI 247

Query: 902 PVD 904
           P +
Sbjct: 248 PFE 250

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.9 bits (228), Expect = 3e-20
 Identities = 63/281 (22%), Positives = 98/281 (34%), Gaps = 23/281 (8%)

Query: 62  VECDPRSHSVASIDLSNANIAGPFPSL-LCRLENLTFLTLFNNSINSTLPDDISACQN-- 118
           VE      S+  +       A       + +  +L  LT+    I S +           
Sbjct: 36  VELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGIS 95

Query: 119 -LQHLDLSQNLLTGTLTPALADL--PNLKFLDLTGNNFSGDIPESFGRFQK----LEVIS 171
            LQ L L    +TGT  P L +   P+L  L+L   +++          Q     L+V+S
Sbjct: 96  GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 172 LVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGR------IPPELGNLTNLEILWLTECN 225
           +            +     L  L+LS NP L  R       P +   L  L +       
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 226 LVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSL-TELASVVQIELYNNSLTGDLPTGWSN 284
             G          +L  LDL+ N+L  A  +      + +  + L    L   +P G   
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP- 273

Query: 285 LTSLRLLDASMNDLTG-PIPDDLTRLPLESLNLYENRLEGS 324
              L +LD S N L   P PD+L +  + +L+L  N    S
Sbjct: 274 -AKLSVLDLSYNRLDRNPSPDELPQ--VGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 53/266 (19%), Positives = 87/266 (32%), Gaps = 21/266 (7%)

Query: 338 LRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGE---LEELLMIYNSFT 394
           L+      +     D+ K+  L+ + +   +    I            L+EL +     T
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 395 GQLPDGLGHCQ--SLTRVRLGYNRLTGKVPPLL----WGLPHVYLLELTDNFLSGEISKN 448
           G  P  L       L  + L       +   L     W  P + +L +          + 
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 449 IAGAANLSLLIISKNNLSGSLPEEI----GFLKSLVVLSGSENKFT---GSLPESLTNLA 501
           +     LS L +S N   G              +L VL+          G          
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 502 ELGSLDLHANDLSGELPSSVSSW-KKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR 560
           +L  LDL  N L     +    W  +LN LNL+       +P+ +   + L+ LDLS NR
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNR 285

Query: 561 LSGRIPVGLQNLKLNQLNVSNNRLSG 586
           L  R P   +  ++  L++  N    
Sbjct: 286 LD-RNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 60/291 (20%), Positives = 94/291 (32%), Gaps = 23/291 (7%)

Query: 171 SLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEI 230
           S  +N L        G   +L+ L    +         ++    +L+ L +    +   I
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 231 PDSLGRL---AKLVDLDLALNNLVGAIPSSLTELA--SVVQIELYNNSLTGDLP----TG 281
                R+   + L +L L    + G  P  L E     +  + L N S            
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144

Query: 282 WSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPG----LY 336
                 L++L  +         + +   P L +L+L +N   G      A  P     L 
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 337 ELRLFRNRLN---GTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGE-LEELLMIYNS 392
            L L    +    G           L+ +DLS+N       A  C+    L  L + +  
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 393 FTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
              Q+P GL     L+ + L YNRL     P    LP V  L L  N    
Sbjct: 265 LK-QVPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 82.3 bits (203), Expect = 5e-17
 Identities = 49/232 (21%), Positives = 80/232 (34%), Gaps = 19/232 (8%)

Query: 382 ELEELLMIYNSFTGQLPD-GLGHCQSLTRVRLGYNRLTGKVPPL---LWGLPHVYLLELT 437
            LE LL   ++         +    SL R+ +   R+  ++      + G+  +  L L 
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103

Query: 438 DNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEI------GFLKSLVVLSGSENKFTG 491
           +  ++G     +  A    L I++  N+S +  +             L VLS ++     
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163

Query: 492 SLPESLTNLAELGSLDLHANDLSGELPSSVS----SWKKLNELNLADNLF---YGNIPED 544
              E +     L +LDL  N   GE     +     +  L  L L +       G     
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223

Query: 545 IGNLSVLNYLDLSNNRLSGRIPVGLQNL--KLNQLNVSNNRLSGELPSLFAK 594
                 L  LDLS+N L         +   +LN LN+S   L      L AK
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK 275

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.1 bits (187), Expect = 5e-15
 Identities = 59/302 (19%), Positives = 98/302 (32%), Gaps = 27/302 (8%)

Query: 212 NLTNLEILWLTECNLVGEIPDSL--GRLAKLVDLDLALNNLVGAIPSSLTELASVVQIEL 269
           N ++ +  W +  N +G     L  G  +    L            + + +  S+ ++ +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75

Query: 270 YNNSLTGDLPT------GWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEG 323
               +   +        G S L  L L +  +     P   + T   L  LNL       
Sbjct: 76  RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135

Query: 324 SLPATIAD-----SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIP--AS 376
              A +A+      PGL  L + +          +     L  +DLS+N   GE    ++
Sbjct: 136 -RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194

Query: 377 LCEKG--ELEELLMIYNSFT---GQLPDGLGHCQSLTRVRLGYNRLTGKVPPLL-WGLPH 430
           LC      L+ L +         G           L  + L +N L              
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L L+   L  ++ K +   A LS+L +S N L    P     L  +  LS   N F 
Sbjct: 255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFL 309

Query: 491 GS 492
            S
Sbjct: 310 DS 311

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 50/245 (20%), Positives = 92/245 (37%), Gaps = 65/245 (26%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y+IL+       +GSG+ G V++ V  + G     K               +      
Sbjct: 51  DYYDILE------ELGSGAFGVVHRCVEKATGRVFVAKF--------------INTPYPL 90

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
           D+      + E+  + ++ H  ++ L      +   +L+ E+              GG L
Sbjct: 91  DK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF------------LSGGEL 135

Query: 795 LDWPTRYKII--------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
            D     +I          +         EGL ++H     SIVH D+K  NI+ +    
Sbjct: 136 FD-----RIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKA 187

Query: 840 ARV--ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
           + V   DFG+A  ++     + + V   +  + APE      V   +D+++ GV+   L+
Sbjct: 188 SSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244

Query: 898 TGRLP 902
           +G  P
Sbjct: 245 SGLSP 249

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 52/246 (21%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
            +EY +        ++G G  G V+    L++   VA+K               + + +V
Sbjct: 30  EAEYRLGP------LLGKGGFGTVFAGHRLTDRLQVAIKV--------------IPRNRV 69

Query: 735 QDQVQDDGFQA---EVETLGKIR----HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL 787
                         EV  L K+     H  +++L     T++  +LV E        DL 
Sbjct: 70  LGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA--QDLF 127

Query: 788 HSC--KGGLLDWPTRYKI--IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RV 842
                KG L + P+R     +V A +   + H   V   VHRD+K  NIL+D   G  ++
Sbjct: 128 DYITEKGPLGEGPSRCFFGQVVAAIQ---HCHSRGV---VHRDIKDENILIDLRRGCAKL 181

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEY----AYTLRVNEKSDIYSFGVVILELVT 898
            DFG   ++      +  +   G+  Y  PE+     Y       + ++S G+++ ++V 
Sbjct: 182 IDFGSGALL----HDEPYTDFDGTRVYSPPEWISRHQYH---ALPATVWSLGILLYDMVC 234

Query: 899 GRLPVD 904
           G +P +
Sbjct: 235 GDIPFE 240

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 53/243 (21%), Positives = 84/243 (34%), Gaps = 60/243 (24%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
              YE+         IG GS     + +  +     AVK +     K             
Sbjct: 21  TDGYEV------KEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDP-------- 62

Query: 735 QDQVQDDGFQAEVETLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
                      E+E L +  +H NI+ L           +V E M  G L D +   +  
Sbjct: 63  ---------TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QK- 111

Query: 794 LLDWPTRY------KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL----DGDFGARVA 843
                  +       ++    + + YLH      +VHRD+K +NIL           R+ 
Sbjct: 112 ------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRIC 162

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFGVVILELVTG 899
           DFG AK + A      +     +  ++APE      Y        DI+S GV++  ++TG
Sbjct: 163 DFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAAC----DIWSLGVLLYTMLTG 216

Query: 900 RLP 902
             P
Sbjct: 217 YTP 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 54/240 (22%), Positives = 96/240 (40%), Gaps = 56/240 (23%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            Y++     +++V+G G+  +V   + L   +  AVK               +EK     
Sbjct: 13  VYQL-----QEDVLGEGAHARVQTCINLITSQEYAVKI--------------IEKQPGHI 53

Query: 737 QVQDDGFQAEVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
           +        EVE L + + H+N+++L       D   LV+E M  GS+   +H  +    
Sbjct: 54  R---SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RR--- 106

Query: 796 DWPTRY------KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARVADFG 846
                +       ++ D A  L +LH+     I HRD+K  NIL    +     ++ DF 
Sbjct: 107 ----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFD 159

Query: 847 VAKVVDASGKPK-----SMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVV--IL 894
           +   +  +G         +    GS  Y+APE            +++ D++S GV+  IL
Sbjct: 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.8 bits (226), Expect = 8e-20
 Identities = 46/243 (18%), Positives = 87/243 (35%), Gaps = 69/243 (28%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLW-RGMSKECESGCDVEKGQV 734
           + Y +         +G G    V + +  S G+  A K L  R   ++C +  ++     
Sbjct: 28  NFYIL-----TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA--EILH--- 77

Query: 735 QDQVQDDGFQAEVETLGKIRH-KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
                      E+  L   +    ++ L          +L+ EY              GG
Sbjct: 78  -----------EIAVLELAKSCPRVINLHEVYENTSEIILILEY------------AAGG 114

Query: 794 -LLDWPTRYKII---------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILL-- 834
            +         +          D         EG+ YLH +   +IVH D+K  NILL  
Sbjct: 115 EIFS-----LCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSS 166

Query: 835 -DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV- 892
                  ++ DFG+++ +  +     +  I G+  Y+APE      +   +D+++ G++ 
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

Query: 893 -IL 894
            +L
Sbjct: 224 YML 226

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 93.2 bits (231), Expect = 1e-19
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 17/240 (7%)

Query: 62  VECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQH 121
           +  D         +L   ++          L ++  +   N+ I S     I    N+  
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTK 69

Query: 122 LDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTI 181
           L L+ N LT  + P L +L NL +L L  N    D+  S    +KL+ +SL +N +  + 
Sbjct: 70  LFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI--SD 123

Query: 182 PAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLV 241
              L ++  L+ L L  N      I   L  LT L+ L L +  +  +I   L  L KL 
Sbjct: 124 INGLVHLPQLESLYLGNNKIT--DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 178

Query: 242 DLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGP 301
           +L L+ N++  +   +L  L ++  +EL++           SNL     +  +   L  P
Sbjct: 179 NLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 81.3 bits (200), Expect = 7e-16
 Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 24/230 (10%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            + L+   +    P  L  L+NL +L L  N I       +   + L+ L L  N ++  
Sbjct: 69  KLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-D 123

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
           +   L  LP L+ L L  N  + DI     R  KL+ +SL  N +   I   L  ++ L+
Sbjct: 124 ING-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 178

Query: 193 MLNLSYNPFLPGRIP--PELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL 250
            L LS N      I     L  L NL++L L     + +  +    L     +     +L
Sbjct: 179 NLYLSKN-----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

Query: 251 VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG 300
           V     S          +    ++   LP   + ++ +     ++     
Sbjct: 234 VTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.4 bits (182), Expect = 8e-14
 Identities = 47/296 (15%), Positives = 100/296 (33%), Gaps = 46/296 (15%)

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
               NL +  +      T  +   + ++    + +  ++ G +     +  + L+ N+ T
Sbjct: 23  TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 78

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
            +I                           L + ++L  + L  N++   +  L   L  
Sbjct: 79  -DIK-------------------------PLTNLKNLGWLFLDENKIK-DLSSL-KDLKK 110

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L L  N +S +I+  +     L  L +  N ++      +  L  L  LS  +N+ +
Sbjct: 111 LKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166

Query: 491 GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSV 550
             +   L  L +L +L L  N +S +L  +++  K L+ L L              NL V
Sbjct: 167 -DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 551 LNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPG 606
            N +  ++  L     +       +  +     +   LP    +  +        G
Sbjct: 223 PNTVKNTDGSLVTPEIIS------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.0 bits (231), Expect = 1e-19
 Identities = 53/245 (21%), Positives = 97/245 (39%), Gaps = 65/245 (26%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y+I +       +G+G+ G V++V   + G   A K               V      
Sbjct: 157 DHYDIHE------ELGTGAFGVVHRVTERATGNNFAAKF--------------VMTPHES 196

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG-L 794
           D+   +  + E++T+  +RH  +V L       +  +++YE+              GG L
Sbjct: 197 DK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF------------MSGGEL 241

Query: 795 LDWPTRYKII--------VDAA-------EGLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
            +     K+          +A        +GL ++H +   + VH D+K  NI+      
Sbjct: 242 FE-----KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRS 293

Query: 840 ARV--ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV 897
             +   DFG+   +D     +S+ V  G+  + APE A    V   +D++S GV+   L+
Sbjct: 294 NELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350

Query: 898 TGRLP 902
           +G  P
Sbjct: 351 SGLSP 355

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 51/264 (19%), Positives = 99/264 (37%), Gaps = 26/264 (9%)

Query: 89  LCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDL 148
                      L   S+   +    +   ++  +  + + +  ++   +  LPN+  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75

Query: 149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPP 208
            GN  + DI +     + L  + L  N +     + L ++  LK L+L +N      I  
Sbjct: 76  NGNKLT-DI-KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGI--SDING 129

Query: 209 ELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIE 268
            L +L  LE L+L    +       L RL KL  L L  N +     S +  LA + +++
Sbjct: 130 -LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI-----SDIVPLAGLTKLQ 181

Query: 269 ---LYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGS 324
              L  N ++ DL    + L +L +L+    +      +  + L    ++   +  L   
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 237

Query: 325 LPATIADSPGLYELRLFRNRLNGT 348
            P  I+D     +  +  +    T
Sbjct: 238 TPEIISDDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 47/225 (20%), Positives = 84/225 (37%), Gaps = 20/225 (8%)

Query: 98  LTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDI 157
                  I     D   A       +L +  +T  +T    +L ++  +    ++    +
Sbjct: 7   TITVPTPIKQIFSD--DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV 61

Query: 158 PESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLE 217
            +       +  + L  N L    P  L N+  L  L L  N      +   L +L  L+
Sbjct: 62  -QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--DLSS-LKDLKKLK 115

Query: 218 ILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGD 277
            L L E N + +I + L  L +L  L L  N +     + L+ L  +  + L +N ++ D
Sbjct: 116 SLSL-EHNGISDI-NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-D 170

Query: 278 LPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRL 321
           +    + LT L+ L  S N ++      L  L  L+ L L+    
Sbjct: 171 IV-PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQEC 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 22/252 (8%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
             +L   ++          L ++  +   N+ I S     I    N+  L L+ N LT  
Sbjct: 28  KDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-D 82

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
           + P LA+L NL +L L  N    D+  S    +KL+ +SL +N +  +    L ++  L+
Sbjct: 83  IKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLE 137

Query: 193 MLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG 252
            L L  N      I   L  LT L+ L L +  +  +I   L  L KL +L L+  N + 
Sbjct: 138 SLYLGNNKIT--DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLS-KNHIS 191

Query: 253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGP--IPDDLTRLP 310
            +  +L  L ++  +EL++           SNL     +  +   L  P  I DD     
Sbjct: 192 DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD--- 247

Query: 311 LESLNLYENRLE 322
            E  N+  +  E
Sbjct: 248 YEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 24/216 (11%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            + L+   +    P  L  L+NL +L L  N +       +   + L+ L L  N ++  
Sbjct: 72  KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS-D 126

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
           +   L  LP L+ L L  N  + DI     R  KL+ +SL  N +  +    L  ++ L+
Sbjct: 127 ING-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQ 181

Query: 193 MLNLSYNPFLPGRIP--PELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL 250
            L LS N      I     L  L NL++L L     + +  +    L     +     +L
Sbjct: 182 NLYLSKN-----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

Query: 251 VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLT 286
           V   P  +++            ++   LP   + ++
Sbjct: 237 VT--PEIISDDGD-----YEKPNVKWHLPEFTNEVS 265

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 44/265 (16%), Positives = 98/265 (36%), Gaps = 21/265 (7%)

Query: 335 LYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFT 394
             +  L +  +   +     + + +  +  +N+               + +L +  N   
Sbjct: 26  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQYLPN--VTKLFLNGN--- 78

Query: 395 GQLPD--GLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGA 452
            +L D   L + ++L  + L  N++   +  L   L  +  L L  N +S +I+  +   
Sbjct: 79  -KLTDIKPLANLKNLGWLFLDENKVK-DLSSLK-DLKKLKSLSLEHNGIS-DIN-GLVHL 133

Query: 453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAND 512
             L  L +  N ++      +  L  L  LS  +N+ +  +   L  L +L +L L  N 
Sbjct: 134 PQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNH 189

Query: 513 LSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPV-GLQN 571
           +S +L  +++  K L+ L L              NL V N +  ++  L     +    +
Sbjct: 190 IS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD 247

Query: 572 LKLNQLNVSNNRLSGELPSLFAKEM 596
            +   +       + E+  +F + +
Sbjct: 248 YEKPNVKWHLPEFTNEVSFIFYQPV 272

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 11/94 (11%)

Query: 495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIP--EDIGNLSVLN 552
            S    AE    +L    ++     + +    ++++   ++    +I   + I  L  + 
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNS----DIKSVQGIQYLPNVT 71

Query: 553 YLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS 585
            L L+ N+L+  I   L NL  L  L +  N++ 
Sbjct: 72  KLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK 103

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.8 bits (221), Expect = 3e-19
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 47/234 (20%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            +Y+ L        +G G+ G VYK   S G  VA+K++ R +  E              
Sbjct: 21  EKYQKL------EKVGEGTYGVVYKAKDSQGRIVALKRI-R-LDAE-------------- 58

Query: 737 QVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
              D+G  +    E+  L ++ H NIV L     +  C  LV+E+M    L  +L   K 
Sbjct: 59  ---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT 114

Query: 793 GLLDWPTRYKIIV-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
           GL    ++ KI +     G+++ H      I+HRD+K  N+L++ D   ++ADFG+A+  
Sbjct: 115 GLQ--DSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF 169

Query: 852 DASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR 900
               +  +  V+     Y AP+       Y+  V    DI+S G +  E++TG+
Sbjct: 170 GIPVRSYTHEVVT--LWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.5 bits (222), Expect = 3e-19
 Identities = 48/252 (19%), Positives = 90/252 (35%), Gaps = 19/252 (7%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
                 + +    PS L    N   L      +        S   +L+ +++SQN +   
Sbjct: 13  VFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 133 LTP-ALADLPNLKFLDLTGNNFSGDIPES-FGRFQKLEVISLVYNLLDGTIPAFLGNIST 190
           +     ++LP L  + +   N    I    F     L+ + +    +   +P      S 
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSL 128

Query: 191 -LKMLNLSYNPFLPGRIPPEL--GNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL 247
              +L++  N  +   I      G      ILWL +  +  EI +S     +L +L+L+ 
Sbjct: 129 QKVLLDIQDNINI-HTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186

Query: 248 NNLVGAIPS-SLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTG-PIPD 304
           NN +  +P+      +  V +++    +   LP+    NL  LR       +L   P  +
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPTLE 243

Query: 305 DLTRLPLESLNL 316
            L    L   +L
Sbjct: 244 KLVA--LMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 55/312 (17%), Positives = 96/312 (30%), Gaps = 62/312 (19%)

Query: 86  PSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLK 144
              +C   N        + + + +P D+    N   L      L   +   A +   +L+
Sbjct: 3   HHRICHCSNRV-FLCQESKV-TEIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLE 57

Query: 145 FLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPG 204
            ++++ N+    I                          F  N+  L  + +     L  
Sbjct: 58  KIEISQNDVLEVIEAD----------------------VF-SNLPKLHEIRIEKANNLL- 93

Query: 205 RIPPE-LGNLTNLEILWLTECNLVGEIPD-SLGRLAKLVDLDLALNNLVGAIPS-SLTEL 261
            I PE   NL NL+ L ++   +   +PD       + V LD+  N  +  I   S   L
Sbjct: 94  YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152

Query: 262 ASVVQ-IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR 320
           +     + L  N +  ++     N T L                       E      N 
Sbjct: 153 SFESVILWLNKNGIQ-EIHNSAFNGTQL----------------------DELNLSDNNN 189

Query: 321 LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK 380
           LE         + G   L + R R++      L     LR     N +   ++P +L + 
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKL 245

Query: 381 GELEELLMIYNS 392
             L E  + Y S
Sbjct: 246 VALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 41/257 (15%), Positives = 81/257 (31%), Gaps = 19/257 (7%)

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
                 E+++   +P+ +       ELR    +L     G       L  +++S N    
Sbjct: 12  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68

Query: 372 EIPASLCEKGELEELLMIYNSFTGQL----PDGLGHCQSLTRVRLGYNRLTGKVPPLL-W 426
            I A +     L +L  I       L    P+   +  +L  + +    +   +P +   
Sbjct: 69  VIEADVFSN--LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI 125

Query: 427 GLPHVYLLELTDNFLSGEISKN-IAG-AANLSLLIISKNNLSGSLPEEI-GFLKSLVVLS 483
                 LL++ DN     I +N   G +    +L ++KN +   +        +   +  
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184

Query: 484 GSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPE 543
              N       +     +    LD+    +   LPS     + L +L          +P 
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKLP- 240

Query: 544 DIGNLSVLNYLDLSNNR 560
            +  L  L    L+   
Sbjct: 241 TLEKLVALMEASLTYPS 257

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 66/245 (26%), Positives = 99/245 (40%), Gaps = 53/245 (21%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
           H++  +E+E L       ++G G+ GKV  V   + G   A+K L              +
Sbjct: 143 HRVTMNEFEYL------KLLGKGTFGKVILVKEKATGRYYAMKIL--------------K 182

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
           K  +  + +      E   L   RH  +  L     T D    V EY   G L    H  
Sbjct: 183 KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLS 240

Query: 791 KGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
           +  +      R Y      AE    L YLH +   ++V+RD+K  N++LD D   ++ DF
Sbjct: 241 RERVFSEDRARFY-----GAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDF 293

Query: 846 GVAKV-VDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVILELV 897
           G+ K  +      K+       CG   Y+APE      Y   V    D +  GVV+ E++
Sbjct: 294 GLCKEGIKDGATMKTF------CGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMM 343

Query: 898 TGRLP 902
            GRLP
Sbjct: 344 CGRLP 348

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 28/238 (11%), Positives = 56/238 (23%), Gaps = 63/238 (26%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYK---VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           Y +L         G     + ++     L     VA+  +                    
Sbjct: 33  YRLLI------FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGV--------------L 70

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
                    +    L +I    + ++     TR   L+V E++  GSL ++         
Sbjct: 71  PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPS 127

Query: 796 DWPTR-YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDAS 854
             P    + +   A      H      +       + + +  D    +A        +  
Sbjct: 128 --PVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPDANP- 181

Query: 855 GKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
                                       + DI   G  +  L+  R P+        L
Sbjct: 182 ----------------------------QDDIRGIGASLYALLVNRWPLPEAGVRSGL 211

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.4 bits (220), Expect = 5e-19
 Identities = 73/271 (26%), Positives = 110/271 (40%), Gaps = 74/271 (27%)

Query: 657 NGRAIDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVY----KVVLSNGEAVAV 712
           + + I  +        K   S++E+L       V+G GS GKV+           +  A+
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELL------KVLGQGSFGKVFLVKKISGSDARQLYAM 57

Query: 713 KKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET------LGKIRHKNIVKLWCCCT 766
           K L              +K  +      D     V T      L ++ H  IVKL     
Sbjct: 58  KVL--------------KKATL---KVRD----RVRTKMERDILVEVNHPFIVKLHYAFQ 96

Query: 767 TRDCKL-LVYEYMPNGSLGDL-LHSCKGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCV 819
           T   KL L+ +++  G  GDL     K  +      + Y      AE    L +LH    
Sbjct: 97  TEG-KLYLILDFL-RG--GDLFTRLSKEVMFTEEDVKFY-----LAELALALDHLHSL-- 145

Query: 820 PSIVHRDVKSNNILLDGDFGARVADFGVAKV-VDASGKPKSMSVIAGSCG---YIAPE-- 873
             I++RD+K  NILLD +   ++ DFG++K  +D   K  S       CG   Y+APE  
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF------CGTVEYMAPEVV 198

Query: 874 --YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               +T       D +SFGV++ E++TG LP
Sbjct: 199 NRRGHTQSA----DWWSFGVLMFEMLTGTLP 225

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.0 bits (211), Expect = 7e-19
 Identities = 28/207 (13%), Positives = 75/207 (36%), Gaps = 13/207 (6%)

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
           +     L  +      P                   +ST     +   +L ++ L+   +
Sbjct: 2   AAEQTGLKASQDNVNIP-----DSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV 56

Query: 130 TGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNIS 189
           T  LT  +    N+K L +   + + +          LE + ++   +       L  ++
Sbjct: 57  T-DLTG-IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLT 112

Query: 190 TLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNN 249
           +L +L++S++      I  ++  L  +  + L+    + +I   L  L +L  L++  + 
Sbjct: 113 SLTLLDISHSA-HDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170

Query: 250 LVGAIPSSLTELASVVQIELYNNSLTG 276
           +       + +   + Q+  ++ ++ G
Sbjct: 171 VHDY--RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 30/161 (18%), Positives = 69/161 (42%), Gaps = 8/161 (4%)

Query: 428 LPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN 487
           +  +  + L +  ++ +++  I  A N+  L I+  + +      I  L +L  L     
Sbjct: 43  MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGK 98

Query: 488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGN 547
             T     +L+ L  L  LD+  +     + + +++  K+N ++L+ N    +I   +  
Sbjct: 99  DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157

Query: 548 LSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGE 587
           L  L  L++  + +       +++  KLNQL   +  + G+
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 36/220 (16%), Positives = 77/220 (35%), Gaps = 38/220 (17%)

Query: 103 NSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFG 162
           +  N  +PD  S  +   +  L Q+  T  +T A   + +L ++ L   N + D+     
Sbjct: 11  SQDNVNIPD--STFKAYLNGLLGQSS-TANITEA--QMNSLTYITLANINVT-DL-TGIE 63

Query: 163 RFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLT 222
               ++ +++              + +                    +  L+NLE L + 
Sbjct: 64  YAHNIKDLTINNI-----------HATNYN----------------PISGLSNLERLRIM 96

Query: 223 ECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGW 282
             ++  +   +L  L  L  LD++ +    +I + +  L  V  I+L  N    D+    
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155

Query: 283 SNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRL 321
             L  L+ L+   + +       +   P L  L  +   +
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 32/184 (17%), Positives = 68/184 (36%), Gaps = 11/184 (5%)

Query: 382 ELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFL 441
             +  L      +           SLT + L    +T  +  +     ++  L + +   
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTGI-EYAHNIKDLTINNIHA 78

Query: 442 SGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLA 501
           +   +  I+G +NL  L I   +++      +  L SL +L  S +    S+   +  L 
Sbjct: 79  T-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136

Query: 502 ELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIP--EDIGNLSVLNYLDLSNN 559
           ++ S+DL  N    ++   + +  +L  LN+  +     +     I +   LN L   + 
Sbjct: 137 KVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD----GVHDYRGIEDFPKLNQLYAFSQ 191

Query: 560 RLSG 563
            + G
Sbjct: 192 TIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 32/160 (20%), Positives = 66/160 (41%), Gaps = 8/160 (5%)

Query: 429 PHVYLLELTDNFLSGEISKNI--AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSE 486
           P        +  L    + NI  A   +L+ + ++  N++  L   I +  ++  L+ + 
Sbjct: 18  PDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 487 NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIG 546
              T      ++ L+ L  L +   D++ +   ++S    L  L+++ +    +I   I 
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 547 NLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRLS 585
            L  +N +DLS N     I   L+ L  L  LN+  + + 
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 29/190 (15%), Positives = 67/190 (35%), Gaps = 37/190 (19%)

Query: 186 GNISTLKMLNLSYNPF--LPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDL 243
             +++L  + L+      L G     +    N++ L +   +      + +  L+ L  L
Sbjct: 41  AQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHA--TNYNPISGLSNLERL 93

Query: 244 DLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIP 303
            +   ++      +L+ L S+  +++ +++    + T  + L  +  +D S N     I 
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152

Query: 304 DDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWV 362
             L  LP L+SLN+  +         + D  G+ +                     L  +
Sbjct: 153 MPLKTLPELKSLNIQFDG--------VHDYRGIEDF------------------PKLNQL 186

Query: 363 DLSNNQFTGE 372
              +    G+
Sbjct: 187 YAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 26/158 (16%), Positives = 58/158 (36%), Gaps = 7/158 (4%)

Query: 359 LRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLT 418
           L ++ L+N   T            +++L +     T    + +    +L R+R+    +T
Sbjct: 46  LTYITLANINVTDLTGIEYAHN--IKDLTINNIHATN--YNPISGLSNLERLRIMGKDVT 101

Query: 419 GKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKS 478
               P L GL  + LL+++ +     I   I     ++ + +S N     +   +  L  
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPE 160

Query: 479 LVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGE 516
           L  L+   +         + +  +L  L   +  + G+
Sbjct: 161 LKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 25/185 (13%), Positives = 55/185 (29%), Gaps = 9/185 (4%)

Query: 283 SNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFR 342
           S   +        +         +  L    + L    +   L   I  +  + +L +  
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSL--TYITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 343 NRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLG 402
                  P  +   S L  + +     T +   +L     L  L + +++    +   + 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 403 HCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISK 462
               +  + L YN     + PL   LP +  L +  + +     + I     L+ L    
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLK-TLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFS 190

Query: 463 NNLSG 467
             + G
Sbjct: 191 QTIGG 195

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.0 bits (221), Expect = 8e-19
 Identities = 56/246 (22%), Positives = 90/246 (36%), Gaps = 76/246 (30%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
             +Y++        V+G G +GKV ++      E  A+K L            D  K   
Sbjct: 60  IDDYKVTS-----QVLGLGINGKVLQIFNKRTQEKFALKML-----------QDCPK--- 100

Query: 735 QDQVQDDGFQAEVETLGKI-RHKNIVKLWC----CCTTRDCKLLVYEYMPNGSLGDLLHS 789
                    + EVE   +  +  +IV++          R C L+V E             
Sbjct: 101 --------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC------------ 140

Query: 790 CKGG-LLD-----WPTRY------KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--- 834
             GG L           +      +I+    E + YLH     +I HRDVK  N+L    
Sbjct: 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSK 197

Query: 835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE----YAYTLRVNEKSDIYSFG 890
             +   ++ DFG AK   +     S++    +  Y+APE      Y    ++  D++S G
Sbjct: 198 RPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKY----DKSCDMWSLG 250

Query: 891 VV--IL 894
           V+  IL
Sbjct: 251 VIMYIL 256

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 51/240 (21%), Positives = 91/240 (37%), Gaps = 55/240 (22%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +Y++        V+G G +GKV +      G+  A+K L               +     
Sbjct: 29  DYQL-----SKQVLGLGVNGKVLECFHRRTGQKCALKLL----YDSP----KARQ----- 70

Query: 737 QVQDDGFQAEVETLGKI-RHKNIVKLW----CCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
                    EV+   +     +IV +          + C L++ E M  G L   +   +
Sbjct: 71  ---------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE-R 120

Query: 792 GGLLDWPTRY------KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGDFGARV 842
           G        +      +I+ D    + +LH     +I HRDVK  N+L    + D   ++
Sbjct: 121 G-----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            DFG AK         ++     +  Y+APE     + ++  D++S GV++  L+ G  P
Sbjct: 173 TDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.4 bits (215), Expect = 1e-18
 Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 48/236 (20%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +YE L        IG G+ G V+K       E VA+K++ R +  +              
Sbjct: 3   KYEKL------EKIGEGTYGTVFKAKNRETHEIVALKRV-R-LDDD-------------- 40

Query: 737 QVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
              D+G  +    E+  L +++HKNIV+L     +     LV+E+     L     SC G
Sbjct: 41  ---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG 96

Query: 793 GLLDWPTRYKIIV-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
            L   P   K  +    +GL + H      ++HRD+K  N+L++ +   ++A+FG+A+  
Sbjct: 97  DLD--PEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF 151

Query: 852 DASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGRLP 902
               +  S  V+     Y  P+       Y+  +    D++S G +  EL     P
Sbjct: 152 GIPVRCYSAEVVT--LWYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 47/233 (20%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +Y  L        IG G+ G VYK   + GE  A+KK+ R + KE               
Sbjct: 3   KYHGL------EKIGEGTYGVVYKAQNNYGETFALKKI-R-LEKE--------------- 39

Query: 738 VQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
             D+G  +    E+  L +++H NIVKL+    T+   +LV+E++    L  LL  C+GG
Sbjct: 40  --DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG 96

Query: 794 LLDWPTRYKIIV-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
           L       K  +     G++Y H      ++HRD+K  N+L++ +   ++ADFG+A+   
Sbjct: 97  LE--SVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG 151

Query: 853 ASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
              +  +  ++     Y AP+       Y+  +    DI+S G +  E+V G 
Sbjct: 152 IPVRKYTHEIVT--LWYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 33/208 (15%), Positives = 71/208 (34%), Gaps = 13/208 (6%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNN 152
           +   L L    + +      S   N+  + +S ++    L   +  +L  +  +++    
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 153 FSGDIP-ESFGRFQKLEVISLVYNLLDGTIPA--FLGNISTLKMLNLSYNPFLPGRIPPE 209
               I  ++      L+ + +    L    P    + +     +L ++ NP++   IP  
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYM-TSIPVN 149

Query: 210 -LGNLTN-LEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPS-SLTELASVVQ 266
               L N    L L   N    +        KL  + L  N  +  I   +   + S   
Sbjct: 150 AFQGLCNETLTLKLYN-NGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 267 I-ELYNNSLTGDLPTGW-SNLTSLRLLD 292
           + ++   S+T  LP+    +L  L   +
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 40/237 (16%), Positives = 83/237 (35%), Gaps = 22/237 (9%)

Query: 357 SPLRWVDLSNNQFTG--EIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGY 414
                  ++         +P S       + L +I             +  +++R+ +  
Sbjct: 11  HQEEDFRVTCKDIQRIPSLPPST------QTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64

Query: 415 NRLTGKVPP-LLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEE 472
           +    ++     + L  V  +E+ +      I  +       L  L I    L    P+ 
Sbjct: 65  DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL 123

Query: 473 IGF--LKSLVVLSGSENKFTGSLPE-SLTNL-AELGSLDLHANDLSGELPSSVSSWKKLN 528
                     +L  ++N +  S+P  +   L  E  +L L+ N  +  +     +  KL+
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182

Query: 529 ELNLADNLFYGNIPEDI--GNLSVLNYLDLSNNRLSGRIPVG-LQNLKLNQLNVSNN 582
            + L  N +   I +D   G  S  + LD+S   ++  +P   L++LK  +L   N 
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLK--ELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 39/233 (16%), Positives = 76/233 (32%), Gaps = 35/233 (15%)

Query: 213 LTNLEILWLTECNLVGEIP-DSLGRLAKLVDLDLALNNLVGAIPS-SLTELASVVQIELY 270
             + + L L E   +  IP  +   L  +  + ++++  +  + S S   L+ V  IE+ 
Sbjct: 30  PPSTQTLKLIE-THLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 271 NNSLTGDLPTGW-SNLTSLRLLDASMNDLTGPIPDD--LTRLP-LESLNLYENRLEGSLP 326
           N      +       L  L+ L      L    PD   +        L + +N    S+P
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 327 ATIAD--SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELE 384
                        L+L+ N    ++ G     + L  V L+ N++   I           
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK--------- 197

Query: 385 ELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-LLWGLPHVYLLEL 436
                 ++F G +  G       + + +    +T  +P   L  L  +     
Sbjct: 198 ------DAFGG-VYSG------PSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 20/142 (14%), Positives = 47/142 (33%), Gaps = 10/142 (7%)

Query: 454 NLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL 513
                 ++  ++   +P       S   L   E         + +NL  +  + +  +  
Sbjct: 12  QEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67

Query: 514 SGELPSSV-SSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIP--VGL 569
             +L S    +  K+  + + +      I  D    L +L +L + N  L    P    +
Sbjct: 68  LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126

Query: 570 QNLKLNQ-LNVSNNRLSGELPS 590
            +  +   L +++N     +P 
Sbjct: 127 YSTDIFFILEITDNPYMTSIPV 148

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 49/239 (20%), Positives = 89/239 (37%), Gaps = 52/239 (21%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             Y  +        +G G+ G+VYK +     E VA+K++ R +  E             
Sbjct: 34  DRYRRI------TKLGEGTYGEVYKAIDTVTNETVAIKRI-R-LEHE------------- 72

Query: 736 DQVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
               ++G       EV  L +++H+NI++L           L++EY  N  L   +    
Sbjct: 73  ----EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP 127

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR-----VADFG 846
              +        +     G+++ H       +HRD+K  N+LL     +      + DFG
Sbjct: 128 D--VSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182

Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR 900
           +A+      +  +  +I     Y  PE       Y+  V    DI+S   +  E++   
Sbjct: 183 LARAFGIPIRQFTHEIIT--LWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 86.5 bits (215), Expect = 3e-18
 Identities = 69/245 (28%), Positives = 100/245 (40%), Gaps = 56/245 (22%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEK 731
           K+  ++++ L       ++G G+ GKV  V   + G   A+K L     KE      + K
Sbjct: 1   KVTMNDFDYL------KLLGKGTFGKVILVREKATGRYYAMKIL----RKEVI----IAK 46

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL-HSC 790
            +V           E   L   RH  +  L     T D    V EY  NG  G+L  H  
Sbjct: 47  DEV------AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA-NG--GELFFHLS 97

Query: 791 KGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
           +  +      R Y      AE    L YLH      +V+RD+K  N++LD D   ++ DF
Sbjct: 98  RERVFTEERARFY-----GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149

Query: 846 GVAKV-VDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVILELV 897
           G+ K  +      K+       CG   Y+APE      Y   V    D +  GVV+ E++
Sbjct: 150 GLCKEGISDGATMKTF------CGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMM 199

Query: 898 TGRLP 902
            GRLP
Sbjct: 200 CGRLP 204

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 61/271 (22%), Positives = 93/271 (34%), Gaps = 66/271 (24%)

Query: 107 STLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNNFSGDIPESFGRFQ 165
             +PD++    + ++LDLS N L   L   +    P L+ LDL+       I +  G +Q
Sbjct: 20  YKIPDNLPF--STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIED--GAYQ 73

Query: 166 KLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP--FLPGRIPPELGNLTNLEILWLTE 223
            L                     S L  L L+ NP   L          L++L+ L   E
Sbjct: 74  SL---------------------SHLSTLILTGNPIQSLALGAF---SGLSSLQKLVAVE 109

Query: 224 CNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-- 281
            NL   + +                        +L EL       + +N +         
Sbjct: 110 TNLA-SLENF-----------------PIGHLKTLKEL------NVAHNLIQ-SFKLPEY 144

Query: 282 WSNLTSLRLLDASMNDLTGPIPDDLTRLP-----LESLNLYENRLEGSLPATIADSPGLY 336
           +SNLT+L  LD S N +      DL  L        SL+L  N +   +         L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK 203

Query: 337 ELRLFRNRLNGTLPGDLGKNSPLRWVDLSNN 367
           EL L  N+L     G   + + L+ + L  N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 9/209 (4%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNN 152
           +   L L  N +         +   LQ LDLS+  +  T+   A   L +L  L LTGN 
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87

Query: 153 FSGDIPESFGRFQKLEVISLVYNLLDGTIPAFL-GNISTLKMLNLSYNPFLPGRIPPELG 211
                  +F     L+ +  V   L  ++  F  G++ TLK LN+++N     ++P    
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 212 NLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL---NNLVGAIPSSLTELASVVQIE 268
           NLTNLE L L+   +       L  L ++  L+L+L    N +  I     +   + ++ 
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELA 206

Query: 269 LYNNSLTGDLPTG-WSNLTSLRLLDASMN 296
           L  N L   +P G +  LTSL+ +    N
Sbjct: 207 LDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 50/246 (20%), Positives = 77/246 (31%), Gaps = 42/246 (17%)

Query: 324 SLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK-GE 382
            +P  +        L L  N L             L+ +DLS  +    I     +    
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 383 LEELLMIYNSFTGQLPDGL-GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFL 441
           L  L++  N     L  G      SL ++      L          L +  +  L     
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA--------SLENFPIGHLK---- 124

Query: 442 SGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPE---- 495
                        L  L ++ N +  S      F  L +L  L  S NK   S+      
Sbjct: 125 ------------TLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170

Query: 496 SLTNLAELG-SLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDI-GNLSVLNY 553
            L  +  L  SLDL  N ++  +        +L EL L  N    ++P+ I   L+ L  
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQK 228

Query: 554 LDLSNN 559
           + L  N
Sbjct: 229 IWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 42/188 (22%), Positives = 64/188 (34%), Gaps = 33/188 (17%)

Query: 91  RLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDL 148
            L +L+ L L  N I  +L     S   +LQ L   +  L  +L    +  L  LK L++
Sbjct: 74  SLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNV 131

Query: 149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPP 208
             N            F  L                     + L+ L+LS N      I  
Sbjct: 132 AHNLIQ-SFKLP-EYFSNL---------------------TNLEHLDLSSNKI--QSIYC 166

Query: 209 E-LGNLTNLEILWLT---ECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASV 264
             L  L  + +L L+     N +  I     +  +L +L L  N L          L S+
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSL 226

Query: 265 VQIELYNN 272
            +I L+ N
Sbjct: 227 QKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 15/190 (7%)

Query: 406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNL 465
           S   + L +N L        +  P + +L+L+   +           ++LS LI++ N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 466 SGSLPEEIGF--LKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLHANDL-SGELPSSV 521
             SL     F  L SL  L   E     SL      +L  L  L++  N + S +LP   
Sbjct: 89  Q-SLALGA-FSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145

Query: 522 SSWKKLNELNLADNLFYGNIPEDI----GNLSVLNY-LDLSNNRLSGRIPVGL-QNLKLN 575
           S+   L  L+L+ N    +I          + +LN  LDLS N ++  I  G  + ++L 
Sbjct: 146 SNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK 203

Query: 576 QLNVSNNRLS 585
           +L +  N+L 
Sbjct: 204 ELALDTNQLK 213

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 21/199 (10%)

Query: 408 TRVRLGYNRLTGKVPPLLWGLP-HVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLS 466
              +        K+P     LP     L+L+ N L    S +      L +L +S+  + 
Sbjct: 10  ITYQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65

Query: 467 GSLPEEIGF--LKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLHANDLSGELPSSV-S 522
            ++ +   +  L  L  L  + N    SL     + L+ L  L     +L+  L +    
Sbjct: 66  -TIEDGA-YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121

Query: 523 SWKKLNELNLADN-LFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG----LQNLKL--N 575
             K L ELN+A N +    +PE   NL+ L +LDLS+N++   I       L  + L   
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180

Query: 576 QLNVSNNRLSGELPSLFAK 594
            L++S N ++   P  F +
Sbjct: 181 SLDLSLNPMNFIQPGAFKE 199

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 50.7 bits (122), Expect = 8e-07
 Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 6/116 (5%)

Query: 91  RLENLTFLTLFNNSINS-TLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKF---- 145
            L+ L  L + +N I S  LP+  S   NL+HLDLS N +       L  L  +      
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181

Query: 146 LDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPF 201
           LDL+ N  +  I     +  +L+ ++L  N L          +++L+ + L  NP+
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 48.4 bits (116), Expect = 5e-06
 Identities = 28/99 (28%), Positives = 34/99 (34%), Gaps = 5/99 (5%)

Query: 84  PFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQ----HLDLSQNLLTGTLTPALAD 139
             P     L NL  L L +N I S    D+     +      LDLS N +   + P    
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198

Query: 140 LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLD 178
              LK L L  N         F R   L+ I L  N  D
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.5 bits (98), Expect = 8e-04
 Identities = 19/81 (23%), Positives = 29/81 (35%), Gaps = 5/81 (6%)

Query: 75  DLSNANIAGPFPSLLCRLENLTF----LTLFNNSINSTLPDDISACQNLQHLDLSQNLLT 130
           DLS+  I   + + L  L  +      L L  N +N  +         L+ L L  N L 
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK 213

Query: 131 GTLTPALADLPNLKFLDLTGN 151
                    L +L+ + L  N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.8 bits (213), Expect = 6e-18
 Identities = 69/272 (25%), Positives = 111/272 (40%), Gaps = 64/272 (23%)

Query: 663 KSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKV----VLSNGEAVAVKKLWRG 718
           ++        K+G   +E+L       V+G+G+ GKV+ V        G+  A+K L   
Sbjct: 40  RTANLTGHAEKVGIENFELL------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVL--- 90

Query: 719 MSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN-IVKLWCCCTTRDCKL-LVYE 776
             K       V+K +  +  +      E + L  IR    +V L     T   KL L+ +
Sbjct: 91  -KKATI----VQKAKTTEHTR-----TERQVLEHIRQSPFLVTLHYAFQTET-KLHLILD 139

Query: 777 YMPNGSLGDL-LHSCKGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSN 830
           Y+ NG  G+L  H  +         + Y       E    L +LH      I++RD+K  
Sbjct: 140 YI-NG--GELFTHLSQRERFTEHEVQIY-----VGEIVLALEHLHKL---GIIYRDIKLE 188

Query: 831 NILLDGDFGARVADFGVAK--VVDASGKPKSMSVIAGSCG---YIAPE------YAYTLR 879
           NILLD +    + DFG++K  V D + +          CG   Y+AP+        +   
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDF------CGTIEYMAPDIVRGGDSGHDKA 242

Query: 880 VNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
           V    D +S GV++ EL+TG  P   +  +  
Sbjct: 243 V----DWWSLGVLMYELLTGASPFTVDGEKNS 270

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.6 bits (210), Expect = 9e-18
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 46/233 (19%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +YE L       ++G GS G V K      G  VA+KK     S +              
Sbjct: 26  KYENL------GLVGEGSYGMVMKCRNKDTGRIVAIKKF--LESDD-------------- 63

Query: 737 QVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
              D   +     E++ L ++RH+N+V L   C  +    LV+E++ + ++ D L     
Sbjct: 64  ---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN 119

Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
           GL     + K +     G+ + H     +I+HRD+K  NIL+      ++ DFG A+ + 
Sbjct: 120 GLDYQVVQ-KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

Query: 853 ASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
           A G+     V      Y APE       Y   V    D+++ G ++ E+  G 
Sbjct: 176 APGEVYDDEVAT--RWYRAPELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 46/233 (19%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +YE +        IG GS G V+K      G+ VA+KK     S++              
Sbjct: 4   KYEKIG------KIGEGSYGVVFKCRNRDTGQIVAIKKF--LESED-------------- 41

Query: 737 QVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
              D   +     E+  L +++H N+V L      +    LV+EY  + ++   L   + 
Sbjct: 42  ---DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR 97

Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
           G+ +   +  I     + +++ H     + +HRDVK  NIL+      ++ DFG A+++ 
Sbjct: 98  GVPEHLVK-SITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153

Query: 853 ASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
                    V      Y +PE       Y   V    D+++ G V  EL++G 
Sbjct: 154 GPSDYYDDEVAT--RWYRSPELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.2 bits (209), Expect = 2e-17
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 41/233 (17%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
             YE L      + +G G    VYK    +  + VA+KK+  G   E + G +       
Sbjct: 10  KRYEKL------DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN------- 56

Query: 736 DQVQDDGFQA--EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
                    A  E++ L ++ H NI+ L      +    LV+++M    L  ++      
Sbjct: 57  -------RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV 108

Query: 794 LLDWPTRYK-IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
           L   P+  K  ++   +GL YLH      I+HRD+K NN+LLD +   ++ADFG+AK   
Sbjct: 109 LT--PSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

Query: 853 ASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR 900
           +  +  +  V+     Y APE       Y + V    D+++ G ++ EL+   
Sbjct: 164 SPNRAYTHQVVT--RWYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 63/251 (25%), Positives = 105/251 (41%), Gaps = 62/251 (24%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKV----VLSNGEAVAVKKLWRGMSKECESGC 727
            K+    +E+L       V+G G  GKV++V      + G+  A+K L            
Sbjct: 12  EKIRPECFELL------RVLGKGGYGKVFQVRKVTGANTGKIFAMKVL------------ 53

Query: 728 DVEKGQ-VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGD 785
             +K   V++       +AE   L +++H  IV L     T   KL L+ EY+ +G  G+
Sbjct: 54  --KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG-KLYLILEYL-SG--GE 107

Query: 786 L-LHSCKGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFG 839
           L +   + G+        Y      AE    L +LH      I++RD+K  NI+L+    
Sbjct: 108 LFMQLEREGIFMEDTACFY-----LAEISMALGHLHQK---GIIYRDLKPENIMLNHQGH 159

Query: 840 ARVADFGVAKV-VDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGV 891
            ++ DFG+ K  +       +       CG   Y+APE      +   V    D +S G 
Sbjct: 160 VKLTDFGLCKESIHDGTVTHTF------CGTIEYMAPEILMRSGHNRAV----DWWSLGA 209

Query: 892 VILELVTGRLP 902
           ++ +++TG  P
Sbjct: 210 LMYDMLTGAPP 220

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 61/244 (25%), Positives = 102/244 (41%), Gaps = 58/244 (23%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKV--VLSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
            +YE +        IG G+ GKV+K   + + G  VA+K++ R +               
Sbjct: 11  QQYECV------AEIGEGAYGKVFKARDLKNGGRFVALKRV-R-VQTG------------ 50

Query: 735 QDQVQDDGFQA----EVETLGKIR---HKNIVKLWCCCTT----RDCKL-LVYEYMPNGS 782
                ++G       EV  L  +    H N+V+L+  CT     R+ KL LV+E++    
Sbjct: 51  -----EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-D 104

Query: 783 LGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
           L   L       +   T   ++     GL +LH      +VHRD+K  NIL+      ++
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 161

Query: 843 ADFGVAKVVDASGKPKSMS--VIAGSCGYIAPEY----AYTLRVNEKSDIYSFGVVILEL 896
           ADFG+A+         +++  V+     Y APE     +Y   V    D++S G +  E+
Sbjct: 162 ADFGLAR---IYSFQMALTSVVVT--LWYRAPEVLLQSSYATPV----DLWSVGCIFAEM 212

Query: 897 VTGR 900
              +
Sbjct: 213 FRRK 216

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 82.2 bits (204), Expect = 5e-17
 Identities = 53/237 (22%), Positives = 104/237 (43%), Gaps = 48/237 (20%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S+++ L        +G+G+   VYK +  + G  VA+K++ + +  E             
Sbjct: 5   SQFKQL------EKLGNGTYATVYKGLNKTTGVYVALKEV-K-LDSE------------- 43

Query: 736 DQVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPN---GSLGDLLH 788
                +G  +    E+  + +++H+NIV+L+    T +   LV+E+M N     +     
Sbjct: 44  -----EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTV 98

Query: 789 SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
                 L+            +GL++ H +    I+HRD+K  N+L++     ++ DFG+A
Sbjct: 99  GNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR 900
           +         S  V+     Y AP+       Y+  +    DI+S G ++ E++TG+
Sbjct: 156 RAFGIPVNTFSSEVVT--LWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 6e-17
 Identities = 64/246 (26%), Positives = 98/246 (39%), Gaps = 60/246 (24%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S YE +        IG G+ G VYK     +G  VA+K + R +                
Sbjct: 9   SRYEPV------AEIGVGAYGTVYKARDPHSGHFVALKSV-R-VPNG------------- 47

Query: 736 DQVQDDGFQA-------EVETLGKIR---HKNIVKLWCCCTT----RDCKL-LVYEYMPN 780
                 G          EV  L ++    H N+V+L   C T    R+ K+ LV+E++  
Sbjct: 48  ----GGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ 103

Query: 781 GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA 840
             L   L       L   T   ++     GL +LH +C   IVHRD+K  NIL+      
Sbjct: 104 -DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159

Query: 841 RVADFGVAKVVDASGKPKSMS--VIAGSCGYIAPEY----AYTLRVNEKSDIYSFGVVIL 894
           ++ADFG+A+         +++  V+     Y APE      Y   V    D++S G +  
Sbjct: 160 KLADFGLAR---IYSYQMALTPVVVT--LWYRAPEVLLQSTYATPV----DMWSVGCIFA 210

Query: 895 ELVTGR 900
           E+   +
Sbjct: 211 EMFRRK 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 65/235 (27%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA-EV 747
           VIG+GS G VY+  L  +GE VA+KK+                      +QD  F+  E+
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKV----------------------LQDKRFKNREL 98

Query: 748 ETLGKIRHKNIVKLWCCCTT-----RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDWPTRY 801
           + + K+ H NIV+L     +      +  L LV +Y+P     + ++     +    +R 
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYR----VARHYSRA 149

Query: 802 KIIVDAAE----------GLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKV 850
           K  +               L+Y+H      I HRD+K  N+LLD D    ++ DFG AK 
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206

Query: 851 VDASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
           +       ++S I  S  Y APE       YT  +    D++S G V+ EL+ G+
Sbjct: 207 LVRG--EPNVSYIC-SRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 49/234 (20%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKV-VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            Y  L      + +G G+   VYK         VA+K++ R +  E              
Sbjct: 3   TYIKL------DKLGEGTYATVYKGKSKLTDNLVALKEI-R-LEHE-------------- 40

Query: 737 QVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
               +G       EV  L  ++H NIV L     T     LV+EY+    L   L  C  
Sbjct: 41  ----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN 95

Query: 793 GLLDWPTRYKIIV-DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
            +       K+ +     GL+Y H      ++HRD+K  N+L++     ++ADFG+A+  
Sbjct: 96  IIN--MHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAK 150

Query: 852 DASGKPKSMSVIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVILELVTGR 900
               K     V+     Y  P+       Y+ ++    D++  G +  E+ TGR
Sbjct: 151 SIPTKTYDNEVVT--LWYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 48/229 (20%), Positives = 81/229 (35%), Gaps = 22/229 (9%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
             +L   ++          L  +      N++I S     +    NL+ L LS N ++  
Sbjct: 23  KQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQIS-D 77

Query: 133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
           L+P L DL  L+ L +  N    ++  +      L  + L  N L       L ++  L+
Sbjct: 78  LSP-LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNEL--RDTDSLIHLKNLE 131

Query: 193 MLNLSYNPFLPGRIP--PELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL 250
           +L++  N     ++     LG L+ LE+L L   N +      L RL K+  +DL     
Sbjct: 132 ILSIRNN-----KLKSIVMLGFLSKLEVLDLHG-NEITNT-GGLTRLKKVNWIDLTGQKC 184

Query: 251 VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLT 299
           V        EL   +   + +       P   SN  S            
Sbjct: 185 VNEPVKYQPEL--YITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 53/229 (23%), Positives = 77/229 (33%), Gaps = 22/229 (9%)

Query: 76  LSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP 135
                I   FP     L N     L   S+   +         +Q+ +   + +  +L  
Sbjct: 4   QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG 58

Query: 136 ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLN 195
            +    NLK L L+ N  S D+        KLE +S+  N L       + + + L  L 
Sbjct: 59  -MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRL--KNLNGIPS-ACLSRLF 112

Query: 196 LSYNPFLPGRIP--PELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGA 253
           L  N      +     L +L NLEIL +    L   I   LG L+KL  LDL  N +   
Sbjct: 113 LDNN-----ELRDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNT 165

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPI 302
               LT L  V  I+L       +       L     +         P 
Sbjct: 166 --GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 48/273 (17%), Positives = 79/273 (28%), Gaps = 89/273 (32%)

Query: 98  LTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDI 157
                  IN   PD      N    +L +  +T     +  +L  ++  +   +N    +
Sbjct: 2   SIQRPTPINQVFPD--PGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SL 56

Query: 158 PESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLE 217
                 F  L+ + L +N            IS L  L                 +LT LE
Sbjct: 57  -AGMQFFTNLKELHLSHN-----------QISDLSPLK----------------DLTKLE 88

Query: 218 ILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGD 277
            L +                 +L +L+  + +        L+ L       L NN L  D
Sbjct: 89  ELSVNRN--------------RLKNLN-GIPSA------CLSRL------FLDNNELR-D 120

Query: 278 LPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYE 337
                 +L +L +L    N L       +    L  L                    L  
Sbjct: 121 T-DSLIHLKNLEILSIRNNKLK-----SIV--MLGFL------------------SKLEV 154

Query: 338 LRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
           L L  N +  T  G L +   + W+DL+  +  
Sbjct: 155 LDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 35/226 (15%), Positives = 69/226 (30%), Gaps = 26/226 (11%)

Query: 364 LSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP 423
                     P          +  +   S T            +       + +   +  
Sbjct: 4   QRPTPINQVFPDPGLAN--AVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAG 58

Query: 424 LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLK--SLVV 481
           +     ++  L L+ N +S ++S  +     L  L +++N L       +  +    L  
Sbjct: 59  MQ-FFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-----NLNGIPSACLSR 110

Query: 482 LSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNI 541
           L    N+      +SL +L  L  L +  N L   +   +    KL  L+L  N     I
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGN----EI 162

Query: 542 P--EDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNRL 584
                +  L  +N++DL+  +           L   N +   + R 
Sbjct: 163 TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 33/141 (23%), Positives = 55/141 (39%), Gaps = 16/141 (11%)

Query: 448 NIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLD 507
              G AN     + K +++         L  +   +G  +    SL   +     L  L 
Sbjct: 14  PDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELH 69

Query: 508 LHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLN--YLDLSNNRLSGRI 565
           L  N +S +L S +    KL EL++  N     + +++  +       L L NN L    
Sbjct: 70  LSHNQIS-DL-SPLKDLTKLEELSVNRN----RL-KNLNGIPSACLSRLFLDNNELRD-- 120

Query: 566 PVGLQNLK-LNQLNVSNNRLS 585
              L +LK L  L++ NN+L 
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK 141

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 64/234 (27%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQA-EVE 748
           VIG+GS G V++  L   + VA+KK+                      +QD  F+  E++
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKV----------------------LQDKRFKNRELQ 84

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKL------LVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
            +  ++H N+V L     +   K       LV EY+P     + ++           + K
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR----ASRHYAKLK 135

Query: 803 IIVDAAE----------GLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVV 851
             +               L+Y+H      I HRD+K  N+LLD   G  ++ DFG AK++
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

Query: 852 DASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
             +G+P ++S I  S  Y APE       YT  +    DI+S G V+ EL+ G+
Sbjct: 193 I-AGEP-NVSYIC-SRYYRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 67/228 (29%), Positives = 98/228 (42%), Gaps = 49/228 (21%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           V+G GS GKV    +   G+  AVK L              +K  +      +    E  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVL--------------KKDVILQDDDVECTMTEKR 75

Query: 749 TLGKI-RHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDL-LHSCKGGLLDWPTRYKIIV 805
            L     H  + +L+CC  T D +L  V E++ NG  GDL  H  K    D   R +   
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPD-RLFFVMEFV-NG--GDLMFHIQKSRRFDEA-RARFY- 129

Query: 806 DAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV-VDASGKPKSMS 861
            AAE    L +LH      I++RD+K +N+LLD +   ++ADFG+ K  +       +  
Sbjct: 130 -AAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF- 184

Query: 862 VIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                CG   YIAPE      Y   V    D ++ GV++ E++ G  P
Sbjct: 185 -----CGTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.4 bits (199), Expect = 4e-16
 Identities = 68/230 (29%), Positives = 96/230 (41%), Gaps = 53/230 (23%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           VIG GS GKV      +     AVK L              +K  +  + ++    +E  
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVL--------------QKKAILKKKEEKHIMSERN 90

Query: 749 TLGK-IRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDL-LHSCKGGLLDWP-TR-YKI 803
            L K ++H  +V L     T D KL  V +Y+ NG  G+L  H  +      P  R Y  
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTAD-KLYFVLDYI-NG--GELFYHLQRERCFLEPRARFY-- 144

Query: 804 IVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVDASGKPKS 859
              AAE    L YLH     +IV+RD+K  NILLD      + DFG+ K  ++ +    +
Sbjct: 145 ---AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST 198

Query: 860 MSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                  CG   Y+APE      Y   V    D +  G V+ E++ G  P
Sbjct: 199 F------CGTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 50/189 (26%), Positives = 74/189 (39%), Gaps = 15/189 (7%)

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-PIPDDLTRLPLE 312
           +P   T L       L  N L           T L  L+    +LT   +   L    L 
Sbjct: 29  LPKDTTIL------HLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPV--LG 80

Query: 313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE 372
           +L+L  N+L+ SLP      P L  L +  NRL     G L     L+ + L  N+    
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-T 138

Query: 373 IPASLCEK-GELEELLMIYNSFTGQLPDGL-GHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
           +P  L     +LE+L +  N+ T +LP GL    ++L  + L  N L   +P   +G   
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196

Query: 431 VYLLELTDN 439
           +    L  N
Sbjct: 197 LPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 14/206 (6%)

Query: 94  NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF 153
           +   +     ++ + LP D+    +   L LS+NLL       L     L  L+L     
Sbjct: 11  SHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 154 SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPEL-GN 212
           +  +    G    L  + L +N L  ++P     +  L +L++S+N      +P      
Sbjct: 68  T-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL--TSLPLGALRG 122

Query: 213 LTNLEILWLTECNLVGEIPDSL-GRLAKLVDLDLALNNLVGAIPSSL-TELASVVQIELY 270
           L  L+ L+L + N +  +P  L     KL  L LA NNL   +P+ L   L ++  + L 
Sbjct: 123 LGELQELYL-KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMN 296
            NSL   +P G+     L       N
Sbjct: 181 ENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 53/181 (29%), Positives = 73/181 (40%), Gaps = 11/181 (6%)

Query: 406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNL 465
             T + L  N L       L     +  L L    L+ ++  +      L  L +S N L
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL 89

Query: 466 SGSLPEEIGFLKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLHANDLSGELPSSV-SS 523
             SLP     L +L VL  S N+ T SLP      L EL  L L  N+L   LP  + + 
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146

Query: 524 WKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVGL-QNLKLNQLNVSN 581
             KL +L+LA+N     +P  +   L  L+ L L  N L   IP G   +  L    +  
Sbjct: 147 TPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204

Query: 582 N 582
           N
Sbjct: 205 N 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 56/227 (24%), Positives = 75/227 (33%), Gaps = 42/227 (18%)

Query: 57  CSWRGVECDPRSH---------SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINS 107
            S   V CD R+              + LS   +     + L     LT L L    + +
Sbjct: 10  ASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-T 68

Query: 108 TLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKL 167
            L  D      L  LDLS N L  +L      LP L  LD++ N  +  +P   G  + L
Sbjct: 69  KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL--GALRGL 123

Query: 168 EVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPEL-GNLTNLEILWLTECNL 226
                                  L+ L L  N      +PP L      LE L L   N 
Sbjct: 124 ---------------------GELQELYLKGNELK--TLPPGLLTPTPKLEKLSL-ANNN 159

Query: 227 VGEIPDSL-GRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNN 272
           + E+P  L   L  L  L L  N+L   IP        +    L+ N
Sbjct: 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 48/192 (25%), Positives = 68/192 (35%), Gaps = 35/192 (18%)

Query: 406 SLTRVRLGYNRLTGKVPPLLWGLP-HVYLLELTDNFLSGEISKNIAGAANLSLLIISKNN 464
           S   V      LT  +PP    LP    +L L++N L       +     L+ L + +  
Sbjct: 11  SHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

Query: 465 LSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW 524
           L+  L  +   L  L  L  S N+   SLP     L  L  LD+  N L+          
Sbjct: 67  LT-KLQVDGT-LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT---------- 113

Query: 525 KKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGL-QNL-KLNQLNVSNN 582
                 +L      G        L  L  L L  N L   +P GL     KL +L+++NN
Sbjct: 114 ------SLPLGALRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANN 158

Query: 583 RLSGELPSLFAK 594
            L+     L   
Sbjct: 159 NLTELPAGLLNG 170

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 5/99 (5%)

Query: 496 SLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLD 555
            ++ +A    ++    +L+  LP  +        L+L++NL Y      +   + L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 556 LSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAK 594
           L    L+ ++ V      L  L++S+N+L   LP L   
Sbjct: 62  LDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQT 98

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 81.6 bits (201), Expect = 5e-16
 Identities = 71/252 (28%), Positives = 106/252 (42%), Gaps = 67/252 (26%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
            ++  +++  L       V+G GS GKV         E  AVK L              +
Sbjct: 336 DRMKLTDFNFL------MVLGKGSFGKVMLSERKGTDELYAVKIL--------------K 375

Query: 731 KGQVQDQVQDDGFQAEVE-TLG-------KIRHKNIVKLWCCCTTRDCKLLVYEYMPNGS 782
           K  V   +QDD    +VE T+          +   + +L  C  T D    V EY+ NG 
Sbjct: 376 KDVV---IQDD----DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV-NG- 426

Query: 783 LGDL-LHSCKGGLLDWPTRYKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDF 838
            GDL  H  + G    P        AAE   GL +L       I++RD+K +N++LD + 
Sbjct: 427 -GDLMYHIQQVGRFKEP-HAVFY--AAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 479

Query: 839 GARVADFGVAK-VVDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFG 890
             ++ADFG+ K  +      K+       CG   YIAPE      Y   V    D ++FG
Sbjct: 480 HIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAYQPYGKSV----DWWAFG 529

Query: 891 VVILELVTGRLP 902
           V++ E++ G+ P
Sbjct: 530 VLLYEMLAGQAP 541

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.2 bits (196), Expect = 8e-16
 Identities = 72/237 (30%), Positives = 102/237 (43%), Gaps = 67/237 (28%)

Query: 690 VIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
           ++G GS GKV+        +  A+K L              +K  V   + DD    +VE
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKAL--------------KKDVV---LMDD----DVE 62

Query: 749 -TLG-------KIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDL-LHSCKGGLLDWP 798
            T+           H  +  ++C   T++  L  V EY+ NG  GDL  H       D  
Sbjct: 63  CTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLFFVMEYL-NG--GDLMYHIQSCHKFDLS 118

Query: 799 TR--YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK-VVD 852
               Y     AAE   GL +LH      IV+RD+K +NILLD D   ++ADFG+ K  + 
Sbjct: 119 RATFY-----AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170

Query: 853 ASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVILELVTGRLP 902
              K  +       CG   YIAPE      Y   V    D +SFGV++ E++ G+ P
Sbjct: 171 GDAKTNTF------CGTPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.8 bits (195), Expect = 9e-16
 Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 58/246 (23%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S+YE L        IG G+ G+V+K      G+ VA+KK+   M  E             
Sbjct: 17  SKYEKL------AKIGQGTFGEVFKARHRKTGQKVALKKV-L-MENE------------- 55

Query: 736 DQVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTRDCKL--------LVYEYMPNGSL 783
                +GF      E++ L  ++H+N+V L   C T+            LV+++  +  L
Sbjct: 56  ----KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DL 110

Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             LL +            +++     GL Y+H +    I+HRD+K+ N+L+  D   ++A
Sbjct: 111 AGLLSNVLVKFTL-SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166

Query: 844 DFGVAKVVDASGKPKSMS----VIAGSCGYIAPEY-----AYTLRVNEKSDIYSFGVVIL 894
           DFG+A+    +   +       V+     Y  PE       Y   +    D++  G ++ 
Sbjct: 167 DFGLARAFSLAKNSQPNRYTNRVVT--LWYRPPELLLGERDYGPPI----DLWGAGCIMA 220

Query: 895 ELVTGR 900
           E+ T  
Sbjct: 221 EMWTRS 226

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 79.6 bits (197), Expect = 1e-15
 Identities = 90/480 (18%), Positives = 148/480 (30%), Gaps = 91/480 (18%)

Query: 189 STLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL----VGEIPDSLGRLAKLVDLD 244
             ++ L++        R    L  L   +++ L +C L      +I  +L     L +L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 245 LALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLT----G 300
           L  N L       +  +   +Q                +    ++ L      LT    G
Sbjct: 63  LRSNELG---DVGVHCVLQGLQ----------------TPSCKIQKLSLQNCCLTGAGCG 103

Query: 301 PIPDDLTRLP-LESLNLYENRLEGSLPATIAD-----SPGLYELRLFRNRLNGTLPGDLG 354
            +   L  LP L+ L+L +N L  +    + +        L +L+L    L+      L 
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163

Query: 355 K----NSPLRWVDLSNNQFTGEIPASLCE-----KGELEELLMIYNSFTGQ----LPDGL 401
                    + + +SNN         LC+       +LE L +     T      L   +
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223

Query: 402 GHCQSLTRVRLGYNRLTGK-----VPPLLWGLPHVYLLELTDNFLSGE----ISKNIAGA 452
               SL  + LG N+L         P LL     +  L + +  ++ +    + + +   
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283

Query: 453 ANLSLLIISKNNLSGS----LPEEIGF-LKSLVVLSGSENKFTG----SLPESLTNLAEL 503
            +L  L ++ N L       L E +      L  L      FT          L     L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343

Query: 504 GSLDLHANDLSGE--------LPSSVSSWKKLNELNLADNLF----YGNIPEDIGNLSVL 551
             L +  N L           L    S    L  L LAD         ++   +     L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGS---VLRVLWLADCDVSDSSCSSLAATLLANHSL 400

Query: 552 NYLDLSNNRLSGRIPVGLQNL---------KLNQLNVSNNRLSGELPSLFAKEMYRNSFL 602
             LDLSNN L      G+  L          L QL + +   S E+             L
Sbjct: 401 RELDLSNNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 457

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.5 bits (194), Expect = 3e-15
 Identities = 76/460 (16%), Positives = 139/460 (30%), Gaps = 66/460 (14%)

Query: 68  SHSVASIDLSNANIAGPFPSLLCR-LENLTFLTLFNNSINST----LPDDISACQNLQHL 122
           S  + S+D+    ++    + L   L+    + L +  +       +   +     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 123 DLSQNLLTGTLTPALADL-----PNLKFLDLTGNNFS----GDIPESFGRFQKLEVISLV 173
           +L  N L       +          ++ L L     +    G +  +      L+ + L 
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 174 YNLLDGT-----IPAFLGNISTLKMLNLSYNPFLP---GRIPPELGNLTNLEILWLTECN 225
            NLL            L     L+ L L Y          +   L    + + L ++  +
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 226 L----VGEIPDSLGR-LAKLVDLDLALNNL----VGAIPSSLTELASVVQIELYNNSLTG 276
           +    V  +   L     +L  L L    +       +   +   AS+ ++ L +N L  
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241

Query: 277 D-----LPTGWSNLTSLRLLDASMNDLTGP----IPDDLTRLP-LESLNLYENRLEGSLP 326
                  P      + LR L      +T      +   L     L+ L+L  N L     
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301

Query: 327 ATIADS-----PGLYELRLFRNRLNGT----LPGDLGKNSPLRWVDLSNNQFTGEIPASL 377
             + ++       L  L +                L +N  L  + +SNN+        L
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361

Query: 378 CEKGE-----LEELLMIYNSFTGQ----LPDGLGHCQSLTRVRLGYNRLTGK-VPPLLWG 427
           C+        L  L +     +      L   L    SL  + L  N L    +  L+  
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421

Query: 428 LPH----VYLLELTDNFLSGEISKNIAGA--ANLSLLIIS 461
           +      +  L L D + S E+   +        SL +IS
Sbjct: 422 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 77.7 bits (192), Expect = 3e-15
 Identities = 71/247 (28%), Positives = 104/247 (42%), Gaps = 59/247 (23%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEK 731
            LG  ++++L       VIG GS  KV  V L       A+K +              +K
Sbjct: 5   PLGLQDFDLL------RVIGRGSYAKVLLVRLKKTDRIYAMKVV--------------KK 44

Query: 732 GQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLL-H 788
             V D    D  Q E     +   H  +V L  C  T   +L  V EY+ NG  GDL+ H
Sbjct: 45  ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLFFVIEYV-NG--GDLMFH 100

Query: 789 SCKGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
             +   L     R Y     +AE    L+YLH      I++RD+K +N+LLD +   ++ 
Sbjct: 101 MQRQRKLPEEHARFY-----SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLT 152

Query: 844 DFGVAKV-VDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVILE 895
           D+G+ K  +       +       CG   YIAPE      Y   V    D ++ GV++ E
Sbjct: 153 DYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRGEDYGFSV----DWWALGVLMFE 202

Query: 896 LVTGRLP 902
           ++ GR P
Sbjct: 203 MMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.0 bits (190), Expect = 6e-15
 Identities = 70/248 (28%), Positives = 104/248 (41%), Gaps = 59/248 (23%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
             LG  ++++L       VIG GS  KV  V L       A++ +              +
Sbjct: 47  SSLGLQDFDLL------RVIGRGSYAKVLLVRLKKTDRIYAMRVV--------------K 86

Query: 731 KGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLL- 787
           K  V D    D  Q E     +   H  +V L  C  T   +L  V EY+ NG  GDL+ 
Sbjct: 87  KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLFFVIEYV-NG--GDLMF 142

Query: 788 HSCKGGLLDWP-TR-YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
           H  +   L     R Y     +AE    L+YLH      I++RD+K +N+LLD +   ++
Sbjct: 143 HMQRQRKLPEEHARFY-----SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL 194

Query: 843 ADFGVAKV-VDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVIL 894
            D+G+ K  +       +       CG   YIAPE      Y   V    D ++ GV++ 
Sbjct: 195 TDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRGEDYGFSV----DWWALGVLMF 244

Query: 895 ELVTGRLP 902
           E++ GR P
Sbjct: 245 EMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.5 bits (189), Expect = 6e-15
 Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 59/248 (23%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVE 730
            ++  +++  L       V+G GS GKV         E  AVK L              +
Sbjct: 15  DRMKLTDFNFL------MVLGKGSFGKVMLSERKGTDELYAVKIL--------------K 54

Query: 731 KGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDL-L 787
           K  V      +    E   L    +   + +L  C  T D +L  V EY+ NG  GDL  
Sbjct: 55  KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFVMEYV-NG--GDLMY 110

Query: 788 HSCKGGLLDWPTR--YKIIVDAAE---GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
           H  + G    P    Y     AAE   GL +L       I++RD+K +N++LD +   ++
Sbjct: 111 HIQQVGRFKEPHAVFY-----AAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI 162

Query: 843 ADFGVAKV-VDASGKPKSMSVIAGSCG---YIAPE----YAYTLRVNEKSDIYSFGVVIL 894
           ADFG+ K  +      K+       CG   YIAPE      Y   V    D ++FGV++ 
Sbjct: 163 ADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLY 212

Query: 895 ELVTGRLP 902
           E++ G+ P
Sbjct: 213 EMLAGQAP 220

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 55/255 (21%), Positives = 98/255 (38%), Gaps = 72/255 (28%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV---LSNGEAVAVKKLWRGMSKECESGCDVEKGQ 733
             +E          +G G+ G VYK       + +  A+K+                   
Sbjct: 20  DLFEYEGC-----KVGRGTYGHVYKAKRKDGKDDKDYALKQ------------------- 55

Query: 734 VQDQVQDDGFQA----EVETLGKIRHKNIVKLWCCCTTR-DCKL-LVYEYMPNGSLGDLL 787
               ++  G       E+  L +++H N++ L     +  D K+ L+++Y  +    DL 
Sbjct: 56  ----IEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH----DLW 107

Query: 788 HSCKGGLLDWPTRYKIIVDAAE----------GLSYLHHDCVPSIVHRDVKSNNILLDGD 837
           H  K        +  + +              G+ YLH +    ++HRD+K  NIL+ G+
Sbjct: 108 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGE 164

Query: 838 FGAR----VADFGVAKVVDASGKPKSMS---VIAGSCGYIAPE-----YAYTLRVNEKSD 885
              R    +AD G A++ ++  KP +     V+     Y APE       YT  +    D
Sbjct: 165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVT--FWYRAPELLLGARHYTKAI----D 218

Query: 886 IYSFGVVILELVTGR 900
           I++ G +  EL+T  
Sbjct: 219 IWAIGCIFAELLTSE 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 51/231 (22%)

Query: 690 VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ---- 744
           + G G+ G V        G +VA+KK+                      +QD  F+    
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKV----------------------IQDPRFRNREL 67

Query: 745 AEVETLGKIRHKNIVKLWCCCTT------RDCKL-LVYEYMPNGSLGDLLHSCKGGLLDW 797
             ++ L  + H NIV+L     T      RD  L +V EY+P+ +L     +     +  
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP 126

Query: 798 PTRYK--IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDAS 854
           P       +      +  LH   V ++ HRD+K +N+L++   G  ++ DFG AK +   
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-P 184

Query: 855 GKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVILELVTGR 900
            +P +++ I  S  Y APE       YT  V    DI+S G +  E++ G 
Sbjct: 185 SEP-NVAYIC-SRYYRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 55/247 (22%), Positives = 86/247 (34%), Gaps = 54/247 (21%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
             + +         I SGS G V   V S G  VA+K+++  +S                
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV----------- 64

Query: 737 QVQDDGFQA-----EVETLGKIRHKNIVKLWCCCTTRDCKL-----LVYEYMPNGSLGDL 786
            +  D F       E+  L    H NI+ L       +        LV E M    L  +
Sbjct: 65  NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV 123

Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDFGARVAD 844
           +H  +  +     +Y  +     GL  LH        +VHRD+   NILL  +    + D
Sbjct: 124 IHDQRIVISPQHIQY-FMYHILLGLHVLH-----EAGVVHRDLHPGNILLADNNDITICD 177

Query: 845 FGVAKVVDASGKPKSMSVIAGSCGYI------APE-----YAYTLRVNEKSDIYSFGVVI 893
           F +A+   A       +       Y+      APE       +T  V    D++S G V+
Sbjct: 178 FNLAREDTADAN---KT------HYVTHRWYRAPELVMQFKGFTKLV----DMWSAGCVM 224

Query: 894 LELVTGR 900
            E+   +
Sbjct: 225 AEMFNRK 231

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 48/207 (23%), Positives = 76/207 (36%), Gaps = 40/207 (19%)

Query: 57  CSWRGVECDPRS---------HSVASIDLSNANIAG-PFPSLLCRLENLTFLTLFNNSIN 106
           C+   + C  +             A +DLS+ N++         RL NL  L L +N + 
Sbjct: 18  CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL- 76

Query: 107 STLPDDI-SACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNNFSGDIPESFGRF 164
           + +  +      NL++LDLS N L  TL     +DL  L+ L L  N+    +      F
Sbjct: 77  NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDR--NAF 132

Query: 165 QKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPF--LPGRIPPELGNLTNLEILWLT 222
           + +                     + L+ L LS N     P  +  +   L  L +L L+
Sbjct: 133 EDM---------------------AQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171

Query: 223 ECNLVGEIPDSLGRLAKLVDLDLALNN 249
              L       L +L   V   L L+N
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 47/226 (20%), Positives = 72/226 (31%), Gaps = 66/226 (29%)

Query: 107 STLPDDISACQNLQHLDLSQNLLTGTLTP--ALADLPNLKFLDLTGNNFSGDIPESFGRF 164
             +P  + +      LDLS N L+  L        L NL  L L+ N+ +  I      F
Sbjct: 31  PNVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISS--EAF 84

Query: 165 QKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTE 223
             +                       L+ L+LS N      +      +L  LE+L L  
Sbjct: 85  VPV---------------------PNLRYLDLSSNHL--HTLDEFLFSDLQALEVLLLYN 121

Query: 224 CNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-- 281
            N +  +  +            A  ++     + L +L       L  N ++   P    
Sbjct: 122 -NHIVVVDRN------------AFEDM-----AQLQKL------YLSQNQIS-RFPVELI 156

Query: 282 --WSNLTSLRLLDASMNDLTGPIP----DDLTRLPLESLNLYENRL 321
              + L  L LLD S N L   +P      L       L L+ N L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 25/196 (12%)

Query: 403 HCQSLTRVRLGYNRLTGKVPPLLWGLP-HVYLLELTDNFLSGEISKNIA--GAANLSLLI 459
            C S   +     +L   VP     LP +  LL+L+ N LS  +          NL  L+
Sbjct: 17  LCASNI-LSCSKQQLP-NVPQ---SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLL 70

Query: 460 ISKNNLSGSLPEEI-GFLKSLVVLSGSENKFTGSLP-ESLTNLAELGSLDLHANDLSGEL 517
           +S N+L+  +  E    + +L  L  S N    +L     ++L  L  L L+ N +   +
Sbjct: 71  LSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VV 127

Query: 518 PSSV-SSWKKLNELNLADNLFYGNIPEDI----GNLSVLNYLDLSNNRLSGRIPVG---- 568
             +      +L +L L+ N      P ++      L  L  LDLS+N+L  ++P+     
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQK 185

Query: 569 LQNLKLNQLNVSNNRL 584
           L     N L + NN L
Sbjct: 186 LPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 42/179 (23%), Positives = 63/179 (35%), Gaps = 16/179 (8%)

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPD-DLTRLP-LESLNLYENRLEGSLPA- 327
              L  ++P      +   LLD S N+L+    +   TRL  L SL L  N L   + + 
Sbjct: 27  KQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82

Query: 328 TIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK-GELEEL 386
                P L  L L  N L+            L  + L NN     +  +  E   +L++L
Sbjct: 83  AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141

Query: 387 LMIYNSFTGQLPDG----LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL--LELTDN 439
            +  N  + + P            L  + L  N+L       L  LP      L L +N
Sbjct: 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 29/116 (25%), Positives = 44/116 (37%), Gaps = 7/116 (6%)

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN 151
           + NL +L L +N +++      S  Q L+ L L  N +      A  D+  L+ L L+ N
Sbjct: 87  VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146

Query: 152 NFSGDIPE----SFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKM--LNLSYNPF 201
             S   P        +  KL ++ L  N L       L  +       L L  NP 
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.5 bits (174), Expect = 2e-13
 Identities = 31/204 (15%), Positives = 56/204 (27%), Gaps = 30/204 (14%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           FS     + L     IG G  G+V++ +  +   VA+K +                 ++ 
Sbjct: 13  FSHCLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKL--WCCCTTRDCKLLVYEYM----PNGSL------ 783
            ++      + +      R +  + L    C       LL+  +       GS       
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 784 ---------------GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK 828
                          G  L   +  L    T   I+      L+           HRD+ 
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLH 189

Query: 829 SNNILLDGDFGARVADFGVAKVVD 852
             N+LL      ++      K   
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST 213

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 56/250 (22%), Positives = 102/250 (40%), Gaps = 62/250 (24%)

Query: 675 GFSEYEILD---GLDED----NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESG 726
            + +YE      G  +D      +G G   +V++ + ++N E V VK L           
Sbjct: 21  EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----------- 69

Query: 727 CDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCCCTTRDCK--LLVYEYMPNGSL 783
                      V+    + E++ L  +R   NI+ L         +   LV+E++ N   
Sbjct: 70  ---------KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 120

Query: 784 GDLLHSCKGGLLDWPTR---YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA 840
             L  +    L D+  R   Y+I+    + L Y H      I+HRDVK +N+++D +   
Sbjct: 121 KQLYQT----LTDYDIRFYMYEIL----KALDYCHSM---GIMHRDVKPHNVMIDHEHRK 169

Query: 841 -RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE-------YAYTLRVNEKSDIYSFGVV 892
            R+ D+G+A+        +  +V   S  +  PE       Y Y+L      D++S G +
Sbjct: 170 LRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSL------DMWSLGCM 220

Query: 893 ILELVTGRLP 902
           +  ++  + P
Sbjct: 221 LASMIFRKEP 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 51/247 (20%)

Query: 671 FH--KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGC 727
           F+  ++G S + +L        IGSG+ G V           VA+KKL R          
Sbjct: 11  FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN------ 64

Query: 728 DVEKGQVQDQVQDDGFQA--EVETLGKIRHKNIVKLWCCCTTRDCKL------------L 773
                      Q    +A  E+  +  + HKNI+ L       +               +
Sbjct: 65  -----------QTHAKRAYRELVLMKCVNHKNIIGL------LNVFTPQKSLEEFQDVYI 107

Query: 774 VYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL 833
           V E M      +L    +  L      Y ++     G+ +LH      I+HRD+K +NI+
Sbjct: 108 VMELMDA----NLCQVIQMELDHERMSY-LLYQMLCGIKHLHS---AGIIHRDLKPSNIV 159

Query: 834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVI 893
           +  D   ++ DFG+A+    S     M+    +  Y APE    +   E  DI+S G ++
Sbjct: 160 VKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216

Query: 894 LELVTGR 900
            E++ G 
Sbjct: 217 GEMIKGG 223

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 44/197 (22%), Positives = 68/197 (34%), Gaps = 63/197 (31%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
             +Y++        V+G G +GKV ++      E  A+K L            D  K   
Sbjct: 16  IDDYKVTS-----QVLGLGINGKVLQIFNKRTQEKFALKML-----------QDCPK--- 56

Query: 735 QDQVQDDGFQAEVETLGKI-RHKNIVKLWCCC----TTRDCKLLVYEYMPNGSLGDLLHS 789
                    + EVE   +  +  +IV++          R C L+V E             
Sbjct: 57  --------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC------------ 96

Query: 790 CKGG-LLD-----WPTRY------KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--- 834
             GG L           +      +I+    E + YLH     +I HRDVK  N+L    
Sbjct: 97  LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSK 153

Query: 835 DGDFGARVADFGVAKVV 851
             +   ++ DFG AK  
Sbjct: 154 RPNAILKLTDFGFAKET 170

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 49/239 (20%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S + +L        IGSG+ G V           VA+KKL R                  
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------------- 101

Query: 736 DQVQDDGFQA--EVETLGKIRHKNIVKLW----CCCTTRDCK--LLVYEYMPNGSLGDLL 787
              Q    +A  E+  +  + HKNI+ L        T  + +   LV E M      +L 
Sbjct: 102 ---QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLC 154

Query: 788 HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
              +  L      Y ++     G+ +LH   +   +HRD+K +NI++  D   ++ DFG+
Sbjct: 155 QVIQMELDHERMSY-LLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGL 210

Query: 848 AKVVDASGKPKSMSVIAGSCGYI------APEYAYTLRVNEKSDIYSFGVVILELVTGR 900
           A+    S     M+       Y+      APE    +   E  DI+S G ++ E+V  +
Sbjct: 211 ARTAGTSF---MMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 15/196 (7%)

Query: 107 STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPES-FGRFQ 165
           + +P +I A  + + LDL  N L+   + A   L  L+ L L  N     +P   F   +
Sbjct: 29  TAIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85

Query: 166 KLEVISLVYNLLDGTIPA-FLGNISTLKMLNLSYNPF--LPGRIPPELGNLTNLEILWLT 222
            LE + +  N L   +P      +  L  L L  N    LP R+     +LT L  L L 
Sbjct: 86  NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD---SLTKLTYLSLG 141

Query: 223 ECNLVGEIPDSL-GRLAKLVDLDLALNNLVGAIPSSL-TELASVVQIELYNNSLTGDLPT 280
              L   +P  +  +L  L +L L  N L   +P     +L  +  ++L NN L      
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEG 199

Query: 281 GWSNLTSLRLLDASMN 296
            + +L  L++L    N
Sbjct: 200 AFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 50/203 (24%), Positives = 74/203 (36%), Gaps = 35/203 (17%)

Query: 75  DLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISAC-QNLQHLDLSQNLLTGTL 133
           DL +  ++        RL  L  L L +N +  TLP  I    +NL+ L ++ N L   L
Sbjct: 43  DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-AL 100

Query: 134 TP-ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLK 192
                  L NL  L L  N     +P     F  L                     + L 
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLK-SLPP--RVFDSL---------------------TKLT 136

Query: 193 MLNLSYN--PFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSL-GRLAKLVDLDLALNN 249
            L+L YN    LP  +      LT+L+ L L   N +  +P+    +L +L  L L  N 
Sbjct: 137 YLSLGYNELQSLPKGV---FDKLTSLKELRL-YNNQLKRVPEGAFDKLTELKTLKLDNNQ 192

Query: 250 LVGAIPSSLTELASVVQIELYNN 272
           L      +   L  +  ++L  N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 60/236 (25%), Positives = 89/236 (37%), Gaps = 44/236 (18%)

Query: 356 NSPLRWVDLSNNQFT---GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRL 412
           N+    VD S+ + T     IPA        ++L +  N  +            L  + L
Sbjct: 15  NNNKNSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYL 68

Query: 413 GYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE 472
             N+L   +P    G+                         NL  L ++ N L  +LP  
Sbjct: 69  NDNKLQ-TLPA---GIFK--------------------ELKNLETLWVTDNKLQ-ALPIG 103

Query: 473 I-GFLKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLHANDLSGELPSSV-SSWKKLNE 529
           +   L +L  L    N+   SLP  +  +L +L  L L  N+L   LP  V      L E
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161

Query: 530 LNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVGL-QNLK-LNQLNVSNN 582
           L L +N     +PE     L+ L  L L NN+L  R+P G   +L+ L  L +  N
Sbjct: 162 LRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 47/149 (31%), Positives = 67/149 (44%), Gaps = 13/149 (8%)

Query: 453 ANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLH 509
           A+   L +  N LS SLP +  F  L  L +L  ++NK   +LP  +   L  L +L + 
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKA-FHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVT 93

Query: 510 ANDLSGELPSSVSSW-KKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPV 567
            N L   LP  V      L EL L  N    ++P  +  +L+ L YL L  N L   +P 
Sbjct: 94  DNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150

Query: 568 GL-QNL-KLNQLNVSNNRLSGELPSLFAK 594
           G+   L  L +L + NN+L       F K
Sbjct: 151 GVFDKLTSLKELRLYNNQLKRVPEGAFDK 179

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 52/230 (22%), Positives = 89/230 (38%), Gaps = 37/230 (16%)

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
             S++    +L  ++P+ I       +L L  N+L+        + + LR + L++N+  
Sbjct: 18  KNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-LLWGLP 429
             +PA +                       L    +L  + +  N+L   +P  +   L 
Sbjct: 75  -TLPAGI--------------------FKELK---NLETLWVTDNKLQ-ALPIGVFDQLV 109

Query: 430 HVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSE 486
           ++  L L  N L   +   +      L+ L +  N L  SLP+ + F  L SL  L    
Sbjct: 110 NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV-FDKLTSLKELRLYN 166

Query: 487 NKFTGSLPESL-TNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADN 535
           N+    +PE     L EL +L L  N L      +  S +KL  L L +N
Sbjct: 167 NQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 32/112 (28%), Positives = 46/112 (41%), Gaps = 2/112 (1%)

Query: 91  RLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
           +L NL  L L  N + S LP  +  +   L +L L  N L          L +LK L L 
Sbjct: 107 QLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLY 165

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPF 201
            N        +F +  +L+ + L  N L         ++  LKML L  NP+
Sbjct: 166 NNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 27/89 (30%), Positives = 38/89 (42%), Gaps = 2/89 (2%)

Query: 91  RLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
            L  LT+L+L  N + S LP  +     +L+ L L  N L      A   L  LK L L 
Sbjct: 131 SLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLD 189

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLD 178
            N        +F   +KL+++ L  N  D
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQENPWD 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.8 bits (166), Expect = 6e-12
 Identities = 51/269 (18%), Positives = 92/269 (34%), Gaps = 85/269 (31%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYK-VVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y +         +G+GS G V +   + +G+  A+KK+                      
Sbjct: 9   YSLGK------TLGTGSFGIVCEVFDIESGKRFALKKV---------------------- 40

Query: 738 VQDDGFQA-EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
           +QD  ++  E++ +  + H NI+KL     T   +       P+        +       
Sbjct: 41  LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHH 100

Query: 797 WPTR--------------------YKIIVDAAE-------------------GLSYLHHD 817
                                   +K++                         + ++H  
Sbjct: 101 KSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS- 159

Query: 818 CVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPE--- 873
               I HRD+K  N+L++      ++ DFG AK +    +P S++ I  S  Y APE   
Sbjct: 160 --LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI-PSEP-SVAYIC-SRFYRAPELML 214

Query: 874 --YAYTLRVNEKSDIYSFGVVILELVTGR 900
               YT  +    D++S G V  EL+ G+
Sbjct: 215 GATEYTPSI----DLWSIGCVFGELILGK 239

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 8e-12
 Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 72/250 (28%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           + +E+         +GSG+ G V   +   +GE VA+KKL R                  
Sbjct: 18  TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------------- 63

Query: 736 DQVQDDGFQA--EVETLGKIRHKNIVKLWCCCTTRDCKL------------LVYEYMPNG 781
              +    +A  E+  L  ++H+N++ L       D               LV  +M   
Sbjct: 64  ---EIFAKRAYRELLLLKHMQHENVIGL------LDVFTPASSLRNFYDFYLVMPFMQT- 113

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
              DL         +   +Y ++    +GL Y+H      +VHRD+K  N+ ++ D   +
Sbjct: 114 ---DLQKIMGLKFSEEKIQY-LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELK 166

Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYI------APE-----YAYTLRVNEKSDIYSFG 890
           + DFG+A+  DA      M+      GY+      APE       Y   V    DI+S G
Sbjct: 167 ILDFGLARHADA-----EMT------GYVVTRWYRAPEVILSWMHYNQTV----DIWSVG 211

Query: 891 VVILELVTGR 900
            ++ E++TG+
Sbjct: 212 CIMAEMLTGK 221

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 46/244 (18%), Positives = 86/244 (35%), Gaps = 54/244 (22%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y ++        +G G    V+    + N   VA+K +                    + 
Sbjct: 21  YILVR------KLGWGHFSTVWLAKDMVNNTHVAMKIV-------------RGDKVYTEA 61

Query: 738 VQDDGFQAEVETLGKIR-----------HKNIVKLWCCCTTRDCKL----LVYEYMPNGS 782
            +D     E++ L ++              +I+KL      +        +V+E +   +
Sbjct: 62  AED-----EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GEN 115

Query: 783 LGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD------G 836
           L  L+   +   +      +I      GL Y+H  C   I+H D+K  N+L++       
Sbjct: 116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173

Query: 837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEL 896
               ++AD G A   D     +  +    +  Y +PE          +DI+S   +I EL
Sbjct: 174 LIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 228

Query: 897 VTGR 900
           +TG 
Sbjct: 229 ITGD 232

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 66.3 bits (161), Expect = 3e-11
 Identities = 43/239 (17%), Positives = 74/239 (30%), Gaps = 36/239 (15%)

Query: 85  FPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLK 144
           +       E L    L        L  ++ +C+ LQ L+        T+   +  L  L 
Sbjct: 341 WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399

Query: 145 FLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPG 204
           +   T   FS        R      +  + +             + +++L+L++      
Sbjct: 400 YEKETLQYFSTLKAVDPMR---AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--- 453

Query: 205 RIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASV 264
            +   L  L  +  L L+  N +  +P +L  L  L  L  + N L      ++  +   
Sbjct: 454 TVLCHLEQLLLVTHLDLSH-NRLRALPPALAALRCLEVLQASDNAL-----ENVDGV--- 504

Query: 265 VQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-PIPDDLTRLP-LESLNLYENRL 321
                             +NL  L+ L    N L        L   P L  LNL  N L
Sbjct: 505 ------------------ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.9 bits (152), Expect = 3e-10
 Identities = 51/305 (16%), Positives = 94/305 (30%), Gaps = 26/305 (8%)

Query: 304 DDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTL----PGDLGKNSPL 359
           +    L    ++  E  L       +     +  L L  +    ++    P    + S +
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299

Query: 360 RWVDLSNNQFTGEIPAS----LCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN 415
              DL       ++P      +    + ++  ++               + L R  L   
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359

Query: 416 RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF 475
           + T  +   L     +  LE  + +        I     L  L+  K  L      +   
Sbjct: 360 KST-VLQSELESCKELQELEPENKWCL---LTIILLMRALDPLLYEKETLQYFSTLKAVD 415

Query: 476 LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADN 535
                 L    +KF           A++  L L   DL+  +   +     +  L+L+ N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHN 473

Query: 536 LFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS--------G 586
                +P  +  L  L  L  S+N L   +  G+ NL +L +L + NNRL          
Sbjct: 474 RL-RALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530

Query: 587 ELPSL 591
             P L
Sbjct: 531 SCPRL 535

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.5 bits (151), Expect = 5e-10
 Identities = 29/125 (23%), Positives = 52/125 (41%), Gaps = 12/125 (9%)

Query: 55  SPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLT---LFNNSINSTLPD 111
           S               V  + L++ ++     ++LC LE L  +T   L +N +   LP 
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDL-----TVLCHLEQLLLVTHLDLSHNRL-RALPP 480

Query: 112 DISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSG-DIPESFGRFQKLEVI 170
            ++A + L+ L  S N L   +   +A+LP L+ L L  N        +      +L ++
Sbjct: 481 ALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538

Query: 171 SLVYN 175
           +L  N
Sbjct: 539 NLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.9 bits (147), Expect = 1e-09
 Identities = 48/256 (18%), Positives = 89/256 (34%), Gaps = 17/256 (6%)

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
           L + +L +   + +       S    E  L ++R       D   +  L   +LS  + T
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST 362

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTG--KVPPLLWGL 428
             + + L    EL+EL          +   +     L   +      +    V P+    
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM---- 417

Query: 429 PHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENK 488
                L+   +    E S      A++ +L ++  +L+  +   +  L  +  L  S N+
Sbjct: 418 -RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR 474

Query: 489 FTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPE--DIG 546
              +LP +L  L  L  L    N L   +   V++  +L EL L +N           + 
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL-QQSAAIQPLV 530

Query: 547 NLSVLNYLDLSNNRLS 562
           +   L  L+L  N L 
Sbjct: 531 SCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 23/82 (28%), Positives = 34/82 (41%), Gaps = 4/82 (4%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTG-T 132
           +DLS+  +    P  L  L  L  L   +N++ +   D ++    LQ L L  N L    
Sbjct: 468 LDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSA 524

Query: 133 LTPALADLPNLKFLDLTGNNFS 154
               L   P L  L+L GN+  
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSLC 546

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 54/258 (20%), Positives = 96/258 (37%), Gaps = 73/258 (28%)

Query: 672 HKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVE 730
             +    +++       + IG G+ G V       N   VA+KK+               
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--------------- 60

Query: 731 KGQVQDQVQDDGFQA---------EVETLGKIRHKNIVKLWCCCTTRDCKL-----LVYE 776
                       F+          E++ L + RH+NI+ +         +      +V +
Sbjct: 61  ----------SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110

Query: 777 YMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILL 834
            M    L  LL +    L +    Y  +     GL Y+H     S  ++HRD+K +N+LL
Sbjct: 111 LMET-DLYKLLKT--QHLSNDHICY-FLYQILRGLKYIH-----SANVLHRDLKPSNLLL 161

Query: 835 DGDFGARVADFGVAKVVDASGKPKS-MSVIAGSCGYI------APE-----YAYTLRVNE 882
           +     ++ DFG+A+V D        ++       Y+      APE       YT  +  
Sbjct: 162 NTTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSI-- 213

Query: 883 KSDIYSFGVVILELVTGR 900
             DI+S G ++ E+++ R
Sbjct: 214 --DIWSVGCILAEMLSNR 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 56/302 (18%), Positives = 100/302 (33%), Gaps = 97/302 (32%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRG------MSKECESGCDV 729
           S++E   D L     +G G+ G+V +      +A  + K          M KE  +  + 
Sbjct: 15  SKWEFPRDRLKLGKPLGRGAFGQVIE-----ADAFGIDKTATCRTVAVKMLKEGATHSEH 69

Query: 730 EKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLV-YEYMPNGSLGDLL 787
                          +E++ L  I  H N+V L   CT     L+V  E+   G+L   L
Sbjct: 70  R-----------ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

Query: 788 HSCKGGLLDWPTR---------YKIIVDA----------------------AEGLSYLHH 816
            S +   + + T+         Y   +                         + LS +  
Sbjct: 119 RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178

Query: 817 DCVPSIVHRDVKSNNILLD-------------------GDFGAR-----------VADFG 846
           +  P  +++D  +   L+                     D  AR           + DFG
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 238

Query: 847 VAKVVDASGKPKSMSVIAGSCGYI-----APEYAYTLRVNEKSDIYSFGVVILELVT-GR 900
           +A+ +      K    +      +     APE  +      +SD++SFGV++ E+ + G 
Sbjct: 239 LARDIY-----KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293

Query: 901 LP 902
            P
Sbjct: 294 SP 295

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 35/158 (22%), Positives = 58/158 (36%), Gaps = 16/158 (10%)

Query: 57  CSWRGVECDPRSH---------SVASIDLSNANIAG-PFPSLLCRLENLTFLTLFNNSIN 106
           C    V+C  +             A + L+N          +  +L  L  +   NN I 
Sbjct: 11  CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI- 69

Query: 107 STLPDDI-SACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQ 165
           + + +        +  + L+ N L          L +LK L L  N  +    +SF    
Sbjct: 70  TDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLS 129

Query: 166 KLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSYNPF 201
            + ++SL  N +  T+   AF   + +L  LNL  NPF
Sbjct: 130 SVRLLSLYDNQI-TTVAPGAF-DTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 30/149 (20%), Positives = 56/149 (37%), Gaps = 20/149 (13%)

Query: 203 PGRIPPELGNLTNLEILWLTECNLVGEIP--DSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
           P  IP           L L   N    +       +L +L  ++ + N +      +   
Sbjct: 27  PEHIP------QYTAELRLNN-NEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEG 79

Query: 261 LASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGPIP----DDLTRLPLESLN 315
            + V +I L +N L  ++    +  L SL+ L    N +T  +       L+   +  L+
Sbjct: 80  ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSS--VRLLS 135

Query: 316 LYENRLEGSLPATIADS-PGLYELRLFRN 343
           LY+N++  ++     D+   L  L L  N
Sbjct: 136 LYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 30/137 (21%), Positives = 54/137 (39%), Gaps = 12/137 (8%)

Query: 453 ANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLH 509
              + L ++ N  +  L     F  L  L  ++ S NK T  + E +    + +  + L 
Sbjct: 32  QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT 89

Query: 510 ANDLSGELPSSV-SSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPV 567
           +N L   +   +    + L  L L  N     +  D    LS +  L L +N+++  +  
Sbjct: 90  SNRLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146

Query: 568 G-LQNL-KLNQLNVSNN 582
           G    L  L+ LN+  N
Sbjct: 147 GAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 32/139 (23%), Positives = 65/139 (46%), Gaps = 11/139 (7%)

Query: 405 QSLTRVRLGYNRLTGKVPP--LLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIIS 461
           Q    +RL  N  T  +    +   LP +  +  ++N ++ +I +    GA+ ++ ++++
Sbjct: 32  QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT 89

Query: 462 KNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELP 518
            N L  ++  ++ F  L+SL  L    N+ T  +   S   L+ +  L L+ N ++   P
Sbjct: 90  SNRLE-NVQHKM-FKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAP 146

Query: 519 SSVSSWKKLNELNLADNLF 537
            +  +   L+ LNL  N F
Sbjct: 147 GAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 20/105 (19%), Positives = 40/105 (38%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL 133
           I+ SN  I             +  + L +N + +         ++L+ L L  N +T   
Sbjct: 62  INFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVG 121

Query: 134 TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLD 178
             +   L +++ L L  N  +   P +F     L  ++L+ N  +
Sbjct: 122 NDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 27/131 (20%), Positives = 49/131 (37%), Gaps = 6/131 (4%)

Query: 243 LDLALNNLVGAIPSSL-TELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTG 300
           L L  N       + +  +L  + +I   NN +T D+  G +   + +  +  + N L  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN 95

Query: 301 PIPDDLTRLP-LESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKNSP 358
                   L  L++L L  NR+   +          +  L L+ N++    PG       
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154

Query: 359 LRWVDLSNNQF 369
           L  ++L  N F
Sbjct: 155 LSTLNLLANPF 165

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 65.6 bits (159), Expect = 7e-11
 Identities = 113/670 (16%), Positives = 201/670 (30%), Gaps = 220/670 (32%)

Query: 217 EILWLTECNLVGEIPDSLGRLAKLVD-LDLALNNLVGAIPSSLTE-----LASVVQIELY 270
            IL   E + +    D++    +L   L      +V      +       L S ++ E  
Sbjct: 44  SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR 103

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIA 330
             S+   +          R  D   ND       +++RL    L L +            
Sbjct: 104 QPSMMTRM------YIEQR--DRLYNDNQVFAKYNVSRLQPY-LKLRQ------------ 142

Query: 331 DSPGLYELRLFRN-RLNGTLPGDLGK----NSPLR-------------WVDLSNNQFTGE 372
               L ELR  +N  ++G + G  GK                      W++L N      
Sbjct: 143 ---ALLELRPAKNVLIDG-VLG-SGKTWVALDVCLSYKVQCKMDFKIFWLNLKN------ 191

Query: 373 IPASLCEKGELEELLMIYNSFTGQL-PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV 431
                C     E +L +      Q+ P+        + ++L  + +  ++  LL   P+ 
Sbjct: 192 -----CNSP--ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244

Query: 432 Y-LLELTDNFLSGEI-SKNIAGAANLS--LLIISKN-NLSGSLPEEIGFLKSLVVLSGSE 486
             LL L  N     + +     A NLS  +L+ ++   ++  L        SL   S + 
Sbjct: 245 NCLLVL-LN-----VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT- 297

Query: 487 NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIG 546
              T    E  + L +   LD    D    LP  V      N   L+  +   +I + + 
Sbjct: 298 --LT--PDEVKSLLLK--YLDCRPQD----LPREV---LTTNPRRLS--IIAESIRDGLA 342

Query: 547 NLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPG 606
                N+  ++ ++L+  I   L  L+               P+ + ++M+         
Sbjct: 343 TWD--NWKHVNCDKLTTIIESSLNVLE---------------PAEY-RKMFD-------- 376

Query: 607 LCGDLEGLCDGRGEEKNRGYVWVLRSIF-----ILAGLVFVFGLVWFYLKYR-------K 654
               L                    S+F     I      +  L+WF +          K
Sbjct: 377 ---RL--------------------SVFPPSAHIPTI---LLSLIWFDVIKSDVMVVVNK 410

Query: 655 FKNGRAIDK----SKWTLMSF--------------HKLGFSEYEILDGLDEDNVIGSGSS 696
                 ++K    S  ++ S               H+     Y I    D D++I     
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470

Query: 697 GKVYKVV---LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI 753
              Y  +   L N E      L+R +                    D  F   +E   KI
Sbjct: 471 QYFYSHIGHHLKNIEHPERMTLFRMV------------------FLDFRF---LE--QKI 507

Query: 754 RHKNIVKLWCCC-----TTRDCKLLVYE-YM-PN--------GSLGDLLHSCKGGLLDWP 798
           RH +    W        T +  K   Y+ Y+  N         ++ D L   +  L+   
Sbjct: 508 RHDST--AWNASGSILNTLQQLKF--YKPYICDNDPKYERLVNAILDFLPKIEENLIC-- 561

Query: 799 TRYKIIVDAA 808
           ++Y  ++  A
Sbjct: 562 SKYTDLLRIA 571

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 1e-08
 Identities = 61/391 (15%), Positives = 112/391 (28%), Gaps = 113/391 (28%)

Query: 14  LLSPLPSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVEC----DPRSH 69
           +L  L  L    +  +  R   S +          +        S     C         
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLR--IHSIQAELRRLLKSKPYENCLLVLL---- 251

Query: 70  SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL 129
                ++ NA     F +L C+      LT    +    + D +SA     H+ L  +  
Sbjct: 252 -----NVQNAKAWNAF-NLSCK----ILLT----TRFKQVTDFLSA-ATTTHISLDHHS- 295

Query: 130 TGTLTPA-----LA--------DLP------NLKFLDLTGNNFSGDIPESFGRFQKLEVI 170
             TLTP      L         DLP      N + L +   +   D   ++  ++ +   
Sbjct: 296 -MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR-DGLATWDNWKHVN-- 351

Query: 171 SLVYNLLDGTIPAFLGNISTLKMLNLSYNPF--LPG--RIPPELGNLTNLEILWLTECNL 226
               + L   I + L  +   +   + ++     P    IP  L     L ++W    ++
Sbjct: 352 ---CDKLTTIIESSLNVLEPAEYRKM-FDRLSVFPPSAHIPTIL-----LSLIW---FDV 399

Query: 227 VGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLT 286
           +      +  + KL    L         P   T       I +   S+  +L     N  
Sbjct: 400 IKSDVMVV--VNKLHKYSLVEKQ-----PKEST-------ISIP--SIYLELKVKLENEY 443

Query: 287 SL--RLLDA-------SMNDLTGPIPD--------------------DLTRLPLESLNLY 317
           +L   ++D          +DL  P  D                     L R+        
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503

Query: 318 ENRLEGSLPATIADSPG---LYELRLFRNRL 345
           E ++     A  A       L +L+ ++  +
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYI 534

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 2e-07
 Identities = 66/452 (14%), Positives = 116/452 (25%), Gaps = 157/452 (34%)

Query: 215 NLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSL 274
           + +I WL            L        +   L  L+  I  + T  +         +S 
Sbjct: 181 DFKIFWLN-----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSD--------HSS 221

Query: 275 TGDLPTGWSNLTSLRLLDASM--NDLTGPIPDD------------------LTR-----L 309
              L          RLL +    N L   +  +                   TR      
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 310 PLESLNLYENRLEGSLPATIADSPGLYE---LRLFRNRLN---GTLPGDLGKNSPL---- 359
            L +       L+         S  L       L    L+     LP ++   +P     
Sbjct: 280 FLSAATTTHISLDHH-------SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332

Query: 360 -------------RWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQS 406
                         W  ++ ++ T  I +SL    E  E   +++      P        
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSL-NVLEPAEYRKMFDRL-SVFPPSA----- 385

Query: 407 LTRVRLGYNRLTGKVPP----LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISK 462
                         +P     L+W       + +  N L              SL+    
Sbjct: 386 -------------HIPTILLSLIWFDVIKSDVMVVVNKL-----------HKYSLVEKQP 421

Query: 463 NNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSG-ELPSSV 521
              + S+P       S+ +           L   L N        LH + +    +P + 
Sbjct: 422 KESTISIP-------SIYL----------ELKVKLENEYA-----LHRSIVDHYNIPKTF 459

Query: 522 SSWKKLNELNLADNLFYGNIP---------EDIGNLSVLNYLDLSNNRLSGRIPVGLQNL 572
            S   +      D  FY +I          E +    ++ +LD    R        L+  
Sbjct: 460 DSDDLI--PPYLDQYFYSHIGHHLKNIEHPERMTLFRMV-FLDF---RF-------LEQ- 505

Query: 573 KLNQLNVSNNRLSGELPSLFAKEMYRNSFLGN 604
           K+   + + N     L +L   + Y+     N
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFYKPYICDN 537

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 2e-07
 Identities = 91/649 (14%), Positives = 182/649 (28%), Gaps = 187/649 (28%)

Query: 372 EIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGL--- 428
           ++P S+  K E++ ++           D      +++               L W L   
Sbjct: 40  DMPKSILSKEEIDHII--------MSKD------AVSGTLR-----------LFWTLLSK 74

Query: 429 -PHVY------LLELTDNFLSGEISK-NIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV 480
              +       +L +   FL   I       +    + I  ++ L         F K  V
Sbjct: 75  QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV---FAKYNV 131

Query: 481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGE--LPSSVSSWKKLNELNLADNLFY 538
                   +   L ++L  L    ++ +     SG+  +   V    K+ +  +   +F+
Sbjct: 132 S---RLQPYL-KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV-QCKMDFKIFW 186

Query: 539 GNI-----PEDIGNLSVLN--YLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSL 591
            N+     PE +  L +L      +  N  S        N+KL       + +  EL  L
Sbjct: 187 LNLKNCNSPETV--LEMLQKLLYQIDPNWTSR--SDHSSNIKLRI-----HSIQAELRRL 237

Query: 592 FAKEMYRNSFLGNPGLCGDLEGLCDGRGEEKNRGYVWVLRSIF-----IL-----AGLV- 640
              + Y N  L        L  + +               + F     IL       +  
Sbjct: 238 LKSKPYENCLL-------VLLNVQN----------AKAWNA-FNLSCKILLTTRFKQVTD 279

Query: 641 FVFGLVWFYLKYRKFKNGRAIDKS-----KWTLMSFHKLGFSEYEILDG--LDEDNVIGS 693
           F+      ++           D+      K+       L     E+L          +  
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL--PR-EVLTTNPR----RLSI 332

Query: 694 -GSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDG-FQAEVETLG 751
              S +       N + V   KL   +         +E  + +        F        
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNV---LEPAEYRKMFDRLSVFPPSA---- 385

Query: 752 KIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD-WPTRYKIIVDAAEG 810
            I    +  +W      D  ++V          + LH  K  L++  P    I       
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVV----------NKLH--KYSLVEKQPKESTI------- 426

Query: 811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-----MSVIAG 865
              +        ++ ++K     L+ ++           +VD    PK+     +     
Sbjct: 427 --SIPS------IYLELKVK---LENEYALH------RSIVDHYNIPKTFDSDDLIPPYL 469

Query: 866 SCGYIAPEYAYTLRVNEKSDIYS-FGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG 924
              Y      + L+  E  +  + F +V L+           F E+ + +   +  +  G
Sbjct: 470 D-QYFYSHIGHHLKNIEHPERMTLFRMVFLDF---------RFLEQKI-RHDSTAWNASG 518

Query: 925 --VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
             ++ +   K    +K  IC               N P   R+V  + +
Sbjct: 519 SILNTLQQLKF---YKPYICD--------------NDPKYERLVNAILD 550

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 2e-05
 Identities = 78/533 (14%), Positives = 150/533 (28%), Gaps = 140/533 (26%)

Query: 551 LNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGD 610
                     +   + V       N  +     +     S+ +KE   +  + +      
Sbjct: 11  TGEHQYQYKDI---LSVFEDAFVDN-FDC--KDVQDMPKSILSKEEIDH-IIMSK----- 58

Query: 611 LEGLCDGRGEEKNRGY--VWVLRS-------IFILAGLVFVFGLVWFYLKYRKFKNGRAI 661
                    +  +      W L S        F+   L   +   +     +  +   ++
Sbjct: 59  ---------DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK--FLMSPIKTEQRQPSM 107

Query: 662 DKSKW---------TLMSFHKLGFSEYEILDGL--------DEDNVI--GSGSSGKVYKV 702
               +             F K   S  +    L           NV+  G   SGK    
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT--- 164

Query: 703 VLSNGEAVAVKKL---------WRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI 753
            ++  +     K+         W  +         +E  Q      D  + +  +    I
Sbjct: 165 WVAL-DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 754 RHK-NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH------------SCKGGLLDWPTR 800
           + + + ++          +LL  +   N  L  LL+            SCK  LL   TR
Sbjct: 224 KLRIHSIQ------AELRRLLKSKPYEN-CLLVLLNVQNAKAWNAFNLSCKI-LL--TTR 273

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDV-----KSNNILLDGDFGARVADFGVAKV--VDA 853
           +K + D     +  H     S+ H  +     +  ++L       +  D     +     
Sbjct: 274 FKQVTDFLSAATTTH----ISLDHHSMTLTPDEVKSLL------LKYLDCRPQDLPREVL 323

Query: 854 SGKPKSMSVIAGSC--GYIAPEYAYTLRVNEKSDIYSFGVVILELVTGR--------LPV 903
           +  P+ +S+IA S   G    +    +  ++ + I    + +LE    R         P 
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383

Query: 904 DPEFGEKDLVK-WVCSTLDQKGVDHVLDPKL------DCCFKEEICKVLNIGLLCTSPLP 956
                   L   W    + +  V  V++ KL      +   KE    + +I L     L 
Sbjct: 384 SAHIPTILLSLIW--FDVIKSDVMVVVN-KLHKYSLVEKQPKESTISIPSIYLELKVKLE 440

Query: 957 INRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPY----------YHEDASDQG 999
            N  A+ R   ++      N  KT   D  + PY          +H    +  
Sbjct: 441 -NEYALHR--SIVDHY---NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 64.4 bits (157), Expect = 9e-11
 Identities = 54/278 (19%), Positives = 100/278 (35%), Gaps = 70/278 (25%)

Query: 671 FHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDV 729
            +  G     + D     ++IG GS G VY     +  + VA+KK+ R            
Sbjct: 14  LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR------------ 61

Query: 730 EKGQVQDQVQDDGFQA-----EVETLGKIRHKNIVKLWCCCTTRDCKL-----LVYEYMP 779
                   + +D         E+  L +++   I++L+      D        +V E   
Sbjct: 62  --------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113

Query: 780 NGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGD 837
           +  L  L  +    L +   +  I+ +   G +++H        I+HRD+K  N LL+ D
Sbjct: 114 S-DLKKLFKT-PIFLTEEHIKT-ILYNLLLGENFIH-----ESGIIHRDLKPANCLLNQD 165

Query: 838 FGARVADFGVAKVVDASGKPKSMSVIAGSCG--------------------YIAPE---- 873
              +V DFG+A+ +++      ++ +  +                      Y APE    
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225

Query: 874 -YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
              YT  +    DI+S G +  EL+        +   +
Sbjct: 226 QENYTKSI----DIWSTGCIFAELLNMLQSHINDPTNR 259

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 62/262 (23%), Positives = 105/262 (40%), Gaps = 79/262 (30%)

Query: 670 SFHK--LGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESG 726
            F++  +  + +E+     +   +GSG+ G V   V    G  VA+KKL+R         
Sbjct: 10  GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------- 60

Query: 727 CDVEKGQVQDQVQDDGFQA-----EVETLGKIRHKNIVKLWCCCTTRDCKL--------- 772
                             A     E+  L  +RH+N++ L       D            
Sbjct: 61  -----------PFQSELFAKRAYRELRLLKHMRHENVIGL------LDVFTPDETLDDFT 103

Query: 773 ---LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS 829
              LV  +M    LG L+      L +   ++ ++    +GL Y+H      I+HRD+K 
Sbjct: 104 DFYLVMPFMGT-DLGKLMKH--EKLGEDRIQF-LVYQMLKGLRYIHA---AGIIHRDLKP 156

Query: 830 NNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI------APE-----YAYTL 878
            N+ ++ D   ++ DFG+A+  D+      M+      GY+      APE       YT 
Sbjct: 157 GNLAVNEDCELKILDFGLARQADS-----EMT------GYVVTRWYRAPEVILNWMRYTQ 205

Query: 879 RVNEKSDIYSFGVVILELVTGR 900
            V    DI+S G ++ E++TG+
Sbjct: 206 TV----DIWSVGCIMAEMITGK 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 70/254 (27%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            Y I       +++G G+ G V        GE VA+KK+                     
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------------------- 44

Query: 737 QVQDDGFQA---------EVETLGKIRHKNIVKLWCCCTTRDCKL-----LVYEYMPNGS 782
               + F           E++ L   +H+NI+ ++        +      ++ E M    
Sbjct: 45  ----EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-- 98

Query: 783 LGDLLHSCKGGLL-DWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDFG 839
             DL       +L D   +Y  I      +  LH        ++HRD+K +N+L++ +  
Sbjct: 99  --DLHRVISTQMLSDDHIQY-FIYQTLRAVKVLH-----GSNVIHRDLKPSNLLINSNCD 150

Query: 840 ARVADFGVAKVVDASGKPKSMSVIAGSC--GYI------APE-----YAYTLRVNEKSDI 886
            +V DFG+A+++D S    S      S    ++      APE       Y+  +    D+
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DV 206

Query: 887 YSFGVVILELVTGR 900
           +S G ++ EL   R
Sbjct: 207 WSCGCILAELFLRR 220

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 63/373 (16%), Positives = 113/373 (30%), Gaps = 93/373 (24%)

Query: 70  SVASIDLSNANI----AGPFPSLLCRLENLTFLTLFNNSIN----STLPDDISACQNLQH 121
           S+    L    I         ++L   +++  + L  N+I       L ++I++ ++L+ 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 122 LDLSQNLL----------TGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVIS 171
            + S                 L  AL   P L  + L+ N F     E            
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI--------- 115

Query: 172 LVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP 231
                       FL   + L+ L L  N             L       +        + 
Sbjct: 116 -----------DFLSKHTPLEHLYLHNN------------GLGPQAGAKIARALQELAVN 152

Query: 232 DSLGRLAKLVDLDLALNNL----VGAIPSSLTELASVVQIELYNNSLTGD-----LPTGW 282
                   L  +    N L    +     +      +  +++  N +  +     L  G 
Sbjct: 153 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212

Query: 283 SNLTSLRLLDASMNDLTGP----IPDDLTRLP-LESLNLYENRLEGSLPATIADS----- 332
           +    L++LD   N  T      +   L   P L  L L +  L     A + D+     
Sbjct: 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 272

Query: 333 -PGLYELRLFRNRLNGTLPGDLG----------KNSPLRWVDLSNNQFT--GEIPASLCE 379
             GL  LRL  N +                   K   L +++L+ N+F+   ++   + E
Sbjct: 273 NIGLQTLRLQYNEI-----ELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIRE 327

Query: 380 ------KGELEEL 386
                 +GEL+EL
Sbjct: 328 VFSTRGRGELDEL 340

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 59/360 (16%), Positives = 104/360 (28%), Gaps = 86/360 (23%)

Query: 240 LVDLDLALNNL----VGAIPSSLTELASVVQIELYNNSLT-------GDLPTGWSNLTSL 288
           +    L L+ +      ++ + L E  SV +I L  N++         +      +L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 289 RLLDASMNDLTGPIPDDLTRLP--------LESLNLYENRL--EG--SLPATIADSPGLY 336
              D     +   IP+ L  L         L ++ L +N         L   ++    L 
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 337 ELRLFRNRL-------------NGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGEL 383
            L L  N L                +        PLR +    N+          +    
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK---- 181

Query: 384 EELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLT--GKVPPLLWGL---PHVYLLELTD 438
                                + L  V++  N +   G    LL GL     + +L+L D
Sbjct: 182 ----------------TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225

Query: 439 NFLSGEISKNIAGA----ANLSLLIISKNN--------LSGSLPEEIGFLKSLVVLSGSE 486
           N  +   S  +A A     NL  L ++           +  +          L  L    
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF--SKLENIGLQTLRLQY 283

Query: 487 NKFTG----SLPESL-TNLAELGSLDLHANDLS------GELPSSVSSWKKLNELNLADN 535
           N+       +L   +   + +L  L+L+ N  S       E+    S+  +     L D 
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 343

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 63/336 (18%), Positives = 105/336 (31%), Gaps = 76/336 (22%)

Query: 306 LTRLPLESLNLYENRL--EG--SLPATIADSPGLYELRLFRNRLNGTLPGD--------- 352
           + R  +E  +L  + +  E   S+ A + +   + E+ L  N +     G          
Sbjct: 1   MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-----GTEAARWLSEN 55

Query: 353 LGKNSPLRWVDLSNNQ---FTGEIPA-------SLCEKGELEELLMIYNSFTGQ----LP 398
           +     L   + S+        EIP        +L +  +L  + +  N+F       L 
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 399 DGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLL 458
           D L     L  + L  N L  +               +        ++K    A  L  +
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQ------AGAK-----IARALQELAVNKKAKNAPPLRSI 164

Query: 459 IISKNNLSG----SLPEEIGFLKSLVVLSGSENKFT-----GSLPESLTNLAELGSLDLH 509
           I  +N L         +     + L  +   +N          L E L    EL  LDL 
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224

Query: 510 ANDLSGE----LPSSVSSWKKLNELNLADNLFY-------GNIPEDIGNLSVLNYLDLSN 558
            N  +      L  ++ SW  L EL L D L          +    + N+  L  L L  
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQY 283

Query: 559 NRLSGRIPVGLQNL---------KLNQLNVSNNRLS 585
           N +       ++ L          L  L ++ NR S
Sbjct: 284 NEIE---LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 42/271 (15%), Positives = 82/271 (30%), Gaps = 53/271 (19%)

Query: 356 NSPLRWVDLSNNQFTGE----IPASLCEKGELEELLMIYNSFTGQ----LPDGLGHCQSL 407
              +    L  +  T E    + A L E   ++E+++  N+   +    L + +   + L
Sbjct: 3   RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62

Query: 408 TRVRLGYN---RLTGKVPP-------LLWGLPHVYLLELTDNFLSGEISKNIAGA----A 453
                      R+  ++P         L   P ++ + L+DN       + +        
Sbjct: 63  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122

Query: 454 NLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL 513
            L  L +  N L    P+    +     L              L       S+    N L
Sbjct: 123 PLEHLYLHNNGLG---PQAGAKIAR--ALQELAVNKKAKNAPPLR------SIICGRNRL 171

Query: 514 SGE----LPSSVSSWKKLNELNLADNLFY-----GNIPEDIGNLSVLNYLDLSNNRLSGR 564
                     +  S + L+ + +  N          + E +     L  LDL +N  +  
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT-- 229

Query: 565 IPVGLQNL--------KLNQLNVSNNRLSGE 587
             +G   L         L +L +++  LS  
Sbjct: 230 -HLGSSALAIALKSWPNLRELGLNDCLLSAR 259

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.8 bits (150), Expect = 6e-10
 Identities = 46/200 (23%), Positives = 82/200 (41%), Gaps = 41/200 (20%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEK 731
               S+++I D  +  ++IG+GS G V +         VA+KK+ R              
Sbjct: 43  PRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------------- 88

Query: 732 GQVQDQVQDDGFQA-----EVETLGKIRHKNIVKLWCCCTTRDCKL-----LVYEYMPNG 781
                 V +D         E+  L ++ H ++VK+      +D +      +V E   + 
Sbjct: 89  ------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS- 141

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDFG 839
               L  +    L +   +  ++ +   G+ Y+H     S  I+HRD+K  N L++ D  
Sbjct: 142 DFKKLFRT-PVYLTELHIKT-LLYNLLVGVKYVH-----SAGILHRDLKPANCLVNQDCS 194

Query: 840 ARVADFGVAKVVDASGKPKS 859
            +V DFG+A+ VD      S
Sbjct: 195 VKVCDFGLARTVDYPENGNS 214

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 4/112 (3%)

Query: 91  RLENLTFLTLFNNSINS-TLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
              ++  L L N+  N   L       + L+ L      LT ++   L  L  LK L+L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLL-DGTIPAFLGNISTLKMLNLSYNP 200
            N  SG +     +   L  ++L  N + D +    L  +  LK L+L    
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE 124

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 28/104 (26%), Positives = 44/104 (42%), Gaps = 4/104 (3%)

Query: 73  SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT 132
            +D S +N  G    L    E L FL+  N  + S    ++     L+ L+LS N ++G 
Sbjct: 23  VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG 79

Query: 133 LTPALADLPNLKFLDLTGNNFSG-DIPESFGRFQKLEVISLVYN 175
           L       PNL  L+L+GN        E   + + L+ + L   
Sbjct: 80  LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 29/135 (21%), Positives = 48/135 (35%), Gaps = 28/135 (20%)

Query: 187 NISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA 246
             S +K L L  +    G++         LE L      L   I + L +L KL  L+L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 247 LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGP-IPDD 305
                                   +N ++G L        +L  L+ S N +      + 
Sbjct: 73  ------------------------DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108

Query: 306 LTRLP-LESLNLYEN 319
           L +L  L+SL+L+  
Sbjct: 109 LKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 23/80 (28%), Positives = 33/80 (41%), Gaps = 8/80 (10%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDI---SACQNLQHLDLSQNLLT 130
           ++LS+  ++G    L  +  NLT L L  N I       I      +NL+ LDL    +T
Sbjct: 69  LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEVT 126

Query: 131 ---GTLTPALADLPNLKFLD 147
                       LP L +LD
Sbjct: 127 NLNDYRENVFKLLPQLTYLD 146

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 46/233 (19%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE+L       VIG GS G+V K       + VA+K + R   +                
Sbjct: 99  YEVLK------VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQA----------- 140

Query: 738 VQDDGFQAEVETLGKIRHK------NIVKLWCCCTTRD--CKLLVYEYMPNGSLGDLLHS 789
                   E+  L  +R +      N++ +    T R+  C  + +E + + +L +L+  
Sbjct: 141 ------AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--MTFELL-SMNLYELIKK 191

Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--DGDFGARVADFGV 847
            K      P   K      + L  LH      I+H D+K  NILL   G  G +V DFG 
Sbjct: 192 NKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS 248

Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGR 900
           +         + +     S  Y APE     R     D++S G ++ EL+TG 
Sbjct: 249 SCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 59.3 bits (143), Expect = 4e-09
 Identities = 61/269 (22%), Positives = 100/269 (37%), Gaps = 57/269 (21%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IGSGS G++Y    +   E VA+K          E+    +  Q+           E + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK---------LEN-VKTKHPQLLY---------ESKI 55

Query: 750 LGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDA 807
              ++    I  +       D  +LV + +  G SL DL + C    L   T   +    
Sbjct: 56  YRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFC-SRKLSLKTVLMLADQM 112

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLD-GDFGARV--ADFGVAK--VVDASGKPKSMSV 862
              + ++H     S +HRD+K +N L+  G    +V   DFG+AK     ++ +      
Sbjct: 113 INRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 863 IAGSCGYIAPEYA--YTLRVNEKS---DIYSFGVVILELVTGRLPVDPEFGEKDLVKW-- 915
                G     YA   T    E+S   D+ S G V++  + G LP            W  
Sbjct: 170 NKNLTG--TARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP------------WQG 215

Query: 916 -VCSTLDQKGVDHVLDPKLDCCFKEEICK 943
               T  QK  + + + K+     E +C+
Sbjct: 216 LKAGTKKQK-YEKISEKKVATSI-EALCR 242

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 59.6 bits (144), Expect = 4e-09
 Identities = 58/362 (16%), Positives = 117/362 (32%), Gaps = 50/362 (13%)

Query: 85  FPSLLCRLENLTFLTLFNNSIN-STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNL 143
                  LE L F       I+   L      C++L  + +  +     L        NL
Sbjct: 187 LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG-DFEILELVGFFKAAANL 245

Query: 144 KFLDLTGNNFSGDIPESFGRFQKLEVISL--VYNLLDGTIPAFLGNISTLKMLNLSYNPF 201
           +       N    +PE +        +    +  +    +P      + ++ L+L Y   
Sbjct: 246 EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALL 305

Query: 202 LPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLA----KLVDLDLA---LNNLVGAI 254
                   +    NLE+L       +G+    L  LA    +L  L +        +   
Sbjct: 306 ETEDHCTLIQKCPNLEVLETRNV--IGD--RGLEVLAQYCKQLKRLRIERGADEQGMEDE 361

Query: 255 PSSLTE--LASVVQ-------IELYNNSLTGD----LPTGWSNLTSLRLLDASMNDLTGP 301
              +++  L ++ Q       + +Y + +T +    + T   NL   RL+          
Sbjct: 362 EGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDR------ 415

Query: 302 IPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPG--DLGKNSP- 358
             + +T LPL++           + + +     L     +  +   T  G   +G+ SP 
Sbjct: 416 -EERITDLPLDN----------GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPN 464

Query: 359 LRWVDLSNNQFTGEIPASLCEK-GELEELLMIYNSFTGQ-LPDGLGHCQSLTRVRLGYNR 416
           +RW+ L     + E           L++L M    F+ + +   +    SL  + +   R
Sbjct: 465 VRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524

Query: 417 LT 418
            +
Sbjct: 525 AS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 51.1 bits (122), Expect = 2e-06
 Identities = 72/535 (13%), Positives = 149/535 (27%), Gaps = 73/535 (13%)

Query: 90  CRLENLTFLTLF-NNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDL 148
            ++++ T   +       +T         NL+ L L          P  A    +   + 
Sbjct: 45  FKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGK-------PRAAMFNLI--PEN 95

Query: 149 TGNNFSGDIPESFGRFQKLEVISLVYNLL--DGTIPAFLGNISTLKMLNLSYNPFLPGRI 206
            G   +  + E     ++L+ +     ++               L+ L L          
Sbjct: 96  WGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDG 155

Query: 207 PPELG-NLTNLEILWLTECNLVGEIPDSLGRLAK----LVDLDLALNNLVGAIPSSLTEL 261
              +  +   ++ L + E +   +    L  LA+    L  L+  +       P  L  +
Sbjct: 156 LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI 215

Query: 262 ASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENR 320
           A                     +L S+++ D  + +L G           LE        
Sbjct: 216 AR-----------------NCRSLVSVKVGDFEILELVGF----FKAAANLEEFCGGSLN 254

Query: 321 LEGSLPATIADSPGLYELRL--FRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLC 378
            +  +P    +     +L            +P      + +R +DL       E   +L 
Sbjct: 255 EDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLI 314

Query: 379 EKGELEELLMIYNSFTGQLPDGLG-HCQSLTRVRLGYNRLTGKVPP------------LL 425
           +K    E+L   N    +  + L  +C+ L R+R+        +              L 
Sbjct: 315 QKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALA 374

Query: 426 WGLPHVYLLELTDNFLSGE----ISKNIAGAANLSLLIISKNNLSGSLPEEIGF------ 475
            G   +  + +  + ++ E    I   +    +  L+++ +      LP + G       
Sbjct: 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG 434

Query: 476 ---LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGE-LPSSVSSWKKLNELN 531
              L+               L         +  + L     S E L         L +L 
Sbjct: 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLE 494

Query: 532 LADNLFYGN-IPEDIGNLSVLNYLDLSNNRLS----GRIPVGLQNLKLNQLNVSN 581
           +    F    I   +  L  L YL +   R S      + +      +  +    
Sbjct: 495 MRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 59/267 (22%), Positives = 103/267 (38%), Gaps = 81/267 (30%)

Query: 670 SFHKLGF---SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECES 725
           S +  GF   S Y  L        +G G +G V+  V     + VA+KK+          
Sbjct: 1   SMNIHGFDLGSRYMDL------KPLGCGGNGLVFSAVDNDCDKRVAIKKI---------- 44

Query: 726 GCDVEKGQVQDQVQDDGFQA-----EVETLGKIRHKNIVKL----------WCCCTTRDC 770
                       V  D         E++ + ++ H NIVK+                   
Sbjct: 45  ------------VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92

Query: 771 KL----LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRD 826
           +L    +V EYM    L ++L    G LL+   R   +     GL Y+H     +++HRD
Sbjct: 93  ELNSVYIVQEYMET-DLANVLEQ--GPLLEEHARL-FMYQLLRGLKYIHS---ANVLHRD 145

Query: 827 VKSNNILLD-GDFGARVADFGVAKVVDASGKPKS-MSVIAGSCGYI------APE----- 873
           +K  N+ ++  D   ++ DFG+A+++D     K  +S        +      +P      
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS------EGLVTKWYRSPRLLLSP 199

Query: 874 YAYTLRVNEKSDIYSFGVVILELVTGR 900
             YT  +    D+++ G +  E++TG+
Sbjct: 200 NNYTKAI----DMWAAGCIFAEMLTGK 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 73/259 (28%)

Query: 670 SFHK--LGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESG 726
           +F++  L  + +E+ +     + +GSG+ G V        G  VAVKKL R         
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS----- 68

Query: 727 CDVEKGQVQDQVQDDGFQA--EVETLGKIRHKNIVKLWCCCTTRDCKL------------ 772
                            +   E+  L  ++H+N++ L       D               
Sbjct: 69  ------------IIHAKRTYRELRLLKHMKHENVIGL------LDVFTPARSLEEFNDVY 110

Query: 773 LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           LV   M    L +++      L D   ++ +I     GL Y+H      I+HRD+K +N+
Sbjct: 111 LVTHLMGA-DLNNIVKC--QKLTDDHVQF-LIYQILRGLKYIHS---ADIIHRDLKPSNL 163

Query: 833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYI------APE-----YAYTLRVN 881
            ++ D   ++ DFG+A+          M+      GY+      APE       Y   V 
Sbjct: 164 AVNEDCELKILDFGLARHTAD-----EMT------GYVATRWYRAPEIMLNWMHYNQTV- 211

Query: 882 EKSDIYSFGVVILELVTGR 900
              DI+S G ++ EL+TGR
Sbjct: 212 ---DIWSVGCIMAELLTGR 227

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 36/144 (25%), Positives = 60/144 (41%), Gaps = 15/144 (10%)

Query: 93  ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGN 151
           E +T + L  N+I    P   S  + L+ +DLS N ++  L P A   L +L  L L GN
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 152 NFSGDIPESFGRFQKLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSYNPFLPGRIPPE 209
             +      F     L+++ L  N +   +   AF  ++  L +L+L  N      I   
Sbjct: 91  KITELPKSLFEGLFSLQLLLLNANKI-NCLRVDAF-QDLHNLNLLSLYDNKL--QTIAKG 146

Query: 210 -LGNLTNLEILWLT------ECNL 226
               L  ++ + L       +C+L
Sbjct: 147 TFSPLRAIQTMHLAQNPFICDCHL 170

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 33/137 (24%), Positives = 54/137 (39%), Gaps = 11/137 (8%)

Query: 141 PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSY 198
             +  + L  N      P +F  ++KL  I L  N +   +   AF G + +L  L L  
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG-LRSLNSLVLYG 89

Query: 199 N--PFLPGRIPPELGNLTNLEILWLTECNLVGEIP-DSLGRLAKLVDLDLALNNLVGAIP 255
           N    LP  +      L +L++L L   N +  +  D+   L  L  L L  N L     
Sbjct: 90  NKITELPKSL---FEGLFSLQLLLL-NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145

Query: 256 SSLTELASVVQIELYNN 272
            + + L ++  + L  N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 29/122 (23%), Positives = 50/122 (40%), Gaps = 15/122 (12%)

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIP----DDLTRL 309
           +P ++TE+       L  N++    P  +S    LR +D S N ++  +       L   
Sbjct: 30  LPETITEI------RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRS- 81

Query: 310 PLESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQ 368
            L SL LY N++   LP ++ +    L  L L  N++N            L  + L +N+
Sbjct: 82  -LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139

Query: 369 FT 370
             
Sbjct: 140 LQ 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 27/152 (17%)

Query: 203 PGRIPPELGNLTNLEILWLTECNLVGEIP-DSLGRLAKLVDLDLALNNLVGAIPS----S 257
           P  +P        +  + L E N +  IP  +     KL  +DL+ N +   +       
Sbjct: 27  PTNLP------ETITEIRL-EQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78

Query: 258 LTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGPIP----DDLTRLPLE 312
           L  L     + LY N +T +LP   +  L SL+LL  + N +   +      DL  L   
Sbjct: 79  LRSLN---SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNL--N 131

Query: 313 SLNLYENRLEGSLPATIADS-PGLYELRLFRN 343
            L+LY+N+L+ ++          +  + L +N
Sbjct: 132 LLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 5/130 (3%)

Query: 243 LDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGP 301
           + L  N +    P + +    + +I+L NN ++ +L    +  L SL  L    N +T  
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95

Query: 302 IPDDLTRLP-LESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKNSPL 359
                  L  L+ L L  N++   L          L  L L+ N+L     G       +
Sbjct: 96  PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154

Query: 360 RWVDLSNNQF 369
           + + L+ N F
Sbjct: 155 QTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.0 bits (120), Expect = 9e-07
 Identities = 34/136 (25%), Positives = 65/136 (47%), Gaps = 8/136 (5%)

Query: 406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNN 464
           ++T +RL  N +    P        +  ++L++N +S E++ +   G  +L+ L++  N 
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91

Query: 465 LSGSLPEEIGF--LKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSV 521
           ++  LP+ + F  L SL +L  + NK    L   +  +L  L  L L+ N L      + 
Sbjct: 92  IT-ELPKSL-FEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148

Query: 522 SSWKKLNELNLADNLF 537
           S  + +  ++LA N F
Sbjct: 149 SPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 22/88 (25%), Positives = 32/88 (36%)

Query: 91  RLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTG 150
            L +L  L L+ N I            +LQ L L+ N +      A  DL NL  L L  
Sbjct: 78  GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137

Query: 151 NNFSGDIPESFGRFQKLEVISLVYNLLD 178
           N        +F   + ++ + L  N   
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 43/160 (26%), Positives = 63/160 (39%), Gaps = 15/160 (9%)

Query: 406 SLTRVRLGYNRLTGKVPPLLWGLP-HVYLLELTDNFLSGEISKNIAGAANLSLLIISKNN 464
           S   V      LT ++P     LP  +  + L  N +        +    L  + +S N 
Sbjct: 12  SNNIVDCRGKGLT-EIPT---NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ 67

Query: 465 LSGSLPEEIGF--LKSLVVLSGSENKFTGSLPESL-TNLAELGSLDLHANDLSGELPSSV 521
           +S  L  +  F  L+SL  L    NK T  LP+SL   L  L  L L+AN ++  L    
Sbjct: 68  IS-ELAPDA-FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDA 123

Query: 522 -SSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNN 559
                 LN L+L DN     I +     L  +  + L+ N
Sbjct: 124 FQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 31/112 (27%), Positives = 48/112 (42%), Gaps = 9/112 (8%)

Query: 476 LKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSV-SSWKKLNELNLA 533
            K L  +  S N+ +  L   +   L  L SL L+ N ++ ELP S+      L  L L 
Sbjct: 55  YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112

Query: 534 DNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNN 582
            N     +  D   +L  LN L L +N+L   I  G    L  +  ++++ N
Sbjct: 113 ANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)

Query: 362 VDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDG-LGHCQSLTRVRLGYNRLTGK 420
           VD      T EIP +L E   + E+ +  N+    +P G     + L R+ L  N+++ +
Sbjct: 16  VDCRGKGLT-EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-E 70

Query: 421 VPP-LLWGLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIGF--L 476
           + P    GL  +  L L  N ++ E+ K++  G  +L LL+++ N ++  L  +  F  L
Sbjct: 71  LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDA-FQDL 127

Query: 477 KSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAN 511
            +L +LS  +NK       + + L  + ++ L  N
Sbjct: 128 HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 21/69 (30%), Positives = 26/69 (37%), Gaps = 2/69 (2%)

Query: 86  PSLLCRLENLTFLTLFNNSINSTLPDDI-SACQNLQHLDLSQNLLTGTLTPALADLPNLK 144
            SL   L +L  L L  N IN  L  D      NL  L L  N L        + L  ++
Sbjct: 97  KSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155

Query: 145 FLDLTGNNF 153
            + L  N F
Sbjct: 156 TMHLAQNPF 164

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 44/167 (26%), Positives = 65/167 (38%), Gaps = 15/167 (8%)

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-P--IPDDLTRLP 310
           IP+   +L      +L +  L       +  LT L  L+   N L      + DDLT   
Sbjct: 33  IPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE-- 84

Query: 311 LESLNLYENRLEGSLPATIADSP-GLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQF 369
           L +L L  N+L  SLP  + D    L +L L  N+L     G   + + L+ + L+ NQ 
Sbjct: 85  LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143

Query: 370 TGEIPASLCEK-GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN 415
              IPA   +K   L+ L +  N               L  + L  N
Sbjct: 144 Q-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 55/177 (31%), Positives = 74/177 (41%), Gaps = 25/177 (14%)

Query: 203 PGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPS----SL 258
           P  IP       + E L L    L      +   L KL  L+L  N L   + +     L
Sbjct: 30  PSGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDL 82

Query: 259 TELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGPIP----DDLTRLPLES 313
           TEL ++    L NN L   LP G + +LT L  L    N L   +P    D LT+  L+ 
Sbjct: 83  TELGTL---GLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTK--LKE 135

Query: 314 LNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQF 369
           L L  N+L+ S+PA   D    L  L L  N+L     G   +   L+ + L  NQF
Sbjct: 136 LRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 38/156 (24%), Positives = 54/156 (34%), Gaps = 7/156 (4%)

Query: 120 QHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDG 179
           + LDL    L          L  L +L+L  N         F    +L  + L  N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 180 TIPAFLGNISTLKMLNLSYNPF--LPGRIPPELGNLTNLEILWLTECNLVGEIPDSL-GR 236
                  +++ L  L L  N    LP  +      LT L+ L L   N +  IP     +
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKSLPSGV---FDRLTKLKELRL-NTNQLQSIPAGAFDK 153

Query: 237 LAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNN 272
           L  L  L L+ N L      +   L  +  I L+ N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 46/155 (29%), Positives = 63/155 (40%), Gaps = 11/155 (7%)

Query: 434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVLSGSENKFTGS 492
           L+L    L+        G   L+ L +  N L  +L   +   L  L  L  + N+   S
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 493 LPESL-TNLAELGSLDLHANDLSGELPSSV-SSWKKLNELNLADNLFYGNIPEDI-GNLS 549
           LP  +  +L +L  L L  N L   LPS V     KL EL L  N    +IP      L+
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLT 155

Query: 550 VLNYLDLSNNRLSGRIPVG-LQNLK-LNQLNVSNN 582
            L  L LS N+L   +P G    L  L  + +  N
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 42/181 (23%), Positives = 64/181 (35%), Gaps = 34/181 (18%)

Query: 384 EELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
           E+L +                  LT + L YN+L   +     G+      +LT      
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSA---GVFD----DLT------ 83

Query: 444 EISKNIAGAANLSLLIISKNNLSGSLPEEIGF--LKSLVVLSGSENKFTGSLPESL-TNL 500
                      L  L ++ N L+ SLP  + F  L  L  L    N+   SLP  +   L
Sbjct: 84  ----------ELGTLGLANNQLA-SLPLGV-FDHLTQLDKLYLGGNQLK-SLPSGVFDRL 130

Query: 501 AELGSLDLHANDLSGELPSSV-SSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSN 558
            +L  L L+ N L   +P+        L  L+L+ N    ++P      L  L  + L  
Sbjct: 131 TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFG 188

Query: 559 N 559
           N
Sbjct: 189 N 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 11/105 (10%)

Query: 487 NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW-KKLNELNLADNLFYGNIPEDI 545
                    +   L +L  L+L  N L   L + V     +L  L LA+N    ++P  +
Sbjct: 45  TGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL-ASLPLGV 102

Query: 546 -GNLSVLNYLDLSNNRLSGRIPVG----LQNLKLNQLNVSNNRLS 585
             +L+ L+ L L  N+L   +P G    L  LK  +L ++ N+L 
Sbjct: 103 FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK--ELRLNTNQLQ 144

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 61/383 (15%), Positives = 107/383 (27%), Gaps = 94/383 (24%)

Query: 100 LFNNSINSTLPDDISA----CQNLQHLDLSQNLLTGT----LTPALADLP-NLKFLDLTG 150
           +          + +         +  LDLS N L       L  A A+ P ++  L+L+G
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60

Query: 151 NNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPEL 210
           N+      +   +                         + +  LNLS N         EL
Sbjct: 61  NSLGFKNSDELVQ-------------------ILAAIPANVTSLNLSGNFLSYKSS-DEL 100

Query: 211 GNL-----TNLEILWLTECNL----VGEIPDSLGRL-AKLVDLDLALNNL--VGA----- 253
                     + +L L   +       E   +   L A +  L+L  N+L    +     
Sbjct: 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160

Query: 254 ----IPSSLTELASVVQIELYNNSLTGD--------LPTGWSNLTSLRLLDASMNDLT-- 299
               IP+++  L       L  N+L           L +  +++TSL L   S N L   
Sbjct: 161 ILAAIPANVNSL------NLRGNNLASKNCAELAKFLASIPASVTSLDL---SANLLGLK 211

Query: 300 --GPIPDDLTRLP--LESLNLYENRLEGS----LPATIADSPGLYELRLFRNRLNGTLPG 351
               +    + +P  + SLNL  N L G     L         L  + L  + +      
Sbjct: 212 SYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE 271

Query: 352 D-------LGKNSPLRWVDLSNNQFTGEIPASLCE-----KGELEELLMIYNSFT----- 394
                         +  VD +  +        +        G+ +   ++          
Sbjct: 272 QCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKH 331

Query: 395 GQLPDGLGHCQSLTRVRLGYNRL 417
               + L     L         L
Sbjct: 332 QTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 34/189 (17%), Positives = 64/189 (33%), Gaps = 34/189 (17%)

Query: 94  NLTFLTLFNNSINSTLPDDI-----SACQNLQHLDLSQNLLTGTLTPALADL-----PNL 143
           N+  L L  N++ S    ++     S   ++  LDLS NLL       LA +      ++
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227

Query: 144 KFLDLTGNNFSGD----IPESFGRFQKLEVISLVYNLLDGT-------IPAFLGNISTLK 192
             L+L  N   G     +       + L+ + L Y+++          + A   NI  + 
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287

Query: 193 MLNLSYNPFLP-GRIPPELGNL-----TNLEILWLTECNL-----VGEIPDSLGRLAKLV 241
           +++ +     P   I   + NL        ++  L    L          + L    +L 
Sbjct: 288 LVDKNGKEIHPSHSI--PISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELR 345

Query: 242 DLDLALNNL 250
           +       L
Sbjct: 346 ESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 54/311 (17%), Positives = 98/311 (31%), Gaps = 60/311 (19%)

Query: 353 LGKNSPLRWVDLSNNQFTGEIPASLCE-----KGELEELLMIYNSFTGQ----LPDGLGH 403
                 +  +DLS N         L +        +  L +  NS   +    L   L  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 404 C-QSLTRVRLGYNRLTGK-VPPLLWGLPHVYL----LELTDNFLSGEISKNIAGA----- 452
              ++T + L  N L+ K    L+  L  +      L+L  N  S + S     A     
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 453 ANLSLLIISKNN--------LSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAE-- 502
           A+++ L +  N+        L   L      + SL +     N       ++   LA+  
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNL---RGNNLA---SKNCAELAKFL 191

Query: 503 ------LGSLDLHANDLSGELPSSVSS-----WKKLNELNLADNLFYGNIPEDIGNL--- 548
                 + SLDL AN L  +  + ++         +  LNL  N  +G   E++  L   
Sbjct: 192 ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251

Query: 549 -SVLNYLDLSNNRLSGRIPVGLQNL--------KLNQLNVSNNRLSGELPSLFAKEMYRN 599
              L  + L  + +        + L        K+  ++ +   +        +  +   
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIREL 311

Query: 600 SF-LGNPGLCG 609
           S     P L  
Sbjct: 312 SGKADVPSLLN 322

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 51/227 (22%), Positives = 80/227 (35%), Gaps = 42/227 (18%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG GS G +++   L N + VA+K          E     +  Q++D         E  T
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK---------FEP-RRSDAPQLRD---------EYRT 58

Query: 750 LGKIRH-KNIVKLWCCCTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDA 807
              +     I  ++         +LV + +  G SL DLL  C G      T        
Sbjct: 59  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLC-GRKFSVKTVAMAAKQM 115

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR-----VADFGVAK--VVDASGKPKSM 860
              +  +H     S+V+RD+K +N L+            V DFG+ K      + +    
Sbjct: 116 LARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 172

Query: 861 SVIAGSCGYIAPEYA--YTLRVNEKS---DIYSFGVVILELVTGRLP 902
                  G     Y    T    E+S   D+ + G V +  + G LP
Sbjct: 173 REKKNLSG--TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 26/116 (22%), Positives = 48/116 (41%), Gaps = 6/116 (5%)

Query: 87  SLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFL 146
           + L  L+    L L  N+I       +S  +NL+ L L +NL+   +    A    L+ L
Sbjct: 42  ATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98

Query: 147 DLTGNNFSGDIPESFGRFQKLEVISLVYNLL-DGTIPAFLGNISTLKMLNLSYNPF 201
            ++ N  +  +     +   L V+ +  N + +      L  +  L+ L L+ NP 
Sbjct: 99  WISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 35/161 (21%), Positives = 58/161 (36%), Gaps = 36/161 (22%)

Query: 92  LENLTFLTLFNNSIN--STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
                 + L +  I     +   +S  +  +HL LS N +   ++  L+ + NL+ L L 
Sbjct: 22  ATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLG 78

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE 209
            N     I         LE + + YN            I++L                  
Sbjct: 79  RNLIK-KIENLDAVADTLEELWISYN-----------QIASLS----------------G 110

Query: 210 LGNLTNLEILWLTECNLVGEIPD--SLGRLAKLVDLDLALN 248
           +  L NL +L+++  N +    +   L  L KL DL LA N
Sbjct: 111 IEKLVNLRVLYMS-NNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 36/133 (27%), Positives = 53/133 (39%), Gaps = 19/133 (14%)

Query: 194 LNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL--- 250
           L+    P    ++   L  L   + L L   N + +I  SL  +  L  L L  N +   
Sbjct: 30  LHGMIPPIE--KMDATLSTLKACKHLAL-STNNIEKI-SSLSGMENLRILSLGRNLIKKI 85

Query: 251 --VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIP-DDLT 307
             + A+  +L EL       +  N +   L +G   L +LR+L  S N +T     D L 
Sbjct: 86  ENLDAVADTLEEL------WISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLA 137

Query: 308 RLP-LESLNLYEN 319
            L  LE L L  N
Sbjct: 138 ALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 33/146 (22%), Positives = 56/146 (38%), Gaps = 12/146 (8%)

Query: 458 LIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGEL 517
           L      +   +   +  LK+   L+ S N     +  SL+ +  L  L L  N +  ++
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85

Query: 518 PSSVSSWKKLNELNLADNLFYGNIP--EDIGNLSVLNYLDLSNNRLSGRIPVG-LQNLK- 573
            +  +    L EL ++ N     I     I  L  L  L +SNN+++    +  L  L  
Sbjct: 86  ENLDAVADTLEELWISYN----QIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141

Query: 574 LNQLNVSNNRLSGELPSLFAKEMYRN 599
           L  L ++ N L  +     A   YR 
Sbjct: 142 LEDLLLAGNPLYNDYKENNATSEYRI 167

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 6/104 (5%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL 133
           +D   +N  G    L     NL FL+L N  + S    ++     L+ L+LS+N + G L
Sbjct: 31  LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGL 87

Query: 134 TPALADLPNLKFLDLTGNNFS--GDIPESFGRFQKLEVISLVYN 175
                 LPNL  L+L+GN       + E   + + L+ + L   
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 28/113 (24%), Positives = 44/113 (38%), Gaps = 6/113 (5%)

Query: 91  RLENLTFLTLFNNSIN-STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
               +  L L N   N   +    +   NL+ L L    L  +++  L  LP LK L+L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLD--GTIPAFLGNISTLKMLNLSYNP 200
            N   G +     +   L  ++L  N L    T+   L  +  LK L+L    
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCE 131

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 5/115 (4%)

Query: 187 NISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLA 246
             + ++ L L       G+I        NLE L L    L+  +  +L +L KL  L+L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 247 LNNLVGAIPSSLTELASVVQIELYNNSLT--GDLPTGWSNLTSLRLLDASMNDLT 299
            N + G +     +L ++  + L  N L     L      L  L+ LD    ++T
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 8/88 (9%)

Query: 66  PRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDI---SACQNLQHL 122
           P+   +  ++LS   I G    L  +L NLT L L  N +       +      + L+ L
Sbjct: 68  PKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSL 125

Query: 123 DLSQNLLT---GTLTPALADLPNLKFLD 147
           DL    +T            LP L +LD
Sbjct: 126 DLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 96/270 (35%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +YE++        +G G+ G V+K +    GE VAVKK++                   
Sbjct: 9   RKYELVK------KLGKGAYGIVWKSIDRRTGEVVAVKKIF------------------- 43

Query: 736 DQVQDDGFQAEVE---TLGKIR-------HKNIVKLWCCCTTRDCKL--------LVYEY 777
                D FQ   +   T  +I        H+NIV L       +           LV++Y
Sbjct: 44  -----DAFQNSTDAQRTFREIMILTELSGHENIVNL------LNVLRADNDRDVYLVFDY 92

Query: 778 MPNGSLGDLLHSCKGGLL-DWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILL 834
           M      DL    +  +L     +Y ++    + + YLH     S  ++HRD+K +NILL
Sbjct: 93  MET----DLHAVIRANILEPVHKQY-VVYQLIKVIKYLH-----SGGLLHRDMKPSNILL 142

Query: 835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG-------------------YIAPE-- 873
           + +   +VADFG+++      +  +   ++ +                     Y APE  
Sbjct: 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202

Query: 874 ---YAYTLRVNEKSDIYSFGVVILELVTGR 900
                YT  +    D++S G ++ E++ G+
Sbjct: 203 LGSTKYTKGI----DMWSLGCILGEILCGK 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 40/225 (17%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IGSGS G +Y    ++ GE VA+K          E     +  Q+           E + 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIK---------LEC-VKTKHPQLHI---------ESKI 57

Query: 750 LGKIRH-KNIVKLWCCCTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDA 807
              ++    I  +  C    D  ++V E +  G SL DL + C        T   +    
Sbjct: 58  YKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFC-SRKFSLKTVLLLADQM 114

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILL-DGDFGARV--ADFGVAK--VVDASGKPKSMSV 862
              + Y+H     + +HRDVK +N L+  G  G  V   DFG+AK      + +      
Sbjct: 115 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 863 IAGSCGYIAPEYA--YTLRVNEKS---DIYSFGVVILELVTGRLP 902
                G     YA   T    E+S   D+ S G V++    G LP
Sbjct: 172 NKNLTG--TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 42/250 (16%), Positives = 80/250 (32%), Gaps = 24/250 (9%)

Query: 58  SWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTL-FNNSINSTLPDDISAC 116
            W  +  D        +   N +     P +  RL +   +      S       +  + 
Sbjct: 38  RWYRLASDESLWQTLDLTGKNLH-----PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP 92

Query: 117 QNLQHLDLS-QNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISL--V 173
             +QH+DLS   +   TL   L+    L+ L L G   S  I  +  +   L  ++L   
Sbjct: 93  FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 152

Query: 174 YNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPEL--GNLTNLEILWLTECNLVGEIP 231
               +  +   L + S L  LNLS+      +            +  L L+       + 
Sbjct: 153 SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR--KNLQ 210

Query: 232 D-SLGRLAK----LVDLDLALNNLVGAIPSSLTELASVVQIEL----YNNSLTGDLPTGW 282
              L  L +    LV LDL+ + ++        E   +  ++         +  +     
Sbjct: 211 KSDLSTLVRRCPNLVHLDLSDSVMLK--NDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 268

Query: 283 SNLTSLRLLD 292
             + +L+ L 
Sbjct: 269 GEIPTLKTLQ 278

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 43/212 (20%), Positives = 71/212 (33%), Gaps = 35/212 (16%)

Query: 68  SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSIN-STLPDDISACQNLQHLDLSQ 126
           S  V +     + +  P          +  + L N+ I  STL   +S C  LQ+L L  
Sbjct: 69  SQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 127

Query: 127 NLLTGTLTPALADLPNLKFLDLTG-NNFSGDIPESFGRF--------------------- 164
             L+  +   LA   NL  L+L+G + FS    ++                         
Sbjct: 128 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 187

Query: 165 -------QKLEVISL---VYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLT 214
                  + +  ++L     NL    +   +     L  L+LS +  L      E   L 
Sbjct: 188 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247

Query: 215 NLEILWLTECNLVGEI-PDSLGRLAKLVDLDL 245
            L+ L L+ C  +       LG +  L  L +
Sbjct: 248 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 279

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 34/168 (20%), Positives = 64/168 (38%), Gaps = 11/168 (6%)

Query: 67  RSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSI--NSTLPDDISACQNLQHLDL 124
           +   + ++ L    ++ P  + L +  NL  L L   S      L   +S+C  L  L+L
Sbjct: 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 175

Query: 125 S--QNLLTGTLTPALADL-PNLKFLDLTGNNFS---GDIPESFGRFQKLEVISLVY--NL 176
           S   +     +  A+A +   +  L+L+G   +    D+     R   L  + L     L
Sbjct: 176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235

Query: 177 LDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTEC 224
            +         ++ L+ L+LS    +      ELG +  L+ L +   
Sbjct: 236 KNDCFQE-FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 42/189 (22%), Positives = 59/189 (31%), Gaps = 59/189 (31%)

Query: 773 LVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN 831
           +V+E +  G  L   +       L  P   KII    +GL YLH  C   I+H D+K  N
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPEN 177

Query: 832 ILL-------------------------------------------------DGDFGARV 842
           ILL                                                       ++
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           AD G A  V      K  +    +  Y + E       N  +DI+S   +  EL TG   
Sbjct: 238 ADLGNACWVH-----KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292

Query: 903 VDPEFGEKD 911
            +P  GE+ 
Sbjct: 293 FEPHSGEEY 301

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 26/83 (31%), Positives = 34/83 (40%), Gaps = 9/83 (10%)

Query: 73  SIDLSNANIAGPFPSL--LCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLT 130
           +ID S+  I      L     L  L  L + NN I         A  +L  L L+ N L 
Sbjct: 46  AIDFSDNEI----RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

Query: 131 --GTLTPALADLPNLKFLDLTGN 151
             G L P LA L +L +L +  N
Sbjct: 102 ELGDLDP-LASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 22/104 (21%), Positives = 40/104 (38%), Gaps = 6/104 (5%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL 133
           +DL    I     +L   L+    +   +N I     D     + L+ L ++ N +    
Sbjct: 24  LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIG 80

Query: 134 TPALADLPNLKFLDLTGNNFS--GDIPESFGRFQKLEVISLVYN 175
                 LP+L  L LT N+    GD+ +     + L  + ++ N
Sbjct: 81  EGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 22/112 (19%), Positives = 34/112 (30%), Gaps = 6/112 (5%)

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN 151
                 L L    I   + +  +       +D S N +   L      L  LK L +  N
Sbjct: 18  AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNN 74

Query: 152 NFSGDIPESFGRFQKLEVISLVYNLLD--GTIPAFLGNISTLKMLNLSYNPF 201
                          L  + L  N L   G +   L ++ +L  L +  NP 
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 27/117 (23%), Positives = 47/117 (40%), Gaps = 11/117 (9%)

Query: 495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIP--EDIGNLSVLN 552
              TN      LDL    +   + +  ++  + + ++ +DN     I   +    L  L 
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLK 67

Query: 553 YLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS--GELPSLFAKEMYRN-SFLGNP 605
            L ++NNR+        Q L  L +L ++NN L   G+L  L + +       L NP
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 124

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 20/110 (18%), Positives = 37/110 (33%), Gaps = 8/110 (7%)

Query: 115 ACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIP-ESFGRFQKLEVISLV 173
                  L  +++    +L   L    NL  L +        +         +L  +++V
Sbjct: 6   CPHGSSGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 174 YNLLDGTIP--AFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWL 221
            + L   +   AF      L  LNLS+N      +  +     +L+ L L
Sbjct: 65  KSGLR-FVAPDAFHFTPR-LSRLNLSFNALE--SLSWKTVQGLSLQELVL 110

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 18/94 (19%), Positives = 31/94 (32%), Gaps = 1/94 (1%)

Query: 229 EIPDSLGRLAKLVDLDLALNNLVGAIPS-SLTELASVVQIELYNNSLTGDLPTGWSNLTS 287
           +    L     L +L +     +  +    L  L  +  + +  + L    P  +     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 288 LRLLDASMNDLTGPIPDDLTRLPLESLNLYENRL 321
           L  L+ S N L       +  L L+ L L  N L
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 20/95 (21%), Positives = 31/95 (32%), Gaps = 3/95 (3%)

Query: 492 SLPESLTNLAELGSLDLHANDLSGELPS-SVSSWKKLNELNLADNLFYGNIPEDI-GNLS 549
                L     L  L +        L    +    +L  L +  +     +  D      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTP 80

Query: 550 VLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRL 584
            L+ L+LS N L       +Q L L +L +S N L
Sbjct: 81  RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 3e-06
 Identities = 22/102 (21%), Positives = 36/102 (35%), Gaps = 6/102 (5%)

Query: 57  CSWRGVECDPRS----HSVASIDLSNANIAGPFPS-LLCRLENLTFLTLFNNSINSTLPD 111
           C+  G            ++  + + N           L  L  L  LT+  + +    PD
Sbjct: 15  CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74

Query: 112 DISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF 153
                  L  L+LS N L  +L+       +L+ L L+GN  
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 22/90 (24%), Positives = 33/90 (36%), Gaps = 2/90 (2%)

Query: 447 KNIAGAANLSLLIISKNNLSGSLPEE-IGFLKSLVVLSGSENKFTGSLPESLTNLAELGS 505
            ++ GA NL+ L I        L    +  L  L  L+  ++      P++      L  
Sbjct: 25  HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84

Query: 506 LDLHANDLSGELPSSVSSWKKLNELNLADN 535
           L+L  N L   L         L EL L+ N
Sbjct: 85  LNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 20/102 (19%), Positives = 37/102 (36%), Gaps = 5/102 (4%)

Query: 511 NDLSGELPSSVSSWKKLNELNLADNLFYGNIP-EDIGNLSVLNYLDLSNNRLSGRIPVG- 568
            D + +    +   + L EL + +     ++   D+  L  L  L +  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 569 LQNL-KLNQLNVSNNRLSGELPSLFAKEMYRNSFL-GNPGLC 608
                +L++LN+S N L             +   L GNP  C
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 82/493 (16%), Positives = 152/493 (30%), Gaps = 67/493 (13%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISA-CQNLQHLDLSQ---------------NLLTGTL 133
             +E      +F  +  +  P  +      ++ ++L                   +   +
Sbjct: 38  YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWI 97

Query: 134 TPALADLPNLKFLDLTGNNFSGDIPESFGR-FQKLEVISLVY--NLLDGTIPAFLGNIST 190
               +    L+ + L     + D  E   + F+  +V+ L          + A       
Sbjct: 98  EAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRN 157

Query: 191 LKMLNLSYNPFLPGR---IPPELGNLTNLEILWLTECNLVGEIPD-SLGRLAK----LVD 242
           LK L+L  +         +       T+L  L ++      E+   +L RL      L  
Sbjct: 158 LKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKS 215

Query: 243 LDL-------ALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASM 295
           L L        L  L+   P  L EL +          +   L    S    LR L    
Sbjct: 216 LKLNRAVPLEKLATLLQRAP-QLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFW 274

Query: 296 NDLTGPIPDDLTRLP-LESLNL-YENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDL 353
           + +   +P   +    L +LNL Y       L   +   P L  L +     +  L    
Sbjct: 275 DAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLA 334

Query: 354 GKNSPLRWVDLSN-NQFTGEIPASLCEKG---------ELEELLMIYNSFTGQLPDGLG- 402
                LR + +     F  E   +L E+G         +LE +L      T      +  
Sbjct: 335 STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIAR 394

Query: 403 HCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISK 462
           +  ++TR RL               +       LT   L       +    +L  L +S 
Sbjct: 395 NRPNMTRFRLC-------------IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS- 440

Query: 463 NNLSGSLPEEIG-FLKSLVVLSGSENKFTG-SLPESLTNLAELGSLDLHANDLSGE-LPS 519
             L+  + E IG + K + +LS +    +   +   L+    L  L++       + L +
Sbjct: 441 GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLA 500

Query: 520 SVSSWKKLNELNL 532
           + S  + +  L +
Sbjct: 501 NASKLETMRSLWM 513

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 55/369 (14%), Positives = 115/369 (31%), Gaps = 46/369 (12%)

Query: 87  SLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFL 146
            L+ R  NL  L L        L   +     L+ L                      + 
Sbjct: 205 RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGG------------------YT 246

Query: 147 DLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRI 206
                +    +  +    ++L  +S  ++ +   +PA     S L  LNLSY       +
Sbjct: 247 AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDL 306

Query: 207 PPELGNLTNLEILWLTECNLVGEIPDSLGRLA----KLVDLDLA-LNNLVGAIPSSLTEL 261
              L     L+ LW+   + + +    L  LA     L +L +      V     +LTE 
Sbjct: 307 VKLLCQCPKLQRLWV--LDYIED--AGLEVLASTCKDLRELRVFPSEPFVMEPNVALTE- 361

Query: 262 ASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYE--- 318
             +V + +    L   L      +T     +A++  +    P ++TR  L  +       
Sbjct: 362 QGLVSVSMGCPKLESVL-YFCRQMT-----NAALITIARNRP-NMTRFRLCIIEPKAPDY 414

Query: 319 ---NRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSP-LRWVDLSNNQFTGEIP 374
                L+    A +     L  L L    L   +   +G  +  +  + ++    +    
Sbjct: 415 LTLEPLDIGFGAIVEHCKDLRRLSL-SGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473

Query: 375 ASLCEK-GELEELLMIYNSFTGQ-LPDGLGHCQSLTRVRLGYNRLTGK-VPPLLWGLPHV 431
             +      L +L +    F  + L       +++  + +    ++      L   +P +
Sbjct: 474 HHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKL 533

Query: 432 YLLELTDNF 440
            +  + +  
Sbjct: 534 NVEVIDERG 542

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 72/463 (15%), Positives = 148/463 (31%), Gaps = 52/463 (11%)

Query: 69  HSVASIDLSNANI-AGPFPSLLCRLENLTFLTLFNNSI--NSTLPDDISACQNLQHLDLS 125
             +  I L    +       +    +N   L L +        L    + C+NL+ LDL 
Sbjct: 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLR 164

Query: 126 QNLLTGTLTPALADL----PNLKFLDLTG--NNFSGDIPESFG-RFQKLEVISLVYNLLD 178
           ++ +       L+       +L  L+++   +  S    E    R   L+ + L   +  
Sbjct: 165 ESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPL 224

Query: 179 GTIPAFLGNISTLKMLNLSY-----NPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDS 233
             +   L     L+ L          P +   +   L     L  L      +   +P  
Sbjct: 225 EKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAV 284

Query: 234 LGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGD-----LPTGWSNLTSL 288
               ++L  L+L+   +       L      +Q  L+      D     L +   +L  L
Sbjct: 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQ-RLWVLDYIEDAGLEVLASTCKDLREL 343

Query: 289 RLLDASMNDLTGPIPDDLTRLPLESLNLYENRLE-----------GSLPATIADSPGLYE 337
           R+  +    +   +   LT   L S+++   +LE            +L     + P +  
Sbjct: 344 RVFPSEPFVMEPNVA--LTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR 401

Query: 338 LRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQL 397
            RL                   +  D    +       ++ E  +    L +    T ++
Sbjct: 402 FRLC--------------IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKV 447

Query: 398 PDGLG-HCQSLTRVRLGYNRLTGK-VPPLLWGLPHVYLLELTD-NFLSGEISKNIAGAAN 454
            + +G + + +  + + +   +   +  +L G   +  LE+ D  F    +  N +    
Sbjct: 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLET 507

Query: 455 LSLLIISKNNLSGSLPEEIGF-LKSLVVLSGSENKFTGSLPES 496
           +  L +S  ++S    + +G  +  L V    E     S PES
Sbjct: 508 MRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPES 550

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.3 bits (107), Expect = 9e-05
 Identities = 71/532 (13%), Positives = 148/532 (27%), Gaps = 91/532 (17%)

Query: 104 SINSTLPDDI--------------SAC----------QNLQHLDLSQNLLTGTLTPALAD 139
            I  + P+++              ++           +      +            +  
Sbjct: 4   RIALSFPEEVLEHVFSFIQLDKDRNSVSLVCKSWYEIERWCRRKVFIGNCYAVSPATVIR 63

Query: 140 -LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSY 198
             P ++ ++L G     D       +            +   I A   + + L+ + L  
Sbjct: 64  RFPKVRSVELKGKPHFADFNLVPDGWG---------GYVYPWIEAMSSSYTWLEEIRLKR 114

Query: 199 NPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLA----KLVDLDLALNNLVGAI 254
                  +     +  N ++L L+ C       D L  +A     L +LDL  +++    
Sbjct: 115 MVVTDDCLELIAKSFKNFKVLVLSSCEGFST--DGLAAIAATCRNLKELDLRESDVDDVS 172

Query: 255 PSSLTELAS------VVQIELYNNSLTGD----LPTGWSNLTSLRLLDASMNDLTGPIPD 304
              L+           + I    + ++      L T   NL SL+L  A   +    +  
Sbjct: 173 GHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQ 232

Query: 305 DLTRLPLESLNLYENRLEG----SLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLR 360
              +L       Y   +       L   ++    L  L  F + +   LP      S L 
Sbjct: 233 RAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLT 292

Query: 361 WVDLSNNQFTGE-IPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTG 419
            ++LS        +   LC+  +L+ L ++       L      C+ L  +R+       
Sbjct: 293 TLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFP----- 347

Query: 420 KVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF-LKS 478
                         + LT+  L   +S        L  ++     ++ +    I     +
Sbjct: 348 -----SEPFVMEPNVALTEQGLV-SVSMGC---PKLESVLYFCRQMTNAALITIARNRPN 398

Query: 479 LVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFY 538
           +                 L  +       L    L     + V   K L  L+L+  L  
Sbjct: 399 MTRF-------------RLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTD 445

Query: 539 GNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-----KLNQLNVSNNRLS 585
                       +  L ++    S     G+ ++      L +L + +    
Sbjct: 446 KVFEYIGTYAKKMEMLSVAFAGDSDL---GMHHVLSGCDSLRKLEIRDCPFG 494

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 28/173 (16%), Positives = 55/173 (31%), Gaps = 27/173 (15%)

Query: 691 IGSGSSGKVYKVV---------LSNGEAVAVKKLWRGMSKECESG-CDVEKGQVQDQVQD 740
               + G +Y+               +  ++K        + + G    E+   Q   + 
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-------DAKDGRLFNEQNFFQRAAKP 102

Query: 741 DGFQAEVETLGKIRHKNIVKL-WCCCTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWP 798
                  + L       I             + LV   +  G SL   L      +L   
Sbjct: 103 LQVNKW-KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER 159

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAK 849
           +  ++     + L +LH +     VH +V + NI +D +  ++V  A +G A 
Sbjct: 160 SVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 48/228 (21%), Positives = 80/228 (35%), Gaps = 44/228 (19%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
           IG G+ G++     L   E VA+K               +E  + +          E   
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK---------------LEPMKSRAPQ----LHLEYRF 57

Query: 750 LGKIRH-KNIVKLWCCCTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDA 807
             ++     I +++          +V E +  G SL DL   C        T   I +  
Sbjct: 58  YKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLC-DRTFSLKTVLMIAIQL 114

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA------DFGVAKV-VDA-SGKPKS 859
              + Y+H     ++++RDVK  N L+ G  G +        DF +AK  +D  + K   
Sbjct: 115 ISRMEYVHSK---NLIYRDVKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIP 170

Query: 860 MSVIAGSCGYIAPEYA--YTLRVNEKS---DIYSFGVVILELVTGRLP 902
                   G     Y    T    E+S   D+ + G + +  + G LP
Sbjct: 171 YREHKSLTG--TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 14/119 (11%)

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-P--IPDDLTRLP 310
           IP++   L       L++N +T   P  + +L +L+ L    N L   P  + D LT+  
Sbjct: 38  IPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ-- 89

Query: 311 LESLNLYENRLEGSLPATIADSPG-LYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQ 368
           L  L+L  N+L   LP+ + D    L EL +  N+L   LP  + + + L  + L  NQ
Sbjct: 90  LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 40/155 (25%), Positives = 57/155 (36%), Gaps = 30/155 (19%)

Query: 120 QHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDG 179
           Q L L  N +T         L NLK L L  N     +P   G F  L            
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPV--GVFDSL------------ 87

Query: 180 TIPAFLGNISTLKMLNLSYNPF--LPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRL 237
                    + L +L+L  N    LP  +      L +L+ L++  CN + E+P  + RL
Sbjct: 88  ---------TQLTVLDLGTNQLTVLPSAV---FDRLVHLKELFM-CCNKLTELPRGIERL 134

Query: 238 AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNN 272
             L  L L  N L      +   L+S+    L+ N
Sbjct: 135 THLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 34/128 (26%), Positives = 49/128 (38%), Gaps = 6/128 (4%)

Query: 96  TFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALAD-LPNLKFLDLTGNNFS 154
             L L +N I    P    +  NL+ L L  N L   L   + D L  L  LDL  N  +
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 155 GDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE-LGNL 213
                 F R   L+ + +  N L   +P  +  ++ L  L L  N      IP      L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL--KSIPHGAFDRL 158

Query: 214 TNLEILWL 221
           ++L   +L
Sbjct: 159 SSLTHAYL 166

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 38/129 (29%), Positives = 55/129 (42%), Gaps = 8/129 (6%)

Query: 458 LIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTN-LAELGSLDLHANDLSGE 516
           L +  N ++   P     L +L  L    N+   +LP  + + L +L  LDL  N L+  
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 517 LPSSV-SSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG-LQNLK- 573
           LPS+V      L EL +  N     +P  I  L+ L +L L  N+L   IP G    L  
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSS 160

Query: 574 LNQLNVSNN 582
           L    +  N
Sbjct: 161 LTHAYLFGN 169

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.3 bits (124), Expect = 4e-07
 Identities = 28/171 (16%), Positives = 60/171 (35%), Gaps = 18/171 (10%)

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALA--DLPNLKFLDL- 148
           L+ +  L        + L        NL+ L++    L  ++   +   DLPNL+ L L 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 149 -TGNNFSGDIP-------ESFGRFQKLEVISLVYNLLDGTIPAFLGN---ISTLKMLNLS 197
               ++  D          S  RF  L+ + +V       +         +  L+ +++S
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287

Query: 198 YNPFLPG---RIPPELGNLTNLEILWLTECNLVGEIPDSLGR-LAKLVDLD 244
                      +   +  + +L+ + +    L  E+   L + L   +D+ 
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.3 bits (124), Expect = 5e-07
 Identities = 25/176 (14%), Positives = 55/176 (31%), Gaps = 16/176 (9%)

Query: 220 WLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELY--NNSLTGD 277
                    ++   L  +  L +L +   N +         L S+  I     ++ +   
Sbjct: 154 QEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDI 213

Query: 278 LPTGWSNLTSLRLLDASMNDLTGPIPDDL------TRLP-LESLNLYENRLEGSLPATIA 330
           L +   NL  L L     +       +         R P L+ L + +   +  +     
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273

Query: 331 DSP---GLYELRLFRNRLNGT----LPGDLGKNSPLRWVDLSNNQFTGEIPASLCE 379
           +S     L  + +    L       L   + K   L+++++  N  + E+   L +
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.6 bits (112), Expect = 1e-05
 Identities = 22/180 (12%), Positives = 47/180 (26%), Gaps = 36/180 (20%)

Query: 35  LSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS------VASIDLSNANIAGPFPSL 88
           +   D    L +      +        +    +         + S  L ++ +     S 
Sbjct: 159 IEQVDLSPVLDAM-PLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217

Query: 89  LCRLENLTFLTLFNNSINSTLPDDISA------CQNLQHLDLSQNLLTGTLTPALAD--- 139
           L  LE L       +       +            NL+ L +        +     +   
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277

Query: 140 LPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYN 199
           LP L+ +D++    + +                        +   +  I  LK +N+ YN
Sbjct: 278 LPQLETMDISAGVLTDEGARL--------------------LLDHVDKIKHLKFINMKYN 317

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.9 bits (110), Expect = 2e-05
 Identities = 15/74 (20%), Positives = 32/74 (43%), Gaps = 7/74 (9%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQ---NLQHLDLSQNLLTGT----LTPALADLPN 142
            R  NL +L + +    + + +          L+ +D+S  +LT      L   +  + +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 143 LKFLDLTGNNFSGD 156
           LKF+++  N  S +
Sbjct: 309 LKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.5 bits (109), Expect = 3e-05
 Identities = 30/168 (17%), Positives = 57/168 (33%), Gaps = 25/168 (14%)

Query: 261 LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLT--RLP-LESLNLY 317
           L ++  +       T +L  G     +L+ L+     L   + +D+    LP LE L LY
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 318 ENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL 377
               +      +     L+    F N               L+W+ + + +    +    
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPN---------------LKWLGIVDAEEQNVVVEMF 272

Query: 378 CEKG---ELEELLMIYNSFTG----QLPDGLGHCQSLTRVRLGYNRLT 418
            E     +LE + +     T      L D +   + L  + + YN L+
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.6 bits (104), Expect = 1e-04
 Identities = 35/200 (17%), Positives = 59/200 (29%), Gaps = 34/200 (17%)

Query: 419 GKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF--- 475
             + P+L  +P    L       +  +S       NL  L I    L  S+ E+I     
Sbjct: 162 VDLSPVLDAMPL---LNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 476 --LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLA 533
             L+ LV+  G E+            L                          L  L + 
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF------------------PNLKWLGIV 260

Query: 534 DNLFYGNIPEDIGN---LSVLNYLDLSNNRLSGR----IPVGLQNL-KLNQLNVSNNRLS 585
           D      + E       L  L  +D+S   L+      +   +  +  L  +N+  N LS
Sbjct: 261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

Query: 586 GELPSLFAKEMYRNSFLGNP 605
            E+     K +     + + 
Sbjct: 321 DEMKKELQKSLPMKIDVSDS 340

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 5e-04
 Identities = 23/173 (13%), Positives = 50/173 (28%), Gaps = 23/173 (13%)

Query: 179 GTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLG--R 236
             +   L  +  L  L +         +        NL+ L +    L   + + +    
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT----NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217

Query: 237 LAKLVDLDLALNNLVGAIPSSLTELASVVQ---------IELYNNSLTGDLPTGWSN--- 284
           L  L  L L +          +     +           + + +      +   +     
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277

Query: 285 LTSLRLLDASMNDLTG----PIPDDLTRLP-LESLNLYENRLEGSLPATIADS 332
           L  L  +D S   LT      + D + ++  L+ +N+  N L   +   +  S
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 57/238 (23%), Positives = 89/238 (37%), Gaps = 54/238 (22%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVK-----KLWRGMSKECESGCDVEKG 732
           YEI        +IG GS G+V K       E VA+K     K +                
Sbjct: 56  YEIDS------LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL--------------- 94

Query: 733 QVQDQVQDDGFQAEVETLGKIRH------KNIVKLWCCCTTRD--CKLLVYEYMPNGSLG 784
              +Q Q      EV  L  +          IV L      R+  C  LV+E + + +L 
Sbjct: 95  ---NQAQI-----EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC--LVFEML-SYNLY 143

Query: 785 DLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--DGDFGARV 842
           DLL +     +      K        L +L    + SI+H D+K  NILL        ++
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKI 202

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGR 900
            DFG +  +      + +     S  Y +PE    +  +   D++S G +++E+ TG 
Sbjct: 203 VDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 52/201 (25%), Positives = 74/201 (36%), Gaps = 32/201 (15%)

Query: 180 TIPAFLGNIST-LKMLNLSYNPF--LPGRIPPELGNLTNLEILWLTECNL--VGEIPDSL 234
             P    +        NL          +       L +++ +     ++  V  I    
Sbjct: 12  IFPD---DAFAETIKANLKKKSVTDAVTQNE-----LNSIDQIIANNSDIKSVQGIQ--- 60

Query: 235 GRLAKLVDLDLALNNLVGAIPS--SLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLL 291
             L  +  L L  N L   I +   LT L  +    L  N L   LP G +  LT+L+ L
Sbjct: 61  -YLPNVRYLALGGNKLH-DISALKELTNLTYL---ILTGNQLQS-LPNGVFDKLTNLKEL 114

Query: 292 DASMNDLT---GPIPDDLTRLPLESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNG 347
               N L      + D LT   L  LNL  N+L+ SLP  + D    L EL L  N+L  
Sbjct: 115 VLVENQLQSLPDGVFDKLTN--LTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS 171

Query: 348 TLPGDLGKNSPLRWVDLSNNQ 368
              G   K + L+ + L  NQ
Sbjct: 172 LPEGVFDKLTQLKDLRLYQNQ 192

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 61/238 (25%)

Query: 56  PCSWRGVECDPRSH----------SVASIDLSNANIA--GPFPSLLCRLENLTFLTLFNN 103
                      +S           S+  I  +N++I        L     N+ +L L  N
Sbjct: 18  FAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYL----PNVRYLALGGN 73

Query: 104 SINSTLP--DDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESF 161
            ++  +    +++   NL +L L+ N L          L NLK L L  N          
Sbjct: 74  KLHD-ISALKELT---NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN---------- 119

Query: 162 GRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPF--LPGRIPPELGNLTNLEIL 219
            + Q L     V++ L           + L  LNL++N    LP  +      LTNL  L
Sbjct: 120 -QLQSLP--DGVFDKL-----------TNLTYLNLAHNQLQSLPKGV---FDKLTNLTEL 162

Query: 220 WLTECNLVGEIPDSL-GRLAKLVDLDLALNNL----VGAIPSSLTELASVVQIELYNN 272
            L   N +  +P+ +  +L +L DL L  N L     G        L S+  I L++N
Sbjct: 163 DL-SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDR----LTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 58/260 (22%), Positives = 97/260 (37%), Gaps = 57/260 (21%)

Query: 312 ESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
           E++ +     +   P          +  L +  +          NS +  +  +N+    
Sbjct: 1   ETITVSTPIKQ-IFPDDAFAE--TIKANLKKKSVT-DAVTQNELNS-IDQIIANNSDIKS 55

Query: 372 E--IPASLCEKGELEELLMIYNSFTGQLP--DGLGHCQSLTRVRLGYNRLTGKVPPLLWG 427
              I         +  L +  N     +     L    +LT + L  N+L   +P    G
Sbjct: 56  VQGIQYL----PNVRYLALGGNKLH-DISALKELT---NLTYLILTGNQLQ-SLPN---G 103

Query: 428 LPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEI-GFLKSLVVLSGSE 486
           +      +LT                NL  L++ +N L  SLP+ +   L +L  L+ + 
Sbjct: 104 VFD----KLT----------------NLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAH 142

Query: 487 NKFTGSLPE----SLTNLAELGSLDLHANDLSGELPSSV-SSWKKLNELNLADN-LFYGN 540
           N+   SLP+     LTNL E   LDL  N L   LP  V     +L +L L  N L   +
Sbjct: 143 NQLQ-SLPKGVFDKLTNLTE---LDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL--KS 195

Query: 541 IPEDI-GNLSVLNYLDLSNN 559
           +P+ +   L+ L Y+ L +N
Sbjct: 196 VPDGVFDRLTSLQYIWLHDN 215

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 39/134 (29%), Positives = 55/134 (41%), Gaps = 16/134 (11%)

Query: 57  CSWRGVECDPRSH---------SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINS 107
           C    V C  +            V  + L + N     P  L   ++LT + L NN I S
Sbjct: 10  CLDTVVRCSNKGLKVLPKGIPRDVTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRI-S 67

Query: 108 TLPDDI-SACQNLQHLDLSQNLLTGTLTPALAD-LPNLKFLDLTGNNFSGDIPE-SFGRF 164
           TL +   S    L  L LS N L   + P   D L +L+ L L GN+ S  +PE +F   
Sbjct: 68  TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDL 125

Query: 165 QKLEVISLVYNLLD 178
             L  +++  N L 
Sbjct: 126 SALSHLAIGANPLY 139

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 6e-06
 Identities = 28/166 (16%), Positives = 64/166 (38%), Gaps = 13/166 (7%)

Query: 691 IGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL 750
           IG G  G +Y   +++ E+V          +  ++G    + +   +        +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 751 GKIRHKNIVKLWCC----CTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIV 805
            K+++  + K W         +  + ++ +    G  L  +  +         T  ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN-AKRFSRKTVLQLSL 159

Query: 806 DAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAK 849
              + L Y+H       VH D+K++N+LL+     +V   D+G+A 
Sbjct: 160 RILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 46/247 (18%), Positives = 84/247 (34%), Gaps = 58/247 (23%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV--LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           YEI+        +G G+ GKV + +        VA+K + R + K  E+           
Sbjct: 21  YEIVG------NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAA---------- 63

Query: 737 QVQDDGFQAEVETLGKIRHK------NIVKLWCCCTTRD--CKLLVYEYMPNGSLGDLLH 788
                  + E+  L KI+ K        V +          C  + +E +   +  + L 
Sbjct: 64  -------RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC--IAFELL-GKNTFEFL- 112

Query: 789 SCKGGLLDWPTRY--KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
             +     +P  +   +       L +LH      + H D+K  NIL        + +  
Sbjct: 113 -KENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH 168

Query: 847 VA-----------KVVD---ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
            +           +V D   A+   +  + I  +  Y  PE    L   +  D++S G +
Sbjct: 169 KSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCI 228

Query: 893 ILELVTG 899
           + E   G
Sbjct: 229 LFEYYRG 235

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 19/159 (11%)

Query: 57  CSWRGVECDPRSH---------SVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINS 107
           CS   VEC  +               +DL   ++      +   L +LT L L  N +  
Sbjct: 7   CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-Q 65

Query: 108 TLPDDISAC-QNLQHLDLSQNLLTGTLTPALAD-LPNLKFLDLTGNNFSGDIPE-SFGRF 164
           +LP+ +     +L +L+LS N L  +L   + D L  LK L L  N     +P+  F + 
Sbjct: 66  SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKL 123

Query: 165 QKLEVISLVYNLLDGTIP--AFLGNISTLKMLNLSYNPF 201
            +L+ + L  N L  ++P   F   +++L+ + L  NP+
Sbjct: 124 TQLKDLRLYQNQLK-SVPDGVF-DRLTSLQYIWLHDNPW 160

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 40/119 (33%), Positives = 52/119 (43%), Gaps = 13/119 (10%)

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-P--IPDDLTRLP 310
           IP+  T L      +L  NSL       +  LTSL  L    N L   P  + + LT   
Sbjct: 26  IPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS-- 77

Query: 311 LESLNLYENRLEGSLPATIADSPG-LYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQ 368
           L  LNL  N+L+ SLP  + D    L EL L  N+L     G   K + L+ + L  NQ
Sbjct: 78  LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ 135

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 46/133 (34%), Positives = 69/133 (51%), Gaps = 11/133 (8%)

Query: 243 LDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGP 301
           LDL  N+L         EL S+ Q+ L  N L   LP G ++ LTSL  L+ S N L   
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS- 90

Query: 302 IP----DDLTRLPLESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKN 356
           +P    D LT+  L+ L L  N+L+ SLP  + D    L +LRL++N+L     G   + 
Sbjct: 91  LPNGVFDKLTQ--LKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147

Query: 357 SPLRWVDLSNNQF 369
           + L+++ L +N +
Sbjct: 148 TSLQYIWLHDNPW 160

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 43/231 (18%), Positives = 80/231 (34%), Gaps = 35/231 (15%)

Query: 691 IGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSK----ECESGCDVEKGQVQDQVQDDGFQA 745
           IGSG  G +Y     +  E  A   +     +      E        +   +V       
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSEL-------KFYQRVAKKDCIK 97

Query: 746 EVETLGKIRHKNIVKLWCC----CTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTR 800
           +     ++ +  I   +         R  + +V E +  G  L  +      G     T 
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN--GTFKKSTV 153

Query: 801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAK--VVDASGK 856
            ++ +   + L Y+H +     VH D+K+ N+LL      +V  AD+G++     + + K
Sbjct: 154 LQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 857 PKSMSVIAGSCGYIAPEYA--YTLRVNEKS---DIYSFGVVILELVTGRLP 902
               +   G  G    E+      +    S   D+   G  +L  + G+LP
Sbjct: 211 QYQENPRKGHNG--TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 53/251 (21%), Positives = 88/251 (35%), Gaps = 62/251 (24%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           + ++        +G G+ G+V     + N +  AVK + R + K   S            
Sbjct: 37  FLVIR------KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSA----------- 78

Query: 738 VQDDGFQAEVETLGKIRH-----KNIVKLWCCCTTRD--CKLLVYEYMPNGSLGDLLHSC 790
                 + E + L KI++      NIVK        D  C  L++E +   SL +++   
Sbjct: 79  ------KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC--LIFEPL-GPSLYEII--T 127

Query: 791 KGGLLDWPTRY--KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVA 848
           +     +         ++  + L+YL      S+ H D+K  NILLD  +  +       
Sbjct: 128 RNNYNGFHIEDIKLYCIEILKALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRR 184

Query: 849 KVVDASGKPKSMSVIA------GSC--------GYI------APEYAYTLRVNEKSDIYS 888
                  +              G            I      APE    L  +  SD++S
Sbjct: 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWS 244

Query: 889 FGVVILELVTG 899
           FG V+ EL TG
Sbjct: 245 FGCVLAELYTG 255

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 44/292 (15%), Positives = 86/292 (29%), Gaps = 41/292 (14%)

Query: 114 SACQNLQHLDLSQNLLTGTLTPALADL-----PNLKFLDLTGNNFSGDIPESFGR-FQKL 167
               +L+ L+L+   +T      +A +       L  ++L           +    F + 
Sbjct: 69  EVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRA 128

Query: 168 EVISLVYNLLDGT-----IPAFLGNISTLKMLNLSYNPFLP---GRIPPELGNLTNLEIL 219
             + L  N L            L +   +  L LS NP        +   L   T++  L
Sbjct: 129 RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188

Query: 220 WLTECNL----VGEIPDSLGRLAKLVDLDLALNNL----VGAIPSSLTELASVVQIELYN 271
            L    L    +  +   L R  +L +L++A N        A+  +  E  S+  + LY 
Sbjct: 189 SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYF 248

Query: 272 NSLT-------GDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGS 324
           N L+        DL         + +       ++     +   + L  +    N  + +
Sbjct: 249 NELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS-----EYWSVILSEVQRNLNSWDRA 303

Query: 325 LPATIADSPGLYELRLFRNRLNGTLPGDLGK----NSPLRWVDLSNNQFTGE 372
               +     L    L  +R     P    +       +R +          
Sbjct: 304 R---VQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSP 352

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 40/120 (33%), Positives = 54/120 (45%), Gaps = 15/120 (12%)

Query: 254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIP----DDLTRL 309
           IPSS T L      EL +N L       +  LT L  L  S N +   +P    D LT+ 
Sbjct: 26  IPSSATRL------ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTK- 77

Query: 310 PLESLNLYENRLEGSLPATIADS-PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQ 368
            L  L L+EN+L+ SLP  + D    L EL L  N+L     G   + + L+ + L  N 
Sbjct: 78  -LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 23/143 (16%), Positives = 51/143 (35%), Gaps = 20/143 (13%)

Query: 107 STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQK 166
           + LP        +Q +D + + +       +  L  ++ + L   ++  D          
Sbjct: 51  NHLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED----GC---- 102

Query: 167 LEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL 226
           LE +S + NL             ++  + +     +  +    L +  NL+ L+L++   
Sbjct: 103 LERLSQLENL-----------QKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPG 151

Query: 227 VGEIPDSLGRLAK-LVDLDLALN 248
           V E    +      L  L+L L+
Sbjct: 152 VKEKEKIVQAFKTSLPSLELKLD 174

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 6e-04
 Identities = 51/247 (20%), Positives = 96/247 (38%), Gaps = 58/247 (23%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV--LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           YEI+D       +G G+ GKV + +   + G  VAVK + + + + CE+           
Sbjct: 16  YEIVD------TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAA---------- 58

Query: 737 QVQDDGFQAEVETLGKIRHK------NIVKLWCCCTTRD--CKLLVYEYMPNGSLGDLLH 788
                  ++E++ L  +           V++          C  +V+E +   S  D + 
Sbjct: 59  -------RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC--IVFELL-GLSTYDFI- 107

Query: 789 SCKGGLLDWPTRY--KIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
             + G L +   +  K+     + +++LH      + H D+K  NIL          +  
Sbjct: 108 -KENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPK 163

Query: 847 VA-----------KVVD---ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
           +            KVVD   A+   +  S +  +  Y APE    L  ++  D++S G +
Sbjct: 164 IKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223

Query: 893 ILELVTG 899
           ++E   G
Sbjct: 224 LIEYYLG 230

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 28/135 (20%), Positives = 50/135 (37%), Gaps = 16/135 (11%)

Query: 57  CSWRGVECDPRSH---------SVASIDLSNANIAG-PFPSLLCRLENLTFLTLFNNSIN 106
           C    V+C  R               + L++  +       L  RL +L  L L  N + 
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL- 66

Query: 107 STLPDDI-SACQNLQHLDLSQNLLTGTLTPALAD-LPNLKFLDLTGNNFSGDIPE-SFGR 163
           + +  +      ++Q L L +N +   ++  +   L  LK L+L  N  S  +   SF  
Sbjct: 67  TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEH 124

Query: 164 FQKLEVISLVYNLLD 178
              L  ++L  N  +
Sbjct: 125 LNSLTSLNLASNPFN 139

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1002
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.76
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.75
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.72
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.71
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.6
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.56
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.52
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.52
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.52
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.45
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.44
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.3
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.3
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.25
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.24
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.22
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.22
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.04
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.9
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.87
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.86
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.85
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.81
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.81
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.52
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.46
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.32
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.27
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.27
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.26
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.09
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.01
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.77
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.48
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.47
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.34
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.17
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.09
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.07
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.75
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.7
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.66
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.52
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.47
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.45
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.45
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.44
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.28
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.22
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.14
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.66
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.16
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.43
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	81.69
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.99

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=7.5e-84  Score=801.99  Aligned_cols=592  Identities=34%  Similarity=0.536  Sum_probs=466.2

Q ss_pred             CCCCchHHHHHHHHHHHhccCCccccCCCCCCCCCCCCCccceeEEeCCCCeEEEEEcCCCCcCCC---CC---------
Q 001867           19 PSLSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGP---FP---------   86 (1002)
Q Consensus        19 ~~~~~~~~~~~l~~~k~~~~d~~~~l~sw~~~~~~~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~---~~---------   86 (1002)
                      ++.+.++|++||++||+++.||. .+++|+   .+.+||+|.||+|+  +++|+.|||+++++.|.   +|         
T Consensus         6 ~~~~~~~~~~all~~k~~~~~~~-~l~~W~---~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L   79 (768)
T 3rgz_A            6 PSQSLYREIHQLISFKDVLPDKN-LLPDWS---SNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL   79 (768)
T ss_dssp             --CCHHHHHHHHHHHHTTCSCTT-SSTTCC---TTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred             cccCCHHHHHHHHHHHhhCCCcc-cccCCC---CCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence            34457789999999999999998 999996   34689999999999  68999999999998876   33         


Q ss_pred             --------------ccccCCCCCCEEeccCCCCCCCCCC--CccccCcccccccccccccCCCCccc-cccCCccccccc
Q 001867           87 --------------SLLCRLENLTFLTLFNNSINSTLPD--DISACQNLQHLDLSQNLLTGTLTPAL-ADLPNLKFLDLT  149 (1002)
Q Consensus        87 --------------~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~L~~L~~L~Ls  149 (1002)
                                    ..|+.+++|++|+|++|.+++.+|.  .|+.+++|++|+|++|.+++.+|..+ .++++|++|+|+
T Consensus        80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls  159 (768)
T 3rgz_A           80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS  159 (768)
T ss_dssp             CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred             cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence                          5788889999999999999888888  88889999999999888887776654 444555555544


Q ss_pred             cccccCCCCcc-------------------------cccccccceeeeccccccCccccccccccccccccccCCCCCCC
Q 001867          150 GNNFSGDIPES-------------------------FGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPG  204 (1002)
Q Consensus       150 ~N~l~~~~p~~-------------------------~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~  204 (1002)
                      +|++++..|..                         +..+++|++|+|++|++++.+|. ++++++|++|+|++|++ .+
T Consensus       160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l-~~  237 (768)
T 3rgz_A          160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL-SG  237 (768)
T ss_dssp             SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCC-CS
T ss_pred             CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcC-CC
Confidence            44444332221                         13344444444555555444444 44455555555555443 23


Q ss_pred             CCCcccC----------------------CCCccchhhccCcccccccccccccc-cccchhcccCcccccccCcccccc
Q 001867          205 RIPPELG----------------------NLTNLEILWLTECNLVGEIPDSLGRL-AKLVDLDLALNNLVGAIPSSLTEL  261 (1002)
Q Consensus       205 ~~p~~~~----------------------~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~l~~l  261 (1002)
                      .+|..++                      .+++|++|++++|++++.+|..+... ++|++|+|++|++++.+|..|.++
T Consensus       238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l  317 (768)
T 3rgz_A          238 DFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC  317 (768)
T ss_dssp             CHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGC
T ss_pred             cccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcC
Confidence            3333344                      44455555555555555666666554 777777777777777777777777


Q ss_pred             cceeeeeccCCcccCCCCCc-cccccccceeeccccccCCCCCccCCCC--CcceeecCCCcccCcCCcccCC--Ccccc
Q 001867          262 ASVVQIELYNNSLTGDLPTG-WSNLTSLRLLDASMNDLTGPIPDDLTRL--PLESLNLYENRLEGSLPATIAD--SPGLY  336 (1002)
Q Consensus       262 ~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~L~~L~L~~N~l~~~~p~~~~~--l~~L~  336 (1002)
                      ++|+.|++++|++.+.+|.. +.++++|++|++++|++++.+|..+..+  .|+.|++++|++++.+|..+..  +++|+
T Consensus       318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~  397 (768)
T 3rgz_A          318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ  397 (768)
T ss_dssp             TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred             CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence            77777777777777666654 7777777777777777777777666554  4777777777777777777666  67788


Q ss_pred             hhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCcc
Q 001867          337 ELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR  416 (1002)
Q Consensus       337 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~  416 (1002)
                      +|++++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|+.|++++|.+++.+|..++.+++|++|+|++|+
T Consensus       398 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~  477 (768)
T 3rgz_A          398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND  477 (768)
T ss_dssp             EEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             EEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCccc
Q 001867          417 LTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPES  496 (1002)
Q Consensus       417 l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  496 (1002)
                      +++.+|..+..+++|+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|++++|+++|.+|..
T Consensus       478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~  557 (768)
T 3rgz_A          478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA  557 (768)
T ss_dssp             CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred             ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888888777754


Q ss_pred             c----------------------------------------------------------------------cccccCCee
Q 001867          497 L----------------------------------------------------------------------TNLAELGSL  506 (1002)
Q Consensus       497 ~----------------------------------------------------------------------~~l~~L~~L  506 (1002)
                      +                                                                      +.+++|+.|
T Consensus       558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L  637 (768)
T 3rgz_A          558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL  637 (768)
T ss_dssp             GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred             HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence            3                                                                      346789999


Q ss_pred             ecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCc
Q 001867          507 DLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS  585 (1002)
Q Consensus       507 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~  585 (1002)
                      ||++|+++|.+|..|+++++|+.|+|++|+++|.+|+.|+++++|++|||++|+|+|.||..++.+ .|++||||+|+|+
T Consensus       638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~  717 (768)
T 3rgz_A          638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS  717 (768)
T ss_dssp             ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred             ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999 7999999999999


Q ss_pred             CCCChh-hhhhcccccccCCCCCCCCCCCCCCCC
Q 001867          586 GELPSL-FAKEMYRNSFLGNPGLCGDLEGLCDGR  618 (1002)
Q Consensus       586 g~~p~~-~~~~~~~~~~~~n~~~cg~~~~~c~~~  618 (1002)
                      |.||.. .+.++...+|.|||++||.|...|...
T Consensus       718 g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~  751 (768)
T 3rgz_A          718 GPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS  751 (768)
T ss_dssp             EECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred             ccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence            999986 677888899999999999999999753

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=9.1e-67  Score=648.50  Aligned_cols=515  Identities=33%  Similarity=0.508  Sum_probs=435.5

Q ss_pred             CeEEEEEcCCCCcCCCCCccc-cCCCCCCEEeccCCCCCCCCCCC---cccc----------------------Cccccc
Q 001867           69 HSVASIDLSNANIAGPFPSLL-CRLENLTFLTLFNNSINSTLPDD---ISAC----------------------QNLQHL  122 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~p~~---~~~l----------------------~~L~~L  122 (1002)
                      .+++.|||++|.+++..|..+ .++++|++|+|++|++++..|..   +.++                      ++|++|
T Consensus       126 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L  205 (768)
T 3rgz_A          126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL  205 (768)
T ss_dssp             TTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEE
T ss_pred             CCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEE
Confidence            356777777777776666554 66666777777666666555544   4444                      455555


Q ss_pred             ccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCC
Q 001867          123 DLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFL  202 (1002)
Q Consensus       123 ~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~  202 (1002)
                      +|++|.+++.+|. ++++++|++|+|++|++++.+|..|+.+++|++|+|++|++++.+|..  .+++|++|+|++|++ 
T Consensus       206 ~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l-  281 (768)
T 3rgz_A          206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF-  281 (768)
T ss_dssp             ECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEE-
T ss_pred             ECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCcc-
Confidence            5555555544443 555555555555555555555555555555555555555555444443  455555555555553 


Q ss_pred             CCCCCcccCCC-CccchhhccCcccccccccccccccccchhcccCcccccccCcc-cccccceeeeeccCCcccCCCCC
Q 001867          203 PGRIPPELGNL-TNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSS-LTELASVVQIELYNNSLTGDLPT  280 (1002)
Q Consensus       203 ~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~  280 (1002)
                      .+.+|..+..+ ++|++|++++|++++.+|..|+.+++|++|+|++|++++.+|.. +.++++|++|++++|++++.+|.
T Consensus       282 ~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~  361 (768)
T 3rgz_A          282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE  361 (768)
T ss_dssp             EESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCT
T ss_pred             CCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccH
Confidence            34778888775 99999999999999999999999999999999999999888876 99999999999999999999999


Q ss_pred             cccccc-ccceeeccccccCCCCCccCCC--C-CcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCC
Q 001867          281 GWSNLT-SLRLLDASMNDLTGPIPDDLTR--L-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKN  356 (1002)
Q Consensus       281 ~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~--~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  356 (1002)
                      .+.+++ +|+.|++++|++++.+|..+..  . .|+.|++++|++++.+|..+.++++|++|++++|++++.+|..+..+
T Consensus       362 ~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l  441 (768)
T 3rgz_A          362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL  441 (768)
T ss_dssp             THHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred             HHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcC
Confidence            999998 9999999999999988888776  3 49999999999999999999999999999999999999999999999


Q ss_pred             CCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEc
Q 001867          357 SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLEL  436 (1002)
Q Consensus       357 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  436 (1002)
                      ++|+.|+|++|++++.+|..+..+++|++|++++|.+++.+|..++++++|++|+|++|++++.+|.+++.+++|+.|+|
T Consensus       442 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  521 (768)
T 3rgz_A          442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL  521 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEEC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcccCccccccccCCcccEEEccCCcCCCCCccccc------------------------------------------
Q 001867          437 TDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIG------------------------------------------  474 (1002)
Q Consensus       437 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------------------------------------  474 (1002)
                      ++|++++.+|..+..+++|+.|++++|+++|.+|.++.                                          
T Consensus       522 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  601 (768)
T 3rgz_A          522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS  601 (768)
T ss_dssp             CSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCG
T ss_pred             CCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999988886543                                          


Q ss_pred             ----------------------------cccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccc
Q 001867          475 ----------------------------FLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK  526 (1002)
Q Consensus       475 ----------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  526 (1002)
                                                  .+++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..|+++++
T Consensus       602 ~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~  681 (768)
T 3rgz_A          602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG  681 (768)
T ss_dssp             GGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred             hhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCC
Confidence                                        3577899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcccccCCCCCccccccccEEeCcceeeecccCCcccccccceEEecccc-CcCC
Q 001867          527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNR-LSGE  587 (1002)
Q Consensus       527 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~L~~l~ls~N~-l~g~  587 (1002)
                      |+.|||++|+++|.+|..++++++|++|||++|+|+|.||...+-.++....+.+|+ |+|.
T Consensus       682 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY  743 (768)
T ss_dssp             CCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred             CCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence            999999999999999999999999999999999999999987544466666777774 7774

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.3e-61  Score=596.96  Aligned_cols=553  Identities=22%  Similarity=0.219  Sum_probs=484.5

Q ss_pred             CCccceeEEeCC---------CCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCccccccccc
Q 001867           56 PCSWRGVECDPR---------SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQ  126 (1002)
Q Consensus        56 ~C~w~gv~C~~~---------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~  126 (1002)
                      .|.+..|.|+..         ..+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus         3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~   82 (680)
T 1ziw_A            3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH   82 (680)
T ss_dssp             -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred             eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence            356666777531         35799999999999998888999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCC
Q 001867          127 NLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRI  206 (1002)
Q Consensus       127 N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~  206 (1002)
                      |.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+ .+..
T Consensus        83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l-~~~~  161 (680)
T 1ziw_A           83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI-QALK  161 (680)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC-CCBC
T ss_pred             CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc-cccC
Confidence            999977666899999999999999999988889999999999999999999999999999999999999999987 3444


Q ss_pred             CcccC--CCCccchhhccCcccccccccccccc---------------------------cccchhcccCcccccccCcc
Q 001867          207 PPELG--NLTNLEILWLTECNLVGEIPDSLGRL---------------------------AKLVDLDLALNNLVGAIPSS  257 (1002)
Q Consensus       207 p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~~~~  257 (1002)
                      +..+.  .+++|++|++++|++++..|..|..+                           ++|+.|++++|.+++..|..
T Consensus       162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~  241 (680)
T 1ziw_A          162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT  241 (680)
T ss_dssp             HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred             HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence            44443  56899999999999998888877765                           45677888888888888888


Q ss_pred             cccccc--eeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceeecCCCcccC-----cCCc--
Q 001867          258 LTELAS--VVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEG-----SLPA--  327 (1002)
Q Consensus       258 l~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~-----~~p~--  327 (1002)
                      |.++..  |+.|++++|++.+..|..|..+++|++|++++|++++..|..+..++ |+.|++++|...+     .+|.  
T Consensus       242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~  321 (680)
T 1ziw_A          242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID  321 (680)
T ss_dssp             TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred             hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence            988866  99999999999988888999999999999999999988888888775 9999999876553     2333  


Q ss_pred             --ccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCC--CChhhhcc--CcccceeeeccccccCCCCcC
Q 001867          328 --TIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE--IPASLCEK--GELEELLMIYNSFTGQLPDGL  401 (1002)
Q Consensus       328 --~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l--~~L~~L~l~~N~l~~~~p~~l  401 (1002)
                        .|..+++|++|++++|++.+..+..|..+++|++|++++|.++..  .+..|..+  .+|+.|++++|++++..|..+
T Consensus       322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~  401 (680)
T 1ziw_A          322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF  401 (680)
T ss_dssp             TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTT
T ss_pred             hhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhh
Confidence              788899999999999999999999999999999999999986532  22334333  589999999999999999999


Q ss_pred             cCCCCCcEEEccCccccCCCC-CcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCC--CCCccccccccc
Q 001867          402 GHCQSLTRVRLGYNRLTGKVP-PLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLS--GSLPEEIGFLKS  478 (1002)
Q Consensus       402 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~  478 (1002)
                      ..+++|++|+|++|++++.+| ..|.++++|+.|++++|++.+..+..|..+++|+.|++++|.+.  +.+|..++.+++
T Consensus       402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~  481 (680)
T 1ziw_A          402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN  481 (680)
T ss_dssp             TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred             hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence            999999999999999987666 68899999999999999999999999999999999999999987  578999999999


Q ss_pred             cccccccccccCCCCcccccccccCCeeecCCCcCCcccc--------cccccccccccccccCcccccCCC-CCccccc
Q 001867          479 LVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELP--------SSVSSWKKLNELNLADNLFYGNIP-EDIGNLS  549 (1002)
Q Consensus       479 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~ip-~~~~~l~  549 (1002)
                      |+.|++++|++++..|..|..+++|+.|+|++|++++..+        ..|+.+++|+.|+|++|+++ .+| ..|.+++
T Consensus       482 L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~  560 (680)
T 1ziw_A          482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLF  560 (680)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCT
T ss_pred             CCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHccccc
Confidence            9999999999998888889999999999999999997532        34789999999999999999 555 4689999


Q ss_pred             cccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChhh---hhhcccccccCCCCCCCC
Q 001867          550 VLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSLF---AKEMYRNSFLGNPGLCGD  610 (1002)
Q Consensus       550 ~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~~---~~~~~~~~~~~n~~~cg~  610 (1002)
                      +|+.|||++|++++..|..+..+ +|+.|+|++|+|++.+|..+   ...+....+.||||.|+-
T Consensus       561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c  625 (680)
T 1ziw_A          561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC  625 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred             CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence            99999999999997666667888 89999999999999887642   456778889999999973

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5.2e-59  Score=566.00  Aligned_cols=526  Identities=21%  Similarity=0.200  Sum_probs=448.3

Q ss_pred             EEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccc
Q 001867           74 IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF  153 (1002)
Q Consensus        74 l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l  153 (1002)
                      ++.++.+++ .+|..+..  ++++|+|++|.|+++.|.+|.++++|++|+|++|.+++..|..|+++++|++|+|++|++
T Consensus        17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            455666666 45555543  789999999999998899999999999999999999988899999999999999999999


Q ss_pred             cCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccc
Q 001867          154 SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDS  233 (1002)
Q Consensus       154 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~  233 (1002)
                      ++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|++.....|..+ .+++|++|++++|++++..|..
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~  172 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF-PTEKLKVLDFQNNAIHYLSKED  172 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTC-CCTTCCEEECCSSCCCEECHHH
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCccccc-CCcccCEEEcccCcccccChhh
Confidence            988899999999999999999999988888899999999999999997433445444 4999999999999999888999


Q ss_pred             cccccccc--hhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCC--------CCC
Q 001867          234 LGRLAKLV--DLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG--------PIP  303 (1002)
Q Consensus       234 ~~~l~~L~--~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--------~~p  303 (1002)
                      |+.+++|+  .|++++|.+++..|..+.. .+|+.|++++|.   ..+..+..+.++....+..+.+.+        ...
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~  248 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF  248 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred             hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHh
Confidence            99999999  8999999999888877765 689999999987   234445555555444443333221        112


Q ss_pred             ccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcc
Q 001867          304 DDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGEL  383 (1002)
Q Consensus       304 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  383 (1002)
                      ..+....++.|++++|++++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|
T Consensus       249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  327 (606)
T 3t6q_A          249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL  327 (606)
T ss_dssp             GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred             chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence            2222335899999999999888888999999999999999998 678889999999999999999998888899999999


Q ss_pred             cceeeeccccccCCCC-cCcCCCCCcEEEccCccccCCC--CCcCCCCCcceEEEcccCcccCccccccccCCcccEEEc
Q 001867          384 EELLMIYNSFTGQLPD-GLGHCQSLTRVRLGYNRLTGKV--PPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLII  460 (1002)
Q Consensus       384 ~~L~l~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  460 (1002)
                      ++|++++|.+.+.+|. .+..+++|++|++++|++++..  |..+..+++|+.|++++|.+.+..+..+..+++|+.|++
T Consensus       328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  407 (606)
T 3t6q_A          328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL  407 (606)
T ss_dssp             SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred             CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence            9999999999876665 4889999999999999998766  778899999999999999999888999999999999999


Q ss_pred             cCCcCCCCCccc-cccccccccccccccccCCCCcccccccccCCeeecCCCcCCcc---cccccccccccccccccCcc
Q 001867          461 SKNNLSGSLPEE-IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGE---LPSSVSSWKKLNELNLADNL  536 (1002)
Q Consensus       461 s~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~  536 (1002)
                      ++|++.+..|.. +..+++|+.|++++|++++..|..+..+++|++|+|++|++++.   .+..++.+++|++|+|++|.
T Consensus       408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~  487 (606)
T 3t6q_A          408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD  487 (606)
T ss_dssp             TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred             CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence            999998776654 88999999999999999988888999999999999999999873   33678999999999999999


Q ss_pred             cccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh--hhhhcccccccCCCCCCC
Q 001867          537 FYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL--FAKEMYRNSFLGNPGLCG  609 (1002)
Q Consensus       537 l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~n~~~cg  609 (1002)
                      +++.+|..++++++|++|+|++|++++.+|..+..+ .| .|+|++|++++.+|..  ....+....+.|||+.|.
T Consensus       488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             cCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            998888999999999999999999999999999888 68 9999999999888864  446677788999998874

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.6e-58  Score=561.69  Aligned_cols=526  Identities=21%  Similarity=0.194  Sum_probs=451.9

Q ss_pred             cceeEEeCC---------CCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccc
Q 001867           59 WRGVECDPR---------SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLL  129 (1002)
Q Consensus        59 w~gv~C~~~---------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  129 (1002)
                      +..|.|...         ...++.|||++|++++..|..|.++++|++|+|++|++.++.|.+|.++++|++|+|++|.+
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            566888542         35699999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcc
Q 001867          130 TGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE  209 (1002)
Q Consensus       130 ~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~  209 (1002)
                      ++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|++++|++ .+..|..
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l-~~~~~~~  172 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI-HYLSKED  172 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC-CEECHHH
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc-cccChhh
Confidence            998999999999999999999999987788999999999999999999986545555699999999999997 3455677


Q ss_pred             cCCCCccc--hhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCccc-----CCCCCcc
Q 001867          210 LGNLTNLE--ILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLT-----GDLPTGW  282 (1002)
Q Consensus       210 ~~~l~~L~--~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-----~~~~~~~  282 (1002)
                      ++.+++|+  .|++++|++++..|..+.. .+|+.|++++|..   .+..+.++..+....+.-+.+.     ...+..+
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~  248 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF  248 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred             hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccccccccChhHh
Confidence            89999999  8999999999887777654 6899999999872   3444555544443333322221     2223344


Q ss_pred             cccc--ccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCC
Q 001867          283 SNLT--SLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPL  359 (1002)
Q Consensus       283 ~~l~--~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  359 (1002)
                      ..+.  +|+.|++++|++++..+..+..++ |+.|++++|+++ .+|..+..+++|++|++++|++.+..|..+..+++|
T Consensus       249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  327 (606)
T 3t6q_A          249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL  327 (606)
T ss_dssp             GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred             chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence            4444  788899999999887777777765 999999999988 677888889999999999999988888888999999


Q ss_pred             ceEEccCccccCCCCh-hhhccCcccceeeeccccccCC--CCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEc
Q 001867          360 RWVDLSNNQFTGEIPA-SLCEKGELEELLMIYNSFTGQL--PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLEL  436 (1002)
Q Consensus       360 ~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  436 (1002)
                      ++|++++|.+.+.+|. .+..+++|++|++++|.+++..  +..++++++|++|++++|++++..|..|..+++|+.|++
T Consensus       328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  407 (606)
T 3t6q_A          328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL  407 (606)
T ss_dssp             SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEEC
T ss_pred             CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEEC
Confidence            9999999998866655 4888899999999999998766  788899999999999999999888999999999999999


Q ss_pred             ccCcccCccccc-cccCCcccEEEccCCcCCCCCccccccccccccccccccccCC---CCcccccccccCCeeecCCCc
Q 001867          437 TDNFLSGEISKN-IAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG---SLPESLTNLAELGSLDLHAND  512 (1002)
Q Consensus       437 ~~N~i~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~Ls~N~  512 (1002)
                      ++|++.+..+.. +..+++|+.|++++|.+++..|..++.+++|+.|++++|++++   ..+..+..+++|+.|+|++|+
T Consensus       408 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~  487 (606)
T 3t6q_A          408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD  487 (606)
T ss_dssp             TTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred             CCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence            999998876554 8889999999999999998889999999999999999999986   234678999999999999999


Q ss_pred             CCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh
Q 001867          513 LSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       513 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~  591 (1002)
                      +++.+|..|+.+++|+.|+|++|++++.+|..+.+++.| +|+|++|++++.+|..++.+ +|+.|++++|++++..+..
T Consensus       488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  566 (606)
T 3t6q_A          488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI  566 (606)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred             cCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence            999999999999999999999999999999999999999 99999999999888888888 8999999999999877743

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-58  Score=574.24  Aligned_cols=506  Identities=22%  Similarity=0.203  Sum_probs=246.6

Q ss_pred             CeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCC-CCCccccCcccccccccccccCCCCccccccCCccccc
Q 001867           69 HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTL-PDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLD  147 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~  147 (1002)
                      .+++.|||++|.|++..|..|.++++|++|+|++|.+.+.+ |.+|.++++|++|+|++|.|++..|..|.++++|++|+
T Consensus        24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  103 (844)
T 3j0a_A           24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR  103 (844)
T ss_dssp             TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred             CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence            34555555555555555555555555555555555333333 44555555555555555555555555555555555555


Q ss_pred             cccccccCCCCcc--cccccccceeeeccccccCccc-cccccccccccccccCCCCCCCCCCcccCCC--Cccchhhcc
Q 001867          148 LTGNNFSGDIPES--FGRFQKLEVISLVYNLLDGTIP-AFLGNISTLKMLNLSYNPFLPGRIPPELGNL--TNLEILWLT  222 (1002)
Q Consensus       148 Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l--~~L~~L~L~  222 (1002)
                      |++|.+++.+|..  |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+ .+..+..+..+  ++|+.|+++
T Consensus       104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i-~~~~~~~l~~l~~~~L~~L~L~  182 (844)
T 3j0a_A          104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI-FLVCEHELEPLQGKTLSFFSLA  182 (844)
T ss_dssp             CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCC-CCCCSGGGHHHHHCSSCCCEEC
T ss_pred             CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcC-CeeCHHHcccccCCccceEECC
Confidence            5555555444333  5555555555555555554433 3455555555555555553 23344444444  455555555


Q ss_pred             Ccccccccccccccccc------cchhcccCcccccccCcccccc---cceeeeeccCC---------cccCCCCCcccc
Q 001867          223 ECNLVGEIPDSLGRLAK------LVDLDLALNNLVGAIPSSLTEL---ASVVQIELYNN---------SLTGDLPTGWSN  284 (1002)
Q Consensus       223 ~n~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~L~~N---------~l~~~~~~~~~~  284 (1002)
                      +|.+.+..|..++.+.+      |+.|++++|.+++..+..+...   .+++.|.++.+         .+.+..+..|..
T Consensus       183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~  262 (844)
T 3j0a_A          183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG  262 (844)
T ss_dssp             CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred             CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence            55555555444444433      5555555555554444444322   23444444321         122222222332


Q ss_pred             c--cccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCce
Q 001867          285 L--TSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRW  361 (1002)
Q Consensus       285 l--~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  361 (1002)
                      +  ++|+.|++++|.+.+..|..+..++ |+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.
T Consensus       263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  342 (844)
T 3j0a_A          263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY  342 (844)
T ss_dssp             TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred             cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence            2  3455555555555544444444443 555555555555555555555555555555555555555555555555555


Q ss_pred             EEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcc
Q 001867          362 VDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFL  441 (1002)
Q Consensus       362 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i  441 (1002)
                      |+|++|++++..+..|..+++|++|++++|.+++     +..+++|+.|++++|+++ .+|..   ..+++.|++++|++
T Consensus       343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-----i~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l  413 (844)
T 3j0a_A          343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRL  413 (844)
T ss_dssp             EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-----CSSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCC
T ss_pred             EECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-----ccCCCCcchhccCCCCcc-ccccc---ccccceeecccCcc
Confidence            5555555554444445555555555555555542     112445555555555554 22222   23445555555555


Q ss_pred             cCccc-cccccCCcccEEEccCCcCCCCCcc-ccccccccccccccccccC-----CCCcccccccccCCeeecCCCcCC
Q 001867          442 SGEIS-KNIAGAANLSLLIISKNNLSGSLPE-EIGFLKSLVVLSGSENKFT-----GSLPESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       442 ~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      .+... ..+..+++|+.|+|++|++++..+. .+..+++|+.|++++|.++     +..|..|..+++|+.|||++|+|+
T Consensus       414 ~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  493 (844)
T 3j0a_A          414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN  493 (844)
T ss_dssp             CSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHT
T ss_pred             ccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCccc
Confidence            44321 1133445555555555555533222 2333455555555555554     222334455555555555555555


Q ss_pred             cccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCcccccccceEEeccccCcCCC
Q 001867          515 GELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGEL  588 (1002)
Q Consensus       515 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~L~~l~ls~N~l~g~~  588 (1002)
                      +.+|..|..+++|+.|+|++|+|++..|..+.  ++|+.|||++|+|++.+|..+.  +|+.|++++|++....
T Consensus       494 ~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~--~L~~l~l~~Np~~C~c  563 (844)
T 3j0a_A          494 SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV--SLSVLDITHNKFICEC  563 (844)
T ss_dssp             TCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS--SCCEEEEEEECCCCSS
T ss_pred             ccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC--CcCEEEecCCCccccc
Confidence            55555555555555555555555543333333  4555555555555555554432  3445555555554433

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=8.9e-58  Score=562.77  Aligned_cols=520  Identities=21%  Similarity=0.200  Sum_probs=464.2

Q ss_pred             CeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCcccccc
Q 001867           69 HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDL  148 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~L  148 (1002)
                      .+++.|||++|.+++..|..|+++++|++|+|++|+++++.+..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  128 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL  128 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence            46899999999999999999999999999999999999877778999999999999999999888889999999999999


Q ss_pred             ccccccCCCCcccccccccceeeeccccccCccccccc--cccccccccccCCCCCCCCCCcccCCC-------------
Q 001867          149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLG--NISTLKMLNLSYNPFLPGRIPPELGNL-------------  213 (1002)
Q Consensus       149 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~Ls~N~~~~~~~p~~~~~l-------------  213 (1002)
                      ++|++++..|..|+++++|++|++++|++++..+..++  .+++|++|++++|++ .+..|..+..+             
T Consensus       129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l-~~~~~~~~~~l~~L~~L~l~~~~l  207 (680)
T 1ziw_A          129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI-KEFSPGCFHAIGRLFGLFLNNVQL  207 (680)
T ss_dssp             CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC-CCBCTTGGGGSSEECEEECTTCCC
T ss_pred             CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc-cccChhhhhhhhhhhhhhcccccc
Confidence            99999999999999999999999999999988887765  458999999999986 45556555544             


Q ss_pred             --------------CccchhhccCcccccccccccccccc--cchhcccCcccccccCcccccccceeeeeccCCcccCC
Q 001867          214 --------------TNLEILWLTECNLVGEIPDSLGRLAK--LVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGD  277 (1002)
Q Consensus       214 --------------~~L~~L~L~~n~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  277 (1002)
                                    ++|+.|++++|++++..|..|..++.  |++|++++|++++..|..|..+++|+.|++++|++.+.
T Consensus       208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  287 (680)
T 1ziw_A          208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL  287 (680)
T ss_dssp             HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred             ChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCcc
Confidence                          56788889999999999999998876  99999999999999999999999999999999999999


Q ss_pred             CCCccccccccceeeccccccCCC-----CCc----cCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCC
Q 001867          278 LPTGWSNLTSLRLLDASMNDLTGP-----IPD----DLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNG  347 (1002)
Q Consensus       278 ~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~----~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (1002)
                      .|..|..+++|+.|++++|...+.     +|.    .+..++ |+.|++++|++.+..+..|.++++|++|++++|.+..
T Consensus       288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~  367 (680)
T 1ziw_A          288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL  367 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC
T ss_pred             ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhh
Confidence            999999999999999998876542     332    455554 9999999999999999999999999999999998653


Q ss_pred             --CCCCCCCCC--CCCceEEccCccccCCCChhhhccCcccceeeeccccccCCC-CcCcCCCCCcEEEccCccccCCCC
Q 001867          348 --TLPGDLGKN--SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLP-DGLGHCQSLTRVRLGYNRLTGKVP  422 (1002)
Q Consensus       348 --~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p  422 (1002)
                        ..+..|..+  ++|+.|++++|++++..|..|..+++|+.|++++|.+++.+| ..+.++++|++|++++|++++..+
T Consensus       368 ~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  447 (680)
T 1ziw_A          368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR  447 (680)
T ss_dssp             CEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCT
T ss_pred             hhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeCh
Confidence              223344433  589999999999999999999999999999999999998766 689999999999999999999999


Q ss_pred             CcCCCCCcceEEEcccCccc--CccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCc------
Q 001867          423 PLLWGLPHVYLLELTDNFLS--GEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLP------  494 (1002)
Q Consensus       423 ~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------  494 (1002)
                      ..|..+++|+.|++++|.+.  +..|..+..+++|+.|++++|++++..|..++.+++|+.|++++|++++..+      
T Consensus       448 ~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  527 (680)
T 1ziw_A          448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG  527 (680)
T ss_dssp             TTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTS
T ss_pred             hhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCC
Confidence            99999999999999999997  5688899999999999999999998888889999999999999999985321      


Q ss_pred             --ccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccc-c
Q 001867          495 --ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ-N  571 (1002)
Q Consensus       495 --~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~-~  571 (1002)
                        ..|.++++|+.|+|++|+++...+..|+.+++|+.|+|++|++++..|..+.++++|+.|+|++|+|++.+|..+. .
T Consensus       528 ~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  607 (680)
T 1ziw_A          528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA  607 (680)
T ss_dssp             CCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHH
T ss_pred             cchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhccc
Confidence              2478999999999999999966667899999999999999999966666788999999999999999998887776 5


Q ss_pred             c-ccceEEeccccCcCCCC
Q 001867          572 L-KLNQLNVSNNRLSGELP  589 (1002)
Q Consensus       572 l-~L~~l~ls~N~l~g~~p  589 (1002)
                      + +|+.|+|++|++....+
T Consensus       608 ~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          608 FRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             HTTCSEEECTTCCCCBCCC
T ss_pred             ccccCEEEccCCCcccCCc
Confidence            6 79999999999988765

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-57  Score=567.90  Aligned_cols=522  Identities=20%  Similarity=0.186  Sum_probs=455.9

Q ss_pred             EEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCC-CccccccCCccccccccc
Q 001867           73 SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL-TPALADLPNLKFLDLTGN  151 (1002)
Q Consensus        73 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~L~~L~~L~Ls~N  151 (1002)
                      .+|.++++++.. |.   -.++|++|+|++|.|+++.|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|
T Consensus         8 ~~dcs~~~L~~v-P~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLTQV-PQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSSCC-CS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCCCC-CC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            355667788754 44   4579999999999999999999999999999999999666555 788999999999999999


Q ss_pred             cccCCCCcccccccccceeeeccccccCccccc--cccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccc
Q 001867          152 NFSGDIPESFGRFQKLEVISLVYNLLDGTIPAF--LGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGE  229 (1002)
Q Consensus       152 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  229 (1002)
                      ++++..|+.|+++++|++|+|++|.+++.+|..  |+++++|++|+|++|.+.....+..|+++++|++|+|++|.+++.
T Consensus        84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~  163 (844)
T 3j0a_A           84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV  163 (844)
T ss_dssp             CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred             cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence            999999999999999999999999999866654  999999999999999985444456899999999999999999999


Q ss_pred             cccccccc--cccchhcccCcccccccCcccccccc------eeeeeccCCcccCCCCCccccc---cccceeeccc---
Q 001867          230 IPDSLGRL--AKLVDLDLALNNLVGAIPSSLTELAS------VVQIELYNNSLTGDLPTGWSNL---TSLRLLDASM---  295 (1002)
Q Consensus       230 ~p~~~~~l--~~L~~L~L~~N~l~~~~~~~l~~l~~------L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~---  295 (1002)
                      .+..+..+  ++|+.|+++.|.+.+..|..+..+.+      |+.|++++|.+.+..+..+...   ++++.|.++.   
T Consensus       164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~  243 (844)
T 3j0a_A          164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM  243 (844)
T ss_dssp             CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred             CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence            99999988  89999999999999988887777665      9999999999998888877654   5778888773   


Q ss_pred             ------cccCCCCCccCCCC---CcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccC
Q 001867          296 ------NDLTGPIPDDLTRL---PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN  366 (1002)
Q Consensus       296 ------N~l~~~~p~~~~~~---~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  366 (1002)
                            |.+.+..+..+..+   .|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++
T Consensus       244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~  323 (844)
T 3j0a_A          244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY  323 (844)
T ss_dssp             BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred             cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence                  33443344444443   499999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccc
Q 001867          367 NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS  446 (1002)
Q Consensus       367 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~  446 (1002)
                      |++++..|..|..+++|+.|++++|.+.+..+..|.++++|++|+|++|.+++.     ..+++|+.|++++|+++.. |
T Consensus       324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~l-~  397 (844)
T 3j0a_A          324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVTL-P  397 (844)
T ss_dssp             CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCCC-C
T ss_pred             CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcccc-c
Confidence            999988899999999999999999999998899999999999999999999853     2388999999999999854 3


Q ss_pred             cccccCCcccEEEccCCcCCCCC-ccccccccccccccccccccCCCCcc-cccccccCCeeecCCCcCC-----ccccc
Q 001867          447 KNIAGAANLSLLIISKNNLSGSL-PEEIGFLKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLS-----GELPS  519 (1002)
Q Consensus       447 ~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~  519 (1002)
                      ..   ..+++.|++++|++++.. +..++.+++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..|.
T Consensus       398 ~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~  474 (844)
T 3j0a_A          398 KI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD  474 (844)
T ss_dssp             CC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred             cc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence            32   568999999999999642 23466899999999999999965443 4667899999999999997     55567


Q ss_pred             ccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCcccccccceEEeccccCcCCCChhhhhhcccc
Q 001867          520 SVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRN  599 (1002)
Q Consensus       520 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~L~~l~ls~N~l~g~~p~~~~~~~~~~  599 (1002)
                      .|..+++|+.|+|++|.+++.+|..+.++++|+.|+|++|+|++.+|..+. -+|+.|||++|+|+|.+|.. +..+...
T Consensus       475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~-~~~L~~l  552 (844)
T 3j0a_A          475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDV-FVSLSVL  552 (844)
T ss_dssp             CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCC-CSSCCEE
T ss_pred             hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhH-hCCcCEE
Confidence            899999999999999999998899999999999999999999987776665 57999999999999999976 3467778


Q ss_pred             cccCCCCCCC
Q 001867          600 SFLGNPGLCG  609 (1002)
Q Consensus       600 ~~~~n~~~cg  609 (1002)
                      .+.|||+.|+
T Consensus       553 ~l~~Np~~C~  562 (844)
T 3j0a_A          553 DITHNKFICE  562 (844)
T ss_dssp             EEEEECCCCS
T ss_pred             EecCCCcccc
Confidence            8999999993

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=9.8e-58  Score=554.76  Aligned_cols=525  Identities=21%  Similarity=0.182  Sum_probs=438.5

Q ss_pred             EEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCcccccccccc
Q 001867           73 SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN  152 (1002)
Q Consensus        73 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~  152 (1002)
                      .++.++++++. +|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus        15 ~~~c~~~~l~~-ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~   91 (606)
T 3vq2_A           15 TYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP   91 (606)
T ss_dssp             EEECTTSCCSS-CCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             ceEccCCCccc-CCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence            46778888874 555444  789999999999999888899999999999999999998888899999999999999999


Q ss_pred             ccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccccccccc
Q 001867          153 FSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPD  232 (1002)
Q Consensus       153 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~  232 (1002)
                      +++..|..|+++++|++|+|++|++++..+..++++++|++|+|++|.+....+|..++++++|++|++++|++++..|.
T Consensus        92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~  171 (606)
T 3vq2_A           92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN  171 (606)
T ss_dssp             CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred             ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence            99888999999999999999999999888888999999999999999986557899999999999999999999988888


Q ss_pred             ccccccccc----hhcccCcccccccCcccccccceeeeeccCCccc-CCCCCccccccccceeeccccccCCC------
Q 001867          233 SLGRLAKLV----DLDLALNNLVGAIPSSLTELASVVQIELYNNSLT-GDLPTGWSNLTSLRLLDASMNDLTGP------  301 (1002)
Q Consensus       233 ~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~------  301 (1002)
                      .|+.+++|+    +|++++|.+++..+..+... +|+.|++++|.+. +..|..+.++++|+.+++..+.+.+.      
T Consensus       172 ~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~  250 (606)
T 3vq2_A          172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF  250 (606)
T ss_dssp             TTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             hhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence            888888776    69999999997777777665 8999999999887 45667788999999988876665431      


Q ss_pred             ---CCccCCCCCcceeec-CCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhh
Q 001867          302 ---IPDDLTRLPLESLNL-YENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL  377 (1002)
Q Consensus       302 ---~p~~~~~~~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  377 (1002)
                         .+..+..+.++.+++ ..|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|+.|++++|++ +.+| .+
T Consensus       251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~  325 (606)
T 3vq2_A          251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL  325 (606)
T ss_dssp             CGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC
T ss_pred             ChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC
Confidence               122223334777777 77788877777 8888899999999998864 44 788888899999999999 5777 44


Q ss_pred             hccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCC--CCCcCCCCCcceEEEcccCcccCccccccccCCcc
Q 001867          378 CEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGK--VPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANL  455 (1002)
Q Consensus       378 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  455 (1002)
                       .+++|++|++++|...+..  .+..+++|++|++++|++++.  .|..+..+++|+.|++++|.+.+ ++..+..+++|
T Consensus       326 -~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L  401 (606)
T 3vq2_A          326 -DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEEL  401 (606)
T ss_dssp             -CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTC
T ss_pred             -CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCC
Confidence             8888999999998665544  567888999999999988866  37788888999999999998876 44778888899


Q ss_pred             cEEEccCCcCCCCCc-cccccccccccccccccccCCCCcccccccccCCeeecCCCcCCc-cccccccccccccccccc
Q 001867          456 SLLIISKNNLSGSLP-EEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSG-ELPSSVSSWKKLNELNLA  533 (1002)
Q Consensus       456 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls  533 (1002)
                      +.|++++|++.+..| ..++.+++|+.|++++|++++..|..+..+++|++|++++|++++ .+|..|+.+++|+.|+|+
T Consensus       402 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls  481 (606)
T 3vq2_A          402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS  481 (606)
T ss_dssp             CEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred             CeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECC
Confidence            999999999987777 678888999999999999988888888889999999999999887 478888899999999999


Q ss_pred             CcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh--hh-hhcccccccCCCCCCC
Q 001867          534 DNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL--FA-KEMYRNSFLGNPGLCG  609 (1002)
Q Consensus       534 ~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~--~~-~~~~~~~~~~n~~~cg  609 (1002)
                      +|.+++.+|..++++++|++|+|++|++++.+|..++.+ +|+.|||++|+|++ +|..  .. ..+....+.|||+.|+
T Consensus       482 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~  560 (606)
T 3vq2_A          482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACI  560 (606)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCS
T ss_pred             CCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccC
Confidence            999988888888899999999999999998888888888 79999999999884 4443  12 2366677888988875


Q ss_pred             CC
Q 001867          610 DL  611 (1002)
Q Consensus       610 ~~  611 (1002)
                      -+
T Consensus       561 c~  562 (606)
T 3vq2_A          561 CE  562 (606)
T ss_dssp             ST
T ss_pred             Cc
Confidence            43

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=5.7e-58  Score=556.34  Aligned_cols=499  Identities=18%  Similarity=0.263  Sum_probs=296.9

Q ss_pred             chHHHHHHHHHHHhccCCc--------cccCCCCCCCCCCCCCcc---ceeEEeCCCCeEEEEEcCCCCcCCCCCccccC
Q 001867           23 LNQEGLYLERVKLSLSDPD--------SALSSWGRNPRDDSPCSW---RGVECDPRSHSVASIDLSNANIAGPFPSLLCR   91 (1002)
Q Consensus        23 ~~~~~~~l~~~k~~~~d~~--------~~l~sw~~~~~~~~~C~w---~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~   91 (1002)
                      ...|+.||.++|.++.++.        ...++|+.   +.+||.|   .||+|+.. ++|+.|+|++++++|.+|+.|++
T Consensus        28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~---~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~  103 (636)
T 4eco_A           28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF---NKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQ  103 (636)
T ss_dssp             HHHHHHHHHHHHHHTTGGGCCCCC------CCCCC---SSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGG
T ss_pred             HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC---CCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhc
Confidence            3479999999999986552        23457964   4689999   99999865 79999999999999999999999


Q ss_pred             CCCCCEEeccCCCC------CC------CCCCCccccCcccccccccccccCCCCccccc-cCCccccccccccccCCCC
Q 001867           92 LENLTFLTLFNNSI------NS------TLPDDISACQNLQHLDLSQNLLTGTLTPALAD-LPNLKFLDLTGNNFSGDIP  158 (1002)
Q Consensus        92 l~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-L~~L~~L~Ls~N~l~~~~p  158 (1002)
                      |++|++|+|++|.+      .+      .+|...  +..|+ +++++|.+.+.+|..+.. +..+..+++....+..   
T Consensus       104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~---  177 (636)
T 4eco_A          104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK---  177 (636)
T ss_dssp             CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC---
T ss_pred             CccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc---
Confidence            99999999999976      22      334333  56777 889999888887777663 3344444444322221   


Q ss_pred             cccccccccceeeec--cccccCccccccccccccccccccCCCCCCCC-----------------CCcccC--CCCccc
Q 001867          159 ESFGRFQKLEVISLV--YNLLDGTIPAFLGNISTLKMLNLSYNPFLPGR-----------------IPPELG--NLTNLE  217 (1002)
Q Consensus       159 ~~~~~l~~L~~L~L~--~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~-----------------~p~~~~--~l~~L~  217 (1002)
                         .....++.+.+.  +|++++ +|..++++++|++|+|++|++ .+.                 +|..++  ++++|+
T Consensus       178 ---~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l-~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~  252 (636)
T 4eco_A          178 ---SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF-VAENICEAWENENSEYAQQYKTEDLKWDNLKDLT  252 (636)
T ss_dssp             ---CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCC-CGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCC
T ss_pred             ---ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcc-ccccccccccccccchhcccCchhhhhcccCCCC
Confidence               011122222222  345554 455555555555555555553 222                 555555  666666


Q ss_pred             hhhccCcccccccccccccccccchhcccCcc-ccc-ccCcccccc------cceeeeeccCCcccCCCCC--ccccccc
Q 001867          218 ILWLTECNLVGEIPDSLGRLAKLVDLDLALNN-LVG-AIPSSLTEL------ASVVQIELYNNSLTGDLPT--GWSNLTS  287 (1002)
Q Consensus       218 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~l~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~  287 (1002)
                      +|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+..+      ++|+.|++++|+++ .+|.  .+.++++
T Consensus       253 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~  331 (636)
T 4eco_A          253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKK  331 (636)
T ss_dssp             EEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTT
T ss_pred             EEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCC
Confidence            66666666666666666666666666666665 555 555555554      66666666666666 5555  6666666


Q ss_pred             cceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcc-cchhcccccccCCCCCCCCCCCC--CCceEE
Q 001867          288 LRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPG-LYELRLFRNRLNGTLPGDLGKNS--PLRWVD  363 (1002)
Q Consensus       288 L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~  363 (1002)
                      |+.|++++|+++|.+| .+..++ |+.|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|++|+
T Consensus       332 L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~  408 (636)
T 4eco_A          332 LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAID  408 (636)
T ss_dssp             CCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEE
T ss_pred             CCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEE
Confidence            6666666666665555 444332 555555555555 44545555555 555555555555 4444444433  555555


Q ss_pred             ccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccC
Q 001867          364 LSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG  443 (1002)
Q Consensus       364 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~  443 (1002)
                      +++|++++.+|..+....                 ...-.+++|++|+|++|++++..+..+..+++|+.|+|++|+++.
T Consensus       409 Ls~N~l~~~~p~~l~~~~-----------------~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~  471 (636)
T 4eco_A          409 FSYNEIGSVDGKNFDPLD-----------------PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE  471 (636)
T ss_dssp             CCSSCTTTTTTCSSCTTC-----------------SSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSB
T ss_pred             CcCCcCCCcchhhhcccc-----------------cccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCC
Confidence            555555555554444000                 000033444444444444442222223334444555555554442


Q ss_pred             ccccccc-------cCCcccEEEccCCcCCCCCccccc--cccccccccccccccCCCCcccccccccCCeeecCCC---
Q 001867          444 EISKNIA-------GAANLSLLIISKNNLSGSLPEEIG--FLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAN---  511 (1002)
Q Consensus       444 ~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N---  511 (1002)
                      +.+..+.       .+++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++|   
T Consensus       472 i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~l  549 (636)
T 4eco_A          472 IPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA  549 (636)
T ss_dssp             CCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCT
T ss_pred             cCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCccc
Confidence            2222222       2337888888888888 6777776  78888888888888886 7888888888888888654   


Q ss_pred             ---cCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeee
Q 001867          512 ---DLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       512 ---~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                         ++.+.+|..++.+++|+.|+|++|++ +.+|..+.  ++|++|||++|++.
T Consensus       550 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          550 QGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             TCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred             ccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence               44444444444444444444444444 34444433  34444444444443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.2e-57  Score=549.22  Aligned_cols=511  Identities=20%  Similarity=0.178  Sum_probs=450.6

Q ss_pred             CeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCcccccc
Q 001867           69 HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDL  148 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~L  148 (1002)
                      .+++.|+|++|++++..+..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            57999999999999999989999999999999999999999999999999999999999999888999999999999999


Q ss_pred             ccccccCCCCcccccccccceeeeccccccC-ccccccccccccccccccCCCCCCCCCCcccCCCCccc----hhhccC
Q 001867          149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDG-TIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLE----ILWLTE  223 (1002)
Q Consensus       149 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~----~L~L~~  223 (1002)
                      ++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++ .+..|..++.+++|+    +|++++
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l-~~~~~~~~~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI-QTITVNDLQFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCC-CEECTTTTHHHHHCTTCCCEEECTT
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcc-eecChhhhhhhhccccccceeeccC
Confidence            9999998888899999999999999999986 5799999999999999999997 455567788877766    799999


Q ss_pred             cccccccccccccccccchhcccCcccc-cccCcccccccceeeeeccCCcccCC------CCCcccccc--ccceeec-
Q 001867          224 CNLVGEIPDSLGRLAKLVDLDLALNNLV-GAIPSSLTELASVVQIELYNNSLTGD------LPTGWSNLT--SLRLLDA-  293 (1002)
Q Consensus       224 n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~------~~~~~~~l~--~L~~L~L-  293 (1002)
                      |++++..+..+... +|++|++++|.++ +..|..+.++++|+.+++..+.+.+.      .+..+..+.  +++.+++ 
T Consensus       191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  269 (606)
T 3vq2_A          191 NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT  269 (606)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred             CCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence            99997666666555 9999999999987 56778899999999888865554321      122223332  4566677 


Q ss_pred             cccccCCCCCccCCCC-CcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCC
Q 001867          294 SMNDLTGPIPDDLTRL-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE  372 (1002)
Q Consensus       294 s~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  372 (1002)
                      ..|.+.+.+|. +..+ .|+.|++++|.+.. +| .+..+++|++|++++|++ +.+| .+ .+++|+.|++++|+..+.
T Consensus       270 ~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~  343 (606)
T 3vq2_A          270 YTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSIS  343 (606)
T ss_dssp             CCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEE
T ss_pred             ccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccc
Confidence            77888888887 5555 49999999999974 55 888999999999999999 5777 45 899999999999976644


Q ss_pred             CChhhhccCcccceeeeccccccC--CCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccc-ccc
Q 001867          373 IPASLCEKGELEELLMIYNSFTGQ--LPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS-KNI  449 (1002)
Q Consensus       373 ~p~~~~~l~~L~~L~l~~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~  449 (1002)
                      +  .+..+++|++|++++|.+++.  .|..+..+++|++|++++|++++ +|..+..+++|+.|++++|++.+..+ ..+
T Consensus       344 ~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  420 (606)
T 3vq2_A          344 F--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAF  420 (606)
T ss_dssp             C--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTT
T ss_pred             h--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhh
Confidence            4  677899999999999999876  48889999999999999999985 66889999999999999999999887 789


Q ss_pred             ccCCcccEEEccCCcCCCCCccccccccccccccccccccCC-CCcccccccccCCeeecCCCcCCcccccccccccccc
Q 001867          450 AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG-SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLN  528 (1002)
Q Consensus       450 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  528 (1002)
                      ..+++|+.|++++|++++..|..++.+++|+.|++++|++++ .+|..++.+++|+.|+|++|++++.+|..|+.+++|+
T Consensus       421 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  500 (606)
T 3vq2_A          421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ  500 (606)
T ss_dssp             TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             hccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCC
Confidence            999999999999999999999999999999999999999997 4789999999999999999999999999999999999


Q ss_pred             cccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc--ccceEEeccccCcCCCChh
Q 001867          529 ELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL--KLNQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       529 ~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l--~L~~l~ls~N~l~g~~p~~  591 (1002)
                      .|+|++|++++.+|..++++++|++|||++|+++ .+|..+..+  +|+.|++++|++.+..+-.
T Consensus       501 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            9999999999988999999999999999999999 677778887  4999999999999877643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.7e-57  Score=555.02  Aligned_cols=501  Identities=19%  Similarity=0.240  Sum_probs=343.1

Q ss_pred             chHHHHHHHHHHHhccCCccccCCCCCCC----CCCCCCcc------------ceeEEeCCCCeEEEEEcCCCCcCCCCC
Q 001867           23 LNQEGLYLERVKLSLSDPDSALSSWGRNP----RDDSPCSW------------RGVECDPRSHSVASIDLSNANIAGPFP   86 (1002)
Q Consensus        23 ~~~~~~~l~~~k~~~~d~~~~l~sw~~~~----~~~~~C~w------------~gv~C~~~~~~v~~l~L~~~~l~~~~~   86 (1002)
                      ...|+.||++||+++.||     +|+.+.    .+.++|.|            .||+|+. .++|+.|+|++++++|.+|
T Consensus       267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip  340 (876)
T 4ecn_A          267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVP  340 (876)
T ss_dssp             HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEEC
T ss_pred             chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCc
Confidence            457999999999999887     896542    12233999            9999987 6899999999999999999


Q ss_pred             ccccCCCCCCEEec-cCCCCCCCCCCCcccc----C-----ccccccc-------cccccc-----------CCCCcccc
Q 001867           87 SLLCRLENLTFLTL-FNNSINSTLPDDISAC----Q-----NLQHLDL-------SQNLLT-----------GTLTPALA  138 (1002)
Q Consensus        87 ~~~~~l~~L~~L~L-~~n~l~~~~p~~~~~l----~-----~L~~L~L-------s~N~l~-----------~~~~~~~~  138 (1002)
                      +.|++|++|++|+| ++|.++|..|-.-...    .     .++..++       ....++           ...+....
T Consensus       341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~  420 (876)
T 4ecn_A          341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD  420 (876)
T ss_dssp             GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred             hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence            99999999999999 8998877644221111    0     0000000       000000           00111112


Q ss_pred             ccCCcccccccc--ccccCCCCcccccccccceeeeccccccC-----------------ccccccc--ccccccccccc
Q 001867          139 DLPNLKFLDLTG--NNFSGDIPESFGRFQKLEVISLVYNLLDG-----------------TIPAFLG--NISTLKMLNLS  197 (1002)
Q Consensus       139 ~L~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~l~--~l~~L~~L~Ls  197 (1002)
                      ....++.+.+..  |++++ +|..|+++++|++|+|++|++++                 .+|..++  ++++|++|+|+
T Consensus       421 ~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls  499 (876)
T 4ecn_A          421 SRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY  499 (876)
T ss_dssp             CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred             cccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence            233444454444  66665 66667777777777777777766                 3666666  77777777777


Q ss_pred             CCCCCCCCCCcccCCCCccchhhccCcc-ccc-cccccccccc-------ccchhcccCcccccccCc--ccccccceee
Q 001867          198 YNPFLPGRIPPELGNLTNLEILWLTECN-LVG-EIPDSLGRLA-------KLVDLDLALNNLVGAIPS--SLTELASVVQ  266 (1002)
Q Consensus       198 ~N~~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~~~--~l~~l~~L~~  266 (1002)
                      +|++ .+.+|..|+++++|+.|+|++|+ +++ .+|..++.++       +|++|+|++|+++ .+|.  .|.++++|+.
T Consensus       500 ~N~l-~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~  577 (876)
T 4ecn_A          500 NCPN-MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL  577 (876)
T ss_dssp             SCTT-CCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred             CCCC-CccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence            7764 46677777777777777777776 776 6777666655       7777777777777 6666  7777777777


Q ss_pred             eeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCC-C-cceeecCCCcccCcCCcccCCCcc--cchhcccc
Q 001867          267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL-P-LESLNLYENRLEGSLPATIADSPG--LYELRLFR  342 (1002)
Q Consensus       267 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~-L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~  342 (1002)
                      |+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+ . |+.|+|++|+++ .+|..+..++.  |+.|++++
T Consensus       578 L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~  653 (876)
T 4ecn_A          578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY  653 (876)
T ss_dssp             EECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCS
T ss_pred             EECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcC
Confidence            777777777 666 7777777777777777777 666666655 3 777777777777 56666666544  88888888


Q ss_pred             cccCCCCCCCC---C--CCCCCceEEccCccccCCCChhh-hccCcccceeeeccccccCCCCcCcC--------CCCCc
Q 001867          343 NRLNGTLPGDL---G--KNSPLRWVDLSNNQFTGEIPASL-CEKGELEELLMIYNSFTGQLPDGLGH--------CQSLT  408 (1002)
Q Consensus       343 N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~l~~--------l~~L~  408 (1002)
                      |++.+.+|...   .  .+.+|+.|+|++|+++ .+|..+ ..+++|+.|++++|.++ .+|..+..        +++|+
T Consensus       654 N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~  731 (876)
T 4ecn_A          654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLT  731 (876)
T ss_dssp             SCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCC
T ss_pred             CcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCcc
Confidence            88877655322   2  3347889999999998 555554 47888999999999888 45554333        33899


Q ss_pred             EEEccCccccCCCCCcCC--CCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccc
Q 001867          409 RVRLGYNRLTGKVPPLLW--GLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSE  486 (1002)
Q Consensus       409 ~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  486 (1002)
                      .|+|++|+++ .+|..+.  .+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+                  ++++
T Consensus       732 ~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls~  791 (876)
T 4ecn_A          732 TIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAEG  791 (876)
T ss_dssp             EEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTTC
T ss_pred             EEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------Cccc
Confidence            9999999999 6788877  89999999999999987 67788889999999998754                  3445


Q ss_pred             cccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceee
Q 001867          487 NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       487 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      |++.+.+|..|..+++|+.|+|++|+| +.+|..+.  ++|+.|+|++|.+...-+..+.....+..+.|++|++
T Consensus       792 N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~  863 (876)
T 4ecn_A          792 NRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT  863 (876)
T ss_dssp             CBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred             ccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCc
Confidence            555555555555555555555555555 34554443  3555555555555543444444444444555555543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=514.66  Aligned_cols=506  Identities=21%  Similarity=0.203  Sum_probs=441.8

Q ss_pred             EEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccc
Q 001867           74 IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF  153 (1002)
Q Consensus        74 l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l  153 (1002)
                      ++.++.+++ .+|..+.  +++++|+|++|+++++.+.+|.++++|++|+|++|++++..+..|+++++|++|+|++|++
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            455556666 3454443  4799999999999988888999999999999999999988888999999999999999999


Q ss_pred             cCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccc
Q 001867          154 SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDS  233 (1002)
Q Consensus       154 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~  233 (1002)
                      ++..|..|+++++|++|++++|++++..+..++++++|++|+|++|.+....+|..|+++++|++|++++|++++..+..
T Consensus        89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~  168 (570)
T 2z63_A           89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  168 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred             CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence            98888999999999999999999997777789999999999999999754468999999999999999999999888889


Q ss_pred             ccccccc----chhcccCcccccccCcccccccceeeeeccCCcccC-CCCCccccccccceeeccccccCC--------
Q 001867          234 LGRLAKL----VDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTG-DLPTGWSNLTSLRLLDASMNDLTG--------  300 (1002)
Q Consensus       234 ~~~l~~L----~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~--------  300 (1002)
                      ++.+++|    +.|++++|.+++..+..+... +|+.|++++|.... .++..+..+++++.+.+..+.+..        
T Consensus       169 ~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  247 (570)
T 2z63_A          169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  247 (570)
T ss_dssp             GHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECC
T ss_pred             ccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcc
Confidence            9999998    889999999998888888776 89999999985442 244556677777776665443321        


Q ss_pred             -CCCccCCCCCcceeecCCC-cccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhh
Q 001867          301 -PIPDDLTRLPLESLNLYEN-RLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLC  378 (1002)
Q Consensus       301 -~~p~~~~~~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  378 (1002)
                       .....+..+.++.+++++| .+.+..|..+..+++|++|++++|.+. .+|..+..+ +|+.|++++|.++ .+|.  .
T Consensus       248 ~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~  322 (570)
T 2z63_A          248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--L  322 (570)
T ss_dssp             TTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--C
T ss_pred             hhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--c
Confidence             1112223345788899888 888889999999999999999999998 578888888 9999999999999 5665  4


Q ss_pred             ccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCC--CCcCCCCCcceEEEcccCcccCccccccccCCccc
Q 001867          379 EKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKV--PPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLS  456 (1002)
Q Consensus       379 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  456 (1002)
                      .+++|+.|++++|.+.+..+.  ..+++|++|++++|++++..  |..+..+++|+.|++++|.+.+..+. +..+++|+
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~  399 (570)
T 2z63_A          323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLE  399 (570)
T ss_dssp             BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCC
T ss_pred             cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCC
Confidence            788999999999999887766  78999999999999998654  67888999999999999999977665 99999999


Q ss_pred             EEEccCCcCCCCCc-cccccccccccccccccccCCCCcccccccccCCeeecCCCcCC-cccccccccccccccccccC
Q 001867          457 LLIISKNNLSGSLP-EEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLS-GELPSSVSSWKKLNELNLAD  534 (1002)
Q Consensus       457 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~  534 (1002)
                      .|++++|++.+..| ..+..+++|+.|++++|++++..|..+..+++|+.|+|++|.++ +.+|..++.+++|++|+|++
T Consensus       400 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~  479 (570)
T 2z63_A          400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ  479 (570)
T ss_dssp             EEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             EEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCC
Confidence            99999999997766 57899999999999999999999999999999999999999998 68999999999999999999


Q ss_pred             cccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh
Q 001867          535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       535 N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~  591 (1002)
                      |++++..|..++++++|++|+|++|++++.+|..+..+ +|+.|++++|++++.+|..
T Consensus       480 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            99998889999999999999999999999888888888 8999999999999999864

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=6.4e-53  Score=506.15  Aligned_cols=490  Identities=21%  Similarity=0.233  Sum_probs=367.5

Q ss_pred             CCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCc
Q 001867           56 PCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTP  135 (1002)
Q Consensus        56 ~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  135 (1002)
                      .|.|.|+ |+          +++++++. +|..+.  ++|++|+|++|++++..|.+|.++++|++|+|++|++++..|.
T Consensus         3 ~C~~~~~-c~----------~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CD----------GRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EE----------CTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EE----------CCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999998 85          34566663 455443  6889999999999888888888888999999998888887778


Q ss_pred             cccccCCccccccccccccCCCCcccccccccceeeeccccccCc-cccccccccccccccccCCCCCCCCCC-cccCCC
Q 001867          136 ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGT-IPAFLGNISTLKMLNLSYNPFLPGRIP-PELGNL  213 (1002)
Q Consensus       136 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~~~~~~~p-~~~~~l  213 (1002)
                      .|+++++|++|+|++|++++..|..|+++++|++|+|++|++++. .|..++++++|++|++++|.+. +.+| ..++++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~-~~~~~~~~~~l  147 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF-SEIRRIDFAGL  147 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC-CEECTTTTTTC
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc-cccCHhhhhcc
Confidence            888888888888888888877777788888888888888888763 4667788888888888888743 3333 467777


Q ss_pred             CccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCC--C-Cccccccccce
Q 001867          214 TNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDL--P-TGWSNLTSLRL  290 (1002)
Q Consensus       214 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~-~~~~~l~~L~~  290 (1002)
                      ++|++|++++|++++..|..++.+++|++|+++.|.+.......+..+++|+.|++++|++++..  | .....+++|+.
T Consensus       148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~  227 (549)
T 2z81_A          148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK  227 (549)
T ss_dssp             CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred             cccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence            77777777777777777777777777777777777765333223345666666666666666532  1 12234555666


Q ss_pred             eeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCC------CCCCCCCCCCceEEc
Q 001867          291 LDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTL------PGDLGKNSPLRWVDL  364 (1002)
Q Consensus       291 L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~L  364 (1002)
                      |++++|.+++..+..+                   +..+..+++|+.+++++|.+.+..      ...+..+.+|+.|++
T Consensus       228 L~l~~n~l~~~~~~~l-------------------~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l  288 (549)
T 2z81_A          228 LAFRGSVLTDESFNEL-------------------LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI  288 (549)
T ss_dssp             EEEESCEEEHHHHHHH-------------------HGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred             eeccccccchhHHHHH-------------------HHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence            6666665554322211                   122233444555555555544321      123456677888888


Q ss_pred             cCccccCC-----CChhhhccCcccceeeeccccccCCCCcC-cCCCCCcEEEccCccccCCCC---CcCCCCCcceEEE
Q 001867          365 SNNQFTGE-----IPASLCEKGELEELLMIYNSFTGQLPDGL-GHCQSLTRVRLGYNRLTGKVP---PLLWGLPHVYLLE  435 (1002)
Q Consensus       365 s~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~  435 (1002)
                      +++.+...     .+..+...++|++|++++|.+. .+|..+ .++++|++|+|++|++++..|   ..+..+++|+.|+
T Consensus       289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~  367 (549)
T 2z81_A          289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV  367 (549)
T ss_dssp             ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEE
T ss_pred             cccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEE
Confidence            88876532     2333445678899999999887 566555 578999999999999987663   4477889999999


Q ss_pred             cccCcccCccc--cccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcC
Q 001867          436 LTDNFLSGEIS--KNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL  513 (1002)
Q Consensus       436 L~~N~i~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  513 (1002)
                      |++|++++..+  ..+..+++|+.|++++|+++ .+|..++.+++|+.|++++|+++ .+|..+.  ++|++|||++|+|
T Consensus       368 Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l  443 (549)
T 2z81_A          368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNL  443 (549)
T ss_dssp             CTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCC
T ss_pred             ccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCCh
Confidence            99999987643  55888999999999999999 78999999999999999999998 4565442  6899999999999


Q ss_pred             CcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCCh
Q 001867          514 SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPS  590 (1002)
Q Consensus       514 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~  590 (1002)
                      ++.+    ..+++|++|+|++|+++ .+|. .+.+++|++|||++|++++.+|..++.+ +|+.|+|++|++++..|.
T Consensus       444 ~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          444 DSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             SCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             hhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            9753    57899999999999998 7887 5789999999999999999888889888 899999999999999884

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-52  Score=449.64  Aligned_cols=262  Identities=29%  Similarity=0.384  Sum_probs=206.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +++.+.++||+|+||+||+|+++  ..||||+++..               .......+.|.+|+.++++++|||||+++
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~---------------~~~~~~~~~f~~E~~il~~l~HpNIV~l~   98 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVV---------------DPTPEQFQAFRNEVAVLRKTRHVNILLFM   98 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCS---------------SCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEec---------------CCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            56788899999999999999875  46999998432               12344567899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+ +..|+||||+++|+|.++++. ....+++.++..|+.|||.||+|||++   +||||||||+|||+++++.+||
T Consensus        99 g~~~~-~~~~iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki  173 (307)
T 3omv_A           99 GYMTK-DNLAIVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKI  173 (307)
T ss_dssp             EEECS-SSCEEEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEE
T ss_pred             EEEEC-CeEEEEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEE
Confidence            98865 568999999999999999975 345799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT---LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +|||+|+..............+||+.|||||++.+   ..|+.++|||||||++|||+||+.||............+...
T Consensus       174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~  253 (307)
T 3omv_A          174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG  253 (307)
T ss_dssp             CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT
T ss_pred             eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence            99999987765444444556689999999999864   458999999999999999999999997654444333333222


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ..        .|.....+.+....+.+++.+||+.||++|||++||++.|+.+..
T Consensus       254 ~~--------~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          254 YA--------SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             CC--------CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             CC--------CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            11        111111122222358889999999999999999999999988754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.1e-52  Score=450.72  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=214.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++..                 .....++|.+|++++++++||
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------------~~~~~~~f~~E~~il~~l~Hp   75 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----------------SDNARKDFHREAELLTNLQHE   75 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----------------CHHHHHHHHHHHHHHTTCCCT
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----------------ChHHHHHHHHHHHHHHhCCCC
Confidence            35667789999999999999864      4778999998432                 234567899999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-----------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHR  825 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  825 (1002)
                      |||+++|++.+++..|+||||+++|+|.++++...           ...++|.++.+|+.|||.||+|||++   +||||
T Consensus        76 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHR  152 (299)
T 4asz_A           76 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHR  152 (299)
T ss_dssp             TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            99999999999999999999999999999997532           35799999999999999999999999   99999


Q ss_pred             CCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 001867          826 DVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVD  904 (1002)
Q Consensus       826 Dlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~  904 (1002)
                      ||||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus       153 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~  232 (299)
T 4asz_A          153 DLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  232 (299)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999987765544444445679999999999999999999999999999999999 899997


Q ss_pred             CCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          905 PEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      ... ..+....+....    .    .+....+++    ++.+++.+||+.||++|||++||.+.|+++.+.
T Consensus       233 ~~~-~~~~~~~i~~~~----~----~~~p~~~~~----~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          233 QLS-NNEVIECITQGR----V----LQRPRTCPQ----EVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             TSC-HHHHHHHHHHTC----C----CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC-HHHHHHHHHcCC----C----CCCCccchH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            543 333333332211    1    111223333    488999999999999999999999999998643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-51  Score=451.60  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=205.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++..                 .....++|.+|++++++++||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------------~~~~~~~f~~E~~il~~l~Hp  103 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----------------SESARQDFQREAELLTMLQHQ  103 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----------------SHHHHHHHHHHHHHHTTCCCT
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----------------CHHHHHHHHHHHHHHHhCCCC
Confidence            34566789999999999999864      4788999998432                 334567899999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK-------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIV  823 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  823 (1002)
                      |||+++|+|.+.+..|+||||+++|+|.++++...             ..+++|.++++|+.|||.||+|||++   +||
T Consensus       104 nIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~ii  180 (329)
T 4aoj_A          104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFV  180 (329)
T ss_dssp             TBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             CCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---Cee
Confidence            99999999999999999999999999999997542             24699999999999999999999999   999


Q ss_pred             eCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCC
Q 001867          824 HRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP  902 (1002)
Q Consensus       824 HrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p  902 (1002)
                      ||||||+|||+++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus       181 HRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~P  260 (329)
T 4aoj_A          181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP  260 (329)
T ss_dssp             CSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCC
Confidence            999999999999999999999999997765544444456679999999999999999999999999999999999 8999


Q ss_pred             CCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      |.... ..+....+.....   +     +....+++    ++.+++.+||+.||++|||++||++.|+.+.+
T Consensus       261 f~~~~-~~~~~~~i~~g~~---~-----~~p~~~~~----~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          261 WYQLS-NTEAIDCITQGRE---L-----ERPRACPP----EVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             TCSSC-HHHHHHHHHHTCC---C-----CCCTTCCH----HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCC-HHHHHHHHHcCCC---C-----CCcccccH----HHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            97543 2333333322111   1     11123333    47889999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-51  Score=448.82  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=212.2

Q ss_pred             CCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++++.++||+|+||+||+|++.      +++.||||++....                .....++|.+|+.++++++|||
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~----------------~~~~~~~f~~E~~il~~l~HpN   90 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----------------EGPLREEFRHEAMLRARLQHPN   90 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C----------------CC-CHHHHHHHHHHHHHCCCTT
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc----------------ChHHHHHHHHHHHHHHhCCCCC
Confidence            4556789999999999999863      46789999984321                2233567999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIV  823 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  823 (1002)
                      ||+++|++.+++..++||||+++|+|.+++....              ...++|..+.+|+.|||.||+|||++   +||
T Consensus        91 IV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~ii  167 (308)
T 4gt4_A           91 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVV  167 (308)
T ss_dssp             BCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             CCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCC
Confidence            9999999999999999999999999999996532              24699999999999999999999999   999


Q ss_pred             eCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCC
Q 001867          824 HRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLP  902 (1002)
Q Consensus       824 HrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p  902 (1002)
                      ||||||+|||+++++.+||+|||+|+...............||++|||||++.++.|+.++|||||||++|||+| |+.|
T Consensus       168 HRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P  247 (308)
T 4gt4_A          168 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP  247 (308)
T ss_dssp             CSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987765544444556689999999999999999999999999999999999 8999


Q ss_pred             CCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      |... +..++...+....    .    .+....++.    .+.+++.+||+.||++||||+||++.|+.+
T Consensus       248 f~~~-~~~~~~~~i~~~~----~----~~~p~~~~~----~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          248 YCGY-SNQDVVEMIRNRQ----V----LPCPDDCPA----WVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TTTC-CHHHHHHHHHTTC----C----CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCC-CHHHHHHHHHcCC----C----CCCcccchH----HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            9754 3334443332211    1    122233333    488999999999999999999999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.3e-51  Score=447.05  Aligned_cols=273  Identities=25%  Similarity=0.289  Sum_probs=217.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|++.++||+|+||.||+|+.+ +|+.||||++...                      ....+|+.++++++|||||+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~----------------------~~~~~E~~il~~l~HpnIV~  114 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE----------------------VFRVEELVACAGLSSPRIVP  114 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT----------------------TCCTHHHHTTTTCCCTTBCC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH----------------------HhHHHHHHHHHhCCCCCCCc
Confidence            345777889999999999999974 6899999998432                      11246999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-C
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-G  839 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-~  839 (1002)
                      +++++.+++..|+||||++||+|.++++.  .+.+++..++.++.||+.||+|||++   +||||||||+|||++.+| +
T Consensus       115 l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~  189 (336)
T 4g3f_A          115 LYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSR  189 (336)
T ss_dssp             EEEEEEETTEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCC
T ss_pred             EEEEEEECCEEEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCE
Confidence            99999999999999999999999999985  35699999999999999999999999   999999999999999987 6


Q ss_pred             eEEccccCcccccCCCCCc---ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPK---SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      +||+|||+|+.........   .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.............
T Consensus       190 vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  269 (336)
T 4g3f_A          190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA  269 (336)
T ss_dssp             EEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred             EEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            9999999999876543222   2234579999999999999999999999999999999999999998665444433332


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCCCCCCCcchhhccc
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYHEDAS  996 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~  996 (1002)
                      .....   ..    .......    ..+.+++.+||+.||++|||++|+++.+..+....       .+..|||..+...
T Consensus       270 ~~~~~---~~----~~~~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~-------~~l~hPw~~~~~~  331 (336)
T 4g3f_A          270 SEPPP---IR----EIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV-------GGLKSPWKGEYKE  331 (336)
T ss_dssp             HSCCG---GG----GSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT-------TSSCSCSSSSCCC
T ss_pred             cCCCC---ch----hcCccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh-------hhccCCCcCCCCC
Confidence            21110   00    0111222    24778999999999999999999999998876543       2556888776554


Q ss_pred             cCC
Q 001867          997 DQG  999 (1002)
Q Consensus       997 ~~~  999 (1002)
                      +.+
T Consensus       332 Pr~  334 (336)
T 4g3f_A          332 PRG  334 (336)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=488.29  Aligned_cols=491  Identities=20%  Similarity=0.187  Sum_probs=415.5

Q ss_pred             CCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccc
Q 001867           68 SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLD  147 (1002)
Q Consensus        68 ~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~  147 (1002)
                      ..+++.|||++|++++..+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus        27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence            35699999999999999889999999999999999999998899999999999999999999988889999999999999


Q ss_pred             cccccccCCCCcccccccccceeeeccccccC-ccccccccccccccccccCCCCCCCCCCcccCCCCcc----chhhcc
Q 001867          148 LTGNNFSGDIPESFGRFQKLEVISLVYNLLDG-TIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNL----EILWLT  222 (1002)
Q Consensus       148 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L----~~L~L~  222 (1002)
                      |++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++ .+..+..++.+++|    +.|+++
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~~~~~L~l~  185 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLS  185 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC-CEECGGGGHHHHTCTTCCCEEECT
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc-ceecHHHccchhccchhhhhcccC
Confidence            99999997766689999999999999999997 4699999999999999999997 34556778888888    889999


Q ss_pred             CcccccccccccccccccchhcccCccccc-ccCcccccccceeeeeccCCcc------cCCCCCcccccc--ccceeec
Q 001867          223 ECNLVGEIPDSLGRLAKLVDLDLALNNLVG-AIPSSLTELASVVQIELYNNSL------TGDLPTGWSNLT--SLRLLDA  293 (1002)
Q Consensus       223 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l------~~~~~~~~~~l~--~L~~L~L  293 (1002)
                      +|.+++..|..+..+ +|+.|++++|.... ..+..+.++++++.+.+..+.+      .......+..++  .++.+++
T Consensus       186 ~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  264 (570)
T 2z63_A          186 LNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL  264 (570)
T ss_dssp             TCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred             CCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence            999998888888766 89999999985442 3445566666666555443222      222223344443  3566677


Q ss_pred             ccc-ccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccC
Q 001867          294 SMN-DLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG  371 (1002)
Q Consensus       294 s~N-~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  371 (1002)
                      ++| .+.+..|..+..++ |+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|.  ..+++|+.|++++|.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~  339 (570)
T 2z63_A          265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGN  339 (570)
T ss_dssp             EETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCC
T ss_pred             hcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccc
Confidence            777 66777777777664 888888888887 577777777 8888888888887 4443  467788889999888886


Q ss_pred             CCChhhhccCcccceeeeccccccCC--CCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccc-cc
Q 001867          372 EIPASLCEKGELEELLMIYNSFTGQL--PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS-KN  448 (1002)
Q Consensus       372 ~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~  448 (1002)
                      ..+.  ..+++|++|++++|.+++..  |..+.++++|++|++++|++++..+. +..+++|+.|++++|.+.+..+ ..
T Consensus       340 ~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~  416 (570)
T 2z63_A          340 AFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSV  416 (570)
T ss_dssp             BCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCT
T ss_pred             cccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhh
Confidence            6665  67788899999998888654  67788889999999999999865554 8889999999999999988766 56


Q ss_pred             cccCCcccEEEccCCcCCCCCccccccccccccccccccccC-CCCcccccccccCCeeecCCCcCCccccccccccccc
Q 001867          449 IAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT-GSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKL  527 (1002)
Q Consensus       449 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  527 (1002)
                      +..+++|+.|++++|++.+..|..++.+++|+.|++++|+++ +.+|..+..+++|+.|+|++|++++..|..|..+++|
T Consensus       417 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  496 (570)
T 2z63_A          417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL  496 (570)
T ss_dssp             TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCC
Confidence            888999999999999999889999999999999999999998 5789999999999999999999999999999999999


Q ss_pred             ccccccCcccccCCCCCccccccccEEeCcceeeecccCCc
Q 001867          528 NELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG  568 (1002)
Q Consensus       528 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~  568 (1002)
                      +.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..
T Consensus       497 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            99999999999888888999999999999999999988853

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.6e-51  Score=440.49  Aligned_cols=253  Identities=22%  Similarity=0.318  Sum_probs=210.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|+. .+++.||||++.+.              ...+....+.+.+|++++++++|||||++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~--------------~~~~~~~~~~~~~E~~il~~l~HpnIv~l   97 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR--------------HIIKENKVPYVTRERDVMSRLDHPFFVKL   97 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH--------------HHHHTTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHH--------------HCCCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            5688899999999999999996 46899999998543              11223345779999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++|.+++..|+||||++||+|.++++.  .+.+++..++.++.||+.||+|||++   +||||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vK  172 (311)
T 4aw0_A           98 YFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQ  172 (311)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEeCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEE
Confidence            9999999999999999999999999985  35699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+....+.   .
T Consensus       173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~---~  248 (311)
T 4aw0_A          173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAKII---K  248 (311)
T ss_dssp             ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH---H
T ss_pred             EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH---c
Confidence            9999999988655444445567899999999999999999999999999999999999999976532 22222221   1


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                       ..+.  +.   ....+    ++.+++.+|++.||++|||++|+...
T Consensus       249 -~~~~--~p---~~~s~----~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          249 -LEYD--FP---EKFFP----KARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             -TCCC--CC---TTCCH----HHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             -CCCC--CC---cccCH----HHHHHHHHHccCCHhHCcChHHHcCC
Confidence             1111  11   11222    47789999999999999999987543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.8e-51  Score=446.48  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=206.2

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      .+++|++.+.||+|+||+||+|+. .+|+.||||++.+..               ......+.+.+|+.++++++|||||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~~E~~il~~l~HpnIV   86 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR---------------MSSKEREESRREVAVLANMKHPNIV   86 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT---------------SCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH---------------CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence            357899999999999999999996 468999999985431               1234567899999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+++..|+||||++||+|.+++...+...+++..++.|+.||+.||+|||++   +||||||||+|||++.+|.
T Consensus        87 ~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~  163 (350)
T 4b9d_A           87 QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGT  163 (350)
T ss_dssp             CEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCC
T ss_pred             cEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCC
Confidence            9999999999999999999999999999876677789999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+|+......  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+.+.+.    
T Consensus       164 vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i----  237 (350)
T 4b9d_A          164 VQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI----  237 (350)
T ss_dssp             EEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----
T ss_pred             EEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH----
Confidence            9999999998764321  1234567999999999999999999999999999999999999999765322222222    


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .... .    .+.......    ++.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~-~----~~~~~~~s~----~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          238 ISGS-F----PPVSLHYSY----DLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHTC-C----CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCC-C----CCCCccCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111 1    111122222    4778999999999999999999986

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=9.1e-51  Score=493.08  Aligned_cols=462  Identities=21%  Similarity=0.260  Sum_probs=369.9

Q ss_pred             CCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeec
Q 001867           94 NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV  173 (1002)
Q Consensus        94 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  173 (1002)
                      +++.|+|++|.+.|.+|.+|+.|++|++|+|++|.+.. .+..++...           +...+|...  +..|+ ++++
T Consensus        82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~-~~~~~~~~~-----------~~~~~~~~~--~~~l~-l~l~  146 (636)
T 4eco_A           82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV-NERLFGPKG-----------ISANMSDEQ--KQKMR-MHYQ  146 (636)
T ss_dssp             CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGG-TCCSBSTTS-----------BCTTCCHHH--HHHHH-THHH
T ss_pred             CEEEEEecCcccCCcCChHHhcCccceEEECcCCcccc-CCccccccc-----------cccCchHHH--HHHHH-hhHH
Confidence            67788888888888888888888888888888887631 111111000           001223222  34455 5666


Q ss_pred             cccccCcccccccc-ccccccccccCCCCCCCCCCcccCCCCccchhhcc--CcccccccccccccccccchhcccCccc
Q 001867          174 YNLLDGTIPAFLGN-ISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLT--ECNLVGEIPDSLGRLAKLVDLDLALNNL  250 (1002)
Q Consensus       174 ~N~l~~~~p~~l~~-l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~L~~N~l  250 (1002)
                      +|.+.+.+|..+.. +..+..+++....+.       ......++.+++.  .|++++ +|..|+++++|++|+|++|++
T Consensus       147 ~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~-------~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l  218 (636)
T 4eco_A          147 KTFVDYDPREDFSDLIKDCINSDPQQKSIK-------KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF  218 (636)
T ss_dssp             HHHTCCCGGGGSCHHHHHHHHHCTTSCCCC-------CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCC
T ss_pred             HhhhccCchhhHHHHHHHHhhcCccccccc-------cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcc
Confidence            66666555555542 234445555443321       1112234444443  578887 788888888888888888888


Q ss_pred             ccc-----------------cCcccc--cccceeeeeccCCcccCCCCCccccccccceeeccccc-cCC-CCCccCCCC
Q 001867          251 VGA-----------------IPSSLT--ELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMND-LTG-PIPDDLTRL  309 (1002)
Q Consensus       251 ~~~-----------------~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~~  309 (1002)
                      ++.                 +|..+.  ++++|++|+|++|++.+.+|..+.++++|++|++++|+ +++ .+|..+..+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L  298 (636)
T 4eco_A          219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL  298 (636)
T ss_dssp             CGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred             ccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhh
Confidence            875                 888888  89999999999999988999889999999999999998 887 788777663


Q ss_pred             -------CcceeecCCCcccCcCCc--ccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhcc
Q 001867          310 -------PLESLNLYENRLEGSLPA--TIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEK  380 (1002)
Q Consensus       310 -------~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  380 (1002)
                             .|+.|+|++|+++ .+|.  .+..+++|++|++++|+++|.+| .+..+++|++|+|++|+++ .+|..+..+
T Consensus       299 ~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l  375 (636)
T 4eco_A          299 ADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGF  375 (636)
T ss_dssp             HHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEE
T ss_pred             hccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhh
Confidence                   4999999999998 7888  89999999999999999998888 8999999999999999999 888889999


Q ss_pred             Cc-ccceeeeccccccCCCCcCcCCC--CCcEEEccCccccCCCCCcCC-------CCCcceEEEcccCcccCccccccc
Q 001867          381 GE-LEELLMIYNSFTGQLPDGLGHCQ--SLTRVRLGYNRLTGKVPPLLW-------GLPHVYLLELTDNFLSGEISKNIA  450 (1002)
Q Consensus       381 ~~-L~~L~l~~N~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~i~~~~~~~~~  450 (1002)
                      ++ |++|++++|.++ .+|..+..++  +|++|++++|++++..|..|.       .+++|+.|+|++|.++.+.+..+.
T Consensus       376 ~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~  454 (636)
T 4eco_A          376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS  454 (636)
T ss_dssp             CTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHH
T ss_pred             cccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHc
Confidence            99 999999999999 7888888765  899999999999999999888       888999999999999966666677


Q ss_pred             cCCcccEEEccCCcCCCCCcccccc-c-------cccccccccccccCCCCccccc--ccccCCeeecCCCcCCcccccc
Q 001867          451 GAANLSLLIISKNNLSGSLPEEIGF-L-------KSLVVLSGSENKFTGSLPESLT--NLAELGSLDLHANDLSGELPSS  520 (1002)
Q Consensus       451 ~l~~L~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~  520 (1002)
                      .+++|+.|+|++|+++ .+|..+.. .       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..
T Consensus       455 ~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~  531 (636)
T 4eco_A          455 TGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ  531 (636)
T ss_dssp             TTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCG
T ss_pred             cCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChh
Confidence            7999999999999999 66665433 2       39999999999999 7888887  99999999999999998 8999


Q ss_pred             cccccccccccc------cCcccccCCCCCccccccccEEeCcceeeecccCCcccccccceEEeccccCcCC
Q 001867          521 VSSWKKLNELNL------ADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGE  587 (1002)
Q Consensus       521 ~~~l~~L~~L~L------s~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~L~~l~ls~N~l~g~  587 (1002)
                      +..+++|+.|+|      ++|++.+.+|..++++++|++|+|++|++ +.+|..+. -+|+.|||++|++...
T Consensus       532 ~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          532 PLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNISI  602 (636)
T ss_dssp             GGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTCEE
T ss_pred             hhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCccc
Confidence            999999999999      56889999999999999999999999999 68888765 3799999999987643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.3e-50  Score=440.33  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=205.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|++.++||+|+||+||+|+.+ +|+.||||++...                 .....+.+.+|+.++++++|||||++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-----------------~~~~~~~~~~Ei~il~~l~HpnIV~l  136 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYQHENVVEM  136 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG-----------------GCSSGGGGHHHHHHHHHCCCTTBCCE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC-----------------chhHHHHHHHHHHHHHhCCCCCCCcE
Confidence            45778889999999999999974 6899999998532                 11234568899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++|.+++..|+||||++||+|.+++..   +.+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+|
T Consensus       137 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vK  210 (346)
T 4fih_A          137 YNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVK  210 (346)
T ss_dssp             EEEEEETTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEE
Confidence            9999999999999999999999999974   4599999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+|+.......  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+....+.... 
T Consensus       211 l~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~-  286 (346)
T 4fih_A          211 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNL-  286 (346)
T ss_dssp             ECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSS-
T ss_pred             EecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcCC-
Confidence            999999987755432  23456899999999999999999999999999999999999999976532 22222221111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         ....  +......+    ++.+++.+||+.||++|||++|+++
T Consensus       287 ---~~~~--~~~~~~s~----~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          287 ---PPRL--KNLHKVSP----SLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---CCCC--SCGGGSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCC--CccccCCH----HHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0000  11112222    4778999999999999999998874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6e-50  Score=430.89  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=198.0

Q ss_pred             CcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          686 DEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      ++.++||+|+||+||+|.+. +++.||+|++....               ......++|.+|++++++++|||||+++++
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~   93 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------------LTKSERQRFKEEAEMLKGLQHPNIVRFYDS   93 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            45678999999999999974 58899999985421               133456789999999999999999999999


Q ss_pred             Eec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEC-CC
Q 001867          765 CTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLD-GD  837 (1002)
Q Consensus       765 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~~NIll~-~~  837 (1002)
                      |.+    ++..|+||||+++|+|.++++.  .+.+++..+..++.||+.||+|||++   +  ||||||||+|||++ .+
T Consensus        94 ~~~~~~~~~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~  168 (290)
T 3fpq_A           94 WESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPT  168 (290)
T ss_dssp             EEEEETTEEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTT
T ss_pred             EeeccCCCcEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCC
Confidence            865    3568999999999999999985  45699999999999999999999998   6  99999999999998 47


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+|+.....    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||............+.
T Consensus       169 g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~  243 (290)
T 3fpq_A          169 GSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  243 (290)
T ss_dssp             SCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             CCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence            89999999999864332    2345689999999998865 699999999999999999999999976544443333222


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...    ....++   ....+    ++.+++.+||+.||++|||++|+++
T Consensus       244 ~~~----~~~~~~---~~~~~----~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          244 SGV----KPASFD---KVAIP----EVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTC----CCGGGG---GCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCC----CCCCCC---ccCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence            111    111111   11222    3778999999999999999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-49  Score=441.64  Aligned_cols=268  Identities=24%  Similarity=0.339  Sum_probs=219.7

Q ss_pred             HHHH-hcCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHH
Q 001867          678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL  750 (1002)
Q Consensus       678 ~~~~-~~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  750 (1002)
                      +|++ .++|++.+.||+|+||+||+|.+..      ++.||||++....                .....+.|.+|+.++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----------------~~~~~~~~~~E~~il  121 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKIL  121 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHH
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----------------ChHHHHHHHHHHHHH
Confidence            4555 4678899999999999999998642      3579999985421                233456799999999


Q ss_pred             hcCCC-CceeeeeeEEecC-CeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 001867          751 GKIRH-KNIVKLWCCCTTR-DCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYL  814 (1002)
Q Consensus       751 ~~l~h-~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~L  814 (1002)
                      .+++| ||||+++|+|.+. +..|+||||+++|+|.++++..+              ...+++.++..++.|||.||+||
T Consensus       122 ~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL  201 (353)
T 4ase_A          122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  201 (353)
T ss_dssp             HHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred             HHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence            99975 8999999999764 56899999999999999997532              24589999999999999999999


Q ss_pred             hhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          815 HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       815 H~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      |++   +||||||||+|||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|
T Consensus       202 H~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~  278 (353)
T 4ase_A          202 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW  278 (353)
T ss_dssp             HHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             hhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHH
Confidence            999   99999999999999999999999999999876655444455667999999999999999999999999999999


Q ss_pred             HHHh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          895 ELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       895 ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ||+| |+.||........+.+.+....+.        +....+++    ++.+++.+||+.||++|||++||++.|+++.
T Consensus       279 El~t~G~~Pf~~~~~~~~~~~~i~~g~~~--------~~p~~~~~----~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          279 EIFSLGASPYPGVKIDEEFCRRLKEGTRM--------RAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHHHHHTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHHcCCCC--------CCCccCCH----HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            9998 899997655445444444332211        11122333    4788999999999999999999999999986


Q ss_pred             hhc
Q 001867          974 AEN  976 (1002)
Q Consensus       974 ~~~  976 (1002)
                      +.+
T Consensus       347 q~~  349 (353)
T 4ase_A          347 QAN  349 (353)
T ss_dssp             HHT
T ss_pred             HHh
Confidence            544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.1e-48  Score=478.10  Aligned_cols=553  Identities=21%  Similarity=0.184  Sum_probs=338.0

Q ss_pred             cCCccccCCCCCCCCCCCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccC
Q 001867           38 SDPDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQ  117 (1002)
Q Consensus        38 ~d~~~~l~sw~~~~~~~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  117 (1002)
                      .|+...+++|...    -+..|..+.|......   .|-++.+++ .+|..+.  +++++|+|++|+|+++.|.+|.+++
T Consensus         7 ~~~~~~~~~~~~~----~p~~~~~c~~~~~~~~---~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~   76 (635)
T 4g8a_A            7 KDDDDKLAAANSS----IPESWEPCVEVVPNIT---YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFP   76 (635)
T ss_dssp             ----------------------CCSEEEETTTE---EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             CCCcchhhcccCC----CCCCCCCccccCCCCE---EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCC
Confidence            4666778888542    3445666666543332   366677777 4555443  4789999999999988888999999


Q ss_pred             cccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCcccccccccccccccccc
Q 001867          118 NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLS  197 (1002)
Q Consensus       118 ~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  197 (1002)
                      +|++|||++|+|+++.+.+|.+|++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|+
T Consensus        77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls  156 (635)
T 4g8a_A           77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA  156 (635)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence            99999999999998888889999999999999999997777889999999999999999998888889999999999999


Q ss_pred             CCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccc----hhcccCcccccccCcccccccceeeeeccCCc
Q 001867          198 YNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLV----DLDLALNNLVGAIPSSLTELASVVQIELYNNS  273 (1002)
Q Consensus       198 ~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  273 (1002)
                      +|.+....+|..++.+++|++|++++|++++..+..|..+.++.    .++++.|.+....+..+.. ..+..+++.+|.
T Consensus       157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~  235 (635)
T 4g8a_A          157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNF  235 (635)
T ss_dssp             SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCC
T ss_pred             cCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhccc
Confidence            99886667788889999999999999999988888888776655    4678888888665555543 456778888776


Q ss_pred             ccCC-CCCccccccccceeeccccccCC------CCCccCCCC-CcceeecCCCccc---CcCCcccCCCcccchhcccc
Q 001867          274 LTGD-LPTGWSNLTSLRLLDASMNDLTG------PIPDDLTRL-PLESLNLYENRLE---GSLPATIADSPGLYELRLFR  342 (1002)
Q Consensus       274 l~~~-~~~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~~-~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~  342 (1002)
                      .... .+..+..+..++...+..+....      .....+... .+..+.+..+...   ...+..+..+.++..+.+.+
T Consensus       236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~  315 (635)
T 4g8a_A          236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS  315 (635)
T ss_dssp             SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred             ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence            5422 22345556666655554333221      111111111 1222332222211   12223334445555555555


Q ss_pred             cccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccC--C
Q 001867          343 NRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTG--K  420 (1002)
Q Consensus       343 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~  420 (1002)
                      |.+....  .+.....|+.|++++|.+.+..+.   .+..|+.+.+..|.+....  ....+++|+.|++++|.+..  .
T Consensus       316 ~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~  388 (635)
T 4g8a_A          316 VTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGC  388 (635)
T ss_dssp             CEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEE
T ss_pred             ccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCCc--ccccccccccchhhccccccccc
Confidence            5554322  233445566666666666543332   2345555666665554322  23355666666666665542  2


Q ss_pred             CCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCc-cccccccccccccccccccCCCCcccccc
Q 001867          421 VPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP-EEIGFLKSLVVLSGSENKFTGSLPESLTN  499 (1002)
Q Consensus       421 ~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  499 (1002)
                      .+..+..+.+|+.|+++.|.+.. .+..+..+++|+.++++.|+.....+ ..+..+++++.++++.|++++..|..+..
T Consensus       389 ~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~  467 (635)
T 4g8a_A          389 CSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  467 (635)
T ss_dssp             CCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred             cccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccccccccccccccccccc
Confidence            33344455566666666665543 23345556666666666555544433 24455666666666666666555556666


Q ss_pred             cccCCeeecCCCcC-CcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceE
Q 001867          500 LAELGSLDLHANDL-SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQL  577 (1002)
Q Consensus       500 l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l  577 (1002)
                      ++.|+.|+|++|.+ .+.+|..|..+++|++|+|++|+|++.+|..|+++++|++|+|++|+|++.+|..++.+ +|++|
T Consensus       468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L  547 (635)
T 4g8a_A          468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL  547 (635)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred             chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence            66666666666653 33455566666666666666666665556666666666666666666665555555555 56666


Q ss_pred             EeccccCcCCCChhhh---hhcccccccCCCCCCC
Q 001867          578 NVSNNRLSGELPSLFA---KEMYRNSFLGNPGLCG  609 (1002)
Q Consensus       578 ~ls~N~l~g~~p~~~~---~~~~~~~~~~n~~~cg  609 (1002)
                      ||++|+|++.+|....   ..+....+.||||.|.
T Consensus       548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            6666666665554321   2344455566666663

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.5e-49  Score=429.71  Aligned_cols=269  Identities=24%  Similarity=0.267  Sum_probs=202.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|.+.++||+|+||+||+|++ +|+.||||++...                  ......++.|+..+.+++|||||+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~------------------~~~~~~~e~Ei~~~~~l~HpNIv~l~   63 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------------------EERSWFREAEIYQTVMLRHENILGFI   63 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG------------------GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------------------chhhHHHHHHHHHHhcCCCCCCCcEE
Confidence            4567778999999999999998 4899999998321                  12223345567777788999999999


Q ss_pred             eEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCCCcEE
Q 001867          763 CCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC-----VPSIVHRDVKSNNIL  833 (1002)
Q Consensus       763 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiHrDlk~~NIl  833 (1002)
                      +++.+++    ..|+||||+++|+|.++++.   ..++|..+.+++.|++.||+|||+++     .++||||||||+|||
T Consensus        64 g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NIL  140 (303)
T 3hmm_A           64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  140 (303)
T ss_dssp             EEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEE
T ss_pred             EEEEecCCCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEE
Confidence            9998654    57999999999999999975   45899999999999999999999762     358999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCc--ccccccccccccCccccccC------CCCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTL------RVNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      ++.++++||+|||+|+.........  .....+||+.|||||++.+.      .++.++|||||||++|||+||+.||..
T Consensus       141 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             ECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            9999999999999998876543322  12345799999999998754      367899999999999999999877643


Q ss_pred             CCC----------chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          906 EFG----------EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       906 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      ...          .......+.........+..+....  ...+....+.+++.+||+.||++||||+||++.|+++...
T Consensus       221 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG--GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccccccchhcccccchHHHHHHHHhcccCCCCCCccc--cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            211          1111122222222222211111111  1224556788999999999999999999999999998654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=472.54  Aligned_cols=452  Identities=20%  Similarity=0.213  Sum_probs=251.5

Q ss_pred             EEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCcccccccccc
Q 001867           73 SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN  152 (1002)
Q Consensus        73 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~  152 (1002)
                      .+|+++++++. +|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|+
T Consensus         4 ~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~   80 (520)
T 2z7x_B            4 LVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK   80 (520)
T ss_dssp             EEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred             eEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence            46677777663 444444  566666666666666555666666666666666666666556666666666666666666


Q ss_pred             ccCCCCcccccccccceeeeccccccC-ccccccccccccccccccCCCCCCCCCCcccCCCCcc--chhhccCccc--c
Q 001867          153 FSGDIPESFGRFQKLEVISLVYNLLDG-TIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNL--EILWLTECNL--V  227 (1002)
Q Consensus       153 l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L--~~L~L~~n~l--~  227 (1002)
                      ++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|+|++|++..    ..+..+++|  ++|++++|++  .
T Consensus        81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeeccccccc
Confidence            66 34444  56666666666666654 245566666666666666665421    234444444  5555555555  4


Q ss_pred             ccccccccccc-ccchhcccCcccccccCc-ccccccceeeeeccCCc-------ccCCCCCccccccccceeecccccc
Q 001867          228 GEIPDSLGRLA-KLVDLDLALNNLVGAIPS-SLTELASVVQIELYNNS-------LTGDLPTGWSNLTSLRLLDASMNDL  298 (1002)
Q Consensus       228 ~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~Ls~N~l  298 (1002)
                      +..|..+..+. +...+++++|++.+.++. .+..+++|+.|++++|.       +.+.+| .+..+++|+.|++++|  
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~--  230 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNI--  230 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEE--
T ss_pred             ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccc--
Confidence            44444444433 222334444444332222 33344444444444443       333322 3334444444444443  


Q ss_pred             CCCCCccCCCCCcceeecCCCcccCcCCcccC---CCcccchhcccccccCCCCCCCC-----CCCCCCceEEccCcccc
Q 001867          299 TGPIPDDLTRLPLESLNLYENRLEGSLPATIA---DSPGLYELRLFRNRLNGTLPGDL-----GKNSPLRWVDLSNNQFT  370 (1002)
Q Consensus       299 ~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~  370 (1002)
                                           .+++..+..+.   ..++|++|++++|++++.+|..+     ..++.|+.+++++|.+ 
T Consensus       231 ---------------------~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-  288 (520)
T 2z7x_B          231 ---------------------ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-  288 (520)
T ss_dssp             ---------------------EEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-
T ss_pred             ---------------------ccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-
Confidence                                 33321111110   12355555555555555555555     5566666666666666 


Q ss_pred             CCCC-hhhhcc---CcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccc
Q 001867          371 GEIP-ASLCEK---GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS  446 (1002)
Q Consensus       371 ~~~p-~~~~~l---~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~  446 (1002)
                       .+| ..+..+   .+|+.|++++|.+....  .+..+++|++|++++|++++..|..+..                   
T Consensus       289 -~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-------------------  346 (520)
T 2z7x_B          289 -GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGH-------------------  346 (520)
T ss_dssp             -CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCC-------------------
T ss_pred             -ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhcc-------------------
Confidence             333 334333   44555555555544221  1134455555555555555544544444                   


Q ss_pred             cccccCCcccEEEccCCcCCC--CCccccccccccccccccccccCCCCcc-cccccccCCeeecCCCcCCccccccccc
Q 001867          447 KNIAGAANLSLLIISKNNLSG--SLPEEIGFLKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSVSS  523 (1002)
Q Consensus       447 ~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  523 (1002)
                           +++|+.|++++|++++  .+|..++.+++|+.|++++|++++.+|. .+..+++|+.|+|++|++++.+|..+. 
T Consensus       347 -----l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-  420 (520)
T 2z7x_B          347 -----LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-  420 (520)
T ss_dssp             -----CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-
T ss_pred             -----CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-
Confidence                 4455555555555543  3345556666666666666666654544 356667777777777777766666554 


Q ss_pred             ccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCc-cccc-ccceEEeccccCcCCCCh
Q 001867          524 WKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLSGELPS  590 (1002)
Q Consensus       524 l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~-~~~l-~L~~l~ls~N~l~g~~p~  590 (1002)
                       ++|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|.. +..+ +|+.|++++|++++..+.
T Consensus       421 -~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          421 -PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             -TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             -ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence             67777777777777 67777777777777777777777 35554 6666 677777888877776553

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9e-49  Score=417.80  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=190.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+..              .......+++.+|++++++++|||||+
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--------------~~~~~~~~~~~~Ei~il~~l~HpnIv~   77 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKV--------------LAKSDMQGRIEREISYLRLLRHPHIIK   77 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHH--------------cCCHHHHHHHHHHHHHHHHCCCCCCCe
Confidence            46899999999999999999996 568999999985432              122334567999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+ +|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++++
T Consensus        78 ~~~~~~~~~~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~v  151 (275)
T 3hyh_A           78 LYDVIKSKDEIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNV  151 (275)
T ss_dssp             EEEEEECSSEEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCE
T ss_pred             EEEEEEECCEEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCE
Confidence            999999999999999999 7899999974  45699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+|+......   .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.... .....+.+.. 
T Consensus       152 kl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-~~~~~~~i~~-  226 (275)
T 3hyh_A          152 KIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-IPVLFKNISN-  226 (275)
T ss_dssp             EECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH-
T ss_pred             EEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHc-
Confidence            999999998765432   2234689999999999998876 579999999999999999999997542 2222222211 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         ....  +.   ....+    ++.+++.+|++.||++|||++|+++
T Consensus       227 ---~~~~--~p---~~~s~----~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          227 ---GVYT--LP---KFLSP----GAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---TCCC--CC---TTSCH----HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCC--CC---CCCCH----HHHHHHHHHccCChhHCcCHHHHHc
Confidence               1110  01   11222    4778999999999999999999875

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4e-49  Score=473.19  Aligned_cols=480  Identities=22%  Similarity=0.239  Sum_probs=391.3

Q ss_pred             CEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccc
Q 001867           96 TFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN  175 (1002)
Q Consensus        96 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  175 (1002)
                      ...++++|.++. +|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|+.|+++++|++|+|++|
T Consensus         8 ~~c~~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n   84 (549)
T 2z81_A            8 GVCDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN   84 (549)
T ss_dssp             SEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             ceEECCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence            346788889984 666554  79999999999999888999999999999999999999888899999999999999999


Q ss_pred             cccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccccccc-ccccccccccchhcccCccccccc
Q 001867          176 LLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEI-PDSLGRLAKLVDLDLALNNLVGAI  254 (1002)
Q Consensus       176 ~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~  254 (1002)
                      ++++.+|..|+++++|++|+|++|++.....|..++++++|++|++++|++.+.+ +..|..+++|++|++++|++++..
T Consensus        85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  164 (549)
T 2z81_A           85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ  164 (549)
T ss_dssp             CCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred             ccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccC
Confidence            9999988889999999999999999854466788999999999999999844445 468999999999999999999999


Q ss_pred             CcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCC--CccCCC--CCcceeecCCCcccCcCCcccC
Q 001867          255 PSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPI--PDDLTR--LPLESLNLYENRLEGSLPATIA  330 (1002)
Q Consensus       255 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~--~~L~~L~L~~N~l~~~~p~~~~  330 (1002)
                      |..+..+++|+.|++++|.+.......+..+++|++|++++|++++..  |..+..  ..|+.|++++|.+++..+..+ 
T Consensus       165 ~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l-  243 (549)
T 2z81_A          165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL-  243 (549)
T ss_dssp             TTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHH-
T ss_pred             hhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHH-
Confidence            999999999999999999987433333466899999999999998642  111111  125555555555543332221 


Q ss_pred             CCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCC------ChhhhccCcccceeeeccccccC-----CCC
Q 001867          331 DSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEI------PASLCEKGELEELLMIYNSFTGQ-----LPD  399 (1002)
Q Consensus       331 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~------p~~~~~l~~L~~L~l~~N~l~~~-----~p~  399 (1002)
                                         +..+..+++|+.+++++|.+.+..      ...+..+++|+.|.+.++.+...     ++.
T Consensus       244 -------------------~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~  304 (549)
T 2z81_A          244 -------------------LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST  304 (549)
T ss_dssp             -------------------HGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCH
T ss_pred             -------------------HHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchh
Confidence                               223456788999999999988642      23456678899999999887532     122


Q ss_pred             cCcCCCCCcEEEccCccccCCCCCcC-CCCCcceEEEcccCcccCcccc---ccccCCcccEEEccCCcCCCCCc--ccc
Q 001867          400 GLGHCQSLTRVRLGYNRLTGKVPPLL-WGLPHVYLLELTDNFLSGEISK---NIAGAANLSLLIISKNNLSGSLP--EEI  473 (1002)
Q Consensus       400 ~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~i~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p--~~~  473 (1002)
                      .+..+.+|+.|++++|+++ .+|..+ ..+++|+.|++++|++.+..+.   .++.+++|+.|++++|++++..+  ..+
T Consensus       305 ~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  383 (549)
T 2z81_A          305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL  383 (549)
T ss_dssp             HHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHG
T ss_pred             hhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhh
Confidence            2344578999999999998 566665 5799999999999999987643   47889999999999999985432  568


Q ss_pred             ccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccE
Q 001867          474 GFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNY  553 (1002)
Q Consensus       474 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~  553 (1002)
                      +.+++|+.|++++|+++ .+|..+..+++|++|+|++|++++ +|..+.  ++|+.|+|++|++++.+    +.+++|++
T Consensus       384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~  455 (549)
T 2z81_A          384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQE  455 (549)
T ss_dssp             GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCE
T ss_pred             hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcE
Confidence            99999999999999999 789999999999999999999984 454442  68999999999999643    57999999


Q ss_pred             EeCcceeeecccCCccccc-ccceEEeccccCcCCCChh--hhhhcccccccCCCCCCC
Q 001867          554 LDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL--FAKEMYRNSFLGNPGLCG  609 (1002)
Q Consensus       554 L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~n~~~cg  609 (1002)
                      |+|++|+|+ .+|.. ..+ +|+.|||++|++++.+|..  ....+....+.+||+.|.
T Consensus       456 L~Ls~N~l~-~ip~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          456 LYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             EECCSSCCS-SCCCG-GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             EECCCCccC-cCCCc-ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            999999999 68874 456 8999999999999988864  445677788999998765

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.7e-49  Score=483.95  Aligned_cols=460  Identities=20%  Similarity=0.252  Sum_probs=317.2

Q ss_pred             CCCCEEeccCCCCCCCCCCCccccCccccccc-ccccccCCCCcccccc----C-----Cccccccc-------cccccC
Q 001867           93 ENLTFLTLFNNSINSTLPDDISACQNLQHLDL-SQNLLTGTLTPALADL----P-----NLKFLDLT-------GNNFSG  155 (1002)
Q Consensus        93 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~~~~~~~L----~-----~L~~L~Ls-------~N~l~~  155 (1002)
                      .+++.|+|++|.+.|.+|.+|++|++|++|+| ++|.++|..|......    .     .++..++.       ...+++
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            47899999999999999999999999999999 8999987644321111    1     01100000       000110


Q ss_pred             -----------CCCcccccccccceeeecc--ccccCccccccccccccccccccCCCCCCC-----------------C
Q 001867          156 -----------DIPESFGRFQKLEVISLVY--NLLDGTIPAFLGNISTLKMLNLSYNPFLPG-----------------R  205 (1002)
Q Consensus       156 -----------~~p~~~~~l~~L~~L~L~~--N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~-----------------~  205 (1002)
                                 ..+........++.+.+..  |++++ +|..|+++++|++|+|++|++. +                 .
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Ls-g~~i~~~~~~~s~n~~~g~  480 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFT-YDNIAVDWEDANSDYAKQY  480 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCC-GGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCC-CCccccccccccccccccc
Confidence                       1111112334555565654  99998 8999999999999999999974 4                 3


Q ss_pred             CCcccC--CCCccchhhccCcccccccccccccccccchhcccCcc-ccc-ccCccccccc-------ceeeeeccCCcc
Q 001867          206 IPPELG--NLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNN-LVG-AIPSSLTELA-------SVVQIELYNNSL  274 (1002)
Q Consensus       206 ~p~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~l~~l~-------~L~~L~L~~N~l  274 (1002)
                      +|..++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+..++       +|+.|+|++|++
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            899988  99999999999999999999999999999999999998 998 8898888777       999999999999


Q ss_pred             cCCCCC--ccccccccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcc-cchhcccccccCCCCC
Q 001867          275 TGDLPT--GWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPG-LYELRLFRNRLNGTLP  350 (1002)
Q Consensus       275 ~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p  350 (1002)
                      + .+|.  .+.++++|+.|+|++|+++ .+| .+..++ |+.|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|
T Consensus       561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp  635 (876)
T 4ecn_A          561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP  635 (876)
T ss_dssp             C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred             C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence            9 8888  8999999999999999998 777 666654 888888888877 67777777777 777777777777 566


Q ss_pred             CCCCCCCC--CceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCc-CCC
Q 001867          351 GDLGKNSP--LRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPL-LWG  427 (1002)
Q Consensus       351 ~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~  427 (1002)
                      ..+..++.  |+.|+|++|++++.+|...+...                   ...+.+|+.|+|++|+++. +|.. +..
T Consensus       636 ~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~-------------------~~~~~~L~~L~Ls~N~L~~-lp~~~~~~  695 (876)
T 4ecn_A          636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD-------------------DYKGINASTVTLSYNEIQK-FPTELFAT  695 (876)
T ss_dssp             SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTT-------------------TCCCCCEEEEECCSSCCCS-CCHHHHHT
T ss_pred             hhhhccccCCCCEEECcCCcCCCccccchhhhc-------------------cccCCCcCEEEccCCcCCc-cCHHHHcc
Confidence            66665543  77777777777765543221110                   0012245555555555552 2222 224


Q ss_pred             CCcceEEEcccCcccCccccccc-------cCCcccEEEccCCcCCCCCccccc--cccccccccccccccCCCCccccc
Q 001867          428 LPHVYLLELTDNFLSGEISKNIA-------GAANLSLLIISKNNLSGSLPEEIG--FLKSLVVLSGSENKFTGSLPESLT  498 (1002)
Q Consensus       428 l~~L~~L~L~~N~i~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~  498 (1002)
                      +++|+.|+|++|+|+.+.+..+.       ++++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+.
T Consensus       696 l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~  773 (876)
T 4ecn_A          696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL  773 (876)
T ss_dssp             TCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGG
T ss_pred             CCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhh
Confidence            45555555555555522222222       2337788888888887 6777776  78888888888888885 677788


Q ss_pred             ccccCCeeecCC------CcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc
Q 001867          499 NLAELGSLDLHA------NDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL  572 (1002)
Q Consensus       499 ~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l  572 (1002)
                      .+++|+.|+|++      |++.+.+|..|..+++|+.|+|++|.+ +.+|..+.  ++|+.|||++|++....+..+...
T Consensus       774 ~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~  850 (876)
T 4ecn_A          774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPY  850 (876)
T ss_dssp             GCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHH
T ss_pred             cCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHcccc
Confidence            888888888876      555566666666666666666666666 45665544  456666666666554444444333


Q ss_pred             -ccceEEeccccC
Q 001867          573 -KLNQLNVSNNRL  584 (1002)
Q Consensus       573 -~L~~l~ls~N~l  584 (1002)
                       .+..+.|+.|++
T Consensus       851 ~~~~~~~L~~n~~  863 (876)
T 4ecn_A          851 IEAGMYVLLYDKT  863 (876)
T ss_dssp             HHTTCCEEECCTT
T ss_pred             ccchheeecCCCc
Confidence             344444544443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=438.78  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=205.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|++.++||+|+||.||+|+.+ +|+.||||++...                 .....+.+.+|+.+|++++|||||++
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-----------------~~~~~~~~~~Ei~il~~l~HpnIV~l  213 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-----------------KQQRRELLFNEVVIMRDYQHENVVEM  213 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-----------------TCSSGGGHHHHHHHHHHCCCTTBCCE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-----------------chhHHHHHHHHHHHHHhCCCCCCCce
Confidence            46888899999999999999974 6899999998532                 12234568999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++|.+++.+|+||||++||+|.++++.   +.+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+|
T Consensus       214 ~~~~~~~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vK  287 (423)
T 4fie_A          214 YNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVK  287 (423)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEE
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEE
Confidence            9999999999999999999999999974   3599999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+|+.+.....  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... +....+...  
T Consensus       288 l~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~--  362 (423)
T 4fie_A          288 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDN--  362 (423)
T ss_dssp             ECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHS--
T ss_pred             EecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcC--
Confidence            999999987755432  234568999999999999999999999999999999999999999755322 222222111  


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                        .....  +......+    .+.+++.+||+.||++|||++|+++
T Consensus       363 --~~~~~--~~~~~~s~----~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          363 --LPPRL--KNLHKVSP----SLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --CCCCC--SCTTSSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCC--cccccCCH----HHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11000  11122222    4778999999999999999999864

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-49  Score=469.68  Aligned_cols=451  Identities=22%  Similarity=0.233  Sum_probs=317.4

Q ss_pred             CEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccc
Q 001867           96 TFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN  175 (1002)
Q Consensus        96 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  175 (1002)
                      ++|++++|+++. +|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|+.|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            467777777763 555554  67777777777777665566777777777777777777666666777777777777777


Q ss_pred             cccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccccccccccccccccc--chhcccCccc--c
Q 001867          176 LLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKL--VDLDLALNNL--V  251 (1002)
Q Consensus       176 ~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--~  251 (1002)
                      +++ .+|..  .+++|++|+|++|++....+|..|+++++|++|++++|++++   ..+..+++|  ++|++++|.+  .
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            666 34433  566666666666665333445555555555555555555543   233333333  4444444444  3


Q ss_pred             cccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCC
Q 001867          252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIAD  331 (1002)
Q Consensus       252 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~  331 (1002)
                      +..|..+..+..                       +...+++++|++.+.+                      .+..+..
T Consensus       154 ~~~~~~l~~l~~-----------------------~~l~l~l~~n~~~~~~----------------------~~~~~~~  188 (520)
T 2z7x_B          154 KEDPEGLQDFNT-----------------------ESLHIVFPTNKEFHFI----------------------LDVSVKT  188 (520)
T ss_dssp             SCCTTTTTTCCE-----------------------EEEEEECCSSSCCCCC----------------------CCCCCTT
T ss_pred             cccccccccccc-----------------------ceEEEEeccCcchhhh----------------------hhhhhhc
Confidence            333333333221                       1112233333332211                      1123344


Q ss_pred             Ccccchhcccccc-------cCCCCCCCCCCCCCCceEEccCccccCCCChhhh---ccCcccceeeeccccccCCCCcC
Q 001867          332 SPGLYELRLFRNR-------LNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLC---EKGELEELLMIYNSFTGQLPDGL  401 (1002)
Q Consensus       332 l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~~p~~l  401 (1002)
                      +++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+++..+..+.   ..++|++|++++|.+++.+|..+
T Consensus       189 l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~  267 (520)
T 2z7x_B          189 VANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD  267 (520)
T ss_dssp             CSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCC
T ss_pred             ccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccch
Confidence            4555555555554       333444 566777888888888887754333322   24588999999999988888888


Q ss_pred             -----cCCCCCcEEEccCccccCCCC-CcCCCC---CcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccc
Q 001867          402 -----GHCQSLTRVRLGYNRLTGKVP-PLLWGL---PHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE  472 (1002)
Q Consensus       402 -----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  472 (1002)
                           +++++|+.+++++|.+  .+| ..++.+   .+|+.|++++|.+....  .+..+++|+.|++++|++++.+|..
T Consensus       268 ~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~  343 (520)
T 2z7x_B          268 FDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFEN  343 (520)
T ss_dssp             CCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred             hhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhh
Confidence                 8899999999999998  455 455444   67999999999987543  1267899999999999999989999


Q ss_pred             cccccccccccccccccCC--CCcccccccccCCeeecCCCcCCccccc-ccccccccccccccCcccccCCCCCccccc
Q 001867          473 IGFLKSLVVLSGSENKFTG--SLPESLTNLAELGSLDLHANDLSGELPS-SVSSWKKLNELNLADNLFYGNIPEDIGNLS  549 (1002)
Q Consensus       473 ~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~  549 (1002)
                      ++.+++|+.|++++|++++  .+|..++.+++|++|||++|++++.+|. .+..+++|+.|+|++|.+++.+|..+.  +
T Consensus       344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~  421 (520)
T 2z7x_B          344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P  421 (520)
T ss_dssp             CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred             hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence            9999999999999999996  5667899999999999999999985665 589999999999999999998888776  7


Q ss_pred             cccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh---hhhhcccccccCCCCCCC
Q 001867          550 VLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL---FAKEMYRNSFLGNPGLCG  609 (1002)
Q Consensus       550 ~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~---~~~~~~~~~~~~n~~~cg  609 (1002)
                      +|++|+|++|+++ .+|..+..+ +|+.|+|++|+|++ +|..   ....+....+.+||+.|.
T Consensus       422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS  483 (520)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCccc
Confidence            9999999999999 789888788 89999999999995 5543   345667788999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-48  Score=422.08  Aligned_cols=244  Identities=25%  Similarity=0.304  Sum_probs=192.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||+||+|+..    +++.||||++.+...               ......++.+|++++++++||||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---------------~~~~~~~~~~E~~il~~l~HpnI   88 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---------------KVRDRVRTKMERDILVEVNHPFI   88 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE---------------EEEECC------CCCCCCCCTTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc---------------ChHHHHHHHHHHHHHHHCCCCCC
Confidence            46888899999999999999862    468899999854321               11223468889999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      |++++++.+++..|+||||++||+|.+++..  .+.+++..+..++.||+.||+|||++   +||||||||+|||++.+|
T Consensus        89 v~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g  163 (304)
T 3ubd_A           89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEG  163 (304)
T ss_dssp             ECEEEEEEETTEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTS
T ss_pred             CeEEEEEEECCEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCC
Confidence            9999999999999999999999999999985  35699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      .+||+|||+|+.......  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+....+. 
T Consensus       164 ~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~~i~-  239 (304)
T 3ubd_A          164 HIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMIL-  239 (304)
T ss_dssp             CEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH-
T ss_pred             CEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-HHHHHHHH-
Confidence            999999999986544322  23356899999999999999999999999999999999999999976532 22222221 


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                        . ....     ......+    ++.+++.+||+.||++|||+
T Consensus       240 --~-~~~~-----~p~~~s~----~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          240 --K-AKLG-----MPQFLSP----EAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             --H-CCCC-----CCTTSCH----HHHHHHHHHTCSSGGGSTTC
T ss_pred             --c-CCCC-----CCCcCCH----HHHHHHHHHcccCHHHCCCC
Confidence              1 1110     0112222    47789999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5e-47  Score=412.39  Aligned_cols=252  Identities=21%  Similarity=0.355  Sum_probs=188.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....                .....+.+.+|++++++++|||||+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------------~~~~~~~~~~E~~il~~l~HpnIV~   67 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----------------RELAREKVMREVKALAKLEHPGIVR   67 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----------------SHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----------------CHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            34688889999999999999996 468999999985321                2344567999999999999999999


Q ss_pred             eeeEEecCC------------eeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 001867          761 LWCCCTTRD------------CKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV  827 (1002)
Q Consensus       761 l~~~~~~~~------------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  827 (1002)
                      ++++|.+.+            ..|+||||+++|+|.++++.... ...++..++.++.||+.||+|||++   +||||||
T Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDl  144 (299)
T 4g31_A           68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDL  144 (299)
T ss_dssp             EEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCC
T ss_pred             EEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccC
Confidence            999997544            36999999999999999985332 3456677899999999999999999   9999999


Q ss_pred             CCCcEEECCCCCeEEccccCcccccCCCCCc----------ccccccccccccCccccccCCCCCccchhhHHHHHHHHH
Q 001867          828 KSNNILLDGDFGARVADFGVAKVVDASGKPK----------SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELV  897 (1002)
Q Consensus       828 k~~NIll~~~~~~kl~DfGl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell  897 (1002)
                      ||+|||++.++.+||+|||+|+.........          ..+..+||+.|||||++.+..|+.++||||+||++|||+
T Consensus       145 Kp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell  224 (299)
T 4g31_A          145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL  224 (299)
T ss_dssp             CGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             cHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHc
Confidence            9999999999999999999998876543211          123457999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          898 TGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       898 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +   ||...   .+....+... ......    +    .+.+......+++.+||+.||++|||+.|+++
T Consensus       225 ~---Pf~~~---~~~~~~~~~~-~~~~~p----~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          225 Y---PFSTQ---MERVRTLTDV-RNLKFP----P----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             S---CCSSH---HHHHHHHHHH-HTTCCC----H----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c---CCCCc---cHHHHHHHHH-hcCCCC----C----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            6   77532   1211111111 111111    1    11222234567999999999999999999875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=5.3e-46  Score=454.45  Aligned_cols=520  Identities=21%  Similarity=0.190  Sum_probs=428.8

Q ss_pred             ceeEEeCC---------CCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCccccccccccccc
Q 001867           60 RGVECDPR---------SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLT  130 (1002)
Q Consensus        60 ~gv~C~~~---------~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  130 (1002)
                      ..|.|...         +..++.|||++|+|++..+.+|.++++|++|+|++|+|+++.|++|.+|++|++|+|++|+|+
T Consensus        34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            35778532         246999999999999988899999999999999999999988999999999999999999999


Q ss_pred             CCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCc-cccccccccccccccccCCCCCCCCCCcc
Q 001867          131 GTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGT-IPAFLGNISTLKMLNLSYNPFLPGRIPPE  209 (1002)
Q Consensus       131 ~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~  209 (1002)
                      +..+..|.+|++|++|+|++|++++..+..|+++++|++|+|++|++++. .|..++++++|++|+|++|++ .+..+..
T Consensus       114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~  192 (635)
T 4g8a_A          114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTD  192 (635)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC-CEECGGG
T ss_pred             CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc-ccccccc
Confidence            87778899999999999999999988888899999999999999999864 688899999999999999997 3455666


Q ss_pred             cCCCCccc----hhhccCcccccccccccccccccchhcccCccccc-ccCcccccccceeeeeccCC------cccCCC
Q 001867          210 LGNLTNLE----ILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG-AIPSSLTELASVVQIELYNN------SLTGDL  278 (1002)
Q Consensus       210 ~~~l~~L~----~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N------~l~~~~  278 (1002)
                      +..+.+++    .++++.|.++...+..+ ....+..+++.+|.... ..+..+.++..++...+..+      .+....
T Consensus       193 l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  271 (635)
T 4g8a_A          193 LRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  271 (635)
T ss_dssp             GHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred             ccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence            76666554    47788999986555544 44567889999887653 33455667777776655433      233344


Q ss_pred             CCccccccccceeeccccccCCCCCc---cCCCC-CcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCC
Q 001867          279 PTGWSNLTSLRLLDASMNDLTGPIPD---DLTRL-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLG  354 (1002)
Q Consensus       279 ~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  354 (1002)
                      ...+..+..+...++..+........   .+... .++.+++.+|.+....  .+....+|+.|++.+|++.+..+.   
T Consensus       272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---  346 (635)
T 4g8a_A          272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---  346 (635)
T ss_dssp             TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---
T ss_pred             ccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---
Confidence            45667777777777776665432222   22222 3888999888887543  355677899999999999866554   


Q ss_pred             CCCCCceEEccCccccCCCChhhhccCcccceeeecccccc--CCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcce
Q 001867          355 KNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTG--QLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVY  432 (1002)
Q Consensus       355 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  432 (1002)
                      .+..|+.+++++|.+....  ....+++|+.|++++|.+..  ..+..+..+.+|+.++++.|.+.. .+..+..+++|+
T Consensus       347 ~l~~L~~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~  423 (635)
T 4g8a_A          347 KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLE  423 (635)
T ss_dssp             BCTTCCEEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCC
T ss_pred             cchhhhhcccccccCCCCc--ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccccccccccc
Confidence            4567899999999987433  34578899999999998863  456667788999999999999884 566788999999


Q ss_pred             EEEcccCcccCccc-cccccCCcccEEEccCCcCCCCCccccccccccccccccccccC-CCCcccccccccCCeeecCC
Q 001867          433 LLELTDNFLSGEIS-KNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT-GSLPESLTNLAELGSLDLHA  510 (1002)
Q Consensus       433 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~  510 (1002)
                      .+++++|......+ ..+..+.+++.++++.|++.+..|..+..+++|+.|++++|++. +..|..|..+++|+.|||++
T Consensus       424 ~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~  503 (635)
T 4g8a_A          424 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ  503 (635)
T ss_dssp             EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             chhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCC
Confidence            99999888776544 55788999999999999999999999999999999999999854 45788999999999999999


Q ss_pred             CcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc--ccceEEeccccCcCCC
Q 001867          511 NDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL--KLNQLNVSNNRLSGEL  588 (1002)
Q Consensus       511 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l--~L~~l~ls~N~l~g~~  588 (1002)
                      |+|++.+|..|+++++|++|+|++|+|++..|..|.++++|++|||++|+|++.+|..++.+  +|+.|+|++|+++..-
T Consensus       504 N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          504 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             CccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            99999999999999999999999999998888899999999999999999999999999887  6999999999998654


Q ss_pred             C
Q 001867          589 P  589 (1002)
Q Consensus       589 p  589 (1002)
                      .
T Consensus       584 ~  584 (635)
T 4g8a_A          584 E  584 (635)
T ss_dssp             G
T ss_pred             C
Confidence            3

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=6.1e-46  Score=445.91  Aligned_cols=456  Identities=21%  Similarity=0.220  Sum_probs=300.1

Q ss_pred             EEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccc
Q 001867           72 ASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN  151 (1002)
Q Consensus        72 ~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N  151 (1002)
                      ..+|++++++++ +|..+.  ++|++|+|++|.+++..|.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            779999999996 565554  79999999999999888889999999999999999999888888999999999999999


Q ss_pred             cccCCCCcccccccccceeeeccccccCc-cccccccccccccccccCCCCCCCCCCcccCCCCcc--chhhccCccc--
Q 001867          152 NFSGDIPESFGRFQKLEVISLVYNLLDGT-IPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNL--EILWLTECNL--  226 (1002)
Q Consensus       152 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L--~~L~L~~n~l--  226 (1002)
                      +++ .+|..  .+++|++|+|++|++++. +|..|+++++|++|+|++|++..    ..+..+++|  ++|++++|++  
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ----LDLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT----TTTGGGTTSCEEEEEEEESSCCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc----CchhhhhhceeeEEEeecccccc
Confidence            998 56665  788999999999998863 46788888888888888888632    234444444  8888888877  


Q ss_pred             cccccccccccc--ccchhcccCcccccccCc-ccccccceeeeeccCCc-----ccCCCCCccccccccceeecccccc
Q 001867          227 VGEIPDSLGRLA--KLVDLDLALNNLVGAIPS-SLTELASVVQIELYNNS-----LTGDLPTGWSNLTSLRLLDASMNDL  298 (1002)
Q Consensus       227 ~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~-----l~~~~~~~~~~l~~L~~L~Ls~N~l  298 (1002)
                      ++..|..+..+.  .+ .++++.|.+.+.++. .+..+++|+.+++++|+     +.+. ...+..+++|+.|+++++.+
T Consensus       184 ~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l  261 (562)
T 3a79_B          184 KGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIET  261 (562)
T ss_dssp             CSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEE
T ss_pred             cccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcC
Confidence            667777776654  23 446666666654443 34556666666666663     1111 12344455555555554444


Q ss_pred             CCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCC-----CCCCCCceEEccCccccCCC
Q 001867          299 TGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDL-----GKNSPLRWVDLSNNQFTGEI  373 (1002)
Q Consensus       299 ~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~  373 (1002)
                      ++                  |.+.+..+ .+ ..++|++|++++|++++.+|..+     ..++.|+.++++.|.+  .+
T Consensus       262 ~~------------------~~~~~~~~-~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~  319 (562)
T 3a79_B          262 TW------------------KCSVKLFQ-FF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LF  319 (562)
T ss_dssp             CH------------------HHHHHHHH-HH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SS
T ss_pred             cH------------------HHHHHHHH-hh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ec
Confidence            32                  22221111 11 12356666666666666666555     5555556666666655  23


Q ss_pred             C-hhhhcc---CcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCcccccc
Q 001867          374 P-ASLCEK---GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI  449 (1002)
Q Consensus       374 p-~~~~~l---~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~  449 (1002)
                      | ..+..+   .+|++|++++|.+....  ..+.+++|++|++++|++++..|..                        +
T Consensus       320 p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~------------------------~  373 (562)
T 3a79_B          320 SKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQG------------------------C  373 (562)
T ss_dssp             CHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT------------------------C
T ss_pred             ChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhh------------------------h
Confidence            3 222221   34555555555543211  1134455555555555555444444                        4


Q ss_pred             ccCCcccEEEccCCcCCC--CCccccccccccccccccccccCCCCcc-cccccccCCeeecCCCcCCcccccccccccc
Q 001867          450 AGAANLSLLIISKNNLSG--SLPEEIGFLKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSVSSWKK  526 (1002)
Q Consensus       450 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  526 (1002)
                      ..+++|+.|++++|++++  .+|..++.+++|+.|++++|++++.+|. .+..+++|+.|+|++|++++.+|..+.  ++
T Consensus       374 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~  451 (562)
T 3a79_B          374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PK  451 (562)
T ss_dssp             CSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TT
T ss_pred             cccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--Cc
Confidence            445555555555555553  2234566666666677777776653443 466777777788888877777666654  67


Q ss_pred             cccccccCcccccCCCCCccccccccEEeCcceeeecccCCc-cccc-ccceEEeccccCcCCCChh
Q 001867          527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       527 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~-~~~l-~L~~l~ls~N~l~g~~p~~  591 (1002)
                      |+.|+|++|+++ .+|..+..+++|++|+|++|+|+ .+|.. +..+ +|+.|+|++|++++..|-.
T Consensus       452 L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGI  516 (562)
T ss_dssp             CSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred             CCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence            888888888887 67777778888888888888888 45555 6666 6888888888888776643

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.9e-46  Score=444.96  Aligned_cols=440  Identities=22%  Similarity=0.243  Sum_probs=312.9

Q ss_pred             CeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCcccccc
Q 001867           69 HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDL  148 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~L  148 (1002)
                      .+++.|||++|++++..|..|.++++|++|+|++|+++++.|++|.++++|++|+|++|.|+ .+|..  .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            57999999999999988899999999999999999999999999999999999999999999 56665  8999999999


Q ss_pred             ccccccC-CCCcccccccccceeeeccccccCcccccccccccc--ccccccCCCCC-CCCCCcccCCCC--ccchhhcc
Q 001867          149 TGNNFSG-DIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTL--KMLNLSYNPFL-PGRIPPELGNLT--NLEILWLT  222 (1002)
Q Consensus       149 s~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~Ls~N~~~-~~~~p~~~~~l~--~L~~L~L~  222 (1002)
                      ++|++++ .+|..|+++++|++|+|++|++++.   .+.++++|  ++|+|++|++. .+..|..+..+.  .+ .++++
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~  204 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFH  204 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEEC
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEec
Confidence            9999997 3578999999999999999999864   45555665  99999999861 356677777765  33 55889


Q ss_pred             Cccccccccc-ccccccccchhcccCcc-----cccccCcccccccceeeeeccCCcccCCCCCc---cccccccceeec
Q 001867          223 ECNLVGEIPD-SLGRLAKLVDLDLALNN-----LVGAIPSSLTELASVVQIELYNNSLTGDLPTG---WSNLTSLRLLDA  293 (1002)
Q Consensus       223 ~n~l~~~~p~-~~~~l~~L~~L~L~~N~-----l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~L  293 (1002)
                      +|.+.+.+++ .+..+++|+.|++++|+     +.+ ....+.++++|+.|++.++.+.+.....   ....++|++|++
T Consensus       205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l  283 (562)
T 3a79_B          205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI  283 (562)
T ss_dssp             SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEE
T ss_pred             CccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEE
Confidence            9998876654 56789999999999985     222 2345777888888888888776432111   112347888888


Q ss_pred             cccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCC-CCCC---CCCCCceEEccCccc
Q 001867          294 SMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLP-GDLG---KNSPLRWVDLSNNQF  369 (1002)
Q Consensus       294 s~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~---~l~~L~~L~Ls~N~l  369 (1002)
                      ++|+++|.+|..+....                  ...++.|+.+++..|.+  .+| ..+.   ...+|+.|++++|.+
T Consensus       284 ~~n~l~~~ip~~~~~~~------------------~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~  343 (562)
T 3a79_B          284 YNLTITERIDREEFTYS------------------ETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPF  343 (562)
T ss_dssp             EEEEECSCCCCCCCCCC------------------SCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred             eccEeeccccchhhhcc------------------cccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCc
Confidence            88888777766552110                  02333333344444433  122 1111   124577777777777


Q ss_pred             cCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCC--CCcCCCCCcceEEEcccCcccCcccc
Q 001867          370 TGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKV--PPLLWGLPHVYLLELTDNFLSGEISK  447 (1002)
Q Consensus       370 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~i~~~~~~  447 (1002)
                      ....  ....+++|++|++++|.+++.+|..++++++|++|+|++|++++..  |..|..+++|+.|++++|++++    
T Consensus       344 ~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~----  417 (562)
T 3a79_B          344 IHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS----  417 (562)
T ss_dssp             CCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS----
T ss_pred             cccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC----
Confidence            5322  1246677888888888888778888888888888888888887532  2344555555555555554444    


Q ss_pred             ccccCCcccEEEccCCcCCCCCcc-ccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccc
Q 001867          448 NIAGAANLSLLIISKNNLSGSLPE-EIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK  526 (1002)
Q Consensus       448 ~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  526 (1002)
                                          .+|. .+..+++|+.|++++|++++.+|..+.  ++|+.|||++|+|+ .+|..+..+++
T Consensus       418 --------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~  474 (562)
T 3a79_B          418 --------------------HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQA  474 (562)
T ss_dssp             --------------------CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCC
T ss_pred             --------------------ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCC
Confidence                                2222 244455555555555555544444433  56777777777777 55665557777


Q ss_pred             cccccccCcccccCCCCC-ccccccccEEeCcceeeecccC
Q 001867          527 LNELNLADNLFYGNIPED-IGNLSVLNYLDLSNNRLSGRIP  566 (1002)
Q Consensus       527 L~~L~Ls~N~l~~~ip~~-~~~l~~L~~L~Ls~N~l~~~ip  566 (1002)
                      |+.|+|++|+++ .+|.. +..+++|++|+|++|++++..|
T Consensus       475 L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          475 LQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            777777777777 56665 7788888888888888887655

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=414.07  Aligned_cols=264  Identities=20%  Similarity=0.255  Sum_probs=202.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+.               .......+++.+|+++|++++|||||+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~---------------~~~~~~~~~~~~Ei~il~~l~HpnIv~  117 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA---------------FDVVTNAKRTLRELKILKHFKHDNIIA  117 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT---------------TSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc---------------ccchHHHHHHHHHHHHHHhcCCCCcce
Confidence            45788999999999999999996 46999999998432               123344567889999999999999999


Q ss_pred             eeeEEec------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          761 LWCCCTT------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       761 l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++++..      .+.+|+||||++ |+|.+++.  +.+.+++..+..+++||+.||+|||++   +||||||||+|||+
T Consensus       118 l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~  191 (398)
T 4b99_A          118 IKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLV  191 (398)
T ss_dssp             EEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEE
T ss_pred             EeeeeecccccccCCEEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCcccccc
Confidence            9999864      367899999995 78999997  456799999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCC--CcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          835 DGDFGARVADFGVAKVVDASGK--PKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      +.++.+||+|||+|+.+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+.
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~  271 (398)
T 4b99_A          192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ  271 (398)
T ss_dssp             CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred             CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999999987654322  2223456899999999998775 568999999999999999999999976544333


Q ss_pred             HHHHHHHHhhccCccc--------------ccccccc----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          912 LVKWVCSTLDQKGVDH--------------VLDPKLD----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       912 ~~~~~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +......... .....              .+.+...    ...+....++.+++.+|+..||++|||++|+++
T Consensus       272 l~~I~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          272 LQLIMMVLGT-PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHHHCC-CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhcCC-CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            3333222111 00000              0000000    000011134778999999999999999999886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.1e-44  Score=398.38  Aligned_cols=204  Identities=25%  Similarity=0.380  Sum_probs=172.8

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      +.+.|++.++||+|+||+||+|+.+    .++.||+|++.+.                   ....++.+|+++++.+ +|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-------------------~~~~~~~~E~~~l~~~~~h   79 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-------------------SHPIRIAAELQCLTVAGGQ   79 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-------------------SCHHHHHHHHHHHHHTCSB
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-------------------cCHHHHHHHHHHHHHhcCC
Confidence            3567999999999999999999863    4678999988432                   1235678999999998 69


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      ||||+++++|.+++..|+||||+++|+|.++++     .+++.+++.++.|++.||+|||++   +||||||||+|||++
T Consensus        80 ~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~  151 (361)
T 4f9c_A           80 DNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYN  151 (361)
T ss_dssp             TTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             CCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEe
Confidence            999999999999999999999999999999984     389999999999999999999999   999999999999998


Q ss_pred             CC-CCeEEccccCcccccCCCCC--------------------------cccccccccccccCccccccC-CCCCccchh
Q 001867          836 GD-FGARVADFGVAKVVDASGKP--------------------------KSMSVIAGSCGYIAPEYAYTL-RVNEKSDIY  887 (1002)
Q Consensus       836 ~~-~~~kl~DfGl~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvw  887 (1002)
                      .+ +.+||+|||+|+........                          ......+||+.|||||++.+. .++.++|||
T Consensus       152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW  231 (361)
T 4f9c_A          152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW  231 (361)
T ss_dssp             TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred             CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence            76 79999999999865433210                          112345799999999998775 589999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCchh
Q 001867          888 SFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       888 slGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |+||++|||++|+.||....++.+
T Consensus       232 SlG~il~ell~G~~Pf~~~~~~~~  255 (361)
T 4f9c_A          232 SAGVIFLSLLSGRYPFYKASDDLT  255 (361)
T ss_dssp             HHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             hhHHHHHHHHHCCCCCCCCCCHHH
Confidence            999999999999999976655433

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.8e-43  Score=410.18  Aligned_cols=407  Identities=24%  Similarity=0.266  Sum_probs=169.5

Q ss_pred             CCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCccccccccccee
Q 001867           91 RLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVI  170 (1002)
Q Consensus        91 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  170 (1002)
                      ..++|++|++++|.+ +.+|.+|+++++|++|++++|.++|.+|..++.+++|+.+++++|..           .+|++|
T Consensus         9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L   76 (454)
T 1jl5_A            9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL   76 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred             ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence            346677777777777 56677777777777777777777777777777777776666666543           356777


Q ss_pred             eeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCccc
Q 001867          171 SLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL  250 (1002)
Q Consensus       171 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  250 (1002)
                      ++++|.+++. |..   .++|++|++++|.+.  .+|..   +++|++|++++|++++ +|..   .++|++|++++|++
T Consensus        77 ~l~~~~l~~l-p~~---~~~L~~L~l~~n~l~--~lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l  143 (454)
T 1jl5_A           77 ELNNLGLSSL-PEL---PPHLESLVASCNSLT--ELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL  143 (454)
T ss_dssp             ECTTSCCSCC-CSC---CTTCSEEECCSSCCS--SCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred             EecCCccccC-CCC---cCCCCEEEccCCcCC--ccccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCC
Confidence            7777777643 321   256666666666652  24432   2456666666666653 2211   13555555555555


Q ss_pred             ccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccC
Q 001867          251 VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIA  330 (1002)
Q Consensus       251 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~  330 (1002)
                      ++ +| .|.++++|++|++++|++++ +|..+   ++|++|++++|++++ +|                        .+.
T Consensus       144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~------------------------~~~  192 (454)
T 1jl5_A          144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP------------------------ELQ  192 (454)
T ss_dssp             SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC------------------------CCT
T ss_pred             CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc------------------------ccc
Confidence            54 33 35555555555555555553 33222   245555555555553 33                        244


Q ss_pred             CCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEE
Q 001867          331 DSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV  410 (1002)
Q Consensus       331 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  410 (1002)
                      ++++|++|++++|++++ +|...   .+|++|++++|+++ .+| .+..+++|++|++++|++++ +|..   +++|++|
T Consensus       193 ~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L  262 (454)
T 1jl5_A          193 NLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEAL  262 (454)
T ss_dssp             TCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEE
T ss_pred             CCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEE
Confidence            44444444444444443 22211   24444444444444 333 24444444444444444443 2221   2445555


Q ss_pred             EccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccc-ccccccccccccc
Q 001867          411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFL-KSLVVLSGSENKF  489 (1002)
Q Consensus       411 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l  489 (1002)
                      ++++|++++ +|..   +++|+.|++++|++++...    -.++|+.|++++|++++ ++    .+ ++|+.|++++|++
T Consensus       263 ~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~----~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l  329 (454)
T 1jl5_A          263 NVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKL  329 (454)
T ss_dssp             ECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCC
T ss_pred             ECCCCcccc-cCcc---cCcCCEEECcCCccCcccC----cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcc
Confidence            555555543 2222   2445555555555443210    01345555555555542 11    11 3455555555555


Q ss_pred             CCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCccccc--CCCCCcccc-------------ccccEE
Q 001867          490 TGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYG--NIPEDIGNL-------------SVLNYL  554 (1002)
Q Consensus       490 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~ip~~~~~l-------------~~L~~L  554 (1002)
                      ++ +|..   +++|+.|++++|++++ +|.   .+++|++|+|++|++++  .+|.+++++             ++|++|
T Consensus       330 ~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L  401 (454)
T 1jl5_A          330 IE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQL  401 (454)
T ss_dssp             SC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---------------
T ss_pred             cc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEE
Confidence            53 3332   2445555555555552 333   24455555555555554  444444433             556666


Q ss_pred             eCcceeeec--ccCCcccccccceEEeccccCcCCCC
Q 001867          555 DLSNNRLSG--RIPVGLQNLKLNQLNVSNNRLSGELP  589 (1002)
Q Consensus       555 ~Ls~N~l~~--~ip~~~~~l~L~~l~ls~N~l~g~~p  589 (1002)
                      ||++|+++|  .+|..+     +.|++.+|.+.+.+|
T Consensus       402 ~ls~N~l~~~~~iP~sl-----~~L~~~~~~~~~~~~  433 (454)
T 1jl5_A          402 HVETNPLREFPDIPESV-----EDLRMNSERVVDPYE  433 (454)
T ss_dssp             -------------------------------------
T ss_pred             ECCCCcCCccccchhhH-----hheeCcCcccCCccc
Confidence            666666655  444432     233445555555444

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-43  Score=415.69  Aligned_cols=255  Identities=22%  Similarity=0.237  Sum_probs=200.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +++|++.++||+|+||+||+|+.+ +|+.||||++.+.....           ............++.+++.++|||||+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~-----------~~~~~~~~~E~~~l~ll~~~~HP~IV~  256 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----------KQGETLALNERIMLSLVSTGDCPFIVC  256 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHHHSSSCCTTBCC
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch-----------hhhHHHHHHHHHHHHHHhhCCCCCEeE
Confidence            467888999999999999999964 68999999996532110           001111222344567778889999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      ++++|.+.+.+|+||||++||+|.+++..  .+.+++..++.|+.||+.||+|||++   +||||||||+|||++.+|.+
T Consensus       257 l~~~f~~~~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence            99999999999999999999999999985  35699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+|+......    ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||....... ........
T Consensus       332 KL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i  406 (689)
T 3v5w_A          332 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMT  406 (689)
T ss_dssp             EECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHH
T ss_pred             EecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhh
Confidence            999999998775432    234589999999999864 579999999999999999999999997543222 22222211


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                      ... .+.     ......+    ++.+++.+|++.||++|++     ++||.+
T Consensus       407 ~~~-~~~-----~p~~~S~----~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          407 LTM-AVE-----LPDSFSP----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHC-CCC-----CCTTSCH----HHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             cCC-CCC-----CCccCCH----HHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            111 110     0111222    4778999999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-43  Score=416.24  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=208.9

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|+.+ +|+.||+|++...                 .....+.+.+|+.+|++++|||||
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-----------------~~~~~~~~~~Ei~il~~l~hpnIv  217 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------------HESDKETVRKEIQTMSVLRHPTLV  217 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------SHHHHHHHHHHHHHHHHTCCTTBC
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-----------------chhhHHHHHHHHHHHHhCCCCCCC
Confidence            4678999999999999999999964 6899999998432                 233456789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC--
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD--  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~--  837 (1002)
                      +++++|.+++..|+||||++||+|.+++.. +...+++.++..++.||+.||+|||++   +|+||||||+|||++.+  
T Consensus       218 ~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~  293 (573)
T 3uto_A          218 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRS  293 (573)
T ss_dssp             CEEEEEECSSEEEEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSC
T ss_pred             eEEEEEEECCEEEEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCC
Confidence            999999999999999999999999999864 345699999999999999999999999   99999999999999854  


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+|+.+....   .....+||+.|||||++.+..|+.++||||+||++|||++|+.||........+ ..+.
T Consensus       294 ~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-~~i~  369 (573)
T 3uto_A          294 NELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-RNVK  369 (573)
T ss_dssp             CCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHH
T ss_pred             CCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-HHHH
Confidence            889999999999876542   234568999999999999999999999999999999999999999765332222 2221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    .. ...++......+    .+.+++.+||+.||++|||++|+++
T Consensus       370 ~~----~~-~~~~~~~~~~s~----~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          370 SC----DW-NMDDSAFSGISE----DGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TT----CC-CCCSGGGTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hC----CC-CCCcccccCCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    00 011111122233    3678999999999999999999986

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.4e-42  Score=402.63  Aligned_cols=424  Identities=24%  Similarity=0.267  Sum_probs=274.9

Q ss_pred             CeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCcccccc
Q 001867           69 HSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDL  148 (1002)
Q Consensus        69 ~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~L  148 (1002)
                      .+++.++++++++ |.+|..++++++|++|++++|.+.+.+|..++.+.+|+.+++++|..           .+|++|++
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l   78 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL   78 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence            5688999999999 79999999999999999999999999999999999999999988764           56899999


Q ss_pred             ccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccccc
Q 001867          149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVG  228 (1002)
Q Consensus       149 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~  228 (1002)
                      ++|.+++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++.  .+|..   .++|++|++++|++++
T Consensus        79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~--~l~~~---~~~L~~L~L~~n~l~~  145 (454)
T 1jl5_A           79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK--ALSDL---PPLLEYLGVSNNQLEK  145 (454)
T ss_dssp             TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS--CCCSC---CTTCCEEECCSSCCSS
T ss_pred             cCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC--cccCC---CCCCCEEECcCCCCCC
Confidence            9999985 4542   3689999999999997 5653   478999999999873  34332   1689999999999996


Q ss_pred             ccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCC
Q 001867          229 EIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR  308 (1002)
Q Consensus       229 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  308 (1002)
                       +| .|+.+++|++|++++|++++ +|..+   .+|++|++++|++++ +| .+.++++|+.|++++|++++ +|...  
T Consensus       146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--  214 (454)
T 1jl5_A          146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--  214 (454)
T ss_dssp             -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--
T ss_pred             -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--
Confidence             67 69999999999999999996 55543   589999999999997 55 69999999999999999996 44433  


Q ss_pred             CCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceee
Q 001867          309 LPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLM  388 (1002)
Q Consensus       309 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  388 (1002)
                      ..|+.|++++|+++ .+| .+..+++|++|++++|++++ +|..   .++|+.|++++|++++ +|..   .++|++|++
T Consensus       215 ~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l  284 (454)
T 1jl5_A          215 LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDV  284 (454)
T ss_dssp             TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred             CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEEC
Confidence            25899999999998 566 48889999999999999986 4432   3788999999999885 4543   367888888


Q ss_pred             eccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCC-CcceEEEcccCcccCccccccccCCcccEEEccCCcCCC
Q 001867          389 IYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGL-PHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSG  467 (1002)
Q Consensus       389 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~  467 (1002)
                      ++|.+++. |..   .++|++|++++|++++ ++    .+ ++|+.|++++|++++ +|..   +++|+.|++++|+++ 
T Consensus       285 s~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-  350 (454)
T 1jl5_A          285 SENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-  350 (454)
T ss_dssp             CSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-
T ss_pred             cCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-
Confidence            88888762 211   2578888888888875 22    23 478888888888876 3332   467888888888887 


Q ss_pred             CCccccccccccccccccccccCC--CCcccccccccCCeeecCCCcCCcccccccccccccccccccCccccc--CCCC
Q 001867          468 SLPEEIGFLKSLVVLSGSENKFTG--SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYG--NIPE  543 (1002)
Q Consensus       468 ~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~ip~  543 (1002)
                      .+|.   .+++|+.|++++|++++  .+|..++.+        +.|.+.|.+|..   +++|+.|++++|.+++  .+|.
T Consensus       351 ~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~  416 (454)
T 1jl5_A          351 EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE  416 (454)
T ss_dssp             CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC---------------------------------
T ss_pred             cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCCccccchh
Confidence            4565   46778888888888876  566655432        346666677663   4789999999999997  6775


Q ss_pred             CccccccccEEeCcceeeecccCCccccc
Q 001867          544 DIGNLSVLNYLDLSNNRLSGRIPVGLQNL  572 (1002)
Q Consensus       544 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l  572 (1002)
                      +      |+.|.+.+|.+.+.+|......
T Consensus       417 s------l~~L~~~~~~~~~~~~~~~~~~  439 (454)
T 1jl5_A          417 S------VEDLRMNSERVVDPYEFAHETT  439 (454)
T ss_dssp             -----------------------------
T ss_pred             h------HhheeCcCcccCCccccCHHHh
Confidence            4      5667789999998888765543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.5e-42  Score=380.09  Aligned_cols=273  Identities=35%  Similarity=0.580  Sum_probs=230.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|..++++.||||++...                 .....+.+.+|+.++++++||||+++
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~iv~~  100 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----------------SSQGIEEFETEIETLSFCRHPHLVSL  100 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-----------------CSSHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred             HhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-----------------ChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            5789999999999999999999888999999987432                 22345679999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++.+.+..++||||+++|+|.+++.....  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCC
T ss_pred             EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999975432  3599999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc--hhHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE--KDLVKWVC  917 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~--~~~~~~~~  917 (1002)
                      +||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||......  .....|..
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            9999999998765443333334556899999999999889999999999999999999999999754332  33445544


Q ss_pred             HHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          918 STLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ...........+++.. .....+....+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            4444455555666555 34556777889999999999999999999999999998864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-41  Score=379.09  Aligned_cols=283  Identities=40%  Similarity=0.693  Sum_probs=234.4

Q ss_pred             cCCcHHHH-hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhc
Q 001867          674 LGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGK  752 (1002)
Q Consensus       674 ~~~~~~~~-~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  752 (1002)
                      +.+.+... .++|++.+.||+|+||.||+|...+++.||||++.....                ......+.+|+.++++
T Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~~e~~~l~~   83 (326)
T 3uim_A           20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT----------------QGGELQFQTEVEMISM   83 (326)
T ss_dssp             CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------------------CCCHHHHHHHGGGT
T ss_pred             ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC----------------chHHHHHHHHHHHHHh
Confidence            33444443 578999999999999999999988899999999854211                1122358999999999


Q ss_pred             CCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          753 IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       753 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      ++||||+++++++...+..++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+++.++|+||||||+
T Consensus        84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA  163 (326)
T ss_dssp             CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred             ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence            9999999999999999999999999999999999986432  45999999999999999999999986668999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC----CC
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD----PE  906 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~----~~  906 (1002)
                      ||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.    ..
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             hEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            99999999999999999987754432 22334569999999999998889999999999999999999999996    23


Q ss_pred             CCchhHHHHHHHHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ........|+.............+... .....+....+.+++.+||+.||++|||++||++.|+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            334456666666666666666666555 3455677788999999999999999999999999998753

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=4.7e-42  Score=401.57  Aligned_cols=392  Identities=21%  Similarity=0.249  Sum_probs=235.0

Q ss_pred             cccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCcc-ccccccccccccccccC
Q 001867          120 QHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTI-PAFLGNISTLKMLNLSY  198 (1002)
Q Consensus       120 ~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~  198 (1002)
                      +.++.++++++ .+|. +.  ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ +..|+++++|++|+|++
T Consensus        13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            34666667766 3444 22  56777777777777666667777777777777777665333 44556666666666666


Q ss_pred             CCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCC
Q 001867          199 NPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDL  278 (1002)
Q Consensus       199 N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  278 (1002)
                      |++ .+..|..|+++++|++|+|++|++++..|..                      ..|..+++|++|+|++|++.+..
T Consensus        89 n~l-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------------------~~~~~l~~L~~L~L~~n~l~~~~  145 (455)
T 3v47_A           89 NQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSG----------------------NFFKPLTSLEMLVLRDNNIKKIQ  145 (455)
T ss_dssp             CTT-CEECTTTTTTCTTCCEEECTTSCCBTHHHHS----------------------STTTTCTTCCEEECCSSBCCSCC
T ss_pred             Ccc-CccChhhccCcccCCEEeCCCCCCCccccCc----------------------ccccCcccCCEEECCCCccCccC
Confidence            654 2233444555555555555555554433222                      12444455555555555555444


Q ss_pred             CCc-cccccccceeeccccccCCCCCccCCCC---CcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCC
Q 001867          279 PTG-WSNLTSLRLLDASMNDLTGPIPDDLTRL---PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLG  354 (1002)
Q Consensus       279 ~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  354 (1002)
                      |.. +.++++|++|++++|++++..|..+..+   .++.|++++|.+.+..+..+..                .....+.
T Consensus       146 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~  209 (455)
T 3v47_A          146 PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPF  209 (455)
T ss_dssp             CCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTT
T ss_pred             cccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc----------------ccccccc
Confidence            443 4555555555555555555544444332   2444555555444332221110                0011233


Q ss_pred             CCCCCceEEccCccccCCCChhhhcc---CcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcc
Q 001867          355 KNSPLRWVDLSNNQFTGEIPASLCEK---GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV  431 (1002)
Q Consensus       355 ~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  431 (1002)
                      .+++|++|++++|++++..|..+...   .+|+.|++++|.+.+..              +..+.+.+..+..+..+   
T Consensus       210 ~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~---  272 (455)
T 3v47_A          210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGL---  272 (455)
T ss_dssp             TTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGG---
T ss_pred             ccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccc---
Confidence            45678888888888887777766554   44555555544433211              11112221111111111   


Q ss_pred             eEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCC
Q 001867          432 YLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAN  511 (1002)
Q Consensus       432 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  511 (1002)
                                         ..++|+.|++++|++++..|..++.+++|+.|++++|++++..|..|..+++|++|+|++|
T Consensus       273 -------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N  333 (455)
T 3v47_A          273 -------------------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN  333 (455)
T ss_dssp             -------------------TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             -------------------cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCC
Confidence                               1256777777777777667777777777777777777777666777777788888888888


Q ss_pred             cCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCCh
Q 001867          512 DLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPS  590 (1002)
Q Consensus       512 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~  590 (1002)
                      .+++..|..|+.+++|++|+|++|++++..|..++++++|++|+|++|++++..+..++.+ +|+.|+|++|++++.+|.
T Consensus       334 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             CCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            8877777777888888888888888877777778888888888888888886555566666 688888888888888774

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.4e-41  Score=397.67  Aligned_cols=364  Identities=20%  Similarity=0.189  Sum_probs=288.2

Q ss_pred             CCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCC-CccccccCCccccccccccccCCCCcccccccccceee
Q 001867           93 ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL-TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVIS  171 (1002)
Q Consensus        93 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  171 (1002)
                      ++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            68888999998888888888888899999999988887554 55788888999999999988888888888889999999


Q ss_pred             eccccccCccccc--cccccccccccccCCCCCCCCCCcc-cCCCCccchhhccCcccccccccccccc--cccchhccc
Q 001867          172 LVYNLLDGTIPAF--LGNISTLKMLNLSYNPFLPGRIPPE-LGNLTNLEILWLTECNLVGEIPDSLGRL--AKLVDLDLA  246 (1002)
Q Consensus       172 L~~N~l~~~~p~~--l~~l~~L~~L~Ls~N~~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~L~  246 (1002)
                      |++|++++..|..  ++++++|++|+|++|++ .+..|.. +.++++|++|++++|++++..|..+..+  .+|+.|+++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l-~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~  188 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS  188 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBC-CSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCcc-CccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccc
Confidence            9999888755544  88888899999998886 3444554 7888899999999999988888888776  688999999


Q ss_pred             CcccccccCccc--------ccccceeeeeccCCcccCCCCCccccc---cccceeeccccccCCCCCccCCCCCcceee
Q 001867          247 LNNLVGAIPSSL--------TELASVVQIELYNNSLTGDLPTGWSNL---TSLRLLDASMNDLTGPIPDDLTRLPLESLN  315 (1002)
Q Consensus       247 ~N~l~~~~~~~l--------~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~  315 (1002)
                      +|.+.+..+..+        ..+++|+.|++++|++.+..|..+...   ++|+.|++++|.+.+...            
T Consensus       189 ~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~------------  256 (455)
T 3v47_A          189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF------------  256 (455)
T ss_dssp             TCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT------------
T ss_pred             cCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc------------
Confidence            998887655443        356789999999999988888777655   889999999988764321            


Q ss_pred             cCCCcccCcCCcccCC--CcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeecccc
Q 001867          316 LYENRLEGSLPATIAD--SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSF  393 (1002)
Q Consensus       316 L~~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  393 (1002)
                       ..+.+....+..+..  .++|++|++++|++.+..|..+..+++|++|+|++|++++..|..|..+++|++|++++|.+
T Consensus       257 -~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  335 (455)
T 3v47_A          257 -GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL  335 (455)
T ss_dssp             -TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             -chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence             112222222222222  35677788888888777777788888888888888888877777788888888888888888


Q ss_pred             ccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCc
Q 001867          394 TGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP  470 (1002)
Q Consensus       394 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  470 (1002)
                      ++..|..++++++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..|
T Consensus       336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            87777888888888888888888888778888888888888888888888777777888888889999998887766

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.4e-41  Score=379.27  Aligned_cols=261  Identities=25%  Similarity=0.372  Sum_probs=214.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc--------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS--------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-  753 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  753 (1002)
                      ++|++.+.||+|+||.||+|+..        ++..||||++...                ......+.+.+|+.+++++ 
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~  144 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD----------------ATEKDLSDLVSEMEMMKMIG  144 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT----------------CBHHHHHHHHHHHHHHHHSC
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC----------------cCHHHHHHHHHHHHHHHHhc
Confidence            56788899999999999999863        3567999998432                1234567799999999999 


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      +||||+++++++.+.+..|+||||+++|+|.+++....              ...+++..++.++.||+.||+|||++  
T Consensus       145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--  222 (370)
T 2psq_A          145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--  222 (370)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            89999999999999999999999999999999998643              24589999999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ 
T Consensus       223 -~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~  301 (370)
T 2psq_A          223 -KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL  301 (370)
T ss_dssp             -TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcC
Confidence             999999999999999999999999999987765544344445567889999999999999999999999999999999 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      |+.||.... ..+....+......        +....+.    ..+.+++.+||+.||++||+++|+++.|+++...
T Consensus       302 g~~p~~~~~-~~~~~~~~~~~~~~--------~~~~~~~----~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          302 GGSPYPGIP-VEELFKLLKEGHRM--------DKPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             SCCSSTTCC-GGGHHHHHHTTCCC--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCC-HHHHHHHHhcCCCC--------CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            999987543 33333332221110        1111222    2478899999999999999999999999998653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=9.2e-42  Score=376.96  Aligned_cols=291  Identities=30%  Similarity=0.476  Sum_probs=236.4

Q ss_pred             CchHHHHHHHHHHHhccCCccccCCCCCCCCCCCCCc--cceeEEeCCC--CeEEEEEcCCCCcCC--CCCccccCCCCC
Q 001867           22 SLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPCS--WRGVECDPRS--HSVASIDLSNANIAG--PFPSLLCRLENL   95 (1002)
Q Consensus        22 ~~~~~~~~l~~~k~~~~d~~~~l~sw~~~~~~~~~C~--w~gv~C~~~~--~~v~~l~L~~~~l~~--~~~~~~~~l~~L   95 (1002)
                      +..+|++||++||+++.||. .+++|..   +.+||.  |.||+|+..+  ++|+.|+|+++++++  .+|..|+++++|
T Consensus         3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~---~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            3 CNPQDKQALLQIKKDLGNPT-TLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCG-GGTTCCT---TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCHHHHHHHHHHHHhcCCcc-cccCCCC---CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            45689999999999999987 8999953   357898  9999998765  789999999999999  899999999999


Q ss_pred             CEEeccC-CCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeecc
Q 001867           96 TFLTLFN-NSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVY  174 (1002)
Q Consensus        96 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  174 (1002)
                      ++|+|++ |.+.+.+|..|+.+++|++|+|++|.+++.+|..|.++++|++|+|++|++++.+|..|..+++|++|+|++
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  158 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG  158 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence            9999995 999999999999999999999999999988999999999999999999999988999999999999999999


Q ss_pred             ccccCcccccccccc-ccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccc
Q 001867          175 NLLDGTIPAFLGNIS-TLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGA  253 (1002)
Q Consensus       175 N~l~~~~p~~l~~l~-~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  253 (1002)
                      |++++.+|..+++++ +|++|+|++|++ .+.+|..+..++ |++|++++|++++..|..|..+++|++|+|++|++++.
T Consensus       159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l-~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (313)
T 1ogq_A          159 NRISGAIPDSYGSFSKLFTSMTISRNRL-TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD  236 (313)
T ss_dssp             SCCEEECCGGGGCCCTTCCEEECCSSEE-EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred             CcccCcCCHHHhhhhhcCcEEECcCCee-eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee
Confidence            999888888888887 888888888875 356677777776 77777777777777777777777777777777777765


Q ss_pred             cCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCC-CcceeecCCCc
Q 001867          254 IPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL-PLESLNLYENR  320 (1002)
Q Consensus       254 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~  320 (1002)
                      +|. +..+++|++|++++|++++.+|..+..+++|+.|++++|++++.+|.. ..+ .|+.|++++|+
T Consensus       237 ~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          237 LGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             GGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             cCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence            554 666677777777777777667777777777777777777776655554 222 25555555554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.1e-41  Score=369.32  Aligned_cols=263  Identities=32%  Similarity=0.406  Sum_probs=202.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|+. +++.||||++...               .......+.+.+|++++++++||||+++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~   99 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQ---------------DFHAERVNEFLREVAIMKRLRHPNIVLF   99 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCC---------------CCSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCC---------------CCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            35788889999999999999987 4889999998432               1133445678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEECCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~~NIll~~~~  838 (1002)
                      ++++.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++   +  |+||||||+||+++.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~  176 (309)
T 3p86_A          100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKY  176 (309)
T ss_dssp             EEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTC
T ss_pred             EEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCC
Confidence            9999999999999999999999999975321 2489999999999999999999998   8  99999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      .+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+..
T Consensus       177 ~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-~~~~~~~~~  253 (309)
T 3p86_A          177 TVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-AQVVAAVGF  253 (309)
T ss_dssp             CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-HHHHHHHHH
T ss_pred             cEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Confidence            99999999998654332  122345799999999999999999999999999999999999999975432 222222111


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                      .....       +......+    .+.+++.+||+.||++|||++++++.|+.+.....
T Consensus       254 ~~~~~-------~~~~~~~~----~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          254 KCKRL-------EIPRNLNP----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             SCCCC-------CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             cCCCC-------CCCccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            11110       01112222    47889999999999999999999999999876443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-40  Score=364.76  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=206.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...                 .....+.+.+|+.++++++||||++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~E~~~l~~l~hp~iv~   81 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----------------QQPKKELIINEILVMRENKNPNIVN   81 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG-----------------GCSCHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc-----------------cccHHHHHHHHHHHHhcCCCCCCCe
Confidence            46799999999999999999995 56899999998432                 1223566899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..|+||||+++|+|.+++..   ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~  155 (297)
T 3fxz_A           82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSV  155 (297)
T ss_dssp             EEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCE
T ss_pred             EeEEEEECCEEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCE
Confidence            99999999999999999999999999975   3589999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++........  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.................
T Consensus       156 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  233 (297)
T 3fxz_A          156 KLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT  233 (297)
T ss_dssp             EECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred             EEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999999987655432  23345799999999999999999999999999999999999999976533322222211111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                          .. .  +......    ..+.+++.+||+.||++|||++|+++
T Consensus       234 ----~~-~--~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 ----PE-L--QNPEKLS----AIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ----CC-C--SCGGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CC-C--CCccccC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence                00 0  0011122    24778999999999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=368.91  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=210.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|.+.+.||+|+||.||+|... +++.||+|++...                 +....+.+.+|++++++++||||+++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----------------~~~~~~~~~~E~~~l~~l~hp~iv~~   72 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----------------DEETQRTFLKEVKVMRCLEHPNVLKF   72 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----------------CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCcCcccE
Confidence            56778899999999999999974 5899999987331                 34556789999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..++||||+++|+|.++++.. ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~k  148 (310)
T 3s95_A           73 IGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVV  148 (310)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEE
T ss_pred             EEEEecCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEE
Confidence            99999999999999999999999999863 45699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcc------------cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          842 VADFGVAKVVDASGKPKS------------MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      |+|||+++..........            .....||+.|+|||++.+..++.++||||||+++|||++|..|+......
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~  228 (310)
T 3s95_A          149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR  228 (310)
T ss_dssp             ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred             EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence            999999987654332111            11457999999999999999999999999999999999999998653222


Q ss_pred             hh-----HHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          910 KD-----LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       910 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ..     ........         ..   ...+    ..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus       229 ~~~~~~~~~~~~~~~---------~~---~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          229 TMDFGLNVRGFLDRY---------CP---PNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             CTTSSBCHHHHHHHT---------CC---TTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhhhhhcccccc---------CC---CCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11     11111000         00   1111    23778999999999999999999999999987644

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.9e-40  Score=361.91  Aligned_cols=269  Identities=36%  Similarity=0.550  Sum_probs=220.6

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEec
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTT  767 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  767 (1002)
                      .+.||+|+||.||+|.. +++.||||++....             ........+.+.+|+.++++++||||+++++++.+
T Consensus        36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  101 (307)
T 2nru_A           36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV-------------DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD  101 (307)
T ss_dssp             CCEEEECSSEEEEEEES-SSCEEEEEEECCCT-------------TSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCccccCCCeEEEEEEE-CCceEEEEEEeccc-------------CcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec
Confidence            38999999999999987 57899999985421             11233456779999999999999999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCK-GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      .+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg  178 (307)
T 2nru_A          102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFG  178 (307)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            999999999999999999987533 35699999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-hccCc
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL-DQKGV  925 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~  925 (1002)
                      +++...............||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+..... .....
T Consensus       179 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (307)
T 2nru_A          179 LARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI  257 (307)
T ss_dssp             TCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH
T ss_pred             cccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh
Confidence            9987665443333445579999999998765 478999999999999999999999976544333333322221 12233


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          926 DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ...+++............+.+++.+||+.||++|||++++++.|+++.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          258 EDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            4455566666677777889999999999999999999999999999853

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.2e-41  Score=381.40  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=210.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|.+. +++.||||++....                .....+.+.+|+.++++++||||+++
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpniv~~  177 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----------------PPDLKAKFLQEARILKQYSHPNIVRL  177 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----------------CHHHHTTTTHHHHHHTTCCCTTBCCE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----------------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            56778899999999999999985 68999999884321                23345678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++..++..|+||||+++|+|.++++.. +..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       178 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~k  253 (377)
T 3cbl_A          178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLK  253 (377)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEE
Confidence            99999999999999999999999999753 34689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.... ..+....+....
T Consensus       254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-~~~~~~~~~~~~  332 (377)
T 3cbl_A          254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-NQQTREFVEKGG  332 (377)
T ss_dssp             ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-HHHHHHHHHTTC
T ss_pred             ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCC
Confidence            999999986543322111122345778999999998899999999999999999998 899986542 223333222111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      .        .+....++.    .+.+++.+||+.||++|||++++++.|+++...
T Consensus       333 ~--------~~~~~~~~~----~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          333 R--------LPCPELCPD----AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             C--------CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--------CCCCCCCCH----HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            1        011122222    478899999999999999999999999998653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-40  Score=369.74  Aligned_cols=269  Identities=26%  Similarity=0.299  Sum_probs=210.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.++||+|+||.||+|+.. ++.||||++..                  .......+..|+.++++++||||+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~------------------~~~~~~~~~~E~~~l~~l~hpniv~~   83 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI------------------QDKQSWQNEYEVYSLPGMKHENILQF   83 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECG------------------GGHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeec------------------CchHHHHHHHHHHHHhcCCCCCchhh
Confidence            467888999999999999999876 79999999843                  12334556779999999999999999


Q ss_pred             eeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-------CCCCeeeCCCCCC
Q 001867          762 WCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD-------CVPSIVHRDVKSN  830 (1002)
Q Consensus       762 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-------~~~~iiHrDlk~~  830 (1002)
                      ++++....    ..++||||+++|+|.++++.   ..+++..++.++.|++.||+|||+.       +.++|+||||||+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~  160 (322)
T 3soc_A           84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK  160 (322)
T ss_dssp             EEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGG
T ss_pred             cceeccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChH
Confidence            99998754    36999999999999999975   3499999999999999999999985       1238999999999


Q ss_pred             cEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          831 NILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       831 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      ||+++.++.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||..
T Consensus       161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999887665444444456799999999998863     456789999999999999999999975


Q ss_pred             CCCch------------hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          906 EFGEK------------DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       906 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      .....            ....+.. ..........+....  ........+.+++.+||+.||++|||++|+++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          241 PVDEYMLPFEEEIGQHPSLEDMQE-VVVHKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHH-HHTTSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcchhccchhhhhccCCchhhhhh-hhhcccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            43321            1111111 111111111111111  11234456889999999999999999999999999987


Q ss_pred             hh
Q 001867          974 AE  975 (1002)
Q Consensus       974 ~~  975 (1002)
                      +.
T Consensus       318 ~~  319 (322)
T 3soc_A          318 RL  319 (322)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.9e-40  Score=362.12  Aligned_cols=267  Identities=27%  Similarity=0.368  Sum_probs=209.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++....              .......+.+.+|+.++++++||||++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~hp~iv~   75 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP--------------REKEETLKRFEREVHNSSQLSHQNIVS   75 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS--------------SCCHHHHHHHHHHHHHHTTCCBTTBCC
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc--------------cccHHHHHHHHHHHHHHhcCCCCCCce
Confidence            356888999999999999999964 68999999985431              123445678999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++++|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        76 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~  150 (294)
T 4eqm_A           76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTL  150 (294)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             EEEeeeeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            999999999999999999999999999853  4699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||............    .
T Consensus       151 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~----~  225 (294)
T 4eqm_A          151 KIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH----I  225 (294)
T ss_dssp             EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH----H
T ss_pred             EEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----h
Confidence            9999999987654322 2233456999999999999999999999999999999999999999765332222111    1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHHhhhhcc
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-AMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~~~~~~  977 (1002)
                      .. .............+    ..+.+++.+|++.||++|| +++++.+.|+.+....+
T Consensus       226 ~~-~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          226 QD-SVPNVTTDVRKDIP----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             SS-CCCCHHHHSCTTSC----HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             hc-cCCCcchhcccCCC----HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            11 11111011111222    3478899999999999998 99999999998765443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-40  Score=368.54  Aligned_cols=250  Identities=27%  Similarity=0.381  Sum_probs=206.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.+.               .......+.+.+|+.++++++||||++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~hpnIv~   78 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT---------------QLNPTSLQKLFREVRIMKILNHPNIVK   78 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---------------GSCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhh---------------cCCHHHHHHHHHHHHHHHhCCCCCEee
Confidence            46788899999999999999997 57999999998542               113345667889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..|+||||+++|+|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        79 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~  153 (328)
T 3fe3_A           79 LFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNI  153 (328)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             EEEEEEECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCE
Confidence            999999999999999999999999999753  5699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++.......   .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||..... .+....+.. 
T Consensus       154 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~-  228 (328)
T 3fe3_A          154 KIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-KELRERVLR-  228 (328)
T ss_dssp             EECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-
T ss_pred             EEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-
Confidence            999999998765432   23456799999999999888765 799999999999999999999975432 222221111 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                         ....  + |  ....    ..+.+++.+||+.||++|||++|+++.
T Consensus       229 ---~~~~--~-p--~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          229 ---GKYR--I-P--FYMS----TDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---CCCC--C-C--TTSC----HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---CCCC--C-C--CCCC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               1110  0 0  1112    247789999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=375.40  Aligned_cols=266  Identities=25%  Similarity=0.364  Sum_probs=216.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc--------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS--------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-  753 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  753 (1002)
                      ++|.+.+.||+|+||.||+|+..        ++..||||++...                ......+++.+|+++++++ 
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~  132 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----------------ATEKDLSDLISEMEMMKMIG  132 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----------------CCHHHHHHHHHHHHHHHHHC
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----------------cCHHHHHHHHHHHHHHHHhc
Confidence            56778899999999999999862        2357999998432                1234457799999999999 


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      +||||+++++++..++..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||++  
T Consensus       133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  210 (382)
T 3tt0_A          133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--  210 (382)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--
Confidence            89999999999999999999999999999999998643              24699999999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ 
T Consensus       211 -~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~  289 (382)
T 3tt0_A          211 -KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL  289 (382)
T ss_dssp             -TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence             999999999999999999999999999987765544444445568899999999999999999999999999999999 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccc
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS  978 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~  978 (1002)
                      |+.||.... ..+....+......        +.......    ++.+++.+||+.||++|||++|+++.|+++.+....
T Consensus       290 g~~p~~~~~-~~~~~~~~~~~~~~--------~~~~~~~~----~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          290 GGSPYPGVP-VEELFKLLKEGHRM--------DKPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             SCCSSTTCC-HHHHHHHHHTTCCC--------CCCSSCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCCCCC-HHHHHHHHHcCCCC--------CCCccCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            999986542 23333322221111        11122222    478899999999999999999999999999765543


Q ss_pred             cC
Q 001867          979 KT  980 (1002)
Q Consensus       979 ~~  980 (1002)
                      ..
T Consensus       357 ~~  358 (382)
T 3tt0_A          357 QE  358 (382)
T ss_dssp             CC
T ss_pred             CC
Confidence            33

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=365.78  Aligned_cols=261  Identities=27%  Similarity=0.407  Sum_probs=209.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.+.    .+..||||++....                .....+.+.+|+.++++++||||
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i  112 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----------------TERQRRDFLSEASIMGQFDHPNI  112 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----------------CHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----------------CHHHHHHHHHHHHHHHhCCCCCC
Confidence            56788899999999999999974    34569999984321                23456779999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++.+.+..|+||||+++|+|.++++. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus       113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  188 (325)
T 3kul_A          113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNL  188 (325)
T ss_dssp             CCEEEEECGGGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             CcEEEEEEeCCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCC
Confidence            9999999999999999999999999999975 335699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+
T Consensus       189 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~~  267 (325)
T 3kul_A          189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSV  267 (325)
T ss_dssp             CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHHHHH
T ss_pred             CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHH
Confidence            99999999998775543221 2233456788999999998899999999999999999999 9999965432 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      .....        .+.....+    ..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus       268 ~~~~~--------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          268 EEGYR--------LPAPMGCP----HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             HTTCC--------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             HcCCC--------CCCCCCcC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            21110        01112222    24788999999999999999999999999987543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-40  Score=358.86  Aligned_cols=256  Identities=28%  Similarity=0.466  Sum_probs=210.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|...+++.||+|++...                  ....+++.+|++++++++||||++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~   71 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------------AMSEEDFIEEAEVMMKLSHPKLVQLY   71 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT------------------SBCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc------------------ccCHHHHHHHHHHHHhCCCCCEeeEE
Confidence            567788999999999999999988999999998432                  11245689999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  147 (269)
T 4hcu_A           72 GVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV  147 (269)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEE
T ss_pred             EEEecCCceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEe
Confidence            999999999999999999999999975 345699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+....+.....
T Consensus       148 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-~~~~~~~~~~~~  225 (269)
T 4hcu_A          148 SDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR  225 (269)
T ss_dssp             CCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCC
T ss_pred             cccccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhcCcc
Confidence            99999986644321 11223456788999999999999999999999999999999 8999975432 222222211110


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                           . ..+  ....    ..+.+++.+||+.||++||+++|+++.|+++..
T Consensus       226 -----~-~~~--~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          226 -----L-YKP--RLAS----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -----C-CCC--TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----C-CCC--CcCC----HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                 0 001  1122    247889999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=376.75  Aligned_cols=266  Identities=23%  Similarity=0.328  Sum_probs=213.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|++.+.||+|+||.||+|++.      +++.||||++...                .......++.+|+.++++++||
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~hp  134 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----------------CSEQDELDFLMEALIISKFNHQ  134 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----------------CCHHHHHHHHHHHHHHHHCCCT
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----------------cChhhHHHHHHHHHHHHhCCCC
Confidence            46778899999999999999853      4678999998432                1234456789999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-----GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ||+++++++.+.+..++||||+++|+|.+++.....     ..+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus       135 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  211 (367)
T 3l9p_A          135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARN  211 (367)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             CCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhh
Confidence            999999999999999999999999999999986432     4599999999999999999999999   99999999999


Q ss_pred             EEECCCC---CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 001867          832 ILLDGDF---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF  907 (1002)
Q Consensus       832 Ill~~~~---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~  907 (1002)
                      |+++.++   .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       212 Ill~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~  291 (367)
T 3l9p_A          212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  291 (367)
T ss_dssp             EEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999555   499999999986644433333445568999999999999999999999999999999998 999986543


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccC
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKT  980 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~  980 (1002)
                       ..+....+......        +.....+.    .+.+++.+||+.||++||++++|++.|+.+........
T Consensus       292 -~~~~~~~i~~~~~~--------~~~~~~~~----~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~  351 (367)
T 3l9p_A          292 -NQEVLEFVTSGGRM--------DPPKNCPG----PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN  351 (367)
T ss_dssp             -HHHHHHHHHTTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred             -HHHHHHHHHcCCCC--------CCCccCCH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhcc
Confidence             23333322211110        01112222    47889999999999999999999999998876544333

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.7e-40  Score=372.33  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=200.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .++|++.+.||+|+||.||+|+..    ++..||||++...                ......+.+.+|+.++++++|||
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~n  107 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG----------------YTEKQRRDFLGEASIMGQFDHPN  107 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT----------------CCHHHHHHHHHHHHHHTTCCCTT
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc----------------cCHHHHHHHHHHHHHHHhCCCCC
Confidence            357889999999999999999864    4678999998432                12345678999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.+.+..++||||+++|+|.++++. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  183 (373)
T 2qol_A          108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSN  183 (373)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             CCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCC
Confidence            99999999999999999999999999999975 345699999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~  915 (1002)
                      +.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....
T Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-~~~~~~~  262 (373)
T 2qol_A          184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKA  262 (373)
T ss_dssp             CCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-HHHHHHH
T ss_pred             CCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH
Confidence            999999999998765432211 1223345778999999999999999999999999999998 999996543 2232222


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      +.....        .+.....+    ..+.+++.+||+.||++||+++++++.|+++...
T Consensus       263 i~~~~~--------~~~~~~~~----~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          263 VDEGYR--------LPPPMDCP----AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHTTEE--------CCCCTTCB----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHcCCC--------CCCCcccc----HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            221111        11111222    3488899999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.9e-40  Score=366.88  Aligned_cols=254  Identities=24%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||||++....                .....+.+.+|+.+++.++||||++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpnIv~   69 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------------AVDCPENIKKEICINKMLNHENVVK   69 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc----------------ccchHHHHHHHHHHHHhCCCCCCCe
Confidence            468889999999999999999975 68999999984321                1122466889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~  144 (323)
T 3tki_A           70 FYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNL  144 (323)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEEecCCeEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCE
Confidence            99999999999999999999999999973  45699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchh-HHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKD-LVKWVCS  918 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~-~~~~~~~  918 (1002)
                      ||+|||+++...............||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ...+...
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~  224 (323)
T 3tki_A          145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  224 (323)
T ss_dssp             EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT
T ss_pred             EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc
Confidence            9999999987654433333445679999999999987775 7789999999999999999999976543322 2222111


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ...        .+......    ..+.+++.+||+.||++|||++|+++.
T Consensus       225 ~~~--------~~~~~~~~----~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          225 KTY--------LNPWKKID----SAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             CTT--------STTGGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccc--------CCccccCC----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            100        01111222    246789999999999999999999863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.6e-40  Score=367.01  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=207.1

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.+.|++.+.||+|+||.||+|..+ +|+.||+|++.+.....           .......+.+.+|+.++++++||||+
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~-----------~~~~~~~~~~~~E~~il~~l~hpnIv   78 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----------SRRGVCREEIEREVSILRQVLHPNII   78 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTT-----------CSSSBCHHHHHHHHHHHTTCCCTTBC
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccc-----------ccchhHHHHHHHHHHHHHhCCCcCCC
Confidence            3467888999999999999999975 58999999996542210           01122356799999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-  838 (1002)
                      ++++++.+.+..|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||+++.++ 
T Consensus        79 ~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~  153 (361)
T 2yab_A           79 TLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI  153 (361)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS
T ss_pred             cEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCC
Confidence            999999999999999999999999999974  45799999999999999999999999   999999999999998776 


Q ss_pred             ---CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          839 ---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       839 ---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                         .+||+|||+++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|..||........ ...
T Consensus       154 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~  229 (361)
T 2yab_A          154 PIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN  229 (361)
T ss_dssp             SSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH
T ss_pred             CccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence               799999999987755322   2345799999999999999999999999999999999999999976533222 221


Q ss_pred             HHHHhhccCcccccccc-ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPK-LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +..    ....  +++. .....    ..+.+++.+|+..||++|||++|+++
T Consensus       230 i~~----~~~~--~~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          230 ITA----VSYD--FDEEFFSQTS----ELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHT----TCCC--CCHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHh----cCCC--CCchhccCCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111    1110  1111 11222    24778999999999999999999984

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.1e-40  Score=356.05  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=209.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|..+++..||+|++...                  ....+++.+|++++++++||||++++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~   69 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG------------------SMSEDEFFQEAQTMMKLSHPKLVKFY   69 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT------------------TBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccC------------------CCcHHHHHHHHHHHHhCCCCCEeeEE
Confidence            567888999999999999999988889999998432                  11245689999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l  145 (268)
T 3sxs_A           70 GVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKV  145 (268)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEE
T ss_pred             EEEccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEE
Confidence            9999999999999999999999999763 34699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||++........ .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||........ ........ 
T Consensus       146 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~-  222 (268)
T 3sxs_A          146 SDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKVSQGH-  222 (268)
T ss_dssp             CCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTC-
T ss_pred             ccCccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHHHHcCC-
Confidence            99999987654432 22234456778999999998889999999999999999999 9999965432222 11111110 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                           ....+  ....    ..+.+++.+||+.||++|||++|+++.|+++...
T Consensus       223 -----~~~~~--~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 -----RLYRP--HLAS----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -----CCCCC--TTSC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -----CCCCC--CcCh----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                 00001  1122    2477899999999999999999999999988543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.7e-40  Score=362.15  Aligned_cols=262  Identities=24%  Similarity=0.316  Sum_probs=202.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhc--CCCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGK--IRHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|+. +++.||||++..                    .....+.+|.+++..  ++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--------------------~~~~~~~~e~~~~~~~~l~h~niv   65 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS--------------------RDEKSWFRETELYNTVMLRHENIL   65 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG--------------------GGHHHHHHHHHHHHHTCCCCTTBC
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc--------------------ccchhhHHHHHHHHHhhccCcCee
Confidence            46788899999999999999988 589999999832                    123445566666666  7899999


Q ss_pred             eeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeCCC
Q 001867          760 KLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLH--------HDCVPSIVHRDV  827 (1002)
Q Consensus       760 ~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiHrDl  827 (1002)
                      ++++++..    ....++||||+++|+|.++++.   ..+++..+++++.|++.||+|||        +.   +|+||||
T Consensus        66 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dl  139 (301)
T 3q4u_A           66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDL  139 (301)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCC
T ss_pred             eEEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCC
Confidence            99998754    3468999999999999999953   46999999999999999999999        77   9999999


Q ss_pred             CCCcEEECCCCCeEEccccCcccccCCCCCcc--cccccccccccCccccccC------CCCCccchhhHHHHHHHHHhC
Q 001867          828 KSNNILLDGDFGARVADFGVAKVVDASGKPKS--MSVIAGSCGYIAPEYAYTL------RVNEKSDIYSFGVVILELVTG  899 (1002)
Q Consensus       828 k~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGvil~ell~g  899 (1002)
                      ||+||+++.++.+||+|||+++..........  .....||+.|+|||++.+.      .++.++|||||||++|||++|
T Consensus       140 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          140 KSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            99999999999999999999987655433211  2234799999999998876      445799999999999999999


Q ss_pred             ----------CCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 001867          900 ----------RLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLL  969 (1002)
Q Consensus       900 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L  969 (1002)
                                +.||.........................+.+  ..........+.+++.+||+.||++|||++|+++.|
T Consensus       220 ~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  297 (301)
T 3q4u_A          220 MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL  297 (301)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             hcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCCh--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence                      88886543333222222222211111111111  111223456788999999999999999999999999


Q ss_pred             HHh
Q 001867          970 QEV  972 (1002)
Q Consensus       970 ~~~  972 (1002)
                      +++
T Consensus       298 ~~i  300 (301)
T 3q4u_A          298 TKI  300 (301)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-40  Score=374.08  Aligned_cols=264  Identities=23%  Similarity=0.345  Sum_probs=213.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-C
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-R  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  754 (1002)
                      .++|++.+.||+|+||.||+|++      .+++.||||++....                .....+.+.+|+++++++ +
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~   84 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGH   84 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----------------CHHHHHHHHHHHHHHHhhcC
Confidence            46788999999999999999984      235789999984321                233456799999999999 7


Q ss_pred             CCceeeeeeEEecCC-eeeEEEeccCCCChhhhhhhcCC-----------------------------------------
Q 001867          755 HKNIVKLWCCCTTRD-CKLLVYEYMPNGSLGDLLHSCKG-----------------------------------------  792 (1002)
Q Consensus       755 h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------  792 (1002)
                      ||||+++++++.+.+ ..++||||+++|+|.++++....                                         
T Consensus        85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (359)
T 3vhe_A           85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS  164 (359)
T ss_dssp             CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred             CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence            999999999998755 48999999999999999986432                                         


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          793 -----------------------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       793 -----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                                             ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  241 (359)
T 3vhe_A          165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR  241 (359)
T ss_dssp             -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEecccee
Confidence                                   1289999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccCcccc
Q 001867          850 VVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHV  928 (1002)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (1002)
                      ...............||+.|+|||++.+..++.++|||||||++|||++ |+.||............+.......     
T Consensus       242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-----  316 (359)
T 3vhe_A          242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-----  316 (359)
T ss_dssp             CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-----
T ss_pred             eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-----
Confidence            7755544444455678999999999999999999999999999999998 9999976554444433332221110     


Q ss_pred             ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          929 LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       929 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                         ......+    .+.+++.+||+.||++|||++|+++.|+++....
T Consensus       317 ---~~~~~~~----~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          317 ---APDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             ---CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCH----HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence               1111222    4788999999999999999999999999987543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8e-40  Score=361.55  Aligned_cols=263  Identities=23%  Similarity=0.301  Sum_probs=204.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||+||+|+..+++.||+|++....               ........+.+|++++++++||||+++
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~hp~iv~~   84 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---------------EDEGIPSTAIREISLLKELHHPNIVSL   84 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------------------CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc---------------ccchhhHHHHHHHHHHHHcCCCCEeee
Confidence            46788899999999999999999889999999984321               123345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..++||||++ |+|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~k  159 (311)
T 3niz_A           85 IDVIHSERCLTLVFEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALK  159 (311)
T ss_dssp             EEEECCSSCEEEEEECCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             eeEEccCCEEEEEEcCCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEE
Confidence            999999999999999996 588888875 335699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++.......  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.................
T Consensus       160 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  237 (311)
T 3niz_A          160 LADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG  237 (311)
T ss_dssp             ECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHC
T ss_pred             EccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHC
Confidence            999999987654322  2334578999999999876 5689999999999999999999999986655444433332211


Q ss_pred             hccCccc----------------cccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDH----------------VLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~----------------~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      . .....                ..+... ....+....++.+++.+|++.||++|||++|+++
T Consensus       238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          238 T-PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             C-CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             C-CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1 10000                000000 0000111134778999999999999999999884

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.8e-40  Score=363.58  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=204.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++.+..              .......+.+.+|+.++++++||||++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~iv~   69 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV--------------IIAKDEVAHTVTESRVLQNTRHPFLTA   69 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHSCCCTTBCC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH--------------hhhhhHHHHHHHHHHHHHhCCCCcCcc
Confidence            357888899999999999999975 68999999985421              112234567889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++..  .+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+
T Consensus        70 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v  144 (337)
T 1o6l_A           70 LKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHI  144 (337)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             eEEEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCE
Confidence            99999999999999999999999999974  35699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.   
T Consensus       145 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~---  218 (337)
T 1o6l_A          145 KITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL---  218 (337)
T ss_dssp             EECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH---
T ss_pred             EEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-HHHHHHHH---
Confidence            999999998643322  123456799999999999999999999999999999999999999975432 22222111   


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .. ...  + |  ....    ..+.+++.+||+.||++||     +++|+++
T Consensus       219 ~~-~~~--~-p--~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          219 ME-EIR--F-P--RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HC-CCC--C-C--TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cC-CCC--C-C--CCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            11 110  0 1  1122    2477899999999999999     8999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-40  Score=367.16  Aligned_cols=263  Identities=26%  Similarity=0.415  Sum_probs=212.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      .++|++.+.||+|+||.||+|+..      +++.||||++....                .....+.+.+|+.++++++|
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h  109 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----------------SADMQADFQREAALMAEFDN  109 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----------------CHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----------------CHHHHHHHHHHHHHHHhCCC
Confidence            367888999999999999999975      34789999984321                23346779999999999999


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHH
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----------------------GGLLDWPTRYKIIVDAAEGLSY  813 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~  813 (1002)
                      |||+++++++.+.+..++||||+++|+|.+++....                      ...+++..++.++.|++.||+|
T Consensus       110 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~  189 (343)
T 1luf_A          110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY  189 (343)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999998643                      1579999999999999999999


Q ss_pred             HhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHH
Q 001867          814 LHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVI  893 (1002)
Q Consensus       814 LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil  893 (1002)
                      ||++   +|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++
T Consensus       190 LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il  266 (343)
T 1luf_A          190 LSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL  266 (343)
T ss_dssp             HHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             HHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHH
Confidence            9999   9999999999999999999999999999876544333333455688999999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          894 LELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       894 ~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      |||++ |..||.... ..+....+..    ....    +.....+    ..+.+++.+||+.||++||+++++++.|+++
T Consensus       267 ~el~t~g~~p~~~~~-~~~~~~~~~~----~~~~----~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~  333 (343)
T 1luf_A          267 WEIFSYGLQPYYGMA-HEEVIYYVRD----GNIL----ACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM  333 (343)
T ss_dssp             HHHHTTTCCTTTTSC-HHHHHHHHHT----TCCC----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             HHHHhcCCCcCCCCC-hHHHHHHHhC----CCcC----CCCCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence            99999 999996543 2222222211    1111    1111222    2478899999999999999999999999998


Q ss_pred             hhhc
Q 001867          973 GAEN  976 (1002)
Q Consensus       973 ~~~~  976 (1002)
                      ....
T Consensus       334 ~~~~  337 (343)
T 1luf_A          334 CERA  337 (343)
T ss_dssp             TC--
T ss_pred             Hhhh
Confidence            7544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.4e-40  Score=362.09  Aligned_cols=261  Identities=25%  Similarity=0.353  Sum_probs=213.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|.+.+.||+|+||.||+|...      +++.||||++...                ......+.+.+|+.++++++||
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~hp   86 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN----------------ASPSELRDLLSEFNVLKQVNHP   86 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT----------------CCHHHHHHHHHHHHHHTTCCCT
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC----------------CCHHHHHHHHHHHHHHhhCCCC
Confidence            56788899999999999999862      3578999998432                1234457789999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHH
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG----------------------GLLDWPTRYKIIVDAAEGLSYL  814 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~L  814 (1002)
                      ||+++++++.+.+..++||||+++|+|.+++.....                      ..+++..++.++.|++.||+||
T Consensus        87 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  166 (314)
T 2ivs_A           87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL  166 (314)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH
T ss_pred             ceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999986432                      3489999999999999999999


Q ss_pred             hhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          815 HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       815 H~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      |++   +|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|
T Consensus       167 H~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  243 (314)
T 2ivs_A          167 AEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW  243 (314)
T ss_dssp             HHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             HHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHH
Confidence            999   99999999999999999999999999998776544333334456788999999999888999999999999999


Q ss_pred             HHHh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          895 ELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       895 ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ||++ |+.||..... ......+......        +.....+    ..+.+++.+||+.||++||+++|+++.|+++.
T Consensus       244 el~t~g~~p~~~~~~-~~~~~~~~~~~~~--------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          244 EIVTLGGNPYPGIPP-ERLFNLLKTGHRM--------ERPDNCS----EEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             HHHTTSCCSSTTCCG-GGHHHHHHTTCCC--------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCH-HHHHHHhhcCCcC--------CCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999 9999975533 3333332221110        1112222    24788999999999999999999999999986


Q ss_pred             hh
Q 001867          974 AE  975 (1002)
Q Consensus       974 ~~  975 (1002)
                      ..
T Consensus       311 ~~  312 (314)
T 2ivs_A          311 VK  312 (314)
T ss_dssp             HT
T ss_pred             hh
Confidence            54

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.2e-40  Score=363.94  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcE----EEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEA----VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|++. +++.    ||+|.+...                ......+.+.+|+.++++++|||
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~   78 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------------TSPKANKEILDEAYVMASVDNPH   78 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------------------CHHHHHHHHHHHHHCCBTT
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc----------------cCHHHHHHHHHHHHHHHhCCCCC
Confidence            56788899999999999999964 4444    577766321                12234567999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.+.. .++|+||+++|+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        79 iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~  153 (327)
T 3poz_A           79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP  153 (327)
T ss_dssp             BCCEEEEEESSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET
T ss_pred             EeEEEEEEecCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCC
Confidence            999999998765 78999999999999999863 45699999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.... .......+
T Consensus       154 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~~  232 (327)
T 3poz_A          154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSIL  232 (327)
T ss_dssp             TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHH
T ss_pred             CCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC-HHHHHHHH
Confidence            9999999999998766554444445567889999999999999999999999999999999 999997543 33333333


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ......        +......    ..+.+++.+||+.||++||+++|+++.|+.+..
T Consensus       233 ~~~~~~--------~~~~~~~----~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          233 EKGERL--------PQPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HTTCCC--------CCCTTBC----HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HcCCCC--------CCCccCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            221111        1111222    247889999999999999999999999998864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-39  Score=361.62  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=216.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.+.||+|+||.||+|..      .+++.||||++....                .....+.+.+|+.+++++ +|
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~h   86 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----------------HLTEREALMSELKVLSYLGNH   86 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCCC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----------------hHHHHHHHHHHHHHHhhcccC
Confidence            5788889999999999999985      246789999984321                233467799999999999 89


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG----------------GLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      |||+++++++.+.+..++||||+++|+|.+++.....                ..+++..++.++.|++.||+|||++  
T Consensus        87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--  164 (313)
T 1t46_A           87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--  164 (313)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             CCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC--
Confidence            9999999999999999999999999999999986442                2589999999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+|+++|||++ 
T Consensus       165 -~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~  243 (313)
T 1t46_A          165 -NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL  243 (313)
T ss_dssp             -TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence             999999999999999999999999999987766544333444567889999999999999999999999999999999 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      |+.||...................        ......+    ..+.+++.+||+.||++|||++|+++.|+++....
T Consensus       244 g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          244 GSSPYPGMPVDSKFYKMIKEGFRM--------LSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             TCCSSTTCCSSHHHHHHHHHTCCC--------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCCCCcccchhHHHHHhccCCCC--------CCcccCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            999997665444444333322111        0111222    24788999999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-40  Score=368.14  Aligned_cols=265  Identities=23%  Similarity=0.334  Sum_probs=213.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-C
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-R  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  754 (1002)
                      .++|++.+.||+|+||.||+|...      +++.||||++....                .....+.+.+|+.+++++ +
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~  107 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----------------DSSEREALMSELKMMTQLGS  107 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------------CHHHHHHHHHHHHHCC
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----------------CHHHHHHHHHHHHHHHhhcC
Confidence            367888999999999999999962      35689999985321                223356799999999999 8


Q ss_pred             CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHH
Q 001867          755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG---------------------GLLDWPTRYKIIVDAAEGLSY  813 (1002)
Q Consensus       755 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~  813 (1002)
                      ||||+++++++...+..++||||+++|+|.+++.....                     ..+++..++.++.|++.||+|
T Consensus       108 hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  187 (344)
T 1rjb_A          108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF  187 (344)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred             CCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999986432                     248999999999999999999


Q ss_pred             HhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHH
Q 001867          814 LHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVI  893 (1002)
Q Consensus       814 LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil  893 (1002)
                      ||++   +|+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++
T Consensus       188 LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il  264 (344)
T 1rjb_A          188 LEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL  264 (344)
T ss_dssp             HHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             HHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHH
Confidence            9999   9999999999999999999999999999877655443344455678899999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          894 LELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       894 ~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      |||++ |..||............+......        +.....+    ..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       265 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          265 WEIFSLGVNPYPGIPVDANFYKLIQNGFKM--------DQPFYAT----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             HHHTTTSCCSSTTCCCSHHHHHHHHTTCCC--------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCcccCCcHHHHHHHHhcCCCC--------CCCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            99998 999997665444444433322111        1111222    2478899999999999999999999999998


Q ss_pred             hhhcc
Q 001867          973 GAENR  977 (1002)
Q Consensus       973 ~~~~~  977 (1002)
                      ....+
T Consensus       333 ~~~~~  337 (344)
T 1rjb_A          333 LADAE  337 (344)
T ss_dssp             C----
T ss_pred             HHHHH
Confidence            76543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-40  Score=363.36  Aligned_cols=251  Identities=16%  Similarity=0.221  Sum_probs=205.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..                  .....+.+.+|+.++++++||||++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~------------------~~~~~~~~~~E~~~l~~l~hpnIv~   65 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------------------KGTDQVLVKKEISILNIARHRNILH   65 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC------------------CTHHHHHHHHHHHHHHHSCCTTBCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec------------------CcccHHHHHHHHHHHHhCCCCCCCe
Confidence            467888999999999999999975 588999998842                  1234567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC--CC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG--DF  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~--~~  838 (1002)
                      +++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.  ++
T Consensus        66 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~  141 (321)
T 1tki_A           66 LHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSS  141 (321)
T ss_dssp             EEEEEEETTEEEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCC
T ss_pred             EeEEEecCCEEEEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCC
Confidence            99999999999999999999999999975 335699999999999999999999999   9999999999999987  78


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++||||+||++|+|++|..||............ ..
T Consensus       142 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~~  217 (321)
T 1tki_A          142 TIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-MN  217 (321)
T ss_dssp             CEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HH
T ss_pred             CEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-Hc
Confidence            99999999998775432   234557999999999999888999999999999999999999999765332222221 11


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    .. ...+......    .++.+++.+|++.||++|||++|+++
T Consensus       218 ~~----~~-~~~~~~~~~s----~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          218 AE----YT-FDEEAFKEIS----IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TC----CC-CCHHHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC----CC-CChhhhccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11    00 0000111222    24788999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.7e-40  Score=357.63  Aligned_cols=262  Identities=29%  Similarity=0.401  Sum_probs=199.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|+..  ..||||++...               .......+.+.+|+.++++++||||++++
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVT---------------APTPQQLQAFKNEVGVLRKTRHVNILLFM   86 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCS---------------SCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEc--CceEEEEEecc---------------CCCHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence            57888999999999999999864  46999998432               12344567899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      ++. ..+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl  161 (289)
T 3og7_A           87 GYS-TAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKI  161 (289)
T ss_dssp             EEE-CSSSCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEE
T ss_pred             eec-cCCccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEE
Confidence            965 45568999999999999999975 345699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +|||+++...............||+.|+|||++.   +..++.++||||+|+++|||++|+.||............+...
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  241 (289)
T 3og7_A          162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG  241 (289)
T ss_dssp             CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT
T ss_pred             ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc
Confidence            9999998765433333344567999999999986   5678889999999999999999999997665544444443322


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .....    +.......+    ..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       242 ~~~~~----~~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 SLSPD----LSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCCCC----TTSSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccCcc----hhhccccCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            21111    111112222    348889999999999999999999999998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-39  Score=352.75  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=206.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|++. ++.||||++...               .......+.+.+|+.++++++||||++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   73 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVR---------------DWSTRKSRDFNEECPRLRIFSHPNVLPVL   73 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCT---------------TCCHHHHHHHHHHGGGGCCCSCTTEECEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccc---------------ccCHHHHHHHHHHHHHHHhcCCCchhheE
Confidence            56788899999999999999985 889999998542               11334556799999999999999999999


Q ss_pred             eEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEECCCC
Q 001867          763 CCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       763 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~~NIll~~~~  838 (1002)
                      +++.+.  +..++||||+++|+|.+++.......+++..++.++.|++.||+|||++   +  |+||||||+||+++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~  150 (271)
T 3kmu_A           74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDM  150 (271)
T ss_dssp             EEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTS
T ss_pred             EEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCc
Confidence            999887  7889999999999999999876555799999999999999999999998   7  99999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCC---ccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNE---KSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .++++|||++......       ...||+.|+|||++.+..++.   ++||||+|+++|||++|+.||............
T Consensus       151 ~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  223 (271)
T 3kmu_A          151 TARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV  223 (271)
T ss_dssp             CEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred             ceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence            9999999887643322       346899999999988765544   899999999999999999999754322221211


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ..    .. ....+   ....+.    .+.+++.+||+.||++|||++|+++.|+++..
T Consensus       224 ~~----~~-~~~~~---~~~~~~----~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          224 AL----EG-LRPTI---PPGISP----HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HH----SC-CCCCC---CTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             Hh----cC-CCCCC---CCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11    11 11111   112222    47889999999999999999999999998853

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=365.55  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=203.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++.+..              .......+.+.+|+.++++++|||||+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~--------------~~~~~~~~~~~~E~~il~~l~hp~Iv~   79 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK--------------CVERNEVRNVFKELQIMQGLEHPFLVN   79 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh--------------cccHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            356788899999999999999965 58899999985421              112334567889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~v  154 (384)
T 4fr4_A           80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHV  154 (384)
T ss_dssp             EEEEEECSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEEeCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCE
Confidence            99999999999999999999999999984  45799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT---LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      ||+|||+++......   .....+||+.|+|||++.+   ..++.++||||+||++|||++|+.||....... ......
T Consensus       155 kL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~  230 (384)
T 4fr4_A          155 HITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVH  230 (384)
T ss_dssp             EECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHH
T ss_pred             EEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHH
Confidence            999999998765432   2345679999999999864   458999999999999999999999997543222 111111


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-MRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~evl~  967 (1002)
                      ..... ..     +......    ..+.+++.+||+.||++||+ ++++.+
T Consensus       231 ~~~~~-~~-----~~p~~~s----~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          231 TFETT-VV-----TYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHC-CC-----CCCTTSC----HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHhhc-cc-----CCCCcCC----HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11111 00     0001122    24788999999999999998 777664

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.7e-40  Score=361.01  Aligned_cols=264  Identities=28%  Similarity=0.391  Sum_probs=203.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|++     .+++.||||++...                 .....+.+.+|+.++++++|||
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~   72 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------------TEEHLRDFEREIEILKSLQHDN   72 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence            5678889999999999999984     35889999998432                 3345577999999999999999


Q ss_pred             eeeeeeEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++..  ....++||||+++|+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus        73 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~  148 (295)
T 3ugc_A           73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVE  148 (295)
T ss_dssp             BCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEc
Confidence            9999999965  35689999999999999999863 34599999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----
Q 001867          836 GDFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-----  909 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~-----  909 (1002)
                      .++.+||+|||+++........ .......++..|+|||++.+..++.++||||+|+++|||++|..|+......     
T Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~  228 (295)
T 3ugc_A          149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI  228 (295)
T ss_dssp             ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHH
T ss_pred             CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhh
Confidence            9999999999999877544322 1223445778899999999999999999999999999999999998542110     


Q ss_pred             ------hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          910 ------KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       910 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                            ...............    ..+.....+    ..+.+++.+||+.||++|||++|+++.|+++...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          229 GNDKQGQMIVFHLIELLKNNG----RLPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             CTTCCTHHHHHHHHHHHHTTC----CCCCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCccccchhHHHHHHHHhccC----cCCCCcCcC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                  000001111111110    011112223    3488899999999999999999999999998654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4e-40  Score=383.47  Aligned_cols=256  Identities=26%  Similarity=0.476  Sum_probs=209.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|.++++..||||++...                  ....+.+.+|+.++++++||||++++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~iv~l~  249 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------------------SMSVEAFLAEANVMKTLQHDKLVKLH  249 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT------------------SBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC------------------CccHHHHHHHHHHHhhCCCCCEeeEE
Confidence            457778899999999999999988899999998432                  12356799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++. .+..|+||||+++|+|.++++......+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||
T Consensus       250 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl  325 (454)
T 1qcf_A          250 AVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI  325 (454)
T ss_dssp             EEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEE
T ss_pred             EEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEE
Confidence            9987 56789999999999999999865445689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++....... .......+|+.|+|||++....++.++|||||||++|||++ |+.||.... ..+....+.....
T Consensus       326 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~  403 (454)
T 1qcf_A          326 ADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYR  403 (454)
T ss_dssp             CSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHHTCC
T ss_pred             eeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCC
Confidence            99999987643211 11123346788999999999999999999999999999999 999996542 2333333222111


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                              .+....++.    .+.+++.+||+.||++|||+++|++.|+++..
T Consensus       404 --------~~~~~~~~~----~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 --------MPRPENCPE----ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             --------CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             --------CCCCCCCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                    111122333    48889999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=372.71  Aligned_cols=255  Identities=20%  Similarity=0.256  Sum_probs=205.9

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|.. .+|+.||+|++....               ......+.+.+|+.++++++||||+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~---------------~~~~~~~~~~~E~~il~~l~hpnIv   73 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK---------------LSARDHQKLEREARICRLLKHPNIV   73 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS---------------CHHHHHHHHHHHHHHHHHCCBTTBC
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc---------------CCHHHHHHHHHHHHHHHhCCCcCCC
Confidence            356788899999999999999986 468999999985421               1234466789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC---C
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---G  836 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~---~  836 (1002)
                      ++++++.+++..|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||+++   .
T Consensus        74 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~  148 (444)
T 3soa_A           74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLK  148 (444)
T ss_dssp             CEEEEEECSSEEEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSST
T ss_pred             eEEEEEEECCEEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCC
Confidence            999999999999999999999999999885  35699999999999999999999999   999999999999998   4


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ++.+||+|||+++.......  ......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ......+
T Consensus       149 ~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~~~i  225 (444)
T 3soa_A          149 GAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQI  225 (444)
T ss_dssp             TCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHH
T ss_pred             CCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHHHHH
Confidence            67899999999987654322  22345799999999999999999999999999999999999999976532 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....    . ....+......+    .+.+++.+|++.||++|||++|+++
T Consensus       226 ~~~~----~-~~~~~~~~~~s~----~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          226 KAGA----Y-DFPSPEWDTVTP----EAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHTC----C-CCCTTTTTTSCH----HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCC----C-CCCccccccCCH----HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111    1 111122223333    4778999999999999999999986

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.6e-39  Score=377.36  Aligned_cols=361  Identities=19%  Similarity=0.179  Sum_probs=192.2

Q ss_pred             CccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCccccccc
Q 001867           86 PSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQ  165 (1002)
Q Consensus        86 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~  165 (1002)
                      +..++++++|++|+|++|.+++. | .|..+++|++|+|++|+|++. |  ++.+++|++|+|++|++++. |  |++++
T Consensus        35 ~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~  106 (457)
T 3bz5_A           35 TISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLT  106 (457)
T ss_dssp             EEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCT
T ss_pred             ccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCC
Confidence            34556666666777766666653 3 566666666666666666653 2  66666666666666666643 2  66666


Q ss_pred             ccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcc
Q 001867          166 KLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDL  245 (1002)
Q Consensus       166 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  245 (1002)
                      +|++|++++|++++. |  ++++++|++|++++|++..  ++  ++++++|++|++++|+..+.+  .++.+++|++|++
T Consensus       107 ~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~--l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l  177 (457)
T 3bz5_A          107 KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE--ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC  177 (457)
T ss_dssp             TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC--CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred             cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce--ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence            666666666666643 2  5666666666666666521  22  555666666666666433333  3555556666666


Q ss_pred             cCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcC
Q 001867          246 ALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSL  325 (1002)
Q Consensus       246 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~  325 (1002)
                      ++|++++. |  +..+++|+.|++++|++++.   .+..+++|+.|++++|++++ +|                      
T Consensus       178 s~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip----------------------  228 (457)
T 3bz5_A          178 SFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID----------------------  228 (457)
T ss_dssp             CSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC----------------------
T ss_pred             CCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC----------------------
Confidence            66665542 2  45555555555555555543   24555555555555555554 22                      


Q ss_pred             CcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCC
Q 001867          326 PATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQ  405 (1002)
Q Consensus       326 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~  405 (1002)
                         +..+++|++|++++|++++..   +..+++|+.|++++|+              |+.|++++|.+.+.+|  ++.++
T Consensus       229 ---~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~  286 (457)
T 3bz5_A          229 ---VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCR  286 (457)
T ss_dssp             ---CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCT
T ss_pred             ---ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccc
Confidence               233333333444444433322   1223334444444332              2234444444444333  23445


Q ss_pred             CCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccccccc
Q 001867          406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGS  485 (1002)
Q Consensus       406 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  485 (1002)
                      +|+.|++++|+..+.+|.   ..++|+.|++++|             ++|+.|++++|++++. +  ++.+++|+.|+++
T Consensus       287 ~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~  347 (457)
T 3bz5_A          287 KIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCV  347 (457)
T ss_dssp             TCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECC
T ss_pred             cCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECC
Confidence            555555555554444442   2233333333332             4555566666666542 2  5556666666666


Q ss_pred             ccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCcc
Q 001867          486 ENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIG  546 (1002)
Q Consensus       486 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~  546 (1002)
                      +|++++        ++.|..|++++|.++|.     +.+..|+.++|++|+++|.||..+.
T Consensus       348 ~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          348 NAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             SSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred             CCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence            666653        13445556666666654     3445566666666666666665543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=356.06  Aligned_cols=269  Identities=22%  Similarity=0.271  Sum_probs=212.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|.+.+.||+|+||.||+|... +++.||||++....                .....+.+.+|++++++++||||+++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~   72 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------------FLRPVDVQMREFEVLKKLNHKNIVKL   72 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------------GGSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc----------------ccchHHHHHHHHHHHHhcCCCCcceE
Confidence            46788899999999999999975 48999999984321                12235667899999999999999999


Q ss_pred             eeEEecCC--eeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----
Q 001867          762 WCCCTTRD--CKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL----  834 (1002)
Q Consensus       762 ~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll----  834 (1002)
                      ++++....  ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++   +|+||||||+||++    
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  149 (319)
T 4euu_A           73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGE  149 (319)
T ss_dssp             EEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECT
T ss_pred             EEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccC
Confidence            99998655  77999999999999999986433 3499999999999999999999999   99999999999999    


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCccccc--------cCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY--------TLRVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      +.++.+||+|||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          150 DGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             TSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             CCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7778899999999987755432   22456999999999876        567899999999999999999999999755


Q ss_pred             CCchhHHHHHHHHhhccCc---ccc---------cc---ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGV---DHV---------LD---PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~---~~~---------~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      .........+.........   ...         ..   +............+.+++.+|++.||++|||++|+++...+
T Consensus       227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             TCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            4433333333222221110   000         00   11123345566678899999999999999999999999887


Q ss_pred             hh
Q 001867          972 VG  973 (1002)
Q Consensus       972 ~~  973 (1002)
                      ..
T Consensus       307 ~~  308 (319)
T 4euu_A          307 IL  308 (319)
T ss_dssp             HT
T ss_pred             Hh
Confidence            54

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=7.2e-40  Score=380.23  Aligned_cols=358  Identities=20%  Similarity=0.174  Sum_probs=175.6

Q ss_pred             CCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccc
Q 001867          109 LPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNI  188 (1002)
Q Consensus       109 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  188 (1002)
                      .+..++.+++|++|+|++|.+++. | .++.+++|++|+|++|++++. |  ++.+++|++|+|++|++++. +  ++++
T Consensus        34 ~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l  105 (457)
T 3bz5_A           34 DTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPL  105 (457)
T ss_dssp             SEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred             cccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCC
Confidence            333444455555555555555432 2 344455555555555554432 2  44444444444444444432 1  4444


Q ss_pred             cccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeee
Q 001867          189 STLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIE  268 (1002)
Q Consensus       189 ~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  268 (1002)
                                               ++|++|++++|++++ +|  ++.+++|++|++++|++++.   .+..+++|+.|+
T Consensus       106 -------------------------~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~  154 (457)
T 3bz5_A          106 -------------------------TKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELD  154 (457)
T ss_dssp             -------------------------TTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEE
T ss_pred             -------------------------CcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEE
Confidence                                     444444444444443 22  44445555555555555442   144445555555


Q ss_pred             ccCCcccCCCCCccccccccceeeccccccCCCCCccCCCC-CcceeecCCCcccCcCCcccCCCcccchhcccccccCC
Q 001867          269 LYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNG  347 (1002)
Q Consensus       269 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (1002)
                      +++|+..+.+  .+..+++|+.|++++|++++ +|  +..+ .|+.|++++|++++.   .+..+++|++|++++|++++
T Consensus       155 l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          155 CHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             CTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred             CCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence            5555333333  24555566666666666554 22  2222 144444444444432   14444455555555555554


Q ss_pred             CCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCC
Q 001867          348 TLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWG  427 (1002)
Q Consensus       348 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  427 (1002)
                       +|  +..+++|+.|++++|+++                        +..   ++.+++|+.|++++|++          
T Consensus       227 -ip--~~~l~~L~~L~l~~N~l~------------------------~~~---~~~l~~L~~L~l~~n~L----------  266 (457)
T 3bz5_A          227 -ID--VTPLTQLTYFDCSVNPLT------------------------ELD---VSTLSKLTTLHCIQTDL----------  266 (457)
T ss_dssp             -CC--CTTCTTCSEEECCSSCCS------------------------CCC---CTTCTTCCEEECTTCCC----------
T ss_pred             -cC--ccccCCCCEEEeeCCcCC------------------------CcC---HHHCCCCCEEeccCCCC----------
Confidence             22  444455555555555554                        322   23445555555555433          


Q ss_pred             CCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeee
Q 001867          428 LPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLD  507 (1002)
Q Consensus       428 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  507 (1002)
                          +.|++++|.+.+.+|  ++.+++|+.|++++|.+.+.+|.   ...+|+.|++++|             ++|+.|+
T Consensus       267 ----~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~  324 (457)
T 3bz5_A          267 ----LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLY  324 (457)
T ss_dssp             ----SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEE
T ss_pred             ----CEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEE
Confidence                234555555554444  34556666666666665555553   2344444444433             4556666


Q ss_pred             cCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcC
Q 001867          508 LHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSG  586 (1002)
Q Consensus       508 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g  586 (1002)
                      |++|+|++. |  ++.+++|+.|++++|+|++        ++.|..|++++|+++|.     ..+ .+..+++++|+|+|
T Consensus       325 L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g  388 (457)
T 3bz5_A          325 LNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTI  388 (457)
T ss_dssp             CTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEE
T ss_pred             CCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEE
Confidence            666666653 2  5566666666666666653        23445555666666654     122 45566666666666


Q ss_pred             CCChh
Q 001867          587 ELPSL  591 (1002)
Q Consensus       587 ~~p~~  591 (1002)
                      .||..
T Consensus       389 ~ip~~  393 (457)
T 3bz5_A          389 AVSPD  393 (457)
T ss_dssp             ECCTT
T ss_pred             EcChh
Confidence            66643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.5e-40  Score=356.25  Aligned_cols=258  Identities=23%  Similarity=0.350  Sum_probs=207.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|.+.++..||+|++...                  ....+++.+|++++++++||||+++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~   84 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------------SMSEDEFIEEAKVMMNLSHEKLVQL   84 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT------------------SBCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC------------------CCCHHHHHHHHHHHhcCCCCCEeeE
Confidence            3578888999999999999999988889999998532                  1124568999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~k  160 (283)
T 3gen_A           85 YGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVK  160 (283)
T ss_dssp             EEEECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEE
Confidence            99999999999999999999999999753 34699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+....+....
T Consensus       161 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-~~~~~~~~~~~  238 (283)
T 3gen_A          161 VSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL  238 (283)
T ss_dssp             ECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHTTC
T ss_pred             Ecccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-hHHHHHHhccc
Confidence            999999986643321 11223456788999999998999999999999999999998 9999975432 22222221111


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      .     .   .......    ..+.+++.+||+.||++|||++|+++.|+++..+
T Consensus       239 ~-----~---~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 R-----L---YRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             C-----C---CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----C---CCCCcCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            0     0   0011112    2478899999999999999999999999988643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.9e-39  Score=357.58  Aligned_cols=247  Identities=22%  Similarity=0.299  Sum_probs=201.5

Q ss_pred             CCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      |+..+.||+|+||.||+|+.. +|+.||||++...                 .....+.+.+|+.++++++||||+++++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~niv~~~~  109 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-----------------KQQRRELLFNEVVIMRDYQHFNVVEMYK  109 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-----------------TCCSHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-----------------chhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            555678999999999999975 6999999998432                 1223566889999999999999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEc
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA  843 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  843 (1002)
                      ++...+..++||||+++++|.+++..   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       110 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~  183 (321)
T 2c30_A          110 SYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLS  183 (321)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEe
Confidence            99999999999999999999999863   4699999999999999999999999   99999999999999999999999


Q ss_pred             cccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       844 DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +....+..    .
T Consensus       184 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-~~~~~~~~----~  256 (321)
T 2c30_A          184 DFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLRD----S  256 (321)
T ss_dssp             CCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHH----S
T ss_pred             eeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc----C
Confidence            9999987654322  223457999999999999999999999999999999999999999754322 22221111    1


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......  ......    ..+.+++.+||+.||++|||++|+++
T Consensus       257 ~~~~~~--~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          257 PPPKLK--NSHKVS----PVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             SCCCCT--TGGGSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcC--ccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111000  001122    24778999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.5e-39  Score=364.85  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=205.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....               ......+.+.+|+.++++++||||++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------------~~~~~~~~~~~E~~il~~l~hpnIv~   92 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---------------LSARDFQKLEREARICRKLQHPNIVR   92 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---------------CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc---------------CCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            467888999999999999999974 58999999985421               12334567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC--
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF--  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~--  838 (1002)
                      +++++.+.+..|+||||+++|+|.+++..  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++  
T Consensus        93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~  167 (362)
T 2bdw_A           93 LHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG  167 (362)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTT
T ss_pred             EEEEEEeCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCC
Confidence            99999999999999999999999999874  45699999999999999999999999   999999999999998654  


Q ss_pred             -CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          839 -GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 -~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                       .+||+|||++........   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+.
T Consensus       168 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~  243 (362)
T 2bdw_A          168 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIK  243 (362)
T ss_dssp             CCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH
T ss_pred             CCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHH
Confidence             599999999987654322   2345799999999999999999999999999999999999999975432 22222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ..    ... ...+......+    .+.+++.+||+.||++||+++|+++.
T Consensus       244 ~~----~~~-~~~~~~~~~~~----~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          244 AG----AYD-YPSPEWDTVTP----EAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HT----CCC-CCTTGGGGSCH----HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hC----CCC-CCcccccCCCH----HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11    111 11111122232    47789999999999999999998753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=359.75  Aligned_cols=258  Identities=23%  Similarity=0.307  Sum_probs=206.8

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.+.|++.+.||+|+||.||+|... +++.||+|++.......           .......+.+.+|+.++++++||||+
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~hp~iv   77 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS-----------SRRGVSREDIEREVSILKEIQHPNVI   77 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTT-----------CSSSBCHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccc-----------ccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            3456888899999999999999975 58999999986542210           01122356799999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-  838 (1002)
                      ++++++.+.+..++||||+++|+|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++ 
T Consensus        78 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~  152 (326)
T 2y0a_A           78 TLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNV  152 (326)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSS
T ss_pred             cEEEEEEeCCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCC
Confidence            999999999999999999999999999974  45799999999999999999999999   999999999999999887 


Q ss_pred             ---CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          839 ---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       839 ---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                         .+||+|||+++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||........... 
T Consensus       153 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-  228 (326)
T 2y0a_A          153 PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-  228 (326)
T ss_dssp             SSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-
T ss_pred             CCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-
Confidence               799999999987754322   2345799999999999999999999999999999999999999975532222211 


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +...    ... ..++......    ..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~----~~~-~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 VSAV----NYE-FEDEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHT----CCC-CCHHHHTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhc----CCC-cCccccccCC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111    000 0001111222    24778999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4e-39  Score=354.14  Aligned_cols=275  Identities=17%  Similarity=0.175  Sum_probs=217.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...                   ...+.+.+|+.+++++ +|++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~e~~~~~~l~~~~~i~   69 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------------SDAPQLRDEYRTYKLLAGCTGIP   69 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------------TTSCCHHHHHHHHHHTTTCTTCC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-------------------CccHHHHHHHHHHHHHhcCCCCC
Confidence            35688899999999999999996 56899999988432                   1234588899999999 799999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++......++||||+ +++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        70 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~  144 (298)
T 1csn_A           70 NVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNS  144 (298)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSS
T ss_pred             eEEeecCCCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCC
Confidence            9999999999999999999 99999999863 45699999999999999999999999   9999999999999987776


Q ss_pred             -----eEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          840 -----ARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       840 -----~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                           +||+|||+++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  224 (298)
T 1csn_A          145 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  224 (298)
T ss_dssp             TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence                 999999999877654322     1234557999999999999999999999999999999999999999764332


Q ss_pred             hh--HHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCCCCCC
Q 001867          910 KD--LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKL  987 (1002)
Q Consensus       910 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~~  987 (1002)
                      ..  ....+...........    .....+    ..+.+++.+||+.||++||++++|++.|+++.....      ....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~----~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~------~~~~  290 (298)
T 1csn_A          225 TNKQKYERIGEKKQSTPLRE----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN------TTED  290 (298)
T ss_dssp             CHHHHHHHHHHHHHHSCHHH----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT------CCSC
T ss_pred             ccHHHHHHHHhhccCccHHH----HHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC------CCCC
Confidence            22  1111111111111111    011222    247889999999999999999999999999976432      2345


Q ss_pred             Ccchhhc
Q 001867          988 SPYYHED  994 (1002)
Q Consensus       988 ~~~~~~~  994 (1002)
                      .|+.|+.
T Consensus       291 ~~~dw~~  297 (298)
T 1csn_A          291 ENFDWNL  297 (298)
T ss_dssp             SCCGGGC
T ss_pred             CccccCC
Confidence            6677753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.4e-40  Score=366.13  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=215.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC-C-----cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-C
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN-G-----EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-R  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  754 (1002)
                      .++|++.+.||+|+||.||+|.... +     ..||+|++....                .....+.+.+|+.+++++ +
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~  108 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----------------HADEKEALMSELKIMSHLGQ  108 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----------------ChHHHHHHHHHHHHHHhhcC
Confidence            3678889999999999999999642 2     479999984321                233467799999999999 8


Q ss_pred             CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 001867          755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSI  822 (1002)
Q Consensus       755 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  822 (1002)
                      ||||+++++++.+.+..++||||+++|+|.+++....            ...+++..++.++.|++.||+|||++   +|
T Consensus       109 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i  185 (333)
T 2i1m_A          109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NC  185 (333)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             CCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---Cc
Confidence            9999999999999999999999999999999987542            34689999999999999999999999   99


Q ss_pred             eeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCC
Q 001867          823 VHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRL  901 (1002)
Q Consensus       823 iHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~  901 (1002)
                      +||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..
T Consensus       186 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  265 (333)
T 2i1m_A          186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN  265 (333)
T ss_dssp             ECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999987655443333344567889999999999999999999999999999999 889


Q ss_pred             CCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          902 PVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       902 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ||....................        .....+    ..+.+++.+||+.||++|||++|+++.|+++....
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          266 PYPGILVNSKFYKLVKDGYQMA--------QPAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             SSTTCCSSHHHHHHHHHTCCCC--------CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCcccchhHHHHHHHhcCCCCC--------CCCCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            9976554444444333221110        111122    24788999999999999999999999999886543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.9e-39  Score=359.66  Aligned_cols=263  Identities=22%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-Cc---EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-GE---AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.... ++   .||||++...               .......+.+.+|++++++++||||
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~i   87 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD---------------IIASSDIEEFLREAACMKEFDHPHV   87 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------------------CHHHHHHHHHHHHHTTCCCTTB
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc---------------ccCHHHHHHHHHHHHHHHHCCCCce
Confidence            578889999999999999999653 32   7999998432               1123446789999999999999999


Q ss_pred             eeeeeEEecCCee------eEEEeccCCCChhhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 001867          759 VKLWCCCTTRDCK------LLVYEYMPNGSLGDLLHSCKG----GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK  828 (1002)
Q Consensus       759 v~l~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk  828 (1002)
                      +++++++...+..      ++||||+++|+|.+++.....    ..+++..++.++.|++.||+|||++   +|+|||||
T Consensus        88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dik  164 (323)
T 3qup_A           88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLA  164 (323)
T ss_dssp             CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCC
Confidence            9999999877655      999999999999999865332    2599999999999999999999999   99999999


Q ss_pred             CCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 001867          829 SNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF  907 (1002)
Q Consensus       829 ~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~  907 (1002)
                      |+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |+.||....
T Consensus       165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999999987765544444445567889999999999999999999999999999999 899987654


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      .. +....+......        +.....+    ..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       245 ~~-~~~~~~~~~~~~--------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          245 NA-EIYNYLIGGNRL--------KQPPECM----EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             GG-GHHHHHHTTCCC--------CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hH-HHHHHHhcCCCC--------CCCCccC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            33 322222211110        1111222    34888999999999999999999999999987543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.6e-39  Score=355.25  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=200.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|+..+++.||+|++....               .+....+.+.+|+.++++++||||++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~   66 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------------EDEGIPSTTIREISILKELKHSNIVKLY   66 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc---------------cccccchhHHHHHHHHHhcCCCCEeeee
Confidence            5688889999999999999999889999999984321               1122345688999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..++||||++ ++|.+++... .+.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        67 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  141 (288)
T 1ob3_A           67 DVIHTKKRLVLVFEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKI  141 (288)
T ss_dssp             EEEECSSCEEEEEECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             eEEccCCeEEEEEEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            99999999999999996 5999998753 35699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++.......  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..................
T Consensus       142 ~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  219 (288)
T 1ob3_A          142 ADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT  219 (288)
T ss_dssp             CCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             eECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCC
Confidence            99999987653321  22345689999999998764 5899999999999999999999999765433333332221110


Q ss_pred             cc--Ccc-----ccccccc--------cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QK--GVD-----HVLDPKL--------DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~--~~~-----~~~~~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..  ...     ...++..        ..........+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00  000     0000000        0000111234778999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=357.28  Aligned_cols=248  Identities=26%  Similarity=0.335  Sum_probs=204.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++.+..              .......+.+.+|+.+++.++||||++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~Iv~   70 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--------------VVRLKQVEHTNDERLMLSIVTHPFIIR   70 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHSCCBTTBCC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhhhhHHHHHHHHHHHHhhCCCCCCce
Confidence            356888899999999999999975 68999999985431              112234567889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~  145 (318)
T 1fot_A           71 MWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHI  145 (318)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCE
T ss_pred             EeEEEEeCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCE
Confidence            99999999999999999999999999985  35699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++.....     ....+||+.|+|||++.+..++.++||||+||++|||++|+.||........+.....   
T Consensus       146 kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---  217 (318)
T 1fot_A          146 KITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---  217 (318)
T ss_dssp             EECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---
T ss_pred             EEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence            99999999876432     2245799999999999999999999999999999999999999976533222222211   


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                       . ...  +.   ....    .++.+++.+|++.||++||     +++|+++
T Consensus       218 -~-~~~--~p---~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          218 -A-ELR--FP---PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -C-CCC--CC---TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -C-CCC--CC---CCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence             1 110  00   1122    2477899999999999999     8888884

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.8e-40  Score=370.81  Aligned_cols=278  Identities=14%  Similarity=0.188  Sum_probs=211.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|++.+.||+|+||.||+|.+.+      ++.||||++.......      ..............+..|+..++.++||
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~e~~~~~~~~~~~~~~e~~~~~~l~h~  108 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL------FTELKFYQRAAKPEQIQKWIRTRKLKYL  108 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHH------HHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhH------HHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence            478889999999999999999754      4789999985431100      0000111122233455677788888999


Q ss_pred             ceeeeeeEEecC----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          757 NIVKLWCCCTTR----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       757 niv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      ||+++++++...    ...|+||||+ +++|.+++.. ..+.+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni  183 (364)
T 3op5_A          109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL  183 (364)
T ss_dssp             CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence            999999999764    4589999999 9999999986 346799999999999999999999999   999999999999


Q ss_pred             EEC--CCCCeEEccccCcccccCCCCCc-----ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          833 LLD--GDFGARVADFGVAKVVDASGKPK-----SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       833 ll~--~~~~~kl~DfGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      +++  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            998  88999999999998765432211     11344599999999999999999999999999999999999999986


Q ss_pred             CCCchhHHHHHHHHhhccCccccccccc--cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          906 EFGEKDLVKWVCSTLDQKGVDHVLDPKL--DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ................. .....+++.+  ...+.    ++.+++..||+.||++||+++++++.|+++....
T Consensus       264 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          264 NLKDPKYVRDSKIRYRE-NIASLMDKCFPAANAPG----EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             GTTCHHHHHHHHHHHHH-CHHHHHHHHSCTTCCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccCHHHHHHHHHHhhh-hHHHHHHHhcccccCHH----HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            54444444433332221 2222222222  12222    4788999999999999999999999999987644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.8e-39  Score=374.47  Aligned_cols=251  Identities=29%  Similarity=0.400  Sum_probs=206.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|.+. ++.||||+++..                   ...+.+.+|+.++++++||||++++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~~~  252 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------------ATAQAFLAEASVMTQLRHSNLVQLL  252 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC-------------------TTSHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc-------------------hHHHHHHHHHHHHHhccCCCEEEEE
Confidence            56778899999999999999986 789999998431                   1345789999999999999999999


Q ss_pred             eEEecCC-eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          763 CCCTTRD-CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       763 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      +++...+ ..|+||||+++|+|.++++......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       253 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~k  329 (450)
T 1k9a_A          253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK  329 (450)
T ss_dssp             EEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEE
T ss_pred             EEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEE
Confidence            9987665 789999999999999999876556689999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++......     ....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+....
T Consensus       330 l~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~~~  403 (450)
T 1k9a_A          330 VSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGY  403 (450)
T ss_dssp             ECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-TTHHHHHHTTC
T ss_pred             EeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC
Confidence            99999998543321     12357889999999999999999999999999999998 9999975433 33333332211


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ..        +....+++    .+.+++.+||+.||++|||++++++.|+++..
T Consensus       404 ~~--------~~p~~~~~----~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          404 KM--------DAPDGCPP----AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC--------CCCCcCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            10        11122333    47889999999999999999999999998864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.8e-39  Score=353.12  Aligned_cols=263  Identities=22%  Similarity=0.301  Sum_probs=204.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|... +++.||+|++....               ......+.+.+|+.++++++||||+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~   66 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------DDEGVPSSALREICLLKELKHKNIVRL   66 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------------SSTTHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC---------------CcCCcchHHHHHHHHHhcCCCCCEeeE
Confidence            56888899999999999999974 58999999985421               123345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..++||||++ |++.+++.. ..+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~k  141 (292)
T 3o0g_A           67 HDVLHSDKKLTLVFEFCD-QDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             EEEEEETTEEEEEEECCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             EeEEEeCCEEEEEEecCC-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            999999999999999996 566666654 346799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++.......  ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||....+..+....+....
T Consensus       142 l~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~  219 (292)
T 3o0g_A          142 LANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_dssp             ECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred             EeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            999999987654322  233457899999999987765 79999999999999999999999765555444443333222


Q ss_pred             hccCccc------ccc----------ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDH------VLD----------PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~------~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .......      ..+          .......+.....+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            1110000      000          0000111112234778999999999999999998873

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-39  Score=383.53  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=212.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|.++. +..||||++...                  ....+.|.+|+.++++++||||+++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~l  281 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------TMEVEEFLKEAAVMKEIKHPNLVQL  281 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS------------------SSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc------------------ccchHHHHHHHHHHHhcCCCCEeeE
Confidence            457778899999999999999764 889999998432                  1235679999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||+++|+|.++++......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~k  358 (495)
T 1opk_A          282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVK  358 (495)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred             EEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEE
Confidence            99999999999999999999999999876667799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..+.+....
T Consensus       359 l~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~  436 (495)
T 1opk_A          359 VADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDY  436 (495)
T ss_dssp             ECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHHHTTC
T ss_pred             EeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCC
Confidence            999999987654321 12223456789999999998899999999999999999999 888886543 333333332211


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ..        +....++.    .+.+++.+||+.||++|||++++++.|+++.
T Consensus       437 ~~--------~~~~~~~~----~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 RM--------ERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CC--------CCCCCCCH----HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            11        11122232    4788999999999999999999999999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-39  Score=362.87  Aligned_cols=249  Identities=25%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++.+...              ........+.+|+.+++.++||||++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~hpnIv~   73 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--------------KKSDMHMRVEREISYLKLLRHPHIIK   73 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--------------HHTTCSHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--------------cchhHHHHHHHHHHHHHhCCCCCCCe
Confidence            35788899999999999999996 5689999999854211              11222456899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+ +|+|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        74 l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~  147 (336)
T 3h4j_B           74 LYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNV  147 (336)
T ss_dssp             EEEEEECSSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCE
T ss_pred             EEEEEEeCCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCE
Confidence            999999999999999999 78999988753  5699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++........   ....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.........       
T Consensus       148 kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------  217 (336)
T 3h4j_B          148 KIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------  217 (336)
T ss_dssp             EECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------
T ss_pred             EEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------
Confidence            9999999987654322   234579999999999988776 68999999999999999999999754321110       


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         ...............    ..+.+++.+||+.||.+|||++|+++
T Consensus       218 ---~~i~~~~~~~p~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 ---KKVNSCVYVMPDFLS----PGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---CCCCSSCCCCCTTSC----HHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---HHHHcCCCCCcccCC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               000000001111122    24778999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-39  Score=378.67  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=204.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|.++++..||||++...                  ....+.+.+|+.++++++||||++++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hp~iv~~~  245 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY  245 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC------------------CCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence            457778899999999999999988888999998432                  11246789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+ +..++||||+++|+|.++++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus       246 ~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl  321 (452)
T 1fmk_A          246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  321 (452)
T ss_dssp             EEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEE
Confidence            99876 6789999999999999999865556799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+.....
T Consensus       322 ~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~  399 (452)
T 1fmk_A          322 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYR  399 (452)
T ss_dssp             CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCC
T ss_pred             CCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCC
Confidence            99999987654322 12223457789999999999999999999999999999999 899986543 2233322221111


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                              .+....++    ..+.+++.+||+.||++|||++++++.|+++..
T Consensus       400 --------~~~~~~~~----~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 --------MPCPPECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             --------CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --------CCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                    01112233    247889999999999999999999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=9.6e-40  Score=366.10  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=200.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.++||+|+||.||+|+.+ +++.||||++.+..              .......+.+.+|..+++.+ +||||+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~--------------~~~~~~~~~~~~E~~il~~~~~hp~Iv   87 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV--------------ILQDDDVECTMTEKRILSLARNHPFLT   87 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--------------HHHHTTHHHHHHHHHHHHHTTTCTTBC
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH--------------hcchhHHHHHHHHHHHHHhccCCCcee
Confidence            578899999999999999999975 58999999985421              11233456788999999988 699999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus        88 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~  162 (353)
T 3txo_A           88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGH  162 (353)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             eEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCC
Confidence            9999999999999999999999999999753  5699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.  
T Consensus       163 ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~--  237 (353)
T 3txo_A          163 CKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAIL--  237 (353)
T ss_dssp             EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH--
T ss_pred             EEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHH--
Confidence            9999999998543322  22345679999999999999999999999999999999999999997653322 222211  


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM------RRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~evl~  967 (1002)
                       .. ...   .|  ....    ..+.+++.+|++.||++||++      +|+++
T Consensus       238 -~~-~~~---~p--~~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          238 -ND-EVV---YP--TWLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -HC-CCC---CC--TTSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -cC-CCC---CC--CCCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence             11 100   01  1122    247789999999999999998      67764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-39  Score=351.89  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=194.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|.+. ++.||||++......             ......+.+.+|+++++.++||||++++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE-------------DISQTIENVRQEAKLFAMLKHPNIIALR   72 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc-------------cHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            56778899999999999999975 889999998543111             1123356789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC------
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG------  836 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~------  836 (1002)
                      +++.+++..++||||+++++|.+++.   .+.+++..++.++.|++.||+|||+++..+|+||||||+||+++.      
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~  149 (271)
T 3dtc_A           73 GVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD  149 (271)
T ss_dssp             EEECCC--CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred             EEEecCCceEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence            99999999999999999999999985   356999999999999999999999992222999999999999986      


Q ss_pred             --CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          837 --DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       837 --~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                        ++.+||+|||+++.......    ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...........
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  225 (271)
T 3dtc_A          150 LSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG  225 (271)
T ss_dssp             CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred             ccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence              67899999999986654322    234689999999999999999999999999999999999999975432221111


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .    . .....   .+.....+    ..+.+++.+||+.||++|||++|+++.|+++
T Consensus       226 ~----~-~~~~~---~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 V----A-MNKLA---LPIPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             H----H-TSCCC---CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             h----h-cCCCC---CCCCcccC----HHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1    1 11111   01112222    2478899999999999999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.8e-39  Score=358.88  Aligned_cols=264  Identities=18%  Similarity=0.206  Sum_probs=210.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|+. .+++.||||++...                   ...+.+.+|+.+++++ +||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~E~~~l~~l~~h~~i~   68 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-------------------SRAPQLHLEYRFYKQLGSGDGIP   68 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT-------------------CSSCCHHHHHHHHHHHCSCTTSC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc-------------------cchHHHHHHHHHHHHhhCCCCCC
Confidence            35788899999999999999996 56899999988432                   1124588999999999 899999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++...+..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        69 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~  143 (330)
T 2izr_A           69 QVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGN  143 (330)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGG
T ss_pred             EEEEEEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCC
Confidence            9999999999999999999 99999999864 45799999999999999999999999   9999999999999998887


Q ss_pred             -----eEEccccCcccccCCCCCc-----ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          840 -----ARVADFGVAKVVDASGKPK-----SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       840 -----~kl~DfGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                           +||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       144 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~  223 (330)
T 2izr_A          144 KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD  223 (330)
T ss_dssp             TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred             CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence                 9999999998765433211     123567999999999999999999999999999999999999999764322


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                       +............. .. ..+......+    ++.+++..||+.||++||+++++.+.|+++....
T Consensus       224 -~~~~~~~~i~~~~~-~~-~~~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          224 -TLKERYQKIGDTKR-AT-PIEVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             -SHHHHHHHHHHHHH-HS-CHHHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -cHHHHHHHHHhhhc-cC-CHHHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence             22222211111000 00 0000111122    5888999999999999999999999999887544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8e-39  Score=352.96  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=199.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|+.. ++.||||++..                   ....+.+.+|+.++++++||||++++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------------------~~~~~~~~~E~~~l~~l~hp~iv~~~   67 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------------------ESERKAFIVELRQLSRVNHPNIVKLY   67 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------------------TTHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------------------hhHHHHHHHHHHHHhcCCCCCcCeEE
Confidence            45777889999999999999985 78999998732                   22456789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC-e
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-A  840 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~-~  840 (1002)
                      +++.+  ..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +
T Consensus        68 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~  145 (307)
T 2eva_A           68 GACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL  145 (307)
T ss_dssp             EBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEE
T ss_pred             EEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEE
Confidence            98874  47999999999999999985432 35789999999999999999999932129999999999999998887 7


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.  ..
T Consensus       146 kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~  218 (307)
T 2eva_A          146 KICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--VH  218 (307)
T ss_dssp             EECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH--HH
T ss_pred             EEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH--Hh
Confidence            99999999765432     123468999999999999999999999999999999999999997543322211111  11


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccc
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS  978 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~  978 (1002)
                      ... .    .+.....+.    .+.+++.+||+.||++|||++|+++.|+++.+....
T Consensus       219 ~~~-~----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          219 NGT-R----PPLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             TTC-C----CCCBTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             cCC-C----CCcccccCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            111 0    111122222    477899999999999999999999999998764433

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.2e-39  Score=367.97  Aligned_cols=269  Identities=21%  Similarity=0.210  Sum_probs=207.5

Q ss_pred             hcCCCcCCeeeec--CCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          682 LDGLDEDNVIGSG--SSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       682 ~~~~~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .++|++.+.||+|  +||.||+|+.+ +++.||||++....               ......+.+.+|+.++++++||||
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~ni   88 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA---------------CSNEMVTFLQGELHVSKLFNHPNI   88 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG---------------SCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc---------------cChHHHHHHHHHHHHHHhCCCCCC
Confidence            3578889999999  99999999975 68999999985421               123456778999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      |++++++.+++..|+||||+++|+|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  165 (389)
T 3gni_B           89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDG  165 (389)
T ss_dssp             CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTC
T ss_pred             CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            99999999999999999999999999999876667799999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCC-----CcccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          839 GARVADFGVAKVVDASGK-----PKSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      .+||+|||.+........     ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||........
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  245 (389)
T 3gni_B          166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM  245 (389)
T ss_dssp             CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH
T ss_pred             CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999865432211     111223478999999999987  6789999999999999999999999976544433


Q ss_pred             HHHHHHHHhhcc----------------------Ccccc----------ccccccCCCHHHHHHHHHHHHHcCCCCCCCC
Q 001867          912 LVKWVCSTLDQK----------------------GVDHV----------LDPKLDCCFKEEICKVLNIGLLCTSPLPINR  959 (1002)
Q Consensus       912 ~~~~~~~~~~~~----------------------~~~~~----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  959 (1002)
                      ............                      .....          .+.............+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  325 (389)
T 3gni_B          246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR  325 (389)
T ss_dssp             HHHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred             HHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence            322221111000                      00000          0000000111122358889999999999999


Q ss_pred             CCHHHHHHH
Q 001867          960 PAMRRVVKL  968 (1002)
Q Consensus       960 ps~~evl~~  968 (1002)
                      ||++|+++.
T Consensus       326 pta~ell~h  334 (389)
T 3gni_B          326 PSASTLLNH  334 (389)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhcC
Confidence            999999853

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.1e-39  Score=359.52  Aligned_cols=258  Identities=26%  Similarity=0.347  Sum_probs=203.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcE----EEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEA----VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|.+. +++.    ||+|.+....                .....+.+.+|+.++++++|||
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~   76 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----------------GRQSFQAVTDHMLAIGSLDHAH   76 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----------------SCSCBCSCCHHHHHHHTCCCTT
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----------------cHHHHHHHHHHHHHHhcCCCCC
Confidence            46778899999999999999964 4444    7777663221                1122345778999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++. .+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        77 iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~  151 (325)
T 3kex_A           77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSP  151 (325)
T ss_dssp             BCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSS
T ss_pred             cCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCC
Confidence            999999986 45689999999999999999753 35689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+
T Consensus       152 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~  230 (325)
T 3kex_A          152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLL  230 (325)
T ss_dssp             SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-THHHHHH
T ss_pred             CeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-HHHHHHH
Confidence            9999999999998766554444456678889999999999999999999999999999999 9999975432 2333322


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ....... .     +  .....    .+.+++.+||+.||++||+++|+++.|+++..
T Consensus       231 ~~~~~~~-~-----~--~~~~~----~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          231 EKGERLA-Q-----P--QICTI----DVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HTTCBCC-C-----C--TTBCT----TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HcCCCCC-C-----C--CcCcH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            2211110 0     0  11111    36688999999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.2e-39  Score=359.20  Aligned_cols=264  Identities=24%  Similarity=0.365  Sum_probs=213.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc--------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS--------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI  753 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  753 (1002)
                      .++|++.+.||+|+||.||+|...        ++..||||++....                .....+.+.+|+.+++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l   97 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----------------TEKDLSDLVSEMEMMKMI   97 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----------------CHHHHHHHHHHHHHHHHH
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----------------cHHHHHHHHHHHHHHHHh
Confidence            357888999999999999999863        46789999984321                234466789999999999


Q ss_pred             -CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcC
Q 001867          754 -RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG--------------GLLDWPTRYKIIVDAAEGLSYLHHDC  818 (1002)
Q Consensus       754 -~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~  818 (1002)
                       +||||+++++++.+.+..++||||+++|+|.+++.....              ..+++..++.++.|++.||+|||++ 
T Consensus        98 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-  176 (334)
T 2pvf_A           98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-  176 (334)
T ss_dssp             CCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             hcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-
Confidence             899999999999999999999999999999999986432              3489999999999999999999999 


Q ss_pred             CCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh
Q 001867          819 VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT  898 (1002)
Q Consensus       819 ~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~  898 (1002)
                        +|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++
T Consensus       177 --~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt  254 (334)
T 2pvf_A          177 --KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT  254 (334)
T ss_dssp             --TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             --CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence              999999999999999999999999999987765443333344567889999999998889999999999999999999


Q ss_pred             -CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          899 -GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       899 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                       |+.||.... ..+....+......        +......    ..+.+++.+||+.||++||+++|+++.|+++.....
T Consensus       255 ~g~~p~~~~~-~~~~~~~~~~~~~~--------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          255 LGGSPYPGIP-VEELFKLLKEGHRM--------DKPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             TSCCSSTTCC-HHHHHHHHHHTCCC--------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCCcCcCC-HHHHHHHHhcCCCC--------CCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence             999986542 23333222221110        1111222    247889999999999999999999999999976443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.2e-39  Score=349.34  Aligned_cols=259  Identities=23%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|....    +..||+|++...                ......+.+.+|+.++++++||||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~e~~~l~~l~h~~i   78 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------------TSDSVREKFLQEALTMRQFDHPHI   78 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------------TSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----------------CCHHHHHHHHHHHHHHHhCCCCcc
Confidence            567888999999999999998743    457999987331                123456779999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++. ++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        79 v~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  153 (281)
T 1mp8_A           79 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND  153 (281)
T ss_dssp             CCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred             ceEEEEEc-cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCC
Confidence            99999985 45689999999999999999763 45699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |..||...... +....+.
T Consensus       154 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i~  231 (281)
T 1mp8_A          154 CVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIE  231 (281)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH
T ss_pred             CEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHHH
Confidence            9999999999877544322 2234457789999999998999999999999999999997 89999765433 3332222


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ....        .+.....+    ..+.+++.+||+.||++|||++|+++.|+++....
T Consensus       232 ~~~~--------~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          232 NGER--------LPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             TTCC--------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCC--------CCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1110        01112222    24778999999999999999999999999986543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.2e-39  Score=360.72  Aligned_cols=248  Identities=23%  Similarity=0.269  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++.+..              .......+.+.+|+.++++++||||++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~iv~  105 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--------------VVKLKQIEHTLNEKRILQAVNFPFLVK  105 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH--------------hccHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            467888899999999999999975 68999999985421              112234567889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+
T Consensus       106 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~  180 (350)
T 1rdq_E          106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI  180 (350)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCE
Confidence            999999999999999999999999999853  4699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++.....     ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.   
T Consensus       181 kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~---  251 (350)
T 1rdq_E          181 QVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIV---  251 (350)
T ss_dssp             EECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---
T ss_pred             EEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHH---
Confidence            99999999876543     224579999999999999999999999999999999999999997553222 222111   


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                      .. ...  +.   ....    ..+.+++.+||+.||++||+     ++|+++
T Consensus       252 ~~-~~~--~p---~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          252 SG-KVR--FP---SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HC-CCC--CC---TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             cC-CCC--CC---CCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11 110  00   1122    24788999999999999998     888874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3e-39  Score=366.01  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=198.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.++||+|+||.||+|+.+ +++.||+|++.+...              ......+.+..|..++.++ +||||+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~--------------~~~~~~~~~~~E~~il~~~~~hp~Iv  116 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV--------------NDDEDIDWVQTEKHVFEQASNHPFLV  116 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT--------------C----CCHHHHHHHHHHHHTTCTTBC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--------------cCHHHHHHHHHHHHHHHhcCCCCCcC
Confidence            467888999999999999999975 578999999865321              1233445688899999887 799999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus       117 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~  191 (396)
T 4dc2_A          117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGH  191 (396)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             eeEEEEEECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCC
Confidence            9999999999999999999999999999853  5699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch----hHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK----DLVKW  915 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~----~~~~~  915 (1002)
                      +||+|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......    .....
T Consensus       192 ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~  269 (396)
T 4dc2_A          192 IKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  269 (396)
T ss_dssp             EEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred             EEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence            9999999998633222  22345689999999999999999999999999999999999999996432111    11111


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      ...........  +   .....    .++.+++.+||+.||++||++
T Consensus       270 ~~~~i~~~~~~--~---p~~~s----~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          270 LFQVILEKQIR--I---PRSLS----VKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHHCCCC--C---CTTSC----HHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHHhccccC--C---CCcCC----HHHHHHHHHHhcCCHhHcCCC
Confidence            11111111111  0   01122    247789999999999999995

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-39  Score=348.81  Aligned_cols=256  Identities=28%  Similarity=0.438  Sum_probs=209.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|...+++.||+|++...                  ....+.+.+|++++++++||||++++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~   69 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------------AMSEEDFIEEAEVMMKLSHPKLVQLY   69 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------------TBCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc------------------CCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence            467788999999999999999988899999998432                  11235789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl  145 (267)
T 3t9t_A           70 GVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV  145 (267)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEE
T ss_pred             EEEccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEE
Confidence            9999999999999999999999999763 35689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||++....... ........++..|+|||++.+..++.++||||+|+++|||++ |+.||..... ......+.....
T Consensus       146 ~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~i~~~~~  223 (267)
T 3t9t_A          146 SDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR  223 (267)
T ss_dssp             CCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCC
T ss_pred             ccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-HHHHHHHhcCCc
Confidence            9999998664321 111223457788999999998899999999999999999999 8999875432 222222211110


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                           .   .......    ..+.+++.+||+.||++||+++++++.|+++..
T Consensus       224 -----~---~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 -----L---YKPRLAS----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             -----C---CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----C---CCCccCc----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                 0   0011122    247889999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-39  Score=362.52  Aligned_cols=253  Identities=20%  Similarity=0.273  Sum_probs=205.6

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.+.|++.+.||+|+||.||+|..+ +++.||+|++...                 .......+.+|+.++++++||||+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----------------~~~~~~~~~~E~~il~~l~hpnIv  111 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----------------YPLDKYTVKNEISIMNQLHHPKLI  111 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------SHHHHHHHHHHHHHHTTCCSTTBC
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-----------------chhhHHHHHHHHHHHHhCCCcCCC
Confidence            3567889999999999999999974 6889999998432                 123456789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC--C
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG--D  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~--~  837 (1002)
                      ++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.  +
T Consensus       112 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~  187 (387)
T 1kob_A          112 NLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKA  187 (387)
T ss_dssp             CEEEEEECSSEEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTC
T ss_pred             eEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCC
Confidence            999999999999999999999999999875 334699999999999999999999999   9999999999999974  4


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+.
T Consensus       188 ~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i~  263 (387)
T 1kob_A          188 SSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVK  263 (387)
T ss_dssp             CCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH
T ss_pred             CceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence            6799999999987754322   2345799999999999999999999999999999999999999976532222 22111


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .   . .. ....+.......    ++.+++.+||+.||++|||++|+++
T Consensus       264 ~---~-~~-~~~~~~~~~~s~----~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          264 R---C-DW-EFDEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             H---C-CC-CCCSSTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             h---C-CC-CCCccccccCCH----HHHHHHHHHcCCChhHCcCHHHHhh
Confidence            1   1 00 001111122222    4788999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-39  Score=370.46  Aligned_cols=258  Identities=23%  Similarity=0.253  Sum_probs=206.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.++||+|+||+||+|+.++ ++.||+|++.+..              .......+.+.+|+.++..++||||++
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~--------------~~~~~~~~~~~~E~~il~~~~hp~Iv~  138 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--------------MLKRAETACFREERDVLVNGDSKWITT  138 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH--------------HHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH--------------hhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            4678999999999999999999754 7889999985421              112233445889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++.. ..+.+++..++.++.|++.||+|||++   +||||||||+|||++.++.+
T Consensus       139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEeeCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCE
Confidence            99999999999999999999999999975 245799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      ||+|||+++....... ......+||+.|+|||++.     ...++.++||||+||++|||++|+.||......+.+...
T Consensus       215 kL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             EECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            9999999987654332 2233467999999999987     456899999999999999999999999765433333222


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPIN--RPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~  967 (1002)
                      ....... .    +.+......+    .+.+++.+|+..+|++  ||+++|+++
T Consensus       294 ~~~~~~~-~----~p~~~~~~s~----~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          294 MNHKERF-Q----FPTQVTDVSE----NAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HTHHHHC-C----CCSSCCCSCH----HHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhccccc-c----CCcccccCCH----HHHHHHHHHhcccccccCCCCHHHHhC
Confidence            2111111 1    1111122223    3778889999888888  999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4e-39  Score=352.28  Aligned_cols=260  Identities=23%  Similarity=0.374  Sum_probs=215.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|.+.. +..||+|++..                  +....+.+.+|+.++++++||||++
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------------------~~~~~~~~~~E~~~l~~l~h~~i~~   73 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------------------DTMEVEEFLKEAAVMKEIKHPNLVQ   73 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS------------------CSTHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc------------------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence            3568888999999999999999754 88999999843                  2234567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..++||||+++++|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        74 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~  150 (288)
T 3kfa_A           74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV  150 (288)
T ss_dssp             EEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCE
Confidence            999999999999999999999999999876677899999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++........ .......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.... .......+...
T Consensus       151 ~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-~~~~~~~~~~~  228 (288)
T 3kfa_A          151 KVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKD  228 (288)
T ss_dssp             EECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHHHTT
T ss_pred             EEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcc
Confidence            9999999987654432 22334567889999999999999999999999999999999 888886543 33333333221


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ...        +.....+    ..+.+++.+|++.||++|||++|+++.|+++....
T Consensus       229 ~~~--------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          229 YRM--------ERPEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCC--------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCC--------CCCCCCC----HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            111        1112222    24788999999999999999999999999886543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.3e-39  Score=360.63  Aligned_cols=253  Identities=26%  Similarity=0.313  Sum_probs=195.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...                  ....+.+.+|+.++++++||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~   80 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------------------AAIDENVQREIINHRSLRHPNIVR   80 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS------------------TTSCHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC------------------ccccHHHHHHHHHHHhCCCCCCCc
Confidence            467888999999999999999975 6899999998542                  112356889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC-
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-  839 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~-  839 (1002)
                      +++++.+.+..++||||+++|+|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.++. 
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~  155 (361)
T 3uc3_A           81 FKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAP  155 (361)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCc
Confidence            999999999999999999999999999753  4699999999999999999999999   9999999999999987765 


Q ss_pred             -eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          840 -ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEK-SDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       840 -~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                       +||+|||+++......   ......||+.|+|||++.+..+..+ +||||+||++|+|++|+.||..............
T Consensus       156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~  232 (361)
T 3uc3_A          156 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ  232 (361)
T ss_dssp             CEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH
T ss_pred             eEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence             9999999997543322   2234579999999999988877655 8999999999999999999987655555444443


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ....... .  + +......+    .+.+++.+||+.||++|||++|+++.
T Consensus       233 ~~~~~~~-~--~-~~~~~~s~----~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          233 RILSVKY-S--I-PDDIRISP----ECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHTTCC-C--C-CTTSCCCH----HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhcCCC-C--C-CCcCCCCH----HHHHHHHHHccCChhHCcCHHHHHhC
Confidence            3322111 0  0 11111222    47789999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.9e-39  Score=357.46  Aligned_cols=265  Identities=23%  Similarity=0.338  Sum_probs=214.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-C
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-R  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  754 (1002)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++....                .....+.+.+|+.+++++ +
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~   89 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKILIHIGH   89 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCC
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----------------CcHHHHHHHHHHHHHHhccc
Confidence            46788999999999999999984      246889999984321                233456789999999999 6


Q ss_pred             CCceeeeeeEEecCC-eeeEEEeccCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          755 HKNIVKLWCCCTTRD-CKLLVYEYMPNGSLGDLLHSCKG--------------GLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       755 h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      ||||+++++++...+ ..++||||+++|+|.+++.....              ..+++..++.++.|++.||+|||++  
T Consensus        90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--  167 (316)
T 2xir_A           90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--  167 (316)
T ss_dssp             CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC--
Confidence            999999999998654 58999999999999999986432              2389999999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+|+++|||++ 
T Consensus       168 -~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~  246 (316)
T 2xir_A          168 -KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL  246 (316)
T ss_dssp             -TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence             999999999999999999999999999987765544334445568899999999999999999999999999999998 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                      |..||............+......        +......+    .+.+++.+||+.||++|||++|+++.|+++.....
T Consensus       247 g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          247 GASPYPGVKIDEEFCRRLKEGTRM--------RAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCCcccchhHHHHHHhccCccC--------CCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            999997654444443333222111        01111222    47889999999999999999999999999876543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=361.29  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=196.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC--Cceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH--KNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~  760 (1002)
                      +.|++.+.||+|+||.||+|...+++.||||++....               ......+.+.+|+.++++++|  |||++
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~~~iv~   73 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------------ADNQTLDSYRNEIAYLNKLQQHSDKIIR   73 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT---------------CCHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc---------------cchHHHHHHHHHHHHHHhhhhcCCceEE
Confidence            4578889999999999999998889999999985321               134456779999999999986  99999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+|||+ .+++|.+++..  .+.+++..+..++.|++.||+|||++   +|+||||||+||+++ ++.+
T Consensus        74 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~  146 (343)
T 3dbq_A           74 LYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML  146 (343)
T ss_dssp             EEEEEECSSEEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred             EeeeEeeCCEEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcE
Confidence            99999999999999995 58899999985  45699999999999999999999999   999999999999997 6789


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----------LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      ||+|||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......
T Consensus       147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  226 (343)
T 3dbq_A          147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  226 (343)
T ss_dssp             EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence            9999999987765443333445679999999999865           67889999999999999999999999754332


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ....   ........ .    ........   ..+.+++.+||+.||++|||++|+++.
T Consensus       227 ~~~~---~~~~~~~~-~----~~~~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 ISKL---HAIIDPNH-E----IEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHH---HHHHCTTS-C----CCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHH---HHHhcCCc-c----cCCcccCC---HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            2211   11111110 0    01111111   247789999999999999999999854

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-38  Score=353.40  Aligned_cols=270  Identities=26%  Similarity=0.343  Sum_probs=205.7

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC--CCCce
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI--RHKNI  758 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~ni  758 (1002)
                      +.++|++.+.||+|+||.||+|+.. ++.||||++..                    .....+..|.+++...  +||||
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--------------------~~~~~~~~e~~~~~~~~~~h~~i   93 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT--------------------TEEASWFRETEIYQTVLMRHENI   93 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG--------------------GGHHHHHHHHHHHTSTTCCCTTB
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec--------------------cccchhhhHHHHHHHHhhcCCCe
Confidence            4578999999999999999999986 89999999832                    1233455566666655  89999


Q ss_pred             eeeeeEEecC----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeeCCCCC
Q 001867          759 VKLWCCCTTR----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC-----VPSIVHRDVKS  829 (1002)
Q Consensus       759 v~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiHrDlk~  829 (1002)
                      +++++++...    ...++||||+++|+|.++++.   ..+++..++.++.|++.||+|||++.     .++|+||||||
T Consensus        94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp  170 (337)
T 3mdy_A           94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS  170 (337)
T ss_dssp             CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred             eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence            9999999877    788999999999999999975   35999999999999999999999751     23899999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCCcc--cccccccccccCccccccCCCCCc------cchhhHHHHHHHHHhC--
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKPKS--MSVIAGSCGYIAPEYAYTLRVNEK------SDIYSFGVVILELVTG--  899 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslGvil~ell~g--  899 (1002)
                      +||+++.++.+||+|||+++..........  .....||+.|+|||++.+.....+      +|||||||++|||++|  
T Consensus       171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            999999999999999999987654332211  124579999999999987776665      9999999999999999  


Q ss_pred             --------CCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          900 --------RLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       900 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                              +.||.........................+....  ...+...++.+++.+||+.||++|||++|+++.|++
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW--SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG--GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccc--hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence                    6676543332222222222222221111111111  112455678899999999999999999999999999


Q ss_pred             hhhhc
Q 001867          972 VGAEN  976 (1002)
Q Consensus       972 ~~~~~  976 (1002)
                      +....
T Consensus       329 l~~~~  333 (337)
T 3mdy_A          329 MSESQ  333 (337)
T ss_dssp             HHHTT
T ss_pred             HHhhc
Confidence            87644

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-39  Score=362.23  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=196.6

Q ss_pred             CCcCCeeeecCCccEEEEEEc--CC--cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS--NG--EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      |++.+.||+|+||.||+|...  ++  ..||||.+...                .+....+++.+|+.++++++||||++
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~il~~l~hpnIv~  154 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------TDIGEVSQFLTEGIIMKDFSHPNVLS  154 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC----------------SCSHHHHHHHHHHTTSTTCCCTTBCC
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC----------------CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            556789999999999999863  22  36899987431                13345678999999999999999999


Q ss_pred             eeeEEec-CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          761 LWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       761 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      +++++.. ++..++||||+++|+|.++++. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  230 (373)
T 3c1x_A          155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFT  230 (373)
T ss_dssp             CCEEECCCSSCCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             EEEEEEcCCCCeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCC
Confidence            9998754 5678999999999999999975 345689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCc--ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +||+|||+++.........  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||... ...+....+
T Consensus       231 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~  309 (373)
T 3c1x_A          231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYL  309 (373)
T ss_dssp             EEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHH
T ss_pred             EEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHH
Confidence            9999999998764432211  1234457789999999999999999999999999999999 55566543 333333332


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccc
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS  978 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~  978 (1002)
                      ......        ......+.    .+.+++.+||+.||++||+++|+++.|+++......
T Consensus       310 ~~~~~~--------~~p~~~~~----~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          310 LQGRRL--------LQPEYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             HTTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HcCCCC--------CCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            221110        01112222    478899999999999999999999999999765543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.1e-39  Score=358.72  Aligned_cols=250  Identities=25%  Similarity=0.343  Sum_probs=190.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|++.+.||+|+||.||+|+.. +++.||||++...                   ...+.+.+|++++++++||||++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~E~~~l~~l~h~niv~  112 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------------------VDKKIVRTEIGVLLRLSHPNIIK  112 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------------------CHHHHHCCCTTBCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------------hhHHHHHHHHHHHHhCCCCCCcc
Confidence            456888899999999999999975 5789999998432                   12356788999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC---C
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---D  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~---~  837 (1002)
                      +++++.+.+..++||||+++|+|.+++..  .+.+++..++.++.|++.||+|||++   +|+||||||+||+++.   +
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~  187 (349)
T 2w4o_A          113 LKEIFETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPD  187 (349)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTT
T ss_pred             eeeeEecCCeEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCC
Confidence            99999999999999999999999999974  45699999999999999999999999   9999999999999975   8


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||............+.
T Consensus       188 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~  264 (349)
T 2w4o_A          188 APLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL  264 (349)
T ss_dssp             CCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH
T ss_pred             CCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH
Confidence            899999999998765432   22345799999999999999999999999999999999999999976544332222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    .. ....+.......    ++.+++.+||+.||++|||++|+++
T Consensus       265 ~~----~~-~~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          265 NC----EY-YFISPWWDEVSL----NAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TT----CC-CCCTTTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hC----CC-ccCCchhhhCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence            11    11 111121222333    4788999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-39  Score=351.05  Aligned_cols=266  Identities=23%  Similarity=0.277  Sum_probs=196.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccC---------CCccccccccchhhHHhHHHHHHHHh
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECES---------GCDVEKGQVQDQVQDDGFQAEVETLG  751 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~E~~~l~  751 (1002)
                      .++|++.+.||+|+||.||+|.. .+++.||||++..........         ...............+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46788899999999999999996 468899999996542110000         00000001112233567899999999


Q ss_pred             cCCCCceeeeeeEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          752 KIRHKNIVKLWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       752 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                      +++||||+++++++.+  .+..|+||||+++++|.+++.   ...+++..++.++.|++.||+|||++   +|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence            9999999999999986  568899999999999988764   35799999999999999999999999   999999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      +||+++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++||||+||++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999987654322  223457999999999988765   377899999999999999999999754


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .. ......+    ......   .+.......    .+.+++.+||+.||++||+++|+++
T Consensus       244 ~~-~~~~~~~----~~~~~~---~~~~~~~~~----~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RI-MCLHSKI----KSQALE---FPDQPDIAE----DLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SH-HHHHHHH----HHCCCC---CCSSSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cH-HHHHHHH----hcccCC---CCCccccCH----HHHHHHHHHhhcChhhCCCHHHHhc
Confidence            22 1111111    111111   111122222    4788999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-39  Score=361.94  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=199.3

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++.+.|++.+.||+|+||.||+|.. .+|+.||||++...               .......+++.+|+.++++++|||
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~hpn   85 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------------FQSELFAKRAYRELRLLKHMRHEN   85 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---------------TSSHHHHHHHHHHHHHHHHCCBTT
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc---------------ccCHHHHHHHHHHHHHHHhCCCcC
Confidence            44567888999999999999999997 46899999998432               223445677899999999999999


Q ss_pred             eeeeeeEEecCC------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++...+      ..|+||||+ +++|.++++.   ..+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus        86 Iv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~N  158 (367)
T 1cm8_A           86 VIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGN  158 (367)
T ss_dssp             BCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             CCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHH
Confidence            999999998753      459999999 8899999975   4589999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      |+++.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+
T Consensus       159 Ill~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  233 (367)
T 1cm8_A          159 LAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD  233 (367)
T ss_dssp             EEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999876432     234578999999999877 679999999999999999999999997654333


Q ss_pred             hHHHHHHHHhhcc-----------------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          911 DLVKWVCSTLDQK-----------------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       911 ~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .+...........                 ....................+.+++.+|++.||++|||++|+++
T Consensus       234 ~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          234 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            3222221110000                 00000001111111112234788999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.3e-39  Score=358.65  Aligned_cols=247  Identities=21%  Similarity=0.284  Sum_probs=178.7

Q ss_pred             CCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeeeeEE
Q 001867          688 DNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCCC  765 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  765 (1002)
                      .+.||+|+||.||+|..+ +++.||||++.+                    .....+.+|+.+++++. ||||+++++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--------------------~~~~~~~~e~~~l~~l~~h~niv~~~~~~   75 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--------------------RMEANTQKEITALKLCEGHPNIVKLHEVF   75 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG--------------------GGHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh--------------------hhhhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence            478999999999999974 689999999832                    23456789999999997 99999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC---CeEE
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF---GARV  842 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl  842 (1002)
                      .+++..|+||||+++|+|.+++..  .+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++   .+||
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  150 (325)
T 3kn6_A           76 HDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKI  150 (325)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEE
T ss_pred             EcCCEEEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEE
Confidence            999999999999999999999985  45699999999999999999999999   999999999999998765   7999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE---KDLVKWVCST  919 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~---~~~~~~~~~~  919 (1002)
                      +|||+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   ......... 
T Consensus       151 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-  227 (325)
T 3kn6_A          151 IDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-  227 (325)
T ss_dssp             CCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-
T ss_pred             eccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-
Confidence            99999987654322  223456899999999999999999999999999999999999999754321   111122211 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....... ...+......    .++.+++.+|++.||++|||++|+++
T Consensus       228 i~~~~~~-~~~~~~~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          228 IKKGDFS-FEGEAWKNVS----QEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTTTCCC-CCSHHHHTSC----HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHcCCCC-CCcccccCCC----HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1111110 0000111122    34788999999999999999998863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.3e-39  Score=367.83  Aligned_cols=256  Identities=21%  Similarity=0.258  Sum_probs=205.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.++||+|+||.||+|+.+ +++.||+|++.+..              .......+.+.+|+.+++.++||||++
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~--------------~~~~~~~~~~~~E~~il~~l~hp~Iv~  133 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--------------MIKRSDSAFFWEERDIMAFANSPWVVQ  133 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------------HHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh--------------hhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence            467889999999999999999975 58899999985421              112223455889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.++++.   ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+
T Consensus       134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             EEEEEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCE
Confidence            99999999999999999999999999974   3589999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR----VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ||+|||+++....... ......+||+.|+|||++.+..    ++.++||||+||++|||++|+.||........+..+.
T Consensus       208 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  286 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  286 (410)
T ss_dssp             EECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence            9999999987654322 2233567999999999988665    7899999999999999999999997654333322222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPIN--RPAMRRVVKL  968 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~evl~~  968 (1002)
                      ......      ..|.......    .+.+++.+|++.+|++  ||+++||++.
T Consensus       287 ~~~~~~------~~p~~~~~s~----~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          287 NHKNSL------TFPDDNDISK----EAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             THHHHC------CCCTTCCCCH----HHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             hccccc------cCCCcccccH----HHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            211110      0111112222    3778899999999988  9999999853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-38  Score=357.47  Aligned_cols=268  Identities=25%  Similarity=0.310  Sum_probs=210.7

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhc--CCCCc
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGK--IRHKN  757 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~n  757 (1002)
                      .+.++|++.+.||+|+||.||+|+. +++.||||++..                    .....+.+|+++++.  ++|||
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~--------------------~~~~~~~~e~~~~~~~~l~h~n   97 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS--------------------REERSWFREAEIYQTVMLRHEN   97 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG--------------------GGHHHHHHHHHHHHHSCCCCTT
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc--------------------hhHHHHHHHHHHHHHhhcCCCc
Confidence            3467899999999999999999998 489999999832                    234567788888887  68999


Q ss_pred             eeeeeeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeeC
Q 001867          758 IVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLH--------HDCVPSIVHR  825 (1002)
Q Consensus       758 iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiHr  825 (1002)
                      |+++++++...+    ..++||||+++|+|.+++..   ..+++..++.++.|++.||+|||        +.   +|+||
T Consensus        98 i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~  171 (342)
T 1b6c_B           98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHR  171 (342)
T ss_dssp             BCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECS
T ss_pred             EEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeC
Confidence            999999998876    78999999999999999975   35899999999999999999999        77   99999


Q ss_pred             CCCCCcEEECCCCCeEEccccCcccccCCCCCc--ccccccccccccCccccccCC------CCCccchhhHHHHHHHHH
Q 001867          826 DVKSNNILLDGDFGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTLR------VNEKSDIYSFGVVILELV  897 (1002)
Q Consensus       826 Dlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~ell  897 (1002)
                      ||||+||+++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||+
T Consensus       172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~  251 (342)
T 1b6c_B          172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  251 (342)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence            999999999999999999999998776543221  123457999999999987653      336899999999999999


Q ss_pred             hC----------CCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          898 TG----------RLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       898 ~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +|          +.||.........................+....  ...+....+.+++.+||+.||++|||++||++
T Consensus       252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW--QSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99          7788654332222222222221211111111111  12345567889999999999999999999999


Q ss_pred             HHHHhhhhc
Q 001867          968 LLQEVGAEN  976 (1002)
Q Consensus       968 ~L~~~~~~~  976 (1002)
                      .|+++....
T Consensus       330 ~L~~i~~~~  338 (342)
T 1b6c_B          330 TLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHHHHh
Confidence            999987543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.9e-39  Score=349.17  Aligned_cols=258  Identities=26%  Similarity=0.446  Sum_probs=209.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|...+++.||||++...                  ....+.+.+|++++++++||||++++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~h~~i~~~~   74 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------------SMSPDAFLAEANLMKQLQHQRLVRLY   74 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC------------------cccHHHHHHHHHHHHhCCCcCcceEE
Confidence            567888999999999999999888889999998432                  11246789999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.. +..++||||+++++|.+++.......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        75 ~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  150 (279)
T 1qpc_A           75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKI  150 (279)
T ss_dssp             EEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEE
Confidence            99874 4589999999999999999754444699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||++........ .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+....+.... 
T Consensus       151 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~-  227 (279)
T 1qpc_A          151 ADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGY-  227 (279)
T ss_dssp             CCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTC-
T ss_pred             CCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-HHHHHHHhccc-
Confidence            99999987754322 12223456789999999998889999999999999999999 8999865432 22222222111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                          ..   ......+    ..+.+++.+||+.||++|||++++++.|+++....
T Consensus       228 ----~~---~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          228 ----RM---VRPDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ----CC---CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----CC---CCccccc----HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                00   0111222    24788999999999999999999999999986543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-38  Score=355.49  Aligned_cols=282  Identities=26%  Similarity=0.386  Sum_probs=217.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEE--EEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAV--AVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|+.. ++..+  |+|.+....                .....+.+.+|+++++++ +||||
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~hp~i   88 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----------------SKDDHRDFAGELEVLCKLGHHPNI   88 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------------CHHHHHHHHHTTCCCCTTB
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----------------chHHHHHHHHHHHHHHhccCCCch
Confidence            56888899999999999999964 56544  999874321                223456789999999999 89999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      +++++++.+.+..|+||||+++|+|.+++....              ...+++..++.++.|++.||+|||++   +|+|
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH  165 (327)
T 1fvr_A           89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIH  165 (327)
T ss_dssp             CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             hhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence            999999999999999999999999999997532              24799999999999999999999999   9999


Q ss_pred             CCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCC
Q 001867          825 RDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPV  903 (1002)
Q Consensus       825 rDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~  903 (1002)
                      |||||+||+++.++.+||+|||+++......   ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||
T Consensus       166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf  242 (327)
T 1fvr_A          166 RDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  242 (327)
T ss_dssp             SCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999997443221   1223457889999999998889999999999999999998 99999


Q ss_pred             CCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCC
Q 001867          904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKK  983 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~  983 (1002)
                      ..... .+....    ..... .   .+......    ..+.+++.+||+.||++|||++|+++.|+++...........
T Consensus       243 ~~~~~-~~~~~~----~~~~~-~---~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  309 (327)
T 1fvr_A          243 CGMTC-AELYEK----LPQGY-R---LEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT  309 (327)
T ss_dssp             TTCCH-HHHHHH----GGGTC-C---CCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCB
T ss_pred             CCCcH-HHHHHH----hhcCC-C---CCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccc
Confidence            65432 222111    11110 0   01111222    247889999999999999999999999999987666555555


Q ss_pred             CCCCCcchhhccccCC
Q 001867          984 DGKLSPYYHEDASDQG  999 (1002)
Q Consensus       984 ~~~~~~~~~~~~~~~~  999 (1002)
                      ......+...++..|.
T Consensus       310 ~~~~~~~~~~~~~~~~  325 (327)
T 1fvr_A          310 LYEKFTYAGIDCSAEE  325 (327)
T ss_dssp             CTTCCCCCCCCGGGC-
T ss_pred             hhccCCcCCCCCCccc
Confidence            5555555555555553

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=362.71  Aligned_cols=263  Identities=17%  Similarity=0.182  Sum_probs=209.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC---------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN---------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI  753 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  753 (1002)
                      ++|++.+.||+|+||.||+|+...         ++.||+|++..                      .+.+.+|+++++++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~----------------------~~~~~~E~~~l~~l   99 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK----------------------DGRLFNEQNFFQRA   99 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEET----------------------TSTHHHHHHHHHHH
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecc----------------------cchHHHHHHHHHHh
Confidence            578889999999999999999763         78999998832                      14688999999999


Q ss_pred             CCCceee---------------eeeEEec-CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 001867          754 RHKNIVK---------------LWCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD  817 (1002)
Q Consensus       754 ~h~niv~---------------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  817 (1002)
                      +||||++               +++++.. .+..|+||||+ +++|.+++.......+++..++.++.|++.||+|||++
T Consensus       100 ~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  178 (352)
T 2jii_A          100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN  178 (352)
T ss_dssp             CCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            9999988               6677765 77889999999 99999999875457799999999999999999999999


Q ss_pred             CCCCeeeCCCCCCcEEECCCC--CeEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHH
Q 001867          818 CVPSIVHRDVKSNNILLDGDF--GARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFG  890 (1002)
Q Consensus       818 ~~~~iiHrDlk~~NIll~~~~--~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  890 (1002)
                         +|+||||||+||+++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++||||||
T Consensus       179 ---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG  255 (352)
T 2jii_A          179 ---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG  255 (352)
T ss_dssp             ---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred             ---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence               999999999999999988  8999999999876543221     112344799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCC-CchhHHHHHHHHhhccCccccccccc--cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          891 VVILELVTGRLPVDPEF-GEKDLVKWVCSTLDQKGVDHVLDPKL--DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       891 vil~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      |++|||++|+.||.... ........... .... .....++..  ...+.    .+.+++.+||+.||++||+++++++
T Consensus       256 ~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          256 YCMLKWLYGFLPWTNCLPNTEDIMKQKQK-FVDK-PGPFVGPCGHWIRPSE----TLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHSCCTTGGGTTCHHHHHHHHHH-HHHS-CCCEECTTSCEECCCH----HHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhCCCCcccCCcCHHHHHHHHHh-ccCC-hhhhhhhccccCCCcH----HHHHHHHHHHhCChhhCCCHHHHHH
Confidence            99999999999997654 22222222221 1111 111111111  12222    4788999999999999999999999


Q ss_pred             HHHHhhhhcc
Q 001867          968 LLQEVGAENR  977 (1002)
Q Consensus       968 ~L~~~~~~~~  977 (1002)
                      .|+++.....
T Consensus       330 ~L~~~~~~~~  339 (352)
T 2jii_A          330 NLEALLQDLR  339 (352)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHhcC
Confidence            9999976543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.3e-39  Score=357.40  Aligned_cols=250  Identities=25%  Similarity=0.327  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  760 (1002)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++.+..              .......+.+.+|+.+++++ +||||++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~~~~hp~iv~   74 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL--------------VNDDEDIDWVQTEKHVFEQASNHPFLVG   74 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG--------------SCSHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHH--------------hcchHHHHHHHHHHHHHHhcCCCCccCe
Confidence            56788899999999999999975 58899999985431              22344566788999999988 8999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        75 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~  149 (345)
T 3a8x_A           75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI  149 (345)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             EEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence            999999999999999999999999999753  4699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch----hHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK----DLVKWV  916 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~----~~~~~~  916 (1002)
                      ||+|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......    ......
T Consensus       150 kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  227 (345)
T 3a8x_A          150 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL  227 (345)
T ss_dssp             EECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred             EEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence            999999998643322  12345679999999999999999999999999999999999999996422111    111111


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      ..........  +.   ....    .++.+++.+||+.||++||++
T Consensus       228 ~~~i~~~~~~--~p---~~~s----~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          228 FQVILEKQIR--IP---RSLS----VKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHHHCCCC--CC---TTSC----HHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHHHcCCCC--CC---CCCC----HHHHHHHHHHhcCCHhHCCCC
Confidence            1111111111  01   1122    247789999999999999995

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=348.78  Aligned_cols=261  Identities=25%  Similarity=0.329  Sum_probs=209.9

Q ss_pred             CCCcCCeeeecCCccEEEEEEcC-C---cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSN-G---EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      .|+..++||+|+||.||+|...+ +   ..||+|++...                ......+.+.+|+.++++++||||+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~iv   85 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------------TEMQQVEAFLREGLLMRGLNHPNVL   85 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----------------CSHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----------------ccHHHHHHHHHHHHHHHhCCCCCee
Confidence            34566899999999999998532 2   37999988431                1334567899999999999999999


Q ss_pred             eeeeEEecCCee-eEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          760 KLWCCCTTRDCK-LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~-~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      ++++++.+.+.. ++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        86 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~  161 (298)
T 3pls_A           86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESF  161 (298)
T ss_dssp             CCCEEECCSSSCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEecCCCCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence            999999876655 999999999999999975 346789999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCC--CCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASG--KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+||+|||+++......  .........+|+.|+|||.+.+..++.++||||+|+++|+|++|+.|+.......+.....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~  241 (298)
T 3pls_A          162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL  241 (298)
T ss_dssp             CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred             cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence            99999999998654432  1122234567889999999999999999999999999999999777766555555554444


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      .......        .....+    ..+.+++.+||+.||++|||++++++.|+++....
T Consensus       242 ~~~~~~~--------~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          242 AQGRRLP--------QPEYCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             HTTCCCC--------CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hcCCCCC--------CCccch----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            3222111        111122    24788999999999999999999999999987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-38  Score=370.09  Aligned_cols=250  Identities=27%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++.+..              .......+.+.+|+.+++.++||||++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~--------------~~~~~~~~~~~~Ei~~l~~l~HpnIv~   80 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK--------------IRSLDVVGKIRREIQNLKLFRHPHIIK   80 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH--------------HHHTTTHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh--------------ccCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            357888899999999999999975 68999999985421              112223567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++..  .+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+
T Consensus        81 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~v  155 (476)
T 2y94_A           81 LYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNA  155 (476)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCe
Confidence            99999999999999999999999999973  45699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++........   ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... ....+...
T Consensus       156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~  231 (476)
T 2y94_A          156 KIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDG  231 (476)
T ss_dssp             EECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHTT
T ss_pred             EEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcC
Confidence            9999999987654322   234579999999999988765 689999999999999999999997653322 22222111


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                          ...     ......+    .+.+++.+||+.||++|||++|+++
T Consensus       232 ----~~~-----~p~~~s~----~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          232 ----IFY-----TPQYLNP----SVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----CCC-----CCTTCCH----HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CcC-----CCccCCH----HHHHHHHHHcCCCchhCcCHHHHHh
Confidence                100     0111222    4778999999999999999999996

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-39  Score=360.56  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=202.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.+..              .......+.+..|..+++.+ +||||+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~E~~il~~~~~hp~iv   81 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--------------VLMDDDVECTMVEKRVLSLAWEHPFLT   81 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHHHTTCTTBC
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHH--------------hhhhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            467888999999999999999975 58899999985431              11123355678899999876 899999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+++|+|.+++...  +.+++..+..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        82 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~  156 (345)
T 1xjd_A           82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGH  156 (345)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             cEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCC
Confidence            9999999999999999999999999999853  4699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+.. 
T Consensus       157 vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~-  232 (345)
T 1xjd_A          157 IKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRM-  232 (345)
T ss_dssp             EEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-
T ss_pred             EEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHh-
Confidence            9999999998643322  123456799999999999999999999999999999999999999975432 222222111 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR-RVV  966 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl  966 (1002)
                        . ...  + +  ....    ..+.+++.+||+.||++||++. ++.
T Consensus       233 --~-~~~--~-p--~~~s----~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          233 --D-NPF--Y-P--RWLE----KEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --C-CCC--C-C--TTSC----HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --C-CCC--C-C--cccC----HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              1 100  0 1  1122    2477899999999999999997 654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=368.00  Aligned_cols=256  Identities=23%  Similarity=0.264  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||||++.+.              ........+.+.+|+.++.+++||||++
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~--------------~~~~~~~~~~~~~E~~il~~~~hp~Iv~  125 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--------------DMLKRGEVSCFREERDVLVNGDRRWITQ  125 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH--------------HHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH--------------HhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence            467889999999999999999974 6899999998542              1112334556889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++|+|.+++... +..+++..++.++.||+.||+|||++   +|+||||||+||+++.++++
T Consensus       126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCE
Confidence            999999999999999999999999999753 34699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccc-------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-------TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      ||+|||+++....... ......+||+.|+|||++.       +..++.++||||+||++|||++|+.||........+.
T Consensus       202 kL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  280 (412)
T 2vd5_A          202 RLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG  280 (412)
T ss_dssp             EECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999987654432 2223457999999999987       3568999999999999999999999997654333322


Q ss_pred             HHHHHHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINR---PAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~evl~  967 (1002)
                      +........ .     .|.. .....    ++.+++.+|+. +|++|   |+++|+++
T Consensus       281 ~i~~~~~~~-~-----~p~~~~~~s~----~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          281 KIVHYKEHL-S-----LPLVDEGVPE----EARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHTHHHHC-C-----CC----CCCH----HHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHhcccCc-C-----CCccccCCCH----HHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            222111110 0     0111 11222    47789999999 99998   58998874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.6e-38  Score=349.26  Aligned_cols=262  Identities=26%  Similarity=0.353  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ..|++.+.||+|+||.||+|...+    ...||+|.+...                ......+.+.+|+.++++++||||
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~i   88 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------TDIGEVSQFLTEGIIMKDFSHPNV   88 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----------------CSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----------------CCHHHHHHHHHHHHHHHhCCCCCE
Confidence            357778999999999999998643    235899987431                234456779999999999999999


Q ss_pred             eeeeeEEe-cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          759 VKLWCCCT-TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       759 v~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      +++++++. .++..++||||+++|+|.++++. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        89 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~  164 (298)
T 3f66_A           89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK  164 (298)
T ss_dssp             CCCCEEECCSSSCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred             eeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCC
Confidence            99999864 55678999999999999999975 346689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCC--cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKP--KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      +.+||+|||+++........  .......||+.|+|||.+.+..++.++||||+|+++|||++|+.|+.......+....
T Consensus       165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~  244 (298)
T 3f66_A          165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY  244 (298)
T ss_dssp             CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred             CCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            99999999999876543211  1223446788999999999999999999999999999999965554444344443333


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      .......        ......+    ..+.+++.+||+.||++|||++|+++.|+++....
T Consensus       245 ~~~~~~~--------~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          245 LLQGRRL--------LQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             HHTTCCC--------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             HhcCCCC--------CCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            3221111        0011122    24788999999999999999999999999987644

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=357.21  Aligned_cols=258  Identities=24%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcE----EEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEA----VAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|.+. +++.    ||+|.+...                ......+.+.+|+.++++++|||
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~----------------~~~~~~~~~~~E~~~l~~l~hp~   78 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----------------TSPKANKEILDEAYVMASVDNPH   78 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC----------------SSCCCHHHHHHHHHHHTTCCBTT
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc----------------cCHHHHHHHHHHHHHHHhCCCCC
Confidence            56888899999999999999964 4554    466655321                12234567899999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.... .++|+||+++|+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        79 iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~  153 (327)
T 3lzb_A           79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP  153 (327)
T ss_dssp             BCCCCEEEESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET
T ss_pred             eeEEEEEEecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCC
Confidence            999999998765 78999999999999999863 45699999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++...............||+.|+|||++.+..++.++||||+||++|||++ |+.||.... .......+
T Consensus       154 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-~~~~~~~~  232 (327)
T 3lzb_A          154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSIL  232 (327)
T ss_dssp             TEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHH
T ss_pred             CCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHH
Confidence            9999999999988765544444445567889999999999999999999999999999999 999997543 33333333


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ......        +.......    .+.+++.+||+.||++||+++|+++.|+++..
T Consensus       233 ~~~~~~--------~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          233 EKGERL--------PQPPICTI----DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HTTCCC--------CCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HcCCCC--------CCCccCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            221110        11112222    47889999999999999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9e-39  Score=364.13  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=197.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~  760 (1002)
                      +.|++.+.||+|+||.||+|...+++.||||++....               .+....+.+.+|+.++++++  ||||++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~  120 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------------ADNQTLDSYRNEIAYLNKLQQHSDKIIR  120 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT---------------CCHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc---------------ccHHHHHHHHHHHHHHHHcccCCCeEEE
Confidence            3588899999999999999998889999999985421               13445678999999999996  599999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++..++..|+|||+ .+++|.+++...  ..+++..++.++.||+.||+|||++   +|+||||||+||+++ ++.+
T Consensus       121 ~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~  193 (390)
T 2zmd_A          121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML  193 (390)
T ss_dssp             EEEEEECSSEEEEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCE
T ss_pred             EEEEEecCCEEEEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeE
Confidence            99999999999999995 588999999853  4689999999999999999999999   999999999999996 5899


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----------LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      ||+|||+++..............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||......
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  273 (390)
T 2zmd_A          194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  273 (390)
T ss_dssp             EECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             EEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence            9999999987755433333345679999999999865           36889999999999999999999999754332


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .....   ...... ..    ...+...   ...+.+++.+||+.||++||+++|+++.
T Consensus       274 ~~~~~---~~~~~~-~~----~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 ISKLH---AIIDPN-HE----IEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHH---HHHCTT-SC----CCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHH---HHhCcc-cc----CCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            22111   111111 00    0111111   1247789999999999999999999853

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-38  Score=343.79  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=205.8

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|... +++.||||++....                .....+.+.+|+.++++++||||+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~   68 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------------AVDCPENIKKEICINKMLNHENVV   68 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG----------------CTTHHHHHHHHHHHHHTCCCTTBC
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc----------------chhhhHHHHHHHHHHHhcCCCCce
Confidence            3567888999999999999999975 68999999984321                123456789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..++||||+++++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~  143 (276)
T 2yex_A           69 KFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDN  143 (276)
T ss_dssp             CEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             eeeeEEEcCCEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCC
Confidence            999999999999999999999999999973  45699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchh-HHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKD-LVKWVC  917 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~-~~~~~~  917 (1002)
                      +||+|||.+................||+.|+|||++.+..+ +.++||||+|+++|||++|+.||........ ...+..
T Consensus       144 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  223 (276)
T 2yex_A          144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE  223 (276)
T ss_dssp             EEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT
T ss_pred             EEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh
Confidence            99999999987654333233345678999999999987765 6799999999999999999999976543322 222211


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      . .    ..   .+.......    .+.+++.+||+.||++|||++|+++
T Consensus       224 ~-~----~~---~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          224 K-K----TY---LNPWKKIDS----APLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             T-C----TT---STTGGGSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c-c----cc---cCchhhcCH----HHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1 0    00   011112222    4778999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-38  Score=357.43  Aligned_cols=251  Identities=26%  Similarity=0.348  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|+.+. ++.||||++.+..              .......+.+..|..++..+ +||+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~~~~hp~iv   84 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--------------VIQDDDVECTMVEKRVLALPGKPPFLT   84 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHTCTTCCTTBC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--------------hhcchHHHHHHHHHHHHHhcCCCCEEe
Confidence            4678889999999999999999754 7889999985431              11223456788999999988 799999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+++|+|.+++...  +.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus        85 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~  159 (353)
T 2i0e_A           85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH  159 (353)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             eEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence            9999999999999999999999999999853  4599999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+....+.  
T Consensus       160 vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~--  234 (353)
T 2i0e_A          160 IKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIM--  234 (353)
T ss_dssp             EEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH--
T ss_pred             EEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-HHHHHHHH--
Confidence            9999999998643322  123456799999999999999999999999999999999999999975432 22222211  


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                       .. ...  + |  ....    .++.+++.+|++.||++||+     ++|+++
T Consensus       235 -~~-~~~--~-p--~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          235 -EH-NVA--Y-P--KSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -HC-CCC--C-C--TTSC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -hC-CCC--C-C--CCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             11 110  0 0  1122    24778999999999999995     567664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-39  Score=353.40  Aligned_cols=266  Identities=23%  Similarity=0.242  Sum_probs=202.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC---CCc
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR---HKN  757 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~n  757 (1002)
                      .++|++.+.||+|+||+||+|+. .+++.||||++......            .........+.+|+.++++++   |||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~~~e~~~l~~l~~~~h~n   75 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG------------GGGGGLPISTVREVALLRRLEAFEHPN   75 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCC------------TTSSCCCHHHHHHHHHHHHHHHHCCTT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccc------------ccccccchhHHHHHHHHHHHhhcCCCC
Confidence            46899999999999999999996 56899999998543211            011112345667777777764   999


Q ss_pred             eeeeeeEEecCC-----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          758 IVKLWCCCTTRD-----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       758 iv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      |+++++++....     ..++||||++ |+|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        76 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Ni  151 (308)
T 3g33_A           76 VVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI  151 (308)
T ss_dssp             BCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTE
T ss_pred             eEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            999999998755     5799999995 6999999876666699999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      +++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus       152 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  228 (308)
T 3g33_A          152 LVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL  228 (308)
T ss_dssp             EECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999987654322   23457899999999999999999999999999999999999999765443333


Q ss_pred             HHHHHHHhhccCccc----------cccccc----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKGVDH----------VLDPKL----DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ........ ......          .+.+..    ....++....+.+++.+|++.||++|||++|+++
T Consensus       229 ~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIG-LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHC-CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhC-CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            33322211 100000          000000    0000111235788999999999999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-38  Score=357.31  Aligned_cols=258  Identities=20%  Similarity=0.256  Sum_probs=204.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|++.+.||+|+||.||+|..+ +++.||||++......            .......+.+.+|+.++++++||||++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hpnIv~   90 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT------------SSPGLSTEDLKREASICHMLKHPHIVE   90 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------------TSSSCCHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcc------------ccccchHHHHHHHHHHHHhCCCCCCCc
Confidence            457888999999999999999964 6899999998542110            011123567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++.+.+..|+||||+++|+|.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~  167 (351)
T 3c0i_A           91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKE  167 (351)
T ss_dssp             EEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSS
T ss_pred             EEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCC
Confidence            999999999999999999999998887643  234689999999999999999999999   999999999999998665


Q ss_pred             C---eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          839 G---ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       839 ~---~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .   +||+|||+++.......  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...  .......
T Consensus       168 ~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~  243 (351)
T 3c0i_A          168 NSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEG  243 (351)
T ss_dssp             TTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHH
T ss_pred             CCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHH
Confidence            4   99999999987765322  223457999999999999999999999999999999999999999753  1222111


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +..    ..... ..+......    ..+.+++.+||+.||++|||+.|+++
T Consensus       244 i~~----~~~~~-~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          244 IIK----GKYKM-NPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHH----TCCCC-CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHc----CCCCC-CccccccCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111    11100 000111222    24788999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7e-39  Score=358.01  Aligned_cols=252  Identities=20%  Similarity=0.323  Sum_probs=197.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....                .....+.+.+|+.++++++||||++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpniv~   68 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----------------RELAREKVMREVKALAKLEHPGIVR   68 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS----------------TTTHHHHHHHHHHHHTSCCCTTBCC
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC----------------chhHHHHHHHHHHHHHhCCCCCEee
Confidence            467888999999999999999975 78999999985321                2334677999999999999999999


Q ss_pred             eeeEEecCC---------------------------------------------------------eeeEEEeccCCCCh
Q 001867          761 LWCCCTTRD---------------------------------------------------------CKLLVYEYMPNGSL  783 (1002)
Q Consensus       761 l~~~~~~~~---------------------------------------------------------~~~lv~e~~~~g~L  783 (1002)
                      +++++.+..                                                         ..++||||+++|+|
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L  148 (332)
T 3qd2_B           69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL  148 (332)
T ss_dssp             EEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCH
T ss_pred             EEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCH
Confidence            999986543                                                         37999999999999


Q ss_pred             hhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCC-----
Q 001867          784 GDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-----  857 (1002)
Q Consensus       784 ~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~-----  857 (1002)
                      .+++..... ...++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++........     
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~  225 (332)
T 3qd2_B          149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT  225 (332)
T ss_dssp             HHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------
T ss_pred             HHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc
Confidence            999986432 4467778999999999999999999   9999999999999999999999999999887654321     


Q ss_pred             -----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCcccccccc
Q 001867          858 -----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPK  932 (1002)
Q Consensus       858 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (1002)
                           .......||+.|+|||++.+..++.++||||+||++|||++|..|+.      +....... .....        
T Consensus       226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~------~~~~~~~~-~~~~~--------  290 (332)
T 3qd2_B          226 PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERVRIITD-VRNLK--------  290 (332)
T ss_dssp             ------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH------HHHHHHHH-HHTTC--------
T ss_pred             cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh------HHHHHHHH-hhccC--------
Confidence                 12234579999999999999999999999999999999999876642      11111111 11111        


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          933 LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       933 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...........+.+++.+||+.||++|||++|+++
T Consensus       291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            11111222345678999999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=359.56  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             CCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          688 DNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      .+.||+|+||.||+|.. .+|+.||+|++...                 .....+.+.+|++++++++||||+++++++.
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  156 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR-----------------GMKDKEEVKNEISVMNQLDHANLIQLYDAFE  156 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC-----------------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-----------------ccccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            56899999999999996 46899999998432                 2234567999999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE--CCCCCeEEcc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL--DGDFGARVAD  844 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll--~~~~~~kl~D  844 (1002)
                      +.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||++  +.++.+||+|
T Consensus       157 ~~~~~~lv~E~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~D  232 (373)
T 2x4f_A          157 SKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIID  232 (373)
T ss_dssp             CSSEEEEEEECCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEe
Confidence            99999999999999999998875 334689999999999999999999999   99999999999999  5677899999


Q ss_pred             ccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      ||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....    
T Consensus       233 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~----  305 (373)
T 2x4f_A          233 FGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW----  305 (373)
T ss_dssp             CSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----
T ss_pred             CCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----
Confidence            999987754432   2344699999999999988899999999999999999999999976543332222222111    


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHh
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEV  972 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~  972 (1002)
                        ....+.......    .+.+++.+|++.||++|||++|+++  ++.+.
T Consensus       306 --~~~~~~~~~~~~----~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          306 --DLEDEEFQDISE----EAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             --CSCSGGGTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             --CCChhhhccCCH----HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence              011111122233    4788999999999999999999997  56554

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.1e-38  Score=349.95  Aligned_cols=261  Identities=21%  Similarity=0.273  Sum_probs=190.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....                .....+.+.+|+.++++++||||++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hp~iv~   67 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----------------EEGTPSTAIREISLMKELKHENIVR   67 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS----------------TTCSCHHHHHHHHHHTTCCBTTBCC
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc----------------ccccHHHHHHHHHHHHhcCCCCcce
Confidence            357888999999999999999964 68999999985421                1122356889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      +++++.+++..++||||++ |+|.+++....    ...+++..+..++.|++.||+|||++   +|+||||||+||+++.
T Consensus        68 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~  143 (317)
T 2pmi_A           68 LYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINK  143 (317)
T ss_dssp             EEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred             EEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcC
Confidence            9999999999999999997 69999987532    24689999999999999999999999   9999999999999999


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      ++.+||+|||+++.......  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||............
T Consensus       144 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i  221 (317)
T 2pmi_A          144 RGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI  221 (317)
T ss_dssp             TCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99999999999987654322  2234578999999999876 46899999999999999999999999765443333222


Q ss_pred             HHHHhhcc--C---------cc------------ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQK--G---------VD------------HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~--~---------~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ........  .         ..            ..+.+......   ..++.+++.+|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL---DGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccC---CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            22111000  0         00            00000011111   125789999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-38  Score=354.12  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=193.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|++.+....             ........+.+|+.++++++|||
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hp~   82 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-------------RNAKDTAHTKAERNILEEVKHPF   82 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------------------HHHHHHHCCCTT
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-------------hhhhHHHHHHHHHHHHHhCCCCC
Confidence            35688889999999999999997    46899999998543110             12233556789999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++...+..|+||||+++|+|.+++..  .+.+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        83 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~  157 (327)
T 3a62_A           83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ  157 (327)
T ss_dssp             BCCEEEEEECSSCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT
T ss_pred             ccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC
Confidence            99999999999999999999999999999975  34689999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||..............
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  235 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK  235 (327)
T ss_dssp             SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            9999999999976443221  22345799999999999999999999999999999999999999976532222211111


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                          . ...  +.   ....    ..+.+++.+||+.||++||     +++|+++
T Consensus       236 ----~-~~~--~p---~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          236 ----C-KLN--LP---PYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----T-CCC--CC---TTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----C-CCC--CC---CCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                1 000  01   1122    2477899999999999999     7778765

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-38  Score=373.64  Aligned_cols=255  Identities=22%  Similarity=0.273  Sum_probs=207.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+.+ +|+.||||++.+..              .......+.+.+|+.++++++||||+++
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~--------------~~~~~~~~~~~~E~~iL~~l~hp~Iv~l  249 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR--------------IKKRKGEAMALNEKQILEKVNSRFVVSL  249 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh--------------hhhhHHHHHHHHHHHHHHHcCCCCEeeE
Confidence            56778899999999999999974 68999999985421              1123345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..|+||||++||+|.+++.......+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+|
T Consensus       250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK  326 (576)
T 2acx_A          250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR  326 (576)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence            99999999999999999999999999865556699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+++.......   ....+||+.|+|||++.+..++.++||||+||++|||++|+.||................. 
T Consensus       327 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-  402 (576)
T 2acx_A          327 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-  402 (576)
T ss_dssp             ECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-
T ss_pred             EEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-
Confidence            999999987654322   2345799999999999998999999999999999999999999976543222222211111 


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .....  +.   ....    ..+.+++.+|++.||++||     +++|+++
T Consensus       403 ~~~~~--~p---~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          403 EVPEE--YS---ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HCCCC--CC---TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccccc--CC---ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            11100  00   1122    2477899999999999999     7888874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.9e-39  Score=350.59  Aligned_cols=251  Identities=20%  Similarity=0.342  Sum_probs=202.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-C-------cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-G-------EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR  754 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  754 (1002)
                      ++|.+.+.||+|+||.||+|.... +       ..||+|++...                 .....+.+.+|+.++++++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-----------------~~~~~~~~~~E~~~l~~l~   70 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-----------------HRNYSESFFEAASMMSKLS   70 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-----------------GGGGHHHHHHHHHHHHTSC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-----------------cHHHHHHHHHHHHHHHhCC
Confidence            467788999999999999998643 3       47999988432                 2334567999999999999


Q ss_pred             CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       755 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      ||||+++++++.+++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus        71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  146 (289)
T 4fvq_A           71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILL  146 (289)
T ss_dssp             CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEE
Confidence            999999999999999999999999999999999863 34599999999999999999999999   99999999999999


Q ss_pred             CCCCC--------eEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          835 DGDFG--------ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       835 ~~~~~--------~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      +.++.        +||+|||++......      ....||+.|+|||++.+ ..++.++||||+|+++|||++|+.|+..
T Consensus       147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~  220 (289)
T 4fvq_A          147 IREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS  220 (289)
T ss_dssp             EECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence            98887        999999998754321      23458899999999887 6789999999999999999997666654


Q ss_pred             CCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          906 EFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .............   .....    +.   ..    .++.+++.+||+.||++|||++|+++.|+++..
T Consensus       221 ~~~~~~~~~~~~~---~~~~~----~~---~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          221 ALDSQRKLQFYED---RHQLP----AP---KA----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             TSCHHHHHHHHHT---TCCCC----CC---SS----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ccchHHHHHHhhc---cCCCC----CC---CC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            4333332222211   11111    11   11    136788999999999999999999999999865

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=362.41  Aligned_cols=276  Identities=17%  Similarity=0.204  Sum_probs=204.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|...    ++..||+|++.......      ..............+.+|+.+++.++||||
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~------~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni  110 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL------FSELKFYQRVAKKDCIKKWIERKQLDYLGI  110 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHH------HHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcch------HHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence            46888999999999999999975    57889999985431100      000011122233457789999999999999


Q ss_pred             eeeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          759 VKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       759 v~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++++++..    ....|+||||+ +++|.+++....  .+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus       111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  184 (345)
T 2v62_A          111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL  184 (345)
T ss_dssp             CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence            999999987    77899999999 999999998543  799999999999999999999999   99999999999999


Q ss_pred             CCCC--CeEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 001867          835 DGDF--GARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF  907 (1002)
Q Consensus       835 ~~~~--~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~  907 (1002)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  264 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL  264 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8877  9999999999876533211     11235579999999999999999999999999999999999999996543


Q ss_pred             CchhHHHHHHHHhhccCcccccccccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLD-CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ........................... ..+.    ++.+++..||+.||++||++++|++.|+++..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          265 KDPVAVQTAKTNLLDELPQSVLKWAPSGSSCC----EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             TCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cccHHHHHHHHhhcccccHHHHhhccccccHH----HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            333323222222222111111000000 2222    48889999999999999999999999988754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-38  Score=344.56  Aligned_cols=258  Identities=31%  Similarity=0.468  Sum_probs=201.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++.......          ........+.+.+|+.++++++||||+++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG----------ETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTC----------CHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeecccccc----------chhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            5678889999999999999997 468999999985432110          00011122678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++.+..  ++||||+++|+|.+++.. +...+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence            99997665  699999999999998875 345799999999999999999999998   8  999999999999988776


Q ss_pred             -----eEEccccCcccccCCCCCcccccccccccccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh-
Q 001867          840 -----ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY--TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD-  911 (1002)
Q Consensus       840 -----~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~-  911 (1002)
                           +||+|||+++....     ......||+.|+|||++.  ...++.++||||+|+++|||++|+.||........ 
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  237 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK  237 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH
T ss_pred             CCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH
Confidence                 99999999975433     233457999999999984  45578899999999999999999999975433221 


Q ss_pred             HHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          912 LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .......    ......+   ....+    ..+.+++.+||+.||++|||++|+++.|+++
T Consensus       238 ~~~~~~~----~~~~~~~---~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          238 FINMIRE----EGLRPTI---PEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHH----SCCCCCC---CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHhc----cCCCCCC---CcccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111111    1111111   11222    2478899999999999999999999999763

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.5e-39  Score=354.11  Aligned_cols=264  Identities=24%  Similarity=0.371  Sum_probs=198.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....              ..+......+.+|+.++++++||||++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp~iv~   76 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL--------------ARDPSFYLRFRREAQNAAALNHPAIVA   76 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT--------------TTSHHHHHHHHHHHTTCCCCCCTTBCC
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc--------------cCCHHHHHHHHHHHHHHHcCCCCCcce
Confidence            46788899999999999999996 568999999985431              123445667999999999999999999


Q ss_pred             eeeEEecCCe----eeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          761 LWCCCTTRDC----KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       761 l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      +++++.....    .|+||||+++++|.++++..  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~  151 (311)
T 3ork_A           77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISA  151 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET
T ss_pred             EEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcC
Confidence            9999976543    39999999999999999753  4699999999999999999999999   9999999999999999


Q ss_pred             CCCeEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      ++.+||+|||+++........ .......||+.|+|||++.+..++.++||||+|+++|||++|+.||............
T Consensus       152 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~  231 (311)
T 3ork_A          152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH  231 (311)
T ss_dssp             TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            999999999999876544322 2233456899999999999999999999999999999999999999755332222221


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHHhhh
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR-VVKLLQEVGA  974 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e-vl~~L~~~~~  974 (1002)
                          ........  ........    .++.+++.+||+.||++||++.+ +.+.+.+...
T Consensus       232 ----~~~~~~~~--~~~~~~~~----~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          232 ----VREDPIPP--SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ----HHCCCCCH--HHHSTTCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ----hcCCCCCc--ccccCCCC----HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                11111100  00011122    24778999999999999996554 5566666544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-38  Score=355.08  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=206.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE------cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      .++|++.+.||+|+||.||+|++      .+++.||||++...                .......++.+|+.++++++|
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h   92 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----------------CSEQDELDFLMEALIISKFNH   92 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS----------------CCHHHHHHHHHHHHHHHHCCC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc----------------cchhhHHHHHHHHHHHhhCCC
Confidence            35788889999999999999984      34678999998432                123445678999999999999


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-----GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                      |||+++++++.+.+..|+||||+++|+|.+++.....     ..+++..++.++.|++.||+|||++   +|+||||||+
T Consensus        93 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~  169 (327)
T 2yfx_A           93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAAR  169 (327)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             CCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHh
Confidence            9999999999999999999999999999999986432     4589999999999999999999999   9999999999


Q ss_pred             cEEECC---CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 001867          831 NILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE  906 (1002)
Q Consensus       831 NIll~~---~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~  906 (1002)
                      ||+++.   +..+||+|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       170 NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  249 (327)
T 2yfx_A          170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  249 (327)
T ss_dssp             GEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             HEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence            999984   44699999999987655443333445568899999999999999999999999999999998 88998654


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      . ..+....+......        +.....+    ..+.+++.+||+.||++||+++++++.++.+....
T Consensus       250 ~-~~~~~~~~~~~~~~--------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          250 S-NQEVLEFVTSGGRM--------DPPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             C-HHHHHHHHHTTCCC--------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             C-HHHHHHHHhcCCCC--------CCCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            2 22222222211110        0111222    24788999999999999999999999999886544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-38  Score=366.08  Aligned_cols=207  Identities=25%  Similarity=0.367  Sum_probs=172.2

Q ss_pred             CcHHHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC
Q 001867          676 FSEYEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR  754 (1002)
Q Consensus       676 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  754 (1002)
                      ...+++.++|++.+.||+|+||.||+|... +++.||||++...               .......+++.+|+.++++++
T Consensus        19 ~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~   83 (432)
T 3n9x_A           19 IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---------------FEDLIDCKRILREITILNRLK   83 (432)
T ss_dssp             GGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST---------------TTSHHHHHHHHHHHHHHHHCC
T ss_pred             CCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch---------------hcChHHHHHHHHHHHHHHHcC
Confidence            344566788999999999999999999964 5889999998432               224455678999999999999


Q ss_pred             CCceeeeeeEEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          755 HKNIVKLWCCCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       755 h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                      ||||+++++++...     +..|+||||++ |+|.++++.  ...+++..++.++.||+.||+|||++   +|+||||||
T Consensus        84 h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp  157 (432)
T 3n9x_A           84 SDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKP  157 (432)
T ss_dssp             CTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             CCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCH
Confidence            99999999999766     57899999995 699999974  46699999999999999999999999   999999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCC--------------------cccccccccccccCcccc-ccCCCCCccchhh
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKP--------------------KSMSVIAGSCGYIAPEYA-YTLRVNEKSDIYS  888 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws  888 (1002)
                      +||+++.++.+||+|||+++........                    ......+||+.|+|||++ .+..++.++||||
T Consensus       158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS  237 (432)
T 3n9x_A          158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS  237 (432)
T ss_dssp             GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred             HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence            9999999999999999999877543221                    123566899999999985 5667999999999


Q ss_pred             HHHHHHHHHhCCCCC
Q 001867          889 FGVVILELVTGRLPV  903 (1002)
Q Consensus       889 lGvil~ell~g~~p~  903 (1002)
                      +||++|||++|..||
T Consensus       238 lG~il~ell~g~~p~  252 (432)
T 3n9x_A          238 TGCIFAELLNMLQSH  252 (432)
T ss_dssp             HHHHHHHHHTTCTTT
T ss_pred             HHHHHHHHHhccccc
Confidence            999999999865554

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-38  Score=350.18  Aligned_cols=265  Identities=20%  Similarity=0.224  Sum_probs=201.0

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....              ..+....+.+.+|+.++++++||||+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~hp~iv   97 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL--------------SSDPVFRTRMQREARTAGRLQEPHVV   97 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG--------------GGSHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc--------------ccCHHHHHHHHHHHHHHhhcCCCCee
Confidence            3578999999999999999999975 68899999984321              12334457899999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++..++..|+||||+++++|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~  172 (309)
T 2h34_A           98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDF  172 (309)
T ss_dssp             CEEEEEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             EEEEEEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCC
Confidence            9999999999999999999999999999853  4699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .    .....
T Consensus       173 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~----~~~~~  246 (309)
T 2h34_A          173 AYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-S----VMGAH  246 (309)
T ss_dssp             EEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-H----HHHHH
T ss_pred             EEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-H----HHHHH
Confidence            99999999987654322 222345689999999999999999999999999999999999999975421 1    11111


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHHhhhhc
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-AMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~~~~~  976 (1002)
                      ........  .......+.    .+.+++.+||+.||++|| +++++++.|+++....
T Consensus       247 ~~~~~~~~--~~~~~~~~~----~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          247 INQAIPRP--STVRPGIPV----AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHSCCCCG--GGTSTTCCT----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             hccCCCCc--cccCCCCCH----HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            11111100  001112222    477899999999999999 9999999999886544

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.9e-38  Score=349.90  Aligned_cols=264  Identities=23%  Similarity=0.343  Sum_probs=200.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .++|.+.+.||+|+||.||+|...    .+..||+|++....               ......+.+.+|+.++++++|||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~   97 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN---------------SSQREIEEFLSEAACMKDFSHPN   97 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C---------------CCHHHHHHHHHHHHHHHTCCCTT
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc---------------cchhHHHHHHHHHHHHhcCCCCC
Confidence            357888899999999999999864    24589999984321               12344567999999999999999


Q ss_pred             eeeeeeEEecCC-----eeeEEEeccCCCChhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 001867          758 IVKLWCCCTTRD-----CKLLVYEYMPNGSLGDLLHSC----KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK  828 (1002)
Q Consensus       758 iv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk  828 (1002)
                      |+++++++.+.+     ..++||||+++|+|.+++...    ....+++..++.++.|++.||+|||++   +|+|||||
T Consensus        98 iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dik  174 (313)
T 3brb_A           98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLA  174 (313)
T ss_dssp             BCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCS
T ss_pred             eeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            999999998755     349999999999999998532    346799999999999999999999999   99999999


Q ss_pred             CCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 001867          829 SNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEF  907 (1002)
Q Consensus       829 ~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~  907 (1002)
                      |+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus       175 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  254 (313)
T 3brb_A          175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ  254 (313)
T ss_dssp             GGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            9999999999999999999987765443334445567889999999999999999999999999999999 888886553


Q ss_pred             CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      . .............        +.....+    ..+.+++.+||+.||++||+++++++.|+++....
T Consensus       255 ~-~~~~~~~~~~~~~--------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          255 N-HEMYDYLLHGHRL--------KQPEDCL----DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             G-GGHHHHHHTTCCC--------CCBTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             H-HHHHHHHHcCCCC--------CCCcccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            3 3333322211110        1112222    24788999999999999999999999999986543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-38  Score=344.55  Aligned_cols=253  Identities=23%  Similarity=0.300  Sum_probs=205.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++....               ......+.+.+|+.++++++||||++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~   69 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK---------------LSARDFQKLEREARICRKLQHPNIVR   69 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---------------CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc---------------CCHHHHHHHHHHHHHHHHcCCCCcCe
Confidence            467888999999999999999964 58999999985421               13344567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC-
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-  839 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~-  839 (1002)
                      +++++...+..++||||+++++|.+++...  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++. 
T Consensus        70 ~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~  144 (284)
T 3kk8_A           70 LHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG  144 (284)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTT
T ss_pred             EEEEEEcCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCC
Confidence            999999999999999999999999988753  5699999999999999999999999   9999999999999986655 


Q ss_pred             --eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          840 --ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       840 --~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                        +||+|||++........   .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... .....+.
T Consensus       145 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~  220 (284)
T 3kk8_A          145 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIK  220 (284)
T ss_dssp             CCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH
T ss_pred             CcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHH
Confidence              99999999987654322   23457999999999999999999999999999999999999999764322 2222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...    . ....+......+    .+.+++.+|++.||++|||++|+++
T Consensus       221 ~~~----~-~~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          221 AGA----Y-DYPSPEWDTVTP----EAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HTC----C-CCCTTTTTTSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hcc----c-cCCchhhcccCH----HHHHHHHHHcccChhhCCCHHHHhc
Confidence            111    1 111111222333    4778999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-38  Score=351.51  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=203.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +.|+..+.||+|+||.||+|....     +..||||++....                .......+.+|+.++++++|||
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~  107 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----------------TEKQRVDFLGEAGIMGQFSHHN  107 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence            456678899999999999998643     2359999984321                2344567999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~  183 (333)
T 1mqb_A          108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN  183 (333)
T ss_dssp             BCCEEEEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             CCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCC
Confidence            99999999999999999999999999999976 345799999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~  915 (1002)
                      +.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .+....
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-~~~~~~  262 (333)
T 1mqb_A          184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKA  262 (333)
T ss_dssp             CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHH
T ss_pred             CcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-HHHHHH
Confidence            99999999999876543221 12223356789999999999999999999999999999999 9999965432 222222


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                      +....   ..     +.....+    ..+.+++.+||+.||++||+++++++.|+++.....
T Consensus       263 ~~~~~---~~-----~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          263 INDGF---RL-----PTPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             HHTTC---CC-----CCCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHCCC---cC-----CCcccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            21111   00     1111222    247889999999999999999999999999875433

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-38  Score=370.52  Aligned_cols=263  Identities=24%  Similarity=0.276  Sum_probs=199.1

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +.+.++|++.+.||+|+||.||+|... +++.||||++.+.               .......+++.+|+.+++.++|||
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~hpn  122 (464)
T 3ttj_A           58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------------FQNQTHAKRAYRELVLMKCVNHKN  122 (464)
T ss_dssp             EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG---------------GGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc---------------ccChHHHHHHHHHHHHHHhCCCCC
Confidence            445678999999999999999999964 5899999998542               223455677899999999999999


Q ss_pred             eeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++...      ...|+||||+++ ++.+.+.    ..+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus       123 Iv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~N  194 (464)
T 3ttj_A          123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN  194 (464)
T ss_dssp             BCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             CCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHh
Confidence            99999999755      356999999964 5766664    2489999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |+++.++.+||+|||+++......   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.
T Consensus       195 Ill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~  271 (464)
T 3ttj_A          195 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ  271 (464)
T ss_dssp             EEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999998765432   23456799999999999999999999999999999999999999976543333


Q ss_pred             HHHHHHHHhhc------------------c------Cccccccccc-c---CCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 001867          912 LVKWVCSTLDQ------------------K------GVDHVLDPKL-D---CCFKEEICKVLNIGLLCTSPLPINRPAMR  963 (1002)
Q Consensus       912 ~~~~~~~~~~~------------------~------~~~~~~~~~~-~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  963 (1002)
                      +...+......                  .      .....+.... .   ........++.+++.+|++.||++|||++
T Consensus       272 ~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~  351 (464)
T 3ttj_A          272 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  351 (464)
T ss_dssp             HHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHH
Confidence            33322211100                  0      0000000000 0   00011134688999999999999999999


Q ss_pred             HHHH
Q 001867          964 RVVK  967 (1002)
Q Consensus       964 evl~  967 (1002)
                      |+++
T Consensus       352 e~L~  355 (464)
T 3ttj_A          352 DALQ  355 (464)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=363.43  Aligned_cols=270  Identities=22%  Similarity=0.259  Sum_probs=212.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|.+.++||+|+||.||+|... +++.||||++....                .....+.+.+|++++++++||||+++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpnIv~~   72 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS----------------FLRPVDVQMREFEVLKKLNHKNIVKL   72 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG----------------GGSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc----------------ccchHHHHHHHHHHHHhcCCCCCCeE
Confidence            46788899999999999999975 48999999984321                12235667899999999999999999


Q ss_pred             eeEEecCC--eeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE----
Q 001867          762 WCCCTTRD--CKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL----  834 (1002)
Q Consensus       762 ~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll----  834 (1002)
                      ++++...+  ..++||||+++|+|.++++.... ..+++..++.++.|++.||+|||++   +|+||||||+||++    
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  149 (396)
T 4eut_A           73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGE  149 (396)
T ss_dssp             EEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECT
T ss_pred             EEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecC
Confidence            99998755  77999999999999999986432 3499999999999999999999999   99999999999999    


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc--------CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT--------LRVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      +.++.+||+|||+++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~  226 (396)
T 4eut_A          150 DGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (396)
T ss_dssp             TSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             CCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            777789999999998765432   2234569999999998865        56778999999999999999999999754


Q ss_pred             CCchhHHHHHHHHhhccCccc---c------------ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          907 FGEKDLVKWVCSTLDQKGVDH---V------------LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~---~------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      .........+...........   .            ..+............+.+++.+||+.||++||+++|+++.+++
T Consensus       227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             TCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            333322222222222111100   0            0011123335566678899999999999999999999999998


Q ss_pred             hhh
Q 001867          972 VGA  974 (1002)
Q Consensus       972 ~~~  974 (1002)
                      +..
T Consensus       307 il~  309 (396)
T 4eut_A          307 ILH  309 (396)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-38  Score=353.59  Aligned_cols=261  Identities=22%  Similarity=0.348  Sum_probs=211.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      .++|++.+.||+|+||.||+|...      +++.||+|++...                ........+.+|+.++++++|
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h   87 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----------------ASMRERIEFLNEASVMKEFNC   87 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----------------SCHHHHHHHHHHHHHGGGCCC
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc----------------cCHHHHHHHHHHHHHHHhcCC
Confidence            357888999999999999999864      3678999998432                123345678999999999999


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV  827 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDl  827 (1002)
                      |||+++++++.+.+..++||||+++|+|.++++...        ...+++..++.++.|++.||+|||++   +|+||||
T Consensus        88 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~di  164 (322)
T 1p4o_A           88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDL  164 (322)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCC
T ss_pred             CCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCC
Confidence            999999999999999999999999999999987532        14679999999999999999999999   9999999


Q ss_pred             CCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 001867          828 KSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPE  906 (1002)
Q Consensus       828 k~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~  906 (1002)
                      ||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+|+++|||++ |+.||...
T Consensus       165 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          165 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             SGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             ccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            99999999999999999999987655433333344567889999999999999999999999999999999 88888654


Q ss_pred             CCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      . ..+....+..    ...    .+.....+    ..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       245 ~-~~~~~~~~~~----~~~----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          245 S-NEQVLRFVME----GGL----LDKPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             C-HHHHHHHHHT----TCC----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             C-HHHHHHHHHc----CCc----CCCCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            2 2222222211    111    01112222    247889999999999999999999999988744

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=349.00  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=199.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++...               .......+.+.+|+.++++++||||++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~i~~   66 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---------------EDDPVIKKIALREIRMLKQLKHPNLVN   66 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC---------------CC-HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc---------------ccchHHHHHHHHHHHHHHhCCCCCccc
Confidence            467888999999999999999975 5899999988432               123344677889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++++|.+++..  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        67 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  141 (311)
T 4agu_A           67 LLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVI  141 (311)
T ss_dssp             EEEEEEETTEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             hhheeecCCeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCE
Confidence            99999999999999999999999998873  45699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++........  ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+...... ..
T Consensus       142 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~  218 (311)
T 4agu_A          142 KLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR-KT  218 (311)
T ss_dssp             EECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HH
T ss_pred             EEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HH
Confidence            9999999987654322  2234578999999999876 668999999999999999999999997654333322221 11


Q ss_pred             hhc-----------c-Ccc--cccccccc----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQ-----------K-GVD--HVLDPKLD----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~-----------~-~~~--~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...           . ...  ...++...    ...+.....+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          219 LGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            100           0 000  00011000    000111234788999999999999999999984

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-38  Score=362.20  Aligned_cols=251  Identities=24%  Similarity=0.317  Sum_probs=192.6

Q ss_pred             HhcCCCcC-CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhc-CCCCc
Q 001867          681 ILDGLDED-NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGK-IRHKN  757 (1002)
Q Consensus       681 ~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~n  757 (1002)
                      +.++|.+. +.||+|+||+||+|..+ +++.||||++..                      ...+.+|++++.+ .+|||
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----------------------~~~~~~E~~~~~~~~~hp~  116 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------------CPKARREVELHWRASQCPH  116 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------------------SHHHHHHHHHHHHHTTSTT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----------------------chhHHHHHHHHHHhcCCCC
Confidence            45667665 68999999999999975 688999999832                      1346778888754 47999


Q ss_pred             eeeeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          758 IVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       758 iv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      |+++++++..    .+..|+||||+++|+|.+++.......+++..++.++.||+.||+|||++   +|+||||||+||+
T Consensus       117 iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nil  193 (400)
T 1nxk_A          117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLL  193 (400)
T ss_dssp             BCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             cceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEE
Confidence            9999999875    56789999999999999999865556799999999999999999999999   9999999999999


Q ss_pred             ECC---CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          834 LDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       834 l~~---~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      ++.   ++.+||+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       194 l~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  270 (400)
T 1nxk_A          194 YTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_dssp             ESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred             EecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence            987   7889999999998664332   2335578999999999999999999999999999999999999997654322


Q ss_pred             ---hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          911 ---DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       911 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                         .....+..    ... ....+.......    ++.+++.+||+.||++|||++|+++.
T Consensus       271 ~~~~~~~~i~~----~~~-~~~~~~~~~~s~----~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          271 ISPGMKTRIRM----GQY-EFPNPEWSEVSE----EVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             SCCSHHHHHHH----TCC-CCCTTTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccHHHHHHHHc----Ccc-cCCCcccccCCH----HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               12222111    111 011111122233    47889999999999999999999964

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.9e-38  Score=350.02  Aligned_cols=257  Identities=22%  Similarity=0.289  Sum_probs=206.9

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.+.|++.+.||+|+||.||+|... +|+.||+|++.......           .......+.+.+|+.++++++||||+
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~iv   78 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA-----------SRRGVSREEIEREVSILRQVLHHNVI   78 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS-----------CSSSBCHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc-----------cccchhHHHHHHHHHHHHhCCCCCcc
Confidence            3467888999999999999999975 58999999986542211           11122356799999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-  838 (1002)
                      ++++++.+.+..++||||+++++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++ 
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~  153 (321)
T 2a2a_A           79 TLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNI  153 (321)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTS
T ss_pred             eEEEEEecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCC
Confidence            999999999999999999999999999974  45689999999999999999999999   999999999999999887 


Q ss_pred             ---CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          839 ---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       839 ---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                         .+||+|||++........   .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ....
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~  229 (321)
T 2a2a_A          154 PIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLAN  229 (321)
T ss_dssp             SSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHH
T ss_pred             CcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHH
Confidence               799999999987655322   234469999999999999999999999999999999999999997543222 2211


Q ss_pred             HHHHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +..    ...  ..++.. ....    ..+.+++.+||+.||++|||++|+++
T Consensus       230 i~~----~~~--~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          230 ITS----VSY--DFDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHT----TCC--CCCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHh----ccc--ccChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111    000  011111 1122    24778999999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-38  Score=360.13  Aligned_cols=250  Identities=23%  Similarity=0.244  Sum_probs=192.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHH-HhcCCCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET-LGKIRHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|+.+ +++.||||++.+..              .......+.+.+|..+ ++.++||||+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~--------------~~~~~~~~~~~~e~~~ll~~~~hp~Iv  102 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA--------------ILKKKEEKHIMSERNVLLKNVKHPFLV  102 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGG--------------BC-------------CCBCCCCCTTBC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHH--------------hhhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            467888999999999999999975 57899999985432              1123334556777777 5678999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+++|+|.+++..  .+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus       103 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~  177 (373)
T 2r5t_A          103 GLHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGH  177 (373)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             CEEEEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCC
Confidence            999999999999999999999999999985  34689999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++.......  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........+.....  
T Consensus       178 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--  253 (373)
T 2r5t_A          178 IVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--  253 (373)
T ss_dssp             EEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--
T ss_pred             EEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--
Confidence            99999999986433221  23456799999999999999999999999999999999999999975432222222111  


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                        . ...  +.   ....    ..+.+++.+|++.||++||++.+..
T Consensus       254 --~-~~~--~~---~~~~----~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          254 --K-PLQ--LK---PNIT----NSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             --S-CCC--CC---SSSC----HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             --c-ccC--CC---CCCC----HHHHHHHHHHcccCHHhCCCCCCCH
Confidence              1 110  11   1122    2477899999999999999986433

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=357.49  Aligned_cols=252  Identities=13%  Similarity=0.151  Sum_probs=205.7

Q ss_pred             cCCCcCCeeeecCCccEEEEE------EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--
Q 001867          683 DGLDEDNVIGSGSSGKVYKVV------LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--  754 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--  754 (1002)
                      ++|.+.+.||+|+||.||+|.      ..+++.||||++..                    ....++..|++++++++  
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--------------------~~~~~~~~e~~~~~~l~~~  124 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--------------------ANPWEFYIGTQLMERLKPS  124 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--------------------CCHHHHHHHHHHHHHSCGG
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--------------------CChhHHHHHHHHHHHhhhh
Confidence            457788999999999999993      45688999999832                    12456788888888887  


Q ss_pred             -CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCC
Q 001867          755 -HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC---KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSN  830 (1002)
Q Consensus       755 -h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~  830 (1002)
                       |+||+++++++...+..|+||||+++|+|.+++...   ....+++..++.++.|++.||+|||++   +||||||||+
T Consensus       125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~  201 (365)
T 3e7e_A          125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPD  201 (365)
T ss_dssp             GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGG
T ss_pred             hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHH
Confidence             999999999999999999999999999999999753   346799999999999999999999999   9999999999


Q ss_pred             cEEECC-----------CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhC
Q 001867          831 NILLDG-----------DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG  899 (1002)
Q Consensus       831 NIll~~-----------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g  899 (1002)
                      ||+++.           ++.+||+|||+++..............+||+.|||||++.+..++.++|||||||++|||++|
T Consensus       202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  281 (365)
T 3e7e_A          202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG  281 (365)
T ss_dssp             GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence            999998           899999999999876544344445567899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHHHhhccCccccccccccC-CCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHHhhhhc
Q 001867          900 RLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDC-CFKEEICKVLNIGLLCTSPLPINR-PAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       900 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~R-ps~~evl~~L~~~~~~~  976 (1002)
                      +.||.......                ..+...... ...+   .+.+++..|++.+|.+| |+++++.+.|+++....
T Consensus       282 ~~pf~~~~~~~----------------~~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          282 TYMKVKNEGGE----------------CKPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             SCCCEEEETTE----------------EEECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCccccCCCCc----------------eeechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            99985432111                001111111 1223   35677788999999998 78999999999887654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.8e-38  Score=346.99  Aligned_cols=268  Identities=21%  Similarity=0.327  Sum_probs=203.3

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++...              ...+....+.+.+|+.++++++||||+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~h~~i~   95 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIF--------------DLMDAKARADCIKEIDLLKQLNHPNVI   95 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTT--------------SSCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehh--------------hccCHHHHHHHHHHHHHHHhCCCCCEe
Confidence            356788899999999999999996 56899999998432              112345567899999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++...+..++||||+++++|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~  172 (310)
T 2wqm_A           96 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT  172 (310)
T ss_dssp             CEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             eEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCC
Confidence            9999999999999999999999999998752  346799999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||++........  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......  .....
T Consensus       173 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~  248 (310)
T 2wqm_A          173 GVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCK  248 (310)
T ss_dssp             SCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH--HHHHH
T ss_pred             CCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH--HHHHH
Confidence            9999999999987654322  2234468999999999999999999999999999999999999997543221  11111


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                      . ..........   ......    .+.+++.+||+.||++|||++++++.|+++.+..+
T Consensus       249 ~-~~~~~~~~~~---~~~~~~----~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          249 K-IEQCDYPPLP---SDHYSE----ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             H-HHTTCSCCCC---TTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H-hhcccCCCCc---ccccCH----HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            1 1111111110   012222    47789999999999999999999999999987543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5e-39  Score=381.15  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=208.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||.||+|.+.++..||||++...                  ....+.|.+|++++++++||||++++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~~~  328 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY  328 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC------------------CCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence            457778899999999999999988889999998432                  11246799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+ +..|+||||+++|+|.++++......+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||
T Consensus       329 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl  404 (535)
T 2h8h_A          329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  404 (535)
T ss_dssp             EEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEE
Confidence            99876 6789999999999999999865556799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+....+.....
T Consensus       405 ~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~  482 (535)
T 2h8h_A          405 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYR  482 (535)
T ss_dssp             CCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-HHHHHHHHHTTCC
T ss_pred             cccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCC
Confidence            99999986643211 11123356789999999999999999999999999999999 899986543 2233332221111


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                              .+....++    ..+.+++.+||+.||++|||+++|++.|+++..
T Consensus       483 --------~~~~~~~~----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 --------MPCPPECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             --------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             --------CCCCCCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                    01112222    247889999999999999999999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.1e-38  Score=344.97  Aligned_cols=276  Identities=18%  Similarity=0.239  Sum_probs=210.4

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+.++|++.+.||+|+||.||+|.. .+++.||||++...                   .....+.+|+.++++++|+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~~e~~~l~~l~~~~~   66 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------------TKHPQLHIESKIYKMMQGGVG   66 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------------------CCCHHHHHHHHHHHTTSTT
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-------------------ccchHHHHHHHHHHHhcCCCC
Confidence            4457899999999999999999996 56899999986332                   123458889999999998776


Q ss_pred             eeeeeEE-ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---
Q 001867          759 VKLWCCC-TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---  834 (1002)
Q Consensus       759 v~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll---  834 (1002)
                      +..++++ ...+..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||++   
T Consensus        67 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~  141 (296)
T 4hgt_A           67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLG  141 (296)
T ss_dssp             CCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCG
T ss_pred             CCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeecc
Confidence            6666555 6778889999999 99999999753 35699999999999999999999999   99999999999999   


Q ss_pred             CCCCCeEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          835 DGDFGARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +.++.+||+|||+++........     .......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       142 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  221 (296)
T 4hgt_A          142 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred             CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence            78899999999999877654321     1223557999999999999999999999999999999999999999754322


Q ss_pred             --hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCCCCCC
Q 001867          910 --KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKL  987 (1002)
Q Consensus       910 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~~  987 (1002)
                        ..................    .....+    ..+.+++.+||+.||++|||++++++.|+++......      ...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~------~~~  287 (296)
T 4hgt_A          222 TKRQKYERISEKKMSTPIEV----LCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF------SYD  287 (296)
T ss_dssp             SSSSHHHHHHHHHHHSCHHH----HTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC------CTT
T ss_pred             hhhhhhhhhhcccccchhhh----hhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC------Ccc
Confidence              122221111111111000    001122    2488899999999999999999999999999765432      334


Q ss_pred             Ccchhh
Q 001867          988 SPYYHE  993 (1002)
Q Consensus       988 ~~~~~~  993 (1002)
                      .|+.|+
T Consensus       288 ~~~dw~  293 (296)
T 4hgt_A          288 YVFDWN  293 (296)
T ss_dssp             CCCGGG
T ss_pred             Cccchh
Confidence            566665

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-38  Score=344.02  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=208.1

Q ss_pred             CCCcCC-eeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          684 GLDEDN-VIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       684 ~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +|.+.+ .||+|+||.||+|...   ++..||||++...                ......+.+.+|++++++++||||+
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~i~   73 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------------TEKADTEEMMREAQIMHQLDNPYIV   73 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----------------CCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----------------cchhHHHHHHHHHHHHHhCCCCCEe
Confidence            344444 8999999999999853   5788999998432                1234567799999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++. .+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        74 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~  148 (287)
T 1u59_A           74 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY  148 (287)
T ss_dssp             CEEEEEE-SSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTE
T ss_pred             EEEEEec-CCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCC
Confidence            9999994 5568999999999999999975 345699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +||+|||++.......... ......||+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+....+.
T Consensus       149 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~i~  227 (287)
T 1u59_A          149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIE  227 (287)
T ss_dssp             EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHH
T ss_pred             EEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHh
Confidence            9999999998775443221 1223456889999999998889999999999999999998 9999976533 23332222


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                      ....    .    +.....+    ..+.+++..||+.||++||+++++++.|+++.....
T Consensus       228 ~~~~----~----~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          228 QGKR----M----ECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             TTCC----C----CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cCCc----C----CCCCCcC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            1110    0    1111222    248889999999999999999999999999865443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=348.92  Aligned_cols=246  Identities=24%  Similarity=0.295  Sum_probs=193.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.++||+|+||+||+|+.. +++.||||++....               ........+..|+..+.++ +||||+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~~~~~~~h~~iv  120 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF---------------RGPKDRARKLAEVGSHEKVGQHPCCV  120 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC---------------CSHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc---------------cChHHHHHHHHHHHHHHHhcCCCcEE
Confidence            367888999999999999999975 68999999874321               1233344555666666555 899999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+ +++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       121 ~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~  195 (311)
T 3p1a_A          121 RLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGR  195 (311)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGC
T ss_pred             EEEEEEEeCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCC
Confidence            9999999999999999999 78999988764 45699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...   ... ..    
T Consensus       196 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~-~~----  263 (311)
T 3p1a_A          196 CKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGW-QQ----  263 (311)
T ss_dssp             EEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHH-HH----
T ss_pred             EEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHH-HH----
Confidence            9999999998765432   2334569999999998876 7899999999999999999997776432   111 11    


Q ss_pred             hhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......    .+.. ....    ..+.+++.+||+.||++|||++|+++
T Consensus       264 ~~~~~~----~~~~~~~~~----~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          264 LRQGYL----PPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HTTTCC----CHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhccCC----CcccccCCC----HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            111111    1111 1122    34788999999999999999999984

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-38  Score=354.34  Aligned_cols=268  Identities=22%  Similarity=0.253  Sum_probs=205.7

Q ss_pred             CCcHHHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC
Q 001867          675 GFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI  753 (1002)
Q Consensus       675 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  753 (1002)
                      +-+..++.++|++.+.||+|+||.||+|.. .+++.||+|++.+....            .......+.+.+|+.+++++
T Consensus        18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l   85 (345)
T 3hko_A           18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR------------QINPKDVERIKTEVRLMKKL   85 (345)
T ss_dssp             CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------------C---CHHHHHHHHHHHHHHC
T ss_pred             CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhc------------ccCHHHHHHHHHHHHHHHhC
Confidence            344567788999999999999999999996 46889999998543110            11234467899999999999


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------------------------------CCCC
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------------------------------GGLL  795 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l  795 (1002)
                      +||||+++++++.+.+..++||||+++|+|.+++....                                      ...+
T Consensus        86 ~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (345)
T 3hko_A           86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQ  165 (345)
T ss_dssp             CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHH
T ss_pred             CCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999985210                                      1224


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC--CeEEccccCcccccCCCC--CcccccccccccccC
Q 001867          796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF--GARVADFGVAKVVDASGK--PKSMSVIAGSCGYIA  871 (1002)
Q Consensus       796 ~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~--~~kl~DfGl~~~~~~~~~--~~~~~~~~gt~~y~a  871 (1002)
                      ++..++.++.|++.||+|||++   +|+||||||+||+++.++  .+||+|||+++.......  ........||+.|+|
T Consensus       166 ~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  242 (345)
T 3hko_A          166 REKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA  242 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred             cHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence            6778899999999999999999   999999999999998776  899999999987644222  112345679999999


Q ss_pred             cccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHH
Q 001867          872 PEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGL  949 (1002)
Q Consensus       872 PE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  949 (1002)
                      ||++.+  ..++.++|||||||++|||++|+.||.................      ....+......+    .+.+++.
T Consensus       243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~----~~~~li~  312 (345)
T 3hko_A          243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL------CFENPNYNVLSP----LARDLLS  312 (345)
T ss_dssp             HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------CTTSGGGGGSCH----HHHHHHH
T ss_pred             chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc------ccCCcccccCCH----HHHHHHH
Confidence            999875  6788999999999999999999999976543332222221111      011111122222    4778999


Q ss_pred             HcCCCCCCCCCCHHHHHH
Q 001867          950 LCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       950 ~cl~~dP~~Rps~~evl~  967 (1002)
                      +||+.||++||++.|+++
T Consensus       313 ~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          313 NLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHSCSCTTTSCCHHHHHH
T ss_pred             HHcCCChhHCCCHHHHhc
Confidence            999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.6e-38  Score=356.46  Aligned_cols=258  Identities=23%  Similarity=0.250  Sum_probs=203.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-----C
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-----H  755 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h  755 (1002)
                      .++|++.++||+|+||.||+|+. .+++.||||++..                  .......+..|+.+++++.     |
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------------------~~~~~~~~~~e~~~l~~l~~~~~~h   95 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------------------IKKYTRSAKIEADILKKIQNDDINN   95 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------------------CHHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------------------chhhhhhhHHHHHHHHHhcccCCCC
Confidence            46899999999999999999997 4688999999842                  2334566788999999986     9


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |||+++++++...+..++||||+ +++|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus        96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~  171 (360)
T 3llt_A           96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLD  171 (360)
T ss_dssp             GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred             CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEc
Confidence            99999999999999999999999 99999999876667799999999999999999999999   999999999999997


Q ss_pred             C-------------------------CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHH
Q 001867          836 G-------------------------DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFG  890 (1002)
Q Consensus       836 ~-------------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  890 (1002)
                      .                         ++.+||+|||+++......     ....||+.|+|||++.+..++.++||||+|
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHH
Confidence            5                         7889999999998654332     245689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccC-----------ccccccc-----ccc--CCCHH-------------
Q 001867          891 VVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKG-----------VDHVLDP-----KLD--CCFKE-------------  939 (1002)
Q Consensus       891 vil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-----~~~--~~~~~-------------  939 (1002)
                      |++|||++|+.||....... ....+........           ....++.     ...  .....             
T Consensus       247 ~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  325 (360)
T 3llt_A          247 CVLAELYTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK  325 (360)
T ss_dssp             HHHHHHHHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred             HHHHHHHHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence            99999999999997653322 2222221111000           0000000     000  00000             


Q ss_pred             --HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          940 --EICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       940 --~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                        ....+.+++.+||+.||++|||++|+++
T Consensus       326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          326 IIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              0134679999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=352.67  Aligned_cols=251  Identities=23%  Similarity=0.302  Sum_probs=203.2

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.......         .........+.+.+|+.++++++||||+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~Iv   92 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE---------DCWIEDPKLGKVTLEIAILSRVEHANII   92 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCT---------TSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccc---------ccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence            456789999999999999999996 568899999986542110         0111122345678899999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNG-SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      ++++++.+.+..++||||+.+| +|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A           93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             CEEEEEECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred             eEEEEEeeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence            9999999999999999999777 99999974  45699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||+++.......   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....         
T Consensus       168 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------  235 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------  235 (335)
T ss_dssp             CEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred             cEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence            999999999987755432   234579999999999988876 7899999999999999999999964210         


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                            ....... ......+    .+.+++.+||+.||++|||++|+++.
T Consensus       236 ------~~~~~~~-~~~~~~~----~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ------TVEAAIH-PPYLVSK----ELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------GTTTCCC-CSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------HHhhccC-CCcccCH----HHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000000 0111222    47889999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-38  Score=344.30  Aligned_cols=253  Identities=26%  Similarity=0.333  Sum_probs=197.4

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.+.|.+.+.||+|+||.||+|.. .++..||+|++....                .....+.+.+|++++++++||||+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~hp~iv   83 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR----------------SQVPMEQIEAEIEVLKSLDHPNII   83 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG----------------CCSCHHHHHHHHHHHHTCCCTTBC
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc----------------cchhHHHHHHHHHHHHhCCCchHH
Confidence            456788899999999999999996 468899999985431                122356789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---  834 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll---  834 (1002)
                      ++++++.+.+..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+||++   
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~  160 (285)
T 3is5_A           84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDT  160 (285)
T ss_dssp             CEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSS
T ss_pred             hHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecC
Confidence            9999999999999999999999999988643  346799999999999999999999999   99999999999999   


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      +.++.+||+|||+++.......   .....||+.|+|||++. ..++.++||||+|+++|||++|+.||..... .+...
T Consensus       161 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-~~~~~  235 (285)
T 3is5_A          161 SPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-EEVQQ  235 (285)
T ss_dssp             STTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH
T ss_pred             CCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-HHHHh
Confidence            4567899999999987654322   23456899999999875 5688999999999999999999999975432 22211


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....   . ....  ........+    .+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~---~-~~~~--~~~~~~~~~----~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          236 KATY---K-EPNY--AVECRPLTP----QAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHH---C-CCCC--CC--CCCCH----HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             hhcc---C-Cccc--ccccCcCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111   1 1010  001111222    4778999999999999999999984

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=5.9e-38  Score=367.23  Aligned_cols=150  Identities=27%  Similarity=0.356  Sum_probs=86.4

Q ss_pred             cCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccc
Q 001867          402 GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVV  481 (1002)
Q Consensus       402 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  481 (1002)
                      ..+++|++|++++|++++..|  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..|  ++.+++|+.
T Consensus       240 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~  313 (466)
T 1o6v_A          240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTY  313 (466)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSE
T ss_pred             hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCE
Confidence            344444444444444443332  4444455555555555544333  4555555666666666554332  556666666


Q ss_pred             ccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceee
Q 001867          482 LSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       482 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      |++++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++.+|  +..+++|+.|++++|++
T Consensus       314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~  387 (466)
T 1o6v_A          314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW  387 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred             EECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence            6666666665444  55666666666666666654  356666666777777777666555  66667777777777777


Q ss_pred             ec
Q 001867          562 SG  563 (1002)
Q Consensus       562 ~~  563 (1002)
                      ++
T Consensus       388 ~~  389 (466)
T 1o6v_A          388 TN  389 (466)
T ss_dssp             EC
T ss_pred             cC
Confidence            65

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-37  Score=342.28  Aligned_cols=276  Identities=18%  Similarity=0.227  Sum_probs=214.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....                   ..+.+.+|+.++++++|++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~~e~~~l~~l~~~~~i~   68 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-------------------KHPQLHIESKIYKMMQGGVGIP   68 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-------------------SCCHHHHHHHHHHHHTTSTTCC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-------------------chhHHHHHHHHHHHhhcCCCCC
Confidence            46788899999999999999996 578999999874321                   1235889999999999877666


Q ss_pred             eeeEE-ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC---C
Q 001867          761 LWCCC-TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---G  836 (1002)
Q Consensus       761 l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~---~  836 (1002)
                      .+.++ ...+..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++   .
T Consensus        69 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  143 (296)
T 3uzp_A           69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKK  143 (296)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGG
T ss_pred             ccccccCCCCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCC
Confidence            55555 5677889999999 99999999753 35699999999999999999999999   999999999999994   7


Q ss_pred             CCCeEEccccCcccccCCCCCc-----ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc--
Q 001867          837 DFGARVADFGVAKVVDASGKPK-----SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE--  909 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~--  909 (1002)
                      ++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  
T Consensus       144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  223 (296)
T 3uzp_A          144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  223 (296)
T ss_dssp             TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred             CCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh
Confidence            8899999999998776543311     123557999999999999999999999999999999999999999753221  


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCCCCCCCc
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSP  989 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~~~~  989 (1002)
                      ......+...........    .....+    .++.+++.+||+.||++|||++++++.|+++......      ....|
T Consensus       224 ~~~~~~~~~~~~~~~~~~----~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~------~~~~~  289 (296)
T 3uzp_A          224 RQKYERISEKKMSTPIEV----LCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF------SYDYV  289 (296)
T ss_dssp             SSHHHHHHHHHHHSCHHH----HTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC------CSSCC
T ss_pred             hhhhhhhcccccCCchHH----HHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC------ccccc
Confidence            222222221111111000    001222    2478899999999999999999999999999765432      35567


Q ss_pred             chhhcc
Q 001867          990 YYHEDA  995 (1002)
Q Consensus       990 ~~~~~~  995 (1002)
                      +.|+..
T Consensus       290 ~dw~~~  295 (296)
T 3uzp_A          290 FDWNML  295 (296)
T ss_dssp             CGGGGC
T ss_pred             cccccc
Confidence            878753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.2e-38  Score=342.08  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=202.1

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|... ++..||+|++....                 ....+.+.+|++++++++||||+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~~i~   69 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-----------------VEDVDRFKQEIEIMKSLDHPNII   69 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-----------------CSCHHHHHHHHHHHHTCCCTTBC
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-----------------cchHHHHHHHHHHHHhCCCCCEe
Confidence            4567888999999999999999975 47799999985421                 12356789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---CC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DG  836 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll---~~  836 (1002)
                      ++++++.+.+..++||||+++++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||++   +.
T Consensus        70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  144 (277)
T 3f3z_A           70 RLYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSP  144 (277)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSST
T ss_pred             eEEEEEecCCeEEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCC
Confidence            999999999999999999999999999875  34589999999999999999999999   99999999999999   78


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ++.+||+|||++........   .....||+.|+|||++.+. ++.++||||+|+++|||++|+.||............ 
T Consensus       145 ~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-  219 (277)
T 3f3z_A          145 DSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-  219 (277)
T ss_dssp             TCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             CCcEEEEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence            88999999999987654432   2345799999999987654 899999999999999999999999764332222111 


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    .... ..........    ..+.+++.+|++.||++|||+.++++
T Consensus       220 ~~----~~~~-~~~~~~~~~~----~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          220 RE----GTFT-FPEKDWLNVS----PQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HH----CCCC-CCHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             Hh----CCCC-CCchhhhcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11    1000 0000001122    24788999999999999999999975

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.3e-38  Score=342.74  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.+.+    +..||+|++....                .....+.+.+|+.++++++||||
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i   75 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----------------TLDNKEKFMSEAVIMKNLDHPHI   75 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----------------CHHHHHHHHHHHHHHHHHCCTTB
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----------------CchHHHHHHHHHHHHHhCCCCCc
Confidence            567888999999999999998643    3369999884321                23346779999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++.++ ..++||||+++++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        76 ~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  150 (281)
T 3cc6_A           76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPE  150 (281)
T ss_dssp             CCEEEEECSS-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETT
T ss_pred             ceEEEEEcCC-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCC
Confidence            9999998754 568999999999999999763 35689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... +....+.
T Consensus       151 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~  228 (281)
T 3cc6_A          151 CVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLE  228 (281)
T ss_dssp             EEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHH
T ss_pred             cEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHh
Confidence            999999999987654322 12234457889999999998999999999999999999998 99999754333 3332222


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      .....        +.....+    ..+.+++.+||+.||++||+++|+++.|+++...
T Consensus       229 ~~~~~--------~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          229 KGDRL--------PKPDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HTCCC--------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCC--------CCCCCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            21110        1111222    2478899999999999999999999999988653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.3e-38  Score=343.23  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=200.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++....              .........+.+|+.++++++||||++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   73 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--------------LEKAGVEHQLRREVEIQSHLRHPNILR   73 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------------HHHHTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc--------------cchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            356888899999999999999965 57799999985421              112233567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  148 (279)
T 3fdn_A           74 LYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL  148 (279)
T ss_dssp             EEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCE
T ss_pred             hhheEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCE
Confidence            999999999999999999999999999753  4589999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++.......    .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...+..  
T Consensus       149 ~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~--  221 (279)
T 3fdn_A          149 KIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRISR--  221 (279)
T ss_dssp             EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH--
T ss_pred             EEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHHHh--
Confidence            999999986544322    2345689999999999999999999999999999999999999975432221 111111  


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                        ....     ......    ..+.+++.+||+.||++|||++|+++.
T Consensus       222 --~~~~-----~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 --VEFT-----FPDFVT----EGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --TCCC-----CCTTSC----HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --CCCC-----CCCcCC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0000     001122    247789999999999999999999964

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.3e-38  Score=369.91  Aligned_cols=255  Identities=24%  Similarity=0.294  Sum_probs=205.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.++||+|+||.||+|+.+ +|+.||+|++.+..              .......+.+.+|+.++++++||||+++
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~--------------~~~~~~~~~~~~E~~iL~~l~hp~Iv~l  250 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR--------------LKKRKGYQGAMVEKKILAKVHSRFIVSL  250 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH--------------hhhhHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            56788899999999999999975 68999999985431              1122345678899999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++.+.+..|+||||++||+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+||+++.+|.
T Consensus       251 ~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~  327 (543)
T 3c4z_A          251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGN  327 (543)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred             EEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCC
Confidence            999999999999999999999999987543  45799999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++.......  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||................
T Consensus       328 vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i  405 (543)
T 3c4z_A          328 VRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV  405 (543)
T ss_dssp             EEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH
T ss_pred             EEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH
Confidence            99999999987654322  1234579999999999999999999999999999999999999997654322222222222


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM-----RRVV  966 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl  966 (1002)
                      ... ...  +   .....    ..+.+++.+||+.||++||++     +++.
T Consensus       406 ~~~-~~~--~---p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          406 LEQ-AVT--Y---PDKFS----PASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             HHC-CCC--C---CTTSC----HHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             hhc-ccC--C---CcccC----HHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence            211 110  0   01122    247789999999999999975     5665

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.8e-38  Score=354.18  Aligned_cols=249  Identities=28%  Similarity=0.355  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|+..+.||+|+||.||+|+. .+++.||||++....              .......+.+.+|++++++++||||+++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hpniv~~  119 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--------------KQSNEKWQDIIKEVRFLQKLRHPNTIQY  119 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS--------------SCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc--------------ccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            3477788999999999999996 578999999985321              1133445678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..++||||++ |+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       120 ~~~~~~~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  194 (348)
T 1u5q_A          120 RGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK  194 (348)
T ss_dssp             EEEEEETTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEE
T ss_pred             EEEEEECCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence            999999999999999996 6888888653 35799999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      |+|||++......      ....||+.|+|||++.   +..++.++|||||||++|||++|+.||.............  
T Consensus       195 L~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~--  266 (348)
T 1u5q_A          195 LGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--  266 (348)
T ss_dssp             ECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--
T ss_pred             EeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--
Confidence            9999999865432      2346999999999874   5678999999999999999999999997543322222211  


Q ss_pred             HhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                        ... .....   .....    ..+.+++.+||+.||++|||++++++.
T Consensus       267 --~~~-~~~~~---~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          267 --QNE-SPALQ---SGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --HSC-CCCCC---CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --hcC-CCCCC---CCCCC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              111 11110   11122    247789999999999999999999853

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.2e-38  Score=361.41  Aligned_cols=261  Identities=22%  Similarity=0.295  Sum_probs=196.0

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+.++|.+.+.||+|+||.||+|... +++.||||++.+....         ............+.+|+.++++++||||
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~~~~~~E~~~l~~l~hpni  202 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFA---------IGSAREADPALNVETEIEILKKLNHPCI  202 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGT---------TC--------CCHHHHHHHHHHCCCTTB
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhc---------ccccccchhHHHHHHHHHHHHhCCCCCE
Confidence            44678999999999999999999964 5899999998653211         0011122334568999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++.. +..|+||||+++|+|.+++..  .+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus       203 v~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          203 IKIKNFFDA-EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             CCCCEEEES-SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred             eeEEEEEec-CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence            999999865 457999999999999999873  46799999999999999999999999   999999999999997544


Q ss_pred             ---CeEEccccCcccccCCCCCcccccccccccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          839 ---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT---LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       839 ---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                         .+||+|||+++......   ......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.........
T Consensus       277 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~  353 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL  353 (419)
T ss_dssp             SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred             CcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence               59999999998765432   2334579999999999853   56788999999999999999999999865554444


Q ss_pred             HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+.....    . ...+......    ..+.+++.+||+.||++||+++|+++
T Consensus       354 ~~~i~~~~~----~-~~~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          354 KDQITSGKY----N-FIPEVWAEVS----EKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHTTCC----C-CCHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCC----C-CCchhhcccC----HHHHHHHHHHccCChhHCcCHHHHhC
Confidence            443322111    0 0001111222    24788999999999999999999886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=352.89  Aligned_cols=276  Identities=23%  Similarity=0.297  Sum_probs=199.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHH--HhcCCCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET--LGKIRHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|+. +++.||||++...                    ....+..|.++  +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------------------~~~~~~~e~~~~~~~~~~h~~i~   70 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA--------------------NRQNFINEKNIYRVPLMEHDNIA   70 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG--------------------GHHHHHHHHHHHTSTTCCCTTBC
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc--------------------chhhHHHHHHHHHHHhccCcchh
Confidence            46788889999999999999987 5899999998421                    12334444444  4558999999


Q ss_pred             eeeeEEec-----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeeCCCC
Q 001867          760 KLWCCCTT-----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC------VPSIVHRDVK  828 (1002)
Q Consensus       760 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~iiHrDlk  828 (1002)
                      ++++++..     ....++||||+++|+|.+++..   ...++..++.++.|++.||+|||+..      .++|+|||||
T Consensus        71 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dik  147 (336)
T 3g2f_A           71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN  147 (336)
T ss_dssp             CEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCS
T ss_pred             hheecccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccc
Confidence            99986642     2356899999999999999975   33589999999999999999999862      2389999999


Q ss_pred             CCcEEECCCCCeEEccccCcccccCCCC------CcccccccccccccCcccccc-------CCCCCccchhhHHHHHHH
Q 001867          829 SNNILLDGDFGARVADFGVAKVVDASGK------PKSMSVIAGSCGYIAPEYAYT-------LRVNEKSDIYSFGVVILE  895 (1002)
Q Consensus       829 ~~NIll~~~~~~kl~DfGl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~e  895 (1002)
                      |+||+++.++.+||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++||
T Consensus       148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e  227 (336)
T 3g2f_A          148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE  227 (336)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence            9999999999999999999987654321      112234569999999999876       456679999999999999


Q ss_pred             HHhCCCCCCCCCCchhH-------------HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 001867          896 LVTGRLPVDPEFGEKDL-------------VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM  962 (1002)
Q Consensus       896 ll~g~~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  962 (1002)
                      |++|+.||.........             ................+.+.. ........++.+++.+||+.||++|||+
T Consensus       228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             HHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcch
Confidence            99998887543322110             001111111111111111111 1122345568999999999999999999


Q ss_pred             HHHHHHHHHhhhhccccCCC
Q 001867          963 RRVVKLLQEVGAENRSKTGK  982 (1002)
Q Consensus       963 ~evl~~L~~~~~~~~~~~~~  982 (1002)
                      +|+++.|+++..........
T Consensus       307 ~e~l~~L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          307 QXAEERMAELMMIWERNKSV  326 (336)
T ss_dssp             HHHHHHHHHHHHCCCC----
T ss_pred             HHHHHHHHHHHHHHHhcccC
Confidence            99999999997654444433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-38  Score=359.39  Aligned_cols=266  Identities=22%  Similarity=0.342  Sum_probs=195.6

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCc
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKN  757 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n  757 (1002)
                      .+.++|++.+.||+|+||.||+|.. .+++.||||++...               .......+++.+|+.+++++. |||
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---------------~~~~~~~~~~~~E~~~l~~l~~h~n   70 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------------FQNSTDAQRTFREIMILTELSGHEN   70 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----------------CCHHHHHHHHHHHHHHHHTTTCTT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc---------------ccChHHHHHHHHHHHHHHhccCCCC
Confidence            4567899999999999999999996 46899999998432               223455677889999999997 999


Q ss_pred             eeeeeeEEecCC--eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCTTRD--CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++...+  ..|+||||++ |+|.++++.   ..+++..+..++.|++.||+|||++   +|+||||||+||+++
T Consensus        71 iv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~  143 (388)
T 3oz6_A           71 IVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLN  143 (388)
T ss_dssp             BCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred             CCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEc
Confidence            999999997544  6899999996 699999875   4689999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCC-------------------CcccccccccccccCcccccc-CCCCCccchhhHHHHHHH
Q 001867          836 GDFGARVADFGVAKVVDASGK-------------------PKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILE  895 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~e  895 (1002)
                      .++.+||+|||+++.......                   .......+||+.|+|||++.+ ..++.++||||+||++||
T Consensus       144 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~e  223 (388)
T 3oz6_A          144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE  223 (388)
T ss_dssp             TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred             CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHH
Confidence            999999999999987643211                   112334579999999999876 678999999999999999


Q ss_pred             HHhCCCCCCCCCCchhHHHHHHHHhhccCccc---cc------------------cccccCCCH-------------HHH
Q 001867          896 LVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDH---VL------------------DPKLDCCFK-------------EEI  941 (1002)
Q Consensus       896 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~------------------~~~~~~~~~-------------~~~  941 (1002)
                      |++|+.||........+..... .........   +.                  .......++             ...
T Consensus       224 ll~g~~pf~~~~~~~~~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (388)
T 3oz6_A          224 ILCGKPIFPGSSTMNQLERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN  302 (388)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred             HHhCCCCCCCCCHHHHHHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence            9999999976543333333221 110000000   00                  000000000             112


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          942 CKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       942 ~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .++.+++.+||+.||++|||++|+++.
T Consensus       303 ~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          303 EEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            247899999999999999999999865

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-38  Score=345.15  Aligned_cols=253  Identities=28%  Similarity=0.396  Sum_probs=199.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|... ++.||||++...                   ...+.+.+|+.++++++||||+++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------------------~~~~~~~~E~~~l~~l~h~~iv~~   79 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------------ATAQAFLAEASVMTQLRHSNLVQL   79 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-------------------C--HHHHHTHHHHTTCCCTTBCCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch-------------------hHHHHHHHHHHHHHhCCCCCEeeE
Confidence            357888899999999999999875 889999988421                   134678999999999999999999


Q ss_pred             eeEEecC-CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          762 WCCCTTR-DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       762 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      ++++.+. +..++||||+++++|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  156 (278)
T 1byg_A           80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVA  156 (278)
T ss_dssp             EEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             EEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcE
Confidence            9997654 5789999999999999999865444589999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++.......     ....+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .+....+...
T Consensus       157 ~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~  230 (278)
T 1byg_A          157 KVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG  230 (278)
T ss_dssp             EECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHHHHHTTT
T ss_pred             EEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhcC
Confidence            999999998654332     23357889999999999999999999999999999998 9999975432 3322222111


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      .     ..   +.....++    .+.+++.+||+.||++||+++|+++.|+++...
T Consensus       231 ~-----~~---~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 Y-----KM---DAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             C-----CC---CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----CC---CCcccCCH----HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            0     00   11122222    478899999999999999999999999998653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.6e-38  Score=342.41  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=205.6

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...                     .+.+.+|++++++++||||+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------------~~~~~~e~~~l~~l~h~~i~   67 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---------------------NEKAEREVKALAKLDHVNIV   67 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC---------------------SGGGHHHHHHHHHCCCTTBC
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc---------------------cHHHHHHHHHHHhCCCCCEE
Confidence            3467888999999999999999975 7899999998431                     13567899999999999999


Q ss_pred             eeeeEEec----------------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 001867          760 KLWCCCTT----------------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIV  823 (1002)
Q Consensus       760 ~l~~~~~~----------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  823 (1002)
                      ++++++..                ....++||||+++|+|.+++.......+++..++.++.|++.||+|||++   +|+
T Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~  144 (284)
T 2a19_B           68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLI  144 (284)
T ss_dssp             CEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             EEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            99998864                44579999999999999999876667899999999999999999999999   999


Q ss_pred             eCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          824 HRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       824 HrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                      ||||||+||+++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|||++|..|+
T Consensus       145 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             eccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            999999999999999999999999987755432   22346899999999999999999999999999999999999886


Q ss_pred             CCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ...   .   .... ........       .....    .+.+++.+||+.||++||++.|+++.++.+..
T Consensus       222 ~~~---~---~~~~-~~~~~~~~-------~~~~~----~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          222 FET---S---KFFT-DLRDGIIS-------DIFDK----KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHH---H---HHHH-HHHTTCCC-------TTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             hhH---H---HHHH-Hhhccccc-------ccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            321   1   1111 11111111       11122    37788999999999999999999999998864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-38  Score=354.90  Aligned_cols=266  Identities=27%  Similarity=0.353  Sum_probs=207.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|++     .+++.||||++...                 .....+.+.+|++++++++|||
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~   85 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----------------GPDQQRDFQREIQILKALHSDF   85 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhcCCCc
Confidence            5688889999999999999984     35889999998432                 3344567999999999999999


Q ss_pred             eeeeeeEEe--cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCT--TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++.  +.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus        86 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~  161 (327)
T 3lxl_A           86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVE  161 (327)
T ss_dssp             BCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             eeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEEC
Confidence            999999987  4567899999999999999998633 4599999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch----
Q 001867          836 GDFGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK----  910 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~----  910 (1002)
                      .++.+||+|||+++......... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......    
T Consensus       162 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~  241 (327)
T 3lxl_A          162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM  241 (327)
T ss_dssp             ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC
T ss_pred             CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc
Confidence            99999999999998775443221 2234468888999999998889999999999999999999999985421100    


Q ss_pred             ------hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          911 ------DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       911 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                            ..............    ..+.....+    ..+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          242 GCERDVPALSRLLELLEEGQ----RLPAPPACP----AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             C----CCHHHHHHHHHHTTC----CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             ccccccccHHHHHHHhhccc----CCCCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence                  00011111111110    011112222    347889999999999999999999999999875443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=376.18  Aligned_cols=253  Identities=22%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             eeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          690 VIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      .||+|+||.||+|.+.   ++..||||+++...                .....+.+.+|+.++++++|||||++++++.
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  406 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----------------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ  406 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC----------------SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC----------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence            7999999999999864   45679999985421                2234677999999999999999999999998


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      . +..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       407 ~-~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          407 A-EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             S-SSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            6 568999999999999999975 345699999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccC
Q 001867          847 VAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKG  924 (1002)
Q Consensus       847 l~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  924 (1002)
                      +++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+......  
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~~~~~--  558 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRM--  558 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHHHHTTCCC--
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC--
Confidence            998765432211 1223346689999999999999999999999999999998 9999976533 3333333221110  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          925 VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                            +....++.    .+.+++..||+.||++||++++|++.|+.+....
T Consensus       559 ------~~p~~~~~----~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          559 ------ECPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             ------CCCTTCCH----HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCcCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                  11122333    4888999999999999999999999999986543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=351.17  Aligned_cols=264  Identities=20%  Similarity=0.268  Sum_probs=205.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|+. .+++.||||++...                 .....+.+.+|+.++++++||||+++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~iv~~   91 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----------------EQQDREEAQREADMHRLFNHPNILRL   91 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----------------SHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----------------CHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            5688899999999999999997 57899999988432                 33456778999999999999999999


Q ss_pred             eeEEe----cCCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          762 WCCCT----TRDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       762 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      ++++.    .....++||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~  168 (317)
T 2buj_A           92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLG  168 (317)
T ss_dssp             CEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred             EEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence            99997    345789999999999999998753  346799999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCc-------ccccccccccccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          836 GDFGARVADFGVAKVVDASGKPK-------SMSVIAGSCGYIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      .++.+||+|||++..........       ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||..
T Consensus       169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            99999999999987654221110       112345799999999987543   68899999999999999999999853


Q ss_pred             CCCc-hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccc
Q 001867          906 EFGE-KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRS  978 (1002)
Q Consensus       906 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~  978 (1002)
                      .... .........     ..   ..+......    ..+.+++.+||+.||++||+++++++.|+++.+....
T Consensus       249 ~~~~~~~~~~~~~~-----~~---~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          249 VFQKGDSVALAVQN-----QL---SIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             HHHTTSCHHHHHHC-----C-----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             hhcccchhhHHhhc-----cC---CCCccccCC----HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence            1111 111111111     00   011112222    2488899999999999999999999999998754443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.6e-38  Score=344.35  Aligned_cols=260  Identities=24%  Similarity=0.310  Sum_probs=205.4

Q ss_pred             cCCCcCC-eeeecCCccEEEEEE---cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDN-VIGSGSSGKVYKVVL---SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~-~LG~G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|.+.+ .||+|+||.||+|.+   .+++.||||++...               ..+....+.+.+|+.++++++||||
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~i   80 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---------------ANDPALKDELLAEANVMQQLDNPYI   80 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------------CHHHHHHHHHHHHHHTCCCTTB
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc---------------ccCHHHHHHHHHHHHHHHhCCCCCE
Confidence            4566666 899999999999964   24688999998432               1123446779999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++ ..+..++||||+++++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        81 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~  154 (291)
T 1xbb_A           81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH  154 (291)
T ss_dssp             CCEEEEE-ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             EEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence            9999999 55678999999999999999985  35699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+||+|||++.......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ..+....+
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~  233 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAML  233 (291)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH
T ss_pred             cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH
Confidence            99999999998775543221 1223456789999999988889999999999999999999 999997543 22222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ....    ..    +.....+    ..+.+++.+||+.||++||+++++++.|+++....
T Consensus       234 ~~~~----~~----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          234 EKGE----RM----GCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             HTTC----CC----CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HcCC----CC----CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            2111    00    1111222    24888999999999999999999999999986544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.1e-38  Score=342.25  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=198.8

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|.+.+.||+|+||.||+|.. .++..||+|++...               .......+.+.+|+.++++++||||++++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~---------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   91 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR---------------KLTKSERQRFKEEAEMLKGLQHPNIVRFY   91 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG---------------GSCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecch---------------hhCHHHHHHHHHHHHHHHhCCCCCeeeee
Confidence            366778999999999999996 45789999998532               12344567899999999999999999999


Q ss_pred             eEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEC-
Q 001867          763 CCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLD-  835 (1002)
Q Consensus       763 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~~NIll~-  835 (1002)
                      +++..    ....++||||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +  |+||||||+||+++ 
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~  166 (290)
T 1t4h_A           92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITG  166 (290)
T ss_dssp             EEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESS
T ss_pred             eeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEEC
Confidence            99865    45689999999999999999753  5689999999999999999999998   7  99999999999998 


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .++.+||+|||++......    ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||............
T Consensus       167 ~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  241 (290)
T 1t4h_A          167 PTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR  241 (290)
T ss_dssp             TTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred             CCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH
Confidence            7889999999999765433    223456999999999876 45899999999999999999999999765444433332


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......    ....+   ....    ..+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~----~~~~~---~~~~----~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          242 VTSGVK----PASFD---KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HTTTCC----CGGGG---GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccCC----ccccC---CCCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence            221111    11111   1111    24788999999999999999999883

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-38  Score=347.90  Aligned_cols=263  Identities=25%  Similarity=0.355  Sum_probs=205.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +.|++.+.||+|+||.||+|++     .+++.||||++....                .....+.+.+|+.++++++|||
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~   84 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----------------GGNHIADLKKEIEILRNLYHEN   84 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------------------CCHHHHHHHHHHHHTCCCTT
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc----------------cchhHHHHHHHHHHHHhCCCCC
Confidence            4577789999999999999984     358899999985321                1223567899999999999999


Q ss_pred             eeeeeeEEecC--CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCTTR--DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++...  ...++||||+++|+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus        85 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~  160 (302)
T 4e5w_A           85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE  160 (302)
T ss_dssp             BCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             eeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEc
Confidence            99999999876  6689999999999999999653 35699999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC-------
Q 001867          836 GDFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF-------  907 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~-------  907 (1002)
                      .++.+||+|||++......... .......||..|+|||++.+..++.++||||+|+++|||++|+.|+....       
T Consensus       161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  240 (302)
T 4e5w_A          161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI  240 (302)
T ss_dssp             ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred             CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence            9999999999999877654322 12234568888999999999899999999999999999999998864221       


Q ss_pred             ---CchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          908 ---GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       908 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                         ..................    .+.....+    ..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          241 GPTHGQMTVTRLVNTLKEGKR----LPCPPNCP----DEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CSCCGGGHHHHHHHHHHTTCC----CCCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccccCHHHHHHHHhccCC----CCCCCCCC----HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence               011111111111111110    01111222    34888999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=354.65  Aligned_cols=261  Identities=22%  Similarity=0.302  Sum_probs=195.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++.....                ......+.+|+.++++++||||+++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~~iv~~   65 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----------------EGAPCTAIREVSLLKDLKHANIVTL   65 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------------------CCCCCCCHHHHSCCCCTTBCCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----------------cccchhHHHHHHHHHhcCCCCCCee
Confidence            56888899999999999999975 689999999843211                1112234579999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..++||||++ |+|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        66 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~k  140 (324)
T 3mtl_A           66 HDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELK  140 (324)
T ss_dssp             EEEEECSSCEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEE
T ss_pred             eeEEeeCCEEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEE
Confidence            999999999999999996 6999998763 45699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||+++.......  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...+....
T Consensus       141 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~  217 (324)
T 3mtl_A          141 LADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRIL  217 (324)
T ss_dssp             ECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred             EccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence            999999986543322  2234568999999999876 5689999999999999999999999976543332 22222221


Q ss_pred             hccC---cccccc---------cccc-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKG---VDHVLD---------PKLD-----CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~---~~~~~~---------~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....   ......         +...     ...+.....+.+++.+|++.||++|||++|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            1110   000000         0000     000011234778999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.3e-38  Score=353.71  Aligned_cols=253  Identities=21%  Similarity=0.275  Sum_probs=199.5

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCc
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKN  757 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n  757 (1002)
                      .+.++|++.+.||+|+||.||+|..+ +++.||||++.+..                     ....+|++++.++ +|||
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------------------~~~~~E~~~l~~~~~hp~   77 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---------------------RDPTEEIEILLRYGQHPN   77 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT---------------------CCCHHHHHHHHHHTTSTT
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc---------------------CChHHHHHHHHHhcCCCC
Confidence            34567889999999999999999975 58899999985421                     1235688888887 7999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++.+.+..|+||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||++..+
T Consensus        78 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~  152 (342)
T 2qr7_A           78 IITLKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDE  152 (342)
T ss_dssp             BCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSS
T ss_pred             cCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecC
Confidence            99999999999999999999999999999974  45699999999999999999999999   99999999999998543


Q ss_pred             -C---CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          838 -F---GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       838 -~---~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                       +   .+||+|||+++.......  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~  229 (342)
T 2qr7_A          153 SGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPE  229 (342)
T ss_dssp             SCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHH
T ss_pred             CCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHH
Confidence             3   499999999987654432  223457899999999998888999999999999999999999999753221 111


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....... ..... ...+.......    .+.+++.+|++.||++||+++|+++
T Consensus       230 ~~~~~i~-~~~~~-~~~~~~~~~s~----~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          230 EILARIG-SGKFS-LSGGYWNSVSD----TAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHH-HCCCC-CCSTTTTTSCH----HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHc-cCCcc-cCccccccCCH----HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2221111 11111 11111122222    4778999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-38  Score=368.74  Aligned_cols=251  Identities=23%  Similarity=0.286  Sum_probs=195.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.+..              .........+.+|+.++++++||||++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~iv~  212 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV--------------IVAKDEVAHTLTENRVLQNSRHPFLTA  212 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH--------------HC-------------CCCCCSCTTSCC
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhh--------------hhhhHHHHHHHHHHHHHHhCCCCeEee
Confidence            46788899999999999999996 468999999985421              112233456788999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      +++++.+.+..|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +   +|+||||||+||+++.++.
T Consensus       213 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~  287 (446)
T 4ejn_A          213 LKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGH  287 (446)
T ss_dssp             EEEEEEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSC
T ss_pred             EEEEEeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCC
Confidence            999999999999999999999999999753  569999999999999999999998 7   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.. 
T Consensus       288 ~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~-  363 (446)
T 4ejn_A          288 IKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM-  363 (446)
T ss_dssp             EEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-
T ss_pred             EEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHHh-
Confidence            9999999998643322  223456799999999999999999999999999999999999999975432 222222111 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                        . ...  +   .....    ..+.+++.+||+.||++||     +++|+++
T Consensus       364 --~-~~~--~---p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          364 --E-EIR--F---PRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --C-CCC--C---CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --C-CCC--C---CccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              1 110  0   01122    2477899999999999999     9999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.9e-38  Score=364.49  Aligned_cols=200  Identities=26%  Similarity=0.401  Sum_probs=158.7

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++.++|++.+.||+|+||.||+|... +++.||||++.+.               ..+....+++.+|+.++++++|||
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---------------~~~~~~~~~~~~E~~~l~~l~h~n  113 (458)
T 3rp9_A           49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---------------FEDLIDCKRILREIAILNRLNHDH  113 (458)
T ss_dssp             CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST---------------TSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh---------------hcCHHHHHHHHHHHHHHHhCCCCC
Confidence            445678999999999999999999964 6899999998432               224455678999999999999999


Q ss_pred             eeeeeeEEec-----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          758 IVKLWCCCTT-----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       758 iv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      ||++++++..     ....|+||||+ +|+|.+++.  ....+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus       114 iv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NI  187 (458)
T 3rp9_A          114 VVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANC  187 (458)
T ss_dssp             BCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             CCceEEEEecCCcccCceEEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhE
Confidence            9999999954     35789999998 689999987  446799999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCC-------------------------cccccccccccccCcccc-ccCCCCCccch
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKP-------------------------KSMSVIAGSCGYIAPEYA-YTLRVNEKSDI  886 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv  886 (1002)
                      |++.++.+||+|||+++........                         ......+||+.|+|||++ .+..++.++||
T Consensus       188 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Di  267 (458)
T 3rp9_A          188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV  267 (458)
T ss_dssp             EECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHH
T ss_pred             EECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHH
Confidence            9999999999999999876533211                         123455789999999976 56679999999


Q ss_pred             hhHHHHHHHHHhC
Q 001867          887 YSFGVVILELVTG  899 (1002)
Q Consensus       887 wslGvil~ell~g  899 (1002)
                      ||+||++|||++|
T Consensus       268 wSlG~il~elltg  280 (458)
T 3rp9_A          268 WSIGCIFAELLNM  280 (458)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999999994

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.4e-38  Score=348.28  Aligned_cols=263  Identities=28%  Similarity=0.410  Sum_probs=206.9

Q ss_pred             CCcCCeeeecCCccEEEEEEc-----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLS-----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      |++.+.||+|+||.||++.+.     +++.||||++...                ......+.+.+|++++++++||||+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~iv   96 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD----------------AGPQHRSGWKQEIDILRTLYHEHII   96 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT----------------CCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc----------------cChHHHHHHHHHHHHHHhCCCcchh
Confidence            377899999999999988652     5789999998432                1234567799999999999999999


Q ss_pred             eeeeEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++.+  ....++||||+++|+|.+++..   ..+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        97 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~  170 (318)
T 3lxp_A           97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDND  170 (318)
T ss_dssp             CEEEEEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             hEEEEEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCC
Confidence            99999987  4678999999999999999975   3499999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-------
Q 001867          838 FGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-------  909 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~-------  909 (1002)
                      +.+||+|||++.......... ......||..|+|||++.+..++.++||||+|+++|||++|+.||......       
T Consensus       171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence            999999999998876543221 223446788999999999988999999999999999999999998643111       


Q ss_pred             --hhH-HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhcc
Q 001867          910 --KDL-VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENR  977 (1002)
Q Consensus       910 --~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~  977 (1002)
                        ... ............    ..+.....+    ..+.+++.+||+.||++|||++|+++.|+++.....
T Consensus       251 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGE----RLPRPDKCP----AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTC----CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccchhHHHHHHHHhccc----CCCCCcccc----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence              000 000111111110    011112222    348889999999999999999999999999876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.6e-38  Score=340.38  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=206.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++.......           .......+.+.+|+.++++++||||++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~i~~   72 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSS-----------SRRGVSREEIEREVNILREIRHPNIIT   72 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT-----------CSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccc-----------cccchHHHHHHHHHHHHHhCCCCCeee
Confidence            356888899999999999999975 68999999986542211           111223567999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC--
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF--  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~--  838 (1002)
                      +++++.+.+..++||||+++++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++  
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  147 (283)
T 3bhy_A           73 LHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVP  147 (283)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSS
T ss_pred             hhheecCCCeEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCC
Confidence            99999999999999999999999999975  34689999999999999999999999   999999999999998877  


Q ss_pred             --CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 --GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 --~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                        .+||+|||++........   .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...+
T Consensus       148 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~  223 (283)
T 3bhy_A          148 NPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNI  223 (283)
T ss_dssp             SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH
T ss_pred             CCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHh
Confidence              799999999987654322   2344689999999999999999999999999999999999999976432221 1111


Q ss_pred             HHHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHhh
Q 001867          917 CSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEVG  973 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~~  973 (1002)
                      ..    ....  .++.. ....    ..+.+++.+||+.||++||+++|+++  +++++.
T Consensus       224 ~~----~~~~--~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          224 SA----VNYD--FDEEYFSNTS----ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HT----TCCC--CCHHHHTTCC----HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             Hh----cccC--CcchhcccCC----HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            11    0000  01111 1122    24778999999999999999999997  566654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9e-38  Score=339.63  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=183.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....              .......+.+.+|+.++++++||||++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   75 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA--------------MYKAGMVQRVQNEVKIHCQLKHPSILE   75 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHTTBCCTTBCC
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh--------------hhhhhHHHHHHHHHHHHHhCCCCCeEe
Confidence            45688889999999999999997 568999999984321              111223467899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~  151 (278)
T 3cok_A           76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNI  151 (278)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCE
T ss_pred             EEEEEccCCeEEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCE
Confidence            99999999999999999999999999985 335799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++........  ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...........     .
T Consensus       152 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----~  224 (278)
T 3cok_A          152 KIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-----V  224 (278)
T ss_dssp             EECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C
T ss_pred             EEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-----H
Confidence            9999999987653322  12235689999999999998899999999999999999999999975432221111     0


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...      +.......   ...+.+++.+||+.||++|||++++++
T Consensus       225 ~~~------~~~~~~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          225 VLA------DYEMPSFL---SIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CSS------CCCCCTTS---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhc------ccCCcccc---CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            000      01111111   124778999999999999999999885

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-38  Score=358.08  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=186.9

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++.++|++.+.||+|+||.||+|.. .+|+.||||++...               .......+++.+|+.++++++|||
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~hpn   89 (367)
T 2fst_X           25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------------FQSIIHAKRTYRELRLLKHMKHEN   89 (367)
T ss_dssp             EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST---------------TSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc---------------ccCHHHHHHHHHHHHHHHhCCCCC
Confidence            44567899999999999999999996 56899999998432               223445677889999999999999


Q ss_pred             eeeeeeEEecC------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTR------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++...      ...|+||||+ +++|.++++.   ..+++..+..++.||+.||+|||++   +|+||||||+|
T Consensus        90 Iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~N  162 (367)
T 2fst_X           90 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSN  162 (367)
T ss_dssp             BCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             CCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhh
Confidence            99999999754      5679999999 7899999864   5699999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      |+++.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus       163 Ill~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  237 (367)
T 2fst_X          163 LAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID  237 (367)
T ss_dssp             EEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999865432     234578999999999876 678999999999999999999999997654333


Q ss_pred             hHHHHHHHHhhccC------------------ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          911 DLVKWVCSTLDQKG------------------VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .+...... .....                  ...................+.+++.+|++.||++|||++|+++.
T Consensus       238 ~l~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          238 QLKLILRL-VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHH-HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHH-hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            32222221 10000                  00000000000000112347889999999999999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.7e-38  Score=353.15  Aligned_cols=278  Identities=20%  Similarity=0.287  Sum_probs=210.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|.. +++.||||++.........................+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788899999999999999999 89999999996542211000000011111122233789999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhh------hhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDL------LHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll  834 (1002)
                      ++++.+.+..++||||+++|+|.++      +.......+++..++.++.|++.||+|||+ +   +|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            9999999999999999999999999      665446789999999999999999999999 8   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCC-ccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          835 DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNE-KSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      +.++.+||+|||.+......    ......||+.|+|||++.+. .++. ++||||+|+++|||++|+.||.......+.
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999876443    23345789999999999877 5666 999999999999999999999866543443


Q ss_pred             HHHHHHHhhccCcc--cccccc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKGVD--HVLDPK----LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+..........  ....+.    ...........+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            33332111100000  000000    00000111235788999999999999999999985

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-38  Score=367.50  Aligned_cols=326  Identities=22%  Similarity=0.189  Sum_probs=239.0

Q ss_pred             ccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEcc
Q 001867          287 SLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLS  365 (1002)
Q Consensus       287 ~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  365 (1002)
                      +++.|+|++|++++..+..+..++ |++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  112 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS  112 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence            444555555555444444444443 5555555555555556666666777777777777776666667777777777777


Q ss_pred             CccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCcc
Q 001867          366 NNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEI  445 (1002)
Q Consensus       366 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  445 (1002)
                      +|++++..|..|..+++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.+..
T Consensus       113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~  192 (477)
T 2id5_A          113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR  192 (477)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred             CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence            77777777777777777777777777777777777777888888888888887766667777888888888888887777


Q ss_pred             ccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccccccccc
Q 001867          446 SKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWK  525 (1002)
Q Consensus       446 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  525 (1002)
                      +..|..+++|+.|++++|.+.+.+|..+....+|+.|++++|++++..+..+..+++|+.|+|++|++++..+..|..++
T Consensus       193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  272 (477)
T 2id5_A          193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL  272 (477)
T ss_dssp             TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCT
T ss_pred             hhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccc
Confidence            77788888888888888877777777776677888888888888854446778888888888888888887778888888


Q ss_pred             ccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh-hhhhcccccccC
Q 001867          526 KLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL-FAKEMYRNSFLG  603 (1002)
Q Consensus       526 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~  603 (1002)
                      +|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+ +|+.|+|++|++....+-. .........+.+
T Consensus       273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~  352 (477)
T 2id5_A          273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNR  352 (477)
T ss_dssp             TCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTT
T ss_pred             cCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCc
Confidence            88888888888887778888888888888888888887666667777 7888888888887665433 223334466778


Q ss_pred             CCCCCCCCC
Q 001867          604 NPGLCGDLE  612 (1002)
Q Consensus       604 n~~~cg~~~  612 (1002)
                      +...|+.|.
T Consensus       353 ~~~~C~~p~  361 (477)
T 2id5_A          353 QQPTCATPE  361 (477)
T ss_dssp             CCCBEEESG
T ss_pred             cCceeCCch
Confidence            888887653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-38  Score=356.54  Aligned_cols=257  Identities=22%  Similarity=0.259  Sum_probs=202.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEE----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|+.    .+++.||||++.+....             ......+.+.+|+++++++ +|||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~~h~~  120 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-------------QKAKTTEHTRTERQVLEHIRQSPF  120 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-------------EEESSGGGCCCHHHHHHHHHTCTT
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh-------------hhhhHHHHHHHHHHHHHHccCCCc
Confidence            5678889999999999999997    36899999998543110             1122345577899999999 6999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      |+++++++...+..++||||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus       121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  195 (355)
T 1vzo_A          121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN  195 (355)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             eeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            999999999999999999999999999999853  4699999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      +.+||+|||+++....... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||............
T Consensus       196 ~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  274 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  274 (355)
T ss_dssp             SCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             CcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH
Confidence            9999999999986643322 22334579999999999885  34789999999999999999999999765443333333


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVKL  968 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~~  968 (1002)
                      .........      +......    ..+.+++.+||+.||++||     +++|+++.
T Consensus       275 ~~~~~~~~~------~~~~~~~----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          275 SRRILKSEP------PYPQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHHCCC------CCCTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHhccCC------CCCcccC----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            322221110      0111122    2477899999999999999     99999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=340.76  Aligned_cols=257  Identities=23%  Similarity=0.302  Sum_probs=202.2

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|.. .+++.||+|++.....             .......+.+.+|+.++++++||||+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~i~   69 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-------------RRIPNGEANVKKEIQLLRRLRHKNVI   69 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-------------HHSTTHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-------------cccchhHHHHHHHHHHHHhcCCCCee
Confidence            357899999999999999999996 4688999999854211             01123457799999999999999999


Q ss_pred             eeeeEEe--cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCT--TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++.  +.+..++||||++++ |.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        70 ~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~  145 (305)
T 2wtk_C           70 QLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTG  145 (305)
T ss_dssp             CEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             EEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCC
Confidence            9999984  456789999999765 88888776677899999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      +.+||+|||++................||+.|+|||++.+..  ++.++||||+|+++|||++|+.||..... ......
T Consensus       146 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~  224 (305)
T 2wtk_C          146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-YKLFEN  224 (305)
T ss_dssp             CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHH
T ss_pred             CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHHH
Confidence            999999999998776543333444567999999999987644  37799999999999999999999975422 222111


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      +.    ....     +.......    .+.+++.+||+.||++|||++|+++.
T Consensus       225 i~----~~~~-----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          225 IG----KGSY-----AIPGDCGP----PLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HH----HCCC-----CCCSSSCH----HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             Hh----cCCC-----CCCCccCH----HHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11    1111     01112222    47789999999999999999999963

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.4e-38  Score=348.11  Aligned_cols=255  Identities=19%  Similarity=0.252  Sum_probs=201.6

Q ss_pred             hcCCCcC-CeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCce
Q 001867          682 LDGLDED-NVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNI  758 (1002)
Q Consensus       682 ~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni  758 (1002)
                      .+.|.+. +.||+|+||.||+|... +++.||+|++....               ........+.+|+.+++++. ||||
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~~i   91 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR---------------RGQDCRAEILHEIAVLELAKSCPRV   91 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEE---------------TTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhh---------------cchHHHHHHHHHHHHHHhccCCCCE
Confidence            3456665 88999999999999975 58999999985431               12233567899999999995 6999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC--
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG--  836 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~--  836 (1002)
                      +++++++.+.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+++.  
T Consensus        92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A           92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBT
T ss_pred             EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCC
Confidence            99999999999999999999999999999765567899999999999999999999999   9999999999999987  


Q ss_pred             -CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          837 -DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       837 -~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                       ++.+||+|||+++.......   .....||+.|+|||++.+..++.++||||+|+++|||++|+.||............
T Consensus       169 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  245 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI  245 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence             78999999999987654322   23457999999999999999999999999999999999999999765332222221


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .. ..     .....+.......    .+.+++.+||+.||++|||++|+++
T Consensus       246 ~~-~~-----~~~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          246 SQ-VN-----VDYSEETFSSVSQ----LATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HH-TC-----CCCCTTTTTTSCH----HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Hh-cc-----cccCchhhcccCH----HHHHHHHHHcCCChhhCcCHHHHhC
Confidence            11 10     0111111122222    4778999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=8.4e-38  Score=376.64  Aligned_cols=252  Identities=25%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             CeeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          689 NVIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      +.||+|+||.||+|.+.   .++.||||+++..               ..+....+++.+|+.++++++|||||++++++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---------------~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  439 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---------------ANDPALKDELLAEANVMQQLDNPYIVRMIGIC  439 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGG---------------GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccc---------------cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            47999999999999753   4678999998542               12334467899999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      .. +..++||||+++|+|.+++..  ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       440 ~~-~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DF  513 (635)
T 4fl3_A          440 EA-ESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  513 (635)
T ss_dssp             ES-SSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCT
T ss_pred             ec-CCEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEc
Confidence            75 457899999999999999974  45699999999999999999999999   9999999999999999999999999


Q ss_pred             cCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          846 GVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       846 Gl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+...... 
T Consensus       514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~~~~~-  591 (635)
T 4fl3_A          514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLEKGERM-  591 (635)
T ss_dssp             THHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCC-
T ss_pred             CCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCC-
Confidence            999877544321 22334457789999999999999999999999999999998 9999975432 2333322221111 


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                             +....++    .++.+++..||+.||++||++++|++.|+++..
T Consensus       592 -------~~p~~~~----~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          592 -------GCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             -------CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   1112223    348889999999999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-37  Score=345.50  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=194.7

Q ss_pred             cCCCcC-CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          683 DGLDED-NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       683 ~~~~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      +.|++. +.||+|+||.||+|.. .+++.||||++...                 .....+.+.+|++++.++ +||||+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~~~~h~~i~   74 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-----------------PGHIRSRVFREVEMLYQCQGHRNVL   74 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-----------------SSCCHHHHHHHHHHHHHTCCCTTBC
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-----------------cchhHHHHHHHHHHHHHhcCCCCee
Confidence            456664 7899999999999995 46899999998532                 122356789999999985 799999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  149 (316)
T 2ac3_A           75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQ  149 (316)
T ss_dssp             CEEEEEEETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSS
T ss_pred             eEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCC
Confidence            9999999999999999999999999999853  4689999999999999999999999   9999999999999998776


Q ss_pred             ---eEEccccCcccccCCCC-----CcccccccccccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          840 ---ARVADFGVAKVVDASGK-----PKSMSVIAGSCGYIAPEYAYT-----LRVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       840 ---~kl~DfGl~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                         +||+|||++........     ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||...
T Consensus       150 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          150 VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence               99999999986643221     111224469999999999875     55889999999999999999999999764


Q ss_pred             CCch----------hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          907 FGEK----------DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       907 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+          ................ ...+......    ..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          230 CGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDKDWAHIS----CAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCSCSCC----CCHHHHHHHHHHHHHCCCC-CCHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccccccccccchhHHHHHHHHHhccCcc-cCchhcccCC----HHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            3221          0001111111111110 0001111122    24788999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.1e-38  Score=350.66  Aligned_cols=265  Identities=23%  Similarity=0.355  Sum_probs=202.1

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...               .......+.+.+|+.++++++||||+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~iv   87 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES---------------DDDKMVKKIAMREIKLLKQLRHENLV   87 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC---------------SSCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC---------------CCchHHHHHHHHHHHHHhhCCCCCEe
Confidence            3577888999999999999999975 4899999998442               12344566788999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..++||||+++++|.++..  ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~  162 (331)
T 4aaa_A           88 NLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGV  162 (331)
T ss_dssp             CEEEEEEETTEEEEEEECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             eEEEEeecCCEEEEEEecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCc
Confidence            99999999999999999999988888866  345699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS  918 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~  918 (1002)
                      +||+|||+++.......  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...............
T Consensus       163 ~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  240 (331)
T 4aaa_A          163 VKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC  240 (331)
T ss_dssp             EEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            99999999987654322  22345689999999998775 7899999999999999999999999766444333332221


Q ss_pred             Hhh-----------ccCcccccccccc------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          919 TLD-----------QKGVDHVLDPKLD------CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       919 ~~~-----------~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...           .........+...      ...+.....+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            100           0000000011110      000111235889999999999999999999885

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.8e-37  Score=361.44  Aligned_cols=217  Identities=29%  Similarity=0.400  Sum_probs=174.3

Q ss_pred             CCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcce
Q 001867          353 LGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVY  432 (1002)
Q Consensus       353 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  432 (1002)
                      +..+++|+.|++++|++++.  ..+..+++|++|++++|.+++..|  ++.+++|++|++++|++++.  ..+..+++|+
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~  246 (466)
T 1o6v_A          173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLT  246 (466)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred             hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCC
Confidence            55566666666666666533  236666777777777777765544  66788888889988888754  4678889999


Q ss_pred             EEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCc
Q 001867          433 LLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAND  512 (1002)
Q Consensus       433 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  512 (1002)
                      .|++++|.+.+..+  +..+++|+.|++++|++++..|  ++.+++|+.|++++|++++..|  +..+++|+.|+|++|+
T Consensus       247 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~  320 (466)
T 1o6v_A          247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN  320 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSC
T ss_pred             EEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCc
Confidence            99999999987765  8888999999999999986544  8889999999999999986544  7889999999999999


Q ss_pred             CCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCC
Q 001867          513 LSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGE  587 (1002)
Q Consensus       513 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~  587 (1002)
                      +++..|  ++.+++|+.|++++|.+++.  ..++++++|+.|++++|++++.+|  +..+ +|+.|++++|++++.
T Consensus       321 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          321 ISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             CSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             CCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            998776  78899999999999999864  478889999999999999998777  6667 799999999999884

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.7e-38  Score=348.72  Aligned_cols=264  Identities=19%  Similarity=0.230  Sum_probs=194.8

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....               ......+.+.+|+.++++++||||+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv   96 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---------------EEEGVPGTAIREVSLLKELQHRNII   96 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------------------CHHHHHHGGGCCCTTBC
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc---------------cccccchhHHHHHHHHHHcCCCCcc
Confidence            457899999999999999999996 468999999984321               1223345678999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC----
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD----  835 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~----  835 (1002)
                      ++++++.+++..++||||++ |+|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++    
T Consensus        97 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A           97 ELKSVIHHNHRLHLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             CEEEEEEETTEEEEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred             eEEEEEecCCEEEEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence            99999999999999999996 599999985  34599999999999999999999999   999999999999994    


Q ss_pred             -CCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          836 -GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       836 -~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                       .++.+||+|||+++.......  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..........
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  248 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF  248 (329)
T ss_dssp             --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH
Confidence             445599999999987654322  23345689999999998875 48999999999999999999999997654444333


Q ss_pred             HHHHHHhhccC--cccc--------ccccccCCCHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQKG--VDHV--------LDPKLDCCFKE------EICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~--~~~~--------~~~~~~~~~~~------~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...........  ....        ..+........      ...++.+++.+|++.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            33322110000  0000        00000000000      1135778999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8e-38  Score=349.17  Aligned_cols=252  Identities=20%  Similarity=0.267  Sum_probs=199.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|.. .+++.||||++..                    ...+.+.+|+.++++++ ||||+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--------------------~~~~~~~~E~~~l~~l~~~~~i~   94 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------------------VKKKKIKREIKILENLRGGPNII   94 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--------------------CCHHHHHHHHHHHHHHTTSTTBC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--------------------cchHHHHHHHHHHHHcCCCCCEE
Confidence            46788899999999999999986 5689999999832                    12466899999999997 99999


Q ss_pred             eeeeEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++.+  ....++||||+++++|.++++.     +++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        95 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~  166 (330)
T 3nsz_A           95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHE  166 (330)
T ss_dssp             CEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             EeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCC
Confidence            99999987  6678999999999999999853     89999999999999999999999   99999999999999977


Q ss_pred             C-CeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          838 F-GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~-~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      + .+||+|||+++.......   .....||..|+|||++.+ ..++.++||||+||++|||++|+.||.......+....
T Consensus       167 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~  243 (330)
T 3nsz_A          167 HRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  243 (330)
T ss_dssp             TTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             CCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence            6 899999999987654432   234578999999999877 67899999999999999999999999765443332222


Q ss_pred             HHHHhhccC---------------------------ccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKG---------------------------VDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .........                           ...........   ....++.+++.+|++.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH---LVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGG---GCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111110000                           00000100000   01235788999999999999999999884

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-37  Score=341.77  Aligned_cols=252  Identities=20%  Similarity=0.324  Sum_probs=206.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....              .......+.+.+|+.++++++||||++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~iv~   79 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--------------LLKPHQREKMSMEISIHRSLAHQHVVG   79 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--------------CCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhh--------------ccCHHHHHHHHHHHHHHHhCCCCCEee
Confidence            356888899999999999999975 57899999985421              123455678999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++++|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  154 (294)
T 2rku_A           80 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV  154 (294)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             eeeeeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCE
Confidence            999999999999999999999999998753  4699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++........  ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||............    .
T Consensus       155 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~  228 (294)
T 2rku_A          155 KIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----K  228 (294)
T ss_dssp             EECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H
T ss_pred             EEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----h
Confidence            9999999987654322  223456899999999999989999999999999999999999999764322221111    1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                       .....  +   .....    ..+.+++.+||+.||++|||++|+++.
T Consensus       229 -~~~~~--~---~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          229 -KNEYS--I---PKHIN----PVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -TTCCC--C---CTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -hccCC--C---ccccC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             11100  0   01122    247789999999999999999999863

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8e-38  Score=339.64  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=195.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|... +++.||||++....              .......+.+.+|+.++++++||||++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   75 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK--------------IRSLDVVGKIKREIQNLKLFRHPHIIK   75 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc--------------ccchhHHHHHHHHHHHHhcCCCCCEeE
Confidence            357888899999999999999975 68999999985421              112233567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..++||||+++++|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  150 (276)
T 2h6d_A           76 LYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNA  150 (276)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCE
T ss_pred             EEEEEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCE
Confidence            999999999999999999999999999753  4589999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||++........   .....||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||..... ......+.. 
T Consensus       151 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~-  225 (276)
T 2h6d_A          151 KIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-PTLFKKIRG-  225 (276)
T ss_dssp             EECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH-
T ss_pred             EEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhc-
Confidence            9999999987654322   224468999999999987765 5899999999999999999999975422 222221111 


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         ...     .......    ..+.+++.+||+.||++|||++|+++
T Consensus       226 ---~~~-----~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          226 ---GVF-----YIPEYLN----RSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ---CCC-----CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---Ccc-----cCchhcC----HHHHHHHHHHccCChhhCCCHHHHHh
Confidence               100     0001122    24778999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-37  Score=347.42  Aligned_cols=265  Identities=21%  Similarity=0.274  Sum_probs=200.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.....               .......+.+|+.++++++||||++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~   80 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---------------KEGFPITALREIKILQLLKHENVVN   80 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC---------------SSSSCHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc---------------cccchHHHHHHHHHHHhccCCCccc
Confidence            46788899999999999999997 5689999999844311               1222456789999999999999999


Q ss_pred             eeeEEec--------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          761 LWCCCTT--------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       761 l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      +++++..        .+..|+||||++ |+|.+.+.. ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI  155 (351)
T 3mi9_A           81 LIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANV  155 (351)
T ss_dssp             EEEEEEEC--------CEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             HhheeeccccccccCCceEEEEEeccC-CCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHE
Confidence            9999986        456899999996 588777765 335699999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCC--CcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          833 LLDGDFGARVADFGVAKVVDASGK--PKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +++.++.+||+|||+++.......  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus       156 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  235 (351)
T 3mi9_A          156 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ  235 (351)
T ss_dssp             EECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            999999999999999987653322  122345578999999998876 45799999999999999999999999765433


Q ss_pred             hhHHHHHHHHhhccCccc--ccc-----------ccccCCCHHH------HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDH--VLD-----------PKLDCCFKEE------ICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~--~~~-----------~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .... .+...........  ..+           ........+.      ...+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          236 HQLA-LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHH-HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHH-HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            3222 2222111110000  000           0000000111      124778999999999999999999886

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-37  Score=356.82  Aligned_cols=202  Identities=25%  Similarity=0.273  Sum_probs=175.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC------C
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI------R  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~  754 (1002)
                      ..+|++.+.||+|+||.||+|... +++.||||++..                  .......+.+|+.+++.+      +
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~------------------~~~~~~~~~~E~~~l~~l~~~~~~~  157 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------------------EKRFHRQAAEEIRILEHLRKQDKDN  157 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS------------------CHHHHHHHHHHHHHHHHHHTTCTTS
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC------------------ccchHHHHHHHHHHHHHHhhccccC
Confidence            457888999999999999999864 588999999843                  223345677888888776      5


Q ss_pred             CCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          755 HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       755 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      |+||+++++++...+..++||||++ ++|.+++.......+++..++.++.||+.||+|||++   +|+||||||+||++
T Consensus       158 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl  233 (429)
T 3kvw_A          158 TMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILL  233 (429)
T ss_dssp             CSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEE
T ss_pred             CcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEE
Confidence            7899999999999999999999995 7999999876667799999999999999999999999   99999999999999


Q ss_pred             CCCCC--eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          835 DGDFG--ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       835 ~~~~~--~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      +.++.  +||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       234 ~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          234 KQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            99887  9999999997654332     24578999999999999999999999999999999999999997664433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-37  Score=348.95  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|... +|+.||||++......         ..........+.+.+|+.+++++ +||||+
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---------~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv  163 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER---------LSPEQLEEVREATRRETHILRQVAGHPHII  163 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSC---------CCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---------cCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            467889999999999999999975 6999999998543211         00011123356788999999999 799999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++...+..|+||||+++++|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       164 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             CEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999999753  4699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT------LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      +||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||..... ....
T Consensus       239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~  314 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-ILML  314 (365)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH
T ss_pred             EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-HHHH
Confidence            99999999987765432   234579999999998863      3578899999999999999999999975422 2222


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..+...    ... ...+......    ..+.+++.+||+.||++|||++|+++
T Consensus       315 ~~i~~~----~~~-~~~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 RMIMEG----QYQ-FSSPEWDDRS----STVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHT----CCC-CCHHHHSSSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhC----CCC-CCCcccccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            221111    110 0011112222    24788999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=349.20  Aligned_cols=264  Identities=27%  Similarity=0.382  Sum_probs=206.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-----cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-----SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ++|++.+.||+|+||.||+|+.     .+++.||||++...                 .....+.+.+|++++++++|||
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~  103 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----------------TEEHLRDFEREIEILKSLQHDN  103 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----------------CSHHHHHHHHHHHHHHTCCCTT
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence            4678889999999999999984     36889999998432                 2344667999999999999999


Q ss_pred             eeeeeeEEecCC--eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          758 IVKLWCCCTTRD--CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       758 iv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      |+++++++...+  ..++||||+++++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++
T Consensus       104 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~  179 (326)
T 2w1i_A          104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVE  179 (326)
T ss_dssp             BCCEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEE
T ss_pred             eeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEc
Confidence            999999987654  789999999999999999863 35699999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----
Q 001867          836 GDFGARVADFGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE-----  909 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~-----  909 (1002)
                      .++.+||+|||++........... .....++..|+|||++.+..++.++||||||+++|||++|..|+......     
T Consensus       180 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~  259 (326)
T 2w1i_A          180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI  259 (326)
T ss_dssp             ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHH
T ss_pred             CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhh
Confidence            999999999999987755432111 22345777899999999888999999999999999999999987532100     


Q ss_pred             ------hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          910 ------KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       910 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                            ......+.........    .+.....+    ..+.+++.+||+.||++|||++|+++.|+++...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          260 GNDKQGQMIVFHLIELLKNNGR----LPRPDGCP----DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             CTTCCTHHHHHHHHHHHHTTCC----CCCCTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccchhhhHHHHHHHhhcCCC----CCCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                  0000011111111100    01112222    3488899999999999999999999999998653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-37  Score=364.97  Aligned_cols=255  Identities=26%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+.++|++.++||+|+||+||+|... +++.||||++.+...               .......+.+|++++++++||||
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpni   83 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---------------KNKDTSTILREVELLKKLDHPNI   83 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH---------------BCSCHHHHHHHHHHHHHCCCTTB
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc---------------cchHHHHHHHHHHHHHhCCCCCc
Confidence            34577889999999999999999974 689999999854211               12235678999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC---
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---  835 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~---  835 (1002)
                      +++++++.+.+..|+||||+++|+|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++   
T Consensus        84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~  158 (486)
T 3mwu_A           84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKE  158 (486)
T ss_dssp             CCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSS
T ss_pred             CeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCC
Confidence            99999999999999999999999999988753  4699999999999999999999999   999999999999995   


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .++.+||+|||+++.......   .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+....
T Consensus       159 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~  233 (486)
T 3mwu_A          159 KDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKR  233 (486)
T ss_dssp             TTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH
T ss_pred             CCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence            456799999999987654322   234579999999999875 589999999999999999999999976532 222222


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      +....    .. ...+.......    .+.+++.+||+.||++|||+.|+++.
T Consensus       234 i~~~~----~~-~~~~~~~~~s~----~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          234 VETGK----YA-FDLPQWRTISD----DAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHTC----CC-SCSGGGGGSCH----HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHhCC----CC-CCCcccCCCCH----HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22111    11 00111222222    47789999999999999999999963

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-37  Score=346.61  Aligned_cols=251  Identities=20%  Similarity=0.321  Sum_probs=206.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...              ........+.+.+|+.++++++||||++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~--------------~~~~~~~~~~~~~E~~~l~~l~h~~iv~  105 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKS--------------LLLKPHQREKMSMEISIHRSLAHQHVVG  105 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG--------------GCCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechh--------------hhcCHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            356888899999999999999975 4789999998542              1223455678999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++++|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       106 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  180 (335)
T 2owb_A          106 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV  180 (335)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred             EEEEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCE
Confidence            999999999999999999999999998753  5699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............   
T Consensus       181 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---  255 (335)
T 2owb_A          181 KIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---  255 (335)
T ss_dssp             EECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---
T ss_pred             EEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc---
Confidence            9999999987654322  22345799999999999999999999999999999999999999975432222221111   


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                        ....  +.   ....    ..+.+++.+||+.||++||+++|+++
T Consensus       256 --~~~~--~~---~~~~----~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          256 --NEYS--IP---KHIN----PVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --TCCC--CC---TTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CCCC--CC---ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence              1100  00   1122    24778999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-37  Score=342.19  Aligned_cols=251  Identities=25%  Similarity=0.327  Sum_probs=202.1

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|.+.+.||+|+||.||+|+.. +|+.||+|++...                 .....+.+.+|+.++++++||||+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i~   69 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS-----------------PAFRDSSLENEIAVLKKIKHENIV   69 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------------------HHHHHHHHHHHCCCTTBC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc-----------------cccchHHHHHHHHHHHhCCCCCee
Confidence            4567888999999999999999975 6899999998532                 112245688999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---CC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DG  836 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll---~~  836 (1002)
                      ++++++.+.+..++||||+++++|.+++...  +.+++..+..++.|++.||+|||++   +|+||||||+||++   +.
T Consensus        70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~  144 (304)
T 2jam_A           70 TLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEE  144 (304)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSST
T ss_pred             ehhhhcccCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCC
Confidence            9999999999999999999999999998753  4689999999999999999999999   99999999999999   77


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ++.+||+|||++......    ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+
T Consensus       145 ~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i  219 (304)
T 2jam_A          145 NSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKI  219 (304)
T ss_dssp             TCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHH
T ss_pred             CCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHH
Confidence            889999999999764332    22344689999999999999999999999999999999999999975432 2222221


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    ... ....+.....+    ..+.+++.+|++.||++||+++|+++
T Consensus       220 ~~----~~~-~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          220 KE----GYY-EFESPFWDDIS----ESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HH----CCC-CCCTTTTTTSC----HHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             Hc----CCC-CCCccccccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11    111 11111112222    24788999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.7e-38  Score=345.26  Aligned_cols=262  Identities=30%  Similarity=0.409  Sum_probs=186.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....                .....+.+.+|+.++++++||||++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~   77 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----------------CQTSMDELLKEIQAMSQCHHPNIVS   77 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------------------CCCCCCCTTBCC
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----------------cchhHHHHHHHHHHHhhcCCCCEee
Confidence            46788999999999999999985 468999999874321                1223456889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSC------KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++++...+..++||||+++++|.+++...      ....+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus        78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~  154 (303)
T 2vwi_A           78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILL  154 (303)
T ss_dssp             EEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEE
T ss_pred             EEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEE
Confidence            999999999999999999999999998742      345699999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCC---cccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          835 DGDFGARVADFGVAKVVDASGKP---KSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      +.++.+||+|||++.........   .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.......
T Consensus       155 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  234 (303)
T 2vwi_A          155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK  234 (303)
T ss_dssp             CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred             cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence            99999999999999876543211   11234568999999999876 568999999999999999999999997654333


Q ss_pred             hHHHHHHHHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          911 DLVKWVCSTLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....... ...........++.. .....    .+.+++.+||+.||++||+++|+++
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          235 VLMLTLQ-NDPPSLETGVQDKEMLKKYGK----SFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHHHHT-SSCCCTTC-----CCCCCCCH----HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhc-cCCCccccccccchhhhhhhH----HHHHHHHHHccCChhhCcCHHHHhh
Confidence            2222111 110000011111111 22222    4778999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-37  Score=366.56  Aligned_cols=253  Identities=28%  Similarity=0.378  Sum_probs=205.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||||++.+..              .......+.+.+|+.++++++||||++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~hpniv~   90 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ--------------VKQKTDKESLLREVQLLKQLDHPNIMK   90 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------------CCBSSCHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhh--------------cccchHHHHHHHHHHHHHhCCCCCCCc
Confidence            457888999999999999999975 68999999985431              112334677999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---CCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DGD  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll---~~~  837 (1002)
                      +++++.+.+..|+||||+++|+|.+++..  .+.+++..++.++.|++.||+|||++   +|+||||||+||++   +.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  165 (484)
T 3nyv_A           91 LYEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD  165 (484)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT
T ss_pred             EEEEEEeCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCC
Confidence            99999999999999999999999999874  45699999999999999999999999   99999999999999   567


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+++......   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+....+.
T Consensus       166 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~  240 (484)
T 3nyv_A          166 ANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVE  240 (484)
T ss_dssp             CCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH
T ss_pred             CcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHH
Confidence            899999999998775543   2334579999999998866 689999999999999999999999976432 22222222


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    ... ...+......+    .+.+++.+||+.||++|||++|+++
T Consensus       241 ~~----~~~-~~~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          241 KG----KYT-FELPQWKKVSE----SAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HC----CCC-CCSGGGGGSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cC----CCC-CCCcccccCCH----HHHHHHHHHCCCChhHCcCHHHHhh
Confidence            11    111 01111122222    4778999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1e-37  Score=340.31  Aligned_cols=249  Identities=22%  Similarity=0.367  Sum_probs=203.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++....              .......+.+.+|++++++++||||++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   78 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ--------------LEKEGVEHQLRREIEIQSHLRHPNILR   78 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc--------------cchHHHHHHHHHHHHHHhcCCCCCEee
Confidence            356888899999999999999975 57889999985421              111223467899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++|+|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        79 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  153 (284)
T 2vgo_A           79 MYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGEL  153 (284)
T ss_dssp             EEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCE
T ss_pred             EEEEEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCE
Confidence            999999999999999999999999999853  4589999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++.......    .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...+   .
T Consensus       154 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~---~  225 (284)
T 2vgo_A          154 KIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRI---V  225 (284)
T ss_dssp             EECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH---H
T ss_pred             EEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHH---h
Confidence            999999997654322    2345689999999999999999999999999999999999999975432221 1111   1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      . ...  .+.   ....    ..+.+++.+|++.||++||+++|+++
T Consensus       226 ~-~~~--~~~---~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          226 N-VDL--KFP---PFLS----DGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             T-TCC--CCC---TTSC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-ccc--CCC---CcCC----HHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1 100  001   1122    24778999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.2e-38  Score=341.13  Aligned_cols=258  Identities=23%  Similarity=0.337  Sum_probs=204.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++....               ......+.+.+|+.++++++||||++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~   69 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---------------MTEAEKQMLVSEVNLLRELKHPNIVR   69 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT---------------CCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc---------------CCHHHHHHHHHHHHHHHhcCCCCCCe
Confidence            457888899999999999999975 68999999985421               12345678999999999999999999


Q ss_pred             eeeEEe--cCCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eeeCCCCCCc
Q 001867          761 LWCCCT--TRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPS-----IVHRDVKSNN  831 (1002)
Q Consensus       761 l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----iiHrDlk~~N  831 (1002)
                      +++++.  ..+..++||||+++++|.+++....  ...+++..++.++.|++.||+|||++   +     |+||||||+|
T Consensus        70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~N  146 (279)
T 2w5a_A           70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPAN  146 (279)
T ss_dssp             EEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGG
T ss_pred             EEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhh
Confidence            999885  4678899999999999999987532  35699999999999999999999998   7     9999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |+++.++.+||+|||+++......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+
T Consensus       147 Il~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~  223 (279)
T 2w5a_A          147 VFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKE  223 (279)
T ss_dssp             EEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHH
T ss_pred             EEEcCCCCEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-HHH
Confidence            999999999999999998765432  12234568999999999999899999999999999999999999997542 222


Q ss_pred             HHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          912 LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ....+..    .....    ......    ..+.+++.+||+.||++||+++|+++.+...
T Consensus       224 ~~~~i~~----~~~~~----~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          224 LAGKIRE----GKFRR----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             HHHHHHH----TCCCC----CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             HHHHHhh----ccccc----CCcccC----HHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            2222211    11111    111222    2478899999999999999999999865443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.8e-37  Score=357.79  Aligned_cols=263  Identities=19%  Similarity=0.257  Sum_probs=208.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC-Ccee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH-KNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv  759 (1002)
                      .++|++.++||+|+||.||+|+. .+++.||||++...                   ....++.+|+++++.++| +++.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------------~~~~~~~~E~~il~~L~~~~~i~   66 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------------------TKHPQLLYESKIYRILQGGTGIP   66 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT-------------------CSSCCHHHHHHHHHHTTTSTTCC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------------------cccHHHHHHHHHHHHhcCCCCCC
Confidence            46788999999999999999996 56899999987432                   112357899999999986 6666


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE---CC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL---DG  836 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll---~~  836 (1002)
                      .+..++...+..++||||+ +++|.+++... ...+++..++.++.||+.||+|||++   +|+||||||+|||+   +.
T Consensus        67 ~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~  141 (483)
T 3sv0_A           67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRR  141 (483)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGG
T ss_pred             eEEEEEeeCCEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCC
Confidence            7777777888999999999 99999999753 35699999999999999999999999   99999999999999   58


Q ss_pred             CCCeEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          837 DFGARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      ++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~  221 (483)
T 3sv0_A          142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK  221 (483)
T ss_dssp             TTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred             CCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence            889999999999877654322     122356799999999999999999999999999999999999999976433221


Q ss_pred             H--HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          912 L--VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       912 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      .  ...+........    +.......+.    ++.+++..||+.+|++||++++|++.|+++....
T Consensus       222 ~~~~~~i~~~~~~~~----~~~l~~~~p~----~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          222 KQKYEKISEKKVATS----IEALCRGYPT----EFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHHHHHHHHSC----HHHHHTTSCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhhcccccc----HHHHhcCCcH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            1  111111111111    1111122222    4788999999999999999999999999986533

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-37  Score=351.50  Aligned_cols=261  Identities=24%  Similarity=0.278  Sum_probs=194.7

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+.++|++.+.||+|+||.||+|... +++.||||++...               .......+.+.+|+.+++.++||||
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~hpni   86 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---------------FQNQTHAKRAYRELVLMKCVNHKNI   86 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT---------------TSSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc---------------cCChHHHHHHHHHHHHHHhcCCCCc
Confidence            34578899999999999999999964 6889999998532               1234456778899999999999999


Q ss_pred             eeeeeEEecCC------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          759 VKLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       759 v~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      +++++++...+      ..|+||||++ |+|.+++.    ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        87 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NI  158 (371)
T 2xrw_A           87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  158 (371)
T ss_dssp             CCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cceEEeeccccccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHE
Confidence            99999998665      7899999996 58888885    3489999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      +++.++.+||+|||+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus       159 l~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  235 (371)
T 2xrw_A          159 VVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW  235 (371)
T ss_dssp             EECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998765432   223457899999999999999999999999999999999999999765332222


Q ss_pred             HHHHHHHhhcc--------------------C-----cc----ccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 001867          913 VKWVCSTLDQK--------------------G-----VD----HVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR  963 (1002)
Q Consensus       913 ~~~~~~~~~~~--------------------~-----~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  963 (1002)
                      ...+. .....                    .     ..    ....+............+.+++.+|++.||++|||++
T Consensus       236 ~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~  314 (371)
T 2xrw_A          236 NKVIE-QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD  314 (371)
T ss_dssp             HHHHC--CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHH-HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHH
Confidence            22111 00000                    0     00    0000000001112245688999999999999999999


Q ss_pred             HHHH
Q 001867          964 RVVK  967 (1002)
Q Consensus       964 evl~  967 (1002)
                      |+++
T Consensus       315 e~l~  318 (371)
T 2xrw_A          315 EALQ  318 (371)
T ss_dssp             HHHH
T ss_pred             HHhC
Confidence            9986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.4e-38  Score=341.74  Aligned_cols=246  Identities=21%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|... +++.||+|++....               ........+.+|+..+.++ +||||+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~~e~~~~~~l~~h~~iv   74 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL---------------AGSVDEQNALREVYAHAVLGQHSHVV   74 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC---------------TTSHHHHHHHHHHHHHHHSCSCTTBC
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc---------------cccHHHHHHHHHHHHHHHhCCCCCee
Confidence            467888999999999999999975 78999999985431               1233466788999999999 899999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++.+++..++||||+++++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.+
T Consensus        75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~  151 (289)
T 1x8b_A           75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRT  151 (289)
T ss_dssp             CEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--
T ss_pred             eeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCC
Confidence            99999999999999999999999999997643  26699999999999999999999999   99999999999999844


Q ss_pred             -------------------CCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHH
Q 001867          838 -------------------FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELV  897 (1002)
Q Consensus       838 -------------------~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell  897 (1002)
                                         ..+||+|||.+.......      ...||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  225 (289)
T 1x8b_A          152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA  225 (289)
T ss_dssp             ------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred             CCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence                               479999999998765432      23589999999998766 5668999999999999999


Q ss_pred             hCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          898 TGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       898 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +|..|+...   ... ..+.    ......    .......    .+.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~---~~~-~~~~----~~~~~~----~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          226 GAEPLPRNG---DQW-HEIR----QGRLPR----IPQVLSQ----EFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             TCCCCCSSS---HHH-HHHH----TTCCCC----CSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCCcch---hHH-HHHH----cCCCCC----CCcccCH----HHHHHHHHHhCCCcccCCCHHHHhh
Confidence            998776432   111 1111    111111    1112222    4788999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.7e-37  Score=363.93  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=201.5

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.+.|++.+.||+|+||.||+|+.+ +++.||+|++.+...               .......+.+|+.++++++||||+
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpniv   99 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV---------------STSSNSKLLEEVAVLKLLDHPNIM   99 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------------------CTTHHHHHHHHHHTTCCCTTBC
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc---------------CchHHHHHHHHHHHHHhCCCCCCC
Confidence            3456888999999999999999975 688999999854311               122346688999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC--
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD--  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~--  837 (1002)
                      ++++++.+.+..|+||||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++..  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  174 (494)
T 3lij_A          100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEK  174 (494)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSST
T ss_pred             eEEEEEEeCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCC
Confidence            9999999999999999999999999988753  5699999999999999999999999   99999999999999764  


Q ss_pred             -CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          838 -FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 -~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                       +.+||+|||+++......   ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... .+....+
T Consensus       175 ~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i  249 (494)
T 3lij_A          175 DALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKV  249 (494)
T ss_dssp             TCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred             CCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence             459999999998765432   233457999999999876 5689999999999999999999999976533 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEV  972 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~  972 (1002)
                      ....    . ....+.......    .+.+++.+||+.||++|||++|+++  ++.+.
T Consensus       250 ~~~~----~-~~~~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          250 EKGK----Y-TFDSPEWKNVSE----GAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHTC----C-CCCSGGGTTSCH----HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HhCC----C-CCCchhcccCCH----HHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            2111    1 111122222333    4778999999999999999999985  35444

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.4e-38  Score=343.85  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=198.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc--CCc--EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS--NGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|++.  +++  .||||++....              .......+.+.+|+.++++++||||
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i   83 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--------------LSQPEAMDDFIREVNAMHSLDHRNL   83 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------------CHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc--------------cCCHHHHHHHHHHHHHHHhCCCCCc
Confidence            56888899999999999999853  233  68999874321              1123456789999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++.... .++||||+++++|.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~  158 (291)
T 1u46_A           84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD  158 (291)
T ss_dssp             CCEEEEECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred             ccEEEEEccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence            99999998765 88999999999999999763 35689999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+||+|||++.......... ......+|..|+|||++.+..++.++||||+|+++|||++ |+.||..... .+....+
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~  237 (291)
T 1u46_A          159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI  237 (291)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHH
T ss_pred             CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-HHHHHHH
Confidence            99999999998775543222 1234457889999999998889999999999999999999 9999975432 2222211


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .   ... ..   .+.....+    ..+.+++.+||+.||++|||++++++.|+++.+
T Consensus       238 ~---~~~-~~---~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          238 D---KEG-ER---LPRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             H---TSC-CC---CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             H---ccC-CC---CCCCcCcC----HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            1   111 00   11112222    347889999999999999999999999998864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-37  Score=348.57  Aligned_cols=268  Identities=21%  Similarity=0.256  Sum_probs=200.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +|+.||||++......            .......+.+.+|+.++++++||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~~iv~   76 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------------EAKDGINRTALREIKLLQELSHPNIIG   76 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------------------CTHHHHHHHHHHHCCCTTBCC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc------------hhhhhhhHHHHHHHHHHhhCCCCCCCe
Confidence            467899999999999999999964 5899999998543111            001122346889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           77 LLDAFGHKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             EEEEECCTTCCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             EEEEEeeCCceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence            99999999999999999964 89888875 335689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+++.......  ......||+.|+|||++.+. .++.++||||+||++|||++|..||........+.......
T Consensus       152 kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~  229 (346)
T 1ua2_A          152 KLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL  229 (346)
T ss_dssp             EECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHc
Confidence            9999999987654322  22345789999999998754 58899999999999999999999987654444433333322


Q ss_pred             hhcc--Cccc---ccc----ccccCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          920 LDQK--GVDH---VLD----PKLDCCF-----KEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       920 ~~~~--~~~~---~~~----~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      ....  ....   ..+    ......+     .....++.+++.+|++.||++|||++|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            1110  0000   000    0000001     1112358899999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-37  Score=342.43  Aligned_cols=260  Identities=23%  Similarity=0.309  Sum_probs=199.6

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|... +++.||||++......         ............+.+|++++++++||||+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~~~~~~E~~~l~~l~h~~i~   78 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFA---------IGSAREADPALNVETEIEILKKLNHPCII   78 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC------------------------CHHHHHHHHHHCCCTTBC
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhh---------hcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence            4567889999999999999999974 5789999998543110         00111223345688999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++..++ .|+||||+++++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           79 KIKNFFDAED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             CEEEEEESSS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred             eEeeEEcCCc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence            9999997765 8999999999999999873  45799999999999999999999999   9999999999999987654


Q ss_pred             ---eEEccccCcccccCCCCCcccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          840 ---ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       840 ---~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                         +||+|||+++.....   .......||+.|+|||++.   ...++.++|||||||++|+|++|+.||..........
T Consensus       153 ~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK  229 (322)
T ss_dssp             SCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH
T ss_pred             CCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH
Confidence               999999999876432   2223456899999999864   5678899999999999999999999997655444444


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..+.....    .. .........    ..+.+++.+||+.||++||+++|+++
T Consensus       230 ~~~~~~~~----~~-~~~~~~~~~----~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          230 DQITSGKY----NF-IPEVWAEVS----EKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHTCC----CC-CHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhCcc----cc-CchhhhhcC----HHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            33322111    00 000011122    34788999999999999999999984

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-37  Score=350.61  Aligned_cols=200  Identities=27%  Similarity=0.438  Sum_probs=174.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|... +++.||+|++....                .....+.+.+|+.++++++||||+++
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----------------~~~~~~~~~~E~~~l~~l~h~~iv~~   96 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----------------KPAIRNQIIRELQVLHECNSPYIVGF   96 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----------------CHHHHHHHHHHHGGGGGCCCTTBCCE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----------------CHHHHHHHHHHHHHHHHCCCCCEEEE
Confidence            56888899999999999999975 68999999985421                23456779999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..++||||+++++|.+++...  +.+++..+..++.|++.||+|||+++  +|+||||||+||+++.++.+|
T Consensus        97 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~k  172 (360)
T 3eqc_A           97 YGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIK  172 (360)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEE
T ss_pred             eEEEEECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEE
Confidence            99999999999999999999999999853  45899999999999999999999831  799999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE  906 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~  906 (1002)
                      |+|||++.......    .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       173 l~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          173 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             ECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             EEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999997654321    22347899999999999999999999999999999999999999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.1e-37  Score=353.59  Aligned_cols=257  Identities=23%  Similarity=0.243  Sum_probs=194.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .+|++.+.||+|+||.||+|+..++..||+|++....                     ....+|+++++.++||||++++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---------------------~~~~~E~~il~~l~h~niv~l~   98 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---------------------RFKNRELQIMRIVKHPNVVDLK   98 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT---------------------TSCCHHHHHHHTCCCTTBCCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---------------------chHHHHHHHHHhCCCCCcceEE
Confidence            4688889999999999999998877789999884321                     1123699999999999999999


Q ss_pred             eEEecCC------eeeEEEeccCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          763 CCCTTRD------CKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       763 ~~~~~~~------~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++...+      ..++||||++++ +.+.+..  .....+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus        99 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill  174 (394)
T 4e7w_A           99 AFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLL  174 (394)
T ss_dssp             EEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             EEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEE
Confidence            9996543      378999999764 4443321  2346799999999999999999999999   99999999999999


Q ss_pred             C-CCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          835 D-GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       835 ~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      + .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.+
T Consensus       175 ~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l  251 (394)
T 4e7w_A          175 DPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL  251 (394)
T ss_dssp             ETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            8 789999999999987654432   2244689999999998765 5899999999999999999999999876544444


Q ss_pred             HHHHHHHhhc---------cCccccccccccC------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQ---------KGVDHVLDPKLDC------CFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~---------~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+......         .......-+....      .......++.+++.+||+.||++|||+.|+++
T Consensus       252 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          252 VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            4333211000         0000000000000      00011235889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8e-37  Score=335.26  Aligned_cols=251  Identities=26%  Similarity=0.364  Sum_probs=196.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|.....||+|+||.||+|.. .+++.||||++...                 +....+.+.+|+.++++++||||+++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~iv~~   84 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-----------------DSRYSQPLHEEIALHKHLKHKNIVQY   84 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-----------------CC---HHHHHHHHHHHTCCCTTBCCE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-----------------chHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            3455567999999999999996 46889999998432                 22335678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC-CCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG-DFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~-~~~  839 (1002)
                      ++++...+..++||||+++++|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++. ++.
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  161 (295)
T 2clq_A           85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGV  161 (295)
T ss_dssp             EEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCC
T ss_pred             eeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCC
Confidence            9999999999999999999999999986432 3567999999999999999999999   9999999999999987 899


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +||+|||++........  ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...........  .
T Consensus       162 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~  237 (295)
T 2clq_A          162 LKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--K  237 (295)
T ss_dssp             EEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--H
T ss_pred             EEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--h
Confidence            99999999987654321  223456899999999987643  78999999999999999999999964322221111  1


Q ss_pred             HHhhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .....      ..+.. ....    ..+.+++.+||+.||++||+++|+++
T Consensus       238 ~~~~~------~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          238 VGMFK------VHPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHC------CCCCCCTTSC----HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             hcccc------ccccccccCC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11100      01111 1222    24778999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.6e-38  Score=357.49  Aligned_cols=249  Identities=16%  Similarity=0.135  Sum_probs=192.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHH---HHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE---TLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++....              .......+.+.+|+.   ++++++||||
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~E~~~l~~l~~l~hpni  138 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE--------------RPPSNAIKQMKEEVLRLRLLRGIKNQKQ  138 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC---------------CCTTHHHHHHHHHHGGGGSTTCCSHHH
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecc--------------ccchHHHHHHHHHHHHHHhccccCCHHH
Confidence            5678889999999999999995 568999999985421              123345677999995   4555579999


Q ss_pred             eeee-------eEEecCCe-----------------eeEEEeccCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHH
Q 001867          759 VKLW-------CCCTTRDC-----------------KLLVYEYMPNGSLGDLLHSCKG-----GLLDWPTRYKIIVDAAE  809 (1002)
Q Consensus       759 v~l~-------~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~  809 (1002)
                      |+++       +++.+.+.                 .|+||||+ +|+|.+++.....     ..+++..++.++.||+.
T Consensus       139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~  217 (377)
T 3byv_A          139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR  217 (377)
T ss_dssp             HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence            9998       66665532                 78999999 6899999985321     12335888899999999


Q ss_pred             HHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-----------
Q 001867          810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-----------  878 (1002)
Q Consensus       810 ~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------  878 (1002)
                      ||+|||++   +|+||||||+||+++.++.+||+|||+++....     ......| +.|+|||++.+.           
T Consensus       218 aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~  288 (377)
T 3byv_A          218 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRT  288 (377)
T ss_dssp             HHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred             HHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccc
Confidence            99999999   999999999999999999999999999986432     2234567 999999999887           


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCC
Q 001867          879 RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPIN  958 (1002)
Q Consensus       879 ~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  958 (1002)
                      .++.++|||||||++|||++|+.||........             ...+ .+.....++    .+.+++.+||+.||++
T Consensus       289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~-~~~~~~~~~----~~~~li~~~L~~dp~~  350 (377)
T 3byv_A          289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGG-------------SEWI-FRSCKNIPQ----PVRALLEGFLRYPKED  350 (377)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCCC------CC-------------SGGG-GSSCCCCCH----HHHHHHHHHTCSSGGG
T ss_pred             cCChhhhHHHHHHHHHHHHHCCCCCcccccccc-------------hhhh-hhhccCCCH----HHHHHHHHHcCCCchh
Confidence            899999999999999999999999964322111             1111 111122232    4788999999999999


Q ss_pred             CCCHHHHHH--HHHHhh
Q 001867          959 RPAMRRVVK--LLQEVG  973 (1002)
Q Consensus       959 Rps~~evl~--~L~~~~  973 (1002)
                      |||+.|+++  +++++.
T Consensus       351 Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          351 RLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             CCCHHHHHTSHHHHHHH
T ss_pred             CCCHHHHhhChHHHHHH
Confidence            999999985  555554

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.9e-37  Score=339.57  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=198.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|++.+.||+|+||.||+|... +|+.||+|++...                   ...+.+.+|+.++++++||||++
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------------------~~~~~~~~e~~~l~~l~h~~i~~   88 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-------------------SDLQEIIKEISIMQQCDSPHVVK   88 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-------------------SCCHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-------------------HHHHHHHHHHHHHHhCCCCCCcc
Confidence            467888999999999999999975 5899999998432                   12356889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  164 (314)
T 3com_A           89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHA  164 (314)
T ss_dssp             EEEEEEETTEEEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCE
T ss_pred             EEEEEEeCCEEEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCE
Confidence            99999999999999999999999999874 345799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++........  ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......... ..   .
T Consensus       165 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~---~  238 (314)
T 3com_A          165 KLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-MI---P  238 (314)
T ss_dssp             EECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HH---H
T ss_pred             EEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-HH---h
Confidence            9999999987654322  2234568999999999999999999999999999999999999997543222111 11   1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .. ......  ......    ..+.+++.+||+.||++|||++++++
T Consensus       239 ~~-~~~~~~--~~~~~~----~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          239 TN-PPPTFR--KPELWS----DNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HS-CCCCCS--SGGGSC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cC-CCcccC--CcccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11 100000  011112    24788999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.7e-37  Score=348.34  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=202.3

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|... +++.||||++...                ......+.+.+|++++++++||||+
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~niv   88 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----------------EHQTYCQRTLREIKILLRFRHENII   88 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----------------TCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----------------cCcHHHHHHHHHHHHHHhcCCCCCc
Confidence            3467889999999999999999964 6889999998431                1234457789999999999999999


Q ss_pred             eeeeEEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          760 KLWCCCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       760 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      ++++++...     ...|+||||++ |+|.+++..   ..+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus        89 ~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~  161 (364)
T 3qyz_A           89 GINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLL  161 (364)
T ss_dssp             CCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             cceeEEecCCccccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEE
Confidence            999999754     46899999996 699999874   4599999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCc-ccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          835 DGDFGARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      +.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+..
T Consensus       162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  241 (364)
T 3qyz_A          162 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL  241 (364)
T ss_dssp             CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH
T ss_pred             CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH
Confidence            999999999999998765432211 1234579999999998654 45899999999999999999999999766444433


Q ss_pred             HHHHHHHhhccCcc---------------cccccc---ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKGVD---------------HVLDPK---LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~---------------~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ........ .....               ....+.   .....+....++.+++.+|++.||++|||++|+++
T Consensus       242 ~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          242 NHILGILG-SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHC-SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhC-CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            33221110 00000               000000   00000111234789999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=346.93  Aligned_cols=257  Identities=24%  Similarity=0.321  Sum_probs=188.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  760 (1002)
                      .+|++.++||+|+||.||+|+.. +++.||||++...                 .....+.+.+|+.+++++. ||||++
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~~~~e~~~l~~l~~h~~iv~   90 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----------------EEEKNRAIIQEVCFMKKLSGHPNIVQ   90 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----------------SHHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----------------chHHHHHHHHHHHHHHHhccCCChhh
Confidence            36788899999999999999964 6899999988432                 2344667899999999996 999999


Q ss_pred             eeeEEe--------cCCeeeEEEeccCCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCC
Q 001867          761 LWCCCT--------TRDCKLLVYEYMPNGSLGDLLHSC-KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKS  829 (1002)
Q Consensus       761 l~~~~~--------~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~  829 (1002)
                      +++++.        .....++||||++ |+|.+++... ..+.+++..++.++.|++.||+|||++   +  |+||||||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp  166 (337)
T 3ll6_A           91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKV  166 (337)
T ss_dssp             EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCG
T ss_pred             ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCc
Confidence            999994        3445799999995 7999988652 345799999999999999999999998   8  99999999


Q ss_pred             CcEEECCCCCeEEccccCcccccCCCCCc----------ccccccccccccCcccc---ccCCCCCccchhhHHHHHHHH
Q 001867          830 NNILLDGDFGARVADFGVAKVVDASGKPK----------SMSVIAGSCGYIAPEYA---YTLRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       830 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~el  896 (1002)
                      +||+++.++.+||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|||
T Consensus       167 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el  246 (337)
T 3ll6_A          167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL  246 (337)
T ss_dssp             GGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred             ccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence            99999999999999999998775432211          11244689999999998   566788999999999999999


Q ss_pred             HhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          897 VTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       897 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ++|+.||.......    .......        .+.....+.    .+.+++.+||+.||++||+++|+++.|+++.+..
T Consensus       247 ~~g~~p~~~~~~~~----~~~~~~~--------~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          247 CFRQHPFEDGAKLR----IVNGKYS--------IPPHDTQYT----VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             HHSSCCC----------------CC--------CCTTCCSSG----GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HhCCCCCcchhHHH----hhcCccc--------CCcccccch----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            99999996432211    1111110        011111111    3678899999999999999999999999987643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.9e-37  Score=336.67  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=204.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|++....                .....+.+.+|+.++++++||||++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~   84 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----------------AEDEIEDIQQEITVLSQCDSPYVTK   84 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT----------------CSTTHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc----------------cHHHHHHHHHHHHHHHhCCCCCEeE
Confidence            35688889999999999999986 468899999985421                1223567999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++++|.+++..   ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  158 (303)
T 3a7i_A           85 YYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEV  158 (303)
T ss_dssp             EEEEEEETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCE
Confidence            99999999999999999999999999963   5699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+..  
T Consensus       159 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~--  233 (303)
T 3a7i_A          159 KLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-MKVLFLIPK--  233 (303)
T ss_dssp             EECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHH--
T ss_pred             EEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-HHHHHHhhc--
Confidence            9999999987654322  22345789999999999999999999999999999999999999965422 222211111  


Q ss_pred             hccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          921 DQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       921 ~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                        ...     +.. .....    .+.+++.+||+.||++|||++|+++.
T Consensus       234 --~~~-----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          234 --NNP-----PTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             --SCC-----CCCCSSCCH----HHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             --CCC-----CCCccccCH----HHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              111     111 12222    47789999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.2e-37  Score=348.96  Aligned_cols=273  Identities=21%  Similarity=0.219  Sum_probs=198.4

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +.++|++.+.||+|+||.||+|...+|+.||||++.......      -......+....+.+.+|+.++++++||||++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG------RTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTT------SCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCcc------chhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            357899999999999999999998889999999986532211      00011223344578999999999999999999


Q ss_pred             eeeEEec-----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          761 LWCCCTT-----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       761 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      +++++..     ....|+||||++ |+|.+++.. ....+++..+..++.|++.||+|||++   +|+||||||+||+++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA  168 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence            9999954     346799999996 788888874 345799999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      .++.+||+|||+++......   ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999997544332   2234578999999998876 6789999999999999999999999976543332222


Q ss_pred             HHHHHhhc------------------cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLDQ------------------KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ........                  ...............+.....+.+++.+|++.||++|||++|+++
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            22111000                  000000000000011111234788999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-37  Score=354.03  Aligned_cols=263  Identities=23%  Similarity=0.255  Sum_probs=198.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...                     .....+|+++++.++||||++
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~---------------------~~~~~~E~~il~~l~hpnIv~   64 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD---------------------PRYKNRELDIMKVLDHVNIIK   64 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC---------------------TTSCCHHHHHHTTCCCTTBCC
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC---------------------cchHHHHHHHHHHcCCCCccc
Confidence            35788899999999999999996 56899999998432                     111236999999999999999


Q ss_pred             eeeEEec--------------------------------------CCeeeEEEeccCCCChhhhhhh--cCCCCCCHHHH
Q 001867          761 LWCCCTT--------------------------------------RDCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTR  800 (1002)
Q Consensus       761 l~~~~~~--------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~  800 (1002)
                      +++++..                                      ....++||||++ |+|.+.+..  .....+++..+
T Consensus        65 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~  143 (383)
T 3eb0_A           65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLI  143 (383)
T ss_dssp             EEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHH
T ss_pred             hhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHH
Confidence            9999954                                      334889999997 688777764  24567999999


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC-CCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-
Q 001867          801 YKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-  878 (1002)
Q Consensus       801 ~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-  878 (1002)
                      +.++.|++.||+|||++   +|+||||||+||+++ .++.+||+|||+++.......   .....||+.|+|||++.+. 
T Consensus       144 ~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~  217 (383)
T 3eb0_A          144 SIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGAT  217 (383)
T ss_dssp             HHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCC
Confidence            99999999999999999   999999999999997 688999999999987654432   2244689999999988765 


Q ss_pred             CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------cCccccccccccC------CCHHHHHH
Q 001867          879 RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ---------KGVDHVLDPKLDC------CFKEEICK  943 (1002)
Q Consensus       879 ~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~------~~~~~~~~  943 (1002)
                      .++.++||||+||++|||++|+.||......+.....+......         .......-+....      .+......
T Consensus       218 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (383)
T 3eb0_A          218 EYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL  297 (383)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHH
T ss_pred             CCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHH
Confidence            48999999999999999999999998765444444333211100         0000000010000      00111234


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHH--HHHHh
Q 001867          944 VLNIGLLCTSPLPINRPAMRRVVK--LLQEV  972 (1002)
Q Consensus       944 l~~l~~~cl~~dP~~Rps~~evl~--~L~~~  972 (1002)
                      +.+++.+||+.||++|||+.|+++  +++++
T Consensus       298 ~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence            789999999999999999999984  44444

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.3e-37  Score=339.92  Aligned_cols=264  Identities=22%  Similarity=0.263  Sum_probs=202.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE--cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC---CCC
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL--SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI---RHK  756 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~  756 (1002)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++.....               .......+.+|+.+++++   +||
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~h~   74 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------------EEGMPLSTIREVAVLRHLETFEHP   74 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---------------TTSCBCTHHHHHHHHHHHHHTCCT
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc---------------cccCCchhhHHHHHHHhhhccCCC
Confidence            36788899999999999999997  3578999999854311               111223466777777766   899


Q ss_pred             ceeeeeeEEe-----cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          757 NIVKLWCCCT-----TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       757 niv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ||+++++++.     .....++||||++ |+|.+++.......+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus        75 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~N  150 (326)
T 1blx_A           75 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN  150 (326)
T ss_dssp             TBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             CeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHH
Confidence            9999999997     5667899999996 7999999876666799999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |+++.++.+||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (326)
T 1blx_A          151 ILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  227 (326)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             eEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            999999999999999998654321   23345789999999999999999999999999999999999999976543333


Q ss_pred             HHHHHHHHhhcc--Ccc-------ccc----cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          912 LVKWVCSTLDQK--GVD-------HVL----DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       912 ~~~~~~~~~~~~--~~~-------~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ............  ...       ...    ..............+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            333222111000  000       000    00000111111234778999999999999999999984

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.2e-37  Score=335.69  Aligned_cols=260  Identities=25%  Similarity=0.313  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      .++|++.+.||+|+||.||+|..+ +++.||||++.......        ..........+.+.+|+.+++++. ||||+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGS--------FSAEEVQELREATLKEVDILRKVSGHPNII   87 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTT--------CCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccc--------cCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            467888999999999999999975 68899999985431100        000112334567889999999996 99999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++...+..++||||+++++|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~  162 (298)
T 1phk_A           88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN  162 (298)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             eeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCc
Confidence            9999999999999999999999999999853  5699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY------TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      +||+|||++........   .....||+.|+|||++.      ...++.++||||+|+++|||++|+.||..... ....
T Consensus       163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~  238 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLML  238 (298)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH
T ss_pred             EEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-HHHH
Confidence            99999999987654332   23456899999999875      45688999999999999999999999975432 2222


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..+...    ... ...+......    ..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~----~~~-~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSG----NYQ-FGSPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHT----CCC-CCTTTGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcC----Ccc-cCcccccccC----HHHHHHHHHHccCCcccCCCHHHHHh
Confidence            221111    111 1111112222    24788999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=343.08  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=195.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .+.|++.+.||+|+||.||+|.. .+++.||||++...                  ....+.+.+|+.+++++ +||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------------~~~~~~~~~e~~~l~~l~~h~~i~   84 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------------------GDEEEEIKQEINMLKKYSHHRNIA   84 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------------SSTTHHHHHHHHHHHHHCCSTTBC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC------------------cccHHHHHHHHHHHHhccCCCCee
Confidence            46788899999999999999997 46899999998432                  12245788999999998 799999


Q ss_pred             eeeeEEec------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          760 KLWCCCTT------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       760 ~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      ++++++..      .+..++||||+++|+|.+++...+...+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl  161 (326)
T 2x7f_A           85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVL  161 (326)
T ss_dssp             CEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEE
T ss_pred             eeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEE
Confidence            99999986      46789999999999999999876667799999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFG  908 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~  908 (1002)
                      ++.++.+||+|||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.....
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  239 (326)
T 2x7f_A          162 LTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP  239 (326)
T ss_dssp             ECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             EcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence            99999999999999987654321  223446899999999987     56788999999999999999999999965432


Q ss_pred             chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...... .   . .........   .....    .+.+++.+||+.||++||+++++++
T Consensus       240 ~~~~~~-~---~-~~~~~~~~~---~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          240 MRALFL-I---P-RNPAPRLKS---KKWSK----KFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHH-H---H-HSCCCCCSC---SCSCH----HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHH-h---h-cCccccCCc---cccCH----HHHHHHHHHhccChhhCCCHHHHhh
Confidence            222111 1   1 111111111   12222    4778999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=346.24  Aligned_cols=261  Identities=21%  Similarity=0.349  Sum_probs=198.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|...+  .||+|++.....               .....+.+.+|+.++++++||||+++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~   94 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD---------------NEDQLKAFKREVMAYRQTRHENVVLF   94 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC---------------CCCCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC---------------CHHHHHHHHHHHHHHhcCCCCCEeEE
Confidence            3678889999999999999999753  599999854211               12223457789999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++   +|+||||||+||+++ ++.+|
T Consensus        95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~  169 (319)
T 2y4i_B           95 MGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVV  169 (319)
T ss_dssp             CEEEECSSCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCE
T ss_pred             EEEEecCCceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEE
Confidence            9999999999999999999999999975 335699999999999999999999999   999999999999998 67999


Q ss_pred             EccccCcccccCCCC---CcccccccccccccCcccccc---------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          842 VADFGVAKVVDASGK---PKSMSVIAGSCGYIAPEYAYT---------LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      |+|||+++.......   ........||+.|+|||++.+         ..++.++||||||+++|||++|+.||......
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  249 (319)
T 2y4i_B          170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE  249 (319)
T ss_dssp             ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred             EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999876542211   122234468999999998874         35788999999999999999999999754322


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                       .....+..    ........   ...+.    .+.+++.+||+.||++|||++++++.|+++....
T Consensus       250 -~~~~~~~~----~~~~~~~~---~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          250 -AIIWQMGT----GMKPNLSQ---IGMGK----EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -HHHHHHHT----TCCCCCCC---SSCCT----THHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -HHHHHhcc----CCCCCCCc---CCCCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence             22211111    11111111   11122    3778999999999999999999999999986543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-37  Score=374.95  Aligned_cols=251  Identities=26%  Similarity=0.353  Sum_probs=203.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  759 (1002)
                      .++|++.++||+|+||.||+|+.+ +++.||||++.+..              .......+.+..|..++..+ +||+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~--------------~~~~~~~~~~~~E~~~l~~~~~~~~i~  405 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV--------------VIQDDDVECTMVEKRVLALPGKPPFLT  405 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH--------------HHHTTTTHHHHHHHHHHTCTTCCTTBC
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc--------------cccHHHHHHHHHHHHHHHhccCCCeEE
Confidence            467888999999999999999965 57889999985431              11223456688899999988 699999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.+.+..|+||||+++|+|.++++..  +.+++..++.++.||+.||+|||++   +||||||||+|||++.++.
T Consensus       406 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~  480 (674)
T 3pfq_A          406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH  480 (674)
T ss_dssp             CEEEECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSC
T ss_pred             EEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCc
Confidence            9999999999999999999999999999853  4699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +||+|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+   
T Consensus       481 ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i---  554 (674)
T 3pfq_A          481 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI---  554 (674)
T ss_dssp             EEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH---
T ss_pred             EEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-HHHHHHH---
Confidence            99999999986433322  23456799999999999999999999999999999999999999976432 2222221   


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM-----RRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~evl~  967 (1002)
                      .. ....  + |  ....    .++.+++.+|++.||++||++     +||.+
T Consensus       555 ~~-~~~~--~-p--~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          555 ME-HNVA--Y-P--KSMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HS-SCCC--C-C--TTSC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             Hh-CCCC--C-C--ccCC----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            11 1110  0 0  1122    247889999999999999997     66653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.7e-37  Score=340.26  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=197.5

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      ..+.|++.+.||+|+||.||+|... +++.||+|++...                 .....+.+.+|+.++++++||||+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i~   79 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-----------------SEEELEDYIVEIEILATCDHPYIV   79 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------------------CCHHHHHHHHHHHHHCCCTTBC
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-----------------CHHHHHHHHHHHHHHhcCCCCCEe
Confidence            3467888999999999999999975 5889999998432                 122356789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  155 (302)
T 2j7t_A           80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGD  155 (302)
T ss_dssp             CEEEEEECC-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSC
T ss_pred             eeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCC
Confidence            9999999999999999999999999998753 35699999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCcccc-----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA-----YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      +||+|||++.......  .......||+.|+|||++     .+..++.++||||||+++|+|++|+.||...........
T Consensus       156 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  233 (302)
T 2j7t_A          156 IRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK  233 (302)
T ss_dssp             EEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             EEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            9999999976432211  111234689999999987     466788999999999999999999999975432222222


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    .... .....  .....    ..+.+++.+||+.||++|||++++++
T Consensus       234 ~~----~~~~-~~~~~--~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          234 IA----KSDP-PTLLT--PSKWS----VEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HH----HSCC-CCCSS--GGGSC----HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             Hh----ccCC-cccCC--ccccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11    1111 11000  01122    24778999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.4e-37  Score=361.61  Aligned_cols=264  Identities=23%  Similarity=0.279  Sum_probs=201.6

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|.+.++||+|+||+||+|..+ +++.||+|++.+.......    ............+.+.+|+.++++++||||+
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  109 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR----YSDDNKNIEKFHEEIYNEISLLKSLDHPNII  109 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC--------------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhccccc----ccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            4578999999999999999999975 5789999998653211000    0000001123456789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC-
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF-  838 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~-  838 (1002)
                      ++++++.+.+..|+||||+++|+|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++ 
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTC
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCC
Confidence            9999999999999999999999999998753  4699999999999999999999999   999999999999998776 


Q ss_pred             --CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 --GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 --~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                        .+||+|||+++.......   .....||+.|+|||++. ..++.++||||+||++|+|++|..||..... .+....+
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i  259 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDIIKKV  259 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred             CccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence              699999999987754422   23457999999999877 4689999999999999999999999976432 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    ..... ..+......    .++.+++.+|++.||.+|||++|+++
T Consensus       260 ~~----~~~~~-~~~~~~~~s----~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          260 EK----GKYYF-DFNDWKNIS----DEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HH----CCCCC-CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Hc----CCCCC-CccccCCCC----HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            21    11100 001111222    24788999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.7e-37  Score=340.12  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=195.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~  760 (1002)
                      ++|++.+.||+|+||.||+|...+++.||||++....               ......+.+.+|+.++++++  ||||++
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE---------------ADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS---------------CCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc---------------ccccchHHHHHHHHHHHhccccCCceEE
Confidence            5688899999999999999998889999999985321               13445678999999999997  599999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++...+..++|||+ .+++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++ ++.+
T Consensus        93 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~  165 (313)
T 3cek_A           93 LYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML  165 (313)
T ss_dssp             EEEEEECSSEEEEEECC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred             EEEEeecCCEEEEEEec-CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeE
Confidence            99999999999999995 58899999985  35689999999999999999999999   999999999999996 4899


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-----------LRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      ||+|||+++...............||+.|+|||++.+           ..++.++||||||+++|||++|+.||......
T Consensus       166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            9999999987755433323335579999999999875           46788999999999999999999999754332


Q ss_pred             hhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          910 KDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .....   ...... ..    .......   ..++.+++.+||+.||++||+++|+++.
T Consensus       246 ~~~~~---~~~~~~-~~----~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          246 ISKLH---AIIDPN-HE----IEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHH---HHHCTT-SC----CCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHH---HHHhcc-cc----cCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            22111   111111 00    0111111   1247789999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.5e-37  Score=335.66  Aligned_cols=253  Identities=23%  Similarity=0.297  Sum_probs=187.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||.||+|.. .+++.||||++....               ......+.+.++...++.++||||+++
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~~~~~~~~~~h~~iv~~   71 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---------------NSQEQKRLLMDLDISMRTVDCPFTVTF   71 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC------------------CHHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc---------------CcHHHHHHHHHHHHHHHhCCCCeEEEE
Confidence            5688889999999999999997 568999999984321               122334445556666888899999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++.+++..++||||++ |+|.+++..  .....+++..++.++.|++.||+|||++  .+|+||||||+||+++.++.
T Consensus        72 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~  148 (290)
T 3fme_A           72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQ  148 (290)
T ss_dssp             EEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCC
T ss_pred             eeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCC
Confidence            999999999999999996 688887764  2456799999999999999999999985  28999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA----YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      +||+|||+++.......   .....||+.|+|||++    .+..++.++||||+|+++|||++|+.||............
T Consensus       149 ~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  225 (290)
T 3fme_A          149 VKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ  225 (290)
T ss_dssp             EEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH
T ss_pred             EEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH
Confidence            99999999987654322   2234699999999996    5667889999999999999999999999754332222211


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                         ...... ....   .....    ..+.+++.+||+.||++|||++|+++
T Consensus       226 ---~~~~~~-~~~~---~~~~~----~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          226 ---VVEEPS-PQLP---ADKFS----AEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---HHHSCC-CCCC---TTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HhccCC-CCcc---cccCC----HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence               111111 1100   01122    24788999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.7e-37  Score=333.47  Aligned_cols=253  Identities=26%  Similarity=0.338  Sum_probs=202.3

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|+.. +++.||+|++.....               .....+.+.+|+.++++++||||+
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~i~   84 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---------------KNKDTSTILREVELLKKLDHPNIM   84 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB---------------SSSCHHHHHHHHHHHHTCCCTTBC
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc---------------chHHHHHHHHHHHHHHhccCCCcc
Confidence            4568899999999999999999975 689999999854311               123456789999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC--
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD--  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~--  837 (1002)
                      ++++++.+.+..++||||+++++|.+++...  ..+++..++.++.|++.||+|||++   +|+||||||+||+++.+  
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~  159 (287)
T 2wei_A           85 KLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEK  159 (287)
T ss_dssp             CEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred             EEEEEEeCCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCC
Confidence            9999999999999999999999999988753  4689999999999999999999999   99999999999999754  


Q ss_pred             -CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          838 -FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 -~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                       +.+||+|||++........   .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... ..+....+
T Consensus       160 ~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~  234 (287)
T 2wei_A          160 DCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILKRV  234 (287)
T ss_dssp             TCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHH
T ss_pred             cccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Confidence             4699999999987654322   223458899999998875 48999999999999999999999997543 22222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    ..... ..+.......    ++.+++.+||+.||++|||++|+++
T Consensus       235 ~~----~~~~~-~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          235 ET----GKYAF-DLPQWRTISD----DAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HH----CCCCC-CSGGGTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hc----CCCCC-CchhhhhcCH----HHHHHHHHHcccChhhCcCHHHHhc
Confidence            11    11110 0111122222    4788999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.3e-37  Score=349.44  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=199.5

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      +++.++|.+.+.||+|+||.||+|... +|+.||||++...               .......+.+.+|+.++++++|||
T Consensus        38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~n  102 (371)
T 4exu_A           38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------------FQSEIFAKRAYRELLLLKHMQHEN  102 (371)
T ss_dssp             EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST---------------TSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc---------------ccchhHHHHHHHHHHHHHhcCCCC
Confidence            455678889999999999999999964 6899999998432               123445677899999999999999


Q ss_pred             eeeeeeEEecCCee------eEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTTRDCK------LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |+++++++...+..      |+||||++ ++|.+++.    ..+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus       103 iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~N  174 (371)
T 4exu_A          103 VIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGN  174 (371)
T ss_dssp             BCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             chhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHH
Confidence            99999999877655      99999996 68888874    3499999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      |+++.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+
T Consensus       175 Ill~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  249 (371)
T 4exu_A          175 LAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD  249 (371)
T ss_dssp             EEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             eEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            99999999999999999865432     234568999999999887 778999999999999999999999997654333


Q ss_pred             hHHHHHHHHhhcc-----------------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          911 DLVKWVCSTLDQK-----------------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       911 ~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .............                 ..............+.....+.+++.+|++.||++|||++|+++.
T Consensus       250 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          250 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            3322222110000                 000000000000001112357899999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-36  Score=340.41  Aligned_cols=258  Identities=19%  Similarity=0.238  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE--cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC---
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL--SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK---  756 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---  756 (1002)
                      .++|++.+.||+|+||.||+|..  .+++.||||++..                  .....+.+.+|+.++++++|+   
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------------------~~~~~~~~~~e~~~l~~l~~~~~~   74 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN------------------VDRYCEAARSEIQVLEHLNTTDPN   74 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------------------SHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec------------------CCchhHHHHHHHHHHHHhhhcCCC
Confidence            35788899999999999999986  3588999999842                  123456788999999988655   


Q ss_pred             ---ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          757 ---NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       757 ---niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                         +++++++++...+..++||||+ +++|.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus        75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil  150 (339)
T 1z57_A           75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENIL  150 (339)
T ss_dssp             CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEE
Confidence               5999999999999999999999 89999999876666799999999999999999999999   9999999999999


Q ss_pred             ECC-------------------CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          834 LDG-------------------DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       834 l~~-------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      ++.                   ++.+||+|||+++......     ....||+.|+|||++.+..++.++||||+||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  225 (339)
T 1z57_A          151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILI  225 (339)
T ss_dssp             ESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred             EeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHH
Confidence            987                   6689999999998754332     2446899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCchhHHHHHHHHhhccCc--------ccc---------------------cc--ccccCCCHHHHHH
Q 001867          895 ELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV--------DHV---------------------LD--PKLDCCFKEEICK  943 (1002)
Q Consensus       895 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~---------------------~~--~~~~~~~~~~~~~  943 (1002)
                      ||++|+.||....... ....+.........        ...                     ..  ............+
T Consensus       226 el~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (339)
T 1z57_A          226 EYYLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER  304 (339)
T ss_dssp             HHHHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred             HHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence            9999999997653322 22222111110000        000                     00  0001112234557


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          944 VLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       944 l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +.+++.+||+.||++|||++|+++
T Consensus       305 l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          305 LFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHhCcCcccccCHHHHhc
Confidence            889999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.8e-37  Score=344.37  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=197.5

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|.+.+.||+|+||.||+|... +|+.||||++...               .......+.+.+|+.++++++||||+
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~~iv   86 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------------FQSEIFAKRAYRELLLLKHMQHENVI   86 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST---------------TSSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc---------------ccchHHHHHHHHHHHHHHhcCCCCcc
Confidence            3467888899999999999999974 6899999998432               12344567789999999999999999


Q ss_pred             eeeeEEecCCe------eeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          760 KLWCCCTTRDC------KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       760 ~l~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      ++++++...+.      .|+||||++ ++|.+++.    ..+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl  158 (353)
T 3coi_A           87 GLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLA  158 (353)
T ss_dssp             CCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEE
T ss_pred             cHhheEecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEe
Confidence            99999987654      499999996 68888875    3489999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      ++.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus       159 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  233 (353)
T 3coi_A          159 VNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL  233 (353)
T ss_dssp             ECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH
T ss_pred             ECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999865432     224568999999998876 67899999999999999999999999765433222


Q ss_pred             HHHHHHHhhc-----------------cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQ-----------------KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..........                 ........+............+.+++.+|++.||++|||++|+++
T Consensus       234 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          234 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            2221110000                 000000001111111122235888999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.6e-37  Score=350.65  Aligned_cols=260  Identities=23%  Similarity=0.258  Sum_probs=202.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC------
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR------  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------  754 (1002)
                      .++|++.+.||+|+||.||+|+. .+++.||||++..                  .....+.+.+|+.++++++      
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------------------~~~~~~~~~~E~~~l~~l~~~~~~~   97 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS------------------AEHYTETALDEIRLLKSVRNSDPND   97 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------------------CHHHHHHHHHHHHHHHHHHHSCTTC
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec------------------CCcchHHHHHHHHHHHHHhhcCCCC
Confidence            36789999999999999999986 4588999999842                  2334567889999999985      


Q ss_pred             --CCceeeeeeEEe----cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 001867          755 --HKNIVKLWCCCT----TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK  828 (1002)
Q Consensus       755 --h~niv~l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk  828 (1002)
                        |+||+++++++.    .....++||||+ ++++.+++.......+++..++.++.||+.||+|||+++  +|+|||||
T Consensus        98 ~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDik  174 (397)
T 1wak_A           98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIK  174 (397)
T ss_dssp             GGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCS
T ss_pred             CCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCC
Confidence              788999999998    566889999999 677777776655567999999999999999999999852  79999999


Q ss_pred             CCcEEECCCC-------------------------------------------------CeEEccccCcccccCCCCCcc
Q 001867          829 SNNILLDGDF-------------------------------------------------GARVADFGVAKVVDASGKPKS  859 (1002)
Q Consensus       829 ~~NIll~~~~-------------------------------------------------~~kl~DfGl~~~~~~~~~~~~  859 (1002)
                      |+||+++.++                                                 .+||+|||+++.....     
T Consensus       175 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----  249 (397)
T 1wak_A          175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----  249 (397)
T ss_dssp             GGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----
T ss_pred             HHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----
Confidence            9999999775                                                 7999999999876543     


Q ss_pred             cccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch-----hHHHHHHHHhhccC--------c-
Q 001867          860 MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK-----DLVKWVCSTLDQKG--------V-  925 (1002)
Q Consensus       860 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~--------~-  925 (1002)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......     +....+........        . 
T Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  329 (397)
T 1wak_A          250 FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS  329 (397)
T ss_dssp             SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG
T ss_pred             CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc
Confidence            224468999999999999999999999999999999999999997643321     11111111110000        0 


Q ss_pred             cccccc----------c----------ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          926 DHVLDP----------K----------LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       926 ~~~~~~----------~----------~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...+..          .          ......+....+.+++.+||+.||++|||++|+++
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000          0          01123555667899999999999999999999984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.8e-37  Score=345.68  Aligned_cols=264  Identities=20%  Similarity=0.281  Sum_probs=199.6

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|... +|+.||||++...                ........+.+|+.++++++||||+
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~~iv   72 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----------------DKPLFALRTLREIKILKHFKHENII   72 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----------------SSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc----------------ccchHHHHHHHHHHHHHhCcCCCcC
Confidence            4567888999999999999999975 6889999998421                1234456788999999999999999


Q ss_pred             eeeeEEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          760 KLWCCCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       760 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      ++++++...     ...++||||++ |+|.+++..   +.+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus        73 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~  145 (353)
T 2b9h_A           73 TIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLI  145 (353)
T ss_dssp             CEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeeeeecccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEE
Confidence            999988754     67899999996 699999875   4699999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCCc--------ccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          835 DGDFGARVADFGVAKVVDASGKPK--------SMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      +.++.+||+|||+++.........        ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  225 (353)
T 2b9h_A          146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG  225 (353)
T ss_dssp             CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999998765432211        1223468999999998764 6789999999999999999999999976


Q ss_pred             CCCchhHHHHHHHHhhcc---Cccc---------------cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          906 EFGEKDLVKWVCSTLDQK---GVDH---------------VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~---~~~~---------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..................   ....               ..........+....++.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             SSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            543222222211110000   0000               0000000000111234778999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.1e-37  Score=351.16  Aligned_cols=257  Identities=25%  Similarity=0.285  Sum_probs=194.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ..|++.+.||+|+||.||+|++. +++.||||++...                     .....+|++++++++|||||++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---------------------~~~~~~E~~il~~l~hpniv~l  112 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---------------------KRFKNRELQIMRKLDHCNIVRL  112 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------------TTSCCHHHHHHHTCCCTTBCCE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---------------------chhHHHHHHHHHHcCCCCccce
Confidence            35777899999999999999975 5899999998432                     1123469999999999999999


Q ss_pred             eeEEecC------CeeeEEEeccCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          762 WCCCTTR------DCKLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       762 ~~~~~~~------~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      ++++...      ...++||||+++ ++.+.+..  .....+++..++.++.||+.||+|||++   +|+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIL  188 (420)
T 1j1b_A          113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLL  188 (420)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEE
T ss_pred             eeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEE
Confidence            9998532      236799999964 67666543  2356799999999999999999999999   9999999999999


Q ss_pred             ECCC-CCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          834 LDGD-FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       834 l~~~-~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      ++.+ +.+||+|||+++.......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+.
T Consensus       189 l~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~  265 (420)
T 1j1b_A          189 LDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ  265 (420)
T ss_dssp             EETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9965 5689999999987654332   2234789999999998764 789999999999999999999999987654444


Q ss_pred             HHHHHHHHhh---------ccCccccccccccCC------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          912 LVKWVCSTLD---------QKGVDHVLDPKLDCC------FKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       912 ~~~~~~~~~~---------~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +.+++.....         .........+.....      ......++.+++.+||+.||++||++.|+++
T Consensus       266 l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          266 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            4444332110         000111111111100      0011235789999999999999999999985

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=357.99  Aligned_cols=302  Identities=20%  Similarity=0.127  Sum_probs=179.0

Q ss_pred             ccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceeecC
Q 001867          239 KLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLY  317 (1002)
Q Consensus       239 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~  317 (1002)
                      +++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..+..++ |+.|+|+
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  112 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS  112 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence            445555555555555455555555555555555555555555555555666666665555543333344432 5555555


Q ss_pred             CCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCC
Q 001867          318 ENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQL  397 (1002)
Q Consensus       318 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  397 (1002)
                      +|++.+..+..|..+++|++|++++|++.+..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.+..
T Consensus       113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~  192 (477)
T 2id5_A          113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR  192 (477)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred             CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence            55555555666666677777777777777666667777777777777777777655556666666666666666666666


Q ss_pred             CCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccc
Q 001867          398 PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLK  477 (1002)
Q Consensus       398 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  477 (1002)
                      +..|..+++|+.|++++|.+.+.+|.......                        +|+.|++++|++++..+..+..++
T Consensus       193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~------------------------~L~~L~l~~n~l~~~~~~~~~~l~  248 (477)
T 2id5_A          193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL------------------------NLTSLSITHCNLTAVPYLAVRHLV  248 (477)
T ss_dssp             TTCSCSCTTCCEEEEECCTTCCEECTTTTTTC------------------------CCSEEEEESSCCCSCCHHHHTTCT
T ss_pred             hhhcccCcccceeeCCCCccccccCcccccCc------------------------cccEEECcCCcccccCHHHhcCcc
Confidence            66666666666666666665555554444333                        455555555555533334455555


Q ss_pred             ccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCc
Q 001867          478 SLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLS  557 (1002)
Q Consensus       478 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls  557 (1002)
                      +|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|+
T Consensus       249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  328 (477)
T 2id5_A          249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD  328 (477)
T ss_dssp             TCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECC
T ss_pred             ccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEcc
Confidence            55555555555555445555566666666666666666666666666666666666666665444455666666666666


Q ss_pred             ceeeecc
Q 001867          558 NNRLSGR  564 (1002)
Q Consensus       558 ~N~l~~~  564 (1002)
                      +|+++..
T Consensus       329 ~N~l~c~  335 (477)
T 2id5_A          329 SNPLACD  335 (477)
T ss_dssp             SSCEECS
T ss_pred             CCCccCc
Confidence            6666543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-37  Score=352.28  Aligned_cols=256  Identities=12%  Similarity=0.041  Sum_probs=180.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC--CCCcee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI--RHKNIV  759 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv  759 (1002)
                      ..|.+.+.||+|+||.||+|.+. +++.||||++....              .......+.+.+|+.+++.+  +||||+
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~E~~~~~~l~~~hp~iv  127 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA--------------ENSRSELERLHEATFAAARLLGESPEEA  127 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCS--------------TTHHHHHHHHHHHHHHHHHHHC------
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecc--------------cccccHHHHHHHHHHHHHHhcccChhhh
Confidence            34778899999999999999964 68999999996531              11344566778885444444  699988


Q ss_pred             eee-------eEEecC-----------------CeeeEEEeccCCCChhhhhhhcCCCCCCHHHH------HHHHHHHHH
Q 001867          760 KLW-------CCCTTR-----------------DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTR------YKIIVDAAE  809 (1002)
Q Consensus       760 ~l~-------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~qi~~  809 (1002)
                      +++       +++...                 ...|+||||++ |+|.+++.... ..+++..+      ..++.|++.
T Consensus       128 ~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~  205 (371)
T 3q60_A          128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIR  205 (371)
T ss_dssp             ----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHH
Confidence            755       455433                 23799999998 89999998642 23455666      788899999


Q ss_pred             HHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc--CCCCCccchh
Q 001867          810 GLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT--LRVNEKSDIY  887 (1002)
Q Consensus       810 ~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvw  887 (1002)
                      ||+|||++   +|+||||||+||+++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||
T Consensus       206 aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~Diw  277 (371)
T 3q60_A          206 LAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAW  277 (371)
T ss_dssp             HHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHH
T ss_pred             HHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHH
Confidence            99999999   9999999999999999999999999999866432     113457799999999987  6799999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          888 SFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       888 slGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ||||++|||++|+.||......... .+...............+.....++    .+.+++.+||+.||++|||++|+++
T Consensus       278 SlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          278 QLGLSIYRVWCLFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPD----FVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHHHHHSSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCH----HHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCH----HHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999999999755322100 0000000000000111111122233    4788999999999999999999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.3e-37  Score=336.02  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=192.3

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||.||+|+. .+++.||||++..                  .....+.+.+|+.++++++||||+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------------------~~~~~~~~~~E~~~l~~l~h~~i~   65 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------------------TEEKLSTILSEVMLLASLNHQYVV   65 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------------------EHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------------------cHHHHHHHHHHHHHHHhcCchHHH
Confidence            356788899999999999999996 4689999999843                  233457789999999999999999


Q ss_pred             eeeeEEec-------------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 001867          760 KLWCCCTT-------------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRD  826 (1002)
Q Consensus       760 ~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  826 (1002)
                      ++++++.+             .+..|+||||+++|+|.+++.. ....+++..++.++.|++.||+|||++   +|+|||
T Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~d  141 (303)
T 1zy4_A           66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRD  141 (303)
T ss_dssp             CEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             HHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            99999865             3567999999999999999986 345688999999999999999999999   999999


Q ss_pred             CCCCcEEECCCCCeEEccccCcccccCCCC------------CcccccccccccccCccccccC-CCCCccchhhHHHHH
Q 001867          827 VKSNNILLDGDFGARVADFGVAKVVDASGK------------PKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVI  893 (1002)
Q Consensus       827 lk~~NIll~~~~~~kl~DfGl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil  893 (1002)
                      |||+||+++.++.+||+|||+++.......            ........||+.|+|||++.+. .++.++||||+||++
T Consensus       142 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il  221 (303)
T 1zy4_A          142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF  221 (303)
T ss_dssp             CCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHH
T ss_pred             CCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHH
Confidence            999999999999999999999987653211            1122345689999999998764 689999999999999


Q ss_pred             HHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          894 LELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       894 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      |||++   ||............+.    ..  ...+.+...   ......+.+++.+||+.||++|||++++++
T Consensus       222 ~~l~~---p~~~~~~~~~~~~~~~----~~--~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          222 FEMIY---PFSTGMERVNILKKLR----SV--SIEFPPDFD---DNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHS---CCSSHHHHHHHHHHHH----ST--TCCCCTTCC---TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHh---ccCCchhHHHHHHhcc----cc--ccccCcccc---ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            99998   5543211111111111    11  111111111   112234778999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-36  Score=367.42  Aligned_cols=258  Identities=23%  Similarity=0.322  Sum_probs=204.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|.+..    +..||+|++...                ......+.+.+|+.++++++||||
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~HpnI  453 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----------------TSDSVREKFLQEALTMRQFDHPHI  453 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----------------TCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----------------CCHHHHHHHHHHHHHHHhCCCCCC
Confidence            567888999999999999998742    457999987431                123445779999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      +++++++.+ +..|+||||+++|+|.++++. ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus       454 v~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~  528 (656)
T 2j0j_A          454 VKLIGVITE-NPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND  528 (656)
T ss_dssp             CCEEEEECS-SSCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred             CeEEEEEec-CceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCC
Confidence            999999854 568999999999999999986 345699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .+....+.
T Consensus       529 ~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~~~~~i~  606 (656)
T 2j0j_A          529 CVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIE  606 (656)
T ss_dssp             EEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHH
T ss_pred             CEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHH
Confidence            9999999999876544322 2234457789999999999999999999999999999997 8899875432 22222222


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      ....   .     +.....+    ..+.+++.+||+.||++|||++|+++.|+++...
T Consensus       607 ~~~~---~-----~~~~~~~----~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          607 NGER---L-----PMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HTCC---C-----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCC---C-----CCCcccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            1110   0     1112222    2478899999999999999999999999998653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.8e-36  Score=342.29  Aligned_cols=203  Identities=27%  Similarity=0.294  Sum_probs=172.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CC---
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HK---  756 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~---  756 (1002)
                      .++|++.+.||+|+||+||+|... +++.||||++..                  .......+..|+.+++.++ |+   
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------------------~~~~~~~~~~e~~~l~~l~~~~~~~  114 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------------------KKAFLNQAQIEVRLLELMNKHDTEM  114 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS------------------SHHHHHHHHHHHHHHHHHHHCSSGG
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec------------------cHHHHHHHHHHHHHHHHHHhccccc
Confidence            568899999999999999999965 578999999843                  1233556778888888875 44   


Q ss_pred             --ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          757 --NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       757 --niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                        +|+++++++...+..++||||++ |+|.+++.......+++..++.++.|++.||+|||++ ..+|+||||||+||++
T Consensus       115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll  192 (382)
T 2vx3_A          115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL  192 (382)
T ss_dssp             GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred             ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence              59999999999999999999995 6999999876667799999999999999999999952 1299999999999999


Q ss_pred             C--CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          835 D--GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       835 ~--~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +  .++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       193 ~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          193 CNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             SSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            5  4778999999999876543     22457899999999999999999999999999999999999999865433

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=337.91  Aligned_cols=264  Identities=20%  Similarity=0.291  Sum_probs=193.0

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .+.++|++.+.||+|+||.||+|... +++.||+|++...                 +....+.+.+|+.++++++||||
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i   70 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----------------DPQSVKHALREIKIIRRLDHDNI   70 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----------------SHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----------------ChHHHHHHHHHHHHHHhcCCCCe
Confidence            34567888999999999999999975 4899999988432                 33456778999999999999999


Q ss_pred             eeeeeEEe--------------cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          759 VKLWCCCT--------------TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       759 v~l~~~~~--------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      +++++++.              +....|+||||++ |+|.+++..   +.+++..++.++.|++.||+|||++   +|+|
T Consensus        71 v~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H  143 (320)
T 2i6l_A           71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLH  143 (320)
T ss_dssp             CCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBC
T ss_pred             eEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEec
Confidence            99999884              3467899999996 699999863   5689999999999999999999999   9999


Q ss_pred             CCCCCCcEEEC-CCCCeEEccccCcccccCCCC-CcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCC
Q 001867          825 RDVKSNNILLD-GDFGARVADFGVAKVVDASGK-PKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRL  901 (1002)
Q Consensus       825 rDlk~~NIll~-~~~~~kl~DfGl~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~  901 (1002)
                      |||||+||+++ .++.+||+|||+++....... ........+|..|+|||++.+ ..++.++||||||+++|||++|+.
T Consensus       144 ~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~  223 (320)
T 2i6l_A          144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT  223 (320)
T ss_dssp             CCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCC
Confidence            99999999997 567899999999987654321 112234467899999998765 678999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHHhhc---------cCccc-----ccccc--ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 001867          902 PVDPEFGEKDLVKWVCSTLDQ---------KGVDH-----VLDPK--LDCCFKEEICKVLNIGLLCTSPLPINRPAMRRV  965 (1002)
Q Consensus       902 p~~~~~~~~~~~~~~~~~~~~---------~~~~~-----~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ev  965 (1002)
                      ||...................         .....     ...+.  .....+....++.+++.+||+.||++|||++|+
T Consensus       224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (320)
T 2i6l_A          224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA  303 (320)
T ss_dssp             SSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence            997654332222221110000         00000     00000  000001112357889999999999999999999


Q ss_pred             HH
Q 001867          966 VK  967 (1002)
Q Consensus       966 l~  967 (1002)
                      ++
T Consensus       304 l~  305 (320)
T 2i6l_A          304 LS  305 (320)
T ss_dssp             HT
T ss_pred             hC
Confidence            75

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-36  Score=343.19  Aligned_cols=263  Identities=21%  Similarity=0.215  Sum_probs=187.9

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++...                  ........+|+..++.++||||
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------------~~~~~~~~~~~~~l~~l~h~ni   81 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------------------PRFRNRELQIMQDLAVLHHPNI   81 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECC------------------TTCCCHHHHHHHHHHHHCCTTB
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC------------------ccccHHHHHHHHHHHhcCCCCc
Confidence            44688999999999999999999974 6899999988432                  1122346678888888999999


Q ss_pred             eeeeeEEecCCe-------eeEEEeccCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeeCCC
Q 001867          759 VKLWCCCTTRDC-------KLLVYEYMPNGSLGDLLHS--CKGGLLDWPTRYKIIVDAAEGLSYLH--HDCVPSIVHRDV  827 (1002)
Q Consensus       759 v~l~~~~~~~~~-------~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~iiHrDl  827 (1002)
                      +++++++...+.       .++||||+++ +|.+.+..  .....+++..+..++.|++.||+|||  ++   +|+||||
T Consensus        82 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dl  157 (360)
T 3e3p_A           82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDI  157 (360)
T ss_dssp             CCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCC
T ss_pred             ccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcC
Confidence            999999975433       7899999975 55554432  24567899999999999999999999  87   9999999


Q ss_pred             CCCcEEECC-CCCeEEccccCcccccCCCCCcccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCC
Q 001867          828 KSNNILLDG-DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDP  905 (1002)
Q Consensus       828 k~~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p~~~  905 (1002)
                      ||+||+++. ++.+||+|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus       158 kp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  234 (360)
T 3e3p_A          158 KPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG  234 (360)
T ss_dssp             CGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence            999999996 89999999999987654432   22446899999999986654 89999999999999999999999987


Q ss_pred             CCCchhHHHHHHHHhhc----------cCcc-cccc-------ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          906 EFGEKDLVKWVCSTLDQ----------KGVD-HVLD-------PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       906 ~~~~~~~~~~~~~~~~~----------~~~~-~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .................          .... ...+       .............+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          235 DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            64443333332211100          0000 0000       0000111112346889999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.5e-37  Score=351.57  Aligned_cols=263  Identities=20%  Similarity=0.268  Sum_probs=181.3

Q ss_pred             cCCCc-CCeeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDE-DNVIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      +.|++ +++||+|+||.||+|+.+   +++.||||++...                   .....+.+|+.++++++||||
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-------------------~~~~~~~~E~~~l~~l~hpni   80 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-------------------GISMSACREIALLRELKHPNV   80 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-------------------SCCHHHHHHHHHHHHCCCTTB
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-------------------CCCHHHHHHHHHHHhcCCCCe
Confidence            33544 568999999999999965   4788999998431                   112457899999999999999


Q ss_pred             eeeeeEEe--cCCeeeEEEeccCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCC
Q 001867          759 VKLWCCCT--TRDCKLLVYEYMPNGSLGDLLHSCK-------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKS  829 (1002)
Q Consensus       759 v~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~  829 (1002)
                      +++++++.  .....|+||||++ |+|.+++....       ...+++..++.++.||+.||+|||++   +|+||||||
T Consensus        81 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp  156 (405)
T 3rgf_A           81 ISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKP  156 (405)
T ss_dssp             CCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred             eeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCH
Confidence            99999995  4678999999995 68888876322       23599999999999999999999999   999999999


Q ss_pred             CcEEE----CCCCCeEEccccCcccccCCCCC-cccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCC
Q 001867          830 NNILL----DGDFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       830 ~NIll----~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                      +||++    +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus       157 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  236 (405)
T 3rgf_A          157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  236 (405)
T ss_dssp             GGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence            99999    67789999999999877543221 223456799999999998874 5899999999999999999999999


Q ss_pred             CCCCCc---------hhHHHHHHHHhhc--cCcccc-------------ccccccCCCH---------HHHHHHHHHHHH
Q 001867          904 DPEFGE---------KDLVKWVCSTLDQ--KGVDHV-------------LDPKLDCCFK---------EEICKVLNIGLL  950 (1002)
Q Consensus       904 ~~~~~~---------~~~~~~~~~~~~~--~~~~~~-------------~~~~~~~~~~---------~~~~~l~~l~~~  950 (1002)
                      ......         +.+...+......  .....+             ..........         .....+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~  316 (405)
T 3rgf_A          237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK  316 (405)
T ss_dssp             CCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHH
T ss_pred             CCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHH
Confidence            754321         1111211111000  000000             0000000000         001247789999


Q ss_pred             cCCCCCCCCCCHHHHHHH
Q 001867          951 CTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       951 cl~~dP~~Rps~~evl~~  968 (1002)
                      |++.||++|||++|+++.
T Consensus       317 ~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          317 LLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HSCSSGGGSCCHHHHHTS
T ss_pred             HccCCcccCCCHHHHhcC
Confidence            999999999999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.5e-37  Score=340.72  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=175.1

Q ss_pred             HHHHhcCCCcCC-eeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC
Q 001867          678 EYEILDGLDEDN-VIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       678 ~~~~~~~~~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1002)
                      .+.+.++|.+.+ .||+|+||.||+|... +++.||||++...                  .   .........++.++|
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------------~---~~~~e~~~~~~~~~h   81 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------------------P---KARQEVDHHWQASGG   81 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------------------H---HHHHHHHHHHHHTTS
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------------------H---HHHHHHHHHHHhcCC
Confidence            356678888854 6999999999999975 6899999998431                  1   111222333556789


Q ss_pred             CceeeeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          756 KNIVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       756 ~niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |||+++++++..    ....++||||+++|+|.+++.......+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus        82 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~N  158 (336)
T 3fhr_A           82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPEN  158 (336)
T ss_dssp             TTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             CChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            999999999976    45589999999999999999876666899999999999999999999999   99999999999


Q ss_pred             EEECC---CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 001867          832 ILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG  908 (1002)
Q Consensus       832 Ill~~---~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~  908 (1002)
                      |+++.   ++.+||+|||+++......    .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.....
T Consensus       159 Ill~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (336)
T 3fhr_A          159 LLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG  234 (336)
T ss_dssp             EEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence            99976   4559999999998664332    2345689999999999888899999999999999999999999975433


Q ss_pred             chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....... ........ .....+.......    .+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          235 QAISPGM-KRRIRLGQ-YGFPNPEWSEVSE----DAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------------------CCCTTTSTTCCH----HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhhhhH-HHhhhccc-cccCchhhccCCH----HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2211111 11110000 0111111122233    4788999999999999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.1e-36  Score=347.26  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=185.8

Q ss_pred             CCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeee
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWC  763 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  763 (1002)
                      |...+.||+|+||+||.+...+|+.||||++..                    ...+.+.+|+.+++++ +||||+++++
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~--------------------~~~~~~~~E~~~l~~l~~HpnIv~~~~   76 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--------------------DFCDIALMEIKLLTESDDHPNVIRYYC   76 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG--------------------GGHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH--------------------HHHHHHHHHHHHHHhccCCCCcCeEEE
Confidence            444678999999999877777899999998832                    1234578899999886 8999999999


Q ss_pred             EEecCCeeeEEEeccCCCChhhhhhhcCCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC-
Q 001867          764 CCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL-----LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD-  837 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~-  837 (1002)
                      ++.+++..|+||||++ |+|.+++.......     .++..++.++.||+.||+|||++   +|+||||||+||+++.+ 
T Consensus        77 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~  152 (434)
T 2rio_A           77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSS  152 (434)
T ss_dssp             EEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCH
T ss_pred             EEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCc
Confidence            9999999999999995 79999998533211     13335678999999999999999   99999999999999754 


Q ss_pred             ------------CCeEEccccCcccccCCCCCc--ccccccccccccCcccccc-------CCCCCccchhhHHHHHHHH
Q 001867          838 ------------FGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYT-------LRVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       838 ------------~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~el  896 (1002)
                                  +.+||+|||+++.........  ......||+.|+|||++.+       ..++.++||||+||++|||
T Consensus       153 ~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~el  232 (434)
T 2rio_A          153 RFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI  232 (434)
T ss_dssp             HHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHH
T ss_pred             ccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHH
Confidence                        479999999998876543221  1234579999999999875       5689999999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          897 VT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       897 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ++ |+.||.......  ..........   ..    ...........++.+++.+||+.||++|||+.|+++
T Consensus       233 lt~g~~Pf~~~~~~~--~~i~~~~~~~---~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          233 LSKGKHPFGDKYSRE--SNIIRGIFSL---DE----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HTTSCCTTCSTTTHH--HHHHHTCCCC---CC----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhCCCCCCCCchhhH--HHHhcCCCCc---cc----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            99 999997543322  1111111110   00    001112344557889999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.1e-36  Score=336.55  Aligned_cols=257  Identities=19%  Similarity=0.239  Sum_probs=200.7

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CC-cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc--
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NG-EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN--  757 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--  757 (1002)
                      .++|++.+.||+|+||.||+|... ++ +.||+|++..                  .....+.+.+|+.++++++|++  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~------------------~~~~~~~~~~E~~~l~~l~~~~~~   79 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN------------------VGKYREAARLEINVLKKIKEKDKE   79 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS------------------CHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc------------------cccchhHHHHHHHHHHHHhhcCCC
Confidence            467888999999999999999974 34 6899999842                  2234567888999999987655  


Q ss_pred             ----eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          758 ----IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       758 ----iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                          ++.+++++...+..++||||+ ++++.+++.......+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIl  155 (355)
T 2eu9_A           80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENIL  155 (355)
T ss_dssp             SCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEE
T ss_pred             CceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence                999999999999999999999 77888888765656799999999999999999999999   9999999999999


Q ss_pred             E-------------------CCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          834 L-------------------DGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       834 l-------------------~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      +                   +.++.+||+|||+++......     ....||+.|+|||++.+..++.++||||+||++|
T Consensus       156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  230 (355)
T 2eu9_A          156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILF  230 (355)
T ss_dssp             ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred             EecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHH
Confidence            9                   567899999999998654332     2457999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCchhHHHHHHHHhhccCc--------c-ccc------c----------------ccccCCCHHHHHH
Q 001867          895 ELVTGRLPVDPEFGEKDLVKWVCSTLDQKGV--------D-HVL------D----------------PKLDCCFKEEICK  943 (1002)
Q Consensus       895 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~------~----------------~~~~~~~~~~~~~  943 (1002)
                      ||++|+.||........ ...+.........        . ...      +                +............
T Consensus       231 el~~g~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (355)
T 2eu9_A          231 EYYRGFTLFQTHENREH-LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ  309 (355)
T ss_dssp             HHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred             HHHhCCCCCCCCCHHHH-HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence            99999999976533222 2222111110000        0 000      0                0000111223446


Q ss_pred             HHHHHHHcCCCCCCCCCCHHHHH
Q 001867          944 VLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       944 l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      +.+++.+||+.||++|||++|++
T Consensus       310 l~~li~~~L~~dP~~Rpt~~e~l  332 (355)
T 2eu9_A          310 LFDLMRRMLEFDPAQRITLAEAL  332 (355)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHHHHHHHhcCChhhCcCHHHHh
Confidence            88999999999999999999987

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.7e-36  Score=334.86  Aligned_cols=257  Identities=30%  Similarity=0.450  Sum_probs=161.7

Q ss_pred             CCceEEccCccccC--CCChhhhccCcccceeeec-cccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEE
Q 001867          358 PLRWVDLSNNQFTG--EIPASLCEKGELEELLMIY-NSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLL  434 (1002)
Q Consensus       358 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  434 (1002)
                      +++.|+|++|.+++  .+|..+..+++|++|++++ |.+.+.+|..|+++++|++|+|++|++++.+|..|..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            35555555555555  4555555555555555552 55555555555555555555555555555555555555555555


Q ss_pred             EcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccc-ccccccccccccCCCCcccccccccCCeeecCCCcC
Q 001867          435 ELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLK-SLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL  513 (1002)
Q Consensus       435 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  513 (1002)
                      +|++|.+++.+|..+..+++|+.|++++|++++.+|..++.++ +|+.|++++|++++.+|..+..++ |+.|+|++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            5555555555555566666666666666666656666666665 666666666666666666666665 66666666666


Q ss_pred             CcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh-
Q 001867          514 SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL-  591 (1002)
Q Consensus       514 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~-  591 (1002)
                      ++.+|..|+.+++|+.|+|++|.+++.+|. +..+++|++|+|++|+++|.+|..+..+ +|+.|+|++|+++|.+|.. 
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            666666666666666666666666655444 5666666666666666666666666666 5666666666666666654 


Q ss_pred             hhhhcccccccCCCCCCCCCCCCCC
Q 001867          592 FAKEMYRNSFLGNPGLCGDLEGLCD  616 (1002)
Q Consensus       592 ~~~~~~~~~~~~n~~~cg~~~~~c~  616 (1002)
                      ....+....+.|||++||.|...|+
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p~~~C~  313 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred             cccccChHHhcCCCCccCCCCCCCC
Confidence            4455666788899999999888884

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.9e-36  Score=339.58  Aligned_cols=259  Identities=21%  Similarity=0.273  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-------
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-------  754 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------  754 (1002)
                      ++|++.+.||+|+||.||+|+. .+++.||||++..                  +....+.+.+|+.++++++       
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------------------~~~~~~~~~~e~~~l~~l~~~~~~~~   80 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------------------DKVYTEAAEDEIKLLQRVNDADNTKE   80 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------------------CHHHHHHHHHHHHHHHHHHHTCCSHH
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC------------------CccchhhhhHHHHHHHHhhcccccch
Confidence            5788899999999999999996 5689999999842                  2334567889999999886       


Q ss_pred             ----CCceeeeeeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCC
Q 001867          755 ----HKNIVKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRD  826 (1002)
Q Consensus       755 ----h~niv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  826 (1002)
                          ||||+++++++...+    ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++.  +|+|||
T Consensus        81 ~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~D  157 (373)
T 1q8y_A           81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTD  157 (373)
T ss_dssp             HHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSC
T ss_pred             hccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecC
Confidence                899999999998654    789999999 899999998766677999999999999999999999942  899999


Q ss_pred             CCCCcEEEC------CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 001867          827 VKSNNILLD------GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGR  900 (1002)
Q Consensus       827 lk~~NIll~------~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~  900 (1002)
                      |||+||+++      ..+.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  232 (373)
T 1q8y_A          158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD  232 (373)
T ss_dssp             CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence            999999994      34479999999998765432     2346899999999999999999999999999999999999


Q ss_pred             CCCCCCCCc-----hhHHHHHHHHhhccC-------------------cccccc----------ccccCCCHHHHHHHHH
Q 001867          901 LPVDPEFGE-----KDLVKWVCSTLDQKG-------------------VDHVLD----------PKLDCCFKEEICKVLN  946 (1002)
Q Consensus       901 ~p~~~~~~~-----~~~~~~~~~~~~~~~-------------------~~~~~~----------~~~~~~~~~~~~~l~~  946 (1002)
                      .||......     .+....+........                   ...+..          .............+.+
T Consensus       233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (373)
T 1q8y_A          233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD  312 (373)
T ss_dssp             CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred             CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence            999754321     111111111100000                   000000          0001233556677899


Q ss_pred             HHHHcCCCCCCCCCCHHHHHH
Q 001867          947 IGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       947 l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ++.+||+.||++|||++|+++
T Consensus       313 li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          313 FLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHHhccCccccCCHHHHhh
Confidence            999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=328.09  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=181.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||||++....               ......+.+..+..+++.++||||++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~~~~~~~~~~~h~~i~~   88 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---------------NKEENKRILMDLDVVLKSHDCPYIVQ   88 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS---------------CHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---------------cchHHHHHHHHHHHHHHhcCCCceee
Confidence            467888899999999999999975 68999999985421               12223344555666788889999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      +++++.+.+..++||||+ ++.+..+... ....+++..++.++.|++.||+|||+ .   +|+||||||+||+++.++.
T Consensus        89 ~~~~~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~  163 (318)
T 2dyl_A           89 CFGTFITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQ  163 (318)
T ss_dssp             EEEEEECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSC
T ss_pred             EEEEEecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCC
Confidence            999999999999999999 5555555543 34679999999999999999999998 6   8999999999999999999


Q ss_pred             eEEccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          840 ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      +||+|||++........   .....||+.|+|||++.     ...++.++||||||+++|||++|+.||.......+...
T Consensus       164 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  240 (318)
T 2dyl_A          164 IKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT  240 (318)
T ss_dssp             EEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             EEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH
Confidence            99999999976654322   22446899999999984     55688999999999999999999999976433333222


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....   .. ....  +.......    .+.+++.+||+.||.+||+++|+++
T Consensus       241 ~~~~---~~-~~~~--~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          241 KVLQ---EE-PPLL--PGHMGFSG----DFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHH---SC-CCCC--CSSSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHhc---cC-CCCC--CccCCCCH----HHHHHHHHHccCChhHCcCHHHHhh
Confidence            2211   11 1100  11112222    4778999999999999999999986

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.4e-36  Score=360.16  Aligned_cols=333  Identities=19%  Similarity=0.176  Sum_probs=227.5

Q ss_pred             ccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceee
Q 001867          237 LAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLN  315 (1002)
Q Consensus       237 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~  315 (1002)
                      +.+++.|++++|.+....+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|..+..++ |+.|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            45666777777777766555666677777777777777766666677777777777777776665555554443 55555


Q ss_pred             cCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeecccccc
Q 001867          316 LYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTG  395 (1002)
Q Consensus       316 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  395 (1002)
                      |++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+++                        +
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------~  185 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT------------------------H  185 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS------------------------B
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC------------------------C
Confidence            5555555444444445555555555555555444444555555555555555544                        3


Q ss_pred             CCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccc
Q 001867          396 QLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF  475 (1002)
Q Consensus       396 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  475 (1002)
                      .   .++.+++|+.|++++|.+++     +...++|+.|++++|.+....+..   .++|+.|+|++|++++  +..++.
T Consensus       186 ~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~  252 (597)
T 3oja_B          186 V---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLN  252 (597)
T ss_dssp             C---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGG
T ss_pred             c---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chhhcc
Confidence            2   13445566666666666653     223345666667766665443222   2578888888888875  467888


Q ss_pred             ccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEe
Q 001867          476 LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLD  555 (1002)
Q Consensus       476 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~  555 (1002)
                      +++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..++.+++|++|+
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~  330 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  330 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence            8888888888888888778888888888888888888885 5777778888889999988888 6888888888999999


Q ss_pred             CcceeeecccCCccccc-ccceEEeccccCcCCCChhhhhhcccccccCCCCCCCCC
Q 001867          556 LSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDL  611 (1002)
Q Consensus       556 Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~n~~~cg~~  611 (1002)
                      |++|++++..   +..+ +|+.|+|++|++++..+......+....+.+++..|+.+
T Consensus       331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCcc
Confidence            9999888643   3445 688899999998876555556667777889999999974

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.6e-35  Score=338.59  Aligned_cols=333  Identities=18%  Similarity=0.173  Sum_probs=215.3

Q ss_pred             ccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceee
Q 001867          237 LAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLN  315 (1002)
Q Consensus       237 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~  315 (1002)
                      +++++.|++++|.++...+..|..+++|+.|++++|.+++..+..|..+++|++|++++|++++..|..+..++ |+.|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            45666666766666655444566666666666666666665555666666666666666666655555444443 55555


Q ss_pred             cCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeecccccc
Q 001867          316 LYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTG  395 (1002)
Q Consensus       316 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  395 (1002)
                      |++|+++...+..|..+++|++|++++|++.+..|..+..+++|                        ++|++++|.+++
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L------------------------~~L~l~~n~l~~  179 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSL------------------------QNLQLSSNRLTH  179 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTC------------------------CEEECCSSCCSB
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCC------------------------CEEECCCCcCCc
Confidence            55555553333334444555555555555444444444444444                        444444444443


Q ss_pred             CCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccc
Q 001867          396 QLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGF  475 (1002)
Q Consensus       396 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  475 (1002)
                      .   .++.+++|+.|++++|.+++     +...++|+.|++++|.+.....   ...++|+.|++++|++++.  ..++.
T Consensus       180 ~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~  246 (390)
T 3o6n_A          180 V---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRG---PVNVELTILKLQHNNLTDT--AWLLN  246 (390)
T ss_dssp             C---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGGG
T ss_pred             c---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeeccc---cccccccEEECCCCCCccc--HHHcC
Confidence            2   13445566666666666553     2223456666666666664422   1236777888888887743  56777


Q ss_pred             ccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEe
Q 001867          476 LKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLD  555 (1002)
Q Consensus       476 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~  555 (1002)
                      +++|+.|++++|++++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..++.+++|++|+
T Consensus       247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~  324 (390)
T 3o6n_A          247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  324 (390)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence            8888888888888887777788888888888888888874 5666677888888888888887 6777788888888888


Q ss_pred             CcceeeecccCCccccc-ccceEEeccccCcCCCChhhhhhcccccccCCCCCCCCC
Q 001867          556 LSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSLFAKEMYRNSFLGNPGLCGDL  611 (1002)
Q Consensus       556 Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~n~~~cg~~  611 (1002)
                      |++|++++. |  +..+ +|+.|++++|++++.........+.+..+.+++..|..+
T Consensus       325 L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          325 LDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             CCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCTT
T ss_pred             CCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceeccc
Confidence            888888753 3  4445 688888888888765444455666777788899899864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.8e-36  Score=344.17  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=185.0

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  762 (1002)
                      +|+..++||+|+||+||.....+++.||||++...                    ....+.+|+.+++++ +|||||+++
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~--------------------~~~~~~~E~~~l~~l~~HpnIv~l~   84 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE--------------------CFSFADREVQLLRESDEHPNVIRYF   84 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT--------------------TEEECHHHHHHHHHSCCCTTBCCEE
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH--------------------HHHHHHHHHHHHHhccCCCCcCeEE
Confidence            47778899999999977655667999999998432                    112356899999999 799999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC-----
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD-----  837 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~-----  837 (1002)
                      +++.+.+..|+||||++ |+|.+++.... ...++..++.++.||+.||+|||++   +|+||||||+||+++.+     
T Consensus        85 ~~~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~  159 (432)
T 3p23_A           85 CTEKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGK  159 (432)
T ss_dssp             EEEEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTB
T ss_pred             EEEecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCc
Confidence            99999999999999995 69999998643 3455566789999999999999999   99999999999999532     


Q ss_pred             CCeEEccccCcccccCCCCC-cccccccccccccCccccc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhH
Q 001867          838 FGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAY---TLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDL  912 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~  912 (1002)
                      ..+||+|||+++........ .......||+.|+|||++.   ...++.++||||+||++|||++ |..||.......  
T Consensus       160 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--  237 (432)
T 3p23_A          160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--  237 (432)
T ss_dssp             CCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--
T ss_pred             eeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--
Confidence            35789999999877543221 2234567999999999987   4567889999999999999999 888985432211  


Q ss_pred             HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....   ....... ...     ........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~---~~~~~~~-~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          238 ANIL---LGACSLD-CLH-----PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHH---TTCCCCT-TSC-----TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHH---hccCCcc-ccC-----ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111   1111111 011     11122334678999999999999999999983

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-35  Score=329.34  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=176.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHH-HHhcCCCCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE-TLGKIRHKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~  760 (1002)
                      ++|++.+.||+|+||.||+|... +++.||||++....                ......++..|+. +++.++||||++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~e~~~~~~~~~h~niv~   85 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV----------------DEKEQKQLLMDLDVVMRSSDCPYIVQ   85 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC----------------CHHHHHHHHHHHHHHHSSCCCTTBCC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc----------------CchHHHHHHHHHHHHHHcCCCCcEee
Confidence            56788899999999999999974 68999999985421                1223445556665 777789999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHS---CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      +++++...+..++||||++ |+|.+++..   .....+++..+..++.|++.||+|||++  .+|+||||||+||+++.+
T Consensus        86 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~  162 (327)
T 3aln_A           86 FYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRS  162 (327)
T ss_dssp             EEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETT
T ss_pred             eeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCC
Confidence            9999999999999999996 588887753   2356799999999999999999999985  289999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA----YTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      +.+||+|||+++.......   .....||+.|+|||++    .+..++.++||||||+++|||++|+.||.......+  
T Consensus       163 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--  237 (327)
T 3aln_A          163 GNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--  237 (327)
T ss_dssp             TEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------
T ss_pred             CCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--
Confidence            9999999999987654322   2234689999999998    466789999999999999999999999975322111  


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ...... .................    .+.+++.+||+.||++||+++|+++
T Consensus       238 -~~~~~~-~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 -QLTQVV-KGDPPQLSNSEEREFSP----SFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ---CCCC-CSCCCCCCCCSSCCCCH----HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -HHHHHh-cCCCCCCCCcccccCCH----HHHHHHHHHhhCChhhCcCHHHHHh
Confidence             110000 11111111111112222    4788999999999999999999985

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-35  Score=338.19  Aligned_cols=351  Identities=19%  Similarity=0.142  Sum_probs=211.7

Q ss_pred             cCCCCCCCCCCCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccc
Q 001867           44 LSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLD  123 (1002)
Q Consensus        44 l~sw~~~~~~~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  123 (1002)
                      +++|...  ..+||.|.++.|.....++   +-......  ....-..++++++|++++|.++...+..|..+++|++|+
T Consensus         3 ~~~~~~~--~~C~~~~~~~~c~~~~~~i---~~~~~~~~--~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~   75 (390)
T 3o6n_A            3 VKPRQPE--YKCIDSNLQYDCVFYDVHI---DMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN   75 (390)
T ss_dssp             ----CCE--ECBCC------EEEESCEE---CSSCCCCE--ESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEE
T ss_pred             cCCCCCc--cceehhhhhhccceeeeee---eccccccc--ccccccccCCceEEEecCCchhhCChhHhcccccCcEEE
Confidence            5788542  2234456666665332222   11111111  111223467889999999988865555678888999999


Q ss_pred             cccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCC
Q 001867          124 LSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLP  203 (1002)
Q Consensus       124 Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~  203 (1002)
                      |++|.+++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|+++...+..|+++++|++|+|++|++ .
T Consensus        76 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l-~  154 (390)
T 3o6n_A           76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-E  154 (390)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-C
T ss_pred             CCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCcc-C
Confidence            999988877777888888999999999988887788888888888888888888866666678888888888888876 3


Q ss_pred             CCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccc
Q 001867          204 GRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWS  283 (1002)
Q Consensus       204 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  283 (1002)
                      +..|..+..+++|++|++++|++++.   .++.+++|+.|++++|.+++.     ....+|+.|++++|.+... |..  
T Consensus       155 ~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--  223 (390)
T 3o6n_A          155 RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--  223 (390)
T ss_dssp             BCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--
T ss_pred             ccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--
Confidence            34455677777777777777777743   245566677777777766532     2234556666666665533 211  


Q ss_pred             cccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEE
Q 001867          284 NLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVD  363 (1002)
Q Consensus       284 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  363 (1002)
                      ..++|+.|++++|++++.                         ..+..+++|++|++++|++++..|..|..+++|+.|+
T Consensus       224 ~~~~L~~L~l~~n~l~~~-------------------------~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  278 (390)
T 3o6n_A          224 VNVELTILKLQHNNLTDT-------------------------AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY  278 (390)
T ss_dssp             CCSSCCEEECCSSCCCCC-------------------------GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred             ccccccEEECCCCCCccc-------------------------HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEE
Confidence            124555555555555532                         2344445555555555555544445555555555555


Q ss_pred             ccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccC
Q 001867          364 LSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG  443 (1002)
Q Consensus       364 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~  443 (1002)
                      |++|++++ +|..+..+++|++|++++|.++ .+|..+..+++|++|+|++|++++. +  +..+++|+.|++++|.+..
T Consensus       279 L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          279 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             CCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence            55555542 3333444555555555555555 3444455566666666666666543 2  4556666677777776654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-36  Score=333.29  Aligned_cols=246  Identities=20%  Similarity=0.339  Sum_probs=197.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--CCce
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--HKNI  758 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~ni  758 (1002)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.......           .......+.+.+|+.++++++  ||||
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD-----------WGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCC-----------EEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchh-----------hhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            45788899999999999999986 468899999986542211           001122355778999999996  5999


Q ss_pred             eeeeeEEecCCeeeEEEeccCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC-C
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPN-GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-G  836 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~-~  836 (1002)
                      +++++++...+..++||||+.+ ++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++ .
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN  185 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence            9999999999999999999976 899999985  35689999999999999999999999   999999999999999 7


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      ++.+||+|||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...   .   ..
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~---~~  255 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E---EI  255 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H---HH
T ss_pred             CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---h---hh
Confidence            7899999999998765432    223468999999999887766 67899999999999999999999542   1   11


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    . ..  ...   .....    ++.+++.+||+.||++|||++|+++
T Consensus       256 ~~----~-~~--~~~---~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IR----G-QV--FFR---QRVSS----ECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HH----C-CC--CCS---SCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hc----c-cc--ccc---ccCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence            11    0 00  001   11222    4778999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=329.34  Aligned_cols=247  Identities=21%  Similarity=0.322  Sum_probs=190.1

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC----CC
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI----RH  755 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h  755 (1002)
                      +.++|++.+.||+|+||.||+|.. .+++.||||++.......           .........+.+|+.+++++    +|
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~e~~~l~~l~~~~~h   97 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG-----------WSPLSDSVTCPLEVALLWKVGAGGGH   97 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-------------------CCCCHHHHHHHHHHSSCCC
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccc-----------cccchhhHHHHHHHHHHHhhcccCCC
Confidence            356799999999999999999986 568899999985432110           01112344567789999888    89


Q ss_pred             CceeeeeeEEecCCeeeEEEec-cCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEY-MPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      |||+++++++...+..++|||| +++++|.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus        98 ~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  172 (312)
T 2iwi_A           98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI  172 (312)
T ss_dssp             SSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred             CCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence            9999999999999999999999 789999999985  34699999999999999999999999   99999999999999


Q ss_pred             C-CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          835 D-GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       835 ~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      + .++.+||+|||+++......    .....||..|+|||++.+..+. .++||||+|+++|||++|+.||...   .  
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~--  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---Q--  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H--
T ss_pred             eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---H--
Confidence            9 88999999999998765432    2345689999999998877764 5899999999999999999999632   1  


Q ss_pred             HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       .....     ...  +   .....    ..+.+++.+||+.||++|||++|+++
T Consensus       244 -~~~~~-----~~~--~---~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 -EILEA-----ELH--F---PAHVS----PDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -HHHHT-----CCC--C---CTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -HHhhh-----ccC--C---cccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11110     000  0   01122    24778999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-35  Score=349.96  Aligned_cols=268  Identities=23%  Similarity=0.312  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...                ......+.+.+|++++++++||||++
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----------------~~~~~~~~~~~Ei~iL~~L~HpnIV~   76 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----------------LSPKNRERWCLEIQIMKKLNHPNVVS   76 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----------------CCHHHHHHHHHHHHHHHHCCBTTBCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----------------CCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            47899999999999999999996 46899999987432                12345677999999999999999999


Q ss_pred             eeeEEec------CCeeeEEEeccCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          761 LWCCCTT------RDCKLLVYEYMPNGSLGDLLHSCKG-GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       761 l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      +++++..      .+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.   +|+||||||+||+
T Consensus        77 l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NIL  153 (676)
T 3qa8_A           77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIV  153 (676)
T ss_dssp             EEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEE
T ss_pred             eeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeE
Confidence            9998765      6778999999999999999986332 3689999999999999999999999   9999999999999


Q ss_pred             ECCCCC---eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          834 LDGDFG---ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       834 l~~~~~---~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      ++.++.   +||+|||++........   .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... 
T Consensus       154 l~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-  229 (676)
T 3qa8_A          154 LQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-  229 (676)
T ss_dssp             EECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-
T ss_pred             eecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-
Confidence            997765   89999999987755432   23457999999999999999999999999999999999999999754221 


Q ss_pred             hHHHHHHHHhh--------ccCccc--cc---cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHHh
Q 001867          911 DLVKWVCSTLD--------QKGVDH--VL---DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR-----VVKLLQEV  972 (1002)
Q Consensus       911 ~~~~~~~~~~~--------~~~~~~--~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e-----vl~~L~~~  972 (1002)
                        ..|......        ......  ..   .+............+.+++.+|++.||++|||++|     +.+.++++
T Consensus       230 --~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i  307 (676)
T 3qa8_A          230 --VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI  307 (676)
T ss_dssp             --HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred             --hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence              111100000        000000  00   01112223334456889999999999999999988     55666666


Q ss_pred             hh
Q 001867          973 GA  974 (1002)
Q Consensus       973 ~~  974 (1002)
                      ..
T Consensus       308 L~  309 (676)
T 3qa8_A          308 LS  309 (676)
T ss_dssp             HC
T ss_pred             Hh
Confidence            53

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1e-34  Score=350.11  Aligned_cols=312  Identities=20%  Similarity=0.150  Sum_probs=205.8

Q ss_pred             CCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCccccccccccee
Q 001867           91 RLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVI  170 (1002)
Q Consensus        91 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  170 (1002)
                      .+++++.|++++|.+..+.+..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            45688888888888877666667778888888888888887777788888888888888888887777778888888888


Q ss_pred             eeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCccc
Q 001867          171 SLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL  250 (1002)
Q Consensus       171 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  250 (1002)
                      +|++|.+++.++..|+++++|++|+|++|.+ .+..|..|+++++|++|+|++|.+++..   ++.+++|+.|++++|.+
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l  204 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLL  204 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCC-CBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCC
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcC-CCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcc
Confidence            8888888866666677778888888877775 3444556777777777777777776432   44455666666666665


Q ss_pred             ccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccC
Q 001867          251 VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIA  330 (1002)
Q Consensus       251 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~  330 (1002)
                      ++.     ....+|+.|++++|.+....+..   .++                       |+.|+|++|.+++  +..+.
T Consensus       205 ~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~-----------------------L~~L~L~~n~l~~--~~~l~  251 (597)
T 3oja_B          205 STL-----AIPIAVEELDASHNSINVVRGPV---NVE-----------------------LTILKLQHNNLTD--TAWLL  251 (597)
T ss_dssp             SEE-----ECCTTCSEEECCSSCCCEEECSC---CSC-----------------------CCEEECCSSCCCC--CGGGG
T ss_pred             ccc-----cCCchhheeeccCCccccccccc---CCC-----------------------CCEEECCCCCCCC--Chhhc
Confidence            532     22234555555555554322211   134                       4455555555543  24455


Q ss_pred             CCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEE
Q 001867          331 DSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV  410 (1002)
Q Consensus       331 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  410 (1002)
                      .+++|++|+|++|.+.+..|..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|.++ .+|..+..+++|++|
T Consensus       252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L  329 (597)
T 3oja_B          252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL  329 (597)
T ss_dssp             GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred             cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence            55666666666666665556666666666666666666663 3444555666666666666666 455556667777777


Q ss_pred             EccCccccCCCCCcCCCCCcceEEEcccCcccCc
Q 001867          411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGE  444 (1002)
Q Consensus       411 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~  444 (1002)
                      +|++|++++..   +..+++|+.|++++|.+.+.
T Consensus       330 ~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          330 YLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             ECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred             ECCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence            77777776442   55667777788888877643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.1e-35  Score=316.75  Aligned_cols=235  Identities=13%  Similarity=0.067  Sum_probs=184.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||.||+|... +++.||||++....              ..+....+.+.+|+.++.+++||||++
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~e~~~l~~l~hp~iv~   95 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG--------------VLPDDVLQETLSRTLRLSRIDKPGVAR   95 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC--------------CSCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc--------------ccCHHHHHHHHHHHHHHhcCCCCCcce
Confidence            356888999999999999999975 48999999985431              112345678999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..|+||||+++++|.++++.   + ....++.+++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus        96 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~  168 (286)
T 3uqc_A           96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDV  168 (286)
T ss_dssp             EEEEEEETTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCE
T ss_pred             eeEEEEECCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCE
Confidence            99999999999999999999999999963   2 46667899999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+++|                      |++|       ++.++|||||||++|||++|+.||............     
T Consensus       169 kl~~~~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----  214 (286)
T 3uqc_A          169 VLAYPA----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----  214 (286)
T ss_dssp             EECSCC----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----
T ss_pred             EEEecc----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----
Confidence            998543                      3433       688999999999999999999999765332211000     


Q ss_pred             hccCcccccc--ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          921 DQKGVDHVLD--PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       921 ~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ..........  ......+    ..+.+++.+||+.||++| |++|+++.|+++....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          215 ERDTAGQPIEPADIDRDIP----FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CBCTTSCBCCHHHHCTTSC----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHhccCCCChhhcccCCC----HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0000000000  0001222    247889999999999999 9999999999987543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-34  Score=330.49  Aligned_cols=242  Identities=17%  Similarity=0.138  Sum_probs=178.5

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC-Cceee-
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH-KNIVK-  760 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~-  760 (1002)
                      .|...+.||+|+||.||+|.+ .+|+.||||++.....              ......+.+.+|+.+++.++| ++... 
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~--------------~~~~~~~~~~~E~~~~~~l~~~~~~~~~  144 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--------------PPSNAIKQMKEEVLRLRLLRGIKNQKQA  144 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------------------CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC--------------ccHHHHHHHHHHHHHHHhhccCCCHHHH
Confidence            456678999999999999995 5689999998853211              122335678999999999976 22111 


Q ss_pred             --------------------eeeEEec-----CCeeeEEEeccCCCChhhhhhh-----cCCCCCCHHHHHHHHHHHHHH
Q 001867          761 --------------------LWCCCTT-----RDCKLLVYEYMPNGSLGDLLHS-----CKGGLLDWPTRYKIIVDAAEG  810 (1002)
Q Consensus       761 --------------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-----~~~~~l~~~~~~~i~~qi~~~  810 (1002)
                                          +..++..     ....+++|+++ +++|.++++.     .....+++..++.++.|++.|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~a  223 (413)
T 3dzo_A          145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL  223 (413)
T ss_dssp             HHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHH
Confidence                                1111111     22457777776 7899999852     234568888999999999999


Q ss_pred             HHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCcccc----------ccCCC
Q 001867          811 LSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYA----------YTLRV  880 (1002)
Q Consensus       811 L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~  880 (1002)
                      |+|||++   +|+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..+
T Consensus       224 L~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  294 (413)
T 3dzo_A          224 LASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM  294 (413)
T ss_dssp             HHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred             HHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC
Confidence            9999999   9999999999999999999999999999865433     334567 999999998          55568


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 001867          881 NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP  960 (1002)
Q Consensus       881 ~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  960 (1002)
                      +.++|||||||++|||++|+.||........             ...++. .....+    ..+.+++.+||+.||++||
T Consensus       295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~-------------~~~~~~-~~~~~~----~~~~~li~~~l~~dP~~Rp  356 (413)
T 3dzo_A          295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGG-------------SEWIFR-SCKNIP----QPVRALLEGFLRYPKEDRL  356 (413)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC-------------SGGGGS-SCCCCC----HHHHHHHHHHTCSSGGGSC
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCcchhhh-------------HHHHHh-hcccCC----HHHHHHHHHHccCChhhCc
Confidence            8899999999999999999999975422111             111111 112222    3488899999999999999


Q ss_pred             CHHHHHH
Q 001867          961 AMRRVVK  967 (1002)
Q Consensus       961 s~~evl~  967 (1002)
                      ++.++++
T Consensus       357 t~~~~l~  363 (413)
T 3dzo_A          357 LPLQAME  363 (413)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHHh
Confidence            9777753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.1e-34  Score=313.41  Aligned_cols=231  Identities=23%  Similarity=0.311  Sum_probs=179.9

Q ss_pred             HHHhcCCCcC-CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHH-hcCCC
Q 001867          679 YEILDGLDED-NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL-GKIRH  755 (1002)
Q Consensus       679 ~~~~~~~~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h  755 (1002)
                      ..+.++|.+. +.||+|+||.||+|.. .+++.||+|++..                      ...+.+|+.++ +..+|
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------------------~~~~~~e~~~~~~~~~h   70 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------------CPKARREVELHWRASQC   70 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----------------------SHHHHHHHHHHHHHTTS
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----------------------cHHHHHHHHHHHHhccC
Confidence            3456777776 7899999999999997 5689999999832                      23467888888 55689


Q ss_pred             CceeeeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          756 KNIVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       756 ~niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      |||+++++++..    ....++||||+++|+|.+++.......+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus        71 ~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~N  147 (299)
T 3m2w_A           71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPEN  147 (299)
T ss_dssp             TTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHH
Confidence            999999999986    67789999999999999999876666899999999999999999999999   99999999999


Q ss_pred             EEECC---CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 001867          832 ILLDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG  908 (1002)
Q Consensus       832 Ill~~---~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~  908 (1002)
                      |+++.   ++.+||+|||++.....                        ..++.++||||+||++|||++|+.||.....
T Consensus       148 il~~~~~~~~~~kl~Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~  203 (299)
T 3m2w_A          148 LLYTSKRPNAILKLTDFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  203 (299)
T ss_dssp             EEESSSSTTCCEEECCCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred             EEEecCCCCCcEEEecccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence            99997   78899999999865421                        3357789999999999999999999965422


Q ss_pred             chhHHHHHHHHhhccCcc-c--cccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          909 EKDLVKWVCSTLDQKGVD-H--VLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....     ......... .  ...+......    ..+.+++.+||+.||++|||++|+++
T Consensus       204 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          204 LAIS-----PGMKTRIRMGQYEFPNPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ---------CCSCCSSCTTCCSSCHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhh-----HHHHHHHhhccccCCchhcccCC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1100     000000000 0  0000001122    35788999999999999999999997

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.2e-34  Score=321.78  Aligned_cols=275  Identities=21%  Similarity=0.314  Sum_probs=231.3

Q ss_pred             CCCCchHHHHHHHHHHHhc-cCCccccCCCCC-CCCCCCCCccceeEEe--------CCCCeEEEEEcCCCCcCCCCCcc
Q 001867           19 PSLSLNQEGLYLERVKLSL-SDPDSALSSWGR-NPRDDSPCSWRGVECD--------PRSHSVASIDLSNANIAGPFPSL   88 (1002)
Q Consensus        19 ~~~~~~~~~~~l~~~k~~~-~d~~~~l~sw~~-~~~~~~~C~w~gv~C~--------~~~~~v~~l~L~~~~l~~~~~~~   88 (1002)
                      ...+...|+.||++||+++ .||.+.+++|.. .....++|.|.|+.|+        ....+|+.|+|++++++ .+|..
T Consensus        21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~   99 (328)
T 4fcg_A           21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ   99 (328)
T ss_dssp             --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred             ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence            3446778999999999998 688888899941 1124678999999995        23467999999999998 67888


Q ss_pred             ccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCccccc-----
Q 001867           89 LCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGR-----  163 (1002)
Q Consensus        89 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~-----  163 (1002)
                      +.++++|++|+|++|.++ .+|..|+.+++|++|+|++|.++ .+|..+.++++|++|+|++|++.+.+|..+..     
T Consensus       100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~  177 (328)
T 4fcg_A          100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG  177 (328)
T ss_dssp             GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred             hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence            888999999999999998 78999999999999999999999 77889999999999999999988899987765     


Q ss_pred             ----ccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccc
Q 001867          164 ----FQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAK  239 (1002)
Q Consensus       164 ----l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  239 (1002)
                          +++|++|+|++|+++ .+|..++++++|++|+|++|++.  .+|..++.+++|++|+|++|++.+.+|..++.+++
T Consensus       178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~--~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~  254 (328)
T 4fcg_A          178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS--ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP  254 (328)
T ss_dssp             CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC--CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCC
T ss_pred             hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC--cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCC
Confidence                888888888888888 77778888888888888888873  57777888888888888888888888888888888


Q ss_pred             cchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccC
Q 001867          240 LVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLT  299 (1002)
Q Consensus       240 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  299 (1002)
                      |++|+|++|++.+.+|..+.++++|+.|+|++|.+.+.+|..+.++++|+.+++..|.+.
T Consensus       255 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          255 LKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            888888888888888888888888888888888888888888888888888888777665

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-34  Score=349.67  Aligned_cols=240  Identities=22%  Similarity=0.269  Sum_probs=192.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc--CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS--NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      ++|++.+.||+|+||.||+|.+.  +++.||||++...                .+....+.+.+|+.++++++||||++
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----------------~~~~~~~~~~~E~~~l~~l~hp~iv~  143 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----------------GDAEAQAMAMAERQFLAEVVHPSIVQ  143 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----------------CCHHHHHHHHHHHGGGGGCCCTTBCC
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----------------CCHHHHHHHHHHHHHHHhcCCCCcCe
Confidence            67888999999999999999975  5899999987431                12344667899999999999999999


Q ss_pred             eeeEEecCCe-----eeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          761 LWCCCTTRDC-----KLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       761 l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      +++++...+.     .|+||||+++++|.+++..    .+++..++.++.||+.||+|||++   +|+||||||+||+++
T Consensus       144 ~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~  216 (681)
T 2pzi_A          144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLT  216 (681)
T ss_dssp             EEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred             EeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEe
Confidence            9999987655     6999999999999988752    699999999999999999999999   999999999999998


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .+ .+||+|||+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.......     
T Consensus       217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----  283 (681)
T 2pzi_A          217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----  283 (681)
T ss_dssp             SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----
T ss_pred             CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----
Confidence            75 9999999999876543      245699999999988765 4889999999999999999988875321100     


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHHhh
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-AMRRVVKLLQEVG  973 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~~  973 (1002)
                               ..   ..   .........+.+++.+||+.||++|| +++++.+.+..+.
T Consensus       284 ---------~~---~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 ---------LP---ED---DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ---------CC---TT---CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------cc---cc---ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                     00   00   00011223578899999999999999 5677777776553

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.5e-33  Score=312.97  Aligned_cols=305  Identities=25%  Similarity=0.345  Sum_probs=157.9

Q ss_pred             cccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCC-Ccc
Q 001867          234 LGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL-PLE  312 (1002)
Q Consensus       234 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~  312 (1002)
                      +..+++|++|++++|.+... + .+..+++|++|++++|++++..+  +..+++|++|++++|++++ ++ .+..+ .|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence            45667777777777777643 2 36667777777777777764433  6667777777777776663 22 23333 255


Q ss_pred             eeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccc
Q 001867          313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNS  392 (1002)
Q Consensus       313 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  392 (1002)
                      +|++++|++++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+                  
T Consensus       114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~------------------  172 (347)
T 4fmz_A          114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP------------------  172 (347)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG------------------
T ss_pred             EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh------------------
Confidence            55555555553322  4455555555555554332222 24455555555555555543222                  


Q ss_pred             cccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccc
Q 001867          393 FTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE  472 (1002)
Q Consensus       393 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  472 (1002)
                              +..+++|++|++++|++++..+  +..+++|+.|++++|.+.+..+  +..+++|+.|++++|++++..+  
T Consensus       173 --------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--  238 (347)
T 4fmz_A          173 --------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--  238 (347)
T ss_dssp             --------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred             --------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence                    4444455555555555443222  4444555555555555544333  4445555555555555543222  


Q ss_pred             cccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCcccccccc
Q 001867          473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLN  552 (1002)
Q Consensus       473 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~  552 (1002)
                      +..+++|+.|++++|++++ + ..+..+++|+.|++++|++++.  ..+..+++|+.|+|++|.+++..|..++.+++|+
T Consensus       239 ~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence            4455555555555555553 2 2345555555555555555543  2345555555555555555555555555555555


Q ss_pred             EEeCcceeeecccCCccccc-ccceEEeccccCc
Q 001867          553 YLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS  585 (1002)
Q Consensus       553 ~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~  585 (1002)
                      +|+|++|++++..|  +..+ +|+.|++++|+++
T Consensus       315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            55555555554434  3344 4555555555543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=5.4e-33  Score=312.35  Aligned_cols=308  Identities=24%  Similarity=0.332  Sum_probs=233.4

Q ss_pred             cccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccc
Q 001867          208 PELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTS  287 (1002)
Q Consensus       208 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  287 (1002)
                      ..+..+++|+.|++++|.+.. ++ .+..+++|++|++++|++++..+  +..+++|++|++++|.+++.  ..+..+++
T Consensus        38 ~~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~  111 (347)
T 4fmz_A           38 VTQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN  111 (347)
T ss_dssp             ECHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred             ccchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence            345678899999999999984 44 48999999999999999996544  99999999999999999863  36999999


Q ss_pred             cceeeccccccCCCCCccCCCC-CcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccC
Q 001867          288 LRLLDASMNDLTGPIPDDLTRL-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN  366 (1002)
Q Consensus       288 L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  366 (1002)
                      |++|++++|++++..+  +..+ .|+.|++++|.....++ .+..+++|++|++++|.+.+..+  +..+++|+.|++++
T Consensus       112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~  186 (347)
T 4fmz_A          112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY  186 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTT
T ss_pred             CCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccC
Confidence            9999999999996444  5555 49999999997665544 48999999999999999986655  88999999999999


Q ss_pred             ccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccc
Q 001867          367 NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS  446 (1002)
Q Consensus       367 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~  446 (1002)
                      |++++..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|++++                        ..+
T Consensus       187 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~------------------------~~~  238 (347)
T 4fmz_A          187 NQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD------------------------LSP  238 (347)
T ss_dssp             SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC------------------------CGG
T ss_pred             Cccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC------------------------Ccc
Confidence            99985433  5555666666666665554333  4555555555555555543                        322


Q ss_pred             cccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccc
Q 001867          447 KNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK  526 (1002)
Q Consensus       447 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  526 (1002)
                        +..+++|+.|++++|++++ + +.+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|..++.+++
T Consensus       239 --~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  312 (347)
T 4fmz_A          239 --LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN  312 (347)
T ss_dssp             --GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTT
T ss_pred             --hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhcccc
Confidence              4455566666666666653 2 3466677777777777777743  35777888888888888888888888888888


Q ss_pred             cccccccCcccccCCCCCccccccccEEeCcceeee
Q 001867          527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       527 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      |+.|+|++|.+++..|  ++.+++|++|++++|+++
T Consensus       313 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            8888888888886555  788888888888888875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.4e-34  Score=317.25  Aligned_cols=249  Identities=14%  Similarity=0.103  Sum_probs=181.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-------
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-------  754 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------  754 (1002)
                      .++|++.+.||+|+||+||+|+. +|+.||||++.......         .........+.+.+|+.++++++       
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~   88 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDL---------VNGSHQKTFEEILPEIIISKELSLLSGEVC   88 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSC---------BTTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccc---------cccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence            35677789999999999999998 68999999996542110         00012233466888888888875       


Q ss_pred             --CCceeeeeeEE-----------------ec-------------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHH
Q 001867          755 --HKNIVKLWCCC-----------------TT-------------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK  802 (1002)
Q Consensus       755 --h~niv~l~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~  802 (1002)
                        |||||++.+.+                 .+             .+..|+||||+++|++.+.+..   +.+++..++.
T Consensus        89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~  165 (336)
T 2vuw_A           89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKS  165 (336)
T ss_dssp             SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHH
T ss_pred             ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHH
Confidence              66666665554                 32             6789999999999977666642   5689999999


Q ss_pred             HHHHHHHHHHHHh-hcCCCCeeeCCCCCCcEEECCCC--------------------CeEEccccCcccccCCCCCcccc
Q 001867          803 IIVDAAEGLSYLH-HDCVPSIVHRDVKSNNILLDGDF--------------------GARVADFGVAKVVDASGKPKSMS  861 (1002)
Q Consensus       803 i~~qi~~~L~~LH-~~~~~~iiHrDlk~~NIll~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~  861 (1002)
                      ++.||+.||+||| ++   +|+||||||+|||++.++                    .+||+|||+|+.....       
T Consensus       166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------  235 (336)
T 2vuw_A          166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred             HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence            9999999999999 88   999999999999999887                    8999999999876542       


Q ss_pred             cccccccccCccccccCCCCCccchhhHHHH-HHHHHhCCCCCCCCCCchhHHHHHHHHhh-ccCccccccccccCCCHH
Q 001867          862 VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV-ILELVTGRLPVDPEFGEKDLVKWVCSTLD-QKGVDHVLDPKLDCCFKE  939 (1002)
Q Consensus       862 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvi-l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  939 (1002)
                      ...||+.|||||++.+.. +.++||||+|++ .+++++|..||...    ........... ......   .........
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~  307 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFKT---KCNTPAMKQ  307 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCCSS---CCCSHHHHH
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhccCc---ccchhhhhh
Confidence            347999999999998766 889999998777 78888899887321    00011111111 101110   011112234


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          940 EICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       940 ~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ...++.+++.+|++.|     |++|++
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHH
Confidence            4567889999999865     888877

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.98  E-value=4e-32  Score=303.04  Aligned_cols=287  Identities=22%  Similarity=0.263  Sum_probs=177.0

Q ss_pred             ccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccC
Q 001867          287 SLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN  366 (1002)
Q Consensus       287 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  366 (1002)
                      +++.+++++|.++ .+|..+. ..++.|+|++|.+++..|..|.++++|++|++++|++++..|..|..+++|++|+|++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS-PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             cCCEEECCCCCcc-ccCCCCC-CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            5666777777766 4444432 2466677777777666666677777777777777777766666677777777777777


Q ss_pred             ccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCcccc--CCCCCcCCCCCcceEEEcccCcccCc
Q 001867          367 NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLT--GKVPPLLWGLPHVYLLELTDNFLSGE  444 (1002)
Q Consensus       367 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~i~~~  444 (1002)
                      |+++ .+|..+.  ++|++|++++|.+++..+..+.++++|++|++++|+++  +..|..+..+ +|+.|++++|++++.
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l  187 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI  187 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc
Confidence            7776 4444333  56666666666666555555666666666666666664  2555555555 666666666666543


Q ss_pred             cccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccc
Q 001867          445 ISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW  524 (1002)
Q Consensus       445 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  524 (1002)
                       |..+.  ++|+.|++++|++++..|..+..+++|+.|++++|++++..|..+..+++|+.|+|++|+++ .+|..+..+
T Consensus       188 -~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l  263 (332)
T 2ft3_A          188 -PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL  263 (332)
T ss_dssp             -CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred             -Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence             22222  46666666666666555566666666666666666666655556666666666666666666 556666666


Q ss_pred             cccccccccCcccccCCCCCcccc------ccccEEeCcceeee--cccCCccccc-ccceEEecccc
Q 001867          525 KKLNELNLADNLFYGNIPEDIGNL------SVLNYLDLSNNRLS--GRIPVGLQNL-KLNQLNVSNNR  583 (1002)
Q Consensus       525 ~~L~~L~Ls~N~l~~~ip~~~~~l------~~L~~L~Ls~N~l~--~~ip~~~~~l-~L~~l~ls~N~  583 (1002)
                      ++|+.|+|++|.+++..+..++.+      ..|+.|++++|+++  +..|..+..+ .|+.+++++|+
T Consensus       264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            666666666666665444445432      45666666666665  4445555555 56666666653

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=6.6e-32  Score=301.06  Aligned_cols=288  Identities=21%  Similarity=0.250  Sum_probs=157.7

Q ss_pred             ccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccC
Q 001867          287 SLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN  366 (1002)
Q Consensus       287 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  366 (1002)
                      +++.++++++.++ .+|..+. ..++.|+|++|++++..+..|.++++|++|++++|++++..|..|..+++|++|+|++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCeEEEecCCCcc-ccCccCC-CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            4555566655555 3333332 1355566666666655555566666666666666666655566666666666666666


Q ss_pred             ccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccC--CCCCcCCCCCcceEEEcccCcccCc
Q 001867          367 NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTG--KVPPLLWGLPHVYLLELTDNFLSGE  444 (1002)
Q Consensus       367 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~i~~~  444 (1002)
                      |+++ .+|..+.  ++|++|++++|.+++..+..+.++++|++|++++|+++.  ..+..+..+++|+.|++++|.++..
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l  186 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI  186 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence            6665 3343332  455555555555555555555555566666666655532  4445555555555555555555532


Q ss_pred             cccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccc
Q 001867          445 ISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW  524 (1002)
Q Consensus       445 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  524 (1002)
                       |..+.  ++|+.|++++|++++..|..++.+++|+.|++++|++++..+..+..+++|+.|+|++|+++ .+|..+..+
T Consensus       187 -~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l  262 (330)
T 1xku_A          187 -PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH  262 (330)
T ss_dssp             -CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred             -Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence             22221  45556666666665555555555666666666666665544455555666666666666665 455555566


Q ss_pred             cccccccccCcccccCCCCCccc------cccccEEeCcceeeec--ccCCccccc-ccceEEecccc
Q 001867          525 KKLNELNLADNLFYGNIPEDIGN------LSVLNYLDLSNNRLSG--RIPVGLQNL-KLNQLNVSNNR  583 (1002)
Q Consensus       525 ~~L~~L~Ls~N~l~~~ip~~~~~------l~~L~~L~Ls~N~l~~--~ip~~~~~l-~L~~l~ls~N~  583 (1002)
                      ++|++|+|++|.+++..+..++.      ...|+.|++++|.+..  ..|..+..+ .++.++|++|+
T Consensus       263 ~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            66666666666665444444432      2456666666666542  233444444 56666666653

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=1e-31  Score=299.65  Aligned_cols=288  Identities=21%  Similarity=0.265  Sum_probs=172.5

Q ss_pred             ccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeecc
Q 001867          215 NLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDAS  294 (1002)
Q Consensus       215 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  294 (1002)
                      +++.++++++.++ .+|..+.  ++|+.|++++|.+++..+..|.++++|++|++++|++++..|..|.++++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            3445555555554 3444432  456666666666665555566666666666666666666666667777777777777


Q ss_pred             ccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccC--CCCCCCCCCCCCCceEEccCccccCC
Q 001867          295 MNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLN--GTLPGDLGKNSPLRWVDLSNNQFTGE  372 (1002)
Q Consensus       295 ~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~  372 (1002)
                      +|+++ .+|..+. ..|++|++++|++++..+..|..+++|++|++++|+++  +..+..+..+ +|++|++++|++++ 
T Consensus       111 ~n~l~-~l~~~~~-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-  186 (332)
T 2ft3_A          111 KNHLV-EIPPNLP-SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-  186 (332)
T ss_dssp             SSCCC-SCCSSCC-TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred             CCcCC-ccCcccc-ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence            77766 3443333 34666666666666555555666666666666666664  2555556655 66666666666663 


Q ss_pred             CChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccC
Q 001867          373 IPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGA  452 (1002)
Q Consensus       373 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  452 (1002)
                      +|..+.  +                        +|++|++++|++++..+..|..+++|+.|+|++|.+++..+..+..+
T Consensus       187 l~~~~~--~------------------------~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  240 (332)
T 2ft3_A          187 IPKDLP--E------------------------TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL  240 (332)
T ss_dssp             CCSSSC--S------------------------SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred             cCcccc--C------------------------CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence            333222  3                        44444444444444444444445555555555555554444455555


Q ss_pred             CcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccc------cccCCeeecCCCcCC--cccccccccc
Q 001867          453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTN------LAELGSLDLHANDLS--GELPSSVSSW  524 (1002)
Q Consensus       453 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l  524 (1002)
                      ++|+.|++++|+++ .+|..++.+++|+.|++++|++++..+..|..      ...|+.|++++|++.  +..|..|..+
T Consensus       241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l  319 (332)
T 2ft3_A          241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV  319 (332)
T ss_dssp             TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTB
T ss_pred             CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccccc
Confidence            56666666666665 55666666666666666666666554555543      356788888888887  6777888888


Q ss_pred             cccccccccCcc
Q 001867          525 KKLNELNLADNL  536 (1002)
Q Consensus       525 ~~L~~L~Ls~N~  536 (1002)
                      ++|+.|+|++|+
T Consensus       320 ~~L~~l~l~~n~  331 (332)
T 2ft3_A          320 TDRLAIQFGNYK  331 (332)
T ss_dssp             CCSTTEEC----
T ss_pred             chhhhhhccccc
Confidence            888888888875

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=3.6e-31  Score=295.09  Aligned_cols=267  Identities=21%  Similarity=0.222  Sum_probs=198.4

Q ss_pred             ccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEcc
Q 001867          287 SLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLS  365 (1002)
Q Consensus       287 ~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  365 (1002)
                      +|+.|++++|++++..+..+..++ |++|+|++|++++..|..|..+++|++|++++|+++. +|..+.  ++|++|+++
T Consensus        53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~  129 (330)
T 1xku_A           53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVH  129 (330)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECC
T ss_pred             CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEECC
Confidence            344444444444443333343332 4444444455544555556666666666666666663 333333  578888888


Q ss_pred             CccccCCCChhhhccCcccceeeecccccc--CCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccC
Q 001867          366 NNQFTGEIPASLCEKGELEELLMIYNSFTG--QLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG  443 (1002)
Q Consensus       366 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~  443 (1002)
                      +|++++..+..+..+++|++|++++|.++.  ..+..+.++++|++|++++|++++ +|..+.  ++|+.|++++|.+++
T Consensus       130 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~  206 (330)
T 1xku_A          130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITK  206 (330)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCE
T ss_pred             CCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCc
Confidence            888887777778888888888888888853  677888888999999999999885 454443  788999999999988


Q ss_pred             ccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccccccc
Q 001867          444 EISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSS  523 (1002)
Q Consensus       444 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  523 (1002)
                      ..+..+..+++|+.|++++|++++..+..++.+++|+.|++++|+++ .+|..+..+++|++|+|++|++++..+..|..
T Consensus       207 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~  285 (330)
T 1xku_A          207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP  285 (330)
T ss_dssp             ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred             cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCC
Confidence            88888999999999999999998777778889999999999999998 78888999999999999999999887777754


Q ss_pred             ------ccccccccccCccccc--CCCCCccccccccEEeCccee
Q 001867          524 ------WKKLNELNLADNLFYG--NIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       524 ------l~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                            ...|+.|++++|.+..  ..|..+..+.+|+.++|++|+
T Consensus       286 ~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence                  3778899999998863  456788889999999999985

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=2.9e-35  Score=344.61  Aligned_cols=379  Identities=23%  Similarity=0.195  Sum_probs=237.6

Q ss_pred             cccccccccCCCCCCCCCCcccCCCCccchhhccCccccc----ccccccccccccchhcccCcccccccCcccc-ccc-
Q 001867          189 STLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVG----EIPDSLGRLAKLVDLDLALNNLVGAIPSSLT-ELA-  262 (1002)
Q Consensus       189 ~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~-~l~-  262 (1002)
                      ++|++|+|++|++........+..+++|++|++++|+++.    .++..+..+++|++|+|++|.+....+..+. .+. 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            5678888888876332223336677788888888888774    3456666777888888888877654443332 244 


Q ss_pred             ---ceeeeeccCCcccC----CCCCccccccccceeeccccccCCCCCccCCC------CCcceeecCCCcccCcCCccc
Q 001867          263 ---SVVQIELYNNSLTG----DLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR------LPLESLNLYENRLEGSLPATI  329 (1002)
Q Consensus       263 ---~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------~~L~~L~L~~N~l~~~~p~~~  329 (1002)
                         +|++|++++|+++.    .++..+..+++|++|++++|++++..+..+..      .+|+.|+|++|++++..+.. 
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~-  161 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP-  161 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH-
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH-
Confidence               57777777777763    34666777777777777777765432222111      12555555555555322111 


Q ss_pred             CCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhc-----cCcccceeeeccccccC----CCCc
Q 001867          330 ADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCE-----KGELEELLMIYNSFTGQ----LPDG  400 (1002)
Q Consensus       330 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~----~p~~  400 (1002)
                                         ++..+..+++|++|++++|++++..+..++.     .++|++|++++|.+++.    ++..
T Consensus       162 -------------------l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~  222 (461)
T 1z7x_W          162 -------------------LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI  222 (461)
T ss_dssp             -------------------HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred             -------------------HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence                               1222334455666666666655443333332     34566666666666543    3455


Q ss_pred             CcCCCCCcEEEccCccccCCC-----CCcCCCCCcceEEEcccCcccCc----cccccccCCcccEEEccCCcCCCCCcc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKV-----PPLLWGLPHVYLLELTDNFLSGE----ISKNIAGAANLSLLIISKNNLSGSLPE  471 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~  471 (1002)
                      +..+++|++|++++|++++..     +..+..+++|+.|++++|.++..    ++..+..+++|+.|++++|.+.+..+.
T Consensus       223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            556677777777777765422     23334567777777777777654    455566677788888888877655444


Q ss_pred             ccccc-----cccccccccccccCCC----CcccccccccCCeeecCCCcCCccccccccc-----ccccccccccCccc
Q 001867          472 EIGFL-----KSLVVLSGSENKFTGS----LPESLTNLAELGSLDLHANDLSGELPSSVSS-----WKKLNELNLADNLF  537 (1002)
Q Consensus       472 ~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l  537 (1002)
                      .+...     ++|+.|++++|.+++.    +|..+..+++|+.|||++|++++..+..+..     .++|+.|+|++|.+
T Consensus       303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence            44432     5788888888887754    4556667788888888888887766655543     56888888888888


Q ss_pred             cc----CCCCCccccccccEEeCcceeeecccCCccc-----cc-ccceEEeccccCcCC
Q 001867          538 YG----NIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ-----NL-KLNQLNVSNNRLSGE  587 (1002)
Q Consensus       538 ~~----~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~-----~l-~L~~l~ls~N~l~g~  587 (1002)
                      ++    .+|..+..+++|++|||++|++++.-...+.     .. +|+.|++.+|.+...
T Consensus       383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~  442 (461)
T 1z7x_W          383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  442 (461)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHH
Confidence            75    6777788888888888888888764222211     11 477777777766543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.3e-35  Score=347.46  Aligned_cols=387  Identities=19%  Similarity=0.146  Sum_probs=271.2

Q ss_pred             ccccceeeeccccccCcccc-ccccccccccccccCCCCCCC---CCCcccCCCCccchhhccCcccccccccccc-ccc
Q 001867          164 FQKLEVISLVYNLLDGTIPA-FLGNISTLKMLNLSYNPFLPG---RIPPELGNLTNLEILWLTECNLVGEIPDSLG-RLA  238 (1002)
Q Consensus       164 l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~~~~~---~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~  238 (1002)
                      +++|++|+|++|+++..... .+..+++|++|+|++|.+...   .++..+..+++|++|+|++|.++...+..+. .++
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            36899999999999865443 388899999999999997321   3466788899999999999999875555443 355


Q ss_pred             ----ccchhcccCccccc----ccCcccccccceeeeeccCCcccCCCCCccc-----cccccceeeccccccCCCC---
Q 001867          239 ----KLVDLDLALNNLVG----AIPSSLTELASVVQIELYNNSLTGDLPTGWS-----NLTSLRLLDASMNDLTGPI---  302 (1002)
Q Consensus       239 ----~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~---  302 (1002)
                          +|++|+|++|+++.    .++..+..+++|++|++++|.+++..+..+.     ..++|++|++++|++++..   
T Consensus        82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence                69999999999984    5688899999999999999999865444433     2568999999999998643   


Q ss_pred             -CccCCCC-CcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCC-CCCCCCceEEccCccccCC----CCh
Q 001867          303 -PDDLTRL-PLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDL-GKNSPLRWVDLSNNQFTGE----IPA  375 (1002)
Q Consensus       303 -p~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~----~p~  375 (1002)
                       +..+... .|+.|+|++|.+....+..+..                    .+ ...++|++|+|++|++++.    ++.
T Consensus       162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~--------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  221 (461)
T 1z7x_W          162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQ--------------------GLKDSPCQLEALKLESCGVTSDNCRDLCG  221 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHH--------------------HHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             HHHHHhhCCCCCEEECcCCCcchHHHHHHHH--------------------HHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence             2222222 3777777777766443333321                    00 0123455566666655543    344


Q ss_pred             hhhccCcccceeeeccccccCC-----CCcCcCCCCCcEEEccCccccCC----CCCcCCCCCcceEEEcccCcccCccc
Q 001867          376 SLCEKGELEELLMIYNSFTGQL-----PDGLGHCQSLTRVRLGYNRLTGK----VPPLLWGLPHVYLLELTDNFLSGEIS  446 (1002)
Q Consensus       376 ~~~~l~~L~~L~l~~N~l~~~~-----p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~~~  446 (1002)
                      .+..+++|++|++++|.+++..     +..+..+++|++|++++|++++.    ++..+..+++|+.|++++|.+.+..+
T Consensus       222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~  301 (461)
T 1z7x_W          222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA  301 (461)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred             HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence            5555566666666666655322     22223467788888888877753    45556667788888888888765544


Q ss_pred             ccccc-----CCcccEEEccCCcCCCC----CccccccccccccccccccccCCCCcccccc-----cccCCeeecCCCc
Q 001867          447 KNIAG-----AANLSLLIISKNNLSGS----LPEEIGFLKSLVVLSGSENKFTGSLPESLTN-----LAELGSLDLHAND  512 (1002)
Q Consensus       447 ~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~  512 (1002)
                      ..+..     .++|+.|++++|.+++.    ++..+..+++|+.|++++|++++..+..+..     .++|+.|+|++|.
T Consensus       302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence            44433     26888888888888865    4566777889999999999888655555543     5789999999999


Q ss_pred             CCc----ccccccccccccccccccCcccccCCCCCcc-----ccccccEEeCcceeeecccCCccc
Q 001867          513 LSG----ELPSSVSSWKKLNELNLADNLFYGNIPEDIG-----NLSVLNYLDLSNNRLSGRIPVGLQ  570 (1002)
Q Consensus       513 l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~-----~l~~L~~L~Ls~N~l~~~ip~~~~  570 (1002)
                      +++    .+|..+..+++|++|+|++|.+++.-...+.     ...+|+.|++.+|......+..+.
T Consensus       382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l~  448 (461)
T 1z7x_W          382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ  448 (461)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHH
T ss_pred             CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHHH
Confidence            986    7888888899999999999998854211111     234577777777776655554443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=5.8e-31  Score=296.26  Aligned_cols=284  Identities=22%  Similarity=0.283  Sum_probs=196.1

Q ss_pred             CCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCC
Q 001867           54 DSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL  133 (1002)
Q Consensus        54 ~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  133 (1002)
                      .++|.|.|+ |+          +++++++. +|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|++++..
T Consensus        27 ~~~C~~~~~-c~----------~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~   92 (353)
T 2z80_A           27 SLSCDRNGI-CK----------GSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE   92 (353)
T ss_dssp             CCEECTTSE-EE----------CCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred             CCCCCCCeE-ee----------CCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence            567999887 75          45677774 455444  48899999999998777778888888888888888888777


Q ss_pred             CccccccCCccccccccccccCCCCcccccccccceeeeccccccCccc-cccccccccccccccCCCCCCCCCCcccCC
Q 001867          134 TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIP-AFLGNISTLKMLNLSYNPFLPGRIPPELGN  212 (1002)
Q Consensus       134 ~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~  212 (1002)
                      +..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..++++++|++|++++|.......+..+++
T Consensus        93 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~  172 (353)
T 2z80_A           93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG  172 (353)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred             HhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccC
Confidence            7788888888888888888886555557888888888888888875444 467777777777777774333333456666


Q ss_pred             CCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCcccc---ccccc
Q 001867          213 LTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSN---LTSLR  289 (1002)
Q Consensus       213 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~---l~~L~  289 (1002)
                      +++|++|++++|++++..|..+..+++|++|++++|+++...+..+..+++|+.|++++|.+++..+..+..   .+.  
T Consensus       173 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~--  250 (353)
T 2z80_A          173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL--  250 (353)
T ss_dssp             CCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCC--
T ss_pred             CCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccch--
Confidence            666777777776666666666666666666666666665433333344555666666655555443332211   122  


Q ss_pred             eeeccccccCCCCCccCCCCCcceeecCCCcccC----cCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEcc
Q 001867          290 LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEG----SLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLS  365 (1002)
Q Consensus       290 ~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  365 (1002)
                                           ++.++|+++.+.+    .+|..+..+++|++|++++|+++.+.+..|..+++|++|+|+
T Consensus       251 ---------------------l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~  309 (353)
T 2z80_A          251 ---------------------IKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLH  309 (353)
T ss_dssp             ---------------------CCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             ---------------------hhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEee
Confidence                                 4445555555443    456778888888889999998885544446888889999999


Q ss_pred             CccccCCCC
Q 001867          366 NNQFTGEIP  374 (1002)
Q Consensus       366 ~N~l~~~~p  374 (1002)
                      +|++++..|
T Consensus       310 ~N~~~~~~~  318 (353)
T 2z80_A          310 TNPWDCSCP  318 (353)
T ss_dssp             SSCBCCCHH
T ss_pred             CCCccCcCC
Confidence            998886544

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2.8e-33  Score=338.71  Aligned_cols=409  Identities=14%  Similarity=0.072  Sum_probs=208.4

Q ss_pred             CCCCccccCcccccccccccc---cCCCCcccc------------ccCCccccccccccccCCCCcccccc--cccceee
Q 001867          109 LPDDISACQNLQHLDLSQNLL---TGTLTPALA------------DLPNLKFLDLTGNNFSGDIPESFGRF--QKLEVIS  171 (1002)
Q Consensus       109 ~p~~~~~l~~L~~L~Ls~N~l---~~~~~~~~~------------~L~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~  171 (1002)
                      .+..+..+++|++|+|+++.-   .+.+|..++            .+++|++|+|++|.+++..+..+...  .+|++|+
T Consensus        65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~  144 (592)
T 3ogk_B           65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK  144 (592)
T ss_dssp             HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred             hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence            444566788888888877532   123343333            45556666666555554444444432  2255555


Q ss_pred             ecccc-ccC-ccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccc----cccccccccccchhcc
Q 001867          172 LVYNL-LDG-TIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGE----IPDSLGRLAKLVDLDL  245 (1002)
Q Consensus       172 L~~N~-l~~-~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L  245 (1002)
                      |++|. ++. .++....++++|++|+|+                         +|.+++.    ++..+..+++|++|++
T Consensus       145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~-------------------------~~~~~~~~~~~l~~~~~~~~~L~~L~L  199 (592)
T 3ogk_B          145 LDKCSGFTTDGLLSIVTHCRKIKTLLME-------------------------ESSFSEKDGKWLHELAQHNTSLEVLNF  199 (592)
T ss_dssp             EESCEEEEHHHHHHHHHHCTTCSEEECT-------------------------TCEEECCCSHHHHHHHHHCCCCCEEEC
T ss_pred             CcCCCCcCHHHHHHHHhhCCCCCEEECc-------------------------cccccCcchhHHHHHHhcCCCccEEEe
Confidence            55544 110 111222234444444444                         4444333    2223345556666666


Q ss_pred             cCcccc----cccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcc
Q 001867          246 ALNNLV----GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRL  321 (1002)
Q Consensus       246 ~~N~l~----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l  321 (1002)
                      ++|.++    +.++..+.++++|+.|++++|.+.+ ++..+..+++|+.|+++.+......+                  
T Consensus       200 ~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~------------------  260 (592)
T 3ogk_B          200 YMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMP------------------  260 (592)
T ss_dssp             TTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCT------------------
T ss_pred             eccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchH------------------
Confidence            666665    2233344456666666666666664 44556666777777766432210000                  


Q ss_pred             cCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCC-hhhhccCcccceeeeccccccCCCCc
Q 001867          322 EGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIP-ASLCEKGELEELLMIYNSFTGQLPDG  400 (1002)
Q Consensus       322 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~  400 (1002)
                        ..+..+..+++|+.|.++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|++|+++++...+.++..
T Consensus       261 --~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~  337 (592)
T 3ogk_B          261 --EKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVL  337 (592)
T ss_dssp             --TSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHH
T ss_pred             --HHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHH
Confidence              1112222333334444333211 1233334444455555555555443222 22344555555555522222222223


Q ss_pred             CcCCCCCcEEEcc-----------CccccCCC-CCcCCCCCcceEEEcccCcccCcccccccc-CCcccEEEcc----CC
Q 001867          401 LGHCQSLTRVRLG-----------YNRLTGKV-PPLLWGLPHVYLLELTDNFLSGEISKNIAG-AANLSLLIIS----KN  463 (1002)
Q Consensus       401 l~~l~~L~~L~L~-----------~N~l~~~~-p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~-l~~L~~L~Ls----~N  463 (1002)
                      +..+++|++|+|+           .|.+++.. +..+..+++|+.|+++.|.+++.....+.. +++|+.|+++    .|
T Consensus       338 ~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n  417 (592)
T 3ogk_B          338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREE  417 (592)
T ss_dssp             HHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCS
T ss_pred             HHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCc
Confidence            3445566666666           24443221 112234566666666666666555555544 6667777764    55


Q ss_pred             cCCCC-----Ccccccccccccccccccc--ccCCCCcccccc-cccCCeeecCCCcCCc-ccccccccccccccccccC
Q 001867          464 NLSGS-----LPEEIGFLKSLVVLSGSEN--KFTGSLPESLTN-LAELGSLDLHANDLSG-ELPSSVSSWKKLNELNLAD  534 (1002)
Q Consensus       464 ~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~  534 (1002)
                      ++++.     ++..+..+++|+.|+++.|  .+++..+..+.. +++|+.|+|++|++++ .++..+..+++|+.|+|++
T Consensus       418 ~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~  497 (592)
T 3ogk_B          418 RITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG  497 (592)
T ss_dssp             CCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEES
T ss_pred             cccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccC
Confidence            66543     2333555677777777533  355444444433 6677777777777765 3344556677777777777


Q ss_pred             cccccC-CCCCccccccccEEeCcceeeecc
Q 001867          535 NLFYGN-IPEDIGNLSVLNYLDLSNNRLSGR  564 (1002)
Q Consensus       535 N~l~~~-ip~~~~~l~~L~~L~Ls~N~l~~~  564 (1002)
                      |.+++. ++..+..+++|++|+|++|++++.
T Consensus       498 n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          498 CCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             CCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            776644 333345677777777777777654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=7.5e-30  Score=287.19  Aligned_cols=282  Identities=20%  Similarity=0.220  Sum_probs=175.8

Q ss_pred             cccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEE
Q 001867          284 NLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVD  363 (1002)
Q Consensus       284 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  363 (1002)
                      .++.....++++|.++ .+|..+.. .|++|++++|++++..+..+.++++|++|++++|++++..|..|..+++|++|+
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLTE-AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD  106 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCCeEeeCCCCCcc-cccccccc-cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEE
Confidence            3445555677777777 45554433 577788888887766666777888888888888888877777788888888888


Q ss_pred             ccCccccCCCChhhhccCcccceeeeccccccCCC-CcCcCCCCCcEEEccCc-cccCCCCCcCCCCCcceEEEcccCcc
Q 001867          364 LSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLP-DGLGHCQSLTRVRLGYN-RLTGKVPPLLWGLPHVYLLELTDNFL  441 (1002)
Q Consensus       364 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~i  441 (1002)
                      |++|++++..+..+..+++|++|++++|.+++..+ ..+.++++|++|++++| .+++..+..|.++++|+.|++++|.+
T Consensus       107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l  186 (353)
T 2z80_A          107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL  186 (353)
T ss_dssp             CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence            88888875555557777777777777777764433 36667777777777776 35555556666666666666666666


Q ss_pred             cCccccccccCCcccEEEccCCcCCCCCcc-ccccccccccccccccccCCCCccccc---ccccCCeeecCCCcCCccc
Q 001867          442 SGEISKNIAGAANLSLLIISKNNLSGSLPE-EIGFLKSLVVLSGSENKFTGSLPESLT---NLAELGSLDLHANDLSGEL  517 (1002)
Q Consensus       442 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~  517 (1002)
                      .+..+..+..+++|+.|++++|++. .+|. .+..+++|+.|++++|++++..+..+.   ....++.++|++|.+++  
T Consensus       187 ~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~--  263 (353)
T 2z80_A          187 QSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD--  263 (353)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH--
T ss_pred             CccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC--
Confidence            6666666666666666666666665 3333 233456666666666666544333222   12333344444433332  


Q ss_pred             ccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCc-cccc-ccceEEeccccCcCCCC
Q 001867          518 PSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLSGELP  589 (1002)
Q Consensus       518 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~-~~~l-~L~~l~ls~N~l~g~~p  589 (1002)
                                       |.+. .+|+.++++++|++|||++|+++ .+|.. ++.+ +|+.|+|++|++++..|
T Consensus       264 -----------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          264 -----------------ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             -----------------HHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             -----------------cchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence                             2222 35556666666666666666666 34444 3555 56666666666666655

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1.6e-29  Score=278.54  Aligned_cols=231  Identities=17%  Similarity=0.234  Sum_probs=161.5

Q ss_pred             cccchhcccccccCCCCCCCCCCCCCCceEEccCccccCC--CChhhhccCcccceeeeccccccCCCCcCcCCCCCcEE
Q 001867          333 PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE--IPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV  410 (1002)
Q Consensus       333 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  410 (1002)
                      ++|++|++++|+++...+..|..+++|++|+|++|+++..  .+..+..+++|++|++++|.+++ +|..+..+++|++|
T Consensus        28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L  106 (306)
T 2z66_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL  106 (306)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEE
T ss_pred             CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEE
Confidence            4566666666666655555567777777777777777632  25666667777777777777763 45557777777777


Q ss_pred             EccCccccCCCC-CcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCC-CCccccccccccccccccccc
Q 001867          411 RLGYNRLTGKVP-PLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSG-SLPEEIGFLKSLVVLSGSENK  488 (1002)
Q Consensus       411 ~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~  488 (1002)
                      ++++|++++..+ ..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+++ .+|..++.+++|+.|++++|+
T Consensus       107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  186 (306)
T 2z66_A          107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  186 (306)
T ss_dssp             ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence            777777776554 466777777777777777776666667777777777777777765 466677777777777777777


Q ss_pred             cCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccc-cccEEeCcceeeecc
Q 001867          489 FTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLS-VLNYLDLSNNRLSGR  564 (1002)
Q Consensus       489 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~-~L~~L~Ls~N~l~~~  564 (1002)
                      +++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+++.+|..+..++ +|++|+|++|++++.
T Consensus       187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            7766666777777777777777777766666677777777777777777777777777763 677777777777654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=8.1e-30  Score=280.94  Aligned_cols=283  Identities=19%  Similarity=0.181  Sum_probs=208.0

Q ss_pred             eeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCC--CCCCCCCCCCCceEEccCc
Q 001867          290 LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGT--LPGDLGKNSPLRWVDLSNN  367 (1002)
Q Consensus       290 ~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N  367 (1002)
                      .++.+++.++ .+|..+. ..++.|+|++|+++...+..|..+++|++|++++|+++..  .+..+..+++|++|+|++|
T Consensus        11 ~l~c~~~~l~-~ip~~~~-~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n   88 (306)
T 2z66_A           11 EIRCNSKGLT-SVPTGIP-SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN   88 (306)
T ss_dssp             EEECCSSCCS-SCCSCCC-TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSC
T ss_pred             EEEcCCCCcc-cCCCCCC-CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCC
Confidence            3444444444 2333222 1355555555555544444456666666666666666522  2344555677777777777


Q ss_pred             cccCCCChhhhccCcccceeeeccccccCCC-CcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccC-cc
Q 001867          368 QFTGEIPASLCEKGELEELLMIYNSFTGQLP-DGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG-EI  445 (1002)
Q Consensus       368 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~-~~  445 (1002)
                      +++ .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|++++..|..|..+++|+.|++++|.+.+ ..
T Consensus        89 ~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  167 (306)
T 2z66_A           89 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL  167 (306)
T ss_dssp             SEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEE
T ss_pred             ccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccc
Confidence            777 456667777778888888887776555 577888888888888888888888888888888888888888876 57


Q ss_pred             ccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccccccccc
Q 001867          446 SKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWK  525 (1002)
Q Consensus       446 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  525 (1002)
                      |..+..+++|+.|++++|++++..|..++.+++|+.|++++|++++..+..+..+++|+.|||++|++++..|..+..++
T Consensus       168 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  247 (306)
T 2z66_A          168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP  247 (306)
T ss_dssp             CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCC
T ss_pred             hhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhh
Confidence            78888888999999999999877788888899999999999999877777888899999999999999998898888884


Q ss_pred             -ccccccccCcccccCCCC--CccccccccEEeCcceeeecccCCcccccccc
Q 001867          526 -KLNELNLADNLFYGNIPE--DIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLN  575 (1002)
Q Consensus       526 -~L~~L~Ls~N~l~~~ip~--~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~L~  575 (1002)
                       +|++|+|++|.+++.-+.  ....+...+.+.+..|.+....|..++...+.
T Consensus       248 ~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g~~~~  300 (306)
T 2z66_A          248 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVL  300 (306)
T ss_dssp             TTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTTCBGG
T ss_pred             ccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCCceee
Confidence             899999999999865321  12345556666777888888888777665443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=6.2e-29  Score=275.83  Aligned_cols=233  Identities=23%  Similarity=0.279  Sum_probs=163.0

Q ss_pred             cccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEc
Q 001867          333 PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRL  412 (1002)
Q Consensus       333 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L  412 (1002)
                      +++++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|++|++++|.++ .+|..++++++|++|+|
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            45566666666665 44555555666666666666666 55555555566666666666555 45555555555666666


Q ss_pred             cCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCC
Q 001867          413 GYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGS  492 (1002)
Q Consensus       413 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  492 (1002)
                      ++|++.+.+|..+...               ..+..+.++++|+.|++++|+++ .+|..++.+++|+.|++++|++++ 
T Consensus       158 ~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-  220 (328)
T 4fcg_A          158 RACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-  220 (328)
T ss_dssp             EEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-
T ss_pred             CCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-
Confidence            5555555555544320               01122345778888888888887 777778888888888888888884 


Q ss_pred             CcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc
Q 001867          493 LPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL  572 (1002)
Q Consensus       493 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l  572 (1002)
                      +|..+..+++|+.|+|++|.+.+.+|..++.+++|+.|+|++|.+.+.+|..++++++|++|+|++|++.|.+|..+..+
T Consensus       221 l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L  300 (328)
T 4fcg_A          221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL  300 (328)
T ss_dssp             CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGS
T ss_pred             CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhc
Confidence            66678888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             -ccceEEeccccCc
Q 001867          573 -KLNQLNVSNNRLS  585 (1002)
Q Consensus       573 -~L~~l~ls~N~l~  585 (1002)
                       +++.+++..|.+.
T Consensus       301 ~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          301 PANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCEEECCGGGSC
T ss_pred             cCceEEeCCHHHHH
Confidence             6888888777665

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.8e-30  Score=283.99  Aligned_cols=249  Identities=22%  Similarity=0.217  Sum_probs=195.1

Q ss_pred             cCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccc-cCCCChhhh-------ccCcccceeeeccccccCCCCc
Q 001867          329 IADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQF-TGEIPASLC-------EKGELEELLMIYNSFTGQLPDG  400 (1002)
Q Consensus       329 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~l~~N~l~~~~p~~  400 (1002)
                      ++..++|++|++++|.+  .+|..+...  |+.|+|++|++ ...+|..+.       .+++|++|++++|.+++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45556777777777777  455544433  77788888887 345666555       6788888888888888888877


Q ss_pred             C--cCCCCCcEEEccCccccCCCCCcCCCC-----CcceEEEcccCcccCccccccccCCcccEEEccCCcCCCC--Ccc
Q 001867          401 L--GHCQSLTRVRLGYNRLTGKVPPLLWGL-----PHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGS--LPE  471 (1002)
Q Consensus       401 l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~  471 (1002)
                      +  +.+++|++|+|++|++++. |..+..+     ++|++|+|++|++.+..+..|..+++|+.|++++|++.+.  .|.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            6  7888888888888888876 7777766     8888888888888888888888888888888888887765  344


Q ss_pred             cc--ccccccccccccccccCC--CCc-ccccccccCCeeecCCCcCCcccc-cccccccccccccccCcccccCCCCCc
Q 001867          472 EI--GFLKSLVVLSGSENKFTG--SLP-ESLTNLAELGSLDLHANDLSGELP-SSVSSWKKLNELNLADNLFYGNIPEDI  545 (1002)
Q Consensus       472 ~~--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip~~~  545 (1002)
                      .+  +.+++|+.|++++|++++  .++ ..+..+++|+.|||++|++++.+| ..+..+++|+.|+|++|.|+ .+|..+
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~  272 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL  272 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence            44  788899999999998883  122 334577899999999999998775 55677889999999999998 788887


Q ss_pred             cccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCC
Q 001867          546 GNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGE  587 (1002)
Q Consensus       546 ~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~  587 (1002)
                      .  ++|++|||++|+|++. |. +..+ +|+.|+|++|++++.
T Consensus       273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred             c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence            7  8899999999999875 66 7777 799999999998864

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=2.8e-28  Score=265.58  Aligned_cols=257  Identities=22%  Similarity=0.218  Sum_probs=134.7

Q ss_pred             ceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCcc
Q 001867          289 RLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQ  368 (1002)
Q Consensus       289 ~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  368 (1002)
                      +.++.+++.++ .+|..+. ..++.|+|++|++++..+..|..+++|++|++++|++++..|..|..+++|++|+|++|+
T Consensus        14 ~~~~c~~~~l~-~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~   91 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (285)
T ss_dssp             CEEECCSSCCS-SCCTTCC-TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             eEEEcCcCCcc-cCCcCCC-CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence            34555555555 2333221 135555555555554444445555555555555555555445555555555555555554


Q ss_pred             -ccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCcccc
Q 001867          369 -FTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISK  447 (1002)
Q Consensus       369 -l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~  447 (1002)
                       ++...|                        ..+..+++|++|++++|++++..|..|..+++|+.|++++|.+++..+.
T Consensus        92 ~l~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  147 (285)
T 1ozn_A           92 QLRSVDP------------------------ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD  147 (285)
T ss_dssp             TCCCCCT------------------------TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CccccCH------------------------HHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHh
Confidence             443334                        4444444555555555555544444444555555555555555544444


Q ss_pred             ccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccccccccccc
Q 001867          448 NIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKL  527 (1002)
Q Consensus       448 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  527 (1002)
                      .+..+++|+.|++++|++++..+..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..+..+++|
T Consensus       148 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  227 (285)
T 1ozn_A          148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL  227 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred             HhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence            45555555555555555554444445555566666666666655555566666666666666666665555556666666


Q ss_pred             ccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc
Q 001867          528 NELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL  572 (1002)
Q Consensus       528 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l  572 (1002)
                      +.|+|++|.++...+.. .-...++.+..+.|.+....|..+...
T Consensus       228 ~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~g~  271 (285)
T 1ozn_A          228 QYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAGR  271 (285)
T ss_dssp             CEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTTC
T ss_pred             CEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhCCc
Confidence            66666666665433221 112334445566666666666665543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.5e-28  Score=267.66  Aligned_cols=251  Identities=20%  Similarity=0.179  Sum_probs=215.9

Q ss_pred             hhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCcc
Q 001867          337 ELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR  416 (1002)
Q Consensus       337 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~  416 (1002)
                      +++.+++.++. +|..+  .++|++|+|++|++++..+..|..+++|++|++++|.+++..|..|.++++|++|++++|+
T Consensus        15 ~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~   91 (285)
T 1ozn_A           15 TTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (285)
T ss_dssp             EEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence            44555555553 33332  3578888888888887777778888888888888888888888899999999999999997


Q ss_pred             -ccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcc
Q 001867          417 -LTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE  495 (1002)
Q Consensus       417 -l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  495 (1002)
                       +++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|++++..+..++.+++|+.|++++|++++..+.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  171 (285)
T 1ozn_A           92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER  171 (285)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence             8877799999999999999999999999999999999999999999999977777899999999999999999976667


Q ss_pred             cccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-cc
Q 001867          496 SLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KL  574 (1002)
Q Consensus       496 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L  574 (1002)
                      .|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..|..+..+++|++|+|++|+++...+.. ... .+
T Consensus       172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l  250 (285)
T 1ozn_A          172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWL  250 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHH
T ss_pred             HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHH
Confidence            7999999999999999999999999999999999999999999776677999999999999999999755532 111 46


Q ss_pred             ceEEeccccCcCCCChh
Q 001867          575 NQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       575 ~~l~ls~N~l~g~~p~~  591 (1002)
                      +.++.+.|.+.+..|..
T Consensus       251 ~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          251 QKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHCCSEECCCBEEESGG
T ss_pred             HhcccccCccccCCchH
Confidence            66778889998888865

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=4.8e-28  Score=281.93  Aligned_cols=226  Identities=21%  Similarity=0.165  Sum_probs=125.3

Q ss_pred             cchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccC
Q 001867          335 LYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGY  414 (1002)
Q Consensus       335 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~  414 (1002)
                      +++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|++++|.+++..+..|.++++|++|+|++
T Consensus        77 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  156 (452)
T 3zyi_A           77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN  156 (452)
T ss_dssp             CSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCS
T ss_pred             ccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCC
Confidence            34444444444444444444444444444444444444444444444444444444444444444455555555555555


Q ss_pred             ccccCCCCCcCCCCCcceEEEccc-CcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCC
Q 001867          415 NRLTGKVPPLLWGLPHVYLLELTD-NFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSL  493 (1002)
Q Consensus       415 N~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  493 (1002)
                      |++++..+..|..+++|+.|++++ |.+..+.+..|.++++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..
T Consensus       157 N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~  234 (452)
T 3zyi_A          157 NPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIR  234 (452)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEEC
T ss_pred             CCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccC
Confidence            555544444555555555555555 33333333445556666666666666653 33 3555666666666666666555


Q ss_pred             cccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeee
Q 001867          494 PESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       494 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      |..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.
T Consensus       235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             GGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             cccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            666666666666666666666666666666666666666666666544555566666666666666655

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.5e-29  Score=277.41  Aligned_cols=251  Identities=22%  Similarity=0.230  Sum_probs=158.5

Q ss_pred             cccccccceeeccccccCCCCCccCCCCCcceeecCCCccc-CcCCcccC-------CCcccchhcccccccCCCCCCCC
Q 001867          282 WSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLE-GSLPATIA-------DSPGLYELRLFRNRLNGTLPGDL  353 (1002)
Q Consensus       282 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~  353 (1002)
                      ++..++|+.|++++|.+  .+|..+... ++.|+|++|++. ..+|..+.       ++++|++|++++|++++.+|..+
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  115 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL  115 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence            44556666666666666  444433332 666666666663 34454444       57778888888888877777765


Q ss_pred             --CCCCCCceEEccCccccCCCChhhhcc-----CcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCC
Q 001867          354 --GKNSPLRWVDLSNNQFTGEIPASLCEK-----GELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLW  426 (1002)
Q Consensus       354 --~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  426 (1002)
                        ..+++|++|+|++|++++. |..+..+     ++|++|++++|.+++..|..|+++++|++|+|++|++.+..+    
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----  190 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG----  190 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH----
T ss_pred             HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH----
Confidence              7778888888888888766 6666655     555555555555555555555555555555555555433210    


Q ss_pred             CCCcceEEEcccCcccCcccccc--ccCCcccEEEccCCcCCC--CCc-cccccccccccccccccccCCCCc-cccccc
Q 001867          427 GLPHVYLLELTDNFLSGEISKNI--AGAANLSLLIISKNNLSG--SLP-EEIGFLKSLVVLSGSENKFTGSLP-ESLTNL  500 (1002)
Q Consensus       427 ~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l  500 (1002)
                                        .+..+  ..+++|+.|+|++|++++  .++ ..+..+++|+.|++++|++++..| ..+..+
T Consensus       191 ------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l  252 (312)
T 1wwl_A          191 ------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP  252 (312)
T ss_dssp             ------------------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred             ------------------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence                              11222  455666666666666652  111 223456677777777777776554 445567


Q ss_pred             ccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeec
Q 001867          501 AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       501 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      ++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus       253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            77888888888877 6666665  7788888888888754 55 7788888888888888775

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=5.3e-28  Score=280.59  Aligned_cols=227  Identities=20%  Similarity=0.166  Sum_probs=134.4

Q ss_pred             ccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEcc
Q 001867          334 GLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLG  413 (1002)
Q Consensus       334 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~  413 (1002)
                      +++.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+|+
T Consensus        65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  144 (440)
T 3zyj_A           65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR  144 (440)
T ss_dssp             TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred             CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence            44445555555555555555555566666666666655555555555555555555555555555556666666666666


Q ss_pred             CccccCCCCCcCCCCCcceEEEccc-CcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCC
Q 001867          414 YNRLTGKVPPLLWGLPHVYLLELTD-NFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGS  492 (1002)
Q Consensus       414 ~N~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  492 (1002)
                      +|++++..+..|..+++|+.|+|++ |.+..+.+..|.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|++++.
T Consensus       145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~  222 (440)
T 3zyj_A          145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI  222 (440)
T ss_dssp             SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEE
T ss_pred             CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCcc
Confidence            6666655555666666666666665 3333333445566666666666666665 334 355566666666666666655


Q ss_pred             CcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeee
Q 001867          493 LPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       493 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      .|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus       223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            5666666666666666666666666666666666666666666666544455566666666666666654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=4.9e-28  Score=281.88  Aligned_cols=249  Identities=20%  Similarity=0.137  Sum_probs=222.3

Q ss_pred             chhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCc
Q 001867          336 YELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN  415 (1002)
Q Consensus       336 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N  415 (1002)
                      ..++.+++.++ .+|..+.  +++++|+|++|+|++..|..|..+++|++|++++|.+++..|..|.++++|++|+|++|
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            34555555665 3444443  68999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCC-cCCCCCccccccccccccccccccccCCCCc
Q 001867          416 RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKN-NLSGSLPEEIGFLKSLVVLSGSENKFTGSLP  494 (1002)
Q Consensus       416 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  494 (1002)
                      ++++..+..|..+++|+.|+|++|.|..+.+..|..+++|+.|++++| .+....+..+..+++|+.|+|++|++++ +|
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~  212 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP  212 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc
Confidence            999888888999999999999999999888889999999999999995 5553344478999999999999999995 45


Q ss_pred             ccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-c
Q 001867          495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-K  573 (1002)
Q Consensus       495 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~  573 (1002)
                       .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+ +
T Consensus       213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  291 (452)
T 3zyi_A          213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY  291 (452)
T ss_dssp             -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred             -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence             58899999999999999999999999999999999999999998889999999999999999999998777778888 7


Q ss_pred             cceEEeccccCcCCCC
Q 001867          574 LNQLNVSNNRLSGELP  589 (1002)
Q Consensus       574 L~~l~ls~N~l~g~~p  589 (1002)
                      |+.|+|++|++.-...
T Consensus       292 L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          292 LVELHLHHNPWNCDCD  307 (452)
T ss_dssp             CCEEECCSSCEECSTT
T ss_pred             CCEEEccCCCcCCCCC
Confidence            9999999999875433

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=1e-31  Score=324.97  Aligned_cols=429  Identities=16%  Similarity=0.128  Sum_probs=223.0

Q ss_pred             CCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCC---CCCCCCCcc------------ccCccc
Q 001867           56 PCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSI---NSTLPDDIS------------ACQNLQ  120 (1002)
Q Consensus        56 ~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L~  120 (1002)
                      |++|.++.+...  +  .+.+.+ .....++..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        41 ck~W~~~~~~~~--~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSETR--E--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHHC--C--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhccc--c--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            448999954321  1  222322 23334455678899999999988532   244554444            789999


Q ss_pred             ccccccccccCCCCcccccc--CCcccccccccc-ccC-CCCcccccccccceeeeccccccCc----cccccccccccc
Q 001867          121 HLDLSQNLLTGTLTPALADL--PNLKFLDLTGNN-FSG-DIPESFGRFQKLEVISLVYNLLDGT----IPAFLGNISTLK  192 (1002)
Q Consensus       121 ~L~Ls~N~l~~~~~~~~~~L--~~L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~  192 (1002)
                      +|+|++|.+++..+..+..+  .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++.    ++..+.++++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            99999999987666667664  459999999987 321 1233345789999999999998766    445567788999


Q ss_pred             cccccCCCCCC---CCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccc---cccCcccccccceee
Q 001867          193 MLNLSYNPFLP---GRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV---GAIPSSLTELASVVQ  266 (1002)
Q Consensus       193 ~L~Ls~N~~~~---~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~~~~l~~l~~L~~  266 (1002)
                      +|++++|.+..   ..++..+.++++|+.|++++|.+.+ +|..+..+++|++|+++.+...   +..+..+..+++|+.
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~  274 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR  274 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence            99999998620   1223334556666666666666663 4556666666666666543222   122233444445555


Q ss_pred             eeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCC-cccCCCcccchhccccccc
Q 001867          267 IELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLP-ATIADSPGLYELRLFRNRL  345 (1002)
Q Consensus       267 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l  345 (1002)
                      |+++++.. +.+|..+..+++|++|++++|.++                       +... ..+..+++|++|+++++-.
T Consensus       275 L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~-----------------------~~~~~~~~~~~~~L~~L~L~~~~~  330 (592)
T 3ogk_B          275 LGLSYMGP-NEMPILFPFAAQIRKLDLLYALLE-----------------------TEDHCTLIQKCPNLEVLETRNVIG  330 (592)
T ss_dssp             EEETTCCT-TTGGGGGGGGGGCCEEEETTCCCC-----------------------HHHHHHHHTTCTTCCEEEEEGGGH
T ss_pred             cCccccch-hHHHHHHhhcCCCcEEecCCCcCC-----------------------HHHHHHHHHhCcCCCEEeccCccC
Confidence            55444322 233344444445555555444433                       2111 2234445555555542211


Q ss_pred             CCCCCCCCCCCCCCceEEcc-----------CccccCCCChh-hhccCcccceeeeccccccCCCCcCcC-CCCCcEEEc
Q 001867          346 NGTLPGDLGKNSPLRWVDLS-----------NNQFTGEIPAS-LCEKGELEELLMIYNSFTGQLPDGLGH-CQSLTRVRL  412 (1002)
Q Consensus       346 ~~~~p~~~~~l~~L~~L~Ls-----------~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~-l~~L~~L~L  412 (1002)
                      .+.++..+..+++|++|+|+           .|.+++..... ...+++|++|+++.|.+++..+..+.. +++|+.|++
T Consensus       331 ~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l  410 (592)
T 3ogk_B          331 DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRL  410 (592)
T ss_dssp             HHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEE
T ss_pred             HHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEE
Confidence            11111122334556666666           24444322212 233455566666555555444444433 555666666


Q ss_pred             c----CccccCC-----CCCcCCCCCcceEEEcccCc--ccCcccccccc-CCcccEEEccCCcCCCC-Ccccccccccc
Q 001867          413 G----YNRLTGK-----VPPLLWGLPHVYLLELTDNF--LSGEISKNIAG-AANLSLLIISKNNLSGS-LPEEIGFLKSL  479 (1002)
Q Consensus       413 ~----~N~l~~~-----~p~~~~~l~~L~~L~L~~N~--i~~~~~~~~~~-l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L  479 (1002)
                      +    .|++++.     ++..+.++++|+.|++++|.  +++.....+.. +++|+.|++++|++++. ++..+..+++|
T Consensus       411 ~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L  490 (592)
T 3ogk_B          411 VLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL  490 (592)
T ss_dssp             EECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTC
T ss_pred             eecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCccc
Confidence            4    4445432     11223334445555544221  33322222222 34444444444444421 22223334444


Q ss_pred             ccccccccccCCC-CcccccccccCCeeecCCCcCC
Q 001867          480 VVLSGSENKFTGS-LPESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       480 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      +.|++++|.+++. ++..+..+++|+.|+|++|+++
T Consensus       491 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it  526 (592)
T 3ogk_B          491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS  526 (592)
T ss_dssp             CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred             CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence            4444444444322 1222233444444444444444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=4.8e-28  Score=280.91  Aligned_cols=247  Identities=21%  Similarity=0.173  Sum_probs=221.6

Q ss_pred             chhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCc
Q 001867          336 YELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN  415 (1002)
Q Consensus       336 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N  415 (1002)
                      ..++..++.++ .+|..+.  ++++.|+|++|++++..+..|..+++|++|++++|.+++..+..|.++++|++|+|++|
T Consensus        46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n  122 (440)
T 3zyj_A           46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN  122 (440)
T ss_dssp             CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence            45556666666 4555443  67999999999999888899999999999999999999988899999999999999999


Q ss_pred             cccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCc-cccccccccccccccccccCCCCc
Q 001867          416 RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP-EEIGFLKSLVVLSGSENKFTGSLP  494 (1002)
Q Consensus       416 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p  494 (1002)
                      ++++..+..|..+++|+.|+|++|.|....+..|..+++|+.|++++|+..+.++ ..|..+++|+.|++++|+++ .+|
T Consensus       123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~  201 (440)
T 3zyj_A          123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP  201 (440)
T ss_dssp             CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred             cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence            9998888899999999999999999999888899999999999999954444444 57899999999999999999 566


Q ss_pred             ccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-c
Q 001867          495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-K  573 (1002)
Q Consensus       495 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~  573 (1002)
                       .+..+++|+.|||++|++++..|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+ +
T Consensus       202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  280 (440)
T 3zyj_A          202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH  280 (440)
T ss_dssp             -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred             -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence             48899999999999999999999999999999999999999998889999999999999999999998777778888 8


Q ss_pred             cceEEeccccCcCC
Q 001867          574 LNQLNVSNNRLSGE  587 (1002)
Q Consensus       574 L~~l~ls~N~l~g~  587 (1002)
                      |+.|+|++|++.-.
T Consensus       281 L~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          281 LERIHLHHNPWNCN  294 (440)
T ss_dssp             CCEEECCSSCEECS
T ss_pred             CCEEEcCCCCccCC
Confidence            99999999998643

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.1e-29  Score=280.91  Aligned_cols=263  Identities=17%  Similarity=0.123  Sum_probs=189.9

Q ss_pred             eeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccc
Q 001867          313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNS  392 (1002)
Q Consensus       313 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  392 (1002)
                      .++++.+.+.......+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+  +..+++|++|++++|.
T Consensus        14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~   91 (317)
T 3o53_A           14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY   91 (317)
T ss_dssp             EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred             EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence            33444444443444444455566666666666666555566666666666666666664443  6666666666666666


Q ss_pred             cccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccc
Q 001867          393 FTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEE  472 (1002)
Q Consensus       393 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  472 (1002)
                      +++..     ..++|++|++++|++++..+..   +++|+.|++++|++++..+..+..+++|+.|++++|++++..|..
T Consensus        92 l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  163 (317)
T 3o53_A           92 VQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE  163 (317)
T ss_dssp             EEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGG
T ss_pred             ccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHH
Confidence            66422     3367888888888887655443   567888888888888877778888888888888888888766666


Q ss_pred             cc-cccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccc
Q 001867          473 IG-FLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVL  551 (1002)
Q Consensus       473 ~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L  551 (1002)
                      +. .+++|+.|++++|++++. |. ...+++|+.|+|++|++++. |..+..+++|+.|+|++|.++ .+|..+..+++|
T Consensus       164 ~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L  239 (317)
T 3o53_A          164 LAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL  239 (317)
T ss_dssp             GGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTC
T ss_pred             HhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCC
Confidence            64 678888888888888843 33 33588899999999999864 445888899999999999998 688888899999


Q ss_pred             cEEeCcceeee-cccCCccccc-ccceEEec-cccCcCCCC
Q 001867          552 NYLDLSNNRLS-GRIPVGLQNL-KLNQLNVS-NNRLSGELP  589 (1002)
Q Consensus       552 ~~L~Ls~N~l~-~~ip~~~~~l-~L~~l~ls-~N~l~g~~p  589 (1002)
                      +.|+|++|+++ +.+|..+..+ +|+.|+++ .+.++|..|
T Consensus       240 ~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             CEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             CEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            99999999998 7778777777 78888888 446666554

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=8.4e-27  Score=278.12  Aligned_cols=261  Identities=30%  Similarity=0.357  Sum_probs=133.6

Q ss_pred             ceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccc
Q 001867          263 SVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFR  342 (1002)
Q Consensus       263 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  342 (1002)
                      +++.|++++|.++ .+|..+.  ++|+.|++++|+|+. +|..  ...|+.|+|++|++++ +|.   .+++|++|++++
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~~--l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  110 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL--PPELRTLEVSGNQLTS-LPV---LPPGLLELSIFS  110 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCCC--CTTCCEEEECSCCCSC-CCC---CCTTCCEEEECS
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCCc--CCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcC
Confidence            4677777777777 4555444  677777777777763 4431  1236666666666663 333   445566666666


Q ss_pred             cccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCC
Q 001867          343 NRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVP  422 (1002)
Q Consensus       343 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  422 (1002)
                      |++++..+    .+++|+.|++++|++++ +|..   +++|++|++++|.+++ +|.   .+++|+.|++++|++++ +|
T Consensus       111 N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~  177 (622)
T 3g06_A          111 NPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP  177 (622)
T ss_dssp             CCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred             CcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc
Confidence            66654322    34556666666666553 3322   2445555555555543 222   22344555555555543 22


Q ss_pred             CcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCccccccccc
Q 001867          423 PLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAE  502 (1002)
Q Consensus       423 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  502 (1002)
                                                 ..+++|+.|++++|++++ +|..   +++|+.|++++|+++ .+|..   +++
T Consensus       178 ---------------------------~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~  222 (622)
T 3g06_A          178 ---------------------------MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSG  222 (622)
T ss_dssp             ---------------------------CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTT
T ss_pred             ---------------------------ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCC
Confidence                                       223444555555555542 3321   244555555555554 23322   244


Q ss_pred             CCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEecc
Q 001867          503 LGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSN  581 (1002)
Q Consensus       503 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~  581 (1002)
                      |+.|+|++|.|++ +|   ..+++|+.|+|++|.|+ .+|.   .+++|+.|+|++|+|+ .+|..+..+ +|+.|+|++
T Consensus       223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~  293 (622)
T 3g06_A          223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  293 (622)
T ss_dssp             CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred             CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence            5555555555553 33   23345555555555555 3444   3445555555555555 445555555 455555555


Q ss_pred             ccCcCCCCh
Q 001867          582 NRLSGELPS  590 (1002)
Q Consensus       582 N~l~g~~p~  590 (1002)
                      |+++|.+|.
T Consensus       294 N~l~~~~~~  302 (622)
T 3g06_A          294 NPLSERTLQ  302 (622)
T ss_dssp             CCCCHHHHH
T ss_pred             CCCCCcCHH
Confidence            555555444

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=3e-28  Score=288.87  Aligned_cols=195  Identities=18%  Similarity=0.126  Sum_probs=134.2

Q ss_pred             eeeecCCccEEEEE-EcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCceeeeeeEEec
Q 001867          690 VIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTT  767 (1002)
Q Consensus       690 ~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  767 (1002)
                      ..+.|++|.+..++ ..-|+.||||++.+.....       ...........++|.+|+++|+++ .|+||+++++++.+
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~-------~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed  313 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHG-------ILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN  313 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTT-------CSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccc-------cchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE
Confidence            45667777666654 3348899999986542211       011112344567799999999999 69999999999999


Q ss_pred             CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccC
Q 001867          768 RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV  847 (1002)
Q Consensus       768 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  847 (1002)
                      ++..|+||||++|++|.+++..  .+++++.   +|+.||+.||+|+|++   |||||||||+|||++.+|++||+|||+
T Consensus       314 ~~~~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGl  385 (569)
T 4azs_A          314 AQSGWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGS  385 (569)
T ss_dssp             SSEEEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeeccc
Confidence            9999999999999999999984  4567764   4789999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 001867          848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP  902 (1002)
Q Consensus       848 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p  902 (1002)
                      |+.......  .....+||+.|||||++.+ .+..++|+||+|++.+++.++..+
T Consensus       386 Ar~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          386 IVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             EESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            987654432  2335679999999999875 467789999999998887665443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=6e-29  Score=275.08  Aligned_cols=267  Identities=18%  Similarity=0.137  Sum_probs=130.8

Q ss_pred             cchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCC
Q 001867          240 LVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYEN  319 (1002)
Q Consensus       240 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N  319 (1002)
                      ++.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+                
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----------------   75 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD----------------   75 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE----------------
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh----------------
Confidence            4444555555554444444444555555555555555444455555555555555555543221                


Q ss_pred             cccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCC
Q 001867          320 RLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPD  399 (1002)
Q Consensus       320 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  399 (1002)
                               +..+++|++|++++|++++..     ..++|++|++++|++++..                        +.
T Consensus        76 ---------~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~------------------------~~  117 (317)
T 3o53_A           76 ---------LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVS------------------------CS  117 (317)
T ss_dssp             ---------ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEE------------------------EC
T ss_pred             ---------hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcC------------------------cc
Confidence                     333333333333333333211     1134444444444444322                        22


Q ss_pred             cCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccc-cCCcccEEEccCCcCCCCCccccccccc
Q 001867          400 GLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIA-GAANLSLLIISKNNLSGSLPEEIGFLKS  478 (1002)
Q Consensus       400 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  478 (1002)
                         .+++|++|++++|++++..+..+..+++|+.|+|++|.+++..+..+. .+++|+.|+|++|++++. |. ...+++
T Consensus       118 ---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~  192 (317)
T 3o53_A          118 ---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAK  192 (317)
T ss_dssp             ---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTT
T ss_pred             ---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-cccccc
Confidence               133455555555555544444455555555555555555544444442 445555555555555532 22 223555


Q ss_pred             cccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccc-cCCCCCccccccccEEeCc
Q 001867          479 LVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFY-GNIPEDIGNLSVLNYLDLS  557 (1002)
Q Consensus       479 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~ip~~~~~l~~L~~L~Ls  557 (1002)
                      |+.|++++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.++ +.+|..++.+++|+.|+++
T Consensus       193 L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          193 LKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             CCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             CCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            5555555555553 3334555555555555555555 34555555555566666665555 4555555555556666655


Q ss_pred             -ceeeecccCC
Q 001867          558 -NNRLSGRIPV  567 (1002)
Q Consensus       558 -~N~l~~~ip~  567 (1002)
                       .+.++|..|.
T Consensus       271 ~~~~l~~~~~~  281 (317)
T 3o53_A          271 TVKKLTGQNEE  281 (317)
T ss_dssp             HHHHHHSSSSC
T ss_pred             CchhccCCchh
Confidence             3345554443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=9.8e-27  Score=277.53  Aligned_cols=268  Identities=31%  Similarity=0.399  Sum_probs=207.1

Q ss_pred             cccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecC
Q 001867          238 AKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLY  317 (1002)
Q Consensus       238 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~  317 (1002)
                      .+++.|++++|.++ .+|..+.  ++|+.|+|++|.++. +|.   .+++|++|+|++|++++ +|.  ....|+.|+|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls  109 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV--LPPGLLELSIF  109 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC--CCTTCCEEEEC
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC--CCCCCCEEECc
Confidence            46899999999999 6676665  799999999999994 554   57899999999999985 555  22359999999


Q ss_pred             CCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCC
Q 001867          318 ENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQL  397 (1002)
Q Consensus       318 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  397 (1002)
                      +|++++. |.   .+++|+.|++++|++++ +|..   +++|++|+|++|++++ +|.   ...+|+.|++++|.+++ +
T Consensus       110 ~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l  176 (622)
T 3g06_A          110 SNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-L  176 (622)
T ss_dssp             SCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred             CCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-C
Confidence            9999964 43   57889999999999996 4443   4889999999999995 444   34689999999999996 5


Q ss_pred             CCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccc
Q 001867          398 PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLK  477 (1002)
Q Consensus       398 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  477 (1002)
                      |   ..+++|+.|++++|++++ +|..   +++|+.|++++|.+                        + .+|..   ++
T Consensus       177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l------------------------~-~l~~~---~~  221 (622)
T 3g06_A          177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRL------------------------T-SLPAL---PS  221 (622)
T ss_dssp             C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC------------------------S-SCCCC---CT
T ss_pred             c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcc------------------------c-ccCCC---CC
Confidence            5   457899999999999985 3332   24455555555544                        4 23322   35


Q ss_pred             ccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCc
Q 001867          478 SLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLS  557 (1002)
Q Consensus       478 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls  557 (1002)
                      +|+.|++++|+|++ +|   ..+++|+.|+|++|+|++ +|.   .+++|+.|+|++|.|+ .+|..++++++|+.|+|+
T Consensus       222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~  292 (622)
T 3g06_A          222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  292 (622)
T ss_dssp             TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred             CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence            66677777777764 45   345778888888888874 454   5678888888888888 788889999999999999


Q ss_pred             ceeeecccCCccccc
Q 001867          558 NNRLSGRIPVGLQNL  572 (1002)
Q Consensus       558 ~N~l~~~ip~~~~~l  572 (1002)
                      +|++++.+|..+..+
T Consensus       293 ~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          293 GNPLSERTLQALREI  307 (622)
T ss_dssp             SCCCCHHHHHHHHHH
T ss_pred             CCCCCCcCHHHHHhc
Confidence            999998888877665

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=5.5e-28  Score=282.95  Aligned_cols=233  Identities=18%  Similarity=0.116  Sum_probs=147.4

Q ss_pred             cccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEc
Q 001867          333 PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRL  412 (1002)
Q Consensus       333 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L  412 (1002)
                      ++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|  +..+++|++|++++|.+++..+     .++|++|++
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA  106 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence            355555555555555555555666666666666666654443  5555555555555555554222     266777777


Q ss_pred             cCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccc-cccccccccccccccCC
Q 001867          413 GYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIG-FLKSLVVLSGSENKFTG  491 (1002)
Q Consensus       413 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~  491 (1002)
                      ++|++++..+.   .+++|+.|+|++|.+++..|..++.+++|+.|+|++|++++..|..+. .+++|+.|+|++|.|++
T Consensus       107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            77777655443   246677777777777776666677777777777777777766666665 56777777777777764


Q ss_pred             CCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeee-cccCCccc
Q 001867          492 SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS-GRIPVGLQ  570 (1002)
Q Consensus       492 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~-~~ip~~~~  570 (1002)
                      . |. +..+++|+.|+|++|.|++.+| .+..+++|+.|+|++|.|++ +|..++.+++|+.|+|++|+++ +.+|..+.
T Consensus       184 ~-~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~  259 (487)
T 3oja_A          184 V-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (487)
T ss_dssp             E-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred             c-cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence            3 22 3346777777777777775433 36777777777777777773 6666777777777777777776 55555555


Q ss_pred             cc-ccceEEe
Q 001867          571 NL-KLNQLNV  579 (1002)
Q Consensus       571 ~l-~L~~l~l  579 (1002)
                      .+ .+..+++
T Consensus       260 ~l~~L~~l~~  269 (487)
T 3oja_A          260 KNQRVQTVAK  269 (487)
T ss_dssp             TCHHHHHHHH
T ss_pred             hCCCCcEEec
Confidence            44 4444444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=1.1e-27  Score=280.40  Aligned_cols=223  Identities=19%  Similarity=0.189  Sum_probs=199.5

Q ss_pred             CCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEE
Q 001867          355 KNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLL  434 (1002)
Q Consensus       355 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  434 (1002)
                      ..++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|  ++.+++|++|+|++|++++..+     .++|+.|
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L  104 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL  104 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence            44589999999999999889999999999999999999998776  9999999999999999986443     3899999


Q ss_pred             EcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCccccc-ccccCCeeecCCCcC
Q 001867          435 ELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLT-NLAELGSLDLHANDL  513 (1002)
Q Consensus       435 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l  513 (1002)
                      ++++|.|++..+..   +++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..+. .+++|+.|+|++|.|
T Consensus       105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l  181 (487)
T 3oja_A          105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (487)
T ss_dssp             ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence            99999999877654   57899999999999998899999999999999999999998888886 799999999999999


Q ss_pred             CcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCc-CCCChh
Q 001867          514 SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS-GELPSL  591 (1002)
Q Consensus       514 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~-g~~p~~  591 (1002)
                      ++..+  +..+++|+.|+|++|.+++ +|+.++.+++|+.|+|++|+|++ +|..+..+ +|+.|++++|++. +.+|..
T Consensus       182 ~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~  257 (487)
T 3oja_A          182 YDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF  257 (487)
T ss_dssp             CEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred             ccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence            97743  3459999999999999996 56669999999999999999996 78888887 8999999999998 555543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=2.7e-26  Score=247.55  Aligned_cols=217  Identities=23%  Similarity=0.276  Sum_probs=157.9

Q ss_pred             CCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCC
Q 001867           54 DSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL  133 (1002)
Q Consensus        54 ~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  133 (1002)
                      .++|.|.|+.|.... .++.+++++++++. +|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|.|+...
T Consensus         2 ~~~C~~~~~~C~c~~-~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCNN-NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEET-TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeCC-CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            468999999987543 35679999999985 565444  58999999999999887788999999999999999998766


Q ss_pred             CccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCC
Q 001867          134 TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNL  213 (1002)
Q Consensus       134 ~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l  213 (1002)
                      +..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|+++++|++|+|++|.+. ...+..|..+
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l  156 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL  156 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred             hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCC
Confidence            667788999999999999998777777888888888888888888777777788888888888888752 2222335666


Q ss_pred             CccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCccc
Q 001867          214 TNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLT  275 (1002)
Q Consensus       214 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  275 (1002)
                      ++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus       157 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            66666666666666555555555556666666555555444444444444444444444443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=1.1e-30  Score=316.09  Aligned_cols=455  Identities=18%  Similarity=0.174  Sum_probs=231.7

Q ss_pred             CCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCC---CCCCCC------------ccccCccc
Q 001867           56 PCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSIN---STLPDD------------ISACQNLQ  120 (1002)
Q Consensus        56 ~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~p~~------------~~~l~~L~  120 (1002)
                      |++|+++..    .....+++++..-. .....+..+++|++|+|+++...   +..|..            +..+++|+
T Consensus        34 ck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~  108 (594)
T 2p1m_B           34 CKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE  108 (594)
T ss_dssp             CHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             HHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence            457998822    12345566543322 22245678889999999987532   122222            23567788


Q ss_pred             ccccccccccCCCCcccc-ccCCccccccccc-cccCC-CCcccccccccceeeeccccccCccccccc----ccccccc
Q 001867          121 HLDLSQNLLTGTLTPALA-DLPNLKFLDLTGN-NFSGD-IPESFGRFQKLEVISLVYNLLDGTIPAFLG----NISTLKM  193 (1002)
Q Consensus       121 ~L~Ls~N~l~~~~~~~~~-~L~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~----~l~~L~~  193 (1002)
                      +|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++
T Consensus       109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~  188 (594)
T 2p1m_B          109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS  188 (594)
T ss_dssp             EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred             eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence            888888877765555554 5778888888877 44422 344445677788888887777655444433    4557777


Q ss_pred             ccccCCC--CCCCCCCcccCCCCccchhhccCc-ccccccccccccccccchhcccCc-------ccccccCcccccccc
Q 001867          194 LNLSYNP--FLPGRIPPELGNLTNLEILWLTEC-NLVGEIPDSLGRLAKLVDLDLALN-------NLVGAIPSSLTELAS  263 (1002)
Q Consensus       194 L~Ls~N~--~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~N-------~l~~~~~~~l~~l~~  263 (1002)
                      |++++|.  +....++..+.++++|++|++++| .+. .++..+..+++|++|+++.+       .+.+ ++..+.++++
T Consensus       189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~  266 (594)
T 2p1m_B          189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKE  266 (594)
T ss_dssp             EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTT
T ss_pred             EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCC
Confidence            7777664  100011111233466666666666 333 25555556666666664333       2222 1223444444


Q ss_pred             eeee-eccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcC-CcccCCCcccchhccc
Q 001867          264 VVQI-ELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSL-PATIADSPGLYELRLF  341 (1002)
Q Consensus       264 L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~  341 (1002)
                      |+.| .+.+... +.++..+..+++|+.|++++|.+                       ++.. +..+..+++|++|+++
T Consensus       267 L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l-----------------------~~~~l~~~~~~~~~L~~L~l~  322 (594)
T 2p1m_B          267 LRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATV-----------------------QSYDLVKLLCQCPKLQRLWVL  322 (594)
T ss_dssp             CCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCC-----------------------CHHHHHHHHTTCTTCCEEEEE
T ss_pred             cccccCCcccch-hhHHHHHHhhCCCCEEEccCCCC-----------------------CHHHHHHHHhcCCCcCEEeCc
Confidence            4444 2222111 12222223344444444444443                       3211 1112344444444444


Q ss_pred             ccccCCC-CCCCCCCCCCCceEEcc---------CccccCCCChhhh-ccCcccceeeeccccccCCCCcCc-CCCCCcE
Q 001867          342 RNRLNGT-LPGDLGKNSPLRWVDLS---------NNQFTGEIPASLC-EKGELEELLMIYNSFTGQLPDGLG-HCQSLTR  409 (1002)
Q Consensus       342 ~N~l~~~-~p~~~~~l~~L~~L~Ls---------~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~  409 (1002)
                      +| +... ++.....+++|+.|+++         .|.+++.....+. .+++|+.|.+..|.+++..+..+. .+++|+.
T Consensus       323 ~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~  401 (594)
T 2p1m_B          323 DY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR  401 (594)
T ss_dssp             GG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCE
T ss_pred             Cc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcce
Confidence            44 2110 00011124445555552         2333322222222 244555555544544433333232 3445555


Q ss_pred             EEccCccccCCCCCcCCCCCcceEEEcccCcccCc-----cccccccCCcccEEEccCCcCCCCCcccccc-cccccccc
Q 001867          410 VRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGE-----ISKNIAGAANLSLLIISKNNLSGSLPEEIGF-LKSLVVLS  483 (1002)
Q Consensus       410 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~  483 (1002)
                      |+|+.|...+                  -|.++..     ++..+..+++|+.|++++ .+++..+..++. +++|+.|+
T Consensus       402 L~L~~~~~~~------------------~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~  462 (594)
T 2p1m_B          402 FRLCIIEPKA------------------PDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLS  462 (594)
T ss_dssp             EEEEESSTTC------------------CCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEE
T ss_pred             eEeecccCCC------------------cccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEee
Confidence            5554110000                  0223211     111244566777777765 555444445554 67777777


Q ss_pred             ccccccCCCCcccc-cccccCCeeecCCCcCCccccc-ccccccccccccccCcccccCCCCCc-cccccccEEeCccee
Q 001867          484 GSENKFTGSLPESL-TNLAELGSLDLHANDLSGELPS-SVSSWKKLNELNLADNLFYGNIPEDI-GNLSVLNYLDLSNNR  560 (1002)
Q Consensus       484 Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~ip~~~-~~l~~L~~L~Ls~N~  560 (1002)
                      |++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|.++..-...+ ..+++|+...+..+.
T Consensus       463 L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          463 VAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             EESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred             ccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence            77777765444444 5577788888888887654443 34557788888888887754333334 346677666666554


Q ss_pred             e
Q 001867          561 L  561 (1002)
Q Consensus       561 l  561 (1002)
                      -
T Consensus       543 ~  543 (594)
T 2p1m_B          543 A  543 (594)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.5e-25  Score=242.67  Aligned_cols=207  Identities=22%  Similarity=0.203  Sum_probs=135.7

Q ss_pred             ccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccC
Q 001867          383 LEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISK  462 (1002)
Q Consensus       383 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~  462 (1002)
                      |++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..+.++++|+.|++++
T Consensus        30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~  109 (276)
T 2z62_A           30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE  109 (276)
T ss_dssp             CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence            44444444444444444455555555555555555555555555556666666666666555555666666666666666


Q ss_pred             CcCCCCCccccccccccccccccccccCCC-CcccccccccCCeeecCCCcCCcccccccccccccc----cccccCccc
Q 001867          463 NNLSGSLPEEIGFLKSLVVLSGSENKFTGS-LPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLN----ELNLADNLF  537 (1002)
Q Consensus       463 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l  537 (1002)
                      |++.+..+..++.+++|+.|++++|++++. +|..+..+++|++|+|++|++++..+..+..+++|+    .|++++|.+
T Consensus       110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l  189 (276)
T 2z62_A          110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM  189 (276)
T ss_dssp             SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCC
T ss_pred             CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcc
Confidence            666655555667777777777777777653 577777777788888888877777777777777776    677888888


Q ss_pred             ccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCCh
Q 001867          538 YGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPS  590 (1002)
Q Consensus       538 ~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~  590 (1002)
                      ++ +|.......+|++|+|++|++++..+..+..+ +|+.|+|++|++++..|.
T Consensus       190 ~~-~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  242 (276)
T 2z62_A          190 NF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  242 (276)
T ss_dssp             CE-ECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred             cc-cCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence            74 44444444578888888888886655556666 688888888888877764

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=2e-25  Score=241.82  Aligned_cols=209  Identities=22%  Similarity=0.147  Sum_probs=168.7

Q ss_pred             CCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEc
Q 001867          357 SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLEL  436 (1002)
Q Consensus       357 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  436 (1002)
                      ++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|.++++|++|+|++|++++..+..|.++++|+.|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            35677777777777666666777777777777777777666667777888888888888887777777888888888888


Q ss_pred             ccCcccCccccccccCCcccEEEccCCcCCCC-CccccccccccccccccccccCCCCcccccccccCC----eeecCCC
Q 001867          437 TDNFLSGEISKNIAGAANLSLLIISKNNLSGS-LPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELG----SLDLHAN  511 (1002)
Q Consensus       437 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N  511 (1002)
                      ++|.+.+..+..+..+++|+.|++++|++++. +|..++.+++|+.|++++|++++..+..+..+++|+    .|++++|
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n  187 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence            88888877777788888888888888888763 588888999999999999999877777888888887    8999999


Q ss_pred             cCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccC
Q 001867          512 DLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIP  566 (1002)
Q Consensus       512 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip  566 (1002)
                      ++++..+..+.. .+|+.|+|++|.+++..+..+..+++|+.|+|++|++++..|
T Consensus       188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             cccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            999776666655 489999999999996666667899999999999999998665

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=6.9e-26  Score=267.17  Aligned_cols=194  Identities=14%  Similarity=0.195  Sum_probs=150.1

Q ss_pred             CcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          686 DEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      ...+.||+|+||.||+|.. .++.+|+|+......         ...........+++.+|++++++++||||+++..++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~---------~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  408 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGY---------RDERLDENIRKSRTAREARYLALVKDFGIPAPYIFD  408 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTT---------SCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccc---------cchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEE
Confidence            3467899999999999954 478899998743211         111222334466789999999999999999766666


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      ...+..|+||||+++++|.++++.          +..++.|++.||+|||++   +|+||||||+||+++.  .+||+||
T Consensus       409 ~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DF  473 (540)
T 3en9_A          409 VDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDF  473 (540)
T ss_dssp             EETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCC
T ss_pred             EeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEEC
Confidence            677788999999999999999974          568999999999999999   9999999999999998  9999999


Q ss_pred             cCcccccCCCCCc-----ccccccccccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 001867          846 GVAKVVDASGKPK-----SMSVIAGSCGYIAPEYAYT--LRVNEKSDIYSFGVVILELVTGRLPVD  904 (1002)
Q Consensus       846 Gl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~ell~g~~p~~  904 (1002)
                      |+++.........     ......||+.|||||++..  ..|+.++|+|+..+-..+-+.++.+|.
T Consensus       474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9999875432111     1235679999999999887  568888999999999999888777663

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=1.8e-29  Score=305.54  Aligned_cols=404  Identities=17%  Similarity=0.141  Sum_probs=177.1

Q ss_pred             CccccCcccccccccccccC---CCCcc------------ccccCCccccccccccccCCCCcccc-cccccceeeeccc
Q 001867          112 DISACQNLQHLDLSQNLLTG---TLTPA------------LADLPNLKFLDLTGNNFSGDIPESFG-RFQKLEVISLVYN  175 (1002)
Q Consensus       112 ~~~~l~~L~~L~Ls~N~l~~---~~~~~------------~~~L~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N  175 (1002)
                      .+..+++|++|+|+++....   ..|..            +..+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus        61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~  140 (594)
T 2p1m_B           61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC  140 (594)
T ss_dssp             HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred             HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence            35556777777777764221   11111            12345566666666655544444443 4555555555555


Q ss_pred             -cccCc-cccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccccccccccc----ccccccchhcccCcc
Q 001867          176 -LLDGT-IPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSL----GRLAKLVDLDLALNN  249 (1002)
Q Consensus       176 -~l~~~-~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~----~~l~~L~~L~L~~N~  249 (1002)
                       .++.. ++..+.++++|++|+|++|.                         +++..+..+    ..+++|++|++++|.
T Consensus       141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~-------------------------i~~~~~~~l~~~~~~~~~L~~L~l~~~~  195 (594)
T 2p1m_B          141 EGFSTDGLAAIAATCRNLKELDLRESD-------------------------VDDVSGHWLSHFPDTYTSLVSLNISCLA  195 (594)
T ss_dssp             EEEEHHHHHHHHHHCTTCCEEECTTCE-------------------------EECCCGGGGGGSCTTCCCCCEEECTTCC
T ss_pred             CCCCHHHHHHHHHhCCCCCEEeCcCCc-------------------------cCCcchHHHHHHhhcCCcCcEEEecccC
Confidence             33321 23333345555555555554                         332222222    133455555555544


Q ss_pred             --ccc-ccCcccccccceeeeeccCC-cccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcC
Q 001867          250 --LVG-AIPSSLTELASVVQIELYNN-SLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSL  325 (1002)
Q Consensus       250 --l~~-~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~  325 (1002)
                        +.. .++..+..+++|+.|++++| .+. .++..+..+++|+.|+++.+..                +++.|.+.+ +
T Consensus       196 ~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~----------------~~~~~~~~~-l  257 (594)
T 2p1m_B          196 SEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTA----------------EVRPDVYSG-L  257 (594)
T ss_dssp             SCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCC----------------CCCHHHHHH-H
T ss_pred             CcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccC----------------ccchhhHHH-H
Confidence              110 01111223455556666555 222 2444555566666666544321                012222222 2


Q ss_pred             CcccCCCcccchh-cccccccCCCCCCCCCCCCCCceEEccCccccCCCCh-hhhccCcccceeeecccccc-CCCCcCc
Q 001867          326 PATIADSPGLYEL-RLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPA-SLCEKGELEELLMIYNSFTG-QLPDGLG  402 (1002)
Q Consensus       326 p~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~-~~p~~l~  402 (1002)
                      +..+.++++|+.| .+.+... +.++..+..+++|+.|+|++|.+++.... .+..+++|++|++++| ++. .++....
T Consensus       258 ~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~  335 (594)
T 2p1m_B          258 SVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAS  335 (594)
T ss_dssp             HHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHH
T ss_pred             HHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHH
Confidence            2244555555555 2222111 12222233456777777777776543222 2345667777777766 331 1222223


Q ss_pred             CCCCCcEEEccC---------ccccCCCCCcC-CCCCcceEEEcccCcccCccccccc-cCCcccEEEcc--C----CcC
Q 001867          403 HCQSLTRVRLGY---------NRLTGKVPPLL-WGLPHVYLLELTDNFLSGEISKNIA-GAANLSLLIIS--K----NNL  465 (1002)
Q Consensus       403 ~l~~L~~L~L~~---------N~l~~~~p~~~-~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls--~----N~l  465 (1002)
                      .+++|++|++++         |.+++.....+ .++++|+.|+++.|.+++.....+. .+++|+.|+++  +    |++
T Consensus       336 ~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l  415 (594)
T 2p1m_B          336 TCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYL  415 (594)
T ss_dssp             HCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTT
T ss_pred             hCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccc
Confidence            466777777733         33332111111 1245555555555555444333333 34555555555  2    333


Q ss_pred             CCCC-----ccccccccccccccccccccCCCCcccccc-cccCCeeecCCCcCCccccccc-ccccccccccccCcccc
Q 001867          466 SGSL-----PEEIGFLKSLVVLSGSENKFTGSLPESLTN-LAELGSLDLHANDLSGELPSSV-SSWKKLNELNLADNLFY  538 (1002)
Q Consensus       466 ~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~  538 (1002)
                      ++..     +..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.++
T Consensus       416 ~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          416 TLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             TCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred             cCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence            3111     11133344444444443 333322223322 4444444444444443333332 33444444444444443


Q ss_pred             cCCCC-CccccccccEEeCcceee
Q 001867          539 GNIPE-DIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       539 ~~ip~-~~~~l~~L~~L~Ls~N~l  561 (1002)
                      +..+. .+..+++|++|+|++|++
T Consensus       495 ~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          495 DKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHHHHHHhCCCCCEEeeeCCCC
Confidence            22222 122344444444444444

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.7e-25  Score=241.55  Aligned_cols=182  Identities=23%  Similarity=0.217  Sum_probs=100.5

Q ss_pred             cCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccc
Q 001867          402 GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVV  481 (1002)
Q Consensus       402 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  481 (1002)
                      ..+++|++|++++|++++.  ..+..+++|++|++++|.+++..+..+..+++|+.|++++|++++..|..++.+++|+.
T Consensus        60 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  137 (272)
T 3rfs_A           60 QYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY  137 (272)
T ss_dssp             GGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence            3444444444444444431  23444444444444444444444444455555555555555555444444555555666


Q ss_pred             ccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceee
Q 001867          482 LSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       482 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      |++++|++++..+..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|.+++..|..++.+++|++|+|++|++
T Consensus       138 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  217 (272)
T 3rfs_A          138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  217 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence            66666655554444555666666666666666655555566666666666666666655555566666666666666666


Q ss_pred             ecccCCcccccccceEEeccccCcCCCChh
Q 001867          562 SGRIPVGLQNLKLNQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       562 ~~~ip~~~~~l~L~~l~ls~N~l~g~~p~~  591 (1002)
                      ++..|      .++.|+++.|.++|.+|..
T Consensus       218 ~~~~~------~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          218 DCTCP------GIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CCCTT------TTHHHHHHHHHTGGGBBCT
T ss_pred             cccCc------HHHHHHHHHHhCCCcccCc
Confidence            65444      2455566666666666643

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=3.1e-24  Score=231.38  Aligned_cols=201  Identities=22%  Similarity=0.216  Sum_probs=105.7

Q ss_pred             CceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEccc
Q 001867          359 LRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTD  438 (1002)
Q Consensus       359 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  438 (1002)
                      .+.+++++|+++ .+|..+.  +++++|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|++++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            455666666655 3343322  3445555555555544444555566666666666666554444455555555555555


Q ss_pred             CcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccc
Q 001867          439 NFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELP  518 (1002)
Q Consensus       439 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  518 (1002)
                      |.+.+..+..+..+++|+.|++++|++++..|..++.+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            55555444445555555555555555554444445555555555555555554333445555555555555555555444


Q ss_pred             cccccccccccccccCcccccCCCCCccccccccEEeCcceeee
Q 001867          519 SSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       519 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      ..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|++.
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            44555555555555555555333334455555555555555544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=7.8e-25  Score=236.29  Aligned_cols=187  Identities=20%  Similarity=0.141  Sum_probs=110.3

Q ss_pred             hhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCccc
Q 001867          377 LCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLS  456 (1002)
Q Consensus       377 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  456 (1002)
                      +..+++|++|++++|.+++.  ..+..+++|++|+|++|++++..+..|..+++|+.|++++|++++..+..+..+++|+
T Consensus        59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  136 (272)
T 3rfs_A           59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT  136 (272)
T ss_dssp             GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence            33344444444444444331  2344555555555555555555555555555555555555555555555555566666


Q ss_pred             EEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcc
Q 001867          457 LLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNL  536 (1002)
Q Consensus       457 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  536 (1002)
                      .|++++|++++..|..++.+++|+.|++++|++++..+..+..+++|+.|+|++|++++..|..++.+++|+.|+|++|.
T Consensus       137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  216 (272)
T 3rfs_A          137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  216 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence            66666666665555555666666666666666665555556666666666666666666666666666667777777666


Q ss_pred             cccCCCCCccccccccEEeCcceeeecccCCccccc
Q 001867          537 FYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL  572 (1002)
Q Consensus       537 l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l  572 (1002)
                      +.+.       +++|+.|+++.|+++|.+|..++.+
T Consensus       217 ~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          217 WDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             BCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             cccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence            6543       3356666777777777777666554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=7.1e-24  Score=230.60  Aligned_cols=133  Identities=31%  Similarity=0.267  Sum_probs=69.0

Q ss_pred             cCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccc
Q 001867          451 GAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNEL  530 (1002)
Q Consensus       451 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  530 (1002)
                      .+++|+.|++++|+++ .+|..+..+++|+.|++++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|
T Consensus        75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  153 (290)
T 1p9a_G           75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL  153 (290)
T ss_dssp             CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence            3444444555555444 444445555555555555555554444455555555555555555555545555555555555


Q ss_pred             cccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCc
Q 001867          531 NLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLS  585 (1002)
Q Consensus       531 ~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~  585 (1002)
                      +|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+... +|+.|+|++|++.
T Consensus       154 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            55555555333333445555555555555555 344444333 4555555555554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=9.8e-24  Score=229.49  Aligned_cols=203  Identities=23%  Similarity=0.186  Sum_probs=139.8

Q ss_pred             CCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcce
Q 001867          353 LGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVY  432 (1002)
Q Consensus       353 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  432 (1002)
                      +..+++++.+++++|.++ .+|..+.  ++++.|++++|.+++..+..|.++++|++|+|++|++++..+.  ..+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            455666777777777777 4444443  4677777777777766666777777777777777777654332  5667777


Q ss_pred             EEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCc
Q 001867          433 LLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAND  512 (1002)
Q Consensus       433 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  512 (1002)
                      .|+|++|+++ .+|..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            7777777776 445566667777777777777776555667777777777777777776555666677777777777777


Q ss_pred             CCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeee
Q 001867          513 LSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       513 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      |++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            77665566677777777777777776 66777777777777777777765

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=3.6e-24  Score=235.93  Aligned_cols=223  Identities=21%  Similarity=0.223  Sum_probs=174.4

Q ss_pred             CCceEEccCccccCCCCh---hhhccCcccceeeeccccccCCCCcC--cCCCCCcEEEccCccccCCCC----CcCCCC
Q 001867          358 PLRWVDLSNNQFTGEIPA---SLCEKGELEELLMIYNSFTGQLPDGL--GHCQSLTRVRLGYNRLTGKVP----PLLWGL  428 (1002)
Q Consensus       358 ~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~l~~N~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l  428 (1002)
                      .++.+.+.++.++...-.   .+..+++|++|++++|.+++..|..+  ..+++|++|+|++|++++..+    ..++.+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            466677776666522111   12234568888888888888888877  888888888888888887655    345578


Q ss_pred             CcceEEEcccCcccCccccccccCCcccEEEccCCcCCCC--C--ccccccccccccccccccccCCCCcc----ccccc
Q 001867          429 PHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGS--L--PEEIGFLKSLVVLSGSENKFTGSLPE----SLTNL  500 (1002)
Q Consensus       429 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l  500 (1002)
                      ++|++|+|++|.+.+..+..+..+++|+.|+|++|++.+.  +  +..++.+++|++|+|++|+++ .+|.    .++.+
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l  223 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG  223 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence            8888888888888888888888888999999999987642  2  234578899999999999997 4444    35778


Q ss_pred             ccCCeeecCCCcCCcccccccccc---cccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccce
Q 001867          501 AELGSLDLHANDLSGELPSSVSSW---KKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQ  576 (1002)
Q Consensus       501 ~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~  576 (1002)
                      ++|++|||++|++++..|..+..+   ++|+.|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+ +|+.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~  298 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN  298 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence            999999999999998888888777   69999999999999 7888875  7999999999999963 43 4556 7999


Q ss_pred             EEeccccCcC
Q 001867          577 LNVSNNRLSG  586 (1002)
Q Consensus       577 l~ls~N~l~g  586 (1002)
                      |+|++|+|+.
T Consensus       299 L~L~~N~l~~  308 (310)
T 4glp_A          299 LTLDGNPFLV  308 (310)
T ss_dssp             EECSSTTTSC
T ss_pred             EECcCCCCCC
Confidence            9999999874

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=8.3e-26  Score=252.44  Aligned_cols=264  Identities=20%  Similarity=0.262  Sum_probs=193.0

Q ss_pred             CCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCC--CCCCEEeccCCCCCCCCCCCccccCcccccccccccccCC-
Q 001867           56 PCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRL--ENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT-  132 (1002)
Q Consensus        56 ~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-  132 (1002)
                      |++|+++.|++.  .++.+|++++++.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. 
T Consensus        36 c~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~  109 (336)
T 2ast_B           36 CKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST  109 (336)
T ss_dssp             CHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred             HHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence            558999988743  4678999998876   5667777  8999999999999887665 55789999999999998865 


Q ss_pred             CCccccccCCccccccccccccCCCCcccccccccceeeeccc-cccCc-cccccccccccccccccCC-CCCCCCCCcc
Q 001867          133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN-LLDGT-IPAFLGNISTLKMLNLSYN-PFLPGRIPPE  209 (1002)
Q Consensus       133 ~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~Ls~N-~~~~~~~p~~  209 (1002)
                      ++..+..+++|++|+|++|++++..|..|+.+++|++|+|++| .+++. ++..+.++++|++|++++| .+....++..
T Consensus       110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~  189 (336)
T 2ast_B          110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA  189 (336)
T ss_dssp             HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred             HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence            7777888999999999999988888888888999999999998 67753 6777888889999999988 6532235666


Q ss_pred             cCCCC-ccchhhccCc--ccc-cccccccccccccchhcccCcc-cccccCcccccccceeeeeccCCc-ccCCCCCccc
Q 001867          210 LGNLT-NLEILWLTEC--NLV-GEIPDSLGRLAKLVDLDLALNN-LVGAIPSSLTELASVVQIELYNNS-LTGDLPTGWS  283 (1002)
Q Consensus       210 ~~~l~-~L~~L~L~~n--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~  283 (1002)
                      +..++ +|++|++++|  .++ +.+|..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +.......+.
T Consensus       190 ~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~  269 (336)
T 2ast_B          190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG  269 (336)
T ss_dssp             HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGG
T ss_pred             HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHh
Confidence            77788 8888888888  444 4556677778888888888887 666667777777888888888874 2222222466


Q ss_pred             cccccceeeccccccCCCCCccCCCC--CcceeecCCCcccCcCCccc
Q 001867          284 NLTSLRLLDASMNDLTGPIPDDLTRL--PLESLNLYENRLEGSLPATI  329 (1002)
Q Consensus       284 ~l~~L~~L~Ls~N~l~~~~p~~~~~~--~L~~L~L~~N~l~~~~p~~~  329 (1002)
                      ++++|+.|++++| ++.   ..+..+  .+..|++++|++++..|..+
T Consensus       270 ~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~  313 (336)
T 2ast_B          270 EIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTI  313 (336)
T ss_dssp             GCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred             cCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcc
Confidence            7777777777777 321   112221  14444555555554444443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=4.6e-23  Score=219.64  Aligned_cols=158  Identities=19%  Similarity=0.182  Sum_probs=77.9

Q ss_pred             CCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccccccc
Q 001867          406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGS  485 (1002)
Q Consensus       406 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  485 (1002)
                      +|+.|+|++|++++..+..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..+..++.+++|+.|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            45555555555554444445445555555555554444444444444555555555555544444444444555555555


Q ss_pred             ccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeec
Q 001867          486 ENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       486 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      +|+|++..+..|..+++|+.|+|++|+|++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|++++
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            555544333344445555555555555554444445555555555555555554444444455555555555555543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=3.8e-25  Score=249.43  Aligned_cols=253  Identities=19%  Similarity=0.174  Sum_probs=137.2

Q ss_pred             ecCCCcccCcCCcccCCCcccchhcccccccCCCCC----CCCCCCC-CCceEEccCccccCCCChhhhcc-----Cccc
Q 001867          315 NLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLP----GDLGKNS-PLRWVDLSNNQFTGEIPASLCEK-----GELE  384 (1002)
Q Consensus       315 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~  384 (1002)
                      .++.|.+++.+|..+...++|++|+|++|++++..+    ..+..++ +|++|+|++|++++..+..++.+     ++|+
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            334444444444444333444444444444443333    3344444 56666666666665555555554     5556


Q ss_pred             ceeeeccccccCCCCcCc----CC-CCCcEEEccCccccCCCCCcC----CC-CCcceEEEcccCcccCccccc----cc
Q 001867          385 ELLMIYNSFTGQLPDGLG----HC-QSLTRVRLGYNRLTGKVPPLL----WG-LPHVYLLELTDNFLSGEISKN----IA  450 (1002)
Q Consensus       385 ~L~l~~N~l~~~~p~~l~----~l-~~L~~L~L~~N~l~~~~p~~~----~~-l~~L~~L~L~~N~i~~~~~~~----~~  450 (1002)
                      +|++++|.+++..+..+.    .+ ++|++|+|++|++++..+..+    .. .++|+.|+|++|.+++.....    +.
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~  163 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA  163 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence            666666655554444332    22 566666666666665444332    22 246666666666666433222    23


Q ss_pred             cCC-cccEEEccCCcCCCCCccccccc-----cccccccccccccCCC----Cccccccc-ccCCeeecCCCcCCcccc-
Q 001867          451 GAA-NLSLLIISKNNLSGSLPEEIGFL-----KSLVVLSGSENKFTGS----LPESLTNL-AELGSLDLHANDLSGELP-  518 (1002)
Q Consensus       451 ~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l~~~~p-  518 (1002)
                      ... +|+.|+|++|++++..+..++..     ++|+.|+|++|++++.    ++..+..+ ++|+.|||++|++++..+ 
T Consensus       164 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  243 (362)
T 3goz_A          164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE  243 (362)
T ss_dssp             TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred             cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence            333 67777777777765555444433     4677777777776642    34444442 467777777777765544 


Q ss_pred             ---cccccccccccccccCccccc-------CCCCCccccccccEEeCcceeeecccCC
Q 001867          519 ---SSVSSWKKLNELNLADNLFYG-------NIPEDIGNLSVLNYLDLSNNRLSGRIPV  567 (1002)
Q Consensus       519 ---~~~~~l~~L~~L~Ls~N~l~~-------~ip~~~~~l~~L~~L~Ls~N~l~~~ip~  567 (1002)
                         ..+..+++|+.|+|++|.+.+       .++..+.++++|++|||++|++.+..|.
T Consensus       244 ~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~  302 (362)
T 3goz_A          244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI  302 (362)
T ss_dssp             HHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred             HHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence               234555667777777776432       2334556666677777777776655443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=2.3e-23  Score=228.83  Aligned_cols=194  Identities=24%  Similarity=0.296  Sum_probs=140.7

Q ss_pred             CCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceE
Q 001867          354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL  433 (1002)
Q Consensus       354 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  433 (1002)
                      ..+++|+.|++++|.++. ++ .+..+++|++|++++|.+++..+  +..+++|++|+|++|++++.  ..+..+++|+.
T Consensus        38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~  111 (308)
T 1h6u_A           38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT  111 (308)
T ss_dssp             HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred             HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence            345566666666666663 33 45666666666666666664433  67777777777777777653  25677777777


Q ss_pred             EEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcC
Q 001867          434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL  513 (1002)
Q Consensus       434 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  513 (1002)
                      |++++|.+++..+  +..+++|+.|++++|++++..+  ++.+++|+.|++++|++++ ++. +..+++|+.|+|++|++
T Consensus       112 L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             EECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCC
T ss_pred             EECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCcc
Confidence            7777777776432  7777888888888888875433  7788888888888888885 333 78888888888888888


Q ss_pred             CcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeec
Q 001867          514 SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       514 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      ++..+  +..+++|+.|+|++|++++..  .+..+++|+.|+|++|++++
T Consensus       186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          186 SDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             CcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            86554  788888888888888888544  37888888888888888875

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=7.7e-23  Score=217.88  Aligned_cols=209  Identities=21%  Similarity=0.211  Sum_probs=175.2

Q ss_pred             CCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccc
Q 001867          405 QSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSG  484 (1002)
Q Consensus       405 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  484 (1002)
                      .+.++++++++.++ .+|..+.  ++++.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            45788999999998 5665554  68999999999999999999999999999999999999888888999999999999


Q ss_pred             cccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecc
Q 001867          485 SENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGR  564 (1002)
Q Consensus       485 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~  564 (1002)
                      ++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..++.+++|++|+|++|++++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            99999987788899999999999999999988888899999999999999999976677899999999999999999988


Q ss_pred             cCCccccc-ccceEEeccccCcCCCChh-hhhhc------ccccccCCCCCCCCCCC-CCCC
Q 001867          565 IPVGLQNL-KLNQLNVSNNRLSGELPSL-FAKEM------YRNSFLGNPGLCGDLEG-LCDG  617 (1002)
Q Consensus       565 ip~~~~~l-~L~~l~ls~N~l~g~~p~~-~~~~~------~~~~~~~n~~~cg~~~~-~c~~  617 (1002)
                      .|..+..+ +|+.|+|++|++++..... .....      ......|| .+|+.+.. .|..
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~C~~  231 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGTGQ-NLHESPDGVTCSD  231 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHHHHSGGGBCC--------CCGGGCBBTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCCccccHHHHHHHHhcccceeeccCc-ccccCCCcCccCC
Confidence            88788888 8999999999999875433 22111      11223344 36776654 7764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=2.5e-23  Score=229.23  Aligned_cols=205  Identities=19%  Similarity=0.162  Sum_probs=132.4

Q ss_pred             cccchhcccccccCCCCCCCC--CCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEE
Q 001867          333 PGLYELRLFRNRLNGTLPGDL--GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRV  410 (1002)
Q Consensus       333 ~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L  410 (1002)
                      ++|++|++++|++.+..|..+  ..+++|++|+|++|++++..+..-                    ...+..+++|++|
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~--------------------~~~~~~~~~L~~L  150 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLA--------------------ELQQWLKPGLKVL  150 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHH--------------------HHHTTBCSCCCEE
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhH--------------------HHHhhhccCCCEE
Confidence            446666666666666666555  556666666666666654333100                    0122345556666


Q ss_pred             EccCccccCCCCCcCCCCCcceEEEcccCcccCc--c--ccccccCCcccEEEccCCcCCCCCcc----ccccccccccc
Q 001867          411 RLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGE--I--SKNIAGAANLSLLIISKNNLSGSLPE----EIGFLKSLVVL  482 (1002)
Q Consensus       411 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~--~--~~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L  482 (1002)
                      +|++|++++..|..|..+++|++|+|++|++.+.  .  +..+..+++|+.|+|++|+++ .+|.    .++.+++|+.|
T Consensus       151 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L  229 (310)
T 4glp_A          151 SIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSL  229 (310)
T ss_dssp             EEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSE
T ss_pred             EeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEE
Confidence            6666666555555566666666666666665432  1  122356677777777777776 3333    24667888888


Q ss_pred             cccccccCCCCccccccc---ccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcce
Q 001867          483 SGSENKFTGSLPESLTNL---AELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNN  559 (1002)
Q Consensus       483 ~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N  559 (1002)
                      +|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|++++ +|. +..+++|+.|+|++|
T Consensus       230 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~-~~~-~~~l~~L~~L~L~~N  304 (310)
T 4glp_A          230 DLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR-APQ-PDELPEVDNLTLDGN  304 (310)
T ss_dssp             ECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS-CCC-TTSCCCCSCEECSST
T ss_pred             ECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC-Cch-hhhCCCccEEECcCC
Confidence            888888887767777666   58888888888888 5676664  788888888888885 344 677888888999988


Q ss_pred             eeec
Q 001867          560 RLSG  563 (1002)
Q Consensus       560 ~l~~  563 (1002)
                      +++.
T Consensus       305 ~l~~  308 (310)
T 4glp_A          305 PFLV  308 (310)
T ss_dssp             TTSC
T ss_pred             CCCC
Confidence            8863

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=2.4e-23  Score=220.09  Aligned_cols=178  Identities=15%  Similarity=0.187  Sum_probs=112.6

Q ss_pred             CCCEEeccCCCCCCCCCCCccccCccccccccccc-ccCCCCccccccCCcccccccc-ccccCCCCcccccccccceee
Q 001867           94 NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNL-LTGTLTPALADLPNLKFLDLTG-NNFSGDIPESFGRFQKLEVIS  171 (1002)
Q Consensus        94 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~  171 (1002)
                      +|++|+|++|+++++.+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            78889999988888777788888888888888886 8766666788888888888887 888866667788888888888


Q ss_pred             eccccccCccccccccccccc---cccccCC-CCCCCCCCcccCCCCccc-hhhccCcccccccccccccccccchhccc
Q 001867          172 LVYNLLDGTIPAFLGNISTLK---MLNLSYN-PFLPGRIPPELGNLTNLE-ILWLTECNLVGEIPDSLGRLAKLVDLDLA  246 (1002)
Q Consensus       172 L~~N~l~~~~p~~l~~l~~L~---~L~Ls~N-~~~~~~~p~~~~~l~~L~-~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  246 (1002)
                      +++|++++ +|. ++++++|+   +|++++| .+ ....+..|.++++|+ +|++++|+++...+..|.. ++|++|+++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l-~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~  187 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYM-TSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN  187 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTC-CEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcch-hhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence            88888875 444 66666665   6666666 43 112222345555555 5555555554222222222 444444444


Q ss_pred             Ccc-cccccCcccccc-cceeeeeccCCccc
Q 001867          247 LNN-LVGAIPSSLTEL-ASVVQIELYNNSLT  275 (1002)
Q Consensus       247 ~N~-l~~~~~~~l~~l-~~L~~L~L~~N~l~  275 (1002)
                      +|+ +++..+..|.++ ++|+.|++++|+++
T Consensus       188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             TCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            442 443333444444 44444444444444

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=5.2e-25  Score=248.31  Aligned_cols=254  Identities=20%  Similarity=0.140  Sum_probs=207.6

Q ss_pred             hcccccccCCCCCCCCCCCCCCceEEccCccccCCCC----hhhhccC-cccceeeeccccccCCCCcCcCC-----CCC
Q 001867          338 LRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIP----ASLCEKG-ELEELLMIYNSFTGQLPDGLGHC-----QSL  407 (1002)
Q Consensus       338 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l-----~~L  407 (1002)
                      +.+++|.+++.+|..+...++|++|||++|++++..+    ..+..++ +|++|++++|.+++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            5688999999888888888889999999999998777    7778888 89999999999998888888775     999


Q ss_pred             cEEEccCccccCCCCCcCC----CC-CcceEEEcccCcccCcccccccc-----CCcccEEEccCCcCCCCCccc----c
Q 001867          408 TRVRLGYNRLTGKVPPLLW----GL-PHVYLLELTDNFLSGEISKNIAG-----AANLSLLIISKNNLSGSLPEE----I  473 (1002)
Q Consensus       408 ~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~p~~----~  473 (1002)
                      ++|+|++|++++..+..+.    .+ ++|+.|+|++|.+++..+..+..     .++|+.|+|++|++++..+..    +
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            9999999999987776443    34 89999999999999887766543     369999999999999654443    4


Q ss_pred             cccc-ccccccccccccCCCCccccccc-----ccCCeeecCCCcCCcc----cccccccc-cccccccccCcccccCCC
Q 001867          474 GFLK-SLVVLSGSENKFTGSLPESLTNL-----AELGSLDLHANDLSGE----LPSSVSSW-KKLNELNLADNLFYGNIP  542 (1002)
Q Consensus       474 ~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l~~~ip  542 (1002)
                      ..++ +|+.|+|++|++++..+..+...     ++|++|||++|.+++.    ++..+..+ ++|+.|+|++|.+++..+
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  242 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL  242 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred             hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence            4555 99999999999998777655544     6999999999999973    55566654 599999999999986544


Q ss_pred             ----CCccccccccEEeCcceeeeccc-------CCccccc-ccceEEeccccCcCCCChh
Q 001867          543 ----EDIGNLSVLNYLDLSNNRLSGRI-------PVGLQNL-KLNQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       543 ----~~~~~l~~L~~L~Ls~N~l~~~i-------p~~~~~l-~L~~l~ls~N~l~g~~p~~  591 (1002)
                          ..+..+++|++|+|++|++++..       +..+..+ +|+.||+++|++.+..|..
T Consensus       243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~  303 (362)
T 3goz_A          243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP  303 (362)
T ss_dssp             HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHH
T ss_pred             HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHH
Confidence                34567899999999999955433       3345556 6999999999998776644

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=1.9e-25  Score=254.44  Aligned_cols=236  Identities=25%  Similarity=0.295  Sum_probs=171.7

Q ss_pred             CCCCCCceEEccCccccCCCChh----hhccCcccceeeecc---ccccCCCCcC-------cCCCCCcEEEccCccccC
Q 001867          354 GKNSPLRWVDLSNNQFTGEIPAS----LCEKGELEELLMIYN---SFTGQLPDGL-------GHCQSLTRVRLGYNRLTG  419 (1002)
Q Consensus       354 ~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~l~~N---~l~~~~p~~l-------~~l~~L~~L~L~~N~l~~  419 (1002)
                      ..+++|+.|+|++|++++..+..    +..+++|++|++++|   .+++.+|..+       ..+++|++|+|++|++++
T Consensus        29 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~  108 (386)
T 2ca6_A           29 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP  108 (386)
T ss_dssp             HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred             hcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCH
Confidence            33444455555555544332222    334445555555543   2333334333       577888888888888876


Q ss_pred             ----CCCCcCCCCCcceEEEcccCcccCcccccccc----C---------CcccEEEccCCcCC-CCCc---cccccccc
Q 001867          420 ----KVPPLLWGLPHVYLLELTDNFLSGEISKNIAG----A---------ANLSLLIISKNNLS-GSLP---EEIGFLKS  478 (1002)
Q Consensus       420 ----~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~----l---------~~L~~L~Ls~N~l~-~~~p---~~~~~l~~  478 (1002)
                          .+|..+..+++|+.|+|++|.+....+..+..    +         ++|+.|++++|+++ +.+|   ..+..+++
T Consensus       109 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~  188 (386)
T 2ca6_A          109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL  188 (386)
T ss_dssp             TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCC
Confidence                35667777888888888888886544444433    3         88999999999987 4455   46678889


Q ss_pred             cccccccccccC--C---CCcccccccccCCeeecCCCcCC----cccccccccccccccccccCcccccC----CCCCc
Q 001867          479 LVVLSGSENKFT--G---SLPESLTNLAELGSLDLHANDLS----GELPSSVSSWKKLNELNLADNLFYGN----IPEDI  545 (1002)
Q Consensus       479 L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----ip~~~  545 (1002)
                      |+.|++++|+++  |   ..|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|.+++.    +|..+
T Consensus       189 L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l  268 (386)
T 2ca6_A          189 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF  268 (386)
T ss_dssp             CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHH
T ss_pred             cCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHH
Confidence            999999999987  2   34447888999999999999996    67888899999999999999999865    56776


Q ss_pred             --cccccccEEeCcceeeec----ccCCcc-ccc-ccceEEeccccCcCCCC
Q 001867          546 --GNLSVLNYLDLSNNRLSG----RIPVGL-QNL-KLNQLNVSNNRLSGELP  589 (1002)
Q Consensus       546 --~~l~~L~~L~Ls~N~l~~----~ip~~~-~~l-~L~~l~ls~N~l~g~~p  589 (1002)
                        +.+++|+.|+|++|++++    .+|..+ .++ +|+.|+|++|++++..|
T Consensus       269 ~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          269 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             hhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence              448999999999999998    588877 556 79999999999998775

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=6.2e-23  Score=216.98  Aligned_cols=178  Identities=16%  Similarity=0.176  Sum_probs=83.3

Q ss_pred             CCceEEccCccccCCCChhhhccCcccceeeeccc-cccCCCCcCcCCCCCcEEEccC-ccccCCCCCcCCCCCcceEEE
Q 001867          358 PLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNS-FTGQLPDGLGHCQSLTRVRLGY-NRLTGKVPPLLWGLPHVYLLE  435 (1002)
Q Consensus       358 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~  435 (1002)
                      +|++|++++|++++..+..|..+++|++|++++|. +++..+..|.++++|++|++++ |++++..+..|.++++|+.|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            45556666665554444445445555555555553 4444444445555555555554 555444444444444444444


Q ss_pred             cccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc---ccccccc-ccCCCCcccccccccCC-eeecCC
Q 001867          436 LTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV---VLSGSEN-KFTGSLPESLTNLAELG-SLDLHA  510 (1002)
Q Consensus       436 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~  510 (1002)
                      +++|.+++                         +|. ++.+++|+   .|++++| ++++..+..|..+++|+ .|++++
T Consensus       112 l~~n~l~~-------------------------lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~  165 (239)
T 2xwt_C          112 IFNTGLKM-------------------------FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN  165 (239)
T ss_dssp             EEEECCCS-------------------------CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred             CCCCCCcc-------------------------ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence            44444443                         332 33333333   4444444 44433333444445555 555555


Q ss_pred             CcCCcccccccccccccccccccCcc-cccCCCCCcccc-ccccEEeCcceeee
Q 001867          511 NDLSGELPSSVSSWKKLNELNLADNL-FYGNIPEDIGNL-SVLNYLDLSNNRLS  562 (1002)
Q Consensus       511 N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~ip~~~~~l-~~L~~L~Ls~N~l~  562 (1002)
                      |+++...+..|.. ++|+.|+|++|. +++..+..+.++ ++|+.|+|++|+++
T Consensus       166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            5554222222333 455555555552 443333444555 55555555555555

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=9.9e-26  Score=256.84  Aligned_cols=240  Identities=23%  Similarity=0.273  Sum_probs=169.6

Q ss_pred             cccCCCcccchhcccccccCCC----CCCCCCCCCCCceEEccCc---cccCCCChhh-------hccCcccceeeeccc
Q 001867          327 ATIADSPGLYELRLFRNRLNGT----LPGDLGKNSPLRWVDLSNN---QFTGEIPASL-------CEKGELEELLMIYNS  392 (1002)
Q Consensus       327 ~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~l~~N~  392 (1002)
                      ..+..+++|++|+|++|+++..    ++..+..+++|++|+|++|   ++++.+|..+       ..+++|++|++++|.
T Consensus        26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~  105 (386)
T 2ca6_A           26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  105 (386)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence            3344444455555555554433    2223445566666666664   3334444444       456666666666666


Q ss_pred             ccc----CCCCcCcCCCCCcEEEccCccccCCCCCcCCC----C---------CcceEEEcccCccc-Cccc---ccccc
Q 001867          393 FTG----QLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWG----L---------PHVYLLELTDNFLS-GEIS---KNIAG  451 (1002)
Q Consensus       393 l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~----l---------~~L~~L~L~~N~i~-~~~~---~~~~~  451 (1002)
                      +++    .+|..+..+++|++|+|++|++++..+..+..    +         ++|+.|+|++|+++ +..+   ..+..
T Consensus       106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~  185 (386)
T 2ca6_A          106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS  185 (386)
T ss_dssp             CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence            665    35556667777777777777775433333332    2         77888888888876 2333   45667


Q ss_pred             CCcccEEEccCCcCCC-----CCccccccccccccccccccccC----CCCcccccccccCCeeecCCCcCCcc----cc
Q 001867          452 AANLSLLIISKNNLSG-----SLPEEIGFLKSLVVLSGSENKFT----GSLPESLTNLAELGSLDLHANDLSGE----LP  518 (1002)
Q Consensus       452 l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p  518 (1002)
                      +++|+.|++++|+++.     ..|..+..+++|+.|+|++|+++    +.+|..+..+++|+.|+|++|.+++.    +|
T Consensus       186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~  265 (386)
T 2ca6_A          186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV  265 (386)
T ss_dssp             CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred             CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHH
Confidence            8899999999998872     34447888999999999999996    57888899999999999999999876    56


Q ss_pred             cccc--cccccccccccCccccc----CCCCCc-cccccccEEeCcceeeecccC
Q 001867          519 SSVS--SWKKLNELNLADNLFYG----NIPEDI-GNLSVLNYLDLSNNRLSGRIP  566 (1002)
Q Consensus       519 ~~~~--~l~~L~~L~Ls~N~l~~----~ip~~~-~~l~~L~~L~Ls~N~l~~~ip  566 (1002)
                      ..+.  .+++|+.|+|++|.+++    .+|..+ .++++|++|+|++|++++..|
T Consensus       266 ~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             HHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            6764  38999999999999997    488888 678999999999999998765

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=4.1e-22  Score=223.33  Aligned_cols=223  Identities=15%  Similarity=0.126  Sum_probs=153.8

Q ss_pred             cccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCC-hhhhccCcccc-eeeeccccccCCCCcCcCCCCCcEE
Q 001867          333 PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIP-ASLCEKGELEE-LLMIYNSFTGQLPDGLGHCQSLTRV  410 (1002)
Q Consensus       333 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~l~~N~l~~~~p~~l~~l~~L~~L  410 (1002)
                      +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+| ..|.+++++.+ +.+..|++++..|..|.++++|++|
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            345666666666665555567777777777777777655444 34566666554 4555677777777777888888888


Q ss_pred             EccCccccCCCCCcCCCCCcceEEEccc-CcccCccccccccCC-cccEEEccCCcCCCCCccccccccccccccccc-c
Q 001867          411 RLGYNRLTGKVPPLLWGLPHVYLLELTD-NFLSGEISKNIAGAA-NLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSE-N  487 (1002)
Q Consensus       411 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N  487 (1002)
                      ++++|++++..+..+....++..|++.+ |.+..+.+..|..+. .++.|+|++|+|+ .+|.......+|+.|++++ |
T Consensus       110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n  188 (350)
T 4ay9_X          110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN  188 (350)
T ss_dssp             EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCT
T ss_pred             cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCC
Confidence            8888888776666676777777777754 566666666666654 5778888888887 4555555667788888874 5


Q ss_pred             ccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCccee
Q 001867          488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       488 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                      .++...+..|..+++|+.|||++|+|+...+..|.+|++|+.+++.  .++ .+| .+.++++|+.++++++.
T Consensus       189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             cccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--CcC-cCC-CchhCcChhhCcCCCCc
Confidence            5663333567888888888888888886666667777777776653  343 566 47778888888887654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=2.7e-22  Score=207.09  Aligned_cols=187  Identities=22%  Similarity=0.289  Sum_probs=120.3

Q ss_pred             CCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCC
Q 001867           54 DSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL  133 (1002)
Q Consensus        54 ~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  133 (1002)
                      .+.|.|.+|.|+..            +++ .+|..+  .++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus         4 ~C~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~   68 (208)
T 2o6s_A            4 RCSCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP   68 (208)
T ss_dssp             TCEEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred             CCEECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccC
Confidence            45689999999743            222 122222  246677777777776665566666777777777777777555


Q ss_pred             CccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCC
Q 001867          134 TPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNL  213 (1002)
Q Consensus       134 ~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l  213 (1002)
                      +..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++. +..+..+..+
T Consensus        69 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l  147 (208)
T 2o6s_A           69 NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL  147 (208)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTC
T ss_pred             hhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-eeCHHHhccC
Confidence            555666777777777777777555555667777777777777777666666667777777777777652 2233346667


Q ss_pred             CccchhhccCcccccccccccccccccchhcccCcccccccCcccccccc
Q 001867          214 TNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELAS  263 (1002)
Q Consensus       214 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  263 (1002)
                      ++|++|++++|.+.+       .+++|+.|+++.|+++|.+|..++.++.
T Consensus       148 ~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          148 TSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            777777777776553       2346677777777777777766665543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=3.4e-24  Score=239.37  Aligned_cols=229  Identities=17%  Similarity=0.182  Sum_probs=146.2

Q ss_pred             cccchhcccccccCCCCCCCCCCCCCCceEEccCccccCC-CChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEE
Q 001867          333 PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE-IPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVR  411 (1002)
Q Consensus       333 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  411 (1002)
                      ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++..+..           
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~-----------  137 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT-----------  137 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHH-----------
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHH-----------
Confidence            4555556666666554443 34566777777777776644 4444544444444444444444444444           


Q ss_pred             ccCccccCCCCCcCCCCCcceEEEcccC-cccCc-cccccccCCcccEEEccCC-cCCCC-Ccccccccc-ccccccccc
Q 001867          412 LGYNRLTGKVPPLLWGLPHVYLLELTDN-FLSGE-ISKNIAGAANLSLLIISKN-NLSGS-LPEEIGFLK-SLVVLSGSE  486 (1002)
Q Consensus       412 L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~Ls~  486 (1002)
                                   +..+++|+.|++++| .+++. .+..+..+++|+.|++++| .+++. ++..+..++ +|+.|++++
T Consensus       138 -------------l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          138 -------------LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             -------------HTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             -------------HhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence                         444444444444444 34332 3444556666777777777 66643 456667777 777777777


Q ss_pred             c--ccC-CCCcccccccccCCeeecCCCc-CCcccccccccccccccccccCcc-cccCCCCCccccccccEEeCcceee
Q 001867          487 N--KFT-GSLPESLTNLAELGSLDLHAND-LSGELPSSVSSWKKLNELNLADNL-FYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       487 N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      |  .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|+.|+|++|. ++......++++++|+.|+|++|  
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~--  282 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI--  282 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS--
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc--
Confidence            7  444 3456677778888888888888 777777788888888888888885 32222225778888999999888  


Q ss_pred             ecccCC-ccccc--ccceEEeccccCcCCCChh
Q 001867          562 SGRIPV-GLQNL--KLNQLNVSNNRLSGELPSL  591 (1002)
Q Consensus       562 ~~~ip~-~~~~l--~L~~l~ls~N~l~g~~p~~  591 (1002)
                         ++. .+..+  .+..|++++|+++|..|..
T Consensus       283 ---i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          283 ---VPDGTLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             ---SCTTCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             ---cCHHHHHHHHhhCcceEEecccCccccCCc
Confidence               333 45555  4888889999999888864

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=3.5e-22  Score=219.41  Aligned_cols=192  Identities=23%  Similarity=0.301  Sum_probs=134.9

Q ss_pred             CcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEE
Q 001867          332 SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVR  411 (1002)
Q Consensus       332 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  411 (1002)
                      +++|++|++++|.+.. ++ .+..+++|++|+|++|++++..+  +..+++|++|++++|.+++.  ..+..+++|++|+
T Consensus        40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~  113 (308)
T 1h6u_A           40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD  113 (308)
T ss_dssp             HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred             cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence            4455555555555543 22 35556666666666666664333  66666666666666666642  2567777788888


Q ss_pred             ccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCC
Q 001867          412 LGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG  491 (1002)
Q Consensus       412 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  491 (1002)
                      |++|++++..  .+..+++|+.|++++|.+++..+  +..+++|+.|++++|++++. +. ++.+++|+.|++++|++++
T Consensus       114 l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          114 LTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             CTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCc
Confidence            8888877543  27777888888888888876554  77788888888888888753 33 7788888888888888885


Q ss_pred             CCcccccccccCCeeecCCCcCCcccccccccccccccccccCccccc
Q 001867          492 SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYG  539 (1002)
Q Consensus       492 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  539 (1002)
                      ..+  +..+++|+.|+|++|++++..|  +..+++|+.|+|++|.+++
T Consensus       188 ~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             Chh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            433  7888888888888888886653  7888888888888888874

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=6.1e-22  Score=221.94  Aligned_cols=222  Identities=20%  Similarity=0.214  Sum_probs=148.2

Q ss_pred             CCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCC
Q 001867           55 SPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLT  134 (1002)
Q Consensus        55 ~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  134 (1002)
                      +-|.|+.|.|+            +++++ .+|..+  .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+|
T Consensus         7 C~C~~~~v~C~------------~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~   71 (350)
T 4ay9_X            7 CHCSNRVFLCQ------------ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE   71 (350)
T ss_dssp             SEEETTEEEEE------------STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred             cEeeCCEEEec------------CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence            33677777775            34555 345544  2589999999999997777789999999999999999876555


Q ss_pred             -ccccccCCccc-cccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCC
Q 001867          135 -PALADLPNLKF-LDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGN  212 (1002)
Q Consensus       135 -~~~~~L~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~  212 (1002)
                       .+|.++++|++ +.+++|+++...|+.|..+++|++|++++|++++..+..+....++..|++.++.-+....+..|..
T Consensus        72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~  151 (350)
T 4ay9_X           72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG  151 (350)
T ss_dssp             TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred             hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence             46888888775 6677789998888889999999999999999987777777777777788776543222222233444


Q ss_pred             CC-ccchhhccCcccccccccccccccccchhcccC-cccccccCcccccccceeeeeccCCcccCCCCCccccccccce
Q 001867          213 LT-NLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL-NNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRL  290 (1002)
Q Consensus       213 l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  290 (1002)
                      +. .++.|+|++|+|+. +|.......+|++|++++ |.++...+.+|.++++|+.|+|++|+++...+..|.++++|+.
T Consensus       152 ~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~  230 (350)
T 4ay9_X          152 LSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA  230 (350)
T ss_dssp             SBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEEC
T ss_pred             cchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhh
Confidence            43 46666666666663 333333445666666653 4454444445566666666666666666444444444444444


Q ss_pred             ee
Q 001867          291 LD  292 (1002)
Q Consensus       291 L~  292 (1002)
                      ++
T Consensus       231 l~  232 (350)
T 4ay9_X          231 RS  232 (350)
T ss_dssp             TT
T ss_pred             cc
Confidence            33

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=2.6e-21  Score=199.74  Aligned_cols=162  Identities=20%  Similarity=0.138  Sum_probs=89.9

Q ss_pred             cccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEcc
Q 001867          382 ELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIIS  461 (1002)
Q Consensus       382 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  461 (1002)
                      +|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..+..+++|+.|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            44444444444444444445555556666666666555444445555555555555555555444445555556666666


Q ss_pred             CCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCC
Q 001867          462 KNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNI  541 (1002)
Q Consensus       462 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i  541 (1002)
                      +|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|+|++|.+.+.       +++|+.|+++.|+++|.+
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~i  181 (208)
T 2o6s_A          109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV  181 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTB
T ss_pred             CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCcee
Confidence            6665544444455566666666666666644444455666666666666655432       335566666666666666


Q ss_pred             CCCcccccc
Q 001867          542 PEDIGNLSV  550 (1002)
Q Consensus       542 p~~~~~l~~  550 (1002)
                      |++++.++.
T Consensus       182 p~~~~~l~~  190 (208)
T 2o6s_A          182 RNSAGSVAP  190 (208)
T ss_dssp             BCTTSSBCT
T ss_pred             eccCccccC
Confidence            666555543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=4.9e-22  Score=214.57  Aligned_cols=161  Identities=14%  Similarity=0.091  Sum_probs=119.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCcccc--ccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEK--GQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .|.+.+.||+|+||.||+|...+|+.||+|++....... ........  ...........+.+|+.++++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~-~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSF-KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC-------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCch-hhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            455679999999999999999779999999985431110 00000000  00000124667999999999998  5 666


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.. +..|+||||++||+|.+ +..        .....++.|++.||+|||++   +|+||||||+||+++ ++.+|
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vk  232 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIW  232 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEE
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEE
Confidence            665544 55699999999999988 431        23457999999999999999   999999999999999 99999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCcccccc
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT  877 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  877 (1002)
                      |+|||+|+.               +..|+|||++.+
T Consensus       233 l~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          233 IIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             ECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EEECCCCeE---------------CCCCCHHHHHHH
Confidence            999999863               335789998653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=3e-21  Score=227.25  Aligned_cols=166  Identities=32%  Similarity=0.368  Sum_probs=107.7

Q ss_pred             cccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEcc
Q 001867          382 ELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIIS  461 (1002)
Q Consensus       382 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  461 (1002)
                      +|++|++++|.++ .+|   ..+++|++|+|++|+|++ +|. +..  +|+.|+|++|.|++ +|.   .+++|+.|+|+
T Consensus        81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  148 (571)
T 3cvr_A           81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD  148 (571)
T ss_dssp             TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred             CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence            3444444444444 233   234566666666666664 444 433  56666666666665 232   45667777777


Q ss_pred             CCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccccccccccc-------ccccccC
Q 001867          462 KNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKL-------NELNLAD  534 (1002)
Q Consensus       462 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~  534 (1002)
                      +|++++ +|.   .+++|+.|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++
T Consensus       149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~  216 (571)
T 3cvr_A          149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE  216 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred             CCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence            777764 554   46677777777777775 565 55  77788888888877 4555 544  56       8888888


Q ss_pred             cccccCCCCCccccccccEEeCcceeeecccCCccccc
Q 001867          535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL  572 (1002)
Q Consensus       535 N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l  572 (1002)
                      |.|+ .+|..++.+++|+.|+|++|+|++.+|..+..+
T Consensus       217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence            8887 688888888888888888888888888777665

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=4.5e-21  Score=225.74  Aligned_cols=188  Identities=25%  Similarity=0.359  Sum_probs=103.0

Q ss_pred             cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeec
Q 001867          311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIY  390 (1002)
Q Consensus       311 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  390 (1002)
                      ++.|+|++|.+++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +             
T Consensus        61 L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l-------------  118 (571)
T 3cvr_A           61 FSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-L-------------  118 (571)
T ss_dssp             CSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-C-------------
T ss_pred             ccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-h-------------
Confidence            5666666666664 443332  45555555555555 233   234555555555555553 333 3             


Q ss_pred             cccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCc
Q 001867          391 NSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP  470 (1002)
Q Consensus       391 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  470 (1002)
                                 ..  +|++|+|++|+|++ +|.   .+++|+.|+|++|.|+++ |.   .+++|+.|+|++|++++ +|
T Consensus       119 -----------~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~L~~-lp  176 (571)
T 3cvr_A          119 -----------PA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTML-PE---LPTSLEVLSVRNNQLTF-LP  176 (571)
T ss_dssp             -----------CT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC
T ss_pred             -----------hc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcC-CC---cCCCcCEEECCCCCCCC-cc
Confidence                       32  45555555555554 333   345555555555555542 22   34556666666666654 44


Q ss_pred             cccccccccccccccccccCCCCcccccccccC-------CeeecCCCcCCcccccccccccccccccccCcccccCCCC
Q 001867          471 EEIGFLKSLVVLSGSENKFTGSLPESLTNLAEL-------GSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPE  543 (1002)
Q Consensus       471 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~  543 (1002)
                      . |.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|.
T Consensus       177 ~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          177 E-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             C-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             h-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            4 44  56666666666666 4454 433  45       67777777776 4566666677777777777777776776


Q ss_pred             Ccccccc
Q 001867          544 DIGNLSV  550 (1002)
Q Consensus       544 ~~~~l~~  550 (1002)
                      .++.+..
T Consensus       249 ~l~~l~~  255 (571)
T 3cvr_A          249 SLSQQTA  255 (571)
T ss_dssp             HHHHHHH
T ss_pred             HHHHhhc
Confidence            6666544

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=8.2e-21  Score=232.21  Aligned_cols=228  Identities=21%  Similarity=0.194  Sum_probs=130.7

Q ss_pred             hHHHHHHHHHHHhccC-CccccCCCCCCCCCCCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccC
Q 001867           24 NQEGLYLERVKLSLSD-PDSALSSWGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFN  102 (1002)
Q Consensus        24 ~~~~~~l~~~k~~~~d-~~~~l~sw~~~~~~~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~  102 (1002)
                      ..++.+|+++..+... ....-..|..  ....++.|.++.++.  .+++.|+|.++++... +..+     |+.++|+.
T Consensus       131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~  200 (727)
T 4b8c_D          131 DCTKQALMEMADTLTDSKTAKKQQPTG--DSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQAL-----LQHKKLSQ  200 (727)
T ss_dssp             -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred             ccchhhhhhhhhhcccccCcccCCCcC--CCCccccCCCceecC--CccceEEeeCCCCCcc-hhhH-----hhcCccCc
Confidence            4567788888877632 2233445643  223467899998875  5699999999998864 3332     33444444


Q ss_pred             CCCCC---------CCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeec
Q 001867          103 NSINS---------TLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV  173 (1002)
Q Consensus       103 n~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  173 (1002)
                      |.|.+         ..|..|..+++|++|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|+
T Consensus       201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls  278 (727)
T 4b8c_D          201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLS  278 (727)
T ss_dssp             ---------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECT
T ss_pred             ccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCc
Confidence            44432         45778888999999999999998 67777778999999999999998 788889999999999999


Q ss_pred             cccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccc-cchhcccCccccc
Q 001867          174 YNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAK-LVDLDLALNNLVG  252 (1002)
Q Consensus       174 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L~~N~l~~  252 (1002)
                      +|+|+ .+|..|++|++|++|+|++|.+  ..+|..|+++++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++
T Consensus       279 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l--~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~  355 (727)
T 4b8c_D          279 HNRLT-SLPAELGSCFQLKYFYFFDNMV--TTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI  355 (727)
T ss_dssp             TSCCS-SCCSSGGGGTTCSEEECCSSCC--CCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred             CCcCC-ccChhhcCCCCCCEEECCCCCC--CccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence            99998 6788899999999999999987  478888999999999999999999888888876533 3457888888888


Q ss_pred             ccCcccccccceeeeeccCC
Q 001867          253 AIPSSLTELASVVQIELYNN  272 (1002)
Q Consensus       253 ~~~~~l~~l~~L~~L~L~~N  272 (1002)
                      .+|..+      ..|+++.|
T Consensus       356 ~~p~~l------~~l~l~~n  369 (727)
T 4b8c_D          356 PLPHER------RFIEINTD  369 (727)
T ss_dssp             CCCCC---------------
T ss_pred             cCcccc------ceeEeecc
Confidence            777644      44556555

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=1.4e-19  Score=196.73  Aligned_cols=151  Identities=25%  Similarity=0.324  Sum_probs=100.5

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +..+++|++|+|++|++++..+  +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++ + +.++.+++|+
T Consensus        64 ~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~  137 (291)
T 1h6t_A           64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE  137 (291)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCC
T ss_pred             HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCC
Confidence            4555566666666666654433  55566666666666666542  236666677777777777764 2 3566677777


Q ss_pred             cccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCccee
Q 001867          481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                      .|++++|++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|+
T Consensus       138 ~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~  211 (291)
T 1h6t_A          138 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE  211 (291)
T ss_dssp             EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEE
T ss_pred             EEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCc
Confidence            777777777743  467777777777777777776555  7777777777777777773 44 37777778888888887


Q ss_pred             eec
Q 001867          561 LSG  563 (1002)
Q Consensus       561 l~~  563 (1002)
                      ++.
T Consensus       212 i~~  214 (291)
T 1h6t_A          212 CLN  214 (291)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            774

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=8.2e-20  Score=217.65  Aligned_cols=196  Identities=19%  Similarity=0.206  Sum_probs=120.6

Q ss_pred             cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeec
Q 001867          311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIY  390 (1002)
Q Consensus       311 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  390 (1002)
                      +..+.+..+.+....+  +..+++|+.|++++|.+... + .+..+++|+.|+|++|+|++..|  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            4556666666664433  45567777777777777643 2 46777777777777777775444  66667777777777


Q ss_pred             cccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCc
Q 001867          391 NSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP  470 (1002)
Q Consensus       391 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  470 (1002)
                      |.+++ + ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++++..|
T Consensus        97 N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A           97 NKIKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SCCCC-C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCC-C-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            77664 2 2566666777777777766642  3355666666666666666654  445566666666666666664444


Q ss_pred             cccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccc
Q 001867          471 EEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVS  522 (1002)
Q Consensus       471 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  522 (1002)
                        ++.+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++.....+.
T Consensus       171 --l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~~p~~~~~  218 (605)
T 1m9s_A          171 --LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPINHQS  218 (605)
T ss_dssp             --GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEECCCCCCCS
T ss_pred             --hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcCCcccccc
Confidence              5566666666666666653 22 455666666666666666544333333

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=9.3e-20  Score=189.45  Aligned_cols=153  Identities=18%  Similarity=0.144  Sum_probs=83.8

Q ss_pred             cEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccc-cccccCCcccEEEccCCcCCCCCccccccccccccccccc
Q 001867          408 TRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEIS-KNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSE  486 (1002)
Q Consensus       408 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  486 (1002)
                      +.+++++|.++. +|..+.  +.++.|+|++|.|++..+ ..|..+++|+.|+|++|++++..+..|+.+++|+.|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            578888888874 454432  234566666666665533 3355555555555555555544444555555555555555


Q ss_pred             cccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeec
Q 001867          487 NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       487 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      |++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            55554444445555555555555555555555555555555555555555554445555555555555555555543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.80  E-value=5.4e-22  Score=235.16  Aligned_cols=203  Identities=21%  Similarity=0.177  Sum_probs=152.3

Q ss_pred             CCCCCCceEEccCccccCCCChhhhccCcccceeeeccc-------------cccCCCCcCcCCCCCcEEE-ccCccccC
Q 001867          354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNS-------------FTGQLPDGLGHCQSLTRVR-LGYNRLTG  419 (1002)
Q Consensus       354 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~  419 (1002)
                      ...++|+.|+|++|+++ .+|..+..+++|+.|++++|.             +.+..|..++++++|+.|+ ++.|++. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            45677888888888887 778888888888888886664             4556666677777777777 6666542 


Q ss_pred             CCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccc
Q 001867          420 KVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTN  499 (1002)
Q Consensus       420 ~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  499 (1002)
                                +|..+.+++|.|....+      ..|+.|+|++|++++ +|. ++.+++|+.|+|++|+|+ .+|..|+.
T Consensus       424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~  484 (567)
T 1dce_A          424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA  484 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred             ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence                      45556666777664432      247888888888885 666 888888888888888888 77888888


Q ss_pred             cccCCeeecCCCcCCcccccccccccccccccccCcccccCC-CCCccccccccEEeCcceeeecccCCccc---cc-cc
Q 001867          500 LAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNI-PEDIGNLSVLNYLDLSNNRLSGRIPVGLQ---NL-KL  574 (1002)
Q Consensus       500 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i-p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~---~l-~L  574 (1002)
                      +++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..++.+++|+.|+|++|+|++.+|....   .+ +|
T Consensus       485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L  562 (567)
T 1dce_A          485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV  562 (567)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred             CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence            8888888888888886 56 7888888888888888888766 88888888888888888888876654321   23 56


Q ss_pred             ceEEe
Q 001867          575 NQLNV  579 (1002)
Q Consensus       575 ~~l~l  579 (1002)
                      +.||+
T Consensus       563 ~~L~l  567 (567)
T 1dce_A          563 SSILT  567 (567)
T ss_dssp             SEEEC
T ss_pred             CccCC
Confidence            66653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=2.5e-19  Score=186.20  Aligned_cols=156  Identities=19%  Similarity=0.170  Sum_probs=120.0

Q ss_pred             eEEEcccCcccCccccccccCCcccEEEccCCcCCCCCc-cccccccccccccccccccCCCCcccccccccCCeeecCC
Q 001867          432 YLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP-EEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHA  510 (1002)
Q Consensus       432 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  510 (1002)
                      +.+++++|.++. +|..+.  ..++.|+|++|++++..| ..|+.+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            467888888775 344442  346788888888876544 3577888888888888888876666788888888888888


Q ss_pred             CcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCC
Q 001867          511 NDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELP  589 (1002)
Q Consensus       511 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p  589 (1002)
                      |++++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+..+ +|+.|+|++|++++..+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            88887777778888888888888888887777888888888888888888887777777777 68888888888877665


Q ss_pred             h
Q 001867          590 S  590 (1002)
Q Consensus       590 ~  590 (1002)
                      -
T Consensus       171 l  171 (220)
T 2v70_A          171 L  171 (220)
T ss_dssp             G
T ss_pred             h
Confidence            3

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=2.6e-19  Score=213.35  Aligned_cols=159  Identities=25%  Similarity=0.303  Sum_probs=105.9

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +..+++|+.|+|++|++++..|  +..+++|+.|+|++|.|.+.  ..+..+++|+.|+|++|++++ + +.++.+++|+
T Consensus        61 l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~  134 (605)
T 1m9s_A           61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE  134 (605)
T ss_dssp             GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCS
T ss_pred             HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-C-ccccCCCccC
Confidence            4555555666666665554433  55556666666666665542  246666667777777777764 2 3466777777


Q ss_pred             cccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCccee
Q 001867          481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                      .|+|++|++++.  ..+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|+
T Consensus       135 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~  208 (605)
T 1m9s_A          135 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE  208 (605)
T ss_dssp             EEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEE
T ss_pred             EEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCc
Confidence            777777777753  567777888888888888877666  7777888888888888874 33 57778888888888888


Q ss_pred             eecccCCcccc
Q 001867          561 LSGRIPVGLQN  571 (1002)
Q Consensus       561 l~~~ip~~~~~  571 (1002)
                      +++.....+..
T Consensus       209 l~~~p~~~~~~  219 (605)
T 1m9s_A          209 CLNKPINHQSN  219 (605)
T ss_dssp             EECCCCCCCSS
T ss_pred             CcCCccccccc
Confidence            87644433333

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=4.7e-19  Score=184.11  Aligned_cols=153  Identities=22%  Similarity=0.169  Sum_probs=100.9

Q ss_pred             cEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccccccccc
Q 001867          408 TRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN  487 (1002)
Q Consensus       408 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  487 (1002)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|.|+++.+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            46667777766 3444332  45666666666666666656666666666666666666655666666667777777777


Q ss_pred             ccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeec
Q 001867          488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       488 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      +|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.|++..+..+..+++|+.|+|++|++..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            7764444456667777777777777776666677777777777777777775555566677777777777776653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=3.3e-19  Score=186.65  Aligned_cols=161  Identities=24%  Similarity=0.292  Sum_probs=135.9

Q ss_pred             CCCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCC
Q 001867           53 DDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT  132 (1002)
Q Consensus        53 ~~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  132 (1002)
                      +.+.|+|.+|.|+..            +++ .+|..+.  ++|++|+|++|+|+++.|..|..+++|++|+|++|+|+..
T Consensus        15 ~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i   79 (229)
T 3e6j_A           15 SQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL   79 (229)
T ss_dssp             TTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence            467899999999643            333 3444333  7899999999999998899999999999999999999877


Q ss_pred             CCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCC
Q 001867          133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGN  212 (1002)
Q Consensus       133 ~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~  212 (1002)
                      .+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|++. ...+..+..
T Consensus        80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~  157 (229)
T 3e6j_A           80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDR  157 (229)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC-CCCTTTTTT
T ss_pred             ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC-ccCHHHHhC
Confidence            7777899999999999999999877788899999999999999999 77888899999999999999873 333456889


Q ss_pred             CCccchhhccCccccccc
Q 001867          213 LTNLEILWLTECNLVGEI  230 (1002)
Q Consensus       213 l~~L~~L~L~~n~l~~~~  230 (1002)
                      +++|+.|+|++|.+....
T Consensus       158 l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          158 LSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CTTCCEEECTTSCBCTTB
T ss_pred             CCCCCEEEeeCCCccCCc
Confidence            999999999999988543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=2.2e-21  Score=229.84  Aligned_cols=175  Identities=20%  Similarity=0.156  Sum_probs=103.0

Q ss_pred             ccCcccccccccccccCCCCccccccCCcccccccccc-------------ccCCCCcccccccccceee-eccc-----
Q 001867          115 ACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN-------------FSGDIPESFGRFQKLEVIS-LVYN-----  175 (1002)
Q Consensus       115 ~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N-----  175 (1002)
                      .+++|+.|+|++|+|+ .+|..+++|++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|     
T Consensus       347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L  425 (567)
T 1dce_A          347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL  425 (567)
T ss_dssp             TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchh
Confidence            3455555555555555 445555555555555554443             3444555555555555555 4444     


Q ss_pred             --------cccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccC
Q 001867          176 --------LLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL  247 (1002)
Q Consensus       176 --------~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  247 (1002)
                              .++...+      ..|+.|+|++|.+.  .+|. ++++++|+.|+|++|+|+ .+|..|+.+++|++|+|++
T Consensus       426 ~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~--~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~  495 (567)
T 1dce_A          426 RSKFLLENSVLKMEY------ADVRVLHLAHKDLT--VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD  495 (567)
T ss_dssp             HHHHHHHHHHHHHHH------TTCSEEECTTSCCS--SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred             hhhhhhcccccccCc------cCceEEEecCCCCC--CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCC
Confidence                    3332211      13666677766652  3554 666666666666666666 5566666666666666666


Q ss_pred             cccccccCcccccccceeeeeccCCcccCCC-CCccccccccceeeccccccCCCC
Q 001867          248 NNLVGAIPSSLTELASVVQIELYNNSLTGDL-PTGWSNLTSLRLLDASMNDLTGPI  302 (1002)
Q Consensus       248 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~  302 (1002)
                      |+|++ +| .+.++++|+.|+|++|++++.. |..+..+++|+.|+|++|++++.+
T Consensus       496 N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          496 NALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             SCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             CCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            66665 34 5666666666666666666555 666666666666666666666443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=2.1e-19  Score=195.47  Aligned_cols=172  Identities=20%  Similarity=0.250  Sum_probs=129.0

Q ss_pred             CCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceE
Q 001867          354 GKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL  433 (1002)
Q Consensus       354 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  433 (1002)
                      ..+++|+.|++++|.++.. + .+..+++|++|++++|.+++..+  +.++++|++|+|++|++++ +| .+..+++|+.
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence            3455566666666666633 2 35666666666666666665444  6777777777777777765 22 3777788888


Q ss_pred             EEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcC
Q 001867          434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL  513 (1002)
Q Consensus       434 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  513 (1002)
                      |++++|.+++.  ..+..+++|+.|++++|++++.  ..++.+++|+.|++++|++++..|  +..+++|+.|+|++|.+
T Consensus       117 L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          117 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence            88888887764  4577888888888888888854  578888999999999999986544  88899999999999999


Q ss_pred             CcccccccccccccccccccCccccc
Q 001867          514 SGELPSSVSSWKKLNELNLADNLFYG  539 (1002)
Q Consensus       514 ~~~~p~~~~~l~~L~~L~Ls~N~l~~  539 (1002)
                      ++. | .+..+++|+.|+|++|.++.
T Consensus       191 ~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          191 SDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             CCC-h-hhccCCCCCEEECcCCcccC
Confidence            864 4 48889999999999999885

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=4.4e-19  Score=199.50  Aligned_cols=162  Identities=19%  Similarity=0.153  Sum_probs=68.9

Q ss_pred             eEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCc-CCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccC
Q 001867          361 WVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLG-HCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDN  439 (1002)
Q Consensus       361 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  439 (1002)
                      .+++++|+++ .+|..+.  ..++.|+|++|.+++..+..+. ++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            4445555444 2333221  1233344444444433333343 4444444444444444444444444444444444444


Q ss_pred             cccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccc---cccccCCeeecCCCcCCcc
Q 001867          440 FLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESL---TNLAELGSLDLHANDLSGE  516 (1002)
Q Consensus       440 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~  516 (1002)
                      +|+...+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|   ..+++|+.|||++|+|++.
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  178 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL  178 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence            4444444444444444444444444443334444444444444444444442222222   3344444444444444443


Q ss_pred             ccccccccc
Q 001867          517 LPSSVSSWK  525 (1002)
Q Consensus       517 ~p~~~~~l~  525 (1002)
                      .+..+..++
T Consensus       179 ~~~~~~~l~  187 (361)
T 2xot_A          179 PLTDLQKLP  187 (361)
T ss_dssp             CHHHHHHSC
T ss_pred             CHHHhhhcc
Confidence            333444443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.77  E-value=1.1e-19  Score=222.33  Aligned_cols=161  Identities=23%  Similarity=0.247  Sum_probs=117.8

Q ss_pred             eeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCC
Q 001867          388 MIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSG  467 (1002)
Q Consensus       388 l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~  467 (1002)
                      +..|.+. ..|..+..+++|+.|+|++|++. .+|..++.+++|+.|+|++|.|+ .+|..|..+++|+.|+|++|+|+ 
T Consensus       208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-  283 (727)
T 4b8c_D          208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-  283 (727)
T ss_dssp             ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred             cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence            3445444 56777888888899999999888 56666778888888899888888 67788888999999999999998 


Q ss_pred             CCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccc-cccccccCcccccCCCCCcc
Q 001867          468 SLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK-LNELNLADNLFYGNIPEDIG  546 (1002)
Q Consensus       468 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~ip~~~~  546 (1002)
                      .+|..|+.+++|+.|+|++|.|+ .+|..|+.|++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|..  
T Consensus       284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~--  360 (727)
T 4b8c_D          284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE--  360 (727)
T ss_dssp             SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred             ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc--
Confidence            77888999999999999999997 77888999999999999999999998988876543 345889999999888864  


Q ss_pred             ccccccEEeCcce
Q 001867          547 NLSVLNYLDLSNN  559 (1002)
Q Consensus       547 ~l~~L~~L~Ls~N  559 (1002)
                          |+.|++++|
T Consensus       361 ----l~~l~l~~n  369 (727)
T 4b8c_D          361 ----RRFIEINTD  369 (727)
T ss_dssp             -------------
T ss_pred             ----cceeEeecc
Confidence                455667766

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=2.9e-19  Score=200.96  Aligned_cols=173  Identities=28%  Similarity=0.245  Sum_probs=93.4

Q ss_pred             EEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccc-cCCcccEEEccCCcCCCCCcccccccccccccccccc
Q 001867          409 RVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIA-GAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSEN  487 (1002)
Q Consensus       409 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  487 (1002)
                      .+++++|+++. +|..+.  +.++.|+|++|.|++..+..+. .+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            44445554442 333221  2344555555555544444444 5555555555555555444455555555666666666


Q ss_pred             ccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCC-c---cccccccEEeCcceeeec
Q 001867          488 KFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPED-I---GNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       488 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~-~---~~l~~L~~L~Ls~N~l~~  563 (1002)
                      +|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++ +|.. +   ..+++|+.|||++|+|++
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            6554444455666666666666666665556666666666666666666663 3333 2   456666666666666664


Q ss_pred             ccCCccccc-c--cceEEeccccCc
Q 001867          564 RIPVGLQNL-K--LNQLNVSNNRLS  585 (1002)
Q Consensus       564 ~ip~~~~~l-~--L~~l~ls~N~l~  585 (1002)
                      ..+..+..+ .  ++.|+|++|++.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             cCHHHhhhccHhhcceEEecCCCcc
Confidence            333444444 2  456666666665

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.76  E-value=2.4e-18  Score=180.01  Aligned_cols=135  Identities=23%  Similarity=0.239  Sum_probs=70.9

Q ss_pred             cccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccccccccccccccccccc
Q 001867          454 NLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLA  533 (1002)
Q Consensus       454 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  533 (1002)
                      +|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus        41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls  120 (229)
T 3e6j_A           41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC  120 (229)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEecc
Confidence            34444444444444444444444555555555555543333444555555555555555555444555555555555555


Q ss_pred             CcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCC
Q 001867          534 DNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELP  589 (1002)
Q Consensus       534 ~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p  589 (1002)
                      +|+|+ .+|..+..+++|++|+|++|+|++..+..+..+ +|+.|+|++|++.+..+
T Consensus       121 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          121 CNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            55555 555555555556666666665554444445555 55566666666555443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.76  E-value=2.1e-18  Score=179.14  Aligned_cols=132  Identities=22%  Similarity=0.252  Sum_probs=65.0

Q ss_pred             CcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccc
Q 001867          407 LTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSE  486 (1002)
Q Consensus       407 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  486 (1002)
                      |+.|+|++|+|++..+..|..+++|+.|+|++|+|+++.+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++
T Consensus        34 l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~  113 (220)
T 2v9t_B           34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNA  113 (220)
T ss_dssp             CCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCC
Confidence            34444444444433333444444444444444444444444444444444444444444433333344555555555555


Q ss_pred             cccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccc
Q 001867          487 NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFY  538 (1002)
Q Consensus       487 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  538 (1002)
                      |++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       114 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          114 NKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            5555544555555555555555555555555555555555555555555554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.75  E-value=6.8e-19  Score=188.27  Aligned_cols=170  Identities=22%  Similarity=0.239  Sum_probs=97.6

Q ss_pred             CcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEE
Q 001867          332 SPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVR  411 (1002)
Q Consensus       332 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  411 (1002)
                      +.++..+++++|.+++..  .+..+++|+.|++++|+++ .++ .+..+++|++|++++|.+++..+  +.++++|++|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            455666667666666433  4566667777777777776 333 45666666666666666665433  66666666666


Q ss_pred             ccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCC
Q 001867          412 LGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG  491 (1002)
Q Consensus       412 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  491 (1002)
                      |++|++++. |....  ++|+.|+|++|++++.  ..+..+++|+.|++++|++++. | .++.+++|+.|++++|++++
T Consensus        92 L~~N~l~~l-~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           92 VNRNRLKNL-NGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             CCSSCCSCC-TTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             CCCCccCCc-Ccccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence            666666642 22222  5566666666666543  2355555566666666655532 2 45555555555555555554


Q ss_pred             CCcccccccccCCeeecCCCcCCcc
Q 001867          492 SLPESLTNLAELGSLDLHANDLSGE  516 (1002)
Q Consensus       492 ~~p~~~~~l~~L~~L~Ls~N~l~~~  516 (1002)
                      .  ..+..+++|+.|++++|++++.
T Consensus       165 ~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          165 T--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             h--HHhccCCCCCEEeCCCCcccCC
Confidence            3  4455555555555555555544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=2e-18  Score=175.19  Aligned_cols=153  Identities=22%  Similarity=0.313  Sum_probs=86.3

Q ss_pred             cEEEccCCcCCCCCccccccccccccccccccccCCCCcc-cccccccCCeeecCCCcCCcccccccccccccccccccC
Q 001867          456 SLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE-SLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLAD  534 (1002)
Q Consensus       456 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  534 (1002)
                      +.+++++|+++ .+|..+..  +|+.|++++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            34555555554 44544332  556666666666543332 355666666666666666666566666666666666666


Q ss_pred             cccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChhhh-hhcccccccCCCCCCCCC
Q 001867          535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSLFA-KEMYRNSFLGNPGLCGDL  611 (1002)
Q Consensus       535 N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~~~-~~~~~~~~~~n~~~cg~~  611 (1002)
                      |+|++..|..|+++++|++|+|++|++++.+|..+..+ +|+.|+|++|++++..+-..+ ..+....+.++...|+.|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            66665555556666666666666666666666666555 566666666666665553222 112223444555556554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.75  E-value=9.1e-19  Score=187.28  Aligned_cols=170  Identities=18%  Similarity=0.175  Sum_probs=118.8

Q ss_pred             cCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEE
Q 001867          380 KGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLI  459 (1002)
Q Consensus       380 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  459 (1002)
                      +.++..+++++|.+++..  .+..+++|++|++++|+++. +| .+..+++|+.|+|++|+|++..+  +..+++|+.|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            445566666666665432  45667777777777777763 33 46667777777777777766554  67777777777


Q ss_pred             ccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCccccc
Q 001867          460 ISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYG  539 (1002)
Q Consensus       460 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  539 (1002)
                      +++|++++ +|....  ++|+.|++++|++++ ++ .+..+++|+.|+|++|++++. | .++.+++|+.|+|++|.+++
T Consensus        92 L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           92 VNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             CCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             CCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence            77777774 343222  777888888887774 33 577788888888888888764 3 57778888888888888875


Q ss_pred             CCCCCccccccccEEeCcceeeecc
Q 001867          540 NIPEDIGNLSVLNYLDLSNNRLSGR  564 (1002)
Q Consensus       540 ~ip~~~~~l~~L~~L~Ls~N~l~~~  564 (1002)
                      .  ..+..+++|+.|+|++|++++.
T Consensus       165 ~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          165 T--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             h--HHhccCCCCCEEeCCCCcccCC
Confidence            4  6677888888888888888754

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=2e-18  Score=176.18  Aligned_cols=153  Identities=20%  Similarity=0.233  Sum_probs=84.3

Q ss_pred             cCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccc
Q 001867          402 GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVV  481 (1002)
Q Consensus       402 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  481 (1002)
                      ..+++|+.|++++|+++ .+| .+..+++|+.|++++|.+..  +..+..+++|+.|++++|++++..|..++.+++|+.
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            44556666666666665 333 35555555555555554432  224555556666666666665545555555666666


Q ss_pred             ccccccccCCCCcccccccccCCeeecCCCc-CCcccccccccccccccccccCcccccCCCCCccccccccEEeCccee
Q 001867          482 LSGSENKFTGSLPESLTNLAELGSLDLHAND-LSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       482 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                      |++++|++++..|..+..+++|+.|+|++|+ ++ .+| .+..+++|+.|++++|.+++ ++ .+..+++|+.|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            6666666655555555566666666666665 33 333 45555666666666666553 33 55556666666666665


Q ss_pred             ee
Q 001867          561 LS  562 (1002)
Q Consensus       561 l~  562 (1002)
                      +.
T Consensus       193 i~  194 (197)
T 4ezg_A          193 IG  194 (197)
T ss_dssp             --
T ss_pred             cC
Confidence            54

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.72  E-value=8.4e-18  Score=170.67  Aligned_cols=113  Identities=24%  Similarity=0.321  Sum_probs=91.0

Q ss_pred             cccEEEccCCcCCCCCcc-ccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccc
Q 001867          454 NLSLLIISKNNLSGSLPE-EIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL  532 (1002)
Q Consensus       454 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  532 (1002)
                      +|+.|++++|++++..+. .++.+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|+.+++|++|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            566777777777655443 4777888888888888888777888888888888888888888888888888888888888


Q ss_pred             cCcccccCCCCCccccccccEEeCcceeeecccC
Q 001867          533 ADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIP  566 (1002)
Q Consensus       533 s~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip  566 (1002)
                      ++|+|++.+|..++.+++|++|+|++|++++..+
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            8888888888888888888888888888887665

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=6.1e-18  Score=180.30  Aligned_cols=153  Identities=18%  Similarity=0.164  Sum_probs=108.5

Q ss_pred             CCcCCeeeecCCccEEEEEE-cCCcE--EEEEEeeccccccccCC------Ccccc-ccccchhhHHhHHHHHHHHhcCC
Q 001867          685 LDEDNVIGSGSSGKVYKVVL-SNGEA--VAVKKLWRGMSKECESG------CDVEK-GQVQDQVQDDGFQAEVETLGKIR  754 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~~~~~~------~~~~~-~~~~~~~~~~~~~~E~~~l~~l~  754 (1002)
                      |++.+.||+|+||.||+|.. .+|+.  ||||++...........      ..... ...........+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999997 67889  99999754311100000      00000 00001223457889999999998


Q ss_pred             CCce--eeeeeEEecCCeeeEEEeccCC-C----ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeeCC
Q 001867          755 HKNI--VKLWCCCTTRDCKLLVYEYMPN-G----SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLH-HDCVPSIVHRD  826 (1002)
Q Consensus       755 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiHrD  826 (1002)
                      |+++  +.++++    +..++||||+.+ |    +|.++...     .++..+..++.|++.|++||| +.   +|+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence            8754  344432    356899999942 4    66665432     234567889999999999999 88   999999


Q ss_pred             CCCCcEEECCCCCeEEccccCcccc
Q 001867          827 VKSNNILLDGDFGARVADFGVAKVV  851 (1002)
Q Consensus       827 lk~~NIll~~~~~~kl~DfGl~~~~  851 (1002)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999765

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.71  E-value=1.7e-17  Score=169.35  Aligned_cols=132  Identities=20%  Similarity=0.251  Sum_probs=77.7

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +..+++|++|++++|.++  .+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++++..|..++.+++|+
T Consensus        62 l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~  139 (197)
T 4ezg_A           62 IEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN  139 (197)
T ss_dssp             GGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCC
T ss_pred             HhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCC
Confidence            444455555555555443  222445555555555555555555555556666666666666666655566666666666


Q ss_pred             cccccccc-cCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccc
Q 001867          481 VLSGSENK-FTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFY  538 (1002)
Q Consensus       481 ~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  538 (1002)
                      .|++++|+ ++ .+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|++.
T Consensus       140 ~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          140 SIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             EEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC---
T ss_pred             EEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcccC
Confidence            66666666 44 444 566677777777777777653 3 5667777777777777765

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.66  E-value=1.4e-17  Score=184.67  Aligned_cols=101  Identities=14%  Similarity=0.082  Sum_probs=62.9

Q ss_pred             CCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCc-EEEccCccccCCCCCcCCCCCcceEEE
Q 001867          357 SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLT-RVRLGYNRLTGKVPPLLWGLPHVYLLE  435 (1002)
Q Consensus       357 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~  435 (1002)
                      ++|+.|+|++|+++...+..|..+.+|+++++.+| ++...+.+|.++++|+ .+++.+ +++.+.+.+|.++++|+.++
T Consensus       226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~  303 (329)
T 3sb4_A          226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL  303 (329)
T ss_dssp             TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred             CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence            44555555555555444445555555555555555 4445556666666676 677666 56555566677777777777


Q ss_pred             cccCcccCccccccccCCcccEEE
Q 001867          436 LTDNFLSGEISKNIAGAANLSLLI  459 (1002)
Q Consensus       436 L~~N~i~~~~~~~~~~l~~L~~L~  459 (1002)
                      +++|.++.+.+..|.++++|+.++
T Consensus       304 l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          304 ATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             eCCCccCccchhhhcCCcchhhhc
Confidence            777777766666777777777665

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=1.8e-16  Score=157.14  Aligned_cols=132  Identities=24%  Similarity=0.186  Sum_probs=72.5

Q ss_pred             CCCcEEEccCcccc-CCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccccc
Q 001867          405 QSLTRVRLGYNRLT-GKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLS  483 (1002)
Q Consensus       405 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  483 (1002)
                      ++|++|++++|+++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++.+|..++.+++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            55666677766666 45555555666666666666665544  4455555566666666666544555555555555555


Q ss_pred             ccccccCCCC-cccccccccCCeeecCCCcCCcccc---cccccccccccccccCcccc
Q 001867          484 GSENKFTGSL-PESLTNLAELGSLDLHANDLSGELP---SSVSSWKKLNELNLADNLFY  538 (1002)
Q Consensus       484 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~  538 (1002)
                      +++|++++.. +..+..+++|+.|++++|++++..+   ..+..+++|+.|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            5555555321 1445555555555555555554333   24445555555555555544

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=2.4e-16  Score=159.77  Aligned_cols=128  Identities=27%  Similarity=0.327  Sum_probs=81.4

Q ss_pred             cEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCc
Q 001867          456 SLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADN  535 (1002)
Q Consensus       456 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  535 (1002)
                      +.+++++|+++ .+|..+.  ++|+.|++++|+|+ .+|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            34556666665 4454332  46666666666666 55666666666666666666666666666666666666666666


Q ss_pred             ccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCC
Q 001867          536 LFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGE  587 (1002)
Q Consensus       536 ~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~  587 (1002)
                      +|++..|..|..+++|++|+|++|+|++..+..+..+ +|+.|+|++|++...
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            6666555666667777777777777765444456555 567777777766543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.65  E-value=3e-17  Score=182.05  Aligned_cols=100  Identities=11%  Similarity=0.103  Sum_probs=58.3

Q ss_pred             ccccceeeccccccC--CCCCccCCCCCcceeecCCCcccCcCCcccCC--------CcccchhcccccccCCCCCCCCC
Q 001867          285 LTSLRLLDASMNDLT--GPIPDDLTRLPLESLNLYENRLEGSLPATIAD--------SPGLYELRLFRNRLNGTLPGDLG  354 (1002)
Q Consensus       285 l~~L~~L~Ls~N~l~--~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~  354 (1002)
                      +++|+.|||++|++.  ...+..+..  +..+.+..|.|   .+..|.+        +++|++|.|.+ .++.+.+.+|.
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~--~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~  121 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPN--GKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFK  121 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGG--GCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTT
T ss_pred             hccCeEEecCcceeEEecCccccccc--ccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHhh
Confidence            566777777777776  111111111  23344444432   2344555        77777777777 77766677777


Q ss_pred             CCCCCceEEccCccccCCCChhhhccCcccceeeec
Q 001867          355 KNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIY  390 (1002)
Q Consensus       355 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  390 (1002)
                      .+++|+.|++++|.++...+..|....++..+.+..
T Consensus       122 ~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~  157 (329)
T 3sb4_A          122 GCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS  157 (329)
T ss_dssp             TCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred             cCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence            777777777777777655556665555555444433

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.64  E-value=2e-16  Score=156.83  Aligned_cols=132  Identities=24%  Similarity=0.189  Sum_probs=61.2

Q ss_pred             CcceEEEcccCccc-CccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeee
Q 001867          429 PHVYLLELTDNFLS-GEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLD  507 (1002)
Q Consensus       429 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  507 (1002)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..++.+++|+.|++++|++++.+|..+..+++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555554 34444444455555555555554432  4444444555555555555443444444444455555


Q ss_pred             cCCCcCCccc-ccccccccccccccccCcccccCCC---CCccccccccEEeCcceeee
Q 001867          508 LHANDLSGEL-PSSVSSWKKLNELNLADNLFYGNIP---EDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       508 Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ip---~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      |++|++++.. +..+..+++|+.|+|++|.+++..+   ..+..+++|++|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            5555444321 1344444444444444444442222   13444444444444444443

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=1.7e-16  Score=174.91  Aligned_cols=151  Identities=13%  Similarity=0.114  Sum_probs=104.3

Q ss_pred             CCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCcccc-ccccc--------hhhHHhHHHHHHHHhcCCC
Q 001867          685 LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEK-GQVQD--------QVQDDGFQAEVETLGKIRH  755 (1002)
Q Consensus       685 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~E~~~l~~l~h  755 (1002)
                      |++.+.||+|+||.||+|...+|+.||||+++...... .   .+.. ..+..        ........+|...+.++.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sf-r---~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISF-R---TVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECC-C---CCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccH-H---HHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            78899999999999999999899999999986432210 0   0000 00000        0111223467777777754


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      .++....-+...  ..++||||++|++|.++...        +....++.|++.++.|||+.   +||||||||.|||++
T Consensus       173 ~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          173 EGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR  239 (397)
T ss_dssp             TTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred             cCCCCCeeeecc--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence            443222212122  23799999998888765431        23457889999999999998   999999999999998


Q ss_pred             CCCC----------eEEccccCccccc
Q 001867          836 GDFG----------ARVADFGVAKVVD  852 (1002)
Q Consensus       836 ~~~~----------~kl~DfGl~~~~~  852 (1002)
                      +++.          +.|+||+-+....
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCcccccccccceEEEEeCCcccCC
Confidence            7763          8999999887544

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.62  E-value=3.6e-16  Score=151.55  Aligned_cols=127  Identities=20%  Similarity=0.198  Sum_probs=58.6

Q ss_pred             CCCcEEEccCcccc-CCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccccc
Q 001867          405 QSLTRVRLGYNRLT-GKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLS  483 (1002)
Q Consensus       405 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  483 (1002)
                      ++|+.|++++|+++ +.+|..+..+++|+.|++++|.+++.                          ..++.+++|+.|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~~l~~L~~L~   70 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--------------------------ANLPKLNKLKKLE   70 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--------------------------TTCCCCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--------------------------hhhhcCCCCCEEE
Confidence            45555555555555 44454444444444444444444433                          2333344444444


Q ss_pred             ccccccCCCCcccccccccCCeeecCCCcCCcc-cccccccccccccccccCcccccCCC---CCccccccccEEeCc
Q 001867          484 GSENKFTGSLPESLTNLAELGSLDLHANDLSGE-LPSSVSSWKKLNELNLADNLFYGNIP---EDIGNLSVLNYLDLS  557 (1002)
Q Consensus       484 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ip---~~~~~l~~L~~L~Ls  557 (1002)
                      +++|++++.+|..+..+++|++|++++|++++. .|..++.+++|+.|++++|.+++..+   ..++.+++|++||++
T Consensus        71 Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            444444433444444444444444444444432 22444444455555555555443322   234445555555544

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=4.6e-16  Score=150.84  Aligned_cols=129  Identities=24%  Similarity=0.210  Sum_probs=89.0

Q ss_pred             cCcccceeeeccccc-cCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEE
Q 001867          380 KGELEELLMIYNSFT-GQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLL  458 (1002)
Q Consensus       380 l~~L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  458 (1002)
                      .++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++|+.|++++|.+++.+|..+..+++|+.|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            478999999999999 78999999999999999999999976  677778888877777777776555555556666666


Q ss_pred             EccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccc---ccccccccccccccc
Q 001867          459 IISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELP---SSVSSWKKLNELNLA  533 (1002)
Q Consensus       459 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls  533 (1002)
                      ++++|++++. |                      .|..+..+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        94 ~ls~N~i~~~-~----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDL-S----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSH-H----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCCh-H----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            6666665532 1                      12444455555555555555554433   345555555555554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.61  E-value=1.5e-15  Score=154.01  Aligned_cols=110  Identities=25%  Similarity=0.288  Sum_probs=95.5

Q ss_pred             CcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccc
Q 001867          453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL  532 (1002)
Q Consensus       453 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  532 (1002)
                      ++|+.|+|++|+++ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            46777888888887 67788888888999999999998777788999999999999999999888889999999999999


Q ss_pred             cCcccccCCCCCccccccccEEeCcceeeec
Q 001867          533 ADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       533 s~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      ++|.|++..+..|..+++|+.|+|++|++..
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            9999996555678899999999999999985

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.61  E-value=1e-15  Score=153.15  Aligned_cols=133  Identities=21%  Similarity=0.197  Sum_probs=92.8

Q ss_pred             ccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccC
Q 001867          455 LSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLAD  534 (1002)
Q Consensus       455 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  534 (1002)
                      .+.+++++|+++ .+|..+  .++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|+.+++|++|+|++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            345666666666 445433  35677777777777765555667777777777777777766666677777777777777


Q ss_pred             cccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCCh
Q 001867          535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPS  590 (1002)
Q Consensus       535 N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~  590 (1002)
                      |.+++..+..+..+++|++|+|++|++++..+..+..+ +|+.|+|++|++++..|.
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            77776555567777778888888887776555455666 677788888888777663

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.60  E-value=1.9e-15  Score=151.09  Aligned_cols=114  Identities=23%  Similarity=0.194  Sum_probs=91.6

Q ss_pred             CcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccc
Q 001867          453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL  532 (1002)
Q Consensus       453 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  532 (1002)
                      ++|+.|++++|++++..+..++.+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            46677777777777655666777888888888888888666666788888888889888888877778888899999999


Q ss_pred             cCcccccCCCCCccccccccEEeCcceeeecccC
Q 001867          533 ADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIP  566 (1002)
Q Consensus       533 s~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip  566 (1002)
                      ++|.+++..+..+..+++|++|+|++|++++..|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            9999986555556889999999999999987665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.56  E-value=2.6e-14  Score=161.74  Aligned_cols=256  Identities=13%  Similarity=0.076  Sum_probs=135.4

Q ss_pred             ccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCC
Q 001867          229 EIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTR  308 (1002)
Q Consensus       229 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  308 (1002)
                      +...+|.++ +|+.+++..| ++.+...+|.+ .+|+.+.+.+ .+..+.+.+|.++++|+.++++.|+++......|..
T Consensus       127 I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~  202 (401)
T 4fdw_A          127 IPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVY  202 (401)
T ss_dssp             ECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTT
T ss_pred             ehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEee
Confidence            334445543 4666665544 55455555655 3566666664 555555567777777777777777776444444444


Q ss_pred             CCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceee
Q 001867          309 LPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLM  388 (1002)
Q Consensus       309 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  388 (1002)
                      ..|+.+.|..+ ++......|.++++|+.+.+..| ++.+...+|.+ .+|+.+++ .|.++......|..+.+|+.+.+
T Consensus       203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l  278 (401)
T 4fdw_A          203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT  278 (401)
T ss_dssp             CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred             cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence            44666666533 55455566666666666666553 44444445554 55666655 23344333444444444444444


Q ss_pred             eccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCC
Q 001867          389 IYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGS  468 (1002)
Q Consensus       389 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~  468 (1002)
                      .+|.+..                   +.+..+.+.+|.++++|+.+++. +.++.+....|.++.+|+.++|..| ++..
T Consensus       279 ~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I  337 (401)
T 4fdw_A          279 YGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQI  337 (401)
T ss_dssp             ESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEE
T ss_pred             CCccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEE
Confidence            4443320                   00002334445555555555555 2344444555555555555555333 4333


Q ss_pred             CccccccccccccccccccccCCCCcccccccc-cCCeeecCCCcCC
Q 001867          469 LPEEIGFLKSLVVLSGSENKFTGSLPESLTNLA-ELGSLDLHANDLS  514 (1002)
Q Consensus       469 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~  514 (1002)
                      -+..|..+ +|+.+++++|.+....+..|..++ +++.|++..|.+.
T Consensus       338 ~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          338 NFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             cHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            34455555 566666666655544445555553 5667776666544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.55  E-value=2.3e-14  Score=162.22  Aligned_cols=248  Identities=9%  Similarity=-0.006  Sum_probs=134.3

Q ss_pred             CccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCC
Q 001867          280 TGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPL  359 (1002)
Q Consensus       280 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  359 (1002)
                      .+|.++ +|+.+++..| ++......|....|+.+.+.. .++...+..|.++++|+.+++.+|+++.+....|. .++|
T Consensus       130 ~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L  205 (401)
T 4fdw_A          130 DAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGI  205 (401)
T ss_dssp             TTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCC
T ss_pred             hhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-eccc
Confidence            344442 4555554433 332222233333344444442 33334444555555555555555555544444444 3455


Q ss_pred             ceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccC
Q 001867          360 RWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDN  439 (1002)
Q Consensus       360 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  439 (1002)
                      +.+.|.++ ++                        .....+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .|
T Consensus       206 ~~l~lp~~-l~------------------------~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~  257 (401)
T 4fdw_A          206 EEVLLPVT-LK------------------------EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PN  257 (401)
T ss_dssp             SEEECCTT-CC------------------------EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ET
T ss_pred             CEEEeCCc-hh------------------------eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CC
Confidence            55555422 33                        333444444444555554432 33333334444 44555555 23


Q ss_pred             cccCccccccccCCcccEEEccCCcCC-----CCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCC
Q 001867          440 FLSGEISKNIAGAANLSLLIISKNNLS-----GSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       440 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      .++.+....|.++.+|+.+++.+|.+.     ...+..|..+++|+.+.+. |.++..-..+|.++++|+.++|.+| ++
T Consensus       258 ~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~  335 (401)
T 4fdw_A          258 GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT  335 (401)
T ss_dssp             TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC
T ss_pred             CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc
Confidence            344444555555555666655555443     2334566677777777777 3466445567777888888888554 66


Q ss_pred             cccccccccccccccccccCcccccCCCCCccccc-cccEEeCcceeee
Q 001867          515 GELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLS-VLNYLDLSNNRLS  562 (1002)
Q Consensus       515 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~-~L~~L~Ls~N~l~  562 (1002)
                      ..-+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..|.+.
T Consensus       336 ~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          336 QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            5667778888 888888888877755556677774 6777877766544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=4.1e-17  Score=166.59  Aligned_cols=111  Identities=19%  Similarity=0.206  Sum_probs=49.3

Q ss_pred             cCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccc
Q 001867          451 GAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNEL  530 (1002)
Q Consensus       451 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  530 (1002)
                      .+++|+.|++++|++++ +| .++.+++|+.|++++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.|
T Consensus        46 ~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L  120 (198)
T 1ds9_A           46 TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL  120 (198)
T ss_dssp             HTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE
T ss_pred             cCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEE
Confidence            33333334444443332 33 3444444444444444444 334444444444444444444443 22 34444455555


Q ss_pred             cccCcccccCCC--CCccccccccEEeCcceeeecccCC
Q 001867          531 NLADNLFYGNIP--EDIGNLSVLNYLDLSNNRLSGRIPV  567 (1002)
Q Consensus       531 ~Ls~N~l~~~ip--~~~~~l~~L~~L~Ls~N~l~~~ip~  567 (1002)
                      +|++|.+++ +|  ..+..+++|++|++++|++++.+|.
T Consensus       121 ~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A          121 YMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             EESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             ECCCCcCCc-hhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            555555442 22  2444555555555555555544443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=9.6e-17  Score=163.83  Aligned_cols=155  Identities=25%  Similarity=0.325  Sum_probs=112.4

Q ss_pred             CcCCCCCcEEEccCccccCCCCC------cCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPP------LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIG  474 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  474 (1002)
                      +.....++.++++.|.+++..|.      .+..+++|+.|++++|.+++ +| .+..+++|+.|++++|+++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            34456677777777777777776      67777888888888888776 34 7777788888888888877 6677777


Q ss_pred             cccccccccccccccCCCCcccccccccCCeeecCCCcCCcccc-cccccccccccccccCcccccCCCCC---------
Q 001867          475 FLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELP-SSVSSWKKLNELNLADNLFYGNIPED---------  544 (1002)
Q Consensus       475 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip~~---------  544 (1002)
                      .+++|+.|++++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+++.+|..         
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            77788888888888874 45 57777888888888888775433 46777788888888888887666653         


Q ss_pred             -ccccccccEEeCcceeee
Q 001867          545 -IGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       545 -~~~l~~L~~L~Ls~N~l~  562 (1002)
                       +..+++|+.||  +|.++
T Consensus       169 ~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          169 VVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHCSSCSEEC--CGGGT
T ss_pred             HHHhCCCcEEEC--CcccC
Confidence             66777777766  55444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.52  E-value=8.6e-15  Score=146.19  Aligned_cols=133  Identities=20%  Similarity=0.174  Sum_probs=72.2

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +.++.+|++|++++|+++. +|......++|+.|++++|.|++.                          ..++.+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--------------------------~~l~~l~~L~   67 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--------------------------DGFPLLRRLK   67 (176)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--------------------------CCCCCCSSCC
T ss_pred             cCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--------------------------cccccCCCCC
Confidence            3455666666666666663 233222222444444444444432                          3444455555


Q ss_pred             cccccccccCCCCcccccccccCCeeecCCCcCCccccc--ccccccccccccccCcccccCCCCC----ccccccccEE
Q 001867          481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPS--SVSSWKKLNELNLADNLFYGNIPED----IGNLSVLNYL  554 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~ip~~----~~~l~~L~~L  554 (1002)
                      .|++++|++++..|..+..+++|+.|+|++|+++ .+|.  .+..+++|+.|+|++|.++ .+|..    ++.+++|+.|
T Consensus        68 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~L  145 (176)
T 1a9n_A           68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL  145 (176)
T ss_dssp             EEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred             EEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcccee
Confidence            5555555555332233355566666666666664 3343  5566666666666666665 45553    6667777777


Q ss_pred             eCcceeee
Q 001867          555 DLSNNRLS  562 (1002)
Q Consensus       555 ~Ls~N~l~  562 (1002)
                      |+++|.+.
T Consensus       146 d~~~n~~~  153 (176)
T 1a9n_A          146 DFQKVKLK  153 (176)
T ss_dssp             TTEECCHH
T ss_pred             CCCcCCHH
Confidence            77777654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.52  E-value=6.1e-15  Score=147.25  Aligned_cols=133  Identities=16%  Similarity=0.197  Sum_probs=114.4

Q ss_pred             ccccCCcccEEEccCCcCCCCCcccccccc-ccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccc
Q 001867          448 NIAGAANLSLLIISKNNLSGSLPEEIGFLK-SLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK  526 (1002)
Q Consensus       448 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  526 (1002)
                      .+..+.+|+.|++++|+++ .+|. +..+. +|+.|++++|++++.  ..+..+++|++|+|++|+|++..|..|+.+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            4566788999999999998 4555 44544 999999999999964  68999999999999999999776677799999


Q ss_pred             cccccccCcccccCCCC--CccccccccEEeCcceeeecccCCc----cccc-ccceEEeccccCcC
Q 001867          527 LNELNLADNLFYGNIPE--DIGNLSVLNYLDLSNNRLSGRIPVG----LQNL-KLNQLNVSNNRLSG  586 (1002)
Q Consensus       527 L~~L~Ls~N~l~~~ip~--~~~~l~~L~~L~Ls~N~l~~~ip~~----~~~l-~L~~l~ls~N~l~g  586 (1002)
                      |+.|+|++|.++ .+|.  .++.+++|+.|+|++|+++ .+|..    +..+ +|+.||+++|.+..
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            999999999996 6777  8999999999999999998 56764    7777 89999999998763

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.52  E-value=9.9e-14  Score=157.77  Aligned_cols=315  Identities=11%  Similarity=0.036  Sum_probs=140.1

Q ss_pred             CCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccc
Q 001867          105 INSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAF  184 (1002)
Q Consensus       105 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  184 (1002)
                      ++.+-..+|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.....+|.++.+|+.+.+..+ +......+
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            3334445666666666666653 244444555666666666666543 33333445555555555544432 22233333


Q ss_pred             cccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccce
Q 001867          185 LGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASV  264 (1002)
Q Consensus       185 l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L  264 (1002)
                      |.++..+........                           ......+|.++++|+.+.+..+. ......+|.++.+|
T Consensus       136 F~~~~~~~~~~~~~~---------------------------~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L  187 (394)
T 4fs7_A          136 FKGCDFKEITIPEGV---------------------------TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKL  187 (394)
T ss_dssp             TTTCCCSEEECCTTC---------------------------CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTC
T ss_pred             eecccccccccCccc---------------------------cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCc
Confidence            433322222211111                           11223345555555555554332 22334455555555


Q ss_pred             eeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccc
Q 001867          265 VQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNR  344 (1002)
Q Consensus       265 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  344 (1002)
                      +.+.+..| ++.....+|.++..|+.+.+..+... .....+....|+.+.+..+ ++......+.++..|+.+.+..+.
T Consensus       188 ~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~  264 (394)
T 4fs7_A          188 KSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK  264 (394)
T ss_dssp             CBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT
T ss_pred             eEEEcCCC-ceEeCchhhccccccceeecCCCceE-eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCc
Confidence            55555444 33334445666666666655544332 1111122223444444322 222333445555555555555443


Q ss_pred             cCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCc
Q 001867          345 LNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPL  424 (1002)
Q Consensus       345 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  424 (1002)
                      .. +....|.....++.+....+.+.   ...|....+|+.+.+.++ ++.....+|.++.+|+.++|..+ ++.+...+
T Consensus       265 ~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          265 LR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             CE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             ce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence            32 44445555555555555544332   223444444444444332 33333444444555555544322 33333334


Q ss_pred             CCCCCcceEEEcccCcccCccccccccCCcccEEEc
Q 001867          425 LWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLII  460 (1002)
Q Consensus       425 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  460 (1002)
                      |.++.+|+.+++..| ++.+...+|.++.+|+.+++
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l  373 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVEL  373 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence            444444444444333 33333333444444444433

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.51  E-value=1.8e-13  Score=155.58  Aligned_cols=335  Identities=11%  Similarity=0.015  Sum_probs=220.1

Q ss_pred             cCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcc
Q 001867           81 IAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPES  160 (1002)
Q Consensus        81 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~  160 (1002)
                      ++.+-..+|.++++|+.+.|.. .++.+-..+|.+|++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +......+
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            4444567899999999999975 477777889999999999999865 66566788999999999988765 44456677


Q ss_pred             cccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCccccccccccccccccc
Q 001867          161 FGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKL  240 (1002)
Q Consensus       161 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  240 (1002)
                      |.+...++.......  ......+|.++++|+.+.+..+..  ..-...|.++++|+.+.+..+ ++.....+|.++..|
T Consensus       136 F~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~--~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L  210 (394)
T 4fs7_A          136 FKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSME--TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL  210 (394)
T ss_dssp             TTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCC--EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred             eecccccccccCccc--cccchhhhcccCCCcEEecCCccc--eeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence            877765554443333  334457789999999999987642  222346778888888888766 554666778888888


Q ss_pred             chhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCCc
Q 001867          241 VDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENR  320 (1002)
Q Consensus       241 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~  320 (1002)
                      +.+.+..+...  +........+|+.+.+..+ ++.....+|..+..|+.+.+..+...                     
T Consensus       211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~---------------------  266 (394)
T 4fs7_A          211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR---------------------  266 (394)
T ss_dssp             CBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE---------------------
T ss_pred             ceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce---------------------
Confidence            88887765443  2222333456666666433 23344455666777777766655432                     


Q ss_pred             ccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCc
Q 001867          321 LEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDG  400 (1002)
Q Consensus       321 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  400 (1002)
                         .....|..+..++.+....+.+   ....|....+|+.+.+.++ ++.....+|..+.+|+.+.+.++ ++.....+
T Consensus       267 ---i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          267 ---IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             ---ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             ---eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence               2233344444444444443332   2234556666666666544 44444556666677777776533 55555677


Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEE
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLL  458 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  458 (1002)
                      |.+|.+|+.+++..| ++.+...+|.++++|+.+++..+ +. .+...|.++++|+.+
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            788888888888766 66566777888888888888655 22 234567777776654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=6.3e-14  Score=138.78  Aligned_cols=105  Identities=27%  Similarity=0.267  Sum_probs=59.6

Q ss_pred             cEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCc
Q 001867          456 SLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADN  535 (1002)
Q Consensus       456 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  535 (1002)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|||++|+|++..|..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            45666666665 3454432  55556666666666555555556666666666666666555555555555666666666


Q ss_pred             ccccCCCCCccccccccEEeCcceeeec
Q 001867          536 LFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       536 ~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      +|++..|..|..+++|++|+|++|+++.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            5554444445555555555555555554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.45  E-value=1.1e-13  Score=137.06  Aligned_cols=110  Identities=21%  Similarity=0.232  Sum_probs=99.4

Q ss_pred             ccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCc
Q 001867          478 SLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLS  557 (1002)
Q Consensus       478 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls  557 (1002)
                      ..+.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            4678999999999 5787664  899999999999999999999999999999999999997767778999999999999


Q ss_pred             ceeeecccCCccccc-ccceEEeccccCcCCCCh
Q 001867          558 NNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPS  590 (1002)
Q Consensus       558 ~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~  590 (1002)
                      +|+|++..|..+..+ +|+.|+|++|++++..+.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            999998777778888 899999999999987663

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.44  E-value=1.6e-13  Score=136.41  Aligned_cols=105  Identities=24%  Similarity=0.248  Sum_probs=62.9

Q ss_pred             cEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCc
Q 001867          456 SLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADN  535 (1002)
Q Consensus       456 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  535 (1002)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45666666665 4555443  56666666666666555666666666666666666666555555566666666666666


Q ss_pred             ccccCCCCCccccccccEEeCcceeeec
Q 001867          536 LFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       536 ~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      +|++..+..|..+++|++|+|++|++..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccc
Confidence            6664333346666666666666666653

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=2.9e-13  Score=134.43  Aligned_cols=110  Identities=28%  Similarity=0.325  Sum_probs=82.0

Q ss_pred             eeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCcccccc
Q 001867           61 GVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADL  140 (1002)
Q Consensus        61 gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L  140 (1002)
                      +++|..     +.+++++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+
T Consensus         9 ~C~C~~-----~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l   80 (174)
T 2r9u_A            9 QCSCDQ-----TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKL   80 (174)
T ss_dssp             TSEECS-----SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             CCEECC-----cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCc
Confidence            556742     46888888886 4555553  788888888888888778888888888888888888886655667777


Q ss_pred             CCccccccccccccCCCCcccccccccceeeecccccc
Q 001867          141 PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLD  178 (1002)
Q Consensus       141 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  178 (1002)
                      ++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        81 ~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           81 TQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             chhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            88888888888877655556777777777777777766

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.30  E-value=2.7e-12  Score=143.25  Aligned_cols=102  Identities=22%  Similarity=0.191  Sum_probs=52.4

Q ss_pred             ccccc-ccCCCCcccccccccCCeeecCC-CcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCccee
Q 001867          483 SGSEN-KFTGSLPESLTNLAELGSLDLHA-NDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       483 ~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                      +++++ +++ .+|. +..+++|+.|+|++ |.|++..|..|+.|++|+.|+|++|+|++.+|..|++|++|++|||++|+
T Consensus        14 ~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~   91 (347)
T 2ifg_A           14 RCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (347)
T ss_dssp             ECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence            44444 444 3444 55555555555553 55555444555555555555555555555445555555555555555555


Q ss_pred             eecccCCcccccccceEEeccccCcC
Q 001867          561 LSGRIPVGLQNLKLNQLNVSNNRLSG  586 (1002)
Q Consensus       561 l~~~ip~~~~~l~L~~l~ls~N~l~g  586 (1002)
                      |++.+|..+..+.|+.|+|++|+|..
T Consensus        92 l~~~~~~~~~~~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A           92 LESLSWKTVQGLSLQELVLSGNPLHC  117 (347)
T ss_dssp             CSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             cceeCHHHcccCCceEEEeeCCCccC
Confidence            55444444444445555555555543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.30  E-value=1.8e-14  Score=161.44  Aligned_cols=159  Identities=21%  Similarity=0.152  Sum_probs=77.4

Q ss_pred             CCCcEEEccCccccCCCCCcCC-----CCCcceEEEcccCcccCcccccc-ccCCcccEEEccCCcCCCCCccccc----
Q 001867          405 QSLTRVRLGYNRLTGKVPPLLW-----GLPHVYLLELTDNFLSGEISKNI-AGAANLSLLIISKNNLSGSLPEEIG----  474 (1002)
Q Consensus       405 ~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~----  474 (1002)
                      ++|+.|+|++|+++......+.     ..++|+.|+|++|.|+......+ ..+.+|+.|+|++|+++......++    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            4566666666666532222221     11455556666655543322222 2234566666666666533333332    


Q ss_pred             -cccccccccccccccCC----CCcccccccccCCeeecCCCcCCccc----ccccccccccccccccCcccccC----C
Q 001867          475 -FLKSLVVLSGSENKFTG----SLPESLTNLAELGSLDLHANDLSGEL----PSSVSSWKKLNELNLADNLFYGN----I  541 (1002)
Q Consensus       475 -~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----i  541 (1002)
                       ..++|+.|+|++|.|+.    .++..+..+++|++|||++|.|++..    +..+...++|+.|+|++|.|+..    +
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence             23455666666665542    12233344555666666666655322    33444455555555555555432    2


Q ss_pred             CCCccccccccEEeCcceeeec
Q 001867          542 PEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       542 p~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      +..+...++|++|||++|+++.
T Consensus       232 ~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          232 ARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHHHCSSCCEEECTTSSCCH
T ss_pred             HHHHHhCCCCCEEeccCCCCCH
Confidence            2333344556666666665554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.25  E-value=5.9e-11  Score=134.80  Aligned_cols=90  Identities=11%  Similarity=0.084  Sum_probs=47.8

Q ss_pred             CCCCCCccccC-cccccccccccccCCCCccccccCCcccccccccc---ccCCCCcccccccccceeeeccccccCccc
Q 001867          107 STLPDDISACQ-NLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN---FSGDIPESFGRFQKLEVISLVYNLLDGTIP  182 (1002)
Q Consensus       107 ~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  182 (1002)
                      .+-..+|.++. .|+.+.+..+ ++.+...+|.++++|+.+.++.|.   ++..-..+|.++.+|+.+.+..+ ++.+..
T Consensus        53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~  130 (394)
T 4gt6_A           53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS  130 (394)
T ss_dssp             EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred             EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence            33445666663 4666666543 554555666666666666666553   44333445555555555555433 332334


Q ss_pred             cccccccccccccccC
Q 001867          183 AFLGNISTLKMLNLSY  198 (1002)
Q Consensus       183 ~~l~~l~~L~~L~Ls~  198 (1002)
                      .+|.++.+|+.+.+..
T Consensus       131 ~aF~~c~~L~~i~lp~  146 (394)
T 4gt6_A          131 EAFHHCEELDTVTIPE  146 (394)
T ss_dssp             TTTTTCTTCCEEECCT
T ss_pred             hhhhhhcccccccccc
Confidence            4455555555555543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.24  E-value=5.3e-11  Score=135.14  Aligned_cols=334  Identities=11%  Similarity=0.099  Sum_probs=198.6

Q ss_pred             CCCccccCCC-CCCEEeccCCCCCCCCCCCccccCccccccccccc---ccCCCCccccccCCccccccccccccCCCCc
Q 001867           84 PFPSLLCRLE-NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNL---LTGTLTPALADLPNLKFLDLTGNNFSGDIPE  159 (1002)
Q Consensus        84 ~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~  159 (1002)
                      +-..+|.+.. .|+.+.+..+ ++.+-..+|.++++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++.....
T Consensus        54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~  131 (394)
T 4gt6_A           54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE  131 (394)
T ss_dssp             ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred             cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence            3455787774 5999999764 777778899999999999998874   66566778999999999998766 5546667


Q ss_pred             ccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccc
Q 001867          160 SFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAK  239 (1002)
Q Consensus       160 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  239 (1002)
                      +|..+.+|+.+.+..+ +..+....|.++.+|+.+.+..+-   ..+........+|+.+.+..+-.. ....+|..+.+
T Consensus       132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~~---~~I~~~aF~~~~l~~i~ip~~~~~-i~~~af~~c~~  206 (394)
T 4gt6_A          132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDSV---TAIEERAFTGTALTQIHIPAKVTR-IGTNAFSECFA  206 (394)
T ss_dssp             TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTTC---CEECTTTTTTCCCSEEEECTTCCE-ECTTTTTTCTT
T ss_pred             hhhhhcccccccccce-eeeecccceeccccccccccccee---eEeccccccccceeEEEECCcccc-cccchhhhccc
Confidence            8999999999999754 444667788889999998887662   123222222345666666544322 44455666655


Q ss_pred             cchhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCCcceeecCCC
Q 001867          240 LVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYEN  319 (1002)
Q Consensus       240 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N  319 (1002)
                      +.......+..... ...+                       +.............          .....+..+.+. +
T Consensus       207 l~~~~~~~~~~~~~-~~~~-----------------------~~~~~~~~~~~~~~----------~~~~~~~~~~ip-~  251 (394)
T 4gt6_A          207 LSTITSDSESYPAI-DNVL-----------------------YEKSANGDYALIRY----------PSQREDPAFKIP-N  251 (394)
T ss_dssp             CCEEEECCSSSCBS-SSCE-----------------------EEECTTSCEEEEEC----------CTTCCCSEEECC-T
T ss_pred             cceecccccccccc-ccee-----------------------eccccccccccccc----------ccccccceEEcC-C
Confidence            55554443333211 1110                       00000000000000          000001111111 1


Q ss_pred             cccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCC
Q 001867          320 RLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPD  399 (1002)
Q Consensus       320 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  399 (1002)
                      .+.......|.++..|+.+.+.++... +...+|.+.+.|+.+.+. +.++......|.++.+|+.+.+..+ ++.....
T Consensus       252 ~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~  328 (394)
T 4gt6_A          252 GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDD  328 (394)
T ss_dssp             TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred             cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence            222233445666666666666544332 445566667777777775 4455455566667777777777643 5555667


Q ss_pred             cCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCC
Q 001867          400 GLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLS  466 (1002)
Q Consensus       400 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~  466 (1002)
                      +|.+|.+|+.+.+..+ ++.+...+|.++.+|+.+++.+|....   ..+....+|+.+.+..|.+.
T Consensus       329 aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          329 AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred             HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence            7888888888888644 665666778888888888888776532   35667778888887776553

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.22  E-value=1.1e-13  Score=155.04  Aligned_cols=188  Identities=21%  Similarity=0.157  Sum_probs=101.2

Q ss_pred             CCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCc-CCCCCcEEEccCccccCCCCCcC-CCCCcceEE
Q 001867          357 SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLG-HCQSLTRVRLGYNRLTGKVPPLL-WGLPHVYLL  434 (1002)
Q Consensus       357 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L  434 (1002)
                      +.|+.|+|++|.++......+...                    +. ..++|++|+|++|.++......+ ..+++|+.|
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~--------------------L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L  131 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAV--------------------LGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL  131 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHH--------------------HSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEE
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHH--------------------HhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHh
Confidence            457777777777764433333322                    00 11344444444444432211111 123445555


Q ss_pred             EcccCcccCcccccc-----ccCCcccEEEccCCcCCCC----CccccccccccccccccccccCCC----Ccccccccc
Q 001867          435 ELTDNFLSGEISKNI-----AGAANLSLLIISKNNLSGS----LPEEIGFLKSLVVLSGSENKFTGS----LPESLTNLA  501 (1002)
Q Consensus       435 ~L~~N~i~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~  501 (1002)
                      +|++|.|+......+     ...++|+.|+|++|.++..    ++..+..+++|+.|+|++|+|+..    ++..+...+
T Consensus       132 ~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~  211 (372)
T 3un9_A          132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR  211 (372)
T ss_dssp             ECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred             hcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence            555555544333332     1345666777777766532    233345566777777777777632    245566677


Q ss_pred             cCCeeecCCCcCCcc----cccccccccccccccccCcccccCCCCCcccc---cc--ccEEe--Ccceeeecc
Q 001867          502 ELGSLDLHANDLSGE----LPSSVSSWKKLNELNLADNLFYGNIPEDIGNL---SV--LNYLD--LSNNRLSGR  564 (1002)
Q Consensus       502 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l---~~--L~~L~--Ls~N~l~~~  564 (1002)
                      +|+.|||++|.|++.    ++..+...++|++|+|++|.|+..-...+..+   ..  |+.+.  +..|.++..
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~~~  285 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEY  285 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CHHH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccCHH
Confidence            888888888888753    33444556788888888888875444444433   22  77777  777777643

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.22  E-value=8.4e-12  Score=139.27  Aligned_cols=104  Identities=25%  Similarity=0.188  Sum_probs=86.0

Q ss_pred             EEEccCC-cCCCCCccccccccccccccccc-cccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccC
Q 001867          457 LLIISKN-NLSGSLPEEIGFLKSLVVLSGSE-NKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLAD  534 (1002)
Q Consensus       457 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  534 (1002)
                      .++.+++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|.+|++|+.|||++|+|++.+|..|.+|++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4577777 787 5777 88888899999986 888877778889999999999999999988888899999999999999


Q ss_pred             cccccCCCCCccccccccEEeCcceeeec
Q 001867          535 NLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       535 N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      |+|++..|..+..++ |+.|+|++|+|..
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            999855555555555 9999999999874

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=5.6e-11  Score=126.89  Aligned_cols=145  Identities=17%  Similarity=0.078  Sum_probs=112.7

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      ..++|++...+|.|+++.||++... ++.+++|+.....                 ......+.+|+.+++.+. +..+.
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~-----------------~~~~~~~~~E~~~l~~l~~~~~vP   73 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-----------------KGTTYDVEREKDMMLWLEGKLPVP   73 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGG-----------------TTSTTCHHHHHHHHHHHTTTSCCC
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCccc-----------------CCCHHHHHHHHHHHHHHhcCCCCC
Confidence            4567877888898999999999754 6899999873210                 012345889999999885 67788


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC---------------------  818 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------  818 (1002)
                      ++++++.+.+..|+||||++|.+|.+.+.       +......++.+++++++.||+..                     
T Consensus        74 ~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~  146 (263)
T 3tm0_A           74 KVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL  146 (263)
T ss_dssp             CEEEEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred             eEEEEEecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence            99999999899999999999999887642       11224578899999999999810                     


Q ss_pred             -----------------------------------CCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          819 -----------------------------------VPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       819 -----------------------------------~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                                                         .+.++|+|++|.||+++.+..+.|+||+.+..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                               13689999999999998765567999997753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.04  E-value=2e-10  Score=122.33  Aligned_cols=129  Identities=18%  Similarity=0.133  Sum_probs=97.5

Q ss_pred             eecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc--eeeeeeEEecCC
Q 001867          692 GSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN--IVKLWCCCTTRD  769 (1002)
Q Consensus       692 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~  769 (1002)
                      +.|..+.||++...+|+.+++|+....                    ....+.+|+.+++.+.+.+  +.+++++....+
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--------------------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~   88 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--------------------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG   88 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC--------------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc--------------------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence            466679999998777888999986221                    1245788999999886434  566888888888


Q ss_pred             eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 001867          770 CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC-------------------------------  818 (1002)
Q Consensus       770 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------------------------------  818 (1002)
                      ..++||||++|.++.  ...     .+   ...++.+++..++.||+..                               
T Consensus        89 ~~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (264)
T 1nd4_A           89 RDWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL  158 (264)
T ss_dssp             CEEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred             CCEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence            899999999998884  221     12   2367788888899998742                               


Q ss_pred             ------------------------CCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          819 ------------------------VPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       819 ------------------------~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                                              ...++|||++|.||+++.++.+.|+|||.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                    01399999999999998766667999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.90  E-value=4.2e-09  Score=117.80  Aligned_cols=144  Identities=15%  Similarity=0.217  Sum_probs=107.6

Q ss_pred             cCCeeeecCCccEEEEEEcCCcEEEEEEee--ccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--CCceeeee
Q 001867          687 EDNVIGSGSSGKVYKVVLSNGEAVAVKKLW--RGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--HKNIVKLW  762 (1002)
Q Consensus       687 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~  762 (1002)
                      ..+.++.|.++.||++... +..+++|+..  ...                .......+.+|+.+++.+.  +..+++++
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~----------------~~~~~~~~~~E~~~l~~L~~~~vpvP~~~  104 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK----------------LLPSAHAIEREYRVMDALAGTDVPVAKMY  104 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC--------------------------CHHHHHHHHHHHTTSSSCCCCEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC----------------CCCcHHHHHHHHHHHHHhhcCCCCCCcEE
Confidence            3567899999999998875 4678888753  110                0112356888999999987  45678899


Q ss_pred             eEEecC---CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------
Q 001867          763 CCCTTR---DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC---------------------  818 (1002)
Q Consensus       763 ~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------  818 (1002)
                      +++.+.   +..|+||||++|..+.+..    ...++..+...++.+++..|+.||+..                     
T Consensus       105 ~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3dxp_A          105 ALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIE  180 (359)
T ss_dssp             EEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHH
T ss_pred             EECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHH
Confidence            888776   4589999999988775421    134778889999999999999999731                     


Q ss_pred             ----------------------------------CCCeeeCCCCCCcEEECCCCC--eEEccccCcccc
Q 001867          819 ----------------------------------VPSIVHRDVKSNNILLDGDFG--ARVADFGVAKVV  851 (1002)
Q Consensus       819 ----------------------------------~~~iiHrDlk~~NIll~~~~~--~kl~DfGl~~~~  851 (1002)
                                                        .+.++|||+++.||+++.++.  +.|+||+.+..-
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          181 RWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                              247999999999999987653  689999998753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.87  E-value=2.1e-08  Score=112.99  Aligned_cols=147  Identities=12%  Similarity=0.066  Sum_probs=86.5

Q ss_pred             CCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccc
Q 001867          398 PDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLK  477 (1002)
Q Consensus       398 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  477 (1002)
                      ...+..+.+|+.+.+..+ ++......|.+...|+.+.+..+ ++.+....|.++.+|+.+.+..+ +.......|..+.
T Consensus       210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~  286 (379)
T 4h09_A          210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS  286 (379)
T ss_dssp             TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred             ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence            344555566666666543 33344555666666666666554 44455556666666666666543 3323344566667


Q ss_pred             ccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccc
Q 001867          478 SLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLS  549 (1002)
Q Consensus       478 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~  549 (1002)
                      +|+.+.+.++.++..-..+|.++++|+.++|..+ ++.+-..+|.++.+|+.+.+..+ ++..-..+|.+.+
T Consensus       287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS  356 (379)
T ss_dssp             TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred             ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence            7777777766666444567777777777777654 55455567777777777777544 4422234455543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.86  E-value=3.3e-10  Score=125.60  Aligned_cols=85  Identities=13%  Similarity=0.262  Sum_probs=47.5

Q ss_pred             ccccCCeeecCCCcCCcccccccc---cccccccccccCcccccC----CCCCccccccccEEeCcceeeecccCCcccc
Q 001867          499 NLAELGSLDLHANDLSGELPSSVS---SWKKLNELNLADNLFYGN----IPEDIGNLSVLNYLDLSNNRLSGRIPVGLQN  571 (1002)
Q Consensus       499 ~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~  571 (1002)
                      .+++|+.|+|++|.+++..+..+.   .+++|+.|+|+.|.+++.    ++..+..+++|+.|+|++|.++...-..+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~  329 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK  329 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence            356677777777776644433332   466677777777776642    3444455677777777777666432222222


Q ss_pred             cccceEEecccc
Q 001867          572 LKLNQLNVSNNR  583 (1002)
Q Consensus       572 l~L~~l~ls~N~  583 (1002)
                      .-...+++++|+
T Consensus       330 alg~~~~~~~~~  341 (362)
T 2ra8_A          330 SLPMKIDVSDSQ  341 (362)
T ss_dssp             HCCSEEECCSBC
T ss_pred             HcCCEEEecCCc
Confidence            012345666655

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.85  E-value=2.3e-08  Score=112.78  Aligned_cols=109  Identities=15%  Similarity=0.065  Sum_probs=56.6

Q ss_pred             CCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcc
Q 001867          352 DLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV  431 (1002)
Q Consensus       352 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  431 (1002)
                      .|.....|+.+.+..+ ++......|....+|+.+.+..+ +.......|.++++|+.+.+.++.++.+...+|.++.+|
T Consensus       235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L  312 (379)
T 4h09_A          235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL  312 (379)
T ss_dssp             TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred             cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence            3344444444444433 33233334444444444444322 333334455566666666666665655555566666666


Q ss_pred             eEEEcccCcccCccccccccCCcccEEEccCC
Q 001867          432 YLLELTDNFLSGEISKNIAGAANLSLLIISKN  463 (1002)
Q Consensus       432 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N  463 (1002)
                      +.+.|.++ ++.+...+|.++.+|+.+.+..+
T Consensus       313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             CEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             CEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            66666543 44455566666677776666543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.81  E-value=7.4e-10  Score=122.82  Aligned_cols=155  Identities=18%  Similarity=0.220  Sum_probs=91.3

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccc--cCCcccEEEccC--CcCCCC-----Ccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIA--GAANLSLLIISK--NNLSGS-----LPE  471 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~  471 (1002)
                      +..+++|+.|+|++|.-. ..+. + .+++|+.|+|..|.+.......+.  .+++|+.|+|+.  |...+.     +..
T Consensus       168 l~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~  244 (362)
T 2ra8_A          168 LDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP  244 (362)
T ss_dssp             HHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG
T ss_pred             HhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH
Confidence            345566666666665211 1222 2 256677777766666543333333  566777777642  221111     111


Q ss_pred             cc--ccccccccccccccccCCCCccccc---ccccCCeeecCCCcCCcc----cccccccccccccccccCcccccCCC
Q 001867          472 EI--GFLKSLVVLSGSENKFTGSLPESLT---NLAELGSLDLHANDLSGE----LPSSVSSWKKLNELNLADNLFYGNIP  542 (1002)
Q Consensus       472 ~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip  542 (1002)
                      .+  ..+++|+.|+|++|.+++..+..+.   .+++|++|||+.|.|++.    ++..+..+++|+.|+|++|.++...-
T Consensus       245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~  324 (362)
T 2ra8_A          245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK  324 (362)
T ss_dssp             GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred             HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence            12  2467888888888887643333332   477889999999988864    34455678889999999888774322


Q ss_pred             CCccc-cccccEEeCccee
Q 001867          543 EDIGN-LSVLNYLDLSNNR  560 (1002)
Q Consensus       543 ~~~~~-l~~L~~L~Ls~N~  560 (1002)
                      ..+.. +  ...+++++|+
T Consensus       325 ~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          325 KELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHC--CSEEECCSBC
T ss_pred             HHHHHHc--CCEEEecCCc
Confidence            22332 2  3568888887

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.81  E-value=3.8e-09  Score=115.15  Aligned_cols=187  Identities=21%  Similarity=0.215  Sum_probs=123.1

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCc--eeeeeeE
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKN--IVKLWCC  764 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~  764 (1002)
                      .+.++.|....||++.    +.+++|+...                   ......+.+|+.+++.+. +..  +.+++..
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------------------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~   81 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------------------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFT   81 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS-------------------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC-------------------cchHHHHHHHHHHHHHHHhcCCCCCCceEee
Confidence            4579999999999863    5688887521                   133567899999998873 332  3445544


Q ss_pred             EecCC---eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc------------------------
Q 001867          765 CTTRD---CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD------------------------  817 (1002)
Q Consensus       765 ~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------  817 (1002)
                      ....+   ..|+|||+++|.++.+...    ..++..++..++.|++..++.||+.                        
T Consensus        82 ~~~~~~~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (304)
T 3sg8_A           82 GMPSETYQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKI  157 (304)
T ss_dssp             CCCCSSCSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHH
T ss_pred             cCCCCCCCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHH
Confidence            43332   3589999999988865332    2367788888999999999999961                        


Q ss_pred             -------------------------------CCCCeeeCCCCCCcEEECC--CCCeEEccccCcccccCCCCCccccc--
Q 001867          818 -------------------------------CVPSIVHRDVKSNNILLDG--DFGARVADFGVAKVVDASGKPKSMSV--  862 (1002)
Q Consensus       818 -------------------------------~~~~iiHrDlk~~NIll~~--~~~~kl~DfGl~~~~~~~~~~~~~~~--  862 (1002)
                                                     ..+.++|+|++|.||+++.  +..+.++||+.+...+..........  
T Consensus       158 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~  237 (304)
T 3sg8_A          158 KKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD  237 (304)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT
T ss_pred             HHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc
Confidence                                           1136899999999999997  45678999999876433210000000  


Q ss_pred             ----------ccccccccC-ccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          863 ----------IAGSCGYIA-PEYAYTLRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       863 ----------~~gt~~y~a-PE~~~~~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                                .....++.. |+.....  ....+.|++|.++|++.+|+.+|
T Consensus       238 ~~~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          238 EEYGMEFVSKILNHYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TSCCHHHHHHHHHHHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cccCHHHHHHHHHHcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence                      000001111 2221111  12368999999999999998665

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.71  E-value=1.6e-10  Score=121.31  Aligned_cols=160  Identities=18%  Similarity=0.153  Sum_probs=97.4

Q ss_pred             CCccceeEEeCCCCeEEEEEcCC---CCcCCCCC-ccccCCCCCCEEeccCCCCCCCCC-CCccccCcccc--ccccccc
Q 001867           56 PCSWRGVECDPRSHSVASIDLSN---ANIAGPFP-SLLCRLENLTFLTLFNNSINSTLP-DDISACQNLQH--LDLSQNL  128 (1002)
Q Consensus        56 ~C~w~gv~C~~~~~~v~~l~L~~---~~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~--L~Ls~N~  128 (1002)
                      .|.|.|+.|+....+|+.+...+   ..+.+.++ ..+..++.  .|..++|.-++.++ +.|...+.|..  ++++.|.
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            58999999998776776665543   22333332 22222221  22223333332222 12555666666  6777774


Q ss_pred             cc---CCCCccccccCCccccccccccccC--CCCcccccccccceeeeccccccCcccccccccc--ccccccccCCCC
Q 001867          129 LT---GTLTPALADLPNLKFLDLTGNNFSG--DIPESFGRFQKLEVISLVYNLLDGTIPAFLGNIS--TLKMLNLSYNPF  201 (1002)
Q Consensus       129 l~---~~~~~~~~~L~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~~  201 (1002)
                      ..   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|++|+|++|.+
T Consensus       155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl  232 (267)
T 3rw6_A          155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL  232 (267)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred             HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence            33   2222223567888888888888887  4556777888888888888888865  3344444  888889988886


Q ss_pred             CCCCCCc-------ccCCCCccchhh
Q 001867          202 LPGRIPP-------ELGNLTNLEILW  220 (1002)
Q Consensus       202 ~~~~~p~-------~~~~l~~L~~L~  220 (1002)
                      . +.+|.       .+..+++|+.|+
T Consensus       233 ~-~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          233 C-DTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             G-GGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             c-cccCcchhHHHHHHHHCcccCeEC
Confidence            3 34442       356677777765

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.46  E-value=1.5e-08  Score=106.39  Aligned_cols=16  Identities=31%  Similarity=0.268  Sum_probs=6.7

Q ss_pred             cccEEeCcceeeeccc
Q 001867          550 VLNYLDLSNNRLSGRI  565 (1002)
Q Consensus       550 ~L~~L~Ls~N~l~~~i  565 (1002)
                      +|++|+|++|.+++.+
T Consensus       221 ~L~~L~L~~Npl~~~~  236 (267)
T 3rw6_A          221 KLEELWLDGNSLCDTF  236 (267)
T ss_dssp             CCSEEECTTSTTGGGC
T ss_pred             CcceEEccCCcCcccc
Confidence            3444444444444333

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.32  E-value=3.6e-08  Score=98.57  Aligned_cols=112  Identities=19%  Similarity=0.159  Sum_probs=47.1

Q ss_pred             ccCCcccEEEccCC-cCCCC----CccccccccccccccccccccCCC----CcccccccccCCeeecCCCcCCcc----
Q 001867          450 AGAANLSLLIISKN-NLSGS----LPEEIGFLKSLVVLSGSENKFTGS----LPESLTNLAELGSLDLHANDLSGE----  516 (1002)
Q Consensus       450 ~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----  516 (1002)
                      ...++|+.|+|++| .+...    +...+...++|+.|+|++|+|+..    +...+...+.|++|+|++|.|++.    
T Consensus        33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~  112 (185)
T 1io0_A           33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA  112 (185)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence            33444555555554 44321    112222334444455555544321    122233334555555555555432    


Q ss_pred             cccccccccccccccc--cCcccccC----CCCCccccccccEEeCcceee
Q 001867          517 LPSSVSSWKKLNELNL--ADNLFYGN----IPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       517 ~p~~~~~l~~L~~L~L--s~N~l~~~----ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      +...+...+.|++|+|  ++|.|+..    +.+.+...++|++|+|++|++
T Consensus       113 l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A          113 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence            2233333444444555  44444422    122223334455555555544

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=2.5e-06  Score=90.98  Aligned_cols=135  Identities=18%  Similarity=0.142  Sum_probs=99.2

Q ss_pred             eeeecCCc-cEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceeeeeeEEe
Q 001867          690 VIGSGSSG-KVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVKLWCCCT  766 (1002)
Q Consensus       690 ~LG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  766 (1002)
                      .+..|..| .||+.... ++..+.+|+-.                    ......+.+|..+++.+. +--+.++++++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~--------------------~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~   90 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGK--------------------GSVANDVTDEMVRLNWLTAFMPLPTIKHFIR   90 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEE--------------------THHHHHHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECC--------------------CCCHhHHHHHHHHHHHhccCCCcCeEEEEEE
Confidence            45566666 58998754 46678899752                    223456888999998875 334778899999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC----------------------------  818 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------  818 (1002)
                      +.+..++|||+++|.++.+.....      ......++.+++..|+.||+..                            
T Consensus        91 ~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (272)
T 4gkh_A           91 TPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA  164 (272)
T ss_dssp             ETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred             ECCeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence            999999999999998887765421      1234456777778888887530                            


Q ss_pred             ---------------------------CCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          819 ---------------------------VPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       819 ---------------------------~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                                                 .+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                       12478999999999999777677999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.27  E-value=5.2e-06  Score=90.13  Aligned_cols=137  Identities=18%  Similarity=0.179  Sum_probs=98.4

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC---ceeeeeeE
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK---NIVKLWCC  764 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~  764 (1002)
                      .+.++.|....||++    ++.++||+..                   .......+.+|+.+++.+.+.   .+.+++.+
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~-------------------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~   80 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK-------------------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYI   80 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES-------------------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC-------------------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEee
Confidence            456899999999998    5778888741                   122356789999999998642   35666666


Q ss_pred             Ee-cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------
Q 001867          765 CT-TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD--------------------------  817 (1002)
Q Consensus       765 ~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------  817 (1002)
                      .. ..+..++||||++|..+.+..-    ..++..+...++.+++..|+.||+.                          
T Consensus        81 ~~~~~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~  156 (306)
T 3tdw_A           81 GKRSDGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAV  156 (306)
T ss_dssp             EECTTSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHH
T ss_pred             cccCCCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHH
Confidence            64 4566789999999988876321    1245566666677777777766653                          


Q ss_pred             -------------------------------CCCCeeeCCCCCCcEEECC---CCCe-EEccccCcccc
Q 001867          818 -------------------------------CVPSIVHRDVKSNNILLDG---DFGA-RVADFGVAKVV  851 (1002)
Q Consensus       818 -------------------------------~~~~iiHrDlk~~NIll~~---~~~~-kl~DfGl~~~~  851 (1002)
                                                     ..+.++|+|++|.||+++.   ++.+ .|+||+.+..-
T Consensus       157 ~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          157 EDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                           1225699999999999987   4554 89999988653

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.26  E-value=9.5e-08  Score=95.43  Aligned_cols=119  Identities=15%  Similarity=0.109  Sum_probs=60.8

Q ss_pred             cCcCCCCCcEEEccCc-cccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCC----Cccccc
Q 001867          400 GLGHCQSLTRVRLGYN-RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGS----LPEEIG  474 (1002)
Q Consensus       400 ~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~  474 (1002)
                      .+...++|++|+|++| .+......                    .+...+...++|+.|+|++|++...    +.+.+.
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~--------------------~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~   90 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLK--------------------ACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLK   90 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHH--------------------HHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHH--------------------HHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHH
Confidence            3455667777777777 66521111                    1112223334445555555544321    122233


Q ss_pred             cccccccccccccccCCC----CcccccccccCCeeec--CCCcCCccc----ccccccccccccccccCcccc
Q 001867          475 FLKSLVVLSGSENKFTGS----LPESLTNLAELGSLDL--HANDLSGEL----PSSVSSWKKLNELNLADNLFY  538 (1002)
Q Consensus       475 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~  538 (1002)
                      ..++|+.|+|++|.|+..    +...+...+.|++|+|  ++|.|+...    ...+...++|+.|+|++|.+.
T Consensus        91 ~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             hCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            334555555665555532    2344555566777777  667666442    233444466777777777664

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.01  E-value=8.5e-06  Score=90.70  Aligned_cols=83  Identities=10%  Similarity=0.083  Sum_probs=55.2

Q ss_pred             Cee-eecCCccEEEEEEc-------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-C--Cc
Q 001867          689 NVI-GSGSSGKVYKVVLS-------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-H--KN  757 (1002)
Q Consensus       689 ~~L-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~n  757 (1002)
                      +.| +.|..+.+|++...       +++.+++|+......             . .......+.+|+.+++.+. +  -.
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~-------------~-~~~~~~~~~~E~~~l~~L~~~~~vp   91 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAED-------------V-PVFPTYRLDHQFEVIRLVGELTDVP   91 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGG-------------C-CSSSCCCHHHHHHHHHHHHHHCCSC
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCc-------------c-ccCchhHHHHHHHHHHHHhhcCCCC
Confidence            567 88889999998764       267788887522100             0 0001245788888888874 3  35


Q ss_pred             eeeeeeEEecC---CeeeEEEeccCCCChhh
Q 001867          758 IVKLWCCCTTR---DCKLLVYEYMPNGSLGD  785 (1002)
Q Consensus       758 iv~l~~~~~~~---~~~~lv~e~~~~g~L~~  785 (1002)
                      +.+++++..+.   +..|+||||++|..+.+
T Consensus        92 vP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A           92 VPRVRWIETTGDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             CCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred             CCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence            67788877655   45689999999877654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.78  E-value=9.2e-05  Score=81.67  Aligned_cols=30  Identities=27%  Similarity=0.426  Sum_probs=27.3

Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      ..++|||+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            489999999999999888899999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.77  E-value=0.00012  Score=78.95  Aligned_cols=137  Identities=19%  Similarity=0.207  Sum_probs=92.0

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC---CCceeeeeeE
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR---HKNIVKLWCC  764 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~  764 (1002)
                      .+.|+.|....+|++.. +++.++||+...                    .....+..|...++.+.   ...+++++++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~--------------------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~   99 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINER--------------------SYRSMFRAEADQLALLAKTNSINVPLVYGI   99 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEG--------------------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEE
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCc--------------------ccHHHHHHHHHHHHHHHhhCCCCcceEEEE
Confidence            46789999999999886 467888997621                    12566889999998884   3668889998


Q ss_pred             EecCCeeeEEEeccCCCChhh-----------hhhhcCC-C-------------------CCCHHHHH---HHHH-----
Q 001867          765 CTTRDCKLLVYEYMPNGSLGD-----------LLHSCKG-G-------------------LLDWPTRY---KIIV-----  805 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~-----  805 (1002)
                      ....+..++||||+++..+..           .++.... .                   .-+|....   ++..     
T Consensus       100 ~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a  179 (312)
T 3jr1_A          100 GNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQIC  179 (312)
T ss_dssp             EECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHH
T ss_pred             eecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHH
Confidence            888888999999999876521           1222111 0                   12454332   1111     


Q ss_pred             -----------HHHHH-HHHHhh-cCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          806 -----------DAAEG-LSYLHH-DCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       806 -----------qi~~~-L~~LH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                                 +++.. ...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       180 ~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          180 KEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                       11111 123432 1246899999999999999887 8899974

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.63  E-value=0.00015  Score=81.71  Aligned_cols=82  Identities=15%  Similarity=0.151  Sum_probs=49.2

Q ss_pred             CCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC--Cc-eeeeee
Q 001867          688 DNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH--KN-IVKLWC  763 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~n-iv~l~~  763 (1002)
                      .+.+|.|.++.||++... +++.++||.......        +.. . ......+++..|.++++.+..  |. +.+++.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r--------~~~-~-~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~  104 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAK--------VVG-E-SWPLTIDRARIESSALIRQGEHVPHLVPRVFY  104 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-----------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhc--------ccC-C-CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence            457899999999999753 468899998632110        000 0 001123456778888887742  33 445554


Q ss_pred             EEecCCeeeEEEeccCCC
Q 001867          764 CCTTRDCKLLVYEYMPNG  781 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g  781 (1002)
                      +  +.+..++||||+++.
T Consensus       105 ~--d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          105 S--DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             E--ETTTTEEEECCCTTS
T ss_pred             E--cCCccEEEEEeCCCc
Confidence            3  344568999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.48  E-value=0.00034  Score=75.00  Aligned_cols=77  Identities=19%  Similarity=0.182  Sum_probs=53.8

Q ss_pred             CcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-C--Cceeeee
Q 001867          686 DEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-H--KNIVKLW  762 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~  762 (1002)
                      .-.+.+|.|..+.||++...||+.|.||+....                 .......|..|+..|+.+. .  --+++++
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-----------------~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~   80 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDD-----------------APALDGLFRAEALGLDWLGRSFGSPVPQVA   80 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTT-----------------CCCCTTHHHHHHHHHHHHTCSTTCCSCCEE
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-----------------CcchhhHHHHHHHHHHHHHhhCCCCcceEE
Confidence            335678999999999999999999999975221                 1112345788999998874 2  2344555


Q ss_pred             eEEecCCeeeEEEeccCCCCh
Q 001867          763 CCCTTRDCKLLVYEYMPNGSL  783 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L  783 (1002)
                      ++.    ..++||||++++..
T Consensus        81 ~~~----~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           81 GWD----DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEE----TTEEEEECCCCCCC
T ss_pred             ecc----CceEEEEeecccCC
Confidence            542    24799999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.47  E-value=1.8e-05  Score=76.81  Aligned_cols=82  Identities=15%  Similarity=0.150  Sum_probs=36.8

Q ss_pred             ccccccccccccCCCCccccccCCcccccccccc-ccCCCCcccccc----cccceeeecccc-ccCccccccccccccc
Q 001867          119 LQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNN-FSGDIPESFGRF----QKLEVISLVYNL-LDGTIPAFLGNISTLK  192 (1002)
Q Consensus       119 L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~l~~l~~L~  192 (1002)
                      |++|||+++.|+...-..+.++++|++|+|++|. |+..--..++.+    ++|++|+|++|. |+..--..+.++++|+
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~  142 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK  142 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence            4444444444433322334445555555555552 332211223322    246666666553 4433333445555666


Q ss_pred             cccccCCC
Q 001867          193 MLNLSYNP  200 (1002)
Q Consensus       193 ~L~Ls~N~  200 (1002)
                      +|+|+++.
T Consensus       143 ~L~L~~c~  150 (176)
T 3e4g_A          143 YLFLSDLP  150 (176)
T ss_dssp             EEEEESCT
T ss_pred             EEECCCCC
Confidence            66665553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.34  E-value=5.4e-05  Score=73.40  Aligned_cols=83  Identities=16%  Similarity=0.113  Sum_probs=38.8

Q ss_pred             CcceEEEcccCcccCccccccccCCcccEEEccCCc-CCCCCccccccc----cccccccccccc-cCCCCccccccccc
Q 001867          429 PHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNN-LSGSLPEEIGFL----KSLVVLSGSENK-FTGSLPESLTNLAE  502 (1002)
Q Consensus       429 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~  502 (1002)
                      ..|+.||++++.|+...-..+.++++|+.|+|+++. ++..--..++.+    ++|+.|+|++|. +|..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            345566666665555444455556666666666653 432211222222    234555555442 44222223344444


Q ss_pred             CCeeecCCC
Q 001867          503 LGSLDLHAN  511 (1002)
Q Consensus       503 L~~L~Ls~N  511 (1002)
                      |++|+|+++
T Consensus       141 L~~L~L~~c  149 (176)
T 3e4g_A          141 LKYLFLSDL  149 (176)
T ss_dssp             CCEEEEESC
T ss_pred             CCEEECCCC
Confidence            555555444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.17  E-value=0.0015  Score=74.09  Aligned_cols=78  Identities=14%  Similarity=0.049  Sum_probs=48.3

Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccC---CCCCccchhhHHHHHHHH
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILEL  896 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~el  896 (1002)
                      +.++|+|++|.||+++.++ ++++||+.+..-......... ...-...|++|+.....   ......++......+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999998776 999999998754322110000 00011346666654321   112234556788888887


Q ss_pred             HhC
Q 001867          897 VTG  899 (1002)
Q Consensus       897 l~g  899 (1002)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.09  E-value=0.0014  Score=70.62  Aligned_cols=129  Identities=13%  Similarity=0.093  Sum_probs=75.2

Q ss_pred             CCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce-eeeeeEEe
Q 001867          688 DNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI-VKLWCCCT  766 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~  766 (1002)
                      .+.|+.|....+|++     +.+++|+.....                  .......+|+.+++.+...++ .+++++. 
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~------------------~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-   78 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT------------------EEYINRANEAVAAREAAKAGVSPEVLHVD-   78 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----------------------CCCHHHHHHHHHHHHHTTSSCCEEEEC-
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCc------------------cceeCHHHHHHHHHHHHHcCCCCceEEEE-
Confidence            678999999999998     568888763210                  011223567777777642222 4555443 


Q ss_pred             cCCeeeEEEecc-CCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------
Q 001867          767 TRDCKLLVYEYM-PNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD----------------------------  817 (1002)
Q Consensus       767 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------  817 (1002)
                       .+.-++++||+ +|.++...-...         ...++.++++.|+-||+.                            
T Consensus        79 -~~~~~~v~e~i~~g~~l~~~~~~~---------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (301)
T 3dxq_A           79 -PATGVMVTRYIAGAQTMSPEKFKT---------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTL  148 (301)
T ss_dssp             -TTTCCEEEECCTTCEECCHHHHHH---------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCC
T ss_pred             -CCCCEEEEeecCCCccCCHhhHhh---------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCc
Confidence             33347899999 654443210000         001122222222222221                            


Q ss_pred             ----------------------CCCCeeeCCCCCCcEEECCCCCeEEccccCcccc
Q 001867          818 ----------------------CVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV  851 (1002)
Q Consensus       818 ----------------------~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~  851 (1002)
                                            ....++|+|+.+.||+ ..++.+.++||..+..-
T Consensus       149 ~~~~~~l~~~~~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          149 PAGYHDVVREAGGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CTTHHHHHHHHHHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             hhhHHHHHHHHHHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence                                  1236899999999999 55678899999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.07  E-value=0.0014  Score=71.86  Aligned_cols=33  Identities=33%  Similarity=0.371  Sum_probs=28.2

Q ss_pred             CCeeeCCCCCCcEEECCC----CCeEEccccCccccc
Q 001867          820 PSIVHRDVKSNNILLDGD----FGARVADFGVAKVVD  852 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~----~~~kl~DfGl~~~~~  852 (1002)
                      ..++|||+.+.||+++.+    +.+.++||+.+..-.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            489999999999999874    678999999887543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.75  E-value=0.002  Score=73.01  Aligned_cols=72  Identities=19%  Similarity=0.219  Sum_probs=48.0

Q ss_pred             CeeeecCCccEEEEEEcC--------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          689 NVIGSGSSGKVYKVVLSN--------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      +.|+.|....||++...+        ++.+.+|+....                   ...+.+..|..+++.+. +.-..
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-------------------~~~~~li~E~~~l~~L~~~g~~P  139 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-------------------ETESHLVAESVIFTLLSERHLGP  139 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-------------------CCHHHHHHHHHHHHHHHHTTSSS
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-------------------CcHHHHHHHHHHHHHHHhCCCCC
Confidence            568889999999998753        478899876210                   01134557888888875 32235


Q ss_pred             eeeeEEecCCeeeEEEeccCCCCh
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSL  783 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L  783 (1002)
                      ++++.+.+    .+|+||++|.++
T Consensus       140 ~l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          140 KLYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             CEEEEETT----EEEECCCCEEEC
T ss_pred             cEEEEeCC----CEEEEEeCCccc
Confidence            67766542    389999986444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.70  E-value=0.0079  Score=65.46  Aligned_cols=141  Identities=13%  Similarity=0.161  Sum_probs=80.7

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC--ceeeeeeE--
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK--NIVKLWCC--  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~--  764 (1002)
                      +.++ |....||++...+|+.+++|+....                  ....+.+..|..+++.+...  .+++++..  
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~------------------~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g   92 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE------------------RWTADQILEEHQFALQLVNDEVPVAAPVAFNG   92 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTT------------------TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTT
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCC------------------CCCHHHHHHHHHHHHHHHHcCCeecceeecCC
Confidence            4566 8888999988777778999987321                  01234567788888777421  24444443  


Q ss_pred             ---EecCCeeeEEEeccCCCChh-----hh---------hhhc-C------CCCCCHHHH----HHH-------------
Q 001867          765 ---CTTRDCKLLVYEYMPNGSLG-----DL---------LHSC-K------GGLLDWPTR----YKI-------------  803 (1002)
Q Consensus       765 ---~~~~~~~~lv~e~~~~g~L~-----~~---------l~~~-~------~~~l~~~~~----~~i-------------  803 (1002)
                         ....+..+++|||++|..+.     .+         ++.. .      ....++...    ..+             
T Consensus        93 ~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  172 (328)
T 1zyl_A           93 QTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKA  172 (328)
T ss_dssp             BSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHH
T ss_pred             cEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHH
Confidence               12245668899999875432     10         1110 0      011222211    001             


Q ss_pred             --HHHHHHHHHHHhhc----CCCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          804 --IVDAAEGLSYLHHD----CVPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       804 --~~qi~~~L~~LH~~----~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                        ...+...++.+.+.    ....++|+|+++.||+++ + .+.++||+.+..
T Consensus       173 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          173 AFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              11111122333221    223789999999999999 4 899999988764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.69  E-value=0.011  Score=58.46  Aligned_cols=104  Identities=18%  Similarity=0.152  Sum_probs=68.5

Q ss_pred             CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCccc
Q 001867          781 GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSM  860 (1002)
Q Consensus       781 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~  860 (1002)
                      -+|.+.|+. .+.+++++++|.++.|.+.+|.-.-.+.. . ..+=+.|..|++..+|.|...+ +.+.           
T Consensus        33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            378898886 56789999999999999999877622100 1 1223447899999999888764 1110           


Q ss_pred             ccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       861 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                         .....+.|||... ...+.+.=|||+|+++|..+--..|-
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence               0122466888753 34567889999999999999755554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.66  E-value=0.0032  Score=68.46  Aligned_cols=142  Identities=13%  Similarity=0.172  Sum_probs=78.9

Q ss_pred             CeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc--eeeeeeE--
Q 001867          689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN--IVKLWCC--  764 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~--  764 (1002)
                      +.|+.|....+|++...+| .+++|+....                   ...+.+..|+.+++.+....  +.+++..  
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-------------------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~   87 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-------------------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD   87 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----------------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-------------------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence            4577788899999987655 6788887321                   12234666777777764212  3333321  


Q ss_pred             ----EecCCeeeEEEeccCCCChhh--------------hhhhcC-C--CC----C---CHHHHHH------------HH
Q 001867          765 ----CTTRDCKLLVYEYMPNGSLGD--------------LLHSCK-G--GL----L---DWPTRYK------------II  804 (1002)
Q Consensus       765 ----~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~-~--~~----l---~~~~~~~------------i~  804 (1002)
                          ....+..+++|+|++|..+..              -++... .  .+    .   .|...+.            +.
T Consensus        88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~  167 (322)
T 2ppq_A           88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR  167 (322)
T ss_dssp             CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred             CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence                123456789999998865421              011110 0  00    1   1222110            00


Q ss_pred             HHHHHHHHHHhhc----CCCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          805 VDAAEGLSYLHHD----CVPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       805 ~qi~~~L~~LH~~----~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                      ..+...++++++.    ...+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            1134445555532    124899999999999998775568999997753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.52  E-value=0.0054  Score=67.85  Aligned_cols=140  Identities=15%  Similarity=0.173  Sum_probs=83.8

Q ss_pred             CeeeecCCccEEEEEEc--------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          689 NVIGSGSSGKVYKVVLS--------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      +.+..|-...+|++...        +++.|.+|+.-.                  .......+.+|..+++.+. +.-..
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~------------------~~~~~~~~~rE~~vl~~L~~~gv~P  117 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA------------------ILQGVDSLVLESVMFAILAERSLGP  117 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------------------CCHHHHHHHHHHHHHHHHTTSSC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC------------------ccchHHHHHHHHHHHHHHHhcCCCC
Confidence            56778899999999864        247888887511                  0112345668999998874 33346


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhh-----------------hhhcC---CCCCC--HHHHHHHHHHHHH--------
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDL-----------------LHSCK---GGLLD--WPTRYKIIVDAAE--------  809 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-----------------l~~~~---~~~l~--~~~~~~i~~qi~~--------  809 (1002)
                      ++++++.+    .+||||++|.++..-                 ++...   .+...  +.++.++..++..        
T Consensus       118 ~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~  193 (379)
T 3feg_A          118 QLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPE  193 (379)
T ss_dssp             CEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCS
T ss_pred             eEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccch
Confidence            67766654    299999998655321                 11100   11222  4566666655422        


Q ss_pred             -----------HHHHHh----hc-CCCCeeeCCCCCCcEEECCC----CCeEEccccCccc
Q 001867          810 -----------GLSYLH----HD-CVPSIVHRDVKSNNILLDGD----FGARVADFGVAKV  850 (1002)
Q Consensus       810 -----------~L~~LH----~~-~~~~iiHrDlk~~NIll~~~----~~~kl~DfGl~~~  850 (1002)
                                 .+..|.    .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       194 ~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          194 MNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             CCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                       223332    21 22378999999999999876    6899999998864

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.47  E-value=0.00039  Score=68.70  Aligned_cols=17  Identities=18%  Similarity=0.112  Sum_probs=9.0

Q ss_pred             ccccccccEEeCcceee
Q 001867          545 IGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       545 ~~~l~~L~~L~Ls~N~l  561 (1002)
                      +..-+.|+.|+|+.|..
T Consensus       153 L~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          153 IEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHCSSCCEEECCCCCH
T ss_pred             HHhCCCcCeEeccCCCc
Confidence            33345566666665543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.45  E-value=0.008  Score=68.40  Aligned_cols=74  Identities=18%  Similarity=0.136  Sum_probs=47.0

Q ss_pred             CCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce-eeeeeEE
Q 001867          688 DNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI-VKLWCCC  765 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~  765 (1002)
                      .+.|+.|-...+|++...+ ++.+++|+.....            ...      .+...|..+++.+...++ .++++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~------------~~~------idR~~E~~vl~~L~~~gl~P~ll~~~  174 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT------------DEI------INREREKKISCILYNKNIAKKIYVFF  174 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C------------CSC------SCHHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh------------hhh------cCHHHHHHHHHHHHhcCCCCCEEEEe
Confidence            3578889999999998764 4788888762210            001      113578888888864334 5677766


Q ss_pred             ecCCeeeEEEeccCCCCh
Q 001867          766 TTRDCKLLVYEYMPNGSL  783 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L  783 (1002)
                      . +   ..||||++|.++
T Consensus       175 ~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          175 T-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             T-T---EEEEECCCSEEC
T ss_pred             C-C---eEEEEeeCCccC
Confidence            3 2   359999987544

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.45  E-value=0.00044  Score=68.33  Aligned_cols=60  Identities=15%  Similarity=0.195  Sum_probs=30.0

Q ss_pred             cccccccccCcccccC----CCCCccccccccEEeCcce---eeecc----cCCccc-ccccceEEeccccC
Q 001867          525 KKLNELNLADNLFYGN----IPEDIGNLSVLNYLDLSNN---RLSGR----IPVGLQ-NLKLNQLNVSNNRL  584 (1002)
Q Consensus       525 ~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~Ls~N---~l~~~----ip~~~~-~l~L~~l~ls~N~l  584 (1002)
                      +.|+.|+|++|.|+..    +-+.+..-+.|++|+|++|   .+...    +-..+. +-+|..|+++.|..
T Consensus        98 ~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A           98 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             CccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            3444444444444421    2233444456777888755   33322    222222 12688888887754

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.44  E-value=0.0025  Score=58.77  Aligned_cols=35  Identities=26%  Similarity=0.220  Sum_probs=15.6

Q ss_pred             cccccccCcccccCCCCCccccccccEEeCcceee
Q 001867          527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       527 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      |+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus        33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            44444444444422223344444555555555543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.38  E-value=0.0054  Score=56.51  Aligned_cols=56  Identities=20%  Similarity=0.262  Sum_probs=33.9

Q ss_pred             EEEcCCCCcC-CCCCccccCCCCCCEEeccCCCCCCCCCCCccccCccccccccccccc
Q 001867           73 SIDLSNANIA-GPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLT  130 (1002)
Q Consensus        73 ~l~L~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  130 (1002)
                      .+|.++++++ ..+|..+.  ++|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5777777776 23443222  25667777777776655556666666666666666543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.28  E-value=0.0086  Score=66.47  Aligned_cols=73  Identities=15%  Similarity=0.112  Sum_probs=42.9

Q ss_pred             CeeeecCCccEEEEEEcC---------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc-e
Q 001867          689 NVIGSGSSGKVYKVVLSN---------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN-I  758 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i  758 (1002)
                      +.++.|....+|++...+         ++.+++|+.....                  ....+...|..+++.+...+ +
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~------------------~~~~~~~~E~~~l~~L~~~g~~  100 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV------------------DELYNTISEFEVYKTMSKYKIA  100 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG------------------GGTSCHHHHHHHHHHHHHTTSS
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc------------------cceecHHHHHHHHHHHHhcCCC
Confidence            467888889999998653         2688888763210                  00112467888888775223 4


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCCh
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSL  783 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L  783 (1002)
                      .++++..  .  -++||||++|..+
T Consensus       101 P~~~~~~--~--~~~v~e~i~G~~l  121 (369)
T 3c5i_A          101 PQLLNTF--N--GGRIEEWLYGDPL  121 (369)
T ss_dssp             CCEEEEE--T--TEEEEECCCSEEC
T ss_pred             CceEEec--C--CcEEEEEecCCcC
Confidence            4666554  2  2689999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.22  E-value=0.023  Score=62.10  Aligned_cols=32  Identities=16%  Similarity=0.353  Sum_probs=28.2

Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccc
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVV  851 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~  851 (1002)
                      ..++|+|+.+.||+++.++.+.++||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47999999999999998888999999887653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.66  E-value=0.1  Score=58.41  Aligned_cols=139  Identities=16%  Similarity=0.194  Sum_probs=83.0

Q ss_pred             CeeeecCCccEEEEEEcC--------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          689 NVIGSGSSGKVYKVVLSN--------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      +.+..|-...+|++...+        ++.|++|+.-...                  ....+..+|..+++.+. +.-..
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t------------------~~~idR~~E~~~l~~L~~~gi~P  137 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV------------------GKFYDSKVELDVFRYLSNINIAP  137 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-------------------CCCCHHHHHHHHHHHHHTTSSC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc------------------chhcCHHHHHHHHHHHHhcCCCC
Confidence            467788899999998753        5788888752210                  01123467888887774 33345


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhh--h---------------hhh--c---------CCCCCCHHHHHHHHHHHH---
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGD--L---------------LHS--C---------KGGLLDWPTRYKIIVDAA---  808 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~--~---------------l~~--~---------~~~~l~~~~~~~i~~qi~---  808 (1002)
                      ++++.+.    -+.||||++|..|..  +               ++.  .         ...+--+.++.++..++-   
T Consensus       138 ~l~~~~~----~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~  213 (424)
T 3mes_A          138 NIIADFP----EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQV  213 (424)
T ss_dssp             CEEEEET----TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHH
T ss_pred             CEEEEcC----CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhh
Confidence            5665432    268999999865421  0               000  0         011112455544443332   


Q ss_pred             ----------------HHHHHHhh---------------------cCCCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          809 ----------------EGLSYLHH---------------------DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       809 ----------------~~L~~LH~---------------------~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                                      ..+.+|.+                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       214 ~~~~~~~~~~~~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          214 SKNNFQIDKELYSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HTCC--CCHHHHHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             cccchhhccccHHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence                            22233321                     11237899999999999 7788999999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.16  E-value=0.62  Score=51.87  Aligned_cols=30  Identities=27%  Similarity=0.372  Sum_probs=25.2

Q ss_pred             CeeeCCCCCCcEEE------CCCCCeEEccccCccc
Q 001867          821 SIVHRDVKSNNILL------DGDFGARVADFGVAKV  850 (1002)
Q Consensus       821 ~iiHrDlk~~NIll------~~~~~~kl~DfGl~~~  850 (1002)
                      .++|+|+.+.||++      +++..++++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            45799999999999      4566799999998864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.43  E-value=3  Score=41.45  Aligned_cols=84  Identities=10%  Similarity=-0.013  Sum_probs=61.1

Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeeeCCCCCCcE
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLS-YLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      .||++  -...-.+++.+.+.++.-+++.=...++     ..+...+++++.+++.... +++.+     +|--++|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceE
Confidence            57887  3334466777667666654432222332     3788999999999998887 67765     7788999999


Q ss_pred             EECCCCCeEEccccCcc
Q 001867          833 LLDGDFGARVADFGVAK  849 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~  849 (1002)
                      +++.++.+++.-.|+-.
T Consensus       116 ~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             EECTTCCEEESCCEETT
T ss_pred             EEeCCCcEEEEEcCCcc
Confidence            99999999998777644

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=81.69  E-value=0.4  Score=33.88  Aligned_cols=16  Identities=13%  Similarity=0.146  Sum_probs=8.8

Q ss_pred             HHHHHhhhheeeeeec
Q 001867          641 FVFGLVWFYLKYRKFK  656 (1002)
Q Consensus       641 ~~~~~v~~~~~~r~~~  656 (1002)
                      ++...+|+|+|+|+.+
T Consensus        26 ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           26 VVALGIGLFMRRRHIV   41 (44)
T ss_dssp             HHHHHHHHHHHTTTCC
T ss_pred             HHHHHHHHHhhhhHhh
Confidence            3444556666666544

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.99  E-value=2.9  Score=41.30  Aligned_cols=122  Identities=9%  Similarity=0.054  Sum_probs=79.6

Q ss_pred             HHHHHhcCCCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeC
Q 001867          746 EVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHR  825 (1002)
Q Consensus       746 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  825 (1002)
                      |+..+.. .||+.+.. ..-.+++.+.+.++.-+  +..+|-.-   +..+...+++++.+|+....+++.+     +|-
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf  103 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRTR-----YTF  103 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGSS-----EEC
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcCc-----eEE
Confidence            3444433 58888866 45556666555555543  23333221   2378899999999999988777766     788


Q ss_pred             CCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 001867          826 DVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV  903 (1002)
Q Consensus       826 Dlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~  903 (1002)
                      -++|+||+++.++.+++.-.|+...+.+..                        .+...=.-.+=+++..+++++..|
T Consensus       104 ~L~P~NL~f~~~~~p~i~~RGik~~l~P~~------------------------~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          104 VLAPDELFFTRDGLPIAKTRGLQNVVDPLP------------------------VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CCSGGGEEECTTSCEEESCCEETTTBSCCC------------------------CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEecceEEEcCCCCEEEEEccCccCCCCCC------------------------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            899999999999999998777644332211                        011111224557788888888877

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1002
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-29
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-24
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	8e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	8e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 2e-64
 Identities = 81/299 (27%), Positives = 120/299 (40%), Gaps = 34/299 (11%)

Query: 678 EYEILDG-LDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           ++EI DG +     IGSGS G VYK        VAVK L                     
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKML---------------NVTAPT 44

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
             Q   F+ EV  L K RH NI+      T      +V ++    SL   LH  +    +
Sbjct: 45  PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKF-E 102

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                 I    A+G+ YLH     SI+HRD+KSNNI L  D   ++ DFG+A V      
Sbjct: 103 MIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159

Query: 857 PKSMSVIAGSCGYIAPEYAYTLR---VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
                 ++GS  ++APE          + +SD+Y+FG+V+ EL+TG+LP         ++
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
             V            L P L          +  +   C       RP   +++  ++ +
Sbjct: 220 FMVG--------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 2e-61
 Identities = 66/295 (22%), Positives = 129/295 (43%), Gaps = 36/295 (12%)

Query: 678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           E+E+  + L     +G+G  G+V+    +    VAVK L                   Q 
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL------------------KQG 48

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
            +  D F AE   + +++H+ +V+L+   T ++   ++ EYM NGSL D L +  G  L 
Sbjct: 49  SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLT 107

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                 +    AEG++++        +HRD+++ NIL+      ++ADFG+A++++   +
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNE 163

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             +         + APE         KSD++SFG+++ E+VT      P     ++++ +
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

Query: 917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
                    D+  +            ++  +  LC    P +RP    +  +L++
Sbjct: 224 ERGYRMVRPDNCPE------------ELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-58
 Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 36/299 (12%)

Query: 674 LGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKG 732
           L    +EI  + L  +  +G G  G+V+    +    VA+K L                 
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--------------- 51

Query: 733 QVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                +  + F  E + + K+RH+ +V+L+   +      +V EYM  GSL D L    G
Sbjct: 52  ---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETG 107

Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
             L  P    +    A G++Y+        VHRD+++ NIL+  +   +VADFG+A++++
Sbjct: 108 KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 164

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
              +  +         + APE A   R   KSD++SFG+++ EL T      P    +++
Sbjct: 165 -DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223

Query: 913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           +  V     ++G      P+      +       +   C    P  RP    +   L++
Sbjct: 224 LDQV-----ERGYRMPCPPECPESLHD-------LMCQCWRKEPEERPTFEYLQAFLED 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 5e-58
 Identities = 72/300 (24%), Positives = 113/300 (37%), Gaps = 47/300 (15%)

Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQ 733
           L   E ++L        IG G  G V       G  VAVK +                  
Sbjct: 4   LNMKELKLLQ------TIGKGEFGDVMLGDY-RGNKVAVKCI------------------ 38

Query: 734 VQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL-LVYEYMPNGSLGDLLHSCKG 792
            ++      F AE   + ++RH N+V+L          L +V EYM  GSL D L S   
Sbjct: 39  -KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 97

Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            +L      K  +D  E + YL      + VHRD+ + N+L+  D  A+V+DFG+ K   
Sbjct: 98  SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
                 +         + APE     + + KSD++SFG+++ E+ +      P    KD+
Sbjct: 155 -----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209

Query: 913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           V  V         D                 V  +   C       RP+  ++ + L+ +
Sbjct: 210 VPRVEKGYKMDAPDGCPP------------AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (503), Expect = 2e-57
 Identities = 66/305 (21%), Positives = 127/305 (41%), Gaps = 39/305 (12%)

Query: 675 GFSEYEILDGLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDVE 730
            F++   +  +  + VIG+G  G+V    L         VA+K L  G +++        
Sbjct: 18  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-------- 69

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
                   Q   F +E   +G+  H N++ L    T     +++ E+M NGSL D     
Sbjct: 70  --------QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ 120

Query: 791 KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             G         ++   A G+ YL        VHRD+ + NIL++ +   +V+DFG+++ 
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 851 VDASGKPKSMSVIAGSCG---YIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEF 907
           ++      + +   G      + APE     +    SD++S+G+V+ E+++       + 
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237

Query: 908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
             +D++  +         D+ L P +DC        +  + L C      +RP   ++V 
Sbjct: 238 TNQDVINAIEQ-------DYRLPPPMDC-----PSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 968 LLQEV 972
            L ++
Sbjct: 286 TLDKM 290

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (500), Expect = 3e-57
 Identities = 60/306 (19%), Positives = 122/306 (39%), Gaps = 36/306 (11%)

Query: 669 MSFHKLGFSEYEI-LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESG 726
           M      + ++E+    +   + +G G  G+VY+ V       VAVK L           
Sbjct: 2   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--------- 52

Query: 727 CDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL 786
                    D ++ + F  E   + +I+H N+V+L   CT      ++ E+M  G+L D 
Sbjct: 53  ---------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103

Query: 787 LHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG 846
           L  C    +       +    +  + YL      + +HRD+ + N L+  +   +VADFG
Sbjct: 104 LRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFG 160

Query: 847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           +++++       + +       + APE     + + KSD+++FGV++ E+ T  +   P 
Sbjct: 161 LSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219

Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
                + + +      +  +   +            KV  +   C    P +RP+   + 
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPE------------KVYELMRACWQWNPSDRPSFAEIH 267

Query: 967 KLLQEV 972
           +  + +
Sbjct: 268 QAFETM 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-57
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 41/296 (13%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           SE   +        IGSG  G V+     N + VA+K +                     
Sbjct: 5   SELTFV------QEIGSGQFGLVHLGYWLNKDKVAIKTIRE------------------G 40

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
            + ++ F  E E + K+ H  +V+L+  C  +    LV+E+M +G L D L + + GL  
Sbjct: 41  AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFA 99

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
             T   + +D  EG++YL   C   ++HRD+ + N L+  +   +V+DFG+ + V     
Sbjct: 100 AETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             S         + +PE     R + KSD++SFGV++ E+ +            ++V+ +
Sbjct: 157 TSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

Query: 917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
            +         +  P+L          V  I   C    P +RPA  R+++ L E+
Sbjct: 216 STGFR------LYKPRL------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-56
 Identities = 55/244 (22%), Positives = 105/244 (43%), Gaps = 31/244 (12%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           ++E +      + +G+G+ G V+KV    +G  +A K +   +                 
Sbjct: 7   DFEKI------SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------------- 46

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
               +    E++ L +     IV  +    +     +  E+M  GSL  +L   K G + 
Sbjct: 47  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIP 102

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                K+ +   +GL+YL       I+HRDVK +NIL++     ++ DFGV+  +     
Sbjct: 103 EQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
               +   G+  Y++PE       + +SDI+S G+ ++E+  GR P+ P   ++  + + 
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

Query: 917 CSTL 920
           C   
Sbjct: 217 CQVE 220

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-56
 Identities = 57/296 (19%), Positives = 107/296 (36%), Gaps = 41/296 (13%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
            +   L        +G+G  G V          VA+K +                     
Sbjct: 4   KDLTFL------KELGTGQFGVVKYGKWRGQYDVAIKMIKE------------------G 39

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
            + +D F  E + +  + H+ +V+L+  CT +    ++ EYM NG L + L         
Sbjct: 40  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQ 98

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
                ++  D  E + YL        +HRD+ + N L++     +V+DFG+++ V    +
Sbjct: 99  TQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDE 154

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
             S         +  PE     + + KSDI++FGV++ E+ +        F   +  + +
Sbjct: 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214

Query: 917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
              L         +            KV  I   C       RP  + ++  + +V
Sbjct: 215 AQGLRLYRPHLASE------------KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 5e-56
 Identities = 67/308 (21%), Positives = 116/308 (37%), Gaps = 47/308 (15%)

Query: 690 VIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVET 749
            IG G  G+V++     GE VAVK                       + +    +AE+  
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIF------------------SSREERSWFREAEIYQ 50

Query: 750 LGKIRHKNIVKLWCCCTTRDCKL----LVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIV 805
              +RH+NI+         +       LV +Y  +GSL D L+      +      K+ +
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLAL 107

Query: 806 DAAEGLSYLHHDCV-----PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP--K 858
             A GL++LH + V     P+I HRD+KS NIL+  +    +AD G+A   D++      
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167

Query: 859 SMSVIAGSCGYIAPEYAYT------LRVNEKSDIYSFGVVILELVTGRLPVDPE------ 906
           + +   G+  Y+APE              +++DIY+ G+V  E+                
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227

Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKL--DCCFKEEICKVLNIGLLCTSPLPINRPAMRR 964
           + +          + +   +  L P +       E +  +  I   C       R    R
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 965 VVKLLQEV 972
           + K L ++
Sbjct: 288 IKKTLSQL 295

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (488), Expect = 2e-55
 Identities = 70/323 (21%), Positives = 125/323 (38%), Gaps = 65/323 (20%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVE 730
           +  E +        IG G+ G+V++              VAVK L    S +        
Sbjct: 13  NNIEYV------RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-------- 58

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
                       FQ E   + +  + NIVKL   C       L++EYM  G L + L S 
Sbjct: 59  --------MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 110

Query: 791 KGGL----------------------LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK 828
                                     L    +  I    A G++YL        VHRD+ 
Sbjct: 111 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167

Query: 829 SNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYS 888
           + N L+  +   ++ADFG+++ + ++   K+    A    ++ PE  +  R   +SD+++
Sbjct: 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227

Query: 889 FGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIG 948
           +GVV+ E+ +  L        ++++ +            V D  +  C +    ++ N+ 
Sbjct: 228 YGVVLWEIFSYGLQPYYGMAHEEVIYY------------VRDGNILACPENCPLELYNLM 275

Query: 949 LLCTSPLPINRPAMRRVVKLLQE 971
            LC S LP +RP+   + ++LQ 
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQR 298

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-54
 Identities = 67/297 (22%), Positives = 123/297 (41%), Gaps = 43/297 (14%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +YE+L        IG+GS G+  K+   S+G+ +  K+L                     
Sbjct: 5   DYEVL------YTIGTGSYGRCQKIRRKSDGKILVWKEL---------------DYGSMT 43

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLL--VYEYMPNGSLGDLLHSC--KG 792
           + +     +EV  L +++H NIV+ +     R    L  V EY   G L  ++     + 
Sbjct: 44  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 103

Query: 793 GLLDWPTRYKIIVDAAEGLSYLH--HDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV 850
             LD     +++      L   H   D   +++HRD+K  N+ LDG    ++ DFG+A++
Sbjct: 104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163

Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK 910
           ++            G+  Y++PE    +  NEKSDI+S G ++ EL     P    F +K
Sbjct: 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQK 220

Query: 911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
           +L   +      +G    +  +      E I +         +    +RP++  +++
Sbjct: 221 ELAGKIR-----EGKFRRIPYRYSDELNEIITR-------MLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 3e-54
 Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 42/294 (14%)

Query: 682 LDG--LDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQV 738
            DG  L  D  IG GS   VYK +       VA  +L               + +   + 
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL---------------QDRKLTKS 50

Query: 739 QDDGFQAEVETLGKIRHKNIVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGL 794
           +   F+ E E L  ++H NIV+ +    +    + C +LV E M +G+L   L   +  +
Sbjct: 51  ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKV 108

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVDA 853
           +             +GL +LH    P I+HRD+K +NI + G  G  ++ D G+A +  A
Sbjct: 109 MKIKVLRSWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV 913
           S        + G+  ++APE  Y  + +E  D+Y+FG+ +LE+ T   P         + 
Sbjct: 168 S----FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222

Query: 914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
           + V S +     D V  P++             I   C       R +++ ++ 
Sbjct: 223 RRVTSGVKPASFDKVAIPEVK-----------EIIEGCIRQNKDERYSIKDLLN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-54
 Identities = 67/304 (22%), Positives = 116/304 (38%), Gaps = 52/304 (17%)

Query: 665 KWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKEC 723
           +W L         ++EI         +G G  G VY      +   +A+K L        
Sbjct: 2   QWAL--------EDFEIG------RPLGKGKFGNVYLAREKQSKFILALKVL-------- 39

Query: 724 ESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
                  K Q++    +   + EVE    +RH NI++L+          L+ EY P G++
Sbjct: 40  ------FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 93

Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
              L        D       I + A  LSY H      ++HRD+K  N+LL      ++A
Sbjct: 94  YRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIA 148

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
           DFG +    +S      + + G+  Y+ PE       +EK D++S GV+  E + G+ P 
Sbjct: 149 DFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204

Query: 904 DPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR 963
           +     ++  K +            ++        E    +++         P  RP +R
Sbjct: 205 EAN-TYQETYKRISR----------VEFTFPDFVTEGARDLIS---RLLKHNPSQRPMLR 250

Query: 964 RVVK 967
            V++
Sbjct: 251 EVLE 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-53
 Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 37/289 (12%)

Query: 687 EDNVIGSGSSGKVYKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           ED  +GSG+ G V K         + VAVK L               K +  D    D  
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL---------------KNEANDPALKDEL 55

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
            AE   + ++ +  IV++   C   +  +LV E    G L   L   +   +      ++
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIEL 112

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-KSMSV 862
           +   + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     K+ + 
Sbjct: 113 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169

Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ 922
                 + APE     + + KSD++SFGV++ E  +            ++   +      
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 229

Query: 923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
                               ++ ++  LC +    NRP    V   L+ 
Sbjct: 230 GCPAGCPR------------EMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-53
 Identities = 58/289 (20%), Positives = 115/289 (39%), Gaps = 37/289 (12%)

Query: 687 EDNVIGSGSSGKVYKVVL---SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
            D  +G G+ G V + V         VA+K L +G  K      D E+            
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEE-----------M 56

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKI 803
             E + + ++ +  IV+L   C      +LV E    G L   L   +  +       ++
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI-PVSNVAEL 114

Query: 804 IVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKS-MSV 862
           +   + G+ YL      + VHRD+ + N+LL     A+++DFG++K + A     +  S 
Sbjct: 115 LHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

Query: 863 IAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ 922
                 + APE     + + +SD++S+GV + E ++       +    +++ ++     +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-----E 226

Query: 923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           +G      P+       E+  ++     C      +RP    V + ++ 
Sbjct: 227 QGKRMECPPECP----PELYALM---SDCWIYKWEDRPDFLTVEQRMRA 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-53
 Identities = 66/292 (22%), Positives = 110/292 (37%), Gaps = 39/292 (13%)

Query: 688 DNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGF 743
           + VIG G  G VY   L +        AVK L R                + D  +   F
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR----------------ITDIGEVSQF 75

Query: 744 QAEVETLGKIRHKNIVKLWCCCTTRDCK-LLVYEYMPNGSLGDLLHSCKGGLLDWPTRYK 802
             E   +    H N++ L   C   +   L+V  YM +G L +     +           
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIG 134

Query: 803 IIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG--KPKSM 860
             +  A+G   +        VHRD+ + N +LD  F  +VADFG+A+ +         + 
Sbjct: 135 FGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 861 SVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL 920
           +       ++A E   T +   KSD++SFGV++ EL+T   P  P+    D+  ++    
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251

Query: 921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
                ++  DP            +  + L C  P    RP+   +V  +  +
Sbjct: 252 RLLQPEYCPDP------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 9e-53
 Identities = 66/293 (22%), Positives = 120/293 (40%), Gaps = 38/293 (12%)

Query: 685 LDEDNVIGSGSSGKVYKVVLSNGE-----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQ 739
           +    VIG+G  G+VYK +L          VA+K L  G +++                Q
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK----------------Q 52

Query: 740 DDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPT 799
              F  E   +G+  H NI++L    +     +++ EYM NG+L   L   K G      
Sbjct: 53  RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQ 111

Query: 800 RYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP-K 858
              ++   A G+ YL +    + VHRD+ + NIL++ +   +V+DFG+++V++   +   
Sbjct: 112 LVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168

Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCS 918
           + S       + APE     +    SD++SFG+V+ E++T       E    +++K +  
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228

Query: 919 TLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
                                    +  + + C       RP    +V +L +
Sbjct: 229 GFRLPTPMDCPS------------AIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 2e-51
 Identities = 67/326 (20%), Positives = 125/326 (38%), Gaps = 58/326 (17%)

Query: 671 FHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVVLSNG---EAVAVKKLWRGMSKECESGC 727
           +  L +++ +        +VIG G+ G+V K  +         A+K++    SK+     
Sbjct: 4   YPVLDWNDIKFQ------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----- 52

Query: 728 DVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL 786
                          F  E+E L K+  H NI+ L   C  R    L  EY P+G+L D 
Sbjct: 53  -----------DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 101

Query: 787 LH--------------SCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           L               +     L          D A G+ YL        +HRD+ + NI
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNI 158

Query: 833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
           L+  ++ A++ADFG+++  +   K    ++      ++A E          SD++S+GV+
Sbjct: 159 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215

Query: 893 ILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCT 952
           + E+V+            +L + +      +   +  D            +V ++   C 
Sbjct: 216 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD------------EVYDLMRQCW 263

Query: 953 SPLPINRPAMRRVVKLLQEVGAENRS 978
              P  RP+  +++  L  +  E ++
Sbjct: 264 REKPYERPSFAQILVSLNRMLEERKT 289

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 5e-51
 Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 40/292 (13%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +++++        +G G+ G+V   V     EAVAVK +              +  +  D
Sbjct: 6   DWDLV------QTLGEGAYGEVQLAVNRVTEEAVAVKIV--------------DMKRAVD 45

Query: 737 QVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
             ++   + E+     + H+N+VK +      + + L  EY   G L D +       + 
Sbjct: 46  CPEN--IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMP 101

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGK 856
            P   +       G+ YLH      I HRD+K  N+LLD     +++DFG+A V   + +
Sbjct: 102 EPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158

Query: 857 PKSMSVIAGSCGYIAPEYAYTLRVN-EKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
            + ++ + G+  Y+APE       + E  D++S G+V+  ++ G LP D           
Sbjct: 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218

Query: 916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
                 +K        K+D      + K            P  R  +  + K
Sbjct: 219 WK----EKKTYLNPWKKIDSAPLALLHK-------ILVENPSARITIPDIKK 259

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 6e-51
 Identities = 61/324 (18%), Positives = 113/324 (34%), Gaps = 66/324 (20%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDV 729
               E         V+GSG+ GKV                VAVK L              
Sbjct: 36  RENLEFGK------VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---------- 79

Query: 730 EKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH 788
                 D  + +   +E++ + ++  H+NIV L   CT      L++EY   G L + L 
Sbjct: 80  ------DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133

Query: 789 SCKG---------------------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDV 827
           S +                       +L +          A+G+ +L      S VHRD+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190

Query: 828 KSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIY 887
            + N+L+      ++ DFG+A+ + +               ++APE  +      KSD++
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250

Query: 888 SFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLN 946
           S+G+++ E+ + G  P      + +  K + +        +  +            ++  
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE------------EIYI 298

Query: 947 IGLLCTSPLPINRPAMRRVVKLLQ 970
           I   C +     RP+   +   L 
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSFLG 322

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (456), Expect = 7e-51
 Identities = 67/293 (22%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +  L        IG GS G VY    + N E VA+KK+                   Q  
Sbjct: 17  FSDL------REIGHGSFGAVYFARDVRNSEVVAIKKM--------------SYSGKQSN 56

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
            +      EV  L K+RH N ++   C        LV EY    +   L        L  
Sbjct: 57  EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQE 114

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                +   A +GL+YLH     +++HRDVK+ NILL      ++ DFG A ++      
Sbjct: 115 VEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----- 166

Query: 858 KSMSVIAGSCGYIAPEYAYTL---RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
              +   G+  ++APE    +   + + K D++S G+  +EL   + P+        L  
Sbjct: 167 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225

Query: 915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
                  Q     +        F+  +         C   +P +RP    ++K
Sbjct: 226 IA-----QNESPALQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-50
 Identities = 67/304 (22%), Positives = 115/304 (37%), Gaps = 41/304 (13%)

Query: 674 LGFSEYEILDGLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCDV 729
           +G  +  +L+       +G GS G V +           +VAVK L              
Sbjct: 5   IGEKDLRLLE------KLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-------------- 44

Query: 730 EKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHS 789
           +   +      D F  EV  +  + H+N+++L+    T   K +V E  P GSL D L  
Sbjct: 45  KPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK 103

Query: 790 CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAK 849
              G     T  +  V  AEG+ YL        +HRD+ + N+LL      ++ DFG+ +
Sbjct: 104 -HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159

Query: 850 VVDASGKPKSMS-VIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
            +  +     M         + APE   T   +  SD + FGV + E+ T          
Sbjct: 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
              ++  +         +    P+ + C ++    + N+ + C +  P +RP    +   
Sbjct: 220 GSQILHKIDK-------EGERLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDF 268

Query: 969 LQEV 972
           L E 
Sbjct: 269 LLEA 272

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-50
 Identities = 60/319 (18%), Positives = 113/319 (35%), Gaps = 54/319 (16%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDV 729
            ++E   + L     +G+G+ GKV +              VAVK L              
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----------- 64

Query: 730 EKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLH 788
                    + +   +E++ L  +  H NIV L   CT     L++ EY   G L + L 
Sbjct: 65  -----AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119

Query: 789 SCKGGL----------------LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
             +                   LD           A+G+++L      + +HRD+ + NI
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176

Query: 833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
           LL      ++ DFG+A+ +                 ++APE  +      +SD++S+G+ 
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236

Query: 893 ILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCT 952
           + EL +      P          +        +              E+  ++     C 
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKM--------IKEGFRMLSPEHAPAEMYDIM---KTCW 285

Query: 953 SPLPINRPAMRRVVKLLQE 971
              P+ RP  +++V+L+++
Sbjct: 286 DADPLKRPTFKQIVQLIEK 304

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-50
 Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 46/295 (15%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           +EI+        +G G+ GKVYK          A K +     +E E             
Sbjct: 14  WEIIG------ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED------------ 55

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                +  E++ L    H NIVKL       +   ++ E+   G++  ++       L  
Sbjct: 56  -----YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTE 109

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                +     + L+YLH      I+HRD+K+ NIL   D   ++ADFGV+     +   
Sbjct: 110 SQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164

Query: 858 KSMSVIAGSCGYIAPEYAYTL-----RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           +      G+  ++APE            + K+D++S G+ ++E+     P      E + 
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNP 220

Query: 913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
           ++ +      +        +    FK+ + K       C       R    ++++
Sbjct: 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-48
 Identities = 64/307 (20%), Positives = 116/307 (37%), Gaps = 39/307 (12%)

Query: 678 EYEIL-DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKG 732
           +YEI  + ++    IG G  G V++ +  +      AVA+K      S            
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---------- 50

Query: 733 QVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG 792
                   + F  E  T+ +  H +IVKL    T  +   ++ E    G L   L   K 
Sbjct: 51  ------VREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY 103

Query: 793 GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD 852
            L D  +        +  L+YL        VHRD+ + N+L+  +   ++ DFG+++ ++
Sbjct: 104 SL-DLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
            S   K+ S       ++APE     R    SD++ FGV + E++   +         D+
Sbjct: 160 DSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

Query: 913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
           +  +     + G    + P         + K       C +  P  RP    +   L  +
Sbjct: 219 IGRI-----ENGERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTI 266

Query: 973 GAENRSK 979
             E +++
Sbjct: 267 LEEEKAQ 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-48
 Identities = 55/231 (23%), Positives = 89/231 (38%), Gaps = 26/231 (11%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEK 731
           K    +++         ++G GS   V     L+     A+K L              EK
Sbjct: 4   KKRPEDFKFG------KILGEGSFSTVVLARELATSREYAIKIL--------------EK 43

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
             +  + +      E + + ++ H   VKL+      +       Y  NG L   +    
Sbjct: 44  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI- 102

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
            G  D         +    L YLH      I+HRD+K  NILL+ D   ++ DFG AKV+
Sbjct: 103 -GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158

Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               K    +   G+  Y++PE        + SD+++ G +I +LV G  P
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-48
 Identities = 59/309 (19%), Positives = 119/309 (38%), Gaps = 46/309 (14%)

Query: 678 EYEI-LDGLDEDNVIGSGSSGKVYKVVL------SNGEAVAVKKLWRGMSKECESGCDVE 730
           E+E+  + +     +G GS G VY+ V            VA+K +    S          
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-------- 65

Query: 731 KGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC 790
                   +   F  E   + +    ++V+L    +     L++ E M  G L   L S 
Sbjct: 66  --------ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 117

Query: 791 KGGL--------LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV 842
           +  +               ++  + A+G++YL+ +     VHRD+ + N ++  DF  ++
Sbjct: 118 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            DFG+ + +  +   +          +++PE          SD++SFGVV+ E+ T    
Sbjct: 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234

Query: 903 VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAM 962
                  + ++++V        ++  L  K D C       +  +  +C    P  RP+ 
Sbjct: 235 PYQGLSNEQVLRFV--------MEGGLLDKPDNCPDM----LFELMRMCWQYNPKMRPSF 282

Query: 963 RRVVKLLQE 971
             ++  ++E
Sbjct: 283 LEIISSIKE 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 9e-48
 Identities = 62/300 (20%), Positives = 115/300 (38%), Gaps = 44/300 (14%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGE----AVAVKKLWRGMSKECESGCDVEK 731
           +E++ +       V+GSG+ G VYK + +  GE     VA+K+L    S +         
Sbjct: 9   TEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--------- 53

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
                   +     E   +  + + ++ +L   C T     L+ + MP G L D +    
Sbjct: 54  -------ANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVRE-H 104

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
              +         V  A+G++YL       +VHRD+ + N+L+      ++ DFG+AK++
Sbjct: 105 KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161

Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
            A  K            ++A E         +SD++S+GV + EL+T            +
Sbjct: 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

Query: 912 LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE 971
           +   +              P+   C  +    V  I + C      +RP  R ++    +
Sbjct: 222 ISSILEK--------GERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSK 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-47
 Identities = 61/290 (21%), Positives = 121/290 (41%), Gaps = 43/290 (14%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y   +       IG G+SG VY  + ++ G+ VA++++                  +Q Q
Sbjct: 22  YTRFE------KIGQGASGTVYTAMDVATGQEVAIRQM-----------------NLQQQ 58

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
            + +    E+  + + ++ NIV         D   +V EY+  GSL D++        D 
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DE 115

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                +  +  + L +LH +    ++HRD+KS+NILL  D   ++ DFG    +      
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
           +S  V  G+  ++APE         K DI+S G++ +E++ G  P    +  ++ ++ + 
Sbjct: 173 RSTMV--GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALY 226

Query: 918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
                   +     KL   F++ + +       C       R + + +++
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNR-------CLDMDVEKRGSAKELLQ 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-47
 Identities = 68/320 (21%), Positives = 123/320 (38%), Gaps = 55/320 (17%)

Query: 677 SEYEI-LDGLDEDNVIGSGSSGKVYKVVL--------SNGEAVAVKKLWRGMSKECESGC 727
             +E+  D L     +G G+ G+V             +    VAVK L            
Sbjct: 6   PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------------ 53

Query: 728 DVEKGQVQDQVQDDGFQAEVETLGKI-RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDL 786
             +    +  + D    +E+E +  I +HKNI+ L   CT      ++ EY   G+L + 
Sbjct: 54  --KSDATEKDLSD--LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 787 LHSCKG--------------GLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI 832
           L + +                 L            A G+ YL        +HRD+ + N+
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 166

Query: 833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVV 892
           L+  D   ++ADFG+A+ +      K  +       ++APE  +      +SD++SFGV+
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226

Query: 893 ILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCT 952
           + E+ T      P    ++L K +          H +D   +C       ++  +   C 
Sbjct: 227 LWEIFTLGGSPYPGVPVEELFKLLKE-------GHRMDKPSNC-----TNELYMMMRDCW 274

Query: 953 SPLPINRPAMRRVVKLLQEV 972
             +P  RP  +++V+ L  +
Sbjct: 275 HAVPSQRPTFKQLVEDLDRI 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (426), Expect = 2e-46
 Identities = 50/227 (22%), Positives = 97/227 (42%), Gaps = 33/227 (14%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y+I +       +G+G+ G V++V   + G   A K +      + E+            
Sbjct: 28  YDIHE------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET------------ 69

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                 + E++T+  +RH  +V L       +  +++YE+M  G L + +   +   +  
Sbjct: 70  -----VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSE 123

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAKVVDASG 855
               + +    +GL ++H +     VH D+K  NI+        +   DFG+   +D   
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             +S+ V  G+  + APE A    V   +D++S GV+   L++G  P
Sbjct: 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (413), Expect = 9e-45
 Identities = 48/230 (20%), Positives = 94/230 (40%), Gaps = 33/230 (14%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
           +  Y+IL+       +GSG+ G V++ V  + G     K +                   
Sbjct: 28  YDYYDILE------ELGSGAFGVVHRCVEKATGRVFVAKFI-----------------NT 64

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
              +     + E+  + ++ H  ++ L      +   +L+ E++  G L D + + +   
Sbjct: 65  PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYK 123

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAKVVD 852
           +        +  A EGL ++H     SIVH D+K  NI+ +    + V   DFG+A  ++
Sbjct: 124 MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                  + V   +  + APE      V   +D+++ GV+   L++G  P
Sbjct: 181 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  158 bits (400), Expect = 7e-44
 Identities = 63/300 (21%), Positives = 113/300 (37%), Gaps = 40/300 (13%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
           +  YE  +      ++G G S  V + +     +  AVK +                   
Sbjct: 2   YENYEPKE------ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGS--------FSAE 47

Query: 735 QDQVQDDGFQAEVETLGKIR-HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
           + Q   +    EV+ L K+  H NI++L     T     LV++ M  G L D L   +  
Sbjct: 48  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKV 105

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
            L      KI+    E +  LH      IVHRD+K  NILLD D   ++ DFG +  +D 
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162

Query: 854 SGKPKSMSVIAGSCGYIAPEYAYTLRV------NEKSDIYSFGVVILELVTGRLPVDPEF 907
               + +  + G+  Y+APE              ++ D++S GV++  L+ G  P     
Sbjct: 163 G---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR- 218

Query: 908 GEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
            +  +++ + S       ++         + + +  +++         P  R      + 
Sbjct: 219 KQMLMLRMIMSG------NYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 64/334 (19%), Positives = 114/334 (34%), Gaps = 64/334 (19%)

Query: 661 IDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV------LSNGEAVAVKK 714
            D SKW             ++         +G G+ G+V +         +    VAVK 
Sbjct: 3   YDASKWEFP------RDRLKLGK------PLGRGAFGQVIEADAFGIDKTATCRTVAVKM 50

Query: 715 LWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH-KNIVKLWCCCTTRDCKL- 772
           L  G +                  +     +E++ L  I H  N+V L   CT     L 
Sbjct: 51  LKEGATHS----------------EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94

Query: 773 LVYEYMPNGSLGDLLHSCKG--------------GLLDWPTRYKIIVDAAEGLSYLHHDC 818
           ++ E+   G+L   L S +                 L            A+G+ +L    
Sbjct: 95  VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-- 152

Query: 819 VPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL 878
               +HRD+ + NILL      ++ DFG+A+ +                 ++APE  +  
Sbjct: 153 -RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 211

Query: 879 RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFK 938
               +SD++SFGV++ E+ +        +    + +  C  L +         +      
Sbjct: 212 VYTIQSDVWSFGVLLWEIFSLG---ASPYPGVKIDEEFCRRLKEG-----TRMRAPDYTT 263

Query: 939 EEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV 972
            E+ + +   L C    P  RP    +V+ L  +
Sbjct: 264 PEMYQTM---LDCWHGEPSQRPTFSELVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  155 bits (392), Expect = 8e-43
 Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 43/290 (14%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE+ +      ++G G   +V+    L     VAVK L                   +D 
Sbjct: 9   YELGE------ILGFGGMSEVHLARDLRLHRDVAVKVL--------------RADLARDP 48

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKL----LVYEYMPNGSLGDLLHSCKGG 793
                F+ E +    + H  IV ++              +V EY+   +L D++H+    
Sbjct: 49  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP- 107

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDA 853
            +      ++I DA + L++ H      I+HRDVK  NI++      +V DFG+A+ +  
Sbjct: 108 -MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163

Query: 854 SGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL 912
           SG      + + G+  Y++PE A    V+ +SD+YS G V+ E++TG  P    F     
Sbjct: 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSP 219

Query: 913 VKWVCSTLDQKGV-DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA 961
           V      + +  +        L       + K         +  P NR  
Sbjct: 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLK-------ALAKNPENRYQ 262

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (396), Expect = 8e-43
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 31/227 (13%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
            +++IL        +G+GS G+V+ +    NG   A+K L              +K  V 
Sbjct: 4   QDFQIL------RTLGTGSFGRVHLIRSRHNGRYYAMKVL--------------KKEIVV 43

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
              Q +    E   L  + H  I+++W          ++ +Y+  G L  LL   +    
Sbjct: 44  RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN 103

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
                Y     AAE    L +     I++RD+K  NILLD +   ++ DFG AK V    
Sbjct: 104 PVAKFY-----AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---- 154

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            P     + G+  YIAPE   T   N+  D +SFG++I E++ G  P
Sbjct: 155 -PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 9e-43
 Identities = 45/230 (19%), Positives = 96/230 (41%), Gaps = 34/230 (14%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
           + +Y I +       +G G  G V++ V  S+ +    K +               K + 
Sbjct: 4   YEKYMIAE------DLGRGEFGIVHRCVETSSKKTYMAKFV---------------KVKG 42

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
            DQV     + E+  L   RH+NI+ L     + +  ++++E++    + + +++     
Sbjct: 43  TDQVL---VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFE 98

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV--ADFGVAKVVD 852
           L+       +    E L +LH     +I H D++  NI+      + +   +FG A+ + 
Sbjct: 99  LNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
                 +  ++  +  Y APE      V+  +D++S G ++  L++G  P
Sbjct: 156 PG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 1e-42
 Identities = 56/290 (19%), Positives = 105/290 (36%), Gaps = 38/290 (13%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y+  D      V+G+G+  +V         + VA+K +               K  ++ +
Sbjct: 11  YDFRD------VLGTGAFSEVILAEDKRTQKLVAIKCI--------------AKKALEGK 50

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                 + E+  L KI+H NIV L     +     L+ + +  G L D +   + G    
Sbjct: 51  EGS--MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTE 106

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
               ++I    + + YLH   +     +        LD D    ++DFG++K+ D     
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV- 165

Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
             +S   G+ GY+APE       ++  D +S GV+   L+ G  P    F +++  K   
Sbjct: 166 --LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLFE 219

Query: 918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
             L     ++  D        +     +          P  R    + ++
Sbjct: 220 QILKA---EYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-41
 Identities = 61/243 (25%), Positives = 99/243 (40%), Gaps = 30/243 (12%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           ++ +        ++G GS GKV+        +  A+K L              +K  V  
Sbjct: 3   DFILHK------MLGKGSFGKVFLAEFKKTNQFFAIKAL--------------KKDVVLM 42

Query: 737 QVQDDGFQAEVETLGK-IRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLL 795
               +    E   L     H  +  ++C   T++    V EY+  G L   + SC     
Sbjct: 43  DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--F 100

Query: 796 DWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASG 855
           D         +   GL +LH      IV+RD+K +NILLD D   ++ADFG+ K      
Sbjct: 101 DLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157

Query: 856 KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW 915
              +     G+  YIAPE     + N   D +SFGV++ E++ G+ P   +  E++L   
Sbjct: 158 AKTNTFC--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHS 214

Query: 916 VCS 918
           +  
Sbjct: 215 IRM 217

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-40
 Identities = 64/294 (21%), Positives = 113/294 (38%), Gaps = 31/294 (10%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           ++ +        IG G+ G VYK      GE VA+KK+               +   + +
Sbjct: 4   FQKV------EKIGEGTYGVVYKARNKLTGEVVALKKI---------------RLDTETE 42

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E+  L ++ H NIVKL     T +   LV+E++       +  S   G +  
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPL 101

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
           P     +    +GL++ H      ++HRD+K  N+L++ +   ++ADFG+A+      + 
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158

Query: 858 KSMSVIAGSCGYIAPE-YAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV 916
            +  V   +  Y APE        +   DI+S G +  E+VT R     +  E D +  +
Sbjct: 159 YTHEV--VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-SEIDQLFRI 215

Query: 917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
             TL                +K    K          P P++      + ++L 
Sbjct: 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP-PLDEDGRSLLSQMLH 268

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 7e-40
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 21/216 (9%)

Query: 689 NVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEV 747
           + +G G    VYK    +  + VA+KK+             +          +     E+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKI------------KLGHRSEAKDGINRTALREI 51

Query: 748 ETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDA 807
           + L ++ H NI+ L      +    LV+++M       +       +L        ++  
Sbjct: 52  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMT 109

Query: 808 AEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSC 867
            +GL YLH      I+HRD+K NN+LLD +   ++ADFG+AK   +  +  +  V   + 
Sbjct: 110 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTR 164

Query: 868 GYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLP 902
            Y APE  +  R+     D+++ G ++ EL+     
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-39
 Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 24/232 (10%)

Query: 676 FSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQV 734
           F +  + D  D    +GSG    V K    S G   A K + +  +K    G   E    
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED--- 59

Query: 735 QDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGL 794
                    + EV  L +I+H N++ L      +   +L+ E +  G L D     +   
Sbjct: 60  --------IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKES 109

Query: 795 LDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR----VADFGVAKV 850
           L      + +     G   +++     I H D+K  NI+L      +    + DFG+A  
Sbjct: 110 LTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166

Query: 851 VDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           +D   +      I G+  ++APE      +  ++D++S GV+   L++G  P
Sbjct: 167 IDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (373), Expect = 2e-39
 Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 28/230 (12%)

Query: 682 LDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQD 740
           ++      +IG G  G+VY       G+  A+K L              +K +++ +  +
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL--------------DKKRIKMKQGE 48

Query: 741 DGFQAEVET---LGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                E      +       IV +     T D    + + M  G L   L   + G+   
Sbjct: 49  TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSE 106

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                   +   GL ++H+     +V+RD+K  NILLD     R++D G+A         
Sbjct: 107 ADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----K 159

Query: 858 KSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPE 906
           K      G+ GY+APE     +  +  +D +S G ++ +L+ G  P    
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 27/224 (12%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQV 738
           Y  L        IG G+ G VYK   + GE  A+KK+               + + +D+ 
Sbjct: 4   YHGL------EKIGEGTYGVVYKAQNNYGETFALKKI---------------RLEKEDEG 42

Query: 739 QDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWP 798
                  E+  L +++H NIVKL+    T+   +LV+E++       L      G L+  
Sbjct: 43  IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESV 100

Query: 799 TRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPK 858
           T    ++    G++Y H      ++HRD+K  N+L++ +   ++ADFG+A+      + K
Sbjct: 101 TAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156

Query: 859 SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               I             + + +   DI+S G +  E+V G   
Sbjct: 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (363), Expect = 1e-38
 Identities = 52/304 (17%), Positives = 95/304 (31%), Gaps = 46/304 (15%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y +         IGSGS G +Y    ++ GE VA+K                       +
Sbjct: 9   YRLGR------KIGSGSFGDIYLGTDIAAGEEVAIKLE-------------------CVK 43

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLW-CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
            +      E +    ++    +     C    D  ++V E +        L +       
Sbjct: 44  TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFS 101

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL---LDGDFGARVADFGVAKVVDA 853
             T   +       + Y+H     + +HRDVK +N L           + DFG+AK    
Sbjct: 102 LKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158

Query: 854 SG-----KPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           +        +    + G+  Y +      +  + + D+ S G V++    G LP      
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL 968
                K+       +         L   +  E    LN    C S    ++P    + +L
Sbjct: 219 ATKRQKYE---RISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQL 272

Query: 969 LQEV 972
            + +
Sbjct: 273 FRNL 276

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-38
 Identities = 62/299 (20%), Positives = 106/299 (35%), Gaps = 34/299 (11%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKV--VLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           +YE +        IG G+ GKV+K   + + G  VA+K++             V+ G+  
Sbjct: 8   QYECV------AEIGEGAYGKVFKARDLKNGGRFVALKRV------------RVQTGEEG 49

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPN----GSLGDLLHSCK 791
             +      A +  L    H N+V+L+  CT           +        L   L    
Sbjct: 50  MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP 109

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
              +   T   ++     GL +LH      +VHRD+K  NIL+      ++ADFG+A++ 
Sbjct: 110 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 166

Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
                  S+     +  Y APE           D++S G +  E+   +      F    
Sbjct: 167 SFQMALTSV---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSS 219

Query: 912 LVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
            V  +   LD  G+    D   D     +     +   +      I+      ++K L 
Sbjct: 220 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-38
 Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 28/231 (12%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEK 731
           K+  ++++ L       ++G G+ GKV  V   + G   A+K L               K
Sbjct: 1   KVTMNDFDYLK------LLGKGTFGKVILVREKATGRYYAMKIL--------------RK 40

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK 791
             +  + +      E   L   RH  +  L     T D    V EY   G L   L   +
Sbjct: 41  EVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER 100

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVV 851
               +    Y      AE +S L +     +V+RD+K  N++LD D   ++ DFG+ K  
Sbjct: 101 VFTEERARFY-----GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155

Query: 852 DASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
            + G    M    G+  Y+APE           D +  GVV+ E++ GRLP
Sbjct: 156 ISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 6e-38
 Identities = 60/296 (20%), Positives = 104/296 (35%), Gaps = 29/296 (9%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y  L      + IG G+ G V       N   VA+KK+                 + Q  
Sbjct: 10  YTNL------SYIGEGAYGMVCSAYDNVNKVRVAIKKI--------------SPFEHQTY 49

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLG-DLLHSCKGGLLD 796
            Q      E++ L + RH+NI+ +         + +   Y+    +G DL    K   L 
Sbjct: 50  CQR--TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS 107

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVD-ASG 855
                  +     GL Y+H     +++HRD+K +N+LL+     ++ DFG+A+V D    
Sbjct: 108 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164

Query: 856 KPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK 914
               ++    +  Y APE         +  DI+S G ++ E+++ R     +     L  
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224

Query: 915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQ 970
            +         D      L            N           +  A+  + K+L 
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-37
 Identities = 63/299 (21%), Positives = 109/299 (36%), Gaps = 48/299 (16%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +Y++        V+G G +GKV ++      E  A+K L     ++C             
Sbjct: 12  DYKVTS-----QVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPK----------- 50

Query: 737 QVQDDGFQAEVETLGKI-RHKNIVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCK 791
                  + EVE   +  +  +IV++          R C L+V E +  G L   +    
Sbjct: 51  ------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 104

Query: 792 GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---GDFGARVADFGVA 848
                     +I+    E + YLH     +I HRDVK  N+L      +   ++ DFG A
Sbjct: 105 DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161

Query: 849 KVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG 908
           K   +     +      +  Y+APE     + ++  D++S GV++  L+ G  P    F 
Sbjct: 162 KETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FY 214

Query: 909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK 967
               +        +  +     P  +     E  K+L   LL T P    R  +   + 
Sbjct: 215 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT--QRMTITEFMN 271

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 5e-37
 Identities = 56/255 (21%), Positives = 95/255 (37%), Gaps = 32/255 (12%)

Query: 665 KWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKEC 723
           KW   S +     +++ +        +G+GS G+V  V    +G   A+K L        
Sbjct: 29  KWETPSQNTAQLDQFDRIK------TLGTGSFGRVMLVKHKESGNHYAMKIL-------- 74

Query: 724 ESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSL 783
                 +K +V    Q +    E   L  +    +VKL           +V EY+  G +
Sbjct: 75  ------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128

Query: 784 GDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVA 843
              L   + G    P              YLH      +++RD+K  N+L+D     +V 
Sbjct: 129 FSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVT 183

Query: 844 DFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPV 903
           DFG AK             + G+   +APE   +   N+  D ++ GV+I E+  G  P 
Sbjct: 184 DFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

Query: 904 DPEFGEKDLVKWVCS 918
             +     + + + S
Sbjct: 239 FAD-QPIQIYEKIVS 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-37
 Identities = 53/243 (21%), Positives = 93/243 (38%), Gaps = 28/243 (11%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           YE L+       IG G+ G V+K       E VA+K++               +    D+
Sbjct: 4   YEKLE------KIGEGTYGTVFKAKNRETHEIVALKRV---------------RLDDDDE 42

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDW 797
                   E+  L +++HKNIV+L     +     LV+E+               G LD 
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDP 100

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKP 857
                 +    +GL + H      ++HRD+K  N+L++ +   ++A+FG+A+      + 
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

Query: 858 KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC 917
            S  V+                 +   D++S G +  EL     P+ P     D +K + 
Sbjct: 158 YSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216

Query: 918 STL 920
             L
Sbjct: 217 RLL 219

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  138 bits (349), Expect = 8e-37
 Identities = 51/306 (16%), Positives = 96/306 (31%), Gaps = 48/306 (15%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y++         IG GS G +++   L N + VA+K   R                   +
Sbjct: 7   YKVGR------RIGEGSFGVIFEGTNLLNNQQVAIKFEPR-------------------R 41

Query: 738 VQDDGFQAEVETLGKIRH-KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLD 796
                 + E  T   +     I  ++         +LV + +  G   + L    G    
Sbjct: 42  SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFS 99

Query: 797 WPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-----GDFGARVADFGVAKVV 851
             T           +  +H     S+V+RD+K +N L+            V DFG+ K  
Sbjct: 100 VKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156

Query: 852 DASGKPK-----SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPE 906
                 +         ++G+  Y++         + + D+ + G V +  + G LP    
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216

Query: 907 FGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV 966
               +  K+       +        +L   F EE  K ++      +      P    + 
Sbjct: 217 KAATNKQKYE---RIGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQ 270

Query: 967 KLLQEV 972
            L  +V
Sbjct: 271 GLFSKV 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 47/231 (20%), Positives = 93/231 (40%), Gaps = 30/231 (12%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S+Y++        ++GSG  G VY  + +S+   VA+K + +    +     +  +    
Sbjct: 4   SQYQVGP------LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR---- 53

Query: 736 DQVQDDGFQAEVETLGKIR--HKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGG 793
                     EV  L K+      +++L       D  +L+ E            + + G
Sbjct: 54  -------VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERG 105

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVD 852
            L             E + + H+     ++HRD+K  NIL+D + G  ++ DFG   ++ 
Sbjct: 106 ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL- 161

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLP 902
              K    +   G+  Y  PE+    R     + ++S G+++ ++V G +P
Sbjct: 162 ---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-36
 Identities = 59/227 (25%), Positives = 87/227 (38%), Gaps = 37/227 (16%)

Query: 686 DEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQ 744
            +  VIG+GS G VY+  L  +GE VA+KK+ +                           
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------------------KN 61

Query: 745 AEVETLGKIRHKNIVKLWCCCTTRDCK------LLVYEYMPNGSLGDLLH-SCKGGLLDW 797
            E++ + K+ H NIV+L     +   K       LV +Y+P        H S     L  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 798 PTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA-RVADFGVAKVVDASGK 856
                 +      L+Y+H      I HRD+K  N+LLD D    ++ DFG AK +     
Sbjct: 122 IYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178

Query: 857 PKSMSVIAGSCGYIAP-EYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
             S         Y AP             D++S G V+ EL+ G+  
Sbjct: 179 NVSYICS---RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-35
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 38/242 (15%)

Query: 677 SEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQ 735
           S+YE L        IG G+ G+V+K      G+ VA+KK+     KE             
Sbjct: 10  SKYEKL------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------------- 50

Query: 736 DQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCK--------LLVYEYMPNGSLGDLL 787
                     E++ L  ++H+N+V L   C T+            LV+++  +   G L 
Sbjct: 51  --GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 108

Query: 788 HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
           +      L    R          L+ L++     I+HRD+K+ N+L+  D   ++ADFG+
Sbjct: 109 NVLVKFTLSEIKRV-----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163

Query: 848 AKVVDASGK--PKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVD 904
           A+    +    P   +    +  Y  PE     R      D++  G ++ E+ T    + 
Sbjct: 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223

Query: 905 PE 906
             
Sbjct: 224 GN 225

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-33
 Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 32/237 (13%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVVL----SNGEAVAVKKLWRGMSKECESGCD 728
           K+G   +E+L       V+G+G+ GKV+ V        G+  A+K L +           
Sbjct: 20  KVGIENFELLK------VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK----------- 62

Query: 729 VEKGQVQDQVQDDGFQAEVETLGKIRHK-NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLL 787
                VQ     +  + E + L  IR    +V L     T     L+ +Y+  G L   L
Sbjct: 63  --ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120

Query: 788 HSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGV 847
              +         Y       E +  L H     I++RD+K  NILLD +    + DFG+
Sbjct: 121 SQRERFTEHEVQIY-----VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175

Query: 848 AKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR--VNEKSDIYSFGVVILELVTGRLP 902
           +K    + + +      G+  Y+AP+         ++  D +S GV++ EL+TG  P
Sbjct: 176 SKEFV-ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 9e-33
 Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 48/250 (19%)

Query: 661 IDKSKWTLMSFHKLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGM 719
           + K+ W +        + Y  L        +GSG+ G V   V    G  VA+KKL    
Sbjct: 9   VTKTAWEV-------RAVYRDLQ------PVGSGAYGAVCSAVDGRTGAKVAIKKL---- 51

Query: 720 SKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCK------LL 773
                          Q ++       E+  L  +RH+N++ L    T  +         L
Sbjct: 52  -----------YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100

Query: 774 VYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL 833
           V  +M      DL    K   L       ++    +GL Y+H   +    HRD+K  N+ 
Sbjct: 101 VMPFMG----TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLA 153

Query: 834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-TLRVNEKSDIYSFGVV 892
           ++ D   ++ DFG+A+  D       M+    +  Y APE     +R  +  DI+S G +
Sbjct: 154 VNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208

Query: 893 ILELVTGRLP 902
           + E++TG+  
Sbjct: 209 MAEMITGKTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 9e-32
 Identities = 56/237 (23%), Positives = 91/237 (38%), Gaps = 33/237 (13%)

Query: 673 KLGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEK 731
           ++G S + +L        IGSG+ G V           VA+KKL                
Sbjct: 7   EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---------------S 51

Query: 732 GQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCK------LLVYEYMPNGSLGD 785
              Q+Q        E+  +  + HKNI+ L    T +          LV E M       
Sbjct: 52  RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 111

Query: 786 LLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF 845
           +         D      ++     G+ +LH      I+HRD+K +NI++  D   ++ DF
Sbjct: 112 IQMEL-----DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163

Query: 846 GVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
           G+A+    S     M+    +  Y APE    +   E  DI+S G ++ E+V  ++ 
Sbjct: 164 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (306), Expect = 6e-31
 Identities = 56/306 (18%), Positives = 117/306 (38%), Gaps = 50/306 (16%)

Query: 678 EYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQD 736
           +Y+++        +G G   +V++ + ++N E V VK L                     
Sbjct: 36  DYQLVR------KLGRGKYSEVFEAINITNNEKVVVKIL--------------------K 69

Query: 737 QVQDDGFQAEVETLGKIR-HKNIVKLWCCCTTRDCKL--LVYEYMPNGSLGDLLHSCKGG 793
            V+    + E++ L  +R   NI+ L         +   LV+E++ N     L  +    
Sbjct: 70  PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---- 125

Query: 794 LLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG-ARVADFGVAKVVD 852
            L        + +  + L Y H      I+HRDVK +N+++D +    R+ D+G+A+   
Sbjct: 126 -LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 853 ASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPEFGEKD 911
                +  +V   S  +  PE     +  +   D++S G ++  ++  + P        D
Sbjct: 182 PG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 912 LVKWVCSTLDQKGV-------DHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRR 964
            +  +   L  + +       +  LDP+ +        K     +   +   ++  A+  
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

Query: 965 VVKLLQ 970
           + KLL+
Sbjct: 299 LDKLLR 304

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 8e-30
 Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 33/241 (13%)

Query: 670 SFHK--LGFSEYEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESG 726
           +F++  L  + +E+ +     + +GSG+ G V        G  VAVKKL           
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL----------- 51

Query: 727 CDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDC-----KLLVYEYMPNG 781
                   Q  +       E+  L  ++H+N++ L    T          + +  ++   
Sbjct: 52  ----SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107

Query: 782 SLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR 841
            L ++    K   L       +I     GL Y+H   +    HRD+K +N+ ++ D   +
Sbjct: 108 DLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELK 161

Query: 842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL 901
           + DFG+A+  D     +    +A             +  N+  DI+S G ++ EL+TGR 
Sbjct: 162 ILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

Query: 902 P 902
            
Sbjct: 218 L 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (293), Expect = 7e-29
 Identities = 48/247 (19%), Positives = 88/247 (35%), Gaps = 42/247 (17%)

Query: 679 YEILDGLDEDNVIGSGSSGKVYKVV-LSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQ 737
           Y ++        +G G    V+    + N   VA+K +                    D+
Sbjct: 15  YILVR------KLGWGHFSTVWLAKDMVNNTHVAMKIVRG------------------DK 50

Query: 738 VQDDGFQAEVETLGKIRHKNIVKLWCCCTTRDCKLLVY--EYMPNGSLG----------- 784
           V  +  + E++ L ++   +  K          KLL +     PNG              
Sbjct: 51  VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL 110

Query: 785 -DLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD-GDFGARV 842
             L+   +   +      +I      GL Y+H  C   I+H D+K  N+L++  D    +
Sbjct: 111 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168

Query: 843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLP 902
               +A + +A    +  +    +  Y +PE          +DI+S   +I EL+TG   
Sbjct: 169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

Query: 903 VDPEFGE 909
            +P+ G 
Sbjct: 229 FEPDEGH 235

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  103 bits (256), Expect = 2e-24
 Identities = 77/303 (25%), Positives = 119/303 (39%), Gaps = 11/303 (3%)

Query: 30  LERVKLSLSDPDSALSSWGRNPRDDSPCSWRGVECDPRSHS--VASIDLSNANIAGPF-- 85
           L ++K  L +P + LSSW     D    +W GV CD  + +  V ++DLS  N+  P+  
Sbjct: 11  LLQIKKDLGNP-TTLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68

Query: 86  PSLLCRLENLTFLTLFNN-SINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLK 144
           PS L  L  L FL +    ++   +P  I+    L +L ++   ++G +   L+ +  L 
Sbjct: 69  PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128

Query: 145 FLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPG 204
            LD + N  SG +P S      L  I+   N + G IP   G+ S L          L G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188

Query: 205 RIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASV 264
           +IPP   NL    +                             +         L++  + 
Sbjct: 189 KIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248

Query: 265 VQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEG 323
           +   L NN + G LP G + L  L  L+ S N+L G IP     L   +      N+   
Sbjct: 249 LD--LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC 305

Query: 324 SLP 326
             P
Sbjct: 306 GSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.1 bits (201), Expect = 2e-17
 Identities = 58/256 (22%), Positives = 100/256 (39%), Gaps = 4/256 (1%)

Query: 337 ELRLFRNRLNG--TLPGDLGKNSPLRWVDLSNN-QFTGEIPASLCEKGELEELLMIYNSF 393
            L L    L     +P  L     L ++ +       G IP ++ +  +L  L + + + 
Sbjct: 54  NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113

Query: 394 TGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAA 453
           +G +PD L   ++L  +   YN L+G +PP +  LP++  +    N +SG I  +    +
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173

Query: 454 NLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL 513
            L   +    N             +L  +  S N   G       +          A + 
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQKIHLAKNS 232

Query: 514 SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLK 573
                  V   K LN L+L +N  YG +P+ +  L  L+ L++S N L G IP G    +
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292

Query: 574 LNQLNVSNNRLSGELP 589
            +    +NN+     P
Sbjct: 293 FDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 76.3 bits (186), Expect = 2e-15
 Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 6/281 (2%)

Query: 147 DLTGNNFSGDIPESFGRFQKLEVISLVYNLLDG--TIPAFLGNISTLKMLNLSYNPFLPG 204
           D     + G + ++  +  ++  + L    L     IP+ L N+  L  L +     L G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 205 RIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASV 264
            IPP +  LT L  L++T  N+ G IPD L ++  LV LD + N L G +P S++ L ++
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 265 VQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGS 324
           V I    N ++G +P  + + + L        +               +       +   
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211

Query: 325 LPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELE 384
             + +  S    +             G +G +  L  +DL NN+  G +P  L +   L 
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 385 ELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR-LTGKVPPL 424
            L + +N+  G++P   G+ Q         N+ L G   PL
Sbjct: 272 SLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG--SPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 71.3 bits (173), Expect = 7e-14
 Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 11/271 (4%)

Query: 277 DLPTGWSNLTSLRLLDASMNDLTG--PIPDDLTRLP-LESLNLYEN-RLEGSLPATIADS 332
           D  T    + +L L   S  +L    PIP  L  LP L  L +     L G +P  IA  
Sbjct: 44  DTDTQTYRVNNLDL---SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100

Query: 333 PGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNS 392
             L+ L +    ++G +P  L +   L  +D S N  +G +P S+     L  +    N 
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 393 FTGQLPDGLGHCQSLTR-VRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAG 451
            +G +PD  G    L   + +  NRLTGK+PP    L   ++    +           + 
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220

Query: 452 AANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAN 511
                + +   +         +    + + L    N+  G+LP+ LT L  L SL++  N
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRN--NRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 512 DLSGELPSSVSSWKKLNELNLADNLFYGNIP 542
           +L GE+P    + ++ +    A+N      P
Sbjct: 279 NLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.9 bits (172), Expect = 1e-13
 Identities = 54/289 (18%), Positives = 94/289 (32%), Gaps = 26/289 (8%)

Query: 232 DSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLR-- 289
           D+  +  ++ +LDL+  NL    P                      +P+  +NL  L   
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFL 81

Query: 290 LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTL 349
            +    N +    P       L  L +    + G++P  ++    L  L    N L+GTL
Sbjct: 82  YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141

Query: 350 PGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTR 409
           P  +     L  +    N+ +G IP S     +L   + I  +             +   
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA 200

Query: 410 VRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSL 469
                  +      +L+G                     +  + NL+ L +  N + G+L
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260

Query: 470 PEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELP 518
           P+ +  LK L  L+ S N   G +P+   NL          N      P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.0 bits (141), Expect = 8e-10
 Identities = 20/68 (29%), Positives = 31/68 (45%), Gaps = 1/68 (1%)

Query: 141 PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            NL  LDL  N   G +P+   + + L  +++ +N L G IP   GN+    +   + N 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302

Query: 201 FLPGRIPP 208
            L G   P
Sbjct: 303 CLCGSPLP 310

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.4 bits (239), Expect = 2e-23
 Identities = 33/207 (15%), Positives = 67/207 (32%), Gaps = 21/207 (10%)

Query: 689 NVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVE 748
            ++G G    V+           VK    G +   +     + G       D  F     
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYG-------DLHFSVLAI 58

Query: 749 TLGKIRHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAA 808
              +   + + KL      +      Y +  N  L +L+ + +   +      +++    
Sbjct: 59  RSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMIL 113

Query: 809 EGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCG 868
           E ++  +H     IVH D+   N+L+  + G  + DF  +  V          ++     
Sbjct: 114 EEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE---EGWREILERDVR 166

Query: 869 YIAPEYAYTLRVNEKSDIYSFGVVILE 895
            I     ++     + DI S    IL+
Sbjct: 167 NII--TYFSRTYRTEKDINSAIDRILQ 191

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 98.5 bits (244), Expect = 2e-22
 Identities = 97/434 (22%), Positives = 157/434 (36%), Gaps = 59/434 (13%)

Query: 102 NNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESF 161
           +  IN    D   A        L +  +T T++    DL  +  L          I +  
Sbjct: 9   DTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGV 62

Query: 162 GRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWL 221
                L  I+   N L    P  L N++ L  + ++ N          L NLT L +   
Sbjct: 63  EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120

Query: 222 TECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG 281
              ++      +     +L    +          S ++ L+ +  ++  +          
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTI----------SDISALSGLTSLQQLSFGNQVTDLKP 170

Query: 282 WSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLF 341
            +NLT+L  LD S N ++           LESL    N++    P  I  +  L EL L 
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLT-NLESLIATNNQISDITPLGILTN--LDELSLN 227

Query: 342 RNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGL 401
            N+L     G L   + L  +DL+NNQ +   P                          L
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLAP--------------------------L 259

Query: 402 GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIIS 461
                LT ++LG N+++   P  L GL  +  LEL +N    E    I+   NL+ L + 
Sbjct: 260 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLY 315

Query: 462 KNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSV 521
            NN+S   P  +  L  L  L  + NK +     SL NL  +  L    N +S   P  +
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369

Query: 522 SSWKKLNELNLADN 535
           ++  ++ +L L D 
Sbjct: 370 ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 91.6 bits (226), Expect = 4e-20
 Identities = 84/388 (21%), Positives = 145/388 (37%), Gaps = 41/388 (10%)

Query: 212 NLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYN 271
            L       L + N+   +  +   L ++  L      +       +  L ++ QI   N
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 272 NSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLE--------- 322
           N LT   P    NLT L  +  + N +    P                  +         
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 323 -------GSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPA 375
                   +  + I+   GL  L+        T    L   + L  +D+S+N+ +     
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 376 SLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLE 435
           +     E   L+   N  +   P G     +L  + L  N+L       L  L ++  L+
Sbjct: 194 AKLTNLE--SLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 436 LTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE 495
           L +N +S      ++G   L+ L +  N +S   P  +  L +L  L  +EN+     P 
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI 303

Query: 496 SLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLD 555
             +NL  L  L L+ N++S   P  VSS  KL  L  A+N         + NL+ +N+L 
Sbjct: 304 --SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357

Query: 556 LSNNRLSGRIPVGLQNL-KLNQLNVSNN 582
             +N++S   P  L NL ++ QL +++ 
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.0 bits (214), Expect = 1e-18
 Identities = 74/381 (19%), Positives = 126/381 (33%), Gaps = 49/381 (12%)

Query: 230 IPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLR 289
             D+   LA+ +   L   N+   +  S T+L  V  ++     +   +  G   L +L 
Sbjct: 16  FTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLT 69

Query: 290 LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTL 349
            ++ S N LT   P       L  L             T   +          N     +
Sbjct: 70  QINFSNNQLTDITPLK----NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 125

Query: 350 PGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTR 409
                  +  R    SN          +     L  L  +           L +  +L R
Sbjct: 126 DPLKNLTNLNRLELSSNTISD------ISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 410 VRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSL 469
           + +  N+++         L ++  L  T+N +S      I    NL  L ++ N L    
Sbjct: 180 LDISSNKVSDISVL--AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-- 233

Query: 470 PEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK--- 526
              +  L +L  L  + N+ +   P  L+ L +L  L L AN +S   P +  +      
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291

Query: 527 -----------------LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGL 569
                            L  L L  N      P  + +L+ L  L  +NN++S      L
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347

Query: 570 QNLK-LNQLNVSNNRLSGELP 589
            NL  +N L+  +N++S   P
Sbjct: 348 ANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 86.2 bits (212), Expect = 2e-18
 Identities = 70/387 (18%), Positives = 120/387 (31%), Gaps = 57/387 (14%)

Query: 65  DPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDL 124
           D          L   N+          L+ +T L      I S   D +    NL  ++ 
Sbjct: 18  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINF 73

Query: 125 SQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPE------------------------- 159
           S N LT      L +L  L  + +  N  +   P                          
Sbjct: 74  SNNQLTDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 160 -----------SFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPP 208
                      +      L  ++ +  L  G     L  ++ L  L              
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 209 ELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIE 268
            L  LTNLE L  T   +    P  +     L +L L  N L      +L  L ++  ++
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 269 LYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPAT 328
           L NN ++   P   S LT L  L    N ++   P                  +    + 
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED---ISP 302

Query: 329 IADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLM 388
           I++   L  L L+ N ++   P  +   + L+ +  +NN+ +    +SL     +  L  
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 389 IYNSFTGQLPDGLGHCQSLTRVRLGYN 415
            +N  +   P  L +   +T++ L   
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.2 bits (199), Expect = 8e-17
 Identities = 41/212 (19%), Positives = 73/212 (34%), Gaps = 33/212 (15%)

Query: 57  CSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISAC 116
                +    +  ++ S+  +N  I+   P  +    NL  L+L  N +       +++ 
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASL 240

Query: 117 QNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIP------------------ 158
            NL  LDL+ N ++      L+ L  L  L L  N  S   P                  
Sbjct: 241 TNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298

Query: 159 --ESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNL 216
                   + L  ++L +N +    P  + +++ L+ L  + N          L NLTN+
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV---SDVSSLANLTNI 353

Query: 217 EILWLTECNLVGEIPDSLGRLAKLVDLDLALN 248
             L      +    P  L  L ++  L L   
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.8 bits (185), Expect = 5e-15
 Identities = 67/374 (17%), Positives = 118/374 (31%), Gaps = 39/374 (10%)

Query: 70  SVASIDLSNANIAGPFPSL--LCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQN 127
            V ++      I     S+  +  L NLT +   NN +    P  +     L  + ++ N
Sbjct: 45  QVTTLQADRLGIK----SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98

Query: 128 LLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGN 187
            +      A         L          +       +     + + ++          +
Sbjct: 99  QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI----------S 148

Query: 188 ISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLAL 247
             +        +          L NLT LE L     +        L +L  L  L    
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD--ISSNKVSDISVLAKLTNLESLIATN 206

Query: 248 NNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLT 307
           N +    P  +    ++ ++ L  N L        ++LT+L  LD + N ++   P  L+
Sbjct: 207 NQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 260

Query: 308 RLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKN-SPLRWVDLS 365
            L  L  L L  N++    P       GL  L       N         N   L ++ L 
Sbjct: 261 GLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315

Query: 366 NNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLL 425
            N  +   P S   K  L+ L    N  +      L +  ++  +  G+N+++   P  L
Sbjct: 316 FNNISDISPVSSLTK--LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369

Query: 426 WGLPHVYLLELTDN 439
             L  +  L L D 
Sbjct: 370 ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.4 bits (119), Expect = 6e-07
 Identities = 56/291 (19%), Positives = 104/291 (35%), Gaps = 22/291 (7%)

Query: 314 LNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEI 373
             L +  +  ++  +  D   +  L+  R  +  ++ G +   + L  ++ SNNQ T   
Sbjct: 27  TVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDIT 82

Query: 374 PASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL 433
           P        L +L+ I  +             +       +N     + PL        L
Sbjct: 83  PL-----KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 137

Query: 434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSL 493
              ++         +I+  + L+ L         +  + +  L +L  L  S NK +   
Sbjct: 138 ELSSNTI------SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 494 PESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNY 553
             +   L  L SL    N +S   P  +     L+EL+L  N         + +L+ L  
Sbjct: 192 VLA--KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 245

Query: 554 LDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSGELPSLFAKEMYRNSFLGN 604
           LDL+NN++S   P+     KL +L +  N++S   P      +       N
Sbjct: 246 LDLANNQISNLAPLS-GLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.9 bits (237), Expect = 5e-22
 Identities = 56/296 (18%), Positives = 95/296 (32%), Gaps = 26/296 (8%)

Query: 57  CSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISAC 116
           C  R V+C          DL                 +   L L NN I      D    
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLP---------------PDTALLDLQNNKITEIKDGDFKNL 54

Query: 117 QNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNL 176
           +NL  L L  N ++     A A L  L+ L L+ N       +     Q+L V       
Sbjct: 55  KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114

Query: 177 LDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGR 236
           +  ++   L  +  +++          G        +  L  + + + N+   IP  L  
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLK--SSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL-- 169

Query: 237 LAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMN 296
              L +L L  N +     +SL  L ++ ++ L  NS++       +N   LR L  + N
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229

Query: 297 DLTGPIPDDLTRLPLESLNLYENRLEG------SLPATIADSPGLYELRLFRNRLN 346
            L            ++ + L+ N +          P           + LF N + 
Sbjct: 230 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 88.6 bits (218), Expect = 1e-19
 Identities = 61/271 (22%), Positives = 103/271 (38%), Gaps = 18/271 (6%)

Query: 324 SLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGEL 383
            +P  +   P    L L  N++     GD      L  + L NN+ +   P +     +L
Sbjct: 24  KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 384 EELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFL-- 441
           E L +  N             Q L       N +T     +  GL  + ++EL  N L  
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKS 138

Query: 442 SGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLA 501
           SG  +    G   LS + I+  N++ ++P+  G   SL  L    NK T     SL  L 
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLN 195

Query: 502 ELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRL 561
            L  L L  N +S     S+++   L EL+L +N     +P  + +   +  + L NN +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254

Query: 562 SG-------RIPVGLQNLKLNQLNVSNNRLS 585
           S              +    + +++ +N + 
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.0 bits (214), Expect = 4e-19
 Identities = 51/264 (19%), Positives = 95/264 (35%), Gaps = 7/264 (2%)

Query: 205 RIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASV 264
           ++P +L    +  +L L    +          L  L  L L  N +    P +   L  +
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 265 VQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGS 324
            ++ L  N L          L  LR+ +  +  +   + + L ++ +  L     +  G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 325 LPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELE 384
                     L  +R+    +  T+P  L  +  L  + L  N+ T    ASL     L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKITKVDAASLKGLNNLA 198

Query: 385 ELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGE 444
           +L + +NS +      L +   L  + L  N+L  KVP  L    ++ ++ L +N +S  
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257

Query: 445 ISKNIAGAANLSLLI-ISKNNLSG 467
            S +       +     S  +L  
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFS 281

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.5 bits (197), Expect = 7e-17
 Identities = 59/295 (20%), Positives = 101/295 (34%), Gaps = 17/295 (5%)

Query: 271 NNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATI 329
           +  L   +P          LLD   N +T     D   L  L +L L  N++    P   
Sbjct: 19  DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75

Query: 330 ADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMI 389
           A    L  L L +N+L             LR  +    +    +   L +   +E L   
Sbjct: 76  APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTN 134

Query: 390 YNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNI 449
               +G         + L+ +R+    +T     L   L     L L  N ++   + ++
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASL 191

Query: 450 AGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLH 509
            G  NL+ L +S N++S      +     L  L  + NK     P  L +   +  + LH
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLH 250

Query: 510 ANDLSG------ELPSSVSSWKKLNELNLADN-LFYGNI-PEDIGNLSVLNYLDL 556
            N++S         P   +     + ++L  N + Y  I P     + V   + L
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.4 bits (158), Expect = 7e-12
 Identities = 34/192 (17%), Positives = 68/192 (35%), Gaps = 6/192 (3%)

Query: 406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNL 465
            L  V+     L  KVP  L   P   LL+L +N ++     +     NL  LI+  N +
Sbjct: 11  HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 466 SGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWK 525
           S   P     L  L  L  S+N+      +    L EL   +     +   + + ++   
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 526 KLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLS 585
            +  L        G        +  L+Y+ +++  ++        +L   +L++  N+++
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT--ELHLDGNKIT 184

Query: 586 GELPSLFAKEMY 597
               +       
Sbjct: 185 KVDAASLKGLNN 196

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (215), Expect = 2e-19
 Identities = 59/270 (21%), Positives = 94/270 (34%), Gaps = 7/270 (2%)

Query: 57  CSWRGVECDPR--SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDIS 114
           C  +G++  P     +   I L    I+    +      NLT L L +N +        +
Sbjct: 18  CPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 115 ACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV 173
               L+ LDLS N    ++ P     L  L  L L         P  F     L+ + L 
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137

Query: 174 YNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDS 233
            N L         ++  L  L L  N  +          L +L+ L L +  +    P +
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

Query: 234 LGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDA 293
              L +L+ L L  NNL      +L  L ++  + L +N    D          L+    
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRG 255

Query: 294 SMNDLTGPIPDDLTRLPLESLNLYENRLEG 323
           S +++   +P  L    L    L  N L+G
Sbjct: 256 SSSEVPCSLPQRLAGRDL--KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (201), Expect = 1e-17
 Identities = 59/284 (20%), Positives = 96/284 (33%), Gaps = 10/284 (3%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
           C  E     +     + + +P  I A    Q + L  N ++     +     NL  L L 
Sbjct: 8   CYNEPKVTTSCPQQGLQA-VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLH 64

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTI-PAFLGNISTLKMLNLSYNPFLPGRIPP 208
            N  +     +F     LE + L  N    ++ PA    +  L  L+L          P 
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPG 123

Query: 209 ELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIE 268
               L  L+ L+L +  L     D+   L  L  L L  N +      +   L S+ ++ 
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 269 LYNNSLTGDLPTGWSNLTSLRLLDASMNDLTG-PIPDDLTRLPLESLNLYENRLEGSLPA 327
           L+ N +    P  + +L  L  L    N+L+  P         L+ L L +N       A
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243

Query: 328 TIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTG 371
                  L + R   + +  +LP  L          L+ N   G
Sbjct: 244 -RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (196), Expect = 6e-17
 Identities = 57/238 (23%), Positives = 85/238 (35%), Gaps = 2/238 (0%)

Query: 141 PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
              + + L GN  S     SF   + L ++ L  N+L     A    ++ L+ L+LS N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 201 FLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTE 260
            L    P     L  L  L L  C L    P     LA L  L L  N L      +  +
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 261 LASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL-PLESLNLYEN 319
           L ++  + L+ N ++      +  L SL  L    N +    P     L  L +L L+ N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 320 RLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL 377
            L       +A    L  LRL  N               L+    S+++    +P  L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW-LQKFRGSSSEVPCSLPQRL 268

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (186), Expect = 1e-15
 Identities = 51/247 (20%), Positives = 79/247 (31%), Gaps = 3/247 (1%)

Query: 348 TLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSL 407
            +P  +      + + L  N+ +    AS      L  L +  N               L
Sbjct: 25  AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 408 TRVRLGYNRLTGKVPP-LLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLS 466
            ++ L  N     V P    GL  ++ L L    L         G A L  L +  N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 467 GSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKK 526
               +    L +L  L    N+ +     +   L  L  L LH N ++   P +     +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 527 LNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSG 586
           L  L L  N       E +  L  L YL L++N              L +   S++ +  
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262

Query: 587 ELPSLFA 593
            LP   A
Sbjct: 263 SLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.2 bits (183), Expect = 3e-15
 Identities = 52/264 (19%), Positives = 93/264 (35%), Gaps = 8/264 (3%)

Query: 206 IPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVV 265
           +P  +      + ++L    +      S      L  L L  N L     ++ T LA + 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 266 QIELYNNSLTGDL-PTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEG 323
           Q++L +N+    + P  +  L  L  L      L    P     L  L+ L L +N L+ 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 324 SLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGEL 383
               T  D   L  L L  NR++            L  + L  N+     P +  + G L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 384 EELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
             L +  N+ +    + L   ++L  +RL  N               +     + + +  
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPC 262

Query: 444 EISKNIAGAANLSLLIISKNNLSG 467
            + + +AG     L  ++ N+L G
Sbjct: 263 SLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (132), Expect = 8e-09
 Identities = 40/174 (22%), Positives = 57/174 (32%), Gaps = 4/174 (2%)

Query: 53  DDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDD 112
           D       G        ++  + L +  +          L NLT L L  N I+S     
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172

Query: 113 ISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISL 172
                +L  L L QN +      A  DL  L  L L  NN S    E+    + L+ + L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232

Query: 173 VYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGN--LTNLEILWLTEC 224
             N       A     + L+    S +  +P  +P  L    L  L    L  C
Sbjct: 233 NDNPWVCDCRA-RPLWAWLQKFRGSSSE-VPCSLPQRLAGRDLKRLAANDLQGC 284

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (135), Expect = 4e-09
 Identities = 47/282 (16%), Positives = 88/282 (31%), Gaps = 20/282 (7%)

Query: 146 LDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGR 205
           LDLTG N   D+       Q +       + +D  +         ++ ++LS +      
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 206 IPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIP--------SS 257
           +   L   + L+ L L    L   I ++L + + LV L+L+  +              S 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 258 LTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPD--DLTRLPLESLN 315
           L EL      +     +   +      +T L L     N     +          +    
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 316 LYENRLEGSLPATIADSPGLYELRLFR-NRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIP 374
                L+            L  L L R   +      +LG+   L+ + +      G + 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 375 ASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLT----RVRL 412
                K  L  L +  + FT      +G+ ++      + RL
Sbjct: 243 LL---KEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRL 281

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (127), Expect = 4e-08
 Identities = 38/244 (15%), Positives = 75/244 (30%), Gaps = 11/244 (4%)

Query: 68  SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSIN-STLPDDISACQNLQHLDLSQ 126
           S  V +     + +  P          +  + L N+ I  STL   +S C  LQ+L L  
Sbjct: 22  SQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80

Query: 127 NLLTGTLTPALADLPNLKFLDLTGNNFSGDIP--------ESFGRFQKLEVISLVYNLLD 178
             L+  +   LA   NL  L+L+G +   +                            + 
Sbjct: 81  LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140

Query: 179 GTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLA 238
             +      I+ L +     N                + +       L  +      +L 
Sbjct: 141 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200

Query: 239 KLVDLDLA-LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMND 297
            L  L L+   +++      L E+ ++  ++++     G L      L  L++  +    
Sbjct: 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTT 260

Query: 298 LTGP 301
           +  P
Sbjct: 261 IARP 264

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 1e-07
 Identities = 41/276 (14%), Positives = 87/276 (31%), Gaps = 21/276 (7%)

Query: 313 SLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGE 372
           +L+L    L   +   +  S G+   R  R+ ++  L  +      ++ +DLSN+     
Sbjct: 4   TLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61

Query: 373 -IPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHV 431
            +   L +  +L+ L +     +  + + L    +L R+ L       +           
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 432 YLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTG 491
            L EL  ++      K++  A       I++ NLSG          S +V          
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL- 180

Query: 492 SLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLAD-NLFYGNIPEDIGNLSV 550
                             +  L  +          L  L+L+           ++G +  
Sbjct: 181 --------------DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 551 LNYLDLSNNRLSGRIPVGLQNLKLNQLNVSNNRLSG 586
           L  L +      G + +  + L    L ++ +  + 
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALP--HLQINCSHFTT 260

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 5e-07
 Identities = 34/263 (12%), Positives = 85/263 (32%), Gaps = 20/263 (7%)

Query: 194 LNLSYNPFLPGRIPPELGNLTNLEILWLTEC-NLVGEIPDSLGRLAKLVDLDLALNNL-V 251
           L+L+     P       G L +  ++      + + +         ++  +DL+ + + V
Sbjct: 5   LDLTGKNLHPD----VTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60

Query: 252 GAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPL 311
             +   L++ + +  + L    L+  +    +  ++L  L+ S                 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 312 ESLNLY---------ENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWV 362
             L+           E  ++ ++         L      +N     L   + +   L  +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 363 DLSNN-QFTGEIPASLCEKGELEELLMIY-NSFTGQLPDGLGHCQSLTRVRLGYNRLTGK 420
           DLS++     +      +   L+ L +        +    LG   +L  +++      G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 421 VPPLLWGLPHVYLLELTDNFLSG 443
           +  L   LPH   L++  +  + 
Sbjct: 241 LQLLKEALPH---LQINCSHFTT 260

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 34/226 (15%), Positives = 66/226 (29%), Gaps = 37/226 (16%)

Query: 67  RSHSVASIDLSNANI-AGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLS 125
               V  +DLSN+ I       +L +   L  L+L    ++  + + ++   NL  L+LS
Sbjct: 44  SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103

Query: 126 Q--NLLTGTLTPALADLPNLKFLDLT-------------------------------GNN 152
                    L   L+    L  L+L+                                  
Sbjct: 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQ 163

Query: 153 FSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGN 212
            S            + +      +L          ++ L+ L+LS    +      ELG 
Sbjct: 164 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223

Query: 213 LTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSL 258
           +  L+ L +      G +      L     L +  ++       ++
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTI 266

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.2 bits (127), Expect = 5e-09
 Identities = 29/122 (23%), Positives = 46/122 (37%), Gaps = 6/122 (4%)

Query: 120 QHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDG 179
           + L L+   LT      L  L  +  LDL+ N      P +    + LEV+    N L+ 
Sbjct: 1   RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 180 TIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAK 239
                  N+  L+ L L  N          L +   L +L L   +L  +      RLA+
Sbjct: 58  VDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114

Query: 240 LV 241
           ++
Sbjct: 115 ML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.6 bits (115), Expect = 2e-07
 Identities = 30/125 (24%), Positives = 47/125 (37%), Gaps = 8/125 (6%)

Query: 98  LTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDI 157
           L L +  +  T+   +     + HLDLS N L     PALA L  L+ L  + N    + 
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNAL--EN 57

Query: 158 PESFGRFQKLEVISLVYNLL-DGTIPAFLGNISTLKMLNLSYNPF--LPGRIPPELGNLT 214
            +      +L+ + L  N L        L +   L +LNL  N      G        L 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 215 NLEIL 219
           ++  +
Sbjct: 118 SVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 3e-06
 Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 6/107 (5%)

Query: 458 LIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGEL 517
           L ++  +L+      +  L  +  L  S N+     P +L  L  L  L    N    E 
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA--LEN 57

Query: 518 PSSVSSWKKLNELNLADN-LFYGNIPEDIGNLSVLNYLDLSNNRLSG 563
              V++  +L EL L +N L      + + +   L  L+L  N L  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 22/110 (20%), Positives = 39/110 (35%), Gaps = 7/110 (6%)

Query: 192 KMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV 251
           ++L+L++       +   L  L  +  L L+   L    P +L  L  L  L    ++  
Sbjct: 1   RVLHLAHKDL---TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQA--SDNA 54

Query: 252 GAIPSSLTELASVVQIELYNNSLTG-DLPTGWSNLTSLRLLDASMNDLTG 300
                 +  L  + ++ L NN L          +   L LL+   N L  
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 29/109 (26%), Positives = 43/109 (39%), Gaps = 7/109 (6%)

Query: 481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGN 540
           VL  +    T      L  L  +  LDL  N L    P ++++ + L  L    +     
Sbjct: 2   VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQA--SDNALE 56

Query: 541 IPEDIGNLSVLNYLDLSNNRLSGRIPVG-LQNL-KLNQLNVSNNRLSGE 587
             + + NL  L  L L NNRL     +  L +  +L  LN+  N L  E
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 2e-04
 Identities = 22/105 (20%), Positives = 38/105 (36%), Gaps = 24/105 (22%)

Query: 74  IDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLP---------------------DD 112
           + L++ ++       L +L  +T L L +N + +  P                     D 
Sbjct: 3   LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 113 ISACQNLQHLDLSQNLLTGTLTP-ALADLPNLKFLDLTGNNFSGD 156
           ++    LQ L L  N L  +     L   P L  L+L GN+   +
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 2e-08
 Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 10/103 (9%)

Query: 116 CQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYN 175
              L       N  +  +       P+L+ L+++ N    ++P    R   LE +   +N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFN 314

Query: 176 LLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEI 218
            L   +P    N   LK L++ YNP      P    ++ +L +
Sbjct: 315 HL-AEVPELPQN---LKQLHVEYNPLR--EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 27/87 (31%), Positives = 37/87 (42%), Gaps = 8/87 (9%)

Query: 508 LHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPV 567
            + N  S E+ S       L ELN+++N     +P     L     L  S N L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLE---RLIASFNHLA-EVPE 321

Query: 568 GLQNLKLNQLNVSNNRLSGELPSLFAK 594
             QNLK  QL+V  N L  E P +   
Sbjct: 322 LPQNLK--QLHVEYNPLR-EFPDIPES 345

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 1e-05
 Identities = 19/94 (20%), Positives = 41/94 (43%), Gaps = 9/94 (9%)

Query: 340 LFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPD 399
            + N  +  +         L  +++SNN+   E+PA       LE L+  +N    ++P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321

Query: 400 GLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL 433
                Q+L ++ + YN L  + P +   +  + +
Sbjct: 322 LP---QNLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 1e-05
 Identities = 26/93 (27%), Positives = 34/93 (36%), Gaps = 9/93 (9%)

Query: 436 LTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPE 495
              N  S EI        +L  L +S N L   LP     L+ L+    S N     +PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIA---SFNHLA-EVPE 321

Query: 496 SLTNLAELGSLDLHANDLSGELPSSVSSWKKLN 528
              NL +   L +  N L  E P    S + L 
Sbjct: 322 LPQNLKQ---LHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 9/93 (9%)

Query: 198 YNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSS 257
           Y       I        +LE L ++   L+ E+P    RL +   L  + N+L   +P  
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVPEL 322

Query: 258 LTELASVVQIELYNNSLTGDLPTGWSNLTSLRL 290
              L    Q+ +  N L    P    ++  LR+
Sbjct: 323 PQNL---KQLHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.4 bits (103), Expect = 5e-05
 Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 9/99 (9%)

Query: 47  WGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSIN 106
              N    +  S           S+  +++SN  +    P+L  RLE L       N + 
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHL- 316

Query: 107 STLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKF 145
           + +P+     QNL+ L +  N L          + +L+ 
Sbjct: 317 AEVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.5 bits (98), Expect = 2e-04
 Identities = 25/100 (25%), Positives = 39/100 (39%), Gaps = 10/100 (10%)

Query: 403 HCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISK 462
               L       N  + ++  L    P +  L +++N L  E+         L  LI S 
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASF 313

Query: 463 NNLSGSLPEEIGFLKSLVVLSGSENKFTG--SLPESLTNL 500
           N+L+  +PE    LK L V     N       +PES+ +L
Sbjct: 314 NHLA-EVPELPQNLKQLHV---EYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 8e-04
 Identities = 21/89 (23%), Positives = 33/89 (37%), Gaps = 9/89 (10%)

Query: 269 LYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPAT 328
            Y N+ + ++ +      SL  L+ S N L   +P    R  LE L    N L   +P  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR--LERLIASFNHLA-EVPEL 322

Query: 329 IADSPGLYELRLFRNRLNG--TLPGDLGK 355
                 L +L +  N L     +P  +  
Sbjct: 323 P---QNLKQLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 19/66 (28%), Positives = 26/66 (39%), Gaps = 8/66 (12%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
           C       L L N  + S+LP+      +L+ L  S N LT  L        +LK L + 
Sbjct: 35  CLDRQAHELELNNLGL-SSLPELPP---HLESLVASCNSLT-ELPEL---PQSLKSLLVD 86

Query: 150 GNNFSG 155
            NN   
Sbjct: 87  NNNLKA 92

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 36/210 (17%), Positives = 64/210 (30%), Gaps = 10/210 (4%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLT 149
            ++ +   +     ++ + LP D+    +   L LS+NLL       L     L  L+L 
Sbjct: 7   SKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL- 62

Query: 150 GNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPE 209
                            L V+  +    +      L   +   +  L  +      +P  
Sbjct: 63  ----DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 210 LGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDL-DLALNNLVGAIPSSLTELASVVQIE 268
                        + N +  +P  L      ++   LA NNL       L  L ++  + 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 269 LYNNSLTGDLPTGWSNLTSLRLLDASMNDL 298
           L  NSL   +P G+     L       N  
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (126), Expect = 4e-08
 Identities = 43/203 (21%), Positives = 69/203 (33%), Gaps = 7/203 (3%)

Query: 311 LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT 370
              +N  +  L  +LP  +        L L  N L       L   + L  ++L   + T
Sbjct: 12  HLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68

Query: 371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPH 430
                           L + ++    LP       +LT + + +NRLT      L GL  
Sbjct: 69  KLQVDGTLPV---LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125

Query: 431 VYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFT 490
           +  L L  N L       +     L  L ++ NNL+      +  L++L  L   EN   
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

Query: 491 GSLPESLTNLAELGSLDLHANDL 513
            ++P+       L    LH N  
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 2e-07
 Identities = 44/209 (21%), Positives = 72/209 (34%), Gaps = 9/209 (4%)

Query: 139 DLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSY 198
            + +   ++    N +  +P    +     ++ L  NLL     A L   + L  LNL  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 199 NPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSL 258
                 ++   L  L  L++      +L                LD++ N L      +L
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL----TVLDVSFNRLTSLPLGAL 120

Query: 259 TELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLY 317
             L  + ++ L  N L    P   +    L  L  + N+LT      L  L  L++L L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 318 ENRLEGSLPATIADSPGLYELRLFRNRLN 346
           EN L  ++P     S  L    L  N   
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 6e-06
 Identities = 54/267 (20%), Positives = 83/267 (31%), Gaps = 25/267 (9%)

Query: 377 LCEKGELEELLMIYNSFTG--QLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLL 434
           +CE  ++   L +         LP  L   +  T + L  N L       L         
Sbjct: 3   ICEVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTR---- 56

Query: 435 ELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLP--EEIGFLKSLVVLSGSENKFTGS 492
            LT   L       +     L +L     + +           L +L VL  S N+ T  
Sbjct: 57  -LTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 493 LPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLN 552
              +L  L EL  L L  N+L    P  ++   KL +L+LA+N         +  L  L+
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 553 YLDLSNNRLSGRIPVGLQNLK-LNQLNVSNNR---------LSGELPSLFAKEMYRNSFL 602
            L L  N L   IP G      L    +  N              L             +
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGV 234

Query: 603 GNPGLCGDLEGL-CDGRGEEKNRGYVW 628
               +  ++  + CD    +K   Y +
Sbjct: 235 DVKAMTSNVASVQCD--NSDKFPVYKY 259

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 43/188 (22%), Positives = 53/188 (28%), Gaps = 25/188 (13%)

Query: 57  CSWRGVECDPR--SHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTL----- 109
           C  R +   P         + LS   +     + L     LT L L    +         
Sbjct: 17  CDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL 76

Query: 110 ----------------PDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNF 153
                           P        L  LD+S N LT     AL  L  L+ L L GN  
Sbjct: 77  PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136

Query: 154 SGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNL 213
               P       KLE +SL  N L       L  +  L  L L  N      IP      
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY--TIPKGFFGS 194

Query: 214 TNLEILWL 221
             L   +L
Sbjct: 195 HLLPFAFL 202

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 1e-04
 Identities = 20/72 (27%), Positives = 30/72 (41%), Gaps = 1/72 (1%)

Query: 85  FPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLK 144
            P LL     L  L+L NN++       ++  +NL  L L +N L  T+         L 
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198

Query: 145 FLDLTGNNFSGD 156
           F  L GN +  +
Sbjct: 199 FAFLHGNPWLCN 210

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 2e-08
 Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 5/91 (5%)

Query: 94  NLTFLTLFNNSINST-LPDDISACQNLQHLDLSQNLLTG----TLTPALADLPNLKFLDL 148
           ++  L +    ++     + +   Q  Q + L    LT      ++ AL   P L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDG 179
             N           +  +     +    L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 3e-08
 Identities = 14/96 (14%), Positives = 30/96 (31%), Gaps = 10/96 (10%)

Query: 68  SHSVASIDLSNANIA-GPFPSLLCRLENLTFLTLFNNSIN----STLPDDISACQNLQHL 122
           S  + S+D+    ++   +  LL  L+    + L +  +       +   +     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 123 DLSQNLLTGTLTPALADL-----PNLKFLDLTGNNF 153
           +L  N L       +          ++ L L     
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 3e-08
 Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 13/91 (14%)

Query: 94  NLTFLTLFNNSINST----LPDDISACQNLQHLDLSQNLLTGTLTPALAD-----LPNLK 144
            L  L L +  ++ +    L   + A  +L+ LDLS N L       L +        L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 145 FLDLTGNNFSGDIPESFGRFQK----LEVIS 171
            L L    +S ++ +     +K    L VIS
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 9e-07
 Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 4/96 (4%)

Query: 191 LKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL----VGEIPDSLGRLAKLVDLDLA 246
           ++ L++        R    L  L   +++ L +C L      +I  +L     L +L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 247 LNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGW 282
            N L       + +       ++   SL     TG 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 18/114 (15%), Positives = 30/114 (26%), Gaps = 27/114 (23%)

Query: 118 NLQHLDLSQNLLTGT-LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNL 176
           ++Q LD+    L+       L  L   + + L     +    +                 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD---------------- 46

Query: 177 LDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELG-----NLTNLEILWLTECN 225
               I + L     L  LNL  N  L       +          ++ L L  C 
Sbjct: 47  ----ISSALRVNPALAELNLRSNE-LGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 15/101 (14%), Positives = 29/101 (28%), Gaps = 9/101 (8%)

Query: 101 FNNSINSTLPDDISACQNLQHLDLSQNLLTGT----LTPALADLPNLKFLDLTGNNFSGD 156
            +  +             L+ L L+   ++ +    L   L    +L+ LDL+ N     
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 157 IPESFGRFQK-----LEVISLVYNLLDGTIPAFLGNISTLK 192
                    +     LE + L        +   L  +   K
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 16/91 (17%), Positives = 31/91 (34%), Gaps = 6/91 (6%)

Query: 502 ELGSLDLHANDLSGE-LPSSVSSWKKLNELNLADNLF----YGNIPEDIGNLSVLNYLDL 556
           ++ SLD+   +LS       +   ++   + L D         +I   +     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 557 SNNRLSGRIPVGL-QNLKLNQLNVSNNRLSG 586
            +N L       + Q L+     +    L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 6e-06
 Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 9/82 (10%)

Query: 503 LGSLDLHANDLSGE----LPSSVSSWKKLNELNLADNLFYGNIPEDIG-----NLSVLNY 553
           L  L L   D+S      L +++ +   L EL+L++N         +         +L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 554 LDLSNNRLSGRIPVGLQNLKLN 575
           L L +   S  +   LQ L+ +
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 12/76 (15%), Positives = 26/76 (34%), Gaps = 5/76 (6%)

Query: 309 LPLESLNLYENRL-EGSLPATIADSPGLYELRLFRNRLNG----TLPGDLGKNSPLRWVD 363
           L ++SL++    L +      +        +RL    L       +   L  N  L  ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 364 LSNNQFTGEIPASLCE 379
           L +N+        + +
Sbjct: 62  LRSNELGDVGVHCVLQ 77

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 15/84 (17%), Positives = 29/84 (34%), Gaps = 5/84 (5%)

Query: 454 NLSLLIISKNNLSGS-LPEEIGFLKSLVVLSGSENKFTG----SLPESLTNLAELGSLDL 508
           ++  L I    LS +   E +  L+   V+   +   T      +  +L     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 509 HANDLSGELPSSVSSWKKLNELNL 532
            +N+L       V    +     +
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 16/113 (14%), Positives = 34/113 (30%), Gaps = 13/113 (11%)

Query: 47  WGRNPRDDSPCSWRGVECDPRSHSVASIDLSNANI----AGPFPSLLCRLENLTFLTLFN 102
              N  +D+               +  + L++ ++         + L    +L  L L N
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406

Query: 103 NSINSTLPDDISA-----CQNLQHLDLSQNLLTGTLTPALADL----PNLKFL 146
           N +       +          L+ L L     +  +   L  L    P+L+ +
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 8e-05
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 9/76 (11%)

Query: 335 LYELRLFRNRLNGT----LPGDLGKNSPLRWVDLSNNQFTGEIPASLCE-----KGELEE 385
           L  L L    ++ +    L   L  N  LR +DLSNN         L E        LE+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 386 LLMIYNSFTGQLPDGL 401
           L++    ++ ++ D L
Sbjct: 431 LVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 23/104 (22%), Positives = 32/104 (30%), Gaps = 26/104 (25%)

Query: 141 PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
             L+ L L   + S     S                    + A L    +L+ L+LS N 
Sbjct: 369 SVLRVLWLADCDVSDSSCSS--------------------LAATLLANHSLRELDLSNNC 408

Query: 201 FLPGRIPPELG-----NLTNLEILWLTECNLVGEIPDSLGRLAK 239
            L      +L          LE L L +     E+ D L  L K
Sbjct: 409 -LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 2e-04
 Identities = 10/90 (11%), Positives = 26/90 (28%), Gaps = 5/90 (5%)

Query: 359 LRWVDLSNNQFTGEIPASLCEK-GELEELLMIYNSFTGQ----LPDGLGHCQSLTRVRLG 413
           ++ +D+   + +    A L     + + + +     T      +   L    +L  + L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 414 YNRLTGKVPPLLWGLPHVYLLELTDNFLSG 443
            N L       +         ++    L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 9e-04
 Identities = 23/119 (19%), Positives = 37/119 (31%), Gaps = 27/119 (22%)

Query: 350 PGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTR 409
            G     S LR + L++   +    +SL                       L    SL  
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAA--------------------TLLANHSLRE 401

Query: 410 VRLGYNRLTGK-VPPLLWGLPH----VYLLELTDNFLSGEISKNIAGAA--NLSLLIIS 461
           + L  N L    +  L+  +      +  L L D + S E+   +        SL +IS
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 9/84 (10%)

Query: 454 NLSLLIISKNNLSG----SLPEEIGFLKSLVVLSGSENKFTGSLPESL-----TNLAELG 504
            L +L ++  ++S     SL   +    SL  L  S N    +    L          L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 505 SLDLHANDLSGELPSSVSSWKKLN 528
            L L+    S E+   + + +K  
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 6/80 (7%)

Query: 527 LNELNLADN-LFYGNIPEDIGNLSVLNYLDLSNNRLSGR----IPVGLQNLK-LNQLNVS 580
           +  L++    L      E +  L     + L +  L+      I   L+    L +LN+ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 581 NNRLSGELPSLFAKEMYRNS 600
           +N L         + +   S
Sbjct: 64  SNELGDVGVHCVLQGLQTPS 83

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 15/88 (17%), Positives = 23/88 (26%), Gaps = 8/88 (9%)

Query: 182 PAFLGNISTLKMLNLSYNPFLP---GRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLA 238
                  S L++L L+           +   L    +L  L L+   L       L    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 239 K-----LVDLDLALNNLVGAIPSSLTEL 261
           +     L  L L        +   L  L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 15/101 (14%), Positives = 32/101 (31%), Gaps = 24/101 (23%)

Query: 282 WSNLTSLRLLDASMNDLTG----PIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLY 336
               + LR+L  +  D++      +   L     L  L+L  N L  +    + +S    
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES---- 420

Query: 337 ELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASL 377
              + +                L  + L +  ++ E+   L
Sbjct: 421 ---VRQP------------GCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 15/94 (15%), Positives = 32/94 (34%), Gaps = 13/94 (13%)

Query: 403 HCQSLTRVRLGYNRLTGK----VPPLLWGLPHVYLLELTDNFLSGEISKNIAGA-----A 453
               L  + L    ++      +   L     +  L+L++N L       +  +      
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 454 NLSLLIISKNNLSGSLPEEIGFLK----SLVVLS 483
            L  L++     S  + + +  L+    SL V+S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.002
 Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 11/89 (12%)

Query: 240 LVDLDLALNNLVGA-IPSSLTELASVVQIELYNNSLTGD----LPTGWSNLTSLRLLDAS 294
           +  LD+    L  A     L  L     + L +  LT      + +      +L  L+  
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 295 MNDLTGPIPDDLTR------LPLESLNLY 317
            N+L       + +        ++ L+L 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 9/87 (10%), Positives = 26/87 (29%), Gaps = 5/87 (5%)

Query: 434 LELTDNFLSGE-ISKNIAGAANLSLLIISKNNLSG----SLPEEIGFLKSLVVLSGSENK 488
           L++    LS    ++ +       ++ +    L+      +   +    +L  L+   N+
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 489 FTGSLPESLTNLAELGSLDLHANDLSG 515
                   +    +  S  +    L  
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 21/109 (19%), Positives = 34/109 (31%), Gaps = 23/109 (21%)

Query: 212 NLTNLEILWLTECNLVGE----IPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQI 267
             + L +LWL +C++       +  +L     L +LDL+ N L  A    L E       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR---- 422

Query: 268 ELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLPLESLNL 316
                               L  L       +  + D L  L  +  +L
Sbjct: 423 ---------------QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 5/91 (5%)

Query: 382 ELEELLMIYNSFT-GQLPDGLGHCQSLTRVRLGYNRLTGK----VPPLLWGLPHVYLLEL 436
           +++ L +     +  +  + L   Q    VRL    LT      +   L   P +  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 437 TDNFLSGEISKNIAGAANLSLLIISKNNLSG 467
             N L       +          I K +L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 8e-07
 Identities = 46/240 (19%), Positives = 79/240 (32%), Gaps = 22/240 (9%)

Query: 102 NNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESF 161
             +IN   PD   A  N   +   ++ +T T+T   ADL  +  L   G   +  I E  
Sbjct: 6   PTAINVIFPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGV 59

Query: 162 GRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWL 221
                L  + L  N            I+ L  L               L N++ +  L  
Sbjct: 60  QYLNNLIGLELKDN-----------QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQS 108

Query: 222 TECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG 281
            +   +     +       +     L   +  I +            L   +      T 
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP 168

Query: 282 WSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRL 340
            +NL+ L  L A  N ++   P  L  LP L  ++L  N++    P  +A++  L+ + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 89  LCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDL 148
           L  L  LT L   +N I+   P  +++  NL  + L  N ++      LA+  NL  + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTL 224

Query: 149 T 149
           T
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 37/220 (16%), Positives = 64/220 (29%), Gaps = 21/220 (9%)

Query: 65  DPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDL 124
           DP   +   I    +N+          L+ +T L+ F   + +   + +    NL  L+L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70

Query: 125 SQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLE---VISLVYNLLDGTI 181
             N +T               L          I               I+ V  L   + 
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 182 PAFL----------GNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP 231
              L            ++ L  L               L NL+ L  L   +  +    P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 232 DSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYN 271
             L  L  L+++ L  N +    P  L   +++  + L N
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 32/217 (14%), Positives = 61/217 (28%), Gaps = 23/217 (10%)

Query: 237 LAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMN 296
           LA  + +    +N+   +  +  +L  +  +  +   +T  +  G   L +L  L+   N
Sbjct: 18  LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73

Query: 297 DLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFR-------------- 342
            +T   P        E           S  A +     L                     
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 343 -NRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGL 401
                  +              LS           L    +L  L    N  +   P  L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 402 GHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTD 438
               +L  V L  N+++   P  L    +++++ LT+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 6e-05
 Identities = 31/216 (14%), Positives = 63/216 (29%), Gaps = 21/216 (9%)

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN 151
           L N   +    +++  T+    +    +  L      +T      +  L NL  L+L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 152 NFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELG 211
             +   P           +S         I       +         +      +     
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 212 NLTNLEILWLTEC-------------NLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSL 258
              +L  +                  N        L  L+KL  L    N +    P  L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 259 TELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDAS 294
             L +++++ L NN ++   P   +N ++L ++  +
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 8e-04
 Identities = 17/61 (27%), Positives = 27/61 (44%), Gaps = 5/61 (8%)

Query: 522 SSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVS 580
           ++  KL  L   DN      P  + +L  L  + L NN++S   P  L N   L  + ++
Sbjct: 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

Query: 581 N 581
           N
Sbjct: 226 N 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 39/221 (17%), Positives = 70/221 (31%), Gaps = 18/221 (8%)

Query: 314 LNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEI 373
           +   ++ +  ++  T AD  G+  L  F   +  T+ G +   + L  ++L +NQ T   
Sbjct: 24  IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLA 79

Query: 374 PASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL 433
           P     K    EL          +                 +         L  L     
Sbjct: 80  PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139

Query: 434 LELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSL 493
                + L+G  +             +S  N   S    +  L  L  L   +NK +   
Sbjct: 140 QITNISPLAGLTNLQY----------LSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189

Query: 494 PESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLAD 534
           P  L +L  L  + L  N +S   P  +++   L  + L +
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (104), Expect = 1e-05
 Identities = 20/131 (15%), Positives = 38/131 (29%), Gaps = 6/131 (4%)

Query: 92  LENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN 151
                 L L    I   + +  +       +D S N +          L  LK L +  N
Sbjct: 17  AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNN 73

Query: 152 NFSGDIPESFGRFQKLEVISL-VYNLLDGTIPAFLGNISTLKMLNLSYNP--FLPGRIPP 208
                          L  + L   +L++      L ++ +L  L +  NP          
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 209 ELGNLTNLEIL 219
            +  +  + +L
Sbjct: 134 VIYKVPQVRVL 144

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 12/79 (15%)

Query: 100 LFNNSINST----LPDDISACQN--LQHLDLSQNLLTGTLTPALAD-----LPNLKFLDL 148
           L +  +++     + D  S  +N  LQ L L  N +       L       +P+L FL+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 149 TGNNFSGDIPESFGRFQKL 167
            GN F  +  +     +++
Sbjct: 310 NGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.002
 Identities = 52/320 (16%), Positives = 93/320 (29%), Gaps = 36/320 (11%)

Query: 308 RLPLESLNLYENRLEG----SLPATIADSPGLYELRLFRNRLNG----TLPGDLGKNSPL 359
           R  +E  +L  + +      S+ A + +   + E+ L  N +       L  ++     L
Sbjct: 2   RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61

Query: 360 RWVDLSNNQ---FTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR 416
              + S+        EIP +L    +        ++            Q      L  + 
Sbjct: 62  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121

Query: 417 LTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLS----GSLPEE 472
               +     GL      ++        ++K    A  L  +I  +N L         + 
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181

Query: 473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLS---------GELPSSVSS 523
               + L  +   +N       E L         +L   DL            L  ++ S
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 524 WKKLNELNLADNLFYGNIPEDIGN------LSVLNYLDLSNNRLSGRIPVGLQNL----- 572
           W  L EL L D L        + +         L  L L  N +       L+ +     
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 573 -KLNQLNVSNNRLSGELPSL 591
             L  L ++ NR S E   +
Sbjct: 302 PDLLFLELNGNRFSEEDDVV 321

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 2e-05
 Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 3/146 (2%)

Query: 90  CRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLS-QNLLTGTLTPALADLPNLKFLDL 148
           C     + L    +         +   +NL  L +  Q  L       L  L  L+ L +
Sbjct: 5   CCPHGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63

Query: 149 TGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPP 208
             +      P++F    +L  ++L +N L+ ++        +L+ L LS NP        
Sbjct: 64  VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALR 122

Query: 209 ELGNLTNLEILWLTECNLVGEIPDSL 234
            L       +  + E  L       L
Sbjct: 123 WLQRWEEEGLGGVPEQKLQCHGQGPL 148

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (100), Expect = 4e-05
 Identities = 26/110 (23%), Positives = 39/110 (35%), Gaps = 3/110 (2%)

Query: 84  PFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT--LTPALADLP 141
                L        L   ++   + L         L  L+LS N L     ++  +   P
Sbjct: 33  RSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91

Query: 142 NLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTL 191
           NLK L+L+GN    +      +  KLE + L  N L  T       IS +
Sbjct: 92  NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 8e-04
 Identities = 28/115 (24%), Positives = 40/115 (34%), Gaps = 5/115 (4%)

Query: 454 NLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDL 513
           + S   +    L      ++      VVL+   +    +L     N+ EL SL+L  N L
Sbjct: 21  DGSQQALDLKGLR--SDPDLVAQNIDVVLN-RRSSMAATLRIIEENIPELLSLNLSNNRL 77

Query: 514 SG--ELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIP 566
               ++ S V     L  LNL+ N        D      L  L L  N LS    
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.003
 Identities = 23/104 (22%), Positives = 36/104 (34%), Gaps = 6/104 (5%)

Query: 80  NIAGPFPSLLCRLENLTFLTLFNNSI--NSTLPDDISACQNLQHLDLSQNLLTGTLTPAL 137
           ++A     +   +  L  L L NN +     +   +    NL+ L+LS N L        
Sbjct: 52  SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 111

Query: 138 ADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNL--LDG 179
                L+ L L GN+ S    +         +      L  LDG
Sbjct: 112 IKGLKLEELWLDGNSLSDTFRDQSTY--ISAIRERFPKLLRLDG 153

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (84), Expect = 0.004
 Identities = 30/128 (23%), Positives = 47/128 (36%), Gaps = 6/128 (4%)

Query: 141 PNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNP 200
            + + LDL G     D+  +      L   S +   L         NI  L  LNLS N 
Sbjct: 22  GSQQALDLKGLRSDPDL-VAQNIDVVLNRRSSMAATLRII----EENIPELLSLNLSNNR 76

Query: 201 FL-PGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLT 259
                 +   +    NL+IL L+   L  E      +  KL +L L  N+L        T
Sbjct: 77  LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136

Query: 260 ELASVVQI 267
            ++++ + 
Sbjct: 137 YISAIRER 144

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 5/60 (8%)

Query: 534 DNLFYGNIPEDI-GNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL 591
           DN     +P D+    S    LD+S  R+      GL+NL KL   +  N +   +LP+L
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 9e-05
 Identities = 31/245 (12%), Positives = 67/245 (27%), Gaps = 11/245 (4%)

Query: 86  PSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKF 145
              +C   N  F     + +   +P D+    N   L      L      A +   +L+ 
Sbjct: 2   HHRICHCSNRVF-LCQESKVTE-IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 146 LDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGR 205
           ++++ N+    I               +    +          +   +  L  +      
Sbjct: 58  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117

Query: 206 IPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLV---DLDLALNNLVGAIPSSLTELA 262
           +P      +  ++L   + N+     +    +        L L  N +      +     
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177

Query: 263 SVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRL 321
                   NN+L       +   +   +LD S   +       L  L  L + + Y  + 
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK- 236

Query: 322 EGSLP 326
              LP
Sbjct: 237 --KLP 239

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 42.5 bits (98), Expect = 8e-05
 Identities = 23/169 (13%), Positives = 46/169 (27%), Gaps = 5/169 (2%)

Query: 138 ADLP-NLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNL 196
            D+P +   L L  N       +         V   +       I       ++      
Sbjct: 25  RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84

Query: 197 SYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPS 256
                +          L  L+ L L +  +   +P S   L  L  L+LA +N       
Sbjct: 85  LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA-SNPFNCNCH 143

Query: 257 SLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDD 305
                  + +  L   +     P   S +  +++ D   ++      + 
Sbjct: 144 LAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENS 189

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 9e-05
 Identities = 35/199 (17%), Positives = 60/199 (30%), Gaps = 29/199 (14%)

Query: 65  DPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDL 124
           D         +L   ++          L ++  +   N+ I S     I    N+  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75

Query: 125 SQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAF 184
           + N LT         L NLK L     + +     S  +  K      + +     I   
Sbjct: 76  NGNKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130

Query: 185 ------------------LGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNL 226
                             +  +S L  L+              L  LT L+ L+L++ ++
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190

Query: 227 VGEIPDSLGRLAKLVDLDL 245
                 +L  L  L  L+L
Sbjct: 191 SD--LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 31/200 (15%), Positives = 62/200 (31%), Gaps = 15/200 (7%)

Query: 237 LAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMN 296
            A+ +  +L   ++  A+  +  EL S+ QI   N+ +      G   L ++  L  + N
Sbjct: 23  FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78

Query: 297 DLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKN 356
            LT   P       L++L             +        +     +     + G +   
Sbjct: 79  KLTDIKPLA----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134

Query: 357 SPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNR 416
                   +N      + + L +        +            L     L  + L  N 
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLD-----TLSLEDNQISDIVPLAGLTKLQNLYLSKNH 189

Query: 417 LTGKVPPLLWGLPHVYLLEL 436
           ++      L GL ++ +LEL
Sbjct: 190 ISD--LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 32/215 (14%), Positives = 65/215 (30%), Gaps = 20/215 (9%)

Query: 104 SINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGR 163
            I     DD  A       +L +  +T  +T    +L ++  +    ++           
Sbjct: 13  PIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQY 66

Query: 164 FQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTE 223
              +  + L  N L    P          + NL    +L           +  ++  L  
Sbjct: 67  LPNVTKLFLNGNKLTDIKP----------LANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116

Query: 224 CNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWS 283
            +L       +  L  L  L+            ++    + +      ++   D+    +
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLA 175

Query: 284 NLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLY 317
            LT L+ L  S N ++      L  L  L+ L L+
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 49/214 (22%), Positives = 81/214 (37%), Gaps = 20/214 (9%)

Query: 102 NNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESF 161
           +  IN    D   A        L +  +T T++    DL  +  L          I +  
Sbjct: 5   DTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGV 58

Query: 162 GRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWL 221
                L  I+   N L       L N++ L  + ++ N          L NLT L +   
Sbjct: 59  EYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 116

Query: 222 TECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTG 281
              +   +   +L  L +L      +++      S+L+ L S+ Q+   +N +T   P  
Sbjct: 117 QITD--IDPLKNLTNLNRLELSSNTISD-----ISALSGLTSLQQLNFSSNQVTDLKP-- 167

Query: 282 WSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESL 314
            +NLT+L  LD S N ++      L +L  LESL
Sbjct: 168 LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 3e-04
 Identities = 35/201 (17%), Positives = 68/201 (33%), Gaps = 17/201 (8%)

Query: 230 IPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLR 289
             D+   LA+ +   L   N+   +  S T+L  V  ++     +   +  G   L +L 
Sbjct: 12  FTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLT 65

Query: 290 LLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTL 349
            ++ S N LT          PL++L    + L  +                     N  +
Sbjct: 66  QINFSNNQLTDIT-------PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 118

Query: 350 PGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTR 409
                  +      L  +  T    ++L     L++L    N  T   P  L +  +L R
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLER 176

Query: 410 VRLGYNRLTGKVPPLLWGLPH 430
           + +  N+++     +L  L +
Sbjct: 177 LDISSNKVSD--ISVLAKLTN 195

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 27/192 (14%), Positives = 46/192 (23%), Gaps = 19/192 (9%)

Query: 65  DPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDL 124
           D          L   N+          L+ +T L      I S   D +    NL  ++ 
Sbjct: 14  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINF 69

Query: 125 SQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAF 184
           S N LT               ++         +             + + ++        
Sbjct: 70  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129

Query: 185 LGNISTLKMLNLSYNPFLPGRI-------------PPELGNLTNLEILWLTECNLVGEIP 231
           L  +          +                       L NLT LE L ++   +     
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--I 187

Query: 232 DSLGRLAKLVDL 243
             L +L  L  L
Sbjct: 188 SVLAKLTNLESL 199

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1002
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.81
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.74
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.7
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.67
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.46
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.46
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.45
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.44
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.44
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.42
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.4
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.34
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.28
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.26
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.23
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.51
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.28
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.23
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.91
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.27
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.27
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.24
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.6
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.23
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.2
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.1
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=428.59  Aligned_cols=262  Identities=29%  Similarity=0.384  Sum_probs=206.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||+||+|+.+  ..||||+++...               .+....+.|.+|++++++++|||||+++
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~---------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~   70 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA---------------PTPQQLQAFKNEVGVLRKTRHVNILLFM   70 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSS---------------CCTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEccc---------------CCHHHHHHHHHHHHHHHhCCCCCEeeee
Confidence            57889999999999999999864  469999985321               1234567899999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+ +..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||
T Consensus        71 ~~~~~-~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl  145 (276)
T d1uwha_          71 GYSTA-PQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKI  145 (276)
T ss_dssp             EEECS-SSCEEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEE
T ss_pred             EEEec-cEEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEE
Confidence            98765 568999999999999999975 345699999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT---LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +|||+|+...............||+.|||||++.+   ..++.++|||||||++|||+||+.||............+...
T Consensus       146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~  225 (276)
T d1uwha_         146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG  225 (276)
T ss_dssp             CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT
T ss_pred             ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC
Confidence            99999988765544444556689999999999864   357899999999999999999999997654444443333322


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .....    +.+....++    .++.+++.+||+.||++|||++||++.|+.+.+
T Consensus       226 ~~~p~----~~~~~~~~~----~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         226 YLSPD----LSKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             SCCCC----GGGSCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCc----chhccccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            21111    111112233    348889999999999999999999999998865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-50  Score=426.03  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=204.9

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....                .....+++.+|+.++++++|||||+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------------~~~~~~~~~~Ei~~l~~l~HpnIv~   67 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----------------AVDCPENIKKEICINKMLNHENVVK   67 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------CHHHHHHHHHTCCCTTBCC
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----------------cchHHHHHHHHHHHHHhCCCCCEee
Confidence            46788899999999999999997 468999999985421                1123456899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++.  +.+.+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+
T Consensus        68 ~~~~~~~~~~~~ivmEy~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~  142 (271)
T d1nvra_          68 FYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNL  142 (271)
T ss_dssp             EEEEEEETTEEEEEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred             EeeeeccCceeEEEEeccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCE
Confidence            9999999999999999999999999997  446799999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+|+..............+||+.|||||++.+..+ +.++||||+||++|||++|+.||................
T Consensus       143 KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~  222 (271)
T d1nvra_         143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK  222 (271)
T ss_dssp             EECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT
T ss_pred             EEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence            9999999998765544444456789999999999988776 578999999999999999999997654333222221111


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ...       .+......    .++.+++.+||+.||++|||++|++
T Consensus       223 ~~~-------~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~eil  258 (271)
T d1nvra_         223 KTY-------LNPWKKID----SAPLALLHKILVENPSARITIPDIK  258 (271)
T ss_dssp             CTT-------STTGGGSC----HHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCC-------CCccccCC----HHHHHHHHHHcCCChhHCcCHHHHh
Confidence            100       01111222    2467889999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=423.95  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=203.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||+||+|++++++.||||++...                  ....++|.+|++++++++|||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~------------------~~~~~~~~~E~~~l~~l~HpnIv~~~   66 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG------------------AMSEEDFIEEAEVMMKLSHPKLVQLY   66 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC------------------cCcHHHHHHHHHHHHhcCCCCccccc
Confidence            467788999999999999999988899999998432                  22346799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      |++.+++..++||||+++|+|.+++.. ....+++..+..++.|||.||+|||++   +|+||||||+||++++++.+||
T Consensus        67 g~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl  142 (263)
T d1sm2a_          67 GVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV  142 (263)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEE
T ss_pred             ceeccCCceEEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEe
Confidence            999999999999999999999999875 346689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||+++........ ......||+.|||||++.+..++.++|||||||++|||+|++.|+.......+....+......
T Consensus       143 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~  221 (263)
T d1sm2a_         143 SDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL  221 (263)
T ss_dssp             CSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC
T ss_pred             cccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC
Confidence            999999877554332 2334578999999999999999999999999999999999666655444444444443332111


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                              +....+++    ++.+++.+||+.||++|||++||++.|+++..
T Consensus       222 --------~~p~~~~~----~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         222 --------YKPRLAST----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             --------CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCccccCH----HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                    11122222    47899999999999999999999999999853

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.9e-50  Score=430.82  Aligned_cols=265  Identities=22%  Similarity=0.381  Sum_probs=220.5

Q ss_pred             CcHHHH-hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC
Q 001867          676 FSEYEI-LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI  753 (1002)
Q Consensus       676 ~~~~~~-~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  753 (1002)
                      |.+|++ .++|++.+.||+|+||+||+|.++ +++.||||++...                  ....++|.+|+++++++
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~------------------~~~~~~~~~E~~il~~l   70 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------------------TMEVEEFLKEAAVMKEI   70 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT------------------CSCHHHHHHHHHHHHHC
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc------------------cchHHHHHHHHHHHHhC
Confidence            334444 357888899999999999999975 5889999998432                  22356799999999999


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      +|||||++++++.+++..++||||+++|+|.+++.......+++..+..++.||+.||+|||++   +|+||||||+|||
T Consensus        71 ~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NIL  147 (287)
T d1opja_          71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCL  147 (287)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEE
Confidence            9999999999999999999999999999999999876778899999999999999999999999   9999999999999


Q ss_pred             ECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          834 LDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       834 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      +++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||++|+.||....+.....
T Consensus       148 l~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~  226 (287)
T d1opja_         148 VGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY  226 (287)
T ss_dssp             ECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence            99999999999999987655432 23334568899999999999999999999999999999999888876665555544


Q ss_pred             HHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          914 KWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      +.+......        +.....++    ++.+++.+||+.||++|||++||++.|+.+..
T Consensus       227 ~~i~~~~~~--------~~~~~~~~----~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         227 ELLEKDYRM--------ERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHTTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHhcCCCC--------CCCccchH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            444322111        11122333    47889999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=423.12  Aligned_cols=257  Identities=25%  Similarity=0.429  Sum_probs=212.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||+||+|.+++++.||||++...                  ....+.|.+|++++++++|||||+++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~------------------~~~~~~~~~E~~~l~~l~HpnIv~~~   74 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG------------------SMSPDAFLAEANLMKQLQHQRLVRLY   74 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC------------------cCCHHHHHHHHHHHHhCCCCCEeEEE
Confidence            467788999999999999999988899999998432                  12346799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+ +..++||||+++|+|.+++.......+++..+.+++.||++||+|||++   +|+||||||+||+++.++.+||
T Consensus        75 g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl  150 (272)
T d1qpca_          75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKI  150 (272)
T ss_dssp             EEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             eeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceee
Confidence            98765 5679999999999999988765556799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+||+.|+.......+....+......
T Consensus       151 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~  229 (272)
T d1qpca_         151 ADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM  229 (272)
T ss_dssp             CCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             ccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence            99999998765432 22335578999999999999999999999999999999999777766555544444443322111


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                              +.....++    ++.+++.+||+.||++|||++||++.|+++..
T Consensus       230 --------~~p~~~~~----~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         230 --------VRPDNCPE----ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCcccChH----HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                    11122232    47889999999999999999999999998753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=416.93  Aligned_cols=249  Identities=25%  Similarity=0.395  Sum_probs=206.0

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|++.+..              ..+....+.+.+|++++++++|||||+
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------------~~~~~~~~~~~~E~~il~~l~hpnIv~   70 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--------------LEKAGVEHQLRREVEIQSHLRHPNILR   70 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH--------------ccChHHHHHHHHHHHHHHhcCCCCCCe
Confidence            356888899999999999999974 68899999985431              112334667899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++..  .+.+++..++.++.||+.||+|||++   +||||||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~  145 (263)
T d2j4za1          71 LYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL  145 (263)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             EEEEEEECCEEEEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCE
Confidence            99999999999999999999999999984  35699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+|+......    .....||+.|||||++.+..++.++||||+||++|||++|+.||.... ..+....+..  
T Consensus       146 kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~--  218 (263)
T d2j4za1         146 KIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISR--  218 (263)
T ss_dssp             EECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHT--
T ss_pred             eecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-HHHHHHHHHc--
Confidence            999999998665432    234579999999999999999999999999999999999999996543 2222222111  


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                        ....  +.   ....    .++.+++.+||+.||++|||++|+++
T Consensus       219 --~~~~--~p---~~~s----~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         219 --VEFT--FP---DFVT----EGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --TCCC--CC---TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCC--CC---ccCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              1110  11   1122    24778999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-48  Score=415.94  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=205.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...                 .....+.+.+|+.++++++|||||++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~-----------------~~~~~~~~~~E~~il~~l~HpnIv~~   82 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-----------------QQPKKELIINEILVMRENKNPNIVNY   82 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG-----------------GCSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc-----------------cChHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4689999999999999999996 56999999998542                 12234678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+++|+|.+++..   +.+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vk  156 (293)
T d1yhwa1          83 LDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK  156 (293)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             eEEEEECCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEe
Confidence            9999999999999999999999998864   4599999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+|+.......  .....+||+.|||||++.+..++.++||||+||++|||++|+.||...............   
T Consensus       157 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---  231 (293)
T d1yhwa1         157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---  231 (293)
T ss_dssp             ECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---
T ss_pred             eccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---
Confidence            999999987754432  233557999999999999999999999999999999999999999755433322222211   


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       ......   ......    ..+.+++.+||+.||++|||++|+++
T Consensus       232 -~~~~~~---~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 -GTPELQ---NPEKLS----AIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -CSCCCS---SGGGSC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCCC---CcccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111110   011122    24778999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=408.25  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=211.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.++||+|+||+||+|+.++++.||||++++.                  ....++|.+|+.++++++||||++++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~------------------~~~~~~~~~Ev~~~~~l~HpnIv~~~   65 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG------------------SMSEDEFIEEAKVMMNLSHEKLVQLY   65 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS------------------SSCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC------------------cCCHHHHHHHHHHHHhcCCCceeeEE
Confidence            578899999999999999999988889999998542                  12346799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      |++.+++..++||||+++|+|.+++.. ....+++..+.+++.|+++||+|||++   +|+||||||+||++++++.+||
T Consensus        66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl  141 (258)
T d1k2pa_          66 GVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV  141 (258)
T ss_dssp             EEECCSSSEEEEEECCTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEeeCCceEEEEEccCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEE
Confidence            999999999999999999999999765 335689999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+....+.....
T Consensus       142 ~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~~~~~  219 (258)
T d1k2pa_         142 SDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLR  219 (258)
T ss_dssp             CCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHTTCC
T ss_pred             CcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHHhCCC
Confidence            999999876654332 3334578999999999999999999999999999999998 788987553 3333332222111


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                            .  +.....+    .++.+++.+||+.||++|||++|+++.|.+
T Consensus       220 ------~--~~p~~~~----~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 ------L--YRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ------C--CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------C--CCccccc----HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                  0  1112222    247899999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-48  Score=418.12  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-C---cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-G---EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      +.|++.++||+|+||+||+|..+. +   ..||||++....                .....++|.+|++++++++||||
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~HpnI   89 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----------------TEKQRRDFLSEASIMGQFDHPNV   89 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----------------CHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----------------CHHHHHHHHHHHHHHHhCCCCCC
Confidence            457778899999999999999743 3   358888874321                23456679999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      |+++|++.+++..++||||+++|+|.+++.. ..+.+++.++..++.||+.||+|||++   +|+||||||+|||++.++
T Consensus        90 v~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~  165 (299)
T d1jpaa_          90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNL  165 (299)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred             ccEEEEEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCC
Confidence            9999999999999999999999999998875 345699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcc---cccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 001867          839 GARVADFGVAKVVDASGKPKS---MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~  914 (1002)
                      ++||+|||+++..........   .....||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+...
T Consensus       166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~~~~~  244 (299)
T d1jpaa_         166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDVIN  244 (299)
T ss_dssp             CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHH
T ss_pred             cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence            999999999987765432221   223457899999999999999999999999999999998 899986543 333333


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .+.....        .+.....+    ..+.+++.+||+.||++|||++||++.|+++.+
T Consensus       245 ~i~~~~~--------~~~~~~~~----~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         245 AIEQDYR--------LPPPMDCP----SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHTTCC--------CCCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC--------CCCCccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            3322111        11112233    347889999999999999999999999998864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=419.69  Aligned_cols=253  Identities=22%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+..              .......+.+.+|++++++++|||||++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--------------~~~~~~~~~~~~E~~il~~l~HpnIv~l   73 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--------------IIKENKVPYVTRERDVMSRLDHPFFVKL   73 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHHCCSTTBCCE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH--------------ccCHHHHHHHHHHHHHHHHcCCCCeeEE
Confidence            5688899999999999999997 468999999985421              1123345679999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+++|+|.+++..  .+.+++..++.++.|++.||+|||++   +||||||||+||++++++.+|
T Consensus        74 ~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vk  148 (288)
T d1uu3a_          74 YFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQ  148 (288)
T ss_dssp             EEEEECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEECCEEEEEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEE
Confidence            9999999999999999999999999874  35699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      |+|||+|+..............+||+.|||||++.+..++.++||||+||++|||++|+.||..... .+....+   ..
T Consensus       149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i---~~  224 (288)
T d1uu3a_         149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKI---IK  224 (288)
T ss_dssp             ECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH---HT
T ss_pred             ecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-HHHHHHH---Hc
Confidence            9999999987655444444556899999999999999999999999999999999999999976432 2222211   11


Q ss_pred             ccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          922 QKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                       ....  +.   ....+    ++.+++.+||+.||++|||++|+.+.
T Consensus       225 -~~~~--~p---~~~s~----~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         225 -LEYD--FP---EKFFP----KARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -TCCC--CC---TTCCH----HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -CCCC--CC---ccCCH----HHHHHHHHHccCCHhHCcCHHHHcCC
Confidence             1110  11   12222    47789999999999999999998654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=412.67  Aligned_cols=260  Identities=26%  Similarity=0.417  Sum_probs=205.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCC-----cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNG-----EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      ..|+..++||+|+||+||+|.+++.     ..||||++....                .....++|.+|+.++++++|||
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~~E~~il~~l~H~n   70 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----------------TEKQRVDFLGEAGIMGQFSHHN   70 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHTCCCTT
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----------------ChHHHHHHHHHHHHHHhcCCCC
Confidence            3566788999999999999997542     469999984321                2334567999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ||+++|++.+.+..++||||+++|++.+++.. ....+++.++.+++.||+.||+|||++   +|+||||||+|||++.+
T Consensus        71 Iv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~  146 (283)
T d1mqba_          71 IIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN  146 (283)
T ss_dssp             BCCEEEEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             EeeeeEEEecCCceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCC
Confidence            99999999999999999999999999998775 446799999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+++........ .......||+.|||||++.+..++.++|||||||++|||++|+.|+.......+..+.+
T Consensus       147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i  226 (283)
T d1mqba_         147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI  226 (283)
T ss_dssp             CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH
Confidence            99999999999876544322 22334568999999999999999999999999999999999877776665555555444


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ....+.        +.....+    .++.+++.+||+.||++|||++||++.|+++.+
T Consensus       227 ~~~~~~--------~~~~~~~----~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         227 NDGFRL--------PTPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HTTCCC--------CCCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             hccCCC--------CCchhhH----HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            322211        1111222    347889999999999999999999999998865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=414.78  Aligned_cols=251  Identities=22%  Similarity=0.274  Sum_probs=203.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      +.|++.+.||+|+||+||+|+.. +++.||||++...                 .....+.+.+|++++++++|||||++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-----------------~~~~~~~~~~E~~il~~l~HpnIv~l   74 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-----------------SEEELEDYMVEIDILASCDHPNIVKL   74 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------------SSGGGGGTHHHHHHHHHCCCTTBCCE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-----------------CHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            45778899999999999999974 6899999998542                 12335678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+++|+|.+++... .+.+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~K  150 (288)
T d2jfla1          75 LDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIK  150 (288)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEeeCCeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEE
Confidence            99999999999999999999999998753 45699999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAY-----TLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      |+|||+|+......  .......||+.|||||++.     +..|+.++||||+||++|||++|+.||......+.+....
T Consensus       151 l~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~  228 (288)
T d2jfla1         151 LADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA  228 (288)
T ss_dssp             ECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             EEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            99999997654321  1223567999999999874     4568899999999999999999999997664444333322


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...     ....  +......    .++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~-----~~~~--~~~~~~s----~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         229 KSE-----PPTL--AQPSRWS----SNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HSC-----CCCC--SSGGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCC-----CCCC--CccccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211     1111  0111222    24778999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-48  Score=422.94  Aligned_cols=258  Identities=24%  Similarity=0.355  Sum_probs=211.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC-C-----cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN-G-----EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.++||+|+||+||+|++.. +     ..||||.+....                +......+.+|+.++.++ +|
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~H  100 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----------------DSSEREALMSELKMMTQLGSH  100 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------------------CHHHHHHHHHHHHHCCC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----------------CHHHHHHHHHHHHHHHHhcCC
Confidence            578889999999999999999643 2     369999884321                223456789999999998 89


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHH
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKG---------------------GLLDWPTRYKIIVDAAEGLSYL  814 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~~L~~L  814 (1002)
                      ||||++++++.+.+..|+||||+++|+|.++++..+.                     ..+++..++.++.||+.||+||
T Consensus       101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL  180 (325)
T d1rjba_         101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL  180 (325)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred             CcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999976432                     3589999999999999999999


Q ss_pred             hhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          815 HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       815 H~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      |++   +||||||||+||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|
T Consensus       181 H~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~  257 (325)
T d1rjba_         181 EFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW  257 (325)
T ss_dssp             HHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHH
Confidence            999   99999999999999999999999999998876655444445567899999999999999999999999999999


Q ss_pred             HHHh-CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Q 001867          895 ELVT-GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQE  971 (1002)
Q Consensus       895 ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~  971 (1002)
                      ||+| |+.||........+.+.+......        +.....++    ++.+++.+||+.||++|||++||++.|.+
T Consensus       258 emlt~g~~Pf~~~~~~~~~~~~~~~~~~~--------~~p~~~~~----~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         258 EIFSLGVNPYPGIPVDANFYKLIQNGFKM--------DQPFYATE----EIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHHHHTTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCCCC--------CCCCcCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            9998 899997655555555444332211        11122222    47889999999999999999999999964

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=412.81  Aligned_cols=255  Identities=23%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....               .+....+.+.+|++++++++|||||++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~E~~il~~l~HpnIv~~   68 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS---------------MTEAEKQMLVSEVNLLRELKHPNIVRY   68 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT---------------SCHHHHHHHHHHHHHTTSCCCTTBCCE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh---------------CCHHHHHHHHHHHHHHHHCCCCCEeeE
Confidence            5788899999999999999996 468999999985421               133456779999999999999999999


Q ss_pred             eeEEec--CCeeeEEEeccCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeeCCCCCCcEEEC
Q 001867          762 WCCCTT--RDCKLLVYEYMPNGSLGDLLHSC--KGGLLDWPTRYKIIVDAAEGLSYLHHDC--VPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       762 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiHrDlk~~NIll~  835 (1002)
                      ++++.+  ++..|+||||+++|+|.+++...  ....+++..++.++.|++.||+|||+++  ..+||||||||+|||++
T Consensus        69 ~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~  148 (269)
T d2java1          69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD  148 (269)
T ss_dssp             EEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC
T ss_pred             EEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC
Confidence            999965  45689999999999999998653  3467999999999999999999999972  11499999999999999


Q ss_pred             CCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          836 GDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       836 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      .++.+||+|||+|+.......  ......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+....
T Consensus       149 ~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-~~~~~~~  225 (269)
T d2java1         149 GKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGK  225 (269)
T ss_dssp             TTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHH
T ss_pred             CCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-HHHHHHH
Confidence            999999999999988754322  2335679999999999999999999999999999999999999997542 2332222


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +..    .....    ......+    ++.+++.+||+.||++|||++|+++
T Consensus       226 i~~----~~~~~----~~~~~s~----~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         226 IRE----GKFRR----IPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHH----TCCCC----CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHc----CCCCC----CCcccCH----HHHHHHHHHcCCChhHCcCHHHHHh
Confidence            211    11111    1112222    4778999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=407.13  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=197.7

Q ss_pred             CcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          686 DEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      ++.++||+|+||+||+|... +++.||+|++....               ......+.+.+|++++++++|||||+++++
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~---------------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   76 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK---------------LTKSERQRFKEEAEMLKGLQHPNIVRFYDS   76 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG---------------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh---------------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            44568999999999999974 58899999985421               133456789999999999999999999999


Q ss_pred             Eec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eeeCCCCCCcEEEC-CC
Q 001867          765 CTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPS--IVHRDVKSNNILLD-GD  837 (1002)
Q Consensus       765 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--iiHrDlk~~NIll~-~~  837 (1002)
                      +.+    +...|+||||+++|+|.+++..  ...+++..++.++.||+.||+|||++   +  |+||||||+|||++ .+
T Consensus        77 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~  151 (270)
T d1t4ha_          77 WESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPT  151 (270)
T ss_dssp             EEEESSSCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTT
T ss_pred             EeeccccCCEEEEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCC
Confidence            864    3567999999999999999985  35699999999999999999999998   6  99999999999997 57


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+|+.....    .....+||+.|||||++.+ .++.++||||+||++|||++|+.||..........+.+.
T Consensus       152 ~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~  226 (270)
T d1t4ha_         152 GSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  226 (270)
T ss_dssp             SCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             CCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence            89999999999864432    2235579999999998865 599999999999999999999999976544444333322


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...    ....++   ....+    ++.+++.+||++||++|||++|+++
T Consensus       227 ~~~----~~~~~~---~~~~~----~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         227 SGV----KPASFD---KVAIP----EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTC----CCGGGG---GCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCC----CCcccC---ccCCH----HHHHHHHHHccCCHhHCcCHHHHhC
Confidence            211    111111   11222    3778999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=412.04  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=208.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.+.||+|+||+||+|+++++++||||++...                  ....+.|.+|+.++++++|||||+++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~------------------~~~~~~~~~E~~~l~~l~h~nIv~~~   78 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG------------------TMSPEAFLQEAQVMKKLRHEKLVQLY   78 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT------------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc------------------cCCHHHHHHHHHHHHhcccCCEeEEE
Confidence            568888999999999999999988889999998432                  12246799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+ +..++||||+++|+|..++.....+.++|.+++.++.||+.||+|||++   +|+||||||+|||++.++++||
T Consensus        79 g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl  154 (285)
T d1fmka3          79 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  154 (285)
T ss_dssp             EEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEE
Confidence            99855 5679999999999999998876667799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ  922 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~  922 (1002)
                      +|||+++....... .......||+.|+|||++.++.++.++|||||||++|||++|+.|+.......+....+......
T Consensus       155 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~  233 (285)
T d1fmka3         155 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM  233 (285)
T ss_dssp             CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             cccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence            99999987654432 23334578999999999999999999999999999999999888876665555555544322111


Q ss_pred             cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          923 KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                              +......    .++.+++.+||+.||++||++++|+++|++...
T Consensus       234 --------~~~~~~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         234 --------PCPPECP----ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             --------CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --------CCCcccC----HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                    1112222    247889999999999999999999999988654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=408.60  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=208.1

Q ss_pred             CCCcCC-eeeecCCccEEEEEEc---CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          684 GLDEDN-VIGSGSSGKVYKVVLS---NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       684 ~~~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +|.+.+ +||+|+||+||+|.++   ++..||||++...                ......++|.+|++++++++|||||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----------------~~~~~~~~~~~E~~il~~l~HpnIv   72 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----------------TEKADTEEMMREAQIMHQLDNPYIV   72 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----------------CCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----------------cCHHHHHHHHHHHHHHHhCCCCCEe
Confidence            344455 4999999999999863   3557999998532                1334567899999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFG  839 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~  839 (1002)
                      ++++++.++ ..|+||||+++|+|.+++.. ....+++..+.+++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        73 ~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~  147 (285)
T d1u59a_          73 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY  147 (285)
T ss_dssp             CEEEEEESS-SEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTE
T ss_pred             eEeeeeccC-eEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCc
Confidence            999998754 57999999999999999865 345799999999999999999999999   9999999999999999999


Q ss_pred             eEEccccCcccccCCCCCc-ccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          840 ARVADFGVAKVVDASGKPK-SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       840 ~kl~DfGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +||+|||+++......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.... ..+....+.
T Consensus       148 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~  226 (285)
T d1u59a_         148 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIE  226 (285)
T ss_dssp             EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHH
T ss_pred             eeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHH
Confidence            9999999999876543322 2234568999999999999999999999999999999998 899997653 333333332


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      ....    .    +.....++    ++.+++.+||+.||++|||+.+|.+.|+.....
T Consensus       227 ~~~~----~----~~p~~~~~----~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         227 QGKR----M----ECPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCC----C----CCCTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCC----C----CCCCcCCH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            2111    1    11122333    478899999999999999999999999877543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=406.36  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=201.1

Q ss_pred             CeeeecCCccEEEEEEcC---CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEE
Q 001867          689 NVIGSGSSGKVYKVVLSN---GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCC  765 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  765 (1002)
                      ++||+|+||+||+|.+++   ++.||||++...               ..+....++|.+|++++++++|||||++++++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---------------~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~   77 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE---------------ANDPALKDELLAEANVMQQLDNPYIVRMIGIC   77 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh---------------hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEe
Confidence            579999999999998643   468999998432               12334567899999999999999999999999


Q ss_pred             ecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEccc
Q 001867          766 TTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADF  845 (1002)
Q Consensus       766 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  845 (1002)
                      .++ ..++||||+++|+|.++++.  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        78 ~~~-~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DF  151 (277)
T d1xbba_          78 EAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  151 (277)
T ss_dssp             ESS-SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ccC-CEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccch
Confidence            754 57899999999999999984  45699999999999999999999999   9999999999999999999999999


Q ss_pred             cCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 001867          846 GVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCSTLDQK  923 (1002)
Q Consensus       846 Gl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  923 (1002)
                      |+++.......... .....||+.|||||++.+..++.++|||||||++|||++ |+.||.... ..+....+.....  
T Consensus       152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-~~~~~~~i~~~~~--  228 (277)
T d1xbba_         152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGER--  228 (277)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCC--
T ss_pred             hhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-HHHHHHHHHcCCC--
Confidence            99987755433222 234578999999999999999999999999999999998 899997542 3333333322111  


Q ss_pred             CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          924 GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                        .    +.....++    ++.+++.+||+.||++|||+++|++.|+...
T Consensus       229 --~----~~p~~~~~----~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         229 --M----GCPAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             --C----CCCTTCCH----HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --C----CCCcccCH----HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence              0    11122333    4788999999999999999999999888764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=421.36  Aligned_cols=262  Identities=24%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++....                .....+++.+|+.++++++|||||++
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----------------~~~~~~~~~~Ei~il~~l~HpnIv~l   69 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----------------KPAIRNQIIRELQVLHECNSPYIVGF   69 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC----------------CTTHHHHHHHHGGGGGGCCCTTBCCE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh----------------CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            5688889999999999999996 468999999985421                22345678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCCCCCcEEECCCCCe
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++|.+++..|+||||+++|+|.+++.+.  +.+++..++.++.|++.||.|||+ +   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~v  144 (322)
T d1s9ja_          70 YGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEI  144 (322)
T ss_dssp             EEEEECSSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCE
T ss_pred             EEEEEECCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCE
Confidence            99999999999999999999999999853  469999999999999999999997 5   89999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+|+......    ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.................
T Consensus       145 kl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~  220 (322)
T d1s9ja_         145 KLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE  220 (322)
T ss_dssp             EECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----
T ss_pred             EEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhc
Confidence            999999998765432    2245799999999999999999999999999999999999999976543221110000000


Q ss_pred             hc---------------------cCc--------ccc---ccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQ---------------------KGV--------DHV---LDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~---------------------~~~--------~~~---~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..                     ...        ...   ..+.. ....   ..++.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF---SLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------------------------CCCCHHHHHHHHHTSCCCCCCBTTB---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccC---CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00                     000        000   00001 0111   124778999999999999999999986


Q ss_pred             --HHHHh
Q 001867          968 --LLQEV  972 (1002)
Q Consensus       968 --~L~~~  972 (1002)
                        ++++.
T Consensus       298 Hpf~~~~  304 (322)
T d1s9ja_         298 HAFIKRS  304 (322)
T ss_dssp             SHHHHHH
T ss_pred             CHhhCcC
Confidence              35443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-47  Score=410.55  Aligned_cols=252  Identities=24%  Similarity=0.316  Sum_probs=190.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|++.+.||+|+||+||+|+.+ +++.||||++.+...                ....+.+.+|+.++++++|||||+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~   71 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL----------------EGKEGSMENEIAVLHKIKHPNIVA   71 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------------------CHHHHHHHTCCCTTBCC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh----------------hhHHHHHHHHHHHHHhCCCCCCCc
Confidence            456888999999999999999974 689999999854311                122356889999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC---CC
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD---GD  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~---~~  837 (1002)
                      +++++.+++..|+||||++||+|.+++..  .+.+++..+..++.||+.||+|||++   +|+||||||+||+++   .+
T Consensus        72 l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~  146 (307)
T d1a06a_          72 LDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDED  146 (307)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT
T ss_pred             EEEEEEECCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCC
Confidence            99999999999999999999999999974  56799999999999999999999999   999999999999995   57


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+|+.......   ....+||+.|||||++.+..++.++||||+||++|||++|+.||...... +....+.
T Consensus       147 ~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~  222 (307)
T d1a06a_         147 SKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQIL  222 (307)
T ss_dssp             CCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred             ceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHh
Confidence            8999999999987654322   23457999999999999999999999999999999999999999764322 2222221


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .    ... ....+.....++    ++.+++.+||+.||++|||++|+++
T Consensus       223 ~----~~~-~~~~~~~~~~s~----~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         223 K----AEY-EFDSPYWDDISD----SAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             T----TCC-CCCTTTTTTSCH----HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             c----cCC-CCCCccccCCCH----HHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1    111 011111122333    4778999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-46  Score=414.28  Aligned_cols=253  Identities=20%  Similarity=0.277  Sum_probs=207.6

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.+.|++.+.||+|+||.||+|+. .+|+.||||++...                 .....+.+.+|++++++++|||||
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----------------~~~~~~~~~~Ei~il~~l~HpnIv   89 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----------------YPLDKYTVKNEISIMNQLHHPKLI   89 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------SHHHHHHHHHHHHHHTTCCSTTBC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-----------------chhHHHHHHHHHHHHHhCCCCCCC
Confidence            456789999999999999999996 56999999998532                 223456788999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC--CC
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD--GD  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~--~~  837 (1002)
                      +++++|.+++..|+||||+++|+|.+++.. ....+++.+++.++.||+.||+|||++   +||||||||+|||++  .+
T Consensus        90 ~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~  165 (352)
T d1koba_          90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKA  165 (352)
T ss_dssp             CEEEEEECSSEEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTC
T ss_pred             cEEEEEEECCEEEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCC
Confidence            999999999999999999999999988764 345699999999999999999999999   999999999999997  57


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      +.+||+|||+|+.......   .....||+.|||||++.+..++.++||||+||++|||++|+.||........ ...+.
T Consensus       166 ~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~  241 (352)
T d1koba_         166 SSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVK  241 (352)
T ss_dssp             CCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH
T ss_pred             CeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence            8999999999998765432   3345799999999999999999999999999999999999999975433222 22111


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .   . ... ...+......+    ++.+++.+||+.||++|||++|+++
T Consensus       242 ~---~-~~~-~~~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         242 R---C-DWE-FDEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             H---C-CCC-CCSSTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             h---C-CCC-CCcccccCCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence            1   1 110 01111122333    4778999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-47  Score=410.89  Aligned_cols=247  Identities=26%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      .|+..+.||+|+||+||+|+. .+++.||||++...              ...+....+.+.+|+.++++++|||||+++
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--------------~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~   81 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--------------GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR   81 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECC--------------SSCHHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchh--------------hccCHHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence            477889999999999999996 46889999998543              122344567799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+++..|+||||+++|+|..++..  .+.+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||
T Consensus        82 ~~~~~~~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl  156 (309)
T d1u5ra_          82 GCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL  156 (309)
T ss_dssp             EEEEETTEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred             EEEEECCEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEE
Confidence            999999999999999999999777653  45799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT---LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      +|||+|+.....      ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||........+....   
T Consensus       157 ~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~---  227 (309)
T d1u5ra_         157 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---  227 (309)
T ss_dssp             CCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---
T ss_pred             eecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---
Confidence            999999865432      24579999999999863   468999999999999999999999997543322222211   


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                       .. .......   ....+    .+.+++.+||+.||++|||++|+++
T Consensus       228 -~~-~~~~~~~---~~~s~----~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         228 -QN-ESPALQS---GHWSE----YFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -HS-CCCCCSC---TTSCH----HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -hC-CCCCCCC---CCCCH----HHHHHHHHHCcCChhHCcCHHHHHh
Confidence             11 1111111   11222    4778999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=406.37  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=207.6

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .+.|++.+.||+|+||+||+|+. .+|+.||||++.+.....           .......+.+.+|+.++++++|||||+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~-----------~~~~~~~~~~~~E~~il~~l~HpnIv~   77 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS-----------SRRGVSREDIEREVSILKEIQHPNVIT   77 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTT-----------CSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcch-----------hhhhHHHHHHHHHHHHHHhCCCCCCCc
Confidence            45788999999999999999997 568999999996542211           112234678999999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC--
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF--  838 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~--  838 (1002)
                      +++++.+++..|+||||+++|+|.+++...  +.+++..++.++.|++.||+|||++   +|+||||||+||+++.++  
T Consensus        78 ~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~  152 (293)
T d1jksa_          78 LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVP  152 (293)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSS
T ss_pred             EEEEEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCc
Confidence            999999999999999999999999999753  4699999999999999999999999   999999999999998776  


Q ss_pred             --CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          839 --GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 --~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                        .+|++|||+|+.......   .....||+.|||||++.+..++.++||||+||++|||++|+.||......+. ...+
T Consensus       153 ~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i  228 (293)
T d1jksa_         153 KPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANV  228 (293)
T ss_dssp             SCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred             ccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHHH
Confidence              499999999987754432   2345789999999999999999999999999999999999999976533222 2211


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..    .... ...+......    ..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~----~~~~-~~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         229 SA----VNYE-FEDEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HT----TCCC-CCHHHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Hh----cCCC-CCchhcCCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    1100 0001111222    24778999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-46  Score=408.08  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=211.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|++.+.||+|+||+||+|+.+      +++.||||++....                .....++|.+|++++++++||
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----------------~~~~~~~~~~E~~il~~l~h~   76 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----------------SADMQADFQREAALMAEFDNP   76 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----------------CHHHHHHHHHHHHHHHTCCCT
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----------------ChHHHHHHHHHHHHHHhcCCC
Confidence            56888999999999999999964      35789999984321                233467899999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----------------------GGLLDWPTRYKIIVDAAEGLSYL  814 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~~L~~L  814 (1002)
                      ||+++++++.+.+..+++|||+++|+|.+++....                      ...+++..++.++.|++.||+||
T Consensus        77 niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl  156 (301)
T d1lufa_          77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL  156 (301)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc
Confidence            99999999999999999999999999999987432                      13589999999999999999999


Q ss_pred             hhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          815 HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       815 H~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      |++   +||||||||+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|
T Consensus       157 H~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~  233 (301)
T d1lufa_         157 SER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW  233 (301)
T ss_dssp             HHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence            999   99999999999999999999999999998776554444445667899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          895 ELVTGRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       895 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ||++|..|+....+..+....+....    ..    +.....++    ++.+++.+||+.||++||||.||+++|+++.
T Consensus       234 ell~~~~~p~~~~~~~e~~~~v~~~~----~~----~~p~~~~~----~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         234 EIFSYGLQPYYGMAHEEVIYYVRDGN----IL----ACPENCPL----ELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHTTTCCTTTTSCHHHHHHHHHTTC----CC----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHccCCCCCCCCCHHHHHHHHHcCC----CC----CCCccchH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            99998754333334444444332211    11    11122333    4789999999999999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.2e-46  Score=412.91  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=208.2

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      .++++|++.+.||+|+||.||+|+. .+|+.||||++...                 .....+.+.+|+.++++++||||
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-----------------~~~~~~~~~~E~~il~~l~HpnI   85 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-----------------HESDKETVRKEIQTMSVLRHPTL   85 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-----------------SHHHHHHHHHHHHHHHHTCCTTB
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-----------------chhhHHHHHHHHHHHHhCCCCCC
Confidence            3567899999999999999999996 46899999998432                 23345778999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC--
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG--  836 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~--  836 (1002)
                      |++++++.+++..|+||||+++|+|.+++.. +.+.+++..++.++.||+.||+|||++   +||||||||+|||++.  
T Consensus        86 v~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~  161 (350)
T d1koaa2          86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKR  161 (350)
T ss_dssp             CCEEEEEEETTEEEEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTT
T ss_pred             CcEEEEEEECCEEEEEEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCC
Confidence            9999999999999999999999999999864 345699999999999999999999999   9999999999999964  


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      ++.+||+|||+|+.......   .....||+.|||||++.+..++.++||||+||++|||++|+.||..... .+....+
T Consensus       162 ~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i  237 (350)
T d1koaa2         162 SNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNV  237 (350)
T ss_dssp             SCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred             CCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence            57899999999987755432   3356799999999999999999999999999999999999999975532 2222222


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....  ....   .+......+    .+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~--~~~~---~~~~~~~s~----~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         238 KSCD--WNMD---DSAFSGISE----DGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHTC--CCSC---CGGGGGCCH----HHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HhCC--CCCC---cccccCCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111  0000   111122222    4778999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=397.65  Aligned_cols=252  Identities=29%  Similarity=0.405  Sum_probs=200.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|++.+.||+|+||.||+|+++ |+.||||+++..                   ...+.+.+|++++++++||||+++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-------------------~~~~~~~~E~~~l~~l~HpnIv~~   65 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------------------ATAQAFLAEASVMTQLRHSNLVQL   65 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-------------------C--HHHHHTHHHHTTCCCTTBCCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-------------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            356777899999999999999985 789999998431                   234678999999999999999999


Q ss_pred             eeEEec-CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          762 WCCCTT-RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       762 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +|++.+ .+..|+||||+++|+|.+++.......+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus        66 ~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~  142 (262)
T d1byga_          66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVA  142 (262)
T ss_dssp             EEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             EEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCE
Confidence            999865 46689999999999999999765555689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      |++|||+++.....     .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||... ...+....+...
T Consensus       143 kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~~  216 (262)
T d1byga_         143 KVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG  216 (262)
T ss_dssp             EECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTT
T ss_pred             eecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcC
Confidence            99999999865433     223468899999999999999999999999999999998 56666544 444544444322


Q ss_pred             hhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          920 LDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      .+.        +.....++    ++.+++.+||+.||++|||++|+++.|+++..
T Consensus       217 ~~~--------~~~~~~~~----~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         217 YKM--------DAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC--------CCCccCCH----HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            111        11122222    47789999999999999999999999998854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=404.46  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=207.1

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +++|++.+.||+|+||.||+|+. .+|+.||||++.+..              .......+.+.+|+.++++++|||||+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~--------------~~~~~~~~~~~~E~~il~~l~hp~Iv~   69 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV--------------IIAKDEVAHTVTESRVLQNTRHPFLTA   69 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHSCCCTTBCC
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhh--------------ccCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            46788899999999999999996 568999999985431              122334677899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++..  .+.+++..++.++.|++.||+|||++   +||||||||+|||++.+|.+
T Consensus        70 l~~~~~~~~~~~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~v  144 (337)
T d1o6la_          70 LKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHI  144 (337)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             EEeeeccccccccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCE
Confidence            99999999999999999999999999885  45689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+|+.......  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+..+...   
T Consensus       145 kl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-~~~~~~i~---  218 (337)
T d1o6la_         145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELIL---  218 (337)
T ss_dssp             EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH---
T ss_pred             EEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-HHHHHHHh---
Confidence            9999999987654322  23356899999999999999999999999999999999999999976532 22222211   


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                      . ..+.     ......+    ++.+++.+|+++||++||+     ++|+++
T Consensus       219 ~-~~~~-----~p~~~s~----~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         219 M-EEIR-----FPRTLSP----EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             H-CCCC-----CCTTSCH----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             c-CCCC-----CCccCCH----HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1 1111     0112222    3678999999999999995     888875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=402.68  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=205.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCc--EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGE--AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  758 (1002)
                      ++|++.++||+|+||.||+|.++ ++.  .||||++....                .....+.+.+|+++++++ +||||
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~~E~~~l~~l~~HpnI   73 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----------------SKDDHRDFAGELEVLCKLGHHPNI   73 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------------------CHHHHHHHHHTTCCCCTTB
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----------------ChHHHHHHHHHHHHHHhccCCCCE
Confidence            56777889999999999999975 444  47778764321                223456799999999999 69999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSC--------------KGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVH  824 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  824 (1002)
                      |++++++.+++..++||||+++|+|.++++..              ....+++..+.+++.||+.||.|+|++   +|+|
T Consensus        74 v~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiH  150 (309)
T d1fvra_          74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIH  150 (309)
T ss_dssp             CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             eeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---Cccc
Confidence            99999999999999999999999999999743              236799999999999999999999999   9999


Q ss_pred             CCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 001867          825 RDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVD  904 (1002)
Q Consensus       825 rDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~  904 (1002)
                      |||||+|||++.++.+||+|||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|..|+.
T Consensus       151 rDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~  227 (309)
T d1fvra_         151 RDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  227 (309)
T ss_dssp             SCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence            99999999999999999999999986544322   234468999999999999999999999999999999999776543


Q ss_pred             CCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          905 PEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      ...+..++...+....+        .+.....++    ++.+++.+||+.||++|||++||++.|+++....
T Consensus       228 ~~~~~~~~~~~i~~~~~--------~~~~~~~~~----~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         228 CGMTCAELYEKLPQGYR--------LEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             TTCCHHHHHHHGGGTCC--------CCCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             CCCCHHHHHHHHHhcCC--------CCCCccCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            33344444333321111        011122233    4788999999999999999999999999987544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=403.85  Aligned_cols=258  Identities=24%  Similarity=0.366  Sum_probs=204.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCc----EEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGE----AVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      .+|++.++||+|+||+||+|.+. +|+    +||+|++....                .....++|.+|++++++++|||
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~~E~~~l~~l~Hpn   72 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----------------SPKANKEILDEAYVMASVDNPH   72 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------------------CTHHHHHHHHHHHHHCCCTT
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc----------------CHHHHHHHHHHHHHHHhCCCCC
Confidence            45888899999999999999864 344    58888774321                2234567999999999999999


Q ss_pred             eeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          758 IVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ||++++++.++ ..+++|||+++|+|.+++.. +...+++..+++++.||+.||+|||++   +||||||||+||+++.+
T Consensus        73 Iv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~  147 (317)
T d1xkka_          73 VCRLLGICLTS-TVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP  147 (317)
T ss_dssp             BCCEEEEEESS-SEEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEET
T ss_pred             EeeEEEEEecC-CeeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCC
Confidence            99999999875 46788999999999998876 456799999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |..||... +..++...+
T Consensus       148 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-~~~~~~~~i  226 (317)
T d1xkka_         148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSIL  226 (317)
T ss_dssp             TEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CGGGHHHHH
T ss_pred             CCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-CHHHHHHHH
Confidence            9999999999998776555444455678999999999999999999999999999999999 67777644 344444444


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      ......        +.....++    ++.+++.+||+.||++|||++|+++.|+++..
T Consensus       227 ~~~~~~--------~~p~~~~~----~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         227 EKGERL--------PQPPICTI----DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHTCCC--------CCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCC--------CCCcccCH----HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            332211        11122333    47889999999999999999999999988753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=401.81  Aligned_cols=267  Identities=23%  Similarity=0.323  Sum_probs=205.6

Q ss_pred             HHHH-hcCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHH
Q 001867          678 EYEI-LDGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETL  750 (1002)
Q Consensus       678 ~~~~-~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  750 (1002)
                      .|++ .++|++.+.||+|+||.||+|.+.      +++.||||++....                .....+.+.+|+.++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~~e~~~l   70 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----------------THSEHRALMSELKIL   70 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------------------CHHHHHHHHHHHHHH
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----------------CcHHHHHHHHHHHHH
Confidence            3444 257888999999999999999864      24689999984321                233456678888888


Q ss_pred             hcC-CCCceeeeeeEEecC-CeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 001867          751 GKI-RHKNIVKLWCCCTTR-DCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYL  814 (1002)
Q Consensus       751 ~~l-~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~L  814 (1002)
                      .++ +|+|||.+++++... +..++||||+++|+|.++++..+              ...+++..++.++.||+.||+||
T Consensus        71 ~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl  150 (299)
T d1ywna1          71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  150 (299)
T ss_dssp             HHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH
T ss_pred             HhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH
Confidence            877 589999999998764 56899999999999999997532              24589999999999999999999


Q ss_pred             hhcCCCCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHH
Q 001867          815 HHDCVPSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVIL  894 (1002)
Q Consensus       815 H~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~  894 (1002)
                      |++   +||||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|
T Consensus       151 H~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~  227 (299)
T d1ywna1         151 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW  227 (299)
T ss_dssp             HHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             HhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHH
Confidence            999   99999999999999999999999999998776655544455668999999999999999999999999999999


Q ss_pred             HHHhCC-CCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          895 ELVTGR-LPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       895 ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ||++|. .||........+...+......        +.....++    ++.+++.+||+.||++|||++|+++.|+++.
T Consensus       228 ellt~~~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~----~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         228 EIFSLGASPYPGVKIDEEFCRRLKEGTRM--------RAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             HHHTTSCCSSTTCCCSHHHHHHHHHTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCCCC--------CCCccCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            999975 5676544444444443322211        11122223    4788999999999999999999999999886


Q ss_pred             hh
Q 001867          974 AE  975 (1002)
Q Consensus       974 ~~  975 (1002)
                      +.
T Consensus       296 q~  297 (299)
T d1ywna1         296 QA  297 (299)
T ss_dssp             HH
T ss_pred             hC
Confidence            43

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=395.77  Aligned_cols=259  Identities=23%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|++..    +..||||++...                ......+.+.+|+.++++++||||
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----------------~~~~~~~~~~~E~~~l~~l~HpnI   70 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----------------TSDSVREKFLQEALTMRQFDHPHI   70 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----------------TSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----------------cCHHHHHHHHHHHHHHHhCCCCCE
Confidence            568888999999999999998643    356888887321                134456789999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      |++++++. ++..|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++
T Consensus        71 v~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~  145 (273)
T d1mp8a_          71 VKLIGVIT-ENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND  145 (273)
T ss_dssp             CCEEEEEC-SSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred             eeEEEEEe-cCeEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCC
Confidence            99999996 4678999999999999998765 445799999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~~  917 (1002)
                      .+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.... ..+....+.
T Consensus       146 ~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-~~~~~~~i~  223 (273)
T d1mp8a_         146 CVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIE  223 (273)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHH
T ss_pred             cEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-HHHHHHHHH
Confidence            999999999987654433 23335578999999999999999999999999999999998 788886553 333333332


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAEN  976 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~  976 (1002)
                      .....        +.....+.    ++.+++.+||+.||++|||++||++.|+++....
T Consensus       224 ~~~~~--------~~~~~~~~----~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         224 NGERL--------PMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             TTCCC--------CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCCC--------CCCCCCCH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            21111        11122333    4788999999999999999999999999886543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-45  Score=399.79  Aligned_cols=248  Identities=26%  Similarity=0.346  Sum_probs=205.3

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +++|++.+.||+|+||+||+|+. .+|+.||||++.+..              .......+.+.+|+.++++++|||||+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~--------------~~~~~~~~~~~~E~~il~~l~HpnIv~   68 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI--------------VVRLKQVEHTNDERLMLSIVTHPFIIR   68 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHSCCBTTBCC
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH--------------ccCHHHHHHHHHHHHHHHhccCcChhh
Confidence            35688899999999999999997 468999999985431              112334567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||++||+|..++..  ...+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+
T Consensus        69 ~~~~~~~~~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~v  143 (316)
T d1fota_          69 MWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHI  143 (316)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCE
T ss_pred             eeeeEeeCCeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCE
Confidence            99999999999999999999999999884  45689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+|+......     ...+||+.|||||++.+..++.++||||+||++|||++|+.||.............    
T Consensus       144 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----  214 (316)
T d1fota_         144 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----  214 (316)
T ss_dssp             EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----
T ss_pred             EEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH----
Confidence            999999998765432     34679999999999999999999999999999999999999997643222222211    


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .. ...  +.   ....+    ++.+++.+|++.||++|+     |++|+++
T Consensus       215 ~~-~~~--~p---~~~s~----~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         215 NA-ELR--FP---PFFNE----DVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HC-CCC--CC---TTSCH----HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             cC-CCC--CC---CCCCH----HHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            11 110  11   11222    477899999999999996     8999985

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=398.38  Aligned_cols=259  Identities=25%  Similarity=0.353  Sum_probs=198.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC----CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN----GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++|++.+.||+|+||.||+|+...    ...||||++.+..              .......++|.+|+.++++++||||
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~--------------~~~~~~~~~~~~Ei~~l~~l~H~nI   73 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--------------LSQPEAMDDFIREVNAMHSLDHRNL   73 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------------CHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh--------------cCCHHHHHHHHHHHHHHHhCCCCCE
Confidence            467888899999999999998632    2478999885432              1233445789999999999999999


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCC
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDF  838 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~  838 (1002)
                      |+++|++.++ ..++||||+++|++.+++... .+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++
T Consensus        74 v~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~  148 (273)
T d1u46a_          74 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD  148 (273)
T ss_dssp             CCEEEEECSS-SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred             EEEEEEEeec-chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccccc
Confidence            9999999764 678999999999999987753 35699999999999999999999999   999999999999999999


Q ss_pred             CeEEccccCcccccCCCCCcc-cccccccccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 001867          839 GARVADFGVAKVVDASGKPKS-MSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-GRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       839 ~~kl~DfGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-g~~p~~~~~~~~~~~~~~  916 (1002)
                      .+||+|||+++.......... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||... +..+....+
T Consensus       149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i  227 (273)
T d1u46a_         149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKI  227 (273)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHH
T ss_pred             ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CHHHHHHHH
Confidence            999999999998765543322 234467889999999999999999999999999999998 89998654 333333332


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      ..   .. ..   .+.....++    .+.+++.+||+.||++|||++||++.|+++
T Consensus       228 ~~---~~-~~---~~~~~~~~~----~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         228 DK---EG-ER---LPRPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HT---SC-CC---CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Hh---CC-CC---CCCcccccH----HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            21   11 11   112223333    478899999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=399.61  Aligned_cols=262  Identities=23%  Similarity=0.347  Sum_probs=216.0

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RH  755 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1002)
                      ++|++.++||+|+||.||+|++.      +++.||||+++...                ......++.+|+.+++++ +|
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----------------~~~~~~~~~~E~~~~~~l~~H   86 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----------------HLTEREALMSELKVLSYLGNH   86 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----------------CHHHHHHHHHHHHHHHHHCCC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----------------CHHHHHHHHHHHHHHHhccCC
Confidence            67888999999999999999862      35689999985421                234566799999999999 69


Q ss_pred             CceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          756 KNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK----------------GGLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       756 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      ||||++++++.+++..++||||+++|+|.++++...                ...+++..+..++.||+.||+|||++  
T Consensus        87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--  164 (311)
T d1t46a_          87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--  164 (311)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            999999999999999999999999999999997543                23689999999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhC
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTG  899 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g  899 (1002)
                       +||||||||+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|+
T Consensus       165 -~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~  243 (311)
T d1t46a_         165 -NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL  243 (311)
T ss_dssp             -TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhC
Confidence             9999999999999999999999999999988766555555667899999999999999999999999999999999995


Q ss_pred             CCC-CCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          900 RLP-VDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       900 ~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      +.| |........+.+.+.......        .....+    .++.+++.+||+.||++|||++||+++|+++...
T Consensus       244 g~p~~~~~~~~~~~~~~i~~~~~~~--------~~~~~~----~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         244 GSSPYPGMPVDSKFYKMIKEGFRML--------SPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             TCCSSTTCCSSHHHHHHHHHTCCCC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCC--------Cccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            555 444433344444443322111        111122    2488999999999999999999999999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=401.12  Aligned_cols=252  Identities=16%  Similarity=0.234  Sum_probs=205.6

Q ss_pred             HhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCcee
Q 001867          681 ILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIV  759 (1002)
Q Consensus       681 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  759 (1002)
                      +.++|++.+.||+|+||+||+|..+ +++.||||++...                  ......+.+|++++++++|||||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------------------~~~~~~~~~Ei~il~~l~HpnIv   64 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------------------GTDQVLVKKEISILNIARHRNIL   64 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------------THHHHHHHHHHHHHHHSCCTTBC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------------------cccHHHHHHHHHHHHhCCCCCCC
Confidence            4577899999999999999999975 6889999998432                  22345688999999999999999


Q ss_pred             eeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC--
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD--  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~--  837 (1002)
                      ++++++.+++..|+||||++||+|.+++.. .+..+++.+++.++.||+.||+|||++   +|+||||||+||+++.+  
T Consensus        65 ~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~  140 (321)
T d1tkia_          65 HLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRS  140 (321)
T ss_dssp             CEEEEEEETTEEEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSC
T ss_pred             eEEEEEEECCEEEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCc
Confidence            999999999999999999999999999975 334699999999999999999999999   99999999999999854  


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVC  917 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~  917 (1002)
                      ..+||+|||+++......   ......||+.|+|||...+..++.++||||+||++|+|++|+.||........+.....
T Consensus       141 ~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~  217 (321)
T d1tkia_         141 STIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN  217 (321)
T ss_dssp             CCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             eEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            479999999998765432   23345789999999999999999999999999999999999999976543322222211


Q ss_pred             HHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          918 STLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...   ...   .+......+    ++.+++.+|++.||++|||++|+++
T Consensus       218 ~~~---~~~---~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         218 AEY---TFD---EEAFKEISI----EAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TCC---CCC---HHHHTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCC---CCC---hhhccCCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence            100   000   011112222    3778999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=394.03  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=206.3

Q ss_pred             CCeeeecCCccEEEEEEcCC----cEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeee
Q 001867          688 DNVIGSGSSGKVYKVVLSNG----EAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWC  763 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  763 (1002)
                      .++||+|+||+||+|.+.++    ..||||++.+.                .+....++|.+|++++++++|||||+++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g   95 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLG   95 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC----------------CCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----------------cCHHHHHHHHHHHHHHHhCCCCCEeEEeE
Confidence            46899999999999997432    35899988431                23455678999999999999999999999


Q ss_pred             EEec-CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          764 CCTT-RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       764 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      ++.+ ++..++||||+++|+|.+++.. .....++..+.+++.|++.||.|+|+.   +|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL  171 (311)
T d1r0pa_          96 ICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV  171 (311)
T ss_dssp             EEEETTTEEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEecCCceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEE
Confidence            9865 5688999999999999999875 445688999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCc--ccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          843 ADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      +|||+++.........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....+..+....+....
T Consensus       172 ~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~  251 (311)
T d1r0pa_         172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  251 (311)
T ss_dssp             CSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC
T ss_pred             ecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999998775543322  22345689999999999999999999999999999999999999876655544444433221


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhh
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAE  975 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~  975 (1002)
                      +.      ..|  ...+.    ++.+++.+||+.||++||+++||++.|+++...
T Consensus       252 ~~------~~p--~~~~~----~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         252 RL------LQP--EYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CC------CCC--TTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CC------CCc--ccCcH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            11      011  12222    478899999999999999999999999999754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-45  Score=392.74  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=204.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+..              ..+....+.+.+|++++++++|||||+
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------------~~~~~~~~~~~~E~~~l~~~~hpniv~   71 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--------------ARDPSFYLRFRREAQNAAALNHPAIVA   71 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--------------TTCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh--------------ccCHHHHHHHHHHHHHHHhcCCCCCCc
Confidence            35688899999999999999996 578999999985432              223455678999999999999999999


Q ss_pred             eeeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          761 LWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       761 l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      +++++...+    ..|+||||++||+|.+++..  .+.+++.+++.++.||+.||+|||++   +|+||||||+||+++.
T Consensus        72 ~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~  146 (277)
T d1o6ya_          72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISA  146 (277)
T ss_dssp             EEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred             ccceeeeccCCCceEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCc
Confidence            999997654    37999999999999999874  35699999999999999999999999   9999999999999999


Q ss_pred             CCCeEEccccCcccccCCCCC-cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          837 DFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      ++.++++|||.+......... ......+||+.|||||++.+..++.++||||+||++|||++|+.||......+.... 
T Consensus       147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-  225 (277)
T d1o6ya_         147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-  225 (277)
T ss_dssp             TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-
T ss_pred             cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH-
Confidence            999999999999766443222 223456799999999999999999999999999999999999999975533222222 


Q ss_pred             HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHHhh
Q 001867          916 VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-AMRRVVKLLQEVG  973 (1002)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~evl~~L~~~~  973 (1002)
                         .........  .......++    ++.+++.+|+++||++|| |++++.+.|.++.
T Consensus       226 ---~~~~~~~~~--~~~~~~~s~----~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         226 ---HVREDPIPP--SARHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ---HHHCCCCCG--GGTSSSCCH----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---HHhcCCCCC--chhccCCCH----HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence               222211110  011122222    477899999999999999 8999999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.8e-45  Score=389.72  Aligned_cols=258  Identities=25%  Similarity=0.309  Sum_probs=205.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  760 (1002)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+.....        ......+...+.+.+|+.++++++ |||||+
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~--------~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~   74 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGS--------FSAEEVQELREATLKEVDILRKVSGHPNIIQ   74 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTT--------CCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccc--------hhHHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence            5788899999999999999996 568999999996542110        000112334567889999999997 999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.++++.  .+.+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+
T Consensus        75 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          75 LKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEeecccCcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCe
Confidence            99999999999999999999999999975  35699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT------LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      ||+|||+++.......   .....||+.|+|||++.+      ..++.++||||+||++|||++|+.||...........
T Consensus       150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~  226 (277)
T d1phka_         150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  226 (277)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence            9999999998765432   234579999999998763      3468899999999999999999999976533222222


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ....     ... ...+......+    ++.+++.+||++||++|||++|++
T Consensus       227 i~~~-----~~~-~~~~~~~~~s~----~~~~li~~~L~~~p~~R~s~~eil  268 (277)
T d1phka_         227 IMSG-----NYQ-FGSPEWDDYSD----TVKDLVSRFLVVQPQKRYTAEEAL  268 (277)
T ss_dssp             HHHT-----CCC-CCTTTGGGSCH----HHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             HHhC-----CCC-CCCcccccCCH----HHHHHHHHHccCChhHCcCHHHHH
Confidence            2111     111 11122223333    478899999999999999999884

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-45  Score=395.52  Aligned_cols=260  Identities=26%  Similarity=0.375  Sum_probs=208.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcC--------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSN--------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-  753 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  753 (1002)
                      ++|++.+.||+|+||.||+|+...        +..||||++.+..                ......++.+|+..+.++ 
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~~e~~~l~~~~   76 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----------------TEKDLSDLISEMEMMKMIG   76 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----------------CHHHHHHHHHHHHHHHHHC
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----------------ChHHHHHHHHHHHHHHHhc
Confidence            567888999999999999998632        2479999985431                233456788899999888 


Q ss_pred             CCCceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 001867          754 RHKNIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------------GGLLDWPTRYKIIVDAAEGLSYLHHDCV  819 (1002)
Q Consensus       754 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~  819 (1002)
                      +|||||++++++.+++..++||||+++|+|.+++....              ...+++.++++++.||+.||+|||++  
T Consensus        77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~--  154 (299)
T d1fgka_          77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--  154 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC--
Confidence            79999999999999999999999999999999997543              24689999999999999999999999  


Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHh-
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVT-  898 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~-  898 (1002)
                       +||||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++ 
T Consensus       155 -~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~  233 (299)
T d1fgka_         155 -KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL  233 (299)
T ss_dssp             -TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             -CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence             999999999999999999999999999998876655555566789999999999999999999999999999999998 


Q ss_pred             CCCCCCCCCCchhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhh
Q 001867          899 GRLPVDPEFGEKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGA  974 (1002)
Q Consensus       899 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~  974 (1002)
                      |+.||... ...+....+......        +.....++    ++.+++.+||+.||++|||++||++.|+++.+
T Consensus       234 g~~p~~~~-~~~~~~~~i~~~~~~--------~~p~~~~~----~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         234 GGSPYPGV-PVEELFKLLKEGHRM--------DKPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             SCCSSTTC-CHHHHHHHHHTTCCC--------CCCSSCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCC-CHHHHHHHHHcCCCC--------CCCccchH----HHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            67777543 333333333221111        11122222    47889999999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=397.15  Aligned_cols=260  Identities=21%  Similarity=0.317  Sum_probs=212.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc------CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCC
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS------NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHK  756 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  756 (1002)
                      ++|++.+.||+|+||+||+|.++      +++.||||+++..                ........|.+|++++++++||
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----------------~~~~~~~~~~~E~~il~~l~h~   83 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----------------ASMRERIEFLNEASVMKEFNCH   83 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----------------SCHHHHHHHHHHHHHGGGCCCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc----------------cChHHHHHHHHHHHHHHHcCCC
Confidence            57788899999999999999863      2578999998432                1234456799999999999999


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCC
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCK--------GGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVK  828 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk  828 (1002)
                      |||++++++..++..++||||+++|+|.+++...+        ...+++..+.+++.|+++||+|||++   +|+|||||
T Consensus        84 nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk  160 (308)
T d1p4oa_          84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLA  160 (308)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCS
T ss_pred             CEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEc
Confidence            99999999999999999999999999999987532        14579999999999999999999999   99999999


Q ss_pred             CCcEEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 001867          829 SNNILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFG  908 (1002)
Q Consensus       829 ~~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~  908 (1002)
                      |+|||++.++++||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||+.|+.....
T Consensus       161 ~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         161 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             CCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999877665554445556789999999999999999999999999999999998644433434


Q ss_pred             chhHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Q 001867          909 EKDLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVG  973 (1002)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~  973 (1002)
                      ..+....+.....        .+.....+    ..+.+++.+||+.||++|||+++|++.|++..
T Consensus       241 ~~~~~~~i~~~~~--------~~~p~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         241 NEQVLRFVMEGGL--------LDKPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHHHHHHHHTTCC--------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHHHHHhCCC--------CCCcccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            4443333322111        11112222    24889999999999999999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-44  Score=401.26  Aligned_cols=248  Identities=23%  Similarity=0.262  Sum_probs=205.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +++|++.+.||+|+||.||+|+. .+|+.||||++.+..              ..+....+.+.+|+.++++++|||||+
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~--------------~~~~~~~~~~~~E~~il~~l~hpnIv~  105 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK--------------VVKLKQIEHTLNEKRILQAVNFPFLVK  105 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH--------------ccCHHHHHHHHHHHHHHHHcCCCcEee
Confidence            46788899999999999999997 469999999985421              112334567899999999999999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+.+..++||||+++|+|.+++...  +.+++..++.++.||+.||.|||++   +||||||||+|||++.++.+
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~i  180 (350)
T d1rdqe_         106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI  180 (350)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             cccccccccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCE
Confidence            999999999999999999999999999753  4699999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+|+.....     .....||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+   .
T Consensus       181 kL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i---~  251 (350)
T d1rdqe_         181 QVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKI---V  251 (350)
T ss_dssp             EECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH---H
T ss_pred             Eeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHHHH---h
Confidence            99999999877543     2245799999999999999999999999999999999999999975432 2222211   1


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      .. ...     ......+    ++.+++.+||+.||++|+     |++|+++
T Consensus       252 ~~-~~~-----~p~~~s~----~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         252 SG-KVR-----FPSHFSS----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HC-CCC-----CCTTCCH----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             cC-CCC-----CCccCCH----HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            11 110     0112222    477899999999999994     8999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-44  Score=402.67  Aligned_cols=254  Identities=22%  Similarity=0.239  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      +++|++.+.||+|+||.||+|+.. +|+.||||++.+.....           ............|+.+++.++|||||+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~-----------~~~~~~~~~e~~~~~~l~~~~hpnIv~   71 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----------KQGETLALNERIMLSLVSTGDCPFIVC   71 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-----------HTCHHHHHHHHHHHHHHSSSCCTTBCC
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch-----------hhHHHHHHHHHHHHHHHhcCCCCcEEE
Confidence            367888999999999999999974 68999999985431110           001111222344577888889999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.+++..  ...+++..++.++.||+.||+|||++   +||||||||+|||++.++.+
T Consensus        72 l~~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          72 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCE
T ss_pred             EEEEEEECCEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcE
Confidence            99999999999999999999999999985  35689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCST  919 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~  919 (1002)
                      ||+|||+|+......    .....||+.|||||++.. ..++.++||||+||++|||++|+.||....... ........
T Consensus       147 Kl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~  221 (364)
T d1omwa3         147 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMT  221 (364)
T ss_dssp             EECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHHHS
T ss_pred             EEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc
Confidence            999999998775542    234579999999999864 568999999999999999999999997653322 22221111


Q ss_pred             hhccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 001867          920 LDQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPA-----MRRVVK  967 (1002)
Q Consensus       920 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~evl~  967 (1002)
                      .. ..      +.. ....+    ++.+++.+||+.||++|||     ++|+++
T Consensus       222 ~~-~~------~~~~~~~s~----~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 LT-MA------VELPDSFSP----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SS-CC------CCCCSSSCH----HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cc-CC------CCCCCCCCH----HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11 10      111 12222    3778999999999999999     688874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=392.00  Aligned_cols=270  Identities=24%  Similarity=0.267  Sum_probs=203.5

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      .++|.+.+.||+|+||.||+|+. +|+.||||++...                  .......+.|+..+.+++|||||++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~------------------~~~~~~~e~ei~~~~~~~HpnIv~~   62 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------------------EERSWFREAEIYQTVMLRHENILGF   62 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG------------------GHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc------------------chhHHHHHHHHHHHhhCCCCcCcce
Confidence            34567788999999999999997 5899999988321                  1222334455666667899999999


Q ss_pred             eeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeeCCCCCCcE
Q 001867          762 WCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD-----CVPSIVHRDVKSNNI  832 (1002)
Q Consensus       762 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~iiHrDlk~~NI  832 (1002)
                      ++++.+++    ..|+||||+++|+|.+++++   ..++|..+++++.|+|.||+|+|+.     ..++||||||||+||
T Consensus        63 ~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI  139 (303)
T d1vjya_          63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  139 (303)
T ss_dssp             EEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred             EEEEEeCCCcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence            99998654    57999999999999999975   3589999999999999999999973     124999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCc--ccccccccccccCccccccCC------CCCccchhhHHHHHHHHHhCCCCCC
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTLR------VNEKSDIYSFGVVILELVTGRLPVD  904 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~ell~g~~p~~  904 (1002)
                      |++.++.+||+|||+++.........  ......||+.|||||++.+..      ++.++|||||||++|||+||..||.
T Consensus       140 Ll~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             EEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            99999999999999998876543322  234567999999999987543      5678999999999999999988774


Q ss_pred             CCCCc----------hhHHHHHHHHhhccCccccccccccC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Q 001867          905 PEFGE----------KDLVKWVCSTLDQKGVDHVLDPKLDC--CFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEV  972 (1002)
Q Consensus       905 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~  972 (1002)
                      .....          ................    .|....  ...+....+.+++.+||+.||++|||+.||++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccchhhcccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            32211          1111222222222221    122211  1223456688999999999999999999999999999


Q ss_pred             hhhcc
Q 001867          973 GAENR  977 (1002)
Q Consensus       973 ~~~~~  977 (1002)
                      .....
T Consensus       296 ~~~~~  300 (303)
T d1vjya_         296 SQQEG  300 (303)
T ss_dssp             HHHHC
T ss_pred             HHhcC
Confidence            76543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=399.08  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             HhcCCCcC-CeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC-CCCc
Q 001867          681 ILDGLDED-NVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI-RHKN  757 (1002)
Q Consensus       681 ~~~~~~~~-~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n  757 (1002)
                      +.++|++. ++||+|+||+||+|+. .+++.||||++..                      ...+.+|+.++.++ +|||
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----------------------~~~~~~E~~~~~~~~~hpn   66 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----------------------CPKARREVELHWRASQCPH   66 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----------------------SHHHHHHHHHHHHHTTSTT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----------------------cHHHHHHHHHHHHhcCCCC
Confidence            45778776 4699999999999996 5689999999832                      23467899987654 7999


Q ss_pred             eeeeeeEEec----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEE
Q 001867          758 IVKLWCCCTT----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNIL  833 (1002)
Q Consensus       758 iv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIl  833 (1002)
                      ||+++++|.+    +...|+||||++||+|.+++.......+++.+++.++.||+.||+|||++   +|+||||||+||+
T Consensus        67 Iv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIl  143 (335)
T d2ozaa1          67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLL  143 (335)
T ss_dssp             BCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccc
Confidence            9999999875    46689999999999999999865556799999999999999999999999   9999999999999


Q ss_pred             ECC---CCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          834 LDG---DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       834 l~~---~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                      ++.   ++.+||+|||+|+.......   .....||+.|||||++.+..|+.++||||+||++|+|++|+.||.......
T Consensus       144 l~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~  220 (335)
T d2ozaa1         144 YTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  220 (335)
T ss_dssp             ESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred             cccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence            975   45799999999987765432   234579999999999999999999999999999999999999997543322


Q ss_pred             hHHHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          911 DLVKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      .... +.......... ...+..    .....++.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~-~~~~i~~~~~~-~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         221 ISPG-MKTRIRMGQYE-FPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --------CCCSCSSS-CCTTHH----HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHH-HHHHHhcCCCC-CCCccc----ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2111 11111111100 001111    112235788999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=393.83  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=202.5

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHh-cCCCCceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLG-KIRHKNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~  760 (1002)
                      ++|++.+.||+|+||+||+|+.+ +++.||||++.+..              .......+.+..|+.++. .++|||||+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~--------------~~~~~~~~~~~~e~~~l~~~~~hp~Iv~   67 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV--------------VLMDDDVECTMVEKRVLSLAWEHPFLTH   67 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH--------------HHHTTCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhh--------------ccChHHHHHHHHHHHHHHHhCCCCcEEE
Confidence            57888999999999999999974 68999999985431              112233455677777765 689999999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCe
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGA  840 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~  840 (1002)
                      +++++.+++..|+||||+++|+|.++++.  ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+
T Consensus        68 ~~~~~~~~~~~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~  142 (320)
T d1xjda_          68 MFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI  142 (320)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             EEEEEccCCceeEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCce
Confidence            99999999999999999999999999985  34689999999999999999999999   99999999999999999999


Q ss_pred             EEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          841 RVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       841 kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      ||+|||+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ..+....+.   
T Consensus       143 kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~---  216 (320)
T d1xjda_         143 KIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---  216 (320)
T ss_dssp             EECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH---
T ss_pred             eccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHH---
Confidence            9999999986654332  3345679999999999999999999999999999999999999997653 222222221   


Q ss_pred             hccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 001867          921 DQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR-RVVK  967 (1002)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-evl~  967 (1002)
                       .....  +.   ....+    ++.+++.+||+.||++||++. |+++
T Consensus       217 -~~~~~--~p---~~~s~----~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         217 -MDNPF--YP---RWLEK----EAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -HCCCC--CC---TTSCH----HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -cCCCC--CC---ccCCH----HHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             11110  01   11222    377899999999999999995 6753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=386.24  Aligned_cols=264  Identities=22%  Similarity=0.276  Sum_probs=202.8

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....               ......+++.+|++++++++|||||++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~   66 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---------------ETEGVPSTAIREISLLKELNHPNIVKL   66 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------------------CCHHHHHHHHHHTTCCCTTBCCE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh---------------cChHHHHHHHHHHHHHHhCCCCcEEEe
Confidence            5788899999999999999996 568999999984321               122235678999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+++..|+||||+. |++.+++.......+++..+..++.|++.||+|||++   +||||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~k  142 (298)
T d1gz8a_          67 LDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK  142 (298)
T ss_dssp             EEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccccccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcce
Confidence            999999999999999995 5666666655667899999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||.|+.......  ......||+.|+|||+..... ++.++||||+||++|+|++|+.||......+..........
T Consensus       143 l~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~  220 (298)
T d1gz8a_         143 LADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG  220 (298)
T ss_dssp             ECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             eccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999987754332  233457999999999877655 57899999999999999999999976543333333222211


Q ss_pred             hcc--Ccccc-cc-------ccccCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQK--GVDHV-LD-------PKLDCC-----FKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~--~~~~~-~~-------~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ...  ..... ..       +.....     ......++.+++.+|++.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            100  00000 00       000000     0011135778999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-44  Score=390.26  Aligned_cols=261  Identities=21%  Similarity=0.227  Sum_probs=196.5

Q ss_pred             CCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeEEe
Q 001867          688 DNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCCCT  766 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  766 (1002)
                      .++||+|+||+||+|+. .+|+.||||++......            .......+.+.+|+.++++++|||||++++++.
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------------~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~   70 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS------------EAKDGINRTALREIKLLQELSHPNIIGLLDAFG   70 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh------------hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            47899999999999996 46899999998543111            011122456899999999999999999999999


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcccc
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVADFG  846 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  846 (1002)
                      +++..|+||||++++++..+..  ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        71 ~~~~~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG  145 (299)
T d1ua2a_          71 HKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  145 (299)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             cCCceeehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCc
Confidence            9999999999998877766654  456799999999999999999999999   99999999999999999999999999


Q ss_pred             CcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--c
Q 001867          847 VAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLDQ--K  923 (1002)
Q Consensus       847 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~  923 (1002)
                      +|+.......  .....+||+.|||||++.+. .++.++||||+||++|||++|+.||......+.+..........  .
T Consensus       146 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         146 LAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             GGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            9987655432  22345799999999988654 57999999999999999999999997654444333332221100  0


Q ss_pred             Cccc-------cccccccCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          924 GVDH-------VLDPKLDCCF-----KEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       924 ~~~~-------~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ....       ..........     +....++.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000       0000000111     111235788999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-43  Score=383.41  Aligned_cols=262  Identities=23%  Similarity=0.292  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      ++|++.++||+|+||+||+|++++|+.||||++....               ......+++.+|+.++++++|||||+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~E~~il~~l~hpnIv~~~   66 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---------------EDEGIPSTTIREISILKELKHSNIVKLY   66 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS---------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhh---------------cChHHHHHHHHHHHHHHhCCCCcEEeee
Confidence            5788899999999999999999999999999985431               1223356799999999999999999999


Q ss_pred             eEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEE
Q 001867          763 CCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARV  842 (1002)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  842 (1002)
                      +++.+++..+++|||+.++.+..+..  ..+.+++..+..++.||+.||+|||++   +||||||||+||+++.++.+|+
T Consensus        67 ~~~~~~~~~~i~~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl  141 (286)
T d1ob3a_          67 DVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKI  141 (286)
T ss_dssp             EEEECSSCEEEEEECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             eecccCCceeEEEEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEe
Confidence            99999999999999997766666654  456799999999999999999999999   9999999999999999999999


Q ss_pred             ccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 001867          843 ADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTLD  921 (1002)
Q Consensus       843 ~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~~  921 (1002)
                      +|||.+........  ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+...+.......
T Consensus       142 ~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~  219 (286)
T d1ob3a_         142 ADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT  219 (286)
T ss_dssp             CCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            99999987755432  22344689999999998754 5689999999999999999999999765433333332221110


Q ss_pred             cc--C---------ccc---cccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          922 QK--G---------VDH---VLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       922 ~~--~---------~~~---~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ..  .         ...   ...+.. ....+.....+.+++.+|++.||++|||++|++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell  279 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            00  0         000   000000 000111123477899999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=378.04  Aligned_cols=245  Identities=20%  Similarity=0.336  Sum_probs=195.6

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--CCcee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--HKNIV  759 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv  759 (1002)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+....+           ........++.+|+.++++++  |||||
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~~~~~E~~il~~l~~~h~nIv   72 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD-----------WGELPNGTRVPMEVVLLKKVSSGFSGVI   72 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCC-----------EEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccc-----------hhhhhHHHHHHHHHHHHHHhccCCCCcc
Confidence            5688899999999999999996 468999999996542211           001122344678999999986  89999


Q ss_pred             eeeeEEecCCeeeEEEeccCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC-
Q 001867          760 KLWCCCTTRDCKLLVYEYMPN-GSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD-  837 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~-  837 (1002)
                      ++++++.+++..|+||||+++ +++.+++..  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.+ 
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~  147 (273)
T d1xwsa_          73 RLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR  147 (273)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred             EEEEEEeeCCeEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCC
Confidence            999999999999999999976 578888774  35699999999999999999999999   99999999999999854 


Q ss_pred             CCeEEccccCcccccCCCCCcccccccccccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 001867          838 FGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRV-NEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWV  916 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~  916 (1002)
                      +.+||+|||+|+......    .+...||+.|||||++.+..+ +.++||||+||++|||++|+.||...   ..   ..
T Consensus       148 ~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~---i~  217 (273)
T d1xwsa_         148 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE---II  217 (273)
T ss_dssp             TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH---HH
T ss_pred             CeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---hH---Hh
Confidence            789999999998754432    234579999999999987765 56799999999999999999999642   11   11


Q ss_pred             HHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          917 CSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ..     .  ..+.+   ...+    ++.+++.+||+.||++|||++|+++
T Consensus       218 ~~-----~--~~~~~---~~s~----~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RG-----Q--VFFRQ---RVSS----ECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HC-----C--CCCSS---CCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hc-----c--cCCCC---CCCH----HHHHHHHHHccCCHhHCcCHHHHhc
Confidence            10     0  01111   1222    4778999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=378.95  Aligned_cols=263  Identities=22%  Similarity=0.252  Sum_probs=196.9

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcC---CCCc
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKI---RHKN  757 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~n  757 (1002)
                      ++|++.+.||+|+||+||+|+. ++ ++.||||++.....               .......+.+|+.+++.+   +|||
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~---------------~~~~~~~~~~E~~~l~~l~~~~Hpn   71 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------------EEGMPLSTIREVAVLRHLETFEHPN   71 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---------------TTSCBCTHHHHHHHHHHHHHTCCTT
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc---------------cchHHHHHHHHHHHHHHHhhcCCCC
Confidence            5788899999999999999997 44 56799999854321               112233466788777766   7999


Q ss_pred             eeeeeeEEec-----CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          758 IVKLWCCCTT-----RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       758 iv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      |++++++|..     ....+++|||++++.+.... ......+++..++.++.|++.||+|||++   +||||||||+||
T Consensus        72 Iv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NI  147 (305)
T d1blxa_          72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNI  147 (305)
T ss_dssp             BCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             cceeeeeecccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEE
Confidence            9999999853     34679999999776655443 33557799999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      |++.++.+||+|||+++.....   .......||+.|||||++.+..++.++||||+||++|||++|+.||......+.+
T Consensus       148 Li~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  224 (305)
T d1blxa_         148 LVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL  224 (305)
T ss_dssp             EECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999999999999999865433   2334568999999999999999999999999999999999999999766443333


Q ss_pred             HHHHHHHhhccC--c-------ccc----ccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          913 VKWVCSTLDQKG--V-------DHV----LDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       913 ~~~~~~~~~~~~--~-------~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ............  .       ...    ...............+.+++.+|++.||++|||++|+++
T Consensus       225 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            333222111000  0       000    000000111111224678999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-42  Score=381.54  Aligned_cols=266  Identities=24%  Similarity=0.337  Sum_probs=198.2

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++.+.|++.+.||+|+||+||+|.. .+|+.||||++.+.               .......+.+.+|++++++++||||
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~---------------~~~~~~~~~~~~Ei~il~~l~hpni   79 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------------FQSELFAKRAYRELRLLKHMRHENV   79 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---------------TSSHHHHHHHHHHHHHHHHCCBTTB
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh---------------hcChHHHHHHHHHHHHHHhcCCCCe
Confidence            3456788899999999999999996 46999999998532               1234456778999999999999999


Q ss_pred             eeeeeEEecCC------eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          759 VKLWCCCTTRD------CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       759 v~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      |+++++|...+      ..|+||||+ +.+|..+.+.   ..+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        80 v~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NI  152 (346)
T d1cm8a_          80 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNL  152 (346)
T ss_dssp             CCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             eEEEEEeccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchh
Confidence            99999998654      569999999 6788887753   4699999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |++.++.+|++|||+|+.....     .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus       153 L~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~  227 (346)
T d1cm8a_         153 AVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ  227 (346)
T ss_dssp             EECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             hcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence            9999999999999999876543     234579999999999876 4568999999999999999999999976543332


Q ss_pred             HHHHHHHHhhc-----------------cCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHHh
Q 001867          912 LVKWVCSTLDQ-----------------KGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKL--LQEV  972 (1002)
Q Consensus       912 ~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~--L~~~  972 (1002)
                      ...........                 .....................+.+++.+|++.||++|||++|+++.  ++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            22222111000                 0000000000111111111246789999999999999999999973  5544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.3e-41  Score=365.03  Aligned_cols=273  Identities=17%  Similarity=0.181  Sum_probs=214.1

Q ss_pred             cCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC-Cceee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH-KNIVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~  760 (1002)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...                   .....+.+|+++++.+.| +|++.
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------------~~~~~~~~e~~~~~~l~~~~~i~~   65 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-------------------SDAPQLRDEYRTYKLLAGCTGIPN   65 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-------------------TTSCCHHHHHHHHHHTTTCTTCCC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-------------------cCcHHHHHHHHHHHHhcCCCCCCE
Confidence            56888999999999999999964 6899999987432                   112357889999999975 99999


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC----
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG----  836 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~----  836 (1002)
                      +++++......++||||+ +++|.+++.. .+..+++.++..++.|++.||+|||++   +|+||||||+||+++.    
T Consensus        66 ~~~~~~~~~~~~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~  140 (293)
T d1csna_          66 VYYFGQEGLHNVLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSK  140 (293)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSST
T ss_pred             EEEEeecCCccEEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccc
Confidence            999999999999999999 7899999875 445799999999999999999999999   9999999999999974    


Q ss_pred             -CCCeEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 001867          837 -DFGARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEK  910 (1002)
Q Consensus       837 -~~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~  910 (1002)
                       ++.+||+|||+|+........     ......+||+.|||||++.+..++.++||||+||++|||++|+.||.......
T Consensus       141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~  220 (293)
T d1csna_         141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT  220 (293)
T ss_dssp             TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred             cCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence             567999999999877543221     12335579999999999999999999999999999999999999997654433


Q ss_pred             hHHHH--HHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCCCCCCC
Q 001867          911 DLVKW--VCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLS  988 (1002)
Q Consensus       911 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~~~  988 (1002)
                      .....  +..........+    .....++    ++.+++..|++.+|++||+++.+.+.|+++......      ..++
T Consensus       221 ~~~~~~~i~~~~~~~~~~~----l~~~~p~----~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~------~~~~  286 (293)
T d1csna_         221 NKQKYERIGEKKQSTPLRE----LCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT------TEDE  286 (293)
T ss_dssp             HHHHHHHHHHHHHHSCHHH----HTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC------CSCS
T ss_pred             HHHHHHHHHhccCCCChHH----hcCCCCH----HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC------CCCC
Confidence            22221  111111111111    1122333    477888899999999999999999999988653322      3356


Q ss_pred             cchhh
Q 001867          989 PYYHE  993 (1002)
Q Consensus       989 ~~~~~  993 (1002)
                      ||.|+
T Consensus       287 ~~Dw~  291 (293)
T d1csna_         287 NFDWN  291 (293)
T ss_dssp             CCGGG
T ss_pred             CCCCC
Confidence            77776

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=377.69  Aligned_cols=267  Identities=21%  Similarity=0.245  Sum_probs=197.6

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  758 (1002)
                      ++..+|++.+.||+|+||+||+|.. .+|+.||||++.+.                ......+++.+|++++++++||||
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----------------~~~~~~~~~~~Ei~il~~l~hp~i   68 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----------------EHQTYCQRTLREIKILLRFRHENI   68 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----------------TCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh----------------cChHHHHHHHHHHHHHHHcCCCCC
Confidence            4456788899999999999999986 57999999998431                123445678999999999999999


Q ss_pred             eeeeeEEecCC----eeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEE
Q 001867          759 VKLWCCCTTRD----CKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILL  834 (1002)
Q Consensus       759 v~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll  834 (1002)
                      +++++++....    ..+++++|+.+|+|.+++..   ..+++..++.++.|++.||+|||++   +||||||||+|||+
T Consensus        69 v~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl  142 (345)
T d1pmea_          69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLL  142 (345)
T ss_dssp             CCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             CcEEEEEeeccccccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEE
Confidence            99999997543    23555666779999999974   3599999999999999999999999   99999999999999


Q ss_pred             CCCCCeEEccccCcccccCCCCC-cccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          835 DGDFGARVADFGVAKVVDASGKP-KSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       835 ~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      +.++.+||+|||+++........ ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+..
T Consensus       143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~  222 (345)
T d1pmea_         143 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL  222 (345)
T ss_dssp             CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH
Confidence            99999999999999876543222 12345679999999999854 56789999999999999999999999765332222


Q ss_pred             HHHHHHHhhccCc-----------c-ccccccccCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 001867          913 VKWVCSTLDQKGV-----------D-HVLDPKLDCC-----FKEEICKVLNIGLLCTSPLPINRPAMRRVVKL  968 (1002)
Q Consensus       913 ~~~~~~~~~~~~~-----------~-~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~  968 (1002)
                      .............           . ....+.....     .+....++.+++.+|++.||++|||++|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2211111000000           0 0000000000     00111247789999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-41  Score=367.09  Aligned_cols=278  Identities=18%  Similarity=0.221  Sum_probs=207.3

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc-eee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN-IVK  760 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~  760 (1002)
                      ++|++.+.||+|+||.||+|++ .+|+.||||++...                   ...+++..|++++++++|++ |+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------------------~~~~~~~~E~~i~~~l~~~~~i~~   67 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-------------------TKHPQLHIESKIYKMMQGGVGIPT   67 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC-------------------TTSCCHHHHHHHHHHSTTSTTCCC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh-------------------ccCHHHHHHHHHHHHccCCCcccE
Confidence            4688899999999999999996 46899999987432                   11235788999999998665 555


Q ss_pred             eeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC---C
Q 001867          761 LWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG---D  837 (1002)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~---~  837 (1002)
                      +.+++.+.+..++||||+ ++++.+.+.. ..+.+++..+..++.|++.||+|||++   +||||||||+||+++.   +
T Consensus        68 ~~~~~~~~~~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~  142 (299)
T d1ckia_          68 IRWCGAEGDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKG  142 (299)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGT
T ss_pred             EEEEEecCCEEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCC
Confidence            566667888999999999 6777776654 446799999999999999999999999   9999999999999864   4


Q ss_pred             CCeEEccccCcccccCCCCC-----cccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 001867          838 FGARVADFGVAKVVDASGKP-----KSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDL  912 (1002)
Q Consensus       838 ~~~kl~DfGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~  912 (1002)
                      ..+|++|||+|+........     .......||+.|||||++.+..++.++|||||||++|||++|+.||.........
T Consensus       143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~  222 (299)
T d1ckia_         143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR  222 (299)
T ss_dssp             TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence            57999999999987654322     2234567999999999999999999999999999999999999999765433322


Q ss_pred             HHHHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhhccccCCCCCCCCCcchh
Q 001867          913 VKWVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVKLLQEVGAENRSKTGKKDGKLSPYYH  992 (1002)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~  992 (1002)
                      ...........  ...........++    ++.+++..||+.+|++||+++++.+.|+++......      ..+.||.|
T Consensus       223 ~~~~~~~~~~~--~~~~~~~~~~~p~----~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~------~~~~~~Dw  290 (299)
T d1ckia_         223 QKYERISEKKM--STPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF------SYDYVFDW  290 (299)
T ss_dssp             --HHHHHHHHH--HSCHHHHTTTSCH----HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC------CCSCCCHH
T ss_pred             HHHHHhhcccC--CCChhHhccCCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC------CCCCCcCc
Confidence            22211111000  0000001122233    377889999999999999999999999987543221      23567777


Q ss_pred             hccc
Q 001867          993 EDAS  996 (1002)
Q Consensus       993 ~~~~  996 (1002)
                      +--.
T Consensus       291 ~~~~  294 (299)
T d1ckia_         291 NMLK  294 (299)
T ss_dssp             HHGG
T ss_pred             hhhc
Confidence            6443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-41  Score=367.73  Aligned_cols=264  Identities=20%  Similarity=0.258  Sum_probs=195.4

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVK  760 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  760 (1002)
                      .++|++.++||+|+||+||+|+. ++|+.||||++.....               .....+++.+|+.++++++||||++
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------------~~~~~~~~~~E~~il~~l~h~nii~   73 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---------------KEGFPITALREIKILQLLKHENVVN   73 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C---------------TTSSCHHHHHHHHHHHHCCCTTBCC
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---------------chHHHHHHHHHHHHHHHhcCCCccc
Confidence            46788899999999999999997 5799999999854311               2234566889999999999999999


Q ss_pred             eeeEEec--------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          761 LWCCCTT--------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       761 l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      +++++..        ++..|+||||++++.+..+..  ....+++..++.+++|++.||.|||++   +|+||||||+||
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NI  148 (318)
T d3blha1          74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANV  148 (318)
T ss_dssp             EEEEEEC----------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             eEeeeecccccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchhe
Confidence            9999865        346799999998776655444  456799999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCc--ccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPK--SMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGE  909 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~  909 (1002)
                      +++.++.+|++|||+++.........  .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||......
T Consensus       149 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~  228 (318)
T d3blha1         149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ  228 (318)
T ss_dssp             EECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             eecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH
Confidence            99999999999999998765433221  12335799999999998755 6899999999999999999999999765332


Q ss_pred             hhHHHHHHHHhhccC---cccc--------cc--ccccCCCHHH------HHHHHHHHHHcCCCCCCCCCCHHHHH
Q 001867          910 KDLVKWVCSTLDQKG---VDHV--------LD--PKLDCCFKEE------ICKVLNIGLLCTSPLPINRPAMRRVV  966 (1002)
Q Consensus       910 ~~~~~~~~~~~~~~~---~~~~--------~~--~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~evl  966 (1002)
                      ..... +........   ....        +.  ........+.      ...+.+++.+|++.||++|||++|++
T Consensus       229 ~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL  303 (318)
T d3blha1         229 HQLAL-ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL  303 (318)
T ss_dssp             HHHHH-HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHHH-HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence            22222 211111000   0000        00  0000111111      12456899999999999999999988

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=360.75  Aligned_cols=263  Identities=21%  Similarity=0.272  Sum_probs=206.2

Q ss_pred             cCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeee
Q 001867          683 DGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKL  761 (1002)
Q Consensus       683 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  761 (1002)
                      ++|++.++||+|+||+||+|++ .+++.||||+++...               ......+++.+|+.++++++||||+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~---------------~~~~~~~~~~~E~~il~~l~h~niv~~   66 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---------------DDEGVPSSALREICLLKELKHKNIVRL   66 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC---------------SSTTHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh---------------CChHHHHHHHHHHHHHHhcCcCCEEee
Confidence            5788899999999999999996 568899999985431               133456789999999999999999999


Q ss_pred             eeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeE
Q 001867          762 WCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGAR  841 (1002)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  841 (1002)
                      ++++.+....++|+|++.++++..++.  ..+.+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~iv~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~k  141 (292)
T d1unla_          67 HDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             EEEEECSSEEEEEEECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             ccccccccceeEEeeeccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCcee
Confidence            999999999999999999988888776  456789999999999999999999999   999999999999999999999


Q ss_pred             EccccCcccccCCCCCcccccccccccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 001867          842 VADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLR-VNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKWVCSTL  920 (1002)
Q Consensus       842 l~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~~~~~~  920 (1002)
                      |+|||.++........  .....+++.|+|||++.+.. ++.++||||+||++|||++|+.||....+..+....+....
T Consensus       142 l~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  219 (292)
T d1unla_         142 LANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_dssp             ECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence            9999999887654332  22345788999999887655 68999999999999999999999866555444433333221


Q ss_pred             hccCcc------cc--------c--cccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          921 DQKGVD------HV--------L--DPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       921 ~~~~~~------~~--------~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      ......      ..        .  ..............+.+++.+|++.||.+|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110000      00        0  00001111112234778899999999999999998753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=375.21  Aligned_cols=263  Identities=24%  Similarity=0.275  Sum_probs=195.4

Q ss_pred             CCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCceeeee
Q 001867          684 GLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLW  762 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  762 (1002)
                      +|+..++||+|+||+||+|++. +|+.||||++.+..                     ....+|++++++++||||++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---------------------~~~~~Ei~il~~l~h~niv~~~   79 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---------------------RFKNRELQIMRKLDHCNIVRLR   79 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------------------SSCCHHHHHHHHCCCTTBCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---------------------hHHHHHHHHHHhcCCCCCCcEE
Confidence            4777889999999999999974 68999999985421                     1234699999999999999999


Q ss_pred             eEEecC------CeeeEEEeccCCCChhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEEC
Q 001867          763 CCCTTR------DCKLLVYEYMPNGSLGDLLHS-CKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLD  835 (1002)
Q Consensus       763 ~~~~~~------~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~  835 (1002)
                      ++|...      ...|+||||++++.+..+... .....+++..++.++.||+.||+|||++   +|+||||||+|||++
T Consensus        80 ~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~  156 (350)
T d1q5ka_          80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLD  156 (350)
T ss_dssp             EEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEEC
T ss_pred             EEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEe
Confidence            999543      357899999976543333321 2456799999999999999999999999   999999999999999


Q ss_pred             CCC-CeEEccccCcccccCCCCCcccccccccccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 001867          836 GDF-GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYT-LRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLV  913 (1002)
Q Consensus       836 ~~~-~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~  913 (1002)
                      .++ .+||+|||+++........   ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.+.
T Consensus       157 ~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~  233 (350)
T d1q5ka_         157 PDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV  233 (350)
T ss_dssp             TTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred             cCCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH
Confidence            775 8999999999877554322   23479999999998764 578999999999999999999999997654433333


Q ss_pred             HHHHHHh--------------hccCccccccccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHhh
Q 001867          914 KWVCSTL--------------DQKGVDHVLDPKL-DCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEVG  973 (1002)
Q Consensus       914 ~~~~~~~--------------~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~~  973 (1002)
                      .......              ............. .........++.+++.+|++.||++|||++|+++  +++++.
T Consensus       234 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            3322110              0000000000000 0001111224778999999999999999999996  466654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=370.75  Aligned_cols=257  Identities=23%  Similarity=0.269  Sum_probs=204.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEEc----CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCC-C
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVLS----NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRH-K  756 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~  756 (1002)
                      .++|++.+.||+|+||+||+|+..    +|+.||||++.+...             ..+....+.+.+|++++++++| |
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~-------------~~~~~~~~~~~~E~~il~~l~h~p   89 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI-------------VQKAKTTEHTRTERQVLEHIRQSP   89 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEE-------------EEEESSGGGCCCHHHHHHHHHTCT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHh-------------ccchHHHHHHHHHHHHHHhccCCC
Confidence            467888999999999999999852    478999999854321             1122335668899999999976 8


Q ss_pred             ceeeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECC
Q 001867          757 NIVKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDG  836 (1002)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~  836 (1002)
                      ||+++++++.+....+++|||+++|+|.+++...  +.+++..+..++.|++.||+|+|++   +||||||||+||+++.
T Consensus        90 nIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~  164 (322)
T d1vzoa_          90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS  164 (322)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             eEEEeeeeeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecC
Confidence            9999999999999999999999999999999854  4578999999999999999999999   9999999999999999


Q ss_pred             CCCeEEccccCcccccCCCCCcccccccccccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 001867          837 DFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL--RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVK  914 (1002)
Q Consensus       837 ~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~  914 (1002)
                      ++.+||+|||+++........ ......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||...........
T Consensus       165 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~  243 (322)
T d1vzoa_         165 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE  243 (322)
T ss_dssp             TSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred             CCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999876543322 23356799999999998754  467899999999999999999999987655544444


Q ss_pred             HHHHHhhccCccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 001867          915 WVCSTLDQKGVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRP-----AMRRVVK  967 (1002)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~evl~  967 (1002)
                      ..........      +......    .++.+++.+||++||++||     |++|+++
T Consensus       244 i~~~~~~~~~------~~~~~~s----~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         244 ISRRILKSEP------PYPQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHHCCC------CCCTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHhcccCCC------CCcccCC----HHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            3333322111      0111222    2477899999999999999     4788874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-40  Score=364.20  Aligned_cols=255  Identities=21%  Similarity=0.257  Sum_probs=196.2

Q ss_pred             hcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          682 LDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       682 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      .++|++.++||+|+||+||+|+. .+|+.||||++..                    ...+++.+|++++++++ ||||+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--------------------~~~~~~~~Ei~il~~l~~hpnIv   93 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------------------VKKKKIKREIKILENLRGGPNII   93 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--------------------SCHHHHHHHHHHHHHHTTSTTBC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--------------------HHHHHHHHHHHHHHhccCCCCCc
Confidence            36789999999999999999997 5689999999832                    12456889999999995 99999


Q ss_pred             eeeeEEec--CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCC
Q 001867          760 KLWCCCTT--RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGD  837 (1002)
Q Consensus       760 ~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~  837 (1002)
                      ++++++..  ....++||||+++++|.++.     +.+++..++.++.||+.||+|||++   +|+||||||+|||++.+
T Consensus        94 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~  165 (328)
T d3bqca1          94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHE  165 (328)
T ss_dssp             CEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred             EEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCC
Confidence            99999974  45689999999999997765     3599999999999999999999999   99999999999999866


Q ss_pred             C-CeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 001867          838 F-GARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKDLVKW  915 (1002)
Q Consensus       838 ~-~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~~~~~  915 (1002)
                      + .+||+|||+|+.......   .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||....+..+....
T Consensus       166 ~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~  242 (328)
T d3bqca1         166 HRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  242 (328)
T ss_dssp             TTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             CCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence            5 589999999987765432   3355789999999997765 4799999999999999999999999866544332221


Q ss_pred             HHHHh---------h---ccC---cccccc--------cccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 001867          916 VCSTL---------D---QKG---VDHVLD--------PKLD-CCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       916 ~~~~~---------~---~~~---~~~~~~--------~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +....         .   ...   ......        .... ........++.+++.+|++.||++|||++|+++
T Consensus       243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11110         0   000   000000        0000 000111124778999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=369.93  Aligned_cols=263  Identities=24%  Similarity=0.274  Sum_probs=192.3

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEEc-CCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVLS-NGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      |.+.++|++.++||+|+||+||+|.+. +|+.||||++.+.               ........++.+|+.++++++|||
T Consensus        13 f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~---------------~~~~~~~~~~~~Ei~il~~l~hpn   77 (355)
T d2b1pa1          13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------------FQNQTHAKRAYRELVLMKCVNHKN   77 (355)
T ss_dssp             EEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST---------------TSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             eeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh---------------hcCHHHHHHHHHHHHHHHhcCCCC
Confidence            445678999999999999999999975 6999999998542               123445667899999999999999


Q ss_pred             eeeeeeEEec------CCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCc
Q 001867          758 IVKLWCCCTT------RDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNN  831 (1002)
Q Consensus       758 iv~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~N  831 (1002)
                      ||+++++|..      ....|+||||+.++ +.+.+.    ..+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus        78 Iv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~N  149 (355)
T d2b1pa1          78 IISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSN  149 (355)
T ss_dssp             BCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             eeEEEEEEecccccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccc
Confidence            9999999964      36789999999654 444443    3589999999999999999999999   99999999999


Q ss_pred             EEECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          832 ILLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       832 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      |+++.++.+|++|||+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||........
T Consensus       150 il~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~  226 (355)
T d2b1pa1         150 IVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ  226 (355)
T ss_dssp             EEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH
Confidence            999999999999999998765543   23455799999999999999999999999999999999999999975532222


Q ss_pred             HHHHHHHHh------------------hccC------cccccc----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 001867          912 LVKWVCSTL------------------DQKG------VDHVLD----PKLDCCFKEEICKVLNIGLLCTSPLPINRPAMR  963 (1002)
Q Consensus       912 ~~~~~~~~~------------------~~~~------~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  963 (1002)
                      .........                  ....      ....+.    +............+.+++.+|++.||++|||++
T Consensus       227 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~  306 (355)
T d2b1pa1         227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  306 (355)
T ss_dssp             HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence            211111110                  0000      000000    000111122344678999999999999999999


Q ss_pred             HHHH
Q 001867          964 RVVK  967 (1002)
Q Consensus       964 evl~  967 (1002)
                      |+++
T Consensus       307 elL~  310 (355)
T d2b1pa1         307 DALQ  310 (355)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9973

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=372.14  Aligned_cols=268  Identities=22%  Similarity=0.275  Sum_probs=199.9

Q ss_pred             HHHhcCCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCc
Q 001867          679 YEILDGLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKN  757 (1002)
Q Consensus       679 ~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  757 (1002)
                      |++.++|++.++||+|+||+||+|+. .+|+.||||++.+.               ..+....+++.+|++++++++|||
T Consensus        14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------------~~~~~~~~~~~~Ei~il~~l~h~~   78 (348)
T d2gfsa1          14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------------FQSIIHAKRTYRELRLLKHMKHEN   78 (348)
T ss_dssp             EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---------------TSSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch---------------hcChHHHHHHHHHHHHHHhcCCCC
Confidence            45567899999999999999999996 57999999998432               223445667899999999999999


Q ss_pred             eeeeeeEEecC-----CeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcE
Q 001867          758 IVKLWCCCTTR-----DCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNI  832 (1002)
Q Consensus       758 iv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NI  832 (1002)
                      ||++++++...     ...+++|+|+.+|+|.+++..   +.+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus        79 iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NI  152 (348)
T d2gfsa1          79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNL  152 (348)
T ss_dssp             BCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             eeeEEEEEeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccc
Confidence            99999999643     345677788889999999963   4699999999999999999999999   999999999999


Q ss_pred             EECCCCCeEEccccCcccccCCCCCcccccccccccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 001867          833 LLDGDFGARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTL-RVNEKSDIYSFGVVILELVTGRLPVDPEFGEKD  911 (1002)
Q Consensus       833 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~ell~g~~p~~~~~~~~~  911 (1002)
                      +++.++.+|++|||.+......     .....||+.|+|||+..+. .++.++||||+||++|+|++|+.||........
T Consensus       153 Li~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~  227 (348)
T d2gfsa1         153 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  227 (348)
T ss_dssp             EECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999765432     3345789999999986665 468899999999999999999999976533222


Q ss_pred             HHHHHHHHhhcc-----------------CccccccccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHHHh
Q 001867          912 LVKWVCSTLDQK-----------------GVDHVLDPKLDCCFKEEICKVLNIGLLCTSPLPINRPAMRRVVK--LLQEV  972 (1002)
Q Consensus       912 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~evl~--~L~~~  972 (1002)
                      ............                 ....................+.+++.+|++.||++|||++|+++  ++++.
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         228 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            222221111000                 00000000000000011124678999999999999999999997  45544

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.4e-40  Score=362.46  Aligned_cols=292  Identities=30%  Similarity=0.474  Sum_probs=225.6

Q ss_pred             CCchHHHHHHHHHHHhccCCccccCCCCCCCCCCCCC--ccceeEEeCCC--CeEEEEEcCCCCcCC--CCCccccCCCC
Q 001867           21 LSLNQEGLYLERVKLSLSDPDSALSSWGRNPRDDSPC--SWRGVECDPRS--HSVASIDLSNANIAG--PFPSLLCRLEN   94 (1002)
Q Consensus        21 ~~~~~~~~~l~~~k~~~~d~~~~l~sw~~~~~~~~~C--~w~gv~C~~~~--~~v~~l~L~~~~l~~--~~~~~~~~l~~   94 (1002)
                      .+.++|++||++||+++.||. .+++|..   +.|||  .|.||+|+..+  .||+.|||++++++|  .+|+.+++|++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~---~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~   77 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY   77 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCT---TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCCC---CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence            356899999999999999984 7999953   46899  59999998754  489999999999998  47889999999


Q ss_pred             CCEEeccC-CCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeec
Q 001867           95 LTFLTLFN-NSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV  173 (1002)
Q Consensus        95 L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  173 (1002)
                      |++|+|++ |++.|.+|.+|++|++|++|+|++|++++..+..+..+.+|+++++++|++.+.+|..|+++++|++++++
T Consensus        78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~  157 (313)
T d1ogqa_          78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD  157 (313)
T ss_dssp             CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence            99999986 88988899999999999999999999998888888999999999999999988889999999999999999


Q ss_pred             cccccCcccccccccccc-ccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCccccc
Q 001867          174 YNLLDGTIPAFLGNISTL-KMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVG  252 (1002)
Q Consensus       174 ~N~l~~~~p~~l~~l~~L-~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  252 (1002)
                      +|.+++.+|..+..+.++ +.+++++|++ .+..|..+.++..+ .++++++...+.+|..+..+++|+.+++++|.+.+
T Consensus       158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l-~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~  235 (313)
T d1ogqa_         158 GNRISGAIPDSYGSFSKLFTSMTISRNRL-TGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF  235 (313)
T ss_dssp             SSCCEEECCGGGGCCCTTCCEEECCSSEE-EEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccc-ccccccccccccccccccccccccccccccccccc
Confidence            999888888888877765 6777777775 34556666655444 46667777777777777777777777777777765


Q ss_pred             ccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCC-CcceeecCCCc
Q 001867          253 AIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRL-PLESLNLYENR  320 (1002)
Q Consensus       253 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~  320 (1002)
                      .++ .+..+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|.. ..+ .|+.+++++|+
T Consensus       236 ~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~-~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         236 DLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             BGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             ccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCc-ccCCCCCHHHhCCCc
Confidence            543 4566666777777777776666666666666777766666666655532 222 24444444443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-35  Score=329.42  Aligned_cols=258  Identities=21%  Similarity=0.222  Sum_probs=189.3

Q ss_pred             CCCcCCeeeecCCccEEEEEE-cCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--------
Q 001867          684 GLDEDNVIGSGSSGKVYKVVL-SNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--------  754 (1002)
Q Consensus       684 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------  754 (1002)
                      +|++.++||+|+||+||+|+. .+|+.||||++.+                  +....+.+.+|+.++++++        
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------------------~~~~~~~~~~Ei~~l~~l~~~~~~~~~   75 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------------------DKVYTEAAEDEIKLLQRVNDADNTKED   75 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------------------CHHHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec------------------cccchHHHHHHHHHHHHhcchhhhhhh
Confidence            488899999999999999996 5799999999843                  2233456788898888774        


Q ss_pred             ---CCceeeeeeEEec--CCeeeEEEeccCCCC-hhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeeCCC
Q 001867          755 ---HKNIVKLWCCCTT--RDCKLLVYEYMPNGS-LGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHH-DCVPSIVHRDV  827 (1002)
Q Consensus       755 ---h~niv~l~~~~~~--~~~~~lv~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDl  827 (1002)
                         |+||+++++++..  ....+++|+++..+. ............+++..+..++.|++.||+|||+ .   +|+||||
T Consensus        76 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDl  152 (362)
T d1q8ya_          76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDI  152 (362)
T ss_dssp             HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCC
T ss_pred             hcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccC
Confidence               5789999998864  345666776665543 4444444456789999999999999999999998 6   9999999


Q ss_pred             CCCcEEECCCCC------eEEccccCcccccCCCCCcccccccccccccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 001867          828 KSNNILLDGDFG------ARVADFGVAKVVDASGKPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILELVTGRL  901 (1002)
Q Consensus       828 k~~NIll~~~~~------~kl~DfGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell~g~~  901 (1002)
                      ||+|||++.++.      ++++|||.+.......     ....||+.|+|||++.+..++.++||||+||+++||++|+.
T Consensus       153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~  227 (362)
T d1q8ya_         153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF  227 (362)
T ss_dssp             SGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence            999999986653      8999999998654332     34579999999999999999999999999999999999999


Q ss_pred             CCCCCCCch------hHHHHHHHHhh-----------------ccCccccccc-----------cccCCCHHHHHHHHHH
Q 001867          902 PVDPEFGEK------DLVKWVCSTLD-----------------QKGVDHVLDP-----------KLDCCFKEEICKVLNI  947 (1002)
Q Consensus       902 p~~~~~~~~------~~~~~~~~~~~-----------------~~~~~~~~~~-----------~~~~~~~~~~~~l~~l  947 (1002)
                      ||.......      .....+.....                 .......+..           ...........++.++
T Consensus       228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  307 (362)
T d1q8ya_         228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF  307 (362)
T ss_dssp             CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence            997543211      11111110000                 0000000000           0112234556678999


Q ss_pred             HHHcCCCCCCCCCCHHHHHH
Q 001867          948 GLLCTSPLPINRPAMRRVVK  967 (1002)
Q Consensus       948 ~~~cl~~dP~~Rps~~evl~  967 (1002)
                      +.+|++.||++|||++|+++
T Consensus       308 l~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         308 LSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHCCCChhHCcCHHHHhc
Confidence            99999999999999999975

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.2e-33  Score=309.90  Aligned_cols=257  Identities=30%  Similarity=0.444  Sum_probs=167.5

Q ss_pred             CCceEEccCccccC--CCChhhhccCcccceeeec-cccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEE
Q 001867          358 PLRWVDLSNNQFTG--EIPASLCEKGELEELLMIY-NSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLL  434 (1002)
Q Consensus       358 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  434 (1002)
                      +++.|+|++|.+++  .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..++.|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            35555555555554  3455566666666666654 55555566666666666666666666666556556666666666


Q ss_pred             EcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccc-ccccccccccCCCCcccccccccCCeeecCCCcC
Q 001867          435 ELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSL-VVLSGSENKFTGSLPESLTNLAELGSLDLHANDL  513 (1002)
Q Consensus       435 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  513 (1002)
                      ++++|.+.+.+|..+..++.|+.+++++|.+.+.+|..++.+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            666666666666666666666666666666666666666665554 566666666666666666655433 566666666


Q ss_pred             CcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEeccccCcCCCChh-
Q 001867          514 SGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSNNRLSGELPSL-  591 (1002)
Q Consensus       514 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~N~l~g~~p~~-  591 (1002)
                      .+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+|+|.+|..++.+ +|++|||++|+|+|.+|+. 
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            66666666666667777777776665543 46666667777777777776677666666 5777777777777766654 


Q ss_pred             hhhhcccccccCCCCCCCCCCCCCC
Q 001867          592 FAKEMYRNSFLGNPGLCGDLEGLCD  616 (1002)
Q Consensus       592 ~~~~~~~~~~~~n~~~cg~~~~~c~  616 (1002)
                      ....+...++.||+.+||.|++.|+
T Consensus       289 ~L~~L~~l~l~~N~~l~g~plp~c~  313 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred             cCCCCCHHHhCCCccccCCCCCCCC
Confidence            4456667788899999999999995

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=9.4e-29  Score=279.11  Aligned_cols=354  Identities=26%  Similarity=0.316  Sum_probs=187.7

Q ss_pred             eeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCccc
Q 001867          171 SLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNL  250 (1002)
Q Consensus       171 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  250 (1002)
                      .++.+.+++.+.  ...+.+|++|++++|.+.  .+ ..+..+++|++|+|++|+|++..  .++++++|++|++++|++
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~--~l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SI-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCC--CC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCC--Cc-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccc
Confidence            344444444333  245667778888877762  23 35667777777777777777433  267777777777777777


Q ss_pred             ccccCcccccccceeeeeccCCcccCCCCCccccccccceeeccccccCCCCCccCCCCC-cceeecCCCcccCcCCccc
Q 001867          251 VGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATI  329 (1002)
Q Consensus       251 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~  329 (1002)
                      .+..  .+.++++|+.|++++|.+++..+  ......+..+....|.+....+....... .........     .... 
T Consensus       101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~-  170 (384)
T d2omza2         101 ADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKP-  170 (384)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGG-
T ss_pred             cccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhh-
Confidence            6543  25666666666666666654332  23344555555555555432222111110 111111111     1111 


Q ss_pred             CCCcccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcE
Q 001867          330 ADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTR  409 (1002)
Q Consensus       330 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~  409 (1002)
                                             +.............|...  ....+..+++++.+++++|.+++..|  +..+++|++
T Consensus       171 -----------------------~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~  223 (384)
T d2omza2         171 -----------------------LANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDE  223 (384)
T ss_dssp             -----------------------GTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred             -----------------------hccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCE
Confidence                                   222222333333333322  22333344444444444444443322  234455555


Q ss_pred             EEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccccccccccc
Q 001867          410 VRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKF  489 (1002)
Q Consensus       410 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  489 (1002)
                      |++++|+++.  +..+..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..  .+..++.++.+.++.|++
T Consensus       224 L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l  297 (384)
T d2omza2         224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQL  297 (384)
T ss_dssp             EECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred             EECCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccc
Confidence            5555555553  1234555555555665555554432  555566666666666665322  245556666666666666


Q ss_pred             CCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCcc
Q 001867          490 TGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGL  569 (1002)
Q Consensus       490 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~  569 (1002)
                      ++  +..+..+++++.|++++|++++..|  +..+++|+.|+|++|+++ .+| .++++++|++|+|++|++++.+|  +
T Consensus       298 ~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l  369 (384)
T d2omza2         298 ED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--L  369 (384)
T ss_dssp             SC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred             cc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--h
Confidence            53  2235566666666666666665432  566666666666666665 333 46666666666666666665443  4


Q ss_pred             ccc-ccceEEeccc
Q 001867          570 QNL-KLNQLNVSNN  582 (1002)
Q Consensus       570 ~~l-~L~~l~ls~N  582 (1002)
                      +.+ +|+.|+|++|
T Consensus       370 ~~l~~L~~L~L~~N  383 (384)
T d2omza2         370 ANLTRITQLGLNDQ  383 (384)
T ss_dssp             TTCTTCSEEECCCE
T ss_pred             ccCCCCCEeeCCCC
Confidence            555 5666666666

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=6.8e-29  Score=280.25  Aligned_cols=148  Identities=26%  Similarity=0.347  Sum_probs=99.6

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..  .+..+..++.++++.|.+++  +..+..+++++
T Consensus       237 l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~  310 (384)
T d2omza2         237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLT  310 (384)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCS
T ss_pred             hhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccC
Confidence            4445555555555555554332  445555666666666655433  25556667777777777764  23466677777


Q ss_pred             cccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCccee
Q 001867          481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNR  560 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~  560 (1002)
                      .|++++|++++. + .+..+++|++|+|++|+|++ +| .++.+++|++|+|++|++++.+|  ++++++|+.|+|++|.
T Consensus       311 ~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         311 YLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             EEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             eEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            888888888754 2 37778888888888888874 33 57888888888888888885544  7888888888888884

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=6.6e-26  Score=246.80  Aligned_cols=278  Identities=23%  Similarity=0.313  Sum_probs=200.8

Q ss_pred             CCCCCccceeEEeCCCCeEEEEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCC
Q 001867           53 DDSPCSWRGVECDPRSHSVASIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGT  132 (1002)
Q Consensus        53 ~~~~C~w~gv~C~~~~~~v~~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  132 (1002)
                      ..+-|.|++|.|+.            ++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+...
T Consensus         6 ~~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i   70 (305)
T d1xkua_           6 FRCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI   70 (305)
T ss_dssp             TTCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred             CCCEecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccccc
Confidence            34447788888863            4455 4455553  5899999999999987777899999999999999999988


Q ss_pred             CCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCC-CCCCCcccC
Q 001867          133 LTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFL-PGRIPPELG  211 (1002)
Q Consensus       133 ~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~-~~~~p~~~~  211 (1002)
                      .|..|.++++|++|++++|+++ .+|..+  ...|+.|++.+|.+.+..+..+.....+..++...|... ....+..+.
T Consensus        71 ~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~  147 (305)
T d1xkua_          71 SPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ  147 (305)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGG
T ss_pred             chhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccc
Confidence            8889999999999999999999 456544  347889999999999887778888888888888887642 123345677


Q ss_pred             CCCccchhhccCcccccccccccccccccchhcccCcccccccCcccccccceeeeeccCCcccCCCCCcccccccccee
Q 001867          212 NLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLL  291 (1002)
Q Consensus       212 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  291 (1002)
                      .+++|+.+++++|+++ .+|..+  +++|+.|++++|..++..+..|.+++.++.|++++|.+.+..+..+.++++|++|
T Consensus       148 ~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L  224 (305)
T d1xkua_         148 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL  224 (305)
T ss_dssp             GCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE
T ss_pred             cccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceee
Confidence            7778888888888877 344433  4677777788877777777777777777777777777777777777777777777


Q ss_pred             eccccccCCCCCccCCCCC-cceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccCcccc
Q 001867          292 DASMNDLTGPIPDDLTRLP-LESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFT  370 (1002)
Q Consensus       292 ~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  370 (1002)
                      +|++|+|+ .+|..+..++ |++|+|++|+|+......|..                  +..+..+.+|+.|+|++|+++
T Consensus       225 ~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~------------------~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         225 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP------------------PGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC------------------SSCCTTSCCCSEEECCSSSSC
T ss_pred             eccccccc-ccccccccccCCCEEECCCCccCccChhhccC------------------cchhcccCCCCEEECCCCcCc
Confidence            77777776 3444444432 555555555554332222211                  122345667888888888875

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=3.6e-25  Score=240.87  Aligned_cols=272  Identities=24%  Similarity=0.325  Sum_probs=190.5

Q ss_pred             ccceeeccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEccC
Q 001867          287 SLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSN  366 (1002)
Q Consensus       287 ~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  366 (1002)
                      .++.+|-++++++ .+|..+. ..+++|+|++|+|+...+..|.++++|++|++++|.+....|..|..++.|++|++++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~-~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             cCCEEEecCCCCC-ccCCCCC-CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            5666777777777 4555543 2477777777777755555666666666666666666666666666666666666666


Q ss_pred             ccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCccc--Cc
Q 001867          367 NQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLS--GE  444 (1002)
Q Consensus       367 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~--~~  444 (1002)
                      |+++. +|..+                          ...+..|++++|.+.+..+..+.....+..++...|...  ..
T Consensus        89 n~l~~-l~~~~--------------------------~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~  141 (305)
T d1xkua_          89 NQLKE-LPEKM--------------------------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI  141 (305)
T ss_dssp             SCCSB-CCSSC--------------------------CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB
T ss_pred             CccCc-Cccch--------------------------hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCC
Confidence            66662 33221                          234555555555555444444445555555665555432  23


Q ss_pred             cccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccc
Q 001867          445 ISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSW  524 (1002)
Q Consensus       445 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  524 (1002)
                      .+..+..+++|+.+++++|+++ .+|..+  +++|+.|++++|.+++..+..|..++.++.|++++|.+++..|..+.++
T Consensus       142 ~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l  218 (305)
T d1xkua_         142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT  218 (305)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred             CccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc
Confidence            4455677788888888888887 455443  6788888999998888888888888999999999999998888889999


Q ss_pred             cccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccc------cc-ccceEEeccccCc-CCCChh
Q 001867          525 KKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ------NL-KLNQLNVSNNRLS-GELPSL  591 (1002)
Q Consensus       525 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~------~l-~L~~l~ls~N~l~-g~~p~~  591 (1002)
                      ++|++|+|++|.|+ .+|++|.++++|++|+|++|+|+......+.      .+ +|+.|+|++|+++ +.++..
T Consensus       219 ~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~  292 (305)
T d1xkua_         219 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS  292 (305)
T ss_dssp             TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGG
T ss_pred             ccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHh
Confidence            99999999999998 6788899999999999999999853333332      23 6888999999885 455544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.2e-25  Score=241.96  Aligned_cols=248  Identities=22%  Similarity=0.216  Sum_probs=124.6

Q ss_pred             chhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeee-ccccccCCCCcCcCCCCCcEEEccC
Q 001867          336 YELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMI-YNSFTGQLPDGLGHCQSLTRVRLGY  414 (1002)
Q Consensus       336 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~-~N~l~~~~p~~l~~l~~L~~L~L~~  414 (1002)
                      ++|+|++|+|+++.+.+|.++++|++|++++|++.+..+..+.....++.+... .|.++...+..|.++++|++|++++
T Consensus        35 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~  114 (284)
T d1ozna_          35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR  114 (284)
T ss_dssp             SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCC
Confidence            334444444443333444444445555555555544444444444444444332 3333444445555555555555555


Q ss_pred             ccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCc
Q 001867          415 NRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLP  494 (1002)
Q Consensus       415 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  494 (1002)
                      |.+.+..+..+...++|+.+++++|.|+++.+..|..+++|+.|++++|++++..+..|..+++|+.+++++|++++..|
T Consensus       115 n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~  194 (284)
T d1ozna_         115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP  194 (284)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccCh
Confidence            55554444455555555555555555555545555555555555555555554445555555555555555555555555


Q ss_pred             ccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccccc
Q 001867          495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNLKL  574 (1002)
Q Consensus       495 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~L  574 (1002)
                      ..|..+++|++||+++|++++..|..|+.+++|++|+|++|.+...-+. ..-...++.+....+++....|..+....+
T Consensus       195 ~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g~~l  273 (284)
T d1ozna_         195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDL  273 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTTCBG
T ss_pred             hHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcCCcc
Confidence            5555555555555555555555555555555555555555555543211 011123444555555555555555443322


Q ss_pred             ceEEeccccCcC
Q 001867          575 NQLNVSNNRLSG  586 (1002)
Q Consensus       575 ~~l~ls~N~l~g  586 (1002)
                        .+++.+.|+|
T Consensus       274 --~~l~~~~l~g  283 (284)
T d1ozna_         274 --KRLAANDLQG  283 (284)
T ss_dssp             --GGSCGGGSCC
T ss_pred             --ccCCHHHCCC
Confidence              2344444444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.8e-25  Score=237.05  Aligned_cols=266  Identities=21%  Similarity=0.212  Sum_probs=195.4

Q ss_pred             eccccccCCCCCccCCCCCcceeecCCCcccCcCCcccCCCcccchhcccccccCCCCCCCCCCCCCCceEEcc-Ccccc
Q 001867          292 DASMNDLTGPIPDDLTRLPLESLNLYENRLEGSLPATIADSPGLYELRLFRNRLNGTLPGDLGKNSPLRWVDLS-NNQFT  370 (1002)
Q Consensus       292 ~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~  370 (1002)
                      +.++++++ .+|..+. ..+++|+|++|+|++..+..|.++++|++|++++|++..+.+..+.....+..++.+ .|.++
T Consensus        17 ~c~~~~L~-~iP~~ip-~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~   94 (284)
T d1ozna_          17 SCPQQGLQ-AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR   94 (284)
T ss_dssp             ECCSSCCS-SCCTTCC-TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred             EcCCCCCC-ccCCCCC-CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence            44444454 3444332 135667777777766666667777777777777777777777777777777777654 55666


Q ss_pred             CCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccc
Q 001867          371 GEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIA  450 (1002)
Q Consensus       371 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~  450 (1002)
                      ...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|++++..+..|..+++|+.|++++|.++.+.+..|.
T Consensus        95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~  174 (284)
T d1ozna_          95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR  174 (284)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc
Confidence            66677777777888888888877777777777888888888888888877777788888888888888888888888888


Q ss_pred             cCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccc
Q 001867          451 GAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNEL  530 (1002)
Q Consensus       451 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  530 (1002)
                      ++++|+.+++++|++++..|..|..+++|+.|++++|++++..|..|+.+++|+.|+|++|++...-+ ...-...++.+
T Consensus       175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~  253 (284)
T d1ozna_         175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKF  253 (284)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHC
T ss_pred             cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhC
Confidence            88888888888888888788888888888888888888888777888888888999999888875322 22223346677


Q ss_pred             cccCcccccCCCCCccccccccEEeCcceeeec
Q 001867          531 NLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       531 ~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~  563 (1002)
                      ....++++...|..+.+   +..++++.+.|+|
T Consensus       254 ~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g  283 (284)
T d1ozna_         254 RGSSSEVPCSLPQRLAG---RDLKRLAANDLQG  283 (284)
T ss_dssp             CSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred             cCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence            77777777777776654   3444566666654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6.2e-23  Score=217.87  Aligned_cols=110  Identities=25%  Similarity=0.249  Sum_probs=52.1

Q ss_pred             cCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccc
Q 001867          451 GAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNEL  530 (1002)
Q Consensus       451 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  530 (1002)
                      .+++|+.|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++..+..|..+++|++|
T Consensus        98 ~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L  177 (266)
T d1p9ag_          98 TLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL  177 (266)
T ss_dssp             TCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred             cccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccccee
Confidence            33334444444444433333334444444444444444443333444444555555555555554444445555555555


Q ss_pred             cccCcccccCCCCCccccccccEEeCcceee
Q 001867          531 NLADNLFYGNIPEDIGNLSVLNYLDLSNNRL  561 (1002)
Q Consensus       531 ~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l  561 (1002)
                      +|++|+|+ .+|+.+..+++|+.|+|++|.+
T Consensus       178 ~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             ECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence            55555554 4555555555555555555544

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6.8e-23  Score=217.58  Aligned_cols=177  Identities=28%  Similarity=0.199  Sum_probs=142.3

Q ss_pred             CCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccc
Q 001867          405 QSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSG  484 (1002)
Q Consensus       405 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  484 (1002)
                      ++|++|+|++|+|++..+..|.++++|+.|+|++|+|+.+.  .++.+++|+.|+|++|+++ ..+..+..+++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccccccccccc-ccccccccccccccccc
Confidence            45677777777777666666777777777777777776432  3467788888888888887 45778888899999999


Q ss_pred             cccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecc
Q 001867          485 SENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGR  564 (1002)
Q Consensus       485 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~  564 (1002)
                      ++|++.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|++++..|..|..+++|++|||++|+|+ .
T Consensus       108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~  186 (266)
T d1p9ag_         108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T  186 (266)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred             cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence            999998777788888899999999999998888888888899999999999998777778888999999999999988 6


Q ss_pred             cCCccccc-ccceEEeccccCc
Q 001867          565 IPVGLQNL-KLNQLNVSNNRLS  585 (1002)
Q Consensus       565 ip~~~~~l-~L~~l~ls~N~l~  585 (1002)
                      +|..+..+ +|+.|+|++|++.
T Consensus       187 lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         187 IPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCTTTTTTCCCSEEECCSCCBC
T ss_pred             cChhHCCCCCCCEEEecCCCCC
Confidence            88777666 7888888777664

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=1.3e-22  Score=203.61  Aligned_cols=181  Identities=16%  Similarity=0.144  Sum_probs=124.1

Q ss_pred             CcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccC-CCccccccccchhhHHhHHHHHHHHhcCCCCceeeeeeE
Q 001867          686 DEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECES-GCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNIVKLWCC  764 (1002)
Q Consensus       686 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  764 (1002)
                      .++++||+|+||+||+|...+|+.||||+++.+....... ...................+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3568999999999999999899999999886432210000 000000001112234556778999999999999988766


Q ss_pred             EecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeeCCCCCCcEEECCCCCeEEcc
Q 001867          765 CTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDCVPSIVHRDVKSNNILLDGDFGARVAD  844 (1002)
Q Consensus       765 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  844 (1002)
                      ..    .+++|||+++..+.+         +++.....++.|++.+++|||++   +|+||||||+|||++++ .++++|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence            42    379999998755433         33445678999999999999999   99999999999999865 589999


Q ss_pred             ccCcccccCCCCCcccccccccccccCcc-----ccccCCCCCccchhhHHHHH
Q 001867          845 FGVAKVVDASGKPKSMSVIAGSCGYIAPE-----YAYTLRVNEKSDIYSFGVVI  893 (1002)
Q Consensus       845 fGl~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwslGvil  893 (1002)
                      ||.|+........          .|....     ......|..++|+||..--+
T Consensus       146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999866433210          111110     01245678899999986443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.81  E-value=7.5e-19  Score=194.40  Aligned_cols=137  Identities=28%  Similarity=0.284  Sum_probs=84.9

Q ss_pred             CCCEEeccCCCCCCCCCCCccccCcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeec
Q 001867           94 NLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLV  173 (1002)
Q Consensus        94 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  173 (1002)
                      ++++|+|++|.++. +|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .+++.   .+.|++|+++
T Consensus        39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred             CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence            67888888888874 6653   467888888888888 556543   56777788888777 33321   1357788888


Q ss_pred             cccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccc
Q 001867          174 YNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV  251 (1002)
Q Consensus       174 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  251 (1002)
                      +|+++. +|. ++++++|++|++++|.+.  ..+...   ..+..+.+..+...  .+..+..++.++.|++++|.+.
T Consensus       107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~--~~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLK--KLPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             SSCCSS-CCC-CTTCTTCCEEECCSSCCS--CCCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             cccccc-ccc-hhhhccceeecccccccc--cccccc---ccccchhhcccccc--ccccccccccceeccccccccc
Confidence            887773 343 466777777777777652  333332   23333444433332  2334555566666666666554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.81  E-value=7e-19  Score=194.64  Aligned_cols=96  Identities=25%  Similarity=0.349  Sum_probs=53.4

Q ss_pred             CcccccccccccccCCCCccccccCCccccccccccccCCCCcccccccccceeeeccccccCccccccccccccccccc
Q 001867          117 QNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGNNFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNL  196 (1002)
Q Consensus       117 ~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  196 (1002)
                      .+|++|||++|.|+ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++. ++..   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence            35777788888777 45543   456777777777777 556543   356666777776652 2211   123555555


Q ss_pred             cCCCCCCCCCCcccCCCCccchhhccCcccc
Q 001867          197 SYNPFLPGRIPPELGNLTNLEILWLTECNLV  227 (1002)
Q Consensus       197 s~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~  227 (1002)
                      ++|.+  ..+|. ++.+++|++|++++|.+.
T Consensus       106 ~~n~l--~~lp~-~~~l~~L~~L~l~~~~~~  133 (353)
T d1jl5a_         106 SNNQL--EKLPE-LQNSSFLKIIDVDNNSLK  133 (353)
T ss_dssp             CSSCC--SSCCC-CTTCTTCCEEECCSSCCS
T ss_pred             ccccc--ccccc-hhhhccceeecccccccc
Confidence            55554  13332 344444444444444443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=7.4e-19  Score=175.96  Aligned_cols=171  Identities=20%  Similarity=0.189  Sum_probs=133.9

Q ss_pred             EEEcCCCCcCCCCCccccCCCCCCEEeccCCCCCCC-CCCCccccCcccccccccccccCCCCccccccCCccccccccc
Q 001867           73 SIDLSNANIAGPFPSLLCRLENLTFLTLFNNSINST-LPDDISACQNLQHLDLSQNLLTGTLTPALADLPNLKFLDLTGN  151 (1002)
Q Consensus        73 ~l~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N  151 (1002)
                      .+|.++++++ .+|..+.  +++++|+|++|+|++. .+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            3566677787 4565543  6899999999999864 4667899999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccccccceeeeccccccCccccccccccccccccccCCCCCCCCCCcccCCCCccchhhccCcccccccc
Q 001867          152 NFSGDIPESFGRFQKLEVISLVYNLLDGTIPAFLGNISTLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVGEIP  231 (1002)
Q Consensus       152 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  231 (1002)
                      +|++..|++|.++++|++|+|++|+|++..|.+|.++++|++|+|++|.+..  ......-...++.+.+..+.++...|
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~--~~~~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC--NCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC--SGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc--ccchHHHhhhhhhhcccCCCeEeCCC
Confidence            9998888899999999999999999999889999999999999999998621  11111111235556666666665555


Q ss_pred             cccccccccchhcccCcccc
Q 001867          232 DSLGRLAKLVDLDLALNNLV  251 (1002)
Q Consensus       232 ~~~~~l~~L~~L~L~~N~l~  251 (1002)
                      ..+   ..++.++|+.|.+.
T Consensus       167 ~~l---~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         167 SKV---RDVQIKDLPHSEFK  183 (192)
T ss_dssp             TTT---TTSBGGGSCTTTCC
T ss_pred             hhh---cCCEeeecCHhhCc
Confidence            433   34556667666665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=1.3e-18  Score=179.42  Aligned_cols=206  Identities=22%  Similarity=0.266  Sum_probs=98.1

Q ss_pred             ccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEcc
Q 001867          334 GLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLG  413 (1002)
Q Consensus       334 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~  413 (1002)
                      ++..++++.+++++..  .+..+.+|+.|++++|.|+. + ..+..+++|++|++++|.+++..|  +..+++|++++++
T Consensus        20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~   93 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS   93 (227)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred             HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccc
Confidence            3444566666666432  34456667777777777763 3 235556666666666666554332  5555566666666


Q ss_pred             CccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCC
Q 001867          414 YNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSL  493 (1002)
Q Consensus       414 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  493 (1002)
                      +|.++. ++ .+..+++|+.++++++...+.  ..+.....+..+.++.+.+...  ..+..+++|+.|++++|++++. 
T Consensus        94 ~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-  166 (227)
T d1h6ua2          94 GNPLKN-VS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-  166 (227)
T ss_dssp             SCCCSC-CG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-
T ss_pred             cccccc-cc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc-
Confidence            555542 22 244455555555555544432  1233344444455544444321  1233444444444444444421 


Q ss_pred             cccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCc
Q 001867          494 PESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLS  557 (1002)
Q Consensus       494 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls  557 (1002)
                       ..++++++|+.|||++|++++. | .++.+++|++|+|++|++++ +| .++++++|++|+|+
T Consensus       167 -~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         167 -TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT  225 (227)
T ss_dssp             -GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred             -hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence             1244444444444444444432 1 13444444444444444442 22 13444444444443

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.2e-18  Score=179.68  Aligned_cols=206  Identities=23%  Similarity=0.287  Sum_probs=141.7

Q ss_pred             CCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcc
Q 001867          358 PLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELT  437 (1002)
Q Consensus       358 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  437 (1002)
                      ++..++++.+++++..  .+..+.+|+.|++.+|.++. + ..+.++++|++|++++|++++..|  +..+++|+.++++
T Consensus        20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~   93 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS   93 (227)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred             HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccc
Confidence            3345566677776543  44566777888888887774 3 347778888888888888775443  6777788888888


Q ss_pred             cCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCccc
Q 001867          438 DNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGEL  517 (1002)
Q Consensus       438 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  517 (1002)
                      +|.++.+  ..+.++++|+.++++++...+.  ..+...+.+..+.++++.+...  ..+...++|+.|++++|.+++..
T Consensus        94 ~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~  167 (227)
T d1h6ua2          94 GNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT  167 (227)
T ss_dssp             SCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG
T ss_pred             ccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch
Confidence            8777643  3466777788888877776633  2355667777777777777633  23566777888888888776433


Q ss_pred             ccccccccccccccccCcccccCCCCCccccccccEEeCcceeeecccCCccccc-ccceEEecc
Q 001867          518 PSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSN  581 (1002)
Q Consensus       518 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~  581 (1002)
                        .++++++|+.|+|++|++++ +| .++++++|++|+|++|++++ +| .++++ +|+.|++++
T Consensus       168 --~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         168 --PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             --GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEEE
T ss_pred             --hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEeeC
Confidence              36777788888888887774 44 37777888888888888775 33 25666 677777763

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=4.8e-18  Score=177.13  Aligned_cols=200  Identities=14%  Similarity=0.116  Sum_probs=123.8

Q ss_pred             ccchhcccccccCCCCCCCCCCCCCCceEEccCccccCCC-ChhhhccCcccceeeec-cccccCCCCcCcCCCCCcEEE
Q 001867          334 GLYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEI-PASLCEKGELEELLMIY-NSFTGQLPDGLGHCQSLTRVR  411 (1002)
Q Consensus       334 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~  411 (1002)
                      ++++|++++|+|+.+.+..|.++++|++|++++|.+...+ +..|..++.++++.+.. |.+....+..|.++++|++++
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            4555555666655445555666666777777777665433 33556666666666553 566666667777777788888


Q ss_pred             ccCccccCCCCC-cCCCCCcceEEEcccCcccCccccccccCC-cccEEEccCCcCCCCCcccccccccc-ccccccccc
Q 001867          412 LGYNRLTGKVPP-LLWGLPHVYLLELTDNFLSGEISKNIAGAA-NLSLLIISKNNLSGSLPEEIGFLKSL-VVLSGSENK  488 (1002)
Q Consensus       412 L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~  488 (1002)
                      +++|+++...+. .+..+..+..+...++.+..+.+..+.+++ .+..|++++|+++. ++.......++ +.+++++|+
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNN  188 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTT
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-cccccccchhhhccccccccc
Confidence            887777644332 234456666666677777666666666553 67777777777773 33333333443 334566667


Q ss_pred             cCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccC
Q 001867          489 FTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLAD  534 (1002)
Q Consensus       489 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  534 (1002)
                      ++...+..|.++++|+.|||++|+|+...+..|.++++|+.|++.+
T Consensus       189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            7643344567777777777777777755555667777777666643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=3.3e-22  Score=230.38  Aligned_cols=184  Identities=23%  Similarity=0.137  Sum_probs=97.5

Q ss_pred             CCCCcEEEccCccccC-----CCCCcCCCCCcceEEEcccCcccCcc----ccccccCCcccEEEccCCcCCCCCcccc-
Q 001867          404 CQSLTRVRLGYNRLTG-----KVPPLLWGLPHVYLLELTDNFLSGEI----SKNIAGAANLSLLIISKNNLSGSLPEEI-  473 (1002)
Q Consensus       404 l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-  473 (1002)
                      ...++.+++++|++..     ..+..+.....++.+++++|.+....    ...+...+.++.+++++|.++......+ 
T Consensus       225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~  304 (460)
T d1z7xw1         225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC  304 (460)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred             cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence            3445555555554321     11222233445555555555554321    1223345566666666666542211111 


Q ss_pred             ----ccccccccccccccccCCCCcc----cccccccCCeeecCCCcCCcc----cccccc-cccccccccccCccccc-
Q 001867          474 ----GFLKSLVVLSGSENKFTGSLPE----SLTNLAELGSLDLHANDLSGE----LPSSVS-SWKKLNELNLADNLFYG-  539 (1002)
Q Consensus       474 ----~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~-  539 (1002)
                          .....|+.+++++|.++.....    .+...++|+.|||++|++++.    ++..+. ..+.|+.|+|++|.|+. 
T Consensus       305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~  384 (460)
T d1z7xw1         305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS  384 (460)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence                1234566667776666543222    223445677777777777643    223332 34567777777777763 


Q ss_pred             ---CCCCCccccccccEEeCcceeeecccCCccc-----cc-ccceEEeccccCcCC
Q 001867          540 ---NIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQ-----NL-KLNQLNVSNNRLSGE  587 (1002)
Q Consensus       540 ---~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~-----~l-~L~~l~ls~N~l~g~  587 (1002)
                         .+++.+...++|++|||++|+++......+.     +. .|+.|++++|.+...
T Consensus       385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         385 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             HHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             HHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence               2444555667777888888877654333321     11 477788887777643

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=3.9e-18  Score=177.88  Aligned_cols=213  Identities=16%  Similarity=0.150  Sum_probs=130.9

Q ss_pred             CCCCcCCCCCccccCCCCCCEEeccCCCCCCCCCCCccccCcccccccccccccCCC-CccccccCCcccccccc-cccc
Q 001867           77 SNANIAGPFPSLLCRLENLTFLTLFNNSINSTLPDDISACQNLQHLDLSQNLLTGTL-TPALADLPNLKFLDLTG-NNFS  154 (1002)
Q Consensus        77 ~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~L~~L~~L~Ls~-N~l~  154 (1002)
                      ++.+++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+...+ +..|.+++++++|++.+ |++.
T Consensus        16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~   92 (242)
T d1xwdc1          16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL   92 (242)
T ss_dssp             ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred             eCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence            345565 4554432  47889999999988766678888888999999888877544 44678888888888764 6777


Q ss_pred             CCCCcccccccccceeeeccccccCccc-cccccccccccccccCCCCCCCCCCcccCCCC-ccchhhccCccccccccc
Q 001867          155 GDIPESFGRFQKLEVISLVYNLLDGTIP-AFLGNISTLKMLNLSYNPFLPGRIPPELGNLT-NLEILWLTECNLVGEIPD  232 (1002)
Q Consensus       155 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~  232 (1002)
                      ...+..|.++++|++|++++|++....+ ..+..+..+..+..+++.+. ..-+..+..++ .++.|++++|+++...+.
T Consensus        93 ~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~  171 (242)
T d1xwdc1          93 YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQEIHNC  171 (242)
T ss_dssp             EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCCEECTT
T ss_pred             ccccccccccccccccccchhhhcccccccccccccccccccccccccc-cccccccccccccceeeecccccccccccc
Confidence            6777778888888888888888764333 22344455555555555541 11123344333 566666666666643333


Q ss_pred             cccccccc-chhcccCcccccccCcccccccceeeeeccCCcccCCCCCccccccccceeecc
Q 001867          233 SLGRLAKL-VDLDLALNNLVGAIPSSLTELASVVQIELYNNSLTGDLPTGWSNLTSLRLLDAS  294 (1002)
Q Consensus       233 ~~~~l~~L-~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  294 (1002)
                      .+. ..++ +.+++++|+++...+..|.++++|++|+|++|+++...+..|.++++|+++++.
T Consensus       172 ~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         172 AFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             TTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             ccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            333 3333 333455556654444455666666666666666664444455555555555543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=8.7e-18  Score=170.62  Aligned_cols=145  Identities=27%  Similarity=0.349  Sum_probs=76.4

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +..+++|++|+|++|++++..+  +..+++|+.|++++|+|++. + .+..+++|+.|++++|.+. .+ ..+..+++|+
T Consensus        64 l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~  137 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLE  137 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCC
T ss_pred             HhhCCCCCEEeCCCccccCccc--cccCcccccccccccccccc-c-ccccccccccccccccccc-cc-cccccccccc
Confidence            4455555555555555554221  34455555555555555432 1 3455555555555555554 22 2345555556


Q ss_pred             cccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEEeCc
Q 001867          481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLS  557 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls  557 (1002)
                      .+++++|.+++  +..+..+++|+.+++++|++++..|  ++++++|+.|+|++|+++ .+| .+.++++|++|+|+
T Consensus       138 ~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         138 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             EEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred             ccccccccccc--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEcc
Confidence            66666665552  2234555566666666666654322  555556666666666555 343 35556666666654

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.71  E-value=8.2e-18  Score=168.23  Aligned_cols=42  Identities=29%  Similarity=0.358  Sum_probs=16.7

Q ss_pred             cccccccccccccccccCCCCcccccccccCCeeecCCCcCC
Q 001867          473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       473 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      |..+++|+.|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus        98 F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          98 FLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             STTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             HhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence            333333333333333333333333444444444444444443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=2.9e-17  Score=165.23  Aligned_cols=142  Identities=22%  Similarity=0.333  Sum_probs=69.9

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      ++.+++|++|++++|++++..|  +.++++|+.|++++|.+....  .+.++++|+.|++++|.+...  ..+..+++|+
T Consensus        58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~  131 (199)
T d2omxa2          58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLN  131 (199)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred             cccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--ccccccccccccccccccccc--cccchhhhhH
Confidence            3445555555555555553322  445555555555555544322  244555555555555555421  2244455555


Q ss_pred             cccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCCccccccccEE
Q 001867          481 VLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYL  554 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L  554 (1002)
                      .|++++|+++. ++ .+..+++|+.|++++|++++..  .++++++|+.|++++|+++ .+| .++++++|++|
T Consensus       132 ~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L  199 (199)
T d2omxa2         132 RLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS-DIS-VLAKLTNLESL  199 (199)
T ss_dssp             EEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred             Hhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC-CCc-cccCCCCCCcC
Confidence            55555555542 22 3455555555555555555432  2455555555555555554 232 34555555543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=9.7e-18  Score=170.26  Aligned_cols=181  Identities=27%  Similarity=0.317  Sum_probs=150.0

Q ss_pred             ceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCc
Q 001867          385 ELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNN  464 (1002)
Q Consensus       385 ~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~  464 (1002)
                      ...+..+.+++.++.  ..+.+|++|++++|+++...  .+..+++|+.|++++|+|++..  .++.+++|+.|++++|+
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~  101 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK  101 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence            344555555544432  35778999999999998543  3788999999999999999765  36889999999999999


Q ss_pred             CCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCC
Q 001867          465 LSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPED  544 (1002)
Q Consensus       465 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~  544 (1002)
                      ++ .+| .++.+++|+.|++++|.++. + ..+..+++|+.+++++|.+++  +..++.+++|+.+++++|++++ ++ .
T Consensus       102 i~-~l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~  173 (210)
T d1h6ta2         102 VK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-P  173 (210)
T ss_dssp             CC-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-G
T ss_pred             cc-ccc-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccc-cc-c
Confidence            98 455 58889999999999999973 3 468899999999999999985  3467889999999999999985 54 3


Q ss_pred             ccccccccEEeCcceeeecccCCccccc-ccceEEecc
Q 001867          545 IGNLSVLNYLDLSNNRLSGRIPVGLQNL-KLNQLNVSN  581 (1002)
Q Consensus       545 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~l-~L~~l~ls~  581 (1002)
                      ++++++|+.|+|++|+++. +| .+..+ +|++|+|++
T Consensus       174 l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         174 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            8999999999999999984 66 57777 899999975

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=1.3e-20  Score=216.76  Aligned_cols=383  Identities=22%  Similarity=0.194  Sum_probs=249.6

Q ss_pred             cccccccccCCCCCCCCCCcccCCCCccchhhccCccccc----ccccccccccccchhcccCccccccc----Ccccc-
Q 001867          189 STLKMLNLSYNPFLPGRIPPELGNLTNLEILWLTECNLVG----EIPDSLGRLAKLVDLDLALNNLVGAI----PSSLT-  259 (1002)
Q Consensus       189 ~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~l~-  259 (1002)
                      .+|++||+++|++....+...+..+++++.|+|++|+++.    .+...+..+++|++|||++|.|+...    ...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            4689999999998654445557778899999999999873    33456778899999999999986322    22222 


Q ss_pred             cccceeeeeccCCcccCC----CCCccccccccceeeccccccCCCCCccC----CCC--CcceeecCCCcccCcC----
Q 001867          260 ELASVVQIELYNNSLTGD----LPTGWSNLTSLRLLDASMNDLTGPIPDDL----TRL--PLESLNLYENRLEGSL----  325 (1002)
Q Consensus       260 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~~--~L~~L~L~~N~l~~~~----  325 (1002)
                      ...+|+.|+|++|++++.    ++..+..+++|++|++++|+++......+    ...  ....+......+....    
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  161 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  161 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence            235799999999998754    34567788999999999999864211111    111  1333333333332111    


Q ss_pred             CcccCCCcccchhcccccccCCCC----CCCC-CCCCCCceEEccCccccCCC----ChhhhccCcccceeeecccccc-
Q 001867          326 PATIADSPGLYELRLFRNRLNGTL----PGDL-GKNSPLRWVDLSNNQFTGEI----PASLCEKGELEELLMIYNSFTG-  395 (1002)
Q Consensus       326 p~~~~~l~~L~~L~L~~N~l~~~~----p~~~-~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~-  395 (1002)
                      ...+.....++.+.++++.+....    ...+ ........+++..+.+....    ...+.....++.+.+.+|.+.. 
T Consensus       162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~  241 (460)
T d1z7xw1         162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  241 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence            111223345556666655443100    0000 12234667888887765321    1234456788899998887642 


Q ss_pred             ----CCCCcCcCCCCCcEEEccCccccCCC----CCcCCCCCcceEEEcccCcccCcccccc-----ccCCcccEEEccC
Q 001867          396 ----QLPDGLGHCQSLTRVRLGYNRLTGKV----PPLLWGLPHVYLLELTDNFLSGEISKNI-----AGAANLSLLIISK  462 (1002)
Q Consensus       396 ----~~p~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~Ls~  462 (1002)
                          ..+.......+++.+++++|.+....    ...+...+.++.+++++|.+.......+     .....|+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~  321 (460)
T d1z7xw1         242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  321 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence                22333445678999999999886332    2234567889999999999875433322     2345799999999


Q ss_pred             CcCCCCCcccc----ccccccccccccccccCCC----Cccccc-ccccCCeeecCCCcCCcc----ccccccccccccc
Q 001867          463 NNLSGSLPEEI----GFLKSLVVLSGSENKFTGS----LPESLT-NLAELGSLDLHANDLSGE----LPSSVSSWKKLNE  529 (1002)
Q Consensus       463 N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~  529 (1002)
                      |.++......+    ...++|+.|+|++|+++..    +++.+. ..+.|++|+|++|+|++.    +++.+..+++|++
T Consensus       322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~  401 (460)
T d1z7xw1         322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE  401 (460)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred             cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence            99875543434    3456899999999998742    333333 456799999999999853    4555677789999


Q ss_pred             ccccCcccccCCCCCc----c-ccccccEEeCcceeeecccCCcccc
Q 001867          530 LNLADNLFYGNIPEDI----G-NLSVLNYLDLSNNRLSGRIPVGLQN  571 (1002)
Q Consensus       530 L~Ls~N~l~~~ip~~~----~-~l~~L~~L~Ls~N~l~~~ip~~~~~  571 (1002)
                      |+|++|.|+......+    . +...|+.|++++|++....+..+..
T Consensus       402 L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~  448 (460)
T d1z7xw1         402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA  448 (460)
T ss_dssp             EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHH
T ss_pred             EECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHH
Confidence            9999999875433333    2 3347999999999988766655543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.67  E-value=6e-17  Score=162.85  Aligned_cols=180  Identities=22%  Similarity=0.250  Sum_probs=127.7

Q ss_pred             cchhcccccccCCCCCCCCCCCCCCceEEccCccccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccC
Q 001867          335 LYELRLFRNRLNGTLPGDLGKNSPLRWVDLSNNQFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGY  414 (1002)
Q Consensus       335 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~  414 (1002)
                      ...+.++.+.+++.++  ...+.+++.|++++|.++. + ..+..+++|++|++++|++++..|  ++++++|++|++++
T Consensus        20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~   93 (199)
T d2omxa2          20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN   93 (199)
T ss_dssp             HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccc
Confidence            3344555555554322  2345566777777777763 2 235667777777777777765433  77788888888888


Q ss_pred             ccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCc
Q 001867          415 NRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLP  494 (1002)
Q Consensus       415 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  494 (1002)
                      |.+... + .+.+++.|+.|++++|.+....  .+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++ ++
T Consensus        94 n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~  166 (199)
T d2omxa2          94 NQIADI-T-PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK  166 (199)
T ss_dssp             SCCCCC-G-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG
T ss_pred             cccccc-c-cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-Cc
Confidence            887643 2 3677888888888888876543  4677888889999998887 333 57888899999999999985 33


Q ss_pred             ccccccccCCeeecCCCcCCcccccccccccccccc
Q 001867          495 ESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNEL  530 (1002)
Q Consensus       495 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  530 (1002)
                       .++++++|++|++++|++++ +| .++++++|+.|
T Consensus       167 -~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         167 -PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             -GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             -cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence             48889999999999999985 33 47788888765

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=2.4e-14  Score=137.65  Aligned_cols=109  Identities=17%  Similarity=0.120  Sum_probs=52.3

Q ss_pred             CcCCCCCcEEEccCccccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccc
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLV  480 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  480 (1002)
                      +.++.+|++|+|++|+|+. ++..+..+++|+.|+|++|.|+..  ..+..+++|+.|++++|++++..+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            3455566666666666663 344455555555555555555532  2344455555555555555432222233444444


Q ss_pred             cccccccccCCCCc--ccccccccCCeeecCCCcC
Q 001867          481 VLSGSENKFTGSLP--ESLTNLAELGSLDLHANDL  513 (1002)
Q Consensus       481 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l  513 (1002)
                      .|++++|+++. ++  ..+..+++|++|++++|++
T Consensus        91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i  124 (162)
T d1a9na_          91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPV  124 (162)
T ss_dssp             EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGG
T ss_pred             cceeccccccc-cccccccccccccchhhcCCCcc
Confidence            44444444441 22  1333344444444444444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=2.7e-14  Score=137.26  Aligned_cols=106  Identities=18%  Similarity=0.195  Sum_probs=47.5

Q ss_pred             CcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccc
Q 001867          453 ANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNL  532 (1002)
Q Consensus       453 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  532 (1002)
                      .+++.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|+.|+|
T Consensus        18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L   94 (162)
T d1a9na_          18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   94 (162)
T ss_dssp             TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence            33444444444444 23333344444444444444444 222 2444444555555555554433333444455555555


Q ss_pred             cCcccccCCC--CCccccccccEEeCcceeee
Q 001867          533 ADNLFYGNIP--EDIGNLSVLNYLDLSNNRLS  562 (1002)
Q Consensus       533 s~N~l~~~ip--~~~~~l~~L~~L~Ls~N~l~  562 (1002)
                      ++|+++ .++  ..+..+++|++|++++|+++
T Consensus        95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cccccc-ccccccccccccccchhhcCCCccc
Confidence            555544 222  23444555555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.45  E-value=7e-14  Score=127.62  Aligned_cols=87  Identities=26%  Similarity=0.305  Sum_probs=35.8

Q ss_pred             cccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCC-CCCccccccc
Q 001867          473 IGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNI-PEDIGNLSVL  551 (1002)
Q Consensus       473 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~i-p~~~~~l~~L  551 (1002)
                      ++.+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++. | .++.+++|+.|++++|+|++.. +..++.+++|
T Consensus        16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L   92 (124)
T d1dcea3          16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL   92 (124)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence            334444444444444443 2333344444444444444444421 2 2444444444444444444211 1234444444


Q ss_pred             cEEeCcceeee
Q 001867          552 NYLDLSNNRLS  562 (1002)
Q Consensus       552 ~~L~Ls~N~l~  562 (1002)
                      ++|++++|+++
T Consensus        93 ~~L~l~~N~i~  103 (124)
T d1dcea3          93 VLLNLQGNSLC  103 (124)
T ss_dssp             CEEECTTSGGG
T ss_pred             CEEECCCCcCC
Confidence            44444444444

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.44  E-value=7.8e-14  Score=127.31  Aligned_cols=101  Identities=28%  Similarity=0.332  Sum_probs=51.7

Q ss_pred             EEEcccCcccCccccccccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCc
Q 001867          433 LLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHAND  512 (1002)
Q Consensus       433 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  512 (1002)
                      +|+|++|.|+.. + .+..+.+|+.|++++|+++ .+|+.++.+++|+.|++++|+|++ +| .+..+++|+.|++++|+
T Consensus         2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            455555555432 1 2455555555555555555 344455555555555555555552 33 25555555555555555


Q ss_pred             CCccc-ccccccccccccccccCcccc
Q 001867          513 LSGEL-PSSVSSWKKLNELNLADNLFY  538 (1002)
Q Consensus       513 l~~~~-p~~~~~l~~L~~L~Ls~N~l~  538 (1002)
                      |++.. +..++.+++|+.|++++|.++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            55332 134455555555555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=2.1e-15  Score=160.35  Aligned_cols=209  Identities=17%  Similarity=0.160  Sum_probs=120.4

Q ss_pred             CCCCCceEEccCccccCCC-ChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCCcCCCCCcceE
Q 001867          355 KNSPLRWVDLSNNQFTGEI-PASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPPLLWGLPHVYL  433 (1002)
Q Consensus       355 ~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  433 (1002)
                      ...+|++|||++|.+++.. +..+..+++|++|+++++.+++..+..++.+++|++|+++++.                 
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~-----------------  106 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS-----------------  106 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB-----------------
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccc-----------------
Confidence            4457888888888876432 3334445555555555555554444445555555555555531                 


Q ss_pred             EEcccCcccCcc-ccccccCCcccEEEccCC-cCCCC-Ccccccc-cccccccccccc--ccCCC-CcccccccccCCee
Q 001867          434 LELTDNFLSGEI-SKNIAGAANLSLLIISKN-NLSGS-LPEEIGF-LKSLVVLSGSEN--KFTGS-LPESLTNLAELGSL  506 (1002)
Q Consensus       434 L~L~~N~i~~~~-~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L  506 (1002)
                            .++... ..-...+++|+.|+++++ +++.. +...+.. .++|+.|+++++  .++.. +.....++++|++|
T Consensus       107 ------~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L  180 (284)
T d2astb2         107 ------GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL  180 (284)
T ss_dssp             ------SCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred             ------cccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccc
Confidence                  222111 111233455555555553 23211 1112222 246666666653  23321 22233557788888


Q ss_pred             ecCCC-cCCcccccccccccccccccccC-cccccCCCCCccccccccEEeCcceeeecccCCccccc--ccceEEeccc
Q 001867          507 DLHAN-DLSGELPSSVSSWKKLNELNLAD-NLFYGNIPEDIGNLSVLNYLDLSNNRLSGRIPVGLQNL--KLNQLNVSNN  582 (1002)
Q Consensus       507 ~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ip~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l--~L~~l~ls~N  582 (1002)
                      |+++| .+++..+..+..+++|++|+|++ +.+++.....++++++|+.|+++++ ++   ...+..+  .+..|.++.+
T Consensus       181 ~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L~i~~~  256 (284)
T d2astb2         181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCS  256 (284)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCC
T ss_pred             ccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCccccccCc
Confidence            88875 47777777788888888888888 4677666667888888888888887 22   2344444  4667778888


Q ss_pred             cCcCCCCh
Q 001867          583 RLSGELPS  590 (1002)
Q Consensus       583 ~l~g~~p~  590 (1002)
                      ++++..+.
T Consensus       257 ~ls~~~~~  264 (284)
T d2astb2         257 HFTTIARP  264 (284)
T ss_dssp             CSCCTTCS
T ss_pred             cCCCCCCC
Confidence            88766543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=1.7e-15  Score=161.06  Aligned_cols=221  Identities=21%  Similarity=0.221  Sum_probs=99.6

Q ss_pred             eeeeccCCcccCCCCCcccccc--ccceeeccccccCCCCCccCCCCCcceeecCCCcccCc-CCcccCCCcccchhccc
Q 001867          265 VQIELYNNSLTGDLPTGWSNLT--SLRLLDASMNDLTGPIPDDLTRLPLESLNLYENRLEGS-LPATIADSPGLYELRLF  341 (1002)
Q Consensus       265 ~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~  341 (1002)
                      +.+|++++.+..   +.+..+.  .+..+.++...+.......+....|++|+|++|.+... +...+..+++|++|+++
T Consensus         3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~   79 (284)
T d2astb2           3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE   79 (284)
T ss_dssp             SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred             CEEECCCCCCCc---hHHHHHHhccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence            357777776642   2222221  23445555555543333444444577777777766532 23334445555555555


Q ss_pred             ccccCCCCCCCCCCCCCCceEEccCc-cccCCCChhhhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCc-cccC
Q 001867          342 RNRLNGTLPGDLGKNSPLRWVDLSNN-QFTGEIPASLCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYN-RLTG  419 (1002)
Q Consensus       342 ~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~  419 (1002)
                      +|.+++..+..+..+++|++|+++++ .+++..                       +...+.++++|++|+++++ +++.
T Consensus        80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~-----------------------l~~l~~~~~~L~~L~ls~c~~~~~  136 (284)
T d2astb2          80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-----------------------LQTLLSSCSRLDELNLSWCFDFTE  136 (284)
T ss_dssp             TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH-----------------------HHHHHHHCTTCCEEECCCCTTCCH
T ss_pred             ccCCCcHHHHHHhcCCCCcCccccccccccccc-----------------------cchhhHHHHhcccccccccccccc
Confidence            55544433344444445555555442 232110                       1111234566666666664 2321


Q ss_pred             C-CCCcCC-CCCcceEEEcccC--cccCc-cccccccCCcccEEEccCC-cCCCCCcccccccccccccccccc-ccCCC
Q 001867          420 K-VPPLLW-GLPHVYLLELTDN--FLSGE-ISKNIAGAANLSLLIISKN-NLSGSLPEEIGFLKSLVVLSGSEN-KFTGS  492 (1002)
Q Consensus       420 ~-~p~~~~-~l~~L~~L~L~~N--~i~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~  492 (1002)
                      . ++..+. ..++|+.|+++++  .++.. +...+..+++|+.|++++| .+++.....++.+++|++|+++++ .+++.
T Consensus       137 ~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~  216 (284)
T d2astb2         137 KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE  216 (284)
T ss_dssp             HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGG
T ss_pred             ccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChH
Confidence            0 011111 1244555555443  12211 1111233455555555553 344444444555555555555552 34433


Q ss_pred             CcccccccccCCeeecCCC
Q 001867          493 LPESLTNLAELGSLDLHAN  511 (1002)
Q Consensus       493 ~p~~~~~l~~L~~L~Ls~N  511 (1002)
                      ....++++++|+.|+++++
T Consensus       217 ~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         217 TLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GGGGGGGCTTCCEEECTTS
T ss_pred             HHHHHhcCCCCCEEeeeCC
Confidence            3334444555555555544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.42  E-value=2.7e-15  Score=164.90  Aligned_cols=187  Identities=25%  Similarity=0.281  Sum_probs=119.5

Q ss_pred             CcCCCCCcEEEccCccccCCCC----CcCCCCCcceEEEcccCcccCccccc-------------cccCCcccEEEccCC
Q 001867          401 LGHCQSLTRVRLGYNRLTGKVP----PLLWGLPHVYLLELTDNFLSGEISKN-------------IAGAANLSLLIISKN  463 (1002)
Q Consensus       401 l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L~~L~Ls~N  463 (1002)
                      +..+++|+.|+|++|.++....    ..+...++|+.|++++|.+.......             ......|+.+++++|
T Consensus        89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n  168 (344)
T d2ca6a1          89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN  168 (344)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred             HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence            3445667777777776654322    22334567777777777654221111             124567788888888


Q ss_pred             cCCCC----CccccccccccccccccccccCCC-----CcccccccccCCeeecCCCcCCcc----cccccccccccccc
Q 001867          464 NLSGS----LPEEIGFLKSLVVLSGSENKFTGS-----LPESLTNLAELGSLDLHANDLSGE----LPSSVSSWKKLNEL  530 (1002)
Q Consensus       464 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L  530 (1002)
                      +++..    +...+...+.|+.|++++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|++|
T Consensus       169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L  248 (344)
T d2ca6a1         169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL  248 (344)
T ss_dssp             CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred             cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhh
Confidence            77632    222345567888888888887631     234566778888888888887643    34556778888888


Q ss_pred             cccCcccccCCCCCc----cc--cccccEEeCcceeeeccc----CCccc-cc-ccceEEeccccCcCC
Q 001867          531 NLADNLFYGNIPEDI----GN--LSVLNYLDLSNNRLSGRI----PVGLQ-NL-KLNQLNVSNNRLSGE  587 (1002)
Q Consensus       531 ~Ls~N~l~~~ip~~~----~~--l~~L~~L~Ls~N~l~~~i----p~~~~-~l-~L~~l~ls~N~l~g~  587 (1002)
                      +|++|.|++.-...+    ..  ...|++|||++|+++..-    ...+. +. +|+.|+|++|+++..
T Consensus       249 ~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             hhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence            888888875422222    22  356889999999887532    22332 33 688999999998754

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.40  E-value=1.7e-15  Score=166.37  Aligned_cols=233  Identities=24%  Similarity=0.203  Sum_probs=135.5

Q ss_pred             cceeecCCCcccCc----CCcccCCCcccchhcccccccCCCC----------CCCCCCCCCCceEEccCccccCCCChh
Q 001867          311 LESLNLYENRLEGS----LPATIADSPGLYELRLFRNRLNGTL----------PGDLGKNSPLRWVDLSNNQFTGEIPAS  376 (1002)
Q Consensus       311 L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----------p~~~~~l~~L~~L~Ls~N~l~~~~p~~  376 (1002)
                      ++.|+|++|.+...    +...+...++|+.|+++++......          ...+...++|+.|+|++|.++......
T Consensus        33 l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  112 (344)
T d2ca6a1          33 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP  112 (344)
T ss_dssp             CCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHH
T ss_pred             CCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccc
Confidence            77777777777532    2233445566666666655443211          011233445555555555554332111


Q ss_pred             hhccCcccceeeeccccccCCCCcCcCCCCCcEEEccCccccCCCCC-------------cCCCCCcceEEEcccCcccC
Q 001867          377 LCEKGELEELLMIYNSFTGQLPDGLGHCQSLTRVRLGYNRLTGKVPP-------------LLWGLPHVYLLELTDNFLSG  443 (1002)
Q Consensus       377 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~i~~  443 (1002)
                      +                    ...+..+++|+.|++++|.++.....             .....+.|+.+++++|.+..
T Consensus       113 l--------------------~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~  172 (344)
T d2ca6a1         113 L--------------------IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN  172 (344)
T ss_dssp             H--------------------HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred             h--------------------hhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence            1                    11222345555555555544311000             01234556666666666653


Q ss_pred             c----cccccccCCcccEEEccCCcCCCC-----CccccccccccccccccccccCCC----CcccccccccCCeeecCC
Q 001867          444 E----ISKNIAGAANLSLLIISKNNLSGS-----LPEEIGFLKSLVVLSGSENKFTGS----LPESLTNLAELGSLDLHA  510 (1002)
Q Consensus       444 ~----~~~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~  510 (1002)
                      .    +...+.....|+.|+|++|++...     +...+..+++|+.|+|++|.++..    +...+...++|++|+|++
T Consensus       173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~  252 (344)
T d2ca6a1         173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND  252 (344)
T ss_dssp             GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred             cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence            2    223345567788888888887632     233456778888888888887632    345567788899999999


Q ss_pred             CcCCccccccc----cc--ccccccccccCcccccC----CCCCcc-ccccccEEeCcceeeec
Q 001867          511 NDLSGELPSSV----SS--WKKLNELNLADNLFYGN----IPEDIG-NLSVLNYLDLSNNRLSG  563 (1002)
Q Consensus       511 N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~----ip~~~~-~l~~L~~L~Ls~N~l~~  563 (1002)
                      |.|++.-...+    ..  .+.|+.|++++|.++..    +...+. ++++|+.|+|++|++..
T Consensus       253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             CccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            98886544333    22  35688999999988743    333443 56789999999999874

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.34  E-value=1.4e-14  Score=144.55  Aligned_cols=111  Identities=20%  Similarity=0.224  Sum_probs=49.0

Q ss_pred             cccCCcccEEEccCCcCCCCCccccccccccccccccccccCCCCcccccccccCCeeecCCCcCCcccccccccccccc
Q 001867          449 IAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSGSENKFTGSLPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLN  528 (1002)
Q Consensus       449 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  528 (1002)
                      +..+++|+.|+|++|+++ .++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++..  ..+..+++|+
T Consensus        44 l~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~  118 (198)
T d1m9la_          44 LSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR  118 (198)
T ss_dssp             HHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred             HhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccccc
Confidence            333444444444444443 222 2444444444444444444 3333333334445555555544432  1244445555


Q ss_pred             cccccCcccccCCC--CCccccccccEEeCcceeeeccc
Q 001867          529 ELNLADNLFYGNIP--EDIGNLSVLNYLDLSNNRLSGRI  565 (1002)
Q Consensus       529 ~L~Ls~N~l~~~ip--~~~~~l~~L~~L~Ls~N~l~~~i  565 (1002)
                      .|+|++|+++ .++  ..+..+++|+.|+|++|++....
T Consensus       119 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~  156 (198)
T d1m9la_         119 VLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             EEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred             ccccccchhc-cccccccccCCCccceeecCCCccccCc
Confidence            5555555544 222  23445555555555555554433

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.28  E-value=8.5e-14  Score=138.71  Aligned_cols=144  Identities=24%  Similarity=0.289  Sum_probs=98.8

Q ss_pred             CCcEEEccCc--cccCCCCCcCCCCCcceEEEcccCcccCccccccccCCcccEEEccCCcCCCCCcccccccccccccc
Q 001867          406 SLTRVRLGYN--RLTGKVPPLLWGLPHVYLLELTDNFLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLS  483 (1002)
Q Consensus       406 ~L~~L~L~~N--~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  483 (1002)
                      .++.+++.++  .+. .+|..+..+++|+.|+|++|+|+.+  ..+.++++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc--ccccCCccccChhhcccccc-cccccccccccccccc
Confidence            3455566544  232 3445677778888888888888754  24777888888888888887 5666666667788888


Q ss_pred             ccccccCCCCcccccccccCCeeecCCCcCCcccc-cccccccccccccccCcccccCCCCC----------cccccccc
Q 001867          484 GSENKFTGSLPESLTNLAELGSLDLHANDLSGELP-SSVSSWKKLNELNLADNLFYGNIPED----------IGNLSVLN  552 (1002)
Q Consensus       484 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip~~----------~~~l~~L~  552 (1002)
                      +++|+++. + ..+..+++|+.|+|++|+++.... ..++.+++|+.|+|++|.++...+..          +..+++|+
T Consensus       100 l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~  177 (198)
T d1m9la_         100 ISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK  177 (198)
T ss_dssp             CSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred             cccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcC
Confidence            88888873 3 347777888888888888875432 46777888888888888877544332          44566666


Q ss_pred             EEe
Q 001867          553 YLD  555 (1002)
Q Consensus       553 ~L~  555 (1002)
                      .||
T Consensus       178 ~LD  180 (198)
T d1m9la_         178 KLD  180 (198)
T ss_dssp             EES
T ss_pred             EeC
Confidence            665

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=3.2e-12  Score=121.64  Aligned_cols=105  Identities=20%  Similarity=0.142  Sum_probs=58.9

Q ss_pred             ccccccccccCCCCcccccccccCCeeecCCC-cCCcccccccccccccccccccCcccccCCCCCccccccccEEeCcc
Q 001867          480 VVLSGSENKFTGSLPESLTNLAELGSLDLHAN-DLSGELPSSVSSWKKLNELNLADNLFYGNIPEDIGNLSVLNYLDLSN  558 (1002)
Q Consensus       480 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~Ls~  558 (1002)
                      ..++.+++.++ ..|..+..+++|+.|++++| .|+...+..|.++++|+.|+|++|+|++..|.+|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            34455555554 34555555556666666544 35555555566666666666666666644455566666666666666


Q ss_pred             eeeecccCCcccccccceEEeccccCc
Q 001867          559 NRLSGRIPVGLQNLKLNQLNVSNNRLS  585 (1002)
Q Consensus       559 N~l~~~ip~~~~~l~L~~l~ls~N~l~  585 (1002)
                      |+|+...+..+..++|+.|+|++|++.
T Consensus        90 N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          90 NALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             SCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             CCCcccChhhhccccccccccCCCccc
Confidence            666643333444445666666666653

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=1.6e-11  Score=116.76  Aligned_cols=107  Identities=21%  Similarity=0.159  Sum_probs=64.0

Q ss_pred             CCcEEEccCccccCCCCCcCCCCCcceEEEcccC-cccCccccccccCCcccEEEccCCcCCCCCccccccccccccccc
Q 001867          406 SLTRVRLGYNRLTGKVPPLLWGLPHVYLLELTDN-FLSGEISKNIAGAANLSLLIISKNNLSGSLPEEIGFLKSLVVLSG  484 (1002)
Q Consensus       406 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  484 (1002)
                      ..+.++.+++.+. ..|..+..+++|+.|++++| .|+.+.+..|.++++|+.|+|++|+|+...|..|..+++|+.|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3445566666555 34555555666666666544 355555556666666666666666666555566666666666666


Q ss_pred             cccccCCCCcccccccccCCeeecCCCcCC
Q 001867          485 SENKFTGSLPESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       485 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      ++|+|+...+..|.. .+|+.|+|++|++.
T Consensus        88 s~N~l~~l~~~~~~~-~~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQG-LSLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhcc-ccccccccCCCccc
Confidence            666666333333333 35777777777764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.51  E-value=4.5e-09  Score=100.15  Aligned_cols=82  Identities=23%  Similarity=0.224  Sum_probs=46.8

Q ss_pred             ccccccccccccccccCCC--CcccccccccCCeeecCCCcCCcccccccccccccccccccCcccccCCCCC-------
Q 001867          474 GFLKSLVVLSGSENKFTGS--LPESLTNLAELGSLDLHANDLSGELPSSVSSWKKLNELNLADNLFYGNIPED-------  544 (1002)
Q Consensus       474 ~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~-------  544 (1002)
                      ..+++|++|+|++|+|+..  ++..+..+++|+.|||++|.++...+-.+....+|+.|+|++|.+++.....       
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i  141 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI  141 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence            4456666666666666632  1234556666666677766666443333333445666777777666444322       


Q ss_pred             ccccccccEEe
Q 001867          545 IGNLSVLNYLD  555 (1002)
Q Consensus       545 ~~~l~~L~~L~  555 (1002)
                      +..+++|+.||
T Consensus       142 ~~~~P~L~~LD  152 (162)
T d1koha1         142 RERFPKLLRLD  152 (162)
T ss_dssp             HTTSTTCCEET
T ss_pred             HHHCCCCCEEC
Confidence            44567777665

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=5.6e-08  Score=92.33  Aligned_cols=66  Identities=32%  Similarity=0.215  Sum_probs=26.8

Q ss_pred             ccccccccccccCCCCCCC-CCCcccCCCCccchhhccCcccccccccccccccccchhcccCcccc
Q 001867          186 GNISTLKMLNLSYNPFLPG-RIPPELGNLTNLEILWLTECNLVGEIPDSLGRLAKLVDLDLALNNLV  251 (1002)
Q Consensus       186 ~~l~~L~~L~Ls~N~~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~  251 (1002)
                      .++++|++|+|++|++..- .++..+..+++|+.|+|++|+|+...+-.+.....|+.|++++|.+.
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            3444455555555544211 01122333444444444444444222212222334555555555554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.23  E-value=1.6e-06  Score=89.35  Aligned_cols=146  Identities=16%  Similarity=0.066  Sum_probs=99.8

Q ss_pred             HHhcCCCcCCeeeecCCccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCce
Q 001867          680 EILDGLDEDNVIGSGSSGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNI  758 (1002)
Q Consensus       680 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni  758 (1002)
                      ...+.|+..+..+.++.+.||++.. +++.+.+|+....                 .......+.+|+..++.+. +--+
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~-----------------~~~~~~~~~~E~~~l~~l~~~vpv   72 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSR-----------------YKGTTYDVEREKDMMLWLEGKLPV   72 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGG-----------------GTTSTTCHHHHHHHHHHHTTTSCC
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCC-----------------cccchhhHHHHHHHHHHHhccCCC
Confidence            3355666666555555678999865 4567788876332                 1122345778888887764 4336


Q ss_pred             eeeeeEEecCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------
Q 001867          759 VKLWCCCTTRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHDC--------------------  818 (1002)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------  818 (1002)
                      .+++++..+++..++||++++|.++.+....       ......++.+++..++.||+..                    
T Consensus        73 P~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~  145 (263)
T d1j7la_          73 PKVLHFERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL  145 (263)
T ss_dssp             CCEEEEEEETTEEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred             CcEEEEEecCCceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence            7788888888899999999998887654431       1123345666777777777531                    


Q ss_pred             ------------------------------------CCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          819 ------------------------------------VPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       819 ------------------------------------~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                                                          ...++|+|+.|.||++++++.+.|+||+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                                02478999999999999776667999998763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.91  E-value=1e-05  Score=82.66  Aligned_cols=131  Identities=18%  Similarity=0.124  Sum_probs=87.5

Q ss_pred             eeeecCC-ccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC--CCceeeeeeEEe
Q 001867          690 VIGSGSS-GKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR--HKNIVKLWCCCT  766 (1002)
Q Consensus       690 ~LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  766 (1002)
                      .+..|.. +.||++...++..+.+|.....                    ....+..|+..++.+.  .-.+.+++++..
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~--------------------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~   76 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------------------ALNELQDEAARLSWLATTGVPCAAVLDVVT   76 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC--------------------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc--------------------CHhHHHHHHHHHHHHHhcCCCCCceeeecc
Confidence            3445543 5789998877888888975221                    1234777888887764  233677888888


Q ss_pred             cCCeeeEEEeccCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------
Q 001867          767 TRDCKLLVYEYMPNGSLGDLLHSCKGGLLDWPTRYKIIVDAAEGLSYLHHD-----------------------------  817 (1002)
Q Consensus       767 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------------------------  817 (1002)
                      +++..++||+|++|.++.+..       .+.   ...+.+++..++-||+.                             
T Consensus        77 ~~~~~~~v~~~i~G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (255)
T d1nd4a_          77 EAGRDWLLLGEVPGQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ  146 (255)
T ss_dssp             CSSCEEEEEECCSSEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred             cccceEEEEEeeecccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhcc
Confidence            888899999999886654321       111   12233444445555531                             


Q ss_pred             --------------------------CCCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          818 --------------------------CVPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       818 --------------------------~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                                                ..+.++|+|+.|.||+++.+..+.|+||+.+..
T Consensus       147 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         147 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                                      012479999999999999776678999997753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.27  E-value=2.5e-05  Score=73.82  Aligned_cols=16  Identities=25%  Similarity=0.318  Sum_probs=7.9

Q ss_pred             ccccCCeeecCCCcCC
Q 001867          499 NLAELGSLDLHANDLS  514 (1002)
Q Consensus       499 ~l~~L~~L~Ls~N~l~  514 (1002)
                      ..+.|+.|+|++|.++
T Consensus        70 ~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          70 TSPSLRVLNVESNFLT   85 (167)
T ss_dssp             HCSSCCEEECCSSBCC
T ss_pred             hcccccceeeehhhcc
Confidence            3344555555555544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.27  E-value=3.2e-05  Score=73.06  Aligned_cols=66  Identities=20%  Similarity=0.116  Sum_probs=34.2

Q ss_pred             cccCCcccEEEccCCcCCCCC----ccccccccccccccccccccCCC----CcccccccccCCeeecCCCcCC
Q 001867          449 IAGAANLSLLIISKNNLSGSL----PEEIGFLKSLVVLSGSENKFTGS----LPESLTNLAELGSLDLHANDLS  514 (1002)
Q Consensus       449 ~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  514 (1002)
                      +...++|+.|+|++|.+....    .+.+...+.|+.|+|++|.++..    +-..+..-+.|++|+|++|.+.
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            334455566666666554221    12333455666666666666532    1223444455666666666544

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.24  E-value=0.00039  Score=75.27  Aligned_cols=83  Identities=14%  Similarity=0.129  Sum_probs=48.4

Q ss_pred             CCeeeecCCccEEEEEEcC-CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-C--Cceeeeee
Q 001867          688 DNVIGSGSSGKVYKVVLSN-GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-H--KNIVKLWC  763 (1002)
Q Consensus       688 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~  763 (1002)
                      .+.||.|....||++...+ ++.|+||.-.+....        ....  ......+...|.+.++.+. +  ..+++++.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~--------~g~~--~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~  100 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKV--------VGES--WPLTIDRARIESSALIRQGEHVPHLVPRVFY  100 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC----------CC--CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcc--------cCCC--CCCCHHHHHHHHHHHHHhhhhCCCCcceEEE
Confidence            3568999999999998644 678999975321100        0000  0112234556777777663 2  34555654


Q ss_pred             EEecCCeeeEEEeccCCCC
Q 001867          764 CCTTRDCKLLVYEYMPNGS  782 (1002)
Q Consensus       764 ~~~~~~~~~lv~e~~~~g~  782 (1002)
                      +  +++..++|||++++..
T Consensus       101 ~--d~~~~~lvmE~L~~~~  117 (392)
T d2pula1         101 S--DTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             E--ETTTTEEEECCCTTSE
T ss_pred             E--cCCCCEEEEeccCCcc
Confidence            4  3445679999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.60  E-value=0.0021  Score=67.32  Aligned_cols=135  Identities=13%  Similarity=0.106  Sum_probs=76.8

Q ss_pred             CccEEEEEEcCCcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCCCCce--eeee-----eEEecC
Q 001867          696 SGKVYKVVLSNGEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIRHKNI--VKLW-----CCCTTR  768 (1002)
Q Consensus       696 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~  768 (1002)
                      --.||++..++|+.|++|+..++.                  ...+++..|...+..+....+  +..+     ..+...
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~------------------~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~   96 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER------------------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ   96 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT------------------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC------------------CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeee
Confidence            358999999999999999874431                  234567788888877742211  1111     222345


Q ss_pred             CeeeEEEeccCCCChh-----hhh---------hh----cC---CCCCCHH-------------------HHHHHHHHHH
Q 001867          769 DCKLLVYEYMPNGSLG-----DLL---------HS----CK---GGLLDWP-------------------TRYKIIVDAA  808 (1002)
Q Consensus       769 ~~~~lv~e~~~~g~L~-----~~l---------~~----~~---~~~l~~~-------------------~~~~i~~qi~  808 (1002)
                      +..+.++++++|..+.     .+-         +.    ..   ....+..                   ....+...+.
T Consensus        97 ~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (325)
T d1zyla1          97 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  176 (325)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             eEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHH
Confidence            6778999999764331     110         00    00   0111111                   1111222222


Q ss_pred             HHHHHHhh----cCCCCeeeCCCCCCcEEECCCCCeEEccccCccc
Q 001867          809 EGLSYLHH----DCVPSIVHRDVKSNNILLDGDFGARVADFGVAKV  850 (1002)
Q Consensus       809 ~~L~~LH~----~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl~~~  850 (1002)
                      ..++.+..    ....++||+|+.+.||+++.+  ..++||+-+..
T Consensus       177 ~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         177 ELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            33333322    123478999999999999743  46899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.23  E-value=0.0055  Score=66.00  Aligned_cols=72  Identities=19%  Similarity=0.226  Sum_probs=47.9

Q ss_pred             CeeeecCCccEEEEEEcC--------CcEEEEEEeeccccccccCCCccccccccchhhHHhHHHHHHHHhcCC-CCcee
Q 001867          689 NVIGSGSSGKVYKVVLSN--------GEAVAVKKLWRGMSKECESGCDVEKGQVQDQVQDDGFQAEVETLGKIR-HKNIV  759 (1002)
Q Consensus       689 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  759 (1002)
                      +.|+.|-.-.+|++...+        .+.|.+++.- .                  ........+|..+++.+. +.-..
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~------------------~~~~idr~~E~~i~~~ls~~gl~P  108 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N------------------PETESHLVAESVIFTLLSERHLGP  108 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S------------------CCCHHHHHHHHHHHHHHHHTTSSS
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C------------------cchhhHHHHHHHHHHHHHhCCCCC
Confidence            578889999999998754        2456666651 1                  011234567888888875 44345


Q ss_pred             eeeeEEecCCeeeEEEeccCCCCh
Q 001867          760 KLWCCCTTRDCKLLVYEYMPNGSL  783 (1002)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~g~L  783 (1002)
                      ++++++..    .+|+||++|..+
T Consensus       109 kll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_         109 KLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             CEEEEETT----EEEECCCCEEEC
T ss_pred             eEEEEcCC----ceEEEEeccccC
Confidence            77777643    589999987544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.20  E-value=0.00024  Score=66.67  Aligned_cols=16  Identities=31%  Similarity=0.279  Sum_probs=8.1

Q ss_pred             ccccCCeeecCCCcCC
Q 001867          499 NLAELGSLDLHANDLS  514 (1002)
Q Consensus       499 ~l~~L~~L~Ls~N~l~  514 (1002)
                      ..+.++.+++++|.++
T Consensus        72 ~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          72 VNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HCSSCCEEECCSSCCC
T ss_pred             hcccchhhhhcccccc
Confidence            3445555555555554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.10  E-value=0.00037  Score=65.38  Aligned_cols=64  Identities=22%  Similarity=0.217  Sum_probs=28.7

Q ss_pred             cCCcccEEEccCCcCCCCCc----cccccccccccccccccccCCC----CcccccccccCCee--ecCCCcCC
Q 001867          451 GAANLSLLIISKNNLSGSLP----EEIGFLKSLVVLSGSENKFTGS----LPESLTNLAELGSL--DLHANDLS  514 (1002)
Q Consensus       451 ~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L--~Ls~N~l~  514 (1002)
                      ..+.|+.|++++|.++....    ..+...++++.+++++|.++..    +...+...++|+.+  ++++|.+.
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence            44455555555555442211    1223345566666666655421    12334444555543  33344443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.23  E-value=0.012  Score=61.10  Aligned_cols=30  Identities=27%  Similarity=0.404  Sum_probs=27.0

Q ss_pred             CCeeeCCCCCCcEEECCCCCeEEccccCcc
Q 001867          820 PSIVHRDVKSNNILLDGDFGARVADFGVAK  849 (1002)
Q Consensus       820 ~~iiHrDlk~~NIll~~~~~~kl~DfGl~~  849 (1002)
                      .++||+|+.+.||+++.+...-+.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            489999999999999988777899999875